CLogP	Clinical Information	Clinical Information_clinical_phase	ID	IDNUMBER	PSA	Saltdata	Source1536wWell	any_phase	at_n_Br	at_n_C	at_n_Cl	at_n_F	at_n_H	at_n_I	at_n_N	at_n_O	at_n_P	at_n_S	availability	broad_clinical_phase	broad_disease_area	broad_indication	broad_moa	broad_pert_iname	broad_target	canonical_smiles	chebi_id	chembl_alogp	chembl_atc_classifications	chembl_clinical_phase	chembl_cx_logp	chembl_id	chembl_indication	classyfire_alternative_parents	classyfire_ancestors	classyfire_class	classyfire_classification_version	classyfire_description	classyfire_direct_parent	classyfire_external_descriptors	classyfire_intermediate_nodes	classyfire_kingdom	classyfire_molecular_framework	classyfire_predicted_chebi_terms	classyfire_predicted_lipidmaps_terms	classyfire_subclass	classyfire_substituents	classyfire_superclass	clinical_phase	clinical_phase_description	compound_name	comptox_id	date_broad_drug_list	date_chembl_search	date_classyfire	date_dictionary_np_search	date_drugbank_search	date_drugcentral_search	date_npatlas	date_npclassifier	date_pubchem_name_search	date_pubchem_parent_cid_search	date_pubchem_structure_search	date_unichem_search	date_wikidata_lotus_search	drugcentral_id	fg_n_acyl_halide	fg_n_aldehyde	fg_n_amide	fg_n_amidinium	fg_n_amino_acid	fg_n_amino_hexose	fg_n_anhydride	fg_n_aniline	fg_n_aromatic_amine	fg_n_azo_nitrogen	fg_n_azole	fg_n_carbamate	fg_n_carbo_thioester	fg_n_carbonyl	fg_n_carboxylic_acid	fg_n_cyanamide	fg_n_deoxy_hexose	fg_n_diazo_nitrogen	fg_n_enamine	fg_n_enole	fg_n_ester	fg_n_flavan	fg_n_flavone	fg_n_general_amide	fg_n_glycoside	fg_n_guanidine	fg_n_hexose	fg_n_hydrazine	fg_n_hydrazone	fg_n_hydroxy	fg_n_hydroxy_aliphatic	fg_n_hydroxy_aromatic	fg_n_imine_schiff_base	fg_n_isoflavan	fg_n_isoflavone	fg_n_ketone	fg_n_lactam	fg_n_lactone	fg_n_nitrile	fg_n_nitro	fg_n_nitroso	fg_n_pentose	fg_n_phosphoric_acid	fg_n_phosphoric_ester	fg_n_prim_amide	fg_n_prim_amine	fg_n_quart_amine	fg_n_second_amide	fg_n_second_amine	fg_n_steroid	fg_n_sulfate	fg_n_sulfone	fg_n_sulfonic_acid	fg_n_sulfonic_ester	fg_n_sulfoxide	fg_n_sulfuric_acid_and_ester	fg_n_sulfuric_acid_diester	fg_n_tert_amide	fg_n_tert_amine	first_approval	fmla structure	formula	gtopdb_id	hmdb_id	inchi	inchikey	input_name	input_pubchem_cid	isomeric_smiles	iupac	kegg_ligand_id	lincs_id	logp	lotus_doi	lotus_ncbi_id	lotus_parent_ncbi_id	lotus_parent_taxon	lotus_parent_taxon_name	lotus_parent_taxon_rank_label	lotus_reference	lotus_structure	lotus_structure_label	lotus_taxon	lotus_taxon_name	lotus_taxon_rank_label	mcule_id	mol weight structure	molecular_species	monoisotopic_mass	nHA	nHD	nRB	nRings	natural_product	nmrshiftdb2_id	none	npatlas_cluster_id	npatlas_node_id	npatlas_npaid	npatlas_num_entries	npatlas_original_doi	npatlas_original_name	npatlas_original_organism	npatlas_original_type	npclassifier_class_results	npclassifier_isglycoside	npclassifier_pathway_results	npclassifier_superclass_results	oral	parenteral	plate_id	probes_and_drugs_id	prodrug	pubchem	pubchem_cid	pubchem_logp	row_id	rxnorm_id	schembl_id	smarts	smiles	split_inchikey	structure	structure_source	synonyms	topical	unichem_id	unichem_url	unii	unique_sample_id	usan_stem_definition	volume [nL]	well_location	withdrawn	zinc_id
-1.0		0	1	P1086813	69.6		A1	False	0	16	0	0	18	0	4	2	0	0		0.0						CN1CCN(c2nc(-c3ccccc3)cc(C(=O)O)n2)CC1																							0.0		2-(4-methylpiperazin-1-yl)-6-phenylpyrimidine-4-carboxylic acid		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2		C16H18N4O2	C16H18N4O2			InChI=1S/C16H18N4O2/c1-19-7-9-20(10-8-19)16-17-13(11-14(18-16)15(21)22)12-5-3-2-4-6-12/h2-6,11H,7-10H2,1H3,(H,21,22)	TXZUMXIIPHZAMV-UHFFFAOYSA-N	2-(4-methylpiperazin-1-yl)-6-phenyl-pyrimidine-4-carboxylic acid	24277325	CN1CCN(c2nc(-c3ccccc3)cc(C(=O)O)n2)CC1	2-(4-methylpiperazin-1-yl)-6-phenylpyrimidine-4-carboxylic acid			0.77826													MCULE-7518022111	298.34746		298.142976	6	1	3	3			44									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(24277325)	24277325	-0.3	0			[#6]-[#7]1-[#6]-[#6]-[#7](-[#6]2:[#7]:[#6](-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#6]:[#6](-[#6](=[#8])-[#8]):[#7]:2)-[#6]-[#6]-1	CN1CCN(c2nc(-c3ccccc3)cc(C(=O)O)n2)CC1	TXZUMXIIPHZAMV		parent_pubchem_cid	2-(4-methylpiperazin-1-yl)-6-phenylpyrimidine-4-carboxylic acid;1017484-36-4;starbld0025993;2-(4-methylpiperazin-1-yl)-6-phenylpyrimidine-4-carboxylicacid;MFCD10005931;AKOS015948317;NS-05041;2-(4-methylpiperazin-1-yl)-6-phenyl-pyrimidine-4-carboxylic acid		9824167.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=9824167		pluskal_iocb_peptide_Peptide01_A1_id		100	A1		ZINC000011729745
4.5		0	89	P0120630213	71.2		A2	False	0	22	0	0	24	0	2	3	0	0		0.0						COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c1c(C)cc(C)cc1C																							0.0		Oprea1_400954		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C22H24N2O3	C22H24N2O3			InChI=1S/C22H24N2O3/c1-13-9-14(2)20(15(3)10-13)21(25)24-19(22(26)27-4)11-16-12-23-18-8-6-5-7-17(16)18/h5-10,12,19,23H,11H2,1-4H3,(H,24,25)	GSBPFEDNFWDEJT-UHFFFAOYSA-N	methyl 3-(1H-indol-3-yl)-2-[(2,4,6-trimethylbenzoyl)amino]propanoate	2829678	COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c1c(C)cc(C)cc1C	methyl 3-(1H-indol-3-yl)-2-[(2,4,6-trimethylbenzoyl)amino]propanoate			2.9052900000000017													MCULE-3000067496	364.44818		364.178693	3	2	6	3			45										False					Peptide01			Compound(2829678)	2829678	4.1	1			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#6](=[#8])-[#6]1:[#6](-[#6]):[#6]:[#6](-[#6]):[#6]:[#6]:1-[#6]	COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c1c(C)cc(C)cc1C	GSBPFEDNFWDEJT		parent_pubchem_cid	Oprea1_400954;AKOS002346768;methyl 3-(1H-indol-3-yl)-2-[(2,4,6-trimethylbenzoyl)amino]propanoate		23507583.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23507583		pluskal_iocb_peptide_Peptide01_A1_id		100	A1		
3.6		0	177	P7020554651	84.2		A3	False	1	20	0	0	18	0	3	3	0	0		0.0						Cc1cc(NC(=O)C(Cc2ccccc2)NC(=O)c2ccccc2Br)no1																							0.0		AKOS005585339		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C20H18BrN3O3	C20H18BrN3O3			InChI=1S/C20H18BrN3O3/c1-13-11-18(24-27-13)23-20(26)17(12-14-7-3-2-4-8-14)22-19(25)15-9-5-6-10-16(15)21/h2-11,17H,12H2,1H3,(H,22,25)(H,23,24,26)/t17-/m0/s1	YMQJHTKRVRGXTE-KRWDZBQOSA-N	N-[(1S)-1-benzyl-2-[(5-methylisoxazol-3-yl)amino]-2-oxo-ethyl]-2-bromo-benzamide	24315164	Cc1cc(NC(=O)[C@H](Cc2ccccc2)NC(=O)c2ccccc2Br)no1	2-bromo-N-[(2S)-1-[(5-methyl-1,2-oxazol-3-yl)amino]-1-oxo-3-phenylpropan-2-yl]benzamide			3.180580000000001													MCULE-7272076813	428.28876		427.053154	3	2	6	3			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(24315164)	24315164	4.0	2			[#6]-[#6]1:[#6]:[#6](-[#7]-[#6](=[#8])-[#6@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#35]):[#7]:[#8]:1	Cc1cc(NC(=O)[C@H](Cc2ccccc2)NC(=O)c2ccccc2Br)no1	YMQJHTKRVRGXTE		parent_pubchem_cid	AKOS005585339;N-[(1S)-1-benzyl-2-[(5-methylisoxazol-3-yl)amino]-2-oxo-ethyl]-2-bromo-benzamide		6399318.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=6399318		pluskal_iocb_peptide_Peptide01_A1_id		100	A1		ZINC000012028742
4.6		0	265	P1305501	54.1		A4	False	0	24	0	0	22	0	2	2	0	0		0.0						COc1cccc(C(=O)NCC(c2ccccc2)c2c[nH]c3ccccc23)c1																							0.0		N-[2-(1H-indol-3-yl)-2-phenylethyl]-3-methoxybenzamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C24H22N2O2	C24H22N2O2			InChI=1S/C24H22N2O2/c1-28-19-11-7-10-18(14-19)24(27)26-15-21(17-8-3-2-4-9-17)22-16-25-23-13-6-5-12-20(22)23/h2-14,16,21,25H,15H2,1H3,(H,26,27)	BMZZJKFKOPJMAV-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]-3-methoxy-benzamide	17014647	COc1cccc(C(=O)NCC(c2ccccc2)c2c[nH]c3ccccc23)c1	N-[2-(1H-indol-3-yl)-2-phenylethyl]-3-methoxybenzamide			3.683440000000002													MCULE-6421125006	370.45514		370.168128	2	2	6	4			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(17014647)	17014647	4.7	3			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6](-[#6](=[#8])-[#7]-[#6]-[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:1	COc1cccc(C(=O)NCC(c2ccccc2)c2c[nH]c3ccccc23)c1	BMZZJKFKOPJMAV		parent_pubchem_cid	N-[2-(1H-indol-3-yl)-2-phenylethyl]-3-methoxybenzamide;HMS3456G12;AKOS002334759;AKOS016326712;N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]-3-methoxy-benzamide		24090390.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24090390		pluskal_iocb_peptide_Peptide01_A1_id		100	A1		
0.2		0	9	P3644480	87.1		A5	False	0	12	0	0	21	0	1	5	0	0		0.0						CC(C)(C)OC(=O)N1CCC(O)(CC(=O)O)CC1																							0.0		502482-52-2		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	1	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C12H21NO5	C12H21NO5			InChI=1S/C12H21NO5/c1-11(2,3)18-10(16)13-6-4-12(17,5-7-13)8-9(14)15/h17H,4-8H2,1-3H3,(H,14,15)	CTGKOZWOKCERFN-UHFFFAOYSA-N	2-(1-tert-butoxycarbonyl-4-hydroxy-4-piperidyl)acetic acid	10061106	CC(C)(C)OC(=O)N1CCC(O)(CC(=O)O)CC1	2-[4-hydroxy-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]acetic acid			1.2231													MCULE-3934797206	259.30487		259.141973	5	2	4	1			43										False	Alkaloids				Peptide01			Compound(10061106)	10061106	0.8	4		SCHEMBL1086226	[#6]-[#6](-[#6])(-[#6])-[#8]-[#6](=[#8])-[#7]1-[#6]-[#6]-[#6](-[#8])(-[#6]-[#6](=[#8])-[#8])-[#6]-[#6]-1	CC(C)(C)OC(=O)N1CCC(O)(CC(=O)O)CC1	CTGKOZWOKCERFN		parent_pubchem_cid	502482-52-2;2-(1-(tert-Butoxycarbonyl)-4-hydroxypiperidin-4-yl)acetic acid;MFCD21090571;2-{1-[(tert-butoxy)carbonyl]-4-hydroxypiperidin-4-yl}acetic acid;2-[4-hydroxy-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]acetic acid;2-[1-(tert-Butoxycarbonyl)-4-hydroxypiperidin-4-yl]acetic acid;SCHEMBL1086226;CTGKOZWOKCERFN-UHFFFAOYSA-N;CVA48252;4-carboxymethyl-4-hydroxypiperidine-1-carboxylic acid tert-butyl ester;AKOS015947694;SB44175;1-Boc-4-hydroxy-4-piperidylacetic Acid;NS-03989;SY124042;CS-0035998;EN300-197081;A902114;2-(1-(tert-Butoxycarbonyl)-4-hydroxypiperidin-4-yl)aceticacid;2-(1-(tert-Butoxycarbonyl)-4-hydroxypiperidin-4-yl) acetic acid;4-carboxymethyl-4-hydroxy-piperidine-1-carboxylic acid tert-butyl ester;2-(1-tert-butoxycarbonyl-4-hydroxy-4-piperidyl)acetic acid		32303947.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=32303947		pluskal_iocb_peptide_Peptide01_A1_id		100	A1		ZINC000034148001
5.0		0	97	P0127442789	26.7		A6	False	0	23	0	0	24	0	2	1	0	0		0.0						Oc1cccc(C2N(Cc3ccccc3)CCN2Cc2ccccc2)c1								Benzylamines;1-hydroxy-4-unsubstituted benzenoids;1-hydroxy-2-unsubstituted benzenoids;Azacyclic compounds;Organopnictogen compounds;Organooxygen compounds;Organonitrogen compounds;Hydrocarbon derivatives	1-hydroxy-2-unsubstituted benzenoids;1-hydroxy-4-unsubstituted benzenoids;Azacyclic compounds;Azolidines;Benzene and substituted derivatives;Benzenoids;Benzylamines;Chemical entities;Hydrocarbon derivatives;Imidazolidines;Organic compounds;Organic nitrogen compounds;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenols;Phenylimidazolidines	Azolidines	2.1	This compound belongs to the class of organic compounds known as phenylimidazolidines. These are polycyclic compounds containing an imidazoline substituted by a phenyl group.	Phenylimidazolidines			Organic compounds	Aromatic heteromonocyclic compounds	aralkylamine (CHEBI:18000);phenols (CHEBI:33853);organonitrogen heterocyclic compound (CHEBI:38101);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organooxygen compound (CHEBI:36963);organonitrogen compound (CHEBI:35352);organic molecule (CHEBI:72695);imidazolidines (CHEBI:38261);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);organic heterocyclic compound (CHEBI:24532);oxygen molecular entity (CHEBI:25806);nitrogen molecular entity (CHEBI:51143)		Imidazolidines	Phenylimidazolidine;Benzylamine;1-hydroxy-4-unsubstituted benzenoid;1-hydroxy-2-unsubstituted benzenoid;Phenol;Benzenoid;Monocyclic benzene moiety;Azacycle;Organic nitrogen compound;Organic oxygen compound;Organopnictogen compound;Hydrocarbon derivative;Organooxygen compound;Organonitrogen compound;Aromatic heteromonocyclic compound	Organoheterocyclic compounds	0.0		3-(1,3-dibenzylimidazolidin-2-yl)phenol	DTXSID90347274	2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2		C23H24N2O	C23H24N2O			InChI=1S/C23H24N2O/c26-22-13-7-12-21(16-22)23-24(17-19-8-3-1-4-9-19)14-15-25(23)18-20-10-5-2-6-11-20/h1-13,16,23,26H,14-15,17-18H2	YUHDTDWTWWAETA-UHFFFAOYSA-N	3-(1,3-dibenzylimidazolidin-2-yl)phenol	619642	Oc1cccc(C2N(Cc3ccccc3)CCN2Cc2ccccc2)c1	3-(1,3-dibenzylimidazolidin-2-yl)phenol			3.7822600000000026													MCULE-8781939824	344.46053		344.188863	3	1	5	4			42										False	Alkaloids				Peptide01			Compound(619642)	619642	4.3	5			[#8]-[#6]1:[#6]:[#6]:[#6]:[#6](-[#6]2-[#7](-[#6]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3)-[#6]-[#6]-[#7]-2-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6]:1	Oc1cccc(C2N(Cc3ccccc3)CCN2Cc2ccccc2)c1	YUHDTDWTWWAETA		parent_pubchem_cid	3-(1,3-dibenzylimidazolidin-2-yl)phenol;ChemDiv1_025607;Probes1_000485;Probes2_000425;Oprea1_487714;Oprea1_696872;CBDivE_007489;HMS659L21;DTXSID90347274;YUHDTDWTWWAETA-UHFFFAOYSA-N;STK065886;AKOS000530223;296791-16-7;3-(1,3-Dibenzyl-2-imidazolidinyl)phenol;3-(1,3-Dibenzyl-2-imidazolidinyl)phenol #;Phenol, 3-(1,3-dibenzyl-2-imidazolidinyl)-;SR-01000519590;SR-01000519590-1		22775107.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22775107		pluskal_iocb_peptide_Peptide01_A1_id		100	A1		ZINC000019323984
4.6		0	185	P7020522196	80.2		A7	False	0	22	0	0	20	0	2	4	0	0		0.0						COc1cccc(C=NNc2ccccc2C(=O)O)c1OCc1ccccc1																							0.0		MFCD00737482		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C22H20N2O4	C22H20N2O4			InChI=1S/C22H20N2O4/c1-27-20-13-7-10-17(21(20)28-15-16-8-3-2-4-9-16)14-23-24-19-12-6-5-11-18(19)22(25)26/h2-14,24H,15H2,1H3,(H,25,26)/b23-14+	KMEAQBHSGBXERO-OEAKJJBVSA-N	2-[(2E)-2-[(2-benzyloxy-3-methoxy-phenyl)methylene]hydrazino]benzoic acid	22694832	COc1cccc(/C=N/Nc2ccccc2C(=O)O)c1OCc1ccccc1	2-[(2E)-2-[(3-methoxy-2-phenylmethoxyphenyl)methylidene]hydrazinyl]benzoic acid			2.948840000000001														376.4157		376.142307	6	2	8	3			45										False					Peptide01			Compound(22694832)	22694832	5.1	6			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6](/[#6]=[#7]/[#7]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6](=[#8])-[#8]):[#6]:1-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	COc1cccc(/C=N/Nc2ccccc2C(=O)O)c1OCc1ccccc1	KMEAQBHSGBXERO		parent_pubchem_cid	MFCD00737482;AKOS016362095;2-[(2E)-2-[(2-benzyloxy-3-methoxy-phenyl)methylene]hydrazino]benzoic acid		22930681.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22930681		pluskal_iocb_peptide_Peptide01_A1_id		100	A1		ZINC000004372971
2.5		0	273	P6236877	61.0		A8	False	0	22	0	0	24	0	4	1	0	0		0.0						O=C(NCCc1cnc[nH]1)C1CN(C(c2ccccc2)c2ccccc2)C1								Aralkylamines;Imidazoles;Heteroaromatic compounds;Trialkylamines;Secondary carboxylic acid amides;Azetidines;Amino acids and derivatives;Azacyclic compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Amines;Amino acids and derivatives;Amino acids, peptides, and analogues;Aralkylamines;Azacyclic compounds;Azetidines;Azoles;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Diphenylmethanes;Heteroaromatic compounds;Hydrocarbon derivatives;Imidazoles;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Secondary carboxylic acid amides;Tertiary amines;Trialkylamines	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as diphenylmethanes. These are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups.	Diphenylmethanes			Organic compounds	Aromatic heteromonocyclic compounds	aralkylamine (CHEBI:18000);imidazoles (CHEBI:24780);organic aromatic compound (CHEBI:33659);tertiary amino compound (CHEBI:50996);carboxamide (CHEBI:37622);azetidines (CHEBI:38777);organonitrogen compound (CHEBI:35352);organooxygen compound (CHEBI:36963);organonitrogen heterocyclic compound (CHEBI:38101);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);diarylmethane (CHEBI:51614);chemical entity (CHEBI:24431);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);amine (CHEBI:32952);organic heterocyclic compound (CHEBI:24532);azole (CHEBI:68452);tertiary amine (CHEBI:32876);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712)		Diphenylmethanes	Diphenylmethane;Aralkylamine;Azole;Heteroaromatic compound;Imidazole;Amino acid or derivatives;Azetidine;Carboxamide group;Tertiary aliphatic amine;Tertiary amine;Secondary carboxylic acid amide;Azacycle;Organoheterocyclic compound;Carboxylic acid derivative;Amine;Organonitrogen compound;Organooxygen compound;Hydrocarbon derivative;Carbonyl group;Organic oxide;Organic oxygen compound;Organic nitrogen compound;Aromatic heteromonocyclic compound	Benzenoids	0.0		1081131-15-8		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C22H24N4O	C22H24N4O			InChI=1S/C22H24N4O/c27-22(24-12-11-20-13-23-16-25-20)19-14-26(15-19)21(17-7-3-1-4-8-17)18-9-5-2-6-10-18/h1-10,13,16,19,21H,11-12,14-15H2,(H,23,25)(H,24,27)	XPMXIPQSENSIOH-UHFFFAOYSA-N	1-benzhydryl-N-[2-(1H-imidazol-4-yl)ethyl]azetidine-3-carboxamide	29131717	O=C(NCCc1cnc[nH]1)C1CN(C(c2ccccc2)c2ccccc2)C1	1-benzhydryl-N-[2-(1H-imidazol-5-yl)ethyl]azetidine-3-carboxamide			2.6256700000000004													MCULE-2507094351	360.46278		360.195011	3	2	7	4			44									Imidazole alkaloids	False	Alkaloids	Histidine alkaloids			Peptide01			Compound(29131717)	29131717	2.6	7			[#8]=[#6](-[#7]-[#6]-[#6]-[#6]1:[#6]:[#7]:[#6]:[#7H]:1)-[#6]1-[#6]-[#7](-[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]-1	O=C(NCCc1cnc[nH]1)C1CN(C(c2ccccc2)c2ccccc2)C1	XPMXIPQSENSIOH		parent_pubchem_cid	1081131-15-8;1-benzhydryl-N-[2-(1H-imidazol-4-yl)ethyl]-3-azetanecarboxamide;AKOS016400173;1-benzhydryl-N-[2-(1H-imidazol-4-yl)ethyl]azetidine-3-carboxamide		24264386.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24264386		pluskal_iocb_peptide_Peptide01_A1_id		100	A1		ZINC000020723435
1.8		0	17	P4187372	75.7		A9	False	0	17	0	3	21	0	2	4	0	0		0.0						COC(=O)C(C)CN(CCNC(C)=O)C(=O)c1ccc(C(F)(F)F)cc1																							0.0		AKOS016589950		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0		C17H21F3N2O4	C17H21F3N2O4			InChI=1S/C17H21F3N2O4/c1-11(16(25)26-3)10-22(9-8-21-12(2)23)15(24)13-4-6-14(7-5-13)17(18,19)20/h4-7,11H,8-10H2,1-3H3,(H,21,23)	ARJXOQQSZXMPMM-UHFFFAOYSA-N	methyl 3-[2-acetamidoethyl-[4-(trifluoromethyl)benzoyl]amino]-2-methyl-propanoate	84351803	COC(=O)C(C)CN(CCNC(C)=O)C(=O)c1ccc(C(F)(F)F)cc1	methyl 3-[2-acetamidoethyl-[4-(trifluoromethyl)benzoyl]amino]-2-methylpropanoate			1.98338														374.36312		374.145342	4	1	9	1			46									Simple amide alkaloids	False	Alkaloids	Peptide alkaloids			Peptide01			Compound(84351803)	84351803	2.0	8			[#6]-[#8]-[#6](=[#8])-[#6](-[#6])-[#6]-[#7](-[#6]-[#6]-[#7]-[#6](-[#6])=[#8])-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#6](-[#9])(-[#9])-[#9]):[#6]:[#6]:1	COC(=O)C(C)CN(CCNC(C)=O)C(=O)c1ccc(C(F)(F)F)cc1	ARJXOQQSZXMPMM		parent_pubchem_cid	AKOS016589950;methyl 3-[2-acetamidoethyl-[4-(trifluoromethyl)benzoyl]amino]-2-methyl-propanoate		89787408.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=89787408		pluskal_iocb_peptide_Peptide01_A2_id		100	A2		
2.8		0	105	P1444434	91.4		A10	False	0	16	0	0	20	0	2	4	0	0	-1.0	0.0						CC(C)(C)OC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)O	183830.0	2.69		0.0	2.67	CHEMBL65709																	0.0		Boc-Trp-OH	DTXSID20884506	2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	1	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C16H20N2O4	C16H20N2O4			InChI=1S/C16H20N2O4/c1-16(2,3)22-15(21)18-13(14(19)20)8-10-9-17-12-7-5-4-6-11(10)12/h4-7,9,13,17H,8H2,1-3H3,(H,18,21)(H,19,20)/t13-/m0/s1	NFVNYBJCJGKVQK-ZDUSSCGKSA-N	rac-(2S)-2-(tert-butoxycarbonylamino)-3-(1H-indol-3-yl)propanoic acid	83169	CC(C)(C)OC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	(2S)-3-(1H-indol-3-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid			2.20517													MCULE-3996317718	304.3488	ACID	304.142307	4	3	6	2	1.0		26									Dipeptides	False	Amino acids and Peptides	Small peptides	False	False	Peptide01		-1.0	Compound(83169)	83169	2.0	9		SCHEMBL1003555	[#6]-[#6](-[#6])(-[#6])-[#8]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	CC(C)(C)OC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	NFVNYBJCJGKVQK		parent_pubchem_cid	"Boc-Trp-OH;13139-14-5;N-Boc-L-tryptophan;BOC-L-tryptophan;N-(tert-Butoxycarbonyl)-L-tryptophan;N-[(tert-Butoxy)carbonyl]-L-tryptophan;Boc-L-Trp-OH;L-Tryptophan, N-[(1,1-dimethylethoxy)carbonyl]-;(S)-2-((tert-Butoxycarbonyl)amino)-3-(1H-indol-3-yl)propanoic acid;NSC 334306;tert-Butyloxycarbonyltryptophan;CHEMBL65709;N-tert-Butoxycarbonyl-L-tryptophan;MFCD00065595;tert-Butoxycarbonyltryptophan;(2S)-3-(1H-indol-3-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid;N-tert-Butoxycarbonyltryptophan;tert-Butoxycarbonyl-L-tryptophan;(S)-2-tert-Butoxycarbonylamino-3-(1H-indol-3-yl)-propionic acid;N-tert-Butyloxycarbonyl-L-tryptophan;(2S)-2-{[(tert-butoxy)carbonyl]amino}-3-(1H-indol-3-yl)propanoic acid;N-tert-Butoxycarbonyl-L-(-)-tryptophan;N-((1,1-Dimethylethoxy)carbonyl)-L-tryptophan;L-Tryptophan, N-((1,1-dimethylethoxy)carbonyl)-;Nalpha-Boc-L-tryptophan;BOC-L-TRYPTOPHANE;Boc-trytophan;MFCD00037944;n-boc-tryptophan;BocTrpOH;N-((tert-Butoxy)carbonyl)-L-tryptophan;(tert-butoxycarbonyl)-L-tryptophan;EINECS 236-072-7;Na-Boc-L-tryptophan;t-butoxycarbonyltryptophan;N-t-butoxycarbonyltryptophan;Tryptophan, N-carboxy-, N-tert-butyl ester, L-;N-(t-butoxycarbonyl)tryptophan;SCHEMBL1003555;N-tert.butoxycarbonyl-tryptophan;DTXSID20884506;CHEBI:183830;NFVNYBJCJGKVQK-ZDUSSCGKSA-N;tert-Butyloxycarbonyl-L-tryptophan;CS-D1147;""Nalpha-boc-L-tryptophane;boc-trp-oh"";Nalpha-t-butoxycarbonyl-L-tryptophan;AC7874;BDBM50043801;Nalpha -t-butoxycarbonyl-L-tryptophan;AKOS005175158;AKOS015922872;Na-(tert-Butoxycarbonyl)-L-tryptophan;Nalpha -t-butoxycarbonyl-L-tryptophane;nalpha-tert-butoxycarbonyl-l-tryptophan;N-T-BUTOXYCARBONYL-L-TRYPTOPHAN;Boc-Trp-OH, >=99.0% (TLC);N-alpha-t-Butyloxycarbonyl-L-tryptophane;NCGC00166098-01;AC-17135;AS-12736;AM20060456;B1639;EN300-52850;M03328;A847884;SR-01000388673;J-300267;Q-101608;SR-01000388673-1;Nalpha-(tert-Butoxycarbonyl)-L-tryptophan, Boc-L-Trp-OH;Z756448322;(S)-2-(TERT-BUTOXYCARBONYLAMINO)-3-(1H-INDOL-3-YL)PROPANOIC ACID;rac-(2S)-2-(tert-butoxycarbonylamino)-3-(1H-indol-3-yl)propanoic acid"	False	504480.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=504480		pluskal_iocb_peptide_Peptide01_A2_id		100	A2	False	ZINC000002539209
2.8		0	193	P7013870127	75.1		A11	False	0	17	0	0	15	0	3	2	0	0		0.0						O=C(O)C(Cc1ccccc1)Nc1ncnc2ccccc12																							0.0		3-phenyl-2-[(quinazolin-4-yl)amino]propanoicacid		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C17H15N3O2	C17H15N3O2			InChI=1S/C17H15N3O2/c21-17(22)15(10-12-6-2-1-3-7-12)20-16-13-8-4-5-9-14(13)18-11-19-16/h1-9,11,15H,10H2,(H,21,22)(H,18,19,20)	LTKPIKDYYKMLDA-UHFFFAOYSA-N	3-phenyl-2-(quinazolin-4-ylamino)propanoic acid	2792417	O=C(O)C(Cc1ccccc1)Nc1ncnc2ccccc12	3-phenyl-2-(quinazolin-4-ylamino)propanoic acid			1.87386													MCULE-6636827456	293.328		293.116427	5	2	5	3			44									Quinazoline alkaloids	False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(2792417)	2792417	4.0	10			[#8]=[#6](-[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6]1:[#7]:[#6]:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	O=C(O)C(Cc1ccccc1)Nc1ncnc2ccccc12	LTKPIKDYYKMLDA		parent_pubchem_cid	3-phenyl-2-[(quinazolin-4-yl)amino]propanoicacid;ChemDiv2_004397;3-phenyl-2-(quinazolin-4-ylamino)propanoic acid;Oprea1_409186;HMS1381H19;MFCD04064787;AKOS000272953;AKOS016040491;IDI1_003112;F3098-3252		24786811.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24786811		pluskal_iocb_peptide_Peptide01_A2_id		100	A2		
2.2		0	281	P7126262	124.4		A12	False	0	18	0	0	14	0	4	4	0	0		0.0						O=C(O)c1ccc(Nc2nc(Nc3ccccc3C(=O)O)ncc2)cc1																							0.0		AKOS024459032		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	2	2	0	0	0	0	0	0	0	0	0	0	1	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0		C18H14N4O4	C18H14N4O4			InChI=1S/C18H14N4O4/c23-16(24)11-5-7-12(8-6-11)20-15-9-10-19-18(22-15)21-14-4-2-1-3-13(14)17(25)26/h1-10H,(H,23,24)(H,25,26)(H2,19,20,21,22)	JIEYYXCRGAKHQL-UHFFFAOYSA-N	2-[[4-(4-carboxyanilino)pyrimidin-2-yl]amino]benzoic acid	90489124	O=C(O)c1ccc(Nc2nc(Nc3ccccc3C(=O)O)ncc2)cc1	2-[[4-(4-carboxyanilino)pyrimidin-2-yl]amino]benzoic acid			1.72834													MCULE-9074325918	350.33668		350.101505	8	4	6	3			44									Anthranillic acid derivatives	False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(90489124)	90489124	3.6	11			[#8]=[#6](-[#8])-[#6]1:[#6]:[#6]:[#6](-[#7]-[#6]2:[#7]:[#6](-[#7]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3-[#6](=[#8])-[#8]):[#7]:[#6]:[#6]:2):[#6]:[#6]:1	O=C(O)c1ccc(Nc2nc(Nc3ccccc3C(=O)O)ncc2)cc1	JIEYYXCRGAKHQL		parent_pubchem_cid	AKOS024459032;2-[[4-(4-carboxyanilino)pyrimidin-2-yl]amino]benzoic acid		99993845.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=99993845		pluskal_iocb_peptide_Peptide01_A2_id		100	A2		ZINC000170621813
1.3		0	25	P0108440164	112.4	HCl	A13	False	0	13	0	0	13	0	3	4	0	0		0.0						O=C(O)CCC(Nc1ncnc2ccccc12)C(=O)O																							0.0		Oprea1_067771		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C13H14ClN3O4	C13H13N3O4			InChI=1S/C13H13N3O4/c17-11(18)6-5-10(13(19)20)16-12-8-3-1-2-4-9(8)14-7-15-12/h1-4,7,10H,5-6H2,(H,17,18)(H,19,20)(H,14,15,16)	LAWQEPQQCUWYFV-UHFFFAOYSA-N	2-(quinazolin-4-ylamino)pentanedioic acid;hydrochloride	5041886	O=C(O)CCC(Nc1ncnc2ccccc12)C(=O)O	2-(quinazolin-4-ylamino)pentanedioic acid			0.5506699999999998													MCULE-6843413351	311.72723		275.090606	7	3	6	2			44										False	Alkaloids				Peptide01			Compound(5041886)	5041886	1.9	12			[#8]=[#6](-[#8])-[#6]-[#6]-[#6](-[#7]-[#6]1:[#7]:[#6]:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	O=C(O)CCC(Nc1ncnc2ccccc12)C(=O)O	LAWQEPQQCUWYFV		parent_pubchem_cid	"Oprea1_067771;Oprea1_218062;AKOS001624421;CCG-106195;AB00692538-01;""2-(quinazolin-4-ylamino)pentanedioic acid;hydrochloride"""		23042048.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23042048		pluskal_iocb_peptide_Peptide01_A2_id		100	A2		
0.5		0	113	P6248792	155.5		A14	False	0	12	0	0	14	0	2	6	0	2	-1.0	0.0						CSCCC(NS(=O)(=O)c1cc2c(cc1)[nH]c(=O)o2)C(=O)O		0.61		0.0	0.86	CHEMBL4277216																	0.0		CHEMBL4277216		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0		C12H14N2O6S2	C12H14N2O6S2			InChI=1S/C12H14N2O6S2/c1-21-5-4-9(11(15)16)14-22(18,19)7-2-3-8-10(6-7)20-12(17)13-8/h2-3,6,9,14H,4-5H2,1H3,(H,13,17)(H,15,16)	LXJVNLWNCYFOCQ-UHFFFAOYSA-N	4-methylsulfanyl-2-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]butanoic acid	56728437	CSCCC(NS(=O)(=O)c1cc2c(cc1)[nH]c(=O)o2)C(=O)O	4-methylsulfanyl-2-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]butanoic acid			0.9691599999999998													MCULE-9055636660	346.38318	ACID	346.029328	7	3	7	2	0.0		30										False			False	False	Peptide01		-1.0	Compound(56728437)	56728437	0.7	13			[#6]-[#16]-[#6]-[#6]-[#6](-[#7]-[#16](=[#8])(=[#8])-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#7H]:[#6](=[#8]):[#8]:2)-[#6](=[#8])-[#8]	CSCCC(NS(=O)(=O)c1cc2c(cc1)[nH]c(=O)o2)C(=O)O	LXJVNLWNCYFOCQ		parent_pubchem_cid	CHEMBL4277216;AKOS016387097;4-methylsulfanyl-2-[(2-oxo-3H-1,3-benzoxazol-6-yl)sulfonylamino]butanoic acid	False	24641265.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24641265		pluskal_iocb_peptide_Peptide01_A2_id		100	A2	False	
0.6		0	201	P1901319	95.5		A15	False	0	12	0	0	12	0	2	4	0	0	-1.0	0.0						O=C(O)CCC1(c2ccccc2)NC(=O)NC1=O		0.59		0.0	0.57	CHEMBL1736663		Phenylimidazolidines;Alpha amino acids and derivatives;5-monosubstituted hydantoins;N-acyl ureas;Benzene and substituted derivatives;Dicarboximides;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	5-monosubstituted hydantoins;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Azolidines;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid derivatives;Carboxylic acid imides;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Dicarboximides;Hydantoins;Hydrocarbon derivatives;Imidazolidinediones;Imidazolidines;Imidazolidinones;Monocarboxylic acids and derivatives;N-acyl ureas;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenylhydantoins;Phenylimidazolidines;Ureas;Ureides	Azolidines	2.1	This compound belongs to the class of organic compounds known as phenylhydantoins. These are heterocyclic aromatic compounds containing an imiazolidinedione moiety substituted by a phenyl group.	Phenylhydantoins		Imidazolidinones;Imidazolidinediones;Hydantoins	Organic compounds	Aromatic heteromonocyclic compounds	imidazolidines (CHEBI:38261);organonitrogen compound (CHEBI:35352);organooxygen compound (CHEBI:36963);imidazolidine-2,4-dione (CHEBI:24628);N-acylurea (CHEBI:74266);benzenes (CHEBI:22712);dicarboximide (CHEBI:35356);carbonyl compound (CHEBI:36586);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);organonitrogen heterocyclic compound (CHEBI:38101);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);amino acid (CHEBI:33709);peptide (CHEBI:16670);imidazolidinone (CHEBI:55370);ureas (CHEBI:47857);benzenoid aromatic compound (CHEBI:33836);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806)		Imidazolidines	5-phenylhydantoin;Phenylimidazolidine;Alpha-amino acid or derivatives;5-monosubstituted hydantoin;N-acyl urea;Ureide;Monocyclic benzene moiety;Benzenoid;Dicarboximide;Urea;Carbonic acid derivative;Monocarboxylic acid or derivatives;Carboxylic acid;Carboxylic acid derivative;Azacycle;Hydrocarbon derivative;Organic oxide;Organooxygen compound;Organonitrogen compound;Organopnictogen compound;Organic nitrogen compound;Carbonyl group;Organic oxygen compound;Aromatic heteromonocyclic compound	Organoheterocyclic compounds	0.0		3-(2,5-dioxo-4-phenylimidazolidin-4-yl)propanoic acid		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C12H12N2O4	C12H12N2O4			InChI=1S/C12H12N2O4/c15-9(16)6-7-12(8-4-2-1-3-5-8)10(17)13-11(18)14-12/h1-5H,6-7H2,(H,15,16)(H2,13,14,17,18)	RUWPCCQWDIAGAJ-UHFFFAOYSA-N	3-(2,5-dioxo-4-phenyl-imidazolidin-4-yl)propanoic acid	236331	O=C(O)CCC1(c2ccccc2)NC(=O)NC1=O	3-(2,5-dioxo-4-phenylimidazolidin-4-yl)propanoic acid			0.5313899999999999													MCULE-3252795475	248.24044	ACID	248.079707	4	3	4	2	0.0		29										False	Alkaloids		False	False	Peptide01		-1.0	Compound(236331)	236331	0.5	14		SCHEMBL11010651	[#8]=[#6](-[#8])-[#6]-[#6]-[#6]1(-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#7]-[#6](=[#8])-[#7]-[#6]-1=[#8]	O=C(O)CCC1(c2ccccc2)NC(=O)NC1=O	RUWPCCQWDIAGAJ		parent_pubchem_cid	3-(2,5-dioxo-4-phenylimidazolidin-4-yl)propanoic acid;30741-72-1;6939-92-0;3-(2,5-DIOXO-4-PHENYL-IMIDAZOLIDIN-4-YL)-PROPIONIC ACID;NSC38743;MLS000736986;MFCD08445744;4-Imidazolidinepropanoic acid, 2,5-dioxo-4-phenyl-;3-(2,5-dioxo-4-phenyl-4-imidazolidinyl)propanoic acid;3-(2,5-DIOXO-4-PHENYL-IMIDAZOLIDIN-4-YL)PROPIONIC ACID;NSC-38743;3-(2,5-DIOXO-4-PHENYL-IMIDAZOLIDIN-4-YL)PROPIONICACID;CHEMBL1736663;SCHEMBL11010651;HMS2757I10;BCP31913;AKOS000596429;AKOS016344478;SB40390;AM806569;DS-17947;NCI60_003693;SMR000393944;BB 0261746;CS-0149771;FT-0677972;2,5-Dioxo-4-phenyl-4-imidazolidinepropionic acid;A876101;3-(2,5-dioxo-4-phenylimidazolidin-4-yl)propanoicacid;3-(2,5-Dioxo-4-phenyliMidazolidin-4-yl)propanoic acid                        2,5-Dioxo-4-phenyl-4-imidazolidinepropionic acid;3-(2,5-dioxo-4-phenyl-imidazolidin-4-yl)propanoic acid	False	1032375.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=1032375		pluskal_iocb_peptide_Peptide01_A2_id		100	A2	False	
2.4		0	289	P7126282	124.4		A16	False	0	18	0	1	13	0	4	4	0	0		0.0						O=C(O)c1ccc(Nc2nc(Nc3cccc(C(=O)O)c3)ncc2F)cc1																							0.0		MFCD29050715		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	2	2	0	0	0	0	0	0	0	0	0	0	1	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0		C18H13FN4O4	C18H13FN4O4			InChI=1S/C18H13FN4O4/c19-14-9-20-18(22-13-3-1-2-11(8-13)17(26)27)23-15(14)21-12-6-4-10(5-7-12)16(24)25/h1-9H,(H,24,25)(H,26,27)(H2,20,21,22,23)	HUVAXRKMLSODLE-UHFFFAOYSA-N	3-[[4-(4-carboxyanilino)-5-fluoro-pyrimidin-2-yl]amino]benzoic acid	90489142	O=C(O)c1ccc(Nc2nc(Nc3cccc(C(=O)O)c3)ncc2F)cc1	3-[[4-(4-carboxyanilino)-5-fluoropyrimidin-2-yl]amino]benzoic acid			1.86744													MCULE-1138534453	368.32711		368.092083	8	4	6	3			44										False	Alkaloids				Peptide01			Compound(90489142)	90489142	3.1	15			[#8]=[#6](-[#8])-[#6]1:[#6]:[#6]:[#6](-[#7]-[#6]2:[#7]:[#6](-[#7]-[#6]3:[#6]:[#6]:[#6]:[#6](-[#6](=[#8])-[#8]):[#6]:3):[#7]:[#6]:[#6]:2-[#9]):[#6]:[#6]:1	O=C(O)c1ccc(Nc2nc(Nc3cccc(C(=O)O)c3)ncc2F)cc1	HUVAXRKMLSODLE		parent_pubchem_cid	MFCD29050715;AKOS024459051;3-[[4-(4-carboxyanilino)-5-fluoro-pyrimidin-2-yl]amino]benzoic acid		99993863.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=99993863		pluskal_iocb_peptide_Peptide01_A2_id		100	A2		ZINC000170621831
3.0		0	33	P7211800086	127.2		A17	False	0	22	0	0	23	0	1	6	0	1		0.0						CC(=O)NC(CSC(CC(=O)c1ccc(C)cc1)c1cc2c(cc1)OCO2)C(=O)O																							0.0		AKOS002383909		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C22H23NO6S	C22H23NO6S			InChI=1S/C22H23NO6S/c1-13-3-5-15(6-4-13)18(25)10-21(30-11-17(22(26)27)23-14(2)24)16-7-8-19-20(9-16)29-12-28-19/h3-9,17,21H,10-12H2,1-2H3,(H,23,24)(H,26,27)	JOAAAEPWSLHEFF-UHFFFAOYSA-N	2-acetamido-3-[1-(1,3-benzodioxol-5-yl)-3-oxo-3-(p-tolyl)propyl]sulfanyl-propanoic acid	4055216	CC(=O)NC(CSC(CC(=O)c1ccc(C)cc1)c1cc2c(cc1)OCO2)C(=O)O	2-acetamido-3-[1-(1,3-benzodioxol-5-yl)-3-(4-methylphenyl)-3-oxopropyl]sulfanylpropanoic acid			2.27137													MCULE-9834358170	429.49571		429.124608	7	2	9	3			45										False					Peptide01			Compound(4055216)	4055216	2.8	16			[#6]-[#6](=[#8])-[#7]-[#6](-[#6]-[#16]-[#6](-[#6]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:1)-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1)-[#8]-[#6]-[#8]-2)-[#6](=[#8])-[#8]	CC(=O)NC(CSC(CC(=O)c1ccc(C)cc1)c1cc2c(cc1)OCO2)C(=O)O	JOAAAEPWSLHEFF		parent_pubchem_cid	AKOS002383909;Z56842901;2-acetamido-3-[1-(1,3-benzodioxol-5-yl)-3-oxo-3-(p-tolyl)propyl]sulfanyl-propanoic acid		22993369.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22993369		pluskal_iocb_peptide_Peptide01_A3_id		100	A3		
4.0		0	121	P0112170010	117.0		A18	False	0	20	1	0	18	0	3	5	0	0		0.0						CCOC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c1c(Cl)cc([N+](=O)[O-])cc1								N-acyl-alpha amino acids and derivatives;Alpha amino acid esters;Indolyl carboxylic acids and derivatives;3-alkylindoles;2-halobenzoic acids and derivatives;Nitrobenzenes;Nitroaromatic compounds;Benzoyl derivatives;Fatty acid esters;Chlorobenzenes;Aryl chlorides;Substituted pyrroles;Vinylogous halides;Heteroaromatic compounds;Carboxylic acid esters;Secondary carboxylic acid amides;Organic oxoazanium compounds;Azacyclic compounds;Monocarboxylic acids and derivatives;Propargyl-type 1,3-dipolar organic compounds;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organic zwitterions;Organochlorides;Organonitrogen compounds;Organopnictogen compounds	2-halobenzoic acids and derivatives;3-alkylindoles;Allyl-type 1,3-dipolar organic compounds;Alpha amino acid esters;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Aryl chlorides;Aryl halides;Azacyclic compounds;Benzamides;Benzene and substituted derivatives;Benzenoids;Benzoic acids and derivatives;Benzoyl derivatives;C-nitro compounds;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids and derivatives;Chemical entities;Chlorobenzenes;Fatty Acyls;Fatty acid esters;Halobenzenes;Halobenzoic acids and derivatives;Heteroaromatic compounds;Hippuric acids and derivatives;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Indolyl carboxylic acids and derivatives;Lipids and lipid-like molecules;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids and derivatives;Nitroaromatic compounds;Nitrobenzenes;Organic 1,3-dipolar compounds;Organic acids and derivatives;Organic compounds;Organic nitro compounds;Organic nitrogen compounds;Organic oxides;Organic oxoazanium compounds;Organic oxygen compounds;Organic zwitterions;Organochlorides;Organohalogen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Propargyl-type 1,3-dipolar organic compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Vinyl halides;Vinylogous halides	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as hippuric acids and derivatives. These are compounds containing a hippuric acid or a derivative, with a structure characterized the presence of a benzoyl group linked to the N-terminal of a glycine.	Hippuric acids and derivatives		Benzamides	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-amino acid (CHEBI:51569);alpha-amino acid ester (CHEBI:46874);indolyl carboxylic acid (CHEBI:46867);indoles (CHEBI:24828);carbonyl compound (CHEBI:36586);organohalogen compound (CHEBI:36684);nitrobenzenes (CHEBI:48109);aromatic compound (CHEBI:33655);fatty acid ester (CHEBI:35748);organochlorine compound (CHEBI:36683);pyrroles (CHEBI:26455);organic aromatic compound (CHEBI:33659);carboxylic ester (CHEBI:33308);carboxamide (CHEBI:37622);nitrogen molecular entity (CHEBI:51143);organooxygen compound (CHEBI:36963);organonitrogen heterocyclic compound (CHEBI:38101);dipolar compound (CHEBI:51151);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);zwitterion (CHEBI:27369);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);pnictogen molecular entity (CHEBI:33302);benzamides (CHEBI:22702);N-acylglycine (CHEBI:16180);phenols (CHEBI:33853);chemical entity (CHEBI:24431);amino acid (CHEBI:33709);peptide (CHEBI:16670);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);nitro compound (CHEBI:35715);lipid (CHEBI:18059);haloarene (CHEBI:50887);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806)	Fatty esters (FA07);Fatty Acyls (FA)	Benzoic acids and derivatives	Alpha-amino acid ester;Hippuric acid or derivatives;N-acyl-alpha amino acid or derivatives;Indolyl carboxylic acid derivative;Alpha-amino acid or derivatives;2-halobenzoic acid or derivatives;Halobenzoic acid or derivatives;3-alkylindole;Indole;Indole or derivatives;Nitrobenzene;Nitroaromatic compound;Benzoyl;Chlorobenzene;Fatty acid ester;Halobenzene;Fatty acyl;Aryl halide;Aryl chloride;Substituted pyrrole;Heteroaromatic compound;Vinylogous halide;Pyrrole;Secondary carboxylic acid amide;Carboxamide group;Carboxylic acid ester;Organic nitro compound;C-nitro compound;Carboxylic acid derivative;Organic oxoazanium;Azacycle;Organoheterocyclic compound;Organic 1,3-dipolar compound;Propargyl-type 1,3-dipolar organic compound;Monocarboxylic acid or derivatives;Allyl-type 1,3-dipolar organic compound;Organooxygen compound;Organic nitrogen compound;Organonitrogen compound;Organohalogen compound;Organopnictogen compound;Organic oxygen compound;Organic oxide;Hydrocarbon derivative;Carbonyl group;Organochloride;Organic zwitterion;Aromatic heteropolycyclic compound	Benzenoids	0.0		ChemDiv1_000817		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C20H18ClN3O5	C20H18ClN3O5			InChI=1S/C20H18ClN3O5/c1-2-29-20(26)18(9-12-11-22-17-6-4-3-5-14(12)17)23-19(25)15-8-7-13(24(27)28)10-16(15)21/h3-8,10-11,18,22H,2,9H2,1H3,(H,23,25)	AEGMTRFJZYFDRR-UHFFFAOYSA-N	ethyl 2-[(2-chloro-4-nitro-benzoyl)amino]-3-(1H-indol-3-yl)propanoate	2841306	CCOC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c1c(Cl)cc([N+](=O)[O-])cc1	ethyl 2-[(2-chloro-4-nitrobenzoyl)amino]-3-(1H-indol-3-yl)propanoate			2.71525													MCULE-2236222858	415.83656		415.093498	5	2	8	3			45										False					Peptide01			Compound(2841306)	2841306	3.9	17			[#6]-[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#6](=[#8])-[#6]1:[#6](-[#17]):[#6]:[#6](-[#7+](=[#8])-[#8-]):[#6]:[#6]:1	CCOC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c1c(Cl)cc([N+](=O)[O-])cc1	AEGMTRFJZYFDRR		parent_pubchem_cid	ChemDiv1_000817;HMS589F03;AKOS001595357;AKOS016311762;EU-0035429;SR-01000405340;SR-01000405340-1;2-(2-Chloro-4-nitro-benzoylamino)-3-(1H-indol-3-yl)-propionic acid ethyl ester;ethyl 2-[(2-chloro-4-nitro-benzoyl)amino]-3-(1H-indol-3-yl)propanoate		24480624.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24480624		pluskal_iocb_peptide_Peptide01_A3_id		100	A3		
2.8		0	209	P7020531878	112.9		A19	False	0	20	0	1	21	0	2	4	0	2		0.0						O=S1(=O)CC(NCCc2c[nH]c3ccccc23)C(S(=O)(=O)c2ccc(F)cc2)C1																							0.0		HMS3463F14		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	0		C20H21FN2O4S2	C20H21FN2O4S2			InChI=1S/C20H21FN2O4S2/c21-15-5-7-16(8-6-15)29(26,27)20-13-28(24,25)12-19(20)22-10-9-14-11-23-18-4-2-1-3-17(14)18/h1-8,11,19-20,22-23H,9-10,12-13H2/t19-,20-/m0/s1	DYPADWACCKNIEC-PMACEKPBSA-N	rac-(3S,4R)-4-(4-fluorophenyl)sulfonyl-N-[2-(1H-indol-3-yl)ethyl]-1,1-dioxo-thiolan-3-amine	20996487	O=S1(=O)C[C@H](NCCc2c[nH]c3ccccc23)[C@@H](S(=O)(=O)c2ccc(F)cc2)C1	(3S,4R)-4-(4-fluorophenyl)sulfonyl-N-[2-(1H-indol-3-yl)ethyl]-1,1-dioxothiolan-3-amine			1.4874599999999998													MCULE-6197836508	436.52777		436.092677	5	2	6	4			44										False	Alkaloids				Peptide01			Compound(20996487)	20996487	2.7	18			[#8]=[#16]1(=[#8])-[#6]-[#6@H](-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6@@H](-[#16](=[#8])(=[#8])-[#6]2:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:2)-[#6]-1	O=S1(=O)C[C@H](NCCc2c[nH]c3ccccc23)[C@@H](S(=O)(=O)c2ccc(F)cc2)C1	DYPADWACCKNIEC		parent_pubchem_cid	HMS3463F14;MFCD10089083;AKOS004926373;CCG-156850;(3R4S)-3-(4-FLUOROBENZENESULFONYL)-4-{[2-(1H-INDOL-3-YL)ETHYL]AMINO}-1LAMBDA6-THIOLANE-11-DIONE;rac-(3S,4R)-4-(4-fluorophenyl)sulfonyl-N-[2-(1H-indol-3-yl)ethyl]-1,1-dioxo-thiolan-3-amine		21829208.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=21829208		pluskal_iocb_peptide_Peptide01_A3_id		100	A3		ZINC000019797077
2.2		0	297	P7126257	124.4		A20	False	0	18	0	0	14	0	4	4	0	0		0.0						O=C(O)c1ccc(Nc2nccc(Nc3cccc(C(=O)O)c3)n2)cc1																							0.0		MFCD29050691		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	2	2	0	0	0	0	0	0	0	0	0	0	1	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0		C18H14N4O4	C18H14N4O4			InChI=1S/C18H14N4O4/c23-16(24)11-4-6-13(7-5-11)21-18-19-9-8-15(22-18)20-14-3-1-2-12(10-14)17(25)26/h1-10H,(H,23,24)(H,25,26)(H2,19,20,21,22)	IKLHTNBUNABFEP-UHFFFAOYSA-N	3-[[2-(4-carboxyanilino)pyrimidin-4-yl]amino]benzoic acid	90489119	O=C(O)c1ccc(Nc2nccc(Nc3cccc(C(=O)O)c3)n2)cc1	3-[[2-(4-carboxyanilino)pyrimidin-4-yl]amino]benzoic acid			1.72834													MCULE-7392252121	350.33668		350.101505	8	4	6	3			44										False	Alkaloids				Peptide01			Compound(90489119)	90489119	3.0	19			[#8]=[#6](-[#8])-[#6]1:[#6]:[#6]:[#6](-[#7]-[#6]2:[#7]:[#6]:[#6]:[#6](-[#7]-[#6]3:[#6]:[#6]:[#6]:[#6](-[#6](=[#8])-[#8]):[#6]:3):[#7]:2):[#6]:[#6]:1	O=C(O)c1ccc(Nc2nccc(Nc3cccc(C(=O)O)c3)n2)cc1	IKLHTNBUNABFEP		parent_pubchem_cid	MFCD29050691;AKOS024459027;3-[[2-(4-carboxyanilino)pyrimidin-4-yl]amino]benzoic acid		99993840.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=99993840		pluskal_iocb_peptide_Peptide01_A3_id		100	A3		ZINC000170621808
3.1		0	41	P7020531789	112.9		A21	False	0	21	0	0	24	0	2	4	0	2		0.0						Cc1ccc(S(=O)(=O)C2CS(=O)(=O)CC2NCCc2c[nH]c3ccccc23)cc1																							0.0		HMS3463L08		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	0		C21H24N2O4S2	C21H24N2O4S2			InChI=1S/C21H24N2O4S2/c1-15-6-8-17(9-7-15)29(26,27)21-14-28(24,25)13-20(21)22-11-10-16-12-23-19-5-3-2-4-18(16)19/h2-9,12,20-23H,10-11,13-14H2,1H3/t20-,21-/m0/s1	XGJHIUYQKVQASN-SFTDATJTSA-N	rac-(3S,4R)-N-[2-(1H-indol-3-yl)ethyl]-1,1-dioxo-4-(p-tolylsulfonyl)thiolan-3-amine	20996482	Cc1ccc(S(=O)(=O)[C@H]2CS(=O)(=O)C[C@@H]2NCCc2c[nH]c3ccccc23)cc1	(3S,4R)-N-[2-(1H-indol-3-yl)ethyl]-4-(4-methylphenyl)sulfonyl-1,1-dioxothiolan-3-amine			1.6020700000000003													MCULE-9169205216	432.56443		432.117749	5	2	6	4			44										False	Alkaloids				Peptide01			Compound(20996482)	20996482	3.0	20			[#6]-[#6]1:[#6]:[#6]:[#6](-[#16](=[#8])(=[#8])-[#6@H]2-[#6]-[#16](=[#8])(=[#8])-[#6]-[#6@@H]-2-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	Cc1ccc(S(=O)(=O)[C@H]2CS(=O)(=O)C[C@@H]2NCCc2c[nH]c3ccccc23)cc1	XGJHIUYQKVQASN		parent_pubchem_cid	HMS3463L08;MFCD10043000;AKOS004926390;CCG-156783;(3S4R)-3-{[2-(1H-INDOL-3-YL)ETHYL]AMINO}-4-(4-METHYLBENZENESULFONYL)-1LAMBDA6-THIOLANE-11-DIONE;rac-(3S,4R)-N-[2-(1H-indol-3-yl)ethyl]-1,1-dioxo-4-(p-tolylsulfonyl)thiolan-3-amine		15302713.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=15302713		pluskal_iocb_peptide_Peptide01_A3_id		100	A3		ZINC000019797018
3.9		0	129	P7113220998	58.2		A22	False	0	23	0	0	22	0	2	2	0	0		0.0						O=C(CCc1ccccc1)NNC(=O)C(c1ccccc1)c1ccccc1								Phenylacetamides;Diacylhydrazines;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid derivatives;Carboxylic acid hydrazides;Carboxylic acids and derivatives;Chemical entities;Diacylhydrazines;Diphenylmethanes;Hydrocarbon derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenylacetamides	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as diphenylmethanes. These are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups.	Diphenylmethanes			Organic compounds	Aromatic homomonocyclic compounds	acetamides (CHEBI:22160);organonitrogen compound (CHEBI:35352);organooxygen compound (CHEBI:36963);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);diarylmethane (CHEBI:51614);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);carbohydrazide (CHEBI:35363);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806)		Diphenylmethanes	Diphenylmethane;Phenylacetamide;Diacylhydrazine;Carboxylic acid hydrazide;Carboxylic acid derivative;Organic nitrogen compound;Organic oxygen compound;Organic oxide;Hydrocarbon derivative;Organooxygen compound;Organonitrogen compound;Carbonyl group;Aromatic homomonocyclic compound	Benzenoids	0.0		N'-(2,2-diphenylacetyl)-3-phenylpropanehydrazide		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C23H22N2O2	C23H22N2O2			InChI=1S/C23H22N2O2/c26-21(17-16-18-10-4-1-5-11-18)24-25-23(27)22(19-12-6-2-7-13-19)20-14-8-3-9-15-20/h1-15,22H,16-17H2,(H,24,26)(H,25,27)	JJUJRTBMVQRARA-UHFFFAOYSA-N	N'-(2,2-diphenylacetyl)-3-phenyl-propanehydrazide	3139329	O=C(CCc1ccccc1)NNC(=O)C(c1ccccc1)c1ccccc1	N'-(2,2-diphenylacetyl)-3-phenylpropanehydrazide			3.4345700000000026													MCULE-1176779049	358.44399		358.168128	2	2	7	3			44										False					Peptide01			Compound(3139329)	3139329	4.2	21			[#8]=[#6](-[#6]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#7]-[#6](=[#8])-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	O=C(CCc1ccccc1)NNC(=O)C(c1ccccc1)c1ccccc1	JJUJRTBMVQRARA		parent_pubchem_cid	N'-(2,2-diphenylacetyl)-3-phenylpropanehydrazide;AKOS000499761;SR-01000325845;SR-01000325845-1;F3146-0150;N'-(2,2-diphenylacetyl)-3-phenyl-propanehydrazide		17483130.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=17483130		pluskal_iocb_peptide_Peptide01_A3_id		100	A3		ZINC000004426504
2.4		0	217	P1090467	150.0		A23	False	0	21	0	0	21	0	3	7	0	0	-1.0	0.0						COc1c(OC)cc(C(=O)O)c(NC(=O)NC(Cc2c[nH]c3ccccc23)C(=O)O)c1		2.7		0.0	2.9	CHEMBL1611595																	0.0		MLS001214675		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C21H21N3O7	C21H21N3O7			InChI=1S/C21H21N3O7/c1-30-17-8-13(19(25)26)15(9-18(17)31-2)23-21(29)24-16(20(27)28)7-11-10-22-14-6-4-3-5-12(11)14/h3-6,8-10,16,22H,7H2,1-2H3,(H,25,26)(H,27,28)(H2,23,24,29)/t16-/m0/s1	WSTDWYLHWCKFQQ-INIZCTEOSA-N	4,5-dimethoxy-2-[[rac-(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoylamino]benzoic acid	1785502	COc1c(OC)cc(C(=O)O)c(NC(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)c1	2-[[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoylamino]-4,5-dimethoxybenzoic acid			0.8574300000000004													MCULE-1573084695	427.41742	ACID	427.13795	7	5	8	3	1.0		29										False	Alkaloids	Anthranilic acid alkaloids	False	False	Peptide01		-1.0	Compound(1785502)	1785502	2.0	22			[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]):[#6]:[#6](-[#6](=[#8])-[#8]):[#6](-[#7]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6](=[#8])-[#8]):[#6]:1	COc1c(OC)cc(C(=O)O)c(NC(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)c1	WSTDWYLHWCKFQQ		parent_pubchem_cid	MLS001214675;SMR000543637;CHEMBL1611595;BDBM64117;cid_1785502;HMS2860H19;STL457183;AKOS016383744;N-[(2-carboxy-4,5-dimethoxyphenyl)carbamoyl]-L-tryptophan;2-[[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoylamino]-4,5-dimethoxy-benzoic acid;2-[[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoylamino]-4,5-dimethoxybenzoic acid;2-[[(2S)-3-(1H-indol-3-yl)-1-oxidanyl-1-oxidanylidene-propan-2-yl]carbamoylamino]-4,5-dimethoxy-benzoic acid;2-[[[[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]amino]-oxomethyl]amino]-4,5-dimethoxybenzoic acid;4,5-dimethoxy-2-[[rac-(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoylamino]benzoic acid	False	684171.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=684171		pluskal_iocb_peptide_Peptide01_A3_id		100	A3	False	ZINC000002130345
3.6		0	305	P7126239	90.4		A24	False	0	22	0	0	23	0	5	2	0	0		0.0						O=C(O)c1ccccc1Nc1nc(Nc2ccc(N3CCCCC3)cc2)ncc1																							0.0		AKOS025142287		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1		C22H23N5O2	C22H23N5O2			InChI=1S/C22H23N5O2/c28-21(29)18-6-2-3-7-19(18)25-20-12-13-23-22(26-20)24-16-8-10-17(11-9-16)27-14-4-1-5-15-27/h2-3,6-13H,1,4-5,14-15H2,(H,28,29)(H2,23,24,25,26)	OGIHIOXRGNLPDX-UHFFFAOYSA-N	2-[[2-[4-(1-piperidyl)anilino]pyrimidin-4-yl]amino]benzoic acid	91900817	O=C(O)c1ccccc1Nc1nc(Nc2ccc(N3CCCCC3)cc2)ncc1	2-[[2-(4-piperidin-1-ylanilino)pyrimidin-4-yl]amino]benzoic acid			2.694540000000001														389.46091		389.185175	7	3	6	4			45										False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(91900817)	91900817	5.0	23			[#8]=[#6](-[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#7]-[#6]1:[#7]:[#6](-[#7]-[#6]2:[#6]:[#6]:[#6](-[#7]3-[#6]-[#6]-[#6]-[#6]-[#6]-3):[#6]:[#6]:2):[#7]:[#6]:[#6]:1	O=C(O)c1ccccc1Nc1nc(Nc2ccc(N3CCCCC3)cc2)ncc1	OGIHIOXRGNLPDX		parent_pubchem_cid	AKOS025142287;2-[[2-[4-(1-piperidyl)anilino]pyrimidin-4-yl]amino]benzoic acid		101553121.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=101553121		pluskal_iocb_peptide_Peptide01_A3_id		100	A3		ZINC000170621794
4.2		0	49	P7114600475	55.4		A25	False	0	22	0	0	27	0	1	3	0	0		0.0						COC(=O)C(CC(C)C)NC(=O)CC(c1ccccc1)c1ccccc1								N-acyl-alpha amino acids and derivatives;Diphenylmethanes;Alpha amino acid esters;Fatty acid esters;Fatty amides;Methyl esters;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acid esters;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids and derivatives;Chemical entities;Diphenylmethanes;Fatty Acyls;Fatty acid esters;Fatty amides;Hydrocarbon derivatives;Leucine and derivatives;Lipids and lipid-like molecules;Methyl esters;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Secondary carboxylic acid amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as leucine and derivatives. These are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Leucine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic homomonocyclic compounds	N-acyl-amino acid (CHEBI:51569);diarylmethane (CHEBI:51614);alpha-amino acid ester (CHEBI:46874);fatty acid ester (CHEBI:35748);fatty amide (CHEBI:29348);carboxylic ester (CHEBI:33308);carboxamide (CHEBI:37622);carbonyl compound (CHEBI:36586);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);leucine derivative (CHEBI:47003);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);amino acid (CHEBI:33709);peptide (CHEBI:16670);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);lipid (CHEBI:18059);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806)	Fatty esters (FA07);Fatty amides (FA08);Fatty Acyls (FA)	Amino acids, peptides, and analogues	Leucine or derivatives;Alpha-amino acid ester;Diphenylmethane;N-acyl-alpha amino acid or derivatives;Fatty acid ester;Monocyclic benzene moiety;Fatty amide;Fatty acyl;Benzenoid;Methyl ester;Carboxamide group;Carboxylic acid ester;Secondary carboxylic acid amide;Monocarboxylic acid or derivatives;Hydrocarbon derivative;Organic oxide;Organopnictogen compound;Organic nitrogen compound;Carbonyl group;Organic oxygen compound;Organonitrogen compound;Organooxygen compound;Aromatic homomonocyclic compound	Organic acids and derivatives	0.0		AKOS002381587		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C22H27NO3	C22H27NO3			InChI=1S/C22H27NO3/c1-16(2)14-20(22(25)26-3)23-21(24)15-19(17-10-6-4-7-11-17)18-12-8-5-9-13-18/h4-13,16,19-20H,14-15H2,1-3H3,(H,23,24)	QWMGPOSPZHMDMX-UHFFFAOYSA-N	methyl 2-(3,3-diphenylpropanoylamino)-4-methyl-pentanoate	2914427	COC(=O)C(CC(C)C)NC(=O)CC(c1ccccc1)c1ccccc1	methyl 2-(3,3-diphenylpropanoylamino)-4-methylpentanoate			3.803080000000002													MCULE-7583622933	353.46539		353.199094	3	1	9	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(2914427)	2914427	4.5	24			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=[#8])-[#6]-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	COC(=O)C(CC(C)C)NC(=O)CC(c1ccccc1)c1ccccc1	QWMGPOSPZHMDMX		parent_pubchem_cid	AKOS002381587;AKOS016375547;NCGC00326835-01;AB01321519-02;METHYL 2-(3,3-DIPHENYLPROPANAMIDO)-4-METHYLPENTANOATE;methyl 2-(3,3-diphenylpropanoylamino)-4-methyl-pentanoate		24814153.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24814153		pluskal_iocb_peptide_Peptide01_A4_id		100	A4		
4.2		0	137	P7015122933	71.2		A26	False	1	20	0	0	19	0	2	3	0	0	-1.0	0.0						CCOC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c1ccccc1Br		3.83		0.0	4.12	CHEMBL1400522																	0.0		MLS001204041		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C20H19BrN2O3	C20H19BrN2O3			InChI=1S/C20H19BrN2O3/c1-2-26-20(25)18(23-19(24)15-8-3-5-9-16(15)21)11-13-12-22-17-10-6-4-7-14(13)17/h3-10,12,18,22H,2,11H2,1H3,(H,23,24)	LXXYBCJAIZYCQG-UHFFFAOYSA-N	ethyl 2-[(2-bromobenzoyl)amino]-3-(1H-indol-3-yl)propanoate	2793363	CCOC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c1ccccc1Br	ethyl 2-[(2-bromobenzoyl)amino]-3-(1H-indol-3-yl)propanoate			3.2967600000000017													MCULE-2551384074	415.29003	NEUTRAL	414.057905	3	2	7	3	0.0		30										False	Shikimates and Phenylpropanoids		False	False	Peptide01		-1.0	Compound(2793363)	2793363	4.1	25			[#6]-[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#35]	CCOC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c1ccccc1Br	LXXYBCJAIZYCQG		parent_pubchem_cid	MLS001204041;CHEMBL1400522;HMS2843N20;2-(2-Bromo-benzoylamino)-3-(1H-indol-3-yl)-propionic acid ethyl ester;AKOS000538262;AKOS016315182;NCGC00674593-01;SMR000524450;F3098-8598;ethyl 2-(2-bromobenzamido)-3-(1H-indol-3-yl)propanoate;ETHYL 2-[(2-BROMOPHENYL)FORMAMIDO]-3-(1H-INDOL-3-YL)PROPANOATE;ethyl 2-[(2-bromobenzoyl)amino]-3-(1H-indol-3-yl)propanoate	False	905982.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=905982		pluskal_iocb_peptide_Peptide01_A4_id		100	A4	False	
2.3		0	225	P7714330989	119.2		A27	False	0	23	0	0	28	0	2	6	0	1		0.0						CCOc1cc(NC(=O)c2ccccc2)c(OCC)cc1NC(=O)CC1CCS(=O)(=O)C1																							0.0		AKOS002389022		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	1	0	0	0	0	0	0	0		C23H28N2O6S	C23H28N2O6S			InChI=1S/C23H28N2O6S/c1-3-30-20-14-19(25-23(27)17-8-6-5-7-9-17)21(31-4-2)13-18(20)24-22(26)12-16-10-11-32(28,29)15-16/h5-9,13-14,16H,3-4,10-12,15H2,1-2H3,(H,24,26)(H,25,27)	TURGENBWAZQRDT-UHFFFAOYSA-N	N-[4-[[2-(1,1-dioxothiolan-3-yl)acetyl]amino]-2,5-diethoxy-phenyl]benzamide	18593904	CCOc1cc(NC(=O)c2ccccc2)c(OCC)cc1NC(=O)CC1CCS(=O)(=O)C1	N-[4-[[2-(1,1-dioxothiolan-3-yl)acetyl]amino]-2,5-diethoxyphenyl]benzamide			1.7588499999999998													MCULE-9408419608	460.55341		460.166808	6	2	9	3			45										False					Peptide01			Compound(18593904)	18593904	2.3	26			[#6]-[#6]-[#8]-[#6]1:[#6]:[#6](-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6](-[#8]-[#6]-[#6]):[#6]:[#6]:1-[#7]-[#6](=[#8])-[#6]-[#6]1-[#6]-[#6]-[#16](=[#8])(=[#8])-[#6]-1	CCOc1cc(NC(=O)c2ccccc2)c(OCC)cc1NC(=O)CC1CCS(=O)(=O)C1	TURGENBWAZQRDT		parent_pubchem_cid	AKOS002389022;N-[4-[[2-(1,1-dioxothiolan-3-yl)acetyl]amino]-2,5-diethoxy-phenyl]benzamide		24199455.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24199455		pluskal_iocb_peptide_Peptide01_A4_id		100	A4		
3.1		0	313	P4796927	74.8	HCl	A28	False	0	15	0	0	22	0	6	0	0	0		0.0						CCNc1nc(NCC)nc(Nc2cc(C)cc(C)c2)n1																							0.0		AKOS022128107		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0		C15H23ClN6	C15H22N6			InChI=1S/C15H22N6/c1-5-16-13-19-14(17-6-2)21-15(20-13)18-12-8-10(3)7-11(4)9-12/h7-9H,5-6H2,1-4H3,(H3,16,17,18,19,20,21)	ROQZTGBLFYFSNM-UHFFFAOYSA-N	N4-(3,5-dimethylphenyl)-N2,N6-diethyl-1,3,5-triazine-2,4,6-triamine;hydrochloride	7589388	CCNc1nc(NCC)nc(Nc2cc(C)cc(C)c2)n1	2-N-(3,5-dimethylphenyl)-4-N,6-N-diethyl-1,3,5-triazine-2,4,6-triamine			1.4637799999999996													MCULE-1518767140	322.84376		286.190595	6	3	6	2			43										False	Alkaloids				Peptide01			Compound(7589388)	7589388	3.9	27			[#6]-[#6]-[#7]-[#6]1:[#7]:[#6](-[#7]-[#6]-[#6]):[#7]:[#6](-[#7]-[#6]2:[#6]:[#6](-[#6]):[#6]:[#6](-[#6]):[#6]:2):[#7]:1	CCNc1nc(NCC)nc(Nc2cc(C)cc(C)c2)n1	ROQZTGBLFYFSNM		parent_pubchem_cid	"AKOS022128107;""N4-(3,5-dimethylphenyl)-N2,N6-diethyl-1,3,5-triazine-2,4,6-triamine;hydrochloride"""		9575183.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=9575183		pluskal_iocb_peptide_Peptide01_A4_id		100	A4		ZINC000005255912
3.7		0	57	P7212090661	91.9		A29	False	0	19	0	0	23	0	1	4	0	1	-1.0	0.0						CC(C)(C)c1ccc(S(=O)(=O)NC(Cc2ccccc2)C(=O)O)cc1		2.96		0.0	4.05	CHEMBL1334727																	0.0		((4-(tert-butyl)phenyl)sulfonyl)phenylalanine		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0		C19H23NO4S	C19H23NO4S			InChI=1S/C19H23NO4S/c1-19(2,3)15-9-11-16(12-10-15)25(23,24)20-17(18(21)22)13-14-7-5-4-6-8-14/h4-12,17,20H,13H2,1-3H3,(H,21,22)	AJHUCLCRIWTQMB-UHFFFAOYSA-N	2-[(4-tert-butylphenyl)sulfonylamino]-3-phenyl-propanoic acid	2930429	CC(C)(C)c1ccc(S(=O)(=O)NC(Cc2ccccc2)C(=O)O)cc1	2-[(4-tert-butylphenyl)sulfonylamino]-3-phenylpropanoic acid			2.740870000000001													MCULE-6600601342	361.46346	ACID	361.134779	4	2	7	2	0.0		30										False	Shikimates and Phenylpropanoids		False	False	Peptide01		-1.0	Compound(2930429)	2930429	4.1	28			[#6]-[#6](-[#6])(-[#6])-[#6]1:[#6]:[#6]:[#6](-[#16](=[#8])(=[#8])-[#7]-[#6](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#8]):[#6]:[#6]:1	CC(C)(C)c1ccc(S(=O)(=O)NC(Cc2ccccc2)C(=O)O)cc1	AJHUCLCRIWTQMB		parent_pubchem_cid	((4-(tert-butyl)phenyl)sulfonyl)phenylalanine;159856-01-6;SMR000136061;MLS000531078;2-[(4-tert-butylphenyl)sulfonylamino]-3-phenylpropanoic acid;N-([4-(TERT-BUTYL)PHENYL]SULFONYL)PHENYLALANINE;Cambridge id 7210500;Oprea1_340066;CHEMBL1334727;HMS2455J23;AKOS000805771;AKOS016375378;EU-0045573;N-[(4-tert-butylphenyl)sulfonyl]phenylalanine;EN300-240187;SR-01000665884;SR-01000665884-2;Z45636883;F1174-2311;2-(4-TERT-BUTYLBENZENESULFONAMIDO)-3-PHENYLPROPANOIC ACID;2-[(4-tert-butylphenyl)sulfonylamino]-3-phenyl-propanoic acid	False	663014.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=663014		pluskal_iocb_peptide_Peptide01_A4_id		100	A4	False	
1.8		0	145	P0124050177	94.1		A30	False	0	15	0	0	21	0	1	6	0	0		0.0						COc1cc(C(=O)NC(C(=O)O)C(C)C)cc(OC)c1OC								Valine and derivatives;N-acyl-alpha amino acids;Phenoxy compounds;Methoxybenzenes;Benzoyl derivatives;Anisoles;Alkyl aryl ethers;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Anisoles;Benzamides;Benzene and substituted derivatives;Benzenoids;Benzoic acids and derivatives;Benzoyl derivatives;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Ethers;Hippuric acids;Hippuric acids and derivatives;Hydrocarbon derivatives;Methoxybenzenes;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenol ethers;Phenoxy compounds;Secondary carboxylic acid amides;Valine and derivatives	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as hippuric acids. These are compounds containing hippuric acid, which consists of a of a benzoyl group linked to the N-terminal of a glycine.	Hippuric acids		Benzamides;Hippuric acids and derivatives	Organic compounds	Aromatic homomonocyclic compounds	valine derivative (CHEBI:27267);N-acyl-amino acid (CHEBI:51569);benzenes (CHEBI:22712);methoxybenzene (CHEBI:51683);carbonyl compound (CHEBI:36586);aromatic ether (CHEBI:35618);carboxamide (CHEBI:37622);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);N-acylglycine (CHEBI:16180);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);amino acid (CHEBI:33709);peptide (CHEBI:16670);benzenoid aromatic compound (CHEBI:33836);oxygen molecular entity (CHEBI:25806);ether (CHEBI:25698);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);benzamides (CHEBI:22702);phenols (CHEBI:33853)		Benzoic acids and derivatives	Valine or derivatives;Hippuric acid;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;Alpha-amino acid or derivatives;Phenoxy compound;Anisole;Benzoyl;Methoxybenzene;Phenol ether;Alkyl aryl ether;Carboxamide group;Secondary carboxylic acid amide;Monocarboxylic acid or derivatives;Ether;Carboxylic acid;Carboxylic acid derivative;Organic oxygen compound;Hydrocarbon derivative;Organic nitrogen compound;Carbonyl group;Organic oxide;Organopnictogen compound;Organooxygen compound;Organonitrogen compound;Aromatic homomonocyclic compound	Benzenoids	0.0		3-methyl-2-[(3,4,5-trimethoxybenzoyl)amino]butanoic acid	DTXSID30383070	2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C15H21NO6	C15H21NO6			InChI=1S/C15H21NO6/c1-8(2)12(15(18)19)16-14(17)9-6-10(20-3)13(22-5)11(7-9)21-4/h6-8,12H,1-5H3,(H,16,17)(H,18,19)	QTUHHHIOMGXNRY-UHFFFAOYSA-N	3-methyl-2-[(3,4,5-trimethoxybenzoyl)amino]butanoic acid	2787708	COc1cc(C(=O)NC(C(=O)O)C(C)C)cc(OC)c1OC	3-methyl-2-[(3,4,5-trimethoxybenzoyl)amino]butanoic acid			0.1094600000000005													MCULE-4440694587	311.33772		311.136887	6	2	7	1			43										False	Alkaloids				Peptide01			Compound(2787708)	2787708	2.1	29			[#6]-[#8]-[#6]1:[#6]:[#6](-[#6](=[#8])-[#7]-[#6](-[#6](=[#8])-[#8])-[#6](-[#6])-[#6]):[#6]:[#6](-[#8]-[#6]):[#6]:1-[#8]-[#6]	COc1cc(C(=O)NC(C(=O)O)C(C)C)cc(OC)c1OC	QTUHHHIOMGXNRY		parent_pubchem_cid	3-methyl-2-[(3,4,5-trimethoxybenzoyl)amino]butanoic acid;93709-68-3;CBDivE_013766;CBKinase1_000447;CBKinase1_012847;Cambridge id 5146698;Oprea1_617396;DTXSID30383070;3-methyl-2-[(3,4,5-trimethoxyphenyl)formamido]butanoic acid;MFCD00405582;STL372816;AKOS001581923;AKOS016044997;N-[(3,4,5-trimethoxyphenyl)carbonyl]valine;EN300-08373;AB00074451-01;SR-01000395975;SR-01000395975-1;3-methyl-2-(3,4,5-trimethoxybenzamido)butanoic acid;BRD-A03184879-001-01-2;F0900-2242;3-METHYL-2-[(3,4,5-TRIMETHOXYBENZOYL)AMINO]BUTANOICACID		22923882.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22923882		pluskal_iocb_peptide_Peptide01_A4_id		100	A4		
-0.9		0	233	P7118030744	125.3		A31	False	0	16	0	0	21	0	1	7	0	0		0.0						CC(=O)NC1C(Oc2ccc(C(C)=O)cc2)OC(CO)C(O)C1O																							0.0		N-[2-(4-acetylphenoxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	1	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	3	3	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C16H21NO7	C16H21NO7			InChI=1S/C16H21NO7/c1-8(19)10-3-5-11(6-4-10)23-16-13(17-9(2)20)15(22)14(21)12(7-18)24-16/h3-6,12-16,18,21-22H,7H2,1-2H3,(H,17,20)	OVHOAEHEUDCBPZ-UHFFFAOYSA-N	N-[2-(4-acetylphenoxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-3-yl]acetamide	4634585	CC(=O)NC1C(Oc2ccc(C(C)=O)cc2)OC(CO)C(O)C1O	N-[2-(4-acetylphenoxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide			-1.3054199999999996													MCULE-1333533126	339.34827		339.131802	7	4	5	2			45									Aminosugars	True	Carbohydrates	Aminosugars and aminoglycosides			Peptide01			Compound(4634585)	4634585	-0.7	30			[#6]-[#6](=[#8])-[#7]-[#6]1-[#6](-[#8]-[#6]2:[#6]:[#6]:[#6](-[#6](-[#6])=[#8]):[#6]:[#6]:2)-[#8]-[#6](-[#6]-[#8])-[#6](-[#8])-[#6]-1-[#8]	CC(=O)NC1C(Oc2ccc(C(C)=O)cc2)OC(CO)C(O)C1O	OVHOAEHEUDCBPZ		parent_pubchem_cid	N-[2-(4-acetylphenoxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide;1093406-67-7;AKOS001204750;AKOS016297428;UPCMLD0ENAT5509617:001;AB00674666-01;AB00674666-02;Z55186851;N-[2-(4-acetylphenoxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-3-yl]acetamide		23976810.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23976810		pluskal_iocb_peptide_Peptide01_A4_id		100	A4		
3.5		0	321	P4797233	84.4		A32	False	0	21	0	3	21	0	6	2	0	0		0.0						COc1cccc(Nc2nc(N3CCOCC3)nc(Nc3cccc(C(F)(F)F)c3)n2)c1																							0.0		898648-12-9		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1		C21H21F3N6O2	C21H21F3N6O2			InChI=1S/C21H21F3N6O2/c1-31-17-7-3-6-16(13-17)26-19-27-18(28-20(29-19)30-8-10-32-11-9-30)25-15-5-2-4-14(12-15)21(22,23)24/h2-7,12-13H,8-11H2,1H3,(H2,25,26,27,28,29)	QZPBQOJGSNLVTJ-UHFFFAOYSA-N	N4-(3-methoxyphenyl)-6-morpholino-N2-[3-(trifluoromethyl)phenyl]-1,3,5-triazine-2,4-diamine	18580142	COc1cccc(Nc2nc(N3CCOCC3)nc(Nc3cccc(C(F)(F)F)c3)n2)c1	2-N-(3-methoxyphenyl)-6-morpholin-4-yl-4-N-[3-(trifluoromethyl)phenyl]-1,3,5-triazine-2,4-diamine			1.8026300000000004													MCULE-2339839053	446.43572		446.167809	8	2	7	4			44										False	Alkaloids				Peptide01			Compound(18580142)	18580142	4.7	31			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6](-[#7]-[#6]2:[#7]:[#6](-[#7]3-[#6]-[#6]-[#8]-[#6]-[#6]-3):[#7]:[#6](-[#7]-[#6]3:[#6]:[#6]:[#6]:[#6](-[#6](-[#9])(-[#9])-[#9]):[#6]:3):[#7]:2):[#6]:1	COc1cccc(Nc2nc(N3CCOCC3)nc(Nc3cccc(C(F)(F)F)c3)n2)c1	QZPBQOJGSNLVTJ		parent_pubchem_cid	898648-12-9;N2-(3-methoxyphenyl)-6-morpholino-N4-(3-(trifluoromethyl)phenyl)-1,3,5-triazine-2,4-diamine;2-N-(3-methoxyphenyl)-6-morpholin-4-yl-4-N-[3-(trifluoromethyl)phenyl]-1,3,5-triazine-2,4-diamine;N2-(3-METHOXYPHENYL)-6-(MORPHOLIN-4-YL)-N4-[3-(TRIFLUOROMETHYL)PHENYL]-1,3,5-TRIAZINE-2,4-DIAMINE;AKOS016386117;F2703-0241;N4-(3-methoxyphenyl)-6-morpholino-N2-[3-(trifluoromethyl)phenyl]-1,3,5-triazine-2,4-diamine		16570851.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=16570851		pluskal_iocb_peptide_Peptide01_A4_id		100	A4		ZINC000009708826
3.4		0	65	P7112891475	76.7		A33	False	0	22	0	0	20	0	2	4	0	0		0.0						COc1ccccc1NC(=O)c1ccc(C(=O)Nc2ccccc2OC)cc1																							0.0		N,N'-Bis(o-methoxyphenyl)terephthalamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C22H20N2O4	C22H20N2O4			InChI=1S/C22H20N2O4/c1-27-19-9-5-3-7-17(19)23-21(25)15-11-13-16(14-12-15)22(26)24-18-8-4-6-10-20(18)28-2/h3-14H,1-2H3,(H,23,25)(H,24,26)	JRZCFDYNUTXOCW-UHFFFAOYSA-N	N1,N4-bis(2-methoxyphenyl)terephthalamide	142075	COc1ccccc1NC(=O)c1ccc(C(=O)Nc2ccccc2OC)cc1	1-N,4-N-bis(2-methoxyphenyl)benzene-1,4-dicarboxamide			2.4129400000000008													MCULE-4675617487	376.4157		376.142307	4	2	6	3			44									Anthranillic acid derivatives	False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(142075)	142075	4.1	32			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#6](=[#8])-[#7]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#8]-[#6]):[#6]:[#6]:1	COc1ccccc1NC(=O)c1ccc(C(=O)Nc2ccccc2OC)cc1	JRZCFDYNUTXOCW		parent_pubchem_cid	N,N'-Bis(o-methoxyphenyl)terephthalamide;36360-34-6;Oprea1_015873;DTXSID50957691;AKOS001390229;EU-0009835;SR-01000478053;SR-01000478053-1;N~1~,N~4~-Bis(2-methoxyphenyl)benzene-1,4-dicarboxamide;N1,N4-BIS(2-METHOXYPHENYL)BENZENE-1,4-DICARBOXAMIDE;N1,N4-bis(2-methoxyphenyl)terephthalamide		8359447.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=8359447		pluskal_iocb_peptide_Peptide01_A5_id		100	A5		ZINC000000953723
4.5		0	153	P0124100015	119.0		A34	False	0	26	0	0	23	0	1	7	0	0		0.0						CCc1ccc(NC(=O)C(OC(=O)c2ccccc2)C(OC(=O)c2ccccc2)C(=O)O)cc1																							0.0		2,3-bis(benzoyloxy)-4-((4-ethylphenyl)amino)-4-oxobutanoic acid		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	4	1	0	0	0	0	0	2	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C26H23NO7	C26H23NO7			InChI=1S/C26H23NO7/c1-2-17-13-15-20(16-14-17)27-23(28)21(33-25(31)18-9-5-3-6-10-18)22(24(29)30)34-26(32)19-11-7-4-8-12-19/h3-16,21-22H,2H2,1H3,(H,27,28)(H,29,30)	BMRBVRCSVFQNPL-UHFFFAOYSA-N	2,3-dibenzoyloxy-4-(4-ethylanilino)-4-oxo-butanoic acid	2787747	CCc1ccc(NC(=O)C(OC(=O)c2ccccc2)C(OC(=O)c2ccccc2)C(=O)O)cc1	2,3-dibenzoyloxy-4-(4-ethylanilino)-4-oxobutanoic acid			3.178560000000001													MCULE-2830985135	461.47571		461.147452	7	2	11	3			45										False					Peptide01			Compound(2787747)	2787747	4.7	33			[#6]-[#6]-[#6]1:[#6]:[#6]:[#6](-[#7]-[#6](=[#8])-[#6](-[#8]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](-[#8]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#8]):[#6]:[#6]:1	CCc1ccc(NC(=O)C(OC(=O)c2ccccc2)C(OC(=O)c2ccccc2)C(=O)O)cc1	BMRBVRCSVFQNPL		parent_pubchem_cid	2,3-bis(benzoyloxy)-4-((4-ethylphenyl)amino)-4-oxobutanoic acid;2,3-bis(benzoyloxy)-4-[(4-ethylphenyl)amino]-4-oxobutanoic acid;MFCD00790257;AKOS002266912;AKOS016312121;F3284-0868;2,3-dibenzoyloxy-4-(4-ethylanilino)-4-oxo-butanoic acid		24011005.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24011005		pluskal_iocb_peptide_Peptide01_A5_id		100	A5		
4.9		0	241	P1094969	61.9		A35	False	0	28	0	2	29	0	3	3	0	0		0.0						COC(=O)C(Cc1ccccc1)NC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1																							0.0		AKOS005533520		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1		C28H29F2N3O3	C28H29F2N3O3			InChI=1S/C28H29F2N3O3/c1-36-27(34)25(19-20-5-3-2-4-6-20)31-28(35)33-17-15-32(16-18-33)26(21-7-11-23(29)12-8-21)22-9-13-24(30)14-10-22/h2-14,25-26H,15-19H2,1H3,(H,31,35)/t25-/m0/s1	UHDAASJMMFQMAG-VWLOTQADSA-N	methyl rac-(2S)-2-[[4-[bis(4-fluorophenyl)methyl]piperazine-1-carbonyl]amino]-3-phenyl-propanoate	17580908	COC(=O)[C@H](Cc1ccccc1)NC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1	methyl (2S)-2-[[4-[bis(4-fluorophenyl)methyl]piperazine-1-carbonyl]amino]-3-phenylpropanoate			4.001570000000003													MCULE-9960554887	493.55843		493.217698	4	1	8	4			44										False	Alkaloids				Peptide01			Compound(17580908)	17580908	4.7	34			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#7]1-[#6]-[#6]-[#7](-[#6](-[#6]2:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:2)-[#6]2:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:2)-[#6]-[#6]-1	COC(=O)[C@H](Cc1ccccc1)NC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1	UHDAASJMMFQMAG		parent_pubchem_cid	AKOS005533520;METHYL (2S)-2-[({4-[BIS(4-FLUOROPHENYL)METHYL]PIPERAZINO}CARBONYL)AMINO]-3-PHENYLPROPANOATE;methyl rac-(2S)-2-[[4-[bis(4-fluorophenyl)methyl]piperazine-1-carbonyl]amino]-3-phenyl-propanoate		7160079.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=7160079		pluskal_iocb_peptide_Peptide01_A5_id		100	A5		ZINC000020403774
0.7		0	329	P1098603	95.9		A36	False	0	18	0	0	23	0	1	5	0	0		0.0						CCc1cc(=O)oc2c1ccc(O)c2CNC(C(=O)O)C(C)CC																							0.0		STK921390		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C18H23NO5	C18H23NO5			InChI=1S/C18H23NO5/c1-4-10(3)16(18(22)23)19-9-13-14(20)7-6-12-11(5-2)8-15(21)24-17(12)13/h6-8,10,16,19-20H,4-5,9H2,1-3H3,(H,22,23)/t10-,16+/m1/s1	MTYHBWBJOZPTDY-HWPZZCPQSA-N	rac-(2S,3R)-2-[(4-ethyl-7-hydroxy-2-oxo-chromen-8-yl)methylamino]-3-methyl-pentanoic acid	24279892	CCc1cc(=O)oc2c1ccc(O)c2CN[C@H](C(=O)O)[C@H](C)CC	(2S,3R)-2-[(4-ethyl-7-hydroxy-2-oxochromen-8-yl)methylamino]-3-methylpentanoic acid			2.5495400000000004													MCULE-5672571318	333.38771		333.157623	6	3	7	2			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(24279892)	24279892	0.9	35			[#6]-[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]):[#6]:2-[#6]-[#7]-[#6@H](-[#6](=[#8])-[#8])-[#6@H](-[#6])-[#6]-[#6]	CCc1cc(=O)oc2c1ccc(O)c2CN[C@H](C(=O)O)[C@H](C)CC	MTYHBWBJOZPTDY		parent_pubchem_cid	STK921390;AKOS016387020;N-[(4-ethyl-7-hydroxy-2-oxo-2H-chromen-8-yl)methyl]-L-isoleucine;2-{[(4-ETHYL-7-HYDROXY-2-OXO-2H-CHROMEN-8-YL)METHYL]AMINO}-3-METHYLPENTANOIC ACID;rac-(2S,3R)-2-[(4-ethyl-7-hydroxy-2-oxo-chromen-8-yl)methylamino]-3-methyl-pentanoic acid		13240380.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=13240380		pluskal_iocb_peptide_Peptide01_A5_id		100	A5		ZINC000011866845
2.3		0	73	P7211760310	200.6		A37	False	0	19	0	0	19	0	7	2	0	3		0.0						Cc1cc(C)nc(NS(=O)(=O)c2ccc(Nc3nc(-c4c(C)nc(N)s4)cs3)cc2)n1								Benzenesulfonyl compounds;Aniline and substituted anilines;2,4,5-trisubstituted thiazoles;2,4-disubstituted thiazoles;Pyrimidines and pyrimidine derivatives;Organosulfonamides;2-amino-1,3-thiazoles;Heteroaromatic compounds;Aminosulfonyl compounds;Secondary amines;Azacyclic compounds;Primary amines;Organopnictogen compounds;Organic oxides;Hydrocarbon derivatives	2,4,5-trisubstituted thiazoles;2,4-disubstituted thiazoles;2-amino-1,3-thiazoles;Amines;Aminosulfonyl compounds;Aminothiazoles;Aniline and substituted anilines;Azacyclic compounds;Azoles;Benzene and substituted derivatives;Benzenesulfonamides;Benzenesulfonyl compounds;Benzenoids;Chemical entities;Diazines;Heteroaromatic compounds;Hydrocarbon derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organic sulfonic acids and derivatives;Organoheterocyclic compounds;Organonitrogen compounds;Organopnictogen compounds;Organosulfonamides;Organosulfonic acids and derivatives;Organosulfur compounds;Primary amines;Pyrimidines and pyrimidine derivatives;Secondary amines;Sulfonyls;Thiazoles	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring.	Benzenesulfonamides			Organic compounds	Aromatic heteromonocyclic compounds	benzenes (CHEBI:22712);organosulfur compound (CHEBI:33261);anilines (CHEBI:22562);thiazoles (CHEBI:48901);pyrimidines (CHEBI:39447);sulfonamide (CHEBI:35358);1,3-thiazole (CHEBI:38418);organic aromatic compound (CHEBI:33659);organonitrogen compound (CHEBI:35352);secondary amine (CHEBI:32863);organonitrogen heterocyclic compound (CHEBI:38101);primary amine (CHEBI:32877);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);organic heterocyclic compound (CHEBI:24532);azole (CHEBI:68452);diazines (CHEBI:38313);organooxygen compound (CHEBI:36963);sulfonic acid derivative (CHEBI:33552);sulfone (CHEBI:35850);nitrogen molecular entity (CHEBI:51143);amine (CHEBI:32952);oxygen molecular entity (CHEBI:25806)		Benzenesulfonamides	Benzenesulfonamide;Benzenesulfonyl group;2,4,5-trisubstituted 1,3-thiazole;Aniline or substituted anilines;2,4-disubstituted 1,3-thiazole;Pyrimidine;Organosulfonic acid amide;1,3-thiazol-2-amine;Azole;Organic sulfonic acid or derivatives;Organosulfonic acid or derivatives;Sulfonyl;Thiazole;Aminosulfonyl compound;Heteroaromatic compound;Secondary amine;Organoheterocyclic compound;Azacycle;Amine;Organic oxygen compound;Organic oxide;Primary amine;Organosulfur compound;Hydrocarbon derivative;Organic nitrogen compound;Organopnictogen compound;Organonitrogen compound;Aromatic heteromonocyclic compound	Benzenoids	0.0		4-[[4-(2-amino-4-methyl-1,3-thiazol-5-yl)-1,3-thiazol-2-yl]amino]-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide	DTXSID50364664	2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	1	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	2	0	0	1	0	0	0	0	0	0	0		C19H19N7O2S3	C19H19N7O2S3			InChI=1S/C19H19N7O2S3/c1-10-8-11(2)22-18(21-10)26-31(27,28)14-6-4-13(5-7-14)24-19-25-15(9-29-19)16-12(3)23-17(20)30-16/h4-9H,1-3H3,(H2,20,23)(H,24,25)(H,21,22,26)	ZRDJWNISISVUHP-UHFFFAOYSA-N	4-[[4-(2-amino-4-methyl-thiazol-5-yl)thiazol-2-yl]amino]-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide	1632887	Cc1cc(C)nc(NS(=O)(=O)c2ccc(Nc3nc(-c4c(C)nc(N)s4)cs3)cc2)n1	4-[[4-(2-amino-4-methyl-1,3-thiazol-5-yl)-1,3-thiazol-2-yl]amino]-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide			1.93386													MCULE-1654295333	473.60098		473.076236	8	3	6	4			43										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(1632887)	1632887	3.5	36			[#6]-[#6]1:[#6]:[#6](-[#6]):[#7]:[#6](-[#7]-[#16](=[#8])(=[#8])-[#6]2:[#6]:[#6]:[#6](-[#7]-[#6]3:[#7]:[#6](-[#6]4:[#6](-[#6]):[#7]:[#6](-[#7]):[#16]:4):[#6]:[#16]:3):[#6]:[#6]:2):[#7]:1	Cc1cc(C)nc(NS(=O)(=O)c2ccc(Nc3nc(-c4c(C)nc(N)s4)cs3)cc2)n1	ZRDJWNISISVUHP		parent_pubchem_cid	4-[[4-(2-amino-4-methyl-1,3-thiazol-5-yl)-1,3-thiazol-2-yl]amino]-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide;5766-31-4;CBMicro_032220;ChemDiv1_009075;MixCom6_001884;Oprea1_041378;Oprea1_480465;HMS612M11;DTXSID50364664;AKOS002382659;BIM-0032142.P001;SR-01000477280;SR-01000477280-1;4-[(2'-amino-4'-methyl-4,5'-bi-1,3-thiazol-2-yl)amino]-N-(4,6-dimethyl-2-pyrimidinyl)benzenesulfonamide;4-[[4-(2-amino-4-methyl-thiazol-5-yl)thiazol-2-yl]amino]-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide		15756059.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=15756059		pluskal_iocb_peptide_Peptide01_A5_id		100	A5		ZINC000001895800
2.9		0	161	P0110830293	66.4		A38	False	0	13	1	0	16	0	1	3	0	0		0.0						CC(C)CC(NC(=O)c1ccccc1Cl)C(=O)O																							0.0		Oprea1_076406		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C13H16ClNO3	C13H16ClNO3			InChI=1S/C13H16ClNO3/c1-8(2)7-11(13(17)18)15-12(16)9-5-3-4-6-10(9)14/h3-6,8,11H,7H2,1-2H3,(H,15,16)(H,17,18)	OBOAWEJPTDTTMB-UHFFFAOYSA-N	2-[(2-chlorobenzoyl)amino]-4-methyl-pentanoic acid	2787249	CC(C)CC(NC(=O)c1ccccc1Cl)C(=O)O	2-[(2-chlorobenzoyl)amino]-4-methylpentanoic acid			2.514390000000001													MCULE-9552765487	269.73037		269.081871	3	2	5	1			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(2787249)	2787249	3.1	37			[#6]-[#6](-[#6])-[#6]-[#6](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#17])-[#6](=[#8])-[#8]	CC(C)CC(NC(=O)c1ccccc1Cl)C(=O)O	OBOAWEJPTDTTMB		parent_pubchem_cid	Oprea1_076406;Oprea1_754171;CBDivE_010489;2-[(2-chlorophenyl)formamido]-4-methylpentanoicacid;F0910-0334;HMS1608D02;MFCD00522752;AKOS000131519;AKOS016040443;NCGC00328541-01;2-(2-chlorobenzamido)-4-methylpentanoic acid;AB00275443-03;SR-01000405689;SR-01000405689-1;2-[(2-chlorobenzoyl)amino]-4-methyl-pentanoic acid		23710262.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23710262		pluskal_iocb_peptide_Peptide01_A5_id		100	A5		
1.0		0	249	P1331803	104.7		A39	False	0	17	0	0	22	0	2	5	0	0		0.0						CCC(NC(=O)c1ccc(CNC(=O)C2CCCO2)cc1)C(=O)O																							0.0		AKOS016379427		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C17H22N2O5	C17H22N2O5			InChI=1S/C17H22N2O5/c1-2-13(17(22)23)19-15(20)12-7-5-11(6-8-12)10-18-16(21)14-4-3-9-24-14/h5-8,13-14H,2-4,9-10H2,1H3,(H,18,21)(H,19,20)(H,22,23)	QCKAQRKQYRREBJ-UHFFFAOYSA-N	2-[[4-[(tetrahydrofuran-2-carbonylamino)methyl]benzoyl]amino]butanoic acid	71683685	CCC(NC(=O)c1ccc(CNC(=O)C2CCCO2)cc1)C(=O)O	2-[[4-[(oxolane-2-carbonylamino)methyl]benzoyl]amino]butanoic acid			0.965379999999999													MCULE-1258423195	334.37529		334.152872	5	3	7	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(71683685)	71683685	1.2	38			[#6]-[#6]-[#6](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#6]-[#7]-[#6](=[#8])-[#6]2-[#6]-[#6]-[#6]-[#8]-2):[#6]:[#6]:1)-[#6](=[#8])-[#8]	CCC(NC(=O)c1ccc(CNC(=O)C2CCCO2)cc1)C(=O)O	QCKAQRKQYRREBJ		parent_pubchem_cid	AKOS016379427;2-[[4-[(tetrahydrofuran-2-carbonylamino)methyl]benzoyl]amino]butanoic acid		63752742.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=63752742		pluskal_iocb_peptide_Peptide01_A5_id		100	A5		
3.3		0	337	P1647318	49.4		A40	False	0	22	0	0	26	0	2	2	0	0		0.0						O=C(Cc1ccccc1)NC(Cc1ccccc1)C(=O)N1CCCCC1																							0.0		AKOS027475293		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0		C22H26N2O2	C22H26N2O2			InChI=1S/C22H26N2O2/c25-21(17-19-12-6-2-7-13-19)23-20(16-18-10-4-1-5-11-18)22(26)24-14-8-3-9-15-24/h1-2,4-7,10-13,20H,3,8-9,14-17H2,(H,23,25)/t20-/m0/s1	AKDCXBNGCABAKQ-FQEVSTJZSA-N	2-phenyl-N-[rac-(1S)-1-benzyl-2-oxo-2-(1-piperidyl)ethyl]acetamide	110347369	O=C(Cc1ccccc1)N[C@@H](Cc1ccccc1)C(=O)N1CCCCC1	N-[(2S)-1-oxo-3-phenyl-1-piperidin-1-ylpropan-2-yl]-2-phenylacetamide			2.859680000000001														350.46472		350.199428	2	1	6	3			45									Tripeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(110347369)	110347369	3.5	39			[#8]=[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#7]1-[#6]-[#6]-[#6]-[#6]-[#6]-1	O=C(Cc1ccccc1)N[C@@H](Cc1ccccc1)C(=O)N1CCCCC1	AKDCXBNGCABAKQ		parent_pubchem_cid	AKOS027475293;2-phenyl-N-[rac-(1S)-1-benzyl-2-oxo-2-(1-piperidyl)ethyl]acetamide		17746245.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=17746245		pluskal_iocb_peptide_Peptide01_A5_id		100	A5		ZINC000034931465
0.9		0	81	P0127442333	144.4		A41	False	0	20	0	0	22	0	4	4	0	0		0.0						NC(=O)c1ccccc1NC(=O)CCCCC(=O)Nc1ccccc1C(N)=O																							0.0		N,N'-bis(2-carbamoylphenyl)hexanediamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	4	0	0	0	0	0	0	0	0	0	0	4	0	0	0	0	0	0	0	0	0	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C20H22N4O4	C20H22N4O4			InChI=1S/C20H22N4O4/c21-19(27)13-7-1-3-9-15(13)23-17(25)11-5-6-12-18(26)24-16-10-4-2-8-14(16)20(22)28/h1-4,7-10H,5-6,11-12H2,(H2,21,27)(H2,22,28)(H,23,25)(H,24,26)	WLLPZNOSCPETGF-UHFFFAOYSA-N	N,N'-bis(2-carbamoylphenyl)hexanediamide	1590851	NC(=O)c1ccccc1NC(=O)CCCCC(=O)Nc1ccccc1C(N)=O	N,N'-bis(2-carbamoylphenyl)hexanediamide			1.1513599999999995													MCULE-2921258082	382.42274		382.164105	4	4	9	2			43									Anthranillic acid derivatives;Pyridine alkaloids;Simple amide alkaloids	False	Alkaloids	Nicotinic acid alkaloids;Anthranilic acid alkaloids;Peptide alkaloids			Peptide01			Compound(1590851)	1590851	1.4	40			[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#7]-[#6](=[#8])-[#6]-[#6]-[#6]-[#6]-[#6](=[#8])-[#7]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#6](-[#7])=[#8]	NC(=O)c1ccccc1NC(=O)CCCCC(=O)Nc1ccccc1C(N)=O	WLLPZNOSCPETGF		parent_pubchem_cid	N,N'-bis(2-carbamoylphenyl)hexanediamide;N,N'-bis[2-(aminocarbonyl)phenyl]hexanediamide;CDS1_003784;CBMicro_017288;DivK1c_004824;CCG-6070;STK050768;AKOS000484894;BIM-0017399.P001;AN-329/10738032;N~1~,N~6~-bis[2-(aminocarbonyl)phenyl]hexanediamide		3388938.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=3388938		pluskal_iocb_peptide_Peptide01_A6_id		100	A6		ZINC000001807094
3.5		0	169	P7020554655	84.2		A42	False	0	20	1	0	18	0	3	3	0	0		0.0						Cc1cc(NC(=O)C(Cc2ccccc2)NC(=O)c2cc(Cl)ccc2)no1																							0.0		AKOS005578201		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C20H18ClN3O3	C20H18ClN3O3			InChI=1S/C20H18ClN3O3/c1-13-10-18(24-27-13)23-20(26)17(11-14-6-3-2-4-7-14)22-19(25)15-8-5-9-16(21)12-15/h2-10,12,17H,11H2,1H3,(H,22,25)(H,23,24,26)/t17-/m0/s1	OSARGDWXFJAIDP-KRWDZBQOSA-N	N-[(1S)-1-benzyl-2-[(5-methylisoxazol-3-yl)amino]-2-oxo-ethyl]-3-chloro-benzamide	24315168	Cc1cc(NC(=O)[C@H](Cc2ccccc2)NC(=O)c2cc(Cl)ccc2)no1	3-chloro-N-[(2S)-1-[(5-methyl-1,2-oxazol-3-yl)amino]-1-oxo-3-phenylpropan-2-yl]benzamide			3.071480000000001													MCULE-8670693048	383.83776		383.103669	3	2	6	3			44										False					Peptide01			Compound(24315168)	24315168	3.9	41			[#6]-[#6]1:[#6]:[#6](-[#7]-[#6](=[#8])-[#6@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6](-[#17]):[#6]:[#6]:[#6]:2):[#7]:[#8]:1	Cc1cc(NC(=O)[C@H](Cc2ccccc2)NC(=O)c2cc(Cl)ccc2)no1	OSARGDWXFJAIDP		parent_pubchem_cid	AKOS005578201;N-[(1S)-1-benzyl-2-[(5-methylisoxazol-3-yl)amino]-2-oxo-ethyl]-3-chloro-benzamide		15256123.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=15256123		pluskal_iocb_peptide_Peptide01_A6_id		100	A6		ZINC000012028753
4.9		0	257	P1305416	63.4		A43	False	0	26	0	0	26	0	2	3	0	0		0.0						COc1ccc(C(CNC(=O)COc2ccc(C)cc2)c2c[nH]c3ccccc23)cc1																							0.0		N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-(4-methylphenoxy)acetamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C26H26N2O3	C26H26N2O3			InChI=1S/C26H26N2O3/c1-18-7-11-21(12-8-18)31-17-26(29)28-15-23(19-9-13-20(30-2)14-10-19)24-16-27-25-6-4-3-5-22(24)25/h3-14,16,23,27H,15,17H2,1-2H3,(H,28,29)	OOAUNMBNRPTQDR-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-(4-methylphenoxy)acetamide	17014566	COc1ccc(C(CNC(=O)COc2ccc(C)cc2)c2c[nH]c3ccccc23)cc1	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-(4-methylphenoxy)acetamide			3.2946500000000016													MCULE-5013244823	414.50872		414.194343	3	2	8	4			44										False	Alkaloids				Peptide01			Compound(17014566)	17014566	5.1	42			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6]-[#7]-[#6](=[#8])-[#6]-[#8]-[#6]2:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	COc1ccc(C(CNC(=O)COc2ccc(C)cc2)c2c[nH]c3ccccc23)cc1	OOAUNMBNRPTQDR		parent_pubchem_cid	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-(4-methylphenoxy)acetamide;STL207523;AKOS002335079;AKOS016326660		23461181.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23461181		pluskal_iocb_peptide_Peptide01_A6_id		100	A6		
2.8		0	345	P1157175	113.3		A44	False	0	19	0	0	26	0	8	0	0	1		0.0						S=C(NCc1ccccc1)NNc1nc(N2CCCC2)nc(N2CCCC2)n1																							0.0		898623-44-4		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	2		C19H26N8S	C19H26N8S			InChI=1S/C19H26N8S/c28-19(20-14-15-8-2-1-3-9-15)25-24-16-21-17(26-10-4-5-11-26)23-18(22-16)27-12-6-7-13-27/h1-3,8-9H,4-7,10-14H2,(H2,20,25,28)(H,21,22,23,24)	HYPYGRQCMMEMON-UHFFFAOYSA-N	1-benzyl-3-[(4,6-dipyrrolidin-1-yl-1,3,5-triazin-2-yl)amino]thiourea	7424252	S=C(NCc1ccccc1)NNc1nc(N2CCCC2)nc(N2CCCC2)n1	1-benzyl-3-[(4,6-dipyrrolidin-1-yl-1,3,5-triazin-2-yl)amino]thiourea			0.8666599999999995													MCULE-7508317588	398.53667		398.200114	7	3	8	4			43									Quinolizidine alkaloids	False	Alkaloids	Lysine alkaloids			Peptide01			Compound(7424252)	7424252	3.6	43			[#16]=[#6](-[#7]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#7]-[#6]1:[#7]:[#6](-[#7]2-[#6]-[#6]-[#6]-[#6]-2):[#7]:[#6](-[#7]2-[#6]-[#6]-[#6]-[#6]-2):[#7]:1	S=C(NCc1ccccc1)NNc1nc(N2CCCC2)nc(N2CCCC2)n1	HYPYGRQCMMEMON		parent_pubchem_cid	898623-44-4;1-benzyl-3-[(4,6-dipyrrolidin-1-yl-1,3,5-triazin-2-yl)amino]thiourea;N-benzyl-2-(4,6-di(pyrrolidin-1-yl)-1,3,5-triazin-2-yl)hydrazinecarbothioamide;1-benzyl-3-{[4,6-bis(pyrrolidin-1-yl)-1,3,5-triazin-2-yl]amino}thiourea;N-benzyl-2-[4,6-di(pyrrolidin-1-yl)-1,3,5-triazin-2-yl]hydrazinecarbothioamide;STL270246;AKOS016371770;VU0499607-1;F2797-0216;N-benzyl-2-(4,6-di(pyrrolidin-1-yl)-1,3,5-triazin-2-yl)hydrazine-1-carbothioamide		19951515.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=19951515		pluskal_iocb_peptide_Peptide01_A6_id		100	A6		ZINC000004941995
0.4		0	353	P1094944	139.3		B1	False	0	16	0	0	28	0	4	6	0	0		0.0						CC(C)C(NC(=O)N1CCN(C(=O)NC(C(=O)O)C(C)C)CC1)C(=O)O																							0.0		AKOS005533590		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	4	0	2	0	0	0	0	0	0	0	0	4	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C16H28N4O6	C16H28N4O6			InChI=1S/C16H28N4O6/c1-9(2)11(13(21)22)17-15(25)19-5-7-20(8-6-19)16(26)18-12(10(3)4)14(23)24/h9-12H,5-8H2,1-4H3,(H,17,25)(H,18,26)(H,21,22)(H,23,24)/t11-,12-/m0/s1	SYIQGUTWMBZDPS-RYUDHWBXSA-N	rac-(2S)-3-methyl-2-[[4-[[rac-(1S)-1-carboxy-2-methyl-propyl]carbamoyl]piperazine-1-carbonyl]amino]butanoic acid	7692689	CC(C)[C@H](NC(=O)N1CCN(C(=O)N[C@H](C(=O)O)C(C)C)CC1)C(=O)O	(2S)-2-[[4-[[(1S)-1-carboxy-2-methylpropyl]carbamoyl]piperazine-1-carbonyl]amino]-3-methylbutanoic acid			0.2416000000000017													MCULE-3825606280	372.42476		372.200885	6	4	6	1			44										False	Amino acids and Peptides	Small peptides			Peptide01			Compound(7692689)	7692689	0.6	44			[#6]-[#6](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#7]1-[#6]-[#6]-[#7](-[#6](=[#8])-[#7]-[#6@H](-[#6](=[#8])-[#8])-[#6](-[#6])-[#6])-[#6]-[#6]-1)-[#6](=[#8])-[#8]	CC(C)[C@H](NC(=O)N1CCN(C(=O)N[C@H](C(=O)O)C(C)C)CC1)C(=O)O	SYIQGUTWMBZDPS		parent_pubchem_cid	AKOS005533590;rac-(2S)-3-methyl-2-[[4-[[rac-(1S)-1-carboxy-2-methyl-propyl]carbamoyl]piperazine-1-carbonyl]amino]butanoic acid		23997457.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23997457		pluskal_iocb_peptide_Peptide01_A6_id		100	A6		ZINC000005450922
4.3		0	441	P1100543	127.2		B2	False	0	25	0	0	27	0	1	6	0	1		0.0						COc1c(C)c2c(cc1)c(C)c(CCC(=O)NC(CSCc1ccccc1)C(=O)O)c(=O)o2																							0.0		AKOS016386273		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C25H27NO6S	C25H27NO6S			InChI=1S/C25H27NO6S/c1-15-18-9-11-21(31-3)16(2)23(18)32-25(30)19(15)10-12-22(27)26-20(24(28)29)14-33-13-17-7-5-4-6-8-17/h4-9,11,20H,10,12-14H2,1-3H3,(H,26,27)(H,28,29)/t20-/m1/s1	DRPDQJXWWGSWPA-HXUWFJFHSA-N	rac-(2S)-3-benzylsulfanyl-2-[3-(7-methoxy-4,8-dimethyl-2-oxo-chromen-3-yl)propanoylamino]propanoic acid	24280137	COc1c(C)c2c(cc1)c(C)c(CCC(=O)N[C@H](CSCc1ccccc1)C(=O)O)c(=O)o2	(2S)-3-benzylsulfanyl-2-[3-(7-methoxy-4,8-dimethyl-2-oxochromen-3-yl)propanoylamino]propanoic acid			3.6440600000000014													MCULE-5226468747	469.56104		469.155909	7	2	10	3			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(24280137)	24280137	3.5	45			[#6]-[#8]-[#6]1:[#6](-[#6]):[#6]2:[#6](:[#6]:[#6]:1):[#6](-[#6]):[#6](-[#6]-[#6]-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#16]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]):[#6](=[#8]):[#8]:2	COc1c(C)c2c(cc1)c(C)c(CCC(=O)N[C@H](CSCc1ccccc1)C(=O)O)c(=O)o2	DRPDQJXWWGSWPA		parent_pubchem_cid	AKOS016386273;3-(BENZYLSULFANYL)-2-[3-(7-METHOXY-4,8-DIMETHYL-2-OXO-2H-CHROMEN-3-YL)PROPANAMIDO]PROPANOIC ACID;rac-(2S)-3-benzylsulfanyl-2-[3-(7-methoxy-4,8-dimethyl-2-oxo-chromen-3-yl)propanoylamino]propanoic acid		24532594.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24532594		pluskal_iocb_peptide_Peptide01_A6_id		100	A6		ZINC000011867581
2.2		0	529	P1045783	75.6		B3	False	0	14	0	0	19	0	1	4	0	0		0.0						COc1cccc(C(=O)NC(CC(C)C)C(=O)O)c1																							0.0		N-(3-methoxybenzoyl)leucine		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C14H19NO4	C14H19NO4			InChI=1S/C14H19NO4/c1-9(2)7-12(14(17)18)15-13(16)10-5-4-6-11(8-10)19-3/h4-6,8-9,12H,7H2,1-3H3,(H,15,16)(H,17,18)	MUMMHDPLNMLLKB-UHFFFAOYSA-N	2-[(3-methoxybenzoyl)amino]-4-methyl-pentanoic acid	16775397	COc1cccc(C(=O)NC(CC(C)C)C(=O)O)c1	2-[(3-methoxybenzoyl)amino]-4-methylpentanoic acid			1.40718													MCULE-8950513480	265.31183		265.131408	4	2	6	1			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(16775397)	16775397	2.5	46		SCHEMBL24283565	[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6](-[#6](=[#8])-[#7]-[#6](-[#6]-[#6](-[#6])-[#6])-[#6](=[#8])-[#8]):[#6]:1	COc1cccc(C(=O)NC(CC(C)C)C(=O)O)c1	MUMMHDPLNMLLKB		parent_pubchem_cid	N-(3-methoxybenzoyl)leucine;SCHEMBL24283565;2-[(3-METHOXYBENZOYL)AMINO]-4-METHYLPENTANOIC ACID;STL217729;N-[(3-methoxyphenyl)carbonyl]leucine;AKOS000131302;AKOS016041736;AS-871/03797016;2-[(3-methoxybenzoyl)amino]-4-methyl-pentanoic acid		23828882.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23828882		pluskal_iocb_peptide_Peptide01_A6_id		100	A6		
4.8		0	617	P1305573	45.3		B4	False	0	24	0	1	21	0	2	2	0	0		0.0						CN(C(=O)COc1ccc(F)cc1)C(c1ccccc1)c1c[nH]c2ccccc12																							0.0		STL207673		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C24H21FN2O2	C24H21FN2O2			InChI=1S/C24H21FN2O2/c1-27(23(28)16-29-19-13-11-18(25)12-14-19)24(17-7-3-2-4-8-17)21-15-26-22-10-6-5-9-20(21)22/h2-15,24,26H,16H2,1H3	SBVIQLKIJUMPBB-UHFFFAOYSA-N	2-(4-fluorophenoxy)-N-[1H-indol-3-yl(phenyl)methyl]-N-methyl-acetamide	17014710	CN(C(=O)COc1ccc(F)cc1)C(c1ccccc1)c1c[nH]c2ccccc12	2-(4-fluorophenoxy)-N-[1H-indol-3-yl(phenyl)methyl]-N-methylacetamide			3.933550000000003													MCULE-3067399584	388.44557		388.158706	2	1	6	4			45										False	Alkaloids				Peptide01			Compound(17014710)	17014710	4.8	47			[#6]-[#7](-[#6](=[#8])-[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:1)-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CN(C(=O)COc1ccc(F)cc1)C(c1ccccc1)c1c[nH]c2ccccc12	SBVIQLKIJUMPBB		parent_pubchem_cid	STL207673;AKOS001544227;AKOS016326741;2-(4-fluorophenoxy)-N-[1H-indol-3-yl(phenyl)methyl]-N-methylacetamide;2-(4-FLUOROPHENOXY)-N-[(1H-INDOL-3-YL)(PHENYL)METHYL]-N-METHYLACETAMIDE;2-(4-fluorophenoxy)-N-[1H-indol-3-yl(phenyl)methyl]-N-methyl-acetamide		24083852.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24083852		pluskal_iocb_peptide_Peptide01_A6_id		100	A6		
4.8		0	361	P6052685	73.5		B5	False	0	24	0	1	21	0	2	4	0	0		0.0						COC(=O)C(Cc1ccccc1)NC(=O)c1cc2c(cco2)n1Cc1ccccc1F								N-acyl-alpha amino acids and derivatives;Alpha amino acid esters;Amphetamines and derivatives;Furopyrroles;Pyrrole carboxamides;2-heteroaryl carboxamides;Fatty acid esters;Fluorobenzenes;Substituted pyrroles;Aryl fluorides;Methyl esters;Heteroaromatic compounds;Furans;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Azacyclic compounds;Oxacyclic compounds;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organofluorides;Organonitrogen compounds	2-heteroaryl carboxamides;Alpha amino acid esters;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Aryl fluorides;Aryl halides;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids and derivatives;Chemical entities;Fatty Acyls;Fatty acid esters;Fluorobenzenes;Furans;Furopyrroles;Halobenzenes;Heteroaromatic compounds;Hydrocarbon derivatives;Lipids and lipid-like molecules;Methyl esters;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organofluorides;Organohalogen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Oxacyclic compounds;Phenethylamines;Phenylalanine and derivatives;Pyrrole carboxamides;Pyrrole carboxylic acids and derivatives;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-amino acid (CHEBI:51569);alpha-amino acid ester (CHEBI:46874);amphetamines (CHEBI:35338);furopyrrole (CHEBI:64471);pyrroles (CHEBI:26455);carboxamide (CHEBI:37622);organic aromatic compound (CHEBI:33659);fatty acid ester (CHEBI:35748);organofluorine compound (CHEBI:37143);carboxylic ester (CHEBI:33308);furans (CHEBI:24129);monocarboxylic acid (CHEBI:25384);organonitrogen heterocyclic compound (CHEBI:38101);oxacycle (CHEBI:38104);carbonyl compound (CHEBI:36586);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);organooxygen compound (CHEBI:36963);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);primary amine (CHEBI:32877);organic heterocyclic compound (CHEBI:24532);amide (CHEBI:32988);lipid (CHEBI:18059);organohalogen compound (CHEBI:36684);haloarene (CHEBI:50887);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143)	Fatty esters (FA07);Fatty Acyls (FA)	Amino acids, peptides, and analogues	Phenylalanine or derivatives;Alpha-amino acid ester;N-acyl-alpha amino acid or derivatives;Amphetamine or derivatives;2-heteroaryl carboxamide;Furopyrrole;Pyrrole-2-carboxamide;Pyrrole-2-carboxylic acid or derivatives;Fatty acid ester;Fluorobenzene;Halobenzene;Aryl fluoride;Aryl halide;Monocyclic benzene moiety;Fatty acyl;Substituted pyrrole;Benzenoid;Methyl ester;Pyrrole;Furan;Heteroaromatic compound;Secondary carboxylic acid amide;Carboxamide group;Carboxylic acid ester;Organoheterocyclic compound;Azacycle;Monocarboxylic acid or derivatives;Oxacycle;Organic oxide;Organohalogen compound;Organofluoride;Carbonyl group;Organonitrogen compound;Hydrocarbon derivative;Organic nitrogen compound;Organic oxygen compound;Organooxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		STK940533		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C24H21FN2O4	C24H21FN2O4			InChI=1S/C24H21FN2O4/c1-30-24(29)19(13-16-7-3-2-4-8-16)26-23(28)21-14-22-20(11-12-31-22)27(21)15-17-9-5-6-10-18(17)25/h2-12,14,19H,13,15H2,1H3,(H,26,28)	IOAIJXCSWQZGKQ-UHFFFAOYSA-N	methyl 2-[[4-[(2-fluorophenyl)methyl]furo[3,2-b]pyrrole-5-carbonyl]amino]-3-phenyl-propanoate	45492403	COC(=O)C(Cc1ccccc1)NC(=O)c1cc2c(cco2)n1Cc1ccccc1F	methyl 2-[[4-[(2-fluorophenyl)methyl]furo[3,2-b]pyrrole-5-carbonyl]amino]-3-phenylpropanoate			3.343250000000001													MCULE-6206775369	420.44437		420.148535	3	1	8	4			45										False	Alkaloids				Peptide01			Compound(45492403)	45492403	4.4	48			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:[#8]:2):[#7]:1-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#9]	COC(=O)C(Cc1ccccc1)NC(=O)c1cc2c(cco2)n1Cc1ccccc1F	IOAIJXCSWQZGKQ		parent_pubchem_cid	STK940533;AKOS005669127;methyl N-{[4-(2-fluorobenzyl)-4H-furo[3,2-b]pyrrol-5-yl]carbonyl}phenylalaninate;methyl 2-[[4-[(2-fluorophenyl)methyl]furo[3,2-b]pyrrole-5-carbonyl]amino]-3-phenyl-propanoate		23199108.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23199108		pluskal_iocb_peptide_Peptide01_A7_id		100	A7		
2.4		0	449	P2195371	118.5		B6	False	0	19	1	0	23	0	4	3	0	1		0.0						COCCCNC(=O)C(Cc1ccccc1)NC(=O)c1nc(SC)ncc1Cl																							0.0		STL218833		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C19H23ClN4O3S	C19H23ClN4O3S			InChI=1S/C19H23ClN4O3S/c1-27-10-6-9-21-17(25)15(11-13-7-4-3-5-8-13)23-18(26)16-14(20)12-22-19(24-16)28-2/h3-5,7-8,12,15H,6,9-11H2,1-2H3,(H,21,25)(H,23,26)	ACKRFWQHUQAQFF-UHFFFAOYSA-N	N-[1-benzyl-2-(3-methoxypropylamino)-2-oxo-ethyl]-5-chloro-2-methylsulfanyl-pyrimidine-4-carboxamide	51065840	COCCCNC(=O)C(Cc1ccccc1)NC(=O)c1nc(SC)ncc1Cl	5-chloro-N-[1-(3-methoxypropylamino)-1-oxo-3-phenylpropan-2-yl]-2-methylsulfanylpyrimidine-4-carboxamide			2.12827													MCULE-7384812318	422.93716		422.117939	6	2	10	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51065840)	51065840	2.8	49			[#6]-[#8]-[#6]-[#6]-[#6]-[#7]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]1:[#7]:[#6](-[#16]-[#6]):[#7]:[#6]:[#6]:1-[#17]	COCCCNC(=O)C(Cc1ccccc1)NC(=O)c1nc(SC)ncc1Cl	ACKRFWQHUQAQFF		parent_pubchem_cid	STL218833;AKOS015861464;Nalpha-{[5-chloro-2-(methylsulfanyl)pyrimidin-4-yl]carbonyl}-N-(3-methoxypropyl)phenylalaninamide;N-[1-benzyl-2-(3-methoxypropylamino)-2-oxo-ethyl]-5-chloro-2-methylsulfanyl-pyrimidine-4-carboxamide		23132308.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23132308		pluskal_iocb_peptide_Peptide01_A7_id		100	A7		
3.5		0	537	P2193935	84.5		B7	False	0	24	0	0	30	0	2	4	0	0		0.0						COC(=O)C(Cc1ccccc1)NC(=O)CCNC(=O)c1ccc(C(C)(C)C)cc1																							0.0		STL217428		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C24H30N2O4	C24H30N2O4			InChI=1S/C24H30N2O4/c1-24(2,3)19-12-10-18(11-13-19)22(28)25-15-14-21(27)26-20(23(29)30-4)16-17-8-6-5-7-9-17/h5-13,20H,14-16H2,1-4H3,(H,25,28)(H,26,27)	BXRBICMYKCVENA-UHFFFAOYSA-N	methyl 2-[3-[(4-tert-butylbenzoyl)amino]propanoylamino]-3-phenyl-propanoate	51064812	COC(=O)C(Cc1ccccc1)NC(=O)CCNC(=O)c1ccc(C(C)(C)C)cc1	methyl 2-[3-[(4-tert-butylbenzoyl)amino]propanoylamino]-3-phenylpropanoate			2.84037													MCULE-7542569079	410.5177		410.220557	4	2	10	2			45										False	Amino acids and Peptides				Peptide01			Compound(51064812)	51064812	3.5	50			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]-[#6]-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6])(-[#6])-[#6]):[#6]:[#6]:1	COC(=O)C(Cc1ccccc1)NC(=O)CCNC(=O)c1ccc(C(C)(C)C)cc1	BXRBICMYKCVENA		parent_pubchem_cid	STL217428;AKOS015860110;methyl N-[(4-tert-butylphenyl)carbonyl]-beta-alanylphenylalaninate;methyl 2-[3-[(4-tert-butylbenzoyl)amino]propanoylamino]-3-phenyl-propanoate		22861436.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22861436		pluskal_iocb_peptide_Peptide01_A7_id		100	A7		
4.6		0	625	P1305816	36.1		B8	False	0	21	0	0	24	0	2	1	0	0		0.0						CCCCC(=O)N(C)C(c1ccccc1)c1c[nH]c2ccccc12																							0.0		N-[1H-indol-3-yl(phenyl)methyl]-N-methylpentanamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C21H24N2O	C21H24N2O			InChI=1S/C21H24N2O/c1-3-4-14-20(24)23(2)21(16-10-6-5-7-11-16)18-15-22-19-13-9-8-12-17(18)19/h5-13,15,21-22H,3-4,14H2,1-2H3	MFJUWLLYJQVNIF-UHFFFAOYSA-N	N-[1H-indol-3-yl(phenyl)methyl]-N-methyl-pentanamide	20895155	CCCCC(=O)N(C)C(c1ccccc1)c1c[nH]c2ccccc12	N-[1H-indol-3-yl(phenyl)methyl]-N-methylpentanamide			4.368060000000003													MCULE-4153682716	320.43823		320.188863	1	1	6	3			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(20895155)	20895155	4.4	51			[#6]-[#6]-[#6]-[#6]-[#6](=[#8])-[#7](-[#6])-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CCCCC(=O)N(C)C(c1ccccc1)c1c[nH]c2ccccc12	MFJUWLLYJQVNIF		parent_pubchem_cid	N-[1H-indol-3-yl(phenyl)methyl]-N-methylpentanamide;905779-95-5;AKOS001544254;AKOS016328387;NCGC00279222-01;AB01276284-01;N-[(1H-indol-3-yl)(phenyl)methyl]-N-methylpentanamide;Z1213699252;N-[1H-indol-3-yl(phenyl)methyl]-N-methyl-pentanamide		22629479.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22629479		pluskal_iocb_peptide_Peptide01_A7_id		100	A7		
3.8		0	369	P1100518	128.7		B9	False	0	23	1	0	19	0	2	6	0	0		0.0						Cc1c(CC(=O)NC(Cc2c[nH]c3ccccc23)C(=O)O)c(=O)oc2cc(O)c(Cl)cc12																							0.0		AKOS016379168		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C23H19ClN2O6	C23H19ClN2O6			InChI=1S/C23H19ClN2O6/c1-11-14-7-16(24)19(27)9-20(14)32-23(31)15(11)8-21(28)26-18(22(29)30)6-12-10-25-17-5-3-2-4-13(12)17/h2-5,7,9-10,18,25,27H,6,8H2,1H3,(H,26,28)(H,29,30)/t18-/m1/s1	XBPODIBQTQBLLU-GOSISDBHSA-N	rac-(2R)-2-[[2-(6-chloro-7-hydroxy-4-methyl-2-oxo-chromen-3-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid	24280129	Cc1c(CC(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)O)c(=O)oc2cc(O)c(Cl)cc12	(2R)-2-[[2-(6-chloro-7-hydroxy-4-methyl-2-oxochromen-3-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid			2.7128300000000003													MCULE-5435751359	454.87068		454.093164	6	4	6	4			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(24280129)	24280129	3.0	52			[#6]-[#6]1:[#6](-[#6]-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6](=[#8])-[#8]):[#6](=[#8]):[#8]:[#6]2:[#6]:[#6](-[#8]):[#6](-[#17]):[#6]:[#6]:1:2	Cc1c(CC(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)O)c(=O)oc2cc(O)c(Cl)cc12	XBPODIBQTQBLLU		parent_pubchem_cid	AKOS016379168;2-[2-(6-CHLORO-7-HYDROXY-4-METHYL-2-OXO-2H-CHROMEN-3-YL)ACETAMIDO]-3-(1H-INDOL-3-YL)PROPANOIC ACID;rac-(2R)-2-[[2-(6-chloro-7-hydroxy-4-methyl-2-oxo-chromen-3-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid		24245569.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24245569		pluskal_iocb_peptide_Peptide01_A7_id		100	A7		ZINC000011867574
4.7		0	457	P2195685	47.4		B10	False	0	24	0	0	29	0	3	2	0	0		0.0						Cc1nn(C)c(C)c1CN(C(=O)c1ccc(OCC(C)C)cc1)c1ccccc1																							0.0		AKOS015861721		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1		C24H29N3O2	C24H29N3O2			InChI=1S/C24H29N3O2/c1-17(2)16-29-22-13-11-20(12-14-22)24(28)27(21-9-7-6-8-10-21)15-23-18(3)25-26(5)19(23)4/h6-14,17H,15-16H2,1-5H3	NZESAQHLKAOXHO-UHFFFAOYSA-N	4-isobutoxy-N-phenyl-N-[(1,3,5-trimethylpyrazol-4-yl)methyl]benzamide	52232397	Cc1nn(C)c(C)c1CN(C(=O)c1ccc(OCC(C)C)cc1)c1ccccc1	4-(2-methylpropoxy)-N-phenyl-N-[(1,3,5-trimethylpyrazol-4-yl)methyl]benzamide			3.856880000000003													MCULE-2415034682	391.51763		391.225977	3	0	7	3			44										False	Alkaloids				Peptide01			Compound(52232397)	52232397	4.8	53			[#6]-[#6]1:[#7]:[#7](-[#6]):[#6](-[#6]):[#6]:1-[#6]-[#7](-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]-[#6](-[#6])-[#6]):[#6]:[#6]:1)-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	Cc1nn(C)c(C)c1CN(C(=O)c1ccc(OCC(C)C)cc1)c1ccccc1	NZESAQHLKAOXHO		parent_pubchem_cid	AKOS015861721;4-isobutoxy-N-phenyl-N-[(1,3,5-trimethylpyrazol-4-yl)methyl]benzamide		9646864.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=9646864		pluskal_iocb_peptide_Peptide01_A7_id		100	A7		ZINC000046086184
4.7		0	545	P1310231	54.6		B11	False	0	25	0	0	24	0	2	3	0	0		0.0						COc1ccc(C(c2c[nH]c3ccccc23)N(C)C(=O)c2ccccc2OC)cc1																							0.0		STL210962		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C25H24N2O3	C25H24N2O3			InChI=1S/C25H24N2O3/c1-27(25(28)20-9-5-7-11-23(20)30-3)24(17-12-14-18(29-2)15-13-17)21-16-26-22-10-6-4-8-19(21)22/h4-16,24,26H,1-3H3	SJFXYLRHOSPBHL-UHFFFAOYSA-N	N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-2-methoxy-N-methyl-benzamide	43843740	COc1ccc(C(c2c[nH]c3ccccc23)N(C)C(=O)c2ccccc2OC)cc1	N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-2-methoxy-N-methylbenzamide			3.5293300000000025													MCULE-2214149501	400.48163		400.178693	3	1	6	4			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(43843740)	43843740	4.6	54			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#7](-[#6])-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#8]-[#6]):[#6]:[#6]:1	COc1ccc(C(c2c[nH]c3ccccc23)N(C)C(=O)c2ccccc2OC)cc1	SJFXYLRHOSPBHL		parent_pubchem_cid	STL210962;AKOS002281638;AKOS016329034;N-[1H-indol-3-yl(4-methoxyphenyl)methyl]-2-methoxy-N-methylbenzamide;N-[(1H-INDOL-3-YL)(4-METHOXYPHENYL)METHYL]-2-METHOXY-N-METHYLBENZAMIDE;N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-2-methoxy-N-methyl-benzamide		23070912.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23070912		pluskal_iocb_peptide_Peptide01_A7_id		100	A7		
4.9		0	633	P1308374	63.8		B12	False	0	27	0	0	28	0	2	4	0	0		0.0						CCN(C(=O)COc1ccccc1OC)C(c1ccc(OC)cc1)c1c[nH]c2ccccc12																							0.0		AKOS002297857		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C27H28N2O4	C27H28N2O4			InChI=1S/C27H28N2O4/c1-4-29(26(30)18-33-25-12-8-7-11-24(25)32-3)27(19-13-15-20(31-2)16-14-19)22-17-28-23-10-6-5-9-21(22)23/h5-17,27-28H,4,18H2,1-3H3	NOKBAHJOVQNKMK-UHFFFAOYSA-N	N-ethyl-N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-2-(2-methoxyphenoxy)acetamide	43843355	CCN(C(=O)COc1ccccc1OC)C(c1ccc(OC)cc1)c1c[nH]c2ccccc12	N-ethyl-N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-2-(2-methoxyphenoxy)acetamide			3.276930000000002													MCULE-6507416654	444.53521		444.204907	4	1	9	4			45										False	Alkaloids				Peptide01			Compound(43843355)	43843355	5.0	55			[#6]-[#6]-[#7](-[#6](=[#8])-[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#8]-[#6])-[#6](-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CCN(C(=O)COc1ccccc1OC)C(c1ccc(OC)cc1)c1c[nH]c2ccccc12	NOKBAHJOVQNKMK		parent_pubchem_cid	AKOS002297857;AKOS016330255;N-ethyl-N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-2-(2-methoxyphenoxy)acetamide		23869917.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23869917		pluskal_iocb_peptide_Peptide01_A7_id		100	A7		
3.6		0	377	P1157873	91.7		B13	False	0	20	0	1	22	0	1	3	0	1		0.0						CSCCC(NC(=O)C(C)c1cc(F)c(-c2ccccc2)cc1)C(=O)O																							0.0		AKOS005533763		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C20H22FNO3S	C20H22FNO3S			InChI=1S/C20H22FNO3S/c1-13(19(23)22-18(20(24)25)10-11-26-2)15-8-9-16(17(21)12-15)14-6-4-3-5-7-14/h3-9,12-13,18H,10-11H2,1-2H3,(H,22,23)(H,24,25)/t13?,18-/m0/s1	GTVDYUJJBBUOKB-UWBLVGDVSA-N	rac-(2S)-2-[2-(3-fluoro-4-phenyl-phenyl)propanoylamino]-4-methylsulfanyl-butanoic acid	17585147	CSCC[C@H](NC(=O)C(C)c1cc(F)c(-c2ccccc2)cc1)C(=O)O	(2S)-2-[2-(3-fluoro-4-phenylphenyl)propanoylamino]-4-methylsulfanylbutanoic acid			3.483970000000002													MCULE-8269968457	375.46564		375.130443	4	2	8	2			45										False	Amino acids and Peptides				Peptide01			Compound(17585147)	17585147	4.5	56			[#6]-[#16]-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6](-[#6])-[#6]1:[#6]:[#6](-[#9]):[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6]:[#6]:1)-[#6](=[#8])-[#8]	CSCC[C@H](NC(=O)C(C)c1cc(F)c(-c2ccccc2)cc1)C(=O)O	GTVDYUJJBBUOKB		parent_pubchem_cid	AKOS005533763;rac-(2S)-2-[2-(3-fluoro-4-phenyl-phenyl)propanoylamino]-4-methylsulfanyl-butanoic acid		23765772.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23765772		pluskal_iocb_peptide_Peptide01_A8_id		100	A8		
5.0		0	465	P2195764	84.5		B14	False	0	27	0	0	36	0	2	4	0	0		0.0						COC(=O)C(CC(C)C)NC(=O)C(Cc1ccccc1)NC(=O)c1ccc(C(C)(C)C)cc1																							0.0		STL219220		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	2	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C27H36N2O4	C27H36N2O4			InChI=1S/C27H36N2O4/c1-18(2)16-23(26(32)33-6)29-25(31)22(17-19-10-8-7-9-11-19)28-24(30)20-12-14-21(15-13-20)27(3,4)5/h7-15,18,22-23H,16-17H2,1-6H3,(H,28,30)(H,29,31)	YSBDCWNNIBWMBU-UHFFFAOYSA-N	methyl 2-[[2-[(4-tert-butylbenzoyl)amino]-3-phenyl-propanoyl]amino]-4-methyl-pentanoate	52988597	COC(=O)C(CC(C)C)NC(=O)C(Cc1ccccc1)NC(=O)c1ccc(C(C)(C)C)cc1	methyl 2-[[2-[(4-tert-butylbenzoyl)amino]-3-phenylpropanoyl]amino]-4-methylpentanoate			3.864970000000001													MCULE-1022321654	452.59897		452.267508	4	2	11	2			45									Dipeptides;Tripeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(52988597)	52988597	5.0	57			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6])(-[#6])-[#6]):[#6]:[#6]:1	COC(=O)C(CC(C)C)NC(=O)C(Cc1ccccc1)NC(=O)c1ccc(C(C)(C)C)cc1	YSBDCWNNIBWMBU		parent_pubchem_cid	STL219220;AKOS015861868;methyl N-[(4-tert-butylphenyl)carbonyl]phenylalanylleucinate;methyl 2-[[2-[(4-tert-butylbenzoyl)amino]-3-phenyl-propanoyl]amino]-4-methyl-pentanoate		22733563.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22733563		pluskal_iocb_peptide_Peptide01_A8_id		100	A8		
3.1		0	553	P1263539	62.1		B15	False	0	22	0	0	23	0	7	0	0	0		0.0						CN1CCN(c2nc(Nc3ccccc3)c3cnn(-c4ccccc4)c3n2)CC1																							0.0		6-(4-methylpiperazin-1-yl)-N,1-diphenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	3		C22H23N7	C22H23N7			InChI=1S/C22H23N7/c1-27-12-14-28(15-13-27)22-25-20(24-17-8-4-2-5-9-17)19-16-23-29(21(19)26-22)18-10-6-3-7-11-18/h2-11,16H,12-15H2,1H3,(H,24,25,26)	ZMKWEGYJYLEUQV-UHFFFAOYSA-N	6-(4-methylpiperazin-1-yl)-N,1-diphenyl-pyrazolo[3,4-d]pyrimidin-4-amine	16801583	CN1CCN(c2nc(Nc3ccccc3)c3cnn(-c4ccccc4)c3n2)CC1	6-(4-methylpiperazin-1-yl)-N,1-diphenylpyrazolo[3,4-d]pyrimidin-4-amine			1.5506399999999994													MCULE-6414465730	385.47551		385.201494	6	1	4	5			44										False	Alkaloids				Peptide01			Compound(16801583)	16801583	4.0	58			[#6]-[#7]1-[#6]-[#6]-[#7](-[#6]2:[#7]:[#6](-[#7]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#6]3:[#6]:[#7]:[#7](-[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]:4):[#6]:3:[#7]:2)-[#6]-[#6]-1	CN1CCN(c2nc(Nc3ccccc3)c3cnn(-c4ccccc4)c3n2)CC1	ZMKWEGYJYLEUQV		parent_pubchem_cid	6-(4-methylpiperazin-1-yl)-N,1-diphenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine;921473-21-4;STL485790;AKOS024301560;F2090-0229;6-(4-methylpiperazin-1-yl)-N,1-diphenylpyrazolo[3,4-d]pyrimidin-4-amine;6-(4-methylpiperazin-1-yl)-N,1-diphenyl-pyrazolo[3,4-d]pyrimidin-4-amine		23763989.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23763989		pluskal_iocb_peptide_Peptide01_A8_id		100	A8		ZINC000009573539
4.5		0	641	P1309972	63.8		B16	False	0	26	0	0	26	0	2	4	0	0		0.0						COc1ccc(C(c2c[nH]c3ccccc23)N(C)C(=O)COc2ccccc2OC)cc1																							0.0		AKOS001544280		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C26H26N2O4	C26H26N2O4			InChI=1S/C26H26N2O4/c1-28(25(29)17-32-24-11-7-6-10-23(24)31-3)26(18-12-14-19(30-2)15-13-18)21-16-27-22-9-5-4-8-20(21)22/h4-16,26-27H,17H2,1-3H3	NCWVNJSAIUKQEI-UHFFFAOYSA-N	N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-2-(2-methoxyphenoxy)-N-methyl-acetamide	20895158	COc1ccc(C(c2c[nH]c3ccccc23)N(C)C(=O)COc2ccccc2OC)cc1	N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-2-(2-methoxyphenoxy)-N-methylacetamide			2.8868300000000016													MCULE-8761567650	430.50812		430.189257	4	1	8	4			45										False	Alkaloids				Peptide01			Compound(20895158)	20895158	4.7	59			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#7](-[#6])-[#6](=[#8])-[#6]-[#8]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#8]-[#6]):[#6]:[#6]:1	COc1ccc(C(c2c[nH]c3ccccc23)N(C)C(=O)COc2ccccc2OC)cc1	NCWVNJSAIUKQEI		parent_pubchem_cid	AKOS001544280;AKOS016330354;N-[(1H-INDOL-3-YL)(4-METHOXYPHENYL)METHYL]-2-(2-METHOXYPHENOXY)-N-METHYLACETAMIDE;N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-2-(2-methoxyphenoxy)-N-methyl-acetamide		22693554.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22693554		pluskal_iocb_peptide_Peptide01_A8_id		100	A8		
4.9		0	385	P1098309	101.9		B17	False	0	23	0	0	31	0	1	6	0	0		0.0						CCCCc1cc(=O)oc2c1ccc(OC(C)C(=O)NC(CC(C)C)C(=O)O)c2C																							0.0		EiM07-16987		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C23H31NO6	C23H31NO6			InChI=1S/C23H31NO6/c1-6-7-8-16-12-20(25)30-21-14(4)19(10-9-17(16)21)29-15(5)22(26)24-18(23(27)28)11-13(2)3/h9-10,12-13,15,18H,6-8,11H2,1-5H3,(H,24,26)(H,27,28)/t15?,18-/m0/s1	FDQDRSHFRVLFJO-PKHIMPSTSA-N	rac-(2S)-2-[2-(4-butyl-8-methyl-2-oxo-chromen-7-yl)oxypropanoylamino]-4-methyl-pentanoic acid	16399625	CCCCc1cc(=O)oc2c1ccc(OC(C)C(=O)N[C@@H](CC(C)C)C(=O)O)c2C	(2S)-2-[2-(4-butyl-8-methyl-2-oxochromen-7-yl)oxypropanoylamino]-4-methylpentanoic acid			3.726460000000002													MCULE-3107419240	417.50662		417.215138	6	2	10	2			45									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(16399625)	16399625	4.7	60			[#6]-[#6]-[#6]-[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6](-[#6])-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=[#8])-[#8]):[#6]:2-[#6]	CCCCc1cc(=O)oc2c1ccc(OC(C)C(=O)N[C@@H](CC(C)C)C(=O)O)c2C	FDQDRSHFRVLFJO		parent_pubchem_cid	EiM07-16987;AKOS016390285;2-{2-[(4-BUTYL-8-METHYL-2-OXO-2H-CHROMEN-7-YL)OXY]PROPANAMIDO}-4-METHYLPENTANOIC ACID;rac-(2S)-2-[2-(4-butyl-8-methyl-2-oxo-chromen-7-yl)oxypropanoylamino]-4-methyl-pentanoic acid		22723848.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22723848		pluskal_iocb_peptide_Peptide01_A8_id		100	A8		
3.1		0	473	P2195239	109.8		B18	False	0	23	0	0	28	0	2	4	0	1		0.0						COC(=O)C(CCSC)NC(=O)C(Cc1ccccc1)NC(=O)c1ccc(C)cc1																							0.0		AKOS015861325		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	2	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C23H28N2O4S	C23H28N2O4S			InChI=1S/C23H28N2O4S/c1-16-9-11-18(12-10-16)21(26)25-20(15-17-7-5-4-6-8-17)22(27)24-19(13-14-30-3)23(28)29-2/h4-12,19-20H,13-15H2,1-3H3,(H,24,27)(H,25,26)	XEQGSKCIDKSXGV-UHFFFAOYSA-N	methyl 2-[[2-[(4-methylbenzoyl)amino]-3-phenyl-propanoyl]amino]-4-methylsulfanyl-butanoate	51065746	COC(=O)C(CCSC)NC(=O)C(Cc1ccccc1)NC(=O)c1ccc(C)cc1	methyl 2-[[2-[(4-methylbenzoyl)amino]-3-phenylpropanoyl]amino]-4-methylsulfanylbutanoate			2.58289													MCULE-9852053319	428.55461		428.176978	5	2	11	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51065746)	51065746	3.9	61			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]-[#16]-[#6])-[#7]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:1	COC(=O)C(CCSC)NC(=O)C(Cc1ccccc1)NC(=O)c1ccc(C)cc1	XEQGSKCIDKSXGV		parent_pubchem_cid	AKOS015861325;CCG-356483;methyl 2-[[2-[(4-methylbenzoyl)amino]-3-phenyl-propanoyl]amino]-4-methylsulfanyl-butanoate		23840766.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23840766		pluskal_iocb_peptide_Peptide01_A8_id		100	A8		
4.6		0	561	P2188556	64.1		B19	False	0	26	0	0	31	0	3	4	0	0		0.0						CCN(CC)c1ccc(CN(C(=O)c2cc(OC)c(OC)c(OC)c2)c2ccccn2)cc1																							0.0		STL212884		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1		C26H31N3O4	C26H31N3O4			InChI=1S/C26H31N3O4/c1-6-28(7-2)21-13-11-19(12-14-21)18-29(24-10-8-9-15-27-24)26(30)20-16-22(31-3)25(33-5)23(17-20)32-4/h8-17H,6-7,18H2,1-5H3	BMAZEWULBABYDU-UHFFFAOYSA-N	N-[[4-(diethylamino)phenyl]methyl]-3,4,5-trimethoxy-N-(2-pyridyl)benzamide	35579181	CCN(CC)c1ccc(CN(C(=O)c2cc(OC)c(OC)c(OC)c2)c2ccccn2)cc1	N-[[4-(diethylamino)phenyl]methyl]-3,4,5-trimethoxy-N-pyridin-2-ylbenzamide			2.5427300000000006													MCULE-3178156668	449.55467		449.231456	6	0	10	3			44									Isoquinoline alkaloids	False	Alkaloids	Tyrosine alkaloids			Peptide01			Compound(35579181)	35579181	4.5	62			[#6]-[#6]-[#7](-[#6]-[#6])-[#6]1:[#6]:[#6]:[#6](-[#6]-[#7](-[#6](=[#8])-[#6]2:[#6]:[#6](-[#8]-[#6]):[#6](-[#8]-[#6]):[#6](-[#8]-[#6]):[#6]:2)-[#6]2:[#6]:[#6]:[#6]:[#6]:[#7]:2):[#6]:[#6]:1	CCN(CC)c1ccc(CN(C(=O)c2cc(OC)c(OC)c(OC)c2)c2ccccn2)cc1	BMAZEWULBABYDU		parent_pubchem_cid	STL212884;AKOS004930781;N-[4-(diethylamino)benzyl]-3,4,5-trimethoxy-N-(pyridin-2-yl)benzamide;N-{[4-(DIETHYLAMINO)PHENYL]METHYL}-3,4,5-TRIMETHOXY-N-(PYRIDIN-2-YL)BENZAMIDE;N-[[4-(diethylamino)phenyl]methyl]-3,4,5-trimethoxy-N-(2-pyridyl)benzamide		11570095.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=11570095		pluskal_iocb_peptide_Peptide01_A8_id		100	A8		ZINC000028292993
4.6		0	649	P1301190	63.4		B20	False	0	24	0	0	30	0	2	3	0	0		0.0						CCOc1c(OC)cc(C(CNC(=O)CC(C)C)c2c[nH]c3ccccc23)cc1																							0.0		AKOS001533432		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C24H30N2O3	C24H30N2O3			InChI=1S/C24H30N2O3/c1-5-29-22-11-10-17(13-23(22)28-4)19(14-26-24(27)12-16(2)3)20-15-25-21-9-7-6-8-18(20)21/h6-11,13,15-16,19,25H,5,12,14H2,1-4H3,(H,26,27)	PNRVLUVFHLZKEB-UHFFFAOYSA-N	N-[2-(4-ethoxy-3-methoxy-phenyl)-2-(1H-indol-3-yl)ethyl]-3-methyl-butanamide	17010924	CCOc1c(OC)cc(C(CNC(=O)CC(C)C)c2c[nH]c3ccccc23)cc1	N-[2-(4-ethoxy-3-methoxyphenyl)-2-(1H-indol-3-yl)ethyl]-3-methylbutanamide			3.406740000000001													MCULE-9851578550	394.5183		394.225643	3	2	9	3			45										False	Alkaloids				Peptide01			Compound(17010924)	17010924	4.7	63			[#6]-[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]):[#6]:[#6](-[#6](-[#6]-[#7]-[#6](=[#8])-[#6]-[#6](-[#6])-[#6])-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	CCOc1c(OC)cc(C(CNC(=O)CC(C)C)c2c[nH]c3ccccc23)cc1	PNRVLUVFHLZKEB		parent_pubchem_cid	AKOS001533432;AKOS016325389;N-[2-(4-ethoxy-3-methoxyphenyl)-2-(1H-indol-3-yl)ethyl]-3-methylbutanamide;N-[2-(4-ethoxy-3-methoxy-phenyl)-2-(1H-indol-3-yl)ethyl]-3-methyl-butanamide		23192092.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23192092		pluskal_iocb_peptide_Peptide01_A8_id		100	A8		
1.5		0	393	P6667585	101.4		B21	False	0	18	0	0	17	0	7	1	0	0		0.0						O=C(NCCc1nc2ccccc2[nH]1)C(c1ccccc1)n1cnnn1								Benzimidazoles;Tetrazoles;Imidazoles;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Azacyclic compounds;Azoles;Benzene and substituted derivatives;Benzenoids;Benzimidazoles;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Imidazoles;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenylacetamides;Secondary carboxylic acid amides;Tetrazoles	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as phenylacetamides. These are amide derivatives of phenylacetic acids.	Phenylacetamides			Organic compounds	Aromatic heteropolycyclic compounds	benzimidazoles (CHEBI:22715);tetrazoles (CHEBI:35689);imidazoles (CHEBI:24780);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);acetamides (CHEBI:22160);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);azole (CHEBI:68452);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);organooxygen compound (CHEBI:36963);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712)		Phenylacetamides	Phenylacetamide;Benzimidazole;Azole;Imidazole;Tetrazole;Heteroaromatic compound;Carboxamide group;Secondary carboxylic acid amide;Carboxylic acid derivative;Azacycle;Organoheterocyclic compound;Hydrocarbon derivative;Organic nitrogen compound;Organooxygen compound;Organonitrogen compound;Organic oxide;Carbonyl group;Organic oxygen compound;Aromatic heteropolycyclic compound	Benzenoids	0.0		STL309165		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	6	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C18H17N7O	C18H17N7O			InChI=1S/C18H17N7O/c26-18(17(25-12-20-23-24-25)13-6-2-1-3-7-13)19-11-10-16-21-14-8-4-5-9-15(14)22-16/h1-9,12,17H,10-11H2,(H,19,26)(H,21,22)	XZFCUHIGESFLGJ-UHFFFAOYSA-N	N-[2-(1H-benzimidazol-2-yl)ethyl]-2-phenyl-2-(tetrazol-1-yl)acetamide	71700796	O=C(NCCc1nc2ccccc2[nH]1)C(c1ccccc1)n1cnnn1	N-[2-(1H-benzimidazol-2-yl)ethyl]-2-phenyl-2-(tetrazol-1-yl)acetamide			0.9598599999999992													MCULE-7170255655	347.38249		347.149458	5	2	6	4			45									Quinazoline alkaloids	False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(71700796)	71700796	2.3	64			[#8]=[#6](-[#7]-[#6]-[#6]-[#6]1:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#7H]:1)-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]1:[#6]:[#7]:[#7]:[#7]:1	O=C(NCCc1nc2ccccc2[nH]1)C(c1ccccc1)n1cnnn1	XZFCUHIGESFLGJ		parent_pubchem_cid	STL309165;AKOS016400228;N-[2-(1H-benzimidazol-2-yl)ethyl]-2-phenyl-2-(1H-tetrazol-1-yl)acetamide;N-[2-(1H-1,3-BENZODIAZOL-2-YL)ETHYL]-2-PHENYL-2-(1H-1,2,3,4-TETRAZOL-1-YL)ACETAMIDE;N-[2-(1H-benzimidazol-2-yl)ethyl]-2-phenyl-2-(tetrazol-1-yl)acetamide		65839221.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=65839221		pluskal_iocb_peptide_Peptide01_A9_id		100	A9		
4.0		0	481	P2195233	84.5		B22	False	0	24	0	0	30	0	2	4	0	0		0.0						COC(=O)C(CC(C)C)NC(=O)C(Cc1ccccc1)NC(=O)c1ccc(C)cc1																							0.0		AKOS015861306		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	2	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C24H30N2O4	C24H30N2O4			InChI=1S/C24H30N2O4/c1-16(2)14-21(24(29)30-4)26-23(28)20(15-18-8-6-5-7-9-18)25-22(27)19-12-10-17(3)11-13-19/h5-13,16,20-21H,14-15H2,1-4H3,(H,25,27)(H,26,28)	YNZIMCUIVOUNKM-UHFFFAOYSA-N	methyl 4-methyl-2-[[2-[(4-methylbenzoyl)amino]-3-phenyl-propanoyl]amino]pentanoate	51065741	COC(=O)C(CC(C)C)NC(=O)C(Cc1ccccc1)NC(=O)c1ccc(C)cc1	methyl 4-methyl-2-[[2-[(4-methylbenzoyl)amino]-3-phenylpropanoyl]amino]pentanoate			2.875890000000001													MCULE-2417682469	410.5177		410.220557	4	2	10	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51065741)	51065741	3.7	65			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:1	COC(=O)C(CC(C)C)NC(=O)C(Cc1ccccc1)NC(=O)c1ccc(C)cc1	YNZIMCUIVOUNKM		parent_pubchem_cid	AKOS015861306;methyl 4-methyl-2-[[2-[(4-methylbenzoyl)amino]-3-phenyl-propanoyl]amino]pentanoate		23685262.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23685262		pluskal_iocb_peptide_Peptide01_A9_id		100	A9		
4.6		0	569	P1310505	73.6		B23	False	0	22	0	0	20	0	2	2	0	1		0.0						COc1ccc(C(=O)N(C)C(c2cccs2)c2c[nH]c3ccccc23)cc1																							0.0		AKOS002278826		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C22H20N2O2S	C22H20N2O2S			InChI=1S/C22H20N2O2S/c1-24(22(25)15-9-11-16(26-2)12-10-15)21(20-8-5-13-27-20)18-14-23-19-7-4-3-6-17(18)19/h3-14,21,23H,1-2H3	WISHBFHMDCKWTP-UHFFFAOYSA-N	N-[1H-indol-3-yl(2-thienyl)methyl]-4-methoxy-N-methyl-benzamide	43843851	COc1ccc(C(=O)N(C)C(c2cccs2)c2c[nH]c3ccccc23)cc1	N-[1H-indol-3-yl(thiophen-2-yl)methyl]-4-methoxy-N-methylbenzamide			4.044640000000003													MCULE-1776264699	376.4809		376.124549	2	1	5	4			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(43843851)	43843851	4.4	66			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](=[#8])-[#7](-[#6])-[#6](-[#6]2:[#6]:[#6]:[#6]:[#16]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	COc1ccc(C(=O)N(C)C(c2cccs2)c2c[nH]c3ccccc23)cc1	WISHBFHMDCKWTP		parent_pubchem_cid	AKOS002278826;AKOS016330462;N-[1H-indol-3-yl(2-thienyl)methyl]-4-methoxy-N-methyl-benzamide		24818955.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24818955		pluskal_iocb_peptide_Peptide01_A9_id		100	A9		
4.0		0	657	P7119983278	103.5		B24	False	0	25	0	0	23	0	3	3	0	0		0.0						CCOc1c(OCc2ccccc2)ccc(C2C(C#N)=C(N)Oc3c2ccc(N)c3)c1																							0.0		AKOS002265406		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0		C25H23N3O3	C25H23N3O3			InChI=1S/C25H23N3O3/c1-2-29-23-12-17(8-11-21(23)30-15-16-6-4-3-5-7-16)24-19-10-9-18(27)13-22(19)31-25(28)20(24)14-26/h3-13,24H,2,15,27-28H2,1H3	DGMWHRQVCCLGHT-UHFFFAOYSA-N	2,7-diamino-4-(4-benzyloxy-3-ethoxy-phenyl)-4H-chromene-3-carbonitrile	16446126	CCOc1c(OCc2ccccc2)ccc(C2C(C#N)=C(N)Oc3c2ccc(N)c3)c1	2,7-diamino-4-(3-ethoxy-4-phenylmethoxyphenyl)-4H-chromene-3-carbonitrile			2.5327100000000007													MCULE-5934547871	413.48036		413.173942	6	2	6	4			45										False	Alkaloids				Peptide01			Compound(16446126)	16446126	4.4	67			[#6]-[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6]:[#6]:[#6](-[#6]2-[#6](-[#6]#[#7])=[#6](-[#7])-[#8]-[#6]3:[#6]-2:[#6]:[#6]:[#6](-[#7]):[#6]:3):[#6]:1	CCOc1c(OCc2ccccc2)ccc(C2C(C#N)=C(N)Oc3c2ccc(N)c3)c1	DGMWHRQVCCLGHT		parent_pubchem_cid	AKOS002265406;AKOS016309754;Z1213674253;2,7-diamino-4-(4-benzyloxy-3-ethoxy-phenyl)-4H-chromene-3-carbonitrile		24620770.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24620770		pluskal_iocb_peptide_Peptide01_A9_id		100	A9		
2.0		0	401	P6243670	99.1		B25	False	0	17	0	0	25	0	3	4	0	0		0.0						CCC(C)C(NC(=O)Cn1nc2CCCCCc2cc1=O)C(=O)O																							0.0		AKOS016386989		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C17H25N3O4	C17H25N3O4			InChI=1S/C17H25N3O4/c1-3-11(2)16(17(23)24)18-14(21)10-20-15(22)9-12-7-5-4-6-8-13(12)19-20/h9,11,16H,3-8,10H2,1-2H3,(H,18,21)(H,23,24)/t11-,16+/m1/s1	FWIJZIUADHGHTN-BZNIZROVSA-N	rac-(2S,3R)-3-methyl-2-[[2-(3-oxo-6,7,8,9-tetrahydro-5H-cyclohepta[c]pyridazin-2-yl)acetyl]amino]pentanoic acid	51052894	CC[C@@H](C)[C@H](NC(=O)Cn1nc2CCCCCc2cc1=O)C(=O)O	(2S,3R)-3-methyl-2-[[2-(3-oxo-6,7,8,9-tetrahydro-5H-cyclohepta[c]pyridazin-2-yl)acetyl]amino]pentanoic acid			1.91817													MCULE-5829735533	335.4065		335.184506	5	2	6	2			44										False	Alkaloids				Peptide01			Compound(51052894)	51052894	1.9	68			[#6]-[#6]-[#6@@H](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#7]1:[#7]:[#6]2-[#6]-[#6]-[#6]-[#6]-[#6]-[#6]:2:[#6]:[#6]:1=[#8])-[#6](=[#8])-[#8]	CC[C@@H](C)[C@H](NC(=O)Cn1nc2CCCCCc2cc1=O)C(=O)O	FWIJZIUADHGHTN		parent_pubchem_cid	AKOS016386989;(2S,3R)-3-METHYL-2-{[2-(3-OXO-3,5,6,7,8,9-HEXAHYDRO-2H-CYCLOHEPTA[C]PYRIDAZIN-2-YL)ACETYL]AMINO}PENTANOIC ACID;rac-(2S,3R)-3-methyl-2-[[2-(3-oxo-6,7,8,9-tetrahydro-5H-cyclohepta[c]pyridazin-2-yl)acetyl]amino]pentanoic acid		24299740.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24299740		pluskal_iocb_peptide_Peptide01_A9_id		100	A9		ZINC000049545089
4.4		0	489	P2194876	118.5		B26	False	0	23	1	0	23	0	4	3	0	1		0.0						CCSc1ncc(Cl)c(C(=O)NC(Cc2ccccc2)C(=O)Nc2ccc(OC)cc2)n1																							0.0		AKOS015861173		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C23H23ClN4O3S	C23H23ClN4O3S			InChI=1S/C23H23ClN4O3S/c1-3-32-23-25-14-18(24)20(28-23)22(30)27-19(13-15-7-5-4-6-8-15)21(29)26-16-9-11-17(31-2)12-10-16/h4-12,14,19H,3,13H2,1-2H3,(H,26,29)(H,27,30)	ZMTZWGZPGZUCDC-UHFFFAOYSA-N	N-[1-benzyl-2-(4-methoxyanilino)-2-oxo-ethyl]-5-chloro-2-ethylsulfanyl-pyrimidine-4-carboxamide	51065479	CCSc1ncc(Cl)c(C(=O)NC(Cc2ccccc2)C(=O)Nc2ccc(OC)cc2)n1	5-chloro-2-ethylsulfanyl-N-[1-(4-methoxyanilino)-1-oxo-3-phenylpropan-2-yl]pyrimidine-4-carboxamide			3.169950000000001													MCULE-9483098845	470.98176		470.117939	6	2	9	3			45										False					Peptide01			Compound(51065479)	51065479	4.5	69			[#6]-[#6]-[#16]-[#6]1:[#7]:[#6]:[#6](-[#17]):[#6](-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#7]-[#6]2:[#6]:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:2):[#7]:1	CCSc1ncc(Cl)c(C(=O)NC(Cc2ccccc2)C(=O)Nc2ccc(OC)cc2)n1	ZMTZWGZPGZUCDC		parent_pubchem_cid	AKOS015861173;N-[1-benzyl-2-(4-methoxyanilino)-2-oxo-ethyl]-5-chloro-2-ethylsulfanyl-pyrimidine-4-carboxamide		23649365.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23649365		pluskal_iocb_peptide_Peptide01_A9_id		100	A9		
4.8		0	577	P1307066	64.3		B27	False	0	21	0	1	17	0	2	1	0	1		0.0						CN(C(=O)c1ccc(F)cc1)C(c1cccs1)c1c[nH]c2ccccc12																							0.0		AKOS001912382		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C21H17FN2OS	C21H17FN2OS			InChI=1S/C21H17FN2OS/c1-24(21(25)14-8-10-15(22)11-9-14)20(19-7-4-12-26-19)17-13-23-18-6-3-2-5-16(17)18/h2-13,20,23H,1H3	VDQKEDIWFKDQRJ-UHFFFAOYSA-N	4-fluoro-N-[1H-indol-3-yl(2-thienyl)methyl]-N-methyl-benzamide	20895174	CN(C(=O)c1ccc(F)cc1)C(c1cccs1)c1c[nH]c2ccccc12	4-fluoro-N-[1H-indol-3-yl(thiophen-2-yl)methyl]-N-methylbenzamide			4.637550000000004													MCULE-4310255999	364.44484		364.104562	1	1	4	4			45										False	Alkaloids				Peptide01			Compound(20895174)	20895174	4.5	70			[#6]-[#7](-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:1)-[#6](-[#6]1:[#6]:[#6]:[#6]:[#16]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CN(C(=O)c1ccc(F)cc1)C(c1cccs1)c1c[nH]c2ccccc12	VDQKEDIWFKDQRJ		parent_pubchem_cid	AKOS001912382;AKOS016329114;CCG-154603;4-FLUORO-N-[(1H-INDOL-3-YL)(THIOPHEN-2-YL)METHYL]-N-METHYLBENZAMIDE;4-fluoro-N-[1H-indol-3-yl(2-thienyl)methyl]-N-methyl-benzamide		24516988.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24516988		pluskal_iocb_peptide_Peptide01_A9_id		100	A9		
4.9		0	665	P1307737	63.4		B28	False	0	26	0	0	26	0	2	3	0	0		0.0						CCOc1ccccc1C(=O)NCC(c1ccc(OC)cc1)c1c[nH]c2ccccc12																							0.0		2-ethoxy-N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]benzamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C26H26N2O3	C26H26N2O3			InChI=1S/C26H26N2O3/c1-3-31-25-11-7-5-9-21(25)26(29)28-16-22(18-12-14-19(30-2)15-13-18)23-17-27-24-10-6-4-8-20(23)24/h4-15,17,22,27H,3,16H2,1-2H3,(H,28,29)	DDNQOFQYNVQMGG-UHFFFAOYSA-N	2-ethoxy-N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]benzamide	43007538	CCOc1ccccc1C(=O)NCC(c1ccc(OC)cc1)c1c[nH]c2ccccc12	2-ethoxy-N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]benzamide			3.6197300000000014													MCULE-2293010813	414.50872		414.194343	3	2	8	4			44										False	Alkaloids				Peptide01			Compound(43007538)	43007538	5.0	71			[#6]-[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#6](=[#8])-[#7]-[#6]-[#6](-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CCOc1ccccc1C(=O)NCC(c1ccc(OC)cc1)c1c[nH]c2ccccc12	DDNQOFQYNVQMGG		parent_pubchem_cid	2-ethoxy-N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]benzamide;STL208622;AKOS002292644;AKOS016329950		23359616.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23359616		pluskal_iocb_peptide_Peptide01_A9_id		100	A9		
0.2		0	409	P1094885	85.4		B29	False	0	18	0	0	16	0	2	3	0	0		0.0						O=C(O)C1Cc2c([nH]c3ccccc23)C(c2ccc(O)cc2)N1																							0.0		MFCD00478701		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0		C18H16N2O3	C18H16N2O3			InChI=1S/C18H16N2O3/c21-11-7-5-10(6-8-11)16-17-13(9-15(20-16)18(22)23)12-3-1-2-4-14(12)19-17/h1-8,15-16,19-21H,9H2,(H,22,23)/t15-,16?/m0/s1	OHWUOYUHWJMINH-VYRBHSGPSA-N	rac-(3S)-1-(4-hydroxyphenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid	24279669	O=C(O)[C@@H]1Cc2c([nH]c3ccccc23)C(c2ccc(O)cc2)N1	(3S)-1-(4-hydroxyphenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid			1.50684														308.33982		308.116092	4	4	2	4			46									Carboline alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(24279669)	24279669	0.2	72			[#8]=[#6](-[#8])-[#6@@H]1-[#6]-[#6]2:[#6](:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6](-[#6]2:[#6]:[#6]:[#6](-[#8]):[#6]:[#6]:2)-[#7]-1	O=C(O)[C@@H]1Cc2c([nH]c3ccccc23)C(c2ccc(O)cc2)N1	OHWUOYUHWJMINH		parent_pubchem_cid	MFCD00478701;AKOS016402737;(3S)-1-(4-HYDROXYPHENYL)-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-3-CARBOXYLIC ACID;rac-(3S)-1-(4-hydroxyphenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid		42717613.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=42717613		pluskal_iocb_peptide_Peptide01_A10_id		100	A10		
2.2		0	497	P1045784	75.6		B30	False	0	14	0	0	19	0	1	4	0	0	-1.0	0.0						COc1ccc(C(=O)NC(CC(C)C)C(=O)O)cc1		1.92		0.0	2.19	CHEMBL1514703		N-acyl-alpha amino acids;Hippuric acids;Phenoxy compounds;Methoxybenzenes;Benzoyl derivatives;Anisoles;Alkyl aryl ethers;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Anisoles;Benzamides;Benzene and substituted derivatives;Benzenoids;Benzoic acids and derivatives;Benzoyl derivatives;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Ethers;Hippuric acids;Hippuric acids and derivatives;Hydrocarbon derivatives;Leucine and derivatives;Methoxybenzenes;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenol ethers;Phenoxy compounds;Secondary carboxylic acid amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as leucine and derivatives. These are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Leucine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic homomonocyclic compounds	N-acyl-amino acid (CHEBI:51569);N-acylglycine (CHEBI:16180);benzenes (CHEBI:22712);methoxybenzene (CHEBI:51683);carbonyl compound (CHEBI:36586);aromatic ether (CHEBI:35618);carboxamide (CHEBI:37622);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);leucine derivative (CHEBI:47003);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);benzenoid aromatic compound (CHEBI:33836);benzoic acids (CHEBI:22723);benzamides (CHEBI:22702);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ether (CHEBI:25698);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);carboxylic acid anion (CHEBI:29067);amino acid (CHEBI:33709);peptide (CHEBI:16670);phenols (CHEBI:33853)		Amino acids, peptides, and analogues	Leucine or derivatives;Hippuric acid or derivatives;Hippuric acid;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;Benzamide;Benzoic acid or derivatives;Anisole;Phenoxy compound;Benzoyl;Methoxybenzene;Phenol ether;Alkyl aryl ether;Monocyclic benzene moiety;Benzenoid;Carboxamide group;Secondary carboxylic acid amide;Monocarboxylic acid or derivatives;Ether;Carboxylic acid;Organic nitrogen compound;Hydrocarbon derivative;Organic oxide;Organic oxygen compound;Carbonyl group;Organonitrogen compound;Organooxygen compound;Aromatic homomonocyclic compound	Organic acids and derivatives	0.0		438581-55-6	DTXSID90389795	2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C14H19NO4	C14H19NO4			InChI=1S/C14H19NO4/c1-9(2)8-12(14(17)18)15-13(16)10-4-6-11(19-3)7-5-10/h4-7,9,12H,8H2,1-3H3,(H,15,16)(H,17,18)	HHMXQTYZWQORAJ-UHFFFAOYSA-N	2-[(4-methoxybenzoyl)amino]-4-methyl-pentanoic acid	3144930	COc1ccc(C(=O)NC(CC(C)C)C(=O)O)cc1	2-[(4-methoxybenzoyl)amino]-4-methylpentanoic acid			1.4071799999999997													MCULE-9092831056	265.31183	ACID	265.131408	4	2	6	1	1.0		29									Simple amide alkaloids	False	Alkaloids;Amino acids and Peptides	Peptide alkaloids	False	False	Peptide01		-1.0	Compound(3144930)	3144930	2.5	73			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](=[#8])-[#7]-[#6](-[#6]-[#6](-[#6])-[#6])-[#6](=[#8])-[#8]):[#6]:[#6]:1	COc1ccc(C(=O)NC(CC(C)C)C(=O)O)cc1	HHMXQTYZWQORAJ		parent_pubchem_cid	438581-55-6;2-(4-Methoxy-benzoylamino)-4-methyl-pentanoic acid;2-[(4-methoxybenzoyl)amino]-4-methylpentanoic acid;2-(4-Methoxybenzamido)-4-methylpentanoic acid;(4-Methoxybenzoyl)leucine;TimTec1_007008;Oprea1_260287;Oprea1_301535;MLS002206395;CHEMBL1514703;DTXSID90389795;HMS1553O12;HMS2202P15;HMS3351I19;STL217581;N-[(4-methoxyphenyl)carbonyl]leucine;AKOS000130842;AKOS016338202;SMR001295212;CS-0357265;FT-0678377;2-(4-Methoxybenzamido)-4-methylpentanoicacid;2-(4-methoxybenzoylamino)-4-methylpentanoic acid;SR-01000370522;SR-01000370522-1;BRD-A20935429-001-01-1;L-Leucine,N-(4-methoxybenzoyl)-,monosodium salt(9ci);2-[(4-methoxybenzoyl)amino]-4-methyl-pentanoic acid	False	905474.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=905474		pluskal_iocb_peptide_Peptide01_A10_id		100	A10	False	
4.9		0	585	P1301786	60.9		B31	False	0	25	0	0	28	0	2	4	0	0		0.0						COc1c(OC)cc(CN(C(=O)c2ccc(OCC(C)C)cc2)c2ccccn2)cc1																							0.0		AKOS002326846		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0		C25H28N2O4	C25H28N2O4			InChI=1S/C25H28N2O4/c1-18(2)17-31-21-11-9-20(10-12-21)25(28)27(24-7-5-6-14-26-24)16-19-8-13-22(29-3)23(15-19)30-4/h5-15,18H,16-17H2,1-4H3	UGGSFAQFBANILZ-UHFFFAOYSA-N	N-[(3,4-dimethoxyphenyl)methyl]-4-isobutoxy-N-(2-pyridyl)benzamide	17011414	COc1c(OC)cc(CN(C(=O)c2ccc(OCC(C)C)cc2)c2ccccn2)cc1	N-[(3,4-dimethoxyphenyl)methyl]-4-(2-methylpropoxy)-N-pyridin-2-ylbenzamide			3.103340000000002													MCULE-9754372312	420.51291		420.204907	5	0	9	3			44									Isoquinoline alkaloids	False	Alkaloids	Tyrosine alkaloids			Peptide01			Compound(17011414)	17011414	4.9	74			[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]):[#6]:[#6](-[#6]-[#7](-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6](-[#8]-[#6]-[#6](-[#6])-[#6]):[#6]:[#6]:2)-[#6]2:[#6]:[#6]:[#6]:[#6]:[#7]:2):[#6]:[#6]:1	COc1c(OC)cc(CN(C(=O)c2ccc(OCC(C)C)cc2)c2ccccn2)cc1	UGGSFAQFBANILZ		parent_pubchem_cid	AKOS002326846;N-[(3,4-DIMETHOXYPHENYL)METHYL]-4-(2-METHYLPROPOXY)-N-(PYRIDIN-2-YL)BENZAMIDE;N-[(3,4-dimethoxyphenyl)methyl]-4-isobutoxy-N-(2-pyridyl)benzamide		8576865.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=8576865		pluskal_iocb_peptide_Peptide01_A10_id		100	A10		ZINC000027581158
0.7		0	673	P6239358	167.6		B32	False	0	15	0	0	19	0	5	4	0	1		0.0						Cc1c(C(=O)NC(CCCNC(N)=O)C(=O)O)sc(-n2cccc2)n1																							0.0		EiM08-09953		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	1	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C15H19N5O4S	C15H19N5O4S			InChI=1S/C15H19N5O4S/c1-9-11(25-15(18-9)20-7-2-3-8-20)12(21)19-10(13(22)23)5-4-6-17-14(16)24/h2-3,7-8,10H,4-6H2,1H3,(H,19,21)(H,22,23)(H3,16,17,24)/t10-/m0/s1	PDQSWGIWIXRVFN-JTQLQIEISA-N	rac-(2S)-2-[(4-methyl-2-pyrrol-1-yl-thiazole-5-carbonyl)amino]-5-ureido-pentanoic acid	45493022	Cc1c(C(=O)N[C@@H](CCCNC(N)=O)C(=O)O)sc(-n2cccc2)n1	(2S)-5-(carbamoylamino)-2-[(4-methyl-2-pyrrol-1-yl-1,3-thiazole-5-carbonyl)amino]pentanoic acid			0.5742900000000004													MCULE-8739826425	365.41378		365.115775	5	4	8	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(45493022)	45493022	0.8	75			[#6]-[#6]1:[#6](-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#8])-[#6](=[#8])-[#8]):[#16]:[#6](-[#7]2:[#6]:[#6]:[#6]:[#6]:2):[#7]:1	Cc1c(C(=O)N[C@@H](CCCNC(N)=O)C(=O)O)sc(-n2cccc2)n1	PDQSWGIWIXRVFN		parent_pubchem_cid	EiM08-09953;AKOS005664531;(2S)-5-[(AMINOCARBONYL)AMINO]-2-({[4-METHYL-2-(1H-PYRROL-1-YL)-1,3-THIAZOL-5-YL]CARBONYL}AMINO)PENTANOIC ACID;rac-(2S)-2-[(4-methyl-2-pyrrol-1-yl-thiazole-5-carbonyl)amino]-5-ureido-pentanoic acid		24251269.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24251269		pluskal_iocb_peptide_Peptide01_A10_id		100	A10		ZINC000036358367
3.4		0	417	P1159247	171.9		B33	False	0	18	0	3	19	0	4	5	0	1		0.0						Cc1c(C(=O)NC(CCCNC(N)=O)C(=O)O)sc(-c2ccc(OC(F)(F)F)cc2)n1																							0.0		STK718431		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	1	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C18H19F3N4O5S	C18H19F3N4O5S			InChI=1S/C18H19F3N4O5S/c1-9-13(14(26)25-12(16(27)28)3-2-8-23-17(22)29)31-15(24-9)10-4-6-11(7-5-10)30-18(19,20)21/h4-7,12H,2-3,8H2,1H3,(H,25,26)(H,27,28)(H3,22,23,29)/t12-/m0/s1	KINGFEMOZZAAML-LBPRGKRZSA-N	rac-(2S)-2-[[4-methyl-2-[4-(trifluoromethoxy)phenyl]thiazole-5-carbonyl]amino]-5-ureido-pentanoic acid	42571682	Cc1c(C(=O)N[C@@H](CCCNC(N)=O)C(=O)O)sc(-c2ccc(OC(F)(F)F)cc2)n1	(2S)-5-(carbamoylamino)-2-[[4-methyl-2-[4-(trifluoromethoxy)phenyl]-1,3-thiazole-5-carbonyl]amino]pentanoic acid			1.69677													MCULE-2050277296	460.43513		460.102825	6	4	10	2			44										False	Alkaloids				Peptide01			Compound(42571682)	42571682	2.9	76			[#6]-[#6]1:[#6](-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#8])-[#6](=[#8])-[#8]):[#16]:[#6](-[#6]2:[#6]:[#6]:[#6](-[#8]-[#6](-[#9])(-[#9])-[#9]):[#6]:[#6]:2):[#7]:1	Cc1c(C(=O)N[C@@H](CCCNC(N)=O)C(=O)O)sc(-c2ccc(OC(F)(F)F)cc2)n1	KINGFEMOZZAAML		parent_pubchem_cid	STK718431;AKOS005535818;5-(CARBAMOYLAMINO)-2-({4-METHYL-2-[4-(TRIFLUOROMETHOXY)PHENYL]-1,3-THIAZOL-5-YL}FORMAMIDO)PENTANOIC ACID;N~5~-carbamoyl-N~2~-({4-methyl-2-[4-(trifluoromethoxy)phenyl]-1,3-thiazol-5-yl}carbonyl)-L-ornithine;rac-(2S)-2-[[4-methyl-2-[4-(trifluoromethoxy)phenyl]thiazole-5-carbonyl]amino]-5-ureido-pentanoic acid		23844525.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23844525		pluskal_iocb_peptide_Peptide01_A10_id		100	A10		ZINC000012391934
2.2		0	505	P2195936	104.7		B34	False	0	21	0	0	24	0	2	5	0	0		0.0						COc1ccc(C(=O)NCCCC(=O)NC(Cc2ccccc2)C(=O)O)cc1																							0.0		AKOS015861820		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C21H24N2O5	C21H24N2O5			InChI=1S/C21H24N2O5/c1-28-17-11-9-16(10-12-17)20(25)22-13-5-8-19(24)23-18(21(26)27)14-15-6-3-2-4-7-15/h2-4,6-7,9-12,18H,5,8,13-14H2,1H3,(H,22,25)(H,23,24)(H,26,27)	VOQZFGXPAMONIC-UHFFFAOYSA-N	2-[4-[(4-methoxybenzoyl)amino]butanoylamino]-3-phenyl-propanoic acid	52988660	COc1ccc(C(=O)NCCCC(=O)NC(Cc2ccccc2)C(=O)O)cc1	2-[4-[(4-methoxybenzoyl)amino]butanoylamino]-3-phenylpropanoic acid			1.4454699999999998													MCULE-4351199690	384.43583		384.168522	5	3	10	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(52988660)	52988660	2.4	77			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#8]):[#6]:[#6]:1	COc1ccc(C(=O)NCCCC(=O)NC(Cc2ccccc2)C(=O)O)cc1	VOQZFGXPAMONIC		parent_pubchem_cid	AKOS015861820;2-[4-[(4-methoxybenzoyl)amino]butanoylamino]-3-phenyl-propanoic acid		23236043.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23236043		pluskal_iocb_peptide_Peptide01_A10_id		100	A10		
4.1		0	593	P1688067	98.7		B35	False	0	26	0	0	23	0	3	4	0	0		0.0						O=C1c2c(c(-c3ccccc3O)n[nH]2)C(c2cc(Oc3ccccc3)ccc2)N1CCCO																							0.0		AKOS001846961		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	1	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C26H23N3O4	C26H23N3O4			InChI=1S/C26H23N3O4/c30-15-7-14-29-25(17-8-6-11-19(16-17)33-18-9-2-1-3-10-18)22-23(27-28-24(22)26(29)32)20-12-4-5-13-21(20)31/h1-6,8-13,16,25,30-31H,7,14-15H2,(H,27,28)	ATZKNJQPPLSNBB-UHFFFAOYSA-N	3-(2-hydroxyphenyl)-5-(3-hydroxypropyl)-4-(3-phenoxyphenyl)-1,4-dihydropyrrolo[3,4-c]pyrazol-6-one	135555221	O=C1c2c(c(-c3ccccc3O)n[nH]2)C(c2cc(Oc3ccccc3)ccc2)N1CCCO	3-(2-hydroxyphenyl)-5-(3-hydroxypropyl)-4-(3-phenoxyphenyl)-1,4-dihydropyrrolo[3,4-c]pyrazol-6-one			2.5708200000000008													MCULE-5706451528	441.49091		441.168856	5	3	7	5			45										False	Alkaloids				Peptide01			Compound(135555221)	135555221	3.8	78			[#8]=[#6]1-[#6]2:[#6](:[#6](-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3-[#8]):[#7]:[#7H]:2)-[#6](-[#6]2:[#6]:[#6](-[#8]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#6]:[#6]:[#6]:2)-[#7]-1-[#6]-[#6]-[#6]-[#8]	O=C1c2c(c(-c3ccccc3O)n[nH]2)C(c2cc(Oc3ccccc3)ccc2)N1CCCO	ATZKNJQPPLSNBB		parent_pubchem_cid	AKOS001846961;AKOS016305946;CCG-145126;Z1213667667;3-(2-hydroxyphenyl)-5-(3-hydroxypropyl)-4-(3-phenoxyphenyl)-1H,4H,5H,6H-pyrrolo[3,4-c]pyrazol-6-one;3-(2-hydroxyphenyl)-5-(3-hydroxypropyl)-4-(3-phenoxyphenyl)-1,4-dihydropyrrolo[3,4-c]pyrazol-6-one		24313404.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24313404		pluskal_iocb_peptide_Peptide01_A10_id		100	A10		
2.3		0	681	P1094995	105.7		B36	False	0	20	0	0	26	0	4	4	0	0		0.0						CCC(C)C(NC(=O)N1CCN(C(=O)c2cc3ccccc3[nH]2)CC1)C(=O)O																							0.0		AKOS005533386		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C20H26N4O4	C20H26N4O4			InChI=1S/C20H26N4O4/c1-3-13(2)17(19(26)27)22-20(28)24-10-8-23(9-11-24)18(25)16-12-14-6-4-5-7-15(14)21-16/h4-7,12-13,17,21H,3,8-11H2,1-2H3,(H,22,28)(H,26,27)/t13?,17-/m0/s1	HSQQYSDKJAJVKL-RUINGEJQSA-N	rac-(2S)-2-[[4-(1H-indole-2-carbonyl)piperazine-1-carbonyl]amino]-3-methyl-pentanoic acid	17600448	CCC(C)[C@H](NC(=O)N1CCN(C(=O)c2cc3ccccc3[nH]2)CC1)C(=O)O	(2S)-2-[[4-(1H-indole-2-carbonyl)piperazine-1-carbonyl]amino]-3-methylpentanoic acid			1.65147														386.45462		386.195405	4	3	5	3			46									Carboline alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(17600448)	17600448	2.3	79			[#6]-[#6]-[#6](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#7]1-[#6]-[#6]-[#7](-[#6](=[#8])-[#6]2:[#6]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3:[#7H]:2)-[#6]-[#6]-1)-[#6](=[#8])-[#8]	CCC(C)[C@H](NC(=O)N1CCN(C(=O)c2cc3ccccc3[nH]2)CC1)C(=O)O	HSQQYSDKJAJVKL		parent_pubchem_cid	AKOS005533386;rac-(2S)-2-[[4-(1H-indole-2-carbonyl)piperazine-1-carbonyl]amino]-3-methyl-pentanoic acid		24285619.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24285619		pluskal_iocb_peptide_Peptide01_A10_id		100	A10		
3.0		0	425	P1094963	74.4		B37	False	0	19	0	0	25	0	3	3	0	0		0.0						COC(=O)C(CC(C)C)NC(=O)N1CCc2c(C1)[nH]c1ccccc21																							0.0		AKOS016376087		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C19H25N3O3	C19H25N3O3			InChI=1S/C19H25N3O3/c1-12(2)10-16(18(23)25-3)21-19(24)22-9-8-14-13-6-4-5-7-15(13)20-17(14)11-22/h4-7,12,16,20H,8-11H2,1-3H3,(H,21,24)/t16-/m0/s1	ZFMWAZWQMBYWBZ-INIZCTEOSA-N	methyl rac-(2S)-4-methyl-2-(1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carbonylamino)pentanoate	17571810	COC(=O)[C@H](CC(C)C)NC(=O)N1CCc2c(C1)[nH]c1ccccc21	methyl (2S)-4-methyl-2-(1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carbonylamino)pentanoate			2.28546													MCULE-7226145129	343.4294		343.189592	3	2	5	3			44									Carboline alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(17571810)	17571810	2.9	80			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=[#8])-[#7]1-[#6]-[#6]-[#6]2:[#6](-[#6]-1):[#7H]:[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:2:1	COC(=O)[C@H](CC(C)C)NC(=O)N1CCc2c(C1)[nH]c1ccccc21	ZFMWAZWQMBYWBZ		parent_pubchem_cid	AKOS016376087;methyl rac-(2S)-4-methyl-2-(1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carbonylamino)pentanoate		11297595.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=11297595		pluskal_iocb_peptide_Peptide01_A11_id		100	A11		ZINC000011692315
4.8		0	513	P2195065	118.5		B38	False	0	24	1	0	25	0	4	3	0	1		0.0						CCOc1ccc(NC(=O)C(Cc2ccccc2)NC(=O)c2nc(SCC)ncc2Cl)cc1																							0.0		AKOS015861003		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C24H25ClN4O3S	C24H25ClN4O3S			InChI=1S/C24H25ClN4O3S/c1-3-32-18-12-10-17(11-13-18)27-22(30)20(14-16-8-6-5-7-9-16)28-23(31)21-19(25)15-26-24(29-21)33-4-2/h5-13,15,20H,3-4,14H2,1-2H3,(H,27,30)(H,28,31)	XTRLCGPPUHLFCC-UHFFFAOYSA-N	N-[1-benzyl-2-(4-ethoxyanilino)-2-oxo-ethyl]-5-chloro-2-ethylsulfanyl-pyrimidine-4-carboxamide	51065605	CCOc1ccc(NC(=O)C(Cc2ccccc2)NC(=O)c2nc(SCC)ncc2Cl)cc1	5-chloro-N-[1-(4-ethoxyanilino)-1-oxo-3-phenylpropan-2-yl]-2-ethylsulfanylpyrimidine-4-carboxamide			3.560050000000002													MCULE-9631487762	485.00885		484.133589	6	2	10	3			45										False					Peptide01			Compound(51065605)	51065605	4.9	81			[#6]-[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#7]-[#6](=[#8])-[#6](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#7]-[#6](=[#8])-[#6]2:[#7]:[#6](-[#16]-[#6]-[#6]):[#7]:[#6]:[#6]:2-[#17]):[#6]:[#6]:1	CCOc1ccc(NC(=O)C(Cc2ccccc2)NC(=O)c2nc(SCC)ncc2Cl)cc1	XTRLCGPPUHLFCC		parent_pubchem_cid	AKOS015861003;N-[1-benzyl-2-(4-ethoxyanilino)-2-oxo-ethyl]-5-chloro-2-ethylsulfanyl-pyrimidine-4-carboxamide		24408730.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24408730		pluskal_iocb_peptide_Peptide01_A11_id		100	A11		
4.8		0	601	P1305495	44.9		B39	False	0	23	0	1	19	0	2	1	0	0		0.0						O=C(NCC(c1ccccc1)c1c[nH]c2ccccc12)c1ccccc1F																							0.0		2-fluoro-N-[2-(1H-indol-3-yl)-2-phenylethyl]benzamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C23H19FN2O	C23H19FN2O			InChI=1S/C23H19FN2O/c24-21-12-6-4-11-18(21)23(27)26-14-19(16-8-2-1-3-9-16)20-15-25-22-13-7-5-10-17(20)22/h1-13,15,19,25H,14H2,(H,26,27)	AXONDJBRUIHZEE-UHFFFAOYSA-N	2-fluoro-N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]benzamide	17014642	O=C(NCC(c1ccccc1)c1c[nH]c2ccccc12)c1ccccc1F	2-fluoro-N-[2-(1H-indol-3-yl)-2-phenylethyl]benzamide			4.276350000000003													MCULE-8574951346	358.41908		358.148141	1	2	5	4			45										False	Alkaloids;Shikimates and Phenylpropanoids				Peptide01			Compound(17014642)	17014642	4.8	82			[#8]=[#6](-[#7]-[#6]-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#9]	O=C(NCC(c1ccccc1)c1c[nH]c2ccccc12)c1ccccc1F	AXONDJBRUIHZEE		parent_pubchem_cid	2-fluoro-N-[2-(1H-indol-3-yl)-2-phenylethyl]benzamide;AKOS002334443;AKOS016326706;2-fluoro-N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]benzamide		23713070.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23713070		pluskal_iocb_peptide_Peptide01_A11_id		100	A11		
4.4		0	689	P6236800	123.3		B40	False	0	22	1	0	18	0	3	3	0	1		0.0						O=C(Cc1csc(-c2cc(Cl)ccc2)n1)NC(Cc1c[nH]c2ccccc12)C(=O)O																							0.0		SCHEMBL21560303		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C22H18ClN3O3S	C22H18ClN3O3S			InChI=1S/C22H18ClN3O3S/c23-15-5-3-4-13(8-15)21-25-16(12-30-21)10-20(27)26-19(22(28)29)9-14-11-24-18-7-2-1-6-17(14)18/h1-8,11-12,19,24H,9-10H2,(H,26,27)(H,28,29)/t19-/m0/s1	DOUZACXADCXVSP-IBGZPJMESA-N	rac-(2S)-2-[[2-[2-(3-chlorophenyl)thiazol-4-yl]acetyl]amino]-3-(1H-indol-3-yl)propanoic acid	29148487	O=C(Cc1csc(-c2cc(Cl)ccc2)n1)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	(2S)-2-[[2-[2-(3-chlorophenyl)-1,3-thiazol-4-yl]acetyl]amino]-3-(1H-indol-3-yl)propanoic acid			3.38154													MCULE-5780001941	439.92406		439.07574	4	3	7	4			43										False	Alkaloids				Peptide01			Compound(29148487)	29148487	4.2	83		SCHEMBL21560303	[#8]=[#6](-[#6]-[#6]1:[#6]:[#16]:[#6](-[#6]2:[#6]:[#6](-[#17]):[#6]:[#6]:[#6]:2):[#7]:1)-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	O=C(Cc1csc(-c2cc(Cl)ccc2)n1)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	DOUZACXADCXVSP		parent_pubchem_cid	SCHEMBL21560303;BDBM512997;US11091451, Compound I-49;AKOS016402478;rac-(2S)-2-[[2-[2-(3-chlorophenyl)thiazol-4-yl]acetyl]amino]-3-(1H-indol-3-yl)propanoic acid		23511425.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23511425		pluskal_iocb_peptide_Peptide01_A11_id		100	A11		ZINC000020763500
2.3		0	433	P7568072	71.3		B41	False	0	15	0	0	18	0	2	3	0	0		0.0						CC(C)C(NC(=O)c1cc2c(cc1)n(C)cc2)C(=O)O																							0.0		AKOS025146266		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C15H18N2O3	C15H18N2O3			InChI=1S/C15H18N2O3/c1-9(2)13(15(19)20)16-14(18)11-4-5-12-10(8-11)6-7-17(12)3/h4-9,13H,1-3H3,(H,16,18)(H,19,20)/t13-/m0/s1	RTNTWFVYTULZPM-ZDUSSCGKSA-N	rac-(2S)-3-methyl-2-[(1-methylindole-5-carbonyl)amino]butanoic acid	91901535	CC(C)[C@H](NC(=O)c1cc2c(cc1)n(C)cc2)C(=O)O	(2S)-3-methyl-2-[(1-methylindole-5-carbonyl)amino]butanoic acid			1.53417														274.32231		274.131742	3	2	4	2			45										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(91901535)	91901535	2.2	84			[#6]-[#6](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#7](-[#6]):[#6]:[#6]:2)-[#6](=[#8])-[#8]	CC(C)[C@H](NC(=O)c1cc2c(cc1)n(C)cc2)C(=O)O	RTNTWFVYTULZPM		parent_pubchem_cid	AKOS025146266;(2S)-3-METHYL-2-{[(1-METHYL-1H-INDOL-5-YL)CARBONYL]AMINO}BUTANOIC ACID;rac-(2S)-3-methyl-2-[(1-methylindole-5-carbonyl)amino]butanoic acid		101553834.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=101553834		pluskal_iocb_peptide_Peptide01_A11_id		100	A11		ZINC000170625759
0.8		0	521	P2194252	119.0		B42	False	0	17	0	0	24	0	2	5	0	1		0.0						COC(=O)C(CCSC)NC(=O)CCNC(=O)c1cc(OC)ccc1																							0.0		STL217725		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C17H24N2O5S	C17H24N2O5S			InChI=1S/C17H24N2O5S/c1-23-13-6-4-5-12(11-13)16(21)18-9-7-15(20)19-14(8-10-25-3)17(22)24-2/h4-6,11,14H,7-10H2,1-3H3,(H,18,21)(H,19,20)	WIDQGMPKFHEWDO-UHFFFAOYSA-N	methyl 2-[3-[(3-methoxybenzoyl)amino]propanoylamino]-4-methylsulfanyl-butanoate	51065014	COC(=O)C(CCSC)NC(=O)CCNC(=O)c1cc(OC)ccc1	methyl 2-[3-[(3-methoxybenzoyl)amino]propanoylamino]-4-methylsulfanylbutanoate			0.7088800000000008													MCULE-1109987488	368.45523		368.140593	6	2	11	1			45									Dipeptides;Simple amide alkaloids	False	Alkaloids;Amino acids and Peptides	Peptide alkaloids;Small peptides			Peptide01			Compound(51065014)	51065014	1.4	85			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]-[#16]-[#6])-[#7]-[#6](=[#8])-[#6]-[#6]-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:[#6]:1	COC(=O)C(CCSC)NC(=O)CCNC(=O)c1cc(OC)ccc1	WIDQGMPKFHEWDO		parent_pubchem_cid	STL217725;AKOS015860504;methyl N-[(3-methoxyphenyl)carbonyl]-beta-alanylmethioninate;methyl 2-[3-[(3-methoxybenzoyl)amino]propanoylamino]-4-methylsulfanyl-butanoate		24058665.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24058665		pluskal_iocb_peptide_Peptide01_A11_id		100	A11		
4.6		0	609	P1305262	63.4		B43	False	0	25	0	0	24	0	2	3	0	0		0.0						COc1ccc(C(CNC(=O)c2cc(OC)ccc2)c2c[nH]c3ccccc23)cc1																							0.0		N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-3-methoxybenzamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C25H24N2O3	C25H24N2O3			InChI=1S/C25H24N2O3/c1-29-19-12-10-17(11-13-19)22(23-16-26-24-9-4-3-8-21(23)24)15-27-25(28)18-6-5-7-20(14-18)30-2/h3-14,16,22,26H,15H2,1-2H3,(H,27,28)	AJVSQVXQCTVFFY-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-3-methoxy-benzamide	17014419	COc1ccc(C(CNC(=O)c2cc(OC)ccc2)c2c[nH]c3ccccc23)cc1	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-3-methoxybenzamide			3.229630000000001													MCULE-5007841136	400.48163		400.178693	3	2	7	4			45										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(17014419)	17014419	4.7	86			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6]-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:[#6]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	COc1ccc(C(CNC(=O)c2cc(OC)ccc2)c2c[nH]c3ccccc23)cc1	AJVSQVXQCTVFFY		parent_pubchem_cid	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-3-methoxybenzamide;AKOS002335391;AKOS016326575;N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-3-methoxy-benzamide		23348572.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23348572		pluskal_iocb_peptide_Peptide01_A11_id		100	A11		
4.4		0	697	P6237960	123.3		B44	False	0	22	1	0	18	0	3	3	0	1		0.0						O=C(Cc1csc(-c2ccccc2Cl)n1)NC(Cc1c[nH]c2ccccc12)C(=O)O																							0.0		SCHEMBL20255649		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C22H18ClN3O3S	C22H18ClN3O3S			InChI=1S/C22H18ClN3O3S/c23-17-7-3-1-6-16(17)21-25-14(12-30-21)10-20(27)26-19(22(28)29)9-13-11-24-18-8-4-2-5-15(13)18/h1-8,11-12,19,24H,9-10H2,(H,26,27)(H,28,29)/t19-/m0/s1	BZIPRQIDEWGPJJ-IBGZPJMESA-N	rac-(2S)-2-[[2-[2-(2-chlorophenyl)thiazol-4-yl]acetyl]amino]-3-(1H-indol-3-yl)propanoic acid	39349036	O=C(Cc1csc(-c2ccccc2Cl)n1)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	(2S)-2-[[2-[2-(2-chlorophenyl)-1,3-thiazol-4-yl]acetyl]amino]-3-(1H-indol-3-yl)propanoic acid			3.381540000000001													MCULE-8921303162	439.92406		439.07574	4	3	7	4			43										False	Alkaloids				Peptide01			Compound(39349036)	39349036	4.2	87		SCHEMBL20255649	[#8]=[#6](-[#6]-[#6]1:[#6]:[#16]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#17]):[#7]:1)-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	O=C(Cc1csc(-c2ccccc2Cl)n1)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	BZIPRQIDEWGPJJ		parent_pubchem_cid	SCHEMBL20255649;STK653139;AKOS005583849;N-{[2-(2-chlorophenyl)-1,3-thiazol-4-yl]acetyl}-L-tryptophan;rac-(2S)-2-[[2-[2-(2-chlorophenyl)thiazol-4-yl]acetyl]amino]-3-(1H-indol-3-yl)propanoic acid		23598958.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23598958		pluskal_iocb_peptide_Peptide01_A11_id		100	A11		ZINC000032102312
1.0		0	705	P6248081	72.9		C1	False	0	24	0	0	31	0	3	3	0	0		0.0						CCC(C)C(NC(=O)N1CCN(C(c2ccccc2)c2ccccc2)CC1)C(=O)O																							0.0		rac-(2S,3R)-2-[(4-benzhydrylpiperazine-1-carbonyl)amino]-3-methyl-pentanoic acid		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1		C24H31N3O3	C24H31N3O3			InChI=1S/C24H31N3O3/c1-3-18(2)21(23(28)29)25-24(30)27-16-14-26(15-17-27)22(19-10-6-4-7-11-19)20-12-8-5-9-13-20/h4-13,18,21-22H,3,14-17H2,1-2H3,(H,25,30)(H,28,29)/t18-,21+/m1/s1	CJVYTXQTAVGNHZ-NQIIRXRSSA-N	rac-(2S,3R)-2-[(4-benzhydrylpiperazine-1-carbonyl)amino]-3-methyl-pentanoic acid	25810324	CC[C@@H](C)[C@H](NC(=O)N1CCN(C(c2ccccc2)c2ccccc2)CC1)C(=O)O	(2S,3R)-2-[(4-benzhydrylpiperazin-4-ium-1-carbonyl)amino]-3-methylpentanoate			3.4930800000000017													MCULE-5542697591	409.53297		409.236542	4	2	7	3			44										False	Alkaloids				Peptide01			Compound(25810324)	25810324	2.2	88			[#6]-[#6]-[#6@@H](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#7]1-[#6]-[#6]-[#7](-[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]-[#6]-1)-[#6](=[#8])-[#8]	CC[C@@H](C)[C@H](NC(=O)N1CCN(C(c2ccccc2)c2ccccc2)CC1)C(=O)O	CJVYTXQTAVGNHZ		parent_pubchem_cid	rac-(2S,3R)-2-[(4-benzhydrylpiperazine-1-carbonyl)amino]-3-methyl-pentanoic acid		24813369.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24813369		pluskal_iocb_peptide_Peptide01_A12_id		100	A12		ZINC000013591576
2.8		0	793	P6242047	71.3		C2	False	0	17	0	0	22	0	2	3	0	0		0.0						CC(C)CC(NC(=O)CCn1ccc2ccccc21)C(=O)O								N-acyl-L-alpha-amino acids;N-alkylindoles;Indoles;Substituted pyrroles;Benzenoids;Heteroaromatic compounds;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Leucine and derivatives;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;N-alkylindoles;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as leucine and derivatives. These are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Leucine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-L-alpha-amino acid (CHEBI:48927);indoles (CHEBI:24828);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);leucine derivative (CHEBI:47003);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);N-acyl-amino acid (CHEBI:51569);organic heterocyclic compound (CHEBI:24532);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806)		Amino acids, peptides, and analogues	Leucine or derivatives;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;N-acyl-l-alpha-amino acid;N-alkylindole;Indole;Indole or derivatives;Substituted pyrrole;Benzenoid;Heteroaromatic compound;Pyrrole;Carboxamide group;Secondary carboxylic acid amide;Azacycle;Monocarboxylic acid or derivatives;Carboxylic acid;Organoheterocyclic compound;Organooxygen compound;Organonitrogen compound;Hydrocarbon derivative;Organic oxide;Organic oxygen compound;Organic nitrogen compound;Carbonyl group;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS016376040		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C17H22N2O3	C17H22N2O3			InChI=1S/C17H22N2O3/c1-12(2)11-14(17(21)22)18-16(20)8-10-19-9-7-13-5-3-4-6-15(13)19/h3-7,9,12,14H,8,10-11H2,1-2H3,(H,18,20)(H,21,22)/t14-/m0/s1	ROABMWZHSDROKN-AWEZNQCLSA-N	rac-(2S)-2-(3-indol-1-ylpropanoylamino)-4-methyl-pentanoic acid	49652657	CC(C)C[C@H](NC(=O)CCn1ccc2ccccc21)C(=O)O	(2S)-2-(3-indol-1-ylpropanoylamino)-4-methylpentanoic acid			2.21848													MCULE-2092029166	302.37649		302.163043	3	2	7	2			44									Dipeptides	False	Alkaloids;Amino acids and Peptides	Small peptides			Peptide01			Compound(49652657)	49652657	2.5	89			[#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#6]-[#7]1:[#6]:[#6]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	CC(C)C[C@H](NC(=O)CCn1ccc2ccccc21)C(=O)O	ROABMWZHSDROKN		parent_pubchem_cid	AKOS016376040;(2S)-2-{[3-(1H-INDOL-1-YL)PROPANOYL]AMINO}-4-METHYLPENTANOIC ACID;rac-(2S)-2-(3-indol-1-ylpropanoylamino)-4-methyl-pentanoic acid		24340660.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24340660		pluskal_iocb_peptide_Peptide01_A12_id		100	A12		ZINC000040313171
3.2		0	881	P3461882	96.4		C3	False	0	22	0	0	21	0	3	4	0	0		0.0						COc1cc2c(cc1)n(CC(=O)NC(Cc1c[nH]c3ccccc13)C(=O)O)cc2																							0.0		DTXSID101228311		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C22H21N3O4	C22H21N3O4			InChI=1S/C22H21N3O4/c1-29-16-6-7-20-14(10-16)8-9-25(20)13-21(26)24-19(22(27)28)11-15-12-23-18-5-3-2-4-17(15)18/h2-10,12,19,23H,11,13H2,1H3,(H,24,26)(H,27,28)/t19-/m0/s1	FLSRXHAKOWBIRZ-IBGZPJMESA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[[2-(5-methoxyindol-1-yl)acetyl]amino]propanoic acid	29147785	COc1cc2c(cc1)n(CC(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)O)cc2	(2S)-3-(1H-indol-3-yl)-2-[[2-(5-methoxyindol-1-yl)acetyl]amino]propanoic acid			1.569339999999999													MCULE-8064046932	391.43037		391.153206	4	3	7	4			44									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(29147785)	29147785	3.1	90			[#6]-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#7](-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:1:3)-[#6](=[#8])-[#8]):[#6]:[#6]:2	COc1cc2c(cc1)n(CC(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)O)cc2	FLSRXHAKOWBIRZ		parent_pubchem_cid	DTXSID101228311;AKOS004937980;1212331-08-2;N-[2-(5-Methoxy-1H-indol-1-yl)acetyl]-L-tryptophan;rac-(2S)-3-(1H-indol-3-yl)-2-[[2-(5-methoxyindol-1-yl)acetyl]amino]propanoic acid		23235563.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23235563		pluskal_iocb_peptide_Peptide01_A12_id		100	A12		ZINC000020762030
1.1		0	969	P1094928	109.5		C4	False	0	16	0	0	19	0	3	5	0	0		0.0						COC(=O)CNC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)OC																							0.0		AKOS016382729		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C16H19N3O5	C16H19N3O5			InChI=1S/C16H19N3O5/c1-23-14(20)9-18-16(22)19-13(15(21)24-2)7-10-8-17-12-6-4-3-5-11(10)12/h3-6,8,13,17H,7,9H2,1-2H3,(H2,18,19,22)/t13-/m0/s1	VBXWGAZWNPVJDJ-ZDUSSCGKSA-N	methyl rac-(2S)-3-(1H-indol-3-yl)-2-[(2-methoxy-2-oxo-ethyl)carbamoylamino]propanoate	1748030	COC(=O)CNC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)OC	methyl (2S)-3-(1H-indol-3-yl)-2-[(2-methoxy-2-oxoethyl)carbamoylamino]propanoate			0.2410700000000012													MCULE-4493533781	333.34693		333.132471	5	3	8	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(1748030)	1748030	1.1	91			[#6]-[#8]-[#6](=[#8])-[#6]-[#7]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]-[#6]	COC(=O)CNC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)OC	VBXWGAZWNPVJDJ		parent_pubchem_cid	AKOS016382729;METHYL (2S)-3-(1H-INDOL-3-YL)-2-({[(2-METHOXY-2-OXOETHYL)AMINO]CARBONYL}AMINO)PROPANOATE;methyl rac-(2S)-3-(1H-indol-3-yl)-2-[(2-methoxy-2-oxo-ethyl)carbamoylamino]propanoate		9422253.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=9422253		pluskal_iocb_peptide_Peptide01_A12_id		100	A12		ZINC000002090996
2.3		0	713	P6244738	97.7		C5	False	0	19	0	0	18	0	6	2	0	0		0.0						COc1c(-n2cnnn2)cc(NC(=O)CCc2c[nH]c3ccccc23)cc1																							0.0		3-(1H-indol-3-yl)-N-[4-methoxy-3-(1H-tetrazol-1-yl)phenyl]propanamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	4	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C19H18N6O2	C19H18N6O2			InChI=1S/C19H18N6O2/c1-27-18-8-7-14(10-17(18)25-12-21-23-24-25)22-19(26)9-6-13-11-20-16-5-3-2-4-15(13)16/h2-5,7-8,10-12,20H,6,9H2,1H3,(H,22,26)	YHIPLLBNIICVQR-UHFFFAOYSA-N	3-(1H-indol-3-yl)-N-[4-methoxy-3-(tetrazol-1-yl)phenyl]propanamide	45493492	COc1c(-n2cnnn2)cc(NC(=O)CCc2c[nH]c3ccccc23)cc1	3-(1H-indol-3-yl)-N-[4-methoxy-3-(tetrazol-1-yl)phenyl]propanamide			1.2073399999999992													MCULE-2731094597	362.39431		362.149124	5	2	6	4			44										False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(45493492)	45493492	2.4	92			[#6]-[#8]-[#6]1:[#6](-[#7]2:[#6]:[#7]:[#7]:[#7]:2):[#6]:[#6](-[#7]-[#6](=[#8])-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	COc1c(-n2cnnn2)cc(NC(=O)CCc2c[nH]c3ccccc23)cc1	YHIPLLBNIICVQR		parent_pubchem_cid	3-(1H-indol-3-yl)-N-[4-methoxy-3-(1H-tetrazol-1-yl)phenyl]propanamide;1190261-20-1;EiM08-17310;AKOS005670651;3-(1H-indol-3-yl)-N-[4-methoxy-3-(tetrazol-1-yl)phenyl]propanamide		3514911.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=3514911		pluskal_iocb_peptide_Peptide01_A12_id		100	A12		ZINC000036358970
2.2		0	801	P3463217	120.8		C6	False	0	21	0	0	21	0	5	4	0	1		0.0						O=C(CCc1c[nH]c2ccccc12)N1CCN(S(=O)(=O)c2cccc3nonc23)CC1																							0.0		1-[4-(2,1,3-benzoxadiazol-4-ylsulfonyl)piperazin-1-yl]-3-(1H-indol-3-yl)propan-1-one		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	1	1		C21H21N5O4S	C21H21N5O4S			InChI=1S/C21H21N5O4S/c27-20(9-8-15-14-22-17-5-2-1-4-16(15)17)25-10-12-26(13-11-25)31(28,29)19-7-3-6-18-21(19)24-30-23-18/h1-7,14,22H,8-13H2	UILCZGGPKWRGOK-UHFFFAOYSA-N	1-[4-(2,1,3-benzoxadiazol-4-ylsulfonyl)piperazin-1-yl]-3-(1H-indol-3-yl)propan-1-one	17602089	O=C(CCc1c[nH]c2ccccc12)N1CCN(S(=O)(=O)c2cccc3nonc23)CC1	1-[4-(2,1,3-benzoxadiazol-4-ylsulfonyl)piperazin-1-yl]-3-(1H-indol-3-yl)propan-1-one			1.15024													MCULE-9363324649	439.49662		439.131425	5	1	5	5			43									Carboline alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(17602089)	17602089	1.6	93			[#8]=[#6](-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]1-[#6]-[#6]-[#7](-[#16](=[#8])(=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]3:[#7]:[#8]:[#7]:[#6]:2:3)-[#6]-[#6]-1	O=C(CCc1c[nH]c2ccccc12)N1CCN(S(=O)(=O)c2cccc3nonc23)CC1	UILCZGGPKWRGOK		parent_pubchem_cid	1-[4-(2,1,3-benzoxadiazol-4-ylsulfonyl)piperazin-1-yl]-3-(1H-indol-3-yl)propan-1-one;951967-81-0;STL239892;AKOS016399680		9835274.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=9835274		pluskal_iocb_peptide_Peptide01_A12_id		100	A12		ZINC000013730384
3.4		0	889	P11184250	91.4		C7	False	0	22	0	0	22	0	2	4	0	0		0.0						O=C(CCc1cc2c(cc1)OCC2)NC(Cc1c[nH]c2ccccc12)C(=O)O																							0.0		AKOS027472160		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C22H22N2O4	C22H22N2O4			InChI=1S/C22H22N2O4/c25-21(8-6-14-5-7-20-15(11-14)9-10-28-20)24-19(22(26)27)12-16-13-23-18-4-2-1-3-17(16)18/h1-5,7,11,13,19,23H,6,8-10,12H2,(H,24,25)(H,26,27)/t19-/m0/s1	MMTNHOVIOHMMNR-IBGZPJMESA-N	rac-(2S)-2-[3-(2,3-dihydrobenzofuran-5-yl)propanoylamino]-3-(1H-indol-3-yl)propanoic acid	75491049	O=C(CCc1cc2c(cc1)OCC2)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	(2S)-2-[3-(2,3-dihydro-1-benzofuran-5-yl)propanoylamino]-3-(1H-indol-3-yl)propanoic acid			1.7925399999999996														378.43164		378.157957	4	3	7	4			45									Dipeptides	False	Amino acids and Peptides;Shikimates and Phenylpropanoids	Small peptides			Peptide01			Compound(75491049)	75491049	2.5	94			[#8]=[#6](-[#6]-[#6]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1)-[#8]-[#6]-[#6]-2)-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	O=C(CCc1cc2c(cc1)OCC2)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	MMTNHOVIOHMMNR		parent_pubchem_cid	AKOS027472160;rac-(2S)-2-[3-(2,3-dihydrobenzofuran-5-yl)propanoylamino]-3-(1H-indol-3-yl)propanoic acid		80415461.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=80415461		pluskal_iocb_peptide_Peptide01_A12_id		100	A12		ZINC000096220921
0.4		0	977	P1098887	166.6		C8	False	0	16	0	0	20	0	6	5	0	0		0.0						NC(=O)NCCCC(NC(=O)CCn1nnc2ccccc2c1=O)C(=O)O																							0.0		AKOS016397971		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	4	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C16H20N6O5	C16H20N6O5			InChI=1S/C16H20N6O5/c17-16(27)18-8-3-6-12(15(25)26)19-13(23)7-9-22-14(24)10-4-1-2-5-11(10)20-21-22/h1-2,4-5,12H,3,6-9H2,(H,19,23)(H,25,26)(H3,17,18,27)/t12-/m0/s1	IFNHDUKYMSMXSN-LBPRGKRZSA-N	rac-(2S)-2-[3-(4-oxo-1,2,3-benzotriazin-3-yl)propanoylamino]-5-ureido-pentanoic acid	24279954	NC(=O)NCCC[C@H](NC(=O)CCn1nnc2ccccc2c1=O)C(=O)O	(2S)-5-(carbamoylamino)-2-[3-(4-oxo-1,2,3-benzotriazin-3-yl)propanoylamino]pentanoic acid			-0.3290299999999991													MCULE-9132319643	376.375		376.149518	7	4	9	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(24279954)	24279954	-0.1	95			[#7]-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#6]-[#7]1:[#7]:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8])-[#6](=[#8])-[#8]	NC(=O)NCCC[C@H](NC(=O)CCn1nnc2ccccc2c1=O)C(=O)O	IFNHDUKYMSMXSN		parent_pubchem_cid	AKOS016397971;5-(CARBAMOYLAMINO)-2-[3-(4-OXO-3,4-DIHYDRO-1,2,3-BENZOTRIAZIN-3-YL)PROPANAMIDO]PENTANOIC ACID;rac-(2S)-2-[3-(4-oxo-1,2,3-benzotriazin-3-yl)propanoylamino]-5-ureido-pentanoic acid		23862779.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23862779		pluskal_iocb_peptide_Peptide01_A12_id		100	A12		ZINC000011867198
3.1		0	721	P3462619	101.9		C9	False	0	20	0	0	21	0	1	6	0	0		0.0						O=C(CCC(NC(=O)OCc1ccccc1)C(=O)O)OCc1ccccc1								Benzyloxycarbonyls;Fatty acid esters;Dicarboxylic acids and derivatives;Carbamate esters;Carboxylic acid esters;Carboxylic acids;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Benzene and substituted derivatives;Benzenoids;Benzyloxycarbonyls;Carbamate esters;Carbamic acids and derivatives;Carbonyl compounds;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Dicarboxylic acids and derivatives;Fatty Acyls;Fatty acid esters;Glutamic acid and derivatives;Hydrocarbon derivatives;Lipids and lipid-like molecules;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as glutamic acid and derivatives. These are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Glutamic acid and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic homomonocyclic compounds	carboxylic ester (CHEBI:33308);fatty acid ester (CHEBI:35748);dicarboxylic acid (CHEBI:35692);carbamate ester (CHEBI:23003);carboxylic acid (CHEBI:33575);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);glutamic acid derivative (CHEBI:24315);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);lipid (CHEBI:18059);organooxygen compound (CHEBI:36963);organic acid (CHEBI:64709);carbon oxoacid (CHEBI:35605);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806);carboxylic acid anion (CHEBI:29067);amino acid (CHEBI:33709);peptide (CHEBI:16670)	Fatty esters (FA07);Dicarboxylic acids (FA0117);Fatty Acyls (FA)	Amino acids, peptides, and analogues	Glutamic acid or derivatives;Benzyloxycarbonyl;Fatty acid ester;Monocyclic benzene moiety;Fatty acyl;Benzenoid;Dicarboxylic acid or derivatives;Carbamic acid ester;Carboxylic acid ester;Carboxylic acid;Organic nitrogen compound;Organonitrogen compound;Organooxygen compound;Hydrocarbon derivative;Organic oxide;Carbonyl group;Organic oxygen compound;Aromatic homomonocyclic compound	Organic acids and derivatives	0.0		Z-Glu(OBzl)-OH	DTXSID80388858	2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	1	0	3	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C20H21NO6	C20H21NO6			InChI=1S/C20H21NO6/c22-18(26-13-15-7-3-1-4-8-15)12-11-17(19(23)24)21-20(25)27-14-16-9-5-2-6-10-16/h1-10,17H,11-14H2,(H,21,25)(H,23,24)/t17-/m0/s1	TWIVXHQQTRSWGO-KRWDZBQOSA-N	rac-(2S)-5-benzyloxy-2-(benzyloxycarbonylamino)-5-oxo-pentanoic acid	3049860	O=C(CC[C@H](NC(=O)OCc1ccccc1)C(=O)O)OCc1ccccc1	(2S)-5-oxo-5-phenylmethoxy-2-(phenylmethoxycarbonylamino)pentanoic acid			2.780180000000001													MCULE-2794987345	371.39347		371.136887	6	2	11	2			42										False	Shikimates and Phenylpropanoids				Peptide01			Compound(3049860)	3049860	2.7	96		SCHEMBL7373019	[#8]=[#6](-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8])-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	O=C(CC[C@H](NC(=O)OCc1ccccc1)C(=O)O)OCc1ccccc1	TWIVXHQQTRSWGO		parent_pubchem_cid	Z-Glu(OBzl)-OH;5680-86-4;Cbz-Glu(Obzl)-OH;(S)-5-(Benzyloxy)-2-(((benzyloxy)carbonyl)amino)-5-oxopentanoic acid;NSC 169178;N-Cbz-L-glutamic Acid 5-Benzyl Ester;(2S)-5-(benzyloxy)-2-{[(benzyloxy)carbonyl]amino}-5-oxopentanoic acid;5-Benzyl N-Carbobenzoxy-L-glutamate;MFCD00065697;(2S)-5-oxo-5-phenylmethoxy-2-(phenylmethoxycarbonylamino)pentanoic acid;(S)-2-Benzyloxycarbonylamino-Pentanedioic Acid 5-Benzyl Ester;Z-Glu(OBzl)OH;Z-L-Glu(Bzl)-Oh;Z-Glu-(OBzl)-OH;N-Carbobenzoxy-L-glutamic Acid 5-Benzyl Ester;5-Benzyl N-Cbz-L-glutamate;SCHEMBL7373019;DTXSID80388858;TWIVXHQQTRSWGO-KRWDZBQOSA-N;AMY22619;AKOS015924087;CS-W011790;DS-1091;FD21354;HY-W011074;N-Cbz-L-glutamic acid gamma-benzylester;B3902;EN300-7385845;J-300103;Q-201454;N-alpha-Benzyloxycarbonyl-L-glutamic-acid-gamma-benzyl ester;(S)-5-(benzyloxy)-2-(benzyloxycarbonylamino)-5-oxopentanoic acid;rac-(2S)-5-benzyloxy-2-(benzyloxycarbonylamino)-5-oxo-pentanoic acid		24011201.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24011201		pluskal_iocb_peptide_Peptide01_A13_id		100	A13		ZINC000001678300
3.1		0	809	P11182620	66.0		C10	False	0	23	0	0	27	0	5	1	0	0		0.0						Cc1nc2c(ccc(NC(=O)Cc3c[nH]c4ccccc34)c2)n1CCCN(C)C																							0.0		N-{1-[3-(dimethylamino)propyl]-2-methyl-1H-benzimidazol-5-yl}-2-(1H-indol-3-yl)acetamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	2		C23H27N5O	C23H27N5O			InChI=1S/C23H27N5O/c1-16-25-21-14-18(9-10-22(21)28(16)12-6-11-27(2)3)26-23(29)13-17-15-24-20-8-5-4-7-19(17)20/h4-5,7-10,14-15,24H,6,11-13H2,1-3H3,(H,26,29)	JIDBOGTUFXHBPQ-UHFFFAOYSA-N	N-[1-[3-(dimethylamino)propyl]-2-methyl-benzimidazol-5-yl]-2-(1H-indol-3-yl)acetamide	71701262	Cc1nc2c(ccc(NC(=O)Cc3c[nH]c4ccccc34)c2)n1CCCN(C)C	N-[1-[3-(dimethylamino)propyl]-2-methylbenzimidazol-5-yl]-2-(1H-indol-3-yl)acetamide			2.612050000000001													MCULE-7505226626	389.50454		389.22156	3	2	7	4			44									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(71701262)	71701262	3.1	97			[#6]-[#6]1:[#7]:[#6]2:[#6](:[#6]:[#6]:[#6](-[#7]-[#6](=[#8])-[#6]-[#6]3:[#6]:[#7H]:[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]:3:4):[#6]:2):[#7]:1-[#6]-[#6]-[#6]-[#7](-[#6])-[#6]	Cc1nc2c(ccc(NC(=O)Cc3c[nH]c4ccccc34)c2)n1CCCN(C)C	JIDBOGTUFXHBPQ		parent_pubchem_cid	N-{1-[3-(dimethylamino)propyl]-2-methyl-1H-benzimidazol-5-yl}-2-(1H-indol-3-yl)acetamide;1574408-72-2;EiM08-31641;AKOS022110020;N-{1-[3-(DIMETHYLAMINO)PROPYL]-2-METHYL-1H-1,3-BENZIMIDAZOL-5-YL}-2-(1H-INDOL-3-YL)ACETAMIDE;N-[1-[3-(dimethylamino)propyl]-2-methyl-benzimidazol-5-yl]-2-(1H-indol-3-yl)acetamide		59208819.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=59208819		pluskal_iocb_peptide_Peptide01_A13_id		100	A13		ZINC000095472805
3.9		0	897	P7564852	80.2		C11	False	0	23	0	0	23	0	3	3	0	0		0.0						COc1noc(CCC(=O)NCC(c2ccccc2)c2c[nH]c3ccccc23)c1																							0.0		N-[2-(1H-indol-3-yl)-2-phenylethyl]-3-(3-methoxy-1,2-oxazol-5-yl)propanamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C23H23N3O3	C23H23N3O3			InChI=1S/C23H23N3O3/c1-28-23-13-17(29-26-23)11-12-22(27)25-14-19(16-7-3-2-4-8-16)20-15-24-21-10-6-5-9-18(20)21/h2-10,13,15,19,24H,11-12,14H2,1H3,(H,25,27)	SVAUAIZDSMENJW-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]-3-(3-methoxyisoxazol-5-yl)propanamide	71704401	COc1noc(CCC(=O)NCC(c2ccccc2)c2c[nH]c3ccccc23)c1	N-[2-(1H-indol-3-yl)-2-phenylethyl]-3-(3-methoxy-1,2-oxazol-5-yl)propanamide			2.9904400000000013													MCULE-4284404670	389.45806		389.173942	3	2	8	4			45										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(71704401)	71704401	3.8	98			[#6]-[#8]-[#6]1:[#7]:[#8]:[#6](-[#6]-[#6]-[#6](=[#8])-[#7]-[#6]-[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:1	COc1noc(CCC(=O)NCC(c2ccccc2)c2c[nH]c3ccccc23)c1	SVAUAIZDSMENJW		parent_pubchem_cid	N-[2-(1H-indol-3-yl)-2-phenylethyl]-3-(3-methoxy-1,2-oxazol-5-yl)propanamide;1401558-98-2;EiM08-27895;STL313496;AKOS022115848;N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]-3-(3-methoxyisoxazol-5-yl)propanamide		46325924.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=46325924		pluskal_iocb_peptide_Peptide01_A13_id		100	A13		
2.5		0	985	P1107421	142.0		C12	False	0	22	0	0	28	0	2	7	0	0		0.0						Cc1c(CCC(=O)NCC(=O)NC(CC(C)C)C(=O)O)c(=O)oc2c1ccc(O)c2C																							0.0		EiM07-28458		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C22H28N2O7	C22H28N2O7			InChI=1S/C22H28N2O7/c1-11(2)9-16(21(28)29)24-19(27)10-23-18(26)8-6-15-12(3)14-5-7-17(25)13(4)20(14)31-22(15)30/h5,7,11,16,25H,6,8-10H2,1-4H3,(H,23,26)(H,24,27)(H,28,29)/t16-/m1/s1	JIYZDAQMUUEUEA-MRXNPFEDSA-N	rac-(2R)-2-[[2-[3-(7-hydroxy-4,8-dimethyl-2-oxo-chromen-3-yl)propanoylamino]acetyl]amino]-4-methyl-pentanoic acid	24280403	Cc1c(CCC(=O)NCC(=O)N[C@H](CC(C)C)C(=O)O)c(=O)oc2c1ccc(O)c2C	(2R)-2-[[2-[3-(7-hydroxy-4,8-dimethyl-2-oxochromen-3-yl)propanoylamino]acetyl]amino]-4-methylpentanoic acid			1.6246700000000005													MCULE-3686954592	432.47766		432.189651	7	4	9	2			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(24280403)	24280403	2.0	99			[#6]-[#6]1:[#6](-[#6]-[#6]-[#6](=[#8])-[#7]-[#6]-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6](-[#6])-[#6])-[#6](=[#8])-[#8]):[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]):[#6]:2-[#6]	Cc1c(CCC(=O)NCC(=O)N[C@H](CC(C)C)C(=O)O)c(=O)oc2c1ccc(O)c2C	JIYZDAQMUUEUEA		parent_pubchem_cid	EiM07-28458;AKOS016376064;2-{2-[3-(7-HYDROXY-4,8-DIMETHYL-2-OXO-2H-CHROMEN-3-YL)PROPANAMIDO]ACETAMIDO}-4-METHYLPENTANOIC ACID;rac-(2R)-2-[[2-[3-(7-hydroxy-4,8-dimethyl-2-oxo-chromen-3-yl)propanoylamino]acetyl]amino]-4-methyl-pentanoic acid		23686205.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23686205		pluskal_iocb_peptide_Peptide01_A13_id		100	A13		ZINC000011865402
2.2		0	729	P6243672	99.1		C13	False	0	20	0	0	23	0	3	4	0	0		0.0						O=C(Cn1nc2CCCCCc2cc1=O)NC(Cc1ccccc1)C(=O)O																							0.0		AKOS016402559		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C20H23N3O4	C20H23N3O4			InChI=1S/C20H23N3O4/c24-18(21-17(20(26)27)11-14-7-3-1-4-8-14)13-23-19(25)12-15-9-5-2-6-10-16(15)22-23/h1,3-4,7-8,12,17H,2,5-6,9-11,13H2,(H,21,24)(H,26,27)/t17-/m0/s1	XXNWYOHPHXHNNM-KRWDZBQOSA-N	rac-(2S)-2-[[2-(3-oxo-6,7,8,9-tetrahydro-5H-cyclohepta[c]pyridazin-2-yl)acetyl]amino]-3-phenyl-propanoic acid	51053526	O=C(Cn1nc2CCCCCc2cc1=O)N[C@@H](Cc1ccccc1)C(=O)O	(2S)-2-[[2-(3-oxo-6,7,8,9-tetrahydro-5H-cyclohepta[c]pyridazin-2-yl)acetyl]amino]-3-phenylpropanoic acid			2.06006													MCULE-5967182296	369.42401		369.168856	5	2	6	3			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51053526)	51053526	2.1	100			[#8]=[#6](-[#6]-[#7]1:[#7]:[#6]2-[#6]-[#6]-[#6]-[#6]-[#6]-[#6]:2:[#6]:[#6]:1=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	O=C(Cn1nc2CCCCCc2cc1=O)N[C@@H](Cc1ccccc1)C(=O)O	XXNWYOHPHXHNNM		parent_pubchem_cid	AKOS016402559;2-(2-{3-OXO-2H,3H,5H,6H,7H,8H,9H-CYCLOHEPTA[C]PYRIDAZIN-2-YL}ACETAMIDO)-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[[2-(3-oxo-6,7,8,9-tetrahydro-5H-cyclohepta[c]pyridazin-2-yl)acetyl]amino]-3-phenyl-propanoic acid		24285344.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24285344		pluskal_iocb_peptide_Peptide01_A13_id		100	A13		ZINC000049547060
2.9		0	817	P11184219	91.4		C14	False	0	21	0	0	20	0	2	4	0	0		0.0						O=C(Cc1cc2c(cc1)OCC2)NC(Cc1c[nH]c2ccccc12)C(=O)O																							0.0		AKOS027472137		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C21H20N2O4	C21H20N2O4			InChI=1S/C21H20N2O4/c24-20(10-13-5-6-19-14(9-13)7-8-27-19)23-18(21(25)26)11-15-12-22-17-4-2-1-3-16(15)17/h1-6,9,12,18,22H,7-8,10-11H2,(H,23,24)(H,25,26)/t18-/m0/s1	REUQZQYQUMYSGN-SFHVURJKSA-N	rac-(2S)-2-[[2-(2,3-dihydrobenzofuran-5-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid	75491867	O=C(Cc1cc2c(cc1)OCC2)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	(2S)-2-[[2-(2,3-dihydro-1-benzofuran-5-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid			1.40244														364.40455		364.142307	4	3	6	4			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(75491867)	75491867	2.2	101			[#8]=[#6](-[#6]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1)-[#8]-[#6]-[#6]-2)-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	O=C(Cc1cc2c(cc1)OCC2)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	REUQZQYQUMYSGN		parent_pubchem_cid	AKOS027472137;N-[(2,3-dihydro-1-benzofuran-5-yl)acetyl]-L-tryptophan;rac-(2S)-2-[[2-(2,3-dihydrobenzofuran-5-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid		80416279.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=80416279		pluskal_iocb_peptide_Peptide01_A13_id		100	A13		ZINC000096221940
0.5		0	905	P6243654	124.4		C15	False	0	15	0	0	21	0	3	4	0	1		0.0						CSCCC(NC(=O)Cn1nc2CCCCc2cc1=O)C(=O)O																							0.0		AKOS016387036		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C15H21N3O4S	C15H21N3O4S			InChI=1S/C15H21N3O4S/c1-23-7-6-12(15(21)22)16-13(19)9-18-14(20)8-10-4-2-3-5-11(10)17-18/h8,12H,2-7,9H2,1H3,(H,16,19)(H,21,22)/t12-/m0/s1	HMRXALUEMNXPGR-LBPRGKRZSA-N	rac-(2S)-4-methylsulfanyl-2-[[2-(3-oxo-5,6,7,8-tetrahydrocinnolin-2-yl)acetyl]amino]butanoic acid	51053726	CSCC[C@H](NC(=O)Cn1nc2CCCCc2cc1=O)C(=O)O	(2S)-4-methylsulfanyl-2-[[2-(3-oxo-5,6,7,8-tetrahydrocinnolin-2-yl)acetyl]amino]butanoic acid			1.2350699999999992													MCULE-3259494058	339.41632		339.125277	6	2	7	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51053726)	51053726	0.6	102			[#6]-[#16]-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#7]1:[#7]:[#6]2-[#6]-[#6]-[#6]-[#6]-[#6]:2:[#6]:[#6]:1=[#8])-[#6](=[#8])-[#8]	CSCC[C@H](NC(=O)Cn1nc2CCCCc2cc1=O)C(=O)O	HMRXALUEMNXPGR		parent_pubchem_cid	AKOS016387036;(2S)-4-(METHYLSULFANYL)-2-({2-[3-OXO-5,6,7,8-TETRAHYDRO-2(3H)-CINNOLINYL]ACETYL}AMINO)BUTANOIC ACID;rac-(2S)-4-methylsulfanyl-2-[[2-(3-oxo-5,6,7,8-tetrahydrocinnolin-2-yl)acetyl]amino]butanoic acid		24543316.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24543316		pluskal_iocb_peptide_Peptide01_A13_id		100	A13		ZINC000049547743
4.0		0	993	P7129713	67.4		C16	False	0	25	0	0	38	0	2	3	0	0		0.0						CC(C)C1CCC(C(=O)NC(Cc2ccccc2)C(=O)NCC2CCOCC2)CC1																							0.0		AKOS024459958		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C25H38N2O3	C25H38N2O3			InChI=1S/C25H38N2O3/c1-18(2)21-8-10-22(11-9-21)24(28)27-23(16-19-6-4-3-5-7-19)25(29)26-17-20-12-14-30-15-13-20/h3-7,18,20-23H,8-17H2,1-2H3,(H,26,29)(H,27,28)/t21?,22?,23-/m1/s1	QWWPPLKLWCLNKY-XPPIMPSXSA-N	4-isopropyl-N-[rac-(1R)-1-benzyl-2-oxo-2-(tetrahydropyran-4-ylmethylamino)ethyl]cyclohexanecarboxamide	71691958	CC(C)C1CCC(C(=O)N[C@H](Cc2ccccc2)C(=O)NCC2CCOCC2)CC1	N-[(2R)-1-(oxan-4-ylmethylamino)-1-oxo-3-phenylpropan-2-yl]-4-propan-2-ylcyclohexane-1-carboxamide			3.664390000000002														414.59321		414.288243	3	2	8	3			46										False	Terpenoids				Peptide01			Compound(71691958)	71691958	4.6	103			[#6]-[#6](-[#6])-[#6]1-[#6]-[#6]-[#6](-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#7]-[#6]-[#6]2-[#6]-[#6]-[#8]-[#6]-[#6]-2)-[#6]-[#6]-1	CC(C)C1CCC(C(=O)N[C@H](Cc2ccccc2)C(=O)NCC2CCOCC2)CC1	QWWPPLKLWCLNKY		parent_pubchem_cid	AKOS024459958;4-isopropyl-N-[rac-(1R)-1-benzyl-2-oxo-2-(tetrahydropyran-4-ylmethylamino)ethyl]cyclohexanecarboxamide		42243019.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=42243019		pluskal_iocb_peptide_Peptide01_A13_id		100	A13		
3.8		0	737	P6240657	83.7		C17	False	0	28	0	0	25	0	3	4	0	0		0.0						CN1C(=O)c2ccccc2C(C(=O)NCCc2c[nH]c3ccccc23)C1c1cc2c(cc1)OCO2																							0.0		1219581-53-9		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C28H25N3O4	C28H25N3O4			InChI=1S/C28H25N3O4/c1-31-26(17-10-11-23-24(14-17)35-16-34-23)25(20-7-2-3-8-21(20)28(31)33)27(32)29-13-12-18-15-30-22-9-5-4-6-19(18)22/h2-11,14-15,25-26,30H,12-13,16H2,1H3,(H,29,32)	NVHRBKWBZMERNA-UHFFFAOYSA-N	3-(1,3-benzodioxol-5-yl)-N-[2-(1H-indol-3-yl)ethyl]-2-methyl-1-oxo-3,4-dihydroisoquinoline-4-carboxamide	49657398	CN1C(=O)c2ccccc2C(C(=O)NCCc2c[nH]c3ccccc23)C1c1cc2c(cc1)OCO2	3-(1,3-benzodioxol-5-yl)-N-[2-(1H-indol-3-yl)ethyl]-2-methyl-1-oxo-3,4-dihydroisoquinoline-4-carboxamide			2.5939200000000007													MCULE-5597776868	467.52915		467.184506	4	2	5	6			45										False	Alkaloids				Peptide01			Compound(49657398)	49657398	3.8	104			[#6]-[#7]1-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6]-1-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1)-[#8]-[#6]-[#8]-2	CN1C(=O)c2ccccc2C(C(=O)NCCc2c[nH]c3ccccc23)C1c1cc2c(cc1)OCO2	NVHRBKWBZMERNA		parent_pubchem_cid	1219581-53-9;3-(1,3-benzodioxol-5-yl)-N-[2-(1H-indol-3-yl)ethyl]-2-methyl-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide;AKOS005666740;3-(1,3-BENZODIOXOL-5-YL)-N-[2-(1H-INDOL-3-YL)ETHYL]-2-METHYL-1-OXO-1,2,3,4-TETRAHYDRO-4-ISOQUINOLINECARBOXAMIDE;N-(2-(1H-indol-3-yl)ethyl)-3-(benzo[d][1,3]dioxol-5-yl)-2-methyl-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide;3-(1,3-benzodioxol-5-yl)-N-[2-(1H-indol-3-yl)ethyl]-2-methyl-1-oxo-3,4-dihydroisoquinoline-4-carboxamide		23691968.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23691968		pluskal_iocb_peptide_Peptide01_A14_id		100	A14		
2.7		0	825	P1108440	138.2		C18	False	0	21	0	0	19	0	1	6	0	1		0.0						O=C(Cc1cc(=O)oc2c1ccc(O)c2)NC(CSCc1ccccc1)C(=O)O																							0.0		EiM07-29661		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C21H19NO6S	C21H19NO6S			InChI=1S/C21H19NO6S/c23-15-6-7-16-14(9-20(25)28-18(16)10-15)8-19(24)22-17(21(26)27)12-29-11-13-4-2-1-3-5-13/h1-7,9-10,17,23H,8,11-12H2,(H,22,24)(H,26,27)/t17-/m1/s1	HUKWUYRJEKGMFU-QGZVFWFLSA-N	rac-(2S)-3-benzylsulfanyl-2-[[2-(7-hydroxy-2-oxo-chromen-4-yl)acetyl]amino]propanoic acid	24280678	O=C(Cc1cc(=O)oc2c1ccc(O)c2)N[C@H](CSCc1ccccc1)C(=O)O	(2S)-3-benzylsulfanyl-2-[[2-(7-hydroxy-2-oxochromen-4-yl)acetyl]amino]propanoic acid			2.4435400000000005													MCULE-8326467753	413.45268		413.093308	7	3	8	3			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(24280678)	24280678	2.1	105			[#8]=[#6](-[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]):[#6]:2)-[#7]-[#6@H](-[#6]-[#16]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	O=C(Cc1cc(=O)oc2c1ccc(O)c2)N[C@H](CSCc1ccccc1)C(=O)O	HUKWUYRJEKGMFU		parent_pubchem_cid	EiM07-29661;STL464450;AKOS004938120;S-benzyl-N-[(7-hydroxy-2-oxo-2H-chromen-4-yl)acetyl]-D-cysteine;rac-(2S)-3-benzylsulfanyl-2-[[2-(7-hydroxy-2-oxo-chromen-4-yl)acetyl]amino]propanoic acid		23461526.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23461526		pluskal_iocb_peptide_Peptide01_A14_id		100	A14		ZINC000011865672
3.5		0	913	P3462820	96.6		C19	False	0	21	0	0	22	0	2	3	0	1		0.0						CSCCC(NC(=O)Cn1c(-c2ccccc2)cc2ccccc21)C(=O)O																							0.0		AKOS004938769		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C21H22N2O3S	C21H22N2O3S			InChI=1S/C21H22N2O3S/c1-27-12-11-17(21(25)26)22-20(24)14-23-18-10-6-5-9-16(18)13-19(23)15-7-3-2-4-8-15/h2-10,13,17H,11-12,14H2,1H3,(H,22,24)(H,25,26)/t17-/m0/s1	PJGCEJBXBLECFB-KRWDZBQOSA-N	rac-(2S)-4-methylsulfanyl-2-[[2-(2-phenylindol-1-yl)acetyl]amino]butanoic acid	39315517	CSCC[C@H](NC(=O)Cn1c(-c2ccccc2)cc2ccccc21)C(=O)O	(2S)-4-methylsulfanyl-2-[[2-(2-phenylindol-1-yl)acetyl]amino]butanoic acid			2.8223600000000006													MCULE-8018634377	382.48509		382.135114	4	2	8	3			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(39315517)	39315517	3.7	106			[#6]-[#16]-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#7]1:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	CSCC[C@H](NC(=O)Cn1c(-c2ccccc2)cc2ccccc21)C(=O)O	PJGCEJBXBLECFB		parent_pubchem_cid	AKOS004938769;rac-(2S)-4-methylsulfanyl-2-[[2-(2-phenylindol-1-yl)acetyl]amino]butanoic acid		22689851.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22689851		pluskal_iocb_peptide_Peptide01_A14_id		100	A14		ZINC000032075001
3.4		0	1001	P11569000	75.1		C20	False	0	24	0	0	21	0	3	2	0	0		0.0						O=C(NC(CO)Cc1ccccc1)c1cc(-c2ccncc2)nc2ccccc12																							0.0		AKOS027473888		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C24H21N3O2	C24H21N3O2			InChI=1S/C24H21N3O2/c28-16-19(14-17-6-2-1-3-7-17)26-24(29)21-15-23(18-10-12-25-13-11-18)27-22-9-5-4-8-20(21)22/h1-13,15,19,28H,14,16H2,(H,26,29)/t19-/m0/s1	BWMTWJPZQBTIGE-IBGZPJMESA-N	2-(4-pyridyl)-N-[rac-(1S)-1-benzyl-2-hydroxy-ethyl]quinoline-4-carboxamide	91640928	O=C(N[C@H](CO)Cc1ccccc1)c1cc(-c2ccncc2)nc2ccccc12	N-[(2S)-1-hydroxy-3-phenylpropan-2-yl]-2-pyridin-4-ylquinoline-4-carboxamide			2.71234														383.45387		383.163377	4	2	6	4			45									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(91640928)	91640928	3.4	107			[#8]=[#6](-[#7]-[#6@H](-[#6]-[#8])-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#6](-[#6]2:[#6]:[#6]:[#7]:[#6]:[#6]:2):[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	O=C(N[C@H](CO)Cc1ccccc1)c1cc(-c2ccncc2)nc2ccccc12	BWMTWJPZQBTIGE		parent_pubchem_cid	AKOS027473888;2-(4-pyridyl)-N-[rac-(1S)-1-benzyl-2-hydroxy-ethyl]quinoline-4-carboxamide		96388439.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=96388439		pluskal_iocb_peptide_Peptide01_A14_id		100	A14		ZINC000191019611
1.2		0	745	P6236780	162.6		C21	False	0	17	0	0	20	0	4	4	0	1		0.0						Cc1c(C(=O)NC(CCCNC(N)=O)C(=O)O)sc(-c2ccccc2)n1																							0.0		EiM08-03954		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	1	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C17H20N4O4S	C17H20N4O4S			InChI=1S/C17H20N4O4S/c1-10-13(26-15(20-10)11-6-3-2-4-7-11)14(22)21-12(16(23)24)8-5-9-19-17(18)25/h2-4,6-7,12H,5,8-9H2,1H3,(H,21,22)(H,23,24)(H3,18,19,25)/t12-/m0/s1	XWPGRFLGDKRZRP-LBPRGKRZSA-N	rac-(2S)-2-[(4-methyl-2-phenyl-thiazole-5-carbonyl)amino]-5-ureido-pentanoic acid	71844017	Cc1c(C(=O)N[C@@H](CCCNC(N)=O)C(=O)O)sc(-c2ccccc2)n1	(2S)-5-(carbamoylamino)-2-[(4-methyl-2-phenyl-1,3-thiazole-5-carbonyl)amino]pentanoic acid			1.2605799999999996													MCULE-7114390677	376.43735		376.120526	5	4	8	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(71844017)	71844017	1.7	108			[#6]-[#6]1:[#6](-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#8])-[#6](=[#8])-[#8]):[#16]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#7]:1	Cc1c(C(=O)N[C@@H](CCCNC(N)=O)C(=O)O)sc(-c2ccccc2)n1	XWPGRFLGDKRZRP		parent_pubchem_cid	EiM08-03954;AKOS016388508;5-(CARBAMOYLAMINO)-2-[(4-METHYL-2-PHENYL-1,3-THIAZOL-5-YL)FORMAMIDO]PENTANOIC ACID;rac-(2S)-2-[(4-methyl-2-phenyl-thiazole-5-carbonyl)amino]-5-ureido-pentanoic acid		69226116.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=69226116		pluskal_iocb_peptide_Peptide01_A14_id		100	A14		ZINC000094992899
3.2		0	833	P3463221	135.9		C22	False	0	22	0	0	23	0	5	3	0	2		0.0						O=C(CCCc1c[nH]c2ccccc12)N1CCN(S(=O)(=O)c2cccc3nsnc23)CC1																							0.0		1-[4-(2,1,3-benzothiadiazol-4-ylsulfonyl)piperazin-1-yl]-4-(1H-indol-3-yl)butan-1-one		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	1	1		C22H23N5O3S2	C22H23N5O3S2			InChI=1S/C22H23N5O3S2/c28-21(10-3-5-16-15-23-18-7-2-1-6-17(16)18)26-11-13-27(14-12-26)32(29,30)20-9-4-8-19-22(20)25-31-24-19/h1-2,4,6-9,15,23H,3,5,10-14H2	XGXOQFOUWJWDSP-UHFFFAOYSA-N	1-[4-(2,1,3-benzothiadiazol-4-ylsulfonyl)piperazin-1-yl]-4-(1H-indol-3-yl)butan-1-one	17601652	O=C(CCCc1c[nH]c2ccccc12)N1CCN(S(=O)(=O)c2cccc3nsnc23)CC1	1-[4-(2,1,3-benzothiadiazol-4-ylsulfonyl)piperazin-1-yl]-4-(1H-indol-3-yl)butan-1-one			2.00884													MCULE-5251015857	469.58831		469.124232	5	1	6	5			43									Carboline alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(17601652)	17601652	2.6	109			[#8]=[#6](-[#6]-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]1-[#6]-[#6]-[#7](-[#16](=[#8])(=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]3:[#7]:[#16]:[#7]:[#6]:2:3)-[#6]-[#6]-1	O=C(CCCc1c[nH]c2ccccc12)N1CCN(S(=O)(=O)c2cccc3nsnc23)CC1	XGXOQFOUWJWDSP		parent_pubchem_cid	1-[4-(2,1,3-benzothiadiazol-4-ylsulfonyl)piperazin-1-yl]-4-(1H-indol-3-yl)butan-1-one;951965-47-2;EiM08-17745;STK640932;AKOS005572312;AKOS008497704		6846207.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=6846207		pluskal_iocb_peptide_Peptide01_A14_id		100	A14		ZINC000013728783
2.3		0	921	P7567018	98.9		C23	False	0	13	1	0	17	0	4	1	0	1		0.0						CC(C)Cc1c(C(=O)NCCc2cnc[nH]2)nc(Cl)s1																							0.0		2-chloro-N-[2-(1H-imidazol-4-yl)ethyl]-5-(2-methylpropyl)-1,3-thiazole-4-carboxamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	3	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C13H17ClN4OS	C13H17ClN4OS			InChI=1S/C13H17ClN4OS/c1-8(2)5-10-11(18-13(14)20-10)12(19)16-4-3-9-6-15-7-17-9/h6-8H,3-5H2,1-2H3,(H,15,17)(H,16,19)	AWASFDWDSZUCGT-UHFFFAOYSA-N	2-chloro-N-[2-(1H-imidazol-4-yl)ethyl]-5-isobutyl-thiazole-4-carboxamide	75490482	CC(C)Cc1c(C(=O)NCCc2cnc[nH]2)nc(Cl)s1	2-chloro-N-[2-(1H-imidazol-5-yl)ethyl]-5-(2-methylpropyl)-1,3-thiazole-4-carboxamide			2.52647													MCULE-8765020560	312.82364		312.08116	3	2	6	2			44									Imidazole alkaloids	False	Alkaloids	Histidine alkaloids			Peptide01			Compound(75490482)	75490482	3.3	110			[#6]-[#6](-[#6])-[#6]-[#6]1:[#6](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7]:[#6]:[#7H]:2):[#7]:[#6](-[#17]):[#16]:1	CC(C)Cc1c(C(=O)NCCc2cnc[nH]2)nc(Cl)s1	AWASFDWDSZUCGT		parent_pubchem_cid	2-chloro-N-[2-(1H-imidazol-4-yl)ethyl]-5-(2-methylpropyl)-1,3-thiazole-4-carboxamide;1574398-94-9;EiM08-33807;AKOS025145241;2-chloro-N-[2-(1H-imidazol-4-yl)ethyl]-5-isobutyl-thiazole-4-carboxamide		80414903.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=80414903		pluskal_iocb_peptide_Peptide01_A14_id		100	A14		ZINC000096232256
3.2		0	1009	P7129737	92.5		C24	False	0	25	0	0	37	0	3	3	0	0		0.0						CC(C)C1CCC(C(=O)NC(Cc2ccccc2)C(=O)N2CCC(C(N)=O)CC2)CC1																							0.0		AKOS024459980		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	1	0		C25H37N3O3	C25H37N3O3			InChI=1S/C25H37N3O3/c1-17(2)19-8-10-21(11-9-19)24(30)27-22(16-18-6-4-3-5-7-18)25(31)28-14-12-20(13-15-28)23(26)29/h3-7,17,19-22H,8-16H2,1-2H3,(H2,26,29)(H,27,30)/t19?,21?,22-/m1/s1	NFLMBAJPCIVHSK-KITAHSCOSA-N	1-[rac-(2R)-2-[(4-isopropylcyclohexanecarbonyl)amino]-3-phenyl-propanoyl]piperidine-4-carboxamide	90489189	CC(C)C1CCC(C(=O)N[C@H](Cc2ccccc2)C(=O)N2CCC(C(N)=O)CC2)CC1	1-[(2R)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoyl]piperidine-4-carboxamide			2.8454900000000007														427.59194		427.283492	3	2	7	3			46										False					Peptide01			Compound(90489189)	90489189	3.6	111			[#6]-[#6](-[#6])-[#6]1-[#6]-[#6]-[#6](-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#7]2-[#6]-[#6]-[#6](-[#6](-[#7])=[#8])-[#6]-[#6]-2)-[#6]-[#6]-1	CC(C)C1CCC(C(=O)N[C@H](Cc2ccccc2)C(=O)N2CCC(C(N)=O)CC2)CC1	NFLMBAJPCIVHSK		parent_pubchem_cid	AKOS024459980;1-[rac-(2R)-2-[(4-isopropylcyclohexanecarbonyl)amino]-3-phenyl-propanoyl]piperidine-4-carboxamide		99993908.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=99993908		pluskal_iocb_peptide_Peptide01_A14_id		100	A14		
2.1		0	753	P6245220	88.5		C25	False	0	19	0	0	18	0	6	1	0	0		0.0						O=C(NCCc1c[nH]c2ccccc12)C(c1ccccc1)n1cnnn1																							0.0		EiM08-18158		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	4	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C19H18N6O	C19H18N6O			InChI=1S/C19H18N6O/c26-19(18(25-13-22-23-24-25)14-6-2-1-3-7-14)20-11-10-15-12-21-17-9-5-4-8-16(15)17/h1-9,12-13,18,21H,10-11H2,(H,20,26)/t18-/m1/s1	PDDLZJDJOCZSMF-GOSISDBHSA-N	rac-(2R)-N-[2-(1H-indol-3-yl)ethyl]-2-phenyl-2-(tetrazol-1-yl)acetamide	52901864	O=C(NCCc1c[nH]c2ccccc12)[C@@H](c1ccccc1)n1cnnn1	(2R)-N-[2-(1H-indol-3-yl)ethyl]-2-phenyl-2-(tetrazol-1-yl)acetamide			1.5648599999999993													MCULE-6272987713	346.39491		346.154209	4	2	6	4			44									Imidazole alkaloids;Quinazoline alkaloids	False	Alkaloids	Anthranilic acid alkaloids;Histidine alkaloids			Peptide01			Compound(52901864)	52901864	2.8	112			[#8]=[#6](-[#7]-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6@@H](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]1:[#6]:[#7]:[#7]:[#7]:1	O=C(NCCc1c[nH]c2ccccc12)[C@@H](c1ccccc1)n1cnnn1	PDDLZJDJOCZSMF		parent_pubchem_cid	EiM08-18158;AKOS016400166;rac-(2R)-N-[2-(1H-indol-3-yl)ethyl]-2-phenyl-2-(tetrazol-1-yl)acetamide		13205986.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=13205986		pluskal_iocb_peptide_Peptide01_A15_id		100	A15		ZINC000061721178
3.1		0	841	P1108298	133.2		C26	False	0	22	0	0	21	0	1	7	0	0		0.0						Cc1cc(O)c2c(C)c(CC(=O)NC(Cc3ccc(O)cc3)C(=O)O)c(=O)oc2c1								Phenylalanine and derivatives;N-acyl-L-alpha-amino acids;Hydroxycoumarins;Phenylpropanoic acids;1-benzopyrans;Amphetamines and derivatives;Pyranones and derivatives;1-hydroxy-2-unsubstituted benzenoids;1-hydroxy-4-unsubstituted benzenoids;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactones;Oxacyclic compounds;Carboxylic acids;Monocarboxylic acids and derivatives;Carbonyl compounds;Organic oxides;Organopnictogen compounds;Organonitrogen compounds;Hydrocarbon derivatives	1-benzopyrans;1-hydroxy-2-unsubstituted benzenoids;1-hydroxy-4-unsubstituted benzenoids;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Benzene and substituted derivatives;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;Heteroaromatic compounds;Hydrocarbon derivatives;Hydroxycoumarins;Lactones;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenethylamines;Phenols;Phenylalanine and derivatives;Phenylpropanoic acids;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Secondary carboxylic acid amides;Tyrosine and derivatives	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as tyrosine and derivatives. These are compounds containing tyrosine or a derivative thereof resulting from reaction of tyrosine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Tyrosine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	phenylalanine derivative (CHEBI:25985);N-acyl-L-alpha-amino acid (CHEBI:48927);hydroxycoumarin (CHEBI:37912);benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);1-benzopyran (CHEBI:38443);amphetamines (CHEBI:35338);pyranone (CHEBI:37963);phenols (CHEBI:33853);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactone (CHEBI:25000);oxacycle (CHEBI:38104);monocarboxylic acid (CHEBI:25384);carbonyl compound (CHEBI:36586);organic oxide (CHEBI:25701);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic molecule (CHEBI:72695);tyrosine derivative (CHEBI:62761);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);N-acyl-amino acid (CHEBI:51569);coumarins (CHEBI:23403);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);benzenoid aromatic compound (CHEBI:33836);primary amine (CHEBI:32877);pyrans (CHEBI:26407);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);nitrogen molecular entity (CHEBI:51143)	Benzopyranoids (PK1311)	Amino acids, peptides, and analogues	Tyrosine or derivatives;Phenylalanine or derivatives;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;N-acyl-l-alpha-amino acid;Hydroxycoumarin;Coumarin;3-phenylpropanoic-acid;Benzopyran;Amphetamine or derivatives;1-benzopyran;1-hydroxy-2-unsubstituted benzenoid;1-hydroxy-4-unsubstituted benzenoid;Phenol;Pyranone;Monocyclic benzene moiety;Benzenoid;Pyran;Heteroaromatic compound;Secondary carboxylic acid amide;Carboxamide group;Lactone;Organoheterocyclic compound;Oxacycle;Carboxylic acid;Monocarboxylic acid or derivatives;Organooxygen compound;Hydrocarbon derivative;Organic oxygen compound;Organic nitrogen compound;Organonitrogen compound;Carbonyl group;Organopnictogen compound;Organic oxide;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		EiM07-29502		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	3	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C22H21NO7	C22H21NO7			InChI=1S/C22H21NO7/c1-11-7-17(25)20-12(2)15(22(29)30-18(20)8-11)10-19(26)23-16(21(27)28)9-13-3-5-14(24)6-4-13/h3-8,16,24-25H,9-10H2,1-2H3,(H,23,26)(H,27,28)/t16-/m0/s1	FSJULAQQWFCXPN-INIZCTEOSA-N	rac-(2S)-2-[[2-(5-hydroxy-4,7-dimethyl-2-oxo-chromen-3-yl)acetyl]amino]-3-(4-hydroxyphenyl)propanoic acid	6851315	Cc1cc(O)c2c(C)c(CC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)O)c(=O)oc2c1	(2S)-2-[[2-(5-hydroxy-4,7-dimethyl-2-oxochromen-3-yl)acetyl]amino]-3-(4-hydroxyphenyl)propanoic acid			1.50345													MCULE-5592519118	411.41517		411.131802	7	4	6	3			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(6851315)	6851315	2.3	113			[#6]-[#6]1:[#6]:[#6](-[#8]):[#6]2:[#6](-[#6]):[#6](-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]3:[#6]:[#6]:[#6](-[#8]):[#6]:[#6]:3)-[#6](=[#8])-[#8]):[#6](=[#8]):[#8]:[#6]:2:[#6]:1	Cc1cc(O)c2c(C)c(CC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)O)c(=O)oc2c1	FSJULAQQWFCXPN		parent_pubchem_cid	EiM07-29502;STL464301;AKOS016390740;N-[(5-hydroxy-4,7-dimethyl-2-oxo-2H-chromen-3-yl)acetyl]-L-tyrosine;rac-(2S)-2-[[2-(5-hydroxy-4,7-dimethyl-2-oxo-chromen-3-yl)acetyl]amino]-3-(4-hydroxyphenyl)propanoic acid		22738343.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22738343		pluskal_iocb_peptide_Peptide01_A15_id		100	A15		ZINC000020412609
2.9		0	929	P11571164	84.9		C27	False	0	22	0	0	28	0	4	3	0	0		0.0						CC(C)C(NC(=O)N1CCN(c2ccccc2)CC1)C(=O)Nc1ccc(O)cc1																							0.0		STL316590		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C22H28N4O3	C22H28N4O3			InChI=1S/C22H28N4O3/c1-16(2)20(21(28)23-17-8-10-19(27)11-9-17)24-22(29)26-14-12-25(13-15-26)18-6-4-3-5-7-18/h3-11,16,20,27H,12-15H2,1-2H3,(H,23,28)(H,24,29)	LKNYYDDSVLPADN-UHFFFAOYSA-N	N-[1-[(4-hydroxyphenyl)carbamoyl]-2-methyl-propyl]-4-phenyl-piperazine-1-carboxamide	71707003	CC(C)C(NC(=O)N1CCN(c2ccccc2)CC1)C(=O)Nc1ccc(O)cc1	N-[1-(4-hydroxyanilino)-3-methyl-1-oxobutan-2-yl]-4-phenylpiperazine-1-carboxamide			1.6634699999999996													MCULE-6766343069	396.49346		396.216141	4	3	5	3			45										False					Peptide01			Compound(71707003)	71707003	3.1	114			[#6]-[#6](-[#6])-[#6](-[#7]-[#6](=[#8])-[#7]1-[#6]-[#6]-[#7](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]-[#6]-1)-[#6](=[#8])-[#7]-[#6]1:[#6]:[#6]:[#6](-[#8]):[#6]:[#6]:1	CC(C)C(NC(=O)N1CCN(c2ccccc2)CC1)C(=O)Nc1ccc(O)cc1	LKNYYDDSVLPADN		parent_pubchem_cid	STL316590;AKOS022098881;N-{1-[(4-hydroxyphenyl)amino]-3-methyl-1-oxobutan-2-yl}-4-phenylpiperazine-1-carboxamide;N-[1-[(4-hydroxyphenyl)carbamoyl]-2-methyl-propyl]-4-phenyl-piperazine-1-carboxamide		64979598.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=64979598		pluskal_iocb_peptide_Peptide01_A15_id		100	A15		
2.4		0	1017	P11184860	121.1		C28	False	0	21	0	0	18	0	4	4	0	0		0.0						O=C(CCc1nc(-c2c3cc[nH]c3ccc2)no1)NC(C(=O)O)c1ccccc1																							0.0		AKOS027472520		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	2	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C21H18N4O4	C21H18N4O4			InChI=1S/C21H18N4O4/c26-17(23-19(21(27)28)13-5-2-1-3-6-13)9-10-18-24-20(25-29-18)15-7-4-8-16-14(15)11-12-22-16/h1-8,11-12,19,22H,9-10H2,(H,23,26)(H,27,28)/t19-/m0/s1	CUHMLLWMAHMVCE-IBGZPJMESA-N	rac-(2S)-2-[3-[3-(1H-indol-4-yl)-1,2,4-oxadiazol-5-yl]propanoylamino]-2-phenyl-acetic acid	91639967	O=C(CCc1nc(-c2c3cc[nH]c3ccc2)no1)N[C@H](C(=O)O)c1ccccc1	(2S)-2-[3-[3-(1H-indol-4-yl)-1,2,4-oxadiazol-5-yl]propanoylamino]-2-phenylacetic acid			2.17474														390.40201		390.132805	5	3	7	4			45										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(91639967)	91639967	2.8	115			[#8]=[#6](-[#6]-[#6]-[#6]1:[#7]:[#6](-[#6]2:[#6]3:[#6]:[#6]:[#7H]:[#6]:3:[#6]:[#6]:[#6]:2):[#7]:[#8]:1)-[#7]-[#6@H](-[#6](=[#8])-[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	O=C(CCc1nc(-c2c3cc[nH]c3ccc2)no1)N[C@H](C(=O)O)c1ccccc1	CUHMLLWMAHMVCE		parent_pubchem_cid	AKOS027472520;(2S)-2-({3-[3-(1H-INDOL-4-YL)-1,2,4-OXADIAZOL-5-YL]PROPANOYL}AMINO)-2-PHENYLETHANOIC ACID;rac-(2S)-2-[3-[3-(1H-indol-4-yl)-1,2,4-oxadiazol-5-yl]propanoylamino]-2-phenyl-acetic acid		96242942.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=96242942		pluskal_iocb_peptide_Peptide01_A15_id		100	A15		ZINC000218271999
3.5		0	761	P6241969	105.9		C29	False	0	23	0	0	26	0	2	4	0	1		0.0						CSCCC(NC(=O)CCn1ccc2c1ccc(OCc1ccccc1)c2)C(=O)O								N-acyl-L-alpha-amino acids;N-alkylindoles;Indoles;Phenol ethers;Thia fatty acids;Alkyl aryl ethers;Substituted pyrroles;Benzene and substituted derivatives;Heteroaromatic compounds;Secondary carboxylic acid amides;Sulfenyl compounds;Azacyclic compounds;Carboxylic acids;Dialkylthioethers;Monocarboxylic acids and derivatives;Carbonyl compounds;Organic oxides;Hydrocarbon derivatives;Organonitrogen compounds	Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Dialkylthioethers;Ethers;Fatty Acyls;Fatty acids and conjugates;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Lipids and lipid-like molecules;Methionine and derivatives;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;N-alkylindoles;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organosulfur compounds;Phenol ethers;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Sulfenyl compounds;Thia fatty acids;Thioethers	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as methionine and derivatives. These are compounds containing methionine or a derivative thereof resulting from reaction of methionine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Methionine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-L-alpha-amino acid (CHEBI:48927);indoles (CHEBI:24828);aromatic ether (CHEBI:35618);thia fatty acid (CHEBI:59643);pyrroles (CHEBI:26455);benzenes (CHEBI:22712);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organosulfur compound (CHEBI:33261);organonitrogen heterocyclic compound (CHEBI:38101);carboxylic acid (CHEBI:33575);aliphatic sulfide (CHEBI:22327);monocarboxylic acid (CHEBI:25384);carbonyl compound (CHEBI:36586);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);organonitrogen compound (CHEBI:35352);alpha-amino acid (CHEBI:33704);methionine derivative (CHEBI:25230);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);N-acyl-amino acid (CHEBI:51569);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);lipid (CHEBI:18059);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ether (CHEBI:25698);amide (CHEBI:32988);organic sulfide (CHEBI:16385);nitrogen molecular entity (CHEBI:51143)	Thia fatty acids (FA0113);Fatty Acyls (FA);Fatty Acids and Conjugates (FA01)	Amino acids, peptides, and analogues	Methionine or derivatives;N-acyl-alpha-amino acid;N-acyl-l-alpha-amino acid;N-acyl-alpha amino acid or derivatives;N-alkylindole;Indole;Indole or derivatives;Phenol ether;Alkyl aryl ether;Thia fatty acid;Monocyclic benzene moiety;Substituted pyrrole;Fatty acyl;Benzenoid;Heteroaromatic compound;Pyrrole;Carboxamide group;Secondary carboxylic acid amide;Organoheterocyclic compound;Dialkylthioether;Sulfenyl compound;Thioether;Carboxylic acid;Ether;Monocarboxylic acid or derivatives;Azacycle;Organic oxide;Carbonyl group;Hydrocarbon derivative;Organic nitrogen compound;Organonitrogen compound;Organooxygen compound;Organosulfur compound;Organic oxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS016387124		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C23H26N2O4S	C23H26N2O4S			InChI=1S/C23H26N2O4S/c1-30-14-11-20(23(27)28)24-22(26)10-13-25-12-9-18-15-19(7-8-21(18)25)29-16-17-5-3-2-4-6-17/h2-9,12,15,20H,10-11,13-14,16H2,1H3,(H,24,26)(H,27,28)/t20-/m0/s1	LXWDRKPBEUZCAF-FQEVSTJZSA-N	rac-(2S)-2-[3-(5-benzyloxyindol-1-yl)propanoylamino]-4-methylsulfanyl-butanoic acid	49652329	CSCC[C@H](NC(=O)CCn1ccc2c1ccc(OCc1ccccc1)c2)C(=O)O	(2S)-4-methylsulfanyl-2-[3-(5-phenylmethoxyindol-1-yl)propanoylamino]butanoic acid			2.9873600000000007													MCULE-2427411918	426.53867		426.161328	5	2	11	3			44										False					Peptide01			Compound(49652329)	49652329	3.3	116			[#6]-[#16]-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#6]-[#7]1:[#6]:[#6]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1):[#6]:2)-[#6](=[#8])-[#8]	CSCC[C@H](NC(=O)CCn1ccc2c1ccc(OCc1ccccc1)c2)C(=O)O	LXWDRKPBEUZCAF		parent_pubchem_cid	AKOS016387124;(2S)-2-({3-[5-(BENZYLOXY)-1H-INDOL-1-YL]PROPANOYL}AMINO)-4-(METHYLSULFANYL)BUTANOIC ACID;rac-(2S)-2-[3-(5-benzyloxyindol-1-yl)propanoylamino]-4-methylsulfanyl-butanoic acid		23610493.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23610493		pluskal_iocb_peptide_Peptide01_A15_id		100	A15		ZINC000040310020
3.4		0	849	P7129918	63.4		C30	False	0	23	0	0	26	0	2	3	0	0		0.0						COc1cc2c(cc1)[nH]cc2CCNC(=O)C1(c2ccccc2)CCOCC1								Phenylacetamides;Anisoles;Alkyl aryl ethers;Substituted pyrroles;Oxanes;Heteroaromatic compounds;Secondary carboxylic acid amides;Oxacyclic compounds;Dialkyl ethers;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	3-alkylindoles;Alkyl aryl ethers;Anisoles;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Dialkyl ethers;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Oxanes;Phenol ethers;Phenylacetamides;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as 3-alkylindoles. These are compounds containing an indole moiety that carries an alkyl chain at the 3-position.	3-alkylindoles			Organic compounds	Aromatic heteropolycyclic compounds	acetamides (CHEBI:22160);methoxybenzene (CHEBI:51683);aromatic ether (CHEBI:35618);pyrroles (CHEBI:26455);oxanes (CHEBI:46942);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);oxacycle (CHEBI:38104);ether (CHEBI:25698);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);indoles (CHEBI:24828);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);organooxygen compound (CHEBI:36963);organic heterocyclic compound (CHEBI:24532);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)		Indoles	3-alkylindole;Phenylacetamide;Anisole;Phenol ether;Alkyl aryl ether;Monocyclic benzene moiety;Oxane;Benzenoid;Substituted pyrrole;Heteroaromatic compound;Pyrrole;Carboxamide group;Secondary carboxylic acid amide;Carboxylic acid derivative;Dialkyl ether;Ether;Oxacycle;Azacycle;Organic oxygen compound;Organic nitrogen compound;Hydrocarbon derivative;Organonitrogen compound;Organooxygen compound;Organic oxide;Carbonyl group;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-4-phenyltetrahydro-2H-pyran-4-carboxamide		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C23H26N2O3	C23H26N2O3			InChI=1S/C23H26N2O3/c1-27-19-7-8-21-20(15-19)17(16-25-21)9-12-24-22(26)23(10-13-28-14-11-23)18-5-3-2-4-6-18/h2-8,15-16,25H,9-14H2,1H3,(H,24,26)	WMAXERHIRHGSAK-UHFFFAOYSA-N	N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-4-phenyl-tetrahydropyran-4-carboxamide	71692234	COc1cc2c(cc1)[nH]cc2CCNC(=O)C1(c2ccccc2)CCOCC1	N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-4-phenyloxane-4-carboxamide			2.5833500000000003													MCULE-5017181282	378.47527		378.194343	3	2	6	4			44										False					Peptide01			Compound(71692234)	71692234	3.4	117			[#6]-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#7H]:[#6]:[#6]:2-[#6]-[#6]-[#7]-[#6](=[#8])-[#6]1(-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]-[#6]-[#8]-[#6]-[#6]-1	COc1cc2c(cc1)[nH]cc2CCNC(=O)C1(c2ccccc2)CCOCC1	WMAXERHIRHGSAK		parent_pubchem_cid	N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-4-phenyltetrahydro-2H-pyran-4-carboxamide;1374521-08-0;EiM08-24581;AKOS024460121;N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-4-phenyloxane-4-carboxamide;N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-4-phenyl-tetrahydropyran-4-carboxamide		59971331.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=59971331		pluskal_iocb_peptide_Peptide01_A15_id		100	A15		ZINC000072325968
2.9		0	937	P1122492	69.6		C31	False	0	16	0	0	22	0	2	3	0	0		0.0						CCC(C)C(NC(=O)N1CCCc2ccccc21)C(=O)O																							0.0		AKOS010432062		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C16H22N2O3	C16H22N2O3			InChI=1S/C16H22N2O3/c1-3-11(2)14(15(19)20)17-16(21)18-10-6-8-12-7-4-5-9-13(12)18/h4-5,7,9,11,14H,3,6,8,10H2,1-2H3,(H,17,21)(H,19,20)/t11?,14-/m0/s1	YCXJWZMMTSVQPW-IAXJKZSUSA-N	rac-(2S)-2-(3,4-dihydro-2H-quinoline-1-carbonylamino)-3-methyl-pentanoic acid	17593473	CCC(C)[C@H](NC(=O)N1CCCc2ccccc21)C(=O)O	(2S)-2-(3,4-dihydro-2H-quinoline-1-carbonylamino)-3-methylpentanoic acid			2.21278														290.36534		290.163043	3	2	4	2			46									Quinoline alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(17593473)	17593473	2.8	118			[#6]-[#6]-[#6](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#7]1-[#6]-[#6]-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]-1:2)-[#6](=[#8])-[#8]	CCC(C)[C@H](NC(=O)N1CCCc2ccccc21)C(=O)O	YCXJWZMMTSVQPW		parent_pubchem_cid	AKOS010432062;rac-(2S)-2-(3,4-dihydro-2H-quinoline-1-carbonylamino)-3-methyl-pentanoic acid		23310368.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23310368		pluskal_iocb_peptide_Peptide01_A15_id		100	A15		
2.9		0	1025	P6245539	67.6		C32	False	0	19	0	0	19	0	5	1	0	0		0.0						Cn1ncc(C(=O)NCCc2c[nH]c3ccccc23)c1-n1cccc1								Pyrazole-4-carboxamides;Substituted pyrroles;Benzenoids;Vinylogous amides;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Organooxygen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	3-alkylindoles;Azacyclic compounds;Azoles;Benzenoids;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Pyrazole carboxylic acids and derivatives;Pyrazole-4-carboxamides;Pyrazoles;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Vinylogous amides	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as 3-alkylindoles. These are compounds containing an indole moiety that carries an alkyl chain at the 3-position.	3-alkylindoles			Organic compounds	Aromatic heteropolycyclic compounds	carboxamide (CHEBI:37622);pyrazoles (CHEBI:26410);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);enone (CHEBI:51689);enamine (CHEBI:47989);organic aromatic compound (CHEBI:33659);organonitrogen heterocyclic compound (CHEBI:38101);organooxygen compound (CHEBI:36963);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);indoles (CHEBI:24828);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);azole (CHEBI:68452);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143)		Indoles	3-alkylindole;Pyrazole-4-carboxamide;Benzenoid;Substituted pyrrole;Azole;Pyrazole;Heteroaromatic compound;Vinylogous amide;Pyrrole;Carboxamide group;Secondary carboxylic acid amide;Carboxylic acid derivative;Azacycle;Organic nitrogen compound;Hydrocarbon derivative;Organooxygen compound;Organonitrogen compound;Organic oxide;Organic oxygen compound;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		N-[2-(1H-indol-3-yl)ethyl]-1-methyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-4-carboxamide		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	2		C19H19N5O	C19H19N5O			InChI=1S/C19H19N5O/c1-23-19(24-10-4-5-11-24)16(13-22-23)18(25)20-9-8-14-12-21-17-7-3-2-6-15(14)17/h2-7,10-13,21H,8-9H2,1H3,(H,20,25)	OVCPRVKAWVYLAG-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)ethyl]-1-methyl-5-pyrrol-1-yl-pyrazole-4-carboxamide	38009017	Cn1ncc(C(=O)NCCc2c[nH]c3ccccc23)c1-n1cccc1	N-[2-(1H-indol-3-yl)ethyl]-1-methyl-5-pyrrol-1-ylpyrazole-4-carboxamide			1.9367499999999995													MCULE-4979607529	333.39618		333.15896	2	2	5	4			44									Imidazole alkaloids	False	Alkaloids	Histidine alkaloids			Peptide01			Compound(38009017)	38009017	2.3	119			[#6]-[#7]1:[#7]:[#6]:[#6](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:1-[#7]1:[#6]:[#6]:[#6]:[#6]:1	Cn1ncc(C(=O)NCCc2c[nH]c3ccccc23)c1-n1cccc1	OVCPRVKAWVYLAG		parent_pubchem_cid	N-[2-(1H-indol-3-yl)ethyl]-1-methyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-4-carboxamide;1232801-71-6;EiM08-18495;AKOS005666911;N-[2-(1H-indol-3-yl)ethyl]-1-methyl-5-pyrrol-1-yl-pyrazole-4-carboxamide		6593778.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=6593778		pluskal_iocb_peptide_Peptide01_A15_id		100	A15		ZINC000030862879
2.2		0	769	P6243626	117.5		C33	False	0	23	0	0	23	0	3	6	0	0		0.0						COc1c(OC)cc(-c2nn(CC(=O)NC(Cc3ccccc3)C(=O)O)c(=O)cc2)cc1																							0.0		AKOS016384361		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C23H23N3O6	C23H23N3O6			InChI=1S/C23H23N3O6/c1-31-19-10-8-16(13-20(19)32-2)17-9-11-22(28)26(25-17)14-21(27)24-18(23(29)30)12-15-6-4-3-5-7-15/h3-11,13,18H,12,14H2,1-2H3,(H,24,27)(H,29,30)/t18-/m0/s1	VYTVVDSDIJEJEF-SFHVURJKSA-N	rac-(2S)-2-[[2-[3-(3,4-dimethoxyphenyl)-6-oxo-pyridazin-1-yl]acetyl]amino]-3-phenyl-propanoic acid	51052699	COc1c(OC)cc(-c2nn(CC(=O)N[C@@H](Cc3ccccc3)C(=O)O)c(=O)cc2)cc1	(2S)-2-[[2-[3-(3,4-dimethoxyphenyl)-6-oxopyridazin-1-yl]acetyl]amino]-3-phenylpropanoic acid			1.2799400000000003													MCULE-7713077605	437.45626		437.158685	7	2	9	3			44										False	Amino acids and Peptides				Peptide01			Compound(51052699)	51052699	2.3	120			[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]):[#6]:[#6](-[#6]2:[#7]:[#7](-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3)-[#6](=[#8])-[#8]):[#6](=[#8]):[#6]:[#6]:2):[#6]:[#6]:1	COc1c(OC)cc(-c2nn(CC(=O)N[C@@H](Cc3ccccc3)C(=O)O)c(=O)cc2)cc1	VYTVVDSDIJEJEF		parent_pubchem_cid	AKOS016384361;(2S)-2-({2-[3-(3,4-DIMETHOXYPHENYL)-6-OXO-1(6H)-PYRIDAZINYL]ACETYL}AMINO)-3-PHENYLPROPANOIC ACID;(S)-2-(2-(3-(3,4-dimethoxyphenyl)-6-oxopyridazin-1(6H)-yl)acetamido)-3-phenylpropanoic acid;rac-(2S)-2-[[2-[3-(3,4-dimethoxyphenyl)-6-oxo-pyridazin-1-yl]acetyl]amino]-3-phenyl-propanoic acid		23050709.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23050709		pluskal_iocb_peptide_Peptide01_A16_id		100	A16		ZINC000049544474
3.6		0	857	P11182611	66.0		C34	False	0	24	0	0	29	0	5	1	0	0		0.0						Cc1nc2c(ccc(NC(=O)CCc3c[nH]c4ccccc34)c2)n1CCCN(C)C																							0.0		N-{1-[3-(dimethylamino)propyl]-2-methyl-1H-benzimidazol-5-yl}-3-(1H-indol-3-yl)propanamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	2		C24H29N5O	C24H29N5O			InChI=1S/C24H29N5O/c1-17-26-22-15-19(10-11-23(22)29(17)14-6-13-28(2)3)27-24(30)12-9-18-16-25-21-8-5-4-7-20(18)21/h4-5,7-8,10-11,15-16,25H,6,9,12-14H2,1-3H3,(H,27,30)	BKQWVCJSMUSINU-UHFFFAOYSA-N	N-[1-[3-(dimethylamino)propyl]-2-methyl-benzimidazol-5-yl]-3-(1H-indol-3-yl)propanamide	71707817	Cc1nc2c(ccc(NC(=O)CCc3c[nH]c4ccccc34)c2)n1CCCN(C)C	N-[1-[3-(dimethylamino)propyl]-2-methylbenzimidazol-5-yl]-3-(1H-indol-3-yl)propanamide			3.002150000000001													MCULE-3245376767	403.53163		403.237211	3	2	8	4			44									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(71707817)	71707817	3.4	121			[#6]-[#6]1:[#7]:[#6]2:[#6](:[#6]:[#6]:[#6](-[#7]-[#6](=[#8])-[#6]-[#6]-[#6]3:[#6]:[#7H]:[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]:3:4):[#6]:2):[#7]:1-[#6]-[#6]-[#6]-[#7](-[#6])-[#6]	Cc1nc2c(ccc(NC(=O)CCc3c[nH]c4ccccc34)c2)n1CCCN(C)C	BKQWVCJSMUSINU		parent_pubchem_cid	N-{1-[3-(dimethylamino)propyl]-2-methyl-1H-benzimidazol-5-yl}-3-(1H-indol-3-yl)propanamide;1574465-89-6;EiM08-31631;AKOS022110018;N-[1-[3-(dimethylamino)propyl]-2-methyl-benzimidazol-5-yl]-3-(1H-indol-3-yl)propanamide		52551405.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=52551405		pluskal_iocb_peptide_Peptide01_A16_id		100	A16		ZINC000095478636
3.8		0	945	P1109179	112.5		C35	False	0	18	0	0	19	0	3	3	0	1		0.0						CCC(C)C(NC(=O)c1cc2c(cc1)nc(-n1cccc1)s2)C(=O)O								N-acyl-alpha amino acids;Benzothiazoles;Substituted pyrroles;Benzenoids;Thiazoles;Heteroaromatic compounds;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Azoles;Benzenoids;Benzothiazoles;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Isoleucine and derivatives;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Thiazoles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as isoleucine and derivatives. These are compounds containing isoleucine or a derivative thereof resulting from reaction of isoleucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Isoleucine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-amino acid (CHEBI:51569);benzothiazoles (CHEBI:37947);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);thiazoles (CHEBI:48901);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);isoleucine derivative (CHEBI:24899);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);organic heterocyclic compound (CHEBI:24532);azole (CHEBI:68452);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806)		Amino acids, peptides, and analogues	Isoleucine or derivatives;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;1,3-benzothiazole;Substituted pyrrole;Benzenoid;Azole;Heteroaromatic compound;Pyrrole;Thiazole;Carboxamide group;Secondary carboxylic acid amide;Azacycle;Monocarboxylic acid or derivatives;Carboxylic acid;Organoheterocyclic compound;Organooxygen compound;Organonitrogen compound;Hydrocarbon derivative;Organic oxide;Carbonyl group;Organic oxygen compound;Organic nitrogen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		N-{[2-(1H-Pyrrol-1-yl)-1,3-benzothiazol-6-yl]carbonyl}-L-isoleucine		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C18H19N3O3S	C18H19N3O3S			InChI=1S/C18H19N3O3S/c1-3-11(2)15(17(23)24)20-16(22)12-6-7-13-14(10-12)25-18(19-13)21-8-4-5-9-21/h4-11,15H,3H2,1-2H3,(H,20,22)(H,23,24)	FDTBTRVZDPUVFT-UHFFFAOYSA-N	3-methyl-2-[(2-pyrrol-1-yl-1,3-benzothiazole-6-carbonyl)amino]pentanoic acid	24280946	CCC(C)C(NC(=O)c1cc2c(cc1)nc(-n1cccc1)s2)C(=O)O	3-methyl-2-[(2-pyrrol-1-yl-1,3-benzothiazole-6-carbonyl)amino]pentanoic acid			2.6429600000000004													MCULE-6663801910	357.43443		357.114712	4	2	6	3			45									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(24280946)	24280946	3.7	122			[#6]-[#6]-[#6](-[#6])-[#6](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#7]:[#6](-[#7]1:[#6]:[#6]:[#6]:[#6]:1):[#16]:2)-[#6](=[#8])-[#8]	CCC(C)C(NC(=O)c1cc2c(cc1)nc(-n1cccc1)s2)C(=O)O	FDTBTRVZDPUVFT		parent_pubchem_cid	N-{[2-(1H-Pyrrol-1-yl)-1,3-benzothiazol-6-yl]carbonyl}-L-isoleucine;3-methyl-2-{[2-(1H-pyrrol-1-yl)-1,3-benzothiazol-6-yl]formamido}pentanoic acid;1453874-13-9;AKOS004938135;EN300-717841;3-methyl-2-[(2-pyrrol-1-yl-1,3-benzothiazole-6-carbonyl)amino]pentanoic acid		22680049.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22680049		pluskal_iocb_peptide_Peptide01_A16_id		100	A16		
3.8		0	1033	P6245676	88.5		C36	False	0	20	1	0	19	0	6	1	0	0		0.0						Cc1c(C)c(-n2cnnn2)c(C(=O)NCCc2c[nH]c3c2cc(Cl)cc3)cc1								3-alkylindoles;Benzamides;o-Xylenes;Benzoyl derivatives;Substituted pyrroles;Aryl chlorides;Vinylogous amides;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Organooxygen compounds;Organonitrogen compounds;Organochlorides;Organic oxides;Hydrocarbon derivatives	3-alkylindoles;Aryl chlorides;Aryl halides;Azacyclic compounds;Azoles;Benzamides;Benzene and substituted derivatives;Benzenoids;Benzoic acids and derivatives;Benzoyl derivatives;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organochlorides;Organohalogen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenyltetrazoles and derivatives;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Tetrazoles;Vinylogous amides;Xylenes;o-Xylenes	Azoles	2.1	This compound belongs to the class of organic compounds known as phenyltetrazoles and derivatives. These are compounds containing a phenyltetrazole skeleton, which consists of a tetrazole bound to a phenyl group.	Phenyltetrazoles and derivatives			Organic compounds	Aromatic heteropolycyclic compounds	indoles (CHEBI:24828);benzamides (CHEBI:22702);xylene (CHEBI:27338);carbonyl compound (CHEBI:36586);pyrroles (CHEBI:26455);organochlorine compound (CHEBI:36683);enone (CHEBI:51689);enamine (CHEBI:47989);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organonitrogen heterocyclic compound (CHEBI:38101);organooxygen compound (CHEBI:36963);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);tetrazoles (CHEBI:35689);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);benzoic acids (CHEBI:22723);organohalogen compound (CHEBI:36684);haloarene (CHEBI:50887);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143);azole (CHEBI:68452)		Tetrazoles	Phenyltetrazole;3-alkylindole;Indole or derivatives;Indole;Benzamide;Benzoic acid or derivatives;O-xylene;Benzoyl;Xylene;Benzenoid;Aryl chloride;Substituted pyrrole;Aryl halide;Monocyclic benzene moiety;Pyrrole;Vinylogous amide;Heteroaromatic compound;Secondary carboxylic acid amide;Carboxamide group;Carboxylic acid derivative;Azacycle;Organonitrogen compound;Organooxygen compound;Organic nitrogen compound;Hydrocarbon derivative;Organic oxide;Organic oxygen compound;Organohalogen compound;Organochloride;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		N-[2-(5-chloro-1H-indol-3-yl)ethyl]-3,4-dimethyl-2-(1H-tetrazol-1-yl)benzamide		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	4	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C20H19ClN6O	C20H19ClN6O			InChI=1S/C20H19ClN6O/c1-12-3-5-16(19(13(12)2)27-11-24-25-26-27)20(28)22-8-7-14-10-23-18-6-4-15(21)9-17(14)18/h3-6,9-11,23H,7-8H2,1-2H3,(H,22,28)	HHLKTDPNQSLDMO-UHFFFAOYSA-N	N-[2-(5-chloro-1H-indol-3-yl)ethyl]-3,4-dimethyl-2-(tetrazol-1-yl)benzamide	51043090	Cc1c(C)c(-n2cnnn2)c(C(=O)NCCc2c[nH]c3c2cc(Cl)cc3)cc1	N-[2-(5-chloro-1H-indol-3-yl)ethyl]-3,4-dimethyl-2-(tetrazol-1-yl)benzamide			2.5490700000000004													MCULE-5733295295	394.86703		394.130887	4	2	5	4			44										False	Alkaloids				Peptide01			Compound(51043090)	51043090	3.9	123			[#6]-[#6]1:[#6](-[#6]):[#6](-[#7]2:[#6]:[#7]:[#7]:[#7]:2):[#6](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:2:[#6]:[#6](-[#17]):[#6]:[#6]:3):[#6]:[#6]:1	Cc1c(C)c(-n2cnnn2)c(C(=O)NCCc2c[nH]c3c2cc(Cl)cc3)cc1	HHLKTDPNQSLDMO		parent_pubchem_cid	N-[2-(5-chloro-1H-indol-3-yl)ethyl]-3,4-dimethyl-2-(1H-tetrazol-1-yl)benzamide;1232770-01-2;EiM08-18637;AKOS005662888;N-[2-(5-chloro-1H-indol-3-yl)ethyl]-3,4-dimethyl-2-(tetrazol-1-yl)benzamide		8780826.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=8780826		pluskal_iocb_peptide_Peptide01_A16_id		100	A16		ZINC000044893588
2.6		0	777	P6242013	88.4		C37	False	0	19	0	0	24	0	2	4	0	0	-1.0	0.0						CC(=O)c1cn(CCC(=O)NC(CC(C)C)C(=O)O)c2ccccc12		2.85		0.0	2.29	CHEMBL3438433		N-acyl-L-alpha-amino acids;N-alkylindoles;Indoles;Aryl alkyl ketones;Substituted pyrroles;Benzenoids;Vinylogous amides;Heteroaromatic compounds;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Aryl alkyl ketones;Aryl ketones;Azacyclic compounds;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Ketones;Leucine and derivatives;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;N-alkylindoles;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Vinylogous amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as leucine and derivatives. These are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Leucine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-L-alpha-amino acid (CHEBI:48927);indoles (CHEBI:24828);aromatic ketone (CHEBI:76224);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);enone (CHEBI:51689);enamine (CHEBI:47989);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);leucine derivative (CHEBI:47003);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);carbonyl compound (CHEBI:36586);organooxygen compound (CHEBI:36963);N-acyl-amino acid (CHEBI:51569);organic heterocyclic compound (CHEBI:24532);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ketone (CHEBI:17087);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);carboxylic acid anion (CHEBI:29067);amino acid (CHEBI:33709);peptide (CHEBI:16670)		Amino acids, peptides, and analogues	Leucine or derivatives;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;N-acyl-l-alpha-amino acid;N-alkylindole;Indole;Indole or derivatives;Aryl ketone;Aryl alkyl ketone;Substituted pyrrole;Benzenoid;Pyrrole;Heteroaromatic compound;Vinylogous amide;Secondary carboxylic acid amide;Ketone;Carboxamide group;Monocarboxylic acid or derivatives;Carboxylic acid;Azacycle;Organoheterocyclic compound;Carbonyl group;Organooxygen compound;Organonitrogen compound;Hydrocarbon derivative;Organic oxide;Organic oxygen compound;Organic nitrogen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		CHEMBL3438433		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C19H24N2O4	C19H24N2O4			InChI=1S/C19H24N2O4/c1-12(2)10-16(19(24)25)20-18(23)8-9-21-11-15(13(3)22)14-6-4-5-7-17(14)21/h4-7,11-12,16H,8-10H2,1-3H3,(H,20,23)(H,24,25)/t16-/m0/s1	DLRUNVXFGVLQAI-INIZCTEOSA-N	rac-(2S)-2-[3-(3-acetylindol-1-yl)propanoylamino]-4-methyl-pentanoic acid	49652359	CC(=O)c1cn(CCC(=O)N[C@@H](CC(C)C)C(=O)O)c2ccccc12	(2S)-2-[3-(3-acetylindol-1-yl)propanoylamino]-4-methylpentanoic acid			2.36637													MCULE-7859926402	344.41413	ACID	344.173607	4	2	8	2	1.0		29										False			False	False	Peptide01		-1.0	Compound(49652359)	49652359	2.2	124			[#6]-[#6](=[#8])-[#6]1:[#6]:[#7](-[#6]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=[#8])-[#8]):[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CC(=O)c1cn(CCC(=O)N[C@@H](CC(C)C)C(=O)O)c2ccccc12	DLRUNVXFGVLQAI		parent_pubchem_cid	CHEMBL3438433;EiM08-13482;AKOS016375059;(2S)-2-{[3-(3-ACETYL-1H-INDOL-1-YL)PROPANOYL]AMINO}-4-METHYLPENTANOIC ACID;rac-(2S)-2-[3-(3-acetylindol-1-yl)propanoylamino]-4-methyl-pentanoic acid	False	24756560.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24756560		pluskal_iocb_peptide_Peptide01_A16_id		100	A16	False	ZINC000040310109
3.1		0	865	P6245404	99.1		C38	False	0	25	0	0	21	0	3	4	0	0		0.0						O=C(Cn1nc(-c2cccc3ccccc23)ccc1=O)NC(Cc1ccccc1)C(=O)O																							0.0		AKOS016402534		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C25H21N3O4	C25H21N3O4			InChI=1S/C25H21N3O4/c29-23(26-22(25(31)32)15-17-7-2-1-3-8-17)16-28-24(30)14-13-21(27-28)20-12-6-10-18-9-4-5-11-19(18)20/h1-14,22H,15-16H2,(H,26,29)(H,31,32)/t22-/m0/s1	PHEBCJJRPCWKLL-QFIPXVFZSA-N	rac-(2S)-2-[[2-[3-(1-naphthyl)-6-oxo-pyridazin-1-yl]acetyl]amino]-3-phenyl-propanoic acid	52899856	O=C(Cn1nc(-c2cccc3ccccc23)ccc1=O)N[C@@H](Cc1ccccc1)C(=O)O	(2S)-2-[[2-(3-naphthalen-1-yl-6-oxopyridazin-1-yl)acetyl]amino]-3-phenylpropanoic acid			2.9123400000000004													MCULE-3640112475	427.46382		427.153206	5	2	7	4			44										False	Amino acids and Peptides				Peptide01			Compound(52899856)	52899856	3.6	125			[#8]=[#6](-[#6]-[#7]1:[#7]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:[#6]:1=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	O=C(Cn1nc(-c2cccc3ccccc23)ccc1=O)N[C@@H](Cc1ccccc1)C(=O)O	PHEBCJJRPCWKLL		parent_pubchem_cid	AKOS016402534;(2S)-2-({2-[3-(1-NAPHTHYL)-6-OXO-1(6H)-PYRIDAZINYL]ACETYL}AMINO)-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[[2-[3-(1-naphthyl)-6-oxo-pyridazin-1-yl]acetyl]amino]-3-phenyl-propanoic acid		23842941.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23842941		pluskal_iocb_peptide_Peptide01_A16_id		100	A16		ZINC000061719480
2.4		0	953	P1095008	109.5		C39	False	0	18	1	0	22	0	3	5	0	0		0.0						COC(=O)CCC(NC(=O)NCCc1c[nH]c2c1cc(Cl)cc2)C(=O)OC																							0.0		AKOS016382675		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C18H22ClN3O5	C18H22ClN3O5			InChI=1S/C18H22ClN3O5/c1-26-16(23)6-5-15(17(24)27-2)22-18(25)20-8-7-11-10-21-14-4-3-12(19)9-13(11)14/h3-4,9-10,15,21H,5-8H2,1-2H3,(H2,20,22,25)/t15-/m0/s1	BEWRBAQGWSLQHR-HNNXBMFYSA-N	dimethyl rac-(2S)-2-[2-(5-chloro-1H-indol-3-yl)ethylcarbamoylamino]pentanedioate	24279689	COC(=O)CC[C@H](NC(=O)NCCc1c[nH]c2c1cc(Cl)cc2)C(=O)OC	dimethyl (2S)-2-[2-(5-chloro-1H-indol-3-yl)ethylcarbamoylamino]pentanedioate			1.67467													MCULE-2813447956	395.84614		395.124798	5	3	10	2			44										False					Peptide01			Compound(24279689)	24279689	2.2	126			[#6]-[#8]-[#6](=[#8])-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:1:[#6]:[#6](-[#17]):[#6]:[#6]:2)-[#6](=[#8])-[#8]-[#6]	COC(=O)CC[C@H](NC(=O)NCCc1c[nH]c2c1cc(Cl)cc2)C(=O)OC	BEWRBAQGWSLQHR		parent_pubchem_cid	AKOS016382675;DIMETHYL (2S)-2-[({[2-(5-CHLORO-1H-INDOL-3-YL)ETHYL]AMINO}CARBONYL)AMINO]PENTANEDIOATE;dimethyl rac-(2S)-2-[2-(5-chloro-1H-indol-3-yl)ethylcarbamoylamino]pentanedioate		16455251.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=16455251		pluskal_iocb_peptide_Peptide01_A16_id		100	A16		ZINC000011692340
0.7		0	1041	P11569468	94.0		C40	False	0	17	0	0	26	0	4	3	0	0		0.0						CCC(C)C(CO)NC(=O)CCc1c(C)n2[nH]c(=O)cc2nc1C																							0.0		AKOS027474313		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C17H26N4O3	C17H26N4O3			InChI=1S/C17H26N4O3/c1-5-10(2)14(9-22)19-16(23)7-6-13-11(3)18-15-8-17(24)20-21(15)12(13)4/h8,10,14,22H,5-7,9H2,1-4H3,(H,19,23)(H,20,24)/t10-,14-/m1/s1	QHBUWFDSIGAPQM-QMTHXVAHSA-N	3-(5,7-dimethyl-2-oxo-1H-pyrazolo[1,5-a]pyrimidin-6-yl)-N-[rac-(1S,2R)-1-(hydroxymethyl)-2-methyl-butyl]propanamide	100015145	CC[C@@H](C)[C@@H](CO)NC(=O)CCc1c(C)n2[nH]c(=O)cc2nc1C	3-(5,7-dimethyl-2-oxo-1H-pyrazolo[1,5-a]pyrimidin-6-yl)-N-[(2S,3R)-1-hydroxy-3-methylpentan-2-yl]propanamide			1.61679														334.42177		334.200491	5	3	7	2			45										False	Alkaloids	Peptide alkaloids			Peptide01			Compound(100015145)	100015145	0.7	127			[#6]-[#6]-[#6@@H](-[#6])-[#6@@H](-[#6]-[#8])-[#7]-[#6](=[#8])-[#6]-[#6]-[#6]1:[#6](-[#6]):[#7]2:[#7H]:[#6](=[#8]):[#6]:[#6]:2:[#7]:[#6]:1-[#6]	CC[C@@H](C)[C@@H](CO)NC(=O)CCc1c(C)n2[nH]c(=O)cc2nc1C	QHBUWFDSIGAPQM		parent_pubchem_cid	AKOS027474313;3-(5,7-dimethyl-2-oxo-1H-pyrazolo[1,5-a]pyrimidin-6-yl)-N-[rac-(1S,2R)-1-(hydroxymethyl)-2-methyl-butyl]propanamide		101988291.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=101988291		pluskal_iocb_peptide_Peptide01_A16_id		100	A16		ZINC000218432036
3.9		0	785	P6236257	123.3		C41	False	0	22	0	1	18	0	3	3	0	1		0.0						O=C(Cc1csc(-c2ccc(F)cc2)n1)NC(Cc1c[nH]c2ccccc12)C(=O)O																							0.0		SCHEMBL20255511		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C22H18FN3O3S	C22H18FN3O3S			InChI=1S/C22H18FN3O3S/c23-15-7-5-13(6-8-15)21-25-16(12-30-21)10-20(27)26-19(22(28)29)9-14-11-24-18-4-2-1-3-17(14)18/h1-8,11-12,19,24H,9-10H2,(H,26,27)(H,28,29)/t19-/m0/s1	CIFIJDFAOPFPGU-IBGZPJMESA-N	rac-(2S)-2-[[2-[2-(4-fluorophenyl)thiazol-4-yl]acetyl]amino]-3-(1H-indol-3-yl)propanoic acid	29135216	O=C(Cc1csc(-c2ccc(F)cc2)n1)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	(2S)-2-[[2-[2-(4-fluorophenyl)-1,3-thiazol-4-yl]acetyl]amino]-3-(1H-indol-3-yl)propanoic acid			2.8672400000000007													MCULE-9358600168	423.46946		423.105291	4	3	7	4			43										False	Alkaloids				Peptide01			Compound(29135216)	29135216	2.8	128		SCHEMBL20255511	[#8]=[#6](-[#6]-[#6]1:[#6]:[#16]:[#6](-[#6]2:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:2):[#7]:1)-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	O=C(Cc1csc(-c2ccc(F)cc2)n1)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	CIFIJDFAOPFPGU		parent_pubchem_cid	SCHEMBL20255511;STK645939;AKOS005576983;N-{[2-(4-fluorophenyl)-1,3-thiazol-4-yl]acetyl}-L-tryptophan;rac-(2S)-2-[[2-[2-(4-fluorophenyl)thiazol-4-yl]acetyl]amino]-3-(1H-indol-3-yl)propanoic acid		23745801.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23745801		pluskal_iocb_peptide_Peptide01_A17_id		100	A17		ZINC000020733485
3.1		0	873	P6237064	116.8		C42	False	0	18	0	0	22	0	2	4	0	1		0.0						COc1ccccc1-c1nc(CC(=O)NC(CC(C)C)C(=O)O)cs1																							0.0		SCHEMBL20255547		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C18H22N2O4S	C18H22N2O4S			InChI=1S/C18H22N2O4S/c1-11(2)8-14(18(22)23)20-16(21)9-12-10-25-17(19-12)13-6-4-5-7-15(13)24-3/h4-7,10-11,14H,8-9H2,1-3H3,(H,20,21)(H,22,23)/t14-/m0/s1	SZLLQGPMXSWXHT-AWEZNQCLSA-N	rac-(2S)-2-[[2-[2-(2-methoxyphenyl)thiazol-4-yl]acetyl]amino]-4-methyl-pentanoic acid	29130170	COc1ccccc1-c1nc(CC(=O)N[C@@H](CC(C)C)C(=O)O)cs1	(2S)-2-[[2-[2-(2-methoxyphenyl)-1,3-thiazol-4-yl]acetyl]amino]-4-methylpentanoic acid			2.07956													MCULE-2608272725	362.45104		362.130028	5	2	8	2			43										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(29130170)	29130170	3.2	129		SCHEMBL20255547	[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#6]1:[#7]:[#6](-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=[#8])-[#8]):[#6]:[#16]:1	COc1ccccc1-c1nc(CC(=O)N[C@@H](CC(C)C)C(=O)O)cs1	SZLLQGPMXSWXHT		parent_pubchem_cid	SCHEMBL20255547;AKOS016376082;rac-(2S)-2-[[2-[2-(2-methoxyphenyl)thiazol-4-yl]acetyl]amino]-4-methyl-pentanoic acid		23741668.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23741668		pluskal_iocb_peptide_Peptide01_A17_id		100	A17		ZINC000020720081
2.3		0	961	P3461251	84.9		C43	False	0	18	0	0	17	0	1	5	0	0	-1.0	0.0						O=C(O)C(Cc1ccccc1)NC(=O)C1COc2ccccc2O1		1.64		0.0	2.3	CHEMBL4969896																	0.0		CHEMBL4969896		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C18H17NO5	C18H17NO5			InChI=1S/C18H17NO5/c20-17(16-11-23-14-8-4-5-9-15(14)24-16)19-13(18(21)22)10-12-6-2-1-3-7-12/h1-9,13,16H,10-11H2,(H,19,20)(H,21,22)/t13-,16?/m0/s1	ITLUQYSOARYKJW-KNVGNIICSA-N	rac-(2S)-2-(2,3-dihydro-1,4-benzodioxine-3-carbonylamino)-3-phenyl-propanoic acid	56726575	O=C(N[C@@H](Cc1ccccc1)C(=O)O)C1COc2ccccc2O1	(2S)-2-(2,3-dihydro-1,4-benzodioxine-3-carbonylamino)-3-phenylpropanoic acid			0.6589699999999996													MCULE-6913213372	327.33989	ACID	327.110673	5	2	5	3	0.0		30										False	Amino acids and Peptides;Shikimates and Phenylpropanoids		False	False	Peptide01		-1.0	Compound(56726575)	56726575	2.6	130			[#8]=[#6](-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8])-[#6]1-[#6]-[#8]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#8]-1	O=C(N[C@@H](Cc1ccccc1)C(=O)O)C1COc2ccccc2O1	ITLUQYSOARYKJW		parent_pubchem_cid	CHEMBL4969896;AKOS016402504;N-(2,3-dihydro-1,4-benzodioxine-2-carbonyl)phenylalanine;rac-(2S)-2-(2,3-dihydro-1,4-benzodioxine-3-carbonylamino)-3-phenyl-propanoic acid	False	24176120.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24176120		pluskal_iocb_peptide_Peptide01_A17_id		100	A17	False	
2.7		0	1049	P7567848	71.3		C44	False	0	16	0	0	20	0	2	3	0	0		0.0						CC(C)CC(NC(=O)c1cc2c(cc1)ccn2C)C(=O)O																							0.0		AKOS025146044		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C16H20N2O3	C16H20N2O3			InChI=1S/C16H20N2O3/c1-10(2)8-13(16(20)21)17-15(19)12-5-4-11-6-7-18(3)14(11)9-12/h4-7,9-10,13H,8H2,1-3H3,(H,17,19)(H,20,21)/t13-/m0/s1	FIKJFBKIACZRMB-ZDUSSCGKSA-N	rac-(2S)-4-methyl-2-[(1-methylindole-6-carbonyl)amino]pentanoic acid	91636505	CC(C)C[C@H](NC(=O)c1cc2c(cc1)ccn2C)C(=O)O	(2S)-4-methyl-2-[(1-methylindole-6-carbonyl)amino]pentanoic acid			1.92427														288.3494		288.147392	3	2	5	2			45										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(91636505)	91636505	2.6	131			[#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#6]:[#6]:[#7]:2-[#6])-[#6](=[#8])-[#8]	CC(C)C[C@H](NC(=O)c1cc2c(cc1)ccn2C)C(=O)O	FIKJFBKIACZRMB		parent_pubchem_cid	AKOS025146044;(2S)-4-METHYL-2-{[(1-METHYL-1H-INDOL-6-YL)CARBONYL]AMINO}PENTANOIC ACID;rac-(2S)-4-methyl-2-[(1-methylindole-6-carbonyl)amino]pentanoic acid		94611813.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=94611813		pluskal_iocb_peptide_Peptide01_A17_id		100	A17		ZINC000170625471
1.5		0	1057	P11184854	124.1		D1	False	0	24	0	0	22	0	4	5	0	0		0.0						COc1ccc(-c2cn(CC(=O)NC(Cc3c[nH]c4ccccc34)C(=O)O)c(=O)cn2)cc1																							0.0		AKOS027472516		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C24H22N4O5	C24H22N4O5			InChI=1S/C24H22N4O5/c1-33-17-8-6-15(7-9-17)21-13-28(23(30)12-26-21)14-22(29)27-20(24(31)32)10-16-11-25-19-5-3-2-4-18(16)19/h2-9,11-13,20,25H,10,14H2,1H3,(H,27,29)(H,31,32)/t20-/m0/s1	VWSXEYZFIVBFPH-FQEVSTJZSA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[[2-[5-(4-methoxyphenyl)-2-oxo-pyrazin-1-yl]acetyl]amino]propanoic acid	91639720	COc1ccc(-c2cn(CC(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)O)c(=O)cn2)cc1	(2S)-3-(1H-indol-3-yl)-2-[[2-[5-(4-methoxyphenyl)-2-oxopyrazin-1-yl]acetyl]amino]propanoic acid			1.786629999999999														446.46674		446.15902	6	3	8	4			45									Dipeptides;Pyridine alkaloids	False	Alkaloids;Amino acids and Peptides	Nicotinic acid alkaloids;Small peptides			Peptide01			Compound(91639720)	91639720	2.1	132			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6]2:[#6]:[#7](-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]3:[#6]:[#7H]:[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]:3:4)-[#6](=[#8])-[#8]):[#6](=[#8]):[#6]:[#7]:2):[#6]:[#6]:1	COc1ccc(-c2cn(CC(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)O)c(=O)cn2)cc1	VWSXEYZFIVBFPH		parent_pubchem_cid	AKOS027472516;rac-(2S)-3-(1H-indol-3-yl)-2-[[2-[5-(4-methoxyphenyl)-2-oxo-pyrazin-1-yl]acetyl]amino]propanoic acid		93475949.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=93475949		pluskal_iocb_peptide_Peptide01_A17_id		100	A17		ZINC000218246659
3.5		0	1145	P1157900	82.2		D2	False	0	20	0	0	26	0	2	3	0	0		0.0						O=C(O)CC1(CNC(=O)CCc2c[nH]c3ccccc23)CCCCC1								3-alkylindoles;Substituted pyrroles;Benzenoids;Heteroaromatic compounds;Propargyl-type 1,3-dipolar organic compounds;Monocarboxylic acids and derivatives;Carboxylic acids;Carboximidic acids;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	3-alkylindoles;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzenoids;Carbonyl compounds;Carboximidic acids;Carboximidic acids and derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Gamma amino acids and derivatives;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Monocarboxylic acids and derivatives;Organic 1,3-dipolar compounds;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Propargyl-type 1,3-dipolar organic compounds;Pyrroles;Substituted pyrroles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as gamma amino acids and derivatives. These are amino acids having a (-NH2) group attached to the gamma carbon atom.	Gamma amino acids and derivatives		Amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	indoles (CHEBI:24828);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);organic aromatic compound (CHEBI:33659);dipolar compound (CHEBI:51151);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);carboximidic acid (CHEBI:48378);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);organooxygen compound (CHEBI:36963);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);organic acid (CHEBI:64709);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806);carboxylic acid anion (CHEBI:29067);amino acid (CHEBI:33709);peptide (CHEBI:16670)		Amino acids, peptides, and analogues	Gamma amino acid or derivatives;3-alkylindole;Indole;Indole or derivatives;Substituted pyrrole;Benzenoid;Heteroaromatic compound;Pyrrole;Organoheterocyclic compound;Organic 1,3-dipolar compound;Propargyl-type 1,3-dipolar organic compound;Azacycle;Carboximidic acid;Carboximidic acid derivative;Carboxylic acid;Monocarboxylic acid or derivatives;Carbonyl group;Organic oxide;Organic oxygen compound;Organic nitrogen compound;Organonitrogen compound;Organooxygen compound;Hydrocarbon derivative;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		[1-({[3-(1H-indol-3-yl)propanoyl]amino}methyl)cyclohexyl]acetic acid		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C20H26N2O3	C20H26N2O3			InChI=1S/C20H26N2O3/c23-18(9-8-15-13-21-17-7-3-2-6-16(15)17)22-14-20(12-19(24)25)10-4-1-5-11-20/h2-3,6-7,13,21H,1,4-5,8-12,14H2,(H,22,23)(H,24,25)	SNSCTRWPGBQXRD-UHFFFAOYSA-N	2-[1-[[3-(1H-indol-3-yl)propanoylamino]methyl]cyclohexyl]acetic acid	16408866	O=C(O)CC1(CNC(=O)CCc2c[nH]c3ccccc23)CCCCC1	2-[1-[[3-(1H-indol-3-yl)propanoylamino]methyl]cyclohexyl]acetic acid			3.1587700000000014													MCULE-4620437837	342.44182		342.194343	3	3	7	3			44										False	Alkaloids				Peptide01			Compound(16408866)	16408866	3.2	133			[#8]=[#6](-[#8])-[#6]-[#6]1(-[#6]-[#7]-[#6](=[#8])-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6]-[#6]-[#6]-[#6]-[#6]-1	O=C(O)CC1(CNC(=O)CCc2c[nH]c3ccccc23)CCCCC1	SNSCTRWPGBQXRD		parent_pubchem_cid	[1-({[3-(1H-indol-3-yl)propanoyl]amino}methyl)cyclohexyl]acetic acid;924778-62-1;AKOS004937062;2-[1-({[3-(1H-INDOL-3-YL)PROPANOYL]AMINO}METHYL)CYCLOHEXYL]ACETIC ACID;2-[1-[[3-(1H-indol-3-yl)propanoylamino]methyl]cyclohexyl]acetic acid		23226073.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23226073		pluskal_iocb_peptide_Peptide01_A17_id		100	A17		ZINC000008764735
3.5		0	1233	P1582853	67.7		D3	False	0	19	0	0	18	0	6	0	0	0		0.0						Cc1ccccc1Nc1c2cnn(C)c2nc(Nc2ccccc2)n1																							0.0		896005-10-0		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1		C19H18N6	C19H18N6			InChI=1S/C19H18N6/c1-13-8-6-7-11-16(13)22-17-15-12-20-25(2)18(15)24-19(23-17)21-14-9-4-3-5-10-14/h3-12H,1-2H3,(H2,21,22,23,24)	RKQYVACBKBZREO-UHFFFAOYSA-N	1-methyl-N4-(o-tolyl)-N6-phenyl-pyrazolo[3,4-d]pyrimidine-4,6-diamine	16456675	Cc1ccccc1Nc1c2cnn(C)c2nc(Nc2ccccc2)n1	1-methyl-4-N-(2-methylphenyl)-6-N-phenylpyrazolo[3,4-d]pyrimidine-4,6-diamine			2.15335													MCULE-7839034293	330.39551		330.159295	5	2	4	4			43										False	Alkaloids				Peptide01			Compound(16456675)	16456675	4.3	134		SCHEMBL4057912	[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#7]-[#6]1:[#6]2:[#6]:[#7]:[#7](-[#6]):[#6]:2:[#7]:[#6](-[#7]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#7]:1	Cc1ccccc1Nc1c2cnn(C)c2nc(Nc2ccccc2)n1	RKQYVACBKBZREO		parent_pubchem_cid	896005-10-0;1-methyl-N4-(2-methylphenyl)-N6-phenyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine;SCHEMBL4057912;1-methyl-N6-phenyl-N4-(o-tolyl)-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine;AKOS002311158;CCG-170549;1-methyl-N~4~-(2-methylphenyl)-N~6~-phenyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine;F2031-0457;1-methyl-4-N-(2-methylphenyl)-6-N-phenylpyrazolo[3,4-d]pyrimidine-4,6-diamine;1-methyl-N4-(o-tolyl)-N6-phenyl-pyrazolo[3,4-d]pyrimidine-4,6-diamine		2283665.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=2283665		pluskal_iocb_peptide_Peptide01_A17_id		100	A17		ZINC000017136037
2.4		0	1065	P1095017	106.9		D5	False	0	20	0	0	20	0	2	5	0	0		0.0						O=C(O)C(Cc1ccccc1)NC(=O)N1Cc2ccccc2CC1C(=O)O																							0.0		STL458125		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	2	0	0	0	0	0	0	0	0	3	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C20H20N2O5	C20H20N2O5			InChI=1S/C20H20N2O5/c23-18(24)16(10-13-6-2-1-3-7-13)21-20(27)22-12-15-9-5-4-8-14(15)11-17(22)19(25)26/h1-9,16-17H,10-12H2,(H,21,27)(H,23,24)(H,25,26)/t16-,17-/m0/s1	VEKOJSRNQVRNOJ-IRXDYDNUSA-N	rac-(3S)-2-[[rac-(1S)-1-carboxy-2-phenyl-ethyl]carbamoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid	11876930	O=C(O)[C@H](Cc1ccccc1)NC(=O)N1Cc2ccccc2C[C@H]1C(=O)O	(3S)-2-[[(1S)-1-carboxy-2-phenylethyl]carbamoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid			1.73927													MCULE-2607098492	368.3928		368.137222	5	3	5	3			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(11876930)	11876930	2.3	135			[#8]=[#6](-[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#7]1-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6]-[#6@H]-1-[#6](=[#8])-[#8]	O=C(O)[C@H](Cc1ccccc1)NC(=O)N1Cc2ccccc2C[C@H]1C(=O)O	VEKOJSRNQVRNOJ		parent_pubchem_cid	STL458125;AKOS004937337;(3S)-2-({[(1S)-1-CARBOXY-2-PHENYLETHYL]AMINO}CARBONYL)-1,2,3,4-TETRAHYDRO-3-ISOQUINOLINECARBOXYLIC ACID;(3S)-2-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid;rac-(3S)-2-[[rac-(1S)-1-carboxy-2-phenyl-ethyl]carbamoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid		23686747.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23686747		pluskal_iocb_peptide_Peptide01_A17_id		100	A17		ZINC000004089137
4.2		0	1153	P1099360	88.8		D6	False	0	24	0	0	19	0	1	5	0	0		0.0						O=C(O)CNC(=O)c1c(-c2ccccc2)oc2c1cc(OCc1ccccc1)cc2																							0.0		AKOS016402385		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C24H19NO5	C24H19NO5			InChI=1S/C24H19NO5/c26-21(27)14-25-24(28)22-19-13-18(29-15-16-7-3-1-4-8-16)11-12-20(19)30-23(22)17-9-5-2-6-10-17/h1-13H,14-15H2,(H,25,28)(H,26,27)	IKQJAVNXTUUQNA-UHFFFAOYSA-N	2-[(5-benzyloxy-2-phenyl-benzofuran-3-carbonyl)amino]acetic acid	24280032	O=C(O)CNC(=O)c1c(-c2ccccc2)oc2c1cc(OCc1ccccc1)cc2	2-[(2-phenyl-5-phenylmethoxy-1-benzofuran-3-carbonyl)amino]acetic acid			3.112930000000002													MCULE-6593686563	401.42273		401.126323	4	2	7	4			44										False	Shikimates and Phenylpropanoids				Peptide01			Compound(24280032)	24280032	4.3	136			[#8]=[#6](-[#8])-[#6]-[#7]-[#6](=[#8])-[#6]1:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#8]:[#6]2:[#6]:1:[#6]:[#6](-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1):[#6]:[#6]:2	O=C(O)CNC(=O)c1c(-c2ccccc2)oc2c1cc(OCc1ccccc1)cc2	IKQJAVNXTUUQNA		parent_pubchem_cid	AKOS016402385;2-{[5-(BENZYLOXY)-2-PHENYL-1-BENZOFURAN-3-YL]FORMAMIDO}ACETIC ACID;2-[(5-benzyloxy-2-phenyl-benzofuran-3-carbonyl)amino]acetic acid		23522158.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23522158		pluskal_iocb_peptide_Peptide01_A18_id		100	A18		ZINC000011867340
3.6		0	1241	P6297671	132.9		D7	False	0	23	0	0	17	0	3	3	0	2		0.0						O=C1NC(=O)C2C1Sc1c(sc(=O)n1Cc1ccccc1)C2c1c[nH]c2ccccc12																							0.0		AKOS001695307		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0		C23H17N3O3S2	C23H17N3O3S2			InChI=1S/C23H17N3O3S2/c27-20-17-16(14-10-24-15-9-5-4-8-13(14)15)19-22(30-18(17)21(28)25-20)26(23(29)31-19)11-12-6-2-1-3-7-12/h1-10,16-18,24H,11H2,(H,25,27,28)	IGFATNASWLSOTD-UHFFFAOYSA-N	4-benzyl-8-(1H-indol-3-yl)-2,6-dithia-4,11-diazatricyclo[7.3.0.03,7]dodec-3(7)-ene-5,10,12-trione	4628549	O=C1NC(=O)C2C1Sc1c(sc(=O)n1Cc1ccccc1)C2c1c[nH]c2ccccc12	4-benzyl-8-(1H-indol-3-yl)-2,6-dithia-4,11-diazatricyclo[7.3.0.03,7]dodec-3(7)-ene-5,10,12-trione			3.5175300000000016													MCULE-6484515455	447.53824		447.071133	5	2	3	6			45										False	Alkaloids;Amino acids and Peptides	Peptide alkaloids			Peptide01			Compound(4628549)	4628549	3.2	137			[#8]=[#6]1-[#7]-[#6](=[#8])-[#6]2-[#6]-1-[#16]-[#6]1:[#6](:[#16]:[#6](=[#8]):[#7]:1-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]-2-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	O=C1NC(=O)C2C1Sc1c(sc(=O)n1Cc1ccccc1)C2c1c[nH]c2ccccc12	IGFATNASWLSOTD		parent_pubchem_cid	AKOS001695307;AKOS016297122;SR-01000087492;SR-01000087492-1;4-benzyl-8-(1H-indol-3-yl)-2,6-dithia-4,11-diazatricyclo[7.3.0.03,7]dodec-3(7)-ene-5,10,12-trione		24242043.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24242043		pluskal_iocb_peptide_Peptide01_A18_id		100	A18		
2.7		0	1073	P1157552	69.6		D9	False	0	18	0	0	18	0	2	3	0	0		0.0						O=C(O)C(Cc1ccccc1)NC(=O)N1CCc2ccccc21																							0.0		N-(2,3-dihydro-1H-indol-1-ylcarbonyl)-L-phenylalanine		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C18H18N2O3	C18H18N2O3			InChI=1S/C18H18N2O3/c21-17(22)15(12-13-6-2-1-3-7-13)19-18(23)20-11-10-14-8-4-5-9-16(14)20/h1-9,15H,10-12H2,(H,19,23)(H,21,22)/t15-/m0/s1	DDVFYOSSXIJRGR-HNNXBMFYSA-N	rac-(2S)-2-(indoline-1-carbonylamino)-3-phenyl-propanoic acid	17594240	O=C(O)[C@H](Cc1ccccc1)NC(=O)N1CCc2ccccc21	(2S)-2-(2,3-dihydroindole-1-carbonylamino)-3-phenylpropanoic acid			1.96457													MCULE-3739496625	310.35576		310.131742	3	2	4	3			44										False	Alkaloids				Peptide01			Compound(17594240)	17594240	2.7	138			[#8]=[#6](-[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#7]1-[#6]-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]-1:2	O=C(O)[C@H](Cc1ccccc1)NC(=O)N1CCc2ccccc21	DDVFYOSSXIJRGR		parent_pubchem_cid	N-(2,3-dihydro-1H-indol-1-ylcarbonyl)-L-phenylalanine;(2S)-2-(2,3-dihydroindole-1-carbonylamino)-3-phenylpropanoic acid;1014412-84-0;STL226213;AKOS004937590;rac-(2S)-2-(indoline-1-carbonylamino)-3-phenyl-propanoic acid		22682849.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22682849		pluskal_iocb_peptide_Peptide01_A18_id		100	A18		ZINC000013681800
2.2		0	1161	P1157876	124.6		D10	False	0	22	1	0	20	0	3	5	0	0		0.0						CC(NC(=O)C(Cc1cc(=O)[nH]c2ccccc12)NC(=O)c1ccc(Cl)cc1)C(=O)O																							0.0		AKOS004937033		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	2	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0		C22H20ClN3O5	C22H20ClN3O5			InChI=1S/C22H20ClN3O5/c1-12(22(30)31)24-21(29)18(26-20(28)13-6-8-15(23)9-7-13)10-14-11-19(27)25-17-5-3-2-4-16(14)17/h2-9,11-12,18H,10H2,1H3,(H,24,29)(H,25,27)(H,26,28)(H,30,31)/t12-,18?/m0/s1	VEJGHNSSFYPZQT-RSXQAXDFSA-N	rac-(2S)-2-[[2-[(4-chlorobenzoyl)amino]-3-(2-oxo-1H-quinolin-4-yl)propanoyl]amino]propanoic acid	16416707	C[C@H](NC(=O)C(Cc1cc(=O)[nH]c2ccccc12)NC(=O)c1ccc(Cl)cc1)C(=O)O	(2S)-2-[[2-[(4-chlorobenzoyl)amino]-3-(2-oxo-1H-quinolin-4-yl)propanoyl]amino]propanoic acid			2.4739500000000003													MCULE-3932294656	441.8748		441.109148	5	4	7	3			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(16416707)	16416707	2.1	139			[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6](=[#8]):[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#17]):[#6]:[#6]:1)-[#6](=[#8])-[#8]	C[C@H](NC(=O)C(Cc1cc(=O)[nH]c2ccccc12)NC(=O)c1ccc(Cl)cc1)C(=O)O	VEJGHNSSFYPZQT		parent_pubchem_cid	AKOS004937033;AKOS005556898;rac-(2S)-2-[[2-[(4-chlorobenzoyl)amino]-3-(2-oxo-1H-quinolin-4-yl)propanoyl]amino]propanoic acid		24050102.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24050102		pluskal_iocb_peptide_Peptide01_A18_id		100	A18		
3.9		0	1249	P7008312	71.3		D11	False	0	23	0	0	25	0	7	1	0	0		0.0						COc1ccccc1N1CCN(c2nc(Nc3ccccc3)c3cnn(C)c3n2)CC1																							0.0		6-[4-(2-methoxyphenyl)piperazin-1-yl]-1-methyl-N-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	3		C23H25N7O	C23H25N7O			InChI=1S/C23H25N7O/c1-28-22-18(16-24-28)21(25-17-8-4-3-5-9-17)26-23(27-22)30-14-12-29(13-15-30)19-10-6-7-11-20(19)31-2/h3-11,16H,12-15H2,1-2H3,(H,25,26,27)	QAPLIXUJSBSLLT-UHFFFAOYSA-N	6-[4-(2-methoxyphenyl)piperazin-1-yl]-1-methyl-N-phenyl-pyrazolo[3,4-d]pyrimidin-4-amine	16456630	COc1ccccc1N1CCN(c2nc(Nc3ccccc3)c3cnn(C)c3n2)CC1	6-[4-(2-methoxyphenyl)piperazin-1-yl]-1-methyl-N-phenylpyrazolo[3,4-d]pyrimidin-4-amine			1.0288299999999997													MCULE-4443788627	415.502		415.212058	7	1	5	5			44										False	Alkaloids				Peptide01			Compound(16456630)	16456630	4.1	140			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#7]1-[#6]-[#6]-[#7](-[#6]2:[#7]:[#6](-[#7]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#6]3:[#6]:[#7]:[#7](-[#6]):[#6]:3:[#7]:2)-[#6]-[#6]-1	COc1ccccc1N1CCN(c2nc(Nc3ccccc3)c3cnn(C)c3n2)CC1	QAPLIXUJSBSLLT		parent_pubchem_cid	6-[4-(2-methoxyphenyl)piperazin-1-yl]-1-methyl-N-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine;878063-63-9;AKOS001906781;CCG-170404;6-[4-(2-methoxyphenyl)piperazin-1-yl]-1-methyl-N-phenyl-pyrazolo[3,4-d]pyrimidin-4-amine		4158080.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=4158080		pluskal_iocb_peptide_Peptide01_A18_id		100	A18		ZINC000009212214
1.3		0	1081	P1157538	120.0		D13	False	0	20	0	0	26	0	4	4	0	1		0.0						COC(=O)C(CCSC)NC(=O)N1CCN(C(=O)c2c[nH]c3ccccc23)CC1																							0.0		AKOS005646365		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C20H26N4O4S	C20H26N4O4S			InChI=1S/C20H26N4O4S/c1-28-19(26)17(7-12-29-2)22-20(27)24-10-8-23(9-11-24)18(25)15-13-21-16-6-4-3-5-14(15)16/h3-6,13,17,21H,7-12H2,1-2H3,(H,22,27)/t17-/m0/s1	PRZZAJIPNWDSGR-KRWDZBQOSA-N	methyl rac-(2S)-2-[[4-(1H-indole-3-carbonyl)piperazine-1-carbonyl]amino]-4-methylsulfanyl-butanoate	17591663	COC(=O)[C@H](CCSC)NC(=O)N1CCN(C(=O)c2c[nH]c3ccccc23)CC1	methyl (2S)-2-[[4-(1H-indole-3-carbonyl)piperazine-1-carbonyl]amino]-4-methylsulfanylbutanoate			1.44687													MCULE-1540788854	418.51862		418.167476	5	2	7	3			44									Carboline alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(17591663)	17591663	1.6	141			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]-[#16]-[#6])-[#7]-[#6](=[#8])-[#7]1-[#6]-[#6]-[#7](-[#6](=[#8])-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6]-[#6]-1	COC(=O)[C@H](CCSC)NC(=O)N1CCN(C(=O)c2c[nH]c3ccccc23)CC1	PRZZAJIPNWDSGR		parent_pubchem_cid	AKOS005646365;METHYL (2S)-2-({[4-(1H-INDOL-3-YLCARBONYL)PIPERAZINO]CARBONYL}AMINO)-4-(METHYLSULFANYL)BUTANOATE;methyl rac-(2S)-2-[[4-(1H-indole-3-carbonyl)piperazine-1-carbonyl]amino]-4-methylsulfanyl-butanoate		16735441.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=16735441		pluskal_iocb_peptide_Peptide01_A18_id		100	A18		ZINC000009547955
2.4		0	1169	P1157636	115.8		D14	False	0	19	0	0	25	0	3	5	0	0		0.0						CC(C)CC(NC(=O)C(C(C)C)n1c(=O)[nH]c2ccccc2c1=O)C(=O)O																							0.0		EiM07-17670		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	4	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0		C19H25N3O5	C19H25N3O5			InChI=1S/C19H25N3O5/c1-10(2)9-14(18(25)26)20-16(23)15(11(3)4)22-17(24)12-7-5-6-8-13(12)21-19(22)27/h5-8,10-11,14-15H,9H2,1-4H3,(H,20,23)(H,21,27)(H,25,26)/t14-,15-/m0/s1	OLTOZLDZIHCZAV-GJZGRUSLSA-N	rac-(2S)-4-methyl-2-[[rac-(2S)-2-(2,4-dioxo-1H-quinazolin-3-yl)-3-methyl-butanoyl]amino]pentanoic acid	1787658	CC(C)C[C@H](NC(=O)[C@H](C(C)C)n1c(=O)[nH]c2ccccc2c1=O)C(=O)O	(2S)-2-[[(2S)-2-(2,4-dioxo-1H-quinazolin-3-yl)-3-methylbutanoyl]amino]-4-methylpentanoic acid			2.8737600000000008													MCULE-7389265105	375.4282		375.179421	5	3	7	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(1787658)	1787658	2.7	142			[#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6@H](-[#6](-[#6])-[#6])-[#7]1:[#6](=[#8]):[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8])-[#6](=[#8])-[#8]	CC(C)C[C@H](NC(=O)[C@H](C(C)C)n1c(=O)[nH]c2ccccc2c1=O)C(=O)O	OLTOZLDZIHCZAV		parent_pubchem_cid	EiM07-17670;AKOS016376521;2-[2-(2,4-DIOXO-1,2,3,4-TETRAHYDROQUINAZOLIN-3-YL)-3-METHYLBUTANAMIDO]-4-METHYLPENTANOIC ACID;rac-(2S)-4-methyl-2-[[rac-(2S)-2-(2,4-dioxo-1H-quinazolin-3-yl)-3-methyl-butanoyl]amino]pentanoic acid		24249333.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24249333		pluskal_iocb_peptide_Peptide01_A18_id		100	A18		ZINC000002132171
4.9		0	1257	P7008380	68.1		D15	False	0	25	0	0	28	0	6	1	0	0		0.0						COc1ccc(Nc2c3cnn(C)c3nc(N3CCC(Cc4ccccc4)CC3)n2)cc1																							0.0		6-(4-benzylpiperidin-1-yl)-N-(4-methoxyphenyl)-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	2		C25H28N6O	C25H28N6O			InChI=1S/C25H28N6O/c1-30-24-22(17-26-30)23(27-20-8-10-21(32-2)11-9-20)28-25(29-24)31-14-12-19(13-15-31)16-18-6-4-3-5-7-18/h3-11,17,19H,12-16H2,1-2H3,(H,27,28,29)	NPXZPMKLBWWHMD-UHFFFAOYSA-N	6-(4-benzyl-1-piperidyl)-N-(4-methoxyphenyl)-1-methyl-pyrazolo[3,4-d]pyrimidin-4-amine	16456742	COc1ccc(Nc2c3cnn(C)c3nc(N3CCC(Cc4ccccc4)CC3)n2)cc1	6-(4-benzylpiperidin-1-yl)-N-(4-methoxyphenyl)-1-methylpyrazolo[3,4-d]pyrimidin-4-amine			2.4872299999999994													MCULE-3765083038	428.54151		428.23246	6	1	6	5			44										False	Alkaloids				Peptide01			Compound(16456742)	16456742	5.2	143			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#7]-[#6]2:[#6]3:[#6]:[#7]:[#7](-[#6]):[#6]:3:[#7]:[#6](-[#7]3-[#6]-[#6]-[#6](-[#6]-[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]:4)-[#6]-[#6]-3):[#7]:2):[#6]:[#6]:1	COc1ccc(Nc2c3cnn(C)c3nc(N3CCC(Cc4ccccc4)CC3)n2)cc1	NPXZPMKLBWWHMD		parent_pubchem_cid	6-(4-benzylpiperidin-1-yl)-N-(4-methoxyphenyl)-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine;STK890998;AKOS001910181;6-(4-benzyl-1-piperidyl)-N-(4-methoxyphenyl)-1-methyl-pyrazolo[3,4-d]pyrimidin-4-amine		6541994.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=6541994		pluskal_iocb_peptide_Peptide01_A18_id		100	A18		ZINC000009273300
3.0		0	1089	P6245607	103.5		D17	False	0	20	0	1	21	0	4	3	0	1		0.0						COC(=O)C(CCSC)NC(=O)c1c(-n2cccc2)n(-c2ccc(F)cc2)nc1																							0.0		AKOS016382692		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	2		C20H21FN4O3S	C20H21FN4O3S			InChI=1S/C20H21FN4O3S/c1-28-20(27)17(9-12-29-2)23-18(26)16-13-22-25(15-7-5-14(21)6-8-15)19(16)24-10-3-4-11-24/h3-8,10-11,13,17H,9,12H2,1-2H3,(H,23,26)/t17-/m0/s1	UYVGFQDAJKDGJC-KRWDZBQOSA-N	methyl rac-(2S)-2-[[1-(4-fluorophenyl)-5-pyrrol-1-yl-pyrazole-4-carbonyl]amino]-4-methylsulfanyl-butanoate	51054330	COC(=O)[C@H](CCSC)NC(=O)c1c(-n2cccc2)n(-c2ccc(F)cc2)nc1	methyl (2S)-2-[[1-(4-fluorophenyl)-5-pyrrol-1-ylpyrazole-4-carbonyl]amino]-4-methylsulfanylbutanoate			2.39187													MCULE-2760340097	416.47777		416.13184	5	1	9	3			44										False	Alkaloids				Peptide01			Compound(51054330)	51054330	3.0	144			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]-[#16]-[#6])-[#7]-[#6](=[#8])-[#6]1:[#6](-[#7]2:[#6]:[#6]:[#6]:[#6]:2):[#7](-[#6]2:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:2):[#7]:[#6]:1	COC(=O)[C@H](CCSC)NC(=O)c1c(-n2cccc2)n(-c2ccc(F)cc2)nc1	UYVGFQDAJKDGJC		parent_pubchem_cid	AKOS016382692;METHYL (2S)-2-({[1-(4-FLUOROPHENYL)-5-(1H-PYRROL-1-YL)-1H-PYRAZOL-4-YL]CARBONYL}AMINO)-4-(METHYLSULFANYL)BUTANOATE;methyl rac-(2S)-2-[[1-(4-fluorophenyl)-5-pyrrol-1-yl-pyrazole-4-carbonyl]amino]-4-methylsulfanyl-butanoate		5730200.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=5730200		pluskal_iocb_peptide_Peptide01_A19_id		100	A19		ZINC000049549654
4.3		0	1177	P6238545	80.6		D18	False	0	25	0	0	22	0	2	4	0	0		0.0						COc1cccc(NC(=O)C(Cc2ccccc2)NC(=O)c2cc3ccccc3o2)c1																							0.0		EiM08-08779		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C25H22N2O4	C25H22N2O4			InChI=1S/C25H22N2O4/c1-30-20-12-7-11-19(16-20)26-24(28)21(14-17-8-3-2-4-9-17)27-25(29)23-15-18-10-5-6-13-22(18)31-23/h2-13,15-16,21H,14H2,1H3,(H,26,28)(H,27,29)/t21-/m1/s1	RJNVIGNTCGBXET-OAQYLSRUSA-N	N-[rac-(1R)-1-benzyl-2-(3-methoxyanilino)-2-oxo-ethyl]benzofuran-2-carboxamide	51815153	COc1cccc(NC(=O)[C@@H](Cc2ccccc2)NC(=O)c2cc3ccccc3o2)c1	N-[(2R)-1-(3-methoxyanilino)-1-oxo-3-phenylpropan-2-yl]-1-benzofuran-2-carboxamide			3.0403400000000014													MCULE-3308802982	414.46509		414.157957	3	2	7	4			44										False					Peptide01			Compound(51815153)	51815153	4.8	145			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6](-[#7]-[#6](=[#8])-[#6@@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3:[#8]:2):[#6]:1	COc1cccc(NC(=O)[C@@H](Cc2ccccc2)NC(=O)c2cc3ccccc3o2)c1	RJNVIGNTCGBXET		parent_pubchem_cid	EiM08-08779;AKOS016383498;N-[rac-(1R)-1-benzyl-2-(3-methoxyanilino)-2-oxo-ethyl]benzofuran-2-carboxamide		17049725.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=17049725		pluskal_iocb_peptide_Peptide01_A19_id		100	A19		ZINC000036575540
1.8		0	1265	P7008517	70.5		D19	False	0	20	0	0	23	0	7	1	0	0		0.0						c1ccc(N2CCN(c3nc4nccnc4c(N4CCOCC4)n3)CC2)cc1																							0.0		4-[2-(4-phenylpiperazinyl)pteridin-4-yl]morpholine		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3		C20H23N7O	C20H23N7O			InChI=1S/C20H23N7O/c1-2-4-16(5-3-1)25-8-10-27(11-9-25)20-23-18-17(21-6-7-22-18)19(24-20)26-12-14-28-15-13-26/h1-7H,8-15H2	GSRWCMDHTTYIRT-UHFFFAOYSA-N	4-[2-(4-phenylpiperazin-1-yl)pteridin-4-yl]morpholine	39313333	c1ccc(N2CCN(c3nc4nccnc4c(N4CCOCC4)n3)CC2)cc1	4-[2-(4-phenylpiperazin-1-yl)pteridin-4-yl]morpholine			0.0127500000000011													MCULE-4424273199	377.45261		377.196408	8	0	3	5			44										False	Alkaloids				Peptide01			Compound(39313333)	39313333	2.0	146			[#6]1:[#6]:[#6]:[#6](-[#7]2-[#6]-[#6]-[#7](-[#6]3:[#7]:[#6]4:[#7]:[#6]:[#6]:[#7]:[#6]:4:[#6](-[#7]4-[#6]-[#6]-[#8]-[#6]-[#6]-4):[#7]:3)-[#6]-[#6]-2):[#6]:[#6]:1	c1ccc(N2CCN(c3nc4nccnc4c(N4CCOCC4)n3)CC2)cc1	GSRWCMDHTTYIRT		parent_pubchem_cid	4-[2-(4-phenylpiperazinyl)pteridin-4-yl]morpholine;1144494-09-6;AKOS002337548;NCGC00306848-01;AB01182362-02;Z1013750858;4-[2-(4-phenylpiperazin-1-yl)pteridin-4-yl]morpholine		18006642.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=18006642		pluskal_iocb_peptide_Peptide01_A19_id		100	A19		ZINC000032073514
3.2		0	1097	P1157899	82.2		D21	False	0	17	0	0	22	0	2	3	0	0		0.0						CCCCC(NC(=O)CCc1c[nH]c2ccccc12)C(=O)O																							0.0		N-[3-(1H-indol-3-yl)propanoyl]norleucine		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C17H22N2O3	C17H22N2O3			InChI=1S/C17H22N2O3/c1-2-3-7-15(17(21)22)19-16(20)10-9-12-11-18-14-8-5-4-6-13(12)14/h4-6,8,11,15,18H,2-3,7,9-10H2,1H3,(H,19,20)(H,21,22)	FAKSLANWEKLGIV-UHFFFAOYSA-N	2-[3-(1H-indol-3-yl)propanoylamino]hexanoic acid	16415903	CCCCC(NC(=O)CCc1c[nH]c2ccccc12)C(=O)O	2-[3-(1H-indol-3-yl)propanoylamino]hexanoic acid			2.37697													MCULE-2042341211	302.37649		302.163043	3	3	8	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(16415903)	16415903	2.9	147			[#6]-[#6]-[#6]-[#6]-[#6](-[#7]-[#6](=[#8])-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	CCCCC(NC(=O)CCc1c[nH]c2ccccc12)C(=O)O	FAKSLANWEKLGIV		parent_pubchem_cid	N-[3-(1H-indol-3-yl)propanoyl]norleucine;1009170-24-4;STK717294;AKOS005534038;2-[3-(1H-INDOL-3-YL)PROPANAMIDO]HEXANOIC ACID;2-[3-(1H-indol-3-yl)propanoylamino]hexanoic acid		23033009.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23033009		pluskal_iocb_peptide_Peptide01_A19_id		100	A19		
2.2		0	1185	P3463122	106.7		D22	False	0	24	0	0	25	0	5	3	0	0		0.0						CC(NC(=O)C(C)n1cnc2ccccc2c1=O)C(=O)NCCc1c[nH]c2ccccc12																							0.0		AKOS004938826		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0		C24H25N5O3	C24H25N5O3			InChI=1S/C24H25N5O3/c1-15(22(30)25-12-11-17-13-26-20-9-5-3-7-18(17)20)28-23(31)16(2)29-14-27-21-10-6-4-8-19(21)24(29)32/h3-10,13-16,26H,11-12H2,1-2H3,(H,25,30)(H,28,31)/t15-,16+/m0/s1	WKBONKNLKZTFQC-JKSUJKDBSA-N	rac-(2S)-N-[2-(1H-indol-3-yl)ethyl]-2-[[rac-(2R)-2-(4-oxoquinazolin-3-yl)propanoyl]amino]propanamide	42506715	C[C@H](NC(=O)[C@@H](C)n1cnc2ccccc2c1=O)C(=O)NCCc1c[nH]c2ccccc12	(2S)-N-[2-(1H-indol-3-yl)ethyl]-2-[[(2R)-2-(4-oxoquinazolin-3-yl)propanoyl]amino]propanamide			2.29074													MCULE-9659312760	431.49855		431.19574	4	3	7	4			44									Quinazoline alkaloids	False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(42506715)	42506715	2.5	148			[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6@@H](-[#6])-[#7]1:[#6]:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8])-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	C[C@H](NC(=O)[C@@H](C)n1cnc2ccccc2c1=O)C(=O)NCCc1c[nH]c2ccccc12	WKBONKNLKZTFQC		parent_pubchem_cid	AKOS004938826;N-[2-(1H-INDOL-3-YL)ETHYL]-2-[2-(4-OXO-3,4-DIHYDROQUINAZOLIN-3-YL)PROPANAMIDO]PROPANAMIDE;rac-(2S)-N-[2-(1H-indol-3-yl)ethyl]-2-[[rac-(2R)-2-(4-oxoquinazolin-3-yl)propanoyl]amino]propanamide		5052422.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=5052422		pluskal_iocb_peptide_Peptide01_A19_id		100	A19		ZINC000012296467
4.5		0	1273	P7127796	127.3		D23	False	0	21	0	0	16	0	2	5	0	2		0.0						O=S(=O)(c1ccccc1)c1c(NCc2cc3c(cc2)OCO3)oc(-c2cccs2)n1																							0.0		AKOS002326216		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0		C21H16N2O5S2	C21H16N2O5S2			InChI=1S/C21H16N2O5S2/c24-30(25,15-5-2-1-3-6-15)21-20(28-19(23-21)18-7-4-10-29-18)22-12-14-8-9-16-17(11-14)27-13-26-16/h1-11,22H,12-13H2	MEILBPKNWUNKKU-UHFFFAOYSA-N	4-(benzenesulfonyl)-N-(1,3-benzodioxol-5-ylmethyl)-2-(2-thienyl)oxazol-5-amine	1244713	O=S(=O)(c1ccccc1)c1c(NCc2cc3c(cc2)OCO3)oc(-c2cccs2)n1	4-(benzenesulfonyl)-N-(1,3-benzodioxol-5-ylmethyl)-2-thiophen-2-yl-1,3-oxazol-5-amine			2.620520000000001													MCULE-8199615500	440.50007		440.050064	6	1	6	5			44										False	Shikimates and Phenylpropanoids				Peptide01			Compound(1244713)	1244713	5.0	149			[#8]=[#16](=[#8])(-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6](-[#7]-[#6]-[#6]2:[#6]:[#6]3:[#6](:[#6]:[#6]:2)-[#8]-[#6]-[#8]-3):[#8]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#16]:2):[#7]:1	O=S(=O)(c1ccccc1)c1c(NCc2cc3c(cc2)OCO3)oc(-c2cccs2)n1	MEILBPKNWUNKKU		parent_pubchem_cid	AKOS002326216;Z57362890;n-(1,3-benzodioxol-5-ylmethyl)-4-(phenylsulfonyl)-2-(2-thienyl)-1,3-oxazol-5-amine;4-(benzenesulfonyl)-N-(1,3-benzodioxol-5-ylmethyl)-2-(2-thienyl)oxazol-5-amine		13679146.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=13679146		pluskal_iocb_peptide_Peptide01_A19_id		100	A19		ZINC000001052920
2.9		0	1105	P1098910	111.4		D25	False	0	19	0	0	18	0	4	4	0	0	-1.0	0.0						CC(C(=O)NC(Cc1ccccc1)C(=O)O)n1nnc2ccccc2c1=O		1.16		0.0	3.18	CHEMBL1340917																	0.0		MLS000762431		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C19H18N4O4	C19H18N4O4			InChI=1S/C19H18N4O4/c1-12(23-18(25)14-9-5-6-10-15(14)21-22-23)17(24)20-16(19(26)27)11-13-7-3-2-4-8-13/h2-10,12,16H,11H2,1H3,(H,20,24)(H,26,27)/t12-,16-/m0/s1	FUEXJRMNOZHKNQ-LRDDRELGSA-N	rac-(2S)-3-phenyl-2-[[rac-(2S)-2-(4-oxo-1,2,3-benzotriazin-3-yl)propanoyl]amino]propanoic acid	1853692	C[C@@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)n1nnc2ccccc2c1=O	(2S)-2-[[(2S)-2-(4-oxo-1,2,3-benzotriazin-3-yl)propanoyl]amino]-3-phenylpropanoic acid			1.58136													MCULE-9486044046	366.37971	ACID	366.132805	6	2	6	3	0.0		29									Dipeptides	False	Amino acids and Peptides	Small peptides	False	False	Peptide01		-1.0	Compound(1853692)	1853692	2.9	150			[#6]-[#6@@H](-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8])-[#7]1:[#7]:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8]	C[C@@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)n1nnc2ccccc2c1=O	FUEXJRMNOZHKNQ		parent_pubchem_cid	MLS000762431;CHEMBL1340917;DTXSID901331114;HMS2744P24;EiM07-17608;STK716985;AKOS005533834;(2S)-2-[[(2S)-2-(4-oxo-1,2,3-benzotriazin-3-yl)propanoyl]amino]-3-phenylpropanoic acid;NCGC00305382-01;958946-26-4;SMR000415993;AB00654965-06;N-[(2S)-2-(4-oxo-1,2,3-benzotriazin-3(4H)-yl)propanoyl]-L-phenylalanine;(S)-2-[(S)-2-(4-Oxo-4H-benzo[d][1,2,3]triazin-3-yl)-propionylamino]-3-phenyl-propionic acid;2-[2-(4-OXO-3,4-DIHYDRO-1,2,3-BENZOTRIAZIN-3-YL)PROPANAMIDO]-3-PHENYLPROPANOIC ACID;rac-(2S)-3-phenyl-2-[[rac-(2S)-2-(4-oxo-1,2,3-benzotriazin-3-yl)propanoyl]amino]propanoic acid	False	770843.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=770843		pluskal_iocb_peptide_Peptide01_A19_id		100	A19	False	ZINC000002221400
4.1		0	1193	P1158273	88.2		D26	False	0	25	0	0	28	0	4	3	0	0		0.0						CCC(NC(=O)c1cc2c(ccc(OC)c2)n1C)C(=O)NCCc1c[nH]c2ccccc12																							0.0		1050282-78-4		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	1		C25H28N4O3	C25H28N4O3			InChI=1S/C25H28N4O3/c1-4-20(24(30)26-12-11-16-15-27-21-8-6-5-7-19(16)21)28-25(31)23-14-17-13-18(32-3)9-10-22(17)29(23)2/h5-10,13-15,20,27H,4,11-12H2,1-3H3,(H,26,30)(H,28,31)	UMPVEOOKOJMKPZ-UHFFFAOYSA-N	N-[1-[2-(1H-indol-3-yl)ethylcarbamoyl]propyl]-5-methoxy-1-methyl-indole-2-carboxamide	17594546	CCC(NC(=O)c1cc2c(ccc(OC)c2)n1C)C(=O)NCCc1c[nH]c2ccccc12	N-[1-[2-(1H-indol-3-yl)ethylamino]-1-oxobutan-2-yl]-5-methoxy-1-methylindole-2-carboxamide			2.1068299999999995													MCULE-9249356301	432.52691		432.216141	3	3	8	4			45										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(17594546)	17594546	3.9	151			[#6]-[#6]-[#6](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:[#6](-[#8]-[#6]):[#6]:2):[#7]:1-[#6])-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CCC(NC(=O)c1cc2c(ccc(OC)c2)n1C)C(=O)NCCc1c[nH]c2ccccc12	UMPVEOOKOJMKPZ		parent_pubchem_cid	1050282-78-4;N-[1-({[2-(1H-indol-3-yl)ethyl]amino}carbonyl)propyl]-5-methoxy-1-methyl-1H-indole-2-carboxamide;AKOS005534191;N-[2-(1H-INDOL-3-YL)ETHYL]-2-[(5-METHOXY-1-METHYL-1H-INDOL-2-YL)FORMAMIDO]BUTANAMIDE;N-[1-[2-(1H-indol-3-yl)ethylcarbamoyl]propyl]-5-methoxy-1-methyl-indole-2-carboxamide		24160231.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24160231		pluskal_iocb_peptide_Peptide01_A19_id		100	A19		
1.6		0	1281	P11569936	98.3		D27	False	0	18	0	0	24	0	4	3	0	0		0.0						CCC(C)C(CO)NC(=O)C1CC(=O)N(c2n[nH]c3ccccc23)C1																							0.0		AKOS027474663		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	1	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C18H24N4O3	C18H24N4O3			InChI=1S/C18H24N4O3/c1-3-11(2)15(10-23)19-18(25)12-8-16(24)22(9-12)17-13-6-4-5-7-14(13)20-21-17/h4-7,11-12,15,23H,3,8-10H2,1-2H3,(H,19,25)(H,20,21)/t11-,12?,15-/m1/s1	UVIVKVYXBQDTPB-KKXIITGPSA-N	1-(1H-indazol-3-yl)-5-oxo-N-[rac-(1S,2R)-1-(hydroxymethyl)-2-methyl-butyl]pyrrolidine-3-carboxamide	110204212	CC[C@@H](C)[C@@H](CO)NC(=O)C1CC(=O)N(c2n[nH]c3ccccc23)C1	N-[(2S,3R)-1-hydroxy-3-methylpentan-2-yl]-1-(1H-indazol-3-yl)-5-oxopyrrolidine-3-carboxamide			0.6299700000000004														344.41698		344.184841	4	3	6	3			46									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(110204212)	110204212	1.3	152			[#6]-[#6]-[#6@@H](-[#6])-[#6@@H](-[#6]-[#8])-[#7]-[#6](=[#8])-[#6]1-[#6]-[#6](=[#8])-[#7](-[#6]2:[#7]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6]-1	CC[C@@H](C)[C@@H](CO)NC(=O)C1CC(=O)N(c2n[nH]c3ccccc23)C1	UVIVKVYXBQDTPB		parent_pubchem_cid	AKOS027474663;1-(1H-indazol-3-yl)-5-oxo-N-[rac-(1S,2R)-1-(hydroxymethyl)-2-methyl-butyl]pyrrolidine-3-carboxamide		117132425.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=117132425		pluskal_iocb_peptide_Peptide01_A20_id		100	A20		
1.5		0	1113	P1098844	99.1		D29	False	0	19	0	0	17	0	3	4	0	0		0.0						O=C(Cn1cnc2ccccc2c1=O)NC(Cc1ccccc1)C(=O)O								N-acyl-L-alpha-amino acids;Phenylpropanoic acids;Amphetamines and derivatives;Quinazolines;Pyrimidones;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactams;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Benzodiazines;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Diazanaphthalenes;Diazines;Heteroaromatic compounds;Hydrocarbon derivatives;Lactams;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenethylamines;Phenylalanine and derivatives;Phenylpropanoic acids;Phenylpropanoids and polyketides;Pyrimidines and pyrimidine derivatives;Pyrimidones;Quinazolines;Secondary carboxylic acid amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-L-alpha-amino acid (CHEBI:48927);benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);amphetamines (CHEBI:35338);quinazolines (CHEBI:38530);pyrimidone (CHEBI:38337);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactam (CHEBI:24995);carbonyl compound (CHEBI:36586);carboxylic acid anion (CHEBI:29067);organonitrogen heterocyclic compound (CHEBI:38101);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);amino acid (CHEBI:33709);peptide (CHEBI:16670);N-acyl-amino acid (CHEBI:51569);benzenoid aromatic compound (CHEBI:33836);primary amine (CHEBI:32877);organic heterocyclic compound (CHEBI:24532);azaarene (CHEBI:50893);diazines (CHEBI:38313);pyrimidines (CHEBI:39447);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806)		Amino acids, peptides, and analogues	Phenylalanine or derivatives;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;N-acyl-l-alpha-amino acid;3-phenylpropanoic-acid;Diazanaphthalene;Amphetamine or derivatives;Quinazoline;Pyrimidone;Benzenoid;Monocyclic benzene moiety;Pyrimidine;Heteroaromatic compound;Secondary carboxylic acid amide;Carboxamide group;Lactam;Azacycle;Organoheterocyclic compound;Carboxylic acid;Monocarboxylic acid or derivatives;Hydrocarbon derivative;Organic oxygen compound;Organopnictogen compound;Organonitrogen compound;Organooxygen compound;Organic oxide;Carbonyl group;Organic nitrogen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS004936969		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0		C19H17N3O4	C19H17N3O4			InChI=1S/C19H17N3O4/c23-17(21-16(19(25)26)10-13-6-2-1-3-7-13)11-22-12-20-15-9-5-4-8-14(15)18(22)24/h1-9,12,16H,10-11H2,(H,21,23)(H,25,26)/t16-/m0/s1	SSSABMODNNUTPX-INIZCTEOSA-N	rac-(2S)-2-[[2-(4-oxoquinazolin-3-yl)acetyl]amino]-3-phenyl-propanoic acid	1793048	O=C(Cn1cnc2ccccc2c1=O)N[C@@H](Cc1ccccc1)C(=O)O	(2S)-2-[[2-(4-oxoquinazolin-3-yl)acetyl]amino]-3-phenylpropanoic acid			1.62536													MCULE-4039671304	351.36504		351.121906	5	2	6	3			44									Quinazoline alkaloids	False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(1793048)	1793048	1.8	153			[#8]=[#6](-[#6]-[#7]1:[#6]:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	O=C(Cn1cnc2ccccc2c1=O)N[C@@H](Cc1ccccc1)C(=O)O	SSSABMODNNUTPX		parent_pubchem_cid	AKOS004936969;(S)-2-(2-(4-oxoquinazolin-3(4H)-yl)acetamido)-3-phenylpropanoic acid;(2S)-2-({2-[4-OXO-3(4H)-QUINAZOLINYL]ACETYL}AMINO)-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[[2-(4-oxoquinazolin-3-yl)acetyl]amino]-3-phenyl-propanoic acid		22918458.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22918458		pluskal_iocb_peptide_Peptide01_A20_id		100	A20		ZINC000002137593
4.5		0	1201	P1098247	101.9		D30	False	0	22	0	0	29	0	1	6	0	0		0.0						CCCc1cc(=O)oc2c1ccc(OC(C)C(=O)NC(C(=O)O)C(C)CC)c2C																							0.0		EiM07-16925		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C22H29NO6	C22H29NO6			InChI=1S/C22H29NO6/c1-6-8-15-11-18(24)29-20-13(4)17(10-9-16(15)20)28-14(5)21(25)23-19(22(26)27)12(3)7-2/h9-12,14,19H,6-8H2,1-5H3,(H,23,25)(H,26,27)/t12-,14?,19+/m1/s1	FYRDRWHCLLNEML-JMEGYQLOSA-N	rac-(2S,3R)-3-methyl-2-[2-(8-methyl-2-oxo-4-propyl-chromen-7-yl)oxypropanoylamino]pentanoic acid	24279863	CCCc1cc(=O)oc2c1ccc(OC(C)C(=O)N[C@H](C(=O)O)[C@H](C)CC)c2C	(2S,3R)-3-methyl-2-[2-(8-methyl-2-oxo-4-propylchromen-7-yl)oxypropanoylamino]pentanoic acid			3.3363600000000018													MCULE-4159466737	403.47953		403.199488	6	2	9	2			45									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(24279863)	24279863	4.2	154			[#6]-[#6]-[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6](-[#6])-[#6](=[#8])-[#7]-[#6@H](-[#6](=[#8])-[#8])-[#6@H](-[#6])-[#6]-[#6]):[#6]:2-[#6]	CCCc1cc(=O)oc2c1ccc(OC(C)C(=O)N[C@H](C(=O)O)[C@H](C)CC)c2C	FYRDRWHCLLNEML		parent_pubchem_cid	EiM07-16925;AKOS004937380;3-METHYL-2-{2-[(8-METHYL-2-OXO-4-PROPYL-2H-CHROMEN-7-YL)OXY]PROPANAMIDO}PENTANOIC ACID;rac-(2S,3R)-3-methyl-2-[2-(8-methyl-2-oxo-4-propyl-chromen-7-yl)oxypropanoylamino]pentanoic acid		48322928.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=48322928		pluskal_iocb_peptide_Peptide01_A20_id		100	A20		
1.6		0	1289	P11570049	90.8		D31	False	0	19	0	0	19	0	3	3	0	0		0.0						O=C(Cc1n[nH]c(=O)c2ccccc12)NC(CO)Cc1ccccc1																							0.0		AKOS027474769		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C19H19N3O3	C19H19N3O3			InChI=1S/C19H19N3O3/c23-12-14(10-13-6-2-1-3-7-13)20-18(24)11-17-15-8-4-5-9-16(15)19(25)22-21-17/h1-9,14,23H,10-12H2,(H,20,24)(H,22,25)/t14-/m0/s1	FQWGTWHSZLDHEM-AWEZNQCLSA-N	2-(4-oxo-3H-phthalazin-1-yl)-N-[rac-(1S)-1-benzyl-2-hydroxy-ethyl]acetamide	110204486	O=C(Cc1n[nH]c(=O)c2ccccc12)N[C@H](CO)Cc1ccccc1	N-[(2S)-1-hydroxy-3-phenylpropan-2-yl]-2-(4-oxo-3H-phthalazin-1-yl)acetamide			1.5474499999999998														337.38158		337.142641	4	3	6	3			45										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(110204486)	110204486	1.8	155			[#8]=[#6](-[#6]-[#6]1:[#7]:[#7H]:[#6](=[#8]):[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#6@H](-[#6]-[#8])-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	O=C(Cc1n[nH]c(=O)c2ccccc12)N[C@H](CO)Cc1ccccc1	FQWGTWHSZLDHEM		parent_pubchem_cid	AKOS027474769;AO-022/43513838;N-(1-benzyl-2-hydroxyethyl)-2-(4-oxo-3,4-dihydro-1-phthalazinyl)acetamide;N-(1-hydroxy-3-phenylpropan-2-yl)-2-(4-oxo-3,4-dihydrophthalazin-1-yl)acetamide;2-(4-oxo-3H-phthalazin-1-yl)-N-[rac-(1S)-1-benzyl-2-hydroxy-ethyl]acetamide		117132698.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=117132698		pluskal_iocb_peptide_Peptide01_A20_id		100	A20		ZINC000252484188
3.0		0	1121	P1098949	115.8		D33	False	0	22	0	0	29	0	3	5	0	0	-1.0	0.0						CCC(C)C(NC(=O)C1CCC(Cn2c(=O)[nH]c3ccccc3c2=O)CC1)C(=O)O		2.11		0.0	3.75	CHEMBL4890102																	0.0		CHEMBL4890102		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	4	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0		C22H29N3O5	C22H29N3O5			InChI=1S/C22H29N3O5/c1-3-13(2)18(21(28)29)24-19(26)15-10-8-14(9-11-15)12-25-20(27)16-6-4-5-7-17(16)23-22(25)30/h4-7,13-15,18H,3,8-12H2,1-2H3,(H,23,30)(H,24,26)(H,28,29)/t13-,14?,15?,18+/m1/s1	JVACKGHJWHDABG-RMYJWEKJSA-N	rac-(2S,3R)-2-[[4-[(2,4-dioxo-1H-quinazolin-3-yl)methyl]cyclohexanecarbonyl]amino]-3-methyl-pentanoic acid	8027706	CC[C@@H](C)[C@H](NC(=O)C1CCC(Cn2c(=O)[nH]c3ccccc3c2=O)CC1)C(=O)O	(2S,3R)-2-[[4-[(2,4-dioxo-1H-quinazolin-3-yl)methyl]cyclohexanecarbonyl]amino]-3-methylpentanoic acid			3.483060000000002														415.49353	ACID	415.210721	5	3	7	3	0.0		30										False	Alkaloids		False	False	Peptide01		-1.0	Compound(8027706)	8027706	2.7	156			[#6]-[#6]-[#6@@H](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#6]1-[#6]-[#6]-[#6](-[#6]-[#7]2:[#6](=[#8]):[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3:[#6]:2=[#8])-[#6]-[#6]-1)-[#6](=[#8])-[#8]	CC[C@@H](C)[C@H](NC(=O)C1CCC(Cn2c(=O)[nH]c3ccccc3c2=O)CC1)C(=O)O	JVACKGHJWHDABG		parent_pubchem_cid	CHEMBL4890102;AKOS016387015;2-({4-[(2,4-DIOXO-1,2,3,4-TETRAHYDROQUINAZOLIN-3-YL)METHYL]CYCLOHEXYL}FORMAMIDO)-3-METHYLPENTANOIC ACID;rac-(2S,3R)-2-[[4-[(2,4-dioxo-1H-quinazolin-3-yl)methyl]cyclohexanecarbonyl]amino]-3-methyl-pentanoic acid	False	57237311.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=57237311		pluskal_iocb_peptide_Peptide01_A20_id		100	A20	False	ZINC000008971961
3.0		0	1209	P1098695	131.0		D34	False	0	26	0	0	26	0	2	7	0	0		0.0						O=C(COc1cc2c(cc1)c1c(CCCC1)c(=O)o2)NCC(=O)NC(Cc1ccccc1)C(=O)O																							0.0		AKOS016402561		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C26H26N2O7	C26H26N2O7			InChI=1S/C26H26N2O7/c29-23(28-21(25(31)32)12-16-6-2-1-3-7-16)14-27-24(30)15-34-17-10-11-19-18-8-4-5-9-20(18)26(33)35-22(19)13-17/h1-3,6-7,10-11,13,21H,4-5,8-9,12,14-15H2,(H,27,30)(H,28,29)(H,31,32)/t21-/m0/s1	KGPCJMLPJOTTBS-NRFANRHFSA-N	rac-(2S)-2-[[2-[[2-[(6-oxo-7,8,9,10-tetrahydrobenzo[c]chromen-3-yl)oxy]acetyl]amino]acetyl]amino]-3-phenyl-propanoic acid	6353220	O=C(COc1cc2c(cc1)c1c(CCCC1)c(=O)o2)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)O	(2S)-2-[[2-[[2-[(6-oxo-7,8,9,10-tetrahydrobenzo[c]chromen-3-yl)oxy]acetyl]amino]acetyl]amino]-3-phenylpropanoic acid			1.8238299999999992													MCULE-3315966425	478.50632		478.174001	7	3	9	4			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(6353220)	6353220	3.1	157			[#8]=[#6](-[#6]-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#6]1:[#6](-[#6]-[#6]-[#6]-[#6]-1):[#6](=[#8]):[#8]:2)-[#7]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	O=C(COc1cc2c(cc1)c1c(CCCC1)c(=O)o2)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)O	KGPCJMLPJOTTBS		parent_pubchem_cid	AKOS016402561;2-{2-[2-({6-OXO-6H,7H,8H,9H,10H-CYCLOHEXA[C]CHROMEN-3-YL}OXY)ACETAMIDO]ACETAMIDO}-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[[2-[[2-[(6-oxo-7,8,9,10-tetrahydrobenzo[c]chromen-3-yl)oxy]acetyl]amino]acetyl]amino]-3-phenyl-propanoic acid		60225158.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=60225158		pluskal_iocb_peptide_Peptide01_A20_id		100	A20		ZINC000011866878
3.0		0	1297	P11569509	78.4		D35	False	0	22	0	0	24	0	2	3	0	0		0.0						CC(C)c1c2[nH]cc(C(=O)NC(CO)Cc3ccccc3)c(=O)c2ccc1																							0.0		AKOS027474340		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C22H24N2O3	C22H24N2O3			InChI=1S/C22H24N2O3/c1-14(2)17-9-6-10-18-20(17)23-12-19(21(18)26)22(27)24-16(13-25)11-15-7-4-3-5-8-15/h3-10,12,14,16,25H,11,13H2,1-2H3,(H,23,26)(H,24,27)/t16-/m0/s1	SLYTWRPPDRGGNX-INIZCTEOSA-N	8-isopropyl-4-oxo-N-[rac-(1S)-1-benzyl-2-hydroxy-ethyl]-1H-quinoline-3-carboxamide	91637278	CC(C)c1c2[nH]cc(C(=O)N[C@H](CO)Cc3ccccc3)c(=O)c2ccc1	N-[(2S)-1-hydroxy-3-phenylpropan-2-yl]-4-oxo-8-propan-2-yl-1H-quinoline-3-carboxamide			3.2922400000000023														364.44818		364.178693	4	3	6	3			45										False	Alkaloids				Peptide01			Compound(91637278)	91637278	4.1	158			[#6]-[#6](-[#6])-[#6]1:[#6]2:[#7H]:[#6]:[#6](-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#8])-[#6]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#6](=[#8]):[#6]:2:[#6]:[#6]:[#6]:1	CC(C)c1c2[nH]cc(C(=O)N[C@H](CO)Cc3ccccc3)c(=O)c2ccc1	SLYTWRPPDRGGNX		parent_pubchem_cid	AKOS027474340;AKOS037499409;8-isopropyl-4-oxo-N-[rac-(1S)-1-benzyl-2-hydroxy-ethyl]-1H-quinoline-3-carboxamide		92683170.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=92683170		pluskal_iocb_peptide_Peptide01_A20_id		100	A20		ZINC000217722740
4.6		0	1129	P1098370	117.7		D37	False	0	26	0	0	26	0	2	6	0	0	-1.0	0.0						Cc1c(C)c2c(oc1=O)c(C)c(OC(C)C(=O)NC(Cc1c[nH]c3ccccc13)C(=O)O)cc2		3.78		0.0	4.1	CHEMBL1553377		Coumarins and derivatives;1-benzopyrans;3-alkylindoles;Phenol ethers;Pyranones and derivatives;Alkyl aryl ethers;Substituted pyrroles;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactones;Oxacyclic compounds;Azacyclic compounds;Carboxylic acids;Monocarboxylic acids and derivatives;Carbonyl compounds;Organic oxides;Organonitrogen compounds;Hydrocarbon derivatives	1-benzopyrans;3-alkylindoles;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Lactones;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenol ethers;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acyl-l-alpha-amino acids. These are n-acylated alpha amino acids which have the L-configuration of the alpha-carbon atom.	N-acyl-L-alpha-amino acids		Amino acids and derivatives;Alpha amino acids and derivatives;N-acyl-alpha amino acids and derivatives;N-acyl-alpha amino acids	Organic compounds	Aromatic heteropolycyclic compounds	coumarins (CHEBI:23403);1-benzopyran (CHEBI:38443);indoles (CHEBI:24828);aromatic ether (CHEBI:35618);pyranone (CHEBI:37963);pyrroles (CHEBI:26455);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactone (CHEBI:25000);oxacycle (CHEBI:38104);organonitrogen heterocyclic compound (CHEBI:38101);carboxylic acid (CHEBI:33575);monocarboxylic acid (CHEBI:25384);carbonyl compound (CHEBI:36586);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);organic molecule (CHEBI:72695);N-acyl-L-alpha-amino acid (CHEBI:48927);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);benzenoid aromatic compound (CHEBI:33836);pyrans (CHEBI:26407);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ether (CHEBI:25698);organic acid (CHEBI:64709);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);N-acyl-amino acid (CHEBI:51569);carboxylic acid anion (CHEBI:29067);amino acid (CHEBI:33709);peptide (CHEBI:16670)	Benzopyranoids (PK1311)	Amino acids, peptides, and analogues	N-acyl-l-alpha-amino acid;Coumarin;Benzopyran;1-benzopyran;3-alkylindole;Indole;Indole or derivatives;Phenol ether;Alkyl aryl ether;Pyranone;Pyran;Substituted pyrrole;Benzenoid;Heteroaromatic compound;Pyrrole;Carboxamide group;Secondary carboxylic acid amide;Lactone;Monocarboxylic acid or derivatives;Organoheterocyclic compound;Ether;Carboxylic acid;Oxacycle;Azacycle;Organooxygen compound;Organonitrogen compound;Hydrocarbon derivative;Organic oxide;Organic oxygen compound;Carbonyl group;Organic nitrogen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		SMR000650056		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C26H26N2O6	C26H26N2O6			InChI=1S/C26H26N2O6/c1-13-14(2)26(32)34-23-15(3)22(10-9-18(13)23)33-16(4)24(29)28-21(25(30)31)11-17-12-27-20-8-6-5-7-19(17)20/h5-10,12,16,21,27H,11H2,1-4H3,(H,28,29)(H,30,31)/t16?,21-/m0/s1	LDJHQNUGYVSZMZ-MRNPHLECSA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[2-(3,4,8-trimethyl-2-oxo-chromen-7-yl)oxypropanoylamino]propanoic acid	16399758	Cc1c(C)c2c(oc1=O)c(C)c(OC(C)C(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)O)cc2	(2S)-3-(1H-indol-3-yl)-2-[2-(3,4,8-trimethyl-2-oxochromen-7-yl)oxypropanoylamino]propanoic acid			3.140760000000001													MCULE-2238184835	462.50692	ACID	462.179087	6	3	7	4	1.0		30									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins	False	False	Peptide01		-1.0	Compound(16399758)	16399758	4.0	159			[#6]-[#6]1:[#6](-[#6]):[#6]2:[#6](:[#8]:[#6]:1=[#8]):[#6](-[#6]):[#6](-[#8]-[#6](-[#6])-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:1:3)-[#6](=[#8])-[#8]):[#6]:[#6]:2	Cc1c(C)c2c(oc1=O)c(C)c(OC(C)C(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)O)cc2	LDJHQNUGYVSZMZ		parent_pubchem_cid	SMR000650056;MLS001141036;MLS003901489;CHEMBL1553377;HMS2268C03;EiM07-17048;STL460782;AKOS016376898;AB00864408-07;N-{2-[(3,4,8-trimethyl-2-oxo-2H-chromen-7-yl)oxy]propanoyl}-L-tryptophan;(2S)-3-(1H-indol-3-yl)-2-({2-[(3,4,8-trimethyl-2-oxo-2H-chromen-7-yl)oxy]propanoyl}amino)propanoic acid;956942-50-0;rac-(2S)-3-(1H-indol-3-yl)-2-[2-(3,4,8-trimethyl-2-oxo-chromen-7-yl)oxypropanoylamino]propanoic acid	False	673870.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=673870		pluskal_iocb_peptide_Peptide01_A20_id		100	A20	False	
3.2		0	1217	P7119830564	96.2		D38	False	0	22	0	0	21	0	1	7	0	0		0.0						COC(=O)c1cc(OC)c(OC)cc1NC(=O)c1c(COc2ccccc2)occ1								P-methoxybenzoic acids and derivatives;M-methoxybenzoic acids and derivatives;Benzoic acid esters;Dimethoxybenzenes;Methoxyanilines;Anisoles;Phenoxy compounds;Benzoyl derivatives;Furan-3-carboxylic acid and derivatives;Alkyl aryl ethers;Vinylogous amides;Heteroaromatic compounds;Methyl esters;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Oxacyclic compounds;Organic oxides;Organonitrogen compounds;Organopnictogen compounds;Hydrocarbon derivatives	3-furanilides;Alkyl aryl ethers;Anilides;Aniline and substituted anilines;Anisoles;Aromatic anilides;Benzene and substituted derivatives;Benzenoids;Benzoic acid esters;Benzoic acids and derivatives;Benzoyl derivatives;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids and derivatives;Chemical entities;Dimethoxybenzenes;Ethers;Furan-3-carboxylic acid and derivatives;Furanilides;Furans;Furoic acid and derivatives;Heteroaromatic compounds;Hydrocarbon derivatives;M-methoxybenzoic acids and derivatives;Methoxyanilines;Methoxybenzenes;Methoxybenzoic acids and derivatives;Methyl esters;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;P-methoxybenzoic acids and derivatives;Phenol ethers;Phenoxy compounds;Secondary carboxylic acid amides;Vinylogous amides	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as 3-furanilides. These are aromatic heterocyclic compounds contaning a furan ring that is substituted at the 3-position with an anilide.	3-furanilides		Aromatic anilides;Furanilides	Organic compounds	Aromatic heteromonocyclic compounds	methoxybenzoic acid (CHEBI:25238);benzoate ester (CHEBI:36054);dimethoxybenzene (CHEBI:51681);substituted aniline (CHEBI:48975);methoxybenzene (CHEBI:51683);benzenes (CHEBI:22712);carbonyl compound (CHEBI:36586);furans (CHEBI:24129);aromatic ether (CHEBI:35618);enone (CHEBI:51689);enamine (CHEBI:47989);organic aromatic compound (CHEBI:33659);carboxylic ester (CHEBI:33308);carboxamide (CHEBI:37622);monocarboxylic acid (CHEBI:25384);oxacycle (CHEBI:38104);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organic molecule (CHEBI:72695);anilide (CHEBI:13248);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);benzoic acids (CHEBI:22723);organooxygen compound (CHEBI:36963);anilines (CHEBI:22562);organic heterocyclic compound (CHEBI:24532);oxygen molecular entity (CHEBI:25806);ether (CHEBI:25698);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)		Anilides	3-furanilide;M-methoxybenzoic acid or derivatives;P-methoxybenzoic acid or derivatives;Dimethoxybenzene;O-dimethoxybenzene;Benzoate ester;Methoxyaniline;Benzoic acid or derivatives;Furoic acid or derivatives;Phenol ether;Furan-3-carboxylic acid or derivatives;Phenoxy compound;Anisole;Methoxybenzene;Benzoyl;Alkyl aryl ether;Furan;Methyl ester;Heteroaromatic compound;Vinylogous amide;Carboxylic acid ester;Secondary carboxylic acid amide;Carboxamide group;Oxacycle;Carboxylic acid derivative;Organoheterocyclic compound;Ether;Monocarboxylic acid or derivatives;Organic oxygen compound;Organic nitrogen compound;Hydrocarbon derivative;Organopnictogen compound;Organooxygen compound;Organonitrogen compound;Organic oxide;Aromatic heteromonocyclic compound	Benzenoids	0.0		890613-33-9		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C22H21NO7	C22H21NO7			InChI=1S/C22H21NO7/c1-26-18-11-16(22(25)28-3)17(12-19(18)27-2)23-21(24)15-9-10-29-20(15)13-30-14-7-5-4-6-8-14/h4-12H,13H2,1-3H3,(H,23,24)	CFOLHSFRPKVXFV-UHFFFAOYSA-N	methyl 4,5-dimethoxy-2-[[2-(phenoxymethyl)furan-3-carbonyl]amino]benzoate	7464273	COC(=O)c1cc(OC)c(OC)cc1NC(=O)c1c(COc2ccccc2)occ1	methyl 4,5-dimethoxy-2-[[2-(phenoxymethyl)furan-3-carbonyl]amino]benzoate			1.98273													MCULE-8112259905	411.41517		411.131802	6	1	9	3			43									Anthranillic acid derivatives	False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(7464273)	7464273	3.7	160			[#6]-[#8]-[#6](=[#8])-[#6]1:[#6]:[#6](-[#8]-[#6]):[#6](-[#8]-[#6]):[#6]:[#6]:1-[#7]-[#6](=[#8])-[#6]1:[#6](-[#6]-[#8]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#8]:[#6]:[#6]:1	COC(=O)c1cc(OC)c(OC)cc1NC(=O)c1c(COc2ccccc2)occ1	CFOLHSFRPKVXFV		parent_pubchem_cid	890613-33-9;methyl 4,5-dimethoxy-2-(2-(phenoxymethyl)furan-3-carboxamido)benzoate;METHYL 4,5-DIMETHOXY-2-[2-(PHENOXYMETHYL)FURAN-3-AMIDO]BENZOATE;NSC822532;STL022801;AKOS002250482;methyl 4,5-dimethoxy-2-[[2-(phenoxymethyl)furan-3-carbonyl]amino]benzoate;NSC-822532;VU0607074-1;F3244-0005;methyl 4,5-dimethoxy-2-({[2-(phenoxymethyl)furan-3-yl]carbonyl}amino)benzoate		6488008.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=6488008		pluskal_iocb_peptide_Peptide01_A21_id		100	A21		ZINC000005033018
4.3		0	1137	P1098219	101.9		D41	False	0	24	0	0	25	0	1	6	0	0		0.0						CCCc1cc(=O)oc2c1ccc(OC(C)C(=O)NC(Cc1ccccc1)C(=O)O)c2																							0.0		EiM07-16897		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C24H25NO6	C24H25NO6			InChI=1S/C24H25NO6/c1-3-7-17-13-22(26)31-21-14-18(10-11-19(17)21)30-15(2)23(27)25-20(24(28)29)12-16-8-5-4-6-9-16/h4-6,8-11,13-15,20H,3,7,12H2,1-2H3,(H,25,27)(H,28,29)/t15?,20-/m0/s1	NKZUWQCOEXYFLA-MBABXSBOSA-N	rac-(2S)-2-[2-(2-oxo-4-propyl-chromen-7-yl)oxypropanoylamino]-3-phenyl-propanoic acid	16399528	CCCc1cc(=O)oc2c1ccc(OC(C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)c2	(2S)-2-[2-(2-oxo-4-propylchromen-7-yl)oxypropanoylamino]-3-phenylpropanoic acid			3.224540000000001													MCULE-6578727927	423.46995		423.168188	6	2	9	3			45									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(16399528)	16399528	4.1	161			[#6]-[#6]-[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6](-[#6])-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]):[#6]:2	CCCc1cc(=O)oc2c1ccc(OC(C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)c2	NKZUWQCOEXYFLA		parent_pubchem_cid	EiM07-16897;AKOS004937602;2-{2-[(2-OXO-4-PROPYL-2H-CHROMEN-7-YL)OXY]PROPANAMIDO}-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[2-(2-oxo-4-propyl-chromen-7-yl)oxypropanoylamino]-3-phenyl-propanoic acid		23429895.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23429895		pluskal_iocb_peptide_Peptide01_A21_id		100	A21		
2.2		0	1225	P1045838	66.4		D42	False	0	15	0	0	13	0	1	3	0	0	-1.0	0.0						O=C(NC(C(=O)O)c1ccccc1)c1ccccc1		2.24		0.0	2.46	CHEMBL1722404		N-acyl-alpha amino acids;Hippuric acids;Benzoyl derivatives;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Benzamides;Benzene and substituted derivatives;Benzenoids;Benzoic acids and derivatives;Benzoyl derivatives;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Hippuric acids;Hippuric acids and derivatives;Hydrocarbon derivatives;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;N-benzylbenzamides;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Secondary carboxylic acid amides	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as n-benzylbenzamides. These are compounds containing a benzamide moiety that is N-linked to a benzyl group.	N-benzylbenzamides		Benzamides	Organic compounds	Aromatic homomonocyclic compounds	N-acyl-amino acid (CHEBI:51569);N-acylglycine (CHEBI:16180);carbonyl compound (CHEBI:36586);carboxamide (CHEBI:37622);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);benzamides (CHEBI:22702);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);benzoic acids (CHEBI:22723);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806);carboxylic acid anion (CHEBI:29067);amino acid (CHEBI:33709);peptide (CHEBI:16670);phenols (CHEBI:33853)		Benzoic acids and derivatives	N-benzylbenzamide;Hippuric acid or derivatives;Hippuric acid;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;Alpha-amino acid or derivatives;Benzoyl;Secondary carboxylic acid amide;Carboxamide group;Monocarboxylic acid or derivatives;Carboxylic acid;Carboxylic acid derivative;Organooxygen compound;Organonitrogen compound;Carbonyl group;Organic nitrogen compound;Hydrocarbon derivative;Organic oxide;Organic oxygen compound;Aromatic homomonocyclic compound	Benzenoids	0.0		(benzoylamino)(phenyl)acetic acid	DTXSID50403128	2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C15H13NO3	C15H13NO3			InChI=1S/C15H13NO3/c17-14(12-9-5-2-6-10-12)16-13(15(18)19)11-7-3-1-4-8-11/h1-10,13H,(H,16,17)(H,18,19)	ACDLFRQZDTZESK-UHFFFAOYSA-N	2-benzamido-2-phenyl-acetic acid	4422109	O=C(NC(C(=O)O)c1ccccc1)c1ccccc1	2-benzamido-2-phenylacetic acid			2.13288													MCULE-6362956028	255.27576	ACID	255.089543	3	2	4	2	0.0		28										False	Shikimates and Phenylpropanoids		False	False	Peptide01		-1.0	Compound(4422109)	4422109	2.5	162		SCHEMBL1649573	[#8]=[#6](-[#7]-[#6](-[#6](=[#8])-[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	O=C(NC(C(=O)O)c1ccccc1)c1ccccc1	ACDLFRQZDTZESK		parent_pubchem_cid	(benzoylamino)(phenyl)acetic acid;2-benzamido-2-phenylacetic acid;74536-43-9;2-phenyl-2-(phenylformamido)acetic acid;29670-63-1;2-(benzoylamino)-2-phenylacetic acid;MFCD00666894;SMR000126722;MLS000544965;Bionet2_001416;MLS002206396;SCHEMBL1649573;CHEMBL1722404;DTXSID50403128;ACDLFRQZDTZESK-UHFFFAOYSA-N;HMS1368A08;STK895673;AKOS000264476;AKOS016340002;BENZOYLAMINO-PHENYL-ACETIC ACID;3J-319S;phenyl[(phenylcarbonyl)amino]acetic acid;benzeneacetic acid, .alpha.-(benzoylamino)-;CS-0149807;FT-0683657;EN300-24233;F17497;SR-01000309093;J-501792;SR-01000309093-1;Z85968888;2-benzamido-2-phenyl-acetic acid	False	1036853.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=1036853		pluskal_iocb_peptide_Peptide01_A21_id		100	A21	False	
2.6		0	2	P1045807	66.4		E1	False	0	13	0	2	15	0	1	3	0	0		0.0						CC(C)CC(NC(=O)c1cc(F)c(F)cc1)C(=O)O																							0.0		2-[(3,4-DIFLUOROPHENYL)FORMAMIDO]-4-METHYLPENTANOIC ACID		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C13H15F2NO3	C13H15F2NO3			InChI=1S/C13H15F2NO3/c1-7(2)5-11(13(18)19)16-12(17)8-3-4-9(14)10(15)6-8/h3-4,6-7,11H,5H2,1-2H3,(H,16,17)(H,18,19)	BMPTYIBUFGHYKS-UHFFFAOYSA-N	2-[(3,4-difluorobenzoyl)amino]-4-methyl-pentanoic acid	18070022	CC(C)CC(NC(=O)c1cc(F)c(F)cc1)C(=O)O	2-[(3,4-difluorobenzoyl)amino]-4-methylpentanoic acid			2.13919													MCULE-5083195748	271.2662		271.102	3	2	5	1			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(18070022)	18070022	2.7	163			[#6]-[#6](-[#6])-[#6]-[#6](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6](-[#9]):[#6](-[#9]):[#6]:[#6]:1)-[#6](=[#8])-[#8]	CC(C)CC(NC(=O)c1cc(F)c(F)cc1)C(=O)O	BMPTYIBUFGHYKS		parent_pubchem_cid	2-[(3,4-DIFLUOROPHENYL)FORMAMIDO]-4-METHYLPENTANOIC ACID;1105577-40-9;2-[(3,4-difluorobenzoyl)amino]-4-methylpentanoic acid;MFCD09808884;AKOS000161580;AKOS016352680;NS-04358;2-[(3,4-difluorobenzoyl)amino]-4-methyl-pentanoic acid		23106924.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23106924		pluskal_iocb_peptide_Peptide01_A21_id		100	A21		
3.4		0	90	P0120630100	106.7		E2	False	0	24	0	0	22	0	2	6	0	0		0.0						COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)COc1cc2c(cc1)c(C)cc(=O)o2								Alpha amino acid esters;Coumarins and derivatives;1-benzopyrans;3-alkylindoles;Pyranones and derivatives;Alkyl aryl ethers;Fatty acid esters;Substituted pyrroles;Benzenoids;Methyl esters;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactones;Oxacyclic compounds;Monocarboxylic acids and derivatives;Azacyclic compounds;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organonitrogen compounds;Organopnictogen compounds	1-benzopyrans;3-alkylindoles;Alkyl aryl ethers;Alpha amino acid esters;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;Ethers;Fatty Acyls;Fatty acid esters;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Lactones;Lipids and lipid-like molecules;Methyl esters;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acyl-alpha amino acids and derivatives. These are compounds containing an alpha amino acid (or a derivative thereof) which bears an acyl group at its terminal nitrogen atom.	N-acyl-alpha amino acids and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	alpha-amino acid ester (CHEBI:46874);coumarins (CHEBI:23403);1-benzopyran (CHEBI:38443);indoles (CHEBI:24828);pyranone (CHEBI:37963);aromatic ether (CHEBI:35618);fatty acid ester (CHEBI:35748);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);carboxylic ester (CHEBI:33308);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactone (CHEBI:25000);oxacycle (CHEBI:38104);carbonyl compound (CHEBI:36586);organonitrogen heterocyclic compound (CHEBI:38101);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);N-acyl-amino acid (CHEBI:51569);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);amino acid (CHEBI:33709);peptide (CHEBI:16670);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);pyrans (CHEBI:26407);oxygen molecular entity (CHEBI:25806);ether (CHEBI:25698);lipid (CHEBI:18059);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)	Fatty esters (FA07);Benzopyranoids (PK1311);Fatty Acyls (FA)	Amino acids, peptides, and analogues	Alpha-amino acid ester;N-acyl-alpha amino acid or derivatives;Coumarin;Benzopyran;1-benzopyran;3-alkylindole;Indole;Indole or derivatives;Alkyl aryl ether;Fatty acid ester;Pyranone;Fatty acyl;Pyran;Substituted pyrrole;Benzenoid;Methyl ester;Pyrrole;Heteroaromatic compound;Secondary carboxylic acid amide;Carboxamide group;Carboxylic acid ester;Lactone;Monocarboxylic acid or derivatives;Oxacycle;Ether;Organoheterocyclic compound;Azacycle;Organic oxygen compound;Hydrocarbon derivative;Organic oxide;Organopnictogen compound;Carbonyl group;Organonitrogen compound;Organooxygen compound;Organic nitrogen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		methyl N-{[(4-methyl-2-oxo-2H-chromen-7-yl)oxy]acetyl}tryptophanate		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C24H22N2O6	C24H22N2O6			InChI=1S/C24H22N2O6/c1-14-9-23(28)32-21-11-16(7-8-17(14)21)31-13-22(27)26-20(24(29)30-2)10-15-12-25-19-6-4-3-5-18(15)19/h3-9,11-12,20,25H,10,13H2,1-2H3,(H,26,27)	NLPNTCULNCBQAK-UHFFFAOYSA-N	methyl 3-(1H-indol-3-yl)-2-[[2-(4-methyl-2-oxo-chromen-7-yl)oxyacetyl]amino]propanoate	2787175	COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)COc1cc2c(cc1)c(C)cc(=O)o2	methyl 3-(1H-indol-3-yl)-2-[[2-(4-methyl-2-oxochromen-7-yl)oxyacetyl]amino]propanoate			2.33324													MCULE-1468134708	434.45274		434.147786	6	2	8	4			45									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(2787175)	2787175	3.2	164			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#6](=[#8])-[#6]-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#6](-[#6]):[#6]:[#6](=[#8]):[#8]:2	COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)COc1cc2c(cc1)c(C)cc(=O)o2	NLPNTCULNCBQAK		parent_pubchem_cid	methyl N-{[(4-methyl-2-oxo-2H-chromen-7-yl)oxy]acetyl}tryptophanate;1397006-35-7;CBDivE_012439;STL526540;AKOS001596400;AKOS016311026;EU-0035329;SR-01000079085;SR-01000079085-1;METHYL 3-(1H-INDOL-3-YL)-2-({[(4-METHYL-2-OXO-2H-CHROMEN-7-YL)OXY]ACETYL}AMINO)PROPANOATE;methyl 3-(1H-indol-3-yl)-2-[[2-(4-methyl-2-oxo-chromen-7-yl)oxyacetyl]amino]propanoate		23344415.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23344415		pluskal_iocb_peptide_Peptide01_A21_id		100	A21		
3.4		0	178	P7014610746	75.1		E3	False	1	22	0	0	17	0	4	2	0	0		0.0						O=c1[nH]ncc(NN=Cc2c(OCc3ccccc3)ccc3ccccc23)c1Br																							0.0		STK917979		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C22H17BrN4O2	C22H17BrN4O2			InChI=1S/C22H17BrN4O2/c23-21-19(13-25-27-22(21)28)26-24-12-18-17-9-5-4-8-16(17)10-11-20(18)29-14-15-6-2-1-3-7-15/h1-13H,14H2,(H2,26,27,28)/b24-12-	ZBLIITKZFXILAH-MSXFZWOLSA-N	4-[(2Z)-2-[(2-benzyloxy-1-naphthyl)methylene]hydrazino]-5-bromo-1H-pyridazin-6-one	5916187	O=c1[nH]ncc(N/N=C\c2c(OCc3ccccc3)ccc3ccccc23)c1Br	5-bromo-4-[(2Z)-2-[(2-phenylmethoxynaphthalen-1-yl)methylidene]hydrazinyl]-1H-pyridazin-6-one			4.229630000000003													MCULE-6845450117	449.31039		448.053488	5	2	6	4			44										False					Peptide01			Compound(5916187)	5916187	4.7	165			[#8]=[#6]1:[#7H]:[#7]:[#6]:[#6](-[#7]/[#7]=[#6]\[#6]2:[#6](-[#8]-[#6]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#6]:[#6]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:1-[#35]	O=c1[nH]ncc(N/N=C\c2c(OCc3ccccc3)ccc3ccccc23)c1Br	ZBLIITKZFXILAH		parent_pubchem_cid	STK917979;AKOS002259363;5-[(2Z)-2-{[2-(benzyloxy)naphthalen-1-yl]methylidene}hydrazinyl]-4-bromopyridazin-3(2H)-one;4-[(2Z)-2-[(2-benzyloxy-1-naphthyl)methylene]hydrazino]-5-bromo-1H-pyridazin-6-one		8496604.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=8496604		pluskal_iocb_peptide_Peptide01_A21_id		100	A21		ZINC000012374207
4.9		0	266	P1305571	54.1		E4	False	0	23	0	0	28	0	2	2	0	0		0.0						CCC(CC)C(=O)NCC(c1ccc(OC)cc1)c1c[nH]c2ccccc12																							0.0		2-ethyl-N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]butanamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C23H28N2O2	C23H28N2O2			InChI=1S/C23H28N2O2/c1-4-16(5-2)23(26)25-14-20(17-10-12-18(27-3)13-11-17)21-15-24-22-9-7-6-8-19(21)22/h6-13,15-16,20,24H,4-5,14H2,1-3H3,(H,25,26)	XNLXGSGSALUNCM-UHFFFAOYSA-N	2-ethyl-N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]butanamide	17014708	CCC(CC)C(=O)NCC(c1ccc(OC)cc1)c1c[nH]c2ccccc12	2-ethyl-N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]butanamide			3.8605500000000026													MCULE-3217123405	364.49181		364.215078	2	2	8	3			44										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(17014708)	17014708	4.8	166			[#6]-[#6]-[#6](-[#6]-[#6])-[#6](=[#8])-[#7]-[#6]-[#6](-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CCC(CC)C(=O)NCC(c1ccc(OC)cc1)c1c[nH]c2ccccc12	XNLXGSGSALUNCM		parent_pubchem_cid	2-ethyl-N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]butanamide;STL207671;AKOS002335087;AKOS016326740		24419319.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24419319		pluskal_iocb_peptide_Peptide01_A21_id		100	A21		
3.7		0	10	P1150019	53.1		E5	False	0	17	0	0	15	0	1	2	0	0		0.0						O=C(O)C(Cc1c[nH]c2ccccc12)c1ccccc1																							0.0		3-(1H-indol-3-yl)-2-phenylpropanoic acid		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C17H15NO2	C17H15NO2			InChI=1S/C17H15NO2/c19-17(20)15(12-6-2-1-3-7-12)10-13-11-18-16-9-5-4-8-14(13)16/h1-9,11,15,18H,10H2,(H,19,20)	DMMKMFFBADAPJB-UHFFFAOYSA-N	3-(1H-indol-3-yl)-2-phenyl-propanoic acid	71683616	O=C(O)C(Cc1c[nH]c2ccccc12)c1ccccc1	3-(1H-indol-3-yl)-2-phenylpropanoic acid			3.040960000000002													MCULE-8922709650	265.3146		265.110279	2	2	4	3			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(71683616)	71683616	3.7	167			[#8]=[#6](-[#8])-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	O=C(O)C(Cc1c[nH]c2ccccc12)c1ccccc1	DMMKMFFBADAPJB		parent_pubchem_cid	3-(1H-indol-3-yl)-2-phenylpropanoic acid;1018594-63-2;MFCD10035546;AKOS016401600;NS-04177;3-(1H-indol-3-yl)-2-phenyl-propanoic acid		44281222.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=44281222		pluskal_iocb_peptide_Peptide01_A21_id		100	A21		
2.6		0	98	P7010200028	81.8		E6	False	0	18	0	0	16	0	4	0	0	1	-1.0	0.0						Cc1c(C(Nc2nccs2)c2ccncc2)c2ccccc2[nH]1		4.53		0.0	3.38	CHEMBL1608667																	0.0		307543-54-0		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0		C18H16N4S	C18H16N4S			InChI=1S/C18H16N4S/c1-12-16(14-4-2-3-5-15(14)21-12)17(13-6-8-19-9-7-13)22-18-20-10-11-23-18/h2-11,17,21H,1H3,(H,20,22)	ZHSXKDYZIMWDFM-UHFFFAOYSA-N	N-[(2-methyl-1H-indol-3-yl)-(4-pyridyl)methyl]thiazol-2-amine	5066771	Cc1c(C(Nc2nccs2)c2ccncc2)c2ccccc2[nH]1	N-[(2-methyl-1H-indol-3-yl)-pyridin-4-ylmethyl]-1,3-thiazol-2-amine			3.556160000000002													MCULE-5540889177	320.41902	NEUTRAL	320.109568	3	2	4	4	0.0		29									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids	False	False	Peptide01		-1.0	Compound(5066771)	5066771	3.9	168			[#6]-[#6]1:[#6](-[#6](-[#7]-[#6]2:[#7]:[#6]:[#6]:[#16]:2)-[#6]2:[#6]:[#6]:[#7]:[#6]:[#6]:2):[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#7H]:1	Cc1c(C(Nc2nccs2)c2ccncc2)c2ccccc2[nH]1	ZHSXKDYZIMWDFM		parent_pubchem_cid	307543-54-0;N-[(2-methyl-1H-indol-3-yl)-pyridin-4-ylmethyl]-1,3-thiazol-2-amine;Oprea1_108673;Oprea1_294103;MLS000416297;CHEMBL1608667;HMS2563E23;MFCD02165961;ZINC03851485;AKOS000811453;AKOS016302683;N-[(2-methyl-1H-indol-3-yl)(pyridin-4-yl)methyl]-1,3-thiazol-2-amine;SMR000264117;EU-0039665;SR-01000445617;SR-01000445617-1;Z56800455;F0815-0084;N-((2-methyl-1H-indol-3-yl)(pyridin-4-yl)methyl)thiazol-2-amine;N-[(2-methyl-1H-indol-3-yl)-(4-pyridyl)methyl]thiazol-2-amine	False	904970.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=904970		pluskal_iocb_peptide_Peptide01_A22_id		100	A22	False	ZINC03851485
3.1		0	186	P7020600686	122.1		E7	False	0	22	0	0	26	0	2	5	0	2		0.0						COc1c(C)cc(S(=O)(=O)C2CS(=O)(=O)CC2NCCc2c[nH]c3ccccc23)cc1																							0.0		AKOS002370675		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	0		C22H26N2O5S2	C22H26N2O5S2			InChI=1S/C22H26N2O5S2/c1-15-11-17(7-8-21(15)29-2)31(27,28)22-14-30(25,26)13-20(22)23-10-9-16-12-24-19-6-4-3-5-18(16)19/h3-8,11-12,20,22-24H,9-10,13-14H2,1-2H3/t20-,22-/m0/s1	PPCHMKCHKYFAOI-UNMCSNQZSA-N	rac-(3S,4R)-N-[2-(1H-indol-3-yl)ethyl]-4-(4-methoxy-3-methyl-phenyl)sulfonyl-1,1-dioxo-thiolan-3-amine	17598522	COc1c(C)cc(S(=O)(=O)[C@H]2CS(=O)(=O)C[C@@H]2NCCc2c[nH]c3ccccc23)cc1	(3S,4R)-N-[2-(1H-indol-3-yl)ethyl]-4-(4-methoxy-3-methylphenyl)sulfonyl-1,1-dioxothiolan-3-amine			1.1482600000000007													MCULE-4049485951	462.59092		462.128314	6	2	7	4			44										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(17598522)	17598522	3.0	169			[#6]-[#8]-[#6]1:[#6](-[#6]):[#6]:[#6](-[#16](=[#8])(=[#8])-[#6@H]2-[#6]-[#16](=[#8])(=[#8])-[#6]-[#6@@H]-2-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	COc1c(C)cc(S(=O)(=O)[C@H]2CS(=O)(=O)C[C@@H]2NCCc2c[nH]c3ccccc23)cc1	PPCHMKCHKYFAOI		parent_pubchem_cid	AKOS002370675;rac-(3S,4R)-N-[2-(1H-indol-3-yl)ethyl]-4-(4-methoxy-3-methyl-phenyl)sulfonyl-1,1-dioxo-thiolan-3-amine		3922003.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=3922003		pluskal_iocb_peptide_Peptide01_A22_id		100	A22		ZINC000019821014
3.4		0	274	P1581158	75.2	HCl	E8	False	0	19	0	2	18	0	6	1	0	0		0.0						Fc1cccc(Nc2nc(Nc3ccccc3F)nc(N3CCOCC3)n2)c1																							0.0		AKOS022132455		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1		C19H19ClF2N6O	C19H18F2N6O			InChI=1S/C19H18F2N6O/c20-13-4-3-5-14(12-13)22-17-24-18(23-16-7-2-1-6-15(16)21)26-19(25-17)27-8-10-28-11-9-27/h1-7,12H,8-11H2,(H2,22,23,24,25,26)	BZPSPRCKSLUNLL-UHFFFAOYSA-N	N2-(2-fluorophenyl)-N4-(3-fluorophenyl)-6-morpholino-1,3,5-triazine-2,4-diamine;hydrochloride	18580377	Fc1cccc(Nc2nc(Nc3ccccc3F)nc(N3CCOCC3)n2)c1	2-N-(2-fluorophenyl)-4-N-(3-fluorophenyl)-6-morpholin-4-yl-1,3,5-triazine-2,4-diamine			1.57055													MCULE-8996678363	420.85268		384.151016	7	2	5	4			43									Carboline alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(18580377)	18580377	4.0	170			[#9]-[#6]1:[#6]:[#6]:[#6]:[#6](-[#7]-[#6]2:[#7]:[#6](-[#7]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3-[#9]):[#7]:[#6](-[#7]3-[#6]-[#6]-[#8]-[#6]-[#6]-3):[#7]:2):[#6]:1	Fc1cccc(Nc2nc(Nc3ccccc3F)nc(N3CCOCC3)n2)c1	BZPSPRCKSLUNLL		parent_pubchem_cid	"AKOS022132455;""N2-(2-fluorophenyl)-N4-(3-fluorophenyl)-6-morpholino-1,3,5-triazine-2,4-diamine;hydrochloride"""		3018636.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=3018636		pluskal_iocb_peptide_Peptide01_A22_id		100	A22		ZINC000009762078
2.3		0	18	P11186728	95.5		E9	False	0	18	0	0	18	0	2	4	0	0	-1.0	0.0						CCC(NC(=O)c1ccccc1NC(=O)c1ccccc1)C(=O)O		2.53		0.0	3.36	CHEMBL1314115																	0.0		2-{[2-(benzoylamino)benzoyl]amino}butanoic acid		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C18H18N2O4	C18H18N2O4			InChI=1S/C18H18N2O4/c1-2-14(18(23)24)19-17(22)13-10-6-7-11-15(13)20-16(21)12-8-4-3-5-9-12/h3-11,14H,2H2,1H3,(H,19,22)(H,20,21)(H,23,24)	FZAKTGJDHKFYOP-UHFFFAOYSA-N	2-[(2-benzamidobenzoyl)amino]butanoic acid	3245012	CCC(NC(=O)c1ccccc1NC(=O)c1ccccc1)C(=O)O	2-[(2-benzamidobenzoyl)amino]butanoic acid			2.04187													MCULE-6151741971	326.35516	ACID	326.126657	4	3	6	2	0.0		30									Anthranillic acid derivatives;Dipeptides	False	Alkaloids;Amino acids and Peptides	Anthranilic acid alkaloids;Small peptides	False	False	Peptide01		-1.0	Compound(3245012)	3245012	3.1	171			[#6]-[#6]-[#6](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	CCC(NC(=O)c1ccccc1NC(=O)c1ccccc1)C(=O)O	FZAKTGJDHKFYOP		parent_pubchem_cid	2-{[2-(benzoylamino)benzoyl]amino}butanoic acid;MLS000088458;CHEMBL1314115;HMS2487L05;MFCD00970304;AKOS003320349;SMR000024078;EU-0005171;SR-01000108735;SR-01000108735-1;2-[(2-benzamidobenzoyl)amino]butanoic acid	False	909740.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=909740		pluskal_iocb_peptide_Peptide01_A22_id		100	A22	False	
3.6		0	106	P0112160059	96.6		E10	False	0	20	0	0	22	0	2	4	0	1		0.0						CCOC(=O)C(Cc1c[nH]c2ccccc12)NS(=O)(=O)c1ccc(C)cc1								P-toluenesulfonamides;3-alkylindoles;Benzenesulfonamides;Benzenesulfonyl compounds;Fatty acid esters;Substituted pyrroles;Organosulfonamides;Aminosulfonyl compounds;Heteroaromatic compounds;Carboxylic acid esters;Monocarboxylic acids and derivatives;Azacyclic compounds;Carbonyl compounds;Organic oxides;Organonitrogen compounds;Organopnictogen compounds;Hydrocarbon derivatives	3-alkylindoles;Alpha amino acid esters;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Aminosulfonyl compounds;Azacyclic compounds;Benzene and substituted derivatives;Benzenesulfonamides;Benzenesulfonyl compounds;Benzenoids;Carbonyl compounds;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids and derivatives;Chemical entities;Fatty Acyls;Fatty acid esters;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Lipids and lipid-like molecules;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organic sulfonic acids and derivatives;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Organosulfonamides;Organosulfonic acids and derivatives;Organosulfur compounds;P-toluenesulfonamides;Pyrroles;Substituted pyrroles;Sulfonyls;Toluenes;Tosyl compounds	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as alpha amino acid esters. These are ester derivatives of alpha amino acids.	Alpha amino acid esters		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	sulfonamide (CHEBI:35358);indoles (CHEBI:24828);benzenes (CHEBI:22712);organosulfur compound (CHEBI:33261);fatty acid ester (CHEBI:35748);pyrroles (CHEBI:26455);organonitrogen compound (CHEBI:35352);organic aromatic compound (CHEBI:33659);carboxylic ester (CHEBI:33308);carbonyl compound (CHEBI:36586);organonitrogen heterocyclic compound (CHEBI:38101);organic oxide (CHEBI:25701);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organic molecule (CHEBI:72695);alpha-amino acid ester (CHEBI:46874);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);toluenes (CHEBI:27024);sulfonic acid derivative (CHEBI:33552);organic heterocyclic compound (CHEBI:24532);lipid (CHEBI:18059);organooxygen compound (CHEBI:36963);sulfone (CHEBI:35850);oxygen molecular entity (CHEBI:25806);nitrogen molecular entity (CHEBI:51143);amino acid (CHEBI:33709);peptide (CHEBI:16670)	Fatty esters (FA07);Fatty Acyls (FA)	Amino acids, peptides, and analogues	Alpha-amino acid ester;P-toluenesulfonamide;Benzenesulfonamide;Tosyl compound;3-alkylindole;Indole;Benzenesulfonyl group;Indole or derivatives;Fatty acid ester;Toluene;Monocyclic benzene moiety;Substituted pyrrole;Organosulfonic acid amide;Fatty acyl;Benzenoid;Heteroaromatic compound;Sulfonyl;Aminosulfonyl compound;Organosulfonic acid or derivatives;Organic sulfonic acid or derivatives;Pyrrole;Carboxylic acid ester;Monocarboxylic acid or derivatives;Organoheterocyclic compound;Azacycle;Organosulfur compound;Organooxygen compound;Organonitrogen compound;Hydrocarbon derivative;Organic oxide;Organopnictogen compound;Organic nitrogen compound;Organic oxygen compound;Carbonyl group;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		STL227956		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0		C20H22N2O4S	C20H22N2O4S			InChI=1S/C20H22N2O4S/c1-3-26-20(23)19(12-15-13-21-18-7-5-4-6-17(15)18)22-27(24,25)16-10-8-14(2)9-11-16/h4-11,13,19,21-22H,3,12H2,1-2H3	YCNXJLYOYVQVPB-UHFFFAOYSA-N	ethyl 3-(1H-indol-3-yl)-2-(p-tolylsulfonylamino)propanoate	2787440	CCOC(=O)C(Cc1c[nH]c2ccccc12)NS(=O)(=O)c1ccc(C)cc1	ethyl 3-(1H-indol-3-yl)-2-[(4-methylphenyl)sulfonylamino]propanoate			2.28317													MCULE-2401881732	386.47334		386.130028	4	2	8	3			45										False					Peptide01			Compound(2787440)	2787440	3.7	172			[#6]-[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#16](=[#8])(=[#8])-[#6]1:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:1	CCOC(=O)C(Cc1c[nH]c2ccccc12)NS(=O)(=O)c1ccc(C)cc1	YCNXJLYOYVQVPB		parent_pubchem_cid	STL227956;AKOS000536463;AKOS016308970;ethyl N-[(4-methylphenyl)sulfonyl]tryptophanate;SR-01000405335;SR-01000405335-1;ethyl 3-(1H-indol-3-yl)-2-(p-tolylsulfonylamino)propanoate		24561945.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24561945		pluskal_iocb_peptide_Peptide01_A22_id		100	A22		
3.7		0	194	P1182790	106.3		E11	False	0	25	0	0	26	0	4	2	0	1		0.0						O=C(CCC(=O)N1CCCC1c1nc2ccccc2s1)NCCc1c[nH]c2ccccc12																							0.0		AKOS016398907		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C25H26N4O2S	C25H26N4O2S			InChI=1S/C25H26N4O2S/c30-23(26-14-13-17-16-27-19-7-2-1-6-18(17)19)11-12-24(31)29-15-5-9-21(29)25-28-20-8-3-4-10-22(20)32-25/h1-4,6-8,10,16,21,27H,5,9,11-15H2,(H,26,30)	CJMMBUSNZYNGGW-UHFFFAOYSA-N	4-[2-(1,3-benzothiazol-2-yl)pyrrolidin-1-yl]-N-[2-(1H-indol-3-yl)ethyl]-4-oxo-butanamide	52984216	O=C(CCC(=O)N1CCCC1c1nc2ccccc2s1)NCCc1c[nH]c2ccccc12	4-[2-(1,3-benzothiazol-2-yl)pyrrolidin-1-yl]-N-[2-(1H-indol-3-yl)ethyl]-4-oxobutanamide			3.613940000000002													MCULE-9205345484	446.57557		446.177647	3	2	7	5			45										False	Alkaloids				Peptide01			Compound(52984216)	52984216	3.5	173			[#8]=[#6](-[#6]-[#6]-[#6](=[#8])-[#7]1-[#6]-[#6]-[#6]-[#6]-1-[#6]1:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#16]:1)-[#7]-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	O=C(CCC(=O)N1CCCC1c1nc2ccccc2s1)NCCc1c[nH]c2ccccc12	CJMMBUSNZYNGGW		parent_pubchem_cid	AKOS016398907;4-[2-(1,3-benzothiazol-2-yl)pyrrolidin-1-yl]-N-[2-(1H-indol-3-yl)ethyl]-4-oxo-butanamide		24689208.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24689208		pluskal_iocb_peptide_Peptide01_A22_id		100	A22		
3.6		0	282	P7126261	90.4		E12	False	0	22	0	0	23	0	5	2	0	0		0.0						O=C(O)c1cc(Nc2nc(Nc3ccc(N4CCCCC4)cc3)ncc2)ccc1																							0.0		MFCD29050695		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1		C22H23N5O2	C22H23N5O2			InChI=1S/C22H23N5O2/c28-21(29)16-5-4-6-18(15-16)24-20-11-12-23-22(26-20)25-17-7-9-19(10-8-17)27-13-2-1-3-14-27/h4-12,15H,1-3,13-14H2,(H,28,29)(H2,23,24,25,26)	CIQJAVMXRZRJKO-UHFFFAOYSA-N	3-[[2-[4-(1-piperidyl)anilino]pyrimidin-4-yl]amino]benzoic acid	90489123	O=C(O)c1cc(Nc2nc(Nc3ccc(N4CCCCC4)cc3)ncc2)ccc1	3-[[2-(4-piperidin-1-ylanilino)pyrimidin-4-yl]amino]benzoic acid			2.694540000000001													MCULE-9385182210	389.46091		389.185175	7	3	6	4			44									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(90489123)	90489123	4.4	174			[#8]=[#6](-[#8])-[#6]1:[#6]:[#6](-[#7]-[#6]2:[#7]:[#6](-[#7]-[#6]3:[#6]:[#6]:[#6](-[#7]4-[#6]-[#6]-[#6]-[#6]-[#6]-4):[#6]:[#6]:3):[#7]:[#6]:[#6]:2):[#6]:[#6]:[#6]:1	O=C(O)c1cc(Nc2nc(Nc3ccc(N4CCCCC4)cc3)ncc2)ccc1	CIQJAVMXRZRJKO		parent_pubchem_cid	MFCD29050695;AKOS024459031;3-[[2-[4-(1-piperidyl)anilino]pyrimidin-4-yl]amino]benzoic acid		99993844.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=99993844		pluskal_iocb_peptide_Peptide01_A22_id		100	A22		ZINC000170621812
2.4		0	26	P7119250017	136.7		E13	False	0	22	0	0	17	0	3	5	0	1		0.0						O=C1Nc2c3c1cccc3c(S(=O)(=O)NC(Cc1c[nH]c3ccccc13)C(=O)O)cc2																							0.0		N-[(2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)sulfonyl]tryptophan		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	2	0	0	1	0	0	0	0	0	0	0		C22H17N3O5S	C22H17N3O5S			InChI=1S/C22H17N3O5S/c26-21-15-6-3-5-14-19(9-8-17(24-21)20(14)15)31(29,30)25-18(22(27)28)10-12-11-23-16-7-2-1-4-13(12)16/h1-9,11,18,23,25H,10H2,(H,24,26)(H,27,28)	VQZGXLPNABQRGS-UHFFFAOYSA-N	3-(1H-indol-3-yl)-2-[(2-oxo-1H-benzo[cd]indol-6-yl)sulfonylamino]propanoic acid	3899747	O=C1Nc2c3c1cccc3c(S(=O)(=O)NC(Cc1c[nH]c3ccccc13)C(=O)O)cc2	3-(1H-indol-3-yl)-2-[(2-oxo-1H-benzo[cd]indol-6-yl)sulfonylamino]propanoic acid			1.4061199999999994													MCULE-8867999456	435.46189		435.088892	5	4	6	5			44									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(3899747)	3899747	2.8	175			[#8]=[#6]1-[#7]-[#6]2:[#6]3:[#6]-1:[#6]:[#6]:[#6]:[#6]:3:[#6](-[#16](=[#8])(=[#8])-[#7]-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:1:3)-[#6](=[#8])-[#8]):[#6]:[#6]:2	O=C1Nc2c3c1cccc3c(S(=O)(=O)NC(Cc1c[nH]c3ccccc13)C(=O)O)cc2	VQZGXLPNABQRGS		parent_pubchem_cid	N-[(2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)sulfonyl]tryptophan;AG-690/10785022;AKOS001680674;SR-01000088013;SR-01000088013-1;3-(1H-indol-3-yl)-2-[(2-oxo-1H-benzo[cd]indol-6-yl)sulfonylamino]propanoic acid		23442227.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23442227		pluskal_iocb_peptide_Peptide01_A22_id		100	A22		
3.4		0	114	P7211800088	127.2		E14	False	0	22	1	0	24	0	1	6	0	1	-1.0	0.0						COc1c(OC)cc(C(=O)CC(SCC(NC(C)=O)C(=O)O)c2ccc(Cl)cc2)cc1		3.99		0.0	3.01	CHEMBL1425963																	0.0		MLS001173057		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C22H24ClNO6S	C22H24ClNO6S			InChI=1S/C22H24ClNO6S/c1-13(25)24-17(22(27)28)12-31-21(14-4-7-16(23)8-5-14)11-18(26)15-6-9-19(29-2)20(10-15)30-3/h4-10,17,21H,11-12H2,1-3H3,(H,24,25)(H,27,28)	NXSBVCGZBRRWPU-UHFFFAOYSA-N	2-acetamido-3-[1-(4-chlorophenyl)-3-(3,4-dimethoxyphenyl)-3-oxo-propyl]sulfanyl-propanoic acid	3331087	COc1c(OC)cc(C(=O)CC(SCC(NC(C)=O)C(=O)O)c2ccc(Cl)cc2)cc1	2-acetamido-3-[1-(4-chlorophenyl)-3-(3,4-dimethoxyphenyl)-3-oxopropyl]sulfanylpropanoic acid			2.9595600000000006													MCULE-8892875763	465.95668	ACID	465.101286	7	2	11	2	0.0		30										False	Shikimates and Phenylpropanoids		False	False	Peptide01		-1.0	Compound(3331087)	3331087	3.2	176			[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]):[#6]:[#6](-[#6](=[#8])-[#6]-[#6](-[#16]-[#6]-[#6](-[#7]-[#6](-[#6])=[#8])-[#6](=[#8])-[#8])-[#6]2:[#6]:[#6]:[#6](-[#17]):[#6]:[#6]:2):[#6]:[#6]:1	COc1c(OC)cc(C(=O)CC(SCC(NC(C)=O)C(=O)O)c2ccc(Cl)cc2)cc1	NXSBVCGZBRRWPU		parent_pubchem_cid	MLS001173057;CHEMBL1425963;HMS2879G12;AKOS000808792;AKOS016374414;SMR000588393;Z56804163;F1031-0092;2-acetamido-3-((1-(4-chlorophenyl)-3-(3,4-dimethoxyphenyl)-3-oxopropyl)thio)propanoic acid;2-acetamido-3-[1-(4-chlorophenyl)-3-(3,4-dimethoxyphenyl)-3-oxo-propyl]sulfanyl-propanoic acid	False	914407.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=914407		pluskal_iocb_peptide_Peptide01_A23_id		100	A23	False	
3.4		0	202	P1109227	71.3		E15	False	0	20	0	1	19	0	2	3	0	0		0.0						O=C(CCn1ccc2c1cc(F)cc2)NC(Cc1ccccc1)C(=O)O																							0.0		AKOS005534824		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C20H19FN2O3	C20H19FN2O3			InChI=1S/C20H19FN2O3/c21-16-7-6-15-8-10-23(18(15)13-16)11-9-19(24)22-17(20(25)26)12-14-4-2-1-3-5-14/h1-8,10,13,17H,9,11-12H2,(H,22,24)(H,25,26)/t17-/m0/s1	NQEDZORQBDRZQV-KRWDZBQOSA-N	rac-(2S)-2-[3-(6-fluoroindol-1-yl)propanoylamino]-3-phenyl-propanoic acid	24280974	O=C(CCn1ccc2c1cc(F)cc2)N[C@@H](Cc1ccccc1)C(=O)O	(2S)-2-[3-(6-fluoroindol-1-yl)propanoylamino]-3-phenylpropanoic acid			2.4994700000000005													MCULE-2704450909	354.38443		354.137971	3	2	7	3			44										False	Alkaloids				Peptide01			Compound(24280974)	24280974	2.9	177			[#8]=[#6](-[#6]-[#6]-[#7]1:[#6]:[#6]:[#6]2:[#6]:1:[#6]:[#6](-[#9]):[#6]:[#6]:2)-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	O=C(CCn1ccc2c1cc(F)cc2)N[C@@H](Cc1ccccc1)C(=O)O	NQEDZORQBDRZQV		parent_pubchem_cid	AKOS005534824;rac-(2S)-2-[3-(6-fluoroindol-1-yl)propanoylamino]-3-phenyl-propanoic acid		24579433.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24579433		pluskal_iocb_peptide_Peptide01_A23_id		100	A23		ZINC000011866026
2.6		0	290	P7126276	107.4		E16	False	0	18	0	0	16	0	4	3	0	0		0.0						Cc1cc(Nc2ccccc2C(=O)O)nc(Nc2cc(O)ccc2)n1																							0.0		AKOS024459045		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0		C18H16N4O3	C18H16N4O3			InChI=1S/C18H16N4O3/c1-11-9-16(21-15-8-3-2-7-14(15)17(24)25)22-18(19-11)20-12-5-4-6-13(23)10-12/h2-10,23H,1H3,(H,24,25)(H2,19,20,21,22)	QCRWJYLGIRIICG-UHFFFAOYSA-N	2-[[2-(3-hydroxyanilino)-6-methyl-pyrimidin-4-yl]amino]benzoic acid	90489136	Cc1cc(Nc2ccccc2C(=O)O)nc(Nc2cc(O)ccc2)n1	2-[[2-(3-hydroxyanilino)-6-methylpyrimidin-4-yl]amino]benzoic acid			1.5817499999999998													MCULE-6754070783	336.35322		336.12224	7	4	5	3			44									Anthranillic acid derivatives	False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(90489136)	90489136	4.1	178			[#6]-[#6]1:[#6]:[#6](-[#7]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6](=[#8])-[#8]):[#7]:[#6](-[#7]-[#6]2:[#6]:[#6](-[#8]):[#6]:[#6]:[#6]:2):[#7]:1	Cc1cc(Nc2ccccc2C(=O)O)nc(Nc2cc(O)ccc2)n1	QCRWJYLGIRIICG		parent_pubchem_cid	AKOS024459045;2-[[2-(3-hydroxyanilino)-6-methyl-pyrimidin-4-yl]amino]benzoic acid		99993857.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=99993857		pluskal_iocb_peptide_Peptide01_A23_id		100	A23		ZINC000170621825
1.5		0	34	P1157878	161.9		E17	False	0	23	1	0	20	0	3	7	0	0		0.0						O=C(O)CC(NC(=O)C(Cc1cc(=O)[nH]c2ccccc12)NC(=O)c1ccc(Cl)cc1)C(=O)O																							0.0		AKOS016402391		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	2	0	0	0	0	0	0	0	0	4	2	0	0	0	0	0	0	0	0	2	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0		C23H20ClN3O7	C23H20ClN3O7			InChI=1S/C23H20ClN3O7/c24-14-7-5-12(6-8-14)21(31)26-17(22(32)27-18(23(33)34)11-20(29)30)9-13-10-19(28)25-16-4-2-1-3-15(13)16/h1-8,10,17-18H,9,11H2,(H,25,28)(H,26,31)(H,27,32)(H,29,30)(H,33,34)/t17?,18-/m0/s1	MKLDEWFVEYBALZ-ZVAWYAOSSA-N	rac-(2S)-2-[[2-[(4-chlorobenzoyl)amino]-3-(2-oxo-1H-quinolin-4-yl)propanoyl]amino]butanedioic acid	17591398	O=C(O)C[C@H](NC(=O)C(Cc1cc(=O)[nH]c2ccccc12)NC(=O)c1ccc(Cl)cc1)C(=O)O	(2S)-2-[[2-[(4-chlorobenzoyl)amino]-3-(2-oxo-1H-quinolin-4-yl)propanoyl]amino]butanedioic acid			1.92875														485.88475		485.098978	7	5	9	3			46										False					Peptide01			Compound(17591398)	17591398	1.3	179			[#8]=[#6](-[#8])-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6](=[#8]):[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#17]):[#6]:[#6]:1)-[#6](=[#8])-[#8]	O=C(O)C[C@H](NC(=O)C(Cc1cc(=O)[nH]c2ccccc12)NC(=O)c1ccc(Cl)cc1)C(=O)O	MKLDEWFVEYBALZ		parent_pubchem_cid	AKOS016402391;rac-(2S)-2-[[2-[(4-chlorobenzoyl)amino]-3-(2-oxo-1H-quinolin-4-yl)propanoyl]amino]butanedioic acid		24321827.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24321827		pluskal_iocb_peptide_Peptide01_A23_id		100	A23		
3.7		0	122	P7110950714	91.4		E18	False	0	21	0	0	22	0	2	4	0	0	-1.0	0.0						Cc1cc(OCC(=O)NC(Cc2c[nH]c3ccccc23)C(=O)O)c(C)cc1		2.98		0.0	3.54	CHEMBL1309447																	0.0		2-[2-(2,5-dimethylphenoxy)acetamido]-3-(1H-indol-3-yl)propanoicacid		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C21H22N2O4	C21H22N2O4			InChI=1S/C21H22N2O4/c1-13-7-8-14(2)19(9-13)27-12-20(24)23-18(21(25)26)10-15-11-22-17-6-4-3-5-16(15)17/h3-9,11,18,22H,10,12H2,1-2H3,(H,23,24)(H,25,26)	XARTUSSXSHKXQV-UHFFFAOYSA-N	2-[[2-(2,5-dimethylphenoxy)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid	3151742	Cc1cc(OCC(=O)NC(Cc2c[nH]c3ccccc23)C(=O)O)c(C)cc1	2-[[2-(2,5-dimethylphenoxy)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid			1.9206799999999995													MCULE-8833033257	366.42049	ACID	366.157957	4	3	7	3	0.0		30									Dipeptides	False	Amino acids and Peptides	Small peptides	False	False	Peptide01		-1.0	Compound(3151742)	3151742	3.0	180			[#6]-[#6]1:[#6]:[#6](-[#8]-[#6]-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6](=[#8])-[#8]):[#6](-[#6]):[#6]:[#6]:1	Cc1cc(OCC(=O)NC(Cc2c[nH]c3ccccc23)C(=O)O)c(C)cc1	XARTUSSXSHKXQV		parent_pubchem_cid	2-[2-(2,5-dimethylphenoxy)acetamido]-3-(1H-indol-3-yl)propanoicacid;Oprea1_507588;MLS000716058;CHEMBL1309447;HMS2632C05;MFCD03011471;AKOS000535215;AKOS016045058;SMR000277575;EU-0049304;2-[[2-(2,5-dimethylphenoxy)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid	False	786160.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=786160		pluskal_iocb_peptide_Peptide01_A23_id		100	A23	False	
2.6		0	210	P7020531967	122.1		E19	False	0	21	0	0	24	0	2	5	0	2		0.0						COc1ccc(S(=O)(=O)C2CS(=O)(=O)CC2NCCc2c[nH]c3ccccc23)cc1																							0.0		HMS3463B18		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	0		C21H24N2O5S2	C21H24N2O5S2			InChI=1S/C21H24N2O5S2/c1-28-16-6-8-17(9-7-16)30(26,27)21-14-29(24,25)13-20(21)22-11-10-15-12-23-19-5-3-2-4-18(15)19/h2-9,12,20-23H,10-11,13-14H2,1H3/t20-,21-/m0/s1	NHWURLWKNOOTLU-SFTDATJTSA-N	rac-(3S,4R)-N-[2-(1H-indol-3-yl)ethyl]-4-(4-methoxyphenyl)sulfonyl-1,1-dioxo-thiolan-3-amine	20996490	COc1ccc(S(=O)(=O)[C@H]2CS(=O)(=O)C[C@@H]2NCCc2c[nH]c3ccccc23)cc1	(3S,4R)-N-[2-(1H-indol-3-yl)ethyl]-4-(4-methoxyphenyl)sulfonyl-1,1-dioxothiolan-3-amine			0.8945500000000013													MCULE-3811702012	448.56383		448.112664	6	2	7	4			44										False	Alkaloids				Peptide01			Compound(20996490)	20996490	2.6	181			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#16](=[#8])(=[#8])-[#6@H]2-[#6]-[#16](=[#8])(=[#8])-[#6]-[#6@@H]-2-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	COc1ccc(S(=O)(=O)[C@H]2CS(=O)(=O)C[C@@H]2NCCc2c[nH]c3ccccc23)cc1	NHWURLWKNOOTLU		parent_pubchem_cid	HMS3463B18;MFCD10089132;AKOS004926375;CCG-156912;(3S4R)-3-{[2-(1H-INDOL-3-YL)ETHYL]AMINO}-4-(4-METHOXYBENZENESULFONYL)-1LAMBDA6-THIOLANE-11-DIONE;rac-(3S,4R)-N-[2-(1H-indol-3-yl)ethyl]-4-(4-methoxyphenyl)sulfonyl-1,1-dioxo-thiolan-3-amine		19892935.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=19892935		pluskal_iocb_peptide_Peptide01_A23_id		100	A23		ZINC000019797129
2.6		0	298	P6247969	134.4		E20	False	0	22	0	1	21	0	4	4	0	0		0.0						NC(=O)NCCCC(NC(=O)c1cc(-c2ccc(F)cc2)nc2ccccc12)C(=O)O																							0.0		EiM08-22274		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C22H21FN4O4	C22H21FN4O4			InChI=1S/C22H21FN4O4/c23-14-9-7-13(8-10-14)19-12-16(15-4-1-2-5-17(15)26-19)20(28)27-18(21(29)30)6-3-11-25-22(24)31/h1-2,4-5,7-10,12,18H,3,6,11H2,(H,27,28)(H,29,30)(H3,24,25,31)/t18-/m1/s1	WUZZLJPFDHRLJL-GOSISDBHSA-N	rac-(2R)-2-[[2-(4-fluorophenyl)quinoline-4-carbonyl]amino]-5-ureido-pentanoic acid	71964572	NC(=O)NCCC[C@@H](NC(=O)c1cc(-c2ccc(F)cc2)nc2ccccc12)C(=O)O	(2R)-5-(carbamoylamino)-2-[[2-(4-fluorophenyl)quinoline-4-carbonyl]amino]pentanoic acid			1.80925													MCULE-4022137763	424.43547		424.154683	5	4	8	3			44										False	Alkaloids				Peptide01			Compound(71964572)	71964572	2.3	182			[#7]-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]-[#6@@H](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6](-[#6]2:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:2):[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	NC(=O)NCCC[C@@H](NC(=O)c1cc(-c2ccc(F)cc2)nc2ccccc12)C(=O)O	WUZZLJPFDHRLJL		parent_pubchem_cid	EiM08-22274;AKOS016398013;N~5~-(AMINOCARBONYL)-N~2~-{[2-(4-FLUOROPHENYL)QUINOLIN-4-YL]CARBONYL}-D-ORNITHINE;rac-(2R)-2-[[2-(4-fluorophenyl)quinoline-4-carbonyl]amino]-5-ureido-pentanoic acid		24045774.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24045774		pluskal_iocb_peptide_Peptide01_A23_id		100	A23		ZINC000072401610
1.8		0	42	P7020532287	142.0		E21	False	0	22	0	0	25	0	3	5	0	2		0.0						CC(=O)Nc1ccc(S(=O)(=O)C2CS(=O)(=O)CC2NCCc2c[nH]c3ccccc23)cc1																							0.0		HMS3463N20		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	2	0	0	0	0	0	0	0		C22H25N3O5S2	C22H25N3O5S2			InChI=1S/C22H25N3O5S2/c1-15(26)25-17-6-8-18(9-7-17)32(29,30)22-14-31(27,28)13-21(22)23-11-10-16-12-24-20-5-3-2-4-19(16)20/h2-9,12,21-24H,10-11,13-14H2,1H3,(H,25,26)/t21-,22-/m0/s1	GIDAVQIHGCMLHS-VXKWHMMOSA-N	N-[4-[rac-(3R,4S)-4-[2-(1H-indol-3-yl)ethylamino]-1,1-dioxo-thiolan-3-yl]sulfonylphenyl]acetamide	20996503	CC(=O)Nc1ccc(S(=O)(=O)[C@H]2CS(=O)(=O)C[C@@H]2NCCc2c[nH]c3ccccc23)cc1	N-[4-[(3R,4S)-4-[2-(1H-indol-3-yl)ethylamino]-1,1-dioxothiolan-3-yl]sulfonylphenyl]acetamide			0.9261500000000018													MCULE-9789266171	475.58965		475.123563	6	3	7	4			44										False					Peptide01			Compound(20996503)	20996503	1.8	183			[#6]-[#6](=[#8])-[#7]-[#6]1:[#6]:[#6]:[#6](-[#16](=[#8])(=[#8])-[#6@H]2-[#6]-[#16](=[#8])(=[#8])-[#6]-[#6@@H]-2-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	CC(=O)Nc1ccc(S(=O)(=O)[C@H]2CS(=O)(=O)C[C@@H]2NCCc2c[nH]c3ccccc23)cc1	GIDAVQIHGCMLHS		parent_pubchem_cid	HMS3463N20;MFCD10043082;AKOS001564734;CCG-157121;N-(4-{[(3R4S)-4-{[2-(1H-INDOL-3-YL)ETHYL]AMINO}-11-DIOXO-1LAMBDA6-THIOLAN-3-YL]SULFONYL}PHENYL)ACETAMIDE;N-[4-[rac-(3R,4S)-4-[2-(1H-indol-3-yl)ethylamino]-1,1-dioxo-thiolan-3-yl]sulfonylphenyl]acetamide		10986280.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=10986280		pluskal_iocb_peptide_Peptide01_A23_id		100	A23		ZINC000019797317
3.3		0	130	P0112360002	41.9	HCl	E22	False	0	18	0	0	27	0	1	3	0	0		0.0						C=CCc1ccccc1OCC(O)CN1CC(C)OC(C)C1																							0.0		Oprea1_357986		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1		C18H28ClNO3	C18H27NO3			InChI=1S/C18H27NO3/c1-4-7-16-8-5-6-9-18(16)21-13-17(20)12-19-10-14(2)22-15(3)11-19/h4-6,8-9,14-15,17,20H,1,7,10-13H2,2-3H3	VHNWBUCAXBKHCL-UHFFFAOYSA-N	1-(2-allylphenoxy)-3-(2,6-dimethylmorpholin-4-yl)propan-2-ol;hydrochloride	2843779	C=CCc1ccccc1OCC(O)CN1CC(C)OC(C)C1	1-(2,6-dimethylmorpholin-4-yl)-3-(2-prop-2-enylphenoxy)propan-2-ol			1.7468800000000002													MCULE-7074214910	341.88176		305.199094	4	1	7	2			44										False	Polyketides				Peptide01			Compound(2843779)	2843779	3.3	184			[#6]=[#6]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#8]-[#6]-[#6](-[#8])-[#6]-[#7]1-[#6]-[#6](-[#6])-[#8]-[#6](-[#6])-[#6]-1	C=CCc1ccccc1OCC(O)CN1CC(C)OC(C)C1	VHNWBUCAXBKHCL		parent_pubchem_cid	"Oprea1_357986;AKOS001606174;AKOS016286747;AB00083123-01;""1-(2-allylphenoxy)-3-(2,6-dimethylmorpholin-4-yl)propan-2-ol;hydrochloride"""		22781105.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22781105		pluskal_iocb_peptide_Peptide01_A24_id		100	A24		
2.2		0	218	P7020431942	142.4		E23	False	0	21	0	0	23	0	3	6	0	2		0.0						COc1c(S(=O)(=O)NCCc2c[nH]c3ccccc23)cc(N2C(=O)C(C)CS2(=O)=O)cc1																							0.0		AKOS005561692		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	0		C21H23N3O6S2	C21H23N3O6S2			InChI=1S/C21H23N3O6S2/c1-14-13-31(26,27)24(21(14)25)16-7-8-19(30-2)20(11-16)32(28,29)23-10-9-15-12-22-18-6-4-3-5-17(15)18/h3-8,11-12,14,22-23H,9-10,13H2,1-2H3	KXQDJPFWJGVNBJ-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)ethyl]-2-methoxy-5-(4-methyl-1,1,3-trioxo-1,2-thiazolidin-2-yl)benzenesulfonamide	17597325	COc1c(S(=O)(=O)NCCc2c[nH]c3ccccc23)cc(N2C(=O)C(C)CS2(=O)=O)cc1	N-[2-(1H-indol-3-yl)ethyl]-2-methoxy-5-(4-methyl-1,1,3-trioxo-1,2-thiazolidin-2-yl)benzenesulfonamide			0.5758400000000008													MCULE-9556627758	477.56196		477.102827	6	2	7	4			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(17597325)	17597325	2.1	185			[#6]-[#8]-[#6]1:[#6](-[#16](=[#8])(=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6](-[#7]2-[#6](=[#8])-[#6](-[#6])-[#6]-[#16]-2(=[#8])=[#8]):[#6]:[#6]:1	COc1c(S(=O)(=O)NCCc2c[nH]c3ccccc23)cc(N2C(=O)C(C)CS2(=O)=O)cc1	KXQDJPFWJGVNBJ		parent_pubchem_cid	AKOS005561692;N-[2-(1H-indol-3-yl)ethyl]-2-methoxy-5-(4-methyl-1,1,3-trioxo-1,2-thiazolidin-2-yl)benzenesulfonamide		24762686.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24762686		pluskal_iocb_peptide_Peptide01_A24_id		100	A24		
2.2		0	306	P7126240	124.4		E24	False	0	18	0	0	14	0	4	4	0	0		0.0						O=C(O)c1cc(Nc2nc(Nc3ccccc3C(=O)O)ncc2)ccc1																							0.0		AKOS025142288		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	2	2	0	0	0	0	0	0	0	0	0	0	1	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0		C18H14N4O4	C18H14N4O4			InChI=1S/C18H14N4O4/c23-16(24)11-4-3-5-12(10-11)20-15-8-9-19-18(22-15)21-14-7-2-1-6-13(14)17(25)26/h1-10H,(H,23,24)(H,25,26)(H2,19,20,21,22)	MMELOQRIEQIYEP-UHFFFAOYSA-N	2-[[4-(3-carboxyanilino)pyrimidin-2-yl]amino]benzoic acid	91900818	O=C(O)c1cc(Nc2nc(Nc3ccccc3C(=O)O)ncc2)ccc1	2-[[4-(3-carboxyanilino)pyrimidin-2-yl]amino]benzoic acid			1.7283399999999998														350.33668		350.101505	8	4	6	3			45									Anthranillic acid derivatives	False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(91900818)	91900818	3.6	186			[#8]=[#6](-[#8])-[#6]1:[#6]:[#6](-[#7]-[#6]2:[#7]:[#6](-[#7]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3-[#6](=[#8])-[#8]):[#7]:[#6]:[#6]:2):[#6]:[#6]:[#6]:1	O=C(O)c1cc(Nc2nc(Nc3ccccc3C(=O)O)ncc2)ccc1	MMELOQRIEQIYEP		parent_pubchem_cid	AKOS025142288;2-[[4-(3-carboxyanilino)pyrimidin-2-yl]amino]benzoic acid		101553122.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=101553122		pluskal_iocb_peptide_Peptide01_A24_id		100	A24		ZINC000170621795
2.9		0	50	P7114970019	161.7		E25	False	0	19	0	0	14	0	4	6	0	0		0.0						O=C(O)c1cc(Nc2ccccc2C(=O)O)nc(Nc2ccccc2C(=O)O)n1																							0.0		Oprea1_029019		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	3	3	0	0	0	0	0	0	0	0	0	0	1	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0		C19H14N4O6	C19H14N4O6			InChI=1S/C19H14N4O6/c24-16(25)10-5-1-3-7-12(10)20-15-9-14(18(28)29)22-19(23-15)21-13-8-4-2-6-11(13)17(26)27/h1-9H,(H,24,25)(H,26,27)(H,28,29)(H2,20,21,22,23)	XGPGAYNPTTXYNR-UHFFFAOYSA-N	2,6-bis(2-carboxyanilino)pyrimidine-4-carboxylic acid	1583032	O=C(O)c1cc(Nc2ccccc2C(=O)O)nc(Nc2ccccc2C(=O)O)n1	2,6-bis(2-carboxyanilino)pyrimidine-4-carboxylic acid			1.37183													MCULE-5825001130	394.34663		394.091334	10	5	7	3			44									Anthranillic acid derivatives	False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(1583032)	1583032	4.0	187			[#8]=[#6](-[#8])-[#6]1:[#6]:[#6](-[#7]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6](=[#8])-[#8]):[#7]:[#6](-[#7]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6](=[#8])-[#8]):[#7]:1	O=C(O)c1cc(Nc2ccccc2C(=O)O)nc(Nc2ccccc2C(=O)O)n1	XGPGAYNPTTXYNR		parent_pubchem_cid	Oprea1_029019;Oprea1_408733;HMS1615D20;CCG-23643;AKOS001019045;UNM000011036401;SR-01000085135;SR-01000085135-1;2,6-bis(2-carboxyanilino)pyrimidine-4-carboxylic acid		23115465.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23115465		pluskal_iocb_peptide_Peptide01_A24_id		100	A24		ZINC000001796393
3.9		0	138	P0110830248	66.5		E26	False	0	25	0	0	22	0	2	3	0	0		0.0						O=C(NCCc1ccccc1)C(Cc1ccccc1)N1C(=O)c2ccccc2C1=O																							0.0		Cambridge id 5147728		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	2	0		C25H22N2O3	C25H22N2O3			InChI=1S/C25H22N2O3/c28-23(26-16-15-18-9-3-1-4-10-18)22(17-19-11-5-2-6-12-19)27-24(29)20-13-7-8-14-21(20)25(27)30/h1-14,22H,15-17H2,(H,26,28)	KHMKLDUYGAECHP-UHFFFAOYSA-N	2-(1,3-dioxoisoindolin-2-yl)-3-phenyl-N-(2-phenylethyl)propanamide	2787228	O=C(NCCc1ccccc1)C(Cc1ccccc1)N1C(=O)c2ccccc2C1=O	2-(1,3-dioxoisoindol-2-yl)-3-phenyl-N-(2-phenylethyl)propanamide			3.0339600000000013													MCULE-5678506757	398.46569		398.163043	3	1	7	4			45									Phenylethylamines	False	Alkaloids	Tyrosine alkaloids			Peptide01			Compound(2787228)	2787228	4.2	188			[#8]=[#6](-[#7]-[#6]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]1-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6]-1=[#8]	O=C(NCCc1ccccc1)C(Cc1ccccc1)N1C(=O)c2ccccc2C1=O	KHMKLDUYGAECHP		parent_pubchem_cid	Cambridge id 5147728;Oprea1_222929;Oprea1_338472;CBDivE_008861;CCG-46636;2-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-N-phenethyl-3-phenyl-propionamide;AKOS000536266;AKOS016311796;2-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)-3-phenyl-N-(2-phenylethyl)propanamide;EU-0035512;AB00074477-01;SR-01000405665;SR-01000405665-1;SR-01000405665-2;2-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-phenyl-N-(2-phenylethyl)propanamide;2-(1,3-dioxoisoindolin-2-yl)-3-phenyl-N-(2-phenylethyl)propanamide		23481253.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23481253		pluskal_iocb_peptide_Peptide01_A24_id		100	A24		
1.0		0	226	P7020541025	118.2		E27	False	0	13	0	3	11	0	4	3	0	0		0.0						NC(=O)CC(Nc1nc(C(F)(F)F)nc2ccccc12)C(=O)O																							0.0		3-carbamoyl-2-{[2-(trifluoromethyl)quinazolin-4-yl]amino}propanoic acid		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C13H11F3N4O3	C13H11F3N4O3			InChI=1S/C13H11F3N4O3/c14-13(15,16)12-19-7-4-2-1-3-6(7)10(20-12)18-8(11(22)23)5-9(17)21/h1-4,8H,5H2,(H2,17,21)(H,22,23)(H,18,19,20)	WFZQUTAQITZVCO-UHFFFAOYSA-N	4-amino-4-oxo-2-[[2-(trifluoromethyl)quinazolin-4-yl]amino]butanoic acid	16805602	NC(=O)CC(Nc1nc(C(F)(F)F)nc2ccccc12)C(=O)O	4-amino-4-oxo-2-[[2-(trifluoromethyl)quinazolin-4-yl]amino]butanoic acid			0.5253599999999998													MCULE-7441617018	328.25282		328.078325	6	3	6	2			44									Quinazoline alkaloids	False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(16805602)	16805602	1.8	189			[#7]-[#6](=[#8])-[#6]-[#6](-[#7]-[#6]1:[#7]:[#6](-[#6](-[#9])(-[#9])-[#9]):[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	NC(=O)CC(Nc1nc(C(F)(F)F)nc2ccccc12)C(=O)O	WFZQUTAQITZVCO		parent_pubchem_cid	3-carbamoyl-2-{[2-(trifluoromethyl)quinazolin-4-yl]amino}propanoic acid;1093853-51-0;3-carbamoyl-2-{[2-(trifluoromethyl)quinazolin-4-yl]amino}propanoicacid;4-amino-4-oxo-2-[[2-(trifluoromethyl)quinazolin-4-yl]amino]butanoic acid;4-amino-4-oxo-2-((2-(trifluoromethyl)quinazolin-4-yl)amino)butanoic acid;C13H11F3N4O3;MFCD08762137;AKOS002365402;AKOS016327810;F3308-2791		23187981.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23187981		pluskal_iocb_peptide_Peptide01_A24_id		100	A24		
4.6		0	314	P6052631	73.5		E28	False	0	24	0	0	22	0	2	4	0	0		0.0						COC(=O)C(Cc1ccccc1)NC(=O)c1cc2c(cco2)n1Cc1ccccc1								Alpha amino acid esters;N-acyl-alpha amino acids and derivatives;Amphetamines and derivatives;Pyrrole carboxamides;2-heteroaryl carboxamides;Furopyrroles;Fatty acid esters;Substituted pyrroles;Methyl esters;Heteroaromatic compounds;Furans;Secondary carboxylic acid amides;Oxacyclic compounds;Monocarboxylic acids and derivatives;Azacyclic compounds;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organonitrogen compounds	2-heteroaryl carboxamides;Alpha amino acid esters;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids and derivatives;Chemical entities;Fatty Acyls;Fatty acid esters;Furans;Furopyrroles;Heteroaromatic compounds;Hydrocarbon derivatives;Lipids and lipid-like molecules;Methyl esters;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Oxacyclic compounds;Phenethylamines;Phenylalanine and derivatives;Pyrrole carboxamides;Pyrrole carboxylic acids and derivatives;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	alpha-amino acid ester (CHEBI:46874);N-acyl-amino acid (CHEBI:51569);amphetamines (CHEBI:35338);pyrroles (CHEBI:26455);carboxamide (CHEBI:37622);organic aromatic compound (CHEBI:33659);furopyrrole (CHEBI:64471);fatty acid ester (CHEBI:35748);carboxylic ester (CHEBI:33308);furans (CHEBI:24129);oxacycle (CHEBI:38104);monocarboxylic acid (CHEBI:25384);organonitrogen heterocyclic compound (CHEBI:38101);carbonyl compound (CHEBI:36586);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);organooxygen compound (CHEBI:36963);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);primary amine (CHEBI:32877);organic heterocyclic compound (CHEBI:24532);amide (CHEBI:32988);lipid (CHEBI:18059);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143)	Fatty esters (FA07);Fatty Acyls (FA)	Amino acids, peptides, and analogues	Phenylalanine or derivatives;Alpha-amino acid ester;N-acyl-alpha amino acid or derivatives;Amphetamine or derivatives;2-heteroaryl carboxamide;Furopyrrole;Pyrrole-2-carboxamide;Pyrrole-2-carboxylic acid or derivatives;Fatty acid ester;Monocyclic benzene moiety;Fatty acyl;Benzenoid;Substituted pyrrole;Furan;Heteroaromatic compound;Pyrrole;Methyl ester;Carboxylic acid ester;Carboxamide group;Secondary carboxylic acid amide;Azacycle;Oxacycle;Monocarboxylic acid or derivatives;Organoheterocyclic compound;Organooxygen compound;Organonitrogen compound;Organic oxygen compound;Organic nitrogen compound;Hydrocarbon derivative;Carbonyl group;Organic oxide;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS005658427		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C24H22N2O4	C24H22N2O4			InChI=1S/C24H22N2O4/c1-29-24(28)19(14-17-8-4-2-5-9-17)25-23(27)21-15-22-20(12-13-30-22)26(21)16-18-10-6-3-7-11-18/h2-13,15,19H,14,16H2,1H3,(H,25,27)	FAGGPMNNXQGPNB-UHFFFAOYSA-N	methyl 2-[(4-benzylfuro[3,2-b]pyrrole-5-carbonyl)amino]-3-phenyl-propanoate	49655277	COC(=O)C(Cc1ccccc1)NC(=O)c1cc2c(cco2)n1Cc1ccccc1	methyl 2-[(4-benzylfuro[3,2-b]pyrrole-5-carbonyl)amino]-3-phenylpropanoate			3.204150000000001													MCULE-6014603802	402.45394		402.157957	3	1	8	4			45										False	Alkaloids				Peptide01			Compound(49655277)	49655277	4.3	190			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:[#8]:2):[#7]:1-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	COC(=O)C(Cc1ccccc1)NC(=O)c1cc2c(cco2)n1Cc1ccccc1	FAGGPMNNXQGPNB		parent_pubchem_cid	AKOS005658427;methyl 2-[(4-benzylfuro[3,2-b]pyrrole-5-carbonyl)amino]-3-phenyl-propanoate		24075481.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24075481		pluskal_iocb_peptide_Peptide01_A24_id		100	A24		
3.8		0	58	P7113214671	122.9		E29	False	0	22	0	0	22	0	2	3	0	2		0.0						NS(=O)(=O)c1ccc(CCNC(=O)C(Sc2ccccc2)c2ccccc2)cc1								Phenylacetamides;Benzenesulfonyl compounds;Thiophenol ethers;Alkylarylthioethers;Organosulfonamides;Aminosulfonyl compounds;Secondary carboxylic acid amides;Sulfenyl compounds;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alkylarylthioethers;Aminosulfonyl compounds;Aryl thioethers;Benzene and substituted derivatives;Benzenesulfonamides;Benzenesulfonyl compounds;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Hydrocarbon derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organic sulfonic acids and derivatives;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Organosulfonamides;Organosulfonic acids and derivatives;Organosulfur compounds;Phenylacetamides;Secondary carboxylic acid amides;Sulfenyl compounds;Sulfonyls;Thioethers;Thiophenol ethers	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring.	Benzenesulfonamides			Organic compounds	Aromatic homomonocyclic compounds	acetamides (CHEBI:22160);benzenes (CHEBI:22712);organosulfur compound (CHEBI:33261);organic sulfide (CHEBI:16385);aryl sulfide (CHEBI:35683);sulfonamide (CHEBI:35358);organonitrogen compound (CHEBI:35352);carboxamide (CHEBI:37622);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);organooxygen compound (CHEBI:36963);sulfonic acid derivative (CHEBI:33552);sulfone (CHEBI:35850);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806)		Benzenesulfonamides	Benzenesulfonamide;Phenylacetamide;Benzenesulfonyl group;Aryl thioether;Thiophenol ether;Alkylarylthioether;Organosulfonic acid amide;Organic sulfonic acid or derivatives;Aminosulfonyl compound;Sulfonyl;Organosulfonic acid or derivatives;Carboxamide group;Secondary carboxylic acid amide;Carboxylic acid derivative;Sulfenyl compound;Thioether;Organic nitrogen compound;Hydrocarbon derivative;Organic oxide;Organosulfur compound;Organooxygen compound;Organonitrogen compound;Organopnictogen compound;Organic oxygen compound;Carbonyl group;Aromatic homomonocyclic compound	Benzenoids	0.0		TimTec1_002563		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0		C22H22N2O3S2	C22H22N2O3S2			InChI=1S/C22H22N2O3S2/c23-29(26,27)20-13-11-17(12-14-20)15-16-24-22(25)21(18-7-3-1-4-8-18)28-19-9-5-2-6-10-19/h1-14,21H,15-16H2,(H,24,25)(H2,23,26,27)	YDMRHDOXVOGOFL-UHFFFAOYSA-N	2-phenyl-2-phenylsulfanyl-N-[2-(4-sulfamoylphenyl)ethyl]acetamide	2904537	NS(=O)(=O)c1ccc(CCNC(=O)C(Sc2ccccc2)c2ccccc2)cc1	2-phenyl-2-phenylsulfanyl-N-[2-(4-sulfamoylphenyl)ethyl]acetamide			3.2008600000000023													MCULE-6122526901	426.56024		426.107185	4	2	8	3			45										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(2904537)	2904537	4.0	191			[#7]-[#16](=[#8])(=[#8])-[#6]1:[#6]:[#6]:[#6](-[#6]-[#6]-[#7]-[#6](=[#8])-[#6](-[#16]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6]:[#6]:1	NS(=O)(=O)c1ccc(CCNC(=O)C(Sc2ccccc2)c2ccccc2)cc1	YDMRHDOXVOGOFL		parent_pubchem_cid	TimTec1_002563;Cambridge id 6595901;Oprea1_056802;HMS1541E11;AKOS002322369;AKOS016323483;NCGC00173987-01;N-[4-(AMINOSULFONYL)PHENETHYL]-2-PHENYL-2-(PHENYLSULFANYL)ACETAMIDE;2-phenyl-2-phenylsulfanyl-N-[2-(4-sulfamoylphenyl)ethyl]acetamide		24553406.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24553406		pluskal_iocb_peptide_Peptide01_A24_id		100	A24		
2.8		0	146	P0120630237	91.4		E30	False	0	19	0	0	18	0	2	4	0	0	-1.0	0.0						COc1ccc(C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)O)cc1		2.6		0.0	2.69	CHEMBL1360160		N-acyl-alpha amino acids;3-alkylindoles;Anisoles;Benzoyl derivatives;Methoxybenzenes;Phenoxy compounds;Alkyl aryl ethers;Substituted pyrroles;Heteroaromatic compounds;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Hydrocarbon derivatives;Carbonyl compounds;Organic oxides;Organonitrogen compounds;Organopnictogen compounds	3-alkylindoles;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Anisoles;Azacyclic compounds;Benzamides;Benzene and substituted derivatives;Benzenoids;Benzoic acids and derivatives;Benzoyl derivatives;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Ethers;Heteroaromatic compounds;Hippuric acids;Hippuric acids and derivatives;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Methoxybenzenes;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenol ethers;Phenoxy compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as hippuric acids. These are compounds containing hippuric acid, which consists of a of a benzoyl group linked to the N-terminal of a glycine.	Hippuric acids		Benzamides;Hippuric acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-amino acid (CHEBI:51569);indoles (CHEBI:24828);methoxybenzene (CHEBI:51683);carbonyl compound (CHEBI:36586);benzenes (CHEBI:22712);aromatic ether (CHEBI:35618);pyrroles (CHEBI:26455);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);organonitrogen heterocyclic compound (CHEBI:38101);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);N-acylglycine (CHEBI:16180);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);amino acid (CHEBI:33709);peptide (CHEBI:16670);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);oxygen molecular entity (CHEBI:25806);ether (CHEBI:25698);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);benzamides (CHEBI:22702);phenols (CHEBI:33853)		Benzoic acids and derivatives	N-acyl-alpha amino acid or derivatives;N-acyl-alpha-amino acid;Hippuric acid;Alpha-amino acid or derivatives;3-alkylindole;Indole or derivatives;Indole;Phenoxy compound;Anisole;Phenol ether;Benzoyl;Methoxybenzene;Alkyl aryl ether;Substituted pyrrole;Pyrrole;Heteroaromatic compound;Secondary carboxylic acid amide;Carboxamide group;Carboxylic acid derivative;Carboxylic acid;Ether;Azacycle;Organoheterocyclic compound;Monocarboxylic acid or derivatives;Organic oxygen compound;Organic nitrogen compound;Hydrocarbon derivative;Organopnictogen compound;Organic oxide;Organooxygen compound;Carbonyl group;Organonitrogen compound;Aromatic heteropolycyclic compound	Benzenoids	0.0		3-(1H-indol-3-yl)-2-[(4-methoxyphenyl)formamido]propanoicacid		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C19H18N2O4	C19H18N2O4			InChI=1S/C19H18N2O4/c1-25-14-8-6-12(7-9-14)18(22)21-17(19(23)24)10-13-11-20-16-5-3-2-4-15(13)16/h2-9,11,17,20H,10H2,1H3,(H,21,22)(H,23,24)	IUJUDKHYWKXAIY-UHFFFAOYSA-N	3-(1H-indol-3-yl)-2-[(4-methoxybenzoyl)amino]propanoic acid	2787197	COc1ccc(C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)O)cc1	3-(1H-indol-3-yl)-2-[(4-methoxybenzoyl)amino]propanoic acid			1.6019499999999995													MCULE-9421882964	338.36631	ACID	338.126657	4	3	6	3	1.0		30									Dipeptides	False	Amino acids and Peptides	Small peptides	False	False	Peptide01		-1.0	Compound(2787197)	2787197	2.2	192			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6](=[#8])-[#8]):[#6]:[#6]:1	COc1ccc(C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)O)cc1	IUJUDKHYWKXAIY		parent_pubchem_cid	3-(1H-indol-3-yl)-2-[(4-methoxyphenyl)formamido]propanoicacid;Oprea1_183087;Oprea1_382264;MLS001194830;N-(4-methoxybenzoyl)tryptophan;CHEMBL1360160;HMS2879F05;MFCD00226098;STL566371;AKOS000272740;AKOS016040440;N-[(4-methoxyphenyl)carbonyl]tryptophan;SMR000554751;SR-01000405653;SR-01000405653-1;3-(1H-indol-3-yl)-2-[(4-methoxybenzoyl)amino]propanoic acid	False	784528.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=784528		pluskal_iocb_peptide_Peptide01_B1_id		100	B1	False	
1.4		0	234	P1094986	115.7		E31	False	0	13	0	0	16	0	2	5	0	0		0.0						CC(C)C(NC(=O)Nc1ccccc1C(=O)O)C(=O)O								Valine and derivatives;N-phenylureas;Benzoic acids;Benzoyl derivatives;Dicarboxylic acids and derivatives;Vinylogous amides;Ureas;Carboxylic acids;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Benzene and substituted derivatives;Benzenoids;Benzoic acids;Benzoic acids and derivatives;Benzoyl derivatives;Carbonyl compounds;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Dicarboxylic acids and derivatives;Hydrocarbon derivatives;N-acyl-alpha amino acids and derivatives;N-carbamoyl-alpha amino acids;N-carbamoyl-alpha amino acids and derivatives;N-phenylureas;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Ureas;Valine and derivatives;Vinylogous amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as n-carbamoyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an carbamoyl group at its terminal nitrogen atom.	N-carbamoyl-alpha amino acids		Amino acids and derivatives;Alpha amino acids and derivatives;N-carbamoyl-alpha amino acids and derivatives	Organic compounds	Aromatic homomonocyclic compounds	valine derivative (CHEBI:27267);ureas (CHEBI:47857);benzoic acids (CHEBI:22723);carbonyl compound (CHEBI:36586);dicarboxylic acid (CHEBI:35692);enone (CHEBI:51689);enamine (CHEBI:47989);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);N-carbamoyl-amino acid (CHEBI:21689);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);amino acid (CHEBI:33709);peptide (CHEBI:16670);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806);N-acyl-amino acid (CHEBI:51569)	Dicarboxylic acids (FA0117)	Amino acids, peptides, and analogues	Valine or derivatives;N-carbamoyl-alpha-amino acid;N-phenylurea;Benzoic acid or derivatives;Benzoic acid;Benzoyl;Monocyclic benzene moiety;Benzenoid;Dicarboxylic acid or derivatives;Vinylogous amide;Urea;Carbonic acid derivative;Carboxylic acid;Organic nitrogen compound;Organonitrogen compound;Organooxygen compound;Hydrocarbon derivative;Carbonyl group;Organic oxide;Organopnictogen compound;Organic oxygen compound;Aromatic homomonocyclic compound	Organic acids and derivatives	0.0		AKOS016376740		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C13H16N2O5	C13H16N2O5			InChI=1S/C13H16N2O5/c1-7(2)10(12(18)19)15-13(20)14-9-6-4-3-5-8(9)11(16)17/h3-7,10H,1-2H3,(H,16,17)(H,18,19)(H2,14,15,20)/t10-/m0/s1	OAASKAREXXLWCM-JTQLQIEISA-N	2-[[rac-(1S)-1-carboxy-2-methyl-propyl]carbamoylamino]benzoic acid	908048	CC(C)[C@H](NC(=O)Nc1ccccc1C(=O)O)C(=O)O	2-[[(1S)-1-carboxy-2-methylpropyl]carbamoylamino]benzoic acid			1.18018													MCULE-9798512334	280.28287		280.105922	5	4	5	1			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(908048)	908048	2.7	193			[#6]-[#6](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#7]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#6](=[#8])-[#8])-[#6](=[#8])-[#8]	CC(C)[C@H](NC(=O)Nc1ccccc1C(=O)O)C(=O)O	OAASKAREXXLWCM		parent_pubchem_cid	AKOS016376740;2-[[rac-(1S)-1-carboxy-2-methyl-propyl]carbamoylamino]benzoic acid		23045050.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23045050		pluskal_iocb_peptide_Peptide01_B1_id		100	B1		ZINC000004061910
3.2		0	322	P1264238	93.7		E32	False	0	23	0	0	28	0	6	3	0	0	-1.0	0.0						CCOc1ccc(Nc2nc(Nc3ccc(OCC)cc3)nc(N3CCOCC3)n2)cc1		3.99		0.0	5.06	CHEMBL1398238																	0.0		433692-03-6		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1		C23H28N6O3	C23H28N6O3			InChI=1S/C23H28N6O3/c1-3-31-19-9-5-17(6-10-19)24-21-26-22(25-18-7-11-20(12-8-18)32-4-2)28-23(27-21)29-13-15-30-16-14-29/h5-12H,3-4,13-16H2,1-2H3,(H2,24,25,26,27,28)	DUHNHTWOZHQHFN-UHFFFAOYSA-N	N2,N4-bis(4-ethoxyphenyl)-6-morpholino-1,3,5-triazine-2,4-diamine	2921014	CCOc1ccc(Nc2nc(Nc3ccc(OCC)cc3)nc(N3CCOCC3)n2)cc1	2-N,4-N-bis(4-ethoxyphenyl)-6-morpholin-4-yl-1,3,5-triazine-2,4-diamine			1.1649300000000002													MCULE-7881584452	436.51801	NEUTRAL	436.222289	9	2	9	4	0.0		28										False			False	False	Peptide01		-1.0	Compound(2921014)	2921014	4.5	194			[#6]-[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#7]-[#6]2:[#7]:[#6](-[#7]-[#6]3:[#6]:[#6]:[#6](-[#8]-[#6]-[#6]):[#6]:[#6]:3):[#7]:[#6](-[#7]3-[#6]-[#6]-[#8]-[#6]-[#6]-3):[#7]:2):[#6]:[#6]:1	CCOc1ccc(Nc2nc(Nc3ccc(OCC)cc3)nc(N3CCOCC3)n2)cc1	DUHNHTWOZHQHFN		parent_pubchem_cid	433692-03-6;N2,N4-BIS(4-ETHOXYPHENYL)-6-(MORPHOLIN-4-YL)-1,3,5-TRIAZINE-2,4-DIAMINE;Oprea1_021179;CHEMBL1398238;HMS1802E07;STK037922;2-N,4-N-bis(4-ethoxyphenyl)-6-morpholin-4-yl-1,3,5-triazine-2,4-diamine;AKOS001654074;N,N'-bis(4-ethoxyphenyl)-6-morpholin-4-yl-1,3,5-triazine-2,4-diamine;NCGC00100645-01;F2703-0276;N,N'-bis(4-ethoxyphenyl)-6-(morpholin-4-yl)-1,3,5-triazine-2,4-diamine;N2,N4-bis(4-ethoxyphenyl)-6-morpholino-1,3,5-triazine-2,4-diamine	False	872380.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=872380		pluskal_iocb_peptide_Peptide01_B1_id		100	B1	False	ZINC000008590048
2.9		0	66	P7112894835	116.2		E33	False	0	19	0	0	19	0	1	6	0	1		0.0						COC(=O)c1cc(NC(=O)c2c(OC)cc(SC)cc2)c(C(=O)OC)cc1								p-Phthalate esters;P-phthalic acid and derivatives;Benzoic acid esters;P-sulfanylbenzoic acids and derivatives;Benzamides;Anisoles;Thiophenol ethers;Benzoyl derivatives;Methoxybenzenes;Phenoxy compounds;Alkyl aryl ethers;Alkylarylthioethers;Dicarboxylic acids and derivatives;Methyl esters;Vinylogous amides;Secondary carboxylic acid amides;Sulfenyl compounds;Organic oxides;Hydrocarbon derivatives;Organonitrogen compounds;Organopnictogen compounds	Alkyl aryl ethers;Alkylarylthioethers;Anilides;Anisoles;Aromatic anilides;Aryl thioethers;Benzamides;Benzanilides;Benzene and substituted derivatives;Benzenoids;Benzoic acid esters;Benzoic acids and derivatives;Benzoyl derivatives;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids and derivatives;Chemical entities;Dicarboxylic acids and derivatives;Ethers;Hydrocarbon derivatives;Methoxybenzenes;Methyl esters;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Organosulfur compounds;P-phthalic acid and derivatives;P-sulfanylbenzoic acids and derivatives;Phenol ethers;Phenoxy compounds;Phthalate esters;Phthalic acid and derivatives;Secondary carboxylic acid amides;Sulfanylbenzoic acids and derivatives;Sulfenyl compounds;Thioethers;Thiophenol ethers;Vinylogous amides;p-Phthalate esters	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as benzanilides. These are aromatic compounds containing an anilide group in which the carboxamide group is substituted with a benzene ring. They have the general structure RNC(=O)R', where R,R'= benzene.	Benzanilides		Aromatic anilides	Organic compounds	Aromatic homomonocyclic compounds	phthalate ester (CHEBI:35484);benzenedicarboxylic acid (CHEBI:26094);benzoate ester (CHEBI:36054);carbonyl compound (CHEBI:36586);thiol (CHEBI:29256);benzamides (CHEBI:22702);methoxybenzene (CHEBI:51683);organic sulfide (CHEBI:16385);benzenes (CHEBI:22712);aromatic ether (CHEBI:35618);aryl sulfide (CHEBI:35683);dicarboxylic acid (CHEBI:35692);carboxylic ester (CHEBI:33308);enone (CHEBI:51689);enamine (CHEBI:47989);carboxamide (CHEBI:37622);organosulfur compound (CHEBI:33261);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);organonitrogen compound (CHEBI:35352);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);anilide (CHEBI:13248);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);sulfanylbenzoic acid (CHEBI:59126);oxygen molecular entity (CHEBI:25806);organooxygen compound (CHEBI:36963);ether (CHEBI:25698);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)	Dicarboxylic acids (FA0117)	Anilides	Benzanilide;Para-phthalic acid ester;Phthalate ester;Para_phthalic_acid;P-sulfanylbenzoic acid or derivatives;Benzoate ester;Benzamide;Benzoic acid or derivatives;Anisole;Aryl thioether;Benzoyl;Thiophenol ether;Phenoxy compound;Methoxybenzene;Phenol ether;Alkyl aryl ether;Alkylarylthioether;Dicarboxylic acid or derivatives;Vinylogous amide;Methyl ester;Carboxamide group;Carboxylic acid ester;Secondary carboxylic acid amide;Ether;Thioether;Carboxylic acid derivative;Sulfenyl compound;Organic oxygen compound;Organic nitrogen compound;Hydrocarbon derivative;Organic oxide;Organopnictogen compound;Organonitrogen compound;Organooxygen compound;Organosulfur compound;Aromatic homomonocyclic compound	Benzenoids	0.0		Oprea1_520798		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C19H19NO6S	C19H19NO6S			InChI=1S/C19H19NO6S/c1-24-16-10-12(27-4)6-8-14(16)17(21)20-15-9-11(18(22)25-2)5-7-13(15)19(23)26-3/h5-10H,1-4H3,(H,20,21)	OEGJBGMKJHMNER-UHFFFAOYSA-N	dimethyl 2-[(2-methoxy-4-methylsulfanyl-benzoyl)amino]benzene-1,4-dicarboxylate	1124056	COC(=O)c1cc(NC(=O)c2c(OC)cc(SC)cc2)c(C(=O)OC)cc1	dimethyl 2-[(2-methoxy-4-methylsulfanylbenzoyl)amino]benzene-1,4-dicarboxylate			2.12744													MCULE-9546919343	389.43038		389.093308	7	1	8	2			44									Anthranillic acid derivatives	False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(1124056)	1124056	3.5	195			[#6]-[#8]-[#6](=[#8])-[#6]1:[#6]:[#6](-[#7]-[#6](=[#8])-[#6]2:[#6](-[#8]-[#6]):[#6]:[#6](-[#16]-[#6]):[#6]:[#6]:2):[#6](-[#6](=[#8])-[#8]-[#6]):[#6]:[#6]:1	COC(=O)c1cc(NC(=O)c2c(OC)cc(SC)cc2)c(C(=O)OC)cc1	OEGJBGMKJHMNER		parent_pubchem_cid	Oprea1_520798;Oprea1_527133;AKOS000644290;DIMETHYL 2-{[2-METHOXY-4-(METHYLSULFANYL)BENZOYL]AMINO}TEREPHTHALATE;dimethyl 2-[(2-methoxy-4-methylsulfanyl-benzoyl)amino]benzene-1,4-dicarboxylate		2762125.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=2762125		pluskal_iocb_peptide_Peptide01_B1_id		100	B1		ZINC000000862251
4.0		0	154	P0107620110	72.2		E34	False	0	22	0	0	20	0	2	2	0	0		0.0						NC(=O)c1ccccc1NC(=O)c1ccccc1CCc1ccccc1																							0.0		N-(2-carbamoylphenyl)-2-phenethylbenzamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C22H20N2O2	C22H20N2O2			InChI=1S/C22H20N2O2/c23-21(25)19-12-6-7-13-20(19)24-22(26)18-11-5-4-10-17(18)15-14-16-8-2-1-3-9-16/h1-13H,14-15H2,(H2,23,25)(H,24,26)	QJIBDSLAIQGAQL-UHFFFAOYSA-N	N-(2-carbamoylphenyl)-2-(2-phenylethyl)benzamide	717590	NC(=O)c1ccccc1NC(=O)c1ccccc1CCc1ccccc1	N-(2-carbamoylphenyl)-2-(2-phenylethyl)benzamide			3.223550000000002													MCULE-4123572726	344.4169		344.152478	2	2	6	3			44										False	Alkaloids				Peptide01			Compound(717590)	717590	4.4	196			[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#6]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	NC(=O)c1ccccc1NC(=O)c1ccccc1CCc1ccccc1	QJIBDSLAIQGAQL		parent_pubchem_cid	N-(2-carbamoylphenyl)-2-phenethylbenzamide;Oprea1_852501;MFCD01846926;AKOS001607306;EU-0003833;SR-01000422311;SR-01000422311-1;F0901-6463;N-[2-(aminocarbonyl)phenyl]-2-(2-phenylethyl)benzamide;N-(2-carbamoylphenyl)-2-(2-phenylethyl)benzamide		15861480.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=15861480		pluskal_iocb_peptide_Peptide01_B1_id		100	B1		ZINC000000116287
2.6		0	242	P1158302	82.2		E35	False	0	14	0	0	16	0	2	3	0	0		0.0						CCCC(NC(=O)c1cc2ccccc2[nH]1)C(=O)O								Indolecarboxamides and derivatives;Indoles;Pyrrole carboxamides;2-heteroaryl carboxamides;Substituted pyrroles;Benzenoids;Heteroaromatic compounds;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	2-heteroaryl carboxamides;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indolecarboxamides and derivatives;Indolecarboxylic acids and derivatives;Indoles;Indoles and derivatives;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Pyrrole carboxamides;Pyrrole carboxylic acids and derivatives;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom.	N-acyl-alpha amino acids		Amino acids and derivatives;Alpha amino acids and derivatives;N-acyl-alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	indolecarboxamide (CHEBI:46921);indoles (CHEBI:24828);pyrroles (CHEBI:26455);carboxamide (CHEBI:37622);organic aromatic compound (CHEBI:33659);benzenoid aromatic compound (CHEBI:33836);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);N-acyl-amino acid (CHEBI:51569);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);indolyl carboxylic acid (CHEBI:46867);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806)		Amino acids, peptides, and analogues	N-acyl-alpha-amino acid;Indolecarboxamide derivative;Indolecarboxylic acid derivative;Indole;Indole or derivatives;2-heteroaryl carboxamide;Pyrrole-2-carboxamide;Pyrrole-2-carboxylic acid or derivatives;Benzenoid;Substituted pyrrole;Pyrrole;Heteroaromatic compound;Secondary carboxylic acid amide;Carboxamide group;Azacycle;Organoheterocyclic compound;Carboxylic acid;Monocarboxylic acid or derivatives;Carbonyl group;Organic oxide;Organic oxygen compound;Organic nitrogen compound;Hydrocarbon derivative;Organonitrogen compound;Organooxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		N-(1H-indol-2-ylcarbonyl)norvaline		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C14H16N2O3	C14H16N2O3			InChI=1S/C14H16N2O3/c1-2-5-11(14(18)19)16-13(17)12-8-9-6-3-4-7-10(9)15-12/h3-4,6-8,11,15H,2,5H2,1H3,(H,16,17)(H,18,19)	JIICXBYUQCFWBN-UHFFFAOYSA-N	2-(1H-indole-2-carbonylamino)pentanoic acid	17593400	CCCC(NC(=O)c1cc2ccccc2[nH]1)C(=O)O	2-(1H-indole-2-carbonylamino)pentanoic acid			1.66787													MCULE-5977442793	260.29522		260.116092	3	3	5	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(17593400)	17593400	2.9	197			[#6]-[#6]-[#6]-[#6](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#7H]:1)-[#6](=[#8])-[#8]	CCCC(NC(=O)c1cc2ccccc2[nH]1)C(=O)O	JIICXBYUQCFWBN		parent_pubchem_cid	N-(1H-indol-2-ylcarbonyl)norvaline;MFCD09848362;STL226531;AKOS009821185;2-[(1H-INDOL-2-YL)FORMAMIDO]PENTANOIC ACID;2-(1H-indole-2-carbonylamino)pentanoic acid		24187477.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24187477		pluskal_iocb_peptide_Peptide01_B1_id		100	B1		
4.1		0	330	P4802723	60.3		E36	False	0	21	0	0	26	0	2	2	0	0		0.0						CCCOc1c(OCC)cc(C(CN)c2c[nH]c3ccccc23)cc1																							0.0		2-(3-ethoxy-4-propoxyphenyl)-2-(1H-indol-3-yl)ethanamine		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0		C21H26N2O2	C21H26N2O2			InChI=1S/C21H26N2O2/c1-3-11-25-20-10-9-15(12-21(20)24-4-2)17(13-22)18-14-23-19-8-6-5-7-16(18)19/h5-10,12,14,17,23H,3-4,11,13,22H2,1-2H3	NYFBITYSOMRRBO-UHFFFAOYSA-N	2-(3-ethoxy-4-propoxy-phenyl)-2-(1H-indol-3-yl)ethanamine	16394797	CCCOc1c(OCC)cc(C(CN)c2c[nH]c3ccccc23)cc1	2-(3-ethoxy-4-propoxyphenyl)-2-(1H-indol-3-yl)ethanamine			2.983340000000001													MCULE-3005938411	338.45357		338.199428	3	2	8	3			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(16394797)	16394797	4.0	198			[#6]-[#6]-[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]-[#6]):[#6]:[#6](-[#6](-[#6]-[#7])-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	CCCOc1c(OCC)cc(C(CN)c2c[nH]c3ccccc23)cc1	NYFBITYSOMRRBO		parent_pubchem_cid	2-(3-ethoxy-4-propoxyphenyl)-2-(1H-indol-3-yl)ethanamine;881043-65-8;AKOS005170811;2-(3-ethoxy-4-propoxy-phenyl)-2-(1H-indol-3-yl)ethanamine		23389626.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23389626		pluskal_iocb_peptide_Peptide01_B1_id		100	B1		
2.7		0	74	P7211760203	179.0		E37	False	0	21	0	0	19	0	7	2	0	3		0.0						Cc1cc(C)nc(NS(=O)(=O)c2ccc(Nc3nc(-c4c(C)nc5sccn45)cs3)cc2)n1																							0.0		ChemDiv1_008987		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	1		C21H19N7O2S3	C21H19N7O2S3			InChI=1S/C21H19N7O2S3/c1-12-10-13(2)23-19(22-12)27-33(29,30)16-6-4-15(5-7-16)25-20-26-17(11-32-20)18-14(3)24-21-28(18)8-9-31-21/h4-11H,1-3H3,(H,25,26)(H,22,23,27)	AYSDSVIYOAKLFY-UHFFFAOYSA-N	N-(4,6-dimethylpyrimidin-2-yl)-4-[[4-(6-methylimidazo[2,1-b]thiazol-5-yl)thiazol-2-yl]amino]benzenesulfonamide	4331683	Cc1cc(C)nc(NS(=O)(=O)c2ccc(Nc3nc(-c4c(C)nc5sccn45)cs3)cc2)n1	N-(4,6-dimethylpyrimidin-2-yl)-4-[[4-(6-methylimidazo[2,1-b][1,3]thiazol-5-yl)-1,3-thiazol-2-yl]amino]benzenesulfonamide			2.770760000000001													MCULE-7535944350	497.62328		497.076236	7	2	6	5			44										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(4331683)	4331683	4.8	199			[#6]-[#6]1:[#6]:[#6](-[#6]):[#7]:[#6](-[#7]-[#16](=[#8])(=[#8])-[#6]2:[#6]:[#6]:[#6](-[#7]-[#6]3:[#7]:[#6](-[#6]4:[#6](-[#6]):[#7]:[#6]5:[#16]:[#6]:[#6]:[#7]:4:5):[#6]:[#16]:3):[#6]:[#6]:2):[#7]:1	Cc1cc(C)nc(NS(=O)(=O)c2ccc(Nc3nc(-c4c(C)nc5sccn45)cs3)cc2)n1	AYSDSVIYOAKLFY		parent_pubchem_cid	ChemDiv1_008987;Oprea1_412258;HMS612I11;CCG-19243;AKOS002382949;N-(4,6-dimethylpyrimidin-2-yl)-4-{[4-(6-methylimidazo[2,1-b][1,3]thiazol-5-yl)-1,3-thiazol-2-yl]amino}benzenesulfonamide;SR-01000477231;SR-01000477231-1;N-(4,6-dimethylpyrimidin-2-yl)-4-[[4-(6-methylimidazo[2,1-b]thiazol-5-yl)thiazol-2-yl]amino]benzenesulfonamide		6403963.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=6403963		pluskal_iocb_peptide_Peptide01_B1_id		100	B1		ZINC000006024079
5.0		0	162	P0109750520	74.8		E38	False	0	20	0	0	15	0	3	1	0	1		0.0						C(=NNc1nc2ccccc2s1)c1cc(Oc2ccccc2)ccc1																							0.0		AKOS002346450		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C20H15N3OS	C20H15N3OS			InChI=1S/C20H15N3OS/c1-2-8-16(9-3-1)24-17-10-6-7-15(13-17)14-21-23-20-22-18-11-4-5-12-19(18)25-20/h1-14H,(H,22,23)/b21-14-	UHEFCPUYMNTBLP-STZFKDTASA-N	N-[(Z)-(3-phenoxyphenyl)methyleneamino]-1,3-benzothiazol-2-amine	6076400	C(=N\Nc1nc2ccccc2s1)\c1cc(Oc2ccccc2)ccc1	N-[(Z)-(3-phenoxyphenyl)methylideneamino]-1,3-benzothiazol-2-amine			3.7460400000000025														345.42605		345.093583	4	1	5	4			45										False	Shikimates and Phenylpropanoids				Peptide01			Compound(6076400)	6076400	5.9	200			[#6](=[#7]\[#7]-[#6]1:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#16]:1)\[#6]1:[#6]:[#6](-[#8]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6]:[#6]:[#6]:1	C(=N\Nc1nc2ccccc2s1)\c1cc(Oc2ccccc2)ccc1	UHEFCPUYMNTBLP		parent_pubchem_cid	AKOS002346450;N-[(Z)-(3-phenoxyphenyl)methyleneamino]-1,3-benzothiazol-2-amine		2660313.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=2660313		pluskal_iocb_peptide_Peptide01_B2_id		100	B2		ZINC000031829236
3.6		0	250	P1045788	66.4		E39	False	0	17	0	0	25	0	1	3	0	0		0.0						CC(C)CC(NC(=O)c1ccc(C(C)(C)C)cc1)C(=O)O																							0.0		2241925-37-9		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C17H25NO3	C17H25NO3			InChI=1S/C17H25NO3/c1-11(2)10-14(16(20)21)18-15(19)12-6-8-13(9-7-12)17(3,4)5/h6-9,11,14H,10H2,1-5H3,(H,18,19)(H,20,21)	WIDJYPWEBICQHN-UHFFFAOYSA-N	2-[(4-tert-butylbenzoyl)amino]-4-methyl-pentanoic acid	16771308	CC(C)CC(NC(=O)c1ccc(C(C)(C)C)cc1)C(=O)O	2-[(4-tert-butylbenzoyl)amino]-4-methylpentanoic acid			3.1037800000000013													MCULE-8645783623	291.3937		291.183444	3	2	6	1			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(16771308)	16771308	4.2	201		SCHEMBL22501215	[#6]-[#6](-[#6])-[#6]-[#6](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6])(-[#6])-[#6]):[#6]:[#6]:1)-[#6](=[#8])-[#8]	CC(C)CC(NC(=O)c1ccc(C(C)(C)C)cc1)C(=O)O	WIDJYPWEBICQHN		parent_pubchem_cid	2241925-37-9;Oprea1_699270;SCHEMBL22501215;DL-(4-(tert-Butyl)benzoyl)leucine;AKOS000127992;AKOS016338198;(4-(TERT-BUTYL)BENZOYL)LEUCINE;F88937;2-[(4-tert-butylbenzoyl)amino]-4-methyl-pentanoic acid		23032827.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23032827		pluskal_iocb_peptide_Peptide01_B2_id		100	B2		
2.3		0	338	P7008249	87.9		E40	False	0	16	0	0	20	0	6	1	0	0		0.0						Cc1cc(C)cc(Nc2nc(NCCO)c3cnn(C)c3n2)c1																							0.0		2-((6-((3,5-dimethylphenyl)amino)-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino)ethanol		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1		C16H20N6O	C16H20N6O			InChI=1S/C16H20N6O/c1-10-6-11(2)8-12(7-10)19-16-20-14(17-4-5-23)13-9-18-22(3)15(13)21-16/h6-9,23H,4-5H2,1-3H3,(H2,17,19,20,21)	GFBWLGDGRFIYNY-UHFFFAOYSA-N	2-[[6-(3,5-dimethylanilino)-1-methyl-pyrazolo[3,4-d]pyrimidin-4-yl]amino]ethanol	7162560	Cc1cc(C)cc(Nc2nc(NCCO)c3cnn(C)c3n2)c1	2-[[6-(3,5-dimethylanilino)-1-methylpyrazolo[3,4-d]pyrimidin-4-yl]amino]ethanol			0.4482699999999996													MCULE-3043215489	312.3774		312.169859	6	3	5	3			44										False	Alkaloids	Pseudoalkaloids			Peptide01			Compound(7162560)	7162560	2.4	202			[#6]-[#6]1:[#6]:[#6](-[#6]):[#6]:[#6](-[#7]-[#6]2:[#7]:[#6](-[#7]-[#6]-[#6]-[#8]):[#6]3:[#6]:[#7]:[#7](-[#6]):[#6]:3:[#7]:2):[#6]:1	Cc1cc(C)cc(Nc2nc(NCCO)c3cnn(C)c3n2)c1	GFBWLGDGRFIYNY		parent_pubchem_cid	2-((6-((3,5-dimethylphenyl)amino)-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino)ethanol;897758-30-4;AKOS002311168;2-[[6-(3,5-dimethylanilino)-1-methylpyrazolo[3,4-d]pyrimidin-4-yl]amino]ethanol;F2031-0972;2-[[6-(3,5-dimethylanilino)-1-methyl-pyrazolo[3,4-d]pyrimidin-4-yl]amino]ethanol		5029643.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=5029643		pluskal_iocb_peptide_Peptide01_B2_id		100	B2		ZINC000004272776
2.4		0	82	P7720500029	113.4		E41	False	0	21	0	0	23	0	5	4	0	0		0.0						CCOc1c(NC(=O)c2ccccc2)cc(OCC)c(Nc2nc(=O)[nH]nc2C)c1																							0.0		AKOS016377805		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C21H23N5O4	C21H23N5O4			InChI=1S/C21H23N5O4/c1-4-29-17-12-16(23-20(27)14-9-7-6-8-10-14)18(30-5-2)11-15(17)22-19-13(3)25-26-21(28)24-19/h6-12H,4-5H2,1-3H3,(H,23,27)(H2,22,24,26,28)	SCZAHMWMBFURHQ-UHFFFAOYSA-N	N-[2,5-diethoxy-4-[(6-methyl-3-oxo-2H-1,2,4-triazin-5-yl)amino]phenyl]benzamide	24282847	CCOc1c(NC(=O)c2ccccc2)cc(OCC)c(Nc2nc(=O)[nH]nc2C)c1	N-[2,5-diethoxy-4-[(6-methyl-3-oxo-2H-1,2,4-triazin-5-yl)amino]phenyl]benzamide			1.9904399999999995													MCULE-8712212503	409.44856		409.175004	7	3	8	3			44										False	Alkaloids				Peptide01			Compound(24282847)	24282847	2.2	203			[#6]-[#6]-[#8]-[#6]1:[#6](-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6]:[#6](-[#8]-[#6]-[#6]):[#6](-[#7]-[#6]2:[#7]:[#6](=[#8]):[#7H]:[#7]:[#6]:2-[#6]):[#6]:1	CCOc1c(NC(=O)c2ccccc2)cc(OCC)c(Nc2nc(=O)[nH]nc2C)c1	SCZAHMWMBFURHQ		parent_pubchem_cid	AKOS016377805;N-[2,5-diethoxy-4-[(6-methyl-3-oxo-2H-1,2,4-triazin-5-yl)amino]phenyl]benzamide		11032291.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=11032291		pluskal_iocb_peptide_Peptide01_B2_id		100	B2		ZINC000011990977
3.1		0	170	P7020554649	84.2		E42	False	0	20	0	1	18	0	3	3	0	0		0.0						Cc1cc(NC(=O)C(Cc2ccccc2)NC(=O)c2cc(F)ccc2)no1																							0.0		AKOS005582055		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C20H18FN3O3	C20H18FN3O3			InChI=1S/C20H18FN3O3/c1-13-10-18(24-27-13)23-20(26)17(11-14-6-3-2-4-7-14)22-19(25)15-8-5-9-16(21)12-15/h2-10,12,17H,11H2,1H3,(H,22,25)(H,23,24,26)/t17-/m0/s1	PYUQLBKDCPDNBJ-KRWDZBQOSA-N	N-[(1S)-1-benzyl-2-[(5-methylisoxazol-3-yl)amino]-2-oxo-ethyl]-3-fluoro-benzamide	24315162	Cc1cc(NC(=O)[C@H](Cc2ccccc2)NC(=O)c2cc(F)ccc2)no1	3-fluoro-N-[(2S)-1-[(5-methyl-1,2-oxazol-3-yl)amino]-1-oxo-3-phenylpropan-2-yl]benzamide			2.5571800000000007													MCULE-5998195089	367.38316		367.13322	3	2	6	3			44										False					Peptide01			Compound(24315162)	24315162	3.4	204			[#6]-[#6]1:[#6]:[#6](-[#7]-[#6](=[#8])-[#6@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6](-[#9]):[#6]:[#6]:[#6]:2):[#7]:[#8]:1	Cc1cc(NC(=O)[C@H](Cc2ccccc2)NC(=O)c2cc(F)ccc2)no1	PYUQLBKDCPDNBJ		parent_pubchem_cid	AKOS005582055;N-[(1S)-1-benzyl-2-[(5-methylisoxazol-3-yl)amino]-2-oxo-ethyl]-3-fluoro-benzamide		7521981.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=7521981		pluskal_iocb_peptide_Peptide01_B2_id		100	B2		ZINC000012028734
4.5		0	258	P1305419	82.4		E43	False	0	22	0	0	20	0	2	2	0	1		0.0						COc1ccc(C(CNC(=O)c2cccs2)c2c[nH]c3ccccc23)cc1																							0.0		N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]thiophene-2-carboxamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C22H20N2O2S	C22H20N2O2S			InChI=1S/C22H20N2O2S/c1-26-16-10-8-15(9-11-16)18(13-24-22(25)21-7-4-12-27-21)19-14-23-20-6-3-2-5-17(19)20/h2-12,14,18,23H,13H2,1H3,(H,24,25)	UWQANCXHPSBETI-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]thiophene-2-carboxamide	4878851	COc1ccc(C(CNC(=O)c2cccs2)c2c[nH]c3ccccc23)cc1	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]thiophene-2-carboxamide			3.7449400000000015													MCULE-2838720142	376.4809		376.124549	2	2	6	4			44									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(4878851)	4878851	4.7	205			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6]-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#16]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	COc1ccc(C(CNC(=O)c2cccs2)c2c[nH]c3ccccc23)cc1	UWQANCXHPSBETI		parent_pubchem_cid	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]thiophene-2-carboxamide;796090-49-8;2-Thiophenecarboxamide, N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-;DTXSID201157741;STL207526;AKOS002335287;AKOS016326663;Z30425602;N-[2-(1H-Indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-thiophenecarboxamide		24561313.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24561313		pluskal_iocb_peptide_Peptide01_B2_id		100	B2		
4.7		0	346	P1887879	75.2		E44	False	0	22	1	0	25	0	6	1	0	0		0.0						Cc1c(C)cc(Nc2nc(Nc3c(C)ccc(Cl)c3)nc(N3CCOCC3)n2)cc1																							0.0		946209-00-3		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1		C22H25ClN6O	C22H25ClN6O			InChI=1S/C22H25ClN6O/c1-14-5-7-18(12-16(14)3)24-20-26-21(25-19-13-17(23)6-4-15(19)2)28-22(27-20)29-8-10-30-11-9-29/h4-7,12-13H,8-11H2,1-3H3,(H2,24,25,26,27,28)	QGLATJXOQRCZEY-UHFFFAOYSA-N	N2-(5-chloro-2-methyl-phenyl)-N4-(3,4-dimethylphenyl)-6-morpholino-1,3,5-triazine-2,4-diamine	42477751	Cc1c(C)cc(Nc2nc(Nc3c(C)ccc(Cl)c3)nc(N3CCOCC3)n2)cc1	2-N-(5-chloro-2-methylphenyl)-4-N-(3,4-dimethylphenyl)-6-morpholin-4-yl-1,3,5-triazine-2,4-diamine			2.706880000000001													MCULE-3068528321	424.93715		424.177837	7	2	5	4			44										False	Alkaloids				Peptide01			Compound(42477751)	42477751	5.5	206			[#6]-[#6]1:[#6](-[#6]):[#6]:[#6](-[#7]-[#6]2:[#7]:[#6](-[#7]-[#6]3:[#6](-[#6]):[#6]:[#6]:[#6](-[#17]):[#6]:3):[#7]:[#6](-[#7]3-[#6]-[#6]-[#8]-[#6]-[#6]-3):[#7]:2):[#6]:[#6]:1	Cc1c(C)cc(Nc2nc(Nc3c(C)ccc(Cl)c3)nc(N3CCOCC3)n2)cc1	QGLATJXOQRCZEY		parent_pubchem_cid	946209-00-3;N2-(5-CHLORO-2-METHYLPHENYL)-N4-(3,4-DIMETHYLPHENYL)-6-(MORPHOLIN-4-YL)-1,3,5-TRIAZINE-2,4-DIAMINE;N2-(5-chloro-2-methylphenyl)-N4-(3,4-dimethylphenyl)-6-morpholino-1,3,5-triazine-2,4-diamine;AKOS016391754;F2490-0354;2-N-(5-chloro-2-methylphenyl)-4-N-(3,4-dimethylphenyl)-6-morpholin-4-yl-1,3,5-triazine-2,4-diamine;N2-(5-chloro-2-methyl-phenyl)-N4-(3,4-dimethylphenyl)-6-morpholino-1,3,5-triazine-2,4-diamine		15611031.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=15611031		pluskal_iocb_peptide_Peptide01_B2_id		100	B2		ZINC000012235161
1.8		0	354	P1094052	117.3		F1	False	0	20	0	0	36	0	4	6	0	0		0.0						CCC(C)C(NC(=O)N1CCN(C(=O)NC(C(=O)OC)C(C)CC)CC1)C(=O)OC																							0.0		AKOS005533495		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	4	0	2	0	0	0	0	0	0	0	0	4	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C20H36N4O6	C20H36N4O6			InChI=1S/C20H36N4O6/c1-7-13(3)15(17(25)29-5)21-19(27)23-9-11-24(12-10-23)20(28)22-16(14(4)8-2)18(26)30-6/h13-16H,7-12H2,1-6H3,(H,21,27)(H,22,28)/t13-,14+,15+,16-	GCNHBHXKPVRWGP-SYMSYNOKSA-N	methyl rac-(2S,3R)-3-methyl-2-[[4-[[rac-(1R,2S)-1-methoxycarbonyl-2-methyl-butyl]carbamoyl]piperazine-1-carbonyl]amino]pentanoate	27351997	CC[C@@H](C)[C@H](NC(=O)N1CCN(C(=O)N[C@@H](C(=O)OC)[C@@H](C)CC)CC1)C(=O)OC	methyl (2S,3R)-2-[[4-[[(2R,3S)-1-methoxy-3-methyl-1-oxopentan-2-yl]carbamoyl]piperazine-1-carbonyl]amino]-3-methylpentanoate			1.1986000000000017													MCULE-2432952868	428.53312		428.263485	6	2	10	1			44										False	Amino acids and Peptides	Small peptides			Peptide01			Compound(27351997)	27351997	1.9	207			[#6]-[#6]-[#6@@H](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#7]1-[#6]-[#6]-[#7](-[#6](=[#8])-[#7]-[#6@@H](-[#6](=[#8])-[#8]-[#6])-[#6@@H](-[#6])-[#6]-[#6])-[#6]-[#6]-1)-[#6](=[#8])-[#8]-[#6]	CC[C@@H](C)[C@H](NC(=O)N1CCN(C(=O)N[C@@H](C(=O)OC)[C@@H](C)CC)CC1)C(=O)OC	GCNHBHXKPVRWGP		parent_pubchem_cid	AKOS005533495;methyl rac-(2S,3R)-3-methyl-2-[[4-[[rac-(1R,2S)-1-methoxycarbonyl-2-methyl-butyl]carbamoyl]piperazine-1-carbonyl]amino]pentanoate		14592895.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=14592895		pluskal_iocb_peptide_Peptide01_B2_id		100	B2		ZINC000016810472
3.6		0	442	P7130022	54.1		F2	False	0	22	0	1	23	0	2	2	0	0		0.0						O=C(NCCc1c[nH]c2c1cc(F)cc2)C1(c2ccccc2)CCOCC1																							0.0		N-[2-(5-fluoro-1H-indol-3-yl)ethyl]-4-phenyltetrahydro-2H-pyran-4-carboxamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C22H23FN2O2	C22H23FN2O2			InChI=1S/C22H23FN2O2/c23-18-6-7-20-19(14-18)16(15-25-20)8-11-24-21(26)22(9-12-27-13-10-22)17-4-2-1-3-5-17/h1-7,14-15,25H,8-13H2,(H,24,26)	STLIDIDHVXAQNF-UHFFFAOYSA-N	N-[2-(5-fluoro-1H-indol-3-yl)ethyl]-4-phenyl-tetrahydropyran-4-carboxamide	60181145	O=C(NCCc1c[nH]c2c1cc(F)cc2)C1(c2ccccc2)CCOCC1	N-[2-(5-fluoro-1H-indol-3-yl)ethyl]-4-phenyloxane-4-carboxamide			3.176260000000002													MCULE-2752593116	366.43921		366.174356	2	2	5	4			44										False					Peptide01			Compound(60181145)	60181145	3.5	208			[#8]=[#6](-[#7]-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:1:[#6]:[#6](-[#9]):[#6]:[#6]:2)-[#6]1(-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]-[#6]-[#8]-[#6]-[#6]-1	O=C(NCCc1c[nH]c2c1cc(F)cc2)C1(c2ccccc2)CCOCC1	STLIDIDHVXAQNF		parent_pubchem_cid	N-[2-(5-fluoro-1H-indol-3-yl)ethyl]-4-phenyltetrahydro-2H-pyran-4-carboxamide;1351694-92-2;EiM08-24773;AKOS022136102;N-[2-(5-fluoro-1H-indol-3-yl)ethyl]-4-phenyloxane-4-carboxamide;N-[2-(5-fluoro-1H-indol-3-yl)ethyl]-4-phenyl-tetrahydropyran-4-carboxamide		24268006.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24268006		pluskal_iocb_peptide_Peptide01_B3_id		100	B3		ZINC000072402259
4.7		0	530	P2194117	106.5		F3	False	0	22	1	0	20	0	3	3	0	1		0.0						COC(=O)C(Cc1ccccc1)NC(=O)c1nc(SCc2ccccc2)ncc1Cl																							0.0		AKOS005136614		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C22H20ClN3O3S	C22H20ClN3O3S			InChI=1S/C22H20ClN3O3S/c1-29-21(28)18(12-15-8-4-2-5-9-15)25-20(27)19-17(23)13-24-22(26-19)30-14-16-10-6-3-7-11-16/h2-11,13,18H,12,14H2,1H3,(H,25,27)	HFAPDKHBEIBRAF-UHFFFAOYSA-N	methyl 2-[(2-benzylsulfanyl-5-chloro-pyrimidine-4-carbonyl)amino]-3-phenyl-propanoate	49756864	COC(=O)C(Cc1ccccc1)NC(=O)c1nc(SCc2ccccc2)ncc1Cl	methyl 2-[(2-benzylsulfanyl-5-chloropyrimidine-4-carbonyl)amino]-3-phenylpropanoate			3.6642600000000014													MCULE-4752313250	441.94		441.09139	6	1	9	3			45									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(49756864)	49756864	4.7	209			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]1:[#7]:[#6](-[#16]-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#7]:[#6]:[#6]:1-[#17]	COC(=O)C(Cc1ccccc1)NC(=O)c1nc(SCc2ccccc2)ncc1Cl	HFAPDKHBEIBRAF		parent_pubchem_cid	AKOS005136614;methyl 2-[(2-benzylsulfanyl-5-chloro-pyrimidine-4-carbonyl)amino]-3-phenyl-propanoate		24024277.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24024277		pluskal_iocb_peptide_Peptide01_B3_id		100	B3		
4.7		0	618	P1307969	68.3		F4	False	0	27	0	0	29	0	5	1	0	0		0.0						CN(C)c1ccc(C(CNc2c(C#N)nc(Cc3cccc4ccccc34)o2)N(C)C)cc1																							0.0		AKOS002292772		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	2		C27H29N5O	C27H29N5O			InChI=1S/C27H29N5O/c1-31(2)22-14-12-20(13-15-22)25(32(3)4)18-29-27-24(17-28)30-26(33-27)16-21-10-7-9-19-8-5-6-11-23(19)21/h5-15,25,29H,16,18H2,1-4H3	XQQGNBCSJMBTIH-UHFFFAOYSA-N	5-[[2-(dimethylamino)-2-[4-(dimethylamino)phenyl]ethyl]amino]-2-(1-naphthylmethyl)oxazole-4-carbonitrile	43843267	CN(C)c1ccc(C(CNc2c(C#N)nc(Cc3cccc4ccccc34)o2)N(C)C)cc1	5-[[2-(dimethylamino)-2-[4-(dimethylamino)phenyl]ethyl]amino]-2-(naphthalen-1-ylmethyl)-1,3-oxazole-4-carbonitrile			3.662600000000003													MCULE-9445101800	439.56508		439.237211	5	1	8	4			45										False	Alkaloids				Peptide01			Compound(43843267)	43843267	6.2	210			[#6]-[#7](-[#6])-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6]-[#7]-[#6]2:[#6](-[#6]#[#7]):[#7]:[#6](-[#6]-[#6]3:[#6]:[#6]:[#6]:[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]:3:4):[#8]:2)-[#7](-[#6])-[#6]):[#6]:[#6]:1	CN(C)c1ccc(C(CNc2c(C#N)nc(Cc3cccc4ccccc34)o2)N(C)C)cc1	XQQGNBCSJMBTIH		parent_pubchem_cid	AKOS002292772;AKOS016330051;5-[[2-(dimethylamino)-2-[4-(dimethylamino)phenyl]ethyl]amino]-2-(1-naphthylmethyl)oxazole-4-carbonitrile		23378396.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23378396		pluskal_iocb_peptide_Peptide01_B3_id		100	B3		
2.4		0	362	P1006072	108.7		F5	False	0	20	0	0	23	0	3	4	0	1		0.0						CCOc1c(S(=O)(=O)NCCc2c[nH]c3ccccc23)cc(NC(C)=O)cc1																							0.0		STK983490		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	1	0	0	0	0	0	0	0		C20H23N3O4S	C20H23N3O4S			InChI=1S/C20H23N3O4S/c1-3-27-19-9-8-16(23-14(2)24)12-20(19)28(25,26)22-11-10-15-13-21-18-7-5-4-6-17(15)18/h4-9,12-13,21-22H,3,10-11H2,1-2H3,(H,23,24)	WMNXOTFZSBCTAL-UHFFFAOYSA-N	N-[4-ethoxy-3-[2-(1H-indol-3-yl)ethylsulfamoyl]phenyl]acetamide	24283530	CCOc1c(S(=O)(=O)NCCc2c[nH]c3ccccc23)cc(NC(C)=O)cc1	N-[4-ethoxy-3-[2-(1H-indol-3-yl)ethylsulfamoyl]phenyl]acetamide			1.6118399999999995													MCULE-1803800005	401.48801		401.140927	4	3	8	3			44										False	Alkaloids				Peptide01			Compound(24283530)	24283530	2.5	211			[#6]-[#6]-[#8]-[#6]1:[#6](-[#16](=[#8])(=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6](-[#7]-[#6](-[#6])=[#8]):[#6]:[#6]:1	CCOc1c(S(=O)(=O)NCCc2c[nH]c3ccccc23)cc(NC(C)=O)cc1	WMNXOTFZSBCTAL		parent_pubchem_cid	STK983490;AKOS005646913;Z45538907;N-(4-ethoxy-3-{[2-(1H-indol-3-yl)ethyl]sulfamoyl}phenyl)acetamide;N-[4-ethoxy-3-[2-(1H-indol-3-yl)ethylsulfamoyl]phenyl]acetamide		10004149.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=10004149		pluskal_iocb_peptide_Peptide01_B3_id		100	B3		ZINC000011615628
2.4		0	450	P2195419	93.7		F6	False	0	22	0	0	26	0	2	5	0	0		0.0						COC(=O)C(Cc1ccccc1)NC(=O)CCCNC(=O)c1cc(OC)ccc1																							0.0		AKOS015861506		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C22H26N2O5	C22H26N2O5			InChI=1S/C22H26N2O5/c1-28-18-11-6-10-17(15-18)21(26)23-13-7-12-20(25)24-19(22(27)29-2)14-16-8-4-3-5-9-16/h3-6,8-11,15,19H,7,12-14H2,1-2H3,(H,23,26)(H,24,25)	FTBGFWAJCRBCMO-UHFFFAOYSA-N	methyl 2-[4-[(3-methoxybenzoyl)amino]butanoylamino]-3-phenyl-propanoate	51065888	COC(=O)C(Cc1ccccc1)NC(=O)CCCNC(=O)c1cc(OC)ccc1	methyl 2-[4-[(3-methoxybenzoyl)amino]butanoylamino]-3-phenylpropanoate			1.5338700000000005													MCULE-8656991123	398.46292		398.184172	5	2	11	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51065888)	51065888	2.7	212			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]-[#6]-[#6]-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:[#6]:1	COC(=O)C(Cc1ccccc1)NC(=O)CCCNC(=O)c1cc(OC)ccc1	FTBGFWAJCRBCMO		parent_pubchem_cid	AKOS015861506;methyl 2-[4-[(3-methoxybenzoyl)amino]butanoylamino]-3-phenyl-propanoate		24656083.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24656083		pluskal_iocb_peptide_Peptide01_B3_id		100	B3		
3.5		0	538	P2194114	84.5		F7	False	0	22	0	0	34	0	2	4	0	0		0.0						COC(=O)C(CC(C)C)NC(=O)CCCNC(=O)c1ccc(C(C)(C)C)cc1																							0.0		AKOS015860365		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C22H34N2O4	C22H34N2O4			InChI=1S/C22H34N2O4/c1-15(2)14-18(21(27)28-6)24-19(25)8-7-13-23-20(26)16-9-11-17(12-10-16)22(3,4)5/h9-12,15,18H,7-8,13-14H2,1-6H3,(H,23,26)(H,24,25)	UHVMHUSJXNIKIO-UHFFFAOYSA-N	methyl 2-[4-[(4-tert-butylbenzoyl)amino]butanoylamino]-4-methyl-pentanoate	51064928	COC(=O)C(CC(C)C)NC(=O)CCCNC(=O)c1ccc(C(C)(C)C)cc1	methyl 2-[4-[(4-tert-butylbenzoyl)amino]butanoylamino]-4-methylpentanoate			3.088580000000001													MCULE-5999858074	390.52728		390.251858	4	2	11	1			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51064928)	51064928	4.1	213			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=[#8])-[#6]-[#6]-[#6]-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6])(-[#6])-[#6]):[#6]:[#6]:1	COC(=O)C(CC(C)C)NC(=O)CCCNC(=O)c1ccc(C(C)(C)C)cc1	UHVMHUSJXNIKIO		parent_pubchem_cid	AKOS015860365;methyl 2-[4-[(4-tert-butylbenzoyl)amino]butanoylamino]-4-methyl-pentanoate		24471453.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24471453		pluskal_iocb_peptide_Peptide01_B3_id		100	B3		
4.6		0	626	P1305818	54.6		F8	False	0	25	0	0	24	0	2	3	0	0		0.0						COc1ccc(OCC(=O)N(C)C(c2ccccc2)c2c[nH]c3ccccc23)cc1																							0.0		N-[1H-indol-3-yl(phenyl)methyl]-2-(4-methoxyphenoxy)-N-methylacetamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C25H24N2O3	C25H24N2O3			InChI=1S/C25H24N2O3/c1-27(24(28)17-30-20-14-12-19(29-2)13-15-20)25(18-8-4-3-5-9-18)22-16-26-23-11-7-6-10-21(22)23/h3-16,25-26H,17H2,1-2H3	FDZVQRWWWPSSRY-UHFFFAOYSA-N	N-[1H-indol-3-yl(phenyl)methyl]-2-(4-methoxyphenoxy)-N-methyl-acetamide	20895154	COc1ccc(OCC(=O)N(C)C(c2ccccc2)c2c[nH]c3ccccc23)cc1	N-[1H-indol-3-yl(phenyl)methyl]-2-(4-methoxyphenoxy)-N-methylacetamide			3.3406400000000014													MCULE-8057317884	400.48163		400.178693	3	1	7	4			45										False	Alkaloids				Peptide01			Compound(20895154)	20895154	4.7	214			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]-[#6](=[#8])-[#7](-[#6])-[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	COc1ccc(OCC(=O)N(C)C(c2ccccc2)c2c[nH]c3ccccc23)cc1	FDZVQRWWWPSSRY		parent_pubchem_cid	N-[1H-indol-3-yl(phenyl)methyl]-2-(4-methoxyphenoxy)-N-methylacetamide;905779-96-6;AKOS001911808;AKOS016328389;Z1213699258;N-[(1H-indol-3-yl)(phenyl)methyl]-2-(4-methoxyphenoxy)-N-methylacetamide;N-[1H-indol-3-yl(phenyl)methyl]-2-(4-methoxyphenoxy)-N-methyl-acetamide		24684873.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24684873		pluskal_iocb_peptide_Peptide01_B3_id		100	B3		
0.8		0	370	P1157907	155.8		F9	False	0	17	0	0	22	0	4	6	0	0		0.0						COc1c2cc(C(=O)NC(CCCNC(N)=O)C(=O)O)[nH]c2c(OC)cc1																							0.0		STL461427		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C17H22N4O6	C17H22N4O6			InChI=1S/C17H22N4O6/c1-26-12-5-6-13(27-2)14-9(12)8-11(20-14)15(22)21-10(16(23)24)4-3-7-19-17(18)25/h5-6,8,10,20H,3-4,7H2,1-2H3,(H,21,22)(H,23,24)(H3,18,19,25)/t10-/m0/s1	UPZJJOCQKSTUDK-JTQLQIEISA-N	rac-(2S)-2-[(4,7-dimethoxy-1H-indole-2-carbonyl)amino]-5-ureido-pentanoic acid	16408512	COc1c2cc(C(=O)N[C@@H](CCCNC(N)=O)C(=O)O)[nH]c2c(OC)cc1	(2S)-5-(carbamoylamino)-2-[(4,7-dimethoxy-1H-indole-2-carbonyl)amino]pentanoic acid			-0.5913499999999978													MCULE-6856946925	378.38809		378.153934	6	5	9	2			44										False	Alkaloids				Peptide01			Compound(16408512)	16408512	0.7	215			[#6]-[#8]-[#6]1:[#6]2:[#6]:[#6](-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#8])-[#6](=[#8])-[#8]):[#7H]:[#6]:2:[#6](-[#8]-[#6]):[#6]:[#6]:1	COc1c2cc(C(=O)N[C@@H](CCCNC(N)=O)C(=O)O)[nH]c2c(OC)cc1	UPZJJOCQKSTUDK		parent_pubchem_cid	STL461427;AKOS016385143;N~5~-carbamoyl-N~2~-[(4,7-dimethoxy-1H-indol-2-yl)carbonyl]-L-ornithine;5-(CARBAMOYLAMINO)-2-[(4,7-DIMETHOXY-1H-INDOL-2-YL)FORMAMIDO]PENTANOIC ACID;rac-(2S)-2-[(4,7-dimethoxy-1H-indole-2-carbonyl)amino]-5-ureido-pentanoic acid		24326958.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24326958		pluskal_iocb_peptide_Peptide01_B3_id		100	B3		ZINC000008764305
1.8		0	458	P2195421	93.7		F10	False	0	18	0	0	26	0	2	5	0	0		0.0						COC(=O)C(CC(C)C)NC(=O)CCNC(=O)c1cc(OC)ccc1																							0.0		AKOS015861374		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C18H26N2O5	C18H26N2O5			InChI=1S/C18H26N2O5/c1-12(2)10-15(18(23)25-4)20-16(21)8-9-19-17(22)13-6-5-7-14(11-13)24-3/h5-7,11-12,15H,8-10H2,1-4H3,(H,19,22)(H,20,21)	GUJVMONLGYYCTD-UHFFFAOYSA-N	methyl 2-[3-[(3-methoxybenzoyl)amino]propanoylamino]-4-methyl-pentanoate	51065890	COC(=O)C(CC(C)C)NC(=O)CCNC(=O)c1cc(OC)ccc1	methyl 2-[3-[(3-methoxybenzoyl)amino]propanoylamino]-4-methylpentanoate			1.0018800000000003													MCULE-4978038975	350.41832		350.184172	5	2	10	1			45									Dipeptides;Simple amide alkaloids	False	Alkaloids;Amino acids and Peptides	Peptide alkaloids;Small peptides			Peptide01			Compound(51065890)	51065890	2.1	216			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=[#8])-[#6]-[#6]-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:[#6]:1	COC(=O)C(CC(C)C)NC(=O)CCNC(=O)c1cc(OC)ccc1	GUJVMONLGYYCTD		parent_pubchem_cid	AKOS015861374;methyl 2-[3-[(3-methoxybenzoyl)amino]propanoylamino]-4-methyl-pentanoate		24189042.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24189042		pluskal_iocb_peptide_Peptide01_B4_id		100	B4		
4.2		0	546	P4357593	80.3		F11	False	0	23	0	0	17	0	3	3	0	0	-1.0	0.0						N#Cc1c(NCc2cc3c(cc2)OCO3)oc(Cc2cccc3ccccc23)n1		4.63		0.0	4.01	CHEMBL1459214																	0.0		SMR000045880		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C23H17N3O3	C23H17N3O3			InChI=1S/C23H17N3O3/c24-12-19-23(25-13-15-8-9-20-21(10-15)28-14-27-20)29-22(26-19)11-17-6-3-5-16-4-1-2-7-18(16)17/h1-10,25H,11,13-14H2	LMKAUGIOPZPMFU-UHFFFAOYSA-N	5-(1,3-benzodioxol-5-ylmethylamino)-2-(1-naphthylmethyl)oxazole-4-carbonitrile	664923	N#Cc1c(NCc2cc3c(cc2)OCO3)oc(Cc2cccc3ccccc23)n1	5-(1,3-benzodioxol-5-ylmethylamino)-2-(naphthalen-1-ylmethyl)-1,3-oxazole-4-carbonitrile			2.678390000000001													MCULE-5273935134	383.41024	NEUTRAL	383.126991	5	1	5	5	0.0		29										False	Alkaloids		False	False	Peptide01		-1.0	Compound(664923)	664923	5.8	217			[#7]#[#6]-[#6]1:[#6](-[#7]-[#6]-[#6]2:[#6]:[#6]3:[#6](:[#6]:[#6]:2)-[#8]-[#6]-[#8]-3):[#8]:[#6](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#7]:1	N#Cc1c(NCc2cc3c(cc2)OCO3)oc(Cc2cccc3ccccc23)n1	LMKAUGIOPZPMFU		parent_pubchem_cid	SMR000045880;MLS000042402;MLS002584275;CHEMBL1459214;HMS2179E16;AKOS005184972;Z1213748458;5-(1,3-benzodioxol-5-ylmethylamino)-2-(1-naphthylmethyl)oxazole-4-carbonitrile	False	955691.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=955691		pluskal_iocb_peptide_Peptide01_B4_id		100	B4	False	ZINC000002434635
5.0		0	634	P1307961	73.0		F12	False	0	28	0	0	30	0	2	5	0	0		0.0						CCN(C(=O)c1cc(OC)c(OC)c(OC)c1)C(c1ccc(OC)cc1)c1c[nH]c2ccccc12																							0.0		STL208836		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C28H30N2O5	C28H30N2O5			InChI=1S/C28H30N2O5/c1-6-30(28(31)19-15-24(33-3)27(35-5)25(16-19)34-4)26(18-11-13-20(32-2)14-12-18)22-17-29-23-10-8-7-9-21(22)23/h7-17,26,29H,6H2,1-5H3	FRMCNBGGGNBARQ-UHFFFAOYSA-N	N-ethyl-N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-3,4,5-trimethoxy-benzamide	43843264	CCN(C(=O)c1cc(OC)c(OC)c(OC)c1)C(c1ccc(OC)cc1)c1c[nH]c2ccccc12	N-ethyl-N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-3,4,5-trimethoxybenzamide			3.0118100000000005													MCULE-6117554619	474.5617		474.215472	5	1	9	4			45										False	Alkaloids				Peptide01			Compound(43843264)	43843264	5.0	218			[#6]-[#6]-[#7](-[#6](=[#8])-[#6]1:[#6]:[#6](-[#8]-[#6]):[#6](-[#8]-[#6]):[#6](-[#8]-[#6]):[#6]:1)-[#6](-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CCN(C(=O)c1cc(OC)c(OC)c(OC)c1)C(c1ccc(OC)cc1)c1c[nH]c2ccccc12	FRMCNBGGGNBARQ		parent_pubchem_cid	STL208836;AKOS002291427;AKOS016330048;N-ethyl-N-[1H-indol-3-yl(4-methoxyphenyl)methyl]-3,4,5-trimethoxybenzamide;N-ethyl-N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-3,4,5-trimethoxy-benzamide		23887746.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23887746		pluskal_iocb_peptide_Peptide01_B4_id		100	B4		
3.4		0	378	P11185428	120.1		F13	False	0	24	0	0	24	0	4	4	0	0		0.0						COc1ccc(-c2n[nH]c(C)c2CC(=O)NC(Cc2c[nH]c3ccccc23)C(=O)O)cc1																							0.0		AKOS027472935		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	2	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	0	0	0	0	0	0	0		C24H24N4O4	C24H24N4O4			InChI=1S/C24H24N4O4/c1-14-19(23(28-27-14)15-7-9-17(32-2)10-8-15)12-22(29)26-21(24(30)31)11-16-13-25-20-6-4-3-5-18(16)20/h3-10,13,21,25H,11-12H2,1-2H3,(H,26,29)(H,27,28)(H,30,31)/t21-/m0/s1	DSQWDBHAFHLYDC-NRFANRHFSA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[[2-[3-(4-methoxyphenyl)-5-methyl-1H-pyrazol-4-yl]acetyl]amino]propanoic acid	110208058	COc1ccc(-c2n[nH]c(C)c2CC(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)cc1	(2S)-3-(1H-indol-3-yl)-2-[[2-[3-(4-methoxyphenyl)-5-methyl-1H-pyrazol-4-yl]acetyl]amino]propanoic acid			1.794639999999999														432.48328		432.179755	5	4	8	4			45										False	Alkaloids;Amino acids and Peptides	Tryptophan alkaloids			Peptide01			Compound(110208058)	110208058	2.3	219			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6]2:[#7]:[#7H]:[#6](-[#6]):[#6]:2-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6](=[#8])-[#8]):[#6]:[#6]:1	COc1ccc(-c2n[nH]c(C)c2CC(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)cc1	DSQWDBHAFHLYDC		parent_pubchem_cid	AKOS027472935;(2S)-3-(1H-INDOL-3-YL)-2-({2-[3-(4-METHOXYPHENYL)-5-METHYL-1H-PYRAZOL-4-YL]ACETYL}AMINO)PROPANOIC ACID;rac-(2S)-3-(1H-indol-3-yl)-2-[[2-[3-(4-methoxyphenyl)-5-methyl-1H-pyrazol-4-yl]acetyl]amino]propanoic acid		117136261.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=117136261		pluskal_iocb_peptide_Peptide01_B4_id		100	B4		ZINC000253400226
3.7		0	466	P2196138	143.8		F14	False	0	20	1	0	25	0	4	3	0	2		0.0						CCCSc1ncc(Cl)c(C(=O)NC(CCSC)C(=O)Nc2ccccc2OC)n1																							0.0		AKOS016027422		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C20H25ClN4O3S2	C20H25ClN4O3S2			InChI=1S/C20H25ClN4O3S2/c1-4-10-30-20-22-12-13(21)17(25-20)19(27)24-15(9-11-29-3)18(26)23-14-7-5-6-8-16(14)28-2/h5-8,12,15H,4,9-11H2,1-3H3,(H,23,26)(H,24,27)	VSXZBFZLPFFRFF-UHFFFAOYSA-N	5-chloro-N-[1-[(2-methoxyphenyl)carbamoyl]-3-methylsulfanyl-propyl]-2-propylsulfanyl-pyrimidine-4-carboxamide	52988691	CCCSc1ncc(Cl)c(C(=O)NC(CCSC)C(=O)Nc2ccccc2OC)n1	5-chloro-N-[1-(2-methoxyanilino)-4-methylsulfanyl-1-oxobutan-2-yl]-2-propylsulfanylpyrimidine-4-carboxamide			3.125160000000001													MCULE-3568629608	469.02825		468.10566	7	2	11	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(52988691)	52988691	4.1	220			[#6]-[#6]-[#6]-[#16]-[#6]1:[#7]:[#6]:[#6](-[#17]):[#6](-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]-[#16]-[#6])-[#6](=[#8])-[#7]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#8]-[#6]):[#7]:1	CCCSc1ncc(Cl)c(C(=O)NC(CCSC)C(=O)Nc2ccccc2OC)n1	VSXZBFZLPFFRFF		parent_pubchem_cid	AKOS016027422;5-chloro-N-[1-[(2-methoxyphenyl)carbamoyl]-3-methylsulfanyl-propyl]-2-propylsulfanyl-pyrimidine-4-carboxamide		24134830.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24134830		pluskal_iocb_peptide_Peptide01_B4_id		100	B4		
2.8		0	554	P7006196	78.4		F15	False	0	16	0	0	12	0	2	3	0	0		0.0						NC(=O)c1c(Oc2ccccc2)oc(-c2ccccc2)n1																							0.0		STL370765		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C16H12N2O3	C16H12N2O3			InChI=1S/C16H12N2O3/c17-14(19)13-16(20-12-9-5-2-6-10-12)21-15(18-13)11-7-3-1-4-8-11/h1-10H,(H2,17,19)	CGXIKLDMTXDMEW-UHFFFAOYSA-N	5-phenoxy-2-phenyl-oxazole-4-carboxamide	73253933	NC(=O)c1c(Oc2ccccc2)oc(-c2ccccc2)n1	5-phenoxy-2-phenyl-1,3-oxazole-4-carboxamide			1.87325													MCULE-2648550579	280.28564		280.084792	3	1	4	3			44										False					Peptide01			Compound(73253933)	73253933	3.1	221			[#7]-[#6](=[#8])-[#6]1:[#6](-[#8]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#8]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#7]:1	NC(=O)c1c(Oc2ccccc2)oc(-c2ccccc2)n1	CGXIKLDMTXDMEW		parent_pubchem_cid	STL370765;AKOS024254663;5-phenoxy-2-phenyl-1,3-oxazole-4-carboxamide;5-phenoxy-2-phenyl-oxazole-4-carboxamide		69862716.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=69862716		pluskal_iocb_peptide_Peptide01_B4_id		100	B4		ZINC000096346010
4.5		0	642	P1309974	63.8		F16	False	0	26	0	0	26	0	2	4	0	0		0.0						COc1ccc(OCC(=O)N(C)C(c2ccc(OC)cc2)c2c[nH]c3ccccc23)cc1																							0.0		AKOS001544335		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C26H26N2O4	C26H26N2O4			InChI=1S/C26H26N2O4/c1-28(25(29)17-32-21-14-12-20(31-3)13-15-21)26(18-8-10-19(30-2)11-9-18)23-16-27-24-7-5-4-6-22(23)24/h4-16,26-27H,17H2,1-3H3	WJIBGQGZUDPSIU-UHFFFAOYSA-N	N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-2-(4-methoxyphenoxy)-N-methyl-acetamide	20895160	COc1ccc(OCC(=O)N(C)C(c2ccc(OC)cc2)c2c[nH]c3ccccc23)cc1	N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-2-(4-methoxyphenoxy)-N-methylacetamide			2.8868300000000007													MCULE-9570954682	430.50812		430.189257	4	1	8	4			45										False	Alkaloids				Peptide01			Compound(20895160)	20895160	4.7	222			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]-[#6](=[#8])-[#7](-[#6])-[#6](-[#6]2:[#6]:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	COc1ccc(OCC(=O)N(C)C(c2ccc(OC)cc2)c2c[nH]c3ccccc23)cc1	WJIBGQGZUDPSIU		parent_pubchem_cid	AKOS001544335;AKOS016330356;N-[(1H-INDOL-3-YL)(4-METHOXYPHENYL)METHYL]-2-(4-METHOXYPHENOXY)-N-METHYLACETAMIDE;N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-2-(4-methoxyphenoxy)-N-methyl-acetamide		24280875.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24280875		pluskal_iocb_peptide_Peptide01_B4_id		100	B4		
3.5		0	386	P3462485	75.7		F17	False	0	26	0	0	24	0	2	4	0	0		0.0						COC(=O)C(Cc1ccccc1)NC(=O)C(c1ccccc1)N1Cc2ccccc2C1=O																							0.0		AKOS016382595		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	2	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0		C26H24N2O4	C26H24N2O4			InChI=1S/C26H24N2O4/c1-32-26(31)22(16-18-10-4-2-5-11-18)27-24(29)23(19-12-6-3-7-13-19)28-17-20-14-8-9-15-21(20)25(28)30/h2-15,22-23H,16-17H2,1H3,(H,27,29)/t22-,23-/m0/s1	ZFICSVLOYBUBPD-GOTSBHOMSA-N	methyl rac-(2S)-3-phenyl-2-[[rac-(2S)-2-(1-oxoisoindolin-2-yl)-2-phenyl-acetyl]amino]propanoate	37963706	COC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](c1ccccc1)N1Cc2ccccc2C1=O	methyl (2S)-2-[[(2S)-2-(3-oxo-1H-isoindol-2-yl)-2-phenylacetyl]amino]-3-phenylpropanoate			3.065360000000002													MCULE-1228959285	428.49218		428.173607	4	1	8	4			44										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(37963706)	37963706	3.9	223			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6@H](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]1-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6]-1=[#8]	COC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](c1ccccc1)N1Cc2ccccc2C1=O	ZFICSVLOYBUBPD		parent_pubchem_cid	AKOS016382595;METHYL 2-[2-(1-OXO-2,3-DIHYDRO-1H-ISOINDOL-2-YL)-2-PHENYLACETAMIDO]-3-PHENYLPROPANOATE;methyl rac-(2S)-3-phenyl-2-[[rac-(2S)-2-(1-oxoisoindolin-2-yl)-2-phenyl-acetyl]amino]propanoate		3890439.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=3890439		pluskal_iocb_peptide_Peptide01_B4_id		100	B4		ZINC000030819456
2.1		0	474	P2195697	84.5		F18	False	0	19	0	1	19	0	2	4	0	0		0.0						COC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)c1ccc(F)cc1																							0.0		AKOS015861626		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C19H19FN2O4	C19H19FN2O4			InChI=1S/C19H19FN2O4/c1-26-19(25)16(11-13-5-3-2-4-6-13)22-17(23)12-21-18(24)14-7-9-15(20)10-8-14/h2-10,16H,11-12H2,1H3,(H,21,24)(H,22,23)	BKLJGPLPKNUPOF-UHFFFAOYSA-N	methyl 2-[[2-[(4-fluorobenzoyl)amino]acetyl]amino]-3-phenyl-propanoate	52988567	COC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)c1ccc(F)cc1	methyl 2-[[2-[(4-fluorobenzoyl)amino]acetyl]amino]-3-phenylpropanoate			1.3465799999999992													MCULE-5701797229	358.37268		358.132885	4	2	8	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(52988567)	52988567	2.0	224			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:1	COC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)c1ccc(F)cc1	BKLJGPLPKNUPOF		parent_pubchem_cid	AKOS015861626;methyl 2-[[2-[(4-fluorobenzoyl)amino]acetyl]amino]-3-phenyl-propanoate		23403274.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23403274		pluskal_iocb_peptide_Peptide01_B5_id		100	B5		
4.6		0	562	P2189666	77.5		F19	False	0	27	0	0	31	0	1	6	0	0		0.0						COc1ccc(OCC(O)CN(C(=O)c2ccc(OC(C)C)cc2)c2ccc(OC)cc2)cc1																							0.0		1018051-94-9		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0		C27H31NO6	C27H31NO6			InChI=1S/C27H31NO6/c1-19(2)34-26-9-5-20(6-10-26)27(30)28(21-7-11-23(31-3)12-8-21)17-22(29)18-33-25-15-13-24(32-4)14-16-25/h5-16,19,22,29H,17-18H2,1-4H3	KJNTYMXXXGWGAR-UHFFFAOYSA-N	N-[2-hydroxy-3-(4-methoxyphenoxy)propyl]-4-isopropoxy-N-(4-methoxyphenyl)benzamide	45132853	COc1ccc(OCC(O)CN(C(=O)c2ccc(OC(C)C)cc2)c2ccc(OC)cc2)cc1	N-[2-hydroxy-3-(4-methoxyphenoxy)propyl]-N-(4-methoxyphenyl)-4-propan-2-yloxybenzamide			2.29274													MCULE-8315854267	465.55122		465.215138	6	1	11	3			45										False	Shikimates and Phenylpropanoids				Peptide01			Compound(45132853)	45132853	4.7	225			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]-[#6](-[#8])-[#6]-[#7](-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6](-[#8]-[#6](-[#6])-[#6]):[#6]:[#6]:2)-[#6]2:[#6]:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:2):[#6]:[#6]:1	COc1ccc(OCC(O)CN(C(=O)c2ccc(OC(C)C)cc2)c2ccc(OC)cc2)cc1	KJNTYMXXXGWGAR		parent_pubchem_cid	1018051-94-9;Benzamide, N-[2-hydroxy-3-(4-methoxyphenoxy)propyl]-N-(4-methoxyphenyl)-4-(1-methylethoxy)-;DTXSID701124175;AKOS015859196;N-[2-Hydroxy-3-(4-methoxyphenoxy)propyl]-N-(4-methoxyphenyl)-4-(1-methylethoxy)benzamide;N-[2-hydroxy-3-(4-methoxyphenoxy)propyl]-4-isopropoxy-N-(4-methoxyphenyl)benzamide		23796273.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23796273		pluskal_iocb_peptide_Peptide01_B5_id		100	B5		
4.9		0	650	P1301238	72.6		F20	False	0	27	0	0	28	0	2	4	0	0		0.0						CCOc1c(OC)cc(C(CNC(=O)c2ccc(OC)cc2)c2c[nH]c3ccccc23)cc1																							0.0		AKOS002326661		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C27H28N2O4	C27H28N2O4			InChI=1S/C27H28N2O4/c1-4-33-25-14-11-19(15-26(25)32-3)22(23-17-28-24-8-6-5-7-21(23)24)16-29-27(30)18-9-12-20(31-2)13-10-18/h5-15,17,22,28H,4,16H2,1-3H3,(H,29,30)	MIYROIRQNGWDAS-UHFFFAOYSA-N	N-[2-(4-ethoxy-3-methoxy-phenyl)-2-(1H-indol-3-yl)ethyl]-4-methoxy-benzamide	17010958	CCOc1c(OC)cc(C(CNC(=O)c2ccc(OC)cc2)c2c[nH]c3ccccc23)cc1	N-[2-(4-ethoxy-3-methoxyphenyl)-2-(1H-indol-3-yl)ethyl]-4-methoxybenzamide			3.1659200000000007													MCULE-2664314867	444.53521		444.204907	4	2	9	4			45										False	Alkaloids				Peptide01			Compound(17010958)	17010958	5.0	226			[#6]-[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]):[#6]:[#6](-[#6](-[#6]-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	CCOc1c(OC)cc(C(CNC(=O)c2ccc(OC)cc2)c2c[nH]c3ccccc23)cc1	MIYROIRQNGWDAS		parent_pubchem_cid	AKOS002326661;AKOS016325398;N-[2-(4-ethoxy-3-methoxyphenyl)-2-(1H-indol-3-yl)ethyl]-4-methoxybenzamide;N-[2-(4-ethoxy-3-methoxy-phenyl)-2-(1H-indol-3-yl)ethyl]-4-methoxy-benzamide		23402081.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23402081		pluskal_iocb_peptide_Peptide01_B5_id		100	B5		
3.4		0	394	P6236298	96.4		F21	False	0	23	0	0	23	0	3	4	0	0		0.0						COc1cc2c(cc1)n(CCC(=O)NC(Cc1c[nH]c3ccccc13)C(=O)O)cc2																							0.0		AKOS016384868		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C23H23N3O4	C23H23N3O4			InChI=1S/C23H23N3O4/c1-30-17-6-7-21-15(12-17)8-10-26(21)11-9-22(27)25-20(23(28)29)13-16-14-24-19-5-3-2-4-18(16)19/h2-8,10,12,14,20,24H,9,11,13H2,1H3,(H,25,27)(H,28,29)/t20-/m0/s1	OXCSPHWGLNUPJC-FQEVSTJZSA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[3-(5-methoxyindol-1-yl)propanoylamino]propanoic acid	29148568	COc1cc2c(cc1)n(CCC(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)O)cc2	(2S)-3-(1H-indol-3-yl)-2-[3-(5-methoxyindol-1-yl)propanoylamino]propanoic acid			1.959439999999999													MCULE-4778299978	405.45746		405.168856	4	3	8	4			44										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(29148568)	29148568	2.9	227			[#6]-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#7](-[#6]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:1:3)-[#6](=[#8])-[#8]):[#6]:[#6]:2	COc1cc2c(cc1)n(CCC(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)O)cc2	OXCSPHWGLNUPJC		parent_pubchem_cid	AKOS016384868;N-[3-(5-methoxy-1H-indol-1-yl)propanoyl]-L-tryptophan;rac-(2S)-3-(1H-indol-3-yl)-2-[3-(5-methoxyindol-1-yl)propanoylamino]propanoic acid		24795632.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24795632		pluskal_iocb_peptide_Peptide01_B5_id		100	B5		ZINC000020763677
2.9		0	482	P2195234	84.5		F22	False	0	22	0	0	26	0	2	4	0	0		0.0						COC(=O)CCCNC(=O)C(Cc1ccccc1)NC(=O)c1ccc(C)cc1																							0.0		AKOS015861313		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C22H26N2O4	C22H26N2O4			InChI=1S/C22H26N2O4/c1-16-10-12-18(13-11-16)21(26)24-19(15-17-7-4-3-5-8-17)22(27)23-14-6-9-20(25)28-2/h3-5,7-8,10-13,19H,6,9,14-15H2,1-2H3,(H,23,27)(H,24,26)	LSSSDRXEZITOCC-UHFFFAOYSA-N	methyl 4-[[2-[(4-methylbenzoyl)amino]-3-phenyl-propanoyl]amino]butanoate	51065742	COC(=O)CCCNC(=O)C(Cc1ccccc1)NC(=O)c1ccc(C)cc1	methyl 4-[[2-[(4-methylbenzoyl)amino]-3-phenylpropanoyl]amino]butanoate			2.241389999999999													MCULE-9377789790	382.46352		382.189257	4	2	10	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51065742)	51065742	3.1	228			[#6]-[#8]-[#6](=[#8])-[#6]-[#6]-[#6]-[#7]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:1	COC(=O)CCCNC(=O)C(Cc1ccccc1)NC(=O)c1ccc(C)cc1	LSSSDRXEZITOCC		parent_pubchem_cid	AKOS015861313;methyl 4-[[2-[(4-methylbenzoyl)amino]-3-phenyl-propanoyl]amino]butanoate		23712164.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23712164		pluskal_iocb_peptide_Peptide01_B5_id		100	B5		
4.7		0	570	P2190593	63.8		F23	False	0	26	0	0	26	0	2	4	0	0		0.0						COc1cc(C(=O)N(C)C(c2ccccc2)c2c[nH]c3ccccc23)cc(OC)c1OC																							0.0		AKOS004934496		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C26H26N2O4	C26H26N2O4			InChI=1S/C26H26N2O4/c1-28(26(29)18-14-22(30-2)25(32-4)23(15-18)31-3)24(17-10-6-5-7-11-17)20-16-27-21-13-9-8-12-19(20)21/h5-16,24,27H,1-4H3	YZTMJBUZQSBLSW-UHFFFAOYSA-N	N-[1H-indol-3-yl(phenyl)methyl]-3,4,5-trimethoxy-N-methyl-benzamide	45133013	COc1cc(C(=O)N(C)C(c2ccccc2)c2c[nH]c3ccccc23)cc(OC)c1OC	N-[1H-indol-3-yl(phenyl)methyl]-3,4,5-trimethoxy-N-methylbenzamide			3.075520000000002													MCULE-7955994827	430.50812		430.189257	4	1	7	4			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(45133013)	45133013	4.6	229			[#6]-[#8]-[#6]1:[#6]:[#6](-[#6](=[#8])-[#7](-[#6])-[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6](-[#8]-[#6]):[#6]:1-[#8]-[#6]	COc1cc(C(=O)N(C)C(c2ccccc2)c2c[nH]c3ccccc23)cc(OC)c1OC	YZTMJBUZQSBLSW		parent_pubchem_cid	AKOS004934496;N-[(1H-INDOL-3-YL)(PHENYL)METHYL]-3,4,5-TRIMETHOXY-N-METHYLBENZAMIDE;N-[1H-indol-3-yl(phenyl)methyl]-3,4,5-trimethoxy-N-methyl-benzamide		23759634.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23759634		pluskal_iocb_peptide_Peptide01_B5_id		100	B5		
4.9		0	658	P1307913	54.6		F24	False	0	26	0	0	26	0	2	3	0	0		0.0						CCN(C(=O)COc1ccccc1)C(c1ccc(OC)cc1)c1c[nH]c2ccccc12																							0.0		STL208792		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C26H26N2O3	C26H26N2O3			InChI=1S/C26H26N2O3/c1-3-28(25(29)18-31-21-9-5-4-6-10-21)26(19-13-15-20(30-2)16-14-19)23-17-27-24-12-8-7-11-22(23)24/h4-17,26-27H,3,18H2,1-2H3	LQGXLJLESWOCEQ-UHFFFAOYSA-N	N-ethyl-N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-2-phenoxy-acetamide	43843249	CCN(C(=O)COc1ccccc1)C(c1ccc(OC)cc1)c1c[nH]c2ccccc12	N-ethyl-N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-2-phenoxyacetamide			3.7307400000000026													MCULE-1080941831	414.50872		414.194343	3	1	8	4			45										False	Alkaloids				Peptide01			Compound(43843249)	43843249	5.1	230			[#6]-[#6]-[#7](-[#6](=[#8])-[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CCN(C(=O)COc1ccccc1)C(c1ccc(OC)cc1)c1c[nH]c2ccccc12	LQGXLJLESWOCEQ		parent_pubchem_cid	STL208792;AKOS002294747;AKOS016330032;N-ethyl-N-[1H-indol-3-yl(4-methoxyphenyl)methyl]-2-phenoxyacetamide;N-ethyl-N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-2-phenoxy-acetamide		23989334.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23989334		pluskal_iocb_peptide_Peptide01_B5_id		100	B5		
2.0		0	402	P3458833	114.8		F25	False	0	20	0	0	18	0	6	3	0	0		0.0						COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c1ccc(-n2cnnn2)cc1																							0.0		AKOS005535067		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	4	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C20H18N6O3	C20H18N6O3			InChI=1S/C20H18N6O3/c1-29-20(28)18(10-14-11-21-17-5-3-2-4-16(14)17)23-19(27)13-6-8-15(9-7-13)26-12-22-24-25-26/h2-9,11-12,18,21H,10H2,1H3,(H,23,27)/t18-/m0/s1	CVQCXSOEPBUNDY-SFHVURJKSA-N	methyl rac-(2S)-3-(1H-indol-3-yl)-2-[[4-(tetrazol-1-yl)benzoyl]amino]propanoate	29134519	COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1ccc(-n2cnnn2)cc1	methyl (2S)-3-(1H-indol-3-yl)-2-[[4-(tetrazol-1-yl)benzoyl]amino]propanoate			0.9298499999999996													MCULE-6362243375	390.40486		390.144038	6	2	7	4			44									Imidazole alkaloids;Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids;Histidine alkaloids			Peptide01			Compound(29134519)	29134519	2.4	231			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#7]2:[#6]:[#7]:[#7]:[#7]:2):[#6]:[#6]:1	COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1ccc(-n2cnnn2)cc1	CVQCXSOEPBUNDY		parent_pubchem_cid	AKOS005535067;METHYL 3-(1H-INDOL-3-YL)-2-{[4-(1H-1,2,3,4-TETRAZOL-1-YL)PHENYL]FORMAMIDO}PROPANOATE;methyl rac-(2S)-3-(1H-indol-3-yl)-2-[[4-(tetrazol-1-yl)benzoyl]amino]propanoate		10299429.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=10299429		pluskal_iocb_peptide_Peptide01_B5_id		100	B5		ZINC000020731356
4.2		0	490	P2195185	67.4		F26	False	0	24	0	0	24	0	2	3	0	0		0.0						COc1ccc(NC(=O)C(Cc2ccccc2)NC(=O)c2ccc(C)cc2)cc1																							0.0		AKOS015861447		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C24H24N2O3	C24H24N2O3			InChI=1S/C24H24N2O3/c1-17-8-10-19(11-9-17)23(27)26-22(16-18-6-4-3-5-7-18)24(28)25-20-12-14-21(29-2)15-13-20/h3-15,22H,16H2,1-2H3,(H,25,28)(H,26,27)	KPMSSDVZXYXWKK-UHFFFAOYSA-N	N-[1-benzyl-2-(4-methoxyanilino)-2-oxo-ethyl]-4-methyl-benzamide	51065702	COc1ccc(NC(=O)C(Cc2ccccc2)NC(=O)c2ccc(C)cc2)cc1	N-[1-(4-methoxyanilino)-1-oxo-3-phenylpropan-2-yl]-4-methylbenzamide			2.9762700000000013													MCULE-4073419578	388.47048		388.178693	3	2	7	3			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51065702)	51065702	4.4	232			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#7]-[#6](=[#8])-[#6](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:2):[#6]:[#6]:1	COc1ccc(NC(=O)C(Cc2ccccc2)NC(=O)c2ccc(C)cc2)cc1	KPMSSDVZXYXWKK		parent_pubchem_cid	AKOS015861447;N-[1-benzyl-2-(4-methoxyanilino)-2-oxo-ethyl]-4-methyl-benzamide		24341773.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24341773		pluskal_iocb_peptide_Peptide01_B6_id		100	B6		
4.4		0	578	P1307060	73.6		F27	False	0	22	0	0	20	0	2	2	0	1		0.0						CN(C(=O)COc1ccccc1)C(c1cccs1)c1c[nH]c2ccccc12																							0.0		STL208085		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C22H20N2O2S	C22H20N2O2S			InChI=1S/C22H20N2O2S/c1-24(21(25)15-26-16-8-3-2-4-9-16)22(20-12-7-13-27-20)18-14-23-19-11-6-5-10-17(18)19/h2-14,22-23H,15H2,1H3	ITKASEDOQYPROC-UHFFFAOYSA-N	N-[1H-indol-3-yl(2-thienyl)methyl]-N-methyl-2-phenoxy-acetamide	20895177	CN(C(=O)COc1ccccc1)C(c1cccs1)c1c[nH]c2ccccc12	N-[1H-indol-3-yl(thiophen-2-yl)methyl]-N-methyl-2-phenoxyacetamide			3.855950000000002													MCULE-5478288770	376.4809		376.124549	2	1	6	4			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(20895177)	20895177	4.5	233			[#6]-[#7](-[#6](=[#8])-[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](-[#6]1:[#6]:[#6]:[#6]:[#16]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CN(C(=O)COc1ccccc1)C(c1cccs1)c1c[nH]c2ccccc12	ITKASEDOQYPROC		parent_pubchem_cid	STL208085;AKOS001912497;AKOS016329108;CCG-154604;N-[1H-indol-3-yl(thiophen-2-yl)methyl]-N-methyl-2-phenoxyacetamide;N-[(1H-INDOL-3-YL)(THIOPHEN-2-YL)METHYL]-N-METHYL-2-PHENOXYACETAMIDE;N-[1H-indol-3-yl(2-thienyl)methyl]-N-methyl-2-phenoxy-acetamide		23626718.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23626718		pluskal_iocb_peptide_Peptide01_B6_id		100	B6		
5.0		0	666	P1310234	54.6		F28	False	0	26	0	0	26	0	2	3	0	0		0.0						COc1ccc(C(c2c[nH]c3ccccc23)N(C)C(=O)COc2ccc(C)cc2)cc1																							0.0		AKOS002281038		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C26H26N2O3	C26H26N2O3			InChI=1S/C26H26N2O3/c1-18-8-12-21(13-9-18)31-17-25(29)28(2)26(19-10-14-20(30-3)15-11-19)23-16-27-24-7-5-4-6-22(23)24/h4-16,26-27H,17H2,1-3H3	RMPRHQBFDTZBCI-UHFFFAOYSA-N	N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-N-methyl-2-(4-methylphenoxy)acetamide	43843743	COc1ccc(C(c2c[nH]c3ccccc23)N(C)C(=O)COc2ccc(C)cc2)cc1	N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-N-methyl-2-(4-methylphenoxy)acetamide			3.594350000000002													MCULE-3026547020	414.50872		414.194343	3	1	7	4			45										False	Alkaloids				Peptide01			Compound(43843743)	43843743	5.1	234			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#7](-[#6])-[#6](=[#8])-[#6]-[#8]-[#6]2:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:2):[#6]:[#6]:1	COc1ccc(C(c2c[nH]c3ccccc23)N(C)C(=O)COc2ccc(C)cc2)cc1	RMPRHQBFDTZBCI		parent_pubchem_cid	AKOS002281038;AKOS016329037;N-[(1H-INDOL-3-YL)(4-METHOXYPHENYL)METHYL]-N-METHYL-2-(4-METHYLPHENOXY)ACETAMIDE;N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-N-methyl-2-(4-methylphenoxy)acetamide		23164592.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23164592		pluskal_iocb_peptide_Peptide01_B6_id		100	B6		
3.1		0	410	P3462468	71.3		F29	False	0	19	0	1	17	0	2	3	0	0		0.0						O=C(Cn1ccc2c1cc(F)cc2)NC(Cc1ccccc1)C(=O)O																							0.0		N-[(6-fluoro-1H-indol-1-yl)acetyl]-L-phenylalanine		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C19H17FN2O3	C19H17FN2O3			InChI=1S/C19H17FN2O3/c20-15-7-6-14-8-9-22(17(14)11-15)12-18(23)21-16(19(24)25)10-13-4-2-1-3-5-13/h1-9,11,16H,10,12H2,(H,21,23)(H,24,25)/t16-/m0/s1	ATKINTXKKGBJRD-INIZCTEOSA-N	rac-(2S)-2-[[2-(6-fluoroindol-1-yl)acetyl]amino]-3-phenyl-propanoic acid	29134561	O=C(Cn1ccc2c1cc(F)cc2)N[C@@H](Cc1ccccc1)C(=O)O	(2S)-2-[[2-(6-fluoroindol-1-yl)acetyl]amino]-3-phenylpropanoic acid			2.10937													MCULE-2812208595	340.35734		340.122321	3	2	6	3			44										False					Peptide01			Compound(29134561)	29134561	3.1	235			[#8]=[#6](-[#6]-[#7]1:[#6]:[#6]:[#6]2:[#6]:1:[#6]:[#6](-[#9]):[#6]:[#6]:2)-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	O=C(Cn1ccc2c1cc(F)cc2)N[C@@H](Cc1ccccc1)C(=O)O	ATKINTXKKGBJRD		parent_pubchem_cid	N-[(6-fluoro-1H-indol-1-yl)acetyl]-L-phenylalanine;AKOS016402567;rac-(2S)-2-[[2-(6-fluoroindol-1-yl)acetyl]amino]-3-phenyl-propanoic acid		24204056.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24204056		pluskal_iocb_peptide_Peptide01_B6_id		100	B6		ZINC000020731466
4.4		0	498	P2195266	118.5		F30	False	0	21	1	0	27	0	4	3	0	1		0.0						CCOc1ccc(NC(=O)C(CC(C)C)NC(=O)c2nc(SCC)ncc2Cl)cc1																							0.0		AKOS015861292		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C21H27ClN4O3S	C21H27ClN4O3S			InChI=1S/C21H27ClN4O3S/c1-5-29-15-9-7-14(8-10-15)24-19(27)17(11-13(3)4)25-20(28)18-16(22)12-23-21(26-18)30-6-2/h7-10,12-13,17H,5-6,11H2,1-4H3,(H,24,27)(H,25,28)	RHKSIQREDXACST-UHFFFAOYSA-N	5-chloro-N-[1-[(4-ethoxyphenyl)carbamoyl]-3-methyl-butyl]-2-ethylsulfanyl-pyrimidine-4-carboxamide	51065771	CCOc1ccc(NC(=O)C(CC(C)C)NC(=O)c2nc(SCC)ncc2Cl)cc1	5-chloro-N-[1-(4-ethoxyanilino)-4-methyl-1-oxopentan-2-yl]-2-ethylsulfanylpyrimidine-4-carboxamide			3.418160000000001													MCULE-8425334406	450.99134		450.149239	6	2	10	2			45										False	Alkaloids				Peptide01			Compound(51065771)	51065771	4.6	236			[#6]-[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#7]-[#6](=[#8])-[#6](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=[#8])-[#6]2:[#7]:[#6](-[#16]-[#6]-[#6]):[#7]:[#6]:[#6]:2-[#17]):[#6]:[#6]:1	CCOc1ccc(NC(=O)C(CC(C)C)NC(=O)c2nc(SCC)ncc2Cl)cc1	RHKSIQREDXACST		parent_pubchem_cid	AKOS015861292;5-chloro-N-[1-[(4-ethoxyphenyl)carbamoyl]-3-methyl-butyl]-2-ethylsulfanyl-pyrimidine-4-carboxamide		22711175.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22711175		pluskal_iocb_peptide_Peptide01_B6_id		100	B6		
4.8		0	586	P1305496	44.9		F31	False	0	23	0	1	19	0	2	1	0	0		0.0						O=C(NCC(c1ccccc1)c1c[nH]c2ccccc12)c1ccc(F)cc1																							0.0		4-fluoro-N-[2-(1H-indol-3-yl)-2-phenylethyl]benzamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C23H19FN2O	C23H19FN2O			InChI=1S/C23H19FN2O/c24-18-12-10-17(11-13-18)23(27)26-14-20(16-6-2-1-3-7-16)21-15-25-22-9-5-4-8-19(21)22/h1-13,15,20,25H,14H2,(H,26,27)	RRDHFCQLLKJUHZ-UHFFFAOYSA-N	4-fluoro-N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]benzamide	17014643	O=C(NCC(c1ccccc1)c1c[nH]c2ccccc12)c1ccc(F)cc1	4-fluoro-N-[2-(1H-indol-3-yl)-2-phenylethyl]benzamide			4.276350000000003													MCULE-4032195069	358.41908		358.148141	1	2	5	4			45										False	Alkaloids;Shikimates and Phenylpropanoids				Peptide01			Compound(17014643)	17014643	4.8	237			[#8]=[#6](-[#7]-[#6]-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6]1:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:1	O=C(NCC(c1ccccc1)c1c[nH]c2ccccc12)c1ccc(F)cc1	RRDHFCQLLKJUHZ		parent_pubchem_cid	4-fluoro-N-[2-(1H-indol-3-yl)-2-phenylethyl]benzamide;HMS3456O12;AKOS002334444;AKOS016326707;4-fluoro-N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]benzamide		23211249.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23211249		pluskal_iocb_peptide_Peptide01_B6_id		100	B6		
3.4		0	674	P6236886	132.8		F32	False	0	19	0	0	24	0	2	3	0	2		0.0						CSCCC(NC(=O)Cc1csc(-c2ccc(C(C)C)cc2)n1)C(=O)O																							0.0		SCHEMBL20255487		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C19H24N2O3S2	C19H24N2O3S2			InChI=1S/C19H24N2O3S2/c1-12(2)13-4-6-14(7-5-13)18-20-15(11-26-18)10-17(22)21-16(19(23)24)8-9-25-3/h4-7,11-12,16H,8-10H2,1-3H3,(H,21,22)(H,23,24)/t16-/m0/s1	PBDDKNFDOIVISH-INIZCTEOSA-N	rac-(2S)-2-[[2-[2-(4-isopropylphenyl)thiazol-4-yl]acetyl]amino]-4-methylsulfanyl-butanoic acid	29132811	CSCC[C@H](NC(=O)Cc1csc(-c2ccc(C(C)C)cc2)n1)C(=O)O	(2S)-4-methylsulfanyl-2-[[2-[2-(4-propan-2-ylphenyl)-1,3-thiazol-4-yl]acetyl]amino]butanoic acid			3.309060000000001													MCULE-3847451683	392.54273		392.122835	5	2	9	2			43									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(29132811)	29132811	3.6	238		SCHEMBL20255487	[#6]-[#16]-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#6]1:[#6]:[#16]:[#6](-[#6]2:[#6]:[#6]:[#6](-[#6](-[#6])-[#6]):[#6]:[#6]:2):[#7]:1)-[#6](=[#8])-[#8]	CSCC[C@H](NC(=O)Cc1csc(-c2ccc(C(C)C)cc2)n1)C(=O)O	PBDDKNFDOIVISH		parent_pubchem_cid	SCHEMBL20255487;AKOS016376777;rac-(2S)-2-[[2-[2-(4-isopropylphenyl)thiazol-4-yl]acetyl]amino]-4-methylsulfanyl-butanoic acid		24202806.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24202806		pluskal_iocb_peptide_Peptide01_B6_id		100	B6		ZINC000020726433
4.2		0	418	P3460532	70.7		F33	False	0	25	0	0	20	0	4	1	0	0		0.0						O=C(NCCc1c[nH]c2ccccc12)c1cc(-c2ccncc2)nc2ccccc12								Bipyridines and oligopyridines;3-alkylindoles;Pyridinecarboxylic acids and derivatives;Substituted pyrroles;Benzenoids;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Organooxygen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	3-alkylindoles;Azacyclic compounds;Benzenoids;Bipyridines and oligopyridines;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Pyridinecarboxylic acids and derivatives;Pyridines and derivatives;Pyrroles;Quinoline carboxamides;Quinolines and derivatives;Secondary carboxylic acid amides;Substituted pyrroles	Quinolines and derivatives	2.1	This compound belongs to the class of organic compounds known as quinoline carboxamides. These are quinolines in which the quinoline ring system is substituted by one or more carboxamide groups.	Quinoline carboxamides			Organic compounds	Aromatic heteropolycyclic compounds	bipyridines (CHEBI:50511);indoles (CHEBI:24828);aromatic carboxylic acid (CHEBI:33859);pyridinemonocarboxylic acid (CHEBI:26420);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organonitrogen heterocyclic compound (CHEBI:38101);organooxygen compound (CHEBI:36963);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);quinolines (CHEBI:26513);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);pyridines (CHEBI:26421);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143)		Quinoline carboxamides	Quinoline-4-carboxamide;Bipyridine;3-alkylindole;Indole;Indole or derivatives;Pyridine carboxylic acid or derivatives;Benzenoid;Substituted pyrrole;Pyridine;Pyrrole;Heteroaromatic compound;Secondary carboxylic acid amide;Carboxamide group;Carboxylic acid derivative;Azacycle;Organic oxide;Organic oxygen compound;Organooxygen compound;Organonitrogen compound;Organic nitrogen compound;Hydrocarbon derivative;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		1144438-11-8		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C25H20N4O	C25H20N4O			InChI=1S/C25H20N4O/c30-25(27-14-11-18-16-28-22-7-3-1-5-19(18)22)21-15-24(17-9-12-26-13-10-17)29-23-8-4-2-6-20(21)23/h1-10,12-13,15-16,28H,11,14H2,(H,27,30)	ITBGVAOKFFAONE-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)ethyl]-2-(4-pyridyl)quinoline-4-carboxamide	27645306	O=C(NCCc1c[nH]c2ccccc12)c1cc(-c2ccncc2)nc2ccccc12	N-[2-(1H-indol-3-yl)ethyl]-2-pyridin-4-ylquinoline-4-carboxamide			3.404320000000002													MCULE-4924723349	392.46435		392.163711	3	2	5	5			44										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(27645306)	27645306	4.1	239			[#8]=[#6](-[#7]-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6]1:[#6]:[#6](-[#6]2:[#6]:[#6]:[#7]:[#6]:[#6]:2):[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	O=C(NCCc1c[nH]c2ccccc12)c1cc(-c2ccncc2)nc2ccccc12	ITBGVAOKFFAONE		parent_pubchem_cid	1144438-11-8;N-[2-(1H-indol-3-yl)ethyl]-2-(4-pyridyl)-4-quinolinecarboxamide;N-[2-(1H-indol-3-yl)ethyl]-2-(pyridin-4-yl)quinoline-4-carboxamide;AKOS016400169;N-[2-(1H-indol-3-yl)ethyl]-2-(4-pyridyl)quinoline-4-carboxamide		2451406.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=2451406		pluskal_iocb_peptide_Peptide01_B6_id		100	B6		ZINC000017295613
0.5		0	506	P2194583	166.6		F34	False	0	15	0	0	19	0	3	6	0	1		0.0						CSCCC(NC(=O)CCNC(=O)c1ccc([N+](=O)[O-])cc1)C(=O)O																							0.0		STL218049		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	1		C15H19N3O6S	C15H19N3O6S			InChI=1S/C15H19N3O6S/c1-25-9-7-12(15(21)22)17-13(19)6-8-16-14(20)10-2-4-11(5-3-10)18(23)24/h2-5,12H,6-9H2,1H3,(H,16,20)(H,17,19)(H,21,22)	YITUXOYQSKMYPA-UHFFFAOYSA-N	4-methylsulfanyl-2-[3-[(4-nitrobenzoyl)amino]propanoylamino]butanoic acid	51065243	CSCCC(NC(=O)CCNC(=O)c1ccc([N+](=O)[O-])cc1)C(=O)O	4-methylsulfanyl-2-[3-[(4-nitrobenzoyl)amino]propanoylamino]butanoic acid			0.6018799999999995													MCULE-5296875226	369.39918		369.099456	7	3	10	1			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51065243)	51065243	0.9	240			[#6]-[#16]-[#6]-[#6]-[#6](-[#7]-[#6](=[#8])-[#6]-[#6]-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#7+](=[#8])-[#8-]):[#6]:[#6]:1)-[#6](=[#8])-[#8]	CSCCC(NC(=O)CCNC(=O)c1ccc([N+](=O)[O-])cc1)C(=O)O	YITUXOYQSKMYPA		parent_pubchem_cid	STL218049;AKOS015860735;N-[(4-nitrophenyl)carbonyl]-beta-alanylmethionine;4-methylsulfanyl-2-[3-[(4-nitrobenzoyl)amino]propanoylamino]butanoic acid		24567541.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24567541		pluskal_iocb_peptide_Peptide01_B7_id		100	B7		
5.0		0	594	P1687048	42.4		F35	False	0	23	0	0	24	0	2	2	0	0		0.0						CC(C)COc1ccc(C(=O)N(Cc2ccccc2)c2ccccn2)cc1																							0.0		N-benzyl-4-(2-methylpropoxy)-N-(pyridin-2-yl)benzamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0		C23H24N2O2	C23H24N2O2			InChI=1S/C23H24N2O2/c1-18(2)17-27-21-13-11-20(12-14-21)23(26)25(22-10-6-7-15-24-22)16-19-8-4-3-5-9-19/h3-15,18H,16-17H2,1-2H3	GDGVXBCLMONIQZ-UHFFFAOYSA-N	N-benzyl-4-isobutoxy-N-(2-pyridyl)benzamide	16436146	CC(C)COc1ccc(C(=O)N(Cc2ccccc2)c2ccccn2)cc1	N-benzyl-4-(2-methylpropoxy)-N-pyridin-2-ylbenzamide			4.010960000000003													MCULE-8197859782	360.45993		360.183778	3	0	7	3			44									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(16436146)	16436146	5.0	241			[#6]-[#6](-[#6])-[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](=[#8])-[#7](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]2:[#6]:[#6]:[#6]:[#6]:[#7]:2):[#6]:[#6]:1	CC(C)COc1ccc(C(=O)N(Cc2ccccc2)c2ccccn2)cc1	GDGVXBCLMONIQZ		parent_pubchem_cid	N-benzyl-4-(2-methylpropoxy)-N-(pyridin-2-yl)benzamide;AKOS001511888;N-benzyl-4-isobutoxy-N-(2-pyridyl)benzamide		7977740.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=7977740		pluskal_iocb_peptide_Peptide01_B7_id		100	B7		ZINC000006804383
3.5		0	682	P3460042	101.9		F36	False	0	23	0	0	25	0	1	6	0	0	-1.0	0.0						CC(C)(C)OC(=O)CC(NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O		3.71		0.0	3.6	CHEMBL4633466																	0.0		Fmoc-Asp(OtBu)-OH		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	1	0	3	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C23H25NO6	C23H25NO6			InChI=1S/C23H25NO6/c1-23(2,3)30-20(25)12-19(21(26)27)24-22(28)29-13-18-16-10-6-4-8-14(16)15-9-5-7-11-17(15)18/h4-11,18-19H,12-13H2,1-3H3,(H,24,28)(H,26,27)/t19-/m0/s1	FODJWPHPWBKDON-IBGZPJMESA-N	rac-(2S)-4-tert-butoxy-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-oxo-butanoic acid	2724635	CC(C)(C)OC(=O)C[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O	(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-[(2-methylpropan-2-yl)oxy]-4-oxobutanoic acid			3.2206600000000014													MCULE-4143429275	411.4588	ACID	411.168188	6	2	9	3	0.0		28										False	Shikimates and Phenylpropanoids		False	False	Peptide01		-1.0	Compound(2724635)	2724635	3.5	242		SCHEMBL872021	[#6]-[#6](-[#6])(-[#6])-[#8]-[#6](=[#8])-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#8]-[#6]-[#6]1-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]-1:2)-[#6](=[#8])-[#8]	CC(C)(C)OC(=O)C[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O	FODJWPHPWBKDON		parent_pubchem_cid	Fmoc-Asp(OtBu)-OH;71989-14-5;Fmoc-L-Aspartic acid beta-tert-butyl ester;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(tert-butoxy)-4-oxobutanoic acid;Fmoc-L-Asp(OtBu)-OH;Fmoc-L-aspartic acid 4-tert-butyl ester;MFCD00037131;Fmoc-Asp(Obu)-OH;N-Alpha-Fmoc-L-aspartic acid beta-t-butyl ester;(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-[(2-methylpropan-2-yl)oxy]-4-oxobutanoic acid;Fmoc-Asp(OBut);(2S)-4-(tert-butoxy)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-4-oxobutanoic acid;Fmoc-Asp(Ot-Bu)-OH;4-(tert-butoxy)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-4-oxobutanoic acid;Fmoc-L-Asp(tBu);FmocAsp(OtBu)-OH;4-tert-Butyl N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-aspartate;Fmoc-Asp(tBu)-OH;Fmoc-Asp(t-Bu)-OH;FmocAsp(OBut)OH;Fmoc-L-aspartic acid beta-tert.buty ester;JHQ6MY724T;SCHEMBL872021;CHEMBL4633466;4-tert-Butyl N-Fmoc-L-aspartate;FODJWPHPWBKDON-IBGZPJMESA-N;DTXSID001315581;BCP08108;CS-D1469;HY-Y1169;AKOS015924105;AC-1156;L-aspartic acid, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-, 4-(1,1-dimethylethyl) ester;Fmoc-L-aspartic acid b-tert-butyl ester;AS-14174;BP-23513;BP-30008;N-Fmoc-L-aspartic Acid 4-tert-Butyl Ester;AM20060822;B3150;Fmoc-Asp(OtBu)-OH, >=98.0% (HPLC);EN300-96401;M03404;N-?-FMOC-L-aspartic acid ?-tert-butyl ester;A837378;J-300058;4-tert-Butyl N-(fluoren-9-ylmethoxycarbonyl)-L-aspartate;N-(Fluoren-9-ylmethoxycarbonyl)-L-aspartic acid 4-tert-butyl ester;N-9-Fluorenylmethyloxycarbonyl-L-aspartic acid beta-t-butyl ester;N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-aspartic Acid 4-tert-Butyl Ester;(s)-2-(((9h-fluoren-9-yl)methoxy)carbonylamino)-4-tert-butoxy-4-oxobutanoic acid;N-alpha-(9-Fluorenylmethyloxycarbonyl)-L-aspartic acid beta-t-butyl ester (Fmoc-L-Asp(OtBu)-OH);rac-(2S)-4-tert-butoxy-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-oxo-butanoic acid	False	24152872.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24152872		pluskal_iocb_peptide_Peptide01_B7_id		100	B7	False	ZINC000002384759
0.9		0	426	P6241986	135.7		F37	False	0	18	0	0	24	0	4	5	0	0		0.0						COc1c2c(ccc1)ccn2CCC(=O)NC(CCCNC(N)=O)C(=O)O								N-alkylindoles;Indoles;Anisoles;Alkyl aryl ethers;Substituted pyrroles;Heteroaromatic compounds;Ureas;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Anisoles;Azacyclic compounds;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;N-alkylindoles;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenol ethers;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Ureas	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom.	N-acyl-alpha amino acids		Amino acids and derivatives;Alpha amino acids and derivatives;N-acyl-alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	indoles (CHEBI:24828);methoxybenzene (CHEBI:51683);aromatic ether (CHEBI:35618);pyrroles (CHEBI:26455);organic aromatic compound (CHEBI:33659);ureas (CHEBI:47857);carboxamide (CHEBI:37622);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);N-acyl-amino acid (CHEBI:51569);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);organooxygen compound (CHEBI:36963);ether (CHEBI:25698);organic acid (CHEBI:64709);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)		Amino acids, peptides, and analogues	N-acyl-alpha-amino acid;N-alkylindole;Indole;Indole or derivatives;Anisole;Phenol ether;Alkyl aryl ether;Benzenoid;Substituted pyrrole;Heteroaromatic compound;Pyrrole;Carboxamide group;Urea;Secondary carboxylic acid amide;Carboxylic acid;Ether;Azacycle;Monocarboxylic acid or derivatives;Organoheterocyclic compound;Hydrocarbon derivative;Organic oxygen compound;Organic nitrogen compound;Carbonyl group;Organic oxide;Organonitrogen compound;Organooxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS016386017		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C18H24N4O5	C18H24N4O5			InChI=1S/C18H24N4O5/c1-27-14-6-2-4-12-7-10-22(16(12)14)11-8-15(23)21-13(17(24)25)5-3-9-20-18(19)26/h2,4,6-7,10,13H,3,5,8-9,11H2,1H3,(H,21,23)(H,24,25)(H3,19,20,26)/t13-/m1/s1	NHUCBOCNPNNQCH-CYBMUJFWSA-N	rac-(2R)-2-[3-(7-methoxyindol-1-yl)propanoylamino]-5-ureido-pentanoic acid	49652629	COc1c2c(ccc1)ccn2CCC(=O)N[C@H](CCCNC(N)=O)C(=O)O	(2R)-5-(carbamoylamino)-2-[3-(7-methoxyindol-1-yl)propanoylamino]pentanoic acid			0.1670700000000014													MCULE-1006376487	376.41578		376.17467	5	4	10	2			44										False	Alkaloids				Peptide01			Compound(49652629)	49652629	0.2	243			[#6]-[#8]-[#6]1:[#6]2:[#6](:[#6]:[#6]:[#6]:1):[#6]:[#6]:[#7]:2-[#6]-[#6]-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#8])-[#6](=[#8])-[#8]	COc1c2c(ccc1)ccn2CCC(=O)N[C@H](CCCNC(N)=O)C(=O)O	NHUCBOCNPNNQCH		parent_pubchem_cid	AKOS016386017;rac-(2R)-2-[3-(7-methoxyindol-1-yl)propanoylamino]-5-ureido-pentanoic acid		23879908.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23879908		pluskal_iocb_peptide_Peptide01_B7_id		100	B7		ZINC000040313082
1.3		0	514	P1382657	100.9		F38	False	0	13	0	0	17	0	1	4	0	1		0.0						COc1ccc(C(=O)NC(CCSC)C(=O)O)cc1																							0.0		121429-06-9		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C13H17NO4S	C13H17NO4S			InChI=1S/C13H17NO4S/c1-18-10-5-3-9(4-6-10)12(15)14-11(13(16)17)7-8-19-2/h3-6,11H,7-8H2,1-2H3,(H,14,15)(H,16,17)	MNBUNUWZMJHWFD-UHFFFAOYSA-N	2-[(4-methoxybenzoyl)amino]-4-methylsulfanyl-butanoic acid	3400123	COc1ccc(C(=O)NC(CCSC)C(=O)O)cc1	2-[(4-methoxybenzoyl)amino]-4-methylsulfanylbutanoic acid			1.1141799999999995													MCULE-7925230039	283.34874		283.087829	5	2	7	1			44									Aminoacids;Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(3400123)	3400123	1.8	244		SCHEMBL9831656	[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]-[#16]-[#6])-[#6](=[#8])-[#8]):[#6]:[#6]:1	COc1ccc(C(=O)NC(CCSC)C(=O)O)cc1	MNBUNUWZMJHWFD		parent_pubchem_cid	121429-06-9;2-[(4-methoxyphenyl)formamido]-4-(methylsulfanyl)butanoic acid;2-[(4-methoxybenzoyl)amino]-4-(methylthio)butanoic acid;(4-Methoxybenzoyl)methionine;SCHEMBL9831656;2-[(4-methoxybenzoyl)amino]-4-methylsulfanylbutanoic acid;AKOS000264180;AKOS016338218;CS-0302725;EN300-16571;Z56346820;2-[(4-methoxyphenyl)formamido]-4-(methylsulfanyl)butanoicacid;2-[(4-methoxybenzoyl)amino]-4-methylsulfanyl-butanoic acid		22660292.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22660292		pluskal_iocb_peptide_Peptide01_B7_id		100	B7		
4.4		0	602	P1305773	54.1		F39	False	0	24	0	0	22	0	2	2	0	0		0.0						O=C(COc1ccccc1)NCC(c1ccccc1)c1c[nH]c2ccccc12																							0.0		N-[2-(1H-indol-3-yl)-2-phenylethyl]-2-phenoxyacetamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C24H22N2O2	C24H22N2O2			InChI=1S/C24H22N2O2/c27-24(17-28-19-11-5-2-6-12-19)26-15-21(18-9-3-1-4-10-18)22-16-25-23-14-8-7-13-20(22)23/h1-14,16,21,25H,15,17H2,(H,26,27)	UQYWSHOSLKMPHC-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]-2-phenoxy-acetamide	43842710	O=C(COc1ccccc1)NCC(c1ccccc1)c1c[nH]c2ccccc12	N-[2-(1H-indol-3-yl)-2-phenylethyl]-2-phenoxyacetamide			3.4947500000000016													MCULE-4249060659	370.45514		370.168128	2	2	7	4			45										False	Alkaloids				Peptide01			Compound(43842710)	43842710	4.8	245			[#8]=[#6](-[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6]-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	O=C(COc1ccccc1)NCC(c1ccccc1)c1c[nH]c2ccccc12	UQYWSHOSLKMPHC		parent_pubchem_cid	N-[2-(1H-indol-3-yl)-2-phenylethyl]-2-phenoxyacetamide;905768-29-8;HMS3456E14;AKOS002289894;AKOS016328321;Z29961004;N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]-2-phenoxy-acetamide		23142990.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23142990		pluskal_iocb_peptide_Peptide01_B7_id		100	B7		
2.7		0	690	P6240991	117.5		F40	False	0	20	0	0	19	0	3	3	0	1		0.0						CSCCC(NC(=O)c1cc(-c2ccccn2)nc2ccccc12)C(=O)O								Quinoline carboxamides;N-acyl-alpha amino acids;Bipyridines and oligopyridines;Pyridinecarboxylic acids and derivatives;Thia fatty acids;Benzenoids;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Sulfenyl compounds;Carboxylic acids;Dialkylthioethers;Monocarboxylic acids and derivatives;Carbonyl compounds;Organic oxides;Hydrocarbon derivatives;Organonitrogen compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzenoids;Bipyridines and oligopyridines;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Dialkylthioethers;Fatty Acyls;Fatty acids and conjugates;Heteroaromatic compounds;Hydrocarbon derivatives;Lipids and lipid-like molecules;Methionine and derivatives;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organosulfur compounds;Pyridinecarboxylic acids and derivatives;Pyridines and derivatives;Quinoline carboxamides;Quinolines and derivatives;Secondary carboxylic acid amides;Sulfenyl compounds;Thia fatty acids;Thioethers	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as methionine and derivatives. These are compounds containing methionine or a derivative thereof resulting from reaction of methionine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Methionine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	quinolines (CHEBI:26513);carboxamide (CHEBI:37622);N-acyl-amino acid (CHEBI:51569);bipyridines (CHEBI:50511);aromatic carboxylic acid (CHEBI:33859);pyridinemonocarboxylic acid (CHEBI:26420);thia fatty acid (CHEBI:59643);benzenoid aromatic compound (CHEBI:33836);organic aromatic compound (CHEBI:33659);organonitrogen heterocyclic compound (CHEBI:38101);organosulfur compound (CHEBI:33261);carboxylic acid (CHEBI:33575);aliphatic sulfide (CHEBI:22327);monocarboxylic acid (CHEBI:25384);carbonyl compound (CHEBI:36586);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);organonitrogen compound (CHEBI:35352);alpha-amino acid (CHEBI:33704);methionine derivative (CHEBI:25230);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);pyridines (CHEBI:26421);lipid (CHEBI:18059);amide (CHEBI:32988);organic sulfide (CHEBI:16385);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143)	Thia fatty acids (FA0113);Fatty Acyls (FA);Fatty Acids and Conjugates (FA01)	Amino acids, peptides, and analogues	Methionine or derivatives;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;Quinoline-4-carboxamide;Bipyridine;Quinoline;Pyridine carboxylic acid or derivatives;Thia fatty acid;Pyridine;Fatty acyl;Benzenoid;Heteroaromatic compound;Carboxamide group;Secondary carboxylic acid amide;Organoheterocyclic compound;Dialkylthioether;Sulfenyl compound;Carboxylic acid;Monocarboxylic acid or derivatives;Thioether;Azacycle;Organonitrogen compound;Organic oxide;Organooxygen compound;Organosulfur compound;Hydrocarbon derivative;Carbonyl group;Organic oxygen compound;Organic nitrogen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS016387093		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C20H19N3O3S	C20H19N3O3S			InChI=1S/C20H19N3O3S/c1-27-11-9-17(20(25)26)23-19(24)14-12-18(16-8-4-5-10-21-16)22-15-7-3-2-6-13(14)15/h2-8,10,12,17H,9,11H2,1H3,(H,23,24)(H,25,26)/t17-/m0/s1	SHNRCSJIUFQKJY-KRWDZBQOSA-N	rac-(2S)-4-methylsulfanyl-2-[[2-(2-pyridyl)quinoline-4-carbonyl]amino]butanoic acid	49652539	CSCC[C@H](NC(=O)c1cc(-c2ccccn2)nc2ccccc12)C(=O)O	(2S)-4-methylsulfanyl-2-[(2-pyridin-2-ylquinoline-4-carbonyl)amino]butanoic acid			2.36975													MCULE-2625727491	381.45673		381.114712	6	2	7	3			44									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(49652539)	49652539	2.7	246			[#6]-[#16]-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#7]:2):[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	CSCC[C@H](NC(=O)c1cc(-c2ccccn2)nc2ccccc12)C(=O)O	SHNRCSJIUFQKJY		parent_pubchem_cid	AKOS016387093;(2S)-4-(METHYLSULFANYL)-2-({[2-(2-PYRIDYL)-4-QUINOLYL]CARBONYL}AMINO)BUTANOIC ACID;rac-(2S)-4-methylsulfanyl-2-[[2-(2-pyridyl)quinoline-4-carbonyl]amino]butanoic acid		24734156.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24734156		pluskal_iocb_peptide_Peptide01_B7_id		100	B7		ZINC000040312759
2.9		0	434	P6241983	88.4		F41	False	0	22	0	0	22	0	2	4	0	0		0.0						CC(=O)c1cn(CCC(=O)NC(Cc2ccccc2)C(=O)O)c2ccccc12								N-acyl-L-alpha-amino acids;Phenylpropanoic acids;Amphetamines and derivatives;N-alkylindoles;Indoles;Aryl alkyl ketones;Substituted pyrroles;Vinylogous amides;Heteroaromatic compounds;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Aryl alkyl ketones;Aryl ketones;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Ketones;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;N-alkylindoles;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenethylamines;Phenylalanine and derivatives;Phenylpropanoic acids;Phenylpropanoids and polyketides;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Vinylogous amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-L-alpha-amino acid (CHEBI:48927);benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);amphetamines (CHEBI:35338);indoles (CHEBI:24828);aromatic ketone (CHEBI:76224);pyrroles (CHEBI:26455);enone (CHEBI:51689);enamine (CHEBI:47989);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);monocarboxylic acid (CHEBI:25384);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);carbonyl compound (CHEBI:36586);organooxygen compound (CHEBI:36963);N-acyl-amino acid (CHEBI:51569);benzenoid aromatic compound (CHEBI:33836);primary amine (CHEBI:32877);organic heterocyclic compound (CHEBI:24532);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ketone (CHEBI:17087);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)		Amino acids, peptides, and analogues	Phenylalanine or derivatives;N-acyl-alpha amino acid or derivatives;N-acyl-alpha-amino acid;N-acyl-l-alpha-amino acid;3-phenylpropanoic-acid;Amphetamine or derivatives;N-alkylindole;Indole;Indole or derivatives;Aryl alkyl ketone;Aryl ketone;Monocyclic benzene moiety;Benzenoid;Substituted pyrrole;Heteroaromatic compound;Vinylogous amide;Pyrrole;Carboxamide group;Ketone;Secondary carboxylic acid amide;Organoheterocyclic compound;Azacycle;Monocarboxylic acid or derivatives;Carboxylic acid;Hydrocarbon derivative;Organic oxide;Organic nitrogen compound;Carbonyl group;Organonitrogen compound;Organooxygen compound;Organic oxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		EiM08-13451		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C22H22N2O4	C22H22N2O4			InChI=1S/C22H22N2O4/c1-15(25)18-14-24(20-10-6-5-9-17(18)20)12-11-21(26)23-19(22(27)28)13-16-7-3-2-4-8-16/h2-10,14,19H,11-13H2,1H3,(H,23,26)(H,27,28)/t19-/m0/s1	ZNUSRNITTUOLSF-IBGZPJMESA-N	rac-(2S)-2-[3-(3-acetylindol-1-yl)propanoylamino]-3-phenyl-propanoic acid	49652316	CC(=O)c1cn(CCC(=O)N[C@@H](Cc2ccccc2)C(=O)O)c2ccccc12	(2S)-2-[3-(3-acetylindol-1-yl)propanoylamino]-3-phenylpropanoic acid			2.50826													MCULE-7958366863	378.43164		378.157957	4	2	8	3			44										False					Peptide01			Compound(49652316)	49652316	2.5	247			[#6]-[#6](=[#8])-[#6]1:[#6]:[#7](-[#6]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#8]):[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CC(=O)c1cn(CCC(=O)N[C@@H](Cc2ccccc2)C(=O)O)c2ccccc12	ZNUSRNITTUOLSF		parent_pubchem_cid	EiM08-13451;AKOS016375062;(2S)-2-{[3-(3-ACETYL-1H-INDOL-1-YL)PROPANOYL]AMINO}-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[3-(3-acetylindol-1-yl)propanoylamino]-3-phenyl-propanoic acid		24761577.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24761577		pluskal_iocb_peptide_Peptide01_B7_id		100	B7		ZINC000040309971
4.6		0	522	P2194195	106.5		F42	False	0	19	1	1	21	0	3	3	0	1		0.0						COC(=O)C(CC(C)C)NC(=O)c1nc(SCc2ccc(F)cc2)ncc1Cl																							0.0		AKOS005136612		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C19H21ClFN3O3S	C19H21ClFN3O3S			InChI=1S/C19H21ClFN3O3S/c1-11(2)8-15(18(26)27-3)23-17(25)16-14(20)9-22-19(24-16)28-10-12-4-6-13(21)7-5-12/h4-7,9,11,15H,8,10H2,1-3H3,(H,23,25)	KXGSRTPKDUFEGG-UHFFFAOYSA-N	methyl 2-[[5-chloro-2-[(4-fluorophenyl)methylsulfanyl]pyrimidine-4-carbonyl]amino]-4-methyl-pentanoate	49756827	COC(=O)C(CC(C)C)NC(=O)c1nc(SCc2ccc(F)cc2)ncc1Cl	methyl 2-[[5-chloro-2-[(4-fluorophenyl)methylsulfanyl]pyrimidine-4-carbonyl]amino]-4-methylpentanoate			3.661470000000002													MCULE-5676299052	425.91292		425.097618	6	1	9	2			45									Dipeptides;Pyridine alkaloids	False	Alkaloids;Amino acids and Peptides	Nicotinic acid alkaloids;Small peptides			Peptide01			Compound(49756827)	49756827	4.5	248			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=[#8])-[#6]1:[#7]:[#6](-[#16]-[#6]-[#6]2:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:2):[#7]:[#6]:[#6]:1-[#17]	COC(=O)C(CC(C)C)NC(=O)c1nc(SCc2ccc(F)cc2)ncc1Cl	KXGSRTPKDUFEGG		parent_pubchem_cid	AKOS005136612;methyl 2-[[5-chloro-2-[(4-fluorophenyl)methylsulfanyl]pyrimidine-4-carbonyl]amino]-4-methyl-pentanoate		22839445.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22839445		pluskal_iocb_peptide_Peptide01_B8_id		100	B8		
4.6		0	610	P1305410	63.4		F43	False	0	25	0	1	23	0	2	3	0	0		0.0						COc1ccc(C(CNC(=O)COc2ccc(F)cc2)c2c[nH]c3ccccc23)cc1																							0.0		2-(4-fluorophenoxy)-N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]acetamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C25H23FN2O3	C25H23FN2O3			InChI=1S/C25H23FN2O3/c1-30-19-10-6-17(7-11-19)22(23-15-27-24-5-3-2-4-21(23)24)14-28-25(29)16-31-20-12-8-18(26)9-13-20/h2-13,15,22,27H,14,16H2,1H3,(H,28,29)	WSTNPRBXAYBNJQ-UHFFFAOYSA-N	2-(4-fluorophenoxy)-N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]acetamide	17014560	COc1ccc(C(CNC(=O)COc2ccc(F)cc2)c2c[nH]c3ccccc23)cc1	2-(4-fluorophenoxy)-N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]acetamide			3.180040000000001													MCULE-2467541244	418.47206		418.169271	3	2	8	4			44										False	Alkaloids				Peptide01			Compound(17014560)	17014560	4.8	249			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6]-[#7]-[#6](=[#8])-[#6]-[#8]-[#6]2:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	COc1ccc(C(CNC(=O)COc2ccc(F)cc2)c2c[nH]c3ccccc23)cc1	WSTNPRBXAYBNJQ		parent_pubchem_cid	2-(4-fluorophenoxy)-N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]acetamide;STL207517;AKOS002334756;AKOS016326654		22669206.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22669206		pluskal_iocb_peptide_Peptide01_B8_id		100	B8		
3.8		0	698	P6240937	80.6		F44	False	0	22	0	0	24	0	2	4	0	0		0.0						CC(C)C(NC(=O)Cn1ccc2c1cc(OCc1ccccc1)cc2)C(=O)O																							0.0		AKOS005662168		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C22H24N2O4	C22H24N2O4			InChI=1S/C22H24N2O4/c1-15(2)21(22(26)27)23-20(25)13-24-11-10-17-8-9-18(12-19(17)24)28-14-16-6-4-3-5-7-16/h3-12,15,21H,13-14H2,1-2H3,(H,23,25)(H,26,27)/t21-/m0/s1	DPPHJIRUFKAAJM-NRFANRHFSA-N	rac-(2S)-2-[[2-(6-benzyloxyindol-1-yl)acetyl]amino]-3-methyl-butanoic acid	49654226	CC(C)[C@H](NC(=O)Cn1ccc2c1cc(OCc1ccccc1)cc2)C(=O)O	(2S)-3-methyl-2-[[2-(6-phenylmethoxyindol-1-yl)acetyl]amino]butanoic acid			2.50016													MCULE-1468244018	380.44758		380.173607	4	2	8	3			44										False	Alkaloids				Peptide01			Compound(49654226)	49654226	3.9	250			[#6]-[#6](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#7]1:[#6]:[#6]:[#6]2:[#6]:1:[#6]:[#6](-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1):[#6]:[#6]:2)-[#6](=[#8])-[#8]	CC(C)[C@H](NC(=O)Cn1ccc2c1cc(OCc1ccccc1)cc2)C(=O)O	DPPHJIRUFKAAJM		parent_pubchem_cid	AKOS005662168;(2S)-2-({2-[6-(BENZYLOXY)-1H-INDOL-1-YL]ACETYL}AMINO)-3-METHYLBUTANOIC ACID;rac-(2S)-2-[[2-(6-benzyloxyindol-1-yl)acetyl]amino]-3-methyl-butanoic acid		24127218.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24127218		pluskal_iocb_peptide_Peptide01_B8_id		100	B8		ZINC000040268008
3.2		0	706	P6240938	105.9		G1	False	0	22	0	0	24	0	2	4	0	1		0.0						CSCCC(NC(=O)Cn1ccc2c1cc(OCc1ccccc1)cc2)C(=O)O																							0.0		AKOS005667957		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C22H24N2O4S	C22H24N2O4S			InChI=1S/C22H24N2O4S/c1-29-12-10-19(22(26)27)23-21(25)14-24-11-9-17-7-8-18(13-20(17)24)28-15-16-5-3-2-4-6-16/h2-9,11,13,19H,10,12,14-15H2,1H3,(H,23,25)(H,26,27)/t19-/m0/s1	YXZOWCWVXAKHCF-IBGZPJMESA-N	rac-(2S)-2-[[2-(6-benzyloxyindol-1-yl)acetyl]amino]-4-methylsulfanyl-butanoic acid	49654553	CSCC[C@H](NC(=O)Cn1ccc2c1cc(OCc1ccccc1)cc2)C(=O)O	(2S)-4-methylsulfanyl-2-[[2-(6-phenylmethoxyindol-1-yl)acetyl]amino]butanoic acid			2.5972599999999995													MCULE-8364987093	412.51158		412.145678	5	2	10	3			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(49654553)	49654553	3.5	251			[#6]-[#16]-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#7]1:[#6]:[#6]:[#6]2:[#6]:1:[#6]:[#6](-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1):[#6]:[#6]:2)-[#6](=[#8])-[#8]	CSCC[C@H](NC(=O)Cn1ccc2c1cc(OCc1ccccc1)cc2)C(=O)O	YXZOWCWVXAKHCF		parent_pubchem_cid	AKOS005667957;(2S)-2-({2-[6-(BENZYLOXY)-1H-INDOL-1-YL]ACETYL}AMINO)-4-(METHYLSULFANYL)BUTANOIC ACID;rac-(2S)-2-[[2-(6-benzyloxyindol-1-yl)acetyl]amino]-4-methylsulfanyl-butanoic acid		23773790.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23773790		pluskal_iocb_peptide_Peptide01_B8_id		100	B8		ZINC000040268522
3.5		0	794	P6241968	105.9		G2	False	0	23	0	0	26	0	2	4	0	1		0.0						CSCCC(NC(=O)CCn1ccc2c1cc(OCc1ccccc1)cc2)C(=O)O								N-acyl-L-alpha-amino acids;N-alkylindoles;Indoles;Phenol ethers;Thia fatty acids;Alkyl aryl ethers;Substituted pyrroles;Benzene and substituted derivatives;Heteroaromatic compounds;Secondary carboxylic acid amides;Sulfenyl compounds;Azacyclic compounds;Carboxylic acids;Dialkylthioethers;Monocarboxylic acids and derivatives;Carbonyl compounds;Organic oxides;Hydrocarbon derivatives;Organonitrogen compounds	Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Dialkylthioethers;Ethers;Fatty Acyls;Fatty acids and conjugates;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Lipids and lipid-like molecules;Methionine and derivatives;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;N-alkylindoles;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organosulfur compounds;Phenol ethers;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Sulfenyl compounds;Thia fatty acids;Thioethers	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as methionine and derivatives. These are compounds containing methionine or a derivative thereof resulting from reaction of methionine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Methionine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-L-alpha-amino acid (CHEBI:48927);indoles (CHEBI:24828);aromatic ether (CHEBI:35618);thia fatty acid (CHEBI:59643);pyrroles (CHEBI:26455);benzenes (CHEBI:22712);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organosulfur compound (CHEBI:33261);organonitrogen heterocyclic compound (CHEBI:38101);carboxylic acid (CHEBI:33575);aliphatic sulfide (CHEBI:22327);monocarboxylic acid (CHEBI:25384);carbonyl compound (CHEBI:36586);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);organonitrogen compound (CHEBI:35352);alpha-amino acid (CHEBI:33704);methionine derivative (CHEBI:25230);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);N-acyl-amino acid (CHEBI:51569);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);lipid (CHEBI:18059);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ether (CHEBI:25698);amide (CHEBI:32988);organic sulfide (CHEBI:16385);nitrogen molecular entity (CHEBI:51143)	Thia fatty acids (FA0113);Fatty Acyls (FA);Fatty Acids and Conjugates (FA01)	Amino acids, peptides, and analogues	Methionine or derivatives;N-acyl-alpha-amino acid;N-acyl-l-alpha-amino acid;N-acyl-alpha amino acid or derivatives;N-alkylindole;Indole;Indole or derivatives;Phenol ether;Alkyl aryl ether;Thia fatty acid;Monocyclic benzene moiety;Substituted pyrrole;Fatty acyl;Benzenoid;Heteroaromatic compound;Pyrrole;Carboxamide group;Secondary carboxylic acid amide;Organoheterocyclic compound;Dialkylthioether;Sulfenyl compound;Thioether;Carboxylic acid;Ether;Monocarboxylic acid or derivatives;Azacycle;Organic oxide;Carbonyl group;Hydrocarbon derivative;Organic nitrogen compound;Organonitrogen compound;Organooxygen compound;Organosulfur compound;Organic oxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS016387126		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C23H26N2O4S	C23H26N2O4S			InChI=1S/C23H26N2O4S/c1-30-14-11-20(23(27)28)24-22(26)10-13-25-12-9-18-7-8-19(15-21(18)25)29-16-17-5-3-2-4-6-17/h2-9,12,15,20H,10-11,13-14,16H2,1H3,(H,24,26)(H,27,28)/t20-/m0/s1	MPPJPSAJSNNCAP-FQEVSTJZSA-N	rac-(2S)-2-[3-(6-benzyloxyindol-1-yl)propanoylamino]-4-methylsulfanyl-butanoic acid	49652440	CSCC[C@H](NC(=O)CCn1ccc2c1cc(OCc1ccccc1)cc2)C(=O)O	(2S)-4-methylsulfanyl-2-[3-(6-phenylmethoxyindol-1-yl)propanoylamino]butanoic acid			2.9873600000000007													MCULE-6800430419	426.53867		426.161328	5	2	11	3			44										False					Peptide01			Compound(49652440)	49652440	3.3	252			[#6]-[#16]-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#6]-[#7]1:[#6]:[#6]:[#6]2:[#6]:1:[#6]:[#6](-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1):[#6]:[#6]:2)-[#6](=[#8])-[#8]	CSCC[C@H](NC(=O)CCn1ccc2c1cc(OCc1ccccc1)cc2)C(=O)O	MPPJPSAJSNNCAP		parent_pubchem_cid	AKOS016387126;(2S)-2-({3-[6-(BENZYLOXY)-1H-INDOL-1-YL]PROPANOYL}AMINO)-4-(METHYLSULFANYL)BUTANOIC ACID;rac-(2S)-2-[3-(6-benzyloxyindol-1-yl)propanoylamino]-4-methylsulfanyl-butanoic acid		24289265.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24289265		pluskal_iocb_peptide_Peptide01_B8_id		100	B8		ZINC000040312414
0.4		0	882	P1159728	124.3		G3	False	0	14	0	0	17	0	5	3	0	1		0.0						COC(=O)C(CCSC)NC(=O)c1cc(-n2cnnn2)ccc1								Alpha amino acid esters;N-acyl-alpha amino acids and derivatives;Hippuric acids and derivatives;Phenyltetrazoles and derivatives;Benzoyl derivatives;Fatty acid esters;Methyl esters;Heteroaromatic compounds;Secondary carboxylic acid amides;Sulfenyl compounds;Azacyclic compounds;Monocarboxylic acids and derivatives;Dialkylthioethers;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organonitrogen compounds	Alpha amino acid esters;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Azoles;Benzamides;Benzene and substituted derivatives;Benzenoids;Benzoic acids and derivatives;Benzoyl derivatives;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids and derivatives;Chemical entities;Dialkylthioethers;Fatty Acyls;Fatty acid esters;Heteroaromatic compounds;Hippuric acids and derivatives;Hydrocarbon derivatives;Lipids and lipid-like molecules;Methionine and derivatives;Methyl esters;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organosulfur compounds;Phenyltetrazoles and derivatives;Secondary carboxylic acid amides;Sulfenyl compounds;Tetrazoles;Thioethers	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as methionine and derivatives. These are compounds containing methionine or a derivative thereof resulting from reaction of methionine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Methionine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteromonocyclic compounds	alpha-amino acid ester (CHEBI:46874);N-acyl-amino acid (CHEBI:51569);N-acylglycine (CHEBI:16180);tetrazoles (CHEBI:35689);carbonyl compound (CHEBI:36586);fatty acid ester (CHEBI:35748);carboxylic ester (CHEBI:33308);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organosulfur compound (CHEBI:33261);organonitrogen heterocyclic compound (CHEBI:38101);monocarboxylic acid (CHEBI:25384);aliphatic sulfide (CHEBI:22327);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);alpha-amino acid (CHEBI:33704);methionine derivative (CHEBI:25230);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);organooxygen compound (CHEBI:36963);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);benzoic acids (CHEBI:22723);benzamides (CHEBI:22702);organic heterocyclic compound (CHEBI:24532);azole (CHEBI:68452);lipid (CHEBI:18059);amide (CHEBI:32988);organic sulfide (CHEBI:16385);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143)	Fatty esters (FA07);Fatty Acyls (FA)	Amino acids, peptides, and analogues	Methionine or derivatives;Alpha-amino acid ester;Hippuric acid or derivatives;N-acyl-alpha amino acid or derivatives;Phenyltetrazole;Benzamide;Benzoic acid or derivatives;Benzoyl;Fatty acid ester;Monocyclic benzene moiety;Fatty acyl;Benzenoid;Azole;Heteroaromatic compound;Methyl ester;Tetrazole;Carboxamide group;Carboxylic acid ester;Secondary carboxylic acid amide;Thioether;Monocarboxylic acid or derivatives;Sulfenyl compound;Dialkylthioether;Organoheterocyclic compound;Azacycle;Organonitrogen compound;Organic nitrogen compound;Carbonyl group;Hydrocarbon derivative;Organic oxide;Organooxygen compound;Organosulfur compound;Organic oxygen compound;Aromatic heteromonocyclic compound	Organic acids and derivatives	0.0		AKOS004932435		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	4	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C14H17N5O3S	C14H17N5O3S			InChI=1S/C14H17N5O3S/c1-22-14(21)12(6-7-23-2)16-13(20)10-4-3-5-11(8-10)19-9-15-17-18-19/h3-5,8-9,12H,6-7H2,1-2H3,(H,16,20)/t12-/m0/s1	LJVVVTHWNABZAL-LBPRGKRZSA-N	methyl rac-(2S)-4-methylsulfanyl-2-[[3-(tetrazol-1-yl)benzoyl]amino]butanoate	28935442	COC(=O)[C@H](CCSC)NC(=O)c1cc(-n2cnnn2)ccc1	methyl (2S)-4-methylsulfanyl-2-[[3-(tetrazol-1-yl)benzoyl]amino]butanoate			0.4420799999999994													MCULE-3242180266	335.38729		335.10521	7	1	8	2			44										False	Alkaloids				Peptide01			Compound(28935442)	28935442	1.5	253			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]-[#16]-[#6])-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6](-[#7]2:[#6]:[#7]:[#7]:[#7]:2):[#6]:[#6]:[#6]:1	COC(=O)[C@H](CCSC)NC(=O)c1cc(-n2cnnn2)ccc1	LJVVVTHWNABZAL		parent_pubchem_cid	AKOS004932435;METHYL 4-(METHYLSULFANYL)-2-{[3-(1H-1,2,3,4-TETRAZOL-1-YL)PHENYL]FORMAMIDO}BUTANOATE;methyl rac-(2S)-4-methylsulfanyl-2-[[3-(tetrazol-1-yl)benzoyl]amino]butanoate		2893563.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=2893563		pluskal_iocb_peptide_Peptide01_B8_id		100	B8		ZINC000020427686
4.2		0	970	P3460046	75.6		G4	True	0	21	0	0	23	0	1	4	0	0	-1.0	2.0			PPAR receptor agonist	fmoc-L-leucine		CC(C)CC(NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O		4.02		0.0	4.3	CHEMBL149394		Fluorenes;Carbamate esters;Organic carbonic acids and derivatives;Monocarboxylic acids and derivatives;Carboxylic acids;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Benzenoids;Carbamate esters;Carbamic acids and derivatives;Carbonyl compounds;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Fluorenes;Hydrocarbon derivatives;Leucine and derivatives;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as leucine and derivatives. These are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Leucine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic homopolycyclic compounds	fluorenes (CHEBI:24059);carbamate ester (CHEBI:23003);organooxygen compound (CHEBI:36963);carbonyl compound (CHEBI:36586);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);leucine derivative (CHEBI:47003);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);amino acid (CHEBI:33709);peptide (CHEBI:16670);carbon oxoacid (CHEBI:35605);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806)		Amino acids, peptides, and analogues	Leucine or derivatives;Fluorene;Benzenoid;Carbamic acid ester;Carbonic acid derivative;Carboxylic acid;Monocarboxylic acid or derivatives;Organopnictogen compound;Organooxygen compound;Organonitrogen compound;Organic oxygen compound;Carbonyl group;Organic nitrogen compound;Organic oxide;Hydrocarbon derivative;Aromatic homopolycyclic compound	Organic acids and derivatives	2.0	Phase 2	Fmoc-L-leucine	DTXSID0040751	2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	1	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C21H23NO4	C21H23NO4			InChI=1S/C21H23NO4/c1-13(2)11-19(20(23)24)22-21(25)26-12-18-16-9-5-3-7-14(16)15-8-4-6-10-17(15)18/h3-10,13,18-19H,11-12H2,1-2H3,(H,22,25)(H,23,24)/t19-/m0/s1	CBPJQFCAFFNICX-IBGZPJMESA-N	rac-(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-methyl-pentanoic acid	1549133	CC(C)C[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O	(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-methylpentanoic acid			3.5349600000000017													MCULE-7093196987	353.42176	ACID	353.162708	4	2	7	3	1.0		23										False			False	False	Peptide01	PD020721	-1.0	Compound(1549133)	1549133	4.4	254		SCHEMBL120560	[#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#8]-[#6]-[#6]1-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]-1:2)-[#6](=[#8])-[#8]	CC(C)C[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O	CBPJQFCAFFNICX		parent_pubchem_cid	Fmoc-L-leucine;35661-60-0;Fmoc-Leu-OH;Fmoc-L-Leu-OH;N-Fmoc-L-leucine;fmoc-leucine;N-(9-fluorenylmethoxycarbonyl)-L-leucine;Npc 15199;N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-leucine;(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-methylpentanoic acid;NPC-15199;n-(fluorenyl-9-methoxycarbonyl)leucine;FMOC-LEU;(((9H-fluoren-9-yl)methoxy)carbonyl)-L-leucine;UNII-KF18F70UF3;MLS002695993;KF18F70UF3;DTXSID0040751;EINECS 252-662-7;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-methylpentanoic acid;SMR001562137;(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-4-methylpentanoic acid;N-((9H-Fluoren-9-ylmethoxy)carbonyl)-L-leucine;MFCD00037133;L-Leucine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-;L-LEUCINE, N-((9H-FLUOREN-9-YLMETHOXY)CARBONYL)-;Fmoc leucine;N-Fmoc leucine;NSC-334290;(2S)-2-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-4-METHYLPENTANOIC ACID;Fmoc-L-Leu;Fmoc-L-Leu--OH;Maybridge1_005562;D01ASM;N-.alpha.-Fmoc-L-leucine;DivK1c_001850;SCHEMBL120560;CHEMBL149394;DTXCID8020751;cid_1549133;Fmoc-Leu-OH, >=97.0%;HMS557E18;L-LEUCINE, FMOC PROTECTED;BDBM115093;STR09711;Tox21_301495;(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-methyl-pentanoic acid;(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-methyl-valeric acid;STL466197;(2S)-2-[[9H-fluoren-9-ylmethoxy(oxo)methyl]amino]-4-methylpentanoic acid;(2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-4-methylpentanoic acid;AKOS010398974;AKOS015837135;N-9-fluorenylmethoxycarbonyl-L-leucine;CCG-249806;CS-W019808;N-(9-fluorenylmethyloxycarbonyl)leucine;NSC 334290;CDS1_000810;NCGC00164403-01;NCGC00255677-01;AC-24092;N-(Fluoren-9-ylmethoxycarbonyl)-L-leucine;CAS-35661-60-0;HY-101064;N-[(9-fluorenyl)methoxycarbonyl]-L-leucine;AM20060470;F0295;N-[(9-fluorenyl)-methoxycarbonyl]-L-leucine;EN300-74035;D71213;M03365;N-9-FLUORENYLMETHYLOXYCARBONYL-L-LEUCINE;N-(9-FLUORENYLMETHYLOXYCARBONYL)-LEUCINE;N-[(9H-Fluoren-9-ylmethoxy)carbonyl]leucine #;A822928;SR-05000000436;fluoren-9-yl N-(1-carboxy-3-methylbutyl)carbamate;J-300159;Q-101698;SR-05000000436-2;Q27282223;Z1123720065;N-((9H-FLUOREN-9-YLMETHOXY)CARBONYL)-L-LEUCINE, (-)-;N-alpha-(9-Fluorenylmethyloxycarbonyl)-L-leucine (Fmoc-L-Leu-OH);(S)-2-(((9H-FLUOREN-9-YL)METHOXY)CARBONYLAMINO)-4-METHYLPENTANOIC ACID;rac-(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-methyl-pentanoic acid	False	551303.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=551303	KF18F70UF3	pluskal_iocb_peptide_Peptide01_B8_id		100	B8	False	ZINC000082067500
3.5		0	714	P6241474	116.8		G5	False	0	21	0	0	20	0	2	4	0	1		0.0						COc1cccc(-c2nc(C)c(C(=O)NC(Cc3ccccc3)C(=O)O)s2)c1								N-acyl-alpha amino acids;Phenylpropanoic acids;Amphetamines and derivatives;Thiazolecarboxamides;Phenoxy compounds;2,4,5-trisubstituted thiazoles;2-heteroaryl carboxamides;Methoxybenzenes;Anisoles;Alkyl aryl ethers;Heteroaromatic compounds;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organonitrogen compounds	2,4,5-trisubstituted thiazoles;2-heteroaryl carboxamides;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Anisoles;Azacyclic compounds;Azoles;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Methoxybenzenes;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenethylamines;Phenol ethers;Phenoxy compounds;Phenylalanine and derivatives;Phenylpropanoic acids;Phenylpropanoids and polyketides;Secondary carboxylic acid amides;Thiazolecarboxamides;Thiazolecarboxylic acids and derivatives;Thiazoles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteromonocyclic compounds	N-acyl-amino acid (CHEBI:51569);benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);amphetamines (CHEBI:35338);aromatic amide (CHEBI:62733);thiazoles (CHEBI:48901);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);methoxybenzene (CHEBI:51683);aromatic ether (CHEBI:35618);monocarboxylic acid (CHEBI:25384);organonitrogen heterocyclic compound (CHEBI:38101);carbonyl compound (CHEBI:36586);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);benzenoid aromatic compound (CHEBI:33836);primary amine (CHEBI:32877);organic heterocyclic compound (CHEBI:24532);azole (CHEBI:68452);aromatic carboxylic acid (CHEBI:33859);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ether (CHEBI:25698);nitrogen molecular entity (CHEBI:51143)		Amino acids, peptides, and analogues	Phenylalanine or derivatives;N-acyl-alpha amino acid or derivatives;N-acyl-alpha-amino acid;3-phenylpropanoic-acid;Amphetamine or derivatives;2-heteroaryl carboxamide;Phenol ether;2,4,5-trisubstituted 1,3-thiazole;Phenoxy compound;Thiazolecarboxamide;Thiazolecarboxylic acid or derivatives;Anisole;Methoxybenzene;Alkyl aryl ether;Monocyclic benzene moiety;Benzenoid;Thiazole;Azole;Heteroaromatic compound;Carboxamide group;Secondary carboxylic acid amide;Monocarboxylic acid or derivatives;Ether;Carboxylic acid;Organoheterocyclic compound;Azacycle;Organic oxygen compound;Organic nitrogen compound;Carbonyl group;Hydrocarbon derivative;Organic oxide;Organooxygen compound;Organonitrogen compound;Aromatic heteromonocyclic compound	Organic acids and derivatives	0.0		EiM08-12838		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C21H20N2O4S	C21H20N2O4S			InChI=1S/C21H20N2O4S/c1-13-18(28-20(22-13)15-9-6-10-16(12-15)27-2)19(24)23-17(21(25)26)11-14-7-4-3-5-8-14/h3-10,12,17H,11H2,1-2H3,(H,23,24)(H,25,26)/t17-/m0/s1	LOQFCEXICLTIFK-KRWDZBQOSA-N	rac-(2S)-2-[[2-(3-methoxyphenyl)-4-methyl-thiazole-5-carbonyl]amino]-3-phenyl-propanoic acid	49652119	COc1cccc(-c2nc(C)c(C(=O)N[C@@H](Cc3ccccc3)C(=O)O)s2)c1	(2S)-2-[[2-(3-methoxyphenyl)-4-methyl-1,3-thiazole-5-carbonyl]amino]-3-phenylpropanoic acid			2.54626													MCULE-2058659035	396.46855		396.114378	5	2	7	3			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(49652119)	49652119	4.2	255			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6](-[#6]2:[#7]:[#6](-[#6]):[#6](-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3)-[#6](=[#8])-[#8]):[#16]:2):[#6]:1	COc1cccc(-c2nc(C)c(C(=O)N[C@@H](Cc3ccccc3)C(=O)O)s2)c1	LOQFCEXICLTIFK		parent_pubchem_cid	EiM08-12838;AKOS016388521;(2S)-2-({[2-(3-METHOXYPHENYL)-4-METHYL-1,3-THIAZOL-5-YL]CARBONYL}AMINO)-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[[2-(3-methoxyphenyl)-4-methyl-thiazole-5-carbonyl]amino]-3-phenyl-propanoic acid		23922244.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23922244		pluskal_iocb_peptide_Peptide01_B8_id		100	B8		ZINC000040309229
3.4		0	802	P3461931	87.1		G6	False	0	21	0	1	18	0	3	3	0	0		0.0						O=C(Cn1ccc2c1cc(F)cc2)NC(Cc1c[nH]c2ccccc12)C(=O)O																							0.0		AKOS004938024		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C21H18FN3O3	C21H18FN3O3			InChI=1S/C21H18FN3O3/c22-15-6-5-13-7-8-25(19(13)10-15)12-20(26)24-18(21(27)28)9-14-11-23-17-4-2-1-3-16(14)17/h1-8,10-11,18,23H,9,12H2,(H,24,26)(H,27,28)/t18-/m0/s1	NJOYIFWCNFBYQS-SFHVURJKSA-N	rac-(2S)-2-[[2-(6-fluoroindol-1-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid	29130909	O=C(Cn1ccc2c1cc(F)cc2)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	(2S)-2-[[2-(6-fluoroindol-1-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid			2.16225													MCULE-2253769959	379.39431		379.13322	3	3	6	4			44										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(29130909)	29130909	3.3	256			[#8]=[#6](-[#6]-[#7]1:[#6]:[#6]:[#6]2:[#6]:1:[#6]:[#6](-[#9]):[#6]:[#6]:2)-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	O=C(Cn1ccc2c1cc(F)cc2)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	NJOYIFWCNFBYQS		parent_pubchem_cid	AKOS004938024;rac-(2S)-2-[[2-(6-fluoroindol-1-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid		24430525.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24430525		pluskal_iocb_peptide_Peptide01_B9_id		100	B9		ZINC000020721608
2.0		0	890	P3458806	114.8		G7	False	0	20	0	0	18	0	6	3	0	0		0.0						COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c1ccccc1-n1cnnn1																							0.0		AKOS016382732		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	4	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C20H18N6O3	C20H18N6O3			InChI=1S/C20H18N6O3/c1-29-20(28)17(10-13-11-21-16-8-4-2-6-14(13)16)23-19(27)15-7-3-5-9-18(15)26-12-22-24-25-26/h2-9,11-12,17,21H,10H2,1H3,(H,23,27)/t17-/m0/s1	KGVCSBBXRPOCSZ-KRWDZBQOSA-N	methyl rac-(2S)-3-(1H-indol-3-yl)-2-[[2-(tetrazol-1-yl)benzoyl]amino]propanoate	29130856	COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1ccccc1-n1cnnn1	methyl (2S)-3-(1H-indol-3-yl)-2-[[2-(tetrazol-1-yl)benzoyl]amino]propanoate			0.92985													MCULE-1552220884	390.40486		390.144038	6	2	7	4			44									Imidazole alkaloids;Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids;Histidine alkaloids			Peptide01			Compound(29130856)	29130856	2.5	257			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#7]1:[#6]:[#7]:[#7]:[#7]:1	COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1ccccc1-n1cnnn1	KGVCSBBXRPOCSZ		parent_pubchem_cid	AKOS016382732;METHYL 3-(1H-INDOL-3-YL)-2-{[2-(1H-1,2,3,4-TETRAZOL-1-YL)PHENYL]FORMAMIDO}PROPANOATE;methyl rac-(2S)-3-(1H-indol-3-yl)-2-[[2-(tetrazol-1-yl)benzoyl]amino]propanoate		13174607.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=13174607		pluskal_iocb_peptide_Peptide01_B9_id		100	B9		ZINC000020721473
3.0		0	978	P7138763	75.6		G8	False	0	14	0	0	19	0	1	4	0	0		0.0						CCCCC(NC(=O)OCc1ccccc1)C(=O)O								Alpha amino acids and derivatives;Medium-chain fatty acids;Amino fatty acids;Carbamate esters;Organic carbonic acids and derivatives;Monocarboxylic acids and derivatives;Carboxylic acids;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amino fatty acids;Benzene and substituted derivatives;Benzenoids;Benzyloxycarbonyls;Carbamate esters;Carbamic acids and derivatives;Carbonyl compounds;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Fatty Acyls;Fatty acids and conjugates;Hydrocarbon derivatives;Lipids and lipid-like molecules;Medium-chain fatty acids;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as benzyloxycarbonyls. These are organic compounds containing a carbonyl group substituted with a benzyloxyl group.	Benzyloxycarbonyls			Organic compounds	Aromatic homomonocyclic compounds	organonitrogen compound (CHEBI:35352);organooxygen compound (CHEBI:36963);medium-chain fatty acid (CHEBI:59554);amino fatty acid (CHEBI:59650);carbamate ester (CHEBI:23003);carbonyl compound (CHEBI:36586);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carboxylic ester (CHEBI:33308);chemical entity (CHEBI:24431);amino acid (CHEBI:33709);peptide (CHEBI:16670);lipid (CHEBI:18059);monocarboxylic acid (CHEBI:25384);carbon oxoacid (CHEBI:35605);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712)	Fatty Acids and Conjugates (FA01);Amino fatty acids (FA0110);Fatty Acyls (FA)	Benzyloxycarbonyls	Alpha-amino acid or derivatives;Benzyloxycarbonyl;Medium-chain fatty acid;Amino fatty acid;Fatty acyl;Fatty acid;Carbamic acid ester;Carbonic acid derivative;Carboxylic acid derivative;Carboxylic acid;Monocarboxylic acid or derivatives;Organic nitrogen compound;Organonitrogen compound;Organooxygen compound;Hydrocarbon derivative;Organic oxide;Carbonyl group;Organopnictogen compound;Organic oxygen compound;Aromatic homomonocyclic compound	Benzenoids	0.0		15027-13-1	DTXSID20294762	2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	1	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C14H19NO4	C14H19NO4			InChI=1S/C14H19NO4/c1-2-3-9-12(13(16)17)15-14(18)19-10-11-7-5-4-6-8-11/h4-8,12H,2-3,9-10H2,1H3,(H,15,18)(H,16,17)	NMYWMOZOCYAHNC-UHFFFAOYSA-N	2-(benzyloxycarbonylamino)hexanoic acid	263476	CCCCC(NC(=O)OCc1ccccc1)C(=O)O	2-(phenylmethoxycarbonylamino)hexanoic acid			2.5014900000000004													MCULE-7532806219	265.31183		265.131408	4	2	8	1			42									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(263476)	263476	2.9	258		SCHEMBL150166	[#6]-[#6]-[#6]-[#6]-[#6](-[#7]-[#6](=[#8])-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	CCCCC(NC(=O)OCc1ccccc1)C(=O)O	NMYWMOZOCYAHNC		parent_pubchem_cid	15027-13-1;N-Carbobenzoxy-DL-norleucine;Z-DL-Nle-OH;N-[(Benzyloxy)carbonyl]norleucine;cbz-dl-norleucine;2-(phenylmethoxycarbonylamino)hexanoic acid;2-(((Benzyloxy)carbonyl)amino)hexanoic acid;Z-D-2-aminohexanoic acid;2-{[(benzyloxy)carbonyl]amino}hexanoic acid;MFCD00037271;Z-L-Norleucine;norleucine, N-[(phenylmethoxy)carbonyl]-;Z-L-2-aminohexanoic acid;N-Benzyloxycarbonyl-dl-norleucine;N-Alpha-carbobenzoxy-DL-norleucine;NSC97950;N-Cbz-DL-norleucine;2-(Benzyloxycarbonylamino)hexanoic acid;N-Cbz-aminohexanoic acid;Z-DL-2-aminohexanoic acid;NCIOpen2_006350;SCHEMBL150166;DTXSID20294762;N-[(Benzyloxy)carbonyl]norleucine #;NSC-97950;AKOS009157180;HY-W142017;LS-09791;C0760;CS-0201803;FT-0697726;FT-0698374;FT-0703470;EN300-121142;T70317;A873617;A884180;J-008676		24330109.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24330109		pluskal_iocb_peptide_Peptide01_B9_id		100	B9		
4.2		0	722	P6236253	87.1		G9	False	1	22	0	0	20	0	3	3	0	0		0.0						O=C(CCn1ccc2c1cc(Br)cc2)NC(Cc1c[nH]c2ccccc12)C(=O)O																							0.0		AKOS016402462		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C22H20BrN3O3	C22H20BrN3O3			InChI=1S/C22H20BrN3O3/c23-16-6-5-14-7-9-26(20(14)12-16)10-8-21(27)25-19(22(28)29)11-15-13-24-18-4-2-1-3-17(15)18/h1-7,9,12-13,19,24H,8,10-11H2,(H,25,27)(H,28,29)/t19-/m0/s1	BBGDJRIMHXBWMY-IBGZPJMESA-N	rac-(2S)-2-[3-(6-bromoindol-1-yl)propanoylamino]-3-(1H-indol-3-yl)propanoic acid	29147234	O=C(CCn1ccc2c1cc(Br)cc2)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	(2S)-2-[3-(6-bromoindol-1-yl)propanoylamino]-3-(1H-indol-3-yl)propanoic acid			3.1757500000000007													MCULE-1276200455	454.327		453.068804	3	3	7	4			44									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(29147234)	29147234	3.6	259			[#8]=[#6](-[#6]-[#6]-[#7]1:[#6]:[#6]:[#6]2:[#6]:1:[#6]:[#6](-[#35]):[#6]:[#6]:2)-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	O=C(CCn1ccc2c1cc(Br)cc2)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	BBGDJRIMHXBWMY		parent_pubchem_cid	AKOS016402462;2-[3-(6-BROMO-1H-INDOL-1-YL)PROPANAMIDO]-3-(1H-INDOL-3-YL)PROPANOIC ACID;rac-(2S)-2-[3-(6-bromoindol-1-yl)propanoylamino]-3-(1H-indol-3-yl)propanoic acid		24543816.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24543816		pluskal_iocb_peptide_Peptide01_B9_id		100	B9		ZINC000020760904
2.3		0	810	P3461510	135.9		G10	False	0	20	0	0	19	0	5	3	0	2		0.0						O=C(Cc1c[nH]c2ccccc12)N1CCN(S(=O)(=O)c2cccc3nsnc23)CC1																							0.0		1-[4-(2,1,3-benzothiadiazol-4-ylsulfonyl)piperazin-1-yl]-2-(1H-indol-3-yl)ethanone		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	1	1		C20H19N5O3S2	C20H19N5O3S2			InChI=1S/C20H19N5O3S2/c26-19(12-14-13-21-16-5-2-1-4-15(14)16)24-8-10-25(11-9-24)30(27,28)18-7-3-6-17-20(18)23-29-22-17/h1-7,13,21H,8-12H2	CVRNRZPPZIARBS-UHFFFAOYSA-N	1-[4-(2,1,3-benzothiadiazol-4-ylsulfonyl)piperazin-1-yl]-2-(1H-indol-3-yl)ethanone	42535357	O=C(Cc1c[nH]c2ccccc12)N1CCN(S(=O)(=O)c2cccc3nsnc23)CC1	1-[4-(2,1,3-benzothiadiazol-4-ylsulfonyl)piperazin-1-yl]-2-(1H-indol-3-yl)ethanone			1.22864													MCULE-5677205955	441.53413		441.092931	5	1	4	5			43									Carboline alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(42535357)	42535357	1.9	260			[#8]=[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]1-[#6]-[#6]-[#7](-[#16](=[#8])(=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]3:[#7]:[#16]:[#7]:[#6]:2:3)-[#6]-[#6]-1	O=C(Cc1c[nH]c2ccccc12)N1CCN(S(=O)(=O)c2cccc3nsnc23)CC1	CVRNRZPPZIARBS		parent_pubchem_cid	1-[4-(2,1,3-benzothiadiazol-4-ylsulfonyl)piperazin-1-yl]-2-(1H-indol-3-yl)ethanone;1010885-65-0;EiM08-17864;STK632674;AKOS005564841;AKOS034067697;Z1983887630		7880515.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=7880515		pluskal_iocb_peptide_Peptide01_B9_id		100	B9		ZINC000012322520
2.3		0	898	P6241473	142.1		G11	False	0	17	0	0	20	0	2	4	0	2	-1.0	0.0						COc1cccc(-c2nc(C)c(C(=O)NC(CCSC)C(=O)O)s2)c1		3.06		0.0	2.54	CHEMBL3438436		N-acyl-alpha amino acids;2,4,5-trisubstituted thiazoles;2-heteroaryl carboxamides;Anisoles;Methoxybenzenes;Thiazolecarboxamides;Phenoxy compounds;Alkyl aryl ethers;Thia fatty acids;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Monocarboxylic acids and derivatives;Dialkylthioethers;Carboxylic acids;Sulfenyl compounds;Hydrocarbon derivatives;Organic oxides;Organonitrogen compounds;Carbonyl compounds	2,4,5-trisubstituted thiazoles;2-heteroaryl carboxamides;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Anisoles;Azacyclic compounds;Azoles;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Dialkylthioethers;Ethers;Fatty Acyls;Fatty acids and conjugates;Heteroaromatic compounds;Hydrocarbon derivatives;Lipids and lipid-like molecules;Methionine and derivatives;Methoxybenzenes;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Organosulfur compounds;Phenol ethers;Phenoxy compounds;Secondary carboxylic acid amides;Sulfenyl compounds;Thia fatty acids;Thiazolecarboxamides;Thiazolecarboxylic acids and derivatives;Thiazoles;Thioethers	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as methionine and derivatives. These are compounds containing methionine or a derivative thereof resulting from reaction of methionine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Methionine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteromonocyclic compounds	N-acyl-amino acid (CHEBI:51569);thiazoles (CHEBI:48901);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);methoxybenzene (CHEBI:51683);aromatic amide (CHEBI:62733);benzenes (CHEBI:22712);aromatic ether (CHEBI:35618);thia fatty acid (CHEBI:59643);organonitrogen heterocyclic compound (CHEBI:38101);monocarboxylic acid (CHEBI:25384);aliphatic sulfide (CHEBI:22327);carboxylic acid (CHEBI:33575);organosulfur compound (CHEBI:33261);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);carbonyl compound (CHEBI:36586);alpha-amino acid (CHEBI:33704);methionine derivative (CHEBI:25230);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);organic heterocyclic compound (CHEBI:24532);azole (CHEBI:68452);amide (CHEBI:32988);benzenoid aromatic compound (CHEBI:33836);aromatic carboxylic acid (CHEBI:33859);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ether (CHEBI:25698);lipid (CHEBI:18059);organic sulfide (CHEBI:16385);nitrogen molecular entity (CHEBI:51143);carboxylic acid anion (CHEBI:29067);amino acid (CHEBI:33709);peptide (CHEBI:16670)	Thia fatty acids (FA0113);Fatty Acyls (FA);Fatty Acids and Conjugates (FA01)	Amino acids, peptides, and analogues	Methionine or derivatives;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;2,4,5-trisubstituted 1,3-thiazole;Anisole;2-heteroaryl carboxamide;Phenol ether;Thiazolecarboxamide;Thiazolecarboxylic acid or derivatives;Methoxybenzene;Phenoxy compound;Alkyl aryl ether;Thia fatty acid;Fatty acyl;Monocyclic benzene moiety;Benzenoid;Thiazole;Azole;Heteroaromatic compound;Secondary carboxylic acid amide;Carboxamide group;Monocarboxylic acid or derivatives;Dialkylthioether;Azacycle;Ether;Carboxylic acid;Thioether;Sulfenyl compound;Organoheterocyclic compound;Organic oxygen compound;Organic nitrogen compound;Organonitrogen compound;Carbonyl group;Organooxygen compound;Organosulfur compound;Hydrocarbon derivative;Organic oxide;Aromatic heteromonocyclic compound	Organic acids and derivatives	0.0		CHEMBL3438436		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C17H20N2O4S2	C17H20N2O4S2			InChI=1S/C17H20N2O4S2/c1-10-14(15(20)19-13(17(21)22)7-8-24-3)25-16(18-10)11-5-4-6-12(9-11)23-2/h4-6,9,13H,7-8H2,1-3H3,(H,19,20)(H,21,22)/t13-/m0/s1	WBWWCINDSWPIFI-ZDUSSCGKSA-N	rac-(2S)-2-[[2-(3-methoxyphenyl)-4-methyl-thiazole-5-carbonyl]amino]-4-methylsulfanyl-butanoic acid	49652535	COc1cccc(-c2nc(C)c(C(=O)N[C@@H](CCSC)C(=O)O)s2)c1	(2S)-2-[[2-(3-methoxyphenyl)-4-methyl-1,3-thiazole-5-carbonyl]amino]-4-methylsulfanylbutanoic acid			2.11137													MCULE-3074324182	380.48795	ACID	380.086449	6	2	8	2	1.0		29									Dipeptides	False	Amino acids and Peptides	Small peptides	False	False	Peptide01		-1.0	Compound(49652535)	49652535	3.2	261			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6](-[#6]2:[#7]:[#6](-[#6]):[#6](-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]-[#16]-[#6])-[#6](=[#8])-[#8]):[#16]:2):[#6]:1	COc1cccc(-c2nc(C)c(C(=O)N[C@@H](CCSC)C(=O)O)s2)c1	WBWWCINDSWPIFI		parent_pubchem_cid	CHEMBL3438436;EiM08-12837;AKOS016388512;(2S)-2-({[2-(3-METHOXYPHENYL)-4-METHYL-1,3-THIAZOL-5-YL]CARBONYL}AMINO)-4-(METHYLSULFANYL)BUTANOIC ACID;rac-(2S)-2-[[2-(3-methoxyphenyl)-4-methyl-thiazole-5-carbonyl]amino]-4-methylsulfanyl-butanoic acid	False	22989244.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22989244		pluskal_iocb_peptide_Peptide01_B9_id		100	B9	False	ZINC000040312747
1.1		0	986	P1107669	95.9		G12	False	0	23	0	0	19	0	1	5	0	0		0.0						O=C(O)C(Cc1ccccc1)NCc1c2oc(=O)c3ccccc3c2ccc1O																							0.0		EiM07-28726		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C23H19NO5	C23H19NO5			InChI=1S/C23H19NO5/c25-20-11-10-16-15-8-4-5-9-17(15)23(28)29-21(16)18(20)13-24-19(22(26)27)12-14-6-2-1-3-7-14/h1-11,19,24-25H,12-13H2,(H,26,27)/t19-/m1/s1	WSAMWULVMMTURK-LJQANCHMSA-N	rac-(2R)-2-[(3-hydroxy-6-oxo-benzo[c]chromen-4-yl)methylamino]-3-phenyl-propanoic acid	24280495	O=C(O)[C@@H](Cc1ccccc1)NCc1c2oc(=O)c3ccccc3c2ccc1O	(2R)-2-[(3-hydroxy-6-oxobenzo[c]chromen-4-yl)methylamino]-3-phenylpropanoic acid			2.908520000000001													MCULE-6866741436	389.41158		389.126323	6	3	6	4			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(24280495)	24280495	1.9	262			[#8]=[#6](-[#8])-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6]-[#6]1:[#6]2:[#8]:[#6](=[#8]):[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3:[#6]:2:[#6]:[#6]:[#6]:1-[#8]	O=C(O)[C@@H](Cc1ccccc1)NCc1c2oc(=O)c3ccccc3c2ccc1O	WSAMWULVMMTURK		parent_pubchem_cid	EiM07-28726;AKOS016402590;rac-(2R)-2-[(3-hydroxy-6-oxo-benzo[c]chromen-4-yl)methylamino]-3-phenyl-propanoic acid		1196836.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=1196836		pluskal_iocb_peptide_Peptide01_B9_id		100	B9		ZINC000011865495
1.9		0	730	P6243669	99.1		G13	False	0	17	0	0	25	0	3	4	0	0		0.0						CC(C)CC(NC(=O)Cn1nc2CCCCCc2cc1=O)C(=O)O																							0.0		AKOS016376061		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C17H25N3O4	C17H25N3O4			InChI=1S/C17H25N3O4/c1-11(2)8-14(17(23)24)18-15(21)10-20-16(22)9-12-6-4-3-5-7-13(12)19-20/h9,11,14H,3-8,10H2,1-2H3,(H,18,21)(H,23,24)/t14-/m0/s1	YRSZEQIETAONCY-AWEZNQCLSA-N	rac-(2S)-4-methyl-2-[[2-(3-oxo-6,7,8,9-tetrahydro-5H-cyclohepta[c]pyridazin-2-yl)acetyl]amino]pentanoic acid	51052928	CC(C)C[C@H](NC(=O)Cn1nc2CCCCCc2cc1=O)C(=O)O	(2S)-4-methyl-2-[[2-(3-oxo-6,7,8,9-tetrahydro-5H-cyclohepta[c]pyridazin-2-yl)acetyl]amino]pentanoic acid			1.91817													MCULE-4782457598	335.4065		335.184506	5	2	6	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51052928)	51052928	1.9	263			[#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#7]1:[#7]:[#6]2-[#6]-[#6]-[#6]-[#6]-[#6]-[#6]:2:[#6]:[#6]:1=[#8])-[#6](=[#8])-[#8]	CC(C)C[C@H](NC(=O)Cn1nc2CCCCCc2cc1=O)C(=O)O	YRSZEQIETAONCY		parent_pubchem_cid	AKOS016376061;NCGC00422742-01;4-METHYL-2-(2-{3-OXO-2H,3H,5H,6H,7H,8H,9H-CYCLOHEPTA[C]PYRIDAZIN-2-YL}ACETAMIDO)PENTANOIC ACID;rac-(2S)-4-methyl-2-[[2-(3-oxo-6,7,8,9-tetrahydro-5H-cyclohepta[c]pyridazin-2-yl)acetyl]amino]pentanoic acid		24576364.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24576364		pluskal_iocb_peptide_Peptide01_B9_id		100	B9		ZINC000049545215
4.6		0	818	P11183540	83.6		G14	False	0	26	0	0	23	0	5	1	0	0		0.0						CC(C)C(NC(=O)c1cc(-c2cnccc2)nc2ccccc12)c1nc2ccccc2[nH]1																							0.0		AKOS027471810		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C26H23N5O	C26H23N5O			InChI=1S/C26H23N5O/c1-16(2)24(25-29-21-11-5-6-12-22(21)30-25)31-26(32)19-14-23(17-8-7-13-27-15-17)28-20-10-4-3-9-18(19)20/h3-16,24H,1-2H3,(H,29,30)(H,31,32)/t24-/m0/s1	ZRTOXFSADKSCGQ-DEOSSOPVSA-N	2-(3-pyridyl)-N-[rac-(1S)-1-(1H-benzimidazol-2-yl)-2-methyl-propyl]quinoline-4-carboxamide	75490347	CC(C)[C@H](NC(=O)c1cc(-c2cnccc2)nc2ccccc12)c1nc2ccccc2[nH]1	N-[(1S)-1-(1H-benzimidazol-2-yl)-2-methylpropyl]-2-pyridin-3-ylquinoline-4-carboxamide			3.9539200000000014														421.50611		421.19026	4	2	5	5			45										False	Alkaloids				Peptide01			Compound(75490347)	75490347	4.5	264			[#6]-[#6](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6](-[#6]2:[#6]:[#7]:[#6]:[#6]:[#6]:2):[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6]1:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#7H]:1	CC(C)[C@H](NC(=O)c1cc(-c2cnccc2)nc2ccccc12)c1nc2ccccc2[nH]1	ZRTOXFSADKSCGQ		parent_pubchem_cid	AKOS027471810;N-[(1S)-1-(1H-13-BENZODIAZOL-2-YL)-2-METHYLPROPYL]-2-(PYRIDIN-3-YL)QUINOLINE-4-CARBOXAMIDE;2-(3-pyridyl)-N-[rac-(1S)-1-(1H-benzimidazol-2-yl)-2-methyl-propyl]quinoline-4-carboxamide		80414770.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=80414770		pluskal_iocb_peptide_Peptide01_B10_id		100	B10		ZINC000096232077
2.2		0	906	P6246950	86.1		G15	False	0	20	0	0	22	0	4	3	0	0		0.0						COC(=O)C(Cc1ccccc1)NC(=O)c1c2c(C)nn(C)c2nc(C)c1																							0.0		EiM08-20202		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C20H22N4O3	C20H22N4O3			InChI=1S/C20H22N4O3/c1-12-10-15(17-13(2)23-24(3)18(17)21-12)19(25)22-16(20(26)27-4)11-14-8-6-5-7-9-14/h5-10,16H,11H2,1-4H3,(H,22,25)/t16-/m0/s1	GPRMTUSLRPEYTI-INIZCTEOSA-N	methyl rac-(2S)-3-phenyl-2-[(1,3,6-trimethylpyrazolo[3,4-b]pyridine-4-carbonyl)amino]propanoate	31768493	COC(=O)[C@H](Cc1ccccc1)NC(=O)c1c2c(C)nn(C)c2nc(C)c1	methyl (2S)-3-phenyl-2-[(1,3,6-trimethylpyrazolo[3,4-b]pyridine-4-carbonyl)amino]propanoate			1.4519799999999994													MCULE-6692373477	366.42334		366.169191	5	1	6	3			44										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(31768493)	31768493	2.8	265			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]1:[#6]2:[#6](-[#6]):[#7]:[#7](-[#6]):[#6]:2:[#7]:[#6](-[#6]):[#6]:1	COC(=O)[C@H](Cc1ccccc1)NC(=O)c1c2c(C)nn(C)c2nc(C)c1	GPRMTUSLRPEYTI		parent_pubchem_cid	EiM08-20202;AKOS016391810;methyl rac-(2S)-3-phenyl-2-[(1,3,6-trimethylpyrazolo[3,4-b]pyridine-4-carbonyl)amino]propanoate		7949101.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=7949101		pluskal_iocb_peptide_Peptide01_B10_id		100	B10		ZINC000024363712
3.6		0	994	P7129733	112.2		G16	False	0	21	0	0	28	0	4	2	0	1		0.0						CC(C)C1CCC(C(=O)NC(Cc2ccccc2)C(=O)Nc2nncs2)CC1																							0.0		AKOS024459977		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C21H28N4O2S	C21H28N4O2S			InChI=1S/C21H28N4O2S/c1-14(2)16-8-10-17(11-9-16)19(26)23-18(12-15-6-4-3-5-7-15)20(27)24-21-25-22-13-28-21/h3-7,13-14,16-18H,8-12H2,1-2H3,(H,23,26)(H,24,25,27)/t16?,17?,18-/m1/s1	OKTRHZCAACPPLC-DAWZGUTISA-N	4-isopropyl-N-[rac-(1R)-1-benzyl-2-oxo-2-(1,3,4-thiadiazol-2-ylamino)ethyl]cyclohexanecarboxamide	71691718	CC(C)C1CCC(C(=O)N[C@H](Cc2ccccc2)C(=O)Nc2nncs2)CC1	N-[(2R)-1-oxo-3-phenyl-1-(1,3,4-thiadiazol-2-ylamino)propan-2-yl]-4-propan-2-ylcyclohexane-1-carboxamide			3.231180000000001														400.54691		400.193297	4	2	7	3			45										False					Peptide01			Compound(71691718)	71691718	4.3	266			[#6]-[#6](-[#6])-[#6]1-[#6]-[#6]-[#6](-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#7]-[#6]2:[#7]:[#7]:[#6]:[#16]:2)-[#6]-[#6]-1	CC(C)C1CCC(C(=O)N[C@H](Cc2ccccc2)C(=O)Nc2nncs2)CC1	OKTRHZCAACPPLC		parent_pubchem_cid	AKOS024459977;4-isopropyl-N-[rac-(1R)-1-benzyl-2-oxo-2-(1,3,4-thiadiazol-2-ylamino)ethyl]cyclohexanecarboxamide		48355442.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=48355442		pluskal_iocb_peptide_Peptide01_B10_id		100	B10		ZINC000072404275
1.6		0	738	P1090572	72.9		G17	False	0	27	0	2	27	0	3	3	0	0		0.0						O=C(O)C(Cc1ccccc1)NC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1																							0.0		1014042-03-5		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1		C27H27F2N3O3	C27H27F2N3O3			InChI=1S/C27H27F2N3O3/c28-22-10-6-20(7-11-22)25(21-8-12-23(29)13-9-21)31-14-16-32(17-15-31)27(35)30-24(26(33)34)18-19-4-2-1-3-5-19/h1-13,24-25H,14-18H2,(H,30,35)(H,33,34)/t24-/m0/s1	PHWXZOUICNSUOU-DEOSSOPVSA-N	rac-(2S)-2-[[4-[bis(4-fluorophenyl)methyl]piperazine-1-carbonyl]amino]-3-phenyl-propanoic acid	17579418	O=C(O)[C@H](Cc1ccccc1)NC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1	(2S)-2-[[4-[bis(4-fluorophenyl)methyl]piperazine-1-carbonyl]amino]-3-phenylpropanoic acid			3.913170000000002													MCULE-5068330384	479.53134		479.202048	4	2	7	4			44										False	Alkaloids				Peptide01			Compound(17579418)	17579418	2.1	267			[#8]=[#6](-[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#7]1-[#6]-[#6]-[#7](-[#6](-[#6]2:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:2)-[#6]2:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:2)-[#6]-[#6]-1	O=C(O)[C@H](Cc1ccccc1)NC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1	PHWXZOUICNSUOU		parent_pubchem_cid	1014042-03-5;C27H27F2N3O3;MFCD07638268;AKOS005533432;N-({4-[bis(4-fluorophenyl)methyl]piperazin-1-yl}carbonyl)-L-phenylalanine;(2S)-2-[({4-[BIS(4-FLUOROPHENYL)METHYL]PIPERAZINO}CARBONYL)AMINO]-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[[4-[bis(4-fluorophenyl)methyl]piperazine-1-carbonyl]amino]-3-phenyl-propanoic acid		9361350.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=9361350		pluskal_iocb_peptide_Peptide01_B10_id		100	B10		ZINC000008970849
3.4		0	826	P3458867	126.0		G18	False	0	22	0	0	22	0	2	5	0	1		0.0						COc1c(OC)cc(-c2nc(CC(=O)NC(Cc3ccccc3)C(=O)O)cs2)cc1																							0.0		SCHEMBL20255540		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C22H22N2O5S	C22H22N2O5S			InChI=1S/C22H22N2O5S/c1-28-18-9-8-15(11-19(18)29-2)21-23-16(13-30-21)12-20(25)24-17(22(26)27)10-14-6-4-3-5-7-14/h3-9,11,13,17H,10,12H2,1-2H3,(H,24,25)(H,26,27)/t17-/m0/s1	ZKOXYAAKBAHQBD-KRWDZBQOSA-N	rac-(2S)-2-[[2-[2-(3,4-dimethoxyphenyl)thiazol-4-yl]acetyl]amino]-3-phenyl-propanoic acid	29128692	COc1c(OC)cc(-c2nc(CC(=O)N[C@@H](Cc3ccccc3)C(=O)O)cs2)cc1	(2S)-2-[[2-[2-(3,4-dimethoxyphenyl)-1,3-thiazol-4-yl]acetyl]amino]-3-phenylpropanoic acid			1.76764													MCULE-7577075396	426.49504		426.124943	6	2	9	3			43										False					Peptide01			Compound(29128692)	29128692	3.4	268		SCHEMBL20255540	[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]):[#6]:[#6](-[#6]2:[#7]:[#6](-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3)-[#6](=[#8])-[#8]):[#6]:[#16]:2):[#6]:[#6]:1	COc1c(OC)cc(-c2nc(CC(=O)N[C@@H](Cc3ccccc3)C(=O)O)cs2)cc1	ZKOXYAAKBAHQBD		parent_pubchem_cid	SCHEMBL20255540;AKOS005535096;2-{2-[2-(3,4-DIMETHOXYPHENYL)-1,3-THIAZOL-4-YL]ACETAMIDO}-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[[2-[2-(3,4-dimethoxyphenyl)thiazol-4-yl]acetyl]amino]-3-phenyl-propanoic acid		22776425.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22776425		pluskal_iocb_peptide_Peptide01_B10_id		100	B10		ZINC000020717437
2.1		0	914	P11184247	120.5		G19	False	0	22	0	0	21	0	3	5	0	0		0.0						O=C1CCc2c(cc(OCC(=O)NC(Cc3c[nH]c4ccccc34)C(=O)O)cc2)N1																							0.0		AKOS027472157		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0		C22H21N3O5	C22H21N3O5			InChI=1S/C22H21N3O5/c26-20-8-6-13-5-7-15(10-18(13)24-20)30-12-21(27)25-19(22(28)29)9-14-11-23-17-4-2-1-3-16(14)17/h1-5,7,10-11,19,23H,6,8-9,12H2,(H,24,26)(H,25,27)(H,28,29)/t19-/m0/s1	AWGLNHXEYZKGJA-IBGZPJMESA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[[2-[(2-oxo-3,4-dihydro-1H-quinolin-7-yl)oxy]acetyl]amino]propanoic acid	75491224	O=C1CCc2c(cc(OCC(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)O)cc2)N1	(2S)-3-(1H-indol-3-yl)-2-[[2-[(2-oxo-3,4-dihydro-1H-quinolin-7-yl)oxy]acetyl]amino]propanoic acid			0.862639999999999														407.42977		407.148121	5	4	7	4			45										False	Alkaloids;Amino acids and Peptides	Tryptophan alkaloids			Peptide01			Compound(75491224)	75491224	2.1	269			[#8]=[#6]1-[#6]-[#6]-[#6]2:[#6](:[#6]:[#6](-[#8]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]3:[#6]:[#7H]:[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]:3:4)-[#6](=[#8])-[#8]):[#6]:[#6]:2)-[#7]-1	O=C1CCc2c(cc(OCC(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)O)cc2)N1	AWGLNHXEYZKGJA		parent_pubchem_cid	AKOS027472157;N-{[(2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)oxy]acetyl}-L-tryptophan;rac-(2S)-3-(1H-indol-3-yl)-2-[[2-[(2-oxo-3,4-dihydro-1H-quinolin-7-yl)oxy]acetyl]amino]propanoic acid		80415636.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=80415636		pluskal_iocb_peptide_Peptide01_B10_id		100	B10		ZINC000096221163
3.8		0	1002	P11182984	88.4		G20	False	0	26	0	0	33	0	5	2	0	0		0.0						CC(C)C1CCC(C(=O)NC(Cc2ccccc2)C(=O)NCc2nnc3ccccn23)CC1																							0.0		AKOS027471425		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	3	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	1		C26H33N5O2	C26H33N5O2			InChI=1S/C26H33N5O2/c1-18(2)20-11-13-21(14-12-20)25(32)28-22(16-19-8-4-3-5-9-19)26(33)27-17-24-30-29-23-10-6-7-15-31(23)24/h3-10,15,18,20-22H,11-14,16-17H2,1-2H3,(H,27,33)(H,28,32)/t20?,21?,22-/m0/s1	XWHFAMPRUKSDRK-HRTMPFAESA-N	4-isopropyl-N-[rac-(1S)-1-benzyl-2-oxo-2-([1,2,4]triazolo[4,3-a]pyridin-3-ylmethylamino)ethyl]cyclohexanecarboxamide	121595440	CC(C)C1CCC(C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2nnc3ccccn23)CC1	N-[(2S)-1-oxo-3-phenyl-1-([1,2,4]triazolo[4,3-a]pyridin-3-ylmethylamino)propan-2-yl]-4-propan-2-ylcyclohexane-1-carboxamide			3.2117700000000013														447.58521		447.263425	4	2	8	4			45										False					Peptide01			Compound(121595440)	121595440	4.8	270			[#6]-[#6](-[#6])-[#6]1-[#6]-[#6]-[#6](-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#7]-[#6]-[#6]2:[#7]:[#7]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#7]:2:3)-[#6]-[#6]-1	CC(C)C1CCC(C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2nnc3ccccn23)CC1	XWHFAMPRUKSDRK		parent_pubchem_cid	AKOS027471425;N-[(TRANS-4-ISOPROPYLCYCLOHEXYL)CARBONYL]-N-([1,2,4]TRIAZOLO[4,3-A]PYRIDIN-3-YLMETHYL)-L-PHENYLALANINAMIDE;4-isopropyl-N-[rac-(1S)-1-benzyl-2-oxo-2-([1,2,4]triazolo[4,3-a]pyridin-3-ylmethylamino)ethyl]cyclohexanecarboxamide		147966412.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=147966412		pluskal_iocb_peptide_Peptide01_B10_id		100	B10		ZINC000252508869
1.4		0	746	P6240001	113.7		G21	False	0	17	0	0	20	0	2	4	0	1		0.0						CSCCC(NC(=O)Cn1cc(C(C)=O)c2ccccc21)C(=O)O								N-acyl-L-alpha-amino acids;N-alkylindoles;Indoles;Aryl alkyl ketones;Thia fatty acids;Substituted pyrroles;Benzenoids;Vinylogous amides;Heteroaromatic compounds;Secondary carboxylic acid amides;Dialkylthioethers;Carboxylic acids;Sulfenyl compounds;Azacyclic compounds;Monocarboxylic acids and derivatives;Organic oxides;Hydrocarbon derivatives;Organonitrogen compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Aryl alkyl ketones;Aryl ketones;Azacyclic compounds;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Dialkylthioethers;Fatty Acyls;Fatty acids and conjugates;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Ketones;Lipids and lipid-like molecules;Methionine and derivatives;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;N-alkylindoles;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organosulfur compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Sulfenyl compounds;Thia fatty acids;Thioethers;Vinylogous amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as methionine and derivatives. These are compounds containing methionine or a derivative thereof resulting from reaction of methionine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Methionine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-L-alpha-amino acid (CHEBI:48927);indoles (CHEBI:24828);aromatic ketone (CHEBI:76224);thia fatty acid (CHEBI:59643);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);enone (CHEBI:51689);enamine (CHEBI:47989);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);aliphatic sulfide (CHEBI:22327);carboxylic acid (CHEBI:33575);organosulfur compound (CHEBI:33261);organonitrogen heterocyclic compound (CHEBI:38101);monocarboxylic acid (CHEBI:25384);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);organonitrogen compound (CHEBI:35352);alpha-amino acid (CHEBI:33704);methionine derivative (CHEBI:25230);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);carbonyl compound (CHEBI:36586);organooxygen compound (CHEBI:36963);N-acyl-amino acid (CHEBI:51569);organic heterocyclic compound (CHEBI:24532);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ketone (CHEBI:17087);lipid (CHEBI:18059);amide (CHEBI:32988);organic sulfide (CHEBI:16385);nitrogen molecular entity (CHEBI:51143)	Thia fatty acids (FA0113);Fatty Acyls (FA);Fatty Acids and Conjugates (FA01)	Amino acids, peptides, and analogues	Methionine or derivatives;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;N-acyl-l-alpha-amino acid;N-alkylindole;Indole;Indole or derivatives;Aryl ketone;Aryl alkyl ketone;Thia fatty acid;Substituted pyrrole;Benzenoid;Fatty acyl;Heteroaromatic compound;Vinylogous amide;Pyrrole;Carboxamide group;Secondary carboxylic acid amide;Ketone;Azacycle;Organoheterocyclic compound;Sulfenyl compound;Thioether;Dialkylthioether;Carboxylic acid;Monocarboxylic acid or derivatives;Carbonyl group;Organic oxide;Hydrocarbon derivative;Organonitrogen compound;Organic oxygen compound;Organic nitrogen compound;Organooxygen compound;Organosulfur compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		EiM08-11071		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C17H20N2O4S	C17H20N2O4S			InChI=1S/C17H20N2O4S/c1-11(20)13-9-19(15-6-4-3-5-12(13)15)10-16(21)18-14(17(22)23)7-8-24-2/h3-6,9,14H,7-8,10H2,1-2H3,(H,18,21)(H,22,23)/t14-/m0/s1	AKUOSFHZSPFGEP-AWEZNQCLSA-N	rac-(2S)-2-[[2-(3-acetylindol-1-yl)acetyl]amino]-4-methylsulfanyl-butanoic acid	45490595	CSCC[C@H](NC(=O)Cn1cc(C(C)=O)c2ccccc21)C(=O)O	(2S)-2-[[2-(3-acetylindol-1-yl)acetyl]amino]-4-methylsulfanylbutanoic acid			1.6832699999999998													MCULE-9038486196	348.42395		348.114378	5	2	8	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(45490595)	45490595	1.8	271			[#6]-[#16]-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#7]1:[#6]:[#6](-[#6](-[#6])=[#8]):[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	CSCC[C@H](NC(=O)Cn1cc(C(C)=O)c2ccccc21)C(=O)O	AKUOSFHZSPFGEP		parent_pubchem_cid	EiM08-11071;AKOS016375009;(2S)-2-{[2-(3-ACETYL-1H-INDOL-1-YL)ACETYL]AMINO}-4-(METHYLSULFANYL)BUTANOIC ACID;rac-(2S)-2-[[2-(3-acetylindol-1-yl)acetyl]amino]-4-methylsulfanyl-butanoic acid		22810868.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22810868		pluskal_iocb_peptide_Peptide01_B10_id		100	B10		ZINC000036369955
4.2		0	834	P1108340	121.6		G22	False	0	26	0	0	22	0	2	6	0	0		0.0						Cc1coc2cc3c(cc12)c(C)c(CC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)O)c(=O)o3								N-acyl-alpha amino acids;Indolyl carboxylic acids and derivatives;1-benzopyrans;3-alkylindoles;Benzofurans;Pyranones and derivatives;Substituted pyrroles;Benzenoids;Heteroaromatic compounds;Furans;Secondary carboxylic acid amides;Lactones;Oxacyclic compounds;Monocarboxylic acids and derivatives;Azacyclic compounds;Carboxylic acids;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organonitrogen compounds	1-benzopyrans;3-alkylindoles;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzenoids;Benzofurans;Benzopyrans;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;Furanocoumarins;Furans;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Indolyl carboxylic acids and derivatives;Lactones;Linear furanocoumarins;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Oxacyclic compounds;Phenylpropanoids and polyketides;Psoralens;Pyranones and derivatives;Pyrans;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Coumarins and derivatives	2.1	This compound belongs to the class of organic compounds known as psoralens. These are organic compounds containing a psoralen moiety, which consists of a furan fused to a chromenone to for 7H-furo[3,2-g]chromen-7-one.	Psoralens		Linear furanocoumarins	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-amino acid (CHEBI:51569);indolyl carboxylic acid (CHEBI:46867);1-benzopyran (CHEBI:38443);indoles (CHEBI:24828);benzofurans (CHEBI:35259);pyranone (CHEBI:37963);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);organic aromatic compound (CHEBI:33659);furans (CHEBI:24129);carboxamide (CHEBI:37622);lactone (CHEBI:25000);oxacycle (CHEBI:38104);monocarboxylic acid (CHEBI:25384);organonitrogen heterocyclic compound (CHEBI:38101);carboxylic acid (CHEBI:33575);carbonyl compound (CHEBI:36586);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);psoralens (CHEBI:26369);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);pyrans (CHEBI:26407);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143);coumarins (CHEBI:23403);furanocoumarin (CHEBI:24128)	Benzofuranoids (PK1310);Benzopyranoids (PK1311)	Furanocoumarins	Psoralen;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;Indolyl carboxylic acid derivative;Alpha-amino acid or derivatives;Benzopyran;3-alkylindole;1-benzopyran;Benzofuran;Indole;Indole or derivatives;Pyranone;Benzenoid;Substituted pyrrole;Pyran;Furan;Heteroaromatic compound;Pyrrole;Secondary carboxylic acid amide;Lactone;Carboxamide group;Organoheterocyclic compound;Azacycle;Monocarboxylic acid or derivatives;Oxacycle;Carboxylic acid derivative;Carboxylic acid;Organic oxygen compound;Organic nitrogen compound;Hydrocarbon derivative;Carbonyl group;Organic oxide;Organooxygen compound;Organonitrogen compound;Aromatic heteropolycyclic compound	Phenylpropanoids and polyketides	0.0		AKOS016393834		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C26H22N2O6	C26H22N2O6			InChI=1S/C26H22N2O6/c1-13-12-33-22-10-23-18(8-17(13)22)14(2)19(26(32)34-23)9-24(29)28-21(25(30)31)7-15-11-27-20-6-4-3-5-16(15)20/h3-6,8,10-12,21,27H,7,9H2,1-2H3,(H,28,29)(H,30,31)/t21-/m1/s1	BJTZZEBZJSIVGA-OAQYLSRUSA-N	rac-(2R)-2-[[2-(3,5-dimethyl-7-oxo-furo[3,2-g]chromen-6-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid	24280647	Cc1coc2cc3c(cc12)c(C)c(CC(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)O)c(=O)o3	(2R)-2-[[2-(3,5-dimethyl-7-oxofuro[3,2-g]chromen-6-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid			3.387730000000001													MCULE-6566537366	458.47504		458.147786	5	3	6	5			44									Furocoumarins;Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(24280647)	24280647	3.5	272			[#6]-[#6]1:[#6]:[#8]:[#6]2:[#6]:[#6]3:[#6](:[#6]:[#6]:1:2):[#6](-[#6]):[#6](-[#6]-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]):[#6](=[#8]):[#8]:3	Cc1coc2cc3c(cc12)c(C)c(CC(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)O)c(=O)o3	BJTZZEBZJSIVGA		parent_pubchem_cid	AKOS016393834;2-(2-{3,5-DIMETHYL-7-OXO-7H-FURO[3,2-G]CHROMEN-6-YL}ACETAMIDO)-3-(1H-INDOL-3-YL)PROPANOIC ACID;rac-(2R)-2-[[2-(3,5-dimethyl-7-oxo-furo[3,2-g]chromen-6-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid		23948597.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23948597		pluskal_iocb_peptide_Peptide01_B11_id		100	B11		ZINC000011865647
2.1		0	922	P6243730	91.2		G23	False	0	20	0	0	23	0	5	3	0	0		0.0						COc1c(OC)cc(CCNC(=O)C(Cc2ccccc2)n2cnnn2)cc1																							0.0		AKOS016384779		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	4	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C20H23N5O3	C20H23N5O3			InChI=1S/C20H23N5O3/c1-27-18-9-8-16(13-19(18)28-2)10-11-21-20(26)17(25-14-22-23-24-25)12-15-6-4-3-5-7-15/h3-9,13-14,17H,10-12H2,1-2H3,(H,21,26)/t17-/m0/s1	INBSADVVIVCSPF-KRWDZBQOSA-N	rac-(2S)-N-[2-(3,4-dimethoxyphenyl)ethyl]-3-phenyl-2-(tetrazol-1-yl)propanamide	51054744	COc1c(OC)cc(CCNC(=O)[C@H](Cc2ccccc2)n2cnnn2)cc1	(2S)-N-[2-(3,4-dimethoxyphenyl)ethyl]-3-phenyl-2-(tetrazol-1-yl)propanamide			0.7987599999999992													MCULE-3481387641	381.43801		381.18009	6	1	9	3			44									Phenylethylamines	False	Alkaloids	Tyrosine alkaloids			Peptide01			Compound(51054744)	51054744	2.9	273			[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]):[#6]:[#6](-[#6]-[#6]-[#7]-[#6](=[#8])-[#6@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#7]2:[#6]:[#7]:[#7]:[#7]:2):[#6]:[#6]:1	COc1c(OC)cc(CCNC(=O)[C@H](Cc2ccccc2)n2cnnn2)cc1	INBSADVVIVCSPF		parent_pubchem_cid	AKOS016384779;rac-(2S)-N-[2-(3,4-dimethoxyphenyl)ethyl]-3-phenyl-2-(tetrazol-1-yl)propanamide		1750299.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=1750299		pluskal_iocb_peptide_Peptide01_B11_id		100	B11		ZINC000039994086
4.2		0	1010	P7129708	71.1		G24	False	0	25	0	0	33	0	3	2	0	0		0.0						CC(C)C1CCC(C(=O)NC(Cc2ccccc2)C(=O)NCc2ccccn2)CC1																							0.0		AKOS024459955		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C25H33N3O2	C25H33N3O2			InChI=1S/C25H33N3O2/c1-18(2)20-11-13-21(14-12-20)24(29)28-23(16-19-8-4-3-5-9-19)25(30)27-17-22-10-6-7-15-26-22/h3-10,15,18,20-21,23H,11-14,16-17H2,1-2H3,(H,27,30)(H,28,29)/t20?,21?,23-/m1/s1	CBHYCDCXYDIMQW-YDPRHXJPSA-N	4-isopropyl-N-[rac-(1R)-1-benzyl-2-oxo-2-(2-pyridylmethylamino)ethyl]cyclohexanecarboxamide	71691768	CC(C)C1CCC(C(=O)N[C@H](Cc2ccccc2)C(=O)NCc2ccccn2)CC1	N-[(2R)-1-oxo-3-phenyl-1-(pyridin-2-ylmethylamino)propan-2-yl]-4-propan-2-ylcyclohexane-1-carboxamide			3.7782800000000014														407.56066		407.257277	3	2	8	3			45										False	Alkaloids;Terpenoids				Peptide01			Compound(71691768)	71691768	4.5	274			[#6]-[#6](-[#6])-[#6]1-[#6]-[#6]-[#6](-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#7]-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#7]:2)-[#6]-[#6]-1	CC(C)C1CCC(C(=O)N[C@H](Cc2ccccc2)C(=O)NCc2ccccn2)CC1	CBHYCDCXYDIMQW		parent_pubchem_cid	AKOS024459955;4-isopropyl-N-[rac-(1R)-1-benzyl-2-oxo-2-(2-pyridylmethylamino)ethyl]cyclohexanecarboxamide		66698782.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=66698782		pluskal_iocb_peptide_Peptide01_B11_id		100	B11		ZINC000072405001
1.3		0	754	P6239445	162.6		G25	False	0	17	0	1	19	0	4	4	0	1		0.0						NC(=O)NCCCC(NC(=O)Cc1csc(-c2ccccc2F)n1)C(=O)O																							0.0		SCHEMBL21560116		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	1	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C17H19FN4O4S	C17H19FN4O4S			InChI=1S/C17H19FN4O4S/c18-12-5-2-1-4-11(12)15-21-10(9-27-15)8-14(23)22-13(16(24)25)6-3-7-20-17(19)26/h1-2,4-5,9,13H,3,6-8H2,(H,22,23)(H,24,25)(H3,19,20,26)/t13-/m1/s1	UJFOTRYCLYBWQA-CYBMUJFWSA-N	rac-(2R)-2-[[2-[2-(2-fluorophenyl)thiazol-4-yl]acetyl]amino]-5-ureido-pentanoic acid	45491546	NC(=O)NCCC[C@@H](NC(=O)Cc1csc(-c2ccccc2F)n1)C(=O)O	(2R)-5-(carbamoylamino)-2-[[2-[2-(2-fluorophenyl)-1,3-thiazol-4-yl]acetyl]amino]pentanoic acid			1.0748699999999998													MCULE-4552800358	394.42778		394.111104	5	4	9	2			43									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(45491546)	45491546	1.0	275		SCHEMBL21560116	[#7]-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]-[#6@@H](-[#7]-[#6](=[#8])-[#6]-[#6]1:[#6]:[#16]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#9]):[#7]:1)-[#6](=[#8])-[#8]	NC(=O)NCCC[C@@H](NC(=O)Cc1csc(-c2ccccc2F)n1)C(=O)O	UJFOTRYCLYBWQA		parent_pubchem_cid	SCHEMBL21560116;EiM08-10135;STK657971;AKOS005588083;N~5~-carbamoyl-N~2~-{[2-(2-fluorophenyl)-1,3-thiazol-4-yl]acetyl}-D-ornithine;rac-(2R)-2-[[2-[2-(2-fluorophenyl)thiazol-4-yl]acetyl]amino]-5-ureido-pentanoic acid		24780552.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24780552		pluskal_iocb_peptide_Peptide01_B11_id		100	B11		ZINC000036354458
4.0		0	842	P6241379	123.3		G26	False	0	22	0	1	18	0	3	3	0	1		0.0						Cc1c(C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)O)sc(-c2ccccc2F)n1																							0.0		STK935481		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C22H18FN3O3S	C22H18FN3O3S			InChI=1S/C22H18FN3O3S/c1-12-19(30-21(25-12)15-7-2-4-8-16(15)23)20(27)26-18(22(28)29)10-13-11-24-17-9-5-3-6-14(13)17/h2-9,11,18,24H,10H2,1H3,(H,26,27)(H,28,29)/t18-/m0/s1	UOEBNBGKAVUXPJ-SFHVURJKSA-N	rac-(2S)-2-[[2-(2-fluorophenyl)-4-methyl-thiazole-5-carbonyl]amino]-3-(1H-indol-3-yl)propanoic acid	49657146	Cc1c(C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)sc(-c2ccccc2F)n1	(2S)-2-[[2-(2-fluorophenyl)-4-methyl-1,3-thiazole-5-carbonyl]amino]-3-(1H-indol-3-yl)propanoic acid			3.192050000000002													MCULE-5942126691	423.46946		423.105291	4	3	6	4			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(49657146)	49657146	4.4	276			[#6]-[#6]1:[#6](-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6](=[#8])-[#8]):[#16]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#9]):[#7]:1	Cc1c(C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)sc(-c2ccccc2F)n1	UOEBNBGKAVUXPJ		parent_pubchem_cid	STK935481;AKOS005665041;N-{[2-(2-fluorophenyl)-4-methyl-1,3-thiazol-5-yl]carbonyl}-L-tryptophan;(S)-2-(2-(2-fluorophenyl)-4-methylthiazole-5-carboxamido)-3-(1H-indol-3-yl)propanoic acid;(2S)-2-({[2-(2-FLUOROPHENYL)-4-METHYL-1,3-THIAZOL-5-YL]CARBONYL}AMINO)-3-(1H-INDOL-3-YL)PROPANOIC ACID;rac-(2S)-2-[[2-(2-fluorophenyl)-4-methyl-thiazole-5-carbonyl]amino]-3-(1H-indol-3-yl)propanoic acid		23217206.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23217206		pluskal_iocb_peptide_Peptide01_B11_id		100	B11		ZINC000040287750
5.0		0	930	P11185679	62.7		G27	False	0	26	0	0	24	0	4	1	0	0		0.0						O=C(CCn1ccc2ccccc21)NC(Cc1ccccc1)c1nc2ccccc2[nH]1																							0.0		AKOS025260234		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C26H24N4O	C26H24N4O			InChI=1S/C26H24N4O/c31-25(15-17-30-16-14-20-10-4-7-13-24(20)30)27-23(18-19-8-2-1-3-9-19)26-28-21-11-5-6-12-22(21)29-26/h1-14,16,23H,15,17-18H2,(H,27,31)(H,28,29)	SJNIVTYTKCEORH-UHFFFAOYSA-N	N-[1-(1H-benzimidazol-2-yl)-2-phenyl-ethyl]-3-indol-1-yl-propanamide	73419443	O=C(CCn1ccc2ccccc21)NC(Cc1ccccc1)c1nc2ccccc2[nH]1	N-[1-(1H-benzimidazol-2-yl)-2-phenylethyl]-3-indol-1-ylpropanamide			4.041640000000003														408.50738		408.195011	2	2	7	5			46									Quinazoline alkaloids	False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(73419443)	73419443	4.3	277			[#8]=[#6](-[#6]-[#6]-[#7]1:[#6]:[#6]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#7H]:1	O=C(CCn1ccc2ccccc21)NC(Cc1ccccc1)c1nc2ccccc2[nH]1	SJNIVTYTKCEORH		parent_pubchem_cid	AKOS025260234;N-[1-(1H-1,3-BENZIMIDAZOL-2-YL)-2-PHENYLETHYL]-3-(1H-INDOL-1-YL)PROPANAMIDE;N-[1-(1H-benzimidazol-2-yl)-2-phenyl-ethyl]-3-indol-1-yl-propanamide		76428783.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=76428783		pluskal_iocb_peptide_Peptide01_B11_id		100	B11		
4.4		0	1018	P11185830	99.6		G28	False	0	23	0	0	19	0	5	2	0	0		0.0						O=C(NC(Cc1ccccc1)c1nc2ccccc2[nH]1)c1n[nH]c(-c2ccco2)c1																							0.0		AKOS025256924		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	4	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	0	0	0	0	0	0	0		C23H19N5O2	C23H19N5O2			InChI=1S/C23H19N5O2/c29-23(20-14-18(27-28-20)21-11-6-12-30-21)26-19(13-15-7-2-1-3-8-15)22-24-16-9-4-5-10-17(16)25-22/h1-12,14,19H,13H2,(H,24,25)(H,26,29)(H,27,28)	HFDSFTZACGWXGA-UHFFFAOYSA-N	N-[1-(1H-benzimidazol-2-yl)-2-phenyl-ethyl]-5-(2-furyl)-1H-pyrazole-3-carboxamide	91821123	O=C(NC(Cc1ccccc1)c1nc2ccccc2[nH]1)c1n[nH]c(-c2ccco2)c1	N-[1-(1H-benzimidazol-2-yl)-2-phenylethyl]-5-(furan-2-yl)-1H-pyrazole-3-carboxamide			3.287230000000001														397.44018		397.153875	3	3	6	5			46										False	Alkaloids				Peptide01			Compound(91821123)	91821123	3.7	278			[#8]=[#6](-[#7]-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#7H]:1)-[#6]1:[#7]:[#7H]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#8]:2):[#6]:1	O=C(NC(Cc1ccccc1)c1nc2ccccc2[nH]1)c1n[nH]c(-c2ccco2)c1	HFDSFTZACGWXGA		parent_pubchem_cid	AKOS025256924;N-[1-(1H-1,3-BENZIMIDAZOL-2-YL)-2-PHENYLETHYL]-5-(2-FURYL)-1H-PYRAZOLE-3-CARBOXAMIDE;N-[1-(1H-benzimidazol-2-yl)-2-phenyl-ethyl]-5-(2-furyl)-1H-pyrazole-3-carboxamide		100824834.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=100824834		pluskal_iocb_peptide_Peptide01_B11_id		100	B11		
4.0		0	762	P6240667	83.7		G29	False	0	29	0	0	29	0	3	4	0	0		0.0						COc1c(OC)cc(C2C(C(=O)NCCc3c[nH]c4ccccc34)c3ccccc3C(=O)N2C)cc1								Tetrahydroisoquinolines;3-alkylindoles;Dimethoxybenzenes;Phenoxy compounds;Anisoles;Alkyl aryl ethers;Substituted pyrroles;Tertiary carboxylic acid amides;Heteroaromatic compounds;Tertiary amines;Secondary carboxylic acid amides;Lactams;Amino acids and derivatives;Azacyclic compounds;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides	3-alkylindoles;Alkyl aryl ethers;Amines;Amino acids and derivatives;Amino acids, peptides, and analogues;Anisoles;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Dimethoxybenzenes;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Isoquinolines and derivatives;Isoquinolones and derivatives;Lactams;Methoxybenzenes;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenol ethers;Phenoxy compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Tertiary amines;Tertiary carboxylic acid amides;Tetrahydroisoquinolines	Isoquinolines and derivatives	2.1	This compound belongs to the class of organic compounds known as isoquinolones and derivatives. These are aromatic polycyclic compounds containing a ketone bearing isoquinoline moiety.	Isoquinolones and derivatives			Organic compounds	Aromatic heteropolycyclic compounds	isoquinolines (CHEBI:24922);indoles (CHEBI:24828);dimethoxybenzene (CHEBI:51681);benzenes (CHEBI:22712);methoxybenzene (CHEBI:51683);aromatic ether (CHEBI:35618);pyrroles (CHEBI:26455);carboxamide (CHEBI:37622);organic aromatic compound (CHEBI:33659);tertiary amine (CHEBI:32876);lactam (CHEBI:24995);organonitrogen compound (CHEBI:35352);organooxygen compound (CHEBI:36963);organonitrogen heterocyclic compound (CHEBI:38101);carbonyl compound (CHEBI:36586);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ether (CHEBI:25698);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);amine (CHEBI:32952);amino acid (CHEBI:33709);peptide (CHEBI:16670)		Isoquinolones and derivatives	Isoquinolone;O-dimethoxybenzene;Dimethoxybenzene;3-alkylindole;Tetrahydroisoquinoline;Indole;Indole or derivatives;Phenoxy compound;Anisole;Methoxybenzene;Phenol ether;Alkyl aryl ether;Monocyclic benzene moiety;Benzenoid;Substituted pyrrole;Heteroaromatic compound;Tertiary carboxylic acid amide;Pyrrole;Tertiary amine;Secondary carboxylic acid amide;Amino acid or derivatives;Lactam;Carboxamide group;Azacycle;Carboxylic acid derivative;Ether;Organooxygen compound;Amine;Carbonyl group;Organic oxide;Organic oxygen compound;Organonitrogen compound;Hydrocarbon derivative;Organic nitrogen compound;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		1219584-87-8		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C29H29N3O4	C29H29N3O4			InChI=1S/C29H29N3O4/c1-32-27(18-12-13-24(35-2)25(16-18)36-3)26(21-9-4-5-10-22(21)29(32)34)28(33)30-15-14-19-17-31-23-11-7-6-8-20(19)23/h4-13,16-17,26-27,31H,14-15H2,1-3H3,(H,30,33)	LFOKZWQYEPIHAH-UHFFFAOYSA-N	3-(3,4-dimethoxyphenyl)-N-[2-(1H-indol-3-yl)ethyl]-2-methyl-1-oxo-3,4-dihydroisoquinoline-4-carboxamide	49652726	COc1c(OC)cc(C2C(C(=O)NCCc3c[nH]c4ccccc34)c3ccccc3C(=O)N2C)cc1	3-(3,4-dimethoxyphenyl)-N-[2-(1H-indol-3-yl)ethyl]-2-methyl-1-oxo-3,4-dihydroisoquinoline-4-carboxamide			2.882420000000001													MCULE-6420287347	483.57218		483.215806	4	2	7	5			45										False	Alkaloids				Peptide01			Compound(49652726)	49652726	4.0	279			[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]):[#6]:[#6](-[#6]2-[#6](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]3:[#6]:[#7H]:[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]:3:4)-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3-[#6](=[#8])-[#7]-2-[#6]):[#6]:[#6]:1	COc1c(OC)cc(C2C(C(=O)NCCc3c[nH]c4ccccc34)c3ccccc3C(=O)N2C)cc1	LFOKZWQYEPIHAH		parent_pubchem_cid	1219584-87-8;3-(3,4-dimethoxyphenyl)-N-[2-(1H-indol-3-yl)ethyl]-2-methyl-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxamide;EiM08-11888;AKOS016382020;3-(3,4-DIMETHOXYPHENYL)-N-[2-(1H-INDOL-3-YL)ETHYL]-2-METHYL-1-OXO-1,2,3,4-TETRAHYDRO-4-ISOQUINOLINECARBOXAMIDE;3-(3,4-dimethoxyphenyl)-N-[2-(1H-indol-3-yl)ethyl]-2-methyl-1-oxo-3,4-dihydroisoquinoline-4-carboxamide		22755522.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22755522		pluskal_iocb_peptide_Peptide01_B11_id		100	B11		
4.5		0	850	P3462551	123.3		G30	False	0	22	1	0	18	0	3	3	0	1		0.0						Cc1c(C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)O)sc(-c2ccccc2Cl)n1								Indolyl carboxylic acids and derivatives;3-alkylindoles;Thiazolecarboxamides;2,4,5-trisubstituted thiazoles;2-heteroaryl carboxamides;Chlorobenzenes;Substituted pyrroles;Aryl chlorides;Heteroaromatic compounds;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organochlorides;Organonitrogen compounds	2,4,5-trisubstituted thiazoles;2-heteroaryl carboxamides;3-alkylindoles;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Aryl chlorides;Aryl halides;Azacyclic compounds;Azoles;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Chlorobenzenes;Halobenzenes;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Indolyl carboxylic acids and derivatives;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organochlorides;Organohalogen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Thiazolecarboxamides;Thiazolecarboxylic acids and derivatives;Thiazoles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom.	N-acyl-alpha amino acids		Amino acids and derivatives;Alpha amino acids and derivatives;N-acyl-alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	indolyl carboxylic acid (CHEBI:46867);indoles (CHEBI:24828);aromatic amide (CHEBI:62733);thiazoles (CHEBI:48901);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organochlorine compound (CHEBI:36683);pyrroles (CHEBI:26455);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);organonitrogen heterocyclic compound (CHEBI:38101);carbonyl compound (CHEBI:36586);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);N-acyl-amino acid (CHEBI:51569);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);azole (CHEBI:68452);aromatic carboxylic acid (CHEBI:33859);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);amide (CHEBI:32988);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);organohalogen compound (CHEBI:36684);haloarene (CHEBI:50887);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143)		Amino acids, peptides, and analogues	N-acyl-alpha-amino acid;Indolyl carboxylic acid derivative;3-alkylindole;Indole;Indole or derivatives;2-heteroaryl carboxamide;2,4,5-trisubstituted 1,3-thiazole;Thiazolecarboxamide;Thiazolecarboxylic acid or derivatives;Chlorobenzene;Halobenzene;Aryl chloride;Aryl halide;Monocyclic benzene moiety;Substituted pyrrole;Benzenoid;Thiazole;Azole;Pyrrole;Heteroaromatic compound;Secondary carboxylic acid amide;Carboxamide group;Organoheterocyclic compound;Monocarboxylic acid or derivatives;Azacycle;Carboxylic acid;Organooxygen compound;Organic oxygen compound;Organic oxide;Hydrocarbon derivative;Carbonyl group;Organic nitrogen compound;Organohalogen compound;Organochloride;Organonitrogen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		STL226768		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C22H18ClN3O3S	C22H18ClN3O3S			InChI=1S/C22H18ClN3O3S/c1-12-19(30-21(25-12)15-7-2-4-8-16(15)23)20(27)26-18(22(28)29)10-13-11-24-17-9-5-3-6-14(13)17/h2-9,11,18,24H,10H2,1H3,(H,26,27)(H,28,29)/t18-/m0/s1	OYDCUKRJRXJGKM-SFHVURJKSA-N	rac-(2S)-2-[[2-(2-chlorophenyl)-4-methyl-thiazole-5-carbonyl]amino]-3-(1H-indol-3-yl)propanoic acid	29137239	Cc1c(C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)sc(-c2ccccc2Cl)n1	(2S)-2-[[2-(2-chlorophenyl)-4-methyl-1,3-thiazole-5-carbonyl]amino]-3-(1H-indol-3-yl)propanoic acid			3.706350000000002													MCULE-8358727094	439.92406		439.07574	4	3	6	4			44										False	Alkaloids				Peptide01			Compound(29137239)	29137239	5.0	280			[#6]-[#6]1:[#6](-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6](=[#8])-[#8]):[#16]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#17]):[#7]:1	Cc1c(C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)sc(-c2ccccc2Cl)n1	OYDCUKRJRXJGKM		parent_pubchem_cid	STL226768;AKOS016388517;N-{[2-(2-chlorophenyl)-4-methyl-1,3-thiazol-5-yl]carbonyl}-L-tryptophan;2-{[2-(2-CHLOROPHENYL)-4-METHYL-1,3-THIAZOL-5-YL]FORMAMIDO}-3-(1H-INDOL-3-YL)PROPANOIC ACID;rac-(2S)-2-[[2-(2-chlorophenyl)-4-methyl-thiazole-5-carbonyl]amino]-3-(1H-indol-3-yl)propanoic acid		24372089.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24372089		pluskal_iocb_peptide_Peptide01_B12_id		100	B12		ZINC000020739564
4.1		0	938	P1109177	112.5		G31	False	0	21	0	0	17	0	3	3	0	1		0.0						O=C(NC(Cc1ccccc1)C(=O)O)c1cc2c(cc1)nc(-n1cccc1)s2								N-acyl-alpha amino acids;Phenylpropanoic acids;Amphetamines and derivatives;Benzothiazoles;Substituted pyrroles;Thiazoles;Heteroaromatic compounds;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Azacyclic compounds;Azoles;Benzene and substituted derivatives;Benzenoids;Benzothiazoles;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenethylamines;Phenylalanine and derivatives;Phenylpropanoic acids;Phenylpropanoids and polyketides;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Thiazoles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-amino acid (CHEBI:51569);benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);amphetamines (CHEBI:35338);benzothiazoles (CHEBI:37947);pyrroles (CHEBI:26455);thiazoles (CHEBI:48901);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);monocarboxylic acid (CHEBI:25384);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);benzenoid aromatic compound (CHEBI:33836);primary amine (CHEBI:32877);organic heterocyclic compound (CHEBI:24532);azole (CHEBI:68452);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806)		Amino acids, peptides, and analogues	Phenylalanine or derivatives;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;3-phenylpropanoic-acid;Amphetamine or derivatives;1,3-benzothiazole;Monocyclic benzene moiety;Benzenoid;Substituted pyrrole;Azole;Heteroaromatic compound;Thiazole;Pyrrole;Carboxamide group;Secondary carboxylic acid amide;Organoheterocyclic compound;Azacycle;Monocarboxylic acid or derivatives;Carboxylic acid;Organonitrogen compound;Organic nitrogen compound;Carbonyl group;Hydrocarbon derivative;Organic oxide;Organic oxygen compound;Organooxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS005534767		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C21H17N3O3S	C21H17N3O3S			InChI=1S/C21H17N3O3S/c25-19(22-17(20(26)27)12-14-6-2-1-3-7-14)15-8-9-16-18(13-15)28-21(23-16)24-10-4-5-11-24/h1-11,13,17H,12H2,(H,22,25)(H,26,27)	GYJLUZTYXKBJCJ-UHFFFAOYSA-N	3-phenyl-2-[(2-pyrrol-1-yl-1,3-benzothiazole-6-carbonyl)amino]propanoic acid	24280944	O=C(NC(Cc1ccccc1)C(=O)O)c1cc2c(cc1)nc(-n1cccc1)s2	3-phenyl-2-[(2-pyrrol-1-yl-1,3-benzothiazole-6-carbonyl)amino]propanoic acid			2.7848500000000014													MCULE-2279508197	391.45194		391.099062	4	2	6	4			45										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(24280944)	24280944	4.0	281			[#8]=[#6](-[#7]-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8])-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#7]:[#6](-[#7]1:[#6]:[#6]:[#6]:[#6]:1):[#16]:2	O=C(NC(Cc1ccccc1)C(=O)O)c1cc2c(cc1)nc(-n1cccc1)s2	GYJLUZTYXKBJCJ		parent_pubchem_cid	AKOS005534767;3-PHENYL-2-({[2-(1H-PYRROL-1-YL)-1,3-BENZOTHIAZOL-6-YL]CARBONYL}AMINO)PROPANOIC ACID;3-phenyl-2-[(2-pyrrol-1-yl-1,3-benzothiazole-6-carbonyl)amino]propanoic acid		23757255.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23757255		pluskal_iocb_peptide_Peptide01_B12_id		100	B12		
3.8		0	1026	P11185431	95.1		G32	False	0	21	1	0	20	0	3	3	0	0		0.0						Cc1c(CC(=O)NC(Cc2ccccc2)C(=O)O)c(-c2ccc(Cl)cc2)n[nH]1																							0.0		AKOS027472938		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	2	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C21H20ClN3O3	C21H20ClN3O3			InChI=1S/C21H20ClN3O3/c1-13-17(20(25-24-13)15-7-9-16(22)10-8-15)12-19(26)23-18(21(27)28)11-14-5-3-2-4-6-14/h2-10,18H,11-12H2,1H3,(H,23,26)(H,24,25)(H,27,28)/t18-/m0/s1	PLDSPANMGJZYSP-SFHVURJKSA-N	rac-(2S)-2-[[2-[3-(4-chlorophenyl)-5-methyl-1H-pyrazol-4-yl]acetyl]amino]-3-phenyl-propanoic acid	110204108	Cc1c(CC(=O)N[C@@H](Cc2ccccc2)C(=O)O)c(-c2ccc(Cl)cc2)n[nH]1	(2S)-2-[[2-[3-(4-chlorophenyl)-5-methyl-1H-pyrazol-4-yl]acetyl]amino]-3-phenylpropanoic acid			2.8489700000000004														397.86485		397.119319	4	3	7	3			45										False	Amino acids and Peptides				Peptide01			Compound(110204108)	110204108	3.7	282			[#6]-[#6]1:[#6](-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#8]):[#6](-[#6]2:[#6]:[#6]:[#6](-[#17]):[#6]:[#6]:2):[#7]:[#7H]:1	Cc1c(CC(=O)N[C@@H](Cc2ccccc2)C(=O)O)c(-c2ccc(Cl)cc2)n[nH]1	PLDSPANMGJZYSP		parent_pubchem_cid	AKOS027472938;(2S)-2-({2-[3-(4-CHLOROPHENYL)-5-METHYL-1H-PYRAZOL-4-YL]ACETYL}AMINO)-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[[2-[3-(4-chlorophenyl)-5-methyl-1H-pyrazol-4-yl]acetyl]amino]-3-phenyl-propanoic acid		117132321.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=117132321		pluskal_iocb_peptide_Peptide01_B12_id		100	B12		ZINC000253411965
3.0		0	770	P11186005	80.6		G33	False	0	17	0	0	22	0	2	4	0	0	-1.0	0.0						Cn1cc(CC(NC(=O)OC(C)(C)C)C(=O)O)c2ccccc21		2.7		0.0	2.89	CHEMBL516505																	0.0		109927-44-8		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	1	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1		C17H22N2O4	C17H22N2O4			InChI=1S/C17H22N2O4/c1-17(2,3)23-16(22)18-13(15(20)21)9-11-10-19(4)14-8-6-5-7-12(11)14/h5-8,10,13H,9H2,1-4H3,(H,18,22)(H,20,21)/t13-/m0/s1	OHPBREBKPBFZCY-ZDUSSCGKSA-N	rac-(2S)-2-(tert-butoxycarbonylamino)-3-(1-methylindol-3-yl)propanoic acid	13821419	Cn1cc(C[C@H](NC(=O)OC(C)(C)C)C(=O)O)c2ccccc21	(2S)-3-(1-methylindol-3-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid			2.21557														318.37589	ACID	318.157957	4	2	6	2	0.0		29										False	Alkaloids	Tryptophan alkaloids	False	False	Peptide01		-1.0	Compound(13821419)	13821419	2.6	283		SCHEMBL3013449	[#6]-[#7]1:[#6]:[#6](-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#8]-[#6](-[#6])(-[#6])-[#6])-[#6](=[#8])-[#8]):[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	Cn1cc(C[C@H](NC(=O)OC(C)(C)C)C(=O)O)c2ccccc21	OHPBREBKPBFZCY		parent_pubchem_cid	109927-44-8;(S)-2-((tert-Butoxycarbonyl)amino)-3-(1-methyl-1H-indol-3-yl)propanoic acid;(2S)-2-{[(tert-butoxy)carbonyl]amino}-3-(1-methyl-1H-indol-3-yl)propanoic acid;MFCD28987645;(2S)-3-(1-methylindol-3-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid;N-Boc-1-methyl-L-tryptophan;CHEMBL516505;SCHEMBL3013449;AKOS027473325;NS-05338;N-(tert-butoxycarbonyl)-1-methyltryptophan;CS-0162103;D70010;EN300-302971;AO-022/43512070;Z1508686929;rac-(2S)-2-(tert-butoxycarbonylamino)-3-(1-methylindol-3-yl)propanoic acid	False	548461.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=548461		pluskal_iocb_peptide_Peptide01_B12_id		100	B12	False	ZINC000034161806
2.2		0	858	P1158699	147.5		G34	False	0	22	0	0	21	0	1	7	0	1		0.0						CSCCC(NC(=O)COc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1)C(=O)O																							0.0		HMS3468N04		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	1	1	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C22H21NO7S	C22H21NO7S			InChI=1S/C22H21NO7S/c1-31-8-7-15(22(27)28)23-20(26)12-29-14-9-16(24)21-17(25)11-18(30-19(21)10-14)13-5-3-2-4-6-13/h2-6,9-11,15,24H,7-8,12H2,1H3,(H,23,26)(H,27,28)/t15-/m1/s1	KAASLVRNIIZCIU-OAHLLOKOSA-N	rac-(2R)-2-[[2-(5-hydroxy-4-oxo-2-phenyl-chromen-7-yl)oxyacetyl]amino]-4-methylsulfanyl-butanoic acid	28934626	CSCC[C@@H](NC(=O)COc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1)C(=O)O	(2R)-2-[[2-(5-hydroxy-4-oxo-2-phenylchromen-7-yl)oxyacetyl]amino]-4-methylsulfanylbutanoic acid			2.03353													MCULE-3446084912	443.47917		443.103873	8	3	9	3			44									Flavones	False	Shikimates and Phenylpropanoids	Flavonoids			Peptide01			Compound(28934626)	28934626	2.4	284			[#6]-[#16]-[#6]-[#6]-[#6@@H](-[#7]-[#6](=[#8])-[#6]-[#8]-[#6]1:[#6]:[#6](-[#8]):[#6]2:[#6](=[#8]):[#6]:[#6](-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#8]:[#6]:2:[#6]:1)-[#6](=[#8])-[#8]	CSCC[C@@H](NC(=O)COc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1)C(=O)O	KAASLVRNIIZCIU		parent_pubchem_cid	HMS3468N04;EiM07-30719;AKOS004938032;rac-(2R)-2-[[2-(5-hydroxy-4-oxo-2-phenyl-chromen-7-yl)oxyacetyl]amino]-4-methylsulfanyl-butanoic acid		24662571.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24662571		pluskal_iocb_peptide_Peptide01_B12_id		100	B12		ZINC000020426557
3.8		0	946	P6237090	112.5		G35	False	0	18	0	0	19	0	3	3	0	1		0.0						CCC(C)C(NC(=O)c1cc2c(cc1)nc(-n1cccc1)s2)C(=O)O																							0.0		1820581-17-6		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C18H19N3O3S	C18H19N3O3S			InChI=1S/C18H19N3O3S/c1-3-11(2)15(17(23)24)20-16(22)12-6-7-13-14(10-12)25-18(19-13)21-8-4-5-9-21/h4-11,15H,3H2,1-2H3,(H,20,22)(H,23,24)/t11-,15+/m1/s1	FDTBTRVZDPUVFT-ABAIWWIYSA-N	rac-(2S,3R)-3-methyl-2-[(2-pyrrol-1-yl-1,3-benzothiazole-6-carbonyl)amino]pentanoic acid	42234760	CC[C@@H](C)[C@H](NC(=O)c1cc2c(cc1)nc(-n1cccc1)s2)C(=O)O	(2S,3R)-3-methyl-2-[(2-pyrrol-1-yl-1,3-benzothiazole-6-carbonyl)amino]pentanoic acid			2.6429600000000004													MCULE-4689884760	357.43443		357.114712	4	2	6	3			44									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(42234760)	42234760	3.7	285			[#6]-[#6]-[#6@@H](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#7]:[#6](-[#7]1:[#6]:[#6]:[#6]:[#6]:1):[#16]:2)-[#6](=[#8])-[#8]	CC[C@@H](C)[C@H](NC(=O)c1cc2c(cc1)nc(-n1cccc1)s2)C(=O)O	FDTBTRVZDPUVFT		parent_pubchem_cid	1820581-17-6;(2S,3R)-3-methyl-2-{[2-(1H-pyrrol-1-yl)-1,3-benzothiazol-6-yl]formamido}pentanoic acid;(2S,3R)-3-methyl-2-[(2-pyrrol-1-yl-1,3-benzothiazole-6-carbonyl)amino]pentanoic acid;N-{[2-(1H-Pyrrol-1-yl)-1,3-benzothiazol-6-yl]carbonyl}-L-isoleucine;3-methyl-2-{[2-(1H-pyrrol-1-yl)-1,3-benzothiazol-6-yl]formamido}pentanoic acid;MFCD22371975;AKOS016387018;NS-05685;CS-0279152;EN300-302917;(2-(1h-Pyrrol-1-yl)benzo[d]thiazole-6-carbonyl)-l-alloisoleucine;(2S,3R)-3-methyl-2-{[2-(1H-pyrrol-1-yl)-1,3-benzothiazol-6-yl]formamido}pentanoicacid;rac-(2S,3R)-3-methyl-2-[(2-pyrrol-1-yl-1,3-benzothiazole-6-carbonyl)amino]pentanoic acid		23828074.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23828074		pluskal_iocb_peptide_Peptide01_B12_id		100	B12		ZINC000011865967
3.3		0	1034	P1159300	140.6		G36	False	0	21	0	0	20	0	4	3	0	2		0.0						Cc1c(C(=O)NCCc2c[nH]c3ccccc23)sc(NS(=O)(=O)c2ccccc2)n1																							0.0		AKOS016388494		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	1	0	0	0	0	0	0	0		C21H20N4O3S2	C21H20N4O3S2			InChI=1S/C21H20N4O3S2/c1-14-19(29-21(24-14)25-30(27,28)16-7-3-2-4-8-16)20(26)22-12-11-15-13-23-18-10-6-5-9-17(15)18/h2-10,13,23H,11-12H2,1H3,(H,22,26)(H,24,25)	PWSWPXVHVGCSDN-UHFFFAOYSA-N	2-(benzenesulfonamido)-N-[2-(1H-indol-3-yl)ethyl]-4-methyl-thiazole-5-carboxamide	16944468	Cc1c(C(=O)NCCc2c[nH]c3ccccc23)sc(NS(=O)(=O)c2ccccc2)n1	2-(benzenesulfonamido)-N-[2-(1H-indol-3-yl)ethyl]-4-methyl-1,3-thiazole-5-carboxamide			2.624950000000001													MCULE-4482153387	440.54655		440.097682	4	3	7	4			44										False	Alkaloids				Peptide01			Compound(16944468)	16944468	3.9	286			[#6]-[#6]1:[#6](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#16]:[#6](-[#7]-[#16](=[#8])(=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#7]:1	Cc1c(C(=O)NCCc2c[nH]c3ccccc23)sc(NS(=O)(=O)c2ccccc2)n1	PWSWPXVHVGCSDN		parent_pubchem_cid	AKOS016388494;2-(benzenesulfonamido)-N-[2-(1H-indol-3-yl)ethyl]-4-methyl-thiazole-5-carboxamide		6966586.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=6966586		pluskal_iocb_peptide_Peptide01_B12_id		100	B12		ZINC000008978147
2.8		0	778	P6242031	80.6		G37	False	0	18	0	0	24	0	2	4	0	0		0.0						COc1c2c(ccc1)ccn2CCC(=O)NC(CC(C)C)C(=O)O								N-acyl-L-alpha-amino acids;N-alkylindoles;Indoles;Anisoles;Alkyl aryl ethers;Substituted pyrroles;Heteroaromatic compounds;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Anisoles;Azacyclic compounds;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Leucine and derivatives;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;N-alkylindoles;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenol ethers;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as leucine and derivatives. These are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Leucine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-L-alpha-amino acid (CHEBI:48927);indoles (CHEBI:24828);methoxybenzene (CHEBI:51683);aromatic ether (CHEBI:35618);pyrroles (CHEBI:26455);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);leucine derivative (CHEBI:47003);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);N-acyl-amino acid (CHEBI:51569);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ether (CHEBI:25698);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)		Amino acids, peptides, and analogues	Leucine or derivatives;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;N-acyl-l-alpha-amino acid;N-alkylindole;Indole;Indole or derivatives;Anisole;Phenol ether;Alkyl aryl ether;Benzenoid;Substituted pyrrole;Heteroaromatic compound;Pyrrole;Secondary carboxylic acid amide;Carboxamide group;Organoheterocyclic compound;Azacycle;Carboxylic acid;Ether;Monocarboxylic acid or derivatives;Organic nitrogen compound;Carbonyl group;Organic oxygen compound;Organooxygen compound;Organic oxide;Hydrocarbon derivative;Organonitrogen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS016376039		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C18H24N2O4	C18H24N2O4			InChI=1S/C18H24N2O4/c1-12(2)11-14(18(22)23)19-16(21)8-10-20-9-7-13-5-4-6-15(24-3)17(13)20/h4-7,9,12,14H,8,10-11H2,1-3H3,(H,19,21)(H,22,23)/t14-/m0/s1	QUABYHYQEMEJMF-AWEZNQCLSA-N	rac-(2S)-2-[3-(7-methoxyindol-1-yl)propanoylamino]-4-methyl-pentanoic acid	49652046	COc1c2c(ccc1)ccn2CCC(=O)N[C@@H](CC(C)C)C(=O)O	(2S)-2-[3-(7-methoxyindol-1-yl)propanoylamino]-4-methylpentanoic acid			1.7646699999999993													MCULE-5569480711	332.40298		332.173607	4	2	8	2			44									Dipeptides	False	Alkaloids;Amino acids and Peptides	Small peptides			Peptide01			Compound(49652046)	49652046	2.5	287			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6]2:[#6]:1:[#7](-[#6]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=[#8])-[#8]):[#6]:[#6]:2	COc1c2c(ccc1)ccn2CCC(=O)N[C@@H](CC(C)C)C(=O)O	QUABYHYQEMEJMF		parent_pubchem_cid	AKOS016376039;(2S)-2-{[3-(7-METHOXY-1H-INDOL-1-YL)PROPANOYL]AMINO}-4-METHYLPENTANOIC ACID;rac-(2S)-2-[3-(7-methoxyindol-1-yl)propanoylamino]-4-methyl-pentanoic acid		23158536.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23158536		pluskal_iocb_peptide_Peptide01_B12_id		100	B12		ZINC000040308988
1.5		0	866	P6243653	99.1		G38	False	0	16	0	0	23	0	3	4	0	0		0.0						CCC(C)C(NC(=O)Cn1nc2CCCCc2cc1=O)C(=O)O																							0.0		AKOS016386988		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C16H23N3O4	C16H23N3O4			InChI=1S/C16H23N3O4/c1-3-10(2)15(16(22)23)17-13(20)9-19-14(21)8-11-6-4-5-7-12(11)18-19/h8,10,15H,3-7,9H2,1-2H3,(H,17,20)(H,22,23)/t10-,15+/m1/s1	MFIRDZWODIBWLA-BMIGLBTASA-N	rac-(2S,3R)-3-methyl-2-[[2-(3-oxo-5,6,7,8-tetrahydrocinnolin-2-yl)acetyl]amino]pentanoic acid	51053123	CC[C@@H](C)[C@H](NC(=O)Cn1nc2CCCCc2cc1=O)C(=O)O	(2S,3R)-3-methyl-2-[[2-(3-oxo-5,6,7,8-tetrahydrocinnolin-2-yl)acetyl]amino]pentanoic acid			1.5280699999999998													MCULE-8165568026	321.37941		321.168856	5	2	6	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51053123)	51053123	1.3	288			[#6]-[#6]-[#6@@H](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#7]1:[#7]:[#6]2-[#6]-[#6]-[#6]-[#6]-[#6]:2:[#6]:[#6]:1=[#8])-[#6](=[#8])-[#8]	CC[C@@H](C)[C@H](NC(=O)Cn1nc2CCCCc2cc1=O)C(=O)O	MFIRDZWODIBWLA		parent_pubchem_cid	AKOS016386988;(2S,3R)-3-METHYL-2-({2-[3-OXO-5,6,7,8-TETRAHYDRO-2(3H)-CINNOLINYL]ACETYL}AMINO)PENTANOIC ACID;rac-(2S,3R)-3-methyl-2-[[2-(3-oxo-5,6,7,8-tetrahydrocinnolin-2-yl)acetyl]amino]pentanoic acid		23585251.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23585251		pluskal_iocb_peptide_Peptide01_B13_id		100	B13		ZINC000049545818
3.4		0	954	P11185914	91.4		G39	False	0	19	0	0	18	0	2	4	0	0	-1.0	0.0						O=C(NC(Cc1c[nH]c2ccccc12)C(=O)O)OCc1ccccc1		3.09		0.0	3.34	CHEMBL291603		Benzyloxycarbonyls;Alpha amino acids and derivatives;3-alkylindoles;Substituted pyrroles;Heteroaromatic compounds;Carbamate esters;Organic carbonic acids and derivatives;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	3-alkylindoles;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Benzyloxycarbonyls;Carbamate esters;Carbamic acids and derivatives;Carbonyl compounds;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Indolyl carboxylic acids and derivatives;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Pyrroles;Substituted pyrroles	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as indolyl carboxylic acids and derivatives. These are compounds containing a carboxylic acid chain (of at least 2 carbon atoms) linked to an indole ring.	Indolyl carboxylic acids and derivatives			Organic compounds	Aromatic heteropolycyclic compounds	carboxylic ester (CHEBI:33308);organonitrogen compound (CHEBI:35352);organooxygen compound (CHEBI:36963);indoles (CHEBI:24828);pyrroles (CHEBI:26455);organic aromatic compound (CHEBI:33659);carbamate ester (CHEBI:23003);carbonyl compound (CHEBI:36586);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);organonitrogen heterocyclic compound (CHEBI:38101);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);indolyl carboxylic acid (CHEBI:46867);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);amino acid (CHEBI:33709);peptide (CHEBI:16670);organic heterocyclic compound (CHEBI:24532);carbon oxoacid (CHEBI:35605);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806)		Indolyl carboxylic acids and derivatives	Indolyl carboxylic acid derivative;Alpha-amino acid or derivatives;Benzyloxycarbonyl;3-alkylindole;Indole;Monocyclic benzene moiety;Benzenoid;Substituted pyrrole;Heteroaromatic compound;Carbamic acid ester;Pyrrole;Carbonic acid derivative;Carboxylic acid derivative;Carboxylic acid;Monocarboxylic acid or derivatives;Azacycle;Hydrocarbon derivative;Organic oxide;Organic nitrogen compound;Carbonyl group;Organic oxygen compound;Organopnictogen compound;Organonitrogen compound;Organooxygen compound;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		7432-21-5	DTXSID00225332	2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	1	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C19H18N2O4	C19H18N2O4			InChI=1S/C19H18N2O4/c22-18(23)17(10-14-11-20-16-9-5-4-8-15(14)16)21-19(24)25-12-13-6-2-1-3-7-13/h1-9,11,17,20H,10,12H2,(H,21,24)(H,22,23)/t17-/m0/s1	AHYFYYVVAXRMKB-KRWDZBQOSA-N	rac-(2S)-2-(benzyloxycarbonylamino)-3-(1H-indol-3-yl)propanoic acid	101176	O=C(N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)OCc1ccccc1	(2S)-3-(1H-indol-3-yl)-2-(phenylmethoxycarbonylamino)propanoic acid			2.5521600000000007														338.36631	ACID	338.126657	4	3	7	3	1.0		28									Dipeptides	False	Amino acids and Peptides	Small peptides	False	False	Peptide01		-1.0	Compound(101176)	101176	2.3	289		SCHEMBL220800	[#8]=[#6](-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8])-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	O=C(N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)OCc1ccccc1	AHYFYYVVAXRMKB		parent_pubchem_cid	7432-21-5;Z-Trp-OH;N-Cbz-L-tryptophan;Benzyloxycarbonyltryptophan;Z-L-Trp-OH;N-Carbobenzoxyltryptophan;Nalpha-Cbz-L-tryptophan;L-Tryptophan, N-[(phenylmethoxy)carbonyl]-;N-Carbobenzoxy-L-tryptophan;Cbz-L-Trp-OH;N-Benzyloxycarbonyl-L-tryptophan;N-Cbz-DL-tryptophan;(2S)-3-(1H-indol-3-yl)-2-(phenylmethoxycarbonylamino)propanoic acid;CHEMBL291603;N-[(benzyloxy)carbonyl]-L-tryptophan;MFCD00065700;(S)-2-(((Benzyloxy)carbonyl)amino)-3-(1H-indol-3-yl)propanoic acid;N-[(Benzyloxy)carbonyl]tryptophan #;N(ALPHA)-CBZ-L-TRYPTOPHAN;N-CBZ-tryptophane;Tryptophan, N-[(phenylmethoxy)carbonyl]-;Cbz-L-Trp;EINECS 231-074-4;NSC 521831;CBZ-TRP-OH;(2S)-2-{[(benzyloxy)carbonyl]amino}-3-(1H-indol-3-yl)propanoic acid;N-A-Z-L-TRYPTOPHAN;Z-Trp-OH, 97%;SCHEMBL220800;((benzyloxy)carbonyl)tryptophan;DTXSID00225332;((Benzyloxy)carbonyl)-L-tryptophan;AC1012;BDBM50043807;Nalpha-benzyloxycarbonyl-L-tryptophan;STK921980;(S)-N-benzyloxycarbonyl-L-tryptophan;AKOS005175156;Nalpha -benzyloxycarbonyl-L-tryptophan;AC-8577;CS-W011913;N-alpha-Benzyloxycarbonyl-L-tryptophane;AS-12754;BP-13290;EN300-121297;M03036;N-[(PHENYLMETHOXY)CARBONYL]-L-TRYPTOPHAN;W-104421;(S)-2-Benzyloxycarbonylamino-3-(1H-indol-3-yl)-propionic acid;(S)-2-(BENZYLOXYCARBONYLAMINO)-3-(1H-INDOL-3-YL)PROPANOIC ACID;rac-(2S)-2-(benzyloxycarbonylamino)-3-(1H-indol-3-yl)propanoic acid	False	510027.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=510027		pluskal_iocb_peptide_Peptide01_B13_id		100	B13	False	ZINC000000080832
1.1		0	1042	P1157543	93.7		G40	False	0	15	0	0	20	0	2	5	0	0		0.0						COC(=O)CCC(NC(=O)NCc1ccccc1)C(=O)OC																							0.0		AKOS016382676		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C15H20N2O5	C15H20N2O5			InChI=1S/C15H20N2O5/c1-21-13(18)9-8-12(14(19)22-2)17-15(20)16-10-11-6-4-3-5-7-11/h3-7,12H,8-10H2,1-2H3,(H2,16,17,20)/t12-/m0/s1	VZROCKRGCVLIJU-LBPRGKRZSA-N	dimethyl rac-(2S)-2-(benzylcarbamoylamino)pentanedioate	17588453	COC(=O)CC[C@H](NC(=O)NCc1ccccc1)C(=O)OC	dimethyl (2S)-2-(benzylcarbamoylamino)pentanedioate			0.9258899999999992													MCULE-9856237589	308.33705		308.137222	5	2	9	1			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(17588453)	17588453	1.0	290			[#6]-[#8]-[#6](=[#8])-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#7]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]-[#6]	COC(=O)CC[C@H](NC(=O)NCc1ccccc1)C(=O)OC	VZROCKRGCVLIJU		parent_pubchem_cid	AKOS016382676;dimethyl rac-(2S)-2-(benzylcarbamoylamino)pentanedioate		6965021.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=6965021		pluskal_iocb_peptide_Peptide01_B13_id		100	B13		ZINC000009340611
2.4		0	786	P6242974	99.1		G41	False	0	21	0	1	18	0	3	4	0	0		0.0						O=C(Cn1nc(-c2ccccc2F)ccc1=O)NC(Cc1ccccc1)C(=O)O																							0.0		AKOS016402536		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C21H18FN3O4	C21H18FN3O4			InChI=1S/C21H18FN3O4/c22-16-9-5-4-8-15(16)17-10-11-20(27)25(24-17)13-19(26)23-18(21(28)29)12-14-6-2-1-3-7-14/h1-11,18H,12-13H2,(H,23,26)(H,28,29)/t18-/m0/s1	DMSHJYSWKQMDLE-SFHVURJKSA-N	rac-(2S)-2-[[2-[3-(2-fluorophenyl)-6-oxo-pyridazin-1-yl]acetyl]amino]-3-phenyl-propanoic acid	51053788	O=C(Cn1nc(-c2ccccc2F)ccc1=O)N[C@@H](Cc1ccccc1)C(=O)O	(2S)-2-[[2-[3-(2-fluorophenyl)-6-oxopyridazin-1-yl]acetyl]amino]-3-phenylpropanoic acid			2.32666													MCULE-2951458223	395.39371		395.128134	5	2	7	3			44										False	Amino acids and Peptides				Peptide01			Compound(51053788)	51053788	2.5	291			[#8]=[#6](-[#6]-[#7]1:[#7]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#9]):[#6]:[#6]:[#6]:1=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	O=C(Cn1nc(-c2ccccc2F)ccc1=O)N[C@@H](Cc1ccccc1)C(=O)O	DMSHJYSWKQMDLE		parent_pubchem_cid	AKOS016402536;(2S)-2-({2-[3-(2-FLUOROPHENYL)-6-OXO-1(6H)-PYRIDAZINYL]ACETYL}AMINO)-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[[2-[3-(2-fluorophenyl)-6-oxo-pyridazin-1-yl]acetyl]amino]-3-phenyl-propanoic acid		23287942.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23287942		pluskal_iocb_peptide_Peptide01_B13_id		100	B13		ZINC000049547950
0.2		0	874	P3462497	108.1		G42	False	0	20	0	0	24	0	4	4	0	1		0.0						CS(=O)(=O)N1CCN(C(=O)C(Cc2ccccc2)NC(=O)c2cnccc2)CC1																							0.0		AKOS016386528		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	1	1		C20H24N4O4S	C20H24N4O4S			InChI=1S/C20H24N4O4S/c1-29(27,28)24-12-10-23(11-13-24)20(26)18(14-16-6-3-2-4-7-16)22-19(25)17-8-5-9-21-15-17/h2-9,15,18H,10-14H2,1H3,(H,22,25)/t18-/m0/s1	WAJVGDRFUDJFMK-SFHVURJKSA-N	N-[rac-(1S)-1-benzyl-2-(4-methylsulfonylpiperazin-1-yl)-2-oxo-ethyl]pyridine-3-carboxamide	29129071	CS(=O)(=O)N1CCN(C(=O)[C@H](Cc2ccccc2)NC(=O)c2cnccc2)CC1	N-[(2S)-1-(4-methylsulfonylpiperazin-1-yl)-1-oxo-3-phenylpropan-2-yl]pyridine-3-carboxamide			0.4170800000000016													MCULE-8871726103	416.50268		416.151826	5	1	6	3			44									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(29129071)	29129071	0.7	292			[#6]-[#16](=[#8])(=[#8])-[#7]1-[#6]-[#6]-[#7](-[#6](=[#8])-[#6@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#7]-[#6](=[#8])-[#6]2:[#6]:[#7]:[#6]:[#6]:[#6]:2)-[#6]-[#6]-1	CS(=O)(=O)N1CCN(C(=O)[C@H](Cc2ccccc2)NC(=O)c2cnccc2)CC1	WAJVGDRFUDJFMK		parent_pubchem_cid	AKOS016386528;N~3~-{1-BENZYL-2-[4-(METHYLSULFONYL)PIPERAZINO]-2-OXOETHYL}NICOTINAMIDE;N-[rac-(1S)-1-benzyl-2-(4-methylsulfonylpiperazin-1-yl)-2-oxo-ethyl]pyridine-3-carboxamide		9924845.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=9924845		pluskal_iocb_peptide_Peptide01_B13_id		100	B13		ZINC000020718134
0.9		0	962	P11185911	137.5		G43	False	0	14	0	0	20	0	4	4	0	0	-1.0	0.0						NC(N)=NCCCC(NC(=O)OCc1ccccc1)C(=O)O		0.63		0.0	-0.97	CHEMBL1423296		Alpha amino acids and derivatives;Carbamate esters;Organic carbonic acids and derivatives;Guanidines;Propargyl-type 1,3-dipolar organic compounds;Monocarboxylic acids and derivatives;Carboxylic acids;Carboximidamides;Organopnictogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Benzene and substituted derivatives;Benzenoids;Benzyloxycarbonyls;Carbamate esters;Carbamic acids and derivatives;Carbonyl compounds;Carboximidamides;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Guanidines;Hydrocarbon derivatives;Monocarboxylic acids and derivatives;Organic 1,3-dipolar compounds;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Propargyl-type 1,3-dipolar organic compounds	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as benzyloxycarbonyls. These are organic compounds containing a carbonyl group substituted with a benzyloxyl group.	Benzyloxycarbonyls			Organic compounds	Aromatic homomonocyclic compounds	organonitrogen compound (CHEBI:35352);organooxygen compound (CHEBI:36963);carbamate ester (CHEBI:23003);guanidines (CHEBI:24436);dipolar compound (CHEBI:51151);carbonyl compound (CHEBI:36586);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carboxylic ester (CHEBI:33308);chemical entity (CHEBI:24431);amino acid (CHEBI:33709);peptide (CHEBI:16670);carbon oxoacid (CHEBI:35605);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712)		Benzyloxycarbonyls	Alpha-amino acid or derivatives;Benzyloxycarbonyl;Carbamic acid ester;Guanidine;Carbonic acid derivative;Carboxylic acid derivative;Carboxylic acid;Organic 1,3-dipolar compound;Propargyl-type 1,3-dipolar organic compound;Carboximidamide;Monocarboxylic acid or derivatives;Organic nitrogen compound;Organonitrogen compound;Organooxygen compound;Hydrocarbon derivative;Organic oxide;Organopnictogen compound;Carbonyl group;Organic oxygen compound;Aromatic homomonocyclic compound	Benzenoids	0.0		1234-35-1	DTXSID20883670	2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	1	0	2	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C14H20N4O4	C14H20N4O4			InChI=1S/C14H20N4O4/c15-13(16)17-8-4-7-11(12(19)20)18-14(21)22-9-10-5-2-1-3-6-10/h1-3,5-6,11H,4,7-9H2,(H,18,21)(H,19,20)(H4,15,16,17)/t11-/m0/s1	SJSSFUMSAFMFNM-NSHDSACASA-N	rac-(2S)-2-(benzyloxycarbonylamino)-5-guanidino-pentanoic acid	71055	NC(N)=NCCC[C@H](NC(=O)OCc1ccccc1)C(=O)O	(2S)-5-(diaminomethylideneamino)-2-(phenylmethoxycarbonylamino)pentanoic acid			0.3648900000000007														308.3399	ZWITTERION	308.148455	5	5	10	1	1.0		28									Dipeptides	False	Amino acids and Peptides	Small peptides	False	False	Peptide01		-1.0	Compound(71055)	71055	0.2	293		SCHEMBL631840	[#7]-[#6](-[#7])=[#7]-[#6]-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	NC(N)=NCCC[C@H](NC(=O)OCc1ccccc1)C(=O)O	SJSSFUMSAFMFNM		parent_pubchem_cid	1234-35-1;Z-Arg-OH;Cbz-L-Arginine;Cbz-Arg-OH;L-Arginine, N2-[(phenylmethoxy)carbonyl]-;Nalpha-Cbz-L-arginine;Benzyloxycarbonyl-L-arginine;N~2~-[(benzyloxy)carbonyl]-L-arginine;(2S)-5-(diaminomethylideneamino)-2-(phenylmethoxycarbonylamino)pentanoic acid;MLS000563719;((Benzyloxy)carbonyl)-L-arginine;SMR000388882;(2S)-5-(diaminomethylideneammonio)-2-(phenylmethoxycarbonylamino)pentanoate;Benzyloxycarbonylarginine;Z-L-Arg-OH;MFCD00001762;L-Arginine, N2-((phenylmethoxy)carbonyl)-;n-alpha-benzyloxycarbonyl-l-arginine;Arginine, N2-[(phenylmethoxy)carbonyl]-;EINECS 214-973-6;N-Carbobenzoxy-L-arginine;UPCMLD00WJLM29;(2S)-2-{[(benzyloxy)carbonyl]amino}-5-carbamimidamidopentanoic acid;Arginine, N2-carboxy-, N2-benzyl ester, L-;N-.alpha.-Cbz-L-arginine;2-{[(benzyloxy)carbonyl]amino}-5-carbamimidamidopentanoic acid;cid_71055;SCHEMBL631840;Nalpha-Carbobenzoxy-L-arginine;N-2-Carbobenzyloxy-L-arginine;N2-Benzyloxycarbonyl-L-arginine;CHEMBL1423296;BDBM94463;DTXSID20883670;Arginine, N-(benzyloxy)carbonyl-;HMS2214B21;CMLD4_000213;(S)-N2-(benzyloxycarbonyl)-arginine;AKOS015895268;CS-W012075;HY-W011359;SDCCGMLS-0091585.P001;N2-((Phenylmethoxy)carbonyl)-L-arginine;NCGC00247325-01;Z-Arg-OH, >=96.0% (NT);AC-17163;AS-12757;N-.alpha.-(Benzyloxycarbonyl)arginine, L-;D78041;EN300-302867;M03028;A805075;J-300035;N-alpha-BenZyloxycarbonyl-L-arginine (CbZ-Arg-OH);(2S)-2-(benzyloxycarbonylamino)-5-guanidino-valeric acid;(S)-2-(BENZYLOXYCARBONYLAMINO)-5-GUANIDINOPENTANOIC ACID;(S)-2-(((Benzyloxy)carbonyl)amino)-5-((diaminomethylene)ammonio)pentanoate;(2S)-5-[bis(azanyl)methylideneamino]-2-(phenylmethoxycarbonylamino)pentanoic acid;R40;rac-(2S)-2-(benzyloxycarbonylamino)-5-guanidino-pentanoic acid	False	946946.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=946946		pluskal_iocb_peptide_Peptide01_B13_id		100	B13	False	ZINC000001540612
2.3		0	1050	P7567847	71.3		G44	False	0	15	0	0	18	0	2	3	0	0		0.0						CC(C)C(NC(=O)c1cc2c(cc1)ccn2C)C(=O)O																							0.0		AKOS025146043		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C15H18N2O3	C15H18N2O3			InChI=1S/C15H18N2O3/c1-9(2)13(15(19)20)16-14(18)11-5-4-10-6-7-17(3)12(10)8-11/h4-9,13H,1-3H3,(H,16,18)(H,19,20)/t13-/m0/s1	DKBSJJNIFRNNDR-ZDUSSCGKSA-N	rac-(2S)-3-methyl-2-[(1-methylindole-6-carbonyl)amino]butanoic acid	91637866	CC(C)[C@H](NC(=O)c1cc2c(cc1)ccn2C)C(=O)O	(2S)-3-methyl-2-[(1-methylindole-6-carbonyl)amino]butanoic acid			1.5341699999999998														274.32231		274.131742	3	2	4	2			45										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(91637866)	91637866	2.2	294			[#6]-[#6](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#6]:[#6]:[#7]:2-[#6])-[#6](=[#8])-[#8]	CC(C)[C@H](NC(=O)c1cc2c(cc1)ccn2C)C(=O)O	DKBSJJNIFRNNDR		parent_pubchem_cid	AKOS025146043;(2S)-3-METHYL-2-{[(1-METHYL-1H-INDOL-6-YL)CARBONYL]AMINO}BUTANOIC ACID;rac-(2S)-3-methyl-2-[(1-methylindole-6-carbonyl)amino]butanoic acid		92293316.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=92293316		pluskal_iocb_peptide_Peptide01_B13_id		100	B13		ZINC000170625470
3.3		0	1058	P11185259	84.7		H1	False	0	25	0	0	28	0	6	1	0	0		0.0						Cc1cc(C)nc(NC(Cc2ccccc2)C(=O)NCCc2nc3ccccc3n2C)n1								Alpha amino acid amides;Amphetamines and derivatives;Benzimidazoles;Aminopyrimidines and derivatives;N-substituted imidazoles;Fatty amides;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds;Amines	Alpha amino acid amides;Alpha amino acids and derivatives;Amines;Amino acids and derivatives;Amino acids, peptides, and analogues;Aminopyrimidines and derivatives;Amphetamines and derivatives;Azacyclic compounds;Azoles;Benzene and substituted derivatives;Benzenoids;Benzimidazoles;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Diazines;Fatty Acyls;Fatty amides;Heteroaromatic compounds;Hydrocarbon derivatives;Imidazoles;Lipids and lipid-like molecules;N-substituted imidazoles;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenethylamines;Phenylalanine and derivatives;Pyrimidines and pyrimidine derivatives;Secondary carboxylic acid amides;Substituted imidazoles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	amino acid amide (CHEBI:22475);amphetamines (CHEBI:35338);benzimidazoles (CHEBI:22715);aminopyrimidine (CHEBI:38338);imidazoles (CHEBI:24780);fatty amide (CHEBI:29348);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organonitrogen heterocyclic compound (CHEBI:38101);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);amine (CHEBI:32952);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);organonitrogen compound (CHEBI:35352);organooxygen compound (CHEBI:36963);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);primary amine (CHEBI:32877);organic heterocyclic compound (CHEBI:24532);diazines (CHEBI:38313);pyrimidines (CHEBI:39447);azole (CHEBI:68452);lipid (CHEBI:18059);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143)	Fatty amides (FA08);Fatty Acyls (FA)	Amino acids, peptides, and analogues	Phenylalanine or derivatives;Alpha-amino acid amide;Amphetamine or derivatives;Benzimidazole;Aminopyrimidine;Monocyclic benzene moiety;Fatty amide;N-substituted imidazole;Pyrimidine;Benzenoid;Fatty acyl;Imidazole;Azole;Heteroaromatic compound;Carboxamide group;Secondary carboxylic acid amide;Organoheterocyclic compound;Azacycle;Organic oxide;Organooxygen compound;Organonitrogen compound;Organic oxygen compound;Amine;Carbonyl group;Hydrocarbon derivative;Organic nitrogen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		1630822-69-3		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C25H28N6O	C25H28N6O			InChI=1S/C25H28N6O/c1-17-15-18(2)28-25(27-17)30-21(16-19-9-5-4-6-10-19)24(32)26-14-13-23-29-20-11-7-8-12-22(20)31(23)3/h4-12,15,21H,13-14,16H2,1-3H3,(H,26,32)(H,27,28,30)	UZKOTMGJLPLWMX-UHFFFAOYSA-N	2-[(4,6-dimethylpyrimidin-2-yl)amino]-N-[2-(1-methylbenzimidazol-2-yl)ethyl]-3-phenyl-propanamide	91640610	Cc1cc(C)nc(NC(Cc2ccccc2)C(=O)NCCc2nc3ccccc3n2C)n1	2-[(4,6-dimethylpyrimidin-2-yl)amino]-N-[2-(1-methylbenzimidazol-2-yl)ethyl]-3-phenylpropanamide			2.33437														428.54151		428.23246	5	2	8	4			46										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(91640610)	91640610	4.2	295			[#6]-[#6]1:[#6]:[#6](-[#6]):[#7]:[#6](-[#7]-[#6](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]2:[#7]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3:[#7]:2-[#6]):[#7]:1	Cc1cc(C)nc(NC(Cc2ccccc2)C(=O)NCCc2nc3ccccc3n2C)n1	UZKOTMGJLPLWMX		parent_pubchem_cid	1630822-69-3;2-[(4,6-dimethyl-2-pyrimidinyl)amino]-N-[2-(1-methyl-1H-1,3-benzimidazol-2-yl)ethyl]-3-phenylpropanamide;EiM08-37979;AKOS025257710;2-[(4,6-DIMETHYLPYRIMIDIN-2-YL)AMINO]-N-[2-(1-METHYL-1H-1,3-BENZODIAZOL-2-YL)ETHYL]-3-PHENYLPROPANAMIDE;2-[(4,6-dimethylpyrimidin-2-yl)amino]-N-[2-(1-methylbenzimidazol-2-yl)ethyl]-3-phenyl-propanamide		95283083.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=95283083		pluskal_iocb_peptide_Peptide01_B13_id		100	B13		
4.0		0	1146	P1098312	127.2		H2	False	0	22	0	0	29	0	1	6	0	1		0.0						CCCCc1cc(=O)oc2c1ccc(OC(C)C(=O)NC(CCSC)C(=O)O)c2C																							0.0		EiM07-16990		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C22H29NO6S	C22H29NO6S			InChI=1S/C22H29NO6S/c1-5-6-7-15-12-19(24)29-20-13(2)18(9-8-16(15)20)28-14(3)21(25)23-17(22(26)27)10-11-30-4/h8-9,12,14,17H,5-7,10-11H2,1-4H3,(H,23,25)(H,26,27)/t14?,17-/m0/s1	IGEMCFUXXCCYPI-JRZJBTRGSA-N	rac-(2S)-2-[2-(4-butyl-8-methyl-2-oxo-chromen-7-yl)oxypropanoylamino]-4-methylsulfanyl-butanoic acid	16399253	CCCCc1cc(=O)oc2c1ccc(OC(C)C(=O)N[C@@H](CCSC)C(=O)O)c2C	(2S)-2-[2-(4-butyl-8-methyl-2-oxochromen-7-yl)oxypropanoylamino]-4-methylsulfanylbutanoic acid			3.433460000000002														435.54353		435.171559	7	2	11	2			46									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(16399253)	16399253	4.1	296			[#6]-[#6]-[#6]-[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6](-[#6])-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]-[#16]-[#6])-[#6](=[#8])-[#8]):[#6]:2-[#6]	CCCCc1cc(=O)oc2c1ccc(OC(C)C(=O)N[C@@H](CCSC)C(=O)O)c2C	IGEMCFUXXCCYPI		parent_pubchem_cid	EiM07-16990;AKOS016390287;2-{2-[(4-BUTYL-8-METHYL-2-OXO-2H-CHROMEN-7-YL)OXY]PROPANAMIDO}-4-(METHYLSULFANYL)BUTANOIC ACID;rac-(2S)-2-[2-(4-butyl-8-methyl-2-oxo-chromen-7-yl)oxypropanoylamino]-4-methylsulfanyl-butanoic acid		23786803.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23786803		pluskal_iocb_peptide_Peptide01_B14_id		100	B14		
3.5		0	1234	P1582993	67.7		H3	False	0	20	0	0	20	0	6	0	0	0		0.0						Cc1ccccc1Nc1c2cnn(C)c2nc(NCc2ccccc2)n1																							0.0		SCHEMBL13942975		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1		C20H20N6	C20H20N6			InChI=1S/C20H20N6/c1-14-8-6-7-11-17(14)23-18-16-13-22-26(2)19(16)25-20(24-18)21-12-15-9-4-3-5-10-15/h3-11,13H,12H2,1-2H3,(H2,21,23,24,25)	YNVVVGLRZPUXCY-UHFFFAOYSA-N	N6-benzyl-1-methyl-N4-(o-tolyl)pyrazolo[3,4-d]pyrimidine-4,6-diamine	16456672	Cc1ccccc1Nc1c2cnn(C)c2nc(NCc2ccccc2)n1	6-N-benzyl-1-methyl-4-N-(2-methylphenyl)pyrazolo[3,4-d]pyrimidine-4,6-diamine			2.3477500000000004													MCULE-6791511498	344.4226		344.174945	5	2	5	4			43										False	Alkaloids				Peptide01			Compound(16456672)	16456672	4.2	297		SCHEMBL13942975	[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#7]-[#6]1:[#6]2:[#6]:[#7]:[#7](-[#6]):[#6]:2:[#7]:[#6](-[#7]-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#7]:1	Cc1ccccc1Nc1c2cnn(C)c2nc(NCc2ccccc2)n1	YNVVVGLRZPUXCY		parent_pubchem_cid	SCHEMBL13942975;AKOS002311437;CCG-170555;N6-BENZYL-1-METHYL-N4-(2-METHYLPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDINE-4,6-DIAMINE;N6-benzyl-1-methyl-N4-(o-tolyl)pyrazolo[3,4-d]pyrimidine-4,6-diamine		10102346.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=10102346		pluskal_iocb_peptide_Peptide01_B14_id		100	B14		ZINC000017136032
1.6		0	1066	P1094990	124.0		H5	False	0	17	0	0	23	0	3	4	0	1		0.0						CSCCC(NC(=O)N1c2ccccc2NC(=O)C1C(C)C)C(=O)O																							0.0		AKOS004937624		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	2	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C17H23N3O4S	C17H23N3O4S			InChI=1S/C17H23N3O4S/c1-10(2)14-15(21)18-11-6-4-5-7-13(11)20(14)17(24)19-12(16(22)23)8-9-25-3/h4-7,10,12,14H,8-9H2,1-3H3,(H,18,21)(H,19,24)(H,22,23)/t12-,14-/m0/s1	JUSXNBIUDHGAIG-JSGCOSHPSA-N	rac-(2S)-4-methylsulfanyl-2-[[rac-(2S)-2-isopropyl-3-oxo-2,4-dihydroquinoxaline-1-carbonyl]amino]butanoic acid	7711801	CSCC[C@H](NC(=O)N1c2ccccc2NC(=O)[C@@H]1C(C)C)C(=O)O	(2S)-4-methylsulfanyl-2-[[(2S)-3-oxo-2-propan-2-yl-2,4-dihydroquinoxaline-1-carbonyl]amino]butanoic acid			1.62438													MCULE-4779009865	365.45456		365.140927	5	3	6	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(7711801)	7711801	2.1	298			[#6]-[#16]-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#7]1-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#7]-[#6](=[#8])-[#6@@H]-1-[#6](-[#6])-[#6])-[#6](=[#8])-[#8]	CSCC[C@H](NC(=O)N1c2ccccc2NC(=O)[C@@H]1C(C)C)C(=O)O	JUSXNBIUDHGAIG		parent_pubchem_cid	AKOS004937624;(2S)-2-({[(2S)-2-ISOPROPYL-3-OXO-3,4-DIHYDRO-1(2H)-QUINOXALINYL]CARBONYL}AMINO)-4-(METHYLSULFANYL)BUTANOIC ACID;rac-(2S)-4-methylsulfanyl-2-[[rac-(2S)-2-isopropyl-3-oxo-2,4-dihydroquinoxaline-1-carbonyl]amino]butanoic acid		23062655.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23062655		pluskal_iocb_peptide_Peptide01_B14_id		100	B14		ZINC000008743356
3.5		0	1154	P1158087	97.4		H6	False	0	25	0	0	28	0	4	4	0	0		0.0						COc1c2cc(C(=O)NC(C)C(=O)NCCc3c[nH]c4ccccc34)n(C)c2c(OC)cc1																							0.0		AKOS016387557		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	1		C25H28N4O4	C25H28N4O4			InChI=1S/C25H28N4O4/c1-15(24(30)26-12-11-16-14-27-19-8-6-5-7-17(16)19)28-25(31)20-13-18-21(32-3)9-10-22(33-4)23(18)29(20)2/h5-10,13-15,27H,11-12H2,1-4H3,(H,26,30)(H,28,31)/t15-/m0/s1	JCQYCRDKVLRISO-HNNXBMFYSA-N	4,7-dimethoxy-1-methyl-N-[rac-(1S)-2-[2-(1H-indol-3-yl)ethylamino]-1-methyl-2-oxo-ethyl]indole-2-carboxamide	17571693	COc1c2cc(C(=O)N[C@@H](C)C(=O)NCCc3c[nH]c4ccccc34)n(C)c2c(OC)cc1	N-[(2S)-1-[2-(1H-indol-3-yl)ethylamino]-1-oxopropan-2-yl]-4,7-dimethoxy-1-methylindole-2-carboxamide			1.2629200000000016													MCULE-6010937728	448.52631		448.211055	4	3	8	4			44										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(17571693)	17571693	3.4	299			[#6]-[#8]-[#6]1:[#6]2:[#6]:[#6](-[#6](=[#8])-[#7]-[#6@@H](-[#6])-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]3:[#6]:[#7H]:[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]:3:4):[#7](-[#6]):[#6]:2:[#6](-[#8]-[#6]):[#6]:[#6]:1	COc1c2cc(C(=O)N[C@@H](C)C(=O)NCCc3c[nH]c4ccccc34)n(C)c2c(OC)cc1	JCQYCRDKVLRISO		parent_pubchem_cid	AKOS016387557;2-[(4,7-DIMETHOXY-1-METHYL-1H-INDOL-2-YL)FORMAMIDO]-N-[2-(1H-INDOL-3-YL)ETHYL]PROPANAMIDE;4,7-dimethoxy-1-methyl-N-[rac-(1S)-2-[2-(1H-indol-3-yl)ethylamino]-1-methyl-2-oxo-ethyl]indole-2-carboxamide		10005189.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=10005189		pluskal_iocb_peptide_Peptide01_B14_id		100	B14		ZINC000012664542
4.6		0	1242	P6328526	69.6		H7	False	0	20	0	0	19	0	5	1	0	0		0.0						CC(C)c1c(-c2nnc(Cc3ccccc3)o2)nnn1-c1ccccc1																							0.0		1081142-09-7		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1		C20H19N5O	C20H19N5O			InChI=1S/C20H19N5O/c1-14(2)19-18(22-24-25(19)16-11-7-4-8-12-16)20-23-21-17(26-20)13-15-9-5-3-6-10-15/h3-12,14H,13H2,1-2H3	GSZSSMAUWAFPRX-UHFFFAOYSA-N	2-benzyl-5-(5-isopropyl-1-phenyl-triazol-4-yl)-1,3,4-oxadiazole	29135265	CC(C)c1c(-c2nnc(Cc3ccccc3)o2)nnn1-c1ccccc1	2-benzyl-5-(1-phenyl-5-propan-2-yltriazol-4-yl)-1,3,4-oxadiazole			3.297340000000002													MCULE-6915764141	345.40733		345.15896	4	0	5	4			44										False	Alkaloids				Peptide01			Compound(29135265)	29135265	4.0	300			[#6]-[#6](-[#6])-[#6]1:[#6](-[#6]2:[#7]:[#7]:[#6](-[#6]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#8]:2):[#7]:[#7]:[#7]:1-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	CC(C)c1c(-c2nnc(Cc3ccccc3)o2)nnn1-c1ccccc1	GSZSSMAUWAFPRX		parent_pubchem_cid	1081142-09-7;2-benzyl-5-(5-isopropyl-1-phenyl-1H-1,2,3-triazol-4-yl)-1,3,4-oxadiazole;2-benzyl-5-[1-phenyl-5-(propan-2-yl)-1H-1,2,3-triazol-4-yl]-1,3,4-oxadiazole;AKOS005587126;VU0613363-1;F3375-3061;2-benzyl-5-(1-phenyl-5-propan-2-yltriazol-4-yl)-1,3,4-oxadiazole;2-benzyl-5-(5-isopropyl-1-phenyl-triazol-4-yl)-1,3,4-oxadiazole		10715109.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=10715109		pluskal_iocb_peptide_Peptide01_B14_id		100	B14		ZINC000020733624
2.9		0	1074	P11185218	95.6		H9	False	0	23	0	0	24	0	6	1	0	0	-1.0	0.0						Cc1cc(C)nc(NC(Cc2ccccc2)C(=O)NCc2nc3ccccc3[nH]2)n1		3.31		0.0	2.67	CHEMBL4437862																	0.0		1630822-64-8		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	0	0	0	0	0	0	0		C23H24N6O	C23H24N6O			InChI=1S/C23H24N6O/c1-15-12-16(2)26-23(25-15)29-20(13-17-8-4-3-5-9-17)22(30)24-14-21-27-18-10-6-7-11-19(18)28-21/h3-12,20H,13-14H2,1-2H3,(H,24,30)(H,27,28)(H,25,26,29)	IBHBYNQTXNPZHP-UHFFFAOYSA-N	N-(1H-benzimidazol-2-ylmethyl)-2-[(4,6-dimethylpyrimidin-2-yl)amino]-3-phenyl-propanamide	91640558	Cc1cc(C)nc(NC(Cc2ccccc2)C(=O)NCc2nc3ccccc3[nH]2)n1	N-(1H-benzimidazol-2-ylmethyl)-2-[(4,6-dimethylpyrimidin-2-yl)amino]-3-phenylpropanamide			2.28147														400.48733	NEUTRAL	400.201159	5	3	7	4	0.0		31										False	Alkaloids;Amino acids and Peptides		False	False	Peptide01		-1.0	Compound(91640558)	91640558	3.8	301			[#6]-[#6]1:[#6]:[#6](-[#6]):[#7]:[#6](-[#7]-[#6](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#7]-[#6]-[#6]2:[#7]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3:[#7H]:2):[#7]:1	Cc1cc(C)nc(NC(Cc2ccccc2)C(=O)NCc2nc3ccccc3[nH]2)n1	IBHBYNQTXNPZHP		parent_pubchem_cid	1630822-64-8;N-(1H-1,3-benzimidazol-2-ylmethyl)-2-[(4,6-dimethyl-2-pyrimidinyl)amino]-3-phenylpropanamide;CHEMBL4437862;EiM08-37860;AKOS027472813;N-[(1H-1,3-BENZODIAZOL-2-YL)METHYL]-2-[(4,6-DIMETHYLPYRIMIDIN-2-YL)AMINO]-3-PHENYLPROPANAMIDE;N-(1H-benzimidazol-2-ylmethyl)-2-[(4,6-dimethylpyrimidin-2-yl)amino]-3-phenyl-propanamide	False	92300538.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=92300538		pluskal_iocb_peptide_Peptide01_B14_id		100	B14	False	
3.6		0	1162	P1158159	88.2		H10	False	0	24	0	0	26	0	4	3	0	0		0.0						COc1cc2c(cc1)n(C)c(C(=O)NC(C)C(=O)NCCc1c[nH]c3ccccc13)c2																							0.0		AKOS016383882		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	1		C24H26N4O3	C24H26N4O3			InChI=1S/C24H26N4O3/c1-15(23(29)25-11-10-16-14-26-20-7-5-4-6-19(16)20)27-24(30)22-13-17-12-18(31-3)8-9-21(17)28(22)2/h4-9,12-15,26H,10-11H2,1-3H3,(H,25,29)(H,27,30)/t15-/m0/s1	UCSQOJPDTXFJCE-HNNXBMFYSA-N	5-methoxy-1-methyl-N-[rac-(1S)-2-[2-(1H-indol-3-yl)ethylamino]-1-methyl-2-oxo-ethyl]indole-2-carboxamide	17571788	COc1cc2c(cc1)n(C)c(C(=O)N[C@@H](C)C(=O)NCCc1c[nH]c3ccccc13)c2	N-[(2S)-1-[2-(1H-indol-3-yl)ethylamino]-1-oxopropan-2-yl]-5-methoxy-1-methylindole-2-carboxamide			1.7167300000000003													MCULE-6461312646	418.49982		418.200491	3	3	7	4			44									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(17571788)	17571788	3.4	302			[#6]-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#7](-[#6]):[#6](-[#6](=[#8])-[#7]-[#6@@H](-[#6])-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:1:3):[#6]:2	COc1cc2c(cc1)n(C)c(C(=O)N[C@@H](C)C(=O)NCCc1c[nH]c3ccccc13)c2	UCSQOJPDTXFJCE		parent_pubchem_cid	AKOS016383882;N~2~-(2-{[2-(1H-INDOL-3-YL)ETHYL]AMINO}-1-METHYL-2-OXOETHYL)-5-METHOXY-1-METHYL-1H-INDOLE-2-CARBOXAMIDE;5-methoxy-1-methyl-N-[rac-(1S)-2-[2-(1H-indol-3-yl)ethylamino]-1-methyl-2-oxo-ethyl]indole-2-carboxamide		6512904.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=6512904		pluskal_iocb_peptide_Peptide01_B14_id		100	B14		ZINC000012664558
3.4		0	1250	P7008315	58.9		H11	False	0	18	0	0	22	0	6	0	0	0		0.0						CC1CCN(c2nc(Nc3ccccc3)c3cnn(C)c3n2)CC1																							0.0		1-methyl-6-(4-methylpiperidin-1-yl)-N-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	2		C18H22N6	C18H22N6			InChI=1S/C18H22N6/c1-13-8-10-24(11-9-13)18-21-16(20-14-6-4-3-5-7-14)15-12-19-23(2)17(15)22-18/h3-7,12-13H,8-11H2,1-2H3,(H,20,21,22)	IRIYNWXFUVGMTN-UHFFFAOYSA-N	1-methyl-6-(4-methyl-1-piperidyl)-N-phenyl-pyrazolo[3,4-d]pyrimidin-4-amine	16456633	CC1CCN(c2nc(Nc3ccccc3)c3cnn(C)c3n2)CC1	1-methyl-6-(4-methylpiperidin-1-yl)-N-phenylpyrazolo[3,4-d]pyrimidin-4-amine			1.7729499999999996													MCULE-1642660349	322.41624		322.190595	5	1	3	4			44										False	Alkaloids				Peptide01			Compound(16456633)	16456633	3.8	303			[#6]-[#6]1-[#6]-[#6]-[#7](-[#6]2:[#7]:[#6](-[#7]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#6]3:[#6]:[#7]:[#7](-[#6]):[#6]:3:[#7]:2)-[#6]-[#6]-1	CC1CCN(c2nc(Nc3ccccc3)c3cnn(C)c3n2)CC1	IRIYNWXFUVGMTN		parent_pubchem_cid	1-methyl-6-(4-methylpiperidin-1-yl)-N-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine;HMS1639N21;STK890878;AKOS001906463;CCG-170398;1-methyl-6-(4-methyl-1-piperidyl)-N-phenyl-pyrazolo[3,4-d]pyrimidin-4-amine		15640197.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=15640197		pluskal_iocb_peptide_Peptide01_B14_id		100	B14		ZINC000009212210
2.3		0	1082	P11182922	122.4		H13	False	0	23	0	0	25	0	7	1	0	1		0.0						CSCCC(NC(=O)c1ccc(Nc2nc(C)cc(C)n2)cc1)c1nnc2ccccn12																							0.0		AKOS027471392		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	3	0	0	1	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C23H25N7OS	C23H25N7OS			InChI=1S/C23H25N7OS/c1-15-14-16(2)25-23(24-15)26-18-9-7-17(8-10-18)22(31)27-19(11-13-32-3)21-29-28-20-6-4-5-12-30(20)21/h4-10,12,14,19H,11,13H2,1-3H3,(H,27,31)(H,24,25,26)/t19-/m0/s1	ZEVJCZMGXQOULF-IBGZPJMESA-N	4-[(4,6-dimethylpyrimidin-2-yl)amino]-N-[rac-(1S)-3-methylsulfanyl-1-([1,2,4]triazolo[4,3-a]pyridin-3-yl)propyl]benzamide	71829198	CSCC[C@H](NC(=O)c1ccc(Nc2nc(C)cc(C)n2)cc1)c1nnc2ccccn12	4-[(4,6-dimethylpyrimidin-2-yl)amino]-N-[(1S)-3-methylsulfanyl-1-([1,2,4]triazolo[4,3-a]pyridin-3-yl)propyl]benzamide			2.909670000000001													MCULE-5107909212	447.566		447.184129	7	2	8	4			44										False	Alkaloids				Peptide01			Compound(71829198)	71829198	4.0	304			[#6]-[#16]-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#7]-[#6]2:[#7]:[#6](-[#6]):[#6]:[#6](-[#6]):[#7]:2):[#6]:[#6]:1)-[#6]1:[#7]:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#7]:1:2	CSCC[C@H](NC(=O)c1ccc(Nc2nc(C)cc(C)n2)cc1)c1nnc2ccccn12	ZEVJCZMGXQOULF		parent_pubchem_cid	AKOS027471392;4-[(4,6-dimethylpyrimidin-2-yl)amino]-N-[rac-(1S)-3-methylsulfanyl-1-([1,2,4]triazolo[4,3-a]pyridin-3-yl)propyl]benzamide		68959597.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=68959597		pluskal_iocb_peptide_Peptide01_B15_id		100	B15		ZINC000096116951
4.7		0	1170	P1157985	54.1		H14	False	0	25	0	0	24	0	2	2	0	0		0.0						COc1cc2c(cc1)[nH]cc2CCNC(=O)C(c1ccccc1)c1ccccc1								Phenylacetamides;3-alkylindoles;Anisoles;Alkyl aryl ethers;Substituted pyrroles;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	3-alkylindoles;Alkyl aryl ethers;Anisoles;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Diphenylmethanes;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenol ethers;Phenylacetamides;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as diphenylmethanes. These are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups.	Diphenylmethanes			Organic compounds	Aromatic heteropolycyclic compounds	acetamides (CHEBI:22160);indoles (CHEBI:24828);methoxybenzene (CHEBI:51683);aromatic ether (CHEBI:35618);pyrroles (CHEBI:26455);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organonitrogen heterocyclic compound (CHEBI:38101);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);diarylmethane (CHEBI:51614);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);organic heterocyclic compound (CHEBI:24532);oxygen molecular entity (CHEBI:25806);organooxygen compound (CHEBI:36963);ether (CHEBI:25698);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)		Diphenylmethanes	Diphenylmethane;3-alkylindole;Phenylacetamide;Indole or derivatives;Indole;Anisole;Alkyl aryl ether;Substituted pyrrole;Heteroaromatic compound;Pyrrole;Secondary carboxylic acid amide;Carboxamide group;Azacycle;Organoheterocyclic compound;Ether;Carboxylic acid derivative;Organic nitrogen compound;Organic oxygen compound;Organopnictogen compound;Organic oxide;Hydrocarbon derivative;Organooxygen compound;Organonitrogen compound;Carbonyl group;Aromatic heteropolycyclic compound	Benzenoids	0.0		N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-2,2-diphenylacetamide		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C25H24N2O2	C25H24N2O2			InChI=1S/C25H24N2O2/c1-29-21-12-13-23-22(16-21)20(17-27-23)14-15-26-25(28)24(18-8-4-2-5-9-18)19-10-6-3-7-11-19/h2-13,16-17,24,27H,14-15H2,1H3,(H,26,28)	IEBKEYIXCRCZCT-UHFFFAOYSA-N	N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-2,2-diphenyl-acetamide	16425674	COc1cc2c(cc1)[nH]cc2CCNC(=O)C(c1ccccc1)c1ccccc1	N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-2,2-diphenylacetamide			3.6123400000000014													MCULE-9359682256	384.48223		384.183778	2	2	7	4			44										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(16425674)	16425674	4.1	305			[#6]-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#7H]:[#6]:[#6]:2-[#6]-[#6]-[#7]-[#6](=[#8])-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	COc1cc2c(cc1)[nH]cc2CCNC(=O)C(c1ccccc1)c1ccccc1	IEBKEYIXCRCZCT		parent_pubchem_cid	N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-2,2-diphenylacetamide;929846-49-1;AKOS005533767;N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-2,2-diphenyl-acetamide		7668462.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=7668462		pluskal_iocb_peptide_Peptide01_B15_id		100	B15		ZINC000013655372
4.1		0	1258	P7008430	62.1		H15	False	0	22	0	1	22	0	7	0	0	0		0.0						Cn1ncc2c1nc(Nc1cc(F)ccc1)nc2N1CCN(c2ccccc2)CC1																							0.0		AKOS005579187		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	3		C22H22FN7	C22H22FN7			InChI=1S/C22H22FN7/c1-28-20-19(15-24-28)21(27-22(26-20)25-17-7-5-6-16(23)14-17)30-12-10-29(11-13-30)18-8-3-2-4-9-18/h2-9,14-15H,10-13H2,1H3,(H,25,26,27)	MQRBFDPCOXNCDJ-UHFFFAOYSA-N	N-(3-fluorophenyl)-1-methyl-4-(4-phenylpiperazin-1-yl)pyrazolo[3,4-d]pyrimidin-6-amine	39349841	Cn1ncc2c1nc(Nc1cc(F)ccc1)nc2N1CCN(c2ccccc2)CC1	N-(3-fluorophenyl)-1-methyl-4-(4-phenylpiperazin-1-yl)pyrazolo[3,4-d]pyrimidin-6-amine			1.6217399999999995													MCULE-7204261644	403.46594		403.192072	6	1	4	5			44										False	Alkaloids				Peptide01			Compound(39349841)	39349841	4.2	306			[#6]-[#7]1:[#7]:[#6]:[#6]2:[#6]:1:[#7]:[#6](-[#7]-[#6]1:[#6]:[#6](-[#9]):[#6]:[#6]:[#6]:1):[#7]:[#6]:2-[#7]1-[#6]-[#6]-[#7](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]-[#6]-1	Cn1ncc2c1nc(Nc1cc(F)ccc1)nc2N1CCN(c2ccccc2)CC1	MQRBFDPCOXNCDJ		parent_pubchem_cid	AKOS005579187;AKOS022122642;N-(3-fluorophenyl)-1-methyl-4-(4-phenylpiperazin-1-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-amine;N-(3-fluorophenyl)-1-methyl-4-(4-phenylpiperazin-1-yl)pyrazolo[3,4-d]pyrimidin-6-amine		13347384.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=13347384		pluskal_iocb_peptide_Peptide01_B15_id		100	B15		ZINC000032102943
1.3		0	1090	P1094950	119.0		H17	False	0	15	0	0	20	0	2	5	0	1		0.0						COC(=O)c1ccccc1NC(=O)NC(CCSC)C(=O)OC								Alpha amino acid esters;N-carbamoyl-alpha amino acids;Benzoic acid esters;N-phenylureas;Benzoyl derivatives;Fatty acid esters;Dicarboxylic acids and derivatives;Vinylogous amides;Methyl esters;Ureas;Sulfenyl compounds;Dialkylthioethers;Organopnictogen compounds;Carbonyl compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	Alpha amino acid esters;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Benzene and substituted derivatives;Benzenoids;Benzoic acid esters;Benzoic acids and derivatives;Benzoyl derivatives;Carbonyl compounds;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids and derivatives;Chemical entities;Dialkylthioethers;Dicarboxylic acids and derivatives;Fatty Acyls;Fatty acid esters;Hydrocarbon derivatives;Lipids and lipid-like molecules;Methionine and derivatives;Methyl esters;N-acyl-alpha amino acids and derivatives;N-carbamoyl-alpha amino acids;N-carbamoyl-alpha amino acids and derivatives;N-phenylureas;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Organosulfur compounds;Sulfenyl compounds;Thioethers;Ureas;Vinylogous amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as methionine and derivatives. These are compounds containing methionine or a derivative thereof resulting from reaction of methionine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Methionine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic homomonocyclic compounds	alpha-amino acid ester (CHEBI:46874);N-carbamoyl-amino acid (CHEBI:21689);benzoate ester (CHEBI:36054);ureas (CHEBI:47857);carbonyl compound (CHEBI:36586);fatty acid ester (CHEBI:35748);dicarboxylic acid (CHEBI:35692);enone (CHEBI:51689);enamine (CHEBI:47989);carboxylic ester (CHEBI:33308);organosulfur compound (CHEBI:33261);aliphatic sulfide (CHEBI:22327);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);alpha-amino acid (CHEBI:33704);methionine derivative (CHEBI:25230);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);amino acid (CHEBI:33709);peptide (CHEBI:16670);N-acyl-amino acid (CHEBI:51569);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);lipid (CHEBI:18059);organic sulfide (CHEBI:16385);oxygen molecular entity (CHEBI:25806);nitrogen molecular entity (CHEBI:51143)	Fatty esters (FA07);Dicarboxylic acids (FA0117);Fatty Acyls (FA)	Amino acids, peptides, and analogues	Methionine or derivatives;Alpha-amino acid ester;N-carbamoyl-alpha-amino acid or derivatives;N-carbamoyl-alpha-amino acid;N-phenylurea;Benzoate ester;Benzoic acid or derivatives;Benzoyl;Fatty acid ester;Benzenoid;Dicarboxylic acid or derivatives;Fatty acyl;Monocyclic benzene moiety;Methyl ester;Vinylogous amide;Urea;Carbonic acid derivative;Carboxylic acid ester;Dialkylthioether;Sulfenyl compound;Thioether;Organic oxygen compound;Organic nitrogen compound;Carbonyl group;Hydrocarbon derivative;Organic oxide;Organopnictogen compound;Organosulfur compound;Organooxygen compound;Organonitrogen compound;Aromatic homomonocyclic compound	Organic acids and derivatives	0.0		AKOS016387082		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C15H20N2O5S	C15H20N2O5S			InChI=1S/C15H20N2O5S/c1-21-13(18)10-6-4-5-7-11(10)16-15(20)17-12(8-9-23-3)14(19)22-2/h4-7,12H,8-9H2,1-3H3,(H2,16,17,20)/t12-/m0/s1	RDUOJLWTRNNEQS-LBPRGKRZSA-N	methyl 2-[[rac-(1S)-1-methoxycarbonyl-3-methylsulfanyl-propyl]carbamoylamino]benzoate	1759102	COC(=O)c1ccccc1NC(=O)N[C@@H](CCSC)C(=O)OC	methyl 2-[[(2S)-1-methoxy-4-methylsulfanyl-1-oxobutan-2-yl]carbamoylamino]benzoate			1.4540799999999996													MCULE-9562151856	340.40105		340.109293	6	2	9	1			44										False	Alkaloids;Amino acids and Peptides	Small peptides			Peptide01			Compound(1759102)	1759102	2.4	307			[#6]-[#8]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#7]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]-[#16]-[#6])-[#6](=[#8])-[#8]-[#6]	COC(=O)c1ccccc1NC(=O)N[C@@H](CCSC)C(=O)OC	RDUOJLWTRNNEQS		parent_pubchem_cid	AKOS016387082;METHYL 2-[({[(1S)-1-(METHOXYCARBONYL)-3-(METHYLSULFANYL)PROPYL]AMINO}CARBONYL)AMINO]BENZOATE;methyl 2-[[rac-(1S)-1-methoxycarbonyl-3-methylsulfanyl-propyl]carbamoylamino]benzoate		14243875.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=14243875		pluskal_iocb_peptide_Peptide01_B15_id		100	B15		ZINC000002103915
3.3		0	1178	P6238547	91.1		H18	False	0	25	0	0	29	0	3	3	0	1		0.0						CSCCC(NC(=O)c1cc2ccccc2o1)C(=O)N1CCN(Cc2ccccc2)CC1																							0.0		EiM08-08781		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	1		C25H29N3O3S	C25H29N3O3S			InChI=1S/C25H29N3O3S/c1-32-16-11-21(26-24(29)23-17-20-9-5-6-10-22(20)31-23)25(30)28-14-12-27(13-15-28)18-19-7-3-2-4-8-19/h2-10,17,21H,11-16,18H2,1H3,(H,26,29)/t21-/m1/s1	RRMMDBMINIMIDG-OAQYLSRUSA-N	N-[rac-(1R)-1-(4-benzylpiperazine-1-carbonyl)-3-methylsulfanyl-propyl]benzofuran-2-carboxamide	75366498	CSCC[C@@H](NC(=O)c1cc2ccccc2o1)C(=O)N1CCN(Cc2ccccc2)CC1	N-[(2R)-1-(4-benzylpiperazin-1-yl)-4-methylsulfanyl-1-oxobutan-2-yl]-1-benzofuran-2-carboxamide			3.090860000000001													MCULE-2989103841	451.59218		451.192963	4	1	8	4			44										False					Peptide01			Compound(75366498)	75366498	3.8	308			[#6]-[#16]-[#6]-[#6]-[#6@@H](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#8]:1)-[#6](=[#8])-[#7]1-[#6]-[#6]-[#7](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]-[#6]-1	CSCC[C@@H](NC(=O)c1cc2ccccc2o1)C(=O)N1CCN(Cc2ccccc2)CC1	RRMMDBMINIMIDG		parent_pubchem_cid	EiM08-08781;AKOS016387102;N-[rac-(1R)-1-(4-benzylpiperazine-1-carbonyl)-3-methylsulfanyl-propyl]benzofuran-2-carboxamide		80293207.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=80293207		pluskal_iocb_peptide_Peptide01_B15_id		100	B15		ZINC000080355496
3.2		0	1266	P7008526	70.1		H19	False	0	24	0	0	25	0	7	0	0	0		0.0						c1ccc(CNc2nc(N3CCN(Cc4ccccc4)CC3)nc3nccnc23)cc1																							0.0		N-benzyl-2-(4-benzylpiperazin-1-yl)pteridin-4-amine		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	2		C24H25N7	C24H25N7			InChI=1S/C24H25N7/c1-3-7-19(8-4-1)17-27-23-21-22(26-12-11-25-21)28-24(29-23)31-15-13-30(14-16-31)18-20-9-5-2-6-10-20/h1-12H,13-18H2,(H,26,27,28,29)	SLVUTODAFOPAOL-UHFFFAOYSA-N	N-benzyl-2-(4-benzylpiperazin-1-yl)pteridin-4-amine	45493380	c1ccc(CNc2nc(N3CCN(Cc4ccccc4)CC3)nc3nccnc23)cc1	N-benzyl-2-(4-benzylpiperazin-1-yl)pteridin-4-amine			2.055039999999999													MCULE-7079830803	411.51375		411.217144	7	1	6	5			43										False	Alkaloids				Peptide01			Compound(45493380)	45493380	3.4	309			[#6]1:[#6]:[#6]:[#6](-[#6]-[#7]-[#6]2:[#7]:[#6](-[#7]3-[#6]-[#6]-[#7](-[#6]-[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]:4)-[#6]-[#6]-3):[#7]:[#6]3:[#7]:[#6]:[#6]:[#7]:[#6]:2:3):[#6]:[#6]:1	c1ccc(CNc2nc(N3CCN(Cc4ccccc4)CC3)nc3nccnc23)cc1	SLVUTODAFOPAOL		parent_pubchem_cid	N-benzyl-2-(4-benzylpiperazin-1-yl)pteridin-4-amine;1190287-48-9;STK658857;AKOS002337570;Z1013695844		21068270.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=21068270		pluskal_iocb_peptide_Peptide01_B15_id		100	B15		ZINC000036358827
-0.9		0	1098	P1157615	170.9		H21	False	0	16	0	0	19	0	5	6	0	0		0.0						NC(=O)NCCCC(NC(=O)Cn1c(=O)[nH]c2ccccc2c1=O)C(=O)O																							0.0		AKOS016397977		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	6	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0		C16H19N5O6	C16H19N5O6			InChI=1S/C16H19N5O6/c17-15(26)18-7-3-6-11(14(24)25)19-12(22)8-21-13(23)9-4-1-2-5-10(9)20-16(21)27/h1-2,4-5,11H,3,6-8H2,(H,19,22)(H,20,27)(H,24,25)(H3,17,18,26)/t11-/m0/s1	RVUBUJKUMMZDGJ-NSHDSACASA-N	rac-(2S)-2-[[2-(2,4-dioxo-1H-quinazolin-3-yl)acetyl]amino]-5-ureido-pentanoic acid	1788800	NC(=O)NCCC[C@H](NC(=O)Cn1c(=O)[nH]c2ccccc2c1=O)C(=O)O	(2S)-5-(carbamoylamino)-2-[[2-(2,4-dioxo-1H-quinazolin-3-yl)acetyl]amino]pentanoic acid			0.0790600000000003													MCULE-1014258839	377.35973		377.133533	6	5	8	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(1788800)	1788800	-0.9	310			[#7]-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#7]1:[#6](=[#8]):[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8])-[#6](=[#8])-[#8]	NC(=O)NCCC[C@H](NC(=O)Cn1c(=O)[nH]c2ccccc2c1=O)C(=O)O	RVUBUJKUMMZDGJ		parent_pubchem_cid	AKOS016397977;(S)-2-(2-(2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)acetamido)-5-ureidopentanoic acid;5-(CARBAMOYLAMINO)-2-[2-(2,4-DIOXO-1,2,3,4-TETRAHYDROQUINAZOLIN-3-YL)ACETAMIDO]PENTANOIC ACID;rac-(2S)-2-[[2-(2,4-dioxo-1H-quinazolin-3-yl)acetyl]amino]-5-ureido-pentanoic acid		23699305.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23699305		pluskal_iocb_peptide_Peptide01_B15_id		100	B15		ZINC000002133503
2.3		0	1186	P1099259	90.9		H22	False	0	19	0	0	19	0	1	6	0	0		0.0						COC(=O)c1cc(NC(=O)Cc2ccc(OC)cc2)c(C(=O)OC)cc1								p-Phthalate esters;P-phthalic acid and derivatives;Benzoic acid esters;Phenylacetamides;Anilides;Anisoles;Benzoyl derivatives;Methoxybenzenes;N-arylamides;Phenoxy compounds;Alkyl aryl ethers;Methyl esters;Vinylogous amides;Secondary carboxylic acid amides;Hydrocarbon derivatives;Carbonyl compounds;Organic oxides	Acylaminobenzoic acid and derivatives;Alkyl aryl ethers;Anilides;Anisoles;Benzene and substituted derivatives;Benzenoids;Benzoic acid esters;Benzoic acids and derivatives;Benzoyl derivatives;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids and derivatives;Chemical entities;Ethers;Hydrocarbon derivatives;Methoxybenzenes;Methyl esters;N-arylamides;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;P-phthalic acid and derivatives;Phenol ethers;Phenoxy compounds;Phenylacetamides;Phthalate esters;Phthalic acid and derivatives;Secondary carboxylic acid amides;Vinylogous amides;p-Phthalate esters	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as acylaminobenzoic acid and derivatives. These are derivatives of amino benzoic acid derivatives where the amine group is N-acylated.	Acylaminobenzoic acid and derivatives			Organic compounds	Aromatic homomonocyclic compounds	phthalate ester (CHEBI:35484);benzenedicarboxylic acid (CHEBI:26094);benzoate ester (CHEBI:36054);acetamides (CHEBI:22160);anilide (CHEBI:13248);methoxybenzene (CHEBI:51683);carbonyl compound (CHEBI:36586);aromatic amide (CHEBI:62733);benzenes (CHEBI:22712);aromatic ether (CHEBI:35618);carboxylic ester (CHEBI:33308);enone (CHEBI:51689);enamine (CHEBI:47989);carboxamide (CHEBI:37622);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organooxygen compound (CHEBI:36963);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);benzoic acids (CHEBI:22723);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);oxygen molecular entity (CHEBI:25806);ether (CHEBI:25698);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988)		Benzoic acids and derivatives	Acylaminobenzoic acid or derivatives;Phthalate ester;Para-phthalic acid ester;Para_phthalic_acid;Benzoate ester;Phenylacetamide;Anilide;Phenoxy compound;Anisole;Benzoyl;Methoxybenzene;N-arylamide;Phenol ether;Alkyl aryl ether;Vinylogous amide;Methyl ester;Carboxamide group;Carboxylic acid ester;Secondary carboxylic acid amide;Ether;Carboxylic acid derivative;Organic oxygen compound;Organic nitrogen compound;Carbonyl group;Hydrocarbon derivative;Organic oxide;Organonitrogen compound;Organooxygen compound;Aromatic homomonocyclic compound	Benzenoids	0.0		349093-62-5		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C19H19NO6	C19H19NO6			InChI=1S/C19H19NO6/c1-24-14-7-4-12(5-8-14)10-17(21)20-16-11-13(18(22)25-2)6-9-15(16)19(23)26-3/h4-9,11H,10H2,1-3H3,(H,20,21)	SPHLZUSUJGPKPM-UHFFFAOYSA-N	dimethyl 2-[[2-(4-methoxyphenyl)acetyl]amino]benzene-1,4-dicarboxylate	4302969	COC(=O)c1cc(NC(=O)Cc2ccc(OC)cc2)c(C(=O)OC)cc1	dimethyl 2-[[2-(4-methoxyphenyl)acetyl]amino]benzene-1,4-dicarboxylate			1.4424499999999998													MCULE-7568452103	357.36638		357.121237	6	1	8	2			44									Anthranillic acid derivatives	False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(4302969)	4302969	2.9	311			[#6]-[#8]-[#6](=[#8])-[#6]1:[#6]:[#6](-[#7]-[#6](=[#8])-[#6]-[#6]2:[#6]:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:2):[#6](-[#6](=[#8])-[#8]-[#6]):[#6]:[#6]:1	COC(=O)c1cc(NC(=O)Cc2ccc(OC)cc2)c(C(=O)OC)cc1	SPHLZUSUJGPKPM		parent_pubchem_cid	349093-62-5;dimethyl 2-{[2-(4-methoxyphenyl)acetyl]amino}terephthalate;Oprea1_483080;AKOS001368288;Z30170807;dimethyl 2-(2-(4-methoxyphenyl)acetamido)terephthalate;1,4-DIMETHYL 2-[2-(4-METHOXYPHENYL)ACETAMIDO]BENZENE-1,4-DICARBOXYLATE;dimethyl 2-[[2-(4-methoxyphenyl)acetyl]amino]benzene-1,4-dicarboxylate		16890109.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=16890109		pluskal_iocb_peptide_Peptide01_B15_id		100	B15		ZINC000005513694
4.1		0	1274	P7127855	156.7		H23	False	0	20	0	0	20	0	2	6	0	3		0.0						CCS(=O)(=O)c1nc(S(=O)(=O)c2ccc(C)cc2)c(NCc2cc3c(cc2)OCO3)s1																							0.0		STL011705		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0		C20H20N2O6S3	C20H20N2O6S3			InChI=1S/C20H20N2O6S3/c1-3-30(23,24)20-22-19(31(25,26)15-7-4-13(2)5-8-15)18(29-20)21-11-14-6-9-16-17(10-14)28-12-27-16/h4-10,21H,3,11-12H2,1-2H3	JEZTTYQYMVOAHF-UHFFFAOYSA-N	N-(1,3-benzodioxol-5-ylmethyl)-2-ethylsulfonyl-4-(p-tolylsulfonyl)thiazol-5-amine	29182657	CCS(=O)(=O)c1nc(S(=O)(=O)c2ccc(C)cc2)c(NCc2cc3c(cc2)OCO3)s1	N-(1,3-benzodioxol-5-ylmethyl)-2-ethylsulfonyl-4-(4-methylphenyl)sulfonyl-1,3-thiazol-5-amine			1.6798400000000004													MCULE-1649574556	480.5842		480.048349	8	1	7	4			44										False					Peptide01			Compound(29182657)	29182657	4.6	312			[#6]-[#6]-[#16](=[#8])(=[#8])-[#6]1:[#7]:[#6](-[#16](=[#8])(=[#8])-[#6]2:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:2):[#6](-[#7]-[#6]-[#6]2:[#6]:[#6]3:[#6](:[#6]:[#6]:2)-[#8]-[#6]-[#8]-3):[#16]:1	CCS(=O)(=O)c1nc(S(=O)(=O)c2ccc(C)cc2)c(NCc2cc3c(cc2)OCO3)s1	JEZTTYQYMVOAHF		parent_pubchem_cid	STL011705;AKOS002330788;Z443419866;N-(1,3-benzodioxol-5-ylmethyl)-2-(ethylsulfonyl)-4-[(4-methylphenyl)sulfonyl]-1,3-thiazol-5-amine;N-(1,3-benzodioxol-5-ylmethyl)-2-ethylsulfonyl-4-(p-tolylsulfonyl)thiazol-5-amine		10762460.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=10762460		pluskal_iocb_peptide_Peptide01_B16_id		100	B16		ZINC000020862017
4.6		0	1106	P1098261	117.7		H25	False	0	26	0	0	26	0	2	6	0	0		0.0						CCCc1cc(=O)oc2c1c(OCC(=O)NC(Cc1c[nH]c3ccccc13)C(=O)O)cc(C)c2																							0.0		EiM07-16939		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C26H26N2O6	C26H26N2O6			InChI=1S/C26H26N2O6/c1-3-6-16-12-24(30)34-22-10-15(2)9-21(25(16)22)33-14-23(29)28-20(26(31)32)11-17-13-27-19-8-5-4-7-18(17)19/h4-5,7-10,12-13,20,27H,3,6,11,14H2,1-2H3,(H,28,29)(H,31,32)/t20-/m0/s1	MYKJUCLXXDOUIN-FQEVSTJZSA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[[2-(7-methyl-2-oxo-4-propyl-chromen-5-yl)oxyacetyl]amino]propanoic acid	1769712	CCCc1cc(=O)oc2c1c(OCC(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)O)cc(C)c2	(2S)-3-(1H-indol-3-yl)-2-[[2-(7-methyl-2-oxo-4-propylchromen-5-yl)oxyacetyl]amino]propanoic acid			3.1426300000000014													MCULE-5910032378	462.50692		462.179087	6	3	9	4			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(1769712)	1769712	4.2	313			[#6]-[#6]-[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6](-[#8]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:1:3)-[#6](=[#8])-[#8]):[#6]:[#6](-[#6]):[#6]:2	CCCc1cc(=O)oc2c1c(OCC(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)O)cc(C)c2	MYKJUCLXXDOUIN		parent_pubchem_cid	EiM07-16939;STL460674;AKOS016392318;N-{[(7-methyl-2-oxo-4-propyl-2H-chromen-5-yl)oxy]acetyl}-L-tryptophan;(2S)-3-(1H-INDOL-3-YL)-2-({2-[(7-METHYL-2-OXO-4-PROPYL-2H-CHROMEN-5-YL)OXY]ACETYL}AMINO)PROPANOIC ACID;rac-(2S)-3-(1H-indol-3-yl)-2-[[2-(7-methyl-2-oxo-4-propyl-chromen-5-yl)oxyacetyl]amino]propanoic acid		23438995.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23438995		pluskal_iocb_peptide_Peptide01_B16_id		100	B16		ZINC000002114992
3.9		0	1194	P3461159	83.2		H26	False	0	23	0	0	27	0	3	3	0	0		0.0						COc1ccc(CCNC(=O)C(NC(=O)c2cc3ccccc3[nH]2)C(C)C)cc1																							0.0		EiM08-08651		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0		C23H27N3O3	C23H27N3O3			InChI=1S/C23H27N3O3/c1-15(2)21(23(28)24-13-12-16-8-10-18(29-3)11-9-16)26-22(27)20-14-17-6-4-5-7-19(17)25-20/h4-11,14-15,21,25H,12-13H2,1-3H3,(H,24,28)(H,26,27)/t21-/m1/s1	LDNQTNSRTAYQMZ-OAQYLSRUSA-N	N-[rac-(1R)-1-[2-(4-methoxyphenyl)ethylcarbamoyl]-2-methyl-propyl]-1H-indole-2-carboxamide	51703535	COc1ccc(CCNC(=O)[C@H](NC(=O)c2cc3ccccc3[nH]2)C(C)C)cc1	N-[(2R)-1-[2-(4-methoxyphenyl)ethylamino]-3-methyl-1-oxobutan-2-yl]-1H-indole-2-carboxamide			2.28955													MCULE-6673928962	393.48994		393.205242	3	3	8	3			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51703535)	51703535	4.3	314			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6]-[#6]-[#7]-[#6](=[#8])-[#6@H](-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3:[#7H]:2)-[#6](-[#6])-[#6]):[#6]:[#6]:1	COc1ccc(CCNC(=O)[C@H](NC(=O)c2cc3ccccc3[nH]2)C(C)C)cc1	LDNQTNSRTAYQMZ		parent_pubchem_cid	EiM08-08651;AKOS016376746;2-[(1H-INDOL-2-YL)FORMAMIDO]-N-[2-(4-METHOXYPHENYL)ETHYL]-3-METHYLBUTANAMIDE;N-[rac-(1R)-1-[2-(4-methoxyphenyl)ethylcarbamoyl]-2-methyl-propyl]-1H-indole-2-carboxamide		4225274.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=4225274		pluskal_iocb_peptide_Peptide01_B16_id		100	B16		ZINC000035686256
1.7		0	1282	P11569517	103.7		H27	False	0	18	0	0	24	0	2	3	0	1		0.0						CSCCC(CO)NC(=O)c1c[nH]c2c(C(C)C)cccc2c1=O																							0.0		AKOS027474347		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C18H24N2O3S	C18H24N2O3S			InChI=1S/C18H24N2O3S/c1-11(2)13-5-4-6-14-16(13)19-9-15(17(14)22)18(23)20-12(10-21)7-8-24-3/h4-6,9,11-12,21H,7-8,10H2,1-3H3,(H,19,22)(H,20,23)/t12-/m0/s1	WWEVQTOVFGIPEX-LBPRGKRZSA-N	8-isopropyl-4-oxo-N-[rac-(1S)-1-(hydroxymethyl)-3-methylsulfanyl-propyl]-1H-quinoline-3-carboxamide	91636835	CSCC[C@@H](CO)NC(=O)c1c[nH]c2c(C(C)C)cccc2c1=O	N-[(2S)-1-hydroxy-4-methylsulfanylbutan-2-yl]-4-oxo-8-propan-2-yl-1H-quinoline-3-carboxamide			2.857350000000001														348.46758		348.150764	5	3	7	2			45										False	Alkaloids				Peptide01			Compound(91636835)	91636835	3.1	315			[#6]-[#16]-[#6]-[#6]-[#6@@H](-[#6]-[#8])-[#7]-[#6](=[#8])-[#6]1:[#6]:[#7H]:[#6]2:[#6](-[#6](-[#6])-[#6]):[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8]	CSCC[C@@H](CO)NC(=O)c1c[nH]c2c(C(C)C)cccc2c1=O	WWEVQTOVFGIPEX		parent_pubchem_cid	AKOS027474347;AKOS037499930;8-isopropyl-4-oxo-N-[rac-(1S)-1-(hydroxymethyl)-3-methylsulfanyl-propyl]-1H-quinoline-3-carboxamide		94804765.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=94804765		pluskal_iocb_peptide_Peptide01_B16_id		100	B16		ZINC000217652391
1.6		0	1114	P1098936	115.8		H29	False	0	18	0	0	23	0	3	5	0	0		0.0						CC(C)CC(NC(=O)CCCn1c(=O)[nH]c2ccccc2c1=O)C(=O)O																							0.0		N-[4-(2,4-dioxo-1,4-dihydroquinazolin-3(2H)-yl)butanoyl]-L-leucine		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	4	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0		C18H23N3O5	C18H23N3O5			InChI=1S/C18H23N3O5/c1-11(2)10-14(17(24)25)19-15(22)8-5-9-21-16(23)12-6-3-4-7-13(12)20-18(21)26/h3-4,6-7,11,14H,5,8-10H2,1-2H3,(H,19,22)(H,20,26)(H,24,25)/t14-/m0/s1	BKETUBLOINXZQC-AWEZNQCLSA-N	rac-(2S)-2-[4-(2,4-dioxo-1H-quinazolin-3-yl)butanoylamino]-4-methyl-pentanoic acid	1792121	CC(C)C[C@H](NC(=O)CCCn1c(=O)[nH]c2ccccc2c1=O)C(=O)O	(2S)-2-[4-(2,4-dioxo-1H-quinazolin-3-yl)butanoylamino]-4-methylpentanoic acid			2.45686													MCULE-2517793654	361.40111		361.163771	5	3	8	2			44									Dipeptides	False	Alkaloids;Amino acids and Peptides	Small peptides			Peptide01			Compound(1792121)	1792121	1.5	316			[#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#6]-[#6]-[#7]1:[#6](=[#8]):[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8])-[#6](=[#8])-[#8]	CC(C)C[C@H](NC(=O)CCCn1c(=O)[nH]c2ccccc2c1=O)C(=O)O	BKETUBLOINXZQC		parent_pubchem_cid	N-[4-(2,4-dioxo-1,4-dihydroquinazolin-3(2H)-yl)butanoyl]-L-leucine;AKOS016376029;AKOS037496732;(S)-2-(4-(2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)butanamido)-4-methylpentanoic acid;rac-(2S)-2-[4-(2,4-dioxo-1H-quinazolin-3-yl)butanoylamino]-4-methyl-pentanoic acid		23762696.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23762696		pluskal_iocb_peptide_Peptide01_B16_id		100	B16		ZINC000008972250
4.0		0	1202	P1098183	101.9		H30	False	0	21	0	0	27	0	1	6	0	0		0.0						CCc1cc(=O)oc2c1ccc(OC(C)C(=O)NC(CC(C)C)C(=O)O)c2C																							0.0		EiM07-16861		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C21H27NO6	C21H27NO6			InChI=1S/C21H27NO6/c1-6-14-10-18(23)28-19-12(4)17(8-7-15(14)19)27-13(5)20(24)22-16(21(25)26)9-11(2)3/h7-8,10-11,13,16H,6,9H2,1-5H3,(H,22,24)(H,25,26)/t13?,16-/m0/s1	VREHEELJZXHYGF-VYIIXAMBSA-N	rac-(2S)-2-[2-(4-ethyl-8-methyl-2-oxo-chromen-7-yl)oxypropanoylamino]-4-methyl-pentanoic acid	16399089	CCc1cc(=O)oc2c1ccc(OC(C)C(=O)N[C@@H](CC(C)C)C(=O)O)c2C	(2S)-2-[2-(4-ethyl-8-methyl-2-oxochromen-7-yl)oxypropanoylamino]-4-methylpentanoic acid			2.9462600000000005													MCULE-3262314383	389.45244		389.183838	6	2	8	2			45									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(16399089)	16399089	3.7	317			[#6]-[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6](-[#6])-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=[#8])-[#8]):[#6]:2-[#6]	CCc1cc(=O)oc2c1ccc(OC(C)C(=O)N[C@@H](CC(C)C)C(=O)O)c2C	VREHEELJZXHYGF		parent_pubchem_cid	EiM07-16861;AKOS004937245;(2S)-2-({2-[(4-ETHYL-8-METHYL-2-OXO-2H-CHROMEN-7-YL)OXY]PROPANOYL}AMINO)-4-METHYLPENTANOIC ACID;rac-(2S)-2-[2-(4-ethyl-8-methyl-2-oxo-chromen-7-yl)oxypropanoylamino]-4-methyl-pentanoic acid		22778843.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22778843		pluskal_iocb_peptide_Peptide01_B16_id		100	B16		
-0.5		0	1290	P11570176	110.8		H31	False	0	15	0	0	22	0	4	4	0	0		0.0						Cc1c(CCC(=O)NC(CO)C(C)C)c(=O)n2[nH]c(=O)cc2[nH]1																							0.0		AKOS037623937		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C15H22N4O4	C15H22N4O4			InChI=1S/C15H22N4O4/c1-8(2)11(7-20)17-13(21)5-4-10-9(3)16-12-6-14(22)18-19(12)15(10)23/h6,8,11,16,20H,4-5,7H2,1-3H3,(H,17,21)(H,18,22)/t11-/m1/s1	XRPOTZRITHQYJN-LLVKDONJSA-N	N-[1-(hydroxymethyl)-2-methyl-propyl]-3-(5-methyl-2,7-dioxo-1,4-dihydropyrazolo[1,5-a]pyrimidin-6-yl)propanamide	100015802	Cc1c(CCC(=O)N[C@H](CO)C(C)C)c(=O)n2[nH]c(=O)cc2[nH]1	N-[(2S)-1-hydroxy-3-methylbutan-2-yl]-3-(5-methyl-2,7-dioxo-1,4-dihydropyrazolo[1,5-a]pyrimidin-6-yl)propanamide			1.1661699999999997														322.36699		322.164105	5	4	6	2			45									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(100015802)	100015802	-0.2	318			[#6]-[#6]1:[#6](-[#6]-[#6]-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#8])-[#6](-[#6])-[#6]):[#6](=[#8]):[#7]2:[#7H]:[#6](=[#8]):[#6]:[#6]:2:[#7H]:1	Cc1c(CCC(=O)N[C@H](CO)C(C)C)c(=O)n2[nH]c(=O)cc2[nH]1	XRPOTZRITHQYJN		parent_pubchem_cid	AKOS037623937;N-[1-(hydroxymethyl)-2-methyl-propyl]-3-(5-methyl-2,7-dioxo-1,4-dihydropyrazolo[1,5-a]pyrimidin-6-yl)propanamide		101988948.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=101988948		pluskal_iocb_peptide_Peptide01_B16_id		100	B16		ZINC000218451818
0.6		0	1122	P1098912	166.6		H33	False	0	16	0	0	20	0	6	5	0	0		0.0						CC(C(=O)NC(CCCNC(N)=O)C(=O)O)n1nnc2ccccc2c1=O																							0.0		1014088-57-3		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	4	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C16H20N6O5	C16H20N6O5			InChI=1S/C16H20N6O5/c1-9(22-14(24)10-5-2-3-6-11(10)20-21-22)13(23)19-12(15(25)26)7-4-8-18-16(17)27/h2-3,5-6,9,12H,4,7-8H2,1H3,(H,19,23)(H,25,26)(H3,17,18,27)/t9-,12-/m0/s1	YKIWTIOOYWYIIJ-CABZTGNLSA-N	rac-(2S)-2-[[rac-(2S)-2-(4-oxo-1,2,3-benzotriazin-3-yl)propanoyl]amino]-5-ureido-pentanoic acid	1836990	C[C@@H](C(=O)N[C@@H](CCCNC(N)=O)C(=O)O)n1nnc2ccccc2c1=O	(2S)-5-(carbamoylamino)-2-[[(2S)-2-(4-oxo-1,2,3-benzotriazin-3-yl)propanoyl]amino]pentanoic acid			-0.1581299999999981													MCULE-5082951208	376.375		376.149518	7	4	8	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(1836990)	1836990	0.4	319			[#6]-[#6@@H](-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#8])-[#6](=[#8])-[#8])-[#7]1:[#7]:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8]	C[C@@H](C(=O)N[C@@H](CCCNC(N)=O)C(=O)O)n1nnc2ccccc2c1=O	YKIWTIOOYWYIIJ		parent_pubchem_cid	1014088-57-3;N~5~-carbamoyl-N~2~-[(2S)-2-(4-oxo-1,2,3-benzotriazin-3(4H)-yl)propanoyl]-L-ornithine;EiM07-17611;AKOS004937141;(2S)-5-[(AMINOCARBONYL)AMINO]-2-({(2S)-2-[4-OXO-1,2,3-BENZOTRIAZIN-3(4H)-YL]PROPANOYL}AMINO)PENTANOIC ACID;rac-(2S)-2-[[rac-(2S)-2-(4-oxo-1,2,3-benzotriazin-3-yl)propanoyl]amino]-5-ureido-pentanoic acid		23458397.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23458397		pluskal_iocb_peptide_Peptide01_B16_id		100	B16		ZINC000002203368
3.8		0	1210	P7565657	59.1		H34	False	0	22	0	1	22	0	3	2	0	0		0.0						COCCn1cc(C(=O)NCCc2c[nH]c3c2cc(F)cc3)c2ccccc21								N-alkylindoles;3-alkylindoles;Pyrrole carboxamides;Substituted pyrroles;Benzenoids;Aryl fluorides;Vinylogous amides;Heteroaromatic compounds;Secondary carboxylic acid amides;Dialkyl ethers;Azacyclic compounds;Organonitrogen compounds;Organofluorides;Organic oxides;Hydrocarbon derivatives	3-alkylindoles;Aryl fluorides;Aryl halides;Azacyclic compounds;Benzenoids;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Dialkyl ethers;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Indolecarboxamides and derivatives;Indolecarboxylic acids and derivatives;Indoles;Indoles and derivatives;N-alkylindoles;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organofluorides;Organohalogen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Pyrrole carboxamides;Pyrrole carboxylic acids and derivatives;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Vinylogous amides	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as indolecarboxamides and derivatives. These are compounds containing a carboxamide group attached to an indole.	Indolecarboxamides and derivatives			Organic compounds	Aromatic heteropolycyclic compounds	indoles (CHEBI:24828);pyrroles (CHEBI:26455);carboxamide (CHEBI:37622);benzenoid aromatic compound (CHEBI:33836);organofluorine compound (CHEBI:37143);enone (CHEBI:51689);enamine (CHEBI:47989);organic aromatic compound (CHEBI:33659);ether (CHEBI:25698);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);indolecarboxamide (CHEBI:46921);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);organohalogen compound (CHEBI:36684);haloarene (CHEBI:50887);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);organooxygen compound (CHEBI:36963);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143);indolyl carboxylic acid (CHEBI:46867)		Indolecarboxylic acids and derivatives	Indolecarboxamide derivative;3-alkylindole;N-alkylindole;Indole;Pyrrole-3-carboxamide;Pyrrole-3-carboxylic acid or derivatives;Benzenoid;Aryl halide;Substituted pyrrole;Aryl fluoride;Heteroaromatic compound;Vinylogous amide;Pyrrole;Secondary carboxylic acid amide;Carboxamide group;Azacycle;Carboxylic acid derivative;Dialkyl ether;Ether;Organic oxygen compound;Organic nitrogen compound;Organic oxide;Hydrocarbon derivative;Organohalogen compound;Organofluoride;Organonitrogen compound;Organooxygen compound;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		N-[2-(5-fluoro-1H-indol-3-yl)ethyl]-1-(2-methoxyethyl)-1H-indole-3-carboxamide		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C22H22FN3O2	C22H22FN3O2			InChI=1S/C22H22FN3O2/c1-28-11-10-26-14-19(17-4-2-3-5-21(17)26)22(27)24-9-8-15-13-25-20-7-6-16(23)12-18(15)20/h2-7,12-14,25H,8-11H2,1H3,(H,24,27)	OGWLKBAEEWDFKD-UHFFFAOYSA-N	N-[2-(5-fluoro-1H-indol-3-yl)ethyl]-1-(2-methoxyethyl)indole-3-carboxamide	71707401	COCCn1cc(C(=O)NCCc2c[nH]c3c2cc(F)cc3)c2ccccc21	N-[2-(5-fluoro-1H-indol-3-yl)ethyl]-1-(2-methoxyethyl)indole-3-carboxamide			2.914340000000001													MCULE-6081503327	379.43794		379.169605	2	2	7	4			44									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(71707401)	71707401	3.2	320			[#6]-[#8]-[#6]-[#6]-[#7]1:[#6]:[#6](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:2:[#6]:[#6](-[#9]):[#6]:[#6]:3):[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	COCCn1cc(C(=O)NCCc2c[nH]c3c2cc(F)cc3)c2ccccc21	OGWLKBAEEWDFKD		parent_pubchem_cid	N-[2-(5-fluoro-1H-indol-3-yl)ethyl]-1-(2-methoxyethyl)-1H-indole-3-carboxamide;1401599-88-9;EiM08-29347;AKOS022114752;N-[2-(5-fluoro-1H-indol-3-yl)ethyl]-1-(2-methoxyethyl)indole-3-carboxamide		61457597.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=61457597		pluskal_iocb_peptide_Peptide01_B17_id		100	B17		ZINC000095478230
2.0		0	1298	P1157635	115.8		H35	False	0	18	0	0	23	0	3	5	0	0		0.0						CC(C)C(NC(=O)C(C(C)C)n1c(=O)[nH]c2ccccc2c1=O)C(=O)O																							0.0		AKOS016376741		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	4	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0		C18H23N3O5	C18H23N3O5			InChI=1S/C18H23N3O5/c1-9(2)13(17(24)25)20-15(22)14(10(3)4)21-16(23)11-7-5-6-8-12(11)19-18(21)26/h5-10,13-14H,1-4H3,(H,19,26)(H,20,22)(H,24,25)/t13-,14-/m0/s1	JWBFBOBAOJUPJV-KBPBESRZSA-N	rac-(2S)-3-methyl-2-[[rac-(2S)-2-(2,4-dioxo-1H-quinazolin-3-yl)-3-methyl-butanoyl]amino]butanoic acid	1791823	CC(C)[C@H](NC(=O)[C@H](C(C)C)n1c(=O)[nH]c2ccccc2c1=O)C(=O)O	(2S)-2-[[(2S)-2-(2,4-dioxo-1H-quinazolin-3-yl)-3-methylbutanoyl]amino]-3-methylbutanoic acid			2.4836599999999995													MCULE-8207961658	361.40111		361.163771	5	3	6	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(1791823)	1791823	2.3	321			[#6]-[#6](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#6@H](-[#6](-[#6])-[#6])-[#7]1:[#6](=[#8]):[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8])-[#6](=[#8])-[#8]	CC(C)[C@H](NC(=O)[C@H](C(C)C)n1c(=O)[nH]c2ccccc2c1=O)C(=O)O	JWBFBOBAOJUPJV		parent_pubchem_cid	AKOS016376741;(2S)-2-({(2S)-2-[2,4-DIOXO-1,4-DIHYDRO-3(2H)-QUINAZOLINYL]-3-METHYLBUTANOYL}AMINO)-3-METHYLBUTANOIC ACID;(S)-2-((S)-2-(2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)-3-methylbutanamido)-3-methylbutanoic acid;rac-(2S)-3-methyl-2-[[rac-(2S)-2-(2,4-dioxo-1H-quinazolin-3-yl)-3-methyl-butanoyl]amino]butanoic acid		24529740.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24529740		pluskal_iocb_peptide_Peptide01_B17_id		100	B17		ZINC000002136482
4.1		0	1130	P1098378	117.7		H37	False	0	25	0	0	24	0	2	6	0	0	-1.0	0.0						Cc1cc(OCC(=O)NC(Cc2c[nH]c3ccccc23)C(=O)O)c2c(C)c(C)c(=O)oc2c1		3.39		0.0	3.53	CHEMBL1515550		Coumarins and derivatives;1-benzopyrans;3-alkylindoles;Pyranones and derivatives;Alkyl aryl ethers;Substituted pyrroles;Benzenoids;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactones;Oxacyclic compounds;Monocarboxylic acids and derivatives;Azacyclic compounds;Carboxylic acids;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organonitrogen compounds;Organopnictogen compounds	1-benzopyrans;3-alkylindoles;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Lactones;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acyl-l-alpha-amino acids. These are n-acylated alpha amino acids which have the L-configuration of the alpha-carbon atom.	N-acyl-L-alpha-amino acids		Amino acids and derivatives;Alpha amino acids and derivatives;N-acyl-alpha amino acids and derivatives;N-acyl-alpha amino acids	Organic compounds	Aromatic heteropolycyclic compounds	coumarins (CHEBI:23403);1-benzopyran (CHEBI:38443);indoles (CHEBI:24828);pyranone (CHEBI:37963);aromatic ether (CHEBI:35618);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactone (CHEBI:25000);oxacycle (CHEBI:38104);carbonyl compound (CHEBI:36586);organonitrogen heterocyclic compound (CHEBI:38101);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);N-acyl-L-alpha-amino acid (CHEBI:48927);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);pyrans (CHEBI:26407);oxygen molecular entity (CHEBI:25806);ether (CHEBI:25698);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);amino acid (CHEBI:33709);peptide (CHEBI:16670);N-acyl-amino acid (CHEBI:51569)	Benzopyranoids (PK1311)	Amino acids, peptides, and analogues	N-acyl-l-alpha-amino acid;Coumarin;Benzopyran;1-benzopyran;3-alkylindole;Indole;Indole or derivatives;Alkyl aryl ether;Pyranone;Pyran;Substituted pyrrole;Benzenoid;Heteroaromatic compound;Pyrrole;Secondary carboxylic acid amide;Carboxamide group;Lactone;Organoheterocyclic compound;Oxacycle;Azacycle;Carboxylic acid;Monocarboxylic acid or derivatives;Ether;Organic nitrogen compound;Organic oxide;Hydrocarbon derivative;Organopnictogen compound;Organonitrogen compound;Organooxygen compound;Carbonyl group;Organic oxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		MLS001147804		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C25H24N2O6	C25H24N2O6			InChI=1S/C25H24N2O6/c1-13-8-20(23-14(2)15(3)25(31)33-21(23)9-13)32-12-22(28)27-19(24(29)30)10-16-11-26-18-7-5-4-6-17(16)18/h4-9,11,19,26H,10,12H2,1-3H3,(H,27,28)(H,29,30)/t19-/m0/s1	VKTUYBSQXRKYRL-IBGZPJMESA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[[2-(3,4,7-trimethyl-2-oxo-chromen-5-yl)oxyacetyl]amino]propanoic acid	1751420	Cc1cc(OCC(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)c2c(C)c(C)c(=O)oc2c1	(2S)-3-(1H-indol-3-yl)-2-[[2-(3,4,7-trimethyl-2-oxochromen-5-yl)oxyacetyl]amino]propanoic acid			2.7522600000000006													MCULE-4346915292	448.47983	ACID	448.163436	6	3	7	4	1.0		29									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins	False	False	Peptide01		-1.0	Compound(1751420)	1751420	3.6	322			[#6]-[#6]1:[#6]:[#6](-[#8]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6](=[#8])-[#8]):[#6]2:[#6](-[#6]):[#6](-[#6]):[#6](=[#8]):[#8]:[#6]:2:[#6]:1	Cc1cc(OCC(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)c2c(C)c(C)c(=O)oc2c1	VKTUYBSQXRKYRL		parent_pubchem_cid	MLS001147804;CHEMBL1515550;HMS2267G12;EiM07-17056;STL460790;AKOS004937451;SMR000646983;AB00864167-06;N-{[(3,4,7-trimethyl-2-oxo-2H-chromen-5-yl)oxy]acetyl}-L-tryptophan;rac-(2S)-3-(1H-indol-3-yl)-2-[[2-(3,4,7-trimethyl-2-oxo-chromen-5-yl)oxyacetyl]amino]propanoic acid	False	821353.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=821353		pluskal_iocb_peptide_Peptide01_B17_id		100	B17	False	ZINC000002094842
2.7		0	1218	P7119831895	131.6		H38	False	0	13	0	0	15	0	3	2	0	2		0.0						CCOC(=O)C(Cc1ccccc1)Sc1nnc(N)s1																							0.0		AKOS002324697		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	1	0	2	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0		C13H15N3O2S2	C13H15N3O2S2			InChI=1S/C13H15N3O2S2/c1-2-18-11(17)10(8-9-6-4-3-5-7-9)19-13-16-15-12(14)20-13/h3-7,10H,2,8H2,1H3,(H2,14,15)	UFHFLHRXADHWJT-UHFFFAOYSA-N	ethyl 2-[(5-amino-1,3,4-thiadiazol-2-yl)sulfanyl]-3-phenyl-propanoate	17014953	CCOC(=O)C(Cc1ccccc1)Sc1nnc(N)s1	ethyl 2-[(5-amino-1,3,4-thiadiazol-2-yl)sulfanyl]-3-phenylpropanoate			1.84347													MCULE-1748056329	309.4114		309.060569	6	1	7	2			45										False	Amino acids and Peptides				Peptide01			Compound(17014953)	17014953	3.1	323			[#6]-[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#16]-[#6]1:[#7]:[#7]:[#6](-[#7]):[#16]:1	CCOC(=O)C(Cc1ccccc1)Sc1nnc(N)s1	UFHFLHRXADHWJT		parent_pubchem_cid	AKOS002324697;AKOS016326602;VU0510820-1;ethyl 2-[(5-amino-1,3,4-thiadiazol-2-yl)sulfanyl]-3-phenyl-propanoate		24729089.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24729089		pluskal_iocb_peptide_Peptide01_B17_id		100	B17		
4.2		0	1138	P1098535	117.7		H41	False	0	26	0	0	24	0	2	6	0	0		0.0						O=C(COc1cc2c(cc1)c1c(CCCC1)c(=O)o2)NC(Cc1c[nH]c2ccccc12)C(=O)O																							0.0		AKOS016402474		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C26H24N2O6	C26H24N2O6			InChI=1S/C26H24N2O6/c29-24(28-22(25(30)31)11-15-13-27-21-8-4-3-5-17(15)21)14-33-16-9-10-19-18-6-1-2-7-20(18)26(32)34-23(19)12-16/h3-5,8-10,12-13,22,27H,1-2,6-7,11,14H2,(H,28,29)(H,30,31)/t22-/m0/s1	LBMHQPSKMIUMEV-QFIPXVFZSA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[[2-[(6-oxo-7,8,9,10-tetrahydrobenzo[c]chromen-3-yl)oxy]acetyl]amino]propanoic acid	1798864	O=C(COc1cc2c(cc1)c1c(CCCC1)c(=O)o2)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	(2S)-3-(1H-indol-3-yl)-2-[[2-[(6-oxo-7,8,9,10-tetrahydrobenzo[c]chromen-3-yl)oxy]acetyl]amino]propanoic acid			2.76051													MCULE-2234772965	460.49098		460.163436	6	3	7	5			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(1798864)	1798864	3.9	324			[#8]=[#6](-[#6]-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#6]1:[#6](-[#6]-[#6]-[#6]-[#6]-1):[#6](=[#8]):[#8]:2)-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	O=C(COc1cc2c(cc1)c1c(CCCC1)c(=O)o2)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	LBMHQPSKMIUMEV		parent_pubchem_cid	AKOS016402474;N-{[(6-oxo-7,8,9,10-tetrahydro-6H-benzo[c]chromen-3-yl)oxy]acetyl}-L-tryptophan;(S)-3-(1H-indol-3-yl)-2-(2-((6-oxo-7,8,9,10-tetrahydro-6H-benzo[c]chromen-3-yl)oxy)acetamido)propanoic acid;rac-(2S)-3-(1H-indol-3-yl)-2-[[2-[(6-oxo-7,8,9,10-tetrahydrobenzo[c]chromen-3-yl)oxy]acetyl]amino]propanoic acid		22623347.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22623347		pluskal_iocb_peptide_Peptide01_B17_id		100	B17		ZINC000002146661
5.0		0	1226	P1105377	93.7		H42	False	0	24	0	0	20	0	2	5	0	0		0.0						COC(=O)c1ccc(Oc2c(-c3c(O)cc(OCc4ccccc4)cc3)[nH]nc2)cc1								Diarylethers;Benzoic acid esters;Phenoxy compounds;Phenol ethers;Benzoyl derivatives;Alkyl aryl ethers;1-hydroxy-4-unsubstituted benzenoids;1-hydroxy-2-unsubstituted benzenoids;Methyl esters;Heteroaromatic compounds;Monocarboxylic acids and derivatives;Azacyclic compounds;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	1-hydroxy-2-unsubstituted benzenoids;1-hydroxy-4-unsubstituted benzenoids;Alkyl aryl ethers;Azacyclic compounds;Azoles;Benzene and substituted derivatives;Benzenoids;Benzoic acid esters;Benzoic acids and derivatives;Benzoyl derivatives;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids and derivatives;Chemical entities;Diarylethers;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Methyl esters;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenol ethers;Phenols;Phenoxy compounds;Phenylpyrazoles;Pyrazoles	Azoles	2.1	This compound belongs to the class of organic compounds known as phenylpyrazoles. These are compounds containing a phenylpyrazole skeleton, which consists of a pyrazole bound to a phenyl group.	Phenylpyrazoles			Organic compounds	Aromatic heteromonocyclic compounds	aromatic ether (CHEBI:35618);benzoate ester (CHEBI:36054);benzenes (CHEBI:22712);carbonyl compound (CHEBI:36586);phenols (CHEBI:33853);carboxylic ester (CHEBI:33308);organic aromatic compound (CHEBI:33659);organonitrogen heterocyclic compound (CHEBI:38101);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);ring assembly (CHEBI:36820);pyrazoles (CHEBI:26410);chemical entity (CHEBI:24431);oxygen molecular entity (CHEBI:25806);organooxygen compound (CHEBI:36963);ether (CHEBI:25698);benzenoid aromatic compound (CHEBI:33836);organic heterocyclic compound (CHEBI:24532);nitrogen molecular entity (CHEBI:51143);azole (CHEBI:68452)		Pyrazoles	Phenylpyrazole;Diaryl ether;Benzoate ester;Benzoic acid or derivatives;Phenoxy compound;Phenol ether;Benzoyl;1-hydroxy-4-unsubstituted benzenoid;1-hydroxy-2-unsubstituted benzenoid;Phenol;Alkyl aryl ether;Benzenoid;Monocyclic benzene moiety;Heteroaromatic compound;Methyl ester;Carboxylic acid ester;Azacycle;Monocarboxylic acid or derivatives;Ether;Carboxylic acid derivative;Organic nitrogen compound;Organic oxygen compound;Organopnictogen compound;Organic oxide;Hydrocarbon derivative;Organooxygen compound;Organonitrogen compound;Aromatic heteromonocyclic compound	Organoheterocyclic compounds	0.0		methyl 4-({3-[4-(benzyloxy)-2-hydroxyphenyl]-1H-pyrazol-4-yl}oxy)benzoate		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C24H20N2O5	C24H20N2O5			InChI=1S/C24H20N2O5/c1-29-24(28)17-7-9-18(10-8-17)31-22-14-25-26-23(22)20-12-11-19(13-21(20)27)30-15-16-5-3-2-4-6-16/h2-14,27H,15H2,1H3,(H,25,26)	WSTADHNURUWUMN-UHFFFAOYSA-N	methyl 4-[[3-(4-benzyloxy-2-hydroxy-phenyl)-1H-pyrazol-4-yl]oxy]benzoate	1395735	COC(=O)c1ccc(Oc2c(-c3c(O)cc(OCc4ccccc4)cc3)[nH]nc2)cc1	methyl 4-[[5-(2-hydroxy-4-phenylmethoxyphenyl)-1H-pyrazol-4-yl]oxy]benzoate			2.60112													MCULE-2734880390	416.4374		416.137222	6	2	8	4			44										False	Shikimates and Phenylpropanoids				Peptide01			Compound(1395735)	1395735	4.4	325			[#6]-[#8]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]2:[#6](-[#6]3:[#6](-[#8]):[#6]:[#6](-[#8]-[#6]-[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]:4):[#6]:[#6]:3):[#7H]:[#7]:[#6]:2):[#6]:[#6]:1	COC(=O)c1ccc(Oc2c(-c3c(O)cc(OCc4ccccc4)cc3)[nH]nc2)cc1	WSTADHNURUWUMN		parent_pubchem_cid	methyl 4-({3-[4-(benzyloxy)-2-hydroxyphenyl]-1H-pyrazol-4-yl}oxy)benzoate;1010867-59-0;methyl 4-[[5-(2-hydroxy-4-phenylmethoxyphenyl)-1H-pyrazol-4-yl]oxy]benzoate;MFCD04192090;AKOS002225082;Z2327505498;methyl 4-[[3-(4-benzyloxy-2-hydroxy-phenyl)-1H-pyrazol-4-yl]oxy]benzoate		24664488.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24664488		pluskal_iocb_peptide_Peptide01_B17_id		100	B17		ZINC000005248470
1.4		0	3	P1045978	79.3		I1	False	0	15	0	0	14	0	2	3	0	0		0.0						O=C(NC(Cc1ccccc1)C(=O)O)c1cnccc1																							0.0		36724-78-4	DTXSID00319846	2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C15H14N2O3	C15H14N2O3			InChI=1S/C15H14N2O3/c18-14(12-7-4-8-16-10-12)17-13(15(19)20)9-11-5-2-1-3-6-11/h1-8,10,13H,9H2,(H,17,18)(H,19,20)	KSZPRUJKMRILRZ-UHFFFAOYSA-N	3-phenyl-2-(pyridine-3-carbonylamino)propanoic acid	336554	O=C(NC(Cc1ccccc1)C(=O)O)c1cnccc1	3-phenyl-2-(pyridine-3-carbonylamino)propanoic acid			1.3978800000000002													MCULE-2526201180	270.29043		270.100442	4	2	5	2			42									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(336554)	336554	1.7	326		SCHEMBL2229201	[#8]=[#6](-[#7]-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8])-[#6]1:[#6]:[#7]:[#6]:[#6]:[#6]:1	O=C(NC(Cc1ccccc1)C(=O)O)c1cnccc1	KSZPRUJKMRILRZ		parent_pubchem_cid	36724-78-4;3-phenyl-2-(pyridin-3-ylformamido)propanoic acid;3-phenyl-2-(pyridine-3-carbonylamino)propanoic acid;2-(Nicotinamido)-3-phenylpropanoic acid;NSC351308;3-phenyl-2-[(pyridin-3-yl)formamido]propanoic acid;SCHEMBL2229201;DTXSID00319846;KSZPRUJKMRILRZ-UHFFFAOYSA-N;MFCD00420584;AKOS000128185;AKOS016338223;2-(Nicotinamido)-3-phenylpropanoicacid;NSC 351308;NSC-351308;EN300-57174;Z239128598;3-Phenyl-2-[(pyridine-3-carbonyl)-amino]-propionic acid		23112759.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23112759		pluskal_iocb_peptide_Peptide01_B17_id		100	B17		
4.0		0	91	P0120630214	71.2		I2	False	0	23	0	0	28	0	2	3	0	0		0.0						COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C12CC3CC(CC(C3)C1)C2								Alpha amino acid esters;Indolyl carboxylic acids and derivatives;3-alkylindoles;Fatty acid esters;Substituted pyrroles;Benzenoids;Methyl esters;Heteroaromatic compounds;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	3-alkylindoles;Alpha amino acid esters;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids and derivatives;Chemical entities;Fatty Acyls;Fatty acid esters;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Indolyl carboxylic acids and derivatives;Lipids and lipid-like molecules;Methyl esters;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acyl-alpha amino acids and derivatives. These are compounds containing an alpha amino acid (or a derivative thereof) which bears an acyl group at its terminal nitrogen atom.	N-acyl-alpha amino acids and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	alpha-amino acid ester (CHEBI:46874);indolyl carboxylic acid (CHEBI:46867);indoles (CHEBI:24828);fatty acid ester (CHEBI:35748);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);carboxylic ester (CHEBI:33308);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);monocarboxylic acid (CHEBI:25384);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);N-acyl-amino acid (CHEBI:51569);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);organooxygen compound (CHEBI:36963);organic heterocyclic compound (CHEBI:24532);lipid (CHEBI:18059);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806);amino acid (CHEBI:33709);peptide (CHEBI:16670)	Fatty esters (FA07);Fatty Acyls (FA)	Amino acids, peptides, and analogues	Alpha-amino acid ester;N-acyl-alpha amino acid or derivatives;Indolyl carboxylic acid derivative;3-alkylindole;Indole;Indole or derivatives;Fatty acid ester;Fatty acyl;Substituted pyrrole;Benzenoid;Heteroaromatic compound;Pyrrole;Methyl ester;Carboxylic acid ester;Carboxamide group;Secondary carboxylic acid amide;Azacycle;Monocarboxylic acid or derivatives;Organoheterocyclic compound;Organooxygen compound;Organonitrogen compound;Organic nitrogen compound;Hydrocarbon derivative;Organic oxide;Organic oxygen compound;Carbonyl group;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		SCHEMBL3457054		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C23H28N2O3	C23H28N2O3			InChI=1S/C23H28N2O3/c1-28-21(26)20(9-17-13-24-19-5-3-2-4-18(17)19)25-22(27)23-10-14-6-15(11-23)8-16(7-14)12-23/h2-5,13-16,20,24H,6-12H2,1H3,(H,25,27)	KVOPAWWXZAQLDK-UHFFFAOYSA-N	methyl 2-(adamantane-1-carbonylamino)-3-(1H-indol-3-yl)propanoate	3734771	COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C12CC3CC(CC(C3)C1)C2	methyl 2-(adamantane-1-carbonylamino)-3-(1H-indol-3-yl)propanoate			3.101470000000001													MCULE-4464247344	380.49121		380.209993	3	2	6	5			44										False					Peptide01			Compound(3734771)	3734771	4.0	327		SCHEMBL3457054	[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#6](=[#8])-[#6]12-[#6]-[#6]3-[#6]-[#6](-[#6]-[#6](-[#6]-3)-[#6]-1)-[#6]-2	COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C12CC3CC(CC(C3)C1)C2	KVOPAWWXZAQLDK		parent_pubchem_cid	SCHEMBL3457054;methyl N-(tricyclo[3.3.1.1~3,7~]dec-1-ylcarbonyl)tryptophanate;AKOS002346769;methyl 2-(adamantane-1-carbonylamino)-3-(1H-indol-3-yl)propanoate		23432900.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23432900		pluskal_iocb_peptide_Peptide01_B17_id		100	B17		
0.5		0	179	P6235943	95.9		I3	False	0	20	0	0	19	0	1	5	0	0		0.0						Cc1cc(=O)oc2c1ccc(O)c2CNC(Cc1ccccc1)C(=O)O								7-hydroxycoumarins;Phenylpropanoic acids;1-benzopyrans;Amphetamines and derivatives;D-alpha-amino acids;Pyranones and derivatives;1-hydroxy-2-unsubstituted benzenoids;Aralkylamines;Heteroaromatic compounds;Amino acids;Lactones;Oxacyclic compounds;Monocarboxylic acids and derivatives;Dialkylamines;Carboxylic acids;Hydrocarbon derivatives;Organic oxides;Carbonyl compounds;Organopnictogen compounds	1-benzopyrans;1-hydroxy-2-unsubstituted benzenoids;7-hydroxycoumarins;Alpha amino acids;Alpha amino acids and derivatives;Amines;Amino acids;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Aralkylamines;Benzene and substituted derivatives;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;D-alpha-amino acids;Dialkylamines;Heteroaromatic compounds;Hydrocarbon derivatives;Hydroxycoumarins;Lactones;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenethylamines;Phenols;Phenylalanine and derivatives;Phenylpropanoic acids;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Secondary amines	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	hydroxycoumarin (CHEBI:37912);benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);1-benzopyran (CHEBI:38443);amphetamines (CHEBI:35338);D-alpha-amino acid (CHEBI:16733);pyranone (CHEBI:37963);phenols (CHEBI:33853);aralkylamine (CHEBI:18000);organic aromatic compound (CHEBI:33659);amino acid (CHEBI:33709);lactone (CHEBI:25000);oxacycle (CHEBI:38104);monocarboxylic acid (CHEBI:25384);secondary amino compound (CHEBI:50995);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);carbonyl compound (CHEBI:36586);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);coumarins (CHEBI:23403);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);benzenoid aromatic compound (CHEBI:33836);primary amine (CHEBI:32877);organic acid (CHEBI:64709);organonitrogen compound (CHEBI:35352);alpha-amino acid (CHEBI:33704);pyrans (CHEBI:26407);nitrogen molecular entity (CHEBI:51143);amine (CHEBI:32952);secondary amine (CHEBI:32863);oxygen molecular entity (CHEBI:25806);carboxylic acid anion (CHEBI:29067);peptide (CHEBI:16670)	Benzopyranoids (PK1311)	Amino acids, peptides, and analogues	Phenylalanine or derivatives;7-hydroxycoumarin;Hydroxycoumarin;Coumarin;3-phenylpropanoic-acid;Alpha-amino acid;Amphetamine or derivatives;Benzopyran;D-alpha-amino acid;1-benzopyran;1-hydroxy-2-unsubstituted benzenoid;Aralkylamine;Pyranone;Monocyclic benzene moiety;Benzenoid;Pyran;Heteroaromatic compound;Amino acid;Lactone;Organoheterocyclic compound;Oxacycle;Secondary amine;Monocarboxylic acid or derivatives;Carboxylic acid;Secondary aliphatic amine;Organooxygen compound;Hydrocarbon derivative;Organic nitrogen compound;Carbonyl group;Organonitrogen compound;Organic oxide;Organopnictogen compound;Amine;Organic oxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS016377346		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C20H19NO5	C20H19NO5			InChI=1S/C20H19NO5/c1-12-9-18(23)26-19-14(12)7-8-17(22)15(19)11-21-16(20(24)25)10-13-5-3-2-4-6-13/h2-9,16,21-22H,10-11H2,1H3,(H,24,25)/t16-/m1/s1	MRUNGDSDRLASQM-MRXNPFEDSA-N	rac-(2R)-2-[(7-hydroxy-4-methyl-2-oxo-chromen-8-yl)methylamino]-3-phenyl-propanoic acid	5538669	Cc1cc(=O)oc2c1ccc(O)c2CN[C@H](Cc1ccccc1)C(=O)O	(2R)-2-[(7-hydroxy-4-methyl-2-oxochromen-8-yl)methylamino]-3-phenylpropanoic acid			2.43745													MCULE-4770504156	353.37813		353.126323	6	3	6	3			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(5538669)	5538669	0.7	328			[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]):[#6]:2-[#6]-[#7]-[#6@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	Cc1cc(=O)oc2c1ccc(O)c2CN[C@H](Cc1ccccc1)C(=O)O	MRUNGDSDRLASQM		parent_pubchem_cid	AKOS016377346;2-{[(7-HYDROXY-4-METHYL-2-OXO-2H-CHROMEN-8-YL)METHYL]AMINO}-3-PHENYLPROPANOIC ACID;rac-(2R)-2-[(7-hydroxy-4-methyl-2-oxo-chromen-8-yl)methylamino]-3-phenyl-propanoic acid		4209651.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=4209651		pluskal_iocb_peptide_Peptide01_B18_id		100	B18		ZINC000001518799
4.7		0	267	P1305771	44.9		I4	False	0	20	1	0	21	0	2	1	0	0		0.0						CC(C)C(=O)NCC(c1ccccc1Cl)c1c[nH]c2ccccc12								Chlorobenzenes;Substituted pyrroles;Aryl chlorides;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Organonitrogen compounds;Organochlorides;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	3-alkylindoles;Aryl chlorides;Aryl halides;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Chlorobenzenes;Halobenzenes;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organochlorides;Organohalogen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as 3-alkylindoles. These are compounds containing an indole moiety that carries an alkyl chain at the 3-position.	3-alkylindoles			Organic compounds	Aromatic heteropolycyclic compounds	organochlorine compound (CHEBI:36683);pyrroles (CHEBI:26455);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);indoles (CHEBI:24828);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);organohalogen compound (CHEBI:36684);organic heterocyclic compound (CHEBI:24532);haloarene (CHEBI:50887);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);organooxygen compound (CHEBI:36963);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806)		Indoles	3-alkylindole;Chlorobenzene;Halobenzene;Aryl chloride;Aryl halide;Monocyclic benzene moiety;Benzenoid;Substituted pyrrole;Heteroaromatic compound;Pyrrole;Carboxamide group;Secondary carboxylic acid amide;Carboxylic acid derivative;Azacycle;Organohalogen compound;Organooxygen compound;Organic nitrogen compound;Hydrocarbon derivative;Carbonyl group;Organic oxide;Organic oxygen compound;Organochloride;Organonitrogen compound;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		N-[2-(2-chlorophenyl)-2-(1H-indol-3-yl)ethyl]-2-methylpropanamide		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C20H21ClN2O	C20H21ClN2O			InChI=1S/C20H21ClN2O/c1-13(2)20(24)23-12-16(14-7-3-5-9-18(14)21)17-11-22-19-10-6-4-8-15(17)19/h3-11,13,16,22H,12H2,1-2H3,(H,23,24)	PMKZRWMLBKBKJR-UHFFFAOYSA-N	N-[2-(2-chlorophenyl)-2-(1H-indol-3-yl)ethyl]-2-methyl-propanamide	43842708	CC(C)C(=O)NCC(c1ccccc1Cl)c1c[nH]c2ccccc12	N-[2-(2-chlorophenyl)-2-(1H-indol-3-yl)ethyl]-2-methylpropanamide			4.187560000000002													MCULE-6246776597	340.85617		340.134241	1	2	5	3			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(43842708)	43842708	4.7	329			[#6]-[#6](-[#6])-[#6](=[#8])-[#7]-[#6]-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#17])-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CC(C)C(=O)NCC(c1ccccc1Cl)c1c[nH]c2ccccc12	PMKZRWMLBKBKJR		parent_pubchem_cid	N-[2-(2-chlorophenyl)-2-(1H-indol-3-yl)ethyl]-2-methylpropanamide;905779-88-6;HMS3456A18;AKOS002289785;AKOS016328318;Z30131349;N-[2-(2-chlorophenyl)-2-(1H-indol-3-yl)ethyl]-2-methyl-propanamide		22799570.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22799570		pluskal_iocb_peptide_Peptide01_B18_id		100	B18		
0.8		0	11	P0120390074	152.3		I5	False	0	8	0	0	9	0	1	5	0	2		0.0						O=C(O)CCC(C(=O)O)N1C(=O)CSC1=S																							0.0		16942-88-4	DTXSID90383056	2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	3	2	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0		C8H9NO5S2	C8H9NO5S2			InChI=1S/C8H9NO5S2/c10-5-3-16-8(15)9(5)4(7(13)14)1-2-6(11)12/h4H,1-3H2,(H,11,12)(H,13,14)	ONCPOKGRSJBOQM-UHFFFAOYSA-N	2-(4-oxo-2-thioxo-thiazolidin-3-yl)pentanedioic acid	2787044	O=C(O)CCC(C(=O)O)N1C(=O)CSC1=S	2-(4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl)pentanedioic acid			0.1647													MCULE-9528227103	263.29263		262.992214	7	2	5	1			43										False	Amino acids and Peptides				Peptide01			Compound(2787044)	2787044	0.3	330		SCHEMBL6888295	[#8]=[#6](-[#8])-[#6]-[#6]-[#6](-[#6](=[#8])-[#8])-[#7]1-[#6](=[#8])-[#6]-[#16]-[#6]-1=[#16]	O=C(O)CCC(C(=O)O)N1C(=O)CSC1=S	ONCPOKGRSJBOQM		parent_pubchem_cid	16942-88-4;2-(4-Oxo-2-thioxothiazolidin-3-yl)pentanedioic acid;Pentanedioic acid, 2-(4-oxo-2-thioxo-3-thiazolidinyl)-;2-(4-oxo-2-thioxo-1,3-thiazolidin-3-yl)pentanedioic acid;2-(4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl)pentanedioicacid;CBDivE_001690;SBB015137;Oprea1_616460;Oprea1_785144;C8H9NO5S2;SCHEMBL6888295;DTXSID90383056;NSC822327;STK347674;AKOS000271001;AKOS016039326;NSC-822327;SR-01000496128;SR-01000496128-1;Z56823731;2-(4-oxo-2-thioxo-thiazolidin-3-yl)pentanedioic acid		23023084.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23023084		pluskal_iocb_peptide_Peptide01_B18_id		100	B18		
0.9		0	99	P0108590211	95.9		I6	False	0	11	0	2	11	0	1	5	0	0		0.0						O=C(NC(CO)C(=O)O)c1ccccc1OC(F)F																							0.0		AKOS000162730		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C11H11F2NO5	C11H11F2NO5			InChI=1S/C11H11F2NO5/c12-11(13)19-8-4-2-1-3-6(8)9(16)14-7(5-15)10(17)18/h1-4,7,11,15H,5H2,(H,14,16)(H,17,18)	ZASNOUFYNITKER-UHFFFAOYSA-N	2-[[2-(difluoromethoxy)benzoyl]amino]-3-hydroxy-propanoic acid	3431840	O=C(NC(CO)C(=O)O)c1ccccc1OC(F)F	2-[[2-(difluoromethoxy)benzoyl]amino]-3-hydroxypropanoic acid			-0.0538199999999999													MCULE-1450071089	275.21082		275.060529	5	3	6	1			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(3431840)	3431840	1.1	331			[#8]=[#6](-[#7]-[#6](-[#6]-[#8])-[#6](=[#8])-[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#8]-[#6](-[#9])-[#9]	O=C(NC(CO)C(=O)O)c1ccccc1OC(F)F	ZASNOUFYNITKER		parent_pubchem_cid	AKOS000162730;AKOS016401587;2-[[2-(difluoromethoxy)benzoyl]amino]-3-hydroxy-propanoic acid		23231999.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23231999		pluskal_iocb_peptide_Peptide01_B18_id		100	B18		
1.7		0	187	P7015511020	112.0		I7	False	0	15	0	0	15	0	1	6	0	0	-1.0	0.0						CC(C)CC(C(=O)O)N1C(=O)c2c(cc(C(=O)O)cc2)C1=O		1.48		0.0	1.88	CHEMBL260993		Phthalimides;Isoindoles;N-substituted carboxylic acid imides;Benzenoids;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzenoids;Carbonyl compounds;Carboxylic acid derivatives;Carboxylic acid imides;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Dicarboxylic acids and derivatives;Hydrocarbon derivatives;Isoindoles;Isoindoles and derivatives;Isoindolines;Isoindolones;Leucine and derivatives;Monocarboxylic acids and derivatives;N-substituted carboxylic acid imides;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phthalimides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as leucine and derivatives. These are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Leucine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	phthalimides (CHEBI:82851);isoindoles (CHEBI:24897);dicarboximide (CHEBI:35356);benzenoid aromatic compound (CHEBI:33836);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);leucine derivative (CHEBI:47003);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806);carboxylic acid anion (CHEBI:29067);amino acid (CHEBI:33709);peptide (CHEBI:16670)		Amino acids, peptides, and analogues	Leucine or derivatives;Phthalimide;Isoindolone;Isoindoline;Isoindole;Isoindole or derivatives;Benzenoid;Carboxylic acid imide, n-substituted;Carboxylic acid imide;Carboxylic acid;Azacycle;Organoheterocyclic compound;Monocarboxylic acid or derivatives;Carbonyl group;Organonitrogen compound;Organooxygen compound;Hydrocarbon derivative;Organic oxide;Organic oxygen compound;Organic nitrogen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		131613-54-2		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	4	2	0	0	0	0	0	0	0	0	2	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0		C15H15NO6	C15H15NO6			InChI=1S/C15H15NO6/c1-7(2)5-11(15(21)22)16-12(17)9-4-3-8(14(19)20)6-10(9)13(16)18/h3-4,6-7,11H,5H2,1-2H3,(H,19,20)(H,21,22)	MLBQKULJXDHKHT-UHFFFAOYSA-N	2-(1-carboxy-3-methyl-butyl)-1,3-dioxo-isoindoline-5-carboxylic acid	4323209	CC(C)CC(C(=O)O)N1C(=O)c2c(cc(C(=O)O)cc2)C1=O	2-(1-carboxy-3-methylbutyl)-1,3-dioxoisoindole-5-carboxylic acid			1.31597													MCULE-2918850539	305.2899	ACID	305.089937	6	2	5	2	0.0		30									Isoindole alkaloids	False	Alkaloids	Pseudoalkaloids	False	False	Peptide01		-1.0	Compound(4323209)	4323209	1.7	332			[#6]-[#6](-[#6])-[#6]-[#6](-[#6](=[#8])-[#8])-[#7]1-[#6](=[#8])-[#6]2:[#6](:[#6]:[#6](-[#6](=[#8])-[#8]):[#6]:[#6]:2)-[#6]-1=[#8]	CC(C)CC(C(=O)O)N1C(=O)c2c(cc(C(=O)O)cc2)C1=O	MLBQKULJXDHKHT		parent_pubchem_cid	131613-54-2;2-(1-carboxy-3-methylbutyl)-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid;2-(1-Carboxy-3-methyl-butyl)-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid;2-(1-CARBOXY-3-METHYLBUTYL)-1,3-DIOXOISOINDOLE-5-CARBOXYLIC ACID;Oprea1_202817;CHEMBL260993;MFCD02319304;AKOS000273351;AKOS016040514;CS-0218125;EN300-00193;Z56822336;2-(1-carboxy-3-methylbutyl)-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylicacid;2-(1-Carboxy-3-methylbutyl)-1,3-dioxo-5-isoindolinecarboxylic acid, AldrichCPR;2-(1-carboxy-3-methyl-butyl)-1,3-dioxo-isoindoline-5-carboxylic acid	False	280358.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=280358		pluskal_iocb_peptide_Peptide01_B18_id		100	B18	False	
4.6		0	275	P4796930	75.2	HCl	I8	False	0	21	1	0	23	0	6	1	0	0		0.0						Cc1cc(C)cc(Nc2nc(N3CCOCC3)nc(Nc3cc(Cl)ccc3)n2)c1																							0.0		AKOS022128108		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1		C21H24Cl2N6O	C21H23ClN6O			InChI=1S/C21H23ClN6O/c1-14-10-15(2)12-18(11-14)24-20-25-19(23-17-5-3-4-16(22)13-17)26-21(27-20)28-6-8-29-9-7-28/h3-5,10-13H,6-9H2,1-2H3,(H2,23,24,25,26,27)	SSCHAQRMNSXUGZ-UHFFFAOYSA-N	N4-(3-chlorophenyl)-N2-(3,5-dimethylphenyl)-6-morpholino-1,3,5-triazine-2,4-diamine;hydrochloride	18580259	Cc1cc(C)cc(Nc2nc(N3CCOCC3)nc(Nc3cc(Cl)ccc3)n2)c1	4-N-(3-chlorophenyl)-2-N-(3,5-dimethylphenyl)-6-morpholin-4-yl-1,3,5-triazine-2,4-diamine			2.45317													MCULE-7868118847	447.37103		410.162187	7	2	5	4			43										False	Alkaloids				Peptide01			Compound(18580259)	18580259	5.2	333			[#6]-[#6]1:[#6]:[#6](-[#6]):[#6]:[#6](-[#7]-[#6]2:[#7]:[#6](-[#7]3-[#6]-[#6]-[#8]-[#6]-[#6]-3):[#7]:[#6](-[#7]-[#6]3:[#6]:[#6](-[#17]):[#6]:[#6]:[#6]:3):[#7]:2):[#6]:1	Cc1cc(C)cc(Nc2nc(N3CCOCC3)nc(Nc3cc(Cl)ccc3)n2)c1	SSCHAQRMNSXUGZ		parent_pubchem_cid	"AKOS022128108;""N4-(3-chlorophenyl)-N2-(3,5-dimethylphenyl)-6-morpholino-1,3,5-triazine-2,4-diamine;hydrochloride"""		16233253.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=16233253		pluskal_iocb_peptide_Peptide01_B18_id		100	B18		ZINC000009708906
2.5		0	19	P11639280	66.0		I9	False	0	23	0	0	28	0	6	0	0	0	-1.0	0.0						c1cc2c(N3CCNCC3)nc(-c3cc(NC4CCCCC4)ncc3)cc2cn1		3.85		0.0	3.38	CHEMBL1214998																	0.0		1071135-06-2		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1		C23H28N6	C23H28N6	9681.0		InChI=1S/C23H28N6/c1-2-4-19(5-3-1)27-22-15-17(6-9-26-22)21-14-18-16-25-8-7-20(18)23(28-21)29-12-10-24-11-13-29/h6-9,14-16,19,24H,1-5,10-13H2,(H,26,27)	DIZACSOTRSXCHC-UHFFFAOYSA-N	N-cyclohexyl-4-(1-piperazin-1-yl-2,6-naphthyridin-3-yl)pyridin-2-amine	25020250	c1cc2c(N3CCNCC3)nc(-c3cc(NC4CCCCC4)ncc3)cc2cn1	N-cyclohexyl-4-(1-piperazin-1-yl-2,6-naphthyridin-3-yl)pyridin-2-amine			2.27634														388.51981	BASE	388.237545	6	2	4	5	0.0		26										False	Alkaloids	Nicotinic acid alkaloids	False	False	Peptide01	PD064770	-1.0	Compound(25020250)	25020250	3.6	334		SCHEMBL1424131	[#6]1:[#6]:[#6]2:[#6](-[#7]3-[#6]-[#6]-[#7]-[#6]-[#6]-3):[#7]:[#6](-[#6]3:[#6]:[#6](-[#7]-[#6]4-[#6]-[#6]-[#6]-[#6]-[#6]-4):[#7]:[#6]:[#6]:3):[#6]:[#6]:2:[#6]:[#7]:1	c1cc2c(N3CCNCC3)nc(-c3cc(NC4CCCCC4)ncc3)cc2cn1	DIZACSOTRSXCHC		parent_pubchem_cid	1071135-06-2;CHEMBL1214998;compound 13c [PMID: 20684591];N-cyclohexyl-4-(1-(piperazin-1-yl)-2,6-naphthyridin-3-yl)pyridin-2-amine;2-Pyridinamine, N-cyclohexyl-4-[1-(1-piperazinyl)-2,6-naphthyridin-3-yl]-;GTPL9681;SCHEMBL1424131;DIZACSOTRSXCHC-UHFFFAOYSA-N;BDBM50324315;AKOS037795693;2-yridinamine, N-yclohexyl-4-1-(1-iperazinyl)-2,6-aphthyridin-3-l]-;Cyclohexyl-[4-(1-piperazin-1-yl[2,6]naphthyridin-3-yl)pyridin-2-yl]amine;N-cyclohexyl-4-(1-piperazin-1-yl-2,6-naphthyridin-3-yl)pyridin-2-amine;N-Cyclohexyl-4-[1-(1-piperazinyl)-2,6-naphthyridin-3-yl]-2-pyridinamine;cyclohexyl-[4-(1-piperazin-1-yl-[2,6]naphthyridin-3-yl)-pyridin-2-yl]amine	False	635873.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=635873		pluskal_iocb_peptide_Peptide01_B18_id		100	B18	False	ZINC000058592623
3.1		0	107	P0120630226	80.4		I10	False	0	20	0	0	20	0	2	4	0	0		0.0						COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c1ccccc1OC																							0.0		Oprea1_239492		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C20H20N2O4	C20H20N2O4			InChI=1S/C20H20N2O4/c1-25-18-10-6-4-8-15(18)19(23)22-17(20(24)26-2)11-13-12-21-16-9-5-3-7-14(13)16/h3-10,12,17,21H,11H2,1-2H3,(H,22,23)	RJCLMJGGEJRNPI-UHFFFAOYSA-N	methyl 3-(1H-indol-3-yl)-2-[(2-methoxybenzoyl)amino]propanoate	4549655	COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c1ccccc1OC	methyl 3-(1H-indol-3-yl)-2-[(2-methoxybenzoyl)amino]propanoate			1.69035													MCULE-1771680911	352.3934		352.142307	4	2	7	3			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(4549655)	4549655	3.0	335			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#8]-[#6]	COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c1ccccc1OC	RJCLMJGGEJRNPI		parent_pubchem_cid	Oprea1_239492;AKOS002346771;AKOS016386093;methyl 3-(1H-indol-3-yl)-2-[(2-methoxybenzoyl)amino]propanoate		23279666.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23279666		pluskal_iocb_peptide_Peptide01_B18_id		100	B18		
4.3		0	195	P1113315	83.1		I11	False	0	24	0	0	21	0	3	1	0	1		0.0						O=C(NCCc1csc(-c2ccccn2)n1)C(c1ccccc1)c1ccccc1								Phenylacetamides;2,4-disubstituted thiazoles;Pyridines and derivatives;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	2,4-disubstituted thiazoles;Azacyclic compounds;Azoles;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Diphenylmethanes;Heteroaromatic compounds;Hydrocarbon derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenylacetamides;Pyridines and derivatives;Secondary carboxylic acid amides;Thiazoles	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as diphenylmethanes. These are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups.	Diphenylmethanes			Organic compounds	Aromatic heteromonocyclic compounds	acetamides (CHEBI:22160);thiazoles (CHEBI:48901);pyridines (CHEBI:26421);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);diarylmethane (CHEBI:51614);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);organic heterocyclic compound (CHEBI:24532);azole (CHEBI:68452);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);organooxygen compound (CHEBI:36963);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806)		Diphenylmethanes	Diphenylmethane;Phenylacetamide;2,4-disubstituted 1,3-thiazole;Pyridine;Azole;Heteroaromatic compound;Thiazole;Carboxamide group;Secondary carboxylic acid amide;Carboxylic acid derivative;Azacycle;Organoheterocyclic compound;Hydrocarbon derivative;Organooxygen compound;Organonitrogen compound;Organic oxide;Organic nitrogen compound;Carbonyl group;Organic oxygen compound;Aromatic heteromonocyclic compound	Benzenoids	0.0		AKOS005587121		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C24H21N3OS	C24H21N3OS			InChI=1S/C24H21N3OS/c28-23(22(18-9-3-1-4-10-18)19-11-5-2-6-12-19)26-16-14-20-17-29-24(27-20)21-13-7-8-15-25-21/h1-13,15,17,22H,14,16H2,(H,26,28)	PLVYASGRBCVBTR-UHFFFAOYSA-N	2,2-diphenyl-N-[2-[2-(2-pyridyl)thiazol-4-yl]ethyl]acetamide	28466353	O=C(NCCc1csc(-c2ccccn2)n1)C(c1ccccc1)c1ccccc1	2,2-diphenyl-N-[2-(2-pyridin-2-yl-1,3-thiazol-4-yl)ethyl]acetamide			4.151750000000003													MCULE-9895391522	399.51847		399.140533	3	1	7	4			44									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(28466353)	28466353	4.5	336			[#8]=[#6](-[#7]-[#6]-[#6]-[#6]1:[#6]:[#16]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#7]:2):[#7]:1)-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	O=C(NCCc1csc(-c2ccccn2)n1)C(c1ccccc1)c1ccccc1	PLVYASGRBCVBTR		parent_pubchem_cid	AKOS005587121;2,2-diphenyl-N-(2-(2-(pyridin-2-yl)thiazol-4-yl)ethyl)acetamide;2,2-diphenyl-N-[2-[2-(2-pyridyl)thiazol-4-yl]ethyl]acetamide		2416848.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=2416848		pluskal_iocb_peptide_Peptide01_B19_id		100	B19		ZINC000019942279
2.0		0	283	P7126268	144.7		I12	False	0	18	0	0	14	0	4	5	0	0		0.0						O=C(O)c1cc(Nc2nccc(Nc3cc(C(=O)O)c(O)cc3)n2)ccc1																							0.0		AKOS024459038		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	2	2	0	0	0	0	0	0	0	0	0	0	1	0	0	0	3	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0		C18H14N4O5	C18H14N4O5			InChI=1S/C18H14N4O5/c23-14-5-4-12(9-13(14)17(26)27)20-15-6-7-19-18(22-15)21-11-3-1-2-10(8-11)16(24)25/h1-9,23H,(H,24,25)(H,26,27)(H2,19,20,21,22)	UMVOJVWDPRZUTJ-UHFFFAOYSA-N	5-[[2-(3-carboxyanilino)pyrimidin-4-yl]amino]-2-hydroxy-benzoic acid	90489130	O=C(O)c1cc(Nc2nccc(Nc3cc(C(=O)O)c(O)cc3)n2)ccc1	5-[[2-(3-carboxyanilino)pyrimidin-4-yl]amino]-2-hydroxybenzoic acid			0.9715299999999992													MCULE-2083916651	366.33608		366.09642	9	5	6	3			44										False	Alkaloids				Peptide01			Compound(90489130)	90489130	3.2	337			[#8]=[#6](-[#8])-[#6]1:[#6]:[#6](-[#7]-[#6]2:[#7]:[#6]:[#6]:[#6](-[#7]-[#6]3:[#6]:[#6](-[#6](=[#8])-[#8]):[#6](-[#8]):[#6]:[#6]:3):[#7]:2):[#6]:[#6]:[#6]:1	O=C(O)c1cc(Nc2nccc(Nc3cc(C(=O)O)c(O)cc3)n2)ccc1	UMVOJVWDPRZUTJ		parent_pubchem_cid	AKOS024459038;5-[[2-(3-carboxyanilino)pyrimidin-4-yl]amino]-2-hydroxy-benzoic acid		99993851.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=99993851		pluskal_iocb_peptide_Peptide01_B19_id		100	B19		ZINC000170621819
0.5		0	27	P7118030536	86.6		I13	False	0	18	0	0	26	0	0	7	0	0		0.0						CCOc1ccc(COC2C(C(O)CO)OC3OC(C)(C)OC32)cc1																							0.0		AKOS002375767		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C18H26O7	C18H26O7			InChI=1S/C18H26O7/c1-4-21-12-7-5-11(6-8-12)10-22-15-14(13(20)9-19)23-17-16(15)24-18(2,3)25-17/h5-8,13-17,19-20H,4,9-10H2,1-3H3/t13?,14-,15+,16-,17-/m1/s1	WHHIIMRGPWDFLO-SLUKUZTOSA-N	1-[rac-(3aR,5R,6S,6aR)-6-[(4-ethoxyphenyl)methoxy]-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-5-yl]ethane-1,2-diol	24282799	CCOc1ccc(CO[C@@H]2[C@H]3OC(C)(C)O[C@H]3O[C@@H]2C(O)CO)cc1	1-[(3aR,5R,6S,6aR)-6-[(4-ethoxyphenyl)methoxy]-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-5-yl]ethane-1,2-diol			0.6829799999999993														354.40372		354.167853	7	2	7	3			46										False					Peptide01			Compound(24282799)	24282799	0.8	338			[#6]-[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6]-[#8]-[#6@@H]2-[#6@H]3-[#8]-[#6](-[#6])(-[#6])-[#8]-[#6@H]-3-[#8]-[#6@@H]-2-[#6](-[#8])-[#6]-[#8]):[#6]:[#6]:1	CCOc1ccc(CO[C@@H]2[C@H]3OC(C)(C)O[C@H]3O[C@@H]2C(O)CO)cc1	WHHIIMRGPWDFLO		parent_pubchem_cid	AKOS002375767;SR-01000009190;SR-01000009190-1;1-[rac-(3aR,5R,6S,6aR)-6-[(4-ethoxyphenyl)methoxy]-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-5-yl]ethane-1,2-diol		24058769.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24058769		pluskal_iocb_peptide_Peptide01_B19_id		100	B19		
3.2		0	115	P7110950728	91.4		I14	False	0	20	0	0	20	0	2	4	0	0	-1.0	0.0						Cc1ccccc1OCC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)O		2.67		0.0	3.03	CHEMBL1882880		3-alkylindoles;Phenoxy compounds;Phenol ethers;Toluenes;Alkyl aryl ethers;Substituted pyrroles;Heteroaromatic compounds;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	3-alkylindoles;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenol ethers;Phenoxy compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Toluenes	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom.	N-acyl-alpha amino acids		Amino acids and derivatives;Alpha amino acids and derivatives;N-acyl-alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	indoles (CHEBI:24828);benzenes (CHEBI:22712);aromatic ether (CHEBI:35618);toluenes (CHEBI:27024);pyrroles (CHEBI:26455);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);N-acyl-amino acid (CHEBI:51569);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);organooxygen compound (CHEBI:36963);ether (CHEBI:25698);organic acid (CHEBI:64709);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);carboxylic acid anion (CHEBI:29067);amino acid (CHEBI:33709);peptide (CHEBI:16670)		Amino acids, peptides, and analogues	N-acyl-alpha-amino acid;3-alkylindole;Indole;Indole or derivatives;Phenoxy compound;Phenol ether;Alkyl aryl ether;Toluene;Monocyclic benzene moiety;Substituted pyrrole;Benzenoid;Heteroaromatic compound;Pyrrole;Carboxamide group;Secondary carboxylic acid amide;Azacycle;Monocarboxylic acid or derivatives;Ether;Carboxylic acid;Organoheterocyclic compound;Organooxygen compound;Organonitrogen compound;Organic nitrogen compound;Hydrocarbon derivative;Organic oxide;Carbonyl group;Organic oxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		BAS 05150393		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C20H20N2O4	C20H20N2O4			InChI=1S/C20H20N2O4/c1-13-6-2-5-9-18(13)26-12-19(23)22-17(20(24)25)10-14-11-21-16-8-4-3-7-15(14)16/h2-9,11,17,21H,10,12H2,1H3,(H,22,23)(H,24,25)	XBIUBLLFSQQXGR-UHFFFAOYSA-N	3-(1H-indol-3-yl)-2-[[2-(2-methylphenoxy)acetyl]amino]propanoic acid	3151743	Cc1ccccc1OCC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)O	3-(1H-indol-3-yl)-2-[[2-(2-methylphenoxy)acetyl]amino]propanoic acid			1.6669700000000005													MCULE-9503676515	352.3934	ACID	352.142307	4	3	7	3	1.0		30									Dipeptides	False	Amino acids and Peptides	Small peptides	False	False	Peptide01		-1.0	Compound(3151743)	3151743	2.6	339			[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#8]-[#6]-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	Cc1ccccc1OCC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)O	XBIUBLLFSQQXGR		parent_pubchem_cid	BAS 05150393;Oprea1_797927;MLS000716374;CHEMBL1882880;HMS2647J19;3-(1H-Indol-3-yl)-2-(2-o-tolyloxy-acetylamino)-propionic acid;AKOS000535245;AKOS016050966;SMR000277891;SR-01000368256;SR-01000368256-1;3-(1H-indol-3-yl)-2-[[2-(2-methylphenoxy)acetyl]amino]propanoic acid	False	1177777.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=1177777		pluskal_iocb_peptide_Peptide01_B19_id		100	B19	False	
3.6		0	203	P7020600059	112.9		I15	False	0	22	0	0	26	0	2	4	0	2		0.0						CCc1ccc(S(=O)(=O)C2CS(=O)(=O)CC2NCCc2c[nH]c3ccccc23)cc1																							0.0		MFCD09852104		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	0		C22H26N2O4S2	C22H26N2O4S2			InChI=1S/C22H26N2O4S2/c1-2-16-7-9-18(10-8-16)30(27,28)22-15-29(25,26)14-21(22)23-12-11-17-13-24-20-6-4-3-5-19(17)20/h3-10,13,21-24H,2,11-12,14-15H2,1H3/t21-,22-/m0/s1	JWSAZBZGNJQFGO-VXKWHMMOSA-N	rac-(3S,4R)-4-(4-ethylphenyl)sulfonyl-N-[2-(1H-indol-3-yl)ethyl]-1,1-dioxo-thiolan-3-amine	17596796	CCc1ccc(S(=O)(=O)[C@H]2CS(=O)(=O)C[C@@H]2NCCc2c[nH]c3ccccc23)cc1	(3S,4R)-4-(4-ethylphenyl)sulfonyl-N-[2-(1H-indol-3-yl)ethyl]-1,1-dioxothiolan-3-amine			1.8560500000000004													MCULE-5752571883	446.59152		446.133399	5	2	7	4			44										False					Peptide01			Compound(17596796)	17596796	3.4	340			[#6]-[#6]-[#6]1:[#6]:[#6]:[#6](-[#16](=[#8])(=[#8])-[#6@H]2-[#6]-[#16](=[#8])(=[#8])-[#6]-[#6@@H]-2-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	CCc1ccc(S(=O)(=O)[C@H]2CS(=O)(=O)C[C@@H]2NCCc2c[nH]c3ccccc23)cc1	JWSAZBZGNJQFGO		parent_pubchem_cid	MFCD09852104;AKOS002370770;rac-(3S,4R)-4-(4-ethylphenyl)sulfonyl-N-[2-(1H-indol-3-yl)ethyl]-1,1-dioxo-thiolan-3-amine		12017219.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=12017219		pluskal_iocb_peptide_Peptide01_B19_id		100	B19		ZINC000019820958
2.5		0	291	P7126275	124.4		I16	False	0	19	0	0	16	0	4	4	0	0	-1.0	0.0						Cc1cc(Nc2ccccc2C(=O)O)nc(Nc2ccc(C(=O)O)cc2)n1		3.67		0.0	3.02	CHEMBL2170600		Benzoyl derivatives;Aniline and substituted anilines;Aminopyrimidines and derivatives;Imidolactams;Vinylogous amides;Heteroaromatic compounds;Carboxylic acids;Azacyclic compounds;Organooxygen compounds;Organic oxides;Hydrocarbon derivatives;Amines	Amines;Aminopyrimidines and derivatives;Aniline and substituted anilines;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Benzoic acids;Benzoic acids and derivatives;Benzoyl derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Diazines;Dicarboxylic acids and derivatives;Heteroaromatic compounds;Hydrocarbon derivatives;Imidolactams;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Pyrimidines and pyrimidine derivatives;Vinylogous amides	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as benzoic acids. These are organic Compounds containing a benzene ring which bears at least one carboxyl group.	Benzoic acids			Organic compounds	Aromatic heteromonocyclic compounds	carbonyl compound (CHEBI:36586);anilines (CHEBI:22562);aminopyrimidine (CHEBI:38338);heterocyclic compound (CHEBI:5686);dicarboximide (CHEBI:35356);organosulfur compound (CHEBI:33261);enone (CHEBI:51689);enamine (CHEBI:47989);organic aromatic compound (CHEBI:33659);carboxylic acid (CHEBI:33575);organonitrogen heterocyclic compound (CHEBI:38101);organooxygen compound (CHEBI:36963);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);amine (CHEBI:32952);benzoic acids (CHEBI:22723);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);organic heterocyclic compound (CHEBI:24532);diazines (CHEBI:38313);pyrimidines (CHEBI:39447);organic acid (CHEBI:64709);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143);organonitrogen compound (CHEBI:35352);carboxylic acid anion (CHEBI:29067)		Benzoic acids and derivatives	Benzoic acid;Benzoyl;Aniline or substituted anilines;Aminopyrimidine;Pyrimidine;Imidolactam;Heteroaromatic compound;Vinylogous amide;Carboxylic acid;Carboxylic acid derivative;Organoheterocyclic compound;Azacycle;Organic nitrogen compound;Amine;Hydrocarbon derivative;Organooxygen compound;Organonitrogen compound;Organic oxide;Organic oxygen compound;Aromatic heteromonocyclic compound	Benzenoids	0.0		Bisanilinopyrimidine, 3k		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	2	2	0	0	0	0	0	0	0	0	0	0	1	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0		C19H16N4O4	C19H16N4O4			InChI=1S/C19H16N4O4/c1-11-10-16(22-15-5-3-2-4-14(15)18(26)27)23-19(20-11)21-13-8-6-12(7-9-13)17(24)25/h2-10H,1H3,(H,24,25)(H,26,27)(H2,20,21,22,23)	YLQUKPVGUGPRIK-UHFFFAOYSA-N	2-[[2-(4-carboxyanilino)-6-methyl-pyrimidin-4-yl]amino]benzoic acid	70702126	Cc1cc(Nc2ccccc2C(=O)O)nc(Nc2ccc(C(=O)O)cc2)n1	2-[[2-(4-carboxyanilino)-6-methylpyrimidin-4-yl]amino]benzoic acid			1.98205													MCULE-1966023689	364.36377	ACID	364.117155	8	4	6	3	0.0		29									Anthranillic acid derivatives	False	Alkaloids	Anthranilic acid alkaloids	False	False	Peptide01		-1.0	Compound(70702126)	70702126	4.0	341			[#6]-[#6]1:[#6]:[#6](-[#7]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6](=[#8])-[#8]):[#7]:[#6](-[#7]-[#6]2:[#6]:[#6]:[#6](-[#6](=[#8])-[#8]):[#6]:[#6]:2):[#7]:1	Cc1cc(Nc2ccccc2C(=O)O)nc(Nc2ccc(C(=O)O)cc2)n1	YLQUKPVGUGPRIK		parent_pubchem_cid	Bisanilinopyrimidine, 3k;CHEMBL2170600;BDBM92797;AKOS024459044;2-[[2-(4-carboxyanilino)-6-methyl-pyrimidin-4-yl]amino]benzoic acid	False	31981146.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=31981146		pluskal_iocb_peptide_Peptide01_B19_id		100	B19	False	ZINC000089469956
3.0		0	35	P7116565302	103.3		I17	False	0	20	0	0	20	0	6	2	0	0	-1.0	0.0						O=C(O)c1cc(Nc2nc(N3CCCC3)nc(Nc3ccccc3)n2)ccc1		3.66		0.0	3.66	CHEMBL1540009																	0.0		3-[(4-anilino-6-pyrrolidin-1-yl-1,3,5-triazin-2-yl)amino]benzoic acid		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	3	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1		C20H20N6O2	C20H20N6O2			InChI=1S/C20H20N6O2/c27-17(28)14-7-6-10-16(13-14)22-19-23-18(21-15-8-2-1-3-9-15)24-20(25-19)26-11-4-5-12-26/h1-3,6-10,13H,4-5,11-12H2,(H,27,28)(H2,21,22,23,24,25)	JMXVCIRSULFZLE-UHFFFAOYSA-N	3-[(4-anilino-6-pyrrolidin-1-yl-1,3,5-triazin-2-yl)amino]benzoic acid	2068150	O=C(O)c1cc(Nc2nc(N3CCCC3)nc(Nc3ccccc3)n2)ccc1	3-[(4-anilino-6-pyrrolidin-1-yl-1,3,5-triazin-2-yl)amino]benzoic acid			1.6994399999999985													MCULE-5171241090	376.4214	ACID	376.164774	8	3	6	4	0.0		27									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids	False	False	Peptide01		-1.0	Compound(2068150)	2068150	4.2	342		SCHEMBL15613264	[#8]=[#6](-[#8])-[#6]1:[#6]:[#6](-[#7]-[#6]2:[#7]:[#6](-[#7]3-[#6]-[#6]-[#6]-[#6]-3):[#7]:[#6](-[#7]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#7]:2):[#6]:[#6]:[#6]:1	O=C(O)c1cc(Nc2nc(N3CCCC3)nc(Nc3ccccc3)n2)ccc1	JMXVCIRSULFZLE		parent_pubchem_cid	3-[(4-anilino-6-pyrrolidin-1-yl-1,3,5-triazin-2-yl)amino]benzoic acid;3-{[4-(phenylamino)-6-(pyrrolidin-1-yl)-1,3,5-triazin-2-yl]amino}benzoic acid;3-((4-(Phenylamino)-6-(pyrrolidin-1-yl)-1,3,5-triazin-2-yl)amino)benzoic acid;ChemDiv3_005347;AN-648/25106044;MLS000690623;CHEMBL1540009;SCHEMBL15613264;HMS1488D01;HMS2650O24;STK030552;AKOS000287972;IDI1_023257;SMR000298879;BRD-K85128079-001-01-6;3-{[4-anilino-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino}benzoic acid;433698-74-9	False	883945.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=883945		pluskal_iocb_peptide_Peptide01_B19_id		100	B19	False	ZINC000002597669
3.9		0	123	P7014792109	76.7		I18	False	0	22	0	0	28	0	2	4	0	0		0.0						CCOc1cc(NC(=O)C(C)(C)C)c(OCC)cc1NC(=O)c1ccccc1																							0.0		288844-08-6		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C22H28N2O4	C22H28N2O4			InChI=1S/C22H28N2O4/c1-6-27-18-14-17(24-21(26)22(3,4)5)19(28-7-2)13-16(18)23-20(25)15-11-9-8-10-12-15/h8-14H,6-7H2,1-5H3,(H,23,25)(H,24,26)	NICFVLHKFITHSI-UHFFFAOYSA-N	N-[4-(2,2-dimethylpropanoylamino)-2,5-diethoxy-phenyl]benzamide	1194541	CCOc1cc(NC(=O)C(C)(C)C)c(OCC)cc1NC(=O)c1ccccc1	N-[4-(2,2-dimethylpropanoylamino)-2,5-diethoxyphenyl]benzamide			2.980150000000001													MCULE-3069973000	384.47946		384.204907	4	2	8	2			44										False	Alkaloids;Shikimates and Phenylpropanoids				Peptide01			Compound(1194541)	1194541	4.0	343			[#6]-[#6]-[#8]-[#6]1:[#6]:[#6](-[#7]-[#6](=[#8])-[#6](-[#6])(-[#6])-[#6]):[#6](-[#8]-[#6]-[#6]):[#6]:[#6]:1-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	CCOc1cc(NC(=O)C(C)(C)C)c(OCC)cc1NC(=O)c1ccccc1	NICFVLHKFITHSI		parent_pubchem_cid	288844-08-6;N-[4-(2,2-DIMETHYLPROPANAMIDO)-2,5-DIETHOXYPHENYL]BENZAMIDE;N-{4-[(2,2-dimethylpropanoyl)amino]-2,5-diethoxyphenyl}benzamide;AKOS002258364;N-(2,5-diethoxy-4-pivalamidophenyl)benzamide;VU0509194-1;SR-01000278216;SR-01000278216-1;F3098-7614;N-[4-(2,2-dimethylpropanoylamino)-2,5-diethoxyphenyl]benzamide;N-[4-(2,2-dimethylpropanoylamino)-2,5-diethoxy-phenyl]benzamide		8476555.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=8476555		pluskal_iocb_peptide_Peptide01_B19_id		100	B19		ZINC000000959521
3.0		0	211	P7020532217	122.1		I19	False	0	22	0	0	26	0	2	5	0	2		0.0						CCOc1ccc(S(=O)(=O)C2CS(=O)(=O)CC2NCCc2c[nH]c3ccccc23)cc1																							0.0		HMS3463L20		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	0		C22H26N2O5S2	C22H26N2O5S2			InChI=1S/C22H26N2O5S2/c1-2-29-17-7-9-18(10-8-17)31(27,28)22-15-30(25,26)14-21(22)23-12-11-16-13-24-20-6-4-3-5-19(16)20/h3-10,13,21-24H,2,11-12,14-15H2,1H3/t21-,22-/m0/s1	QZICGGCDQIFQIH-VXKWHMMOSA-N	rac-(3S,4R)-4-(4-ethoxyphenyl)sulfonyl-N-[2-(1H-indol-3-yl)ethyl]-1,1-dioxo-thiolan-3-amine	20996501	CCOc1ccc(S(=O)(=O)[C@H]2CS(=O)(=O)C[C@@H]2NCCc2c[nH]c3ccccc23)cc1	(3S,4R)-4-(4-ethoxyphenyl)sulfonyl-N-[2-(1H-indol-3-yl)ethyl]-1,1-dioxothiolan-3-amine			1.284650000000001													MCULE-4130426326	462.59092		462.128314	6	2	8	4			44										False					Peptide01			Compound(20996501)	20996501	3.0	344			[#6]-[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#16](=[#8])(=[#8])-[#6@H]2-[#6]-[#16](=[#8])(=[#8])-[#6]-[#6@@H]-2-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	CCOc1ccc(S(=O)(=O)[C@H]2CS(=O)(=O)C[C@@H]2NCCc2c[nH]c3ccccc23)cc1	QZICGGCDQIFQIH		parent_pubchem_cid	HMS3463L20;MFCD10089245;AKOS004926367;CCG-157089;(3R4S)-3-(4-ETHOXYBENZENESULFONYL)-4-{[2-(1H-INDOL-3-YL)ETHYL]AMINO}-1LAMBDA6-THIOLANE-11-DIONE;rac-(3S,4R)-4-(4-ethoxyphenyl)sulfonyl-N-[2-(1H-indol-3-yl)ethyl]-1,1-dioxo-thiolan-3-amine		21589279.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=21589279		pluskal_iocb_peptide_Peptide01_B20_id		100	B20		ZINC000019797302
4.2		0	299	P3460666	70.7		I20	False	0	25	0	0	20	0	4	1	0	0		0.0						O=C(NCCc1c[nH]c2ccccc12)c1cc(-c2cnccc2)nc2ccccc12								Bipyridines and oligopyridines;3-alkylindoles;Pyridinecarboxylic acids and derivatives;Substituted pyrroles;Benzenoids;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Organooxygen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	3-alkylindoles;Azacyclic compounds;Benzenoids;Bipyridines and oligopyridines;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Pyridinecarboxylic acids and derivatives;Pyridines and derivatives;Pyrroles;Quinoline carboxamides;Quinolines and derivatives;Secondary carboxylic acid amides;Substituted pyrroles	Quinolines and derivatives	2.1	This compound belongs to the class of organic compounds known as quinoline carboxamides. These are quinolines in which the quinoline ring system is substituted by one or more carboxamide groups.	Quinoline carboxamides			Organic compounds	Aromatic heteropolycyclic compounds	bipyridines (CHEBI:50511);indoles (CHEBI:24828);aromatic carboxylic acid (CHEBI:33859);pyridinemonocarboxylic acid (CHEBI:26420);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organonitrogen heterocyclic compound (CHEBI:38101);organooxygen compound (CHEBI:36963);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);quinolines (CHEBI:26513);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);pyridines (CHEBI:26421);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143)		Quinoline carboxamides	Quinoline-4-carboxamide;Bipyridine;3-alkylindole;Indole;Indole or derivatives;Pyridine carboxylic acid or derivatives;Benzenoid;Substituted pyrrole;Pyridine;Pyrrole;Heteroaromatic compound;Secondary carboxylic acid amide;Carboxamide group;Carboxylic acid derivative;Azacycle;Organic oxide;Organic oxygen compound;Organooxygen compound;Organonitrogen compound;Organic nitrogen compound;Hydrocarbon derivative;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		1031573-65-5		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C25H20N4O	C25H20N4O			InChI=1S/C25H20N4O/c30-25(27-13-11-17-16-28-22-9-3-1-7-19(17)22)21-14-24(18-6-5-12-26-15-18)29-23-10-4-2-8-20(21)23/h1-10,12,14-16,28H,11,13H2,(H,27,30)	XSAACZDYCQIFPG-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)ethyl]-2-(3-pyridyl)quinoline-4-carboxamide	27645295	O=C(NCCc1c[nH]c2ccccc12)c1cc(-c2cnccc2)nc2ccccc12	N-[2-(1H-indol-3-yl)ethyl]-2-pyridin-3-ylquinoline-4-carboxamide			3.404320000000002													MCULE-5334470755	392.46435		392.163711	3	2	5	5			44										False	Alkaloids				Peptide01			Compound(27645295)	27645295	4.1	345			[#8]=[#6](-[#7]-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6]1:[#6]:[#6](-[#6]2:[#6]:[#7]:[#6]:[#6]:[#6]:2):[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	O=C(NCCc1c[nH]c2ccccc12)c1cc(-c2cnccc2)nc2ccccc12	XSAACZDYCQIFPG		parent_pubchem_cid	1031573-65-5;N-[2-(1H-indol-3-yl)ethyl]-2-pyridin-3-ylquinoline-4-carboxamide;N-[2-(1H-indol-3-yl)ethyl]-2-(pyridin-3-yl)quinoline-4-carboxamide;AKOS004996087;BRD-K76529830-001-01-6;N-[2-(1H-indol-3-yl)ethyl]-2-(3-pyridyl)quinoline-4-carboxamide		11200329.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=11200329		pluskal_iocb_peptide_Peptide01_B20_id		100	B20		ZINC000017295598
2.5		0	43	P7119870081	92.9		I21	False	0	12	2	0	15	0	7	0	0	0		0.0						CCN(CC)c1cc(Cl)nc(Nc2cc(Cl)nc(N)n2)n1																							0.0		881939-91-9		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	1		C12H15Cl2N7	C12H15Cl2N7			InChI=1S/C12H15Cl2N7/c1-3-21(4-2)10-6-8(14)17-12(20-10)19-9-5-7(13)16-11(15)18-9/h5-6H,3-4H2,1-2H3,(H3,15,16,17,18,19,20)	INLVRMWFLAXBIC-UHFFFAOYSA-N	6-chloro-N4-[4-chloro-6-(diethylamino)pyrimidin-2-yl]pyrimidine-2,4-diamine	7730541	CCN(CC)c1cc(Cl)nc(Nc2cc(Cl)nc(N)n2)n1	6-chloro-4-N-[4-chloro-6-(diethylamino)pyrimidin-2-yl]pyrimidine-2,4-diamine			1.2229599999999998													MCULE-6761708180	328.20625		327.076599	7	2	5	2			44										False	Alkaloids				Peptide01			Compound(7730541)	7730541	3.5	346			[#6]-[#6]-[#7](-[#6]-[#6])-[#6]1:[#6]:[#6](-[#17]):[#7]:[#6](-[#7]-[#6]2:[#6]:[#6](-[#17]):[#7]:[#6](-[#7]):[#7]:2):[#7]:1	CCN(CC)c1cc(Cl)nc(Nc2cc(Cl)nc(N)n2)n1	INLVRMWFLAXBIC		parent_pubchem_cid	881939-91-9;{2-[(2-amino-6-chloropyrimidin-4-yl)amino]-6-chloropyrimidin-4-yl}diethylamine;N2-(2-amino-6-chloropyrimidin-4-yl)-6-chloro-N4,N4-diethylpyrimidine-2,4-diamine;AKOS002249966;6-chloro-4-N-[4-chloro-6-(diethylamino)pyrimidin-2-yl]pyrimidine-2,4-diamine;VU0608214-1;F3267-0042;6-chloro-N4-[4-chloro-6-(diethylamino)pyrimidin-2-yl]pyrimidine-2,4-diamine		5554364.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=5554364		pluskal_iocb_peptide_Peptide01_B20_id		100	B20		ZINC000005553851
3.9		0	131	P0103040318	101.9		I22	False	0	26	0	0	21	0	1	6	0	0		0.0						O=C(COc1cc2c(cc1)c(-c1ccccc1)cc(=O)o2)NC(Cc1ccccc1)C(=O)O								Phenylalanine and derivatives;N-acyl-alpha amino acids;Phenylpropanoic acids;Coumarins and derivatives;1-benzopyrans;Amphetamines and derivatives;Pyranones and derivatives;Alkyl aryl ethers;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactones;Oxacyclic compounds;Carboxylic acids;Monocarboxylic acids and derivatives;Organopnictogen compounds;Carbonyl compounds;Organic oxides;Organonitrogen compounds;Hydrocarbon derivatives	1-benzopyrans;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Benzene and substituted derivatives;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Lactones;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Neoflavones;Neoflavonoids;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenethylamines;Phenylalanine and derivatives;Phenylpropanoic acids;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Secondary carboxylic acid amides	Neoflavonoids	2.1	This compound belongs to the class of organic compounds known as neoflavones. These are neoflavonoids with a structure based on the 4-phenylcoumarin skeleton.	Neoflavones			Organic compounds	Aromatic heteropolycyclic compounds	phenylalanine derivative (CHEBI:25985);N-acyl-amino acid (CHEBI:51569);benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);coumarins (CHEBI:23403);1-benzopyran (CHEBI:38443);amphetamines (CHEBI:35338);pyranone (CHEBI:37963);aromatic ether (CHEBI:35618);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactone (CHEBI:25000);oxacycle (CHEBI:38104);monocarboxylic acid (CHEBI:25384);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);carbonyl compound (CHEBI:36586);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);organic molecule (CHEBI:72695);neoflavonoid (CHEBI:71971);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);benzenoid aromatic compound (CHEBI:33836);primary amine (CHEBI:32877);pyrans (CHEBI:26407);oxygen molecular entity (CHEBI:25806);ether (CHEBI:25698);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);carboxylic acid anion (CHEBI:29067);amino acid (CHEBI:33709);peptide (CHEBI:16670)	Benzopyranoids (PK1311);Neoflavonoids (PK1210)	Neoflavones	4-phenylcoumarin;Phenylalanine or derivatives;N-acyl-alpha amino acid or derivatives;N-acyl-alpha-amino acid;3-phenylpropanoic-acid;Coumarin;Alpha-amino acid or derivatives;Amphetamine or derivatives;1-benzopyran;Benzopyran;Alkyl aryl ether;Pyranone;Pyran;Monocyclic benzene moiety;Benzenoid;Heteroaromatic compound;Secondary carboxylic acid amide;Lactone;Carboxamide group;Oxacycle;Carboxylic acid derivative;Carboxylic acid;Organoheterocyclic compound;Ether;Monocarboxylic acid or derivatives;Organic oxygen compound;Organic nitrogen compound;Carbonyl group;Organopnictogen compound;Organic oxide;Organooxygen compound;Hydrocarbon derivative;Organonitrogen compound;Aromatic heteropolycyclic compound	Phenylpropanoids and polyketides	0.0		Oprea1_074972		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C26H21NO6	C26H21NO6			InChI=1S/C26H21NO6/c28-24(27-22(26(30)31)13-17-7-3-1-4-8-17)16-32-19-11-12-20-21(18-9-5-2-6-10-18)15-25(29)33-23(20)14-19/h1-12,14-15,22H,13,16H2,(H,27,28)(H,30,31)	GUXSBJFILJLILM-UHFFFAOYSA-N	2-[[2-(2-oxo-4-phenyl-chromen-7-yl)oxyacetyl]amino]-3-phenyl-propanoic acid	3622214	O=C(COc1cc2c(cc1)c(-c1ccccc1)cc(=O)o2)NC(Cc1ccccc1)C(=O)O	2-[[2-(2-oxo-4-phenylchromen-7-yl)oxyacetyl]amino]-3-phenylpropanoic acid			3.2252300000000007													MCULE-8461256735	443.46037		443.136887	6	2	8	4			45									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(3622214)	3622214	4.0	347			[#8]=[#6](-[#6]-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1):[#6]:[#6](=[#8]):[#8]:2)-[#7]-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	O=C(COc1cc2c(cc1)c(-c1ccccc1)cc(=O)o2)NC(Cc1ccccc1)C(=O)O	GUXSBJFILJLILM		parent_pubchem_cid	Oprea1_074972;AKOS002345308;2-[[2-(2-oxo-4-phenyl-chromen-7-yl)oxyacetyl]amino]-3-phenyl-propanoic acid		23438787.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23438787		pluskal_iocb_peptide_Peptide01_B20_id		100	B20		
2.1		0	219	P7020432113	142.4		I23	False	0	21	0	0	23	0	3	6	0	2		0.0						CCOc1c(S(=O)(=O)NCCc2c[nH]c3ccccc23)cc(N2C(=O)CCS2(=O)=O)cc1																							0.0		STK639828		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	0		C21H23N3O6S2	C21H23N3O6S2			InChI=1S/C21H23N3O6S2/c1-2-30-19-8-7-16(24-21(25)10-12-31(24,26)27)13-20(19)32(28,29)23-11-9-15-14-22-18-6-4-3-5-17(15)18/h3-8,13-14,22-23H,2,9-12H2,1H3	MOSSPCVDCGFDQA-UHFFFAOYSA-N	2-ethoxy-N-[2-(1H-indol-3-yl)ethyl]-5-(1,1,3-trioxo-1,2-thiazolidin-2-yl)benzenesulfonamide	17601109	CCOc1c(S(=O)(=O)NCCc2c[nH]c3ccccc23)cc(N2C(=O)CCS2(=O)=O)cc1	2-ethoxy-N-[2-(1H-indol-3-yl)ethyl]-5-(1,1,3-trioxo-1,2-thiazolidin-2-yl)benzenesulfonamide			0.7199400000000005													MCULE-3949037176	477.56196		477.102827	6	2	8	4			44									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(17601109)	17601109	1.9	348			[#6]-[#6]-[#8]-[#6]1:[#6](-[#16](=[#8])(=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6](-[#7]2-[#6](=[#8])-[#6]-[#6]-[#16]-2(=[#8])=[#8]):[#6]:[#6]:1	CCOc1c(S(=O)(=O)NCCc2c[nH]c3ccccc23)cc(N2C(=O)CCS2(=O)=O)cc1	MOSSPCVDCGFDQA		parent_pubchem_cid	STK639828;AKOS005571380;5-(1,1-dioxido-3-oxo-1,2-thiazolidin-2-yl)-2-ethoxy-N-[2-(1H-indol-3-yl)ethyl]benzenesulfonamide;2-ethoxy-N-[2-(1H-indol-3-yl)ethyl]-5-(1,1,3-trioxo-1,2-thiazolidin-2-yl)benzenesulfonamide		17000924.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=17000924		pluskal_iocb_peptide_Peptide01_B20_id		100	B20		ZINC000013726648
2.0		0	307	P7126244	144.7		I24	False	0	18	0	0	14	0	4	5	0	0		0.0						O=C(O)c1ccc(Nc2nccc(Nc3cc(C(=O)O)c(O)cc3)n2)cc1																							0.0		AKOS025142291		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	2	2	0	0	0	0	0	0	0	0	0	0	1	0	0	0	3	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0		C18H14N4O5	C18H14N4O5			InChI=1S/C18H14N4O5/c23-14-6-5-12(9-13(14)17(26)27)20-15-7-8-19-18(22-15)21-11-3-1-10(2-4-11)16(24)25/h1-9,23H,(H,24,25)(H,26,27)(H2,19,20,21,22)	OURBSPIJLLMDPE-UHFFFAOYSA-N	5-[[2-(4-carboxyanilino)pyrimidin-4-yl]amino]-2-hydroxy-benzoic acid	91900821	O=C(O)c1ccc(Nc2nccc(Nc3cc(C(=O)O)c(O)cc3)n2)cc1	5-[[2-(4-carboxyanilino)pyrimidin-4-yl]amino]-2-hydroxybenzoic acid			0.9715299999999996														366.33608		366.09642	9	5	6	3			45										False	Alkaloids				Peptide01			Compound(91900821)	91900821	3.2	349			[#8]=[#6](-[#8])-[#6]1:[#6]:[#6]:[#6](-[#7]-[#6]2:[#7]:[#6]:[#6]:[#6](-[#7]-[#6]3:[#6]:[#6](-[#6](=[#8])-[#8]):[#6](-[#8]):[#6]:[#6]:3):[#7]:2):[#6]:[#6]:1	O=C(O)c1ccc(Nc2nccc(Nc3cc(C(=O)O)c(O)cc3)n2)cc1	OURBSPIJLLMDPE		parent_pubchem_cid	AKOS025142291;5-[[2-(4-carboxyanilino)pyrimidin-4-yl]amino]-2-hydroxy-benzoic acid		101553125.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=101553125		pluskal_iocb_peptide_Peptide01_B20_id		100	B20		ZINC000170621798
4.3		0	51	P7114890207	35.2		I25	False	0	26	0	0	28	0	4	0	0	0		0.0						Cc1c(C(c2cnccc2)N2CCN(Cc3ccccc3)CC2)c2ccccc2[nH]1																							0.0		3-((4-benzylpiperazin-1-yl)(pyridin-3-yl)methyl)-2-methyl-1H-indole		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	2		C26H28N4	C26H28N4			InChI=1S/C26H28N4/c1-20-25(23-11-5-6-12-24(23)28-20)26(22-10-7-13-27-18-22)30-16-14-29(15-17-30)19-21-8-3-2-4-9-21/h2-13,18,26,28H,14-17,19H2,1H3	RCQUCMYEGJIJQZ-UHFFFAOYSA-N	3-[(4-benzylpiperazin-1-yl)-(3-pyridyl)methyl]-2-methyl-1H-indole	3652424	Cc1c(C(c2cnccc2)N2CCN(Cc3ccccc3)CC2)c2ccccc2[nH]1	3-[(4-benzylpiperazin-1-yl)-pyridin-3-ylmethyl]-2-methyl-1H-indole			4.131260000000003													MCULE-4112307594	396.53986		396.231397	3	1	5	5			45										False	Alkaloids				Peptide01			Compound(3652424)	3652424	4.2	350			[#6]-[#6]1:[#6](-[#6](-[#6]2:[#6]:[#7]:[#6]:[#6]:[#6]:2)-[#7]2-[#6]-[#6]-[#7](-[#6]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3)-[#6]-[#6]-2):[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#7H]:1	Cc1c(C(c2cnccc2)N2CCN(Cc3ccccc3)CC2)c2ccccc2[nH]1	RCQUCMYEGJIJQZ		parent_pubchem_cid	3-((4-benzylpiperazin-1-yl)(pyridin-3-yl)methyl)-2-methyl-1H-indole;3-[(4-benzylpiperazin-1-yl)(pyridin-3-yl)methyl]-2-methyl-1H-indole;STL228570;AKOS000808498;AKOS016055470;Z57301052;F1310-0261;3-[(4-benzylpiperazin-1-yl)-(3-pyridyl)methyl]-2-methyl-1H-indole		24247466.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24247466		pluskal_iocb_peptide_Peptide01_B20_id		100	B20		
4.1		0	139	P0133820163	57.8		I26	False	0	23	0	0	21	0	3	1	0	0		0.0						O=C(NCCc1nc2ccccc2[nH]1)C(c1ccccc1)c1ccccc1																							0.0		Oprea1_107452		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C23H21N3O	C23H21N3O			InChI=1S/C23H21N3O/c27-23(24-16-15-21-25-19-13-7-8-14-20(19)26-21)22(17-9-3-1-4-10-17)18-11-5-2-6-12-18/h1-14,22H,15-16H2,(H,24,27)(H,25,26)	CQONFDYLCWWSRQ-UHFFFAOYSA-N	N-[2-(1H-benzimidazol-2-yl)ethyl]-2,2-diphenyl-acetamide	1181854	O=C(NCCc1nc2ccccc2[nH]1)C(c1ccccc1)c1ccccc1	N-[2-(1H-benzimidazol-2-yl)ethyl]-2,2-diphenylacetamide			3.4611500000000017													MCULE-6460977632	355.44332		355.168462	2	2	6	4			44										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(1181854)	1181854	4.4	351			[#8]=[#6](-[#7]-[#6]-[#6]-[#6]1:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#7H]:1)-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	O=C(NCCc1nc2ccccc2[nH]1)C(c1ccccc1)c1ccccc1	CQONFDYLCWWSRQ		parent_pubchem_cid	Oprea1_107452;AKOS001354062;Z90987385;N-[2-(1H-benzimidazol-2-yl)ethyl]-2,2-diphenyl-acetamide		6487805.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=6487805		pluskal_iocb_peptide_Peptide01_B20_id		100	B20		ZINC000000941026
0.3		0	227	P7013870129	118.2		I27	False	0	13	0	0	14	0	4	3	0	0		0.0						NC(=O)CCC(Nc1ncnc2ccccc12)C(=O)O																							0.0		CBKinase1_003499		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C13H14N4O3	C13H14N4O3			InChI=1S/C13H14N4O3/c14-11(18)6-5-10(13(19)20)17-12-8-3-1-2-4-9(8)15-7-16-12/h1-4,7,10H,5-6H2,(H2,14,18)(H,19,20)(H,15,16,17)	TZFIJIOVFYFDMD-UHFFFAOYSA-N	5-amino-5-oxo-2-(quinazolin-4-ylamino)pentanoic acid	2792418	NC(=O)CCC(Nc1ncnc2ccccc12)C(=O)O	5-amino-5-oxo-2-(quinazolin-4-ylamino)pentanoic acid			-0.0486300000000002													MCULE-6058802224	274.28153		274.10659	6	3	6	2			44										False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(2792418)	2792418	1.2	352		SCHEMBL14285630	[#7]-[#6](=[#8])-[#6]-[#6]-[#6](-[#7]-[#6]1:[#7]:[#6]:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	NC(=O)CCC(Nc1ncnc2ccccc12)C(=O)O	TZFIJIOVFYFDMD		parent_pubchem_cid	CBKinase1_003499;CBKinase1_015899;Oprea1_109862;SCHEMBL14285630;MFCD04064788;AKOS000534855;AKOS016313395;AB00682296-01;5-amino-5-oxo-2-(quinazolin-4-ylamino)pentanoic acid		23225250.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23225250		pluskal_iocb_peptide_Peptide01_B21_id		100	B21		
1.7		0	315	P8840403	91.7		I28	False	0	13	0	0	17	0	1	3	0	1		0.0						CCSCCC(NC(=O)c1ccccc1)C(=O)O																							0.0		SCHEMBL4955422		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C13H17NO3S	C13H17NO3S			InChI=1S/C13H17NO3S/c1-2-18-9-8-11(13(16)17)14-12(15)10-6-4-3-5-7-10/h3-7,11H,2,8-9H2,1H3,(H,14,15)(H,16,17)	XTAPCWRFUZKDJM-UHFFFAOYSA-N	2-benzamido-4-ethylsulfanyl-butanoic acid	20131991	CCSCCC(NC(=O)c1ccccc1)C(=O)O	2-benzamido-4-ethylsulfanylbutanoic acid			1.95809														267.34934		267.092914	4	2	7	1			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(20131991)	20131991	2.2	353		SCHEMBL4955422	[#6]-[#6]-[#16]-[#6]-[#6]-[#6](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	CCSCCC(NC(=O)c1ccccc1)C(=O)O	XTAPCWRFUZKDJM		parent_pubchem_cid	SCHEMBL4955422;MFCD29052066;AKOS025146418;2-benzamido-4-ethylsulfanyl-butanoic acid		65042581.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=65042581		pluskal_iocb_peptide_Peptide01_B21_id		100	B21		
2.9		0	59	P7213750066	75.6		I29	False	0	17	0	0	17	0	1	4	0	0	-1.0	0.0						O=C(O)CC(NC(=O)OCc1ccccc1)c1ccccc1		3.13		0.0	3.04	CHEMBL1560691																	0.0		3-{[(benzyloxy)carbonyl]amino}-3-phenylpropanoic acid		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	1	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C17H17NO4	C17H17NO4			InChI=1S/C17H17NO4/c19-16(20)11-15(14-9-5-2-6-10-14)18-17(21)22-12-13-7-3-1-4-8-13/h1-10,15H,11-12H2,(H,18,21)(H,19,20)	POJLWVWXBAHGGO-UHFFFAOYSA-N	3-(benzyloxycarbonylamino)-3-phenyl-propanoic acid	304273	O=C(O)CC(NC(=O)OCc1ccccc1)c1ccccc1	3-phenyl-3-(phenylmethoxycarbonylamino)propanoic acid			3.0193800000000017													MCULE-9156004490	299.32934	ACID	299.115758	4	2	7	2	0.0		29										False	Amino acids and Peptides		False	False	Peptide01		-1.0	Compound(304273)	304273	2.5	354		SCHEMBL6156740	[#8]=[#6](-[#8])-[#6]-[#6](-[#7]-[#6](=[#8])-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	O=C(O)CC(NC(=O)OCc1ccccc1)c1ccccc1	POJLWVWXBAHGGO		parent_pubchem_cid	3-{[(benzyloxy)carbonyl]amino}-3-phenylpropanoic acid;14440-98-3;3-phenyl-3-(phenylmethoxycarbonylamino)propanoic acid;N-[(benzyloxy)carbonyl]-3-phenyl-beta-alanine;14477-66-8;Cbz-DL-beta-phenylalanine;POJLWVWXBAHGGO-UHFFFAOYSA-N;NSC195911;Cbz-DL-|A-phenylalanine;MLS000113773;SCHEMBL6156740;CHEMBL1560691;DTXSID801314537;HMS2175P22;AKOS000164009;AKOS016352317;NSC-195911;N-Cbz-3-amino-3-phenyl propionic acid;SMR000109665;CS-0143907;EN300-100834;AN-329/41128189;SR-01000506522;SR-01000506522-1;3-{[(benzyloxy)carbonyl]amino}-3-phenylpropanoicacid;Z57204687;3-(benzyloxycarbonylamino)-3-phenyl-propanoic acid	False	836067.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=836067		pluskal_iocb_peptide_Peptide01_B21_id		100	B21	False	
4.9		0	147	P0103540374	77.0		I30	False	0	27	0	0	25	0	1	5	0	0		0.0						COc1cc(C(=O)NC(c2ccccc2)c2c(O)ccc3ccccc23)cc(OC)c1OC								Naphthols and derivatives;Phenoxy compounds;Methoxybenzenes;Benzoyl derivatives;Anisoles;Alkyl aryl ethers;1-hydroxy-2-unsubstituted benzenoids;Secondary carboxylic acid amides;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	1-hydroxy-2-unsubstituted benzenoids;Alkyl aryl ethers;Anisoles;Benzamides;Benzene and substituted derivatives;Benzenoids;Benzoic acids and derivatives;Benzoyl derivatives;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Ethers;Hydrocarbon derivatives;Methoxybenzenes;N-benzylbenzamides;Naphthalenes;Naphthols and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenol ethers;Phenols;Phenoxy compounds;Secondary carboxylic acid amides	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as n-benzylbenzamides. These are compounds containing a benzamide moiety that is N-linked to a benzyl group.	N-benzylbenzamides		Benzamides	Organic compounds	Aromatic homopolycyclic compounds	naphthols (CHEBI:25392);benzenes (CHEBI:22712);methoxybenzene (CHEBI:51683);carbonyl compound (CHEBI:36586);aromatic ether (CHEBI:35618);phenols (CHEBI:33853);carboxamide (CHEBI:37622);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);benzamides (CHEBI:22702);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);naphthalenes (CHEBI:25477);oxygen molecular entity (CHEBI:25806);organooxygen compound (CHEBI:36963);ether (CHEBI:25698);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)		Benzoic acids and derivatives	N-benzylbenzamide;2-naphthol;Naphthalene;Phenoxy compound;Anisole;Benzoyl;Methoxybenzene;Phenol ether;Alkyl aryl ether;1-hydroxy-2-unsubstituted benzenoid;Carboxamide group;Secondary carboxylic acid amide;Carboxylic acid derivative;Ether;Hydrocarbon derivative;Organic oxygen compound;Organic nitrogen compound;Organic oxide;Organopnictogen compound;Organooxygen compound;Organonitrogen compound;Aromatic homopolycyclic compound	Benzenoids	0.0		Oprea1_435985		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C27H25NO5	C27H25NO5			InChI=1S/C27H25NO5/c1-31-22-15-19(16-23(32-2)26(22)33-3)27(30)28-25(18-10-5-4-6-11-18)24-20-12-8-7-9-17(20)13-14-21(24)29/h4-16,25,29H,1-3H3,(H,28,30)	DQCPQSBZPWAWPX-UHFFFAOYSA-N	N-[(2-hydroxy-1-naphthyl)-phenyl-methyl]-3,4,5-trimethoxy-benzamide	2787559	COc1cc(C(=O)NC(c2ccccc2)c2c(O)ccc3ccccc23)cc(OC)c1OC	N-[(2-hydroxynaphthalen-1-yl)-phenylmethyl]-3,4,5-trimethoxybenzamide			2.648410000000001													MCULE-4397975383	443.504		443.173273	5	2	7	4			45										False					Peptide01			Compound(2787559)	2787559	5.7	355			[#6]-[#8]-[#6]1:[#6]:[#6](-[#6](=[#8])-[#7]-[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]2:[#6](-[#8]):[#6]:[#6]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6](-[#8]-[#6]):[#6]:1-[#8]-[#6]	COc1cc(C(=O)NC(c2ccccc2)c2c(O)ccc3ccccc23)cc(OC)c1OC	DQCPQSBZPWAWPX		parent_pubchem_cid	Oprea1_435985;Oprea1_579309;MFCD00705657;AKOS001596934;AKOS016311840;SR-01000404732;SR-01000404732-1;F3284-0094;N-((2-hydroxynaphthalen-1-yl)(phenyl)methyl)-3,4,5-trimethoxybenzamide;N-[(2-hydroxy-1-naphthyl)-phenyl-methyl]-3,4,5-trimethoxy-benzamide		23583462.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23583462		pluskal_iocb_peptide_Peptide01_B21_id		100	B21		
2.9		0	235	P1459470	49.4		I31	False	0	19	0	0	26	0	2	2	0	0		0.0						O=C(NCc1ccccc1)C1CCCN1C(=O)C1CCCCC1																							0.0		AKOS016400406		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0		C19H26N2O2	C19H26N2O2			InChI=1S/C19H26N2O2/c22-18(20-14-15-8-3-1-4-9-15)17-12-7-13-21(17)19(23)16-10-5-2-6-11-16/h1,3-4,8-9,16-17H,2,5-7,10-14H2,(H,20,22)/t17-/m0/s1	MSOSYICMXZGZTG-KRWDZBQOSA-N	rac-(2S)-N-benzyl-1-(cyclohexanecarbonyl)pyrrolidine-2-carboxamide	51711512	O=C(NCc1ccccc1)[C@@H]1CCCN1C(=O)C1CCCCC1	(2S)-N-benzyl-1-(cyclohexanecarbonyl)pyrrolidine-2-carboxamide			2.819390000000001													MCULE-6475090389	314.43127		314.199428	2	1	4	3			44										False	Alkaloids				Peptide01			Compound(51711512)	51711512	3.2	356			[#8]=[#6](-[#7]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6@@H]1-[#6]-[#6]-[#6]-[#7]-1-[#6](=[#8])-[#6]1-[#6]-[#6]-[#6]-[#6]-[#6]-1	O=C(NCc1ccccc1)[C@@H]1CCCN1C(=O)C1CCCCC1	MSOSYICMXZGZTG		parent_pubchem_cid	AKOS016400406;rac-(2S)-N-benzyl-1-(cyclohexanecarbonyl)pyrrolidine-2-carboxamide		18491074.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=18491074		pluskal_iocb_peptide_Peptide01_B21_id		100	B21		ZINC000036108870
1.7		0	323	P3460075	140.8		I32	False	0	24	0	0	32	0	4	6	0	0		0.0						CC(C)(C)OC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)N1CCC(C(=O)NCC(=O)O)CC1																							0.0		MFCD05671314		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	1	0	4	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C24H32N4O6	C24H32N4O6			InChI=1S/C24H32N4O6/c1-24(2,3)34-23(33)27-19(12-16-13-25-18-7-5-4-6-17(16)18)22(32)28-10-8-15(9-11-28)21(31)26-14-20(29)30/h4-7,13,15,19,25H,8-12,14H2,1-3H3,(H,26,31)(H,27,33)(H,29,30)/t19-/m0/s1	MADPRIOMRYXOEC-IBGZPJMESA-N	2-[[1-[rac-(2S)-2-(tert-butoxycarbonylamino)-3-(1H-indol-3-yl)propanoyl]piperidine-4-carbonyl]amino]acetic acid	16400375	CC(C)(C)OC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC(C(=O)NCC(=O)O)CC1	2-[[1-[(2S)-3-(1H-indol-3-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoyl]piperidine-4-carbonyl]amino]acetic acid			1.5599700000000012													MCULE-2377881473	472.54584		472.232185	6	4	9	3			44									Tripeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(16400375)	16400375	1.8	357			[#6]-[#6](-[#6])(-[#6])-[#8]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#7]1-[#6]-[#6]-[#6](-[#6](=[#8])-[#7]-[#6]-[#6](=[#8])-[#8])-[#6]-[#6]-1	CC(C)(C)OC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC(C(=O)NCC(=O)O)CC1	MADPRIOMRYXOEC		parent_pubchem_cid	MFCD05671314;AKOS016375506;N-({1-[N-(tert-butoxycarbonyl)-L-tryptophyl]piperidin-4-yl}carbonyl)glycine;2-[[1-[rac-(2S)-2-(tert-butoxycarbonylamino)-3-(1H-indol-3-yl)propanoyl]piperidine-4-carbonyl]amino]acetic acid		22813161.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22813161		pluskal_iocb_peptide_Peptide01_B21_id		100	B21		ZINC000008918188
4.8		0	67	P7115370015	77.0		I33	False	0	22	0	3	18	0	1	5	0	0		0.0						COc1cc(Oc2c(NC(=O)c3cc(OC)c(O)cc3)cc(C(F)(F)F)cc2)ccc1																							0.0		4-hydroxy-3-methoxy-N-[2-(3-methoxyphenoxy)-5-(trifluoromethyl)phenyl]benzamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C22H18F3NO5	C22H18F3NO5			InChI=1S/C22H18F3NO5/c1-29-15-4-3-5-16(12-15)31-19-9-7-14(22(23,24)25)11-17(19)26-21(28)13-6-8-18(27)20(10-13)30-2/h3-12,27H,1-2H3,(H,26,28)	ONVGESAVESPJHI-UHFFFAOYSA-N	4-hydroxy-3-methoxy-N-[2-(3-methoxyphenoxy)-5-(trifluoromethyl)phenyl]benzamide	993002	COc1cc(Oc2c(NC(=O)c3cc(OC)c(O)cc3)cc(C(F)(F)F)cc2)ccc1	4-hydroxy-3-methoxy-N-[2-(3-methoxyphenoxy)-5-(trifluoromethyl)phenyl]benzamide			2.670720000000001													MCULE-8026547552	433.38766		433.113707	5	2	7	3			43										False	Alkaloids				Peptide01			Compound(993002)	993002	4.8	358			[#6]-[#8]-[#6]1:[#6]:[#6](-[#8]-[#6]2:[#6](-[#7]-[#6](=[#8])-[#6]3:[#6]:[#6](-[#8]-[#6]):[#6](-[#8]):[#6]:[#6]:3):[#6]:[#6](-[#6](-[#9])(-[#9])-[#9]):[#6]:[#6]:2):[#6]:[#6]:[#6]:1	COc1cc(Oc2c(NC(=O)c3cc(OC)c(O)cc3)cc(C(F)(F)F)cc2)ccc1	ONVGESAVESPJHI		parent_pubchem_cid	4-hydroxy-3-methoxy-N-[2-(3-methoxyphenoxy)-5-(trifluoromethyl)phenyl]benzamide;MFCD03866864;AKOS002382446;AP-906/41927952		9691522.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=9691522		pluskal_iocb_peptide_Peptide01_B21_id		100	B21		ZINC000000646245
2.5		0	155	P0111000953	94.1		I34	False	0	19	0	0	21	0	1	6	0	0		0.0						COc1cc(C(=O)NC(Cc2ccccc2)C(=O)O)cc(OC)c1OC								N-acyl-alpha amino acids;Hippuric acids;Phenylpropanoic acids;Amphetamines and derivatives;Phenoxy compounds;Anisoles;Methoxybenzenes;Benzoyl derivatives;Alkyl aryl ethers;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organonitrogen compounds;Organopnictogen compounds	Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Anisoles;Benzamides;Benzene and substituted derivatives;Benzenoids;Benzoic acids and derivatives;Benzoyl derivatives;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Ethers;Hippuric acids;Hippuric acids and derivatives;Hydrocarbon derivatives;Methoxybenzenes;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenethylamines;Phenol ethers;Phenoxy compounds;Phenylalanine and derivatives;Phenylpropanoic acids;Phenylpropanoids and polyketides;Secondary carboxylic acid amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic homomonocyclic compounds	N-acyl-amino acid (CHEBI:51569);N-acylglycine (CHEBI:16180);benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);amphetamines (CHEBI:35338);methoxybenzene (CHEBI:51683);carbonyl compound (CHEBI:36586);aromatic ether (CHEBI:35618);carboxamide (CHEBI:37622);carboxylic acid anion (CHEBI:29067);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);amino acid (CHEBI:33709);peptide (CHEBI:16670);benzenoid aromatic compound (CHEBI:33836);benzamides (CHEBI:22702);phenols (CHEBI:33853);primary amine (CHEBI:32877);oxygen molecular entity (CHEBI:25806);ether (CHEBI:25698);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)		Amino acids, peptides, and analogues	Phenylalanine or derivatives;Hippuric acid or derivatives;Hippuric acid;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;3-phenylpropanoic-acid;Amphetamine or derivatives;Benzamide;Benzoic acid or derivatives;Anisole;Phenoxy compound;Benzoyl;Methoxybenzene;Phenol ether;Alkyl aryl ether;Benzenoid;Monocyclic benzene moiety;Secondary carboxylic acid amide;Carboxamide group;Monocarboxylic acid or derivatives;Ether;Carboxylic acid;Hydrocarbon derivative;Carbonyl group;Organopnictogen compound;Organic oxygen compound;Organic oxide;Organonitrogen compound;Organooxygen compound;Organic nitrogen compound;Aromatic homomonocyclic compound	Organic acids and derivatives	0.0		3-phenyl-2-[(3,4,5-trimethoxybenzoyl)amino]propanoic Acid		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C19H21NO6	C19H21NO6			InChI=1S/C19H21NO6/c1-24-15-10-13(11-16(25-2)17(15)26-3)18(21)20-14(19(22)23)9-12-7-5-4-6-8-12/h4-8,10-11,14H,9H2,1-3H3,(H,20,21)(H,22,23)	MUZUXRFKLNSQTA-UHFFFAOYSA-N	3-phenyl-2-[(3,4,5-trimethoxybenzoyl)amino]propanoic acid	2787316	COc1cc(C(=O)NC(Cc2ccccc2)C(=O)O)cc(OC)c1OC	3-phenyl-2-[(3,4,5-trimethoxybenzoyl)amino]propanoic acid			0.6414500000000003													MCULE-3760393527	359.38232		359.136887	6	2	8	2			44										False					Peptide01			Compound(2787316)	2787316	2.7	359			[#6]-[#8]-[#6]1:[#6]:[#6](-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#8]):[#6]:[#6](-[#8]-[#6]):[#6]:1-[#8]-[#6]	COc1cc(C(=O)NC(Cc2ccccc2)C(=O)O)cc(OC)c1OC	MUZUXRFKLNSQTA		parent_pubchem_cid	3-phenyl-2-[(3,4,5-trimethoxybenzoyl)amino]propanoic Acid;303796-46-5;3-PHENYL-2-[(3,4,5-TRIMETHOXYPHENYL)FORMAMIDO]PROPANOIC ACID;3-phenyl-2-[(3,4,5-trimethoxyphenyl)formamido]propanoicacid;Oprea1_776129;MFCD00366726;STL526516;AKOS000272772;AKOS016040445;NS-05694;N-[(3,4,5-trimethoxyphenyl)carbonyl]phenylalanine		24106611.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24106611		pluskal_iocb_peptide_Peptide01_B21_id		100	B21		
0.9		0	243	P7119860111	136.7		I35	False	0	20	0	0	22	0	0	8	0	0		0.0						O=C(Cc1ccccc1)c1c(O)cc(OC2OC(CO)C(O)C(O)C2O)cc1																							0.0		ChemDiv1_019269		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	5	4	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C20H22O8	C20H22O8			InChI=1S/C20H22O8/c21-10-16-17(24)18(25)19(26)20(28-16)27-12-6-7-13(15(23)9-12)14(22)8-11-4-2-1-3-5-11/h1-7,9,16-21,23-26H,8,10H2	JSHQXLPAMKLQOA-UHFFFAOYSA-N	1-[2-hydroxy-4-[3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-phenyl]-2-phenyl-ethanone	6617409	O=C(Cc1ccccc1)c1c(O)cc(OC2OC(CO)C(O)C(O)C2O)cc1	1-[2-hydroxy-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-2-phenylethanone			-1.037940000000001													MCULE-3992069923	390.39354		390.131468	8	5	6	3			45										True	Shikimates and Phenylpropanoids				Peptide01			Compound(6617409)	6617409	0.6	360			[#8]=[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6](-[#8]):[#6]:[#6](-[#8]-[#6]2-[#8]-[#6](-[#6]-[#8])-[#6](-[#8])-[#6](-[#8])-[#6]-2-[#8]):[#6]:[#6]:1	O=C(Cc1ccccc1)c1c(O)cc(OC2OC(CO)C(O)C(O)C2O)cc1	JSHQXLPAMKLQOA		parent_pubchem_cid	ChemDiv1_019269;HMS641L19;STK973383;AKOS002385543;3-hydroxy-4-(phenylacetyl)phenyl hexopyranoside;SR-01000395032;SR-01000395032-1;1-[2-hydroxy-4-[3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-phenyl]-2-phenyl-ethanone		23308599.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23308599		pluskal_iocb_peptide_Peptide01_B22_id		100	B22		
1.4		0	331	P11186113	130.0		I36	False	0	16	0	0	22	0	2	5	0	1		0.0						CSCCC(NC(=O)OCc1ccccc1)C(=O)NC(C)C(=O)O																							0.0		AKOS027473380		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	2	0	0	0	0	0	0	1	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C16H22N2O5S	C16H22N2O5S			InChI=1S/C16H22N2O5S/c1-11(15(20)21)17-14(19)13(8-9-24-2)18-16(22)23-10-12-6-4-3-5-7-12/h3-7,11,13H,8-10H2,1-2H3,(H,17,19)(H,18,22)(H,20,21)	WNPCADDTHHEWIB-UHFFFAOYSA-N	2-[[2-(benzyloxycarbonylamino)-4-methylsulfanyl-butanoyl]amino]propanoic acid	4461147	CSCCC(NC(=O)OCc1ccccc1)C(=O)NC(C)C(=O)O	2-[[4-methylsulfanyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]propanoic acid			1.56909														354.42814		354.124943	6	3	10	1			46									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(4461147)	4461147	1.8	361			[#6]-[#16]-[#6]-[#6]-[#6](-[#7]-[#6](=[#8])-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#7]-[#6](-[#6])-[#6](=[#8])-[#8]	CSCCC(NC(=O)OCc1ccccc1)C(=O)NC(C)C(=O)O	WNPCADDTHHEWIB		parent_pubchem_cid	AKOS027473380;FT-0638455;2-[[2-(benzyloxycarbonylamino)-4-methylsulfanyl-butanoyl]amino]propanoic acid		60285830.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=60285830		pluskal_iocb_peptide_Peptide01_B22_id		100	B22		
4.1		0	75	P0127460113	42.0		I37	False	0	26	0	0	26	0	2	3	0	0		0.0						O=C(C(c1ccccc1)c1ccccc1)N1CCN(Cc2cc3c(cc2)OCO3)CC1																							0.0		1-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-2,2-diphenylethanone		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1		C26H26N2O3	C26H26N2O3			InChI=1S/C26H26N2O3/c29-26(25(21-7-3-1-4-8-21)22-9-5-2-6-10-22)28-15-13-27(14-16-28)18-20-11-12-23-24(17-20)31-19-30-23/h1-12,17,25H,13-16,18-19H2	OIROWQRVDWVAOQ-UHFFFAOYSA-N	1-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-2,2-diphenyl-ethanone	1115161	O=C(C(c1ccccc1)c1ccccc1)N1CCN(Cc2cc3c(cc2)OCO3)CC1	1-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-2,2-diphenylethanone			2.8026500000000008													MCULE-5347045647	414.50872		414.194343	4	0	5	5			44										False	Alkaloids				Peptide01			Compound(1115161)	1115161	4.1	362			[#8]=[#6](-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]1-[#6]-[#6]-[#7](-[#6]-[#6]2:[#6]:[#6]3:[#6](:[#6]:[#6]:2)-[#8]-[#6]-[#8]-3)-[#6]-[#6]-1	O=C(C(c1ccccc1)c1ccccc1)N1CCN(Cc2cc3c(cc2)OCO3)CC1	OIROWQRVDWVAOQ		parent_pubchem_cid	1-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-2,2-diphenylethanone;1-(1,3-benzodioxol-5-ylmethyl)-4-(diphenylacetyl)piperazine;304683-66-7;Oprea1_163668;Oprea1_373432;AKOS001029937;AB00684144-01;SR-01000420280;SR-01000420280-1;Z30923812;1-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-2,2-diphenyl-ethanone		2397476.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=2397476		pluskal_iocb_peptide_Peptide01_B22_id		100	B22		ZINC000019790490
3.1		0	163	P7020554648	84.2		I38	False	0	20	0	1	18	0	3	3	0	0		0.0						Cc1cc(NC(=O)C(Cc2ccccc2)NC(=O)c2ccccc2F)no1																							0.0		AKOS005579095		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C20H18FN3O3	C20H18FN3O3			InChI=1S/C20H18FN3O3/c1-13-11-18(24-27-13)23-20(26)17(12-14-7-3-2-4-8-14)22-19(25)15-9-5-6-10-16(15)21/h2-11,17H,12H2,1H3,(H,22,25)(H,23,24,26)/t17-/m0/s1	ROCGRKVFWHWBFA-KRWDZBQOSA-N	N-[(1S)-1-benzyl-2-[(5-methylisoxazol-3-yl)amino]-2-oxo-ethyl]-2-fluoro-benzamide	24315161	Cc1cc(NC(=O)[C@H](Cc2ccccc2)NC(=O)c2ccccc2F)no1	2-fluoro-N-[(2S)-1-[(5-methyl-1,2-oxazol-3-yl)amino]-1-oxo-3-phenylpropan-2-yl]benzamide			2.5571800000000007													MCULE-9956670593	367.38316		367.13322	3	2	6	3			44										False					Peptide01			Compound(24315161)	24315161	3.4	363			[#6]-[#6]1:[#6]:[#6](-[#7]-[#6](=[#8])-[#6@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#9]):[#7]:[#8]:1	Cc1cc(NC(=O)[C@H](Cc2ccccc2)NC(=O)c2ccccc2F)no1	ROCGRKVFWHWBFA		parent_pubchem_cid	AKOS005579095;N-[(1S)-1-benzyl-2-[(5-methylisoxazol-3-yl)amino]-2-oxo-ethyl]-2-fluoro-benzamide		1353252.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=1353252		pluskal_iocb_peptide_Peptide01_B22_id		100	B22		ZINC000012028730
2.3		0	251	P0116470235	183.7		I39	False	0	21	0	0	24	0	2	8	0	2	-1.0	0.0						CCC(NS(=O)(=O)c1cc2c(cc1)-c1c(cc(S(=O)(=O)NC(CC)C(=O)O)cc1)C2)C(=O)O		1.54		0.0	2.54	CHEMBL1707805																	0.0		307941-66-8		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	2	0	0	0	0	0	0	0	0	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	0		C21H24N2O8S2	C21H24N2O8S2			InChI=1S/C21H24N2O8S2/c1-3-18(20(24)25)22-32(28,29)14-5-7-16-12(10-14)9-13-11-15(6-8-17(13)16)33(30,31)23-19(4-2)21(26)27/h5-8,10-11,18-19,22-23H,3-4,9H2,1-2H3,(H,24,25)(H,26,27)	ZRBXMEJISUSWKV-UHFFFAOYSA-N	2-[[7-(1-carboxypropylsulfamoyl)-9H-fluoren-2-yl]sulfonylamino]butanoic acid	2857934	CCC(NS(=O)(=O)c1cc2c(cc1)-c1c(cc(S(=O)(=O)NC(CC)C(=O)O)cc1)C2)C(=O)O	2-[[7-(1-carboxypropylsulfamoyl)-9H-fluoren-2-yl]sulfonylamino]butanoic acid			0.8353400000000006													MCULE-2849401831	496.56203	ACID	496.097408	8	4	10	3	0.0		30										False			False	False	Peptide01		-1.0	Compound(2857934)	2857934	2.5	364			[#6]-[#6]-[#6](-[#7]-[#16](=[#8])(=[#8])-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1)-[#6]1:[#6](:[#6]:[#6](-[#16](=[#8])(=[#8])-[#7]-[#6](-[#6]-[#6])-[#6](=[#8])-[#8]):[#6]:[#6]:1)-[#6]-2)-[#6](=[#8])-[#8]	CCC(NS(=O)(=O)c1cc2c(cc1)-c1c(cc(S(=O)(=O)NC(CC)C(=O)O)cc1)C2)C(=O)O	ZRBXMEJISUSWKV		parent_pubchem_cid	307941-66-8;CBMicro_027179;Oprea1_241732;Oprea1_368785;MLS001204910;CHEMBL1707805;HMS2832I09;CCG-2803;2-[7-(1-Carboxy-propylsulfamoyl)-9H-fluorene-2-sulfonylamino]-butyric acid;AKOS000581542;AKOS016323519;SMR000514489;BIM-0026945.P001;2,2'-((9H-Fluorene-2,7-disulfonyl)bis(azanediyl))dibutanoic acid;2,2'-((9H-Fluorene-2,7-disulfonyl)bis(azanediyl))dibutanoicacid;2-{[(7-{[(1-CARBOXYPROPYL)AMINO]SULFONYL}-9H-FLUOREN-2-YL)SULFONYL]AMINO}BUTANOIC ACID;2-[[7-(1-carboxypropylsulfamoyl)-9H-fluoren-2-yl]sulfonylamino]butanoic acid	False	1041141.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=1041141		pluskal_iocb_peptide_Peptide01_B22_id		100	B22	False	
0.7		0	339	P7008500	114.3		I40	False	0	16	0	0	16	0	6	3	0	0		0.0						OCCNc1nc(NCc2cc3c(cc2)OCO3)nc2nccnc12																							0.0		2-({2-[(1,3-benzodioxol-5-ylmethyl)amino]pteridin-4-yl}amino)ethanol		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0		C16H16N6O3	C16H16N6O3			InChI=1S/C16H16N6O3/c23-6-5-19-15-13-14(18-4-3-17-13)21-16(22-15)20-8-10-1-2-11-12(7-10)25-9-24-11/h1-4,7,23H,5-6,8-9H2,(H2,18,19,20,21,22)	JWBVFNYESDWRIC-UHFFFAOYSA-N	2-[[2-(1,3-benzodioxol-5-ylmethylamino)pteridin-4-yl]amino]ethanol	39339510	OCCNc1nc(NCc2cc3c(cc2)OCO3)nc2nccnc12	2-[[2-(1,3-benzodioxol-5-ylmethylamino)pteridin-4-yl]amino]ethanol			-1.00437													MCULE-6539557752	340.34432		340.128388	9	3	6	4			44										False	Alkaloids	Pseudoalkaloids			Peptide01			Compound(39339510)	39339510	1.1	365			[#8]-[#6]-[#6]-[#7]-[#6]1:[#7]:[#6](-[#7]-[#6]-[#6]2:[#6]:[#6]3:[#6](:[#6]:[#6]:2)-[#8]-[#6]-[#8]-3):[#7]:[#6]2:[#7]:[#6]:[#6]:[#7]:[#6]:1:2	OCCNc1nc(NCc2cc3c(cc2)OCO3)nc2nccnc12	JWBVFNYESDWRIC		parent_pubchem_cid	2-({2-[(1,3-benzodioxol-5-ylmethyl)amino]pteridin-4-yl}amino)ethanol;1144468-88-1;AKOS002337417;2-[[2-(1,3-benzodioxol-5-ylmethylamino)pteridin-4-yl]amino]ethanol		5814410.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=5814410		pluskal_iocb_peptide_Peptide01_B22_id		100	B22		ZINC000032094575
5.0		0	83	P0127480111	44.5		I41	False	0	24	0	0	21	0	3	0	0	0	-1.0	0.0						Cc1c(C(c2ccccn2)c2c(C)[nH]c3ccccc23)c2ccccc2[nH]1	105262.0	5.84		0.0	4.99	CHEMBL1391179		Substituted pyrroles;Pyridines and derivatives;Benzenoids;Heteroaromatic compounds;Azacyclic compounds;Organopnictogen compounds;Organonitrogen compounds;Hydrocarbon derivatives	3-alkylindoles;Azacyclic compounds;Benzenoids;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Organic compounds;Organic nitrogen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organopnictogen compounds;Pyridines and derivatives;Pyrroles;Substituted pyrroles	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as 3-alkylindoles. These are compounds containing an indole moiety that carries an alkyl chain at the 3-position.	3-alkylindoles			Organic compounds	Aromatic heteropolycyclic compounds	pyrroles (CHEBI:26455);pyridines (CHEBI:26421);benzenoid aromatic compound (CHEBI:33836);organic aromatic compound (CHEBI:33659);organonitrogen heterocyclic compound (CHEBI:38101);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic molecule (CHEBI:72695);indoles (CHEBI:24828);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);nitrogen molecular entity (CHEBI:51143)		Indoles	3-alkylindole;Benzenoid;Substituted pyrrole;Pyridine;Heteroaromatic compound;Pyrrole;Azacycle;Organic nitrogen compound;Organopnictogen compound;Hydrocarbon derivative;Organonitrogen compound;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		104097-72-5		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0		C24H21N3	C24H21N3			InChI=1S/C24H21N3/c1-15-22(17-9-3-5-11-19(17)26-15)24(21-13-7-8-14-25-21)23-16(2)27-20-12-6-4-10-18(20)23/h3-14,24,26-27H,1-2H3	ZXPPRPGYRMWKNG-UHFFFAOYSA-N	2-methyl-3-[(2-methyl-1H-indol-3-yl)-(2-pyridyl)methyl]-1H-indole	2944687	Cc1c(C(c2ccccn2)c2c(C)[nH]c3ccccc23)c2ccccc2[nH]1	2-methyl-3-[(2-methyl-1H-indol-3-yl)-pyridin-2-ylmethyl]-1H-indole		LSM-16625	4.710850000000003													MCULE-4218420202	351.45507	NEUTRAL	351.173548	1	2	3	5	0.0		26									Carboline alkaloids	False	Alkaloids	Tryptophan alkaloids	False	False	Peptide01		-1.0	Compound(2944687)	2944687	5.3	366			[#6]-[#6]1:[#6](-[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#7]:2)-[#6]2:[#6](-[#6]):[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#7H]:1	Cc1c(C(c2ccccn2)c2c(C)[nH]c3ccccc23)c2ccccc2[nH]1	ZXPPRPGYRMWKNG		parent_pubchem_cid	104097-72-5;MLS000534864;2-methyl-3-[(2-methyl-1H-indol-3-yl)-(2-pyridinyl)methyl]-1H-indole;2-methyl-3-[(2-methyl-1H-indol-3-yl)-pyridin-2-ylmethyl]-1H-indole;SMR000142299;2-methyl-3-[(2-methyl-1H-indol-3-yl)(pyridin-2-yl)methyl]-1H-indole;3,3'-(2-pyridinylmethylene)bis(2-methyl-1H-indole);CHEMBL1391179;BDBM57233;cid_2944687;CHEBI:105262;HMS2330L17;2-methyl-3-[(2-methyl-1H-indol-3-yl)(2-pyridinyl)methyl]-1H-indole;STK520700;AKOS000357461;EU-0003980;AE-861/30098025;SR-01000424370;SR-01000424370-1;Q27182975;Z56802399;3,3'-(pyridin-2-ylmethanediyl)bis(2-methyl-1H-indole);3,3'-(pyridin-2-ylmethylene)bis(2-methyl-1H-indole);F0318-0157;2-methyl-3-[(2-methyl-1H-indol-3-yl)-(2-pyridyl)methyl]-1H-indole;2-methyl-3-[(2-methyl-1H-indol-3-yl)-pyridin-2-yl-methyl]-1H-indole	False	747877.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=747877		pluskal_iocb_peptide_Peptide01_B22_id		100	B22	False	ZINC000004116465
1.2		0	171	P7020554638	84.2		I42	False	0	15	0	0	17	0	3	3	0	0		0.0						CC(=O)NC(Cc1ccccc1)C(=O)Nc1noc(C)c1																							0.0		AKOS005587754		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C15H17N3O3	C15H17N3O3			InChI=1S/C15H17N3O3/c1-10-8-14(18-21-10)17-15(20)13(16-11(2)19)9-12-6-4-3-5-7-12/h3-8,13H,9H2,1-2H3,(H,16,19)(H,17,18,20)/t13-/m0/s1	AYRYWAHBFAKVLV-ZDUSSCGKSA-N	(2S)-2-acetamido-N-(5-methylisoxazol-3-yl)-3-phenyl-propanamide	24315151	CC(=O)N[C@@H](Cc1ccccc1)C(=O)Nc1noc(C)c1	(2S)-2-acetamido-N-(5-methyl-1,2-oxazol-3-yl)-3-phenylpropanamide			1.1788899999999998													MCULE-4154117351	287.32104		287.126991	3	2	5	2			44										False					Peptide01			Compound(24315151)	24315151	1.6	367			[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#7]-[#6]1:[#7]:[#8]:[#6](-[#6]):[#6]:1	CC(=O)N[C@@H](Cc1ccccc1)C(=O)Nc1noc(C)c1	AYRYWAHBFAKVLV		parent_pubchem_cid	AKOS005587754;(2S)-2-acetamido-N-(5-methylisoxazol-3-yl)-3-phenyl-propanamide		3378012.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=3378012		pluskal_iocb_peptide_Peptide01_B22_id		100	B22		ZINC000012028700
4.0		0	259	P1305422	67.3		I43	False	0	22	0	0	20	0	2	3	0	0		0.0						COc1ccc(C(CNC(=O)c2ccco2)c2c[nH]c3ccccc23)cc1																							0.0		N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]furan-2-carboxamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C22H20N2O3	C22H20N2O3			InChI=1S/C22H20N2O3/c1-26-16-10-8-15(9-11-16)18(13-24-22(25)21-7-4-12-27-21)19-14-23-20-6-3-2-5-17(19)20/h2-12,14,18,23H,13H2,1H3,(H,24,25)	QJXDVFHZPAYCQF-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]furan-2-carboxamide	4878868	COc1ccc(C(CNC(=O)c2ccco2)c2c[nH]c3ccccc23)cc1	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]furan-2-carboxamide			3.276440000000002													MCULE-1412231183	360.4163		360.147393	2	2	6	4			44									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(4878868)	4878868	4.1	368			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6]-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#8]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	COc1ccc(C(CNC(=O)c2ccco2)c2c[nH]c3ccccc23)cc1	QJXDVFHZPAYCQF		parent_pubchem_cid	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]furan-2-carboxamide;796091-54-8;STL207529;AKOS002335508;AKOS016326666;Z30425468		24137269.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24137269		pluskal_iocb_peptide_Peptide01_B23_id		100	B23		
4.6		0	347	P4797232	75.2		I44	False	0	22	1	1	24	0	6	1	0	0		0.0						CC(C)c1ccc(Nc2nc(Nc3cc(Cl)c(F)cc3)nc(N3CCOCC3)n2)cc1																							0.0		898648-11-8		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1		C22H24ClFN6O	C22H24ClFN6O			InChI=1S/C22H24ClFN6O/c1-14(2)15-3-5-16(6-4-15)25-20-27-21(26-17-7-8-19(24)18(23)13-17)29-22(28-20)30-9-11-31-12-10-30/h3-8,13-14H,9-12H2,1-2H3,(H2,25,26,27,28,29)	MAQUZRJCJTVXHO-UHFFFAOYSA-N	N4-(3-chloro-4-fluoro-phenyl)-N2-(4-isopropylphenyl)-6-morpholino-1,3,5-triazine-2,4-diamine	18580152	CC(C)c1ccc(Nc2nc(Nc3cc(Cl)c(F)cc3)nc(N3CCOCC3)n2)cc1	2-N-(3-chloro-4-fluorophenyl)-6-morpholin-4-yl-4-N-(4-propan-2-ylphenyl)-1,3,5-triazine-2,4-diamine			3.1535400000000013													MCULE-1353449339	442.92758		442.168415	7	2	6	4			44										False					Peptide01			Compound(18580152)	18580152	5.7	369			[#6]-[#6](-[#6])-[#6]1:[#6]:[#6]:[#6](-[#7]-[#6]2:[#7]:[#6](-[#7]-[#6]3:[#6]:[#6](-[#17]):[#6](-[#9]):[#6]:[#6]:3):[#7]:[#6](-[#7]3-[#6]-[#6]-[#8]-[#6]-[#6]-3):[#7]:2):[#6]:[#6]:1	CC(C)c1ccc(Nc2nc(Nc3cc(Cl)c(F)cc3)nc(N3CCOCC3)n2)cc1	MAQUZRJCJTVXHO		parent_pubchem_cid	898648-11-8;N2-(3-chloro-4-fluorophenyl)-N4-(4-isopropylphenyl)-6-morpholino-1,3,5-triazine-2,4-diamine;2-N-(3-chloro-4-fluorophenyl)-6-morpholin-4-yl-4-N-(4-propan-2-ylphenyl)-1,3,5-triazine-2,4-diamine;N2-(3-chloro-4-fluorophenyl)-6-(morpholin-4-yl)-N4-[4-(propan-2-yl)phenyl]-1,3,5-triazine-2,4-diamine;AKOS016376358;F2703-0256;N4-(3-chloro-4-fluoro-phenyl)-N2-(4-isopropylphenyl)-6-morpholino-1,3,5-triazine-2,4-diamine		6973642.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=6973642		pluskal_iocb_peptide_Peptide01_B23_id		100	B23		ZINC000009708836
1.3		0	355	P1094967	139.3		J1	False	0	18	0	0	32	0	4	6	0	0		0.0						CCC(C)C(NC(=O)N1CCN(C(=O)NC(C(=O)O)C(C)CC)CC1)C(=O)O																							0.0		AKOS005533484		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	4	0	2	0	0	0	0	0	0	0	0	4	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C18H32N4O6	C18H32N4O6			InChI=1S/C18H32N4O6/c1-5-11(3)13(15(23)24)19-17(27)21-7-9-22(10-8-21)18(28)20-14(16(25)26)12(4)6-2/h11-14H,5-10H2,1-4H3,(H,19,27)(H,20,28)(H,23,24)(H,25,26)/t11?,12?,13-,14-/m0/s1	UDOHCOMMOSAQOZ-HOAMVYINSA-N	rac-(2S)-3-methyl-2-[[4-[[rac-(1S)-1-carboxy-2-methyl-butyl]carbamoyl]piperazine-1-carbonyl]amino]pentanoic acid	17578609	CCC(C)[C@H](NC(=O)N1CCN(C(=O)N[C@H](C(=O)O)C(C)CC)CC1)C(=O)O	(2S)-2-[[4-[[(1S)-1-carboxy-2-methylbutyl]carbamoyl]piperazine-1-carbonyl]amino]-3-methylpentanoic acid			1.0218000000000012														400.47894		400.232185	6	4	8	1			46									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(17578609)	17578609	1.3	370			[#6]-[#6]-[#6](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#7]1-[#6]-[#6]-[#7](-[#6](=[#8])-[#7]-[#6@H](-[#6](=[#8])-[#8])-[#6](-[#6])-[#6]-[#6])-[#6]-[#6]-1)-[#6](=[#8])-[#8]	CCC(C)[C@H](NC(=O)N1CCN(C(=O)N[C@H](C(=O)O)C(C)CC)CC1)C(=O)O	UDOHCOMMOSAQOZ		parent_pubchem_cid	AKOS005533484;rac-(2S)-3-methyl-2-[[4-[[rac-(1S)-1-carboxy-2-methyl-butyl]carbamoyl]piperazine-1-carbonyl]amino]pentanoic acid		24019545.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24019545		pluskal_iocb_peptide_Peptide01_B23_id		100	B23		
5.0		0	443	P2195915	109.3		J2	False	0	23	1	0	23	0	4	2	0	1		0.0						CCCSc1ncc(Cl)c(C(=O)NC(Cc2ccccc2)C(=O)Nc2ccccc2)n1																							0.0		STL219373		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C23H23ClN4O2S	C23H23ClN4O2S			InChI=1S/C23H23ClN4O2S/c1-2-13-31-23-25-15-18(24)20(28-23)22(30)27-19(14-16-9-5-3-6-10-16)21(29)26-17-11-7-4-8-12-17/h3-12,15,19H,2,13-14H2,1H3,(H,26,29)(H,27,30)	JRRSESFMHVLRCX-UHFFFAOYSA-N	N-(2-anilino-1-benzyl-2-oxo-ethyl)-5-chloro-2-propylsulfanyl-pyrimidine-4-carboxamide	52988649	CCCSc1ncc(Cl)c(C(=O)NC(Cc2ccccc2)C(=O)Nc2ccccc2)n1	N-(1-anilino-1-oxo-3-phenylpropan-2-yl)-5-chloro-2-propylsulfanylpyrimidine-4-carboxamide			4.013860000000002													MCULE-6104306532	454.98236		454.123025	5	2	9	3			45										False					Peptide01			Compound(52988649)	52988649	5.1	371			[#6]-[#6]-[#6]-[#16]-[#6]1:[#7]:[#6]:[#6](-[#17]):[#6](-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#7]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#7]:1	CCCSc1ncc(Cl)c(C(=O)NC(Cc2ccccc2)C(=O)Nc2ccccc2)n1	JRRSESFMHVLRCX		parent_pubchem_cid	STL219373;AKOS015861747;Nalpha-{[5-chloro-2-(propylsulfanyl)pyrimidin-4-yl]carbonyl}-N-phenylphenylalaninamide;N-(2-anilino-1-benzyl-2-oxo-ethyl)-5-chloro-2-propylsulfanyl-pyrimidine-4-carboxamide		23429095.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23429095		pluskal_iocb_peptide_Peptide01_B23_id		100	B23		
4.9		0	531	P2195184	58.2		J3	False	1	23	0	0	21	0	2	2	0	0		0.0						Cc1ccc(C(=O)NC(Cc2ccccc2)C(=O)Nc2ccc(Br)cc2)cc1																							0.0		1246644-35-8		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C23H21BrN2O2	C23H21BrN2O2			InChI=1S/C23H21BrN2O2/c1-16-7-9-18(10-8-16)22(27)26-21(15-17-5-3-2-4-6-17)23(28)25-20-13-11-19(24)12-14-20/h2-14,21H,15H2,1H3,(H,25,28)(H,26,27)	LUBJICQREMXMMS-UHFFFAOYSA-N	N-[1-benzyl-2-(4-bromoanilino)-2-oxo-ethyl]-4-methyl-benzamide	51065701	Cc1ccc(C(=O)NC(Cc2ccccc2)C(=O)Nc2ccc(Br)cc2)cc1	N-[1-(4-bromoanilino)-1-oxo-3-phenylpropan-2-yl]-4-methylbenzamide			4.192580000000003													MCULE-1526415495	437.34002		436.07864	2	2	6	3			45										False	Amino acids and Peptides				Peptide01			Compound(51065701)	51065701	5.1	372			[#6]-[#6]1:[#6]:[#6]:[#6](-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#7]-[#6]2:[#6]:[#6]:[#6](-[#35]):[#6]:[#6]:2):[#6]:[#6]:1	Cc1ccc(C(=O)NC(Cc2ccccc2)C(=O)Nc2ccc(Br)cc2)cc1	LUBJICQREMXMMS		parent_pubchem_cid	1246644-35-8;Benzenepropanamide, N-(4-bromophenyl)-alpha-[(4-methylbenzoyl)amino]-;DTXSID301177996;AKOS015861446;N-(4-Bromophenyl)-alpha-[(4-methylbenzoyl)amino]benzenepropanamide;N-[1-benzyl-2-(4-bromoanilino)-2-oxo-ethyl]-4-methyl-benzamide		24770648.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24770648		pluskal_iocb_peptide_Peptide01_B23_id		100	B23		
4.2		0	619	P1305565	36.1		J4	False	0	20	0	0	22	0	2	1	0	0	-1.0	0.0						CC(C)C(=O)N(C)C(c1ccccc1)c1c[nH]c2ccccc12		4.37		0.0	4.27	CHEMBL1725440																	0.0		MLS-0435776.0001		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C20H22N2O	C20H22N2O			InChI=1S/C20H22N2O/c1-14(2)20(23)22(3)19(15-9-5-4-6-10-15)17-13-21-18-12-8-7-11-16(17)18/h4-14,19,21H,1-3H3	FNNOWYKYJIUIGI-UHFFFAOYSA-N	N-[1H-indol-3-yl(phenyl)methyl]-N,2-dimethyl-propanamide	17014704	CC(C)C(=O)N(C)C(c1ccccc1)c1c[nH]c2ccccc12	N-[1H-indol-3-yl(phenyl)methyl]-N,2-dimethylpropanamide			3.833860000000003													MCULE-9313628326	306.41114	NEUTRAL	306.173213	1	1	4	3	0.0		29									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids	False	False	Peptide01		-1.0	Compound(17014704)	17014704	4.1	373			[#6]-[#6](-[#6])-[#6](=[#8])-[#7](-[#6])-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CC(C)C(=O)N(C)C(c1ccccc1)c1c[nH]c2ccccc12	FNNOWYKYJIUIGI		parent_pubchem_cid	MLS-0435776.0001;N-[1H-indol-3-yl(phenyl)methyl]-N,2-dimethylpropanamide;CHEMBL1725440;BDBM67415;cid_17014704;STL207667;AKOS001911809;AKOS016326736;NCGC00277586-01;AB01282171-01;N-[1H-indol-3-yl(phenyl)methyl]-N,2-dimethyl-propanamide;N-[1H-indol-3-yl(phenyl)methyl]-N,2-dimethyl-propionamide;N-[(1H-INDOL-3-YL)(PHENYL)METHYL]-N,2-DIMETHYLPROPANAMIDE	False	1018756.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=1018756		pluskal_iocb_peptide_Peptide01_B23_id		100	B23	False	
3.5		0	363	P6299551	172.8		J5	False	0	23	0	0	21	0	1	7	0	2		0.0						COc1c(OCc2ccccc2)ccc(C2c3c([nH]c(=O)s3)SCC2(CC(=O)O)C(=O)O)c1																							0.0		AKOS016384155		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	1	0	0	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C23H21NO7S2	C23H21NO7S2			InChI=1S/C23H21NO7S2/c1-30-16-9-14(7-8-15(16)31-11-13-5-3-2-4-6-13)18-19-20(24-22(29)33-19)32-12-23(18,21(27)28)10-17(25)26/h2-9,18H,10-12H2,1H3,(H,24,29)(H,25,26)(H,27,28)	YFNWUOJJUKBOHC-UHFFFAOYSA-N	7-(4-benzyloxy-3-methoxy-phenyl)-6-(carboxymethyl)-2-oxo-5,7-dihydro-3H-thiopyrano[2,3-d]thiazole-6-carboxylic acid	75465130	COc1c(OCc2ccccc2)ccc(C2c3c([nH]c(=O)s3)SCC2(CC(=O)O)C(=O)O)c1	6-(carboxymethyl)-7-(3-methoxy-4-phenylmethoxyphenyl)-2-oxo-5,7-dihydro-3H-thiopyrano[2,3-d][1,3]thiazole-6-carboxylic acid			3.510230000000001													MCULE-1819446818	487.55432		487.075944	9	3	8	4			45										False	Alkaloids				Peptide01			Compound(75465130)	75465130	2.8	374			[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6]:[#6]:[#6](-[#6]2-[#6]3:[#6](:[#7H]:[#6](=[#8]):[#16]:3)-[#16]-[#6]-[#6]-2(-[#6]-[#6](=[#8])-[#8])-[#6](=[#8])-[#8]):[#6]:1	COc1c(OCc2ccccc2)ccc(C2c3c([nH]c(=O)s3)SCC2(CC(=O)O)C(=O)O)c1	YFNWUOJJUKBOHC		parent_pubchem_cid	AKOS016384155;7-(4-benzyloxy-3-methoxy-phenyl)-6-(carboxymethyl)-2-oxo-5,7-dihydro-3H-thiopyrano[2,3-d]thiazole-6-carboxylic acid		80389936.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=80389936		pluskal_iocb_peptide_Peptide01_B23_id		100	B23		
1.8		0	451	P2195933	123.2		J6	False	0	22	0	0	26	0	2	7	0	0		0.0						COc1cc(C(=O)NCCC(=O)NC(Cc2ccccc2)C(=O)O)cc(OC)c1OC																							0.0		AKOS015861811		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C22H26N2O7	C22H26N2O7			InChI=1S/C22H26N2O7/c1-29-17-12-15(13-18(30-2)20(17)31-3)21(26)23-10-9-19(25)24-16(22(27)28)11-14-7-5-4-6-8-14/h4-8,12-13,16H,9-11H2,1-3H3,(H,23,26)(H,24,25)(H,27,28)	DBRLCIGSAPFICM-UHFFFAOYSA-N	3-phenyl-2-[3-[(3,4,5-trimethoxybenzoyl)amino]propanoylamino]propanoic acid	52988658	COc1cc(C(=O)NCCC(=O)NC(Cc2ccccc2)C(=O)O)cc(OC)c1OC	3-phenyl-2-[3-[(3,4,5-trimethoxybenzoyl)amino]propanoylamino]propanoic acid			0.1477500000000022													MCULE-8693238800	430.46172		430.174001	7	3	11	2			45										False	Alkaloids				Peptide01			Compound(52988658)	52988658	1.9	375			[#6]-[#8]-[#6]1:[#6]:[#6](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#8]):[#6]:[#6](-[#8]-[#6]):[#6]:1-[#8]-[#6]	COc1cc(C(=O)NCCC(=O)NC(Cc2ccccc2)C(=O)O)cc(OC)c1OC	DBRLCIGSAPFICM		parent_pubchem_cid	AKOS015861811;3-phenyl-2-[3-[(3,4,5-trimethoxybenzoyl)amino]propanoylamino]propanoic acid		22901509.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22901509		pluskal_iocb_peptide_Peptide01_B23_id		100	B23		
4.7		0	539	P2196115	134.6		J7	False	0	21	1	0	27	0	4	2	0	2		0.0						CCCSc1ncc(Cl)c(C(=O)NC(CCSC)C(=O)Nc2ccc(CC)cc2)n1																							0.0		AKOS016027436		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C21H27ClN4O2S2	C21H27ClN4O2S2			InChI=1S/C21H27ClN4O2S2/c1-4-11-30-21-23-13-16(22)18(26-21)20(28)25-17(10-12-29-3)19(27)24-15-8-6-14(5-2)7-9-15/h6-9,13,17H,4-5,10-12H2,1-3H3,(H,24,27)(H,25,28)	GAZAKBFKXVLEDU-UHFFFAOYSA-N	5-chloro-N-[1-[(4-ethylphenyl)carbamoyl]-3-methylsulfanyl-propyl]-2-propylsulfanyl-pyrimidine-4-carboxamide	52988684	CCCSc1ncc(Cl)c(C(=O)NC(CCSC)C(=O)Nc2ccc(CC)cc2)n1	5-chloro-N-[1-(4-ethylanilino)-4-methylsulfanyl-1-oxobutan-2-yl]-2-propylsulfanylpyrimidine-4-carboxamide			4.086660000000003													MCULE-8948163983	467.05594		466.126396	6	2	11	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(52988684)	52988684	4.9	376			[#6]-[#6]-[#6]-[#16]-[#6]1:[#7]:[#6]:[#6](-[#17]):[#6](-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]-[#16]-[#6])-[#6](=[#8])-[#7]-[#6]2:[#6]:[#6]:[#6](-[#6]-[#6]):[#6]:[#6]:2):[#7]:1	CCCSc1ncc(Cl)c(C(=O)NC(CCSC)C(=O)Nc2ccc(CC)cc2)n1	GAZAKBFKXVLEDU		parent_pubchem_cid	AKOS016027436;5-chloro-N-[1-[(4-ethylphenyl)carbamoyl]-3-methylsulfanyl-propyl]-2-propylsulfanyl-pyrimidine-4-carboxamide		23948474.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23948474		pluskal_iocb_peptide_Peptide01_B24_id		100	B24		
4.4		0	627	P7119981888	72.1		J8	False	0	26	0	0	29	0	1	4	0	1		0.0						CC(C)COc1ccc(C(=O)N(Cc2cccc3ccccc23)C2CCS(=O)(=O)C2)cc1																							0.0		AKOS002277763		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0		C26H29NO4S	C26H29NO4S			InChI=1S/C26H29NO4S/c1-19(2)17-31-24-12-10-21(11-13-24)26(28)27(23-14-15-32(29,30)18-23)16-22-8-5-7-20-6-3-4-9-25(20)22/h3-13,19,23H,14-18H2,1-2H3	MGJKEIHRHPCHFX-UHFFFAOYSA-N	N-(1,1-dioxothiolan-3-yl)-4-isobutoxy-N-(1-naphthylmethyl)benzamide	16445250	CC(C)COc1ccc(C(=O)N(Cc2cccc3ccccc23)C2CCS(=O)(=O)C2)cc1	N-(1,1-dioxothiolan-3-yl)-4-(2-methylpropoxy)-N-(naphthalen-1-ylmethyl)benzamide			3.7038500000000014													MCULE-7467857276	451.58933		451.181729	4	0	7	4			45										False					Peptide01			Compound(16445250)	16445250	5.0	377			[#6]-[#6](-[#6])-[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](=[#8])-[#7](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6]2-[#6]-[#6]-[#16](=[#8])(=[#8])-[#6]-2):[#6]:[#6]:1	CC(C)COc1ccc(C(=O)N(Cc2cccc3ccccc23)C2CCS(=O)(=O)C2)cc1	MGJKEIHRHPCHFX		parent_pubchem_cid	AKOS002277763;AKOS016309968;N-(1,1-dioxothiolan-3-yl)-4-isobutoxy-N-(1-naphthylmethyl)benzamide		23665512.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23665512		pluskal_iocb_peptide_Peptide01_B24_id		100	B24		
3.2		0	371	P11185103	148.9		J9	False	0	22	0	0	20	0	4	4	0	1		0.0						O=C(CCSc1nc(=O)c2ccccc2[nH]1)NC(Cc1c[nH]c2ccccc12)C(=O)O																							0.0		rac-(2S)-3-(1H-indol-3-yl)-2-[3-[(4-oxo-3H-quinazolin-2-yl)sulfanyl]propanoylamino]propanoic acid		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	0	0	0	0	0	0	0		C22H20N4O4S	C22H20N4O4S			InChI=1S/C22H20N4O4S/c27-19(9-10-31-22-25-17-8-4-2-6-15(17)20(28)26-22)24-18(21(29)30)11-13-12-23-16-7-3-1-5-14(13)16/h1-8,12,18,23H,9-11H2,(H,24,27)(H,29,30)(H,25,26,28)/t18-/m0/s1	SJJODFDFZORGLF-SFHVURJKSA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[3-[(4-oxo-3H-quinazolin-2-yl)sulfanyl]propanoylamino]propanoic acid	100002648	O=C(CCSc1nc(=O)c2ccccc2[nH]1)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	(2S)-3-(1H-indol-3-yl)-2-[3-[(4-oxo-1H-quinazolin-2-yl)sulfanyl]propanoylamino]propanoic acid			2.5790300000000004														436.4931		436.120526	6	4	8	4			45										False	Alkaloids				Peptide01			Compound(100002648)	100002648	2.6	378			[#8]=[#6](-[#6]-[#6]-[#16]-[#6]1:[#7]:[#6](=[#8]):[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#7H]:1)-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	O=C(CCSc1nc(=O)c2ccccc2[nH]1)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	SJJODFDFZORGLF		parent_pubchem_cid	rac-(2S)-3-(1H-indol-3-yl)-2-[3-[(4-oxo-3H-quinazolin-2-yl)sulfanyl]propanoylamino]propanoic acid		101975800.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=101975800		pluskal_iocb_peptide_Peptide01_B24_id		100	B24		ZINC000218063437
4.3		0	459	P2196108	134.6		J10	False	1	20	0	0	25	0	4	2	0	2		0.0						CCCSc1ncc(Br)c(C(=O)NC(CCSC)C(=O)Nc2ccc(C)cc2)n1																							0.0		AKOS016027286		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C20H25BrN4O2S2	C20H25BrN4O2S2			InChI=1S/C20H25BrN4O2S2/c1-4-10-29-20-22-12-15(21)17(25-20)19(27)24-16(9-11-28-3)18(26)23-14-7-5-13(2)6-8-14/h5-8,12,16H,4,9-11H2,1-3H3,(H,23,26)(H,24,27)	UTWOGHZGSPJNDH-UHFFFAOYSA-N	5-bromo-N-[3-methylsulfanyl-1-(p-tolylcarbamoyl)propyl]-2-propylsulfanyl-pyrimidine-4-carboxamide	52988679	CCCSc1ncc(Br)c(C(=O)NC(CCSC)C(=O)Nc2ccc(C)cc2)n1	5-bromo-N-[1-(4-methylanilino)-4-methylsulfanyl-1-oxobutan-2-yl]-2-propylsulfanylpyrimidine-4-carboxamide			3.941780000000003													MCULE-6797962507	497.47985		496.06023	6	2	10	2			45										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(52988679)	52988679	4.6	379			[#6]-[#6]-[#6]-[#16]-[#6]1:[#7]:[#6]:[#6](-[#35]):[#6](-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]-[#16]-[#6])-[#6](=[#8])-[#7]-[#6]2:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:2):[#7]:1	CCCSc1ncc(Br)c(C(=O)NC(CCSC)C(=O)Nc2ccc(C)cc2)n1	UTWOGHZGSPJNDH		parent_pubchem_cid	AKOS016027286;5-bromo-N-[3-methylsulfanyl-1-(p-tolylcarbamoyl)propyl]-2-propylsulfanyl-pyrimidine-4-carboxamide		24555538.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24555538		pluskal_iocb_peptide_Peptide01_B24_id		100	B24		
3.1		0	547	P2195808	151.1		J11	False	0	21	1	0	25	0	4	4	0	1		0.0						CC(C)CC(NC(=O)c1ccc(Cl)cc1)C(=O)NCCC(=O)ON=C(N)c1cccs1																							0.0		AKOS015861918		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C21H25ClN4O4S	C21H25ClN4O4S			InChI=1S/C21H25ClN4O4S/c1-13(2)12-16(25-20(28)14-5-7-15(22)8-6-14)21(29)24-10-9-18(27)30-26-19(23)17-4-3-11-31-17/h3-8,11,13,16H,9-10,12H2,1-2H3,(H2,23,26)(H,24,29)(H,25,28)	AXUQYOMGCAWXKB-UHFFFAOYSA-N	[(Z)-[amino(2-thienyl)methylene]amino] 3-[[2-[(4-chlorobenzoyl)amino]-4-methyl-pentanoyl]amino]propanoate	52988610	CC(C)CC(NC(=O)c1ccc(Cl)cc1)C(=O)NCCC(=O)O/N=C(\N)c1cccs1	[(Z)-[amino(thiophen-2-yl)methylidene]amino] 3-[[2-[(4-chlorobenzoyl)amino]-4-methylpentanoyl]amino]propanoate			2.8065800000000003													MCULE-3475524816	464.9748		464.128504	6	3	11	2			45										False	Alkaloids;Amino acids and Peptides	Small peptides			Peptide01			Compound(52988610)	52988610	3.8	380			[#6]-[#6](-[#6])-[#6]-[#6](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#17]):[#6]:[#6]:1)-[#6](=[#8])-[#7]-[#6]-[#6]-[#6](=[#8])-[#8]/[#7]=[#6](\[#7])-[#6]1:[#6]:[#6]:[#6]:[#16]:1	CC(C)CC(NC(=O)c1ccc(Cl)cc1)C(=O)NCCC(=O)O/N=C(\N)c1cccs1	AXUQYOMGCAWXKB		parent_pubchem_cid	AKOS015861918;[(Z)-[amino(2-thienyl)methylene]amino] 3-[[2-[(4-chlorobenzoyl)amino]-4-methyl-pentanoyl]amino]propanoate		23880068.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23880068		pluskal_iocb_peptide_Peptide01_B24_id		100	B24		
4.9		0	635	P1306928	73.6		J12	False	0	23	0	0	22	0	2	2	0	1		0.0						Cc1ccc(OCC(=O)N(C)C(c2cccs2)c2c[nH]c3ccccc23)cc1																							0.0		STL207995		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C23H22N2O2S	C23H22N2O2S			InChI=1S/C23H22N2O2S/c1-16-9-11-17(12-10-16)27-15-22(26)25(2)23(21-8-5-13-28-21)19-14-24-20-7-4-3-6-18(19)20/h3-14,23-24H,15H2,1-2H3	OSGNCGZRSJIKDP-UHFFFAOYSA-N	N-[1H-indol-3-yl(2-thienyl)methyl]-N-methyl-2-(4-methylphenoxy)acetamide	20895179	Cc1ccc(OCC(=O)N(C)C(c2cccs2)c2c[nH]c3ccccc23)cc1	N-[1H-indol-3-yl(thiophen-2-yl)methyl]-N-methyl-2-(4-methylphenoxy)acetamide			4.109660000000003													MCULE-7784923212	390.50799		390.140199	2	1	6	4			45										False	Alkaloids				Peptide01			Compound(20895179)	20895179	4.8	381			[#6]-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]-[#6](=[#8])-[#7](-[#6])-[#6](-[#6]2:[#6]:[#6]:[#6]:[#16]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	Cc1ccc(OCC(=O)N(C)C(c2cccs2)c2c[nH]c3ccccc23)cc1	OSGNCGZRSJIKDP		parent_pubchem_cid	STL207995;AKOS001912612;AKOS016329523;N-[(1H-INDOL-3-YL)(THIOPHEN-2-YL)METHYL]-N-METHYL-2-(4-METHYLPHENOXY)ACETAMIDE;N-[1H-indol-3-yl(thiophen-2-yl)methyl]-N-methyl-2-(4-methylphenoxy)acetamide;N-[1H-indol-3-yl(2-thienyl)methyl]-N-methyl-2-(4-methylphenoxy)acetamide		23868215.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23868215		pluskal_iocb_peptide_Peptide01_B24_id		100	B24		
3.2		0	379	P1157640	115.8		J13	False	0	25	0	0	27	0	3	5	0	0		0.0						O=C(NC(Cc1ccccc1)C(=O)O)C1CCC(Cn2c(=O)[nH]c3ccccc3c2=O)CC1																							0.0		AKOS005540841		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	4	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0		C25H27N3O5	C25H27N3O5			InChI=1S/C25H27N3O5/c29-22(26-21(24(31)32)14-16-6-2-1-3-7-16)18-12-10-17(11-13-18)15-28-23(30)19-8-4-5-9-20(19)27-25(28)33/h1-9,17-18,21H,10-15H2,(H,26,29)(H,27,33)(H,31,32)/t17?,18?,21-/m0/s1	SJQXXJXXLMEDFO-NGICGMGXSA-N	rac-(2S)-2-[[4-[(2,4-dioxo-1H-quinazolin-3-yl)methyl]cyclohexanecarbonyl]amino]-3-phenyl-propanoic acid	17577252	O=C(N[C@@H](Cc1ccccc1)C(=O)O)C1CCC(Cn2c(=O)[nH]c3ccccc3c2=O)CC1	(2S)-2-[[4-[(2,4-dioxo-1H-quinazolin-3-yl)methyl]cyclohexanecarbonyl]amino]-3-phenylpropanoic acid			3.624950000000002													MCULE-2713077594	449.51104		449.195071	5	3	7	4			44										False					Peptide01			Compound(17577252)	17577252	3.0	382			[#8]=[#6](-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8])-[#6]1-[#6]-[#6]-[#6](-[#6]-[#7]2:[#6](=[#8]):[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3:[#6]:2=[#8])-[#6]-[#6]-1	O=C(N[C@@H](Cc1ccccc1)C(=O)O)C1CCC(Cn2c(=O)[nH]c3ccccc3c2=O)CC1	SJQXXJXXLMEDFO		parent_pubchem_cid	AKOS005540841;AKOS016402573;AKOS032394616;N-({trans-4-[(2,4-dioxo-1,4-dihydroquinazolin-3(2H)-yl)methyl]cyclohexyl}carbonyl)-L-phenylalanine;(S)-2-(4-((2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)methyl)cyclohexanecarboxamido)-3-phenylpropanoic acid;rac-(2S)-2-[[4-[(2,4-dioxo-1H-quinazolin-3-yl)methyl]cyclohexanecarbonyl]amino]-3-phenyl-propanoic acid		22978688.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22978688		pluskal_iocb_peptide_Peptide01_B24_id		100	B24		ZINC000013814633
4.3		0	467	P2196140	134.6		J14	False	1	20	0	0	25	0	4	2	0	2		0.0						CCCSc1ncc(Br)c(C(=O)NC(CCSC)C(=O)Nc2cccc(C)c2)n1																							0.0		AKOS016027267		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C20H25BrN4O2S2	C20H25BrN4O2S2			InChI=1S/C20H25BrN4O2S2/c1-4-9-29-20-22-12-15(21)17(25-20)19(27)24-16(8-10-28-3)18(26)23-14-7-5-6-13(2)11-14/h5-7,11-12,16H,4,8-10H2,1-3H3,(H,23,26)(H,24,27)	AURWZUJIYCYHAH-UHFFFAOYSA-N	5-bromo-N-[3-methylsulfanyl-1-(m-tolylcarbamoyl)propyl]-2-propylsulfanyl-pyrimidine-4-carboxamide	52988693	CCCSc1ncc(Br)c(C(=O)NC(CCSC)C(=O)Nc2cccc(C)c2)n1	5-bromo-N-[1-(3-methylanilino)-4-methylsulfanyl-1-oxobutan-2-yl]-2-propylsulfanylpyrimidine-4-carboxamide			3.941780000000003													MCULE-1436814467	497.47985		496.06023	6	2	10	2			45										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(52988693)	52988693	4.6	383			[#6]-[#6]-[#6]-[#16]-[#6]1:[#7]:[#6]:[#6](-[#35]):[#6](-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]-[#16]-[#6])-[#6](=[#8])-[#7]-[#6]2:[#6]:[#6]:[#6]:[#6](-[#6]):[#6]:2):[#7]:1	CCCSc1ncc(Br)c(C(=O)NC(CCSC)C(=O)Nc2cccc(C)c2)n1	AURWZUJIYCYHAH		parent_pubchem_cid	AKOS016027267;5-bromo-N-[3-methylsulfanyl-1-(m-tolylcarbamoyl)propyl]-2-propylsulfanyl-pyrimidine-4-carboxamide		24597006.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24597006		pluskal_iocb_peptide_Peptide01_B24_id		100	B24		
3.3		0	555	P7553758	91.9		J15	False	0	15	0	0	23	0	1	4	0	1		0.0						CCCCC(NS(=O)(=O)c1ccc(C(C)C)cc1)C(=O)O																							0.0		AKOS008943122		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0		C15H23NO4S	C15H23NO4S			InChI=1S/C15H23NO4S/c1-4-5-6-14(15(17)18)16-21(19,20)13-9-7-12(8-10-13)11(2)3/h7-11,14,16H,4-6H2,1-3H3,(H,17,18)	HLWDZYYWCSAAEB-UHFFFAOYSA-N	2-[(4-isopropylphenyl)sulfonylamino]hexanoic acid	43386724	CCCCC(NS(=O)(=O)c1ccc(C(C)C)cc1)C(=O)O	2-[(4-propan-2-ylphenyl)sulfonylamino]hexanoic acid			2.5689800000000007														313.41886		313.134779	4	2	8	1			46										False	Amino acids and Peptides				Peptide01			Compound(43386724)	43386724	3.4	384			[#6]-[#6]-[#6]-[#6]-[#6](-[#7]-[#16](=[#8])(=[#8])-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6])-[#6]):[#6]:[#6]:1)-[#6](=[#8])-[#8]	CCCCC(NS(=O)(=O)c1ccc(C(C)C)cc1)C(=O)O	HLWDZYYWCSAAEB		parent_pubchem_cid	AKOS008943122;2-[(4-isopropylphenyl)sulfonylamino]hexanoic acid		50870063.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=50870063		pluskal_iocb_peptide_Peptide01_C1_id		100	C1		
4.5		0	643	P1309976	92.0		J16	False	0	24	0	0	24	0	2	4	0	1		0.0						COc1cc(C(=O)N(C)C(c2cccs2)c2c[nH]c3ccccc23)cc(OC)c1OC																							0.0		AKOS001910897		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C24H24N2O4S	C24H24N2O4S			InChI=1S/C24H24N2O4S/c1-26(24(27)15-12-19(28-2)23(30-4)20(13-15)29-3)22(21-10-7-11-31-21)17-14-25-18-9-6-5-8-16(17)18/h5-14,22,25H,1-4H3	NXOJMVJWZGEDQJ-UHFFFAOYSA-N	N-[1H-indol-3-yl(2-thienyl)methyl]-3,4,5-trimethoxy-N-methyl-benzamide	20895182	COc1cc(C(=O)N(C)C(c2cccs2)c2c[nH]c3ccccc23)cc(OC)c1OC	N-[1H-indol-3-yl(thiophen-2-yl)methyl]-3,4,5-trimethoxy-N-methylbenzamide			3.137020000000001													MCULE-5255401998	436.53388		436.145678	4	1	7	4			45										False	Alkaloids				Peptide01			Compound(20895182)	20895182	4.3	385			[#6]-[#8]-[#6]1:[#6]:[#6](-[#6](=[#8])-[#7](-[#6])-[#6](-[#6]2:[#6]:[#6]:[#6]:[#16]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6](-[#8]-[#6]):[#6]:1-[#8]-[#6]	COc1cc(C(=O)N(C)C(c2cccs2)c2c[nH]c3ccccc23)cc(OC)c1OC	NXOJMVJWZGEDQJ		parent_pubchem_cid	AKOS001910897;AKOS016330358;N-[(1H-INDOL-3-YL)(THIOPHEN-2-YL)METHYL]-3,4,5-TRIMETHOXY-N-METHYLBENZAMIDE;N-[1H-indol-3-yl(2-thienyl)methyl]-3,4,5-trimethoxy-N-methyl-benzamide		23297856.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23297856		pluskal_iocb_peptide_Peptide01_C1_id		100	C1		
3.4		0	387	P1108200	138.0		J17	False	0	24	0	0	22	0	2	7	0	0		0.0						Cc1cc(=O)oc2c1ccc(OC(C)C(=O)NC(Cc1c[nH]c3c1cc(O)cc3)C(=O)O)c2								N-acyl-alpha amino acids;Coumarins and derivatives;1-benzopyrans;Hydroxyindoles;3-alkylindoles;Phenol ethers;Pyranones and derivatives;Alkyl aryl ethers;1-hydroxy-2-unsubstituted benzenoids;Substituted pyrroles;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactones;Monocarboxylic acids and derivatives;Carboxylic acids;Oxacyclic compounds;Azacyclic compounds;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organonitrogen compounds	1-benzopyrans;1-hydroxy-2-unsubstituted benzenoids;3-alkylindoles;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Hydroxyindoles;Indoles;Indoles and derivatives;Lactones;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;N-acylserotonins;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenol ethers;Phenols;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Pyrroles;Secondary carboxylic acid amides;Serotonins;Substituted pyrroles;Tryptamines and derivatives	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acylserotonins. These are aromatic heterocyclic compounds containing a serotonin, in which the amine group is acylated.	N-acylserotonins		Serotonins	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-amino acid (CHEBI:51569);coumarins (CHEBI:23403);1-benzopyran (CHEBI:38443);hydroxyindoles (CHEBI:84729);indoles (CHEBI:24828);aromatic ether (CHEBI:35618);pyranone (CHEBI:37963);phenols (CHEBI:33853);pyrroles (CHEBI:26455);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactone (CHEBI:25000);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);oxacycle (CHEBI:38104);organonitrogen heterocyclic compound (CHEBI:38101);carbonyl compound (CHEBI:36586);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);benzenoid aromatic compound (CHEBI:33836);pyrans (CHEBI:26407);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ether (CHEBI:25698);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);tryptamines (CHEBI:27162);carboxylic acid anion (CHEBI:29067);amino acid (CHEBI:33709);peptide (CHEBI:16670)	Benzopyranoids (PK1311)	Tryptamines and derivatives	N-acylserotonin;N-acyl-alpha amino acid or derivatives;N-acyl-alpha-amino acid;Coumarin;Alpha-amino acid or derivatives;Benzopyran;Hydroxyindole;1-benzopyran;3-alkylindole;Indole;Phenol ether;Alkyl aryl ether;1-hydroxy-2-unsubstituted benzenoid;Phenol;Pyranone;Pyran;Substituted pyrrole;Benzenoid;Pyrrole;Heteroaromatic compound;Carboxamide group;Lactone;Secondary carboxylic acid amide;Carboxylic acid derivative;Carboxylic acid;Oxacycle;Ether;Azacycle;Monocarboxylic acid or derivatives;Organic oxygen compound;Organic nitrogen compound;Organic oxide;Carbonyl group;Organooxygen compound;Hydrocarbon derivative;Organonitrogen compound;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		5-hydroxy-N-{2-[(4-methyl-2-oxo-2H-chromen-7-yl)oxy]propanoyl}tryptophan		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C24H22N2O7	C24H22N2O7			InChI=1S/C24H22N2O7/c1-12-7-22(28)33-21-10-16(4-5-17(12)21)32-13(2)23(29)26-20(24(30)31)8-14-11-25-19-6-3-15(27)9-18(14)19/h3-7,9-11,13,20,25,27H,8H2,1-2H3,(H,26,29)(H,30,31)	KVDDDSCQLKBLQF-UHFFFAOYSA-N	3-(5-hydroxy-1H-indol-3-yl)-2-[2-(4-methyl-2-oxo-chromen-7-yl)oxypropanoylamino]propanoic acid	4836916	Cc1cc(=O)oc2c1ccc(OC(C)C(=O)NC(Cc1c[nH]c3c1cc(O)cc3)C(=O)O)c2	3-(5-hydroxy-1H-indol-3-yl)-2-[2-(4-methyl-2-oxochromen-7-yl)oxypropanoylamino]propanoic acid			1.87653													MCULE-1765489366	450.45214		450.142701	7	4	7	4			45									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(4836916)	4836916	2.9	386			[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6](-[#6])-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]3:[#6]:1:[#6]:[#6](-[#8]):[#6]:[#6]:3)-[#6](=[#8])-[#8]):[#6]:2	Cc1cc(=O)oc2c1ccc(OC(C)C(=O)NC(Cc1c[nH]c3c1cc(O)cc3)C(=O)O)c2	KVDDDSCQLKBLQF		parent_pubchem_cid	5-hydroxy-N-{2-[(4-methyl-2-oxo-2H-chromen-7-yl)oxy]propanoyl}tryptophan;1214692-03-1;EiM07-29402;AKOS016377277;3-(5-HYDROXY-1H-INDOL-3-YL)-2-{2-[(4-METHYL-2-OXO-2H-CHROMEN-7-YL)OXY]PROPANAMIDO}PROPANOIC ACID;3-(5-hydroxy-1H-indol-3-yl)-2-[2-(4-methyl-2-oxo-chromen-7-yl)oxypropanoylamino]propanoic acid		23894351.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23894351		pluskal_iocb_peptide_Peptide01_C1_id		100	C1		
4.1		0	475	P2194877	118.5		J18	False	0	22	1	0	21	0	4	3	0	1		0.0						COc1ccc(NC(=O)C(Cc2ccccc2)NC(=O)c2nc(SC)ncc2Cl)cc1																							0.0		STL218349		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C22H21ClN4O3S	C22H21ClN4O3S			InChI=1S/C22H21ClN4O3S/c1-30-16-10-8-15(9-11-16)25-20(28)18(12-14-6-4-3-5-7-14)26-21(29)19-17(23)13-24-22(27-19)31-2/h3-11,13,18H,12H2,1-2H3,(H,25,28)(H,26,29)	KZAAKKBYGBXDHY-UHFFFAOYSA-N	N-[1-benzyl-2-(4-methoxyanilino)-2-oxo-ethyl]-5-chloro-2-methylsulfanyl-pyrimidine-4-carboxamide	51065480	COc1ccc(NC(=O)C(Cc2ccccc2)NC(=O)c2nc(SC)ncc2Cl)cc1	5-chloro-N-[1-(4-methoxyanilino)-1-oxo-3-phenylpropan-2-yl]-2-methylsulfanylpyrimidine-4-carboxamide			2.7798500000000006													MCULE-6265633256	456.95467		456.102289	6	2	8	3			45									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(51065480)	51065480	4.2	387			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#7]-[#6](=[#8])-[#6](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#7]-[#6](=[#8])-[#6]2:[#7]:[#6](-[#16]-[#6]):[#7]:[#6]:[#6]:2-[#17]):[#6]:[#6]:1	COc1ccc(NC(=O)C(Cc2ccccc2)NC(=O)c2nc(SC)ncc2Cl)cc1	KZAAKKBYGBXDHY		parent_pubchem_cid	STL218349;AKOS015861174;Nalpha-{[5-chloro-2-(methylsulfanyl)pyrimidin-4-yl]carbonyl}-N-(4-methoxyphenyl)phenylalaninamide;N-[1-benzyl-2-(4-methoxyanilino)-2-oxo-ethyl]-5-chloro-2-methylsulfanyl-pyrimidine-4-carboxamide		24757893.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24757893		pluskal_iocb_peptide_Peptide01_C1_id		100	C1		
4.2		0	563	P4355621	80.3		J19	False	0	22	0	0	15	0	3	3	0	0		0.0						N#Cc1c(NCc2cc3c(cc2)OCO3)oc(-c2cccc3ccccc23)n1																							0.0		AKOS005183474		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C22H15N3O3	C22H15N3O3			InChI=1S/C22H15N3O3/c23-11-18-22(24-12-14-8-9-19-20(10-14)27-13-26-19)28-21(25-18)17-7-3-5-15-4-1-2-6-16(15)17/h1-10,24H,12-13H2	OXWJGHNUUIEMCV-UHFFFAOYSA-N	5-(1,3-benzodioxol-5-ylmethylamino)-2-(1-naphthyl)oxazole-4-carbonitrile	2033460	N#Cc1c(NCc2cc3c(cc2)OCO3)oc(-c2cccc3ccccc23)n1	5-(1,3-benzodioxol-5-ylmethylamino)-2-naphthalen-1-yl-1,3-oxazole-4-carbonitrile			2.4839900000000004													MCULE-4847752366	369.38315		369.111341	5	1	4	5			44										False					Peptide01			Compound(2033460)	2033460	5.5	388			[#7]#[#6]-[#6]1:[#6](-[#7]-[#6]-[#6]2:[#6]:[#6]3:[#6](:[#6]:[#6]:2)-[#8]-[#6]-[#8]-3):[#8]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#7]:1	N#Cc1c(NCc2cc3c(cc2)OCO3)oc(-c2cccc3ccccc23)n1	OXWJGHNUUIEMCV		parent_pubchem_cid	AKOS005183474;NCGC00295244-01;AB01291978-01;Z1213743871;5-{[(2H-1,3-benzodioxol-5-yl)methyl]amino}-2-(naphthalen-1-yl)-1,3-oxazole-4-carbonitrile;5-(1,3-benzodioxol-5-ylmethylamino)-2-(1-naphthyl)oxazole-4-carbonitrile		5634209.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=5634209		pluskal_iocb_peptide_Peptide01_C1_id		100	C1		ZINC000002437186
4.7		0	651	P1305278	58.0		J20	False	1	21	0	0	17	0	2	2	0	0		0.0						O=C(NCC(c1ccc(Br)cc1)c1c[nH]c2ccccc12)c1ccco1																							0.0		N-[2-(4-bromophenyl)-2-(1H-indol-3-yl)ethyl]furan-2-carboxamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C21H17BrN2O2	C21H17BrN2O2			InChI=1S/C21H17BrN2O2/c22-15-9-7-14(8-10-15)17(12-24-21(25)20-6-3-11-26-20)18-13-23-19-5-2-1-4-16(18)19/h1-11,13,17,23H,12H2,(H,24,25)	IYMJPEYXYMUFHX-UHFFFAOYSA-N	N-[2-(4-bromophenyl)-2-(1H-indol-3-yl)ethyl]furan-2-carboxamide	17014434	O=C(NCC(c1ccc(Br)cc1)c1c[nH]c2ccccc12)c1ccco1	N-[2-(4-bromophenyl)-2-(1H-indol-3-yl)ethyl]furan-2-carboxamide			4.492750000000003													MCULE-7680008382	409.28584		408.04734	1	2	5	4			44										False					Peptide01			Compound(17014434)	17014434	4.8	389			[#8]=[#6](-[#7]-[#6]-[#6](-[#6]1:[#6]:[#6]:[#6](-[#35]):[#6]:[#6]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6]1:[#6]:[#6]:[#6]:[#8]:1	O=C(NCC(c1ccc(Br)cc1)c1c[nH]c2ccccc12)c1ccco1	IYMJPEYXYMUFHX		parent_pubchem_cid	N-[2-(4-bromophenyl)-2-(1H-indol-3-yl)ethyl]furan-2-carboxamide;STL207394;AKOS002334637;AKOS016326591		22801221.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22801221		pluskal_iocb_peptide_Peptide01_C1_id		100	C1		
2.1		0	395	P6246785	94.3		J21	False	0	19	0	0	19	0	3	4	0	0		0.0						COC(=O)C(Cc1ccccc1)NC(=O)c1c2c(C)noc2nc(C)c1																							0.0		AKOS016382597		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C19H19N3O4	C19H19N3O4			InChI=1S/C19H19N3O4/c1-11-9-14(16-12(2)22-26-18(16)20-11)17(23)21-15(19(24)25-3)10-13-7-5-4-6-8-13/h4-9,15H,10H2,1-3H3,(H,21,23)/t15-/m0/s1	SQXHEMMLVIATFA-HNNXBMFYSA-N	methyl rac-(2S)-2-[(3,6-dimethylisoxazolo[5,4-b]pyridine-4-carbonyl)amino]-3-phenyl-propanoate	18133193	COC(=O)[C@H](Cc1ccccc1)NC(=O)c1c2c(C)noc2nc(C)c1	methyl (2S)-2-[(3,6-dimethyl-[1,2]oxazolo[5,4-b]pyridine-4-carbonyl)amino]-3-phenylpropanoate			1.7064799999999998													MCULE-8610546274	353.38098		353.137556	5	1	6	3			44										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(18133193)	18133193	3.0	390			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]1:[#6]2:[#6](-[#6]):[#7]:[#8]:[#6]:2:[#7]:[#6](-[#6]):[#6]:1	COC(=O)[C@H](Cc1ccccc1)NC(=O)c1c2c(C)noc2nc(C)c1	SQXHEMMLVIATFA		parent_pubchem_cid	AKOS016382597;METHYL 2-({3,6-DIMETHYL-[1,2]OXAZOLO[5,4-B]PYRIDIN-4-YL}FORMAMIDO)-3-PHENYLPROPANOATE;methyl rac-(2S)-2-[(3,6-dimethylisoxazolo[5,4-b]pyridine-4-carbonyl)amino]-3-phenyl-propanoate		18412700.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=18412700		pluskal_iocb_peptide_Peptide01_C1_id		100	C1		ZINC000071280005
3.2		0	483	P2193921	66.4		J22	False	0	16	1	0	14	0	1	3	0	0		0.0						O=C(NC(Cc1ccccc1)C(=O)O)c1ccc(Cl)cc1								N-acyl-alpha amino acids;Hippuric acids;Phenylpropanoic acids;4-halobenzoic acids and derivatives;Amphetamines and derivatives;Benzoyl derivatives;Chlorobenzenes;Aryl chlorides;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Hydrocarbon derivatives;Carbonyl compounds;Organic oxides;Organochlorides;Organonitrogen compounds;Organopnictogen compounds	4-halobenzoic acids and derivatives;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Aryl chlorides;Aryl halides;Benzamides;Benzene and substituted derivatives;Benzenoids;Benzoic acids and derivatives;Benzoyl derivatives;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Chlorobenzenes;Halobenzenes;Halobenzoic acids and derivatives;Hippuric acids;Hippuric acids and derivatives;Hydrocarbon derivatives;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organochlorides;Organohalogen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenethylamines;Phenylalanine and derivatives;Phenylpropanoic acids;Phenylpropanoids and polyketides;Secondary carboxylic acid amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic homomonocyclic compounds	N-acyl-amino acid (CHEBI:51569);N-acylglycine (CHEBI:16180);benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);carbonyl compound (CHEBI:36586);organohalogen compound (CHEBI:36684);amphetamines (CHEBI:35338);organochlorine compound (CHEBI:36683);carboxamide (CHEBI:37622);carboxylic acid anion (CHEBI:29067);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);amino acid (CHEBI:33709);peptide (CHEBI:16670);benzenoid aromatic compound (CHEBI:33836);benzamides (CHEBI:22702);phenols (CHEBI:33853);primary amine (CHEBI:32877);haloarene (CHEBI:50887);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);nitrogen molecular entity (CHEBI:51143)		Amino acids, peptides, and analogues	Phenylalanine or derivatives;Hippuric acid or derivatives;Hippuric acid;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;3-phenylpropanoic-acid;Amphetamine or derivatives;4-halobenzoic acid or derivatives;Halobenzoic acid or derivatives;Benzamide;Benzoic acid or derivatives;Benzoyl;Chlorobenzene;Halobenzene;Aryl halide;Monocyclic benzene moiety;Benzenoid;Aryl chloride;Secondary carboxylic acid amide;Carboxamide group;Monocarboxylic acid or derivatives;Carboxylic acid;Organopnictogen compound;Organochloride;Carbonyl group;Organooxygen compound;Hydrocarbon derivative;Organic oxide;Organonitrogen compound;Organohalogen compound;Organic nitrogen compound;Organic oxygen compound;Aromatic homomonocyclic compound	Organic acids and derivatives	0.0		2-[(4-chlorophenyl)formamido]-3-phenylpropanoic acid	DTXSID90385075	2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C16H14ClNO3	C16H14ClNO3			InChI=1S/C16H14ClNO3/c17-13-8-6-12(7-9-13)15(19)18-14(16(20)21)10-11-4-2-1-3-5-11/h1-9,14H,10H2,(H,18,19)(H,20,21)	QEVZJOOFVAMXKO-UHFFFAOYSA-N	2-[(4-chlorobenzoyl)amino]-3-phenyl-propanoic acid	2826193	O=C(NC(Cc1ccccc1)C(=O)O)c1ccc(Cl)cc1	2-[(4-chlorobenzoyl)amino]-3-phenylpropanoic acid			2.6562800000000006													MCULE-6213699089	303.74788		303.066221	3	2	5	2			43									Dipeptides	False	Amino acids and Peptides;Shikimates and Phenylpropanoids	Small peptides			Peptide01			Compound(2826193)	2826193	3.4	391		SCHEMBL8510030	[#8]=[#6](-[#7]-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8])-[#6]1:[#6]:[#6]:[#6](-[#17]):[#6]:[#6]:1	O=C(NC(Cc1ccccc1)C(=O)O)c1ccc(Cl)cc1	QEVZJOOFVAMXKO		parent_pubchem_cid	2-[(4-chlorophenyl)formamido]-3-phenylpropanoic acid;2-[(4-chlorobenzoyl)amino]-3-phenylpropanoic acid;1629857-90-4;(4-Chlorobenzoyl)phenylalanine;CDS1_000773;Maybridge1_005525;Cambridge id 6742774;Oprea1_109162;DivK1c_001813;SCHEMBL8510030;HMS557D03;DTXSID90385075;AKOS004093749;CS-0220800;EN300-07584;AB00117968-01;Z85881019;2-[(4-chlorobenzoyl)amino]-3-phenyl-propanoic acid		22798889.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22798889		pluskal_iocb_peptide_Peptide01_C1_id		100	C1		
4.6		0	571	P1310243	91.2		J23	False	0	24	0	0	21	0	3	4	0	0		0.0						COc1ccc(C(c2c[nH]c3ccccc23)N(C)C(=O)c2ccccc2[N+](=O)[O-])cc1																							0.0		STL210974		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	1		C24H21N3O4	C24H21N3O4			InChI=1S/C24H21N3O4/c1-26(24(28)19-8-4-6-10-22(19)27(29)30)23(16-11-13-17(31-2)14-12-16)20-15-25-21-9-5-3-7-18(20)21/h3-15,23,25H,1-2H3	JTFKJBOKJOSSII-UHFFFAOYSA-N	N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-N-methyl-2-nitro-benzamide	43843750	COc1ccc(C(c2c[nH]c3ccccc23)N(C)C(=O)c2ccccc2[N+](=O)[O-])cc1	N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-N-methyl-2-nitrobenzamide			3.5107300000000023													MCULE-4963227011	415.45267		415.153206	4	1	6	4			45										False	Alkaloids				Peptide01			Compound(43843750)	43843750	4.5	392			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#7](-[#6])-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#7+](=[#8])-[#8-]):[#6]:[#6]:1	COc1ccc(C(c2c[nH]c3ccccc23)N(C)C(=O)c2ccccc2[N+](=O)[O-])cc1	JTFKJBOKJOSSII		parent_pubchem_cid	STL210974;AKOS002300905;AKOS016329044;N-[1H-indol-3-yl(4-methoxyphenyl)methyl]-N-methyl-2-nitrobenzamide;N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-N-methyl-2-nitro-benzamide		24254408.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24254408		pluskal_iocb_peptide_Peptide01_C2_id		100	C2		
4.9		0	659	P1301246	91.6		J24	False	0	24	0	0	24	0	2	3	0	1		0.0						CCOc1c(OC)cc(C(CNC(=O)c2cccs2)c2c[nH]c3ccccc23)cc1																							0.0		AKOS001533403		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C24H24N2O3S	C24H24N2O3S			InChI=1S/C24H24N2O3S/c1-3-29-21-11-10-16(13-22(21)28-2)18(14-26-24(27)23-9-6-12-30-23)19-15-25-20-8-5-4-7-17(19)20/h4-13,15,18,25H,3,14H2,1-2H3,(H,26,27)	SVTUTNKMUDRAQU-UHFFFAOYSA-N	N-[2-(4-ethoxy-3-methoxy-phenyl)-2-(1H-indol-3-yl)ethyl]thiophene-2-carboxamide	17010964	CCOc1c(OC)cc(C(CNC(=O)c2cccs2)c2c[nH]c3ccccc23)cc1	N-[2-(4-ethoxy-3-methoxyphenyl)-2-(1H-indol-3-yl)ethyl]thiophene-2-carboxamide			3.681230000000001													MCULE-8242227253	420.53448		420.150764	3	2	8	4			45										False	Alkaloids				Peptide01			Compound(17010964)	17010964	5.1	393			[#6]-[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]):[#6]:[#6](-[#6](-[#6]-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#16]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	CCOc1c(OC)cc(C(CNC(=O)c2cccs2)c2c[nH]c3ccccc23)cc1	SVTUTNKMUDRAQU		parent_pubchem_cid	AKOS001533403;AKOS016325492;N-[2-(4-ethoxy-3-methoxyphenyl)-2-(1H-indol-3-yl)ethyl]thiophene-2-carboxamide;N-[2-(4-ethoxy-3-methoxy-phenyl)-2-(1H-indol-3-yl)ethyl]thiophene-2-carboxamide		23544042.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23544042		pluskal_iocb_peptide_Peptide01_C2_id		100	C2		
1.7		0	403	P11184864	112.7		J25	False	0	15	0	0	16	0	2	5	0	0		0.0						O=C(CCc1cc(=O)[nH]o1)NC(Cc1ccccc1)C(=O)O																							0.0		AKOS027472522		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C15H16N2O5	C15H16N2O5			InChI=1S/C15H16N2O5/c18-13(7-6-11-9-14(19)17-22-11)16-12(15(20)21)8-10-4-2-1-3-5-10/h1-5,9,12H,6-8H2,(H,16,18)(H,17,19)(H,20,21)/t12-/m0/s1	JMCHEIMOXLTYDU-LBPRGKRZSA-N	rac-(2S)-2-[3-(3-hydroxyisoxazol-5-yl)propanoylamino]-3-phenyl-propanoic acid	91636881	O=C(CCc1cc(=O)[nH]o1)N[C@@H](Cc1ccccc1)C(=O)O	(2S)-2-[3-(3-oxo-1,2-oxazol-5-yl)propanoylamino]-3-phenylpropanoic acid			1.50307														304.30517		304.105922	5	3	7	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(91636881)	91636881	0.8	394			[#8]=[#6](-[#6]-[#6]-[#6]1:[#6]:[#6](=[#8]):[#7H]:[#8]:1)-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	O=C(CCc1cc(=O)[nH]o1)N[C@@H](Cc1ccccc1)C(=O)O	JMCHEIMOXLTYDU		parent_pubchem_cid	AKOS027472522;(2S)-2-{[3-(3-HYDROXY-5-ISOXAZOLYL)PROPANOYL]AMINO}-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[3-(3-hydroxyisoxazol-5-yl)propanoylamino]-3-phenyl-propanoic acid		92994709.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=92994709		pluskal_iocb_peptide_Peptide01_C2_id		100	C2		ZINC000217659410
4.9		0	491	P2195265	109.3		J26	False	1	19	1	0	22	0	4	2	0	1		0.0						CCSc1ncc(Cl)c(C(=O)NC(CC(C)C)C(=O)Nc2ccc(Br)cc2)n1																							0.0		AKOS015861291		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C19H22BrClN4O2S	C19H22BrClN4O2S			InChI=1S/C19H22BrClN4O2S/c1-4-28-19-22-10-14(21)16(25-19)18(27)24-15(9-11(2)3)17(26)23-13-7-5-12(20)6-8-13/h5-8,10-11,15H,4,9H2,1-3H3,(H,23,26)(H,24,27)	KQADMAMMQSXLAX-UHFFFAOYSA-N	N-[1-[(4-bromophenyl)carbamoyl]-3-methyl-butyl]-5-chloro-2-ethylsulfanyl-pyrimidine-4-carboxamide	51065770	CCSc1ncc(Cl)c(C(=O)NC(CC(C)C)C(=O)Nc2ccc(Br)cc2)n1	N-[1-(4-bromoanilino)-4-methyl-1-oxopentan-2-yl]-5-chloro-2-ethylsulfanylpyrimidine-4-carboxamide			4.244370000000003													MCULE-1316957599	485.83379		484.033537	5	2	8	2			45										False	Alkaloids				Peptide01			Compound(51065770)	51065770	5.0	395			[#6]-[#6]-[#16]-[#6]1:[#7]:[#6]:[#6](-[#17]):[#6](-[#6](=[#8])-[#7]-[#6](-[#6]-[#6](-[#6])-[#6])-[#6](=[#8])-[#7]-[#6]2:[#6]:[#6]:[#6](-[#35]):[#6]:[#6]:2):[#7]:1	CCSc1ncc(Cl)c(C(=O)NC(CC(C)C)C(=O)Nc2ccc(Br)cc2)n1	KQADMAMMQSXLAX		parent_pubchem_cid	AKOS015861291;N-[1-[(4-bromophenyl)carbamoyl]-3-methyl-butyl]-5-chloro-2-ethylsulfanyl-pyrimidine-4-carboxamide		24245887.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24245887		pluskal_iocb_peptide_Peptide01_C2_id		100	C2		
4.5		0	579	P1305578	72.6		J27	False	0	26	0	0	26	0	2	4	0	0		0.0						COc1cc(C(=O)NCC(c2ccccc2)c2c[nH]c3ccccc23)cc(OC)c1OC																							0.0		Maybridge4_003913		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C26H26N2O4	C26H26N2O4			InChI=1S/C26H26N2O4/c1-30-23-13-18(14-24(31-2)25(23)32-3)26(29)28-15-20(17-9-5-4-6-10-17)21-16-27-22-12-8-7-11-19(21)22/h4-14,16,20,27H,15H2,1-3H3,(H,28,29)	WEWRQRBNINIRDN-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]-3,4,5-trimethoxy-benzamide	2740783	COc1cc(C(=O)NCC(c2ccccc2)c2c[nH]c3ccccc23)cc(OC)c1OC	N-[2-(1H-indol-3-yl)-2-phenylethyl]-3,4,5-trimethoxybenzamide			2.7758200000000013													MCULE-7491155202	430.50812		430.189257	4	2	8	4			45										False	Alkaloids				Peptide01			Compound(2740783)	2740783	4.6	396			[#6]-[#8]-[#6]1:[#6]:[#6](-[#6](=[#8])-[#7]-[#6]-[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6](-[#8]-[#6]):[#6]:1-[#8]-[#6]	COc1cc(C(=O)NCC(c2ccccc2)c2c[nH]c3ccccc23)cc(OC)c1OC	WEWRQRBNINIRDN		parent_pubchem_cid	Maybridge4_003913;N-[2-(1H-indol-3-yl)-2-phenylethyl]-3,4,5-trimethoxybenzamide;Oprea1_094120;HMS1532B19;CCG-48907;AKOS001533515;AKOS016326746;IDI1_032735;SR-01000638402-1;BRD-A93018438-001-01-7;N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]-3,4,5-trimethoxy-benzamide		23745468.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23745468		pluskal_iocb_peptide_Peptide01_C2_id		100	C2		
4.6		0	667	P1306934	64.3		J28	False	0	21	0	0	18	0	2	1	0	1		0.0						CN(C(=O)c1ccccc1)C(c1cccs1)c1c[nH]c2ccccc12																							0.0		STL208001		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C21H18N2OS	C21H18N2OS			InChI=1S/C21H18N2OS/c1-23(21(24)15-8-3-2-4-9-15)20(19-12-7-13-25-19)17-14-22-18-11-6-5-10-16(17)18/h2-14,20,22H,1H3	JIJIDIJAEFPBLN-UHFFFAOYSA-N	N-[1H-indol-3-yl(2-thienyl)methyl]-N-methyl-benzamide	20895165	CN(C(=O)c1ccccc1)C(c1cccs1)c1c[nH]c2ccccc12	N-[1H-indol-3-yl(thiophen-2-yl)methyl]-N-methylbenzamide			4.498450000000004													MCULE-4133550125	346.45441		346.113984	1	1	4	4			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(20895165)	20895165	4.4	397			[#6]-[#7](-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](-[#6]1:[#6]:[#6]:[#6]:[#16]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CN(C(=O)c1ccccc1)C(c1cccs1)c1c[nH]c2ccccc12	JIJIDIJAEFPBLN		parent_pubchem_cid	STL208001;AKOS001912152;AKOS016329529;CCG-154598;N-[1H-indol-3-yl(thiophen-2-yl)methyl]-N-methylbenzamide;N-[(1H-INDOL-3-YL)(THIOPHEN-2-YL)METHYL]-N-METHYLBENZAMIDE;N-[1H-indol-3-yl(2-thienyl)methyl]-N-methyl-benzamide		24819671.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24819671		pluskal_iocb_peptide_Peptide01_C2_id		100	C2		
2.2		0	411	P6240947	135.7		J29	False	0	23	0	0	26	0	4	5	0	0		0.0						NC(=O)NCCCC(NC(=O)Cn1ccc2c1cc(OCc1ccccc1)cc2)C(=O)O								N-alkylindoles;Indoles;Phenol ethers;Alkyl aryl ethers;Substituted pyrroles;Benzene and substituted derivatives;Heteroaromatic compounds;Ureas;Secondary carboxylic acid amides;Azacyclic compounds;Carboxylic acids;Monocarboxylic acids and derivatives;Carbonyl compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;N-alkylindoles;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenol ethers;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Ureas	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom.	N-acyl-alpha amino acids		Amino acids and derivatives;Alpha amino acids and derivatives;N-acyl-alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	indoles (CHEBI:24828);aromatic ether (CHEBI:35618);pyrroles (CHEBI:26455);benzenes (CHEBI:22712);organic aromatic compound (CHEBI:33659);ureas (CHEBI:47857);carboxamide (CHEBI:37622);organonitrogen heterocyclic compound (CHEBI:38101);carboxylic acid (CHEBI:33575);monocarboxylic acid (CHEBI:25384);carbonyl compound (CHEBI:36586);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);N-acyl-amino acid (CHEBI:51569);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);organooxygen compound (CHEBI:36963);ether (CHEBI:25698);organic acid (CHEBI:64709);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)		Amino acids, peptides, and analogues	N-acyl-alpha-amino acid;N-alkylindole;Indole;Indole or derivatives;Phenol ether;Alkyl aryl ether;Monocyclic benzene moiety;Benzenoid;Substituted pyrrole;Heteroaromatic compound;Pyrrole;Carboxamide group;Urea;Secondary carboxylic acid amide;Carboxylic acid;Ether;Azacycle;Monocarboxylic acid or derivatives;Organoheterocyclic compound;Hydrocarbon derivative;Organic nitrogen compound;Organic oxygen compound;Carbonyl group;Organic oxide;Organonitrogen compound;Organooxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		EiM08-12174		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C23H26N4O5	C23H26N4O5			InChI=1S/C23H26N4O5/c24-23(31)25-11-4-7-19(22(29)30)26-21(28)14-27-12-10-17-8-9-18(13-20(17)27)32-15-16-5-2-1-3-6-16/h1-3,5-6,8-10,12-13,19H,4,7,11,14-15H2,(H,26,28)(H,29,30)(H3,24,25,31)/t19-/m1/s1	JNRFZDKHNLKWJT-LJQANCHMSA-N	rac-(2R)-2-[[2-(6-benzyloxyindol-1-yl)acetyl]amino]-5-ureido-pentanoic acid	49652562	NC(=O)NCCC[C@@H](NC(=O)Cn1ccc2c1cc(OCc1ccccc1)cc2)C(=O)O	(2R)-5-(carbamoylamino)-2-[[2-(6-phenylmethoxyindol-1-yl)acetyl]amino]pentanoic acid			1.2926600000000008													MCULE-7485512134	438.48747		438.19032	5	4	11	3			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(49652562)	49652562	2.0	398			[#7]-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]-[#6@@H](-[#7]-[#6](=[#8])-[#6]-[#7]1:[#6]:[#6]:[#6]2:[#6]:1:[#6]:[#6](-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1):[#6]:[#6]:2)-[#6](=[#8])-[#8]	NC(=O)NCCC[C@@H](NC(=O)Cn1ccc2c1cc(OCc1ccccc1)cc2)C(=O)O	JNRFZDKHNLKWJT		parent_pubchem_cid	EiM08-12174;AKOS016398006;N~5~-(AMINOCARBONYL)-N~2~-{[6-(BENZYLOXY)-1H-INDOL-1-YL]ACETYL}-D-ORNITHINE;rac-(2R)-2-[[2-(6-benzyloxyindol-1-yl)acetyl]amino]-5-ureido-pentanoic acid		23668472.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23668472		pluskal_iocb_peptide_Peptide01_C2_id		100	C2		ZINC000040312839
0.6		0	499	P2195261	119.0		J30	False	0	16	0	0	22	0	2	5	0	1		0.0						COC(=O)C(CCSC)NC(=O)CNC(=O)c1ccc(OC)cc1																							0.0		STL218726		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C16H22N2O5S	C16H22N2O5S			InChI=1S/C16H22N2O5S/c1-22-12-6-4-11(5-7-12)15(20)17-10-14(19)18-13(8-9-24-3)16(21)23-2/h4-7,13H,8-10H2,1-3H3,(H,17,20)(H,18,19)	LGPVYLBCVLQULP-UHFFFAOYSA-N	methyl 2-[[2-[(4-methoxybenzoyl)amino]acetyl]amino]-4-methylsulfanyl-butanoate	51065766	COC(=O)C(CCSC)NC(=O)CNC(=O)c1ccc(OC)cc1	methyl 2-[[2-[(4-methoxybenzoyl)amino]acetyl]amino]-4-methylsulfanylbutanoate			0.3187800000000012													MCULE-2330118592	354.42814		354.124943	6	2	10	1			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51065766)	51065766	1.5	399			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]-[#16]-[#6])-[#7]-[#6](=[#8])-[#6]-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:1	COC(=O)C(CCSC)NC(=O)CNC(=O)c1ccc(OC)cc1	LGPVYLBCVLQULP		parent_pubchem_cid	STL218726;AKOS015861273;methyl N-[(4-methoxyphenyl)carbonyl]glycylmethioninate;methyl 2-[[2-[(4-methoxybenzoyl)amino]acetyl]amino]-4-methylsulfanyl-butanoate		23158849.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23158849		pluskal_iocb_peptide_Peptide01_C2_id		100	C2		
3.2		0	587	P1233009	60.3		J31	False	0	19	0	0	22	0	2	2	0	0		0.0						CCOc1c(OC)cc(C(CN)c2c[nH]c3ccccc23)cc1																							0.0		848369-57-3		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0		C19H22N2O2	C19H22N2O2			InChI=1S/C19H22N2O2/c1-3-23-18-9-8-13(10-19(18)22-2)15(11-20)16-12-21-17-7-5-4-6-14(16)17/h4-10,12,15,21H,3,11,20H2,1-2H3	QUPDYGZDDZXIRU-UHFFFAOYSA-N	2-(4-ethoxy-3-methoxy-phenyl)-2-(1H-indol-3-yl)ethanamine	4962765	CCOc1c(OC)cc(C(CN)c2c[nH]c3ccccc23)cc1	2-(4-ethoxy-3-methoxyphenyl)-2-(1H-indol-3-yl)ethanamine			2.2031399999999994													MCULE-1737594090	310.39939		310.168128	3	2	6	3			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(4962765)	4962765	3.1	400			[#6]-[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]):[#6]:[#6](-[#6](-[#6]-[#7])-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	CCOc1c(OC)cc(C(CN)c2c[nH]c3ccccc23)cc1	QUPDYGZDDZXIRU		parent_pubchem_cid	848369-57-3;2-(4-ethoxy-3-methoxyphenyl)-2-(1H-indol-3-yl)ethanamine;2-(4-ethoxy-3-methoxyphenyl)-2-(1H-indol-3-yl)ethan-1-amine;MFCD06650786;AKOS000268963;AKOS016040135;NS-05236;EN300-13981;SR-01000072813;SR-01000072813-1;Z94598637;2-(4-ethoxy-3-methoxy-phenyl)-2-(1H-indol-3-yl)ethanamine		24018260.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24018260		pluskal_iocb_peptide_Peptide01_C3_id		100	C3		
2.4		0	675	P1157513	105.2		J32	False	0	22	0	0	20	0	2	6	0	0		0.0						CCn1cc(C(=O)NC(Cc2ccccc2)C(=O)O)c(=O)c2cc3c(cc21)OCO3								Quinoline-3-carboxamides;N-acyl-alpha amino acids;Phenylpropanoic acids;Hydroquinolones;Amphetamines and derivatives;Hydroquinolines;Pyridinecarboxylic acids and derivatives;Benzodioxoles;Vinylogous amides;Heteroaromatic compounds;Secondary carboxylic acid amides;Acetals;Oxacyclic compounds;Azacyclic compounds;Carboxylic acids;Monocarboxylic acids and derivatives;Organopnictogen compounds;Organonitrogen compounds;Hydrocarbon derivatives;Organic oxides;Carbonyl compounds	Acetals;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Benzodioxoles;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Hydroquinolines;Hydroquinolones;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenethylamines;Phenylalanine and derivatives;Phenylpropanoic acids;Phenylpropanoids and polyketides;Pyridinecarboxylic acids and derivatives;Pyridines and derivatives;Quinoline carboxamides;Quinoline-3-carboxamides;Quinolines and derivatives;Quinolones and derivatives;Secondary carboxylic acid amides;Vinylogous amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	quinolines (CHEBI:26513);carboxamide (CHEBI:37622);N-acyl-amino acid (CHEBI:51569);benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);amphetamines (CHEBI:35338);aromatic carboxylic acid (CHEBI:33859);pyridinemonocarboxylic acid (CHEBI:26420);benzodioxoles (CHEBI:38298);enone (CHEBI:51689);enamine (CHEBI:47989);organic aromatic compound (CHEBI:33659);acetal (CHEBI:59769);oxacycle (CHEBI:38104);organonitrogen heterocyclic compound (CHEBI:38101);monocarboxylic acid (CHEBI:25384);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);carbonyl compound (CHEBI:36586);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);quinolone (CHEBI:23765);benzenoid aromatic compound (CHEBI:33836);primary amine (CHEBI:32877);pyridines (CHEBI:26421);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);ether (CHEBI:25698);nitrogen molecular entity (CHEBI:51143)		Amino acids, peptides, and analogues	Phenylalanine or derivatives;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;Quinoline-3-carboxamide;Dihydroquinolone;3-phenylpropanoic-acid;Amphetamine or derivatives;Dihydroquinoline;Quinoline;Benzodioxole;Pyridine carboxylic acid or derivatives;Benzenoid;Pyridine;Monocyclic benzene moiety;Vinylogous amide;Heteroaromatic compound;Secondary carboxylic acid amide;Carboxamide group;Oxacycle;Azacycle;Organoheterocyclic compound;Acetal;Monocarboxylic acid or derivatives;Carboxylic acid;Organic nitrogen compound;Organic oxygen compound;Organopnictogen compound;Organic oxide;Carbonyl group;Hydrocarbon derivative;Organonitrogen compound;Organooxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		N-[(5-ethyl-8-oxo-5,8-dihydro[1,3]dioxolo[4,5-g]quinolin-7-yl)carbonyl]-L-phenylalanine		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C22H20N2O6	C22H20N2O6			InChI=1S/C22H20N2O6/c1-2-24-11-15(20(25)14-9-18-19(10-17(14)24)30-12-29-18)21(26)23-16(22(27)28)8-13-6-4-3-5-7-13/h3-7,9-11,16H,2,8,12H2,1H3,(H,23,26)(H,27,28)/t16-/m0/s1	GMUVKSIPHPNWJE-INIZCTEOSA-N	rac-(2S)-2-[(5-ethyl-8-oxo-[1,3]dioxolo[4,5-g]quinoline-7-carbonyl)amino]-3-phenyl-propanoic acid	8022642	CCn1cc(C(=O)N[C@@H](Cc2ccccc2)C(=O)O)c(=O)c2cc3c(cc21)OCO3	(2S)-2-[(5-ethyl-8-oxo-[1,3]dioxolo[4,5-g]quinoline-7-carbonyl)amino]-3-phenylpropanoic acid			1.6130299999999995													MCULE-7886658329	408.4145		408.132136	7	2	6	4			44										False	Alkaloids				Peptide01			Compound(8022642)	8022642	3.5	401			[#6]-[#6]-[#7]1:[#6]:[#6](-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#8]):[#6](=[#8]):[#6]2:[#6]:[#6]3:[#6](:[#6]:[#6]:1:2)-[#8]-[#6]-[#8]-3	CCn1cc(C(=O)N[C@@H](Cc2ccccc2)C(=O)O)c(=O)c2cc3c(cc21)OCO3	GMUVKSIPHPNWJE		parent_pubchem_cid	N-[(5-ethyl-8-oxo-5,8-dihydro[1,3]dioxolo[4,5-g]quinolin-7-yl)carbonyl]-L-phenylalanine;EiM07-12794;MFCD08282722;STL372223;AKOS004937300;(2S)-2-[(5-ethyl-8-oxo-[1,3]dioxolo[4,5-g]quinoline-7-carbonyl)amino]-3-phenylpropanoic acid;2-({5-ETHYL-8-OXO-2H,5H,8H-[1,3]DIOXOLO[4,5-G]QUINOLIN-7-YL}FORMAMIDO)-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[(5-ethyl-8-oxo-[1,3]dioxolo[4,5-g]quinoline-7-carbonyl)amino]-3-phenyl-propanoic acid		23488814.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23488814		pluskal_iocb_peptide_Peptide01_C3_id		100	C3		ZINC000006645562
3.9		0	419	P3463373	66.0		J33	False	0	18	0	0	12	0	2	2	0	0		0.0						O=C(O)c1cc(-c2c[nH]c3ccccc23)nc2ccccc12								Pyridinecarboxylic acids;Indoles;Substituted pyrroles;Benzenoids;Heteroaromatic compounds;Carboxylic acids;Azacyclic compounds;Organooxygen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	Azacyclic compounds;Benzenoids;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Pyridinecarboxylic acids;Pyridinecarboxylic acids and derivatives;Pyridines and derivatives;Pyrroles;Quinoline carboxylic acids;Quinolines and derivatives;Substituted pyrroles	Quinolines and derivatives	2.1	This compound belongs to the class of organic compounds known as quinoline carboxylic acids. These are quinolines in which the quinoline ring system is substituted by a carboxyl group at one or more positions.	Quinoline carboxylic acids			Organic compounds	Aromatic heteropolycyclic compounds	pyridines (CHEBI:26421);aromatic carboxylic acid (CHEBI:33859);indoles (CHEBI:24828);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);organic aromatic compound (CHEBI:33659);carboxylic acid (CHEBI:33575);organonitrogen heterocyclic compound (CHEBI:38101);organooxygen compound (CHEBI:36963);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);quinolines (CHEBI:26513);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);pyridinemonocarboxylic acid (CHEBI:26420);organic acid (CHEBI:64709);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143);carboxylic acid anion (CHEBI:29067)		Quinoline carboxylic acids	Quinoline-4-carboxylic acid;Indole;Indole or derivatives;Pyridine carboxylic acid;Pyridine carboxylic acid or derivatives;Pyridine;Benzenoid;Substituted pyrrole;Heteroaromatic compound;Pyrrole;Carboxylic acid;Carboxylic acid derivative;Azacycle;Hydrocarbon derivative;Organic oxide;Organooxygen compound;Organonitrogen compound;Organic oxygen compound;Organic nitrogen compound;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		2-(1H-indol-3-yl)quinoline-4-carboxylic acid	DTXSID60626967	2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C18H12N2O2	C18H12N2O2			InChI=1S/C18H12N2O2/c21-18(22)13-9-17(20-16-8-4-2-5-11(13)16)14-10-19-15-7-3-1-6-12(14)15/h1-10,19H,(H,21,22)	DASAQOOBWVAYSB-UHFFFAOYSA-N	2-(1H-indol-3-yl)quinoline-4-carboxylic acid	22616994	O=C(O)c1cc(-c2c[nH]c3ccccc23)nc2ccccc12	2-(1H-indol-3-yl)quinoline-4-carboxylic acid			2.7897300000000014													MCULE-4551206218	288.30854		288.089878	3	2	2	4			41										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(22616994)	22616994	3.5	402		SCHEMBL7715419	[#8]=[#6](-[#8])-[#6]1:[#6]:[#6](-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	O=C(O)c1cc(-c2c[nH]c3ccccc23)nc2ccccc12	DASAQOOBWVAYSB		parent_pubchem_cid	2-(1H-indol-3-yl)quinoline-4-carboxylic acid;89391-04-8;MFCD16090149;SCHEMBL7715419;DTXSID60626967;DASAQOOBWVAYSB-UHFFFAOYSA-N;BBL032641;STL373528;2-(3-indolyl)-4-quinolinecarboxylic;AKOS015955463;NS-04800;2-(3-indolyl)-4-quinolinecarboxylic acid;2-(3-indolyl)quinoline-4-carboxylic acid;2-( 3-indolyl)-4-quinolinecarboxylic acid;2-(1H-indol-3-yl)-4-quinolinecarboxylic acid;EN300-302937		23926334.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23926334		pluskal_iocb_peptide_Peptide01_C3_id		100	C3		ZINC000040162973
1.6		0	507	P2195734	113.6		J34	False	0	23	0	0	27	0	3	5	0	0		0.0						COC(=O)CCNC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)c1ccc(C)cc1																							0.0		AKOS015861880		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	4	0	0	0	0	0	0	1	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0		C23H27N3O5	C23H27N3O5			InChI=1S/C23H27N3O5/c1-16-8-10-18(11-9-16)22(29)25-15-20(27)26-19(14-17-6-4-3-5-7-17)23(30)24-13-12-21(28)31-2/h3-11,19H,12-15H2,1-2H3,(H,24,30)(H,25,29)(H,26,27)	IMHVERDXLNBNCL-UHFFFAOYSA-N	methyl 3-[[2-[[2-[(4-methylbenzoyl)amino]acetyl]amino]-3-phenyl-propanoyl]amino]propanoate	52988584	COC(=O)CCNC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)c1ccc(C)cc1	methyl 3-[[2-[[2-[(4-methylbenzoyl)amino]acetyl]amino]-3-phenylpropanoyl]amino]propanoate			0.96749													MCULE-1322086478	425.48874		425.195071	5	3	11	2			45									Tripeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(52988584)	52988584	2.1	403			[#6]-[#8]-[#6](=[#8])-[#6]-[#6]-[#7]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:1	COC(=O)CCNC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)c1ccc(C)cc1	IMHVERDXLNBNCL		parent_pubchem_cid	AKOS015861880;methyl 3-[[2-[[2-[(4-methylbenzoyl)amino]acetyl]amino]-3-phenyl-propanoyl]amino]propanoate		23816013.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23816013		pluskal_iocb_peptide_Peptide01_C3_id		100	C3		
5.0		0	595	P1680866	81.4		J35	False	0	23	0	0	20	0	2	2	0	1		0.0						Oc1cc(O)c(-c2csc(=Nc3ccccc3)n2CCc2ccccc2)cc1																							0.0		AKOS002233343		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1		C23H20N2O2S	C23H20N2O2S			InChI=1S/C23H20N2O2S/c26-19-11-12-20(22(27)15-19)21-16-28-23(24-18-9-5-2-6-10-18)25(21)14-13-17-7-3-1-4-8-17/h1-12,15-16,26-27H,13-14H2	JOKVFGGMSVZSCD-UHFFFAOYSA-N	4-[(2Z)-3-(2-phenylethyl)-2-phenylimino-thiazol-4-yl]benzene-1,3-diol	16430701	Oc1cc(O)c(-c2csc(=Nc3ccccc3)n2CCc2ccccc2)cc1	4-[3-(2-phenylethyl)-2-phenylimino-1,3-thiazol-4-yl]benzene-1,3-diol			4.262630000000002													MCULE-4124609936	388.49205		388.124549	5	2	5	4			45										False	Alkaloids				Peptide01			Compound(16430701)	16430701	5.2	404			[#8]-[#6]1:[#6]:[#6](-[#8]):[#6](-[#6]2:[#6]:[#16]:[#6](=[#7]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#7]:2-[#6]-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6]:[#6]:1	Oc1cc(O)c(-c2csc(=Nc3ccccc3)n2CCc2ccccc2)cc1	JOKVFGGMSVZSCD		parent_pubchem_cid	AKOS002233343;4-[(2Z)-3-(2-phenylethyl)-2-phenylimino-thiazol-4-yl]benzene-1,3-diol		24457859.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24457859		pluskal_iocb_peptide_Peptide01_C3_id		100	C3		
2.4		0	683	P6236702	100.4		J36	False	0	20	0	0	21	0	5	1	0	1		0.0						CSCCC(NC(=O)Cc1c[nH]c2ccccc12)c1nnc2ccccn12																							0.0		2-(1H-indol-3-yl)-N-[3-(methylsulfanyl)-1-([1,2,4]triazolo[4,3-a]pyridin-3-yl)propyl]acetamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	3	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C20H21N5OS	C20H21N5OS			InChI=1S/C20H21N5OS/c1-27-11-9-17(20-24-23-18-8-4-5-10-25(18)20)22-19(26)12-14-13-21-16-7-3-2-6-15(14)16/h2-8,10,13,17,21H,9,11-12H2,1H3,(H,22,26)	JTQLJKAYXRVMCS-UHFFFAOYSA-N	2-(1H-indol-3-yl)-N-[3-methylsulfanyl-1-([1,2,4]triazolo[4,3-a]pyridin-3-yl)propyl]acetamide	42653124	CSCCC(NC(=O)Cc1c[nH]c2ccccc12)c1nnc2ccccn12	2-(1H-indol-3-yl)-N-[3-methylsulfanyl-1-([1,2,4]triazolo[4,3-a]pyridin-3-yl)propyl]acetamide			2.611650000000001													MCULE-5789017388	379.48727		379.146681	4	2	7	4			45										False	Alkaloids				Peptide01			Compound(42653124)	42653124	3.1	405			[#6]-[#16]-[#6]-[#6]-[#6](-[#7]-[#6](=[#8])-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6]1:[#7]:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#7]:1:2	CSCCC(NC(=O)Cc1c[nH]c2ccccc12)c1nnc2ccccn12	JTQLJKAYXRVMCS		parent_pubchem_cid	2-(1H-indol-3-yl)-N-[3-(methylsulfanyl)-1-([1,2,4]triazolo[4,3-a]pyridin-3-yl)propyl]acetamide;1081132-34-4;STK633773;AKOS005567728;2-(1H-indol-3-yl)-N-[3-methylsulfanyl-1-([1,2,4]triazolo[4,3-a]pyridin-3-yl)propyl]acetamide		24518055.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24518055		pluskal_iocb_peptide_Peptide01_C3_id		100	C3		
4.1		0	427	P1098342	117.7		J37	False	0	25	0	0	24	0	2	6	0	0		0.0						Cc1c(C)c2c(cc(OC(C)C(=O)NC(Cc3c[nH]c4ccccc34)C(=O)O)cc2)oc1=O																							0.0		EiM07-17020		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C25H24N2O6	C25H24N2O6			InChI=1S/C25H24N2O6/c1-13-14(2)25(31)33-22-11-17(8-9-18(13)22)32-15(3)23(28)27-21(24(29)30)10-16-12-26-20-7-5-4-6-19(16)20/h4-9,11-12,15,21,26H,10H2,1-3H3,(H,27,28)(H,29,30)/t15?,21-/m0/s1	KKNOFXFXJSMTPD-FXMQYSIJSA-N	rac-(2S)-2-[2-(3,4-dimethyl-2-oxo-chromen-7-yl)oxypropanoylamino]-3-(1H-indol-3-yl)propanoic acid	16398645	Cc1c(C)c2c(cc(OC(C)C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)O)cc2)oc1=O	(2S)-2-[2-(3,4-dimethyl-2-oxochromen-7-yl)oxypropanoylamino]-3-(1H-indol-3-yl)propanoic acid			2.887050000000001														448.47983		448.163436	6	3	7	4			46									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(16398645)	16398645	3.6	406			[#6]-[#6]1:[#6](-[#6]):[#6]2:[#6](:[#6]:[#6](-[#8]-[#6](-[#6])-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]3:[#6]:[#7H]:[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]:3:4)-[#6](=[#8])-[#8]):[#6]:[#6]:2):[#8]:[#6]:1=[#8]	Cc1c(C)c2c(cc(OC(C)C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)O)cc2)oc1=O	KKNOFXFXJSMTPD		parent_pubchem_cid	EiM07-17020;STL460754;AKOS016376902;N-{2-[(3,4-dimethyl-2-oxo-2H-chromen-7-yl)oxy]propanoyl}-L-tryptophan;rac-(2S)-2-[2-(3,4-dimethyl-2-oxo-chromen-7-yl)oxypropanoylamino]-3-(1H-indol-3-yl)propanoic acid		22824724.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22824724		pluskal_iocb_peptide_Peptide01_C3_id		100	C3		
1.3		0	515	P2194593	120.8		J38	False	0	15	1	0	19	0	2	4	0	1		0.0						CSCCC(NC(=O)CCNC(=O)c1ccc(Cl)cc1)C(=O)O																							0.0		AKOS015860660		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C15H19ClN2O4S	C15H19ClN2O4S			InChI=1S/C15H19ClN2O4S/c1-23-9-7-12(15(21)22)18-13(19)6-8-17-14(20)10-2-4-11(16)5-3-10/h2-5,12H,6-9H2,1H3,(H,17,20)(H,18,19)(H,21,22)	VOTBPEBREHYDRZ-UHFFFAOYSA-N	2-[3-[(4-chlorobenzoyl)amino]propanoylamino]-4-methylsulfanyl-butanoic acid	51065251	CSCCC(NC(=O)CCNC(=O)c1ccc(Cl)cc1)C(=O)O	2-[3-[(4-chlorobenzoyl)amino]propanoylamino]-4-methylsulfanylbutanoic acid			1.7276899999999995													MCULE-5806173478	358.84668		358.075406	5	3	9	1			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51065251)	51065251	1.7	407			[#6]-[#16]-[#6]-[#6]-[#6](-[#7]-[#6](=[#8])-[#6]-[#6]-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#17]):[#6]:[#6]:1)-[#6](=[#8])-[#8]	CSCCC(NC(=O)CCNC(=O)c1ccc(Cl)cc1)C(=O)O	VOTBPEBREHYDRZ		parent_pubchem_cid	AKOS015860660;2-[3-[(4-chlorobenzoyl)amino]propanoylamino]-4-methylsulfanyl-butanoic acid		23817251.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23817251		pluskal_iocb_peptide_Peptide01_C3_id		100	C3		
4.4		0	603	P1305574	72.6		J39	False	0	26	0	0	26	0	2	4	0	0		0.0						COc1ccc(C(CNC(=O)COc2ccccc2OC)c2c[nH]c3ccccc23)cc1																							0.0		N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-(2-methoxyphenoxy)acetamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C26H26N2O4	C26H26N2O4			InChI=1S/C26H26N2O4/c1-30-19-13-11-18(12-14-19)21(22-16-27-23-8-4-3-7-20(22)23)15-28-26(29)17-32-25-10-6-5-9-24(25)31-2/h3-14,16,21,27H,15,17H2,1-2H3,(H,28,29)	CZHNZQZKQDYSJA-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-(2-methoxyphenoxy)acetamide	17014711	COc1ccc(C(CNC(=O)COc2ccccc2OC)c2c[nH]c3ccccc23)cc1	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-(2-methoxyphenoxy)acetamide			2.58713													MCULE-5943176881	430.50812		430.189257	4	2	9	4			44										False	Alkaloids				Peptide01			Compound(17014711)	17014711	4.7	408			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6]-[#7]-[#6](=[#8])-[#6]-[#8]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#8]-[#6])-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	COc1ccc(C(CNC(=O)COc2ccccc2OC)c2c[nH]c3ccccc23)cc1	CZHNZQZKQDYSJA		parent_pubchem_cid	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-(2-methoxyphenoxy)acetamide;HMS3456C22;STL207674;AKOS002335293;AKOS016326742		24028821.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24028821		pluskal_iocb_peptide_Peptide01_C4_id		100	C4		
3.6		0	691	P6245572	67.6		J40	False	0	19	1	0	18	0	5	1	0	0		0.0						Cn1ncc(C(=O)NCCc2c[nH]c3c2cc(Cl)cc3)c1-n1cccc1								Pyrazole-4-carboxamides;Substituted pyrroles;Benzenoids;Aryl chlorides;Vinylogous amides;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Organooxygen compounds;Organonitrogen compounds;Organochlorides;Organic oxides;Hydrocarbon derivatives	3-alkylindoles;Aryl chlorides;Aryl halides;Azacyclic compounds;Azoles;Benzenoids;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organochlorides;Organohalogen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Pyrazole carboxylic acids and derivatives;Pyrazole-4-carboxamides;Pyrazoles;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Vinylogous amides	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as 3-alkylindoles. These are compounds containing an indole moiety that carries an alkyl chain at the 3-position.	3-alkylindoles			Organic compounds	Aromatic heteropolycyclic compounds	carboxamide (CHEBI:37622);pyrazoles (CHEBI:26410);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);organochlorine compound (CHEBI:36683);enone (CHEBI:51689);enamine (CHEBI:47989);organic aromatic compound (CHEBI:33659);organonitrogen heterocyclic compound (CHEBI:38101);organooxygen compound (CHEBI:36963);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);indoles (CHEBI:24828);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);azole (CHEBI:68452);organohalogen compound (CHEBI:36684);haloarene (CHEBI:50887);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143)		Indoles	3-alkylindole;Pyrazole-4-carboxamide;Aryl chloride;Aryl halide;Benzenoid;Substituted pyrrole;Azole;Pyrazole;Heteroaromatic compound;Pyrrole;Vinylogous amide;Carboxamide group;Secondary carboxylic acid amide;Carboxylic acid derivative;Azacycle;Hydrocarbon derivative;Organooxygen compound;Organonitrogen compound;Organochloride;Organohalogen compound;Organic oxide;Organic oxygen compound;Organic nitrogen compound;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		N-(2-(5-chloro-1H-indol-3-yl)ethyl)-1-methyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-4-carboxamide		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	2		C19H18ClN5O	C19H18ClN5O			InChI=1S/C19H18ClN5O/c1-24-19(25-8-2-3-9-25)16(12-23-24)18(26)21-7-6-13-11-22-17-5-4-14(20)10-15(13)17/h2-5,8-12,22H,6-7H2,1H3,(H,21,26)	SHRQJBFRQVTRAX-UHFFFAOYSA-N	N-[2-(5-chloro-1H-indol-3-yl)ethyl]-1-methyl-5-pyrrol-1-yl-pyrazole-4-carboxamide	51049261	Cn1ncc(C(=O)NCCc2c[nH]c3c2cc(Cl)cc3)c1-n1cccc1	N-[2-(5-chloro-1H-indol-3-yl)ethyl]-1-methyl-5-pyrrol-1-ylpyrazole-4-carboxamide			2.5901500000000004													MCULE-9340569425	367.84121		367.119988	2	2	5	4			44									Imidazole alkaloids	False	Alkaloids	Histidine alkaloids			Peptide01			Compound(51049261)	51049261	3.0	409			[#6]-[#7]1:[#7]:[#6]:[#6](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:2:[#6]:[#6](-[#17]):[#6]:[#6]:3):[#6]:1-[#7]1:[#6]:[#6]:[#6]:[#6]:1	Cn1ncc(C(=O)NCCc2c[nH]c3c2cc(Cl)cc3)c1-n1cccc1	SHRQJBFRQVTRAX		parent_pubchem_cid	N-(2-(5-chloro-1H-indol-3-yl)ethyl)-1-methyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-4-carboxamide;1224160-29-5;AKOS005671249;N-[2-(5-chloro-1H-indol-3-yl)ethyl]-1-methyl-5-pyrrol-1-yl-pyrazole-4-carboxamide		1250955.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=1250955		pluskal_iocb_peptide_Peptide01_C4_id		100	C4		ZINC000044921205
1.6		0	435	P6243643	99.1		J41	False	0	19	0	0	17	0	3	4	0	0		0.0						O=C(Cn1ncc2ccccc2c1=O)NC(Cc1ccccc1)C(=O)O																							0.0		AKOS016402560		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C19H17N3O4	C19H17N3O4			InChI=1S/C19H17N3O4/c23-17(21-16(19(25)26)10-13-6-2-1-3-7-13)12-22-18(24)15-9-5-4-8-14(15)11-20-22/h1-9,11,16H,10,12H2,(H,21,23)(H,25,26)/t16-/m0/s1	KGBKLKAXJLEZNE-INIZCTEOSA-N	rac-(2S)-2-[[2-(1-oxophthalazin-2-yl)acetyl]amino]-3-phenyl-propanoic acid	51054146	O=C(Cn1ncc2ccccc2c1=O)N[C@@H](Cc1ccccc1)C(=O)O	(2S)-2-[[2-(1-oxophthalazin-2-yl)acetyl]amino]-3-phenylpropanoic acid			1.62536													MCULE-8106489806	351.36504		351.121906	5	2	6	3			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51054146)	51054146	1.8	410			[#8]=[#6](-[#6]-[#7]1:[#7]:[#6]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	O=C(Cn1ncc2ccccc2c1=O)N[C@@H](Cc1ccccc1)C(=O)O	KGBKLKAXJLEZNE		parent_pubchem_cid	AKOS016402560;(2S)-2-({2-[1-OXO-2(1H)-PHTHALAZINYL]ACETYL}AMINO)-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[[2-(1-oxophthalazin-2-yl)acetyl]amino]-3-phenyl-propanoic acid		23443601.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23443601		pluskal_iocb_peptide_Peptide01_C4_id		100	C4		ZINC000049549097
3.0		0	523	P2195222	109.8		J42	False	0	19	1	0	27	0	2	4	0	1		0.0						COC(=O)C(CCSC)NC(=O)C(CC(C)C)NC(=O)c1ccc(Cl)cc1																							0.0		AKOS015861270		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	2	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C19H27ClN2O4S	C19H27ClN2O4S			InChI=1S/C19H27ClN2O4S/c1-12(2)11-16(22-17(23)13-5-7-14(20)8-6-13)18(24)21-15(9-10-27-4)19(25)26-3/h5-8,12,15-16H,9-11H2,1-4H3,(H,21,24)(H,22,23)	UYKSDDCKLQPYOZ-UHFFFAOYSA-N	methyl 2-[[2-[(4-chlorobenzoyl)amino]-4-methyl-pentanoyl]amino]-4-methylsulfanyl-butanoate	51065731	COC(=O)C(CCSC)NC(=O)C(CC(C)C)NC(=O)c1ccc(Cl)cc1	methyl 2-[[2-[(4-chlorobenzoyl)amino]-4-methylpentanoyl]amino]-4-methylsulfanylbutanoate			2.8406899999999995													MCULE-9943801071	414.95504		414.138006	5	2	11	1			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51065731)	51065731	3.9	411			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]-[#16]-[#6])-[#7]-[#6](=[#8])-[#6](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#17]):[#6]:[#6]:1	COC(=O)C(CCSC)NC(=O)C(CC(C)C)NC(=O)c1ccc(Cl)cc1	UYKSDDCKLQPYOZ		parent_pubchem_cid	AKOS015861270;methyl 2-[[2-[(4-chlorobenzoyl)amino]-4-methyl-pentanoyl]amino]-4-methylsulfanyl-butanoate		23875838.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23875838		pluskal_iocb_peptide_Peptide01_C4_id		100	C4		
4.6		0	611	P1305261	63.4		J43	False	0	25	0	0	24	0	2	3	0	0		0.0						COc1ccc(C(CNC(=O)c2ccccc2OC)c2c[nH]c3ccccc23)cc1																							0.0		HMS3456I20		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C25H24N2O3	C25H24N2O3			InChI=1S/C25H24N2O3/c1-29-18-13-11-17(12-14-18)21(22-16-26-23-9-5-3-7-19(22)23)15-27-25(28)20-8-4-6-10-24(20)30-2/h3-14,16,21,26H,15H2,1-2H3,(H,27,28)	GYFKQMXNPMQSTD-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-methoxy-benzamide	17014418	COc1ccc(C(CNC(=O)c2ccccc2OC)c2c[nH]c3ccccc23)cc1	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-methoxybenzamide			3.229630000000002													MCULE-5517541065	400.48163		400.178693	3	2	7	4			45										False	Alkaloids				Peptide01			Compound(17014418)	17014418	4.7	412			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6]-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#8]-[#6])-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	COc1ccc(C(CNC(=O)c2ccccc2OC)c2c[nH]c3ccccc23)cc1	GYFKQMXNPMQSTD		parent_pubchem_cid	HMS3456I20;N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-methoxybenzamide;AKOS002335390;AKOS016326574;N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-methoxy-benzamide		23048960.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23048960		pluskal_iocb_peptide_Peptide01_C4_id		100	C4		
3.6		0	699	P6240932	71.3		J44	False	0	19	1	0	17	0	2	3	0	0		0.0						O=C(Cn1ccc2c1cc(Cl)cc2)NC(Cc1ccccc1)C(=O)O								N-acyl-L-alpha-amino acids;Phenylpropanoic acids;Amphetamines and derivatives;N-alkylindoles;Indoles;Substituted pyrroles;Aryl chlorides;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Carboxylic acids;Monocarboxylic acids and derivatives;Organochlorides;Carbonyl compounds;Organic oxides;Hydrocarbon derivatives;Organonitrogen compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Aryl chlorides;Aryl halides;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;N-alkylindoles;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organochlorides;Organohalogen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenethylamines;Phenylalanine and derivatives;Phenylpropanoic acids;Phenylpropanoids and polyketides;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-L-alpha-amino acid (CHEBI:48927);benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);amphetamines (CHEBI:35338);indoles (CHEBI:24828);pyrroles (CHEBI:26455);organochlorine compound (CHEBI:36683);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organonitrogen heterocyclic compound (CHEBI:38101);monocarboxylic acid (CHEBI:25384);carbonyl compound (CHEBI:36586);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);organonitrogen compound (CHEBI:35352);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);N-acyl-amino acid (CHEBI:51569);benzenoid aromatic compound (CHEBI:33836);primary amine (CHEBI:32877);organic heterocyclic compound (CHEBI:24532);organohalogen compound (CHEBI:36684);haloarene (CHEBI:50887);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143)		Amino acids, peptides, and analogues	Phenylalanine or derivatives;N-acyl-l-alpha-amino acid;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;3-phenylpropanoic-acid;Amphetamine or derivatives;N-alkylindole;Indole;Indole or derivatives;Aryl chloride;Aryl halide;Monocyclic benzene moiety;Benzenoid;Substituted pyrrole;Heteroaromatic compound;Pyrrole;Secondary carboxylic acid amide;Carboxamide group;Organoheterocyclic compound;Monocarboxylic acid or derivatives;Azacycle;Carboxylic acid;Organonitrogen compound;Organochloride;Organohalogen compound;Organic nitrogen compound;Carbonyl group;Hydrocarbon derivative;Organic oxide;Organic oxygen compound;Organooxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS016402566		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C19H17ClN2O3	C19H17ClN2O3			InChI=1S/C19H17ClN2O3/c20-15-7-6-14-8-9-22(17(14)11-15)12-18(23)21-16(19(24)25)10-13-4-2-1-3-5-13/h1-9,11,16H,10,12H2,(H,21,23)(H,24,25)/t16-/m0/s1	JPHVYVDCZJYRRU-INIZCTEOSA-N	rac-(2S)-2-[[2-(6-chloroindol-1-yl)acetyl]amino]-3-phenyl-propanoic acid	49652055	O=C(Cn1ccc2c1cc(Cl)cc2)N[C@@H](Cc1ccccc1)C(=O)O	(2S)-2-[[2-(6-chloroindol-1-yl)acetyl]amino]-3-phenylpropanoic acid			2.6236700000000006													MCULE-8708584054	356.81194		356.09277	3	2	6	3			44										False					Peptide01			Compound(49652055)	49652055	3.7	413			[#8]=[#6](-[#6]-[#7]1:[#6]:[#6]:[#6]2:[#6]:1:[#6]:[#6](-[#17]):[#6]:[#6]:2)-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	O=C(Cn1ccc2c1cc(Cl)cc2)N[C@@H](Cc1ccccc1)C(=O)O	JPHVYVDCZJYRRU		parent_pubchem_cid	AKOS016402566;rac-(2S)-2-[[2-(6-chloroindol-1-yl)acetyl]amino]-3-phenyl-propanoic acid		23382983.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23382983		pluskal_iocb_peptide_Peptide01_C4_id		100	C4		ZINC000040309010
3.6		0	707	P6240176	118.7		K1	False	0	20	0	0	19	0	3	4	0	1		0.0						COC(=O)C(Cc1ccccc1)NC(=O)c1c(-c2ccc(OC)cc2)nns1																							0.0		AKOS016385175		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C20H19N3O4S	C20H19N3O4S			InChI=1S/C20H19N3O4S/c1-26-15-10-8-14(9-11-15)17-18(28-23-22-17)19(24)21-16(20(25)27-2)12-13-6-4-3-5-7-13/h3-11,16H,12H2,1-2H3,(H,21,24)/t16-/m1/s1	PIUJUNVLYQQMDL-MRXNPFEDSA-N	methyl rac-(2R)-2-[[4-(4-methoxyphenyl)thiadiazole-5-carbonyl]amino]-3-phenyl-propanoate	71844012	COC(=O)[C@@H](Cc1ccccc1)NC(=O)c1c(-c2ccc(OC)cc2)nns1	methyl (2R)-2-[[4-(4-methoxyphenyl)thiadiazole-5-carbonyl]amino]-3-phenylpropanoate			1.7759499999999997													MCULE-9159054900	397.45613		397.109627	6	1	8	3			44										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(71844012)	71844012	3.6	414			[#6]-[#8]-[#6](=[#8])-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]1:[#6](-[#6]2:[#6]:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:2):[#7]:[#7]:[#16]:1	COC(=O)[C@@H](Cc1ccccc1)NC(=O)c1c(-c2ccc(OC)cc2)nns1	PIUJUNVLYQQMDL		parent_pubchem_cid	AKOS016385175;METHYL 2-{[4-(4-METHOXYPHENYL)-1,2,3-THIADIAZOL-5-YL]FORMAMIDO}-3-PHENYLPROPANOATE;methyl rac-(2R)-2-[[4-(4-methoxyphenyl)thiadiazole-5-carbonyl]amino]-3-phenyl-propanoate		69212723.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=69212723		pluskal_iocb_peptide_Peptide01_C4_id		100	C4		ZINC000094992924
4.0		0	795	P6241976	80.6		K2	False	0	23	0	0	26	0	2	4	0	0		0.0						CC(C)C(NC(=O)CCn1ccc2c1cc(OCc1ccccc1)cc2)C(=O)O								N-acyl-L-alpha-amino acids;N-alkylindoles;Indoles;Phenol ethers;Alkyl aryl ethers;Substituted pyrroles;Benzene and substituted derivatives;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Carboxylic acids;Monocarboxylic acids and derivatives;Carbonyl compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;N-alkylindoles;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenol ethers;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Valine and derivatives	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as valine and derivatives. These are compounds containing valine or a derivative thereof resulting from reaction of valine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Valine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-L-alpha-amino acid (CHEBI:48927);indoles (CHEBI:24828);aromatic ether (CHEBI:35618);pyrroles (CHEBI:26455);benzenes (CHEBI:22712);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organonitrogen heterocyclic compound (CHEBI:38101);carboxylic acid (CHEBI:33575);monocarboxylic acid (CHEBI:25384);carbonyl compound (CHEBI:36586);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);valine derivative (CHEBI:27267);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);N-acyl-amino acid (CHEBI:51569);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ether (CHEBI:25698);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)		Amino acids, peptides, and analogues	N-acyl-alpha-amino acid;Valine or derivatives;N-acyl-alpha amino acid or derivatives;N-acyl-l-alpha-amino acid;N-alkylindole;Indole;Indole or derivatives;Phenol ether;Alkyl aryl ether;Monocyclic benzene moiety;Benzenoid;Substituted pyrrole;Heteroaromatic compound;Pyrrole;Secondary carboxylic acid amide;Carboxamide group;Azacycle;Organoheterocyclic compound;Carboxylic acid;Ether;Monocarboxylic acid or derivatives;Organic nitrogen compound;Carbonyl group;Organic oxygen compound;Organooxygen compound;Organic oxide;Hydrocarbon derivative;Organonitrogen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS016376595		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C23H26N2O4	C23H26N2O4			InChI=1S/C23H26N2O4/c1-16(2)22(23(27)28)24-21(26)11-13-25-12-10-18-8-9-19(14-20(18)25)29-15-17-6-4-3-5-7-17/h3-10,12,14,16,22H,11,13,15H2,1-2H3,(H,24,26)(H,27,28)/t22-/m0/s1	YWABNSKZGUISAZ-QFIPXVFZSA-N	rac-(2S)-2-[3-(6-benzyloxyindol-1-yl)propanoylamino]-3-methyl-butanoic acid	49652174	CC(C)[C@H](NC(=O)CCn1ccc2c1cc(OCc1ccccc1)cc2)C(=O)O	(2S)-3-methyl-2-[3-(6-phenylmethoxyindol-1-yl)propanoylamino]butanoic acid			2.8902600000000005													MCULE-5327460230	394.47467		394.189257	4	2	9	3			44										False	Alkaloids				Peptide01			Compound(49652174)	49652174	3.6	415			[#6]-[#6](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#6]-[#7]1:[#6]:[#6]:[#6]2:[#6]:1:[#6]:[#6](-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1):[#6]:[#6]:2)-[#6](=[#8])-[#8]	CC(C)[C@H](NC(=O)CCn1ccc2c1cc(OCc1ccccc1)cc2)C(=O)O	YWABNSKZGUISAZ		parent_pubchem_cid	AKOS016376595;(2S)-2-({3-[6-(BENZYLOXY)-1H-INDOL-1-YL]PROPANOYL}AMINO)-3-METHYLBUTANOIC ACID;rac-(2S)-2-[3-(6-benzyloxyindol-1-yl)propanoylamino]-3-methyl-butanoic acid		23891528.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23891528		pluskal_iocb_peptide_Peptide01_C4_id		100	C4		ZINC000040309428
3.0		0	883	P3462814	126.0		K3	False	0	19	0	0	24	0	2	5	0	1		0.0						COc1c(OC)cc(-c2nc(CC(=O)NC(CC(C)C)C(=O)O)cs2)cc1								N-acyl-L-alpha-amino acids;Dimethoxybenzenes;Phenoxy compounds;Anisoles;Alkyl aryl ethers;2,4-disubstituted thiazoles;Heteroaromatic compounds;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	2,4-disubstituted thiazoles;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Anisoles;Azacyclic compounds;Azoles;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Dimethoxybenzenes;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Leucine and derivatives;Methoxybenzenes;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenol ethers;Phenoxy compounds;Secondary carboxylic acid amides;Thiazoles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as leucine and derivatives. These are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Leucine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteromonocyclic compounds	N-acyl-L-alpha-amino acid (CHEBI:48927);dimethoxybenzene (CHEBI:51681);benzenes (CHEBI:22712);methoxybenzene (CHEBI:51683);aromatic ether (CHEBI:35618);thiazoles (CHEBI:48901);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);leucine derivative (CHEBI:47003);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);N-acyl-amino acid (CHEBI:51569);benzenoid aromatic compound (CHEBI:33836);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ether (CHEBI:25698);organic heterocyclic compound (CHEBI:24532);azole (CHEBI:68452);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)		Amino acids, peptides, and analogues	Leucine or derivatives;N-acyl-alpha amino acid or derivatives;N-acyl-alpha-amino acid;N-acyl-l-alpha-amino acid;O-dimethoxybenzene;Dimethoxybenzene;Methoxybenzene;Phenol ether;Anisole;Phenoxy compound;2,4-disubstituted 1,3-thiazole;Alkyl aryl ether;Monocyclic benzene moiety;Benzenoid;Azole;Thiazole;Heteroaromatic compound;Carboxamide group;Secondary carboxylic acid amide;Organoheterocyclic compound;Monocarboxylic acid or derivatives;Ether;Carboxylic acid;Azacycle;Organic oxygen compound;Organic nitrogen compound;Carbonyl group;Hydrocarbon derivative;Organic oxide;Organonitrogen compound;Organooxygen compound;Aromatic heteromonocyclic compound	Organic acids and derivatives	0.0		SCHEMBL21560029		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C19H24N2O5S	C19H24N2O5S			InChI=1S/C19H24N2O5S/c1-11(2)7-14(19(23)24)21-17(22)9-13-10-27-18(20-13)12-5-6-15(25-3)16(8-12)26-4/h5-6,8,10-11,14H,7,9H2,1-4H3,(H,21,22)(H,23,24)/t14-/m0/s1	NFXMYEZYUNFDEX-AWEZNQCLSA-N	rac-(2S)-2-[[2-[2-(3,4-dimethoxyphenyl)thiazol-4-yl]acetyl]amino]-4-methyl-pentanoic acid	39377795	COc1c(OC)cc(-c2nc(CC(=O)N[C@@H](CC(C)C)C(=O)O)cs2)cc1	(2S)-2-[[2-[2-(3,4-dimethoxyphenyl)-1,3-thiazol-4-yl]acetyl]amino]-4-methylpentanoic acid			1.62575													MCULE-8050162957	392.47753		392.140593	6	2	9	2			43										False	Alkaloids				Peptide01			Compound(39377795)	39377795	3.1	416		SCHEMBL21560029	[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]):[#6]:[#6](-[#6]2:[#7]:[#6](-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=[#8])-[#8]):[#6]:[#16]:2):[#6]:[#6]:1	COc1c(OC)cc(-c2nc(CC(=O)N[C@@H](CC(C)C)C(=O)O)cs2)cc1	NFXMYEZYUNFDEX		parent_pubchem_cid	SCHEMBL21560029;AKOS016376079;rac-(2S)-2-[[2-[2-(3,4-dimethoxyphenyl)thiazol-4-yl]acetyl]amino]-4-methyl-pentanoic acid		23186444.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23186444		pluskal_iocb_peptide_Peptide01_C5_id		100	C5		ZINC000032124024
2.9		0	971	P1099222	82.2		K4	False	0	15	0	0	18	0	2	3	0	0		0.0						CCC(C)C(NC(=O)c1cc2ccccc2[nH]1)C(=O)O																							0.0		AKOS016387025		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C15H18N2O3	C15H18N2O3			InChI=1S/C15H18N2O3/c1-3-9(2)13(15(19)20)17-14(18)12-8-10-6-4-5-7-11(10)16-12/h4-9,13,16H,3H2,1-2H3,(H,17,18)(H,19,20)/t9-,13+/m1/s1	AMDIGSLXKNGOAS-RNCFNFMXSA-N	rac-(2S,3R)-2-(1H-indole-2-carbonylamino)-3-methyl-pentanoic acid	24279978	CC[C@@H](C)[C@H](NC(=O)c1cc2ccccc2[nH]1)C(=O)O	(2S,3R)-2-(1H-indole-2-carbonylamino)-3-methylpentanoic acid			1.91387													MCULE-5978080490	274.32231		274.131742	3	3	5	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(24279978)	24279978	3.0	417			[#6]-[#6]-[#6@@H](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#7H]:1)-[#6](=[#8])-[#8]	CC[C@@H](C)[C@H](NC(=O)c1cc2ccccc2[nH]1)C(=O)O	AMDIGSLXKNGOAS		parent_pubchem_cid	AKOS016387025;rac-(2S,3R)-2-(1H-indole-2-carbonylamino)-3-methyl-pentanoic acid		61587818.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=61587818		pluskal_iocb_peptide_Peptide01_C5_id		100	C5		ZINC000011867250
1.3		0	715	P6243642	99.1		K5	False	0	16	0	0	19	0	3	4	0	0		0.0						CC(C)CC(NC(=O)Cn1ncc2ccccc2c1=O)C(=O)O																							0.0		AKOS016376063		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C16H19N3O4	C16H19N3O4			InChI=1S/C16H19N3O4/c1-10(2)7-13(16(22)23)18-14(20)9-19-15(21)12-6-4-3-5-11(12)8-17-19/h3-6,8,10,13H,7,9H2,1-2H3,(H,18,20)(H,22,23)/t13-/m0/s1	PXMOFKLSGOOJRU-ZDUSSCGKSA-N	rac-(2S)-4-methyl-2-[[2-(1-oxophthalazin-2-yl)acetyl]amino]pentanoic acid	51053279	CC(C)C[C@H](NC(=O)Cn1ncc2ccccc2c1=O)C(=O)O	(2S)-4-methyl-2-[[2-(1-oxophthalazin-2-yl)acetyl]amino]pentanoic acid			1.4834699999999998													MCULE-2516155737	317.34753		317.137556	5	2	6	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51053279)	51053279	1.6	418			[#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#7]1:[#7]:[#6]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8])-[#6](=[#8])-[#8]	CC(C)C[C@H](NC(=O)Cn1ncc2ccccc2c1=O)C(=O)O	PXMOFKLSGOOJRU		parent_pubchem_cid	AKOS016376063;(2S)-4-METHYL-2-({2-[1-OXO-2(1H)-PHTHALAZINYL]ACETYL}AMINO)PENTANOIC ACID;rac-(2S)-4-methyl-2-[[2-(1-oxophthalazin-2-yl)acetyl]amino]pentanoic acid		23769638.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23769638		pluskal_iocb_peptide_Peptide01_C5_id		100	C5		ZINC000049546295
3.4		0	803	P6237835	116.8		K6	False	0	21	0	0	20	0	2	4	0	1		0.0						COc1ccccc1-c1nc(CC(=O)NC(Cc2ccccc2)C(=O)O)cs1																							0.0		SCHEMBL20255818		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C21H20N2O4S	C21H20N2O4S			InChI=1S/C21H20N2O4S/c1-27-18-10-6-5-9-16(18)20-22-15(13-28-20)12-19(24)23-17(21(25)26)11-14-7-3-2-4-8-14/h2-10,13,17H,11-12H2,1H3,(H,23,24)(H,25,26)/t17-/m0/s1	HSDKJHHHNHDKDS-KRWDZBQOSA-N	rac-(2S)-2-[[2-[2-(2-methoxyphenyl)thiazol-4-yl]acetyl]amino]-3-phenyl-propanoic acid	39346966	COc1ccccc1-c1nc(CC(=O)N[C@@H](Cc2ccccc2)C(=O)O)cs1	(2S)-2-[[2-[2-(2-methoxyphenyl)-1,3-thiazol-4-yl]acetyl]amino]-3-phenylpropanoic acid			2.22145													MCULE-7943782422	396.46855		396.114378	5	2	8	3			43										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(39346966)	39346966	3.4	419		SCHEMBL20255818	[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#6]1:[#7]:[#6](-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#8]):[#6]:[#16]:1	COc1ccccc1-c1nc(CC(=O)N[C@@H](Cc2ccccc2)C(=O)O)cs1	HSDKJHHHNHDKDS		parent_pubchem_cid	SCHEMBL20255818;EiM08-07176;AKOS005580618;rac-(2S)-2-[[2-[2-(2-methoxyphenyl)thiazol-4-yl]acetyl]amino]-3-phenyl-propanoic acid		22999848.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22999848		pluskal_iocb_peptide_Peptide01_C5_id		100	C5		ZINC000032100574
3.9		0	891	P3462813	54.9		K7	False	0	23	0	0	19	0	3	1	0	0		0.0						O=C(NCCc1ccccc1)c1cc(-c2cnccc2)nc2ccccc12								Bipyridines and oligopyridines;Pyridinecarboxylic acids and derivatives;Benzene and substituted derivatives;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Organooxygen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Bipyridines and oligopyridines;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Pyridinecarboxylic acids and derivatives;Pyridines and derivatives;Quinoline carboxamides;Quinolines and derivatives;Secondary carboxylic acid amides	Quinolines and derivatives	2.1	This compound belongs to the class of organic compounds known as quinoline carboxamides. These are quinolines in which the quinoline ring system is substituted by one or more carboxamide groups.	Quinoline carboxamides			Organic compounds	Aromatic heteropolycyclic compounds	bipyridines (CHEBI:50511);aromatic carboxylic acid (CHEBI:33859);pyridinemonocarboxylic acid (CHEBI:26420);benzenes (CHEBI:22712);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organonitrogen heterocyclic compound (CHEBI:38101);organooxygen compound (CHEBI:36963);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);quinolines (CHEBI:26513);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);pyridines (CHEBI:26421);benzenoid aromatic compound (CHEBI:33836);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143)		Quinoline carboxamides	Quinoline-4-carboxamide;Bipyridine;Pyridine carboxylic acid or derivatives;Monocyclic benzene moiety;Pyridine;Benzenoid;Heteroaromatic compound;Secondary carboxylic acid amide;Carboxamide group;Carboxylic acid derivative;Azacycle;Hydrocarbon derivative;Organic oxide;Organooxygen compound;Organonitrogen compound;Organic oxygen compound;Organic nitrogen compound;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		N-(2-phenylethyl)-2-(pyridin-3-yl)quinoline-4-carboxamide		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C23H19N3O	C23H19N3O			InChI=1S/C23H19N3O/c27-23(25-14-12-17-7-2-1-3-8-17)20-15-22(18-9-6-13-24-16-18)26-21-11-5-4-10-19(20)21/h1-11,13,15-16H,12,14H2,(H,25,27)	GMEQYLXEVGMZFZ-UHFFFAOYSA-N	N-(2-phenylethyl)-2-(3-pyridyl)quinoline-4-carboxamide	17720550	O=C(NCCc1ccccc1)c1cc(-c2cnccc2)nc2ccccc12	N-(2-phenylethyl)-2-pyridin-3-ylquinoline-4-carboxamide			3.351440000000002													MCULE-3397908552	353.42738		353.152812	3	1	5	4			44									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(17720550)	17720550	4.0	420			[#8]=[#6](-[#7]-[#6]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#6](-[#6]2:[#6]:[#7]:[#6]:[#6]:[#6]:2):[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	O=C(NCCc1ccccc1)c1cc(-c2cnccc2)nc2ccccc12	GMEQYLXEVGMZFZ		parent_pubchem_cid	N-(2-phenylethyl)-2-(pyridin-3-yl)quinoline-4-carboxamide;954305-63-6;STK732027;AKOS004995991;NCGC00305063-01;AB01301539-01;Z27761789;N-(2-phenylethyl)-2-(3-pyridyl)quinoline-4-carboxamide		16083242.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=16083242		pluskal_iocb_peptide_Peptide01_C5_id		100	C5		ZINC000017357437
1.5		0	979	P1098081	95.9		K8	False	0	25	0	0	21	0	1	5	0	0		0.0						O=C(O)C(Cc1ccccc1)NCc1c2oc(=O)cc(-c3ccccc3)c2ccc1O								Phenylalanine and derivatives;7-hydroxycoumarins;Phenylpropanoic acids;1-benzopyrans;Amphetamines and derivatives;D-alpha-amino acids;Pyranones and derivatives;1-hydroxy-2-unsubstituted benzenoids;Aralkylamines;Heteroaromatic compounds;Lactones;Amino acids;Dialkylamines;Carboxylic acids;Monocarboxylic acids and derivatives;Oxacyclic compounds;Hydrocarbon derivatives;Carbonyl compounds;Organic oxides;Organopnictogen compounds	1-benzopyrans;1-hydroxy-2-unsubstituted benzenoids;7-hydroxycoumarins;Alpha amino acids;Alpha amino acids and derivatives;Amines;Amino acids;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Aralkylamines;Benzene and substituted derivatives;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;D-alpha-amino acids;Dialkylamines;Heteroaromatic compounds;Hydrocarbon derivatives;Hydroxycoumarins;Lactones;Monocarboxylic acids and derivatives;Neoflavones;Neoflavonoids;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenethylamines;Phenols;Phenylalanine and derivatives;Phenylpropanoic acids;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Secondary amines	Neoflavonoids	2.1	This compound belongs to the class of organic compounds known as neoflavones. These are neoflavonoids with a structure based on the 4-phenylcoumarin skeleton.	Neoflavones			Organic compounds	Aromatic heteropolycyclic compounds	phenylalanine derivative (CHEBI:25985);hydroxycoumarin (CHEBI:37912);benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);1-benzopyran (CHEBI:38443);amphetamines (CHEBI:35338);D-alpha-amino acid (CHEBI:16733);pyranone (CHEBI:37963);phenols (CHEBI:33853);aralkylamine (CHEBI:18000);organic aromatic compound (CHEBI:33659);lactone (CHEBI:25000);amino acid (CHEBI:33709);secondary amino compound (CHEBI:50995);monocarboxylic acid (CHEBI:25384);oxacycle (CHEBI:38104);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);organic oxide (CHEBI:25701);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);neoflavonoid (CHEBI:71971);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organonitrogen compound (CHEBI:35352);organooxygen compound (CHEBI:36963);coumarins (CHEBI:23403);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);benzenoid aromatic compound (CHEBI:33836);primary amine (CHEBI:32877);alpha-amino acid (CHEBI:33704);pyrans (CHEBI:26407);nitrogen molecular entity (CHEBI:51143);amine (CHEBI:32952);secondary amine (CHEBI:32863);oxygen molecular entity (CHEBI:25806);carboxylic acid anion (CHEBI:29067);peptide (CHEBI:16670)	Benzopyranoids (PK1311);Neoflavonoids (PK1210)	Neoflavones	4-phenylcoumarin;Phenylalanine or derivatives;7-hydroxycoumarin;Hydroxycoumarin;Coumarin;3-phenylpropanoic-acid;Alpha-amino acid;Alpha-amino acid or derivatives;Benzopyran;1-benzopyran;D-alpha-amino acid;Amphetamine or derivatives;Aralkylamine;1-hydroxy-2-unsubstituted benzenoid;Pyranone;Benzenoid;Monocyclic benzene moiety;Pyran;Heteroaromatic compound;Amino acid or derivatives;Lactone;Amino acid;Carboxylic acid;Monocarboxylic acid or derivatives;Organoheterocyclic compound;Oxacycle;Secondary aliphatic amine;Carboxylic acid derivative;Secondary amine;Organic nitrogen compound;Carbonyl group;Organonitrogen compound;Organooxygen compound;Hydrocarbon derivative;Organic oxide;Amine;Organopnictogen compound;Organic oxygen compound;Aromatic heteropolycyclic compound	Phenylpropanoids and polyketides	0.0		SCHEMBL13780720		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C25H21NO5	C25H21NO5			InChI=1S/C25H21NO5/c27-22-12-11-18-19(17-9-5-2-6-10-17)14-23(28)31-24(18)20(22)15-26-21(25(29)30)13-16-7-3-1-4-8-16/h1-12,14,21,26-27H,13,15H2,(H,29,30)/t21-/m1/s1	LBUXRSIZBJQCAB-OAQYLSRUSA-N	rac-(2R)-2-[(7-hydroxy-2-oxo-4-phenyl-chromen-8-yl)methylamino]-3-phenyl-propanoic acid	5449542	O=C(O)[C@@H](Cc1ccccc1)NCc1c2oc(=O)cc(-c3ccccc3)c2ccc1O	(2R)-2-[(7-hydroxy-2-oxo-4-phenylchromen-8-yl)methylamino]-3-phenylpropanoic acid			3.4707200000000022													MCULE-4863670609	415.44982		415.141973	6	3	7	4			43										False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(5449542)	5449542	2.0	421		SCHEMBL13780720	[#8]=[#6](-[#8])-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6]-[#6]1:[#6]2:[#8]:[#6](=[#8]):[#6]:[#6](-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#6]:2:[#6]:[#6]:[#6]:1-[#8]	O=C(O)[C@@H](Cc1ccccc1)NCc1c2oc(=O)cc(-c3ccccc3)c2ccc1O	LBUXRSIZBJQCAB		parent_pubchem_cid	SCHEMBL13780720;2-{[(7-HYDROXY-2-OXO-4-PHENYL-2H-CHROMEN-8-YL)METHYL]AMINO}-3-PHENYLPROPANOIC ACID;EiM07-16752;AKOS016402589;rac-(2R)-2-[(7-hydroxy-2-oxo-4-phenyl-chromen-8-yl)methylamino]-3-phenyl-propanoic acid		15662389.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=15662389		pluskal_iocb_peptide_Peptide01_C5_id		100	C5		ZINC000000940540
2.8		0	723	P3463147	100.7		K9	False	0	19	0	0	18	0	2	5	0	0		0.0						COc1c(OC)c2c(cc1)[nH]c(C(=O)NC(C(=O)O)c1ccccc1)c2																							0.0		AKOS016383063		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C19H18N2O5	C19H18N2O5			InChI=1S/C19H18N2O5/c1-25-15-9-8-13-12(17(15)26-2)10-14(20-13)18(22)21-16(19(23)24)11-6-4-3-5-7-11/h3-10,16,20H,1-2H3,(H,21,22)(H,23,24)/t16-/m0/s1	IPHKFUFWTCLZCS-INIZCTEOSA-N	rac-(2S)-2-[(4,5-dimethoxy-1H-indole-2-carbonyl)amino]-2-phenyl-acetic acid	51703649	COc1c(OC)c2c(cc1)[nH]c(C(=O)N[C@H](C(=O)O)c1ccccc1)c2	(2S)-2-[(4,5-dimethoxy-1H-indole-2-carbonyl)amino]-2-phenylacetic acid			1.2781399999999996													MCULE-7403697156	354.36571		354.121572	5	3	6	3			44									Carbazole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(51703649)	51703649	2.9	422			[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]):[#6]2:[#6](:[#6]:[#6]:1):[#7H]:[#6](-[#6](=[#8])-[#7]-[#6@H](-[#6](=[#8])-[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1):[#6]:2	COc1c(OC)c2c(cc1)[nH]c(C(=O)N[C@H](C(=O)O)c1ccccc1)c2	IPHKFUFWTCLZCS		parent_pubchem_cid	AKOS016383063;2-[(4,5-DIMETHOXY-1H-INDOL-2-YL)FORMAMIDO]-2-PHENYLACETIC ACID;rac-(2S)-2-[(4,5-dimethoxy-1H-indole-2-carbonyl)amino]-2-phenyl-acetic acid		24422147.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24422147		pluskal_iocb_peptide_Peptide01_C5_id		100	C5		ZINC000035686332
2.3		0	811	P3459741	89.6		K10	False	0	23	0	0	21	0	3	4	0	0		0.0						O=C(NC(Cc1ccccc1)C(=O)Nc1cc2c(cc1)OCCO2)c1cnccc1																							0.0		STL226745		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C23H21N3O4	C23H21N3O4			InChI=1S/C23H21N3O4/c27-22(17-7-4-10-24-15-17)26-19(13-16-5-2-1-3-6-16)23(28)25-18-8-9-20-21(14-18)30-12-11-29-20/h1-10,14-15,19H,11-13H2,(H,25,28)(H,26,27)/t19-/m0/s1	KJQUCLVJDOBQBM-IBGZPJMESA-N	N-[rac-(1S)-1-benzyl-2-(2,3-dihydro-1,4-benzodioxin-6-ylamino)-2-oxo-ethyl]pyridine-3-carboxamide	29132011	O=C(N[C@@H](Cc1ccccc1)C(=O)Nc1cc2c(cc1)OCCO2)c1cnccc1	N-[(2S)-1-(2,3-dihydro-1,4-benzodioxin-6-ylamino)-1-oxo-3-phenylpropan-2-yl]pyridine-3-carboxamide			1.4177499999999996													MCULE-4508644650	403.44152		403.153206	5	2	6	4			44										False					Peptide01			Compound(29132011)	29132011	2.7	423			[#8]=[#6](-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#7]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1)-[#8]-[#6]-[#6]-[#8]-2)-[#6]1:[#6]:[#7]:[#6]:[#6]:[#6]:1	O=C(N[C@@H](Cc1ccccc1)C(=O)Nc1cc2c(cc1)OCCO2)c1cnccc1	KJQUCLVJDOBQBM		parent_pubchem_cid	STL226745;AKOS016400045;N-(2,3-dihydro-1,4-benzodioxin-6-yl)-Nalpha-(pyridin-3-ylcarbonyl)-L-phenylalaninamide;N-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-PHENYL-2-[(PYRIDIN-3-YL)FORMAMIDO]PROPANAMIDE;N-[rac-(1S)-1-benzyl-2-(2,3-dihydro-1,4-benzodioxin-6-ylamino)-2-oxo-ethyl]pyridine-3-carboxamide		10095750.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=10095750		pluskal_iocb_peptide_Peptide01_C5_id		100	C5		ZINC000020724372
2.5		0	899	P3462530	80.3		K11	False	0	22	0	0	21	0	3	3	0	0		0.0						COc1ccc(NC(=O)C(Cc2ccccc2)NC(=O)c2cnccc2)cc1																							0.0		STL226742		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C22H21N3O3	C22H21N3O3			InChI=1S/C22H21N3O3/c1-28-19-11-9-18(10-12-19)24-22(27)20(14-16-6-3-2-4-7-16)25-21(26)17-8-5-13-23-15-17/h2-13,15,20H,14H2,1H3,(H,24,27)(H,25,26)/t20-/m0/s1	UHJIQQFSVMCYGN-FQEVSTJZSA-N	N-[rac-(1S)-1-benzyl-2-(4-methoxyanilino)-2-oxo-ethyl]pyridine-3-carboxamide	29132855	COc1ccc(NC(=O)[C@H](Cc2ccccc2)NC(=O)c2cnccc2)cc1	N-[(2S)-1-(4-methoxyanilino)-1-oxo-3-phenylpropan-2-yl]pyridine-3-carboxamide			2.11756													MCULE-7189111618	375.43097		375.158292	4	2	7	3			44									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(29132855)	29132855	3.0	424			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#7]-[#6](=[#8])-[#6@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#7]-[#6](=[#8])-[#6]2:[#6]:[#7]:[#6]:[#6]:[#6]:2):[#6]:[#6]:1	COc1ccc(NC(=O)[C@H](Cc2ccccc2)NC(=O)c2cnccc2)cc1	UHJIQQFSVMCYGN		parent_pubchem_cid	STL226742;AKOS016385406;N-(4-methoxyphenyl)-Nalpha-(pyridin-3-ylcarbonyl)-L-phenylalaninamide;N-[rac-(1S)-1-benzyl-2-(4-methoxyanilino)-2-oxo-ethyl]pyridine-3-carboxamide		7026938.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=7026938		pluskal_iocb_peptide_Peptide01_C6_id		100	C6		ZINC000020726551
3.1		0	987	P1098680	131.0		K12	False	0	27	0	0	28	0	2	7	0	0		0.0						O=C(O)CCCNC(=O)C(Cc1ccccc1)NC(=O)COc1cc2c(cc1)c1c(CCC1)c(=O)o2																							0.0		AKOS016402309		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C27H28N2O7	C27H28N2O7			InChI=1S/C27H28N2O7/c30-24(16-35-18-11-12-20-19-8-4-9-21(19)27(34)36-23(20)15-18)29-22(14-17-6-2-1-3-7-17)26(33)28-13-5-10-25(31)32/h1-3,6-7,11-12,15,22H,4-5,8-10,13-14,16H2,(H,28,33)(H,29,30)(H,31,32)/t22-/m0/s1	LNGZPANXRWBGBC-QFIPXVFZSA-N	4-[[rac-(2S)-2-[[2-[(4-oxo-2,3-dihydro-1H-cyclopenta[c]chromen-7-yl)oxy]acetyl]amino]-3-phenyl-propanoyl]amino]butanoic acid	24279908	O=C(O)CCCNC(=O)[C@H](Cc1ccccc1)NC(=O)COc1cc2c(cc1)c1c(CCC1)c(=O)o2	4-[[(2S)-2-[[2-[(4-oxo-2,3-dihydro-1H-cyclopenta[c]chromen-7-yl)oxy]acetyl]amino]-3-phenylpropanoyl]amino]butanoic acid			2.2139299999999995													MCULE-1597186557	492.53341		492.189651	7	3	11	4			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(24279908)	24279908	2.8	425			[#8]=[#6](-[#8])-[#6]-[#6]-[#6]-[#7]-[#6](=[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#6]1:[#6](-[#6]-[#6]-[#6]-1):[#6](=[#8]):[#8]:2	O=C(O)CCCNC(=O)[C@H](Cc1ccccc1)NC(=O)COc1cc2c(cc1)c1c(CCC1)c(=O)o2	LNGZPANXRWBGBC		parent_pubchem_cid	AKOS016402309;4-{2-[2-({4-OXO-1H,2H,3H,4H-CYCLOPENTA[C]CHROMEN-7-YL}OXY)ACETAMIDO]-3-PHENYLPROPANAMIDO}BUTANOIC ACID;4-[[rac-(2S)-2-[[2-[(4-oxo-2,3-dihydro-1H-cyclopenta[c]chromen-7-yl)oxy]acetyl]amino]-3-phenyl-propanoyl]amino]butanoic acid		24406486.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24406486		pluskal_iocb_peptide_Peptide01_C6_id		100	C6		ZINC000011866868
2.8		0	731	P1157905	100.7		K13	False	0	19	0	0	18	0	2	5	0	0		0.0						COc1c2cc(C(=O)NC(C(=O)O)c3ccccc3)[nH]c2c(OC)cc1								Indolecarboxamides and derivatives;Indoles;Pyrrole carboxamides;Anisoles;2-heteroaryl carboxamides;Alkyl aryl ethers;Substituted pyrroles;Benzene and substituted derivatives;Heteroaromatic compounds;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	2-heteroaryl carboxamides;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Anisoles;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Indolecarboxamides and derivatives;Indolecarboxylic acids and derivatives;Indoles;Indoles and derivatives;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenol ethers;Pyrrole carboxamides;Pyrrole carboxylic acids and derivatives;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom.	N-acyl-alpha amino acids		Amino acids and derivatives;Alpha amino acids and derivatives;N-acyl-alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	indolecarboxamide (CHEBI:46921);indoles (CHEBI:24828);pyrroles (CHEBI:26455);carboxamide (CHEBI:37622);methoxybenzene (CHEBI:51683);organic aromatic compound (CHEBI:33659);aromatic ether (CHEBI:35618);benzenes (CHEBI:22712);carbonyl compound (CHEBI:36586);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);organonitrogen heterocyclic compound (CHEBI:38101);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);N-acyl-amino acid (CHEBI:51569);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);indolyl carboxylic acid (CHEBI:46867);benzenoid aromatic compound (CHEBI:33836);organooxygen compound (CHEBI:36963);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);ether (CHEBI:25698);nitrogen molecular entity (CHEBI:51143);amino acid (CHEBI:33709);peptide (CHEBI:16670)		Amino acids, peptides, and analogues	N-acyl-alpha-amino acid;Indolecarboxylic acid derivative;Indolecarboxamide derivative;Indole or derivatives;Indole;2-heteroaryl carboxamide;Pyrrole-2-carboxylic acid or derivatives;Pyrrole-2-carboxamide;Anisole;Alkyl aryl ether;Benzenoid;Substituted pyrrole;Monocyclic benzene moiety;Heteroaromatic compound;Pyrrole;Secondary carboxylic acid amide;Carboxamide group;Azacycle;Organoheterocyclic compound;Monocarboxylic acid or derivatives;Ether;Carboxylic acid;Organic nitrogen compound;Organic oxygen compound;Organopnictogen compound;Organic oxide;Hydrocarbon derivative;Organooxygen compound;Organonitrogen compound;Carbonyl group;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		956951-92-1		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C19H18N2O5	C19H18N2O5			InChI=1S/C19H18N2O5/c1-25-14-8-9-15(26-2)17-12(14)10-13(20-17)18(22)21-16(19(23)24)11-6-4-3-5-7-11/h3-10,16,20H,1-2H3,(H,21,22)(H,23,24)/t16-/m0/s1	IWFKXMXHKHTPHT-INIZCTEOSA-N	rac-(2S)-2-[(4,7-dimethoxy-1H-indole-2-carbonyl)amino]-2-phenyl-acetic acid	16407665	COc1c2cc(C(=O)N[C@H](C(=O)O)c3ccccc3)[nH]c2c(OC)cc1	(2S)-2-[(4,7-dimethoxy-1H-indole-2-carbonyl)amino]-2-phenylacetic acid			1.2781399999999994													MCULE-5690956216	354.36571		354.121572	5	3	6	3			44									Carbazole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(16407665)	16407665	2.9	426			[#6]-[#8]-[#6]1:[#6]2:[#6]:[#6](-[#6](=[#8])-[#7]-[#6@H](-[#6](=[#8])-[#8])-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#7H]:[#6]:2:[#6](-[#8]-[#6]):[#6]:[#6]:1	COc1c2cc(C(=O)N[C@H](C(=O)O)c3ccccc3)[nH]c2c(OC)cc1	IWFKXMXHKHTPHT		parent_pubchem_cid	956951-92-1;(2S)-2-[(4,7-dimethoxy-1H-indol-2-yl)formamido]-2-phenylacetic acid;(2S)-2-[(4,7-dimethoxy-1H-indole-2-carbonyl)amino]-2-phenylacetic acid;MFCD08741989;AKOS004937080;NS-05665;EN300-303288;(2S)-2-[(4,7-dimethoxy-1H-indol-2-yl)formamido]-2-phenylaceticacid;{[(4,7-DIMETHOXY-1H-INDOL-2-YL)CARBONYL]AMINO}(PHENYL)ACETIC ACID;rac-(2S)-2-[(4,7-dimethoxy-1H-indole-2-carbonyl)amino]-2-phenyl-acetic acid		23066007.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23066007		pluskal_iocb_peptide_Peptide01_C6_id		100	C6		ZINC000008879506
1.9		0	819	P11184216	101.7		K14	False	0	16	0	0	18	0	2	5	0	0		0.0						COc1noc(CCC(=O)NC(Cc2ccccc2)C(=O)O)c1																							0.0		AKOS027472136		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C16H18N2O5	C16H18N2O5			InChI=1S/C16H18N2O5/c1-22-15-10-12(23-18-15)7-8-14(19)17-13(16(20)21)9-11-5-3-2-4-6-11/h2-6,10,13H,7-9H2,1H3,(H,17,19)(H,20,21)/t13-/m0/s1	OSFQLVRGTUHKTM-ZDUSSCGKSA-N	rac-(2S)-2-[3-(3-methoxyisoxazol-5-yl)propanoylamino]-3-phenyl-propanoic acid	75490218	COc1noc(CCC(=O)N[C@@H](Cc2ccccc2)C(=O)O)c1	(2S)-2-[3-(3-methoxy-1,2-oxazol-5-yl)propanoylamino]-3-phenylpropanoic acid			0.8560699999999992														318.33226		318.121572	5	2	8	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(75490218)	75490218	1.8	427			[#6]-[#8]-[#6]1:[#7]:[#8]:[#6](-[#6]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#8]):[#6]:1	COc1noc(CCC(=O)N[C@@H](Cc2ccccc2)C(=O)O)c1	OSFQLVRGTUHKTM		parent_pubchem_cid	AKOS027472136;N-[3-(3-methoxy-1,2-oxazol-5-yl)propanoyl]-L-phenylalanine;rac-(2S)-2-[3-(3-methoxyisoxazol-5-yl)propanoylamino]-3-phenyl-propanoic acid		80414642.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=80414642		pluskal_iocb_peptide_Peptide01_C6_id		100	C6		ZINC000096231904
2.4		0	907	P3463244	120.8		K15	False	0	20	1	0	18	0	5	4	0	1		0.0						O=C(Cc1c[nH]c2ccccc12)N1CCN(S(=O)(=O)c2ccc(Cl)c3nonc23)CC1																							0.0		1-{4-[(7-chloro-2,1,3-benzoxadiazol-4-yl)sulfonyl]piperazin-1-yl}-2-(1H-indol-3-yl)ethanone		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	1	1		C20H18ClN5O4S	C20H18ClN5O4S			InChI=1S/C20H18ClN5O4S/c21-15-5-6-17(20-19(15)23-30-24-20)31(28,29)26-9-7-25(8-10-26)18(27)11-13-12-22-16-4-2-1-3-14(13)16/h1-6,12,22H,7-11H2	ASGVKQSOPLTQFE-UHFFFAOYSA-N	1-[4-[(4-chloro-2,1,3-benzoxadiazol-7-yl)sulfonyl]piperazin-1-yl]-2-(1H-indol-3-yl)ethanone	42571102	O=C(Cc1c[nH]c2ccccc12)N1CCN(S(=O)(=O)c2ccc(Cl)c3nonc23)CC1	1-[4-[(4-chloro-2,1,3-benzoxadiazol-7-yl)sulfonyl]piperazin-1-yl]-2-(1H-indol-3-yl)ethanone			1.41354													MCULE-2640220442	459.91456		459.076803	5	1	4	5			44										False	Alkaloids				Peptide01			Compound(42571102)	42571102	1.9	428			[#8]=[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]1-[#6]-[#6]-[#7](-[#16](=[#8])(=[#8])-[#6]2:[#6]:[#6]:[#6](-[#17]):[#6]3:[#7]:[#8]:[#7]:[#6]:2:3)-[#6]-[#6]-1	O=C(Cc1c[nH]c2ccccc12)N1CCN(S(=O)(=O)c2ccc(Cl)c3nonc23)CC1	ASGVKQSOPLTQFE		parent_pubchem_cid	1-{4-[(7-chloro-2,1,3-benzoxadiazol-4-yl)sulfonyl]piperazin-1-yl}-2-(1H-indol-3-yl)ethanone;1010919-72-8;AKOS005569006;1-[4-[(4-chloro-2,1,3-benzoxadiazol-7-yl)sulfonyl]piperazin-1-yl]-2-(1H-indol-3-yl)ethanone		14482621.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=14482621		pluskal_iocb_peptide_Peptide01_C6_id		100	C6		ZINC000012391349
1.8		0	995	P7567855	96.6		K16	False	0	15	0	0	18	0	2	3	0	1		0.0						CSCCC(NC(=O)c1cc2c(cc1)n(C)cc2)C(=O)O																							0.0		AKOS025146051		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C15H18N2O3S	C15H18N2O3S			InChI=1S/C15H18N2O3S/c1-17-7-5-10-9-11(3-4-13(10)17)14(18)16-12(15(19)20)6-8-21-2/h3-5,7,9,12H,6,8H2,1-2H3,(H,16,18)(H,19,20)/t12-/m0/s1	PPUWALAZWVFAIK-LBPRGKRZSA-N	rac-(2S)-2-[(1-methylindole-5-carbonyl)amino]-4-methylsulfanyl-butanoic acid	91638336	CSCC[C@H](NC(=O)c1cc2c(cc1)n(C)cc2)C(=O)O	(2S)-2-[(1-methylindole-5-carbonyl)amino]-4-methylsulfanylbutanoic acid			1.63127														306.38631		306.103813	4	2	6	2			45									Dipeptides	False	Alkaloids;Amino acids and Peptides	Small peptides			Peptide01			Compound(91638336)	91638336	1.9	429			[#6]-[#16]-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#7](-[#6]):[#6]:[#6]:2)-[#6](=[#8])-[#8]	CSCC[C@H](NC(=O)c1cc2c(cc1)n(C)cc2)C(=O)O	PPUWALAZWVFAIK		parent_pubchem_cid	AKOS025146051;(2S)-2-{[(1-METHYL-1H-INDOL-5-YL)CARBONYL]AMINO}-4-(METHYLSULFANYL)BUTANOIC ACID;rac-(2S)-2-[(1-methylindole-5-carbonyl)amino]-4-methylsulfanyl-butanoic acid		92089142.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=92089142		pluskal_iocb_peptide_Peptide01_C6_id		100	C6		ZINC000170625479
3.9		0	739	P6235959	101.9		K17	False	0	23	0	0	23	0	1	6	0	0		0.0						CCc1cc2c(cc1OCC(=O)NC(Cc1ccccc1)C(=O)O)oc(=O)cc2C								N-acyl-L-alpha-amino acids;Phenylpropanoic acids;Coumarins and derivatives;1-benzopyrans;Amphetamines and derivatives;Pyranones and derivatives;Alkyl aryl ethers;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactones;Oxacyclic compounds;Carboxylic acids;Monocarboxylic acids and derivatives;Organopnictogen compounds;Carbonyl compounds;Organic oxides;Organonitrogen compounds;Hydrocarbon derivatives	1-benzopyrans;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Benzene and substituted derivatives;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Lactones;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenethylamines;Phenylalanine and derivatives;Phenylpropanoic acids;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Secondary carboxylic acid amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-L-alpha-amino acid (CHEBI:48927);benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);coumarins (CHEBI:23403);1-benzopyran (CHEBI:38443);amphetamines (CHEBI:35338);pyranone (CHEBI:37963);aromatic ether (CHEBI:35618);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactone (CHEBI:25000);oxacycle (CHEBI:38104);carboxylic acid anion (CHEBI:29067);carbonyl compound (CHEBI:36586);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);organic molecule (CHEBI:72695);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);amino acid (CHEBI:33709);peptide (CHEBI:16670);N-acyl-amino acid (CHEBI:51569);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);benzenoid aromatic compound (CHEBI:33836);primary amine (CHEBI:32877);pyrans (CHEBI:26407);oxygen molecular entity (CHEBI:25806);ether (CHEBI:25698);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)	Benzopyranoids (PK1311)	Amino acids, peptides, and analogues	Phenylalanine or derivatives;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;N-acyl-l-alpha-amino acid;Coumarin;3-phenylpropanoic-acid;Benzopyran;1-benzopyran;Amphetamine or derivatives;Alkyl aryl ether;Pyranone;Monocyclic benzene moiety;Benzenoid;Pyran;Heteroaromatic compound;Carboxamide group;Lactone;Secondary carboxylic acid amide;Monocarboxylic acid or derivatives;Ether;Organoheterocyclic compound;Carboxylic acid;Oxacycle;Organic oxygen compound;Organic nitrogen compound;Hydrocarbon derivative;Organic oxide;Carbonyl group;Organopnictogen compound;Organonitrogen compound;Organooxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		2-{2-[(6-ethyl-4-methyl-2-oxo-2H-chromen-7-yl)oxy]acetamido}-3-phenylpropanoic acid		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C23H23NO6	C23H23NO6			InChI=1S/C23H23NO6/c1-3-16-11-17-14(2)9-22(26)30-20(17)12-19(16)29-13-21(25)24-18(23(27)28)10-15-7-5-4-6-8-15/h4-9,11-12,18H,3,10,13H2,1-2H3,(H,24,25)(H,27,28)/t18-/m0/s1	PIFDTDZOSWFTGB-SFHVURJKSA-N	rac-(2S)-2-[[2-(6-ethyl-4-methyl-2-oxo-chromen-7-yl)oxyacetyl]amino]-3-phenyl-propanoic acid	982018	CCc1cc2c(cc1OCC(=O)N[C@@H](Cc1ccccc1)C(=O)O)oc(=O)cc2C	(2S)-2-[[2-(6-ethyl-4-methyl-2-oxochromen-7-yl)oxyacetyl]amino]-3-phenylpropanoic acid			2.69965													MCULE-9117661960	409.44286		409.152537	6	2	8	3			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(982018)	982018	3.5	430			[#6]-[#6]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1-[#8]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]):[#8]:[#6](=[#8]):[#6]:[#6]:2-[#6]	CCc1cc2c(cc1OCC(=O)N[C@@H](Cc1ccccc1)C(=O)O)oc(=O)cc2C	PIFDTDZOSWFTGB		parent_pubchem_cid	2-{2-[(6-ethyl-4-methyl-2-oxo-2H-chromen-7-yl)oxy]acetamido}-3-phenylpropanoic acid;EiM07-30146;STK921507;AKOS004938194;N-{[(6-ethyl-4-methyl-2-oxo-2H-chromen-7-yl)oxy]acetyl}-L-phenylalanine;rac-(2S)-2-[[2-(6-ethyl-4-methyl-2-oxo-chromen-7-yl)oxyacetyl]amino]-3-phenyl-propanoic acid		49215340.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=49215340		pluskal_iocb_peptide_Peptide01_C6_id		100	C6		ZINC000004026628
1.3		0	827	P3461970	122.2		K18	False	0	26	0	0	28	0	2	7	0	0		0.0						CC(=O)N1CCC2(CC1)CC(=O)c1c(cc(OCC(=O)NC(Cc3ccccc3)C(=O)O)cc1)O2																							0.0		AKOS005534969		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	4	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0		C26H28N2O7	C26H28N2O7			InChI=1S/C26H28N2O7/c1-17(29)28-11-9-26(10-12-28)15-22(30)20-8-7-19(14-23(20)35-26)34-16-24(31)27-21(25(32)33)13-18-5-3-2-4-6-18/h2-8,14,21H,9-13,15-16H2,1H3,(H,27,31)(H,32,33)/t21-/m0/s1	VCTROFHGLUIWFW-NRFANRHFSA-N	rac-(2S)-2-[[2-(1'-acetyl-4-oxo-spiro[chromane-2,4'-piperidine]-7-yl)oxyacetyl]amino]-3-phenyl-propanoic acid	29135869	CC(=O)N1CCC2(CC1)CC(=O)c1c(cc(OCC(=O)N[C@@H](Cc3ccccc3)C(=O)O)cc1)O2	(2S)-2-[[2-(1'-acetyl-4-oxospiro[3H-chromene-2,4'-piperidine]-7-yl)oxyacetyl]amino]-3-phenylpropanoic acid			1.1895600000000015													MCULE-9613328598	480.52226		480.189651	7	2	7	4			44										False	Amino acids and Peptides				Peptide01			Compound(29135869)	29135869	2.1	431			[#6]-[#6](=[#8])-[#7]1-[#6]-[#6]-[#6]2(-[#6]-[#6]-1)-[#6]-[#6](=[#8])-[#6]1:[#6](:[#6]:[#6](-[#8]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3)-[#6](=[#8])-[#8]):[#6]:[#6]:1)-[#8]-2	CC(=O)N1CCC2(CC1)CC(=O)c1c(cc(OCC(=O)N[C@@H](Cc3ccccc3)C(=O)O)cc1)O2	VCTROFHGLUIWFW		parent_pubchem_cid	AKOS005534969;2-(2-{1'-ACETYL-4-OXO-3,4-DIHYDROSPIRO[1-BENZOPYRAN-2,4'-PIPERIDIN]-7-YLOXY}ACETAMIDO)-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[[2-(1'-acetyl-4-oxo-spiro[chromane-2,4'-piperidine]-7-yl)oxyacetyl]amino]-3-phenyl-propanoic acid		24670074.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24670074		pluskal_iocb_peptide_Peptide01_C6_id		100	C6		ZINC000020735502
0.4		0	915	P6240012	143.5		K19	False	0	18	0	0	22	0	4	5	0	0		0.0						CC(=O)c1cn(CC(=O)NC(CCCNC(N)=O)C(=O)O)c2ccccc12								N-alkylindoles;Indoles;Aryl alkyl ketones;Substituted pyrroles;Benzenoids;Vinylogous amides;Heteroaromatic compounds;Ureas;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Aryl alkyl ketones;Aryl ketones;Azacyclic compounds;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Ketones;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;N-alkylindoles;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Ureas;Vinylogous amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom.	N-acyl-alpha amino acids		Amino acids and derivatives;Alpha amino acids and derivatives;N-acyl-alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	indoles (CHEBI:24828);aromatic ketone (CHEBI:76224);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);enone (CHEBI:51689);enamine (CHEBI:47989);organic aromatic compound (CHEBI:33659);ureas (CHEBI:47857);carboxamide (CHEBI:37622);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);N-acyl-amino acid (CHEBI:51569);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);organooxygen compound (CHEBI:36963);carbonyl compound (CHEBI:36586);ketone (CHEBI:17087);organic acid (CHEBI:64709);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)		Amino acids, peptides, and analogues	N-acyl-alpha-amino acid;N-alkylindole;Indole;Indole or derivatives;Aryl alkyl ketone;Aryl ketone;Substituted pyrrole;Benzenoid;Pyrrole;Heteroaromatic compound;Vinylogous amide;Carboxamide group;Ketone;Secondary carboxylic acid amide;Urea;Monocarboxylic acid or derivatives;Azacycle;Carboxylic acid;Organoheterocyclic compound;Hydrocarbon derivative;Organooxygen compound;Organonitrogen compound;Organic oxide;Carbonyl group;Organic oxygen compound;Organic nitrogen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS016375007		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	4	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C18H22N4O5	C18H22N4O5			InChI=1S/C18H22N4O5/c1-11(23)13-9-22(15-7-3-2-5-12(13)15)10-16(24)21-14(17(25)26)6-4-8-20-18(19)27/h2-3,5,7,9,14H,4,6,8,10H2,1H3,(H,21,24)(H,25,26)(H3,19,20,27)/t14-/m1/s1	RGHVFRATSNVCPV-CQSZACIVSA-N	rac-(2R)-2-[[2-(3-acetylindol-1-yl)acetyl]amino]-5-ureido-pentanoic acid	45490521	CC(=O)c1cn(CC(=O)N[C@H](CCCNC(N)=O)C(=O)O)c2ccccc12	(2R)-2-[[2-(3-acetylindol-1-yl)acetyl]amino]-5-(carbamoylamino)pentanoic acid			0.3786700000000007													MCULE-5206548004	374.39984		374.15902	5	4	9	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(45490521)	45490521	0.2	432			[#6]-[#6](=[#8])-[#6]1:[#6]:[#7](-[#6]-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#8])-[#6](=[#8])-[#8]):[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CC(=O)c1cn(CC(=O)N[C@H](CCCNC(N)=O)C(=O)O)c2ccccc12	RGHVFRATSNVCPV		parent_pubchem_cid	AKOS016375007;N~2~-[(3-ACETYL-1H-INDOL-1-YL)ACETYL]-N~5~-(AMINOCARBONYL)-D-ORNITHINE;rac-(2R)-2-[[2-(3-acetylindol-1-yl)acetyl]amino]-5-ureido-pentanoic acid		24366296.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24366296		pluskal_iocb_peptide_Peptide01_C7_id		100	C7		ZINC000036369878
1.8		0	1003	P7567850	96.6		K20	False	0	15	0	0	18	0	2	3	0	1		0.0						CSCCC(NC(=O)c1cc2c(cc1)ccn2C)C(=O)O																							0.0		EiM08-36790		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C15H18N2O3S	C15H18N2O3S			InChI=1S/C15H18N2O3S/c1-17-7-5-10-3-4-11(9-13(10)17)14(18)16-12(15(19)20)6-8-21-2/h3-5,7,9,12H,6,8H2,1-2H3,(H,16,18)(H,19,20)/t12-/m0/s1	IRHLQQBQJGAJBH-LBPRGKRZSA-N	rac-(2S)-2-[(1-methylindole-6-carbonyl)amino]-4-methylsulfanyl-butanoic acid	91637336	CSCC[C@H](NC(=O)c1cc2c(cc1)ccn2C)C(=O)O	(2S)-2-[(1-methylindole-6-carbonyl)amino]-4-methylsulfanylbutanoic acid			1.6312699999999998														306.38631		306.103813	4	2	6	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(91637336)	91637336	1.9	433			[#6]-[#16]-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#6]:[#6]:[#7]:2-[#6])-[#6](=[#8])-[#8]	CSCC[C@H](NC(=O)c1cc2c(cc1)ccn2C)C(=O)O	IRHLQQBQJGAJBH		parent_pubchem_cid	EiM08-36790;AKOS025146046;(2S)-2-{[(1-METHYL-1H-INDOL-6-YL)CARBONYL]AMINO}-4-(METHYLSULFANYL)BUTANOIC ACID;rac-(2S)-2-[(1-methylindole-6-carbonyl)amino]-4-methylsulfanyl-butanoic acid		93873615.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=93873615		pluskal_iocb_peptide_Peptide01_C7_id		100	C7		ZINC000170625474
3.4		0	747	P6247024	86.1		K21	False	0	22	0	0	26	0	4	3	0	0		0.0						COC(=O)C(Cc1ccccc1)NC(=O)c1c2c(C)nn(C)c2nc(C(C)C)c1																							0.0		EiM08-20278		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C22H26N4O3	C22H26N4O3			InChI=1S/C22H26N4O3/c1-13(2)17-12-16(19-14(3)25-26(4)20(19)23-17)21(27)24-18(22(28)29-5)11-15-9-7-6-8-10-15/h6-10,12-13,18H,11H2,1-5H3,(H,24,27)/t18-/m0/s1	YXRAVEAJFXDDQO-SFHVURJKSA-N	methyl rac-(2S)-2-[(6-isopropyl-1,3-dimethyl-pyrazolo[3,4-b]pyridine-4-carbonyl)amino]-3-phenyl-propanoate	32615805	COC(=O)[C@H](Cc1ccccc1)NC(=O)c1c2c(C)nn(C)c2nc(C(C)C)c1	methyl (2S)-2-[(1,3-dimethyl-6-propan-2-ylpyrazolo[3,4-b]pyridine-4-carbonyl)amino]-3-phenylpropanoate			2.26696													MCULE-7044705860	394.47752		394.200491	5	1	7	3			44									Pyrazine and Piperazine alkaloids	False	Alkaloids;Amino acids and Peptides	Tetramate alkaloids;Peptide alkaloids			Peptide01			Compound(32615805)	32615805	3.6	434			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6](-[#6](-[#6])-[#6]):[#7]:[#6]2:[#6]:1:[#6](-[#6]):[#7]:[#7]:2-[#6]	COC(=O)[C@H](Cc1ccccc1)NC(=O)c1c2c(C)nn(C)c2nc(C(C)C)c1	YXRAVEAJFXDDQO		parent_pubchem_cid	EiM08-20278;AKOS016387622;METHYL 2-{[1,3-DIMETHYL-6-(PROPAN-2-YL)-1H-PYRAZOLO[3,4-B]PYRIDIN-4-YL]FORMAMIDO}-3-PHENYLPROPANOATE;methyl rac-(2S)-2-[(6-isopropyl-1,3-dimethyl-pyrazolo[3,4-b]pyridine-4-carbonyl)amino]-3-phenyl-propanoate		8381840.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=8381840		pluskal_iocb_peptide_Peptide01_C7_id		100	C7		ZINC000025316070
2.3		0	835	P11569330	68.3		K22	False	0	22	0	0	27	0	3	3	0	0		0.0						COc1cc2c(cc1)[nH]cc2CCNC(=O)CC1(n2cccc2)CCOCC1								Anisoles;Alkyl aryl ethers;Substituted pyrroles;Oxanes;Heteroaromatic compounds;Secondary carboxylic acid amides;Oxacyclic compounds;Dialkyl ethers;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	3-alkylindoles;Alkyl aryl ethers;Anisoles;Azacyclic compounds;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Dialkyl ethers;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Oxanes;Phenol ethers;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as 3-alkylindoles. These are compounds containing an indole moiety that carries an alkyl chain at the 3-position.	3-alkylindoles			Organic compounds	Aromatic heteropolycyclic compounds	methoxybenzene (CHEBI:51683);aromatic ether (CHEBI:35618);pyrroles (CHEBI:26455);oxanes (CHEBI:46942);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);oxacycle (CHEBI:38104);ether (CHEBI:25698);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);indoles (CHEBI:24828);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);organooxygen compound (CHEBI:36963);organic heterocyclic compound (CHEBI:24532);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)		Indoles	3-alkylindole;Anisole;Phenol ether;Alkyl aryl ether;Oxane;Benzenoid;Substituted pyrrole;Heteroaromatic compound;Pyrrole;Carboxamide group;Secondary carboxylic acid amide;Carboxylic acid derivative;Dialkyl ether;Ether;Oxacycle;Azacycle;Organic oxygen compound;Organic nitrogen compound;Organonitrogen compound;Organooxygen compound;Hydrocarbon derivative;Carbonyl group;Organic oxide;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-2-[4-(1H-pyrrol-1-yl)tetrahydro-2H-pyran-4-yl]acetamide		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C22H27N3O3	C22H27N3O3			InChI=1S/C22H27N3O3/c1-27-18-4-5-20-19(14-18)17(16-24-20)6-9-23-21(26)15-22(7-12-28-13-8-22)25-10-2-3-11-25/h2-5,10-11,14,16,24H,6-9,12-13,15H2,1H3,(H,23,26)	INZXKYDTYNIFAO-UHFFFAOYSA-N	N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-2-(4-pyrrol-1-yltetrahydropyran-4-yl)acetamide	100003412	COc1cc2c(cc1)[nH]cc2CCNC(=O)CC1(n2cccc2)CCOCC1	N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-2-(4-pyrrol-1-yloxan-4-yl)acetamide			2.287159999999999														381.47879		381.205242	3	2	7	4			45										False	Alkaloids				Peptide01			Compound(100003412)	100003412	2.1	435			[#6]-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#7H]:[#6]:[#6]:2-[#6]-[#6]-[#7]-[#6](=[#8])-[#6]-[#6]1(-[#7]2:[#6]:[#6]:[#6]:[#6]:2)-[#6]-[#6]-[#8]-[#6]-[#6]-1	COc1cc2c(cc1)[nH]cc2CCNC(=O)CC1(n2cccc2)CCOCC1	INZXKYDTYNIFAO		parent_pubchem_cid	N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-2-[4-(1H-pyrrol-1-yl)tetrahydro-2H-pyran-4-yl]acetamide;1676083-43-4;EiM08-37347;AKOS027474182;N-[2-(5-METHOXY-1H-INDOL-3-YL)ETHYL]-2-[4-(1H-PYRROL-1-YL)OXAN-4-YL]ACETAMIDE;N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-2-(4-pyrrol-1-yltetrahydropyran-4-yl)acetamide		101976564.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=101976564		pluskal_iocb_peptide_Peptide01_C7_id		100	C7		ZINC000218083966
1.3		0	923	P11570048	92.9		K23	False	0	18	0	0	19	0	5	2	0	0		0.0						O=C(NC(CO)Cc1ccccc1)C(c1ccccc1)n1cnnn1																							0.0		AKOS027474768		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	4	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C18H19N5O2	C18H19N5O2			InChI=1S/C18H19N5O2/c24-12-16(11-14-7-3-1-4-8-14)20-18(25)17(23-13-19-21-22-23)15-9-5-2-6-10-15/h1-10,13,16-17,24H,11-12H2,(H,20,25)/t16-,17?/m0/s1	SIZLWKXRZGPBFG-BHWOMJMDSA-N	2-phenyl-N-[rac-(1S)-1-benzyl-2-hydroxy-ethyl]-2-(tetrazol-1-yl)acetamide	122714876	O=C(N[C@H](CO)Cc1ccccc1)C(c1ccccc1)n1cnnn1	N-[(2S)-1-hydroxy-3-phenylpropan-2-yl]-2-phenyl-2-(tetrazol-1-yl)acetamide			0.8728799999999992														337.38443		337.153875	5	2	7	3			46										False	Alkaloids				Peptide01			Compound(122714876)	122714876	2.0	436			[#8]=[#6](-[#7]-[#6@H](-[#6]-[#8])-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]1:[#6]:[#7]:[#7]:[#7]:1	O=C(N[C@H](CO)Cc1ccccc1)C(c1ccccc1)n1cnnn1	SIZLWKXRZGPBFG		parent_pubchem_cid	AKOS027474768;2-phenyl-N-[rac-(1S)-1-benzyl-2-hydroxy-ethyl]-2-(tetrazol-1-yl)acetamide		149118349.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=149118349		pluskal_iocb_peptide_Peptide01_C7_id		100	C7		
1.1		0	1011	P6235911	121.0		K24	False	0	14	0	0	20	0	2	5	0	1		0.0						CC(=O)Nc1ccc(S(=O)(=O)NC(CC(C)C)C(=O)O)cc1																							0.0		(S)-2-(4-acetamidophenylsulfonamido)-4-methylpentanoic acid		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	1	0	0	0	0	0	0	0		C14H20N2O5S	C14H20N2O5S			InChI=1S/C14H20N2O5S/c1-9(2)8-13(14(18)19)16-22(20,21)12-6-4-11(5-7-12)15-10(3)17/h4-7,9,13,16H,8H2,1-3H3,(H,15,17)(H,18,19)/t13-/m0/s1	PMYKMOSLSQSYOI-ZDUSSCGKSA-N	rac-(2S)-2-[(4-acetamidophenyl)sulfonylamino]-4-methyl-pentanoic acid	788536	CC(=O)Nc1ccc(S(=O)(=O)N[C@@H](CC(C)C)C(=O)O)cc1	(2S)-2-[(4-acetamidophenyl)sulfonylamino]-4-methylpentanoic acid			0.9339799999999996													MCULE-7739786127	328.3899		328.109293	5	3	7	1			43									Aminoacids	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(788536)	788536	1.4	437		SCHEMBL9603327	[#6]-[#6](=[#8])-[#7]-[#6]1:[#6]:[#6]:[#6](-[#16](=[#8])(=[#8])-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=[#8])-[#8]):[#6]:[#6]:1	CC(=O)Nc1ccc(S(=O)(=O)N[C@@H](CC(C)C)C(=O)O)cc1	PMYKMOSLSQSYOI		parent_pubchem_cid	(S)-2-(4-acetamidophenylsulfonamido)-4-methylpentanoic acid;64527-19-1;((4-Acetamidophenyl)sulfonyl)-L-leucine;N-{[4-(acetylamino)phenyl]sulfonyl}-L-leucine;N-[[4-(Acetylamino)phenyl]sulfonyl]-L-leucine;SCHEMBL9603327;DTXSID001253216;(2S)-2-[(4-acetamidophenyl)sulfonylamino]-4-methylpentanoic acid;BBL029569;STK921013;AKOS015955399;VS-09306;CS-0317421;2-(4-Acetylamino-benzenesulfonylamino)-4-methyl-pentanoic acid;2-(4-ACETAMIDOBENZENESULFONAMIDO)-4-METHYLPENTANOIC ACID;(2S)-2-(4-ACETAMIDOBENZENESULFONAMIDO)-4-METHYLPENTANOIC ACID;rac-(2S)-2-[(4-acetamidophenyl)sulfonylamino]-4-methyl-pentanoic acid		24226670.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24226670		pluskal_iocb_peptide_Peptide01_C7_id		100	C7		ZINC000004996499
2.5		0	755	P6666936	97.7		K25	False	0	21	0	0	28	0	6	2	0	0		0.0						COc1cc2c(cc1)[nH]cc2CCNC(=O)CC1(Cn2cnnn2)CCCCC1								Anisoles;Alkyl aryl ethers;Substituted pyrroles;Fatty amides;Tetrazoles;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	3-alkylindoles;Alkyl aryl ethers;Anisoles;Azacyclic compounds;Azoles;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Ethers;Fatty Acyls;Fatty amides;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Lipids and lipid-like molecules;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenol ethers;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Tetrazoles	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as 3-alkylindoles. These are compounds containing an indole moiety that carries an alkyl chain at the 3-position.	3-alkylindoles			Organic compounds	Aromatic heteropolycyclic compounds	methoxybenzene (CHEBI:51683);aromatic ether (CHEBI:35618);pyrroles (CHEBI:26455);fatty amide (CHEBI:29348);tetrazoles (CHEBI:35689);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);indoles (CHEBI:24828);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);organooxygen compound (CHEBI:36963);ether (CHEBI:25698);organic heterocyclic compound (CHEBI:24532);lipid (CHEBI:18059);azole (CHEBI:68452);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)	Fatty amides (FA08);Fatty Acyls (FA)	Indoles	3-alkylindole;Anisole;Phenol ether;Alkyl aryl ether;Fatty amide;Substituted pyrrole;Fatty acyl;Benzenoid;Azole;Pyrrole;Heteroaromatic compound;Tetrazole;Carboxamide group;Secondary carboxylic acid amide;Ether;Carboxylic acid derivative;Azacycle;Organic oxygen compound;Hydrocarbon derivative;Organooxygen compound;Organonitrogen compound;Organic oxide;Carbonyl group;Organic nitrogen compound;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		1401572-78-8		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	4	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C21H28N6O2	C21H28N6O2			InChI=1S/C21H28N6O2/c1-29-17-5-6-19-18(11-17)16(13-23-19)7-10-22-20(28)12-21(8-3-2-4-9-21)14-27-15-24-25-26-27/h5-6,11,13,15,23H,2-4,7-10,12,14H2,1H3,(H,22,28)	VEJKNVHUQDRQAO-UHFFFAOYSA-N	N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-2-[1-(tetrazol-1-ylmethyl)cyclohexyl]acetamide	71705532	COc1cc2c(cc1)[nH]cc2CCNC(=O)CC1(Cn2cnnn2)CCCCC1	N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-2-[1-(tetrazol-1-ylmethyl)cyclohexyl]acetamide			1.9169599999999989													MCULE-9432191487	396.49631		396.227374	5	2	8	4			44										False	Alkaloids				Peptide01			Compound(71705532)	71705532	3.0	438			[#6]-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#7H]:[#6]:[#6]:2-[#6]-[#6]-[#7]-[#6](=[#8])-[#6]-[#6]1(-[#6]-[#7]2:[#6]:[#7]:[#7]:[#7]:2)-[#6]-[#6]-[#6]-[#6]-[#6]-1	COc1cc2c(cc1)[nH]cc2CCNC(=O)CC1(Cn2cnnn2)CCCCC1	VEJKNVHUQDRQAO		parent_pubchem_cid	1401572-78-8;N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-2-[1-(1H-1,2,3,4-tetraazol-1-ylmethyl)cyclohexyl]acetamide;EiM08-27221;AKOS016384016;N-[2-(5-METHOXY-1H-INDOL-3-YL)ETHYL]-2-{1-[(1H-1,2,3,4-TETRAZOL-1-YL)METHYL]CYCLOHEXYL}ACETAMIDE;N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-2-[1-(tetrazol-1-ylmethyl)cyclohexyl]acetamide		59160466.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=59160466		pluskal_iocb_peptide_Peptide01_C7_id		100	C7		ZINC000095476615
2.8		0	843	P7130010	97.7		K26	False	0	19	1	0	17	0	6	2	0	0		0.0						COc1cc2c(cc1)[nH]cc2CCNC(=O)c1c(-n2cnnn2)cc(Cl)cc1								3-alkylindoles;4-halobenzoic acids and derivatives;Benzamides;Anisoles;Benzoyl derivatives;Alkyl aryl ethers;Chlorobenzenes;Substituted pyrroles;Aryl chlorides;Vinylogous amides;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Organic oxides;Organochlorides;Organonitrogen compounds;Hydrocarbon derivatives	3-alkylindoles;4-halobenzoic acids and derivatives;Alkyl aryl ethers;Anisoles;Aryl chlorides;Aryl halides;Azacyclic compounds;Azoles;Benzamides;Benzene and substituted derivatives;Benzenoids;Benzoic acids and derivatives;Benzoyl derivatives;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Chlorobenzenes;Ethers;Halobenzenes;Halobenzoic acids and derivatives;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organochlorides;Organohalogen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenol ethers;Phenyltetrazoles and derivatives;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Tetrazoles;Vinylogous amides	Azoles	2.1	This compound belongs to the class of organic compounds known as phenyltetrazoles and derivatives. These are compounds containing a phenyltetrazole skeleton, which consists of a tetrazole bound to a phenyl group.	Phenyltetrazoles and derivatives			Organic compounds	Aromatic heteropolycyclic compounds	indoles (CHEBI:24828);carbonyl compound (CHEBI:36586);organohalogen compound (CHEBI:36684);benzamides (CHEBI:22702);methoxybenzene (CHEBI:51683);aromatic ether (CHEBI:35618);organochlorine compound (CHEBI:36683);pyrroles (CHEBI:26455);enone (CHEBI:51689);enamine (CHEBI:47989);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organonitrogen heterocyclic compound (CHEBI:38101);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);organic molecule (CHEBI:72695);tetrazoles (CHEBI:35689);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);benzoic acids (CHEBI:22723);organooxygen compound (CHEBI:36963);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ether (CHEBI:25698);haloarene (CHEBI:50887);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);azole (CHEBI:68452)		Tetrazoles	Phenyltetrazole;4-halobenzoic acid or derivatives;Halobenzoic acid or derivatives;3-alkylindole;Indole;Indole or derivatives;Benzoic acid or derivatives;Benzamide;Anisole;Phenol ether;Benzoyl;Alkyl aryl ether;Halobenzene;Chlorobenzene;Aryl halide;Aryl chloride;Substituted pyrrole;Monocyclic benzene moiety;Benzenoid;Pyrrole;Vinylogous amide;Heteroaromatic compound;Secondary carboxylic acid amide;Carboxamide group;Carboxylic acid derivative;Azacycle;Ether;Organochloride;Organic oxygen compound;Organonitrogen compound;Organooxygen compound;Organic nitrogen compound;Hydrocarbon derivative;Organic oxide;Organohalogen compound;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		1324059-81-5		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	4	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C19H17ClN6O2	C19H17ClN6O2			InChI=1S/C19H17ClN6O2/c1-28-14-3-5-17-16(9-14)12(10-22-17)6-7-21-19(27)15-4-2-13(20)8-18(15)26-11-23-24-25-26/h2-5,8-11,22H,6-7H2,1H3,(H,21,27)	ZOHHKWZQGBBIOZ-UHFFFAOYSA-N	4-chloro-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-2-(tetrazol-1-yl)benzamide	56762206	COc1cc2c(cc1)[nH]cc2CCNC(=O)c1c(-n2cnnn2)cc(Cl)cc1	4-chloro-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-2-(tetrazol-1-yl)benzamide			1.5878399999999993													MCULE-1435544566	396.83934		396.110151	5	2	6	4			44									Imidazole alkaloids	False	Alkaloids	Histidine alkaloids			Peptide01			Compound(56762206)	56762206	3.2	439			[#6]-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#7H]:[#6]:[#6]:2-[#6]-[#6]-[#7]-[#6](=[#8])-[#6]1:[#6](-[#7]2:[#6]:[#7]:[#7]:[#7]:2):[#6]:[#6](-[#17]):[#6]:[#6]:1	COc1cc2c(cc1)[nH]cc2CCNC(=O)c1c(-n2cnnn2)cc(Cl)cc1	ZOHHKWZQGBBIOZ		parent_pubchem_cid	1324059-81-5;4-chloro-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-2-(1H-1,2,3,4-tetraazol-1-yl)benzamide;EiM08-24743;AKOS024460194;4-CHLORO-N-[2-(5-METHOXY-1H-INDOL-3-YL)ETHYL]-2-(1H-1,2,3,4-TETRAZOL-1-YL)BENZAMIDE;4-chloro-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-2-(tetrazol-1-yl)benzamide		11724155.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=11724155		pluskal_iocb_peptide_Peptide01_C7_id		100	C7		ZINC000071285734
2.1		0	931	P11185727	112.7		K27	False	0	24	0	0	24	0	6	2	0	0		0.0						O=C(CCCNC(=O)c1nccnc1)NC(Cc1ccccc1)c1nc2ccccc2[nH]1								Amphetamines and derivatives;Pyrazinecarboxamides;Benzimidazoles;2-heteroaryl carboxamides;N-acyl amines;Imidazoles;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	2-heteroaryl carboxamides;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Azacyclic compounds;Azoles;Benzene and substituted derivatives;Benzenoids;Benzimidazoles;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Diazines;Fatty Acyls;Fatty amides;Gamma amino acids and derivatives;Heteroaromatic compounds;Hydrocarbon derivatives;Imidazoles;Lipids and lipid-like molecules;N-acyl amines;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenethylamines;Pyrazine carboxylic acids and derivatives;Pyrazinecarboxamides;Pyrazines;Secondary carboxylic acid amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as gamma amino acids and derivatives. These are amino acids having a (-NH2) group attached to the gamma carbon atom.	Gamma amino acids and derivatives		Amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	amphetamines (CHEBI:35338);pyrazines (CHEBI:38314);carboxamide (CHEBI:37622);benzimidazoles (CHEBI:22715);organic aromatic compound (CHEBI:33659);fatty amide (CHEBI:29348);imidazoles (CHEBI:24780);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);organooxygen compound (CHEBI:36963);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);primary amine (CHEBI:32877);organic heterocyclic compound (CHEBI:24532);diazines (CHEBI:38313);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);lipid (CHEBI:18059);azole (CHEBI:68452);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806)	N-acyl amines (FA0802);Fatty Acyls (FA);Fatty amides (FA08)	Amino acids, peptides, and analogues	Gamma amino acid or derivatives;Amphetamine or derivatives;Benzimidazole;Pyrazine carboxylic acid or derivatives;Pyrazinecarboxamide;2-heteroaryl carboxamide;Monocyclic benzene moiety;Fatty amide;N-acyl-amine;Pyrazine;Benzenoid;Fatty acyl;Heteroaromatic compound;Azole;Imidazole;Carboxamide group;Secondary carboxylic acid amide;Organoheterocyclic compound;Azacycle;Hydrocarbon derivative;Organooxygen compound;Organonitrogen compound;Organic oxide;Organic nitrogen compound;Organic oxygen compound;Carbonyl group;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS025258149		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0		C24H24N6O2	C24H24N6O2			InChI=1S/C24H24N6O2/c31-22(11-6-12-27-24(32)21-16-25-13-14-26-21)28-20(15-17-7-2-1-3-8-17)23-29-18-9-4-5-10-19(18)30-23/h1-5,7-10,13-14,16,20H,6,11-12,15H2,(H,27,32)(H,28,31)(H,29,30)	XESQVFRIQGMTRT-UHFFFAOYSA-N	N-[4-[[1-(1H-benzimidazol-2-yl)-2-phenyl-ethyl]amino]-4-oxo-butyl]pyrazine-2-carboxamide	91821899	O=C(CCCNC(=O)c1nccnc1)NC(Cc1ccccc1)c1nc2ccccc2[nH]1	N-[4-[[1-(1H-benzimidazol-2-yl)-2-phenylethyl]amino]-4-oxobutyl]pyrazine-2-carboxamide			2.370549999999999														428.49788		428.196074	5	3	9	4			46										False	Alkaloids	Peptide alkaloids			Peptide01			Compound(91821899)	91821899	2.1	440			[#8]=[#6](-[#6]-[#6]-[#6]-[#7]-[#6](=[#8])-[#6]1:[#7]:[#6]:[#6]:[#7]:[#6]:1)-[#7]-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#7H]:1	O=C(CCCNC(=O)c1nccnc1)NC(Cc1ccccc1)c1nc2ccccc2[nH]1	XESQVFRIQGMTRT		parent_pubchem_cid	AKOS025258149;N-[4-[[1-(1H-benzimidazol-2-yl)-2-phenyl-ethyl]amino]-4-oxo-butyl]pyrazine-2-carboxamide		100825607.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=100825607		pluskal_iocb_peptide_Peptide01_C8_id		100	C8		
3.1		0	1019	P7567856	71.3		K28	False	0	19	0	0	18	0	2	3	0	0		0.0						Cn1ccc2c1ccc(C(=O)NC(Cc1ccccc1)C(=O)O)c2																							0.0		EiM08-36796		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C19H18N2O3	C19H18N2O3			InChI=1S/C19H18N2O3/c1-21-10-9-14-12-15(7-8-17(14)21)18(22)20-16(19(23)24)11-13-5-3-2-4-6-13/h2-10,12,16H,11H2,1H3,(H,20,22)(H,23,24)/t16-/m0/s1	LEHFGVYQOHNISM-INIZCTEOSA-N	rac-(2S)-2-[(1-methylindole-5-carbonyl)amino]-3-phenyl-propanoic acid	91638456	Cn1ccc2c1ccc(C(=O)N[C@@H](Cc1ccccc1)C(=O)O)c2	(2S)-2-[(1-methylindole-5-carbonyl)amino]-3-phenylpropanoic acid			2.06616														322.36691		322.131742	3	2	5	3			45										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(91638456)	91638456	2.9	441			[#6]-[#7]1:[#6]:[#6]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]):[#6]:2	Cn1ccc2c1ccc(C(=O)N[C@@H](Cc1ccccc1)C(=O)O)c2	LEHFGVYQOHNISM		parent_pubchem_cid	EiM08-36796;AKOS025146052;(2S)-2-{[(1-METHYL-1H-INDOL-5-YL)CARBONYL]AMINO}-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[(1-methylindole-5-carbonyl)amino]-3-phenyl-propanoic acid		95875981.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=95875981		pluskal_iocb_peptide_Peptide01_C8_id		100	C8		ZINC000170625480
2.2		0	763	P6239995	135.7		K29	False	0	23	0	0	26	0	4	5	0	0		0.0						NC(=O)NCCCC(NC(=O)Cn1ccc2c1ccc(OCc1ccccc1)c2)C(=O)O																							0.0		EiM08-11065		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C23H26N4O5	C23H26N4O5			InChI=1S/C23H26N4O5/c24-23(31)25-11-4-7-19(22(29)30)26-21(28)14-27-12-10-17-13-18(8-9-20(17)27)32-15-16-5-2-1-3-6-16/h1-3,5-6,8-10,12-13,19H,4,7,11,14-15H2,(H,26,28)(H,29,30)(H3,24,25,31)/t19-/m1/s1	ZBHIZRSGHJAJIS-LJQANCHMSA-N	rac-(2R)-2-[[2-(5-benzyloxyindol-1-yl)acetyl]amino]-5-ureido-pentanoic acid	45494770	NC(=O)NCCC[C@@H](NC(=O)Cn1ccc2c1ccc(OCc1ccccc1)c2)C(=O)O	(2R)-5-(carbamoylamino)-2-[[2-(5-phenylmethoxyindol-1-yl)acetyl]amino]pentanoic acid			1.2926600000000008													MCULE-9188649672	438.48747		438.19032	5	4	11	3			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(45494770)	45494770	2.0	442			[#7]-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]-[#6@@H](-[#7]-[#6](=[#8])-[#6]-[#7]1:[#6]:[#6]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1):[#6]:2)-[#6](=[#8])-[#8]	NC(=O)NCCC[C@@H](NC(=O)Cn1ccc2c1ccc(OCc1ccccc1)c2)C(=O)O	ZBHIZRSGHJAJIS		parent_pubchem_cid	EiM08-11065;AKOS005671915;N~5~-(AMINOCARBONYL)-N~2~-{[5-(BENZYLOXY)-1H-INDOL-1-YL]ACETYL}-D-ORNITHINE;rac-(2R)-2-[[2-(5-benzyloxyindol-1-yl)acetyl]amino]-5-ureido-pentanoic acid		23304910.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23304910		pluskal_iocb_peptide_Peptide01_C8_id		100	C8		ZINC000036360605
3.2		0	851	P3462531	80.3		K30	False	0	22	1	0	20	0	3	3	0	0		0.0						COc1c(Cl)cc(NC(=O)C(Cc2ccccc2)NC(=O)c2cnccc2)cc1																							0.0		STL226743		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C22H20ClN3O3	C22H20ClN3O3			InChI=1S/C22H20ClN3O3/c1-29-20-10-9-17(13-18(20)23)25-22(28)19(12-15-6-3-2-4-7-15)26-21(27)16-8-5-11-24-14-16/h2-11,13-14,19H,12H2,1H3,(H,25,28)(H,26,27)/t19-/m0/s1	VYQNTJFGSUUQQE-IBGZPJMESA-N	N-[rac-(1S)-1-benzyl-2-(3-chloro-4-methoxy-anilino)-2-oxo-ethyl]pyridine-3-carboxamide	29135187	COc1c(Cl)cc(NC(=O)[C@H](Cc2ccccc2)NC(=O)c2cnccc2)cc1	N-[(2S)-1-(3-chloro-4-methoxyanilino)-1-oxo-3-phenylpropan-2-yl]pyridine-3-carboxamide			2.7709600000000005													MCULE-1644725241	409.876		409.119319	4	2	7	3			44									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(29135187)	29135187	3.6	443			[#6]-[#8]-[#6]1:[#6](-[#17]):[#6]:[#6](-[#7]-[#6](=[#8])-[#6@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#7]-[#6](=[#8])-[#6]2:[#6]:[#7]:[#6]:[#6]:[#6]:2):[#6]:[#6]:1	COc1c(Cl)cc(NC(=O)[C@H](Cc2ccccc2)NC(=O)c2cnccc2)cc1	VYQNTJFGSUUQQE		parent_pubchem_cid	STL226743;AKOS016385883;N-(3-CHLORO-4-METHOXYPHENYL)-3-PHENYL-2-[(PYRIDIN-3-YL)FORMAMIDO]PROPANAMIDE;N-(3-chloro-4-methoxyphenyl)-Nalpha-(pyridin-3-ylcarbonyl)-L-phenylalaninamide;N-[rac-(1S)-1-benzyl-2-(3-chloro-4-methoxy-anilino)-2-oxo-ethyl]pyridine-3-carboxamide		14464469.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=14464469		pluskal_iocb_peptide_Peptide01_C8_id		100	C8		ZINC000020733388
3.4		0	939	P11185381	82.7		K31	False	0	23	0	0	23	0	5	1	0	0		0.0						Cc1cc(C)nc(NC(Cc2ccccc2)C(=O)Nc2c3cc[nH]c3ccc2)n1																							0.0		AKOS025260490		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	0	0	0	0	0	0	0		C23H23N5O	C23H23N5O			InChI=1S/C23H23N5O/c1-15-13-16(2)26-23(25-15)28-21(14-17-7-4-3-5-8-17)22(29)27-20-10-6-9-19-18(20)11-12-24-19/h3-13,21,24H,14H2,1-2H3,(H,27,29)(H,25,26,28)	FLAGBUIORFXPCJ-UHFFFAOYSA-N	2-[(4,6-dimethylpyrimidin-2-yl)amino]-N-(1H-indol-4-yl)-3-phenyl-propanamide	91823433	Cc1cc(C)nc(NC(Cc2ccccc2)C(=O)Nc2c3cc[nH]c3ccc2)n1	2-[(4,6-dimethylpyrimidin-2-yl)amino]-N-(1H-indol-4-yl)-3-phenylpropanamide			2.8828700000000005														385.47266		385.19026	4	3	6	4			46										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(91823433)	91823433	4.3	444			[#6]-[#6]1:[#6]:[#6](-[#6]):[#7]:[#6](-[#7]-[#6](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#7]-[#6]2:[#6]3:[#6]:[#6]:[#7H]:[#6]:3:[#6]:[#6]:[#6]:2):[#7]:1	Cc1cc(C)nc(NC(Cc2ccccc2)C(=O)Nc2c3cc[nH]c3ccc2)n1	FLAGBUIORFXPCJ		parent_pubchem_cid	AKOS025260490;AO-022/43513434;2-((4,6-dimethylpyrimidin-2-yl)amino)-N-(1H-indol-4-yl)-3-phenylpropanamide;2-[(4,6-dimethyl-2-pyrimidinyl)amino]-N-(1H-indol-4-yl)-3-phenylpropanamide;2-[(4,6-dimethylpyrimidin-2-yl)amino]-N-(1H-indol-4-yl)-3-phenyl-propanamide		100827136.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=100827136		pluskal_iocb_peptide_Peptide01_C8_id		100	C8		
3.1		0	1027	P11185798	112.3		K32	False	0	28	0	0	26	0	4	4	0	0		0.0						O=C(CC1NC(=O)c2ccccc2NC1=O)NCCc1c[nH]c2c1cc(OCc1ccccc1)cc2								Alpha amino acids and derivatives;3-alkylindoles;Alkyl aryl ethers;Substituted pyrroles;Benzene and substituted derivatives;Vinylogous amides;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactams;Azacyclic compounds;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	1,4-benzodiazepines;3-alkylindoles;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Benzodiazepines;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Lactams;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Vinylogous amides	Benzodiazepines	2.1	This compound belongs to the class of organic compounds known as 1,4-benzodiazepines. These are organic compounds containing a benzene ring fused to a 1,4-azepine.	1,4-benzodiazepines			Organic compounds	Aromatic heteropolycyclic compounds	organonitrogen compound (CHEBI:35352);organooxygen compound (CHEBI:36963);indoles (CHEBI:24828);aromatic ether (CHEBI:35618);pyrroles (CHEBI:26455);benzenes (CHEBI:22712);enone (CHEBI:51689);enamine (CHEBI:47989);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactam (CHEBI:24995);organonitrogen heterocyclic compound (CHEBI:38101);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);benzodiazepine (CHEBI:22720);chemical entity (CHEBI:24431);amino acid (CHEBI:33709);peptide (CHEBI:16670);organic heterocyclic compound (CHEBI:24532);oxygen molecular entity (CHEBI:25806);ether (CHEBI:25698);benzenoid aromatic compound (CHEBI:33836);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)		1,4-benzodiazepines	1,4-benzodiazepine;3-alkylindole;Alpha-amino acid or derivatives;Indole or derivatives;Indole;Alkyl aryl ether;Benzenoid;Substituted pyrrole;Monocyclic benzene moiety;Heteroaromatic compound;Vinylogous amide;Pyrrole;Secondary carboxylic acid amide;Lactam;Carboxamide group;Azacycle;Ether;Carboxylic acid derivative;Organic nitrogen compound;Organic oxygen compound;Organopnictogen compound;Organic oxide;Hydrocarbon derivative;Organooxygen compound;Organonitrogen compound;Carbonyl group;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		AKOS027473228		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	0	0		C28H26N4O4	C28H26N4O4			InChI=1S/C28H26N4O4/c33-26(15-25-28(35)31-24-9-5-4-8-21(24)27(34)32-25)29-13-12-19-16-30-23-11-10-20(14-22(19)23)36-17-18-6-2-1-3-7-18/h1-11,14,16,25,30H,12-13,15,17H2,(H,29,33)(H,31,35)(H,32,34)	YYKPIROMFSWCPG-UHFFFAOYSA-N	N-[2-(5-benzyloxy-1H-indol-3-yl)ethyl]-2-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)acetamide	118986168	O=C(CC1NC(=O)c2ccccc2NC1=O)NCCc1c[nH]c2c1cc(OCc1ccccc1)cc2	2-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)-N-[2-(5-phenylmethoxy-1H-indol-3-yl)ethyl]acetamide			2.11083														482.54382		482.195405	4	4	8	5			46									Benzodiazepine alkaloids	False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(118986168)	118986168	3.0	445			[#8]=[#6](-[#6]-[#6]1-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#7]-[#6]-1=[#8])-[#7]-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:1:[#6]:[#6](-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1):[#6]:[#6]:2	O=C(CC1NC(=O)c2ccccc2NC1=O)NCCc1c[nH]c2c1cc(OCc1ccccc1)cc2	YYKPIROMFSWCPG		parent_pubchem_cid	AKOS027473228;AKOS037500690;N-[2-(5-benzyloxy-1H-indol-3-yl)ethyl]-2-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)acetamide		145498540.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=145498540		pluskal_iocb_peptide_Peptide01_C8_id		100	C8		
3.7		0	771	P1098462	117.7		K33	False	0	25	0	0	22	0	2	6	0	0		0.0						O=C(COc1cc2c(cc1)c1c(CCC1)c(=O)o2)NC(Cc1c[nH]c2ccccc12)C(=O)O								Coumarins and derivatives;1-benzopyrans;3-alkylindoles;Phenol ethers;Pyranones and derivatives;Alkyl aryl ethers;Substituted pyrroles;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactones;Oxacyclic compounds;Azacyclic compounds;Carboxylic acids;Monocarboxylic acids and derivatives;Carbonyl compounds;Organic oxides;Organonitrogen compounds;Hydrocarbon derivatives	1-benzopyrans;3-alkylindoles;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Lactones;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Oxacyclic compounds;Phenol ethers;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom.	N-acyl-alpha amino acids		Amino acids and derivatives;Alpha amino acids and derivatives;N-acyl-alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	coumarins (CHEBI:23403);1-benzopyran (CHEBI:38443);indoles (CHEBI:24828);aromatic ether (CHEBI:35618);pyranone (CHEBI:37963);pyrroles (CHEBI:26455);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactone (CHEBI:25000);oxacycle (CHEBI:38104);organonitrogen heterocyclic compound (CHEBI:38101);carboxylic acid (CHEBI:33575);monocarboxylic acid (CHEBI:25384);carbonyl compound (CHEBI:36586);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);organic molecule (CHEBI:72695);N-acyl-amino acid (CHEBI:51569);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);benzenoid aromatic compound (CHEBI:33836);pyrans (CHEBI:26407);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ether (CHEBI:25698);organic acid (CHEBI:64709);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)	Benzopyranoids (PK1311)	Amino acids, peptides, and analogues	N-acyl-alpha-amino acid;Coumarin;Benzopyran;1-benzopyran;3-alkylindole;Indole;Indole or derivatives;Phenol ether;Alkyl aryl ether;Pyranone;Benzenoid;Substituted pyrrole;Pyran;Pyrrole;Heteroaromatic compound;Secondary carboxylic acid amide;Carboxamide group;Lactone;Azacycle;Organoheterocyclic compound;Carboxylic acid;Ether;Oxacycle;Monocarboxylic acid or derivatives;Carbonyl group;Organic oxygen compound;Organic oxide;Hydrocarbon derivative;Organic nitrogen compound;Organooxygen compound;Organonitrogen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		Oprea1_322231		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C25H22N2O6	C25H22N2O6			InChI=1S/C25H22N2O6/c28-23(27-21(24(29)30)10-14-12-26-20-7-2-1-4-16(14)20)13-32-15-8-9-18-17-5-3-6-19(17)25(31)33-22(18)11-15/h1-2,4,7-9,11-12,21,26H,3,5-6,10,13H2,(H,27,28)(H,29,30)/t21-/m1/s1	FNFQCEGHMNKYIA-OAQYLSRUSA-N	rac-(2R)-3-(1H-indol-3-yl)-2-[[2-[(4-oxo-2,3-dihydro-1H-cyclopenta[c]chromen-7-yl)oxy]acetyl]amino]propanoic acid	23973631	O=C(COc1cc2c(cc1)c1c(CCC1)c(=O)o2)N[C@H](Cc1c[nH]c2ccccc12)C(=O)O	(2R)-3-(1H-indol-3-yl)-2-[[2-[(4-oxo-2,3-dihydro-1H-cyclopenta[c]chromen-7-yl)oxy]acetyl]amino]propanoic acid			2.37041													MCULE-7353882073	446.46389		446.147786	6	3	7	5			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(23973631)	23973631	3.3	446			[#8]=[#6](-[#6]-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#6]1:[#6](-[#6]-[#6]-[#6]-1):[#6](=[#8]):[#8]:2)-[#7]-[#6@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	O=C(COc1cc2c(cc1)c1c(CCC1)c(=O)o2)N[C@H](Cc1c[nH]c2ccccc12)C(=O)O	FNFQCEGHMNKYIA		parent_pubchem_cid	Oprea1_322231;EiM07-17140;AKOS004937452;(2R)-3-(1H-INDOL-3-YL)-2-({2-[(4-OXO-1,2,3,4-TETRAHYDROCYCLOPENTA[C]CHROMEN-7-YL)OXY]ACETYL}AMINO)PROPANOIC ACID;rac-(2R)-3-(1H-indol-3-yl)-2-[[2-[(4-oxo-2,3-dihydro-1H-cyclopenta[c]chromen-7-yl)oxy]acetyl]amino]propanoic acid		48012493.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=48012493		pluskal_iocb_peptide_Peptide01_C8_id		100	C8		ZINC000003195299
2.5		0	859	P1159409	100.3		K34	False	0	22	0	0	19	0	3	4	0	0		0.0						COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c1cc(=O)[nH]c2ccccc12																							0.0		STL465361		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0		C22H19N3O4	C22H19N3O4			InChI=1S/C22H19N3O4/c1-29-22(28)19(10-13-12-23-17-8-4-2-6-14(13)17)25-21(27)16-11-20(26)24-18-9-5-3-7-15(16)18/h2-9,11-12,19,23H,10H2,1H3,(H,24,26)(H,25,27)/t19-/m0/s1	YYNKCDVIQHWDQX-IBGZPJMESA-N	methyl rac-(2S)-3-(1H-indol-3-yl)-2-[(2-oxo-1H-quinoline-4-carbonyl)amino]propanoate	2410202	COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1cc(=O)[nH]c2ccccc12	methyl (2S)-3-(1H-indol-3-yl)-2-[(2-oxo-1H-quinoline-4-carbonyl)amino]propanoate			2.4571300000000003													MCULE-2479257706	389.41443		389.137556	4	3	6	4			44									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(2410202)	2410202	2.4	447			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6](=[#8]):[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1cc(=O)[nH]c2ccccc12	YYNKCDVIQHWDQX		parent_pubchem_cid	STL465361;AKOS016382730;methyl N-[(2-oxo-1,2-dihydroquinolin-4-yl)carbonyl]-L-tryptophanate;METHYL 3-(1H-INDOL-3-YL)-2-[(2-OXO-1,2-DIHYDROQUINOLIN-4-YL)FORMAMIDO]PROPANOATE;methyl rac-(2S)-3-(1H-indol-3-yl)-2-[(2-oxo-1H-quinoline-4-carbonyl)amino]propanoate		1869502.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=1869502		pluskal_iocb_peptide_Peptide01_C8_id		100	C8		ZINC000003294620
2.5		0	947	P1094976	98.7		K35	False	0	18	0	0	25	0	3	4	0	0		0.0						CC(C)CC(NC(=O)N1c2ccccc2NC(=O)C1C(C)C)C(=O)O																							0.0		AKOS004937465		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	2	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C18H25N3O4	C18H25N3O4			InChI=1S/C18H25N3O4/c1-10(2)9-13(17(23)24)20-18(25)21-14-8-6-5-7-12(14)19-16(22)15(21)11(3)4/h5-8,10-11,13,15H,9H2,1-4H3,(H,19,22)(H,20,25)(H,23,24)/t13-,15-/m0/s1	WDHILXRWGHJHIY-ZFWWWQNUSA-N	rac-(2S)-4-methyl-2-[[rac-(2S)-2-isopropyl-3-oxo-2,4-dihydroquinoxaline-1-carbonyl]amino]pentanoic acid	11913857	CC(C)C[C@H](NC(=O)N1c2ccccc2NC(=O)[C@@H]1C(C)C)C(=O)O	(2S)-4-methyl-2-[[(2S)-3-oxo-2-propan-2-yl-2,4-dihydroquinoxaline-1-carbonyl]amino]pentanoic acid			1.9173800000000003													MCULE-5896352239	347.41765		347.184506	4	3	5	2			44										False	Alkaloids;Amino acids and Peptides	Anthranilic acid alkaloids;Small peptides;Tryptophan alkaloids			Peptide01			Compound(11913857)	11913857	2.8	448			[#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#7]1-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#7]-[#6](=[#8])-[#6@@H]-1-[#6](-[#6])-[#6])-[#6](=[#8])-[#8]	CC(C)C[C@H](NC(=O)N1c2ccccc2NC(=O)[C@@H]1C(C)C)C(=O)O	WDHILXRWGHJHIY		parent_pubchem_cid	AKOS004937465;rac-(2S)-4-methyl-2-[[rac-(2S)-2-isopropyl-3-oxo-2,4-dihydroquinoxaline-1-carbonyl]amino]pentanoic acid		22762501.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22762501		pluskal_iocb_peptide_Peptide01_C9_id		100	C9		ZINC000009137909
3.5		0	1035	P7129706	58.6		K36	False	0	23	0	0	34	0	2	3	0	0	-1.0	0.0						CC(C)C1CCC(C(=O)NC(Cc2ccccc2)C(=O)N2CCOCC2)CC1		3.04		0.0	3.45	CHEMBL4949695																	0.0		CHEMBL4949695		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0		C23H34N2O3	C23H34N2O3			InChI=1S/C23H34N2O3/c1-17(2)19-8-10-20(11-9-19)22(26)24-21(16-18-6-4-3-5-7-18)23(27)25-12-14-28-15-13-25/h3-7,17,19-21H,8-16H2,1-2H3,(H,24,26)/t19?,20?,21-/m1/s1	NGMSBFQKCUYDBF-XVAXZDLZSA-N	4-isopropyl-N-[rac-(1R)-1-benzyl-2-morpholino-2-oxo-ethyl]cyclohexanecarboxamide	90489188	CC(C)C1CCC(C(=O)N[C@H](Cc2ccccc2)C(=O)N2CCOCC2)CC1	N-[(2R)-1-morpholin-4-yl-1-oxo-3-phenylpropan-2-yl]-4-propan-2-ylcyclohexane-1-carboxamide			2.9803900000000008														386.53903	NEUTRAL	386.256943	3	1	6	3	0.0		30										False			False	False	Peptide01		-1.0	Compound(90489188)	90489188	3.8	449			[#6]-[#6](-[#6])-[#6]1-[#6]-[#6]-[#6](-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#7]2-[#6]-[#6]-[#8]-[#6]-[#6]-2)-[#6]-[#6]-1	CC(C)C1CCC(C(=O)N[C@H](Cc2ccccc2)C(=O)N2CCOCC2)CC1	NGMSBFQKCUYDBF		parent_pubchem_cid	CHEMBL4949695;AKOS024459953;4-isopropyl-N-[rac-(1R)-1-benzyl-2-morpholino-2-oxo-ethyl]cyclohexanecarboxamide	False	99993907.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=99993907		pluskal_iocb_peptide_Peptide01_C9_id		100	C9	False	ZINC000080331929
0.2		0	779	P6243171	128.4		K37	False	0	17	0	0	23	0	5	3	0	1		0.0						CC(=O)N(CC1CCCO1)c1nc(C)c(C(=O)NCCc2cnc[nH]2)s1								2,4,5-trisubstituted thiazoles;2-heteroaryl carboxamides;Tertiary carboxylic acid amides;Oxolanes;Imidazoles;Acetamides;Heteroaromatic compounds;Tertiary amines;Secondary carboxylic acid amides;Amino acids and derivatives;Oxacyclic compounds;Dialkyl ethers;Azacyclic compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	2,4,5-trisubstituted thiazoles;2-heteroaryl carboxamides;Acetamides;Amines;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Azoles;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Dialkyl ethers;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Imidazoles;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Oxacyclic compounds;Oxolanes;Secondary carboxylic acid amides;Tertiary amines;Tertiary carboxylic acid amides;Thiazolecarboxamides;Thiazolecarboxylic acids and derivatives;Thiazoles	Azoles	2.1	This compound belongs to the class of organic compounds known as thiazolecarboxamides. These are heterocyclic compounds containing a thiazole ring which bears a carboxylic acid amide group.	Thiazolecarboxamides		Thiazolecarboxylic acids and derivatives	Organic compounds	Aromatic heteromonocyclic compounds	thiazoles (CHEBI:48901);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);oxolanes (CHEBI:26912);imidazoles (CHEBI:24780);acetamides (CHEBI:22160);tertiary amine (CHEBI:32876);organonitrogen compound (CHEBI:35352);organooxygen compound (CHEBI:36963);oxacycle (CHEBI:38104);ether (CHEBI:25698);organonitrogen heterocyclic compound (CHEBI:38101);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);aromatic amide (CHEBI:62733);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);azole (CHEBI:68452);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);amine (CHEBI:32952);oxygen molecular entity (CHEBI:25806);aromatic carboxylic acid (CHEBI:33859)		Thiazoles	2-heteroaryl carboxamide;2,4,5-trisubstituted 1,3-thiazole;Thiazolecarboxamide;Imidazole;Heteroaromatic compound;Oxolane;Acetamide;Tertiary carboxylic acid amide;Amino acid or derivatives;Carboxamide group;Secondary carboxylic acid amide;Tertiary amine;Carboxylic acid derivative;Dialkyl ether;Ether;Oxacycle;Azacycle;Organic oxygen compound;Amine;Organic nitrogen compound;Organic oxide;Hydrocarbon derivative;Organonitrogen compound;Organooxygen compound;Carbonyl group;Aromatic heteromonocyclic compound	Organoheterocyclic compounds	0.0		1224156-95-9		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	3	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C17H23N5O3S	C17H23N5O3S			InChI=1S/C17H23N5O3S/c1-11-15(16(24)19-6-5-13-8-18-10-20-13)26-17(21-11)22(12(2)23)9-14-4-3-7-25-14/h8,10,14H,3-7,9H2,1-2H3,(H,18,20)(H,19,24)	POKVVKOWYGTVKQ-UHFFFAOYSA-N	2-[acetyl(tetrahydrofuran-2-ylmethyl)amino]-N-[2-(1H-imidazol-4-yl)ethyl]-4-methyl-thiazole-5-carboxamide	51043632	CC(=O)N(CC1CCCO1)c1nc(C)c(C(=O)NCCc2cnc[nH]2)s1	2-[acetyl(oxolan-2-ylmethyl)amino]-N-[2-(1H-imidazol-5-yl)ethyl]-4-methyl-1,3-thiazole-5-carboxamide			1.1342800000000002													MCULE-7520557163	377.46856		377.152161	5	2	7	3			45									Imidazole alkaloids	False	Alkaloids	Histidine alkaloids			Peptide01			Compound(51043632)	51043632	1.2	450			[#6]-[#6](=[#8])-[#7](-[#6]-[#6]1-[#6]-[#6]-[#6]-[#8]-1)-[#6]1:[#7]:[#6](-[#6]):[#6](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7]:[#6]:[#7H]:2):[#16]:1	CC(=O)N(CC1CCCO1)c1nc(C)c(C(=O)NCCc2cnc[nH]2)s1	POKVVKOWYGTVKQ		parent_pubchem_cid	1224156-95-9;2-[acetyl(tetrahydro-2-furanylmethyl)amino]-N-[2-(1H-imidazol-4-yl)ethyl]-4-methyl-1,3-thiazole-5-carboxamide;EiM08-15463;AKOS005665882;N-[2-(1H-IMIDAZOL-4-YL)ETHYL]-4-METHYL-2-{N-[(OXOLAN-2-YL)METHYL]ACETAMIDO}-1,3-THIAZOLE-5-CARBOXAMIDE;2-[acetyl(tetrahydrofuran-2-ylmethyl)amino]-N-[2-(1H-imidazol-4-yl)ethyl]-4-methyl-thiazole-5-carboxamide		22818936.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22818936		pluskal_iocb_peptide_Peptide01_C9_id		100	C9		
3.3		0	867	P6236036	78.1		K38	False	0	23	0	0	24	0	4	2	0	0		0.0						CCn1cc(C(=O)NC(C)Cc2c[nH]c3ccccc23)c(=O)c2c1nc(C)cc2																							0.0		1010898-24-4		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C23H24N4O2	C23H24N4O2			InChI=1S/C23H24N4O2/c1-4-27-13-19(21(28)18-10-9-14(2)25-22(18)27)23(29)26-15(3)11-16-12-24-20-8-6-5-7-17(16)20/h5-10,12-13,15,24H,4,11H2,1-3H3,(H,26,29)	PXSXQABEBGBSFL-UHFFFAOYSA-N	1-ethyl-N-[2-(1H-indol-3-yl)-1-methyl-ethyl]-7-methyl-4-oxo-1,8-naphthyridine-3-carboxamide	42650464	CCn1cc(C(=O)NC(C)Cc2c[nH]c3ccccc23)c(=O)c2c1nc(C)cc2	1-ethyl-N-[1-(1H-indol-3-yl)propan-2-yl]-7-methyl-4-oxo-1,8-naphthyridine-3-carboxamide			3.4460400000000018													MCULE-2156831007	388.47333		388.189926	4	2	5	4			45										False	Alkaloids				Peptide01			Compound(42650464)	42650464	3.7	451			[#6]-[#6]-[#7]1:[#6]:[#6](-[#6](=[#8])-[#7]-[#6](-[#6])-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6](=[#8]):[#6]2:[#6]:1:[#7]:[#6](-[#6]):[#6]:[#6]:2	CCn1cc(C(=O)NC(C)Cc2c[nH]c3ccccc23)c(=O)c2c1nc(C)cc2	PXSXQABEBGBSFL		parent_pubchem_cid	1010898-24-4;1-ethyl-N~3~-[2-(1H-indol-3-yl)-1-methylethyl]-7-methyl-4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxamide;EiM08-00127;AKOS005565491;1-ethyl-N-[1-(1H-indol-3-yl)propan-2-yl]-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxamide;1-ethyl-N-[2-(1H-indol-3-yl)-1-methyl-ethyl]-7-methyl-4-oxo-1,8-naphthyridine-3-carboxamide		24068561.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24068561		pluskal_iocb_peptide_Peptide01_C9_id		100	C9		
0.7		0	955	P1107667	95.9		K39	False	0	20	0	0	21	0	1	5	0	0		0.0						CC(C)CC(NCc1c2oc(=O)c3ccccc3c2ccc1O)C(=O)O								Isocoumarins and derivatives;Coumarins and derivatives;1-benzopyrans;2-benzopyrans;D-alpha-amino acids;Pyranones and derivatives;1-hydroxy-2-unsubstituted benzenoids;Aralkylamines;Heteroaromatic compounds;Amino acids;Lactones;Carboxylic acid salts;Oxacyclic compounds;Monocarboxylic acids and derivatives;Dialkylamines;Carboxylic acids;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organic salts;Organic zwitterions;Organopnictogen compounds	1-benzopyrans;1-hydroxy-2-unsubstituted benzenoids;2-benzopyrans;Alpha amino acids;Alpha amino acids and derivatives;Amines;Amino acids;Amino acids and derivatives;Amino acids, peptides, and analogues;Aralkylamines;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acid derivatives;Carboxylic acid salts;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;D-alpha-amino acids;Dialkylamines;Heteroaromatic compounds;Hydrocarbon derivatives;Isocoumarins and derivatives;Lactones;Leucine and derivatives;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organic salts;Organic zwitterions;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenols;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Secondary amines	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as leucine and derivatives. These are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Leucine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	isocoumarins (CHEBI:38758);coumarins (CHEBI:23403);1-benzopyran (CHEBI:38443);2-benzopyran (CHEBI:38444);D-alpha-amino acid (CHEBI:16733);pyranone (CHEBI:37963);phenols (CHEBI:33853);aralkylamine (CHEBI:18000);organic aromatic compound (CHEBI:33659);amino acid (CHEBI:33709);lactone (CHEBI:25000);organic salt (CHEBI:24868);oxacycle (CHEBI:38104);monocarboxylic acid (CHEBI:25384);secondary amino compound (CHEBI:50995);carboxylic acid (CHEBI:33575);carbonyl compound (CHEBI:36586);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);zwitterion (CHEBI:27369);organic molecular entity (CHEBI:50860);pnictogen molecular entity (CHEBI:33302);leucine derivative (CHEBI:47003);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);organic acid (CHEBI:64709);organonitrogen compound (CHEBI:35352);alpha-amino acid (CHEBI:33704);pyrans (CHEBI:26407);benzenoid aromatic compound (CHEBI:33836);nitrogen molecular entity (CHEBI:51143);amine (CHEBI:32952);secondary amine (CHEBI:32863);oxygen molecular entity (CHEBI:25806);carboxylic acid anion (CHEBI:29067);peptide (CHEBI:16670)	Benzopyranoids (PK1311)	Amino acids, peptides, and analogues	Leucine or derivatives;Coumarin;Isocoumarin;Alpha-amino acid;Benzopyran;D-alpha-amino acid;1-benzopyran;2-benzopyran;1-hydroxy-2-unsubstituted benzenoid;Pyranone;Aralkylamine;Pyran;Benzenoid;Heteroaromatic compound;Carboxylic acid salt;Lactone;Amino acid;Organoheterocyclic compound;Secondary amine;Oxacycle;Carboxylic acid;Secondary aliphatic amine;Monocarboxylic acid or derivatives;Organic nitrogen compound;Organonitrogen compound;Amine;Organic oxide;Organooxygen compound;Organopnictogen compound;Organic salt;Carbonyl group;Organic oxygen compound;Hydrocarbon derivative;Organic zwitterion;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		EiM07-28724		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C20H21NO5	C20H21NO5			InChI=1S/C20H21NO5/c1-11(2)9-16(19(23)24)21-10-15-17(22)8-7-13-12-5-3-4-6-14(12)20(25)26-18(13)15/h3-8,11,16,21-22H,9-10H2,1-2H3,(H,23,24)/t16-/m1/s1	AZGRIGAFRKZOIP-MRXNPFEDSA-N	rac-(2R)-2-[(3-hydroxy-6-oxo-benzo[c]chromen-4-yl)methylamino]-4-methyl-pentanoic acid	5571109	CC(C)C[C@@H](NCc1c2oc(=O)c3ccccc3c2ccc1O)C(=O)O	(2R)-2-[(3-hydroxy-6-oxobenzo[c]chromen-4-yl)methylamino]-4-methylpentanoic acid			2.7666300000000006													MCULE-9878871631	355.39407		355.141973	6	3	6	3			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(7000813)	7000813	1.6	452			[#6]-[#6](-[#6])-[#6]-[#6@@H](-[#7]-[#6]-[#6]1:[#6]2:[#8]:[#6](=[#8]):[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3:[#6]:2:[#6]:[#6]:[#6]:1-[#8])-[#6](=[#8])-[#8]	CC(C)C[C@@H](NCc1c2oc(=O)c3ccccc3c2ccc1O)C(=O)O	AZGRIGAFRKZOIP		parent_pubchem_cid	EiM07-28724;AKOS016376013;rac-(2R)-2-[(3-hydroxy-6-oxo-benzo[c]chromen-4-yl)methylamino]-4-methyl-pentanoic acid		16085100.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=16085100		pluskal_iocb_peptide_Peptide01_C9_id		100	C9		ZINC000002090528
2.6		0	1043	P1094945	96.9		K40	False	0	23	0	0	28	0	2	5	0	0		0.0						COc1ccc(C2(CNC(=O)NC(Cc3ccccc3)C(=O)O)CCOCC2)cc1																							0.0		AKOS004937302		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C23H28N2O5	C23H28N2O5			InChI=1S/C23H28N2O5/c1-29-19-9-7-18(8-10-19)23(11-13-30-14-12-23)16-24-22(28)25-20(21(26)27)15-17-5-3-2-4-6-17/h2-10,20H,11-16H2,1H3,(H,26,27)(H2,24,25,28)/t20-/m0/s1	CQLMJGQSWBCFAE-FQEVSTJZSA-N	rac-(2S)-2-[[4-(4-methoxyphenyl)tetrahydropyran-4-yl]methylcarbamoylamino]-3-phenyl-propanoic acid	7693896	COc1ccc(C2(CNC(=O)N[C@@H](Cc3ccccc3)C(=O)O)CCOCC2)cc1	(2S)-2-[[4-(4-methoxyphenyl)oxan-4-yl]methylcarbamoylamino]-3-phenylpropanoic acid			2.166669999999999													MCULE-1638382689	412.49001		412.199822	5	3	8	3			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(7693896)	7693896	3.0	453			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6]2(-[#6]-[#7]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3)-[#6](=[#8])-[#8])-[#6]-[#6]-[#8]-[#6]-[#6]-2):[#6]:[#6]:1	COc1ccc(C2(CNC(=O)N[C@@H](Cc3ccccc3)C(=O)O)CCOCC2)cc1	CQLMJGQSWBCFAE		parent_pubchem_cid	AKOS004937302;(2S)-2-[[4-(4-methoxyphenyl)oxan-4-yl]methylcarbamoylamino]-3-phenylpropanoic acid;N-({[4-(4-methoxyphenyl)tetrahydro-2H-pyran-4-yl]methyl}carbamoyl)-L-phenylalanine;(2S)-2-{[({[4-(4-METHOXYPHENYL)TETRAHYDRO-2H-PYRAN-4-YL]METHYL}AMINO)CARBONYL]AMINO}-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[[4-(4-methoxyphenyl)tetrahydropyran-4-yl]methylcarbamoylamino]-3-phenyl-propanoic acid		24402955.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24402955		pluskal_iocb_peptide_Peptide01_C9_id		100	C9		ZINC000005452011
3.1		0	787	P6241991	80.6		K41	False	0	21	0	0	22	0	2	4	0	0		0.0						COc1c2c(ccc1)ccn2CCC(=O)NC(Cc1ccccc1)C(=O)O								N-acyl-L-alpha-amino acids;Phenylpropanoic acids;Amphetamines and derivatives;N-alkylindoles;Indoles;Anisoles;Alkyl aryl ethers;Substituted pyrroles;Heteroaromatic compounds;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organonitrogen compounds	Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Anisoles;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;N-alkylindoles;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenethylamines;Phenol ethers;Phenylalanine and derivatives;Phenylpropanoic acids;Phenylpropanoids and polyketides;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-L-alpha-amino acid (CHEBI:48927);benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);amphetamines (CHEBI:35338);indoles (CHEBI:24828);methoxybenzene (CHEBI:51683);aromatic ether (CHEBI:35618);pyrroles (CHEBI:26455);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);monocarboxylic acid (CHEBI:25384);organonitrogen heterocyclic compound (CHEBI:38101);carbonyl compound (CHEBI:36586);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);N-acyl-amino acid (CHEBI:51569);benzenoid aromatic compound (CHEBI:33836);primary amine (CHEBI:32877);organic heterocyclic compound (CHEBI:24532);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ether (CHEBI:25698);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)		Amino acids, peptides, and analogues	Phenylalanine or derivatives;N-acyl-l-alpha-amino acid;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;3-phenylpropanoic-acid;Amphetamine or derivatives;N-alkylindole;Indole;Indole or derivatives;Anisole;Phenol ether;Alkyl aryl ether;Monocyclic benzene moiety;Benzenoid;Substituted pyrrole;Heteroaromatic compound;Pyrrole;Secondary carboxylic acid amide;Carboxamide group;Organoheterocyclic compound;Monocarboxylic acid or derivatives;Azacycle;Ether;Carboxylic acid;Organonitrogen compound;Organic nitrogen compound;Carbonyl group;Hydrocarbon derivative;Organic oxide;Organooxygen compound;Organic oxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		EiM08-13459		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C21H22N2O4	C21H22N2O4			InChI=1S/C21H22N2O4/c1-27-18-9-5-8-16-10-12-23(20(16)18)13-11-19(24)22-17(21(25)26)14-15-6-3-2-4-7-15/h2-10,12,17H,11,13-14H2,1H3,(H,22,24)(H,25,26)/t17-/m0/s1	MJDHJHINLBEOML-KRWDZBQOSA-N	rac-(2S)-2-[3-(7-methoxyindol-1-yl)propanoylamino]-3-phenyl-propanoic acid	49652716	COc1c2c(ccc1)ccn2CCC(=O)N[C@@H](Cc1ccccc1)C(=O)O	(2S)-2-[3-(7-methoxyindol-1-yl)propanoylamino]-3-phenylpropanoic acid			1.90656													MCULE-5725608312	366.42049		366.157957	4	2	8	3			44										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(49652716)	49652716	2.7	454			[#6]-[#8]-[#6]1:[#6]2:[#6](:[#6]:[#6]:[#6]:1):[#6]:[#6]:[#7]:2-[#6]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	COc1c2c(ccc1)ccn2CCC(=O)N[C@@H](Cc1ccccc1)C(=O)O	MJDHJHINLBEOML		parent_pubchem_cid	EiM08-13459;AKOS016386019;(2S)-2-{[3-(7-METHOXY-1H-INDOL-1-YL)PROPANOYL]AMINO}-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[3-(7-methoxyindol-1-yl)propanoylamino]-3-phenyl-propanoic acid		24744331.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24744331		pluskal_iocb_peptide_Peptide01_C9_id		100	C9		ZINC000040313349
2.8		0	875	P1107402	112.9		K42	False	0	21	0	0	19	0	1	6	0	0		0.0						Cc1c(CC(=O)NC(Cc2ccccc2)C(=O)O)c(=O)oc2c1ccc(O)c2																							0.0		AKOS016379144		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C21H19NO6	C21H19NO6			InChI=1S/C21H19NO6/c1-12-15-8-7-14(23)10-18(15)28-21(27)16(12)11-19(24)22-17(20(25)26)9-13-5-3-2-4-6-13/h2-8,10,17,23H,9,11H2,1H3,(H,22,24)(H,25,26)/t17-/m1/s1	LMTBHHZPNWMKCJ-QGZVFWFLSA-N	rac-(2R)-2-[[2-(7-hydroxy-4-methyl-2-oxo-chromen-3-yl)acetyl]amino]-3-phenyl-propanoic acid	24280393	Cc1c(CC(=O)N[C@H](Cc2ccccc2)C(=O)O)c(=O)oc2c1ccc(O)c2	(2R)-2-[[2-(7-hydroxy-4-methyl-2-oxochromen-3-yl)acetyl]amino]-3-phenylpropanoic acid			2.00655													MCULE-8924800345	381.38868		381.121237	6	3	6	3			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(24280393)	24280393	2.3	455			[#6]-[#6]1:[#6](-[#6]-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#8]):[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]):[#6]:2	Cc1c(CC(=O)N[C@H](Cc2ccccc2)C(=O)O)c(=O)oc2c1ccc(O)c2	LMTBHHZPNWMKCJ		parent_pubchem_cid	AKOS016379144;2-[2-(7-HYDROXY-4-METHYL-2-OXO-2H-CHROMEN-3-YL)ACETAMIDO]-3-PHENYLPROPANOIC ACID;rac-(2R)-2-[[2-(7-hydroxy-4-methyl-2-oxo-chromen-3-yl)acetyl]amino]-3-phenyl-propanoic acid		23468895.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23468895		pluskal_iocb_peptide_Peptide01_C9_id		100	C9		ZINC000011865392
2.0		0	963	P3460027	84.9		K43	False	0	15	0	0	21	0	1	5	0	0	-1.0	0.0						CC(C)(C)OC(=O)NC(COCc1ccccc1)C(=O)O		2.18		0.0	2.23	CHEMBL4958658		Benzylethers;Carbamate esters;Organic carbonic acids and derivatives;Monocarboxylic acids and derivatives;Dialkyl ethers;Carboxylic acids;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Benzene and substituted derivatives;Benzenoids;Benzylethers;Carbamate esters;Carbamic acids and derivatives;Carbonyl compounds;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Dialkyl ethers;Ethers;Hydrocarbon derivatives;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as alpha amino acids and derivatives. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon), or a derivative thereof.	Alpha amino acids and derivatives		Amino acids and derivatives	Organic compounds	Aromatic homomonocyclic compounds	benzyl ether (CHEBI:59859);carbamate ester (CHEBI:23003);organooxygen compound (CHEBI:36963);carbonyl compound (CHEBI:36586);ether (CHEBI:25698);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);amino acid (CHEBI:33709);peptide (CHEBI:16670);carbon oxoacid (CHEBI:35605);oxygen molecular entity (CHEBI:25806);nitrogen molecular entity (CHEBI:51143)		Amino acids, peptides, and analogues	Alpha-amino acid or derivatives;Benzylether;Monocyclic benzene moiety;Benzenoid;Carbamic acid ester;Carbonic acid derivative;Monocarboxylic acid or derivatives;Ether;Dialkyl ether;Carboxylic acid;Organic oxide;Organooxygen compound;Organonitrogen compound;Organic nitrogen compound;Carbonyl group;Organopnictogen compound;Organic oxygen compound;Hydrocarbon derivative;Aromatic homomonocyclic compound	Organic acids and derivatives	0.0		Boc-Ser(Bzl)-OH	DTXSID70885240	2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	1	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C15H21NO5	C15H21NO5			InChI=1S/C15H21NO5/c1-15(2,3)21-14(19)16-12(13(17)18)10-20-9-11-7-5-4-6-8-11/h4-8,12H,9-10H2,1-3H3,(H,16,19)(H,17,18)/t12-/m0/s1	DMBKPDOAQVGTST-LBPRGKRZSA-N	rac-(2S)-3-benzyloxy-2-(tert-butoxycarbonylamino)propanoic acid	90234	CC(C)(C)OC(=O)N[C@@H](COCc1ccccc1)C(=O)O	(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylmethoxypropanoic acid			2.12639													MCULE-9725661560	295.33832	ACID	295.141973	5	2	8	1	1.0		27										False			False	False	Peptide01		-1.0	Compound(90234)	90234	1.9	456		SCHEMBL17051	[#6]-[#6](-[#6])(-[#6])-[#8]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	CC(C)(C)OC(=O)N[C@@H](COCc1ccccc1)C(=O)O	DMBKPDOAQVGTST		parent_pubchem_cid	Boc-Ser(Bzl)-OH;23680-31-1;N-Boc-O-benzyl-L-serine;Boc-O-benzyl-L-serine;(S)-3-(Benzyloxy)-2-((tert-butoxycarbonyl)amino)propanoic acid;N-((1,1-Dimethylethoxy)carbonyl)-O-(phenylmethyl)-L-serine;N-tert-Butoxycarbonyl-O-benzyl-L-serine;o-benzyl-n-(tert-butoxycarbonyl)-l-serine;N-(tert-Butoxycarbonyl)-O-benzyl-L-serine;N-t-Butoxycarbonyl-O-benzyl-L-serine;L-Serine, N-[(1,1-dimethylethoxy)carbonyl]-O-(phenylmethyl)-;O-Benzyl-N-tert-butyloxycarbonylserine;Alanine, 3-(benzyloxy)-N-carboxy-, N-tert-butyl ester, L-;Boc-Ser(Bzl);(S)-3-(benzyloxy)-2-(tert-butoxycarbonylamino)propanoic acid;L-Serine, N-((1,1-dimethylethoxy)carbonyl)-O-(phenylmethyl)-;o-Benzyl-N-(tert-butoxycarbonyl)serine;MFCD00066063;BocSer(Bzl);BocSer(OBzl);Boc-O-Benzylserine;EINECS 245-820-1;N-alpha-tert-BOC-o-benzyl-L-serine;Boc-Ser(OBn);Boc-Ser(Bn)-OH;NSC 334364;N-(tert-butoxycarbonyl)-O-benzylserine;N-BOC-O-benzylserine;O-benzyl Boc-L-serine;BOC-O-benzyl L-serine;(O-benzyl) Boc Serine;Boc-L-Ser(OBzl)-OH;SCHEMBL17051;Boc-Ser(OCH2C6H5)-OH;N-BOC-(O-benzyl)-L-serine;CHEMBL4958658;DTXSID70885240;(2S)-3-(benzyloxy)-2-[(tert-butoxycarbonyl)amino]propanoic acid;(2S)-3-(benzyloxy)-2-{[(tert-butoxy)carbonyl]amino}propanoic acid;STL466181;t-butyloxycarbonyl-O-benzyl-L-serine;AKOS005175154;AKOS015924244;CS-W004063;HY-W004063;N-t-butyloxycarbonyl-O-benzyl-L-serine;N-(t-butoxycarbonyl)-O-benzyl-L-serine;N-tert-butoxycarbonyl O-benzyl L-serine;O-benzyl-N-(t-butoxycarbonyl)-L-serine;AC-12300;AC-17187;AS-12200;Boc-Ser(Bzl)-OH, >=99.0% (T);N-tert-butyloxycarbonyl-O-benzyl-L-serine;Nalpha-t-butoxycarbonyl-O-benzyl-L-serine;o-Benzyl-N-(tert-butoxycarbonyl)serine #;PD196416;N-(t-butoxycarbonyl)-O-benzyl-(L)-serine;N-tert.-butyloxycarbonyl-o-benzyl-l-serine;Nalpha -t-butoxycarbonyl-O-benzyl-L-serine;AM20040529;B1629;N-(tert-Butyloxycarbonyl)-O-Benzyl-L-Serine;N-alpha-t-Butyloxycarbonyl-O-benzyl-L-serine;EN300-302730;M06197;J-300236;Q-101720;(S)-3-benzyloxy-2-tertbutoxycarbonylaminopropionic acid;(S)-3-benzyloxy-2-(tert butoxycarbonylamino)propionic acid;(2S)-3-Benzyloxy-2-(tert-butoxycarbonylamino)propionic acid;D-Serine,N-(1,1-dimethylethoxy)carbonyl]-O-(phenylmethyl)-;(S)-3-(benzyloxy)-2-((tert-butoxycarbonyl)amino) propanoic acid;rac-(2S)-3-benzyloxy-2-(tert-butoxycarbonylamino)propanoic acid	False	24414798.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24414798		pluskal_iocb_peptide_Peptide01_C10_id		100	C10	False	ZINC000002539573
4.3		0	1051	P11185809	99.4		K44	False	0	24	0	0	20	0	6	1	0	0		0.0						O=C(NC(Cc1ccccc1)c1nc2ccccc2[nH]1)c1cc(-c2ccccn2)n[nH]1																							0.0		STL424926		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	4	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	0	0	0	0	0	0	0		C24H20N6O	C24H20N6O			InChI=1S/C24H20N6O/c31-24(22-15-20(29-30-22)17-10-6-7-13-25-17)28-21(14-16-8-2-1-3-9-16)23-26-18-11-4-5-12-19(18)27-23/h1-13,15,21H,14H2,(H,26,27)(H,28,31)(H,29,30)	QMWGEVFQWZNSTP-UHFFFAOYSA-N	N-[1-(1H-benzimidazol-2-yl)-2-phenyl-ethyl]-5-(2-pyridyl)-1H-pyrazole-3-carboxamide	91823019	O=C(NC(Cc1ccccc1)c1nc2ccccc2[nH]1)c1cc(-c2ccccn2)n[nH]1	N-[1-(1H-benzimidazol-2-yl)-2-phenylethyl]-3-pyridin-2-yl-1H-pyrazole-5-carboxamide			3.0892300000000006														408.4666		408.169859	4	3	6	5			46									Carboline alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(91823019)	91823019	3.5	457			[#8]=[#6](-[#7]-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#7H]:1)-[#6]1:[#6]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#7]:2):[#7]:[#7H]:1	O=C(NC(Cc1ccccc1)c1nc2ccccc2[nH]1)c1cc(-c2ccccn2)n[nH]1	QMWGEVFQWZNSTP		parent_pubchem_cid	STL424926;AKOS025259880;N-[1-(1H-benzimidazol-2-yl)-2-phenylethyl]-5-(pyridin-2-yl)-1H-pyrazole-3-carboxamide;N-[1-(1H-1,3-BENZIMIDAZOL-2-YL)-2-PHENYLETHYL]-5-(2-PYRIDYL)-1H-PYRAZOLE-3-CARBOXAMIDE;N-[1-(1H-benzimidazol-2-yl)-2-phenyl-ethyl]-5-(2-pyridyl)-1H-pyrazole-3-carboxamide		100826724.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=100826724		pluskal_iocb_peptide_Peptide01_C10_id		100	C10		
4.1		0	1059	P11185433	110.9		L1	False	0	23	1	0	21	0	4	3	0	0		0.0						Cc1c(CC(=O)NC(Cc2c[nH]c3ccccc23)C(=O)O)c(-c2ccc(Cl)cc2)n[nH]1																							0.0		AKOS027472940		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	2	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	0	0	0	0	0	0	0		C23H21ClN4O3	C23H21ClN4O3			InChI=1S/C23H21ClN4O3/c1-13-18(22(28-27-13)14-6-8-16(24)9-7-14)11-21(29)26-20(23(30)31)10-15-12-25-19-5-3-2-4-17(15)19/h2-9,12,20,25H,10-11H2,1H3,(H,26,29)(H,27,28)(H,30,31)/t20-/m0/s1	GVIAIERXTZLYCE-FQEVSTJZSA-N	rac-(2S)-2-[[2-[3-(4-chlorophenyl)-5-methyl-1H-pyrazol-4-yl]acetyl]amino]-3-(1H-indol-3-yl)propanoic acid	110205295	Cc1c(CC(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)c(-c2ccc(Cl)cc2)n[nH]1	(2S)-2-[[2-[3-(4-chlorophenyl)-5-methyl-1H-pyrazol-4-yl]acetyl]amino]-3-(1H-indol-3-yl)propanoic acid			2.9018500000000005														436.90182		436.130218	4	4	7	4			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(110205295)	110205295	3.0	458			[#6]-[#6]1:[#6](-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6](=[#8])-[#8]):[#6](-[#6]2:[#6]:[#6]:[#6](-[#17]):[#6]:[#6]:2):[#7]:[#7H]:1	Cc1c(CC(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)c(-c2ccc(Cl)cc2)n[nH]1	GVIAIERXTZLYCE		parent_pubchem_cid	AKOS027472940;(2S)-2-({2-[3-(4-CHLOROPHENYL)-5-METHYL-1H-PYRAZOL-4-YL]ACETYL}AMINO)-3-(1H-INDOL-3-YL)PROPANOIC ACID;rac-(2S)-2-[[2-[3-(4-chlorophenyl)-5-methyl-1H-pyrazol-4-yl]acetyl]amino]-3-(1H-indol-3-yl)propanoic acid		117133506.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=117133506		pluskal_iocb_peptide_Peptide01_C10_id		100	C10		ZINC000253402986
4.6		0	1147	P1098234	117.7		L2	False	0	26	0	0	26	0	2	6	0	0		0.0						CCCc1cc(=O)oc2c1ccc(OCC(=O)NC(Cc1c[nH]c3ccccc13)C(=O)O)c2C																							0.0		EiM07-16912		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C26H26N2O6	C26H26N2O6			InChI=1S/C26H26N2O6/c1-3-6-16-12-24(30)34-25-15(2)22(10-9-19(16)25)33-14-23(29)28-21(26(31)32)11-17-13-27-20-8-5-4-7-18(17)20/h4-5,7-10,12-13,21,27H,3,6,11,14H2,1-2H3,(H,28,29)(H,31,32)/t21-/m0/s1	IXQHPAYCHWBNKN-NRFANRHFSA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[[2-(8-methyl-2-oxo-4-propyl-chromen-7-yl)oxyacetyl]amino]propanoic acid	1748520	CCCc1cc(=O)oc2c1ccc(OCC(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)O)c2C	(2S)-3-(1H-indol-3-yl)-2-[[2-(8-methyl-2-oxo-4-propylchromen-7-yl)oxyacetyl]amino]propanoic acid			3.1426300000000005													MCULE-5936631723	462.50692		462.179087	6	3	9	4			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(1748520)	1748520	4.2	459			[#6]-[#6]-[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:1:3)-[#6](=[#8])-[#8]):[#6]:2-[#6]	CCCc1cc(=O)oc2c1ccc(OCC(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)O)c2C	IXQHPAYCHWBNKN		parent_pubchem_cid	EiM07-16912;AKOS016390237;3-(1H-INDOL-3-YL)-2-{2-[(8-METHYL-2-OXO-4-PROPYL-2H-CHROMEN-7-YL)OXY]ACETAMIDO}PROPANOIC ACID;rac-(2S)-3-(1H-indol-3-yl)-2-[[2-(8-methyl-2-oxo-4-propyl-chromen-7-yl)oxyacetyl]amino]propanoic acid		23649734.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23649734		pluskal_iocb_peptide_Peptide01_C10_id		100	C10		ZINC000002091484
2.9		0	1235	P1888726	77.3		L3	False	0	22	0	0	22	0	6	2	0	0	-1.0	0.0						COc1ccc(Nc2nc(N3CCOCC3)c3cnn(-c4ccccc4)c3n2)cc1		3.4		0.0	3.97	CHEMBL5012165																	0.0		897620-65-4		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	2		C22H22N6O2	C22H22N6O2			InChI=1S/C22H22N6O2/c1-29-18-9-7-16(8-10-18)24-22-25-20(27-11-13-30-14-12-27)19-15-23-28(21(19)26-22)17-5-3-2-4-6-17/h2-10,15H,11-14H2,1H3,(H,24,25,26)	STRDELBOLPUUFN-UHFFFAOYSA-N	N-(4-methoxyphenyl)-4-morpholino-1-phenyl-pyrazolo[3,4-d]pyrimidin-6-amine	16801588	COc1ccc(Nc2nc(N3CCOCC3)c3cnn(-c4ccccc4)c3n2)cc1	N-(4-methoxyphenyl)-4-morpholin-4-yl-1-phenylpyrazolo[3,4-d]pyrimidin-6-amine			1.18163													MCULE-9404474132	402.45964	NEUTRAL	402.180424	7	1	5	5	0.0		28										False	Alkaloids		False	False	Peptide01		-1.0	Compound(16801588)	16801588	3.8	460		SCHEMBL10143801	[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#7]-[#6]2:[#7]:[#6](-[#7]3-[#6]-[#6]-[#8]-[#6]-[#6]-3):[#6]3:[#6]:[#7]:[#7](-[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]:4):[#6]:3:[#7]:2):[#6]:[#6]:1	COc1ccc(Nc2nc(N3CCOCC3)c3cnn(-c4ccccc4)c3n2)cc1	STRDELBOLPUUFN		parent_pubchem_cid	897620-65-4;N-(4-methoxyphenyl)-4-(morpholin-4-yl)-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-6-amine;CHEMBL5012165;SCHEMBL10143801;AKOS024254441;CCG-307571;F2090-0857;N-(4-methoxyphenyl)-4-morpholino-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-6-amine;N-(4-methoxyphenyl)-4-morpholino-1-phenyl-pyrazolo[3,4-d]pyrimidin-6-amine	False	10397364.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=10397364		pluskal_iocb_peptide_Peptide01_C10_id		100	C10	False	ZINC000009573631
2.4		0	1067	P1157558	88.1		L5	False	0	18	0	0	26	0	2	5	0	0		0.0						COc1c(OC)cc2CN(C(=O)NC(CC(C)C)C(=O)O)CCc2c1																							0.0		N-[(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)carbonyl]-L-leucine		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C18H26N2O5	C18H26N2O5			InChI=1S/C18H26N2O5/c1-11(2)7-14(17(21)22)19-18(23)20-6-5-12-8-15(24-3)16(25-4)9-13(12)10-20/h8-9,11,14H,5-7,10H2,1-4H3,(H,19,23)(H,21,22)/t14-/m0/s1	ZVZYXODMIYOIQV-AWEZNQCLSA-N	rac-(2S)-2-[(6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-2-carbonyl)amino]-4-methyl-pentanoic acid	16407942	COc1c(OC)cc2CN(C(=O)N[C@@H](CC(C)C)C(=O)O)CCc2c1	(2S)-2-[(6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-2-carbonyl)amino]-4-methylpentanoic acid			1.23656													MCULE-9471097229	350.41832		350.184172	5	2	6	2			44										False	Alkaloids				Peptide01			Compound(16407942)	16407942	2.3	461			[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]):[#6]:[#6]2-[#6]-[#7](-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=[#8])-[#8])-[#6]-[#6]-[#6]:2:[#6]:1	COc1c(OC)cc2CN(C(=O)N[C@@H](CC(C)C)C(=O)O)CCc2c1	ZVZYXODMIYOIQV		parent_pubchem_cid	N-[(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)carbonyl]-L-leucine;STL458117;AKOS004937269;(2S)-2-[(6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-2-carbonyl)amino]-4-methylpentanoic acid;rac-(2S)-2-[(6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-2-carbonyl)amino]-4-methyl-pentanoic acid		24495888.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24495888		pluskal_iocb_peptide_Peptide01_C10_id		100	C10		ZINC000012892695
1.8		0	1155	P1157897	107.5		L6	False	0	16	0	0	20	0	2	3	0	1		0.0						CSCCC(NC(=O)Cc1c(C)[nH]c2ccccc12)C(=O)O																							0.0		N-[(2-methyl-1H-indol-3-yl)acetyl]-L-methionine		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C16H20N2O3S	C16H20N2O3S			InChI=1S/C16H20N2O3S/c1-10-12(11-5-3-4-6-13(11)17-10)9-15(19)18-14(16(20)21)7-8-22-2/h3-6,14,17H,7-9H2,1-2H3,(H,18,19)(H,20,21)/t14-/m0/s1	BNLMCNZEKQFLNJ-AWEZNQCLSA-N	rac-(2S)-2-[[2-(2-methyl-1H-indol-3-yl)acetyl]amino]-4-methylsulfanyl-butanoic acid	16409327	CSCC[C@H](NC(=O)Cc1c(C)[nH]c2ccccc12)C(=O)O	(2S)-2-[[2-(2-methyl-1H-indol-3-yl)acetyl]amino]-4-methylsulfanylbutanoic acid			1.80348													MCULE-3026826096	320.4134		320.119463	4	3	7	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(16409327)	16409327	2.3	462			[#6]-[#16]-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#6]1:[#6](-[#6]):[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	CSCC[C@H](NC(=O)Cc1c(C)[nH]c2ccccc12)C(=O)O	BNLMCNZEKQFLNJ		parent_pubchem_cid	N-[(2-methyl-1H-indol-3-yl)acetyl]-L-methionine;AKOS004937060;rac-(2S)-2-[[2-(2-methyl-1H-indol-3-yl)acetyl]amino]-4-methylsulfanyl-butanoic acid		23933822.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23933822		pluskal_iocb_peptide_Peptide01_C10_id		100	C10		ZINC000008765248
4.3		0	1243	P6463696	104.1		L7	False	0	27	0	0	23	0	1	7	0	0		0.0						COC(=O)c1cc(NC(=O)c2c(C)oc3c2cc(OCc2ccccc2)cc3)c(C(=O)OC)cc1								p-Phthalate esters;P-phthalic acid and derivatives;Benzoic acid esters;Benzofurans;Benzoyl derivatives;Furan-3-carboxylic acid and derivatives;Phenol ethers;Alkyl aryl ethers;Methyl esters;Heteroaromatic compounds;Vinylogous amides;Secondary carboxylic acid amides;Oxacyclic compounds;Organic oxides;Hydrocarbon derivatives;Organonitrogen compounds	3-furanilides;Alkyl aryl ethers;Anilides;Aromatic anilides;Benzene and substituted derivatives;Benzenoids;Benzofurans;Benzoic acid esters;Benzoic acids and derivatives;Benzoyl derivatives;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids and derivatives;Chemical entities;Dicarboxylic acids and derivatives;Ethers;Furan-3-carboxylic acid and derivatives;Furanilides;Furans;Furoic acid and derivatives;Heteroaromatic compounds;Hydrocarbon derivatives;Methyl esters;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;P-phthalic acid and derivatives;Phenol ethers;Phthalate esters;Phthalic acid and derivatives;Secondary carboxylic acid amides;Vinylogous amides;p-Phthalate esters	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as 3-furanilides. These are aromatic heterocyclic compounds contaning a furan ring that is substituted at the 3-position with an anilide.	3-furanilides		Aromatic anilides;Furanilides	Organic compounds	Aromatic heteropolycyclic compounds	phthalate ester (CHEBI:35484);benzenedicarboxylic acid (CHEBI:26094);benzoate ester (CHEBI:36054);benzofurans (CHEBI:35259);carbonyl compound (CHEBI:36586);furans (CHEBI:24129);aromatic ether (CHEBI:35618);carboxylic ester (CHEBI:33308);organic aromatic compound (CHEBI:33659);enone (CHEBI:51689);enamine (CHEBI:47989);carboxamide (CHEBI:37622);oxacycle (CHEBI:38104);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);organonitrogen compound (CHEBI:35352);anilide (CHEBI:13248);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);benzoic acids (CHEBI:22723);organooxygen compound (CHEBI:36963);organic heterocyclic compound (CHEBI:24532);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ether (CHEBI:25698);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)	Benzofuranoids (PK1310)	Anilides	3-furanilide;Phthalate ester;Para-phthalic acid ester;Para_phthalic_acid;Benzoate ester;Benzofuran;Benzoic acid or derivatives;Furoic acid or derivatives;Furan-3-carboxylic acid or derivatives;Benzoyl;Phenol ether;Alkyl aryl ether;Heteroaromatic compound;Furan;Vinylogous amide;Methyl ester;Carboxamide group;Carboxylic acid ester;Secondary carboxylic acid amide;Organoheterocyclic compound;Ether;Carboxylic acid derivative;Oxacycle;Organic nitrogen compound;Hydrocarbon derivative;Organic oxide;Organonitrogen compound;Organooxygen compound;Organic oxygen compound;Aromatic heteropolycyclic compound	Benzenoids	0.0		HMS3478K04		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C27H23NO7	C27H23NO7			InChI=1S/C27H23NO7/c1-16-24(21-14-19(10-12-23(21)35-16)34-15-17-7-5-4-6-8-17)25(29)28-22-13-18(26(30)32-2)9-11-20(22)27(31)33-3/h4-14H,15H2,1-3H3,(H,28,29)	SWTWSENUBBDRMU-UHFFFAOYSA-N	dimethyl 2-[(5-benzyloxy-2-methyl-benzofuran-3-carbonyl)amino]benzene-1,4-dicarboxylate	26841542	COC(=O)c1cc(NC(=O)c2c(C)oc3c2cc(OCc2ccccc2)cc3)c(C(=O)OC)cc1	dimethyl 2-[(2-methyl-5-phenylmethoxy-1-benzofuran-3-carbonyl)amino]benzene-1,4-dicarboxylate			3.600730000000002													MCULE-3268057153	473.48686		473.147452	6	1	9	4			44										False					Peptide01			Compound(26841542)	26841542	5.3	463			[#6]-[#8]-[#6](=[#8])-[#6]1:[#6]:[#6](-[#7]-[#6](=[#8])-[#6]2:[#6](-[#6]):[#8]:[#6]3:[#6]:2:[#6]:[#6](-[#8]-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6]:[#6]:3):[#6](-[#6](=[#8])-[#8]-[#6]):[#6]:[#6]:1	COC(=O)c1cc(NC(=O)c2c(C)oc3c2cc(OCc2ccccc2)cc3)c(C(=O)OC)cc1	SWTWSENUBBDRMU		parent_pubchem_cid	HMS3478K04;AKOS002292187;1,4-DIMETHYL 2-[5-(BENZYLOXY)-2-METHYL-1-BENZOFURAN-3-AMIDO]BENZENE-1,4-DICARBOXYLATE;dimethyl 2-[(5-benzyloxy-2-methyl-benzofuran-3-carbonyl)amino]benzene-1,4-dicarboxylate		10819921.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=10819921		pluskal_iocb_peptide_Peptide01_C10_id		100	C10		ZINC000015880510
2.3		0	1075	P11185257	79.8		L9	False	0	22	0	0	25	0	5	1	0	0		0.0						Cc1cc(C)nc(NC(Cc2ccccc2)C(=O)NCCc2ccncc2)n1								Alpha amino acid amides;Amphetamines and derivatives;Aminopyrimidines and derivatives;Pyridines and derivatives;Fatty amides;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds;Amines	Alpha amino acid amides;Alpha amino acids and derivatives;Amines;Amino acids and derivatives;Amino acids, peptides, and analogues;Aminopyrimidines and derivatives;Amphetamines and derivatives;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Diazines;Fatty Acyls;Fatty amides;Heteroaromatic compounds;Hydrocarbon derivatives;Lipids and lipid-like molecules;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenethylamines;Phenylalanine and derivatives;Pyridines and derivatives;Pyrimidines and pyrimidine derivatives;Secondary carboxylic acid amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteromonocyclic compounds	amino acid amide (CHEBI:22475);amphetamines (CHEBI:35338);aminopyrimidine (CHEBI:38338);pyridines (CHEBI:26421);fatty amide (CHEBI:29348);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organonitrogen heterocyclic compound (CHEBI:38101);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);amine (CHEBI:32952);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);organonitrogen compound (CHEBI:35352);organooxygen compound (CHEBI:36963);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);primary amine (CHEBI:32877);organic heterocyclic compound (CHEBI:24532);diazines (CHEBI:38313);pyrimidines (CHEBI:39447);lipid (CHEBI:18059);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143)	Fatty amides (FA08);Fatty Acyls (FA)	Amino acids, peptides, and analogues	Phenylalanine or derivatives;Alpha-amino acid amide;Amphetamine or derivatives;Aminopyrimidine;Monocyclic benzene moiety;Fatty amide;Pyridine;Fatty acyl;Pyrimidine;Benzenoid;Heteroaromatic compound;Carboxamide group;Secondary carboxylic acid amide;Organoheterocyclic compound;Azacycle;Organooxygen compound;Organonitrogen compound;Organic nitrogen compound;Carbonyl group;Hydrocarbon derivative;Organic oxide;Organic oxygen compound;Amine;Aromatic heteromonocyclic compound	Organic acids and derivatives	0.0		1630823-35-6		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C22H25N5O	C22H25N5O			InChI=1S/C22H25N5O/c1-16-14-17(2)26-22(25-16)27-20(15-19-6-4-3-5-7-19)21(28)24-13-10-18-8-11-23-12-9-18/h3-9,11-12,14,20H,10,13,15H2,1-2H3,(H,24,28)(H,25,26,27)	GFGJOTVYQZRVEJ-UHFFFAOYSA-N	2-[(4,6-dimethylpyrimidin-2-yl)amino]-3-phenyl-N-[2-(4-pyridyl)ethyl]propanamide	91641312	Cc1cc(C)nc(NC(Cc2ccccc2)C(=O)NCCc2ccncc2)n1	2-[(4,6-dimethylpyrimidin-2-yl)amino]-3-phenyl-N-(2-pyridin-4-ylethyl)propanamide			2.27109														375.47745		375.20591	5	2	8	3			46									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(91641312)	91641312	3.5	464			[#6]-[#6]1:[#6]:[#6](-[#6]):[#7]:[#6](-[#7]-[#6](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#6]:[#7]:[#6]:[#6]:2):[#7]:1	Cc1cc(C)nc(NC(Cc2ccccc2)C(=O)NCCc2ccncc2)n1	GFGJOTVYQZRVEJ		parent_pubchem_cid	1630823-35-6;2-[(4,6-dimethyl-2-pyrimidinyl)amino]-3-phenyl-N-[2-(4-pyridyl)ethyl]propanamide;EiM08-37977;AKOS025258961;2-[(4,6-DIMETHYLPYRIMIDIN-2-YL)AMINO]-3-PHENYL-N-[2-(PYRIDIN-4-YL)ETHYL]PROPANAMIDE;2-[(4,6-dimethylpyrimidin-2-yl)amino]-3-phenyl-N-[2-(4-pyridyl)ethyl]propanamide		96353105.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=96353105		pluskal_iocb_peptide_Peptide01_C11_id		100	C11		
2.3		0	1163	P1157898	82.2		L10	False	0	15	0	0	18	0	2	3	0	0		0.0						CCC(NC(=O)CCc1c[nH]c2ccccc12)C(=O)O								Tryptamines and derivatives;3-alkylindoles;Substituted pyrroles;Fatty amides;Benzenoids;Heteroaromatic compounds;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	3-alkylindoles;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Fatty Acyls;Fatty amides;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Lipids and lipid-like molecules;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Tryptamines and derivatives	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom.	N-acyl-alpha amino acids		Amino acids and derivatives;Alpha amino acids and derivatives;N-acyl-alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	tryptamines (CHEBI:27162);indoles (CHEBI:24828);pyrroles (CHEBI:26455);fatty amide (CHEBI:29348);benzenoid aromatic compound (CHEBI:33836);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);N-acyl-amino acid (CHEBI:51569);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);lipid (CHEBI:18059);organooxygen compound (CHEBI:36963);organic acid (CHEBI:64709);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806);carboxylic acid anion (CHEBI:29067);amino acid (CHEBI:33709);peptide (CHEBI:16670)	Fatty amides (FA08);Fatty Acyls (FA)	Amino acids, peptides, and analogues	N-acyl-alpha-amino acid;Triptan;3-alkylindole;Indole;Indole or derivatives;Fatty amide;Substituted pyrrole;Benzenoid;Fatty acyl;Heteroaromatic compound;Pyrrole;Secondary carboxylic acid amide;Carboxamide group;Monocarboxylic acid or derivatives;Organoheterocyclic compound;Carboxylic acid;Azacycle;Hydrocarbon derivative;Carbonyl group;Organooxygen compound;Organonitrogen compound;Organic oxide;Organic oxygen compound;Organic nitrogen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		2-{[3-(1H-indol-3-yl)propanoyl]amino}butanoic acid		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C15H18N2O3	C15H18N2O3			InChI=1S/C15H18N2O3/c1-2-12(15(19)20)17-14(18)8-7-10-9-16-13-6-4-3-5-11(10)13/h3-6,9,12,16H,2,7-8H2,1H3,(H,17,18)(H,19,20)	HHVJPFMSIOVVQZ-UHFFFAOYSA-N	2-[3-(1H-indol-3-yl)propanoylamino]butanoic acid	17585275	CCC(NC(=O)CCc1c[nH]c2ccccc12)C(=O)O	2-[3-(1H-indol-3-yl)propanoylamino]butanoic acid			1.5967699999999998													MCULE-7603241980	274.32231		274.131742	3	3	6	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(17585275)	17585275	2.0	465			[#6]-[#6]-[#6](-[#7]-[#6](=[#8])-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	CCC(NC(=O)CCc1c[nH]c2ccccc12)C(=O)O	HHVJPFMSIOVVQZ		parent_pubchem_cid	2-{[3-(1H-indol-3-yl)propanoyl]amino}butanoic acid;1009553-00-7;STK717293;AKOS004937061;2-[3-(1H-INDOL-3-YL)PROPANAMIDO]BUTANOIC ACID;2-[3-(1H-indol-3-yl)propanoylamino]butanoic acid		24092047.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24092047		pluskal_iocb_peptide_Peptide01_C11_id		100	C11		
3.8		0	1251	P7008316	58.9		L11	False	0	19	0	0	24	0	6	0	0	0		0.0						CC1CC(C)CN(c2nc(Nc3ccccc3)c3cnn(C)c3n2)C1																							0.0		HMS1639L21		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	2		C19H24N6	C19H24N6			InChI=1S/C19H24N6/c1-13-9-14(2)12-25(11-13)19-22-17(21-15-7-5-4-6-8-15)16-10-20-24(3)18(16)23-19/h4-8,10,13-14H,9,11-12H2,1-3H3,(H,21,22,23)	KZTDBJAFXAVOEO-UHFFFAOYSA-N	6-(3,5-dimethyl-1-piperidyl)-1-methyl-N-phenyl-pyrazolo[3,4-d]pyrimidin-4-amine	16456634	CC1CC(C)CN(c2nc(Nc3ccccc3)c3cnn(C)c3n2)C1	6-(3,5-dimethylpiperidin-1-yl)-1-methyl-N-phenylpyrazolo[3,4-d]pyrimidin-4-amine			2.01895													MCULE-5077093620	336.44333		336.206245	5	1	3	4			45										False	Alkaloids	Pseudoalkaloids			Peptide01			Compound(16456634)	16456634	4.2	466			[#6]-[#6]1-[#6]-[#6](-[#6])-[#6]-[#7](-[#6]2:[#7]:[#6](-[#7]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#6]3:[#6]:[#7]:[#7](-[#6]):[#6]:3:[#7]:2)-[#6]-1	CC1CC(C)CN(c2nc(Nc3ccccc3)c3cnn(C)c3n2)C1	KZTDBJAFXAVOEO		parent_pubchem_cid	HMS1639L21;AKOS001548985;AKOS016319024;CCG-170397;6-(3,5-dimethylpiperidin-1-yl)-1-methyl-N-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine;6-(3,5-dimethyl-1-piperidyl)-1-methyl-N-phenyl-pyrazolo[3,4-d]pyrimidin-4-amine		24101309.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24101309		pluskal_iocb_peptide_Peptide01_C11_id		100	C11		
3.8		0	1083	P11568999	75.1		L13	False	0	24	0	0	21	0	3	2	0	0		0.0						O=C(NC(CO)Cc1ccccc1)c1cc(-c2ccccn2)nc2ccccc12																							0.0		AKOS027473887		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C24H21N3O2	C24H21N3O2			InChI=1S/C24H21N3O2/c28-16-18(14-17-8-2-1-3-9-17)26-24(29)20-15-23(22-12-6-7-13-25-22)27-21-11-5-4-10-19(20)21/h1-13,15,18,28H,14,16H2,(H,26,29)/t18-/m0/s1	BXWXZJYUVKDFPR-SFHVURJKSA-N	2-(2-pyridyl)-N-[rac-(1S)-1-benzyl-2-hydroxy-ethyl]quinoline-4-carboxamide	91638832	O=C(N[C@H](CO)Cc1ccccc1)c1cc(-c2ccccn2)nc2ccccc12	N-[(2S)-1-hydroxy-3-phenylpropan-2-yl]-2-pyridin-2-ylquinoline-4-carboxamide			2.71234														383.45387		383.163377	4	2	6	4			45									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(91638832)	91638832	3.4	467			[#8]=[#6](-[#7]-[#6@H](-[#6]-[#8])-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#7]:2):[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	O=C(N[C@H](CO)Cc1ccccc1)c1cc(-c2ccccn2)nc2ccccc12	BXWXZJYUVKDFPR		parent_pubchem_cid	AKOS027473887;2-(2-pyridyl)-N-[rac-(1S)-1-benzyl-2-hydroxy-ethyl]quinoline-4-carboxamide		91947831.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=91947831		pluskal_iocb_peptide_Peptide01_C11_id		100	C11		ZINC000218133432
4.2		0	1171	P1098477	117.7		L14	False	0	26	0	0	24	0	2	6	0	0		0.0						CC(Oc1cc2c(cc1)c1c(CCC1)c(=O)o2)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)O																							0.0		EiM07-17155		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C26H24N2O6	C26H24N2O6			InChI=1S/C26H24N2O6/c1-14(33-16-9-10-19-18-6-4-7-20(18)26(32)34-23(19)12-16)24(29)28-22(25(30)31)11-15-13-27-21-8-3-2-5-17(15)21/h2-3,5,8-10,12-14,22,27H,4,6-7,11H2,1H3,(H,28,29)(H,30,31)/t14?,22-/m0/s1	HLTYOSXGJALPLI-JDMGRSRBSA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[2-[(4-oxo-2,3-dihydro-1H-cyclopenta[c]chromen-7-yl)oxy]propanoylamino]propanoic acid	16399120	CC(Oc1cc2c(cc1)c1c(CCC1)c(=O)o2)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	(2S)-3-(1H-indol-3-yl)-2-[2-[(4-oxo-2,3-dihydro-1H-cyclopenta[c]chromen-7-yl)oxy]propanoylamino]propanoic acid			2.75891														460.49098		460.163436	6	3	7	5			46									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(16399120)	16399120	3.7	468			[#6]-[#6](-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#6]1:[#6](-[#6]-[#6]-[#6]-1):[#6](=[#8]):[#8]:2)-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	CC(Oc1cc2c(cc1)c1c(CCC1)c(=O)o2)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	HLTYOSXGJALPLI		parent_pubchem_cid	EiM07-17155;STK921385;AKOS016376812;N-{2-[(4-oxo-1,2,3,4-tetrahydrocyclopenta[c]chromen-7-yl)oxy]propanoyl}-L-tryptophan;3-(1H-INDOL-3-YL)-2-[2-({4-OXO-1H,2H,3H,4H-CYCLOPENTA[C]CHROMEN-7-YL}OXY)PROPANAMIDO]PROPANOIC ACID;rac-(2S)-3-(1H-indol-3-yl)-2-[2-[(4-oxo-2,3-dihydro-1H-cyclopenta[c]chromen-7-yl)oxy]propanoylamino]propanoic acid		23629135.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23629135		pluskal_iocb_peptide_Peptide01_C11_id		100	C11		
3.8		0	1259	P7008431	71.3		L15	False	0	23	0	0	25	0	7	1	0	0		0.0						COc1ccc(Nc2nc(N3CCN(c4ccccc4)CC3)c3cnn(C)c3n2)cc1																							0.0		AKOS005590717		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	3		C23H25N7O	C23H25N7O			InChI=1S/C23H25N7O/c1-28-21-20(16-24-28)22(27-23(26-21)25-17-8-10-19(31-2)11-9-17)30-14-12-29(13-15-30)18-6-4-3-5-7-18/h3-11,16H,12-15H2,1-2H3,(H,25,26,27)	VSZBNWQABZFXBX-UHFFFAOYSA-N	N-(4-methoxyphenyl)-1-methyl-4-(4-phenylpiperazin-1-yl)pyrazolo[3,4-d]pyrimidin-6-amine	39338200	COc1ccc(Nc2nc(N3CCN(c4ccccc4)CC3)c3cnn(C)c3n2)cc1	N-(4-methoxyphenyl)-1-methyl-4-(4-phenylpiperazin-1-yl)pyrazolo[3,4-d]pyrimidin-6-amine			1.0288300000000004													MCULE-6869223973	415.502		415.212058	7	1	5	5			44										False	Alkaloids				Peptide01			Compound(39338200)	39338200	4.1	469			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#7]-[#6]2:[#7]:[#6]3:[#6](:[#6]:[#7]:[#7]:3-[#6]):[#6](-[#7]3-[#6]-[#6]-[#7](-[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]:4)-[#6]-[#6]-3):[#7]:2):[#6]:[#6]:1	COc1ccc(Nc2nc(N3CCN(c4ccccc4)CC3)c3cnn(C)c3n2)cc1	VSZBNWQABZFXBX		parent_pubchem_cid	AKOS005590717;CCG-313815;N-(4-methoxyphenyl)-1-methyl-4-(4-phenylpiperazin-1-yl)pyrazolo[3,4-d]pyrimidin-6-amine		16517240.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=16517240		pluskal_iocb_peptide_Peptide01_C11_id		100	C11		ZINC000032093431
1.1		0	1091	P11184840	124.7		L17	False	0	17	0	0	20	0	2	5	0	1		0.0						O=C(CC1CCS(=O)(=O)C1)NC(Cc1c[nH]c2ccccc12)C(=O)O																							0.0		AKOS027472506		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	1	0	0	0	0	0	0	0		C17H20N2O5S	C17H20N2O5S			InChI=1S/C17H20N2O5S/c20-16(7-11-5-6-25(23,24)10-11)19-15(17(21)22)8-12-9-18-14-4-2-1-3-13(12)14/h1-4,9,11,15,18H,5-8,10H2,(H,19,20)(H,21,22)/t11?,15-/m0/s1	OOLVASFBVSRBNH-MHTVFEQDSA-N	rac-(2S)-2-[[2-(1,1-dioxothiolan-3-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid	91639586	O=C(CC1CCS(=O)(=O)C1)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	(2S)-2-[[2-(1,1-dioxothiolan-3-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid			0.6214700000000004														364.42335		364.109293	5	3	6	3			46									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(91639586)	91639586	0.3	470			[#8]=[#6](-[#6]-[#6]1-[#6]-[#6]-[#16](=[#8])(=[#8])-[#6]-1)-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	O=C(CC1CCS(=O)(=O)C1)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	OOLVASFBVSRBNH		parent_pubchem_cid	AKOS027472506;Z756449960;(2S)-2-[2-(11-DIOXO-1LAMBDA6-THIOLAN-3-YL)ACETAMIDO]-3-(1H-INDOL-3-YL)PROPANOIC ACID;rac-(2S)-2-[[2-(1,1-dioxothiolan-3-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid		93581510.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=93581510		pluskal_iocb_peptide_Peptide01_C11_id		100	C11		
2.8		0	1179	P1157888	82.2		L18	False	0	17	0	0	14	0	2	3	0	0		0.0						O=C(NC(C(=O)O)c1ccccc1)c1cc2ccccc2[nH]1																							0.0		STL303503		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C17H14N2O3	C17H14N2O3			InChI=1S/C17H14N2O3/c20-16(14-10-12-8-4-5-9-13(12)18-14)19-15(17(21)22)11-6-2-1-3-7-11/h1-10,15,18H,(H,19,20)(H,21,22)/t15-/m0/s1	KQOMEJCJSYLTBW-HNNXBMFYSA-N	rac-(2S)-2-(1H-indole-2-carbonylamino)-2-phenyl-acetic acid	17594272	O=C(N[C@H](C(=O)O)c1ccccc1)c1cc2ccccc2[nH]1	(2S)-2-(1H-indole-2-carbonylamino)-2-phenylacetic acid			2.18576													MCULE-1590930106	294.31273		294.100442	3	3	4	3			44									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(17594272)	17594272	2.9	471			[#8]=[#6](-[#7]-[#6@H](-[#6](=[#8])-[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#7H]:1	O=C(N[C@H](C(=O)O)c1ccccc1)c1cc2ccccc2[nH]1	KQOMEJCJSYLTBW		parent_pubchem_cid	STL303503;AKOS016402221;(2S)-[(1H-indol-2-ylcarbonyl)amino](phenyl)ethanoic acid;rac-(2S)-2-(1H-indole-2-carbonylamino)-2-phenyl-acetic acid		23766830.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23766830		pluskal_iocb_peptide_Peptide01_C11_id		100	C11		ZINC000013681944
3.0		0	1267	P7008527	103.3		L19	False	0	22	0	0	22	0	6	3	0	0		0.0						COc1cc(Nc2nc3nccnc3c(NCc3ccccc3)n2)cc(OC)c1OC																							0.0		{4-[benzylamino]pteridin-2-yl}(3,4,5-trimethoxyphenyl)amine		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0		C22H22N6O3	C22H22N6O3			InChI=1S/C22H22N6O3/c1-29-16-11-15(12-17(30-2)19(16)31-3)26-22-27-20-18(23-9-10-24-20)21(28-22)25-13-14-7-5-4-6-8-14/h4-12H,13H2,1-3H3,(H2,24,25,26,27,28)	BPHFUHVTKQHTAX-UHFFFAOYSA-N	N4-benzyl-N2-(3,4,5-trimethoxyphenyl)pteridine-2,4-diamine	39045466	COc1cc(Nc2nc3nccnc3c(NCc3ccccc3)n2)cc(OC)c1OC	4-N-benzyl-2-N-(3,4,5-trimethoxyphenyl)pteridine-2,4-diamine			0.78911													MCULE-3334714612	418.45904		418.175339	9	2	8	4			43										False	Alkaloids				Peptide01			Compound(39045466)	39045466	3.4	472			[#6]-[#8]-[#6]1:[#6]:[#6](-[#7]-[#6]2:[#7]:[#6]3:[#7]:[#6]:[#6]:[#7]:[#6]:3:[#6](-[#7]-[#6]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#7]:2):[#6]:[#6](-[#8]-[#6]):[#6]:1-[#8]-[#6]	COc1cc(Nc2nc3nccnc3c(NCc3ccccc3)n2)cc(OC)c1OC	BPHFUHVTKQHTAX		parent_pubchem_cid	{4-[benzylamino]pteridin-2-yl}(3,4,5-trimethoxyphenyl)amine;1144497-38-0;STK653053;STL309829;AKOS002337637;AKOS022114626;CCG-305604;Z1013695848;N4-benzyl-N2-(3,4,5-trimethoxyphenyl)pteridine-2,4-diamine;N~4~-benzyl-N~2~-(3,4,5-trimethoxyphenyl)pteridine-2,4-diamine;(2Z)-N-benzyl-2-[(3,4,5-trimethoxyphenyl)imino]-1,2-dihydropteridin-4-amine		4460350.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=4460350		pluskal_iocb_peptide_Peptide01_C12_id		100	C12		ZINC000031818339
2.8		0	1099	P1157886	82.2		L21	False	0	15	0	0	18	0	2	3	0	0		0.0						CC(C)CC(NC(=O)c1cc2ccccc2[nH]1)C(=O)O																							0.0		AKOS010399590		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C15H18N2O3	C15H18N2O3			InChI=1S/C15H18N2O3/c1-9(2)7-13(15(19)20)17-14(18)12-8-10-5-3-4-6-11(10)16-12/h3-6,8-9,13,16H,7H2,1-2H3,(H,17,18)(H,19,20)/t13-/m0/s1	GFQBYYGAPDAZKA-ZDUSSCGKSA-N	rac-(2S)-2-(1H-indole-2-carbonylamino)-4-methyl-pentanoic acid	16409323	CC(C)C[C@H](NC(=O)c1cc2ccccc2[nH]1)C(=O)O	(2S)-2-(1H-indole-2-carbonylamino)-4-methylpentanoic acid			1.91387													MCULE-5460025892	274.32231		274.131742	3	3	5	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(16409323)	16409323	3.4	473			[#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#7H]:1)-[#6](=[#8])-[#8]	CC(C)C[C@H](NC(=O)c1cc2ccccc2[nH]1)C(=O)O	GFQBYYGAPDAZKA		parent_pubchem_cid	AKOS010399590;2-[(1H-INDOL-2-YL)FORMAMIDO]-4-METHYLPENTANOIC ACID;rac-(2S)-2-(1H-indole-2-carbonylamino)-4-methyl-pentanoic acid		24766067.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24766067		pluskal_iocb_peptide_Peptide01_C12_id		100	C12		ZINC000008765243
2.4		0	1187	P1157637	115.8		L22	False	0	19	0	0	25	0	3	5	0	0		0.0						CCC(C)C(NC(=O)C(C(C)C)n1c(=O)[nH]c2ccccc2c1=O)C(=O)O																							0.0		EiM07-17671		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	4	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0		C19H25N3O5	C19H25N3O5			InChI=1S/C19H25N3O5/c1-5-11(4)14(18(25)26)21-16(23)15(10(2)3)22-17(24)12-8-6-7-9-13(12)20-19(22)27/h6-11,14-15H,5H2,1-4H3,(H,20,27)(H,21,23)(H,25,26)/t11-,14+,15+/m1/s1	OGVIIIBTINXGHG-UGFHNGPFSA-N	rac-(2S,3R)-3-methyl-2-[[rac-(2S)-2-(2,4-dioxo-1H-quinazolin-3-yl)-3-methyl-butanoyl]amino]pentanoic acid	1787108	CC[C@@H](C)[C@H](NC(=O)[C@H](C(C)C)n1c(=O)[nH]c2ccccc2c1=O)C(=O)O	(2S,3R)-2-[[(2S)-2-(2,4-dioxo-1H-quinazolin-3-yl)-3-methylbutanoyl]amino]-3-methylpentanoic acid			2.8737600000000008													MCULE-9649902985	375.4282		375.179421	5	3	7	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(1787108)	1787108	2.7	474			[#6]-[#6]-[#6@@H](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#6@H](-[#6](-[#6])-[#6])-[#7]1:[#6](=[#8]):[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8])-[#6](=[#8])-[#8]	CC[C@@H](C)[C@H](NC(=O)[C@H](C(C)C)n1c(=O)[nH]c2ccccc2c1=O)C(=O)O	OGVIIIBTINXGHG		parent_pubchem_cid	EiM07-17671;STL461263;AKOS016376522;N-[(2S)-2-(2,4-dioxo-1,4-dihydroquinazolin-3(2H)-yl)-3-methylbutanoyl]-L-isoleucine;rac-(2S,3R)-3-methyl-2-[[rac-(2S)-2-(2,4-dioxo-1H-quinazolin-3-yl)-3-methyl-butanoyl]amino]pentanoic acid		23439106.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23439106		pluskal_iocb_peptide_Peptide01_C12_id		100	C12		ZINC000002131608
1.7		0	1275	P11186109	119.0		L23	False	0	17	0	0	24	0	2	5	0	1		0.0						COC(=O)C(C)NC(=O)C(CCSC)NC(=O)OCc1ccccc1																							0.0		AKOS027473376		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	2	0	0	0	0	0	0	1	0	3	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C17H24N2O5S	C17H24N2O5S			InChI=1S/C17H24N2O5S/c1-12(16(21)23-2)18-15(20)14(9-10-25-3)19-17(22)24-11-13-7-5-4-6-8-13/h4-8,12,14H,9-11H2,1-3H3,(H,18,20)(H,19,22)	QKUUEZGMKRKEON-UHFFFAOYSA-N	methyl 2-[[2-(benzyloxycarbonylamino)-4-methylsulfanyl-butanoyl]amino]propanoate	4167047	COC(=O)C(C)NC(=O)C(CCSC)NC(=O)OCc1ccccc1	methyl 2-[[4-methylsulfanyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]propanoate			1.6574899999999988														368.45523		368.140593	6	2	11	1			46									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(4167047)	4167047	2.1	475			[#6]-[#8]-[#6](=[#8])-[#6](-[#6])-[#7]-[#6](=[#8])-[#6](-[#6]-[#6]-[#16]-[#6])-[#7]-[#6](=[#8])-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	COC(=O)C(C)NC(=O)C(CCSC)NC(=O)OCc1ccccc1	QKUUEZGMKRKEON		parent_pubchem_cid	AKOS027473376;methyl 2-[[2-(benzyloxycarbonylamino)-4-methylsulfanyl-butanoyl]amino]propanoate		50897112.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=50897112		pluskal_iocb_peptide_Peptide01_C12_id		100	C12		
4.7		0	1107	P1098524	117.7		L25	False	0	27	0	0	26	0	2	6	0	0		0.0						Cc1cc2c(c(OC(C)C(=O)NC(Cc3c[nH]c4ccccc34)C(=O)O)c1)c1c(CCC1)c(=O)o2																							0.0		EiM07-17202		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C27H26N2O6	C27H26N2O6			InChI=1S/C27H26N2O6/c1-14-10-22(24-18-7-5-8-19(18)27(33)35-23(24)11-14)34-15(2)25(30)29-21(26(31)32)12-16-13-28-20-9-4-3-6-17(16)20/h3-4,6,9-11,13,15,21,28H,5,7-8,12H2,1-2H3,(H,29,30)(H,31,32)/t15?,21-/m0/s1	DDVBTUDDYVURFL-FXMQYSIJSA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[2-[(7-methyl-4-oxo-2,3-dihydro-1H-cyclopenta[c]chromen-9-yl)oxy]propanoylamino]propanoic acid	16401400	Cc1cc2c(c(OC(C)C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)O)c1)c1c(CCC1)c(=O)o2	(2S)-3-(1H-indol-3-yl)-2-[2-[(7-methyl-4-oxo-2,3-dihydro-1H-cyclopenta[c]chromen-9-yl)oxy]propanoylamino]propanoic acid			3.012620000000001														474.51807		474.179087	6	3	7	5			46									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(16401400)	16401400	4.1	476			[#6]-[#6]1:[#6]:[#6]2:[#6](:[#6](-[#8]-[#6](-[#6])-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]3:[#6]:[#7H]:[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]:3:4)-[#6](=[#8])-[#8]):[#6]:1):[#6]1:[#6](-[#6]-[#6]-[#6]-1):[#6](=[#8]):[#8]:2	Cc1cc2c(c(OC(C)C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)O)c1)c1c(CCC1)c(=O)o2	DDVBTUDDYVURFL		parent_pubchem_cid	EiM07-17202;AKOS016391140;3-(1H-INDOL-3-YL)-2-[2-({7-METHYL-4-OXO-1H,2H,3H,4H-CYCLOPENTA[C]CHROMEN-9-YL}OXY)PROPANAMIDO]PROPANOIC ACID;rac-(2S)-3-(1H-indol-3-yl)-2-[2-[(7-methyl-4-oxo-2,3-dihydro-1H-cyclopenta[c]chromen-9-yl)oxy]propanoylamino]propanoic acid		24172606.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24172606		pluskal_iocb_peptide_Peptide01_C12_id		100	C12		
4.5		0	1195	P1098418	101.9		L26	False	0	25	0	0	27	0	1	6	0	0		0.0						Cc1c(Cc2ccccc2)c(=O)oc2c1ccc(OCC(=O)NC(CC(C)C)C(=O)O)c2								N-acyl-L-alpha-amino acids;Coumarins and derivatives;1-benzopyrans;Pyranones and derivatives;Alkyl aryl ethers;Benzene and substituted derivatives;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactones;Oxacyclic compounds;Carboxylic acids;Monocarboxylic acids and derivatives;Organopnictogen compounds;Carbonyl compounds;Organic oxides;Organonitrogen compounds;Hydrocarbon derivatives	1-benzopyrans;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Benzene and substituted derivatives;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Lactones;Leucine and derivatives;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Secondary carboxylic acid amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as leucine and derivatives. These are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Leucine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-L-alpha-amino acid (CHEBI:48927);coumarins (CHEBI:23403);1-benzopyran (CHEBI:38443);pyranone (CHEBI:37963);aromatic ether (CHEBI:35618);benzenes (CHEBI:22712);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactone (CHEBI:25000);oxacycle (CHEBI:38104);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);carbonyl compound (CHEBI:36586);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);organic molecule (CHEBI:72695);leucine derivative (CHEBI:47003);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);amino acid (CHEBI:33709);peptide (CHEBI:16670);N-acyl-amino acid (CHEBI:51569);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);pyrans (CHEBI:26407);oxygen molecular entity (CHEBI:25806);ether (CHEBI:25698);benzenoid aromatic compound (CHEBI:33836);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)	Benzopyranoids (PK1311)	Amino acids, peptides, and analogues	Leucine or derivatives;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;N-acyl-l-alpha-amino acid;Coumarin;Benzopyran;1-benzopyran;Alkyl aryl ether;Pyranone;Benzenoid;Monocyclic benzene moiety;Pyran;Heteroaromatic compound;Secondary carboxylic acid amide;Carboxamide group;Lactone;Organoheterocyclic compound;Oxacycle;Carboxylic acid;Ether;Monocarboxylic acid or derivatives;Organic nitrogen compound;Organic oxygen compound;Hydrocarbon derivative;Organooxygen compound;Carbonyl group;Organopnictogen compound;Organic oxide;Organonitrogen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		EiM07-17096		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C25H27NO6	C25H27NO6			InChI=1S/C25H27NO6/c1-15(2)11-21(24(28)29)26-23(27)14-31-18-9-10-19-16(3)20(25(30)32-22(19)13-18)12-17-7-5-4-6-8-17/h4-10,13,15,21H,11-12,14H2,1-3H3,(H,26,27)(H,28,29)/t21-/m0/s1	WNSZRLFJPMFMRV-NRFANRHFSA-N	rac-(2S)-2-[[2-(3-benzyl-4-methyl-2-oxo-chromen-7-yl)oxyacetyl]amino]-4-methyl-pentanoic acid	1748565	Cc1c(Cc2ccccc2)c(=O)oc2c1ccc(OCC(=O)N[C@@H](CC(C)C)C(=O)O)c2	(2S)-2-[[2-(3-benzyl-4-methyl-2-oxochromen-7-yl)oxyacetyl]amino]-4-methylpentanoic acid			3.531450000000002													MCULE-2884634079	437.49704		437.183838	6	2	9	3			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(1748565)	1748565	4.4	477			[#6]-[#6]1:[#6](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=[#8])-[#8]):[#6]:2	Cc1c(Cc2ccccc2)c(=O)oc2c1ccc(OCC(=O)N[C@@H](CC(C)C)C(=O)O)c2	WNSZRLFJPMFMRV		parent_pubchem_cid	EiM07-17096;N-{[(3-benzyl-4-methyl-2-oxo-2H-chromen-7-yl)oxy]acetyl}-L-leucine;AKOS004937607;rac-(2S)-2-[[2-(3-benzyl-4-methyl-2-oxo-chromen-7-yl)oxyacetyl]amino]-4-methyl-pentanoic acid		24772323.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24772323		pluskal_iocb_peptide_Peptide01_C12_id		100	C12		ZINC000002091528
1.9		0	1283	P11570044	98.3		L27	False	0	21	0	0	22	0	4	3	0	0		0.0						O=C(NC(CO)Cc1ccccc1)C1CC(=O)N(c2n[nH]c3ccccc23)C1																							0.0		AKOS027474764		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	1	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C21H22N4O3	C21H22N4O3			InChI=1S/C21H22N4O3/c26-13-16(10-14-6-2-1-3-7-14)22-21(28)15-11-19(27)25(12-15)20-17-8-4-5-9-18(17)23-24-20/h1-9,15-16,26H,10-13H2,(H,22,28)(H,23,24)/t15?,16-/m0/s1	KNHMEPIOZGNWKQ-LYKKTTPLSA-N	1-(1H-indazol-3-yl)-5-oxo-N-[rac-(1S)-1-benzyl-2-hydroxy-ethyl]pyrrolidine-3-carboxamide	110204731	O=C(N[C@H](CO)Cc1ccccc1)C1CC(=O)N(c2n[nH]c3ccccc23)C1	N-[(2S)-1-hydroxy-3-phenylpropan-2-yl]-1-(1H-indazol-3-yl)-5-oxopyrrolidine-3-carboxamide			0.7718599999999993														378.43449		378.169191	4	3	6	4			46										False	Alkaloids				Peptide01			Compound(110204731)	110204731	1.6	478			[#8]=[#6](-[#7]-[#6@H](-[#6]-[#8])-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1-[#6]-[#6](=[#8])-[#7](-[#6]2:[#7]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6]-1	O=C(N[C@H](CO)Cc1ccccc1)C1CC(=O)N(c2n[nH]c3ccccc23)C1	KNHMEPIOZGNWKQ		parent_pubchem_cid	AKOS027474764;N-[(2S)-1-HYDROXY-3-PHENYLPROPAN-2-YL]-1-(1H-INDAZOL-3-YL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE;1-(1H-indazol-3-yl)-5-oxo-N-[rac-(1S)-1-benzyl-2-hydroxy-ethyl]pyrrolidine-3-carboxamide		117132942.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=117132942		pluskal_iocb_peptide_Peptide01_C12_id		100	C12		
3.4		0	1115	P1098316	139.2		L29	False	0	22	0	0	27	0	1	8	0	0		0.0						CCCCc1cc(=O)oc2c1ccc(OC(C)C(=O)NC(CCC(=O)O)C(=O)O)c2C																							0.0		EiM07-16994		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	3	2	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C22H27NO8	C22H27NO8			InChI=1S/C22H27NO8/c1-4-5-6-14-11-19(26)31-20-12(2)17(9-7-15(14)20)30-13(3)21(27)23-16(22(28)29)8-10-18(24)25/h7,9,11,13,16H,4-6,8,10H2,1-3H3,(H,23,27)(H,24,25)(H,28,29)/t13?,16-/m0/s1	AHEAWSJEHSANGR-VYIIXAMBSA-N	rac-(2S)-2-[2-(4-butyl-8-methyl-2-oxo-chromen-7-yl)oxypropanoylamino]pentanedioic acid	16401274	CCCCc1cc(=O)oc2c1ccc(OC(C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)c2C	(2S)-2-[2-(4-butyl-8-methyl-2-oxochromen-7-yl)oxypropanoylamino]pentanedioic acid			2.54516														433.46239		433.173667	8	3	11	2			46									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(16401274)	16401274	2.9	479			[#6]-[#6]-[#6]-[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6](-[#6])-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]-[#6](=[#8])-[#8])-[#6](=[#8])-[#8]):[#6]:2-[#6]	CCCCc1cc(=O)oc2c1ccc(OC(C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)c2C	AHEAWSJEHSANGR		parent_pubchem_cid	EiM07-16994;AKOS016390286;(2S)-2-({2-[(4-butyl-8-methyl-2-oxo-2H-chromen-7-yl)oxy]propanoyl}amino)pentanedioic acid;rac-(2S)-2-[2-(4-butyl-8-methyl-2-oxo-chromen-7-yl)oxypropanoylamino]pentanedioic acid		24271815.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24271815		pluskal_iocb_peptide_Peptide01_C12_id		100	C12		
3.8		0	1203	P7564308	59.1		L30	False	0	23	0	1	24	0	3	2	0	0		0.0						COCCn1cc(CC(=O)NCCc2c[nH]c3c2cc(F)cc3)c2ccccc21																							0.0		N-[2-(5-fluoro-1H-indol-3-yl)ethyl]-2-[1-(2-methoxyethyl)-1H-indol-3-yl]acetamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C23H24FN3O2	C23H24FN3O2			InChI=1S/C23H24FN3O2/c1-29-11-10-27-15-17(19-4-2-3-5-22(19)27)12-23(28)25-9-8-16-14-26-21-7-6-18(24)13-20(16)21/h2-7,13-15,26H,8-12H2,1H3,(H,25,28)	CTAAJJIGPCVNTE-UHFFFAOYSA-N	N-[2-(5-fluoro-1H-indol-3-yl)ethyl]-2-[1-(2-methoxyethyl)indol-3-yl]acetamide	60177004	COCCn1cc(CC(=O)NCCc2c[nH]c3c2cc(F)cc3)c2ccccc21	N-[2-(5-fluoro-1H-indol-3-yl)ethyl]-2-[1-(2-methoxyethyl)indol-3-yl]acetamide			2.843240000000001													MCULE-2697285987	393.46503		393.185255	2	2	8	4			44									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(60177004)	60177004	3.2	480			[#6]-[#8]-[#6]-[#6]-[#7]1:[#6]:[#6](-[#6]-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:2:[#6]:[#6](-[#9]):[#6]:[#6]:3):[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	COCCn1cc(CC(=O)NCCc2c[nH]c3c2cc(F)cc3)c2ccccc21	CTAAJJIGPCVNTE		parent_pubchem_cid	N-[2-(5-fluoro-1H-indol-3-yl)ethyl]-2-[1-(2-methoxyethyl)-1H-indol-3-yl]acetamide;1401586-93-3;EiM08-26868;AKOS025143805;N-[2-(5-fluoro-1H-indol-3-yl)ethyl]-2-[1-(2-methoxyethyl)indol-3-yl]acetamide		60057226.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=60057226		pluskal_iocb_peptide_Peptide01_C13_id		100	C13		ZINC000079480820
2.4		0	1291	P11570305	67.2		L31	False	0	17	0	0	29	0	3	2	0	0		0.0						C=C(C)Cc1c(C)n(CCC(=O)NC(CO)C(C)C)nc1C																							0.0		AKOS032419688		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C17H29N3O2	C17H29N3O2			InChI=1S/C17H29N3O2/c1-11(2)9-15-13(5)19-20(14(15)6)8-7-17(22)18-16(10-21)12(3)4/h12,16,21H,1,7-10H2,2-6H3,(H,18,22)/t16-/m1/s1	NOOHMWPNIJEMBW-MRXNPFEDSA-N	3-[3,5-dimethyl-4-(2-methylallyl)pyrazol-1-yl]-N-[1-(hydroxymethyl)-2-methyl-propyl]propanamide	91639788	C=C(C)Cc1c(C)n(CCC(=O)N[C@H](CO)C(C)C)nc1C	3-[3,5-dimethyl-4-(2-methylprop-2-enyl)pyrazol-1-yl]-N-[(2S)-1-hydroxy-3-methylbutan-2-yl]propanamide			1.97761														307.43958		307.225977	3	2	8	1			45									Simple amide alkaloids	False	Alkaloids	Peptide alkaloids			Peptide01			Compound(91639788)	91639788	2.6	481			[#6]=[#6](-[#6])-[#6]-[#6]1:[#6](-[#6]):[#7](-[#6]-[#6]-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#8])-[#6](-[#6])-[#6]):[#7]:[#6]:1-[#6]	C=C(C)Cc1c(C)n(CCC(=O)N[C@H](CO)C(C)C)nc1C	NOOHMWPNIJEMBW		parent_pubchem_cid	AKOS032419688;3-[3,5-DIMETHYL-4-(2-METHYLALLYL)-1H-PYRAZOL-1-YL]-N-[(1S)-1-(HYDROXYMETHYL)-2-METHYLPROPYL]PROPANAMIDE;3-[3,5-dimethyl-4-(2-methylallyl)pyrazol-1-yl]-N-[1-(hydroxymethyl)-2-methyl-propyl]propanamide		95702459.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=95702459		pluskal_iocb_peptide_Peptide01_C13_id		100	C13		ZINC000218253825
4.8		0	1123	P1098297	101.9		L33	False	0	25	0	0	27	0	1	6	0	0		0.0						CCCCc1cc(=O)oc2c1ccc(OCC(=O)NC(Cc1ccccc1)C(=O)O)c2C								N-acyl-L-alpha-amino acids;Phenylpropanoic acids;Coumarins and derivatives;1-benzopyrans;Amphetamines and derivatives;Pyranones and derivatives;Alkyl aryl ethers;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactones;Oxacyclic compounds;Carboxylic acids;Monocarboxylic acids and derivatives;Organopnictogen compounds;Carbonyl compounds;Organic oxides;Organonitrogen compounds;Hydrocarbon derivatives	1-benzopyrans;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Benzene and substituted derivatives;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Lactones;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenethylamines;Phenylalanine and derivatives;Phenylpropanoic acids;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Secondary carboxylic acid amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-L-alpha-amino acid (CHEBI:48927);benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);coumarins (CHEBI:23403);1-benzopyran (CHEBI:38443);amphetamines (CHEBI:35338);pyranone (CHEBI:37963);aromatic ether (CHEBI:35618);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactone (CHEBI:25000);oxacycle (CHEBI:38104);carboxylic acid anion (CHEBI:29067);carbonyl compound (CHEBI:36586);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);organic molecule (CHEBI:72695);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);amino acid (CHEBI:33709);peptide (CHEBI:16670);N-acyl-amino acid (CHEBI:51569);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);benzenoid aromatic compound (CHEBI:33836);primary amine (CHEBI:32877);pyrans (CHEBI:26407);oxygen molecular entity (CHEBI:25806);ether (CHEBI:25698);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)	Benzopyranoids (PK1311)	Amino acids, peptides, and analogues	Phenylalanine or derivatives;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;N-acyl-l-alpha-amino acid;Coumarin;3-phenylpropanoic-acid;Benzopyran;1-benzopyran;Amphetamine or derivatives;Alkyl aryl ether;Pyranone;Monocyclic benzene moiety;Benzenoid;Pyran;Heteroaromatic compound;Carboxamide group;Lactone;Secondary carboxylic acid amide;Monocarboxylic acid or derivatives;Ether;Organoheterocyclic compound;Carboxylic acid;Oxacycle;Organic oxygen compound;Organic nitrogen compound;Hydrocarbon derivative;Organic oxide;Carbonyl group;Organopnictogen compound;Organonitrogen compound;Organooxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		EiM07-16975		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C25H27NO6	C25H27NO6			InChI=1S/C25H27NO6/c1-3-4-10-18-14-23(28)32-24-16(2)21(12-11-19(18)24)31-15-22(27)26-20(25(29)30)13-17-8-6-5-7-9-17/h5-9,11-12,14,20H,3-4,10,13,15H2,1-2H3,(H,26,27)(H,29,30)/t20-/m0/s1	JCUJHHAQRQYQRF-FQEVSTJZSA-N	rac-(2S)-2-[[2-(4-butyl-8-methyl-2-oxo-chromen-7-yl)oxyacetyl]amino]-3-phenyl-propanoic acid	1761212	CCCCc1cc(=O)oc2c1ccc(OCC(=O)N[C@@H](Cc1ccccc1)C(=O)O)c2C	(2S)-2-[[2-(4-butyl-8-methyl-2-oxochromen-7-yl)oxyacetyl]amino]-3-phenylpropanoic acid			3.4798500000000017													MCULE-1176978453	437.49704		437.183838	6	2	10	3			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(1761212)	1761212	4.6	482			[#6]-[#6]-[#6]-[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]):[#6]:2-[#6]	CCCCc1cc(=O)oc2c1ccc(OCC(=O)N[C@@H](Cc1ccccc1)C(=O)O)c2C	JCUJHHAQRQYQRF		parent_pubchem_cid	EiM07-16975;AKOS016390306;2-{2-[(4-BUTYL-8-METHYL-2-OXO-2H-CHROMEN-7-YL)OXY]ACETAMIDO}-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[[2-(4-butyl-8-methyl-2-oxo-chromen-7-yl)oxyacetyl]amino]-3-phenyl-propanoic acid		24136525.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24136525		pluskal_iocb_peptide_Peptide01_C13_id		100	C13		ZINC000002106217
3.5		0	1211	P6238554	85.9		L34	False	0	25	0	0	24	0	2	5	0	0		0.0						COc1cccc(NC(=O)C(Cc2ccccc2)NC(=O)C2COc3ccccc3O2)c1																							0.0		EiM08-08788		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C25H24N2O5	C25H24N2O5			InChI=1S/C25H24N2O5/c1-30-19-11-7-10-18(15-19)26-24(28)20(14-17-8-3-2-4-9-17)27-25(29)23-16-31-21-12-5-6-13-22(21)32-23/h2-13,15,20,23H,14,16H2,1H3,(H,26,28)(H,27,29)/t20-,23?/m1/s1	DQXJADTXIVEWRC-PPUHSXQSSA-N	N-[rac-(1R)-1-benzyl-2-(3-methoxyanilino)-2-oxo-ethyl]-2,3-dihydro-1,4-benzodioxine-3-carboxamide	75366500	COc1cccc(NC(=O)[C@@H](Cc2ccccc2)NC(=O)C2COc3ccccc3O2)c1	N-[(2R)-1-(3-methoxyanilino)-1-oxo-3-phenylpropan-2-yl]-2,3-dihydro-1,4-benzodioxine-3-carboxamide			1.3786499999999993														432.48043		432.168522	5	2	7	4			46										False	Shikimates and Phenylpropanoids				Peptide01			Compound(75366500)	75366500	3.9	483			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6](-[#7]-[#6](=[#8])-[#6@@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#7]-[#6](=[#8])-[#6]2-[#6]-[#8]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3-[#8]-2):[#6]:1	COc1cccc(NC(=O)[C@@H](Cc2ccccc2)NC(=O)C2COc3ccccc3O2)c1	DQXJADTXIVEWRC		parent_pubchem_cid	EiM08-08788;AKOS016383497;2-[(2,3-DIHYDRO-1,4-BENZODIOXIN-2-YL)FORMAMIDO]-N-(3-METHOXYPHENYL)-3-PHENYLPROPANAMIDE;N-[rac-(1R)-1-benzyl-2-(3-methoxyanilino)-2-oxo-ethyl]-2,3-dihydro-1,4-benzodioxine-3-carboxamide		80293209.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=80293209		pluskal_iocb_peptide_Peptide01_C13_id		100	C13		
3.7		0	1131	P1099219	86.7		L37	False	0	24	0	0	20	0	2	4	0	0		0.0						O=C(Cn1c2ccccc2c(=O)c2ccccc21)NC(Cc1ccccc1)C(=O)O																							0.0		N-[(9-oxoacridin-10(9H)-yl)acetyl]-L-phenylalanine		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C24H20N2O4	C24H20N2O4			InChI=1S/C24H20N2O4/c27-22(25-19(24(29)30)14-16-8-2-1-3-9-16)15-26-20-12-6-4-10-17(20)23(28)18-11-5-7-13-21(18)26/h1-13,19H,14-15H2,(H,25,27)(H,29,30)/t19-/m0/s1	PZZULHSTTMZVJE-IBGZPJMESA-N	rac-(2S)-2-[[2-(9-oxoacridin-10-yl)acetyl]amino]-3-phenyl-propanoic acid	16426275	O=C(Cn1c2ccccc2c(=O)c2ccccc21)N[C@@H](Cc1ccccc1)C(=O)O	(2S)-2-[[2-(9-oxoacridin-10-yl)acetyl]amino]-3-phenylpropanoic acid			2.955140000000001													MCULE-4241592288	400.438		400.142307	5	2	6	4			44									Acridone alkaloids	False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(16426275)	16426275	4.0	484			[#8]=[#6](-[#6]-[#7]1:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6](=[#8]):[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	O=C(Cn1c2ccccc2c(=O)c2ccccc21)N[C@@H](Cc1ccccc1)C(=O)O	PZZULHSTTMZVJE		parent_pubchem_cid	N-[(9-oxoacridin-10(9H)-yl)acetyl]-L-phenylalanine;AKOS005533873;rac-(2S)-2-[[2-(9-oxoacridin-10-yl)acetyl]amino]-3-phenyl-propanoic acid		24603664.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24603664		pluskal_iocb_peptide_Peptide01_C13_id		100	C13		ZINC000006673285
4.2		0	1219	P7119831898	131.6		L38	False	0	16	0	0	21	0	3	2	0	2		0.0						CCCCc1ccc(CC(Sc2nnc(N)s2)C(=O)OC)cc1																							0.0		899942-25-7		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	1	0	2	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0		C16H21N3O2S2	C16H21N3O2S2			InChI=1S/C16H21N3O2S2/c1-3-4-5-11-6-8-12(9-7-11)10-13(14(20)21-2)22-16-19-18-15(17)23-16/h6-9,13H,3-5,10H2,1-2H3,(H2,17,18)	IXSPMOGEDUGEAW-UHFFFAOYSA-N	methyl 2-[(5-amino-1,3,4-thiadiazol-2-yl)sulfanyl]-3-(4-butylphenyl)propanoate	17014956	CCCCc1ccc(CC(Sc2nnc(N)s2)C(=O)OC)cc1	methyl 2-[(5-amino-1,3,4-thiadiazol-2-yl)sulfanyl]-3-(4-butylphenyl)propanoate			2.7412600000000014													MCULE-4777765498	351.49267		351.107519	6	1	9	2			44										False	Alkaloids				Peptide01			Compound(17014956)	17014956	4.7	485			[#6]-[#6]-[#6]-[#6]-[#6]1:[#6]:[#6]:[#6](-[#6]-[#6](-[#16]-[#6]2:[#7]:[#7]:[#6](-[#7]):[#16]:2)-[#6](=[#8])-[#8]-[#6]):[#6]:[#6]:1	CCCCc1ccc(CC(Sc2nnc(N)s2)C(=O)OC)cc1	IXSPMOGEDUGEAW		parent_pubchem_cid	899942-25-7;methyl 2-((5-amino-1,3,4-thiadiazol-2-yl)thio)-3-(4-butylphenyl)propanoate;methyl 2-[(5-amino-1,3,4-thiadiazol-2-yl)sulfanyl]-3-(4-butylphenyl)propanoate;STL017880;AKOS002324923;AKOS016326608;VU0510822-1;F3159-0013		24604839.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24604839		pluskal_iocb_peptide_Peptide01_C13_id		100	C13		
3.2		0	1139	P1098681	131.0		L41	False	0	27	0	0	28	0	2	7	0	0		0.0						Cc1c2oc(=O)c3c(CCC3)c2ccc1OCC(=O)NC(Cc1ccccc1)C(=O)NCCC(=O)O																							0.0		EiM07-17364		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C27H28N2O7	C27H28N2O7			InChI=1S/C27H28N2O7/c1-16-22(11-10-19-18-8-5-9-20(18)27(34)36-25(16)19)35-15-23(30)29-21(14-17-6-3-2-4-7-17)26(33)28-13-12-24(31)32/h2-4,6-7,10-11,21H,5,8-9,12-15H2,1H3,(H,28,33)(H,29,30)(H,31,32)/t21-/m0/s1	CBJUDMBHDIJUTC-NRFANRHFSA-N	3-[[rac-(2S)-2-[[2-[(6-methyl-4-oxo-2,3-dihydro-1H-cyclopenta[c]chromen-7-yl)oxy]acetyl]amino]-3-phenyl-propanoyl]amino]propanoic acid	24279909	Cc1c2oc(=O)c3c(CCC3)c2ccc1OCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCCC(=O)O	3-[[(2S)-2-[[2-[(6-methyl-4-oxo-2,3-dihydro-1H-cyclopenta[c]chromen-7-yl)oxy]acetyl]amino]-3-phenylpropanoyl]amino]propanoic acid			2.0775399999999995													MCULE-5418500876	492.53341		492.189651	7	3	10	4			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(24279909)	24279909	2.8	486			[#6]-[#6]1:[#6]2:[#8]:[#6](=[#8]):[#6]3:[#6](-[#6]-[#6]-[#6]-3):[#6]:2:[#6]:[#6]:[#6]:1-[#8]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#7]-[#6]-[#6]-[#6](=[#8])-[#8]	Cc1c2oc(=O)c3c(CCC3)c2ccc1OCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCCC(=O)O	CBJUDMBHDIJUTC		parent_pubchem_cid	EiM07-17364;AKOS016390333;3-{2-[2-({6-METHYL-4-OXO-1H,2H,3H,4H-CYCLOPENTA[C]CHROMEN-7-YL}OXY)ACETAMIDO]-3-PHENYLPROPANAMIDO}PROPANOIC ACID;3-[[rac-(2S)-2-[[2-[(6-methyl-4-oxo-2,3-dihydro-1H-cyclopenta[c]chromen-7-yl)oxy]acetyl]amino]-3-phenyl-propanoyl]amino]propanoic acid		23094115.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23094115		pluskal_iocb_peptide_Peptide01_C13_id		100	C13		ZINC000011866869
4.6		0	1227	P1105682	99.7		L42	False	0	24	0	0	21	0	3	4	0	0		0.0						COc1ccc(Oc2cnc(N)nc2-c2c(O)cc(OCc3ccccc3)cc2)cc1								Diarylethers;Phenoxy compounds;Methoxybenzenes;Anisoles;Aminopyrimidines and derivatives;Alkyl aryl ethers;1-hydroxy-4-unsubstituted benzenoids;1-hydroxy-2-unsubstituted benzenoids;Heteroaromatic compounds;Azacyclic compounds;Primary amines;Organopnictogen compounds;Hydrocarbon derivatives	1-hydroxy-2-unsubstituted benzenoids;1-hydroxy-4-unsubstituted benzenoids;Alkyl aryl ethers;Amines;Aminopyrimidines and derivatives;Anisoles;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Chemical entities;Diarylethers;Diazines;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Methoxybenzenes;Organic compounds;Organic nitrogen compounds;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenol ethers;Phenols;Phenoxy compounds;Phenylpyrimidines;Primary amines;Pyrimidines and pyrimidine derivatives	Diazines	2.1	This compound belongs to the class of organic compounds known as phenylpyrimidines. These are polycyclic aromatic compounds containing a benzene ring linked to a pyrimidine ring through a CC or CN bond.  Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions.	Phenylpyrimidines			Organic compounds	Aromatic heteromonocyclic compounds	aromatic ether (CHEBI:35618);benzenes (CHEBI:22712);methoxybenzene (CHEBI:51683);aminopyrimidine (CHEBI:38338);phenols (CHEBI:33853);organic aromatic compound (CHEBI:33659);organonitrogen heterocyclic compound (CHEBI:38101);primary amine (CHEBI:32877);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organic molecule (CHEBI:72695);pyrimidines (CHEBI:39447);chemical entity (CHEBI:24431);oxygen molecular entity (CHEBI:25806);organooxygen compound (CHEBI:36963);ether (CHEBI:25698);benzenoid aromatic compound (CHEBI:33836);organic heterocyclic compound (CHEBI:24532);diazines (CHEBI:38313);nitrogen molecular entity (CHEBI:51143);organonitrogen compound (CHEBI:35352);amine (CHEBI:32952)		Pyrimidines and pyrimidine derivatives	4-phenylpyrimidine;5-phenylpyrimidine;Diaryl ether;Anisole;Phenol ether;Phenoxy compound;Methoxybenzene;1-hydroxy-4-unsubstituted benzenoid;Aminopyrimidine;1-hydroxy-2-unsubstituted benzenoid;Alkyl aryl ether;Phenol;Monocyclic benzene moiety;Benzenoid;Heteroaromatic compound;Ether;Azacycle;Organopnictogen compound;Organic nitrogen compound;Organic oxygen compound;Organooxygen compound;Organonitrogen compound;Amine;Primary amine;Hydrocarbon derivative;Aromatic heteromonocyclic compound	Organoheterocyclic compounds	0.0		877791-16-7		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0		C24H21N3O4	C24H21N3O4			InChI=1S/C24H21N3O4/c1-29-17-7-9-18(10-8-17)31-22-14-26-24(25)27-23(22)20-12-11-19(13-21(20)28)30-15-16-5-3-2-4-6-16/h2-14,28H,15H2,1H3,(H2,25,26,27)	WRMMNPNZPPOAGF-UHFFFAOYSA-N	2-[2-amino-5-(4-methoxyphenoxy)pyrimidin-4-yl]-5-benzyloxy-phenol	3777454	COc1ccc(Oc2cnc(N)nc2-c2c(O)cc(OCc3ccccc3)cc2)cc1	2-[2-amino-5-(4-methoxyphenoxy)pyrimidin-4-yl]-5-phenylmethoxyphenol			1.6839099999999998													MCULE-1654918721	415.45267		415.153206	7	2	7	4			44										False	Alkaloids				Peptide01			Compound(3777454)	3777454	4.1	487			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]2:[#6]:[#7]:[#6](-[#7]):[#7]:[#6]:2-[#6]2:[#6](-[#8]):[#6]:[#6](-[#8]-[#6]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#6]:[#6]:2):[#6]:[#6]:1	COc1ccc(Oc2cnc(N)nc2-c2c(O)cc(OCc3ccccc3)cc2)cc1	WRMMNPNZPPOAGF		parent_pubchem_cid	877791-16-7;2-(2-amino-5-(4-methoxyphenoxy)pyrimidin-4-yl)-5-(benzyloxy)phenol;2-[2-amino-5-(4-methoxyphenoxy)pyrimidin-4-yl]-5-(benzyloxy)phenol;2-[2-amino-5-(4-methoxyphenoxy)pyrimidin-4-yl]-5-phenylmethoxyphenol;MFCD05702247;STK848695;AKOS002226369;CCG-313218;VU0616839-1;F3385-1388;2-[2-amino-5-(4-methoxyphenoxy)pyrimidin-4-yl]-5-benzyloxy-phenol		15856150.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=15856150		pluskal_iocb_peptide_Peptide01_C13_id		100	C13		ZINC000005562894
2.5		0	4	P2125456	75.6		M1	False	0	14	0	0	19	0	1	4	0	0	-1.0	0.0						CC(C)(C)OC(=O)NC(Cc1ccccc1)C(=O)O		2.21		0.0	2.57	CHEMBL1222330		Phenylpropanoic acids;Amphetamines and derivatives;Carbamate esters;Organic carbonic acids and derivatives;Monocarboxylic acids and derivatives;Carboxylic acids;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Benzene and substituted derivatives;Benzenoids;Carbamate esters;Carbamic acids and derivatives;Carbonyl compounds;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Hydrocarbon derivatives;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenethylamines;Phenylalanine and derivatives;Phenylpropanoic acids;Phenylpropanoids and polyketides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic homomonocyclic compounds	benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);amphetamines (CHEBI:35338);carbamate ester (CHEBI:23003);organooxygen compound (CHEBI:36963);carbonyl compound (CHEBI:36586);carboxylic acid anion (CHEBI:29067);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);primary amine (CHEBI:32877);amino acid (CHEBI:33709);peptide (CHEBI:16670);carbon oxoacid (CHEBI:35605);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806)		Amino acids, peptides, and analogues	Phenylalanine or derivatives;3-phenylpropanoic-acid;Amphetamine or derivatives;Benzenoid;Monocyclic benzene moiety;Carbamic acid ester;Carbonic acid derivative;Monocarboxylic acid or derivatives;Carboxylic acid;Organopnictogen compound;Organic oxide;Organic nitrogen compound;Hydrocarbon derivative;Organooxygen compound;Organonitrogen compound;Carbonyl group;Organic oxygen compound;Aromatic homomonocyclic compound	Organic acids and derivatives	0.0		13734-34-4	DTXSID90884634	2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	1	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C14H19NO4	C14H19NO4			InChI=1S/C14H19NO4/c1-14(2,3)19-13(18)15-11(12(16)17)9-10-7-5-4-6-8-10/h4-8,11H,9H2,1-3H3,(H,15,18)(H,16,17)/t11-/m0/s1	ZYJPUMXJBDHSIF-NSHDSACASA-N	(2S)-2-(tert-butoxycarbonylamino)-3-phenyl-propanoic acid	77857	CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)O	(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoic acid			2.15229													MCULE-5553035037	265.31183	ACID	265.131408	4	2	6	1	1.0		26									Dipeptides	False	Amino acids and Peptides	Small peptides	False	False	Peptide01		-1.0	Compound(77857)	77857	2.2	488		SCHEMBL66220	[#6]-[#6](-[#6])(-[#6])-[#8]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)O	ZYJPUMXJBDHSIF		parent_pubchem_cid	13734-34-4;Boc-Phe-OH;Boc-L-phenylalanine;N-(tert-Butoxycarbonyl)-L-phenylalanine;Boc-phenylalanine;N-Boc-L-Phenylalanine;N-t-Boc-L-phenylalanine;N-t-Butyloxycarbonyl-L-phenylalanine;(S)-2-((tert-Butoxycarbonyl)amino)-3-phenylpropanoic acid;N-tert-Butyloxycarbonyl-L-phenylalanine;L-Phenylalanine, N-[(1,1-dimethylethoxy)carbonyl]-;MFCD00002663;NSC 111172;t-butoxycarbonyl-L-phenylalanine;(TERT-BUTOXYCARBONYL)-L-PHENYLALANINE;(S)-2-(tert-butoxycarbonylamino)-3-phenylpropanoic acid;Alanine, N-carboxy-3-phenyl-, N-tert-butyl ester, L-;(2S)-2-(tert-butoxycarbonylamino)-3-phenyl-propanoic acid;N-(tert-butyloxycarbonyl)-L-phenylalanine;N-(tert-Butoxycarbonyl)phenylalanine;L-Phenylalanine, N-((1,1-dimethylethoxy)carbonyl)-;N-((1,1-Dimethylethoxy)carbonyl)-N-L-phenylalanine;N-alpha-t-Boc-L-phenylalanine;N-[(1,1-Dimethylethoxy)carbonyl]-N-L-phenylalanine;BocPhe;N-tert-butoxycarbonyl-L-phenylalanine;boc-l-phenylalanin;Boc-PheOH;phenylalanine, N-[(1,1-dimethylethoxy)carbonyl]-;EINECS 237-305-5;N-Boc-Phenylalanine;BOC-L phenylalanine;Phe-NHBOC;Boc-L-phenyl-alanine;N-Boc-L-Phe;BOC-PHE;Boc-(L)-Phe-OH;N-Boc-L-phenyl alanine;(2S)-2-{[(Tert-Butoxy)Carbonyl]Amino}-3-Phenylpropanoic Acid;BOC-L-PHE-OH;N-boc-(L)-phenylalanine;Nalpha -Boc-phenylalanine;(S)-N-Boc-phenylalanine;t-butoxycarbonylphenylalanine;SCHEMBL66220;N-[-(1,1-Dimethylethoxy)-carbonyl]-D-phenylamine;N-t-butoxycarbonylphenylalanine;tert-butoxycarbonylphenylalanine;t-butyloxycarbonyl-phenylalanine;CHEMBL1222330;N-t-butyloxycarbonylphenylalanine;DTXSID90884634;N-tert-butoxycarbonylphenylalanine;(2S)-2-[(tert-butoxycarbonyl)amino]-3-phenylpropanoic acid;N-t butoxycarbonyl-L-phenylalanine;Tert-butoxycarbonyl-L-phenylalanine;CS-D1210;tert-butyloxycarbonyl-l-phenylalanine;tert.-butoxycarbonyI-L-phenylalanine;N-(t-butoxycarbonyl)-L-phenylalanine;tert.-butyoxycarbonyl-L-phenylalanine;N-(tert-Butoxycarbonyl)-phenylalanine;(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoic acid;AKOS015922885;N-tert-butoxycarbonyl-L-phenyl-alanine;N-tert.-butoxycarbonyl-L-phenylalanine;AC-6777;Boc-Phe-OH, >=99.0% (T);N-(t-butyloxycarbonyl)-L-phenylalanine;N-tertiarybutoxycarbonyl-L-phenylalanine;N(tert-butyloxycarbonyl)-L-phenylalanine;AC-24133;AS-12725;BP-21043;HY-79096;N-T-BUTOXYCARBONYL-L-PHENYLALANINE;N-tert-butyloxycarbonyl-(L)-phenylalanine;(S)-N-tert.-butyloxycarbonyl-phenylalanine;Nalpha -t-butyloxycarbonyl-L-phenylalanine;N-(1,1-Dimethylethoxycarbonyl)phenylalanine;2-BOC-AMINO-3-PHENYL-PROPIONIC ACID;B1332;EN300-52848;N-[(1,1-dimethylethoxy)carbonyl]phenylalanine;A20324;M03310;P19756;N-[(1,1dimethylethoxy)carbonyl]-L-phenylalanine;N-{[(1,1-dimethylethyl)oxy]carbonyl}phenylalanine;N-ALPHA-T-BUTYLOXYCARBONYL-L-PHENYLALANINE;(2s)-tert-butoxycarbonylamino-3-phenylpropanoic acid;J-300207;N-[(1,1-dimethylethoxy) carbonyl]-L-phenylalanine;(S)-2-tert-butoxycarbonylamino-3-phenylpropionic acid;N-[[(1,1-dimethylethyl)oxy]carbonyl]-L-phenylalanine;2(S)-(tert-Butoxycarbonylamino)-3-phenylpropionic acid;N-[(1,1-DIMETHYLETHOXY)CARBONYL]-L-PHENYLALANINE;Z756435854;(S)-2-TERT-BUTOXYCARBONYLAMINO-3-PHENYL-PROPIONIC ACID	False	653043.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=653043		pluskal_iocb_peptide_Peptide01_C14_id		100	C14	False	ZINC000001703144
1.8		0	92	P7020020688	115.1		M2	False	0	18	0	0	20	0	4	2	0	1		0.0						CC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)Nc1nc(C)c(C)s1																							0.0		AKOS002358805		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0		C18H20N4O2S	C18H20N4O2S			InChI=1S/C18H20N4O2S/c1-10-11(2)25-18(20-10)22-17(24)16(21-12(3)23)8-13-9-19-15-7-5-4-6-14(13)15/h4-7,9,16,19H,8H2,1-3H3,(H,21,23)(H,20,22,24)	AQFORBXCTLYIML-UHFFFAOYSA-N	2-acetamido-N-(4,5-dimethylthiazol-2-yl)-3-(1H-indol-3-yl)propanamide	4357576	CC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)Nc1nc(C)c(C)s1	2-acetamido-N-(4,5-dimethyl-1,3-thiazol-2-yl)-3-(1H-indol-3-yl)propanamide			1.95398													MCULE-3754674850	356.4497		356.130697	3	3	5	3			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(4357576)	4357576	2.5	489			[#6]-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#7]-[#6]1:[#7]:[#6](-[#6]):[#6](-[#6]):[#16]:1	CC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)Nc1nc(C)c(C)s1	AQFORBXCTLYIML		parent_pubchem_cid	AKOS002358805;AB00682578-01;2-acetamido-N-(4,5-dimethylthiazol-2-yl)-3-(1H-indol-3-yl)propanamide		24602996.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24602996		pluskal_iocb_peptide_Peptide01_C14_id		100	C14		
4.8		0	180	P7020430637	102.6		M3	False	0	19	0	1	26	0	3	3	0	1		0.0						CCC(C)C(NC(=O)OC(C)(C)C)c1nnc(SCc2ccc(F)cc2)o1																							0.0		AKOS002303399		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C19H26FN3O3S	C19H26FN3O3S			InChI=1S/C19H26FN3O3S/c1-6-12(2)15(21-17(24)26-19(3,4)5)16-22-23-18(25-16)27-11-13-7-9-14(20)10-8-13/h7-10,12,15H,6,11H2,1-5H3,(H,21,24)/t12?,15-/m0/s1	IENQXUHPUAOZMB-CVRLYYSRSA-N	tert-butyl N-[rac-(1S)-1-[5-[(4-fluorophenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]-2-methyl-butyl]carbamate	16461888	CCC(C)[C@H](NC(=O)OC(C)(C)C)c1nnc(SCc2ccc(F)cc2)o1	tert-butyl N-[(1S)-1-[5-[(4-fluorophenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]-2-methylbutyl]carbamate			4.895470000000004													MCULE-6257813950	395.49977		395.167891	5	1	9	2			45										False					Peptide01			Compound(16461888)	16461888	4.4	490			[#6]-[#6]-[#6](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#8]-[#6](-[#6])(-[#6])-[#6])-[#6]1:[#7]:[#7]:[#6](-[#16]-[#6]-[#6]2:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:2):[#8]:1	CCC(C)[C@H](NC(=O)OC(C)(C)C)c1nnc(SCc2ccc(F)cc2)o1	IENQXUHPUAOZMB		parent_pubchem_cid	AKOS002303399;AKOS016323065;tert-butyl N-[rac-(1S)-1-[5-[(4-fluorophenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]-2-methyl-butyl]carbamate		23191305.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23191305		pluskal_iocb_peptide_Peptide01_C14_id		100	C14		
4.0		0	268	P1308305	58.0		M4	False	0	21	0	0	18	0	2	2	0	0		0.0						O=C(NCC(c1ccccc1)c1c[nH]c2ccccc12)c1ccco1																							0.0		N-[2-(1H-indol-3-yl)-2-phenylethyl]furan-2-carboxamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C21H18N2O2	C21H18N2O2			InChI=1S/C21H18N2O2/c24-21(20-11-6-12-25-20)23-13-17(15-7-2-1-3-8-15)18-14-22-19-10-5-4-9-16(18)19/h1-12,14,17,22H,13H2,(H,23,24)	UHLUYXHFHFYFAV-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]furan-2-carboxamide	43843334	O=C(NCC(c1ccccc1)c1c[nH]c2ccccc12)c1ccco1	N-[2-(1H-indol-3-yl)-2-phenylethyl]furan-2-carboxamide			3.7302500000000025													MCULE-3072665848	330.38981		330.136828	1	2	5	4			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(43843334)	43843334	4.1	491			[#8]=[#6](-[#7]-[#6]-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6]1:[#6]:[#6]:[#6]:[#8]:1	O=C(NCC(c1ccccc1)c1c[nH]c2ccccc12)c1ccco1	UHLUYXHFHFYFAV		parent_pubchem_cid	N-[2-(1H-indol-3-yl)-2-phenylethyl]furan-2-carboxamide;AKOS002299502;AKOS016330200;Z29960937;N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]furan-2-carboxamide		22945684.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22945684		pluskal_iocb_peptide_Peptide01_C14_id		100	C14		
2.7		0	12	P1999259	64.6		M5	False	0	15	0	0	21	0	1	4	0	0		0.0						COC(=O)C(Cc1ccccc1)NC(=O)OC(C)(C)C								Alpha amino acid esters;Amphetamines and derivatives;Fatty acid esters;Methyl esters;Carbamate esters;Monocarboxylic acids and derivatives;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acid esters;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Benzene and substituted derivatives;Benzenoids;Carbamate esters;Carbamic acids and derivatives;Carbonyl compounds;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids and derivatives;Chemical entities;Fatty Acyls;Fatty acid esters;Hydrocarbon derivatives;Lipids and lipid-like molecules;Methyl esters;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenethylamines;Phenylalanine and derivatives	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic homomonocyclic compounds	alpha-amino acid ester (CHEBI:46874);amphetamines (CHEBI:35338);fatty acid ester (CHEBI:35748);carboxylic ester (CHEBI:33308);carbamate ester (CHEBI:23003);monocarboxylic acid (CHEBI:25384);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);organooxygen compound (CHEBI:36963);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);primary amine (CHEBI:32877);lipid (CHEBI:18059);carbon oxoacid (CHEBI:35605);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806);amino acid (CHEBI:33709);peptide (CHEBI:16670)	Fatty esters (FA07);Fatty Acyls (FA)	Amino acids, peptides, and analogues	Phenylalanine or derivatives;Alpha-amino acid ester;Amphetamine or derivatives;Fatty acid ester;Monocyclic benzene moiety;Fatty acyl;Benzenoid;Methyl ester;Carbamic acid ester;Carboxylic acid ester;Monocarboxylic acid or derivatives;Organic nitrogen compound;Organonitrogen compound;Organooxygen compound;Hydrocarbon derivative;Carbonyl group;Organic oxide;Organic oxygen compound;Aromatic homomonocyclic compound	Organic acids and derivatives	0.0		BOC-DL-PHENYLALANINE METHYL ESTER	DTXSID20396396	2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	1	0	2	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C15H21NO4	C15H21NO4			InChI=1S/C15H21NO4/c1-15(2,3)20-14(18)16-12(13(17)19-4)10-11-8-6-5-7-9-11/h5-9,12H,10H2,1-4H3,(H,16,18)	SDSWSVBXRBXPRL-UHFFFAOYSA-N	methyl 2-(tert-butoxycarbonylamino)-3-phenyl-propanoate	3786800	COC(=O)C(Cc1ccccc1)NC(=O)OC(C)(C)C	methyl 2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoate			2.24069													MCULE-1761186880	279.33892		279.147058	4	1	7	1		10009041.0	42										False					Peptide01			Compound(3786800)	3786800	2.3	492		SCHEMBL1196457	[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#8]-[#6](-[#6])(-[#6])-[#6]	COC(=O)C(Cc1ccccc1)NC(=O)OC(C)(C)C	SDSWSVBXRBXPRL		parent_pubchem_cid	BOC-DL-PHENYLALANINE METHYL ESTER;19901-50-9;methyl 2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoate;MFCD00076977;SCHEMBL1196457;DTXSID20396396;methyl 2-{[(tert-butoxy)carbonyl]amino}-3-phenylpropanoate;SDSWSVBXRBXPRL-UHFFFAOYSA-N;MFCD03762814;AKOS009165362;NS-04578;SY035105;FT-0630135;FT-0699645;A13502;Methyl (tert-butoxycarbonyl)-DL-phenylalaninate;alpha-[[(1,1-dimethylethoxy)carbonyl]amino]benzenepropanoic acid methyl ester;methyl 2-(tert-butoxycarbonylamino)-3-phenyl-propanoate		26015356.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=26015356		pluskal_iocb_peptide_Peptide01_C14_id		100	C14		
1.8		0	100	P0128760953	96.4		M6	False	0	15	0	0	21	0	7	1	0	0	-1.0	0.0						CCNc1nc(NCC)nc(NN=Cc2ccc(OC)cc2)n1		2.19		0.0	3.22	CHEMBL3199200																	0.0		MLS000779726		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0		C15H21N7O	C15H21N7O			InChI=1S/C15H21N7O/c1-4-16-13-19-14(17-5-2)21-15(20-13)22-18-10-11-6-8-12(23-3)9-7-11/h6-10H,4-5H2,1-3H3,(H3,16,17,19,20,21,22)/b18-10+	MWEWBEUOBCNDSG-VCHYOVAHSA-N	N4,N6-diethyl-N2-[(E)-(4-methoxyphenyl)methyleneamino]-1,3,5-triazine-2,4,6-triamine	9624540	CCNc1nc(NCC)nc(N/N=C/c2ccc(OC)cc2)n1	4-N,6-N-diethyl-2-N-[(E)-(4-methoxyphenyl)methylideneamino]-1,3,5-triazine-2,4,6-triamine			0.53085														315.38092	ZWITTERION	315.180758	8	3	8	2	0.0		30										False	Alkaloids		False	False	Peptide01		-1.0	Compound(9624540)	9624540	3.3	493			[#6]-[#6]-[#7]-[#6]1:[#7]:[#6](-[#7]-[#6]-[#6]):[#7]:[#6](-[#7]/[#7]=[#6]/[#6]2:[#6]:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:2):[#7]:1	CCNc1nc(NCC)nc(N/N=C/c2ccc(OC)cc2)n1	MWEWBEUOBCNDSG		parent_pubchem_cid	MLS000779726;CHEMBL3199200;AKOS001057080;SMR000419909;SR-01000035633;SR-01000035633-1;N,N'-Diethyl-6-{N'-[1-(4-methoxy-phenyl)-meth-(E)-ylidene]-hydrazino}-[1,3,5]triazine-2,4-diamine;N4,N6-diethyl-N2-[(E)-(4-methoxyphenyl)methyleneamino]-1,3,5-triazine-2,4,6-triamine	False	20213899.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=20213899		pluskal_iocb_peptide_Peptide01_C14_id		100	C14	False	ZINC000004193000
1.2		0	188	P7018991952	150.9		M7	False	0	23	0	0	22	0	6	4	0	0		0.0						Nc1c(Cc2c(N)n(Cc3ccccc3)c(=O)[nH]c2=O)c(=O)[nH]c(=O)n1Cc1ccccc1																							0.0		AKOS002358310		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	6	0	0	0	0	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	2	0	0	0	0	0	0	0	0	0	0	0		C23H22N6O4	C23H22N6O4			InChI=1S/C23H22N6O4/c24-18-16(20(30)26-22(32)28(18)12-14-7-3-1-4-8-14)11-17-19(25)29(23(33)27-21(17)31)13-15-9-5-2-6-10-15/h1-10H,11-13,24-25H2,(H,26,30,32)(H,27,31,33)	ZJAFKAIGJDLMDR-UHFFFAOYSA-N	6-amino-5-[(6-amino-1-benzyl-2,4-dioxo-pyrimidin-5-yl)methyl]-1-benzyl-pyrimidine-2,4-dione	18593807	Nc1c(Cc2c(N)n(Cc3ccccc3)c(=O)[nH]c2=O)c(=O)[nH]c(=O)n1Cc1ccccc1	6-amino-5-[(6-amino-1-benzyl-2,4-dioxopyrimidin-5-yl)methyl]-1-benzylpyrimidine-2,4-dione			2.8579000000000008													MCULE-4980351067	446.46959		446.170253	6	4	6	4			44										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(18593807)	18593807	0.5	494			[#7]-[#6]1:[#6](-[#6]-[#6]2:[#6](-[#7]):[#7](-[#6]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#6](=[#8]):[#7H]:[#6]:2=[#8]):[#6](=[#8]):[#7H]:[#6](=[#8]):[#7]:1-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	Nc1c(Cc2c(N)n(Cc3ccccc3)c(=O)[nH]c2=O)c(=O)[nH]c(=O)n1Cc1ccccc1	ZJAFKAIGJDLMDR		parent_pubchem_cid	AKOS002358310;6-amino-5-[(6-amino-1-benzyl-2,4-dioxo-pyrimidin-5-yl)methyl]-1-benzyl-pyrimidine-2,4-dione		14836972.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=14836972		pluskal_iocb_peptide_Peptide01_C14_id		100	C14		ZINC000009970915
4.2		0	276	P4797300	75.2	HCl	M8	False	0	21	0	0	24	0	6	1	0	0		0.0						COc1cccc(Nc2nc(N3CCCC3)nc(Nc3cccc(C)c3)n2)c1																							0.0		N4-(3-methoxyphenyl)-N2-(m-tolyl)-6-pyrrolidin-1-yl-1,3,5-triazine-2,4-diamine;hydrochloride		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1		C21H25ClN6O	C21H24N6O			InChI=1S/C21H24N6O/c1-15-7-5-8-16(13-15)22-19-24-20(23-17-9-6-10-18(14-17)28-2)26-21(25-19)27-11-3-4-12-27/h5-10,13-14H,3-4,11-12H2,1-2H3,(H2,22,23,24,25,26)	AJIWENHJCAXTFG-UHFFFAOYSA-N	N4-(3-methoxyphenyl)-N2-(m-tolyl)-6-pyrrolidin-1-yl-1,3,5-triazine-2,4-diamine;hydrochloride	18584647	COc1cccc(Nc2nc(N3CCCC3)nc(Nc3cccc(C)c3)n2)c1	2-N-(3-methoxyphenyl)-4-N-(3-methylphenyl)-6-pyrrolidin-1-yl-1,3,5-triazine-2,4-diamine			1.8558499999999991													MCULE-4107173627	412.926		376.201159	7	2	6	4			43										False	Alkaloids				Peptide01			Compound(18584647)	18584647	5.0	495			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6](-[#7]-[#6]2:[#7]:[#6](-[#7]3-[#6]-[#6]-[#6]-[#6]-3):[#7]:[#6](-[#7]-[#6]3:[#6]:[#6]:[#6]:[#6](-[#6]):[#6]:3):[#7]:2):[#6]:1	COc1cccc(Nc2nc(N3CCCC3)nc(Nc3cccc(C)c3)n2)c1	AJIWENHJCAXTFG		parent_pubchem_cid	"""N4-(3-methoxyphenyl)-N2-(m-tolyl)-6-pyrrolidin-1-yl-1,3,5-triazine-2,4-diamine;hydrochloride"""		4196734.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=4196734		pluskal_iocb_peptide_Peptide01_C14_id		100	C14		ZINC000010213527
2.5		0	20	P7020604298	125.3		M9	False	0	21	0	0	25	0	3	5	0	2		0.0						COc1c(S(=O)(=O)NCCc2c[nH]c3ccccc23)cc(N2CCCCS2(=O)=O)cc1																							0.0		AKOS003064682		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	1		C21H25N3O5S2	C21H25N3O5S2			InChI=1S/C21H25N3O5S2/c1-29-20-9-8-17(24-12-4-5-13-30(24,25)26)14-21(20)31(27,28)23-11-10-16-15-22-19-7-3-2-6-18(16)19/h2-3,6-9,14-15,22-23H,4-5,10-13H2,1H3	VUJZPMJBDMCTIU-UHFFFAOYSA-N	5-(1,1-dioxothiazinan-2-yl)-N-[2-(1H-indol-3-yl)ethyl]-2-methoxy-benzenesulfonamide	24282726	COc1c(S(=O)(=O)NCCc2c[nH]c3ccccc23)cc(N2CCCCS2(=O)=O)cc1	5-(1,1-dioxothiazinan-2-yl)-N-[2-(1H-indol-3-yl)ethyl]-2-methoxybenzenesulfonamide			1.1933399999999998													MCULE-7520003391	463.5785		463.123563	5	2	7	4			44									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(24282726)	24282726	2.6	496			[#6]-[#8]-[#6]1:[#6](-[#16](=[#8])(=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6](-[#7]2-[#6]-[#6]-[#6]-[#6]-[#16]-2(=[#8])=[#8]):[#6]:[#6]:1	COc1c(S(=O)(=O)NCCc2c[nH]c3ccccc23)cc(N2CCCCS2(=O)=O)cc1	VUJZPMJBDMCTIU		parent_pubchem_cid	AKOS003064682;5-(1,1-dioxothiazinan-2-yl)-N-[2-(1H-indol-3-yl)ethyl]-2-methoxy-benzenesulfonamide		4374699.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=4374699		pluskal_iocb_peptide_Peptide01_C15_id		100	C15		ZINC000012004721
4.3		0	108	P7110950737	91.4		M10	False	0	21	1	0	21	0	2	4	0	0	-1.0	0.0						Cc1cc(OCC(=O)NC(Cc2c[nH]c3ccccc23)C(=O)O)cc(C)c1Cl		3.63		0.0	4.14	CHEMBL494311																	0.0		ChemDiv3_014798		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C21H21ClN2O4	C21H21ClN2O4			InChI=1S/C21H21ClN2O4/c1-12-7-15(8-13(2)20(12)22)28-11-19(25)24-18(21(26)27)9-14-10-23-17-6-4-3-5-16(14)17/h3-8,10,18,23H,9,11H2,1-2H3,(H,24,25)(H,26,27)	UKLKRDSPHMZMAK-UHFFFAOYSA-N	2-[[2-(4-chloro-3,5-dimethyl-phenoxy)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid	4087638	Cc1cc(OCC(=O)NC(Cc2c[nH]c3ccccc23)C(=O)O)cc(C)c1Cl	2-[[2-(4-chloro-3,5-dimethylphenoxy)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid			2.5740799999999995													MCULE-5923056306	400.86552	ACID	400.118985	4	3	7	3	0.0		30									Dipeptides	False	Amino acids and Peptides	Small peptides	False	False	Peptide01		-1.0	Compound(4087638)	4087638	3.6	497			[#6]-[#6]1:[#6]:[#6](-[#8]-[#6]-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6](=[#8])-[#8]):[#6]:[#6](-[#6]):[#6]:1-[#17]	Cc1cc(OCC(=O)NC(Cc2c[nH]c3ccccc23)C(=O)O)cc(C)c1Cl	UKLKRDSPHMZMAK		parent_pubchem_cid	ChemDiv3_014798;2-(2-(4-chloro-3,5-dimethylphenoxy)acetamido)-3-(1H-indol-3-yl)propanoic acid;2-[2-(4-CHLORO-3,5-DIMETHYLPHENOXY)ACETAMIDO]-3-(1H-INDOL-3-YL)PROPANOIC ACID;Oprea1_589877;CHEMBL494311;HMS1515A14;MFCD03011494;AKOS001694585;AKOS016050982;F3099-7136;2-[[2-(4-chloro-3,5-dimethyl-phenoxy)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid	False	13122.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=13122		pluskal_iocb_peptide_Peptide01_C15_id		100	C15	False	
3.8		0	196	P1113489	83.1		M11	False	0	24	0	0	21	0	3	1	0	1		0.0						O=C(NCCc1csc(-c2ccncc2)n1)C(c1ccccc1)c1ccccc1								Phenylacetamides;2,4-disubstituted thiazoles;Pyridines and derivatives;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	2,4-disubstituted thiazoles;Azacyclic compounds;Azoles;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Diphenylmethanes;Heteroaromatic compounds;Hydrocarbon derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenylacetamides;Pyridines and derivatives;Secondary carboxylic acid amides;Thiazoles	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as diphenylmethanes. These are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups.	Diphenylmethanes			Organic compounds	Aromatic heteromonocyclic compounds	acetamides (CHEBI:22160);thiazoles (CHEBI:48901);pyridines (CHEBI:26421);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);diarylmethane (CHEBI:51614);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);organic heterocyclic compound (CHEBI:24532);azole (CHEBI:68452);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);organooxygen compound (CHEBI:36963);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806)		Diphenylmethanes	Diphenylmethane;Phenylacetamide;2,4-disubstituted 1,3-thiazole;Pyridine;Azole;Heteroaromatic compound;Thiazole;Carboxamide group;Secondary carboxylic acid amide;Carboxylic acid derivative;Azacycle;Organoheterocyclic compound;Hydrocarbon derivative;Organooxygen compound;Organonitrogen compound;Organic oxide;Organic nitrogen compound;Carbonyl group;Organic oxygen compound;Aromatic heteromonocyclic compound	Benzenoids	0.0		AKOS005590530		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C24H21N3OS	C24H21N3OS			InChI=1S/C24H21N3OS/c28-23(22(18-7-3-1-4-8-18)19-9-5-2-6-10-19)26-16-13-21-17-29-24(27-21)20-11-14-25-15-12-20/h1-12,14-15,17,22H,13,16H2,(H,26,28)	ZQZBALJLUSHINX-UHFFFAOYSA-N	2,2-diphenyl-N-[2-[2-(4-pyridyl)thiazol-4-yl]ethyl]acetamide	28466534	O=C(NCCc1csc(-c2ccncc2)n1)C(c1ccccc1)c1ccccc1	2,2-diphenyl-N-[2-(2-pyridin-4-yl-1,3-thiazol-4-yl)ethyl]acetamide			4.151750000000003													MCULE-3709911163	399.51847		399.140533	3	1	7	4			44									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(28466534)	28466534	4.4	498			[#8]=[#6](-[#7]-[#6]-[#6]-[#6]1:[#6]:[#16]:[#6](-[#6]2:[#6]:[#6]:[#7]:[#6]:[#6]:2):[#7]:1)-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	O=C(NCCc1csc(-c2ccncc2)n1)C(c1ccccc1)c1ccccc1	ZQZBALJLUSHINX		parent_pubchem_cid	AKOS005590530;2,2-diphenyl-N-(2-(2-(pyridin-4-yl)thiazol-4-yl)ethyl)acetamide;2,2-diphenyl-N-[2-[2-(4-pyridyl)thiazol-4-yl]ethyl]acetamide		7205522.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=7205522		pluskal_iocb_peptide_Peptide01_C15_id		100	C15		ZINC000019942511
2.3		0	284	P7126267	107.4		M12	False	0	17	0	0	14	0	4	3	0	0		0.0						O=C(O)c1c(O)ccc(Nc2nc(Nc3ccccc3)ncc2)c1																							0.0		AKOS024459037		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0		C17H14N4O3	C17H14N4O3			InChI=1S/C17H14N4O3/c22-14-7-6-12(10-13(14)16(23)24)19-15-8-9-18-17(21-15)20-11-4-2-1-3-5-11/h1-10,22H,(H,23,24)(H2,18,19,20,21)	ZHBSEFGBICTVGC-UHFFFAOYSA-N	5-[(2-anilinopyrimidin-4-yl)amino]-2-hydroxy-benzoic acid	90489129	O=C(O)c1c(O)ccc(Nc2nc(Nc3ccccc3)ncc2)c1	5-[(2-anilinopyrimidin-4-yl)amino]-2-hydroxybenzoic acid			1.32804													MCULE-6105353360	322.32613		322.10659	7	4	5	3			44										False	Alkaloids				Peptide01			Compound(90489129)	90489129	3.7	499			[#8]=[#6](-[#8])-[#6]1:[#6](-[#8]):[#6]:[#6]:[#6](-[#7]-[#6]2:[#7]:[#6](-[#7]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#7]:[#6]:[#6]:2):[#6]:1	O=C(O)c1c(O)ccc(Nc2nc(Nc3ccccc3)ncc2)c1	ZHBSEFGBICTVGC		parent_pubchem_cid	AKOS024459037;5-[(2-anilinopyrimidin-4-yl)amino]-2-hydroxy-benzoic acid		99993850.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=99993850		pluskal_iocb_peptide_Peptide01_C15_id		100	C15		ZINC000170621818
3.0		0	28	P7117320249	161.3		M13	False	0	22	0	0	19	0	5	4	0	1		0.0						O=C(O)CNC(=O)CC1SC(=NN=Cc2c(-c3ccccc3)[nH]c3ccccc23)NC1=O																							0.0		2-[[2-[(2E)-4-oxo-2-[(E)-(2-phenyl-1H-indol-3-yl)methylenehydrazono]thiazolidin-5-yl]acetyl]amino]acetic acid		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0		C22H19N5O4S	C22H19N5O4S			InChI=1S/C22H19N5O4S/c28-18(23-12-19(29)30)10-17-21(31)26-22(32-17)27-24-11-15-14-8-4-5-9-16(14)25-20(15)13-6-2-1-3-7-13/h1-9,11,17,25H,10,12H2,(H,23,28)(H,29,30)(H,26,27,31)/b24-11+	GFPAMSMSSWZPFE-BHGWPJFGSA-N	2-[[2-[(2E)-4-oxo-2-[(E)-(2-phenyl-1H-indol-3-yl)methylenehydrazono]thiazolidin-5-yl]acetyl]amino]acetic acid	135679241	O=C(O)CNC(=O)CC1S/C(=N\N=C\c2c(-c3ccccc3)[nH]c3ccccc23)NC1=O	2-[[2-[(2Z)-4-oxo-2-[(E)-(2-phenyl-1H-indol-3-yl)methylidenehydrazinylidene]-1,3-thiazolidin-5-yl]acetyl]amino]acetic acid			1.48415														449.49183		449.115775	7	4	7	4			46									Quinoline alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(135679241)	135679241	2.6	500			[#8]=[#6](-[#8])-[#6]-[#7]-[#6](=[#8])-[#6]-[#6]1-[#16]/[#6](=[#7]\[#7]=[#6]\[#6]2:[#6](-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#7]-[#6]-1=[#8]	O=C(O)CNC(=O)CC1S/C(=N\N=C\c2c(-c3ccccc3)[nH]c3ccccc23)NC1=O	GFPAMSMSSWZPFE		parent_pubchem_cid	2-[[2-[(2E)-4-oxo-2-[(E)-(2-phenyl-1H-indol-3-yl)methylenehydrazono]thiazolidin-5-yl]acetyl]amino]acetic acid		24205463.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24205463		pluskal_iocb_peptide_Peptide01_C15_id		100	C15		
4.8		0	116	P0120630133	84.5		M14	False	0	30	0	0	36	0	2	4	0	0		0.0						COC(=O)C(Cc1ccccc1)NC(=O)C(Cc1ccccc1)NC(=O)C12CC3CC(CC(C3)C1)C2								Phenylalanine and derivatives;N-acyl-alpha amino acids and derivatives;Alpha amino acid esters;Alpha amino acid amides;Amphetamines and derivatives;Fatty acid esters;Fatty amides;Methyl esters;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acid amides;Alpha amino acid esters;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids and derivatives;Chemical entities;Fatty Acyls;Fatty acid esters;Fatty amides;Hydrocarbon derivatives;Lipids and lipid-like molecules;Methyl esters;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Peptides;Phenethylamines;Phenylalanine and derivatives;Secondary carboxylic acid amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as peptides. These are compounds containing an amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another.	Peptides			Organic compounds	Aromatic homopolycyclic compounds	phenylalanine derivative (CHEBI:25985);N-acyl-amino acid (CHEBI:51569);alpha-amino acid ester (CHEBI:46874);amino acid amide (CHEBI:22475);amphetamines (CHEBI:35338);fatty acid ester (CHEBI:35748);fatty amide (CHEBI:29348);carboxylic ester (CHEBI:33308);carboxamide (CHEBI:37622);monocarboxylic acid (CHEBI:25384);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);peptide (CHEBI:16670);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);organooxygen compound (CHEBI:36963);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);primary amine (CHEBI:32877);lipid (CHEBI:18059);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806);amino acid (CHEBI:33709)	Fatty esters (FA07);Fatty amides (FA08);Fatty Acyls (FA)	Amino acids, peptides, and analogues	Alpha peptide;Phenylalanine or derivatives;Alpha-amino acid ester;N-acyl-alpha amino acid or derivatives;Alpha-amino acid amide;N-substituted-alpha-amino acid;Alpha-amino acid or derivatives;Amphetamine or derivatives;Fatty acid ester;Fatty acyl;Monocyclic benzene moiety;Benzenoid;Fatty amide;Methyl ester;Carboxylic acid ester;Carboxamide group;Secondary carboxylic acid amide;Monocarboxylic acid or derivatives;Hydrocarbon derivative;Organic oxide;Carbonyl group;Organic oxygen compound;Organic nitrogen compound;Organonitrogen compound;Organooxygen compound;Aromatic homopolycyclic compound	Organic acids and derivatives	0.0		AKOS002346692		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	2	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C30H36N2O4	C30H36N2O4			InChI=1S/C30H36N2O4/c1-36-28(34)26(16-21-10-6-3-7-11-21)31-27(33)25(15-20-8-4-2-5-9-20)32-29(35)30-17-22-12-23(18-30)14-24(13-22)19-30/h2-11,22-26H,12-19H2,1H3,(H,31,33)(H,32,35)	UHSBKUPXEBIWJA-UHFFFAOYSA-N	methyl 2-[[2-(adamantane-1-carbonylamino)-3-phenyl-propanoyl]amino]-3-phenyl-propanoate	3752306	COC(=O)C(Cc1ccccc1)NC(=O)C(Cc1ccccc1)NC(=O)C12CC3CC(CC(C3)C1)C2	methyl 2-[[2-(adamantane-1-carbonylamino)-3-phenylpropanoyl]amino]-3-phenylpropanoate			3.7213800000000017													MCULE-9753454056	488.63242		488.267508	4	2	10	5			45										False	Amino acids and Peptides				Peptide01			Compound(3752306)	3752306	5.4	501			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]12-[#6]-[#6]3-[#6]-[#6](-[#6]-[#6](-[#6]-3)-[#6]-1)-[#6]-2	COC(=O)C(Cc1ccccc1)NC(=O)C(Cc1ccccc1)NC(=O)C12CC3CC(CC(C3)C1)C2	UHSBKUPXEBIWJA		parent_pubchem_cid	AKOS002346692;methyl 2-[[2-(adamantane-1-carbonylamino)-3-phenyl-propanoyl]amino]-3-phenyl-propanoate		24341786.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24341786		pluskal_iocb_peptide_Peptide01_C15_id		100	C15		
4.0		0	204	P7020600241	112.9		M15	False	0	24	0	0	30	0	2	4	0	2		0.0						CC(C)(C)c1ccc(S(=O)(=O)C2CS(=O)(=O)CC2NCCc2c[nH]c3ccccc23)cc1																							0.0		MFCD09852589		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	0		C24H30N2O4S2	C24H30N2O4S2			InChI=1S/C24H30N2O4S2/c1-24(2,3)18-8-10-19(11-9-18)32(29,30)23-16-31(27,28)15-22(23)25-13-12-17-14-26-21-7-5-4-6-20(17)21/h4-11,14,22-23,25-26H,12-13,15-16H2,1-3H3/t22-,23-/m0/s1	QKVCVHLWWBFUSQ-GOTSBHOMSA-N	rac-(3S,4R)-4-(4-tert-butylphenyl)sulfonyl-N-[2-(1H-indol-3-yl)ethyl]-1,1-dioxo-thiolan-3-amine	17597278	CC(C)(C)c1ccc(S(=O)(=O)[C@H]2CS(=O)(=O)C[C@@H]2NCCc2c[nH]c3ccccc23)cc1	(3S,4R)-4-(4-tert-butylphenyl)sulfonyl-N-[2-(1H-indol-3-yl)ethyl]-1,1-dioxothiolan-3-amine			2.5911500000000007													MCULE-5387743896	474.6457		474.164699	5	2	7	4			44										False					Peptide01			Compound(17597278)	17597278	4.3	502			[#6]-[#6](-[#6])(-[#6])-[#6]1:[#6]:[#6]:[#6](-[#16](=[#8])(=[#8])-[#6@H]2-[#6]-[#16](=[#8])(=[#8])-[#6]-[#6@@H]-2-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	CC(C)(C)c1ccc(S(=O)(=O)[C@H]2CS(=O)(=O)C[C@@H]2NCCc2c[nH]c3ccccc23)cc1	QKVCVHLWWBFUSQ		parent_pubchem_cid	MFCD09852589;AKOS002370482;rac-(3S,4R)-4-(4-tert-butylphenyl)sulfonyl-N-[2-(1H-indol-3-yl)ethyl]-1,1-dioxo-thiolan-3-amine		9221255.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=9221255		pluskal_iocb_peptide_Peptide01_C15_id		100	C15		ZINC000019820985
3.2		0	292	P7126290	61.3		M16	False	0	18	0	1	15	0	4	1	0	0		0.0						Oc1ccc(Nc2nc(N3CCc4ccccc43)ncc2F)cc1																							0.0		AKOS024459058		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1		C18H15FN4O	C18H15FN4O			InChI=1S/C18H15FN4O/c19-15-11-20-18(23-10-9-12-3-1-2-4-16(12)23)22-17(15)21-13-5-7-14(24)8-6-13/h1-8,11,24H,9-10H2,(H,20,21,22)	JJQATXZAKGINBM-UHFFFAOYSA-N	4-[(5-fluoro-2-indolin-1-yl-pyrimidin-4-yl)amino]phenol	90489149	Oc1ccc(Nc2nc(N3CCc4ccccc43)ncc2F)cc1	4-[[2-(2,3-dihydroindol-1-yl)-5-fluoropyrimidin-4-yl]amino]phenol			1.71954														322.34485		322.122989	5	2	3	4			48										False	Alkaloids				Peptide01			Compound(90489149)	90489149	3.9	503			[#8]-[#6]1:[#6]:[#6]:[#6](-[#7]-[#6]2:[#7]:[#6](-[#7]3-[#6]-[#6]-[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]-3:4):[#7]:[#6]:[#6]:2-[#9]):[#6]:[#6]:1	Oc1ccc(Nc2nc(N3CCc4ccccc43)ncc2F)cc1	JJQATXZAKGINBM		parent_pubchem_cid	AKOS024459058;4-[(5-fluoro-2-indolin-1-yl-pyrimidin-4-yl)amino]phenol					pluskal_iocb_peptide_Peptide01_C15_id		100	C15		
4.1		0	36	P7216620026	171.4		M17	False	0	18	0	0	16	0	6	0	0	3	-1.0	0.0						Nc1c2c3c(CCC3)sc2nc(SCc2nnc(Nc3ccccc3)s2)n1		4.65		0.0	4.89	CHEMBL4537793																	0.0		575468-55-2		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	1	1	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0		C18H16N6S3	C18H16N6S3			InChI=1S/C18H16N6S3/c19-15-14-11-7-4-8-12(11)26-16(14)22-17(21-15)25-9-13-23-24-18(27-13)20-10-5-2-1-3-6-10/h1-3,5-6H,4,7-9H2,(H,20,24)(H2,19,21,22)	IDVYRNFRUFPEHL-UHFFFAOYSA-N	10-[(5-anilino-1,3,4-thiadiazol-2-yl)methylsulfanyl]-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(8),2(6),9,11-tetraen-12-amine	1589507	Nc1c2c3c(CCC3)sc2nc(SCc2nnc(Nc3ccccc3)s2)n1	10-[(5-anilino-1,3,4-thiadiazol-2-yl)methylsulfanyl]-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-12-amine			2.8072100000000004														412.56042	NEUTRAL	412.059858	7	2	5	5	0.0		32										False			False	False	Peptide01		-1.0	Compound(1589507)	1589507	4.6	504		SCHEMBL5992992	[#7]-[#6]1:[#6]2:[#6]3:[#6](-[#6]-[#6]-[#6]-3):[#16]:[#6]:2:[#7]:[#6](-[#16]-[#6]-[#6]2:[#7]:[#7]:[#6](-[#7]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#16]:2):[#7]:1	Nc1c2c3c(CCC3)sc2nc(SCc2nnc(Nc3ccccc3)s2)n1	IDVYRNFRUFPEHL		parent_pubchem_cid	575468-55-2;10-({[5-(phenylamino)-1,3,4-thiadiazol-2-yl]methyl}sulfanyl)-7-thia-9,11-diazatricyclo[6.4.0.0^{2,6}]dodeca-1(8),2(6),9,11-tetraen-12-amine;CBKinase1_004712;CBKinase1_017112;SCHEMBL5992992;CHEMBL4537793;MFCD03847791;AKOS002180778;2-(((5-(phenylamino)-1,3,4-thiadiazol-2-yl)methyl)thio)-6,7-dihydro-5H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-amine;VU0049815-2;BRD-K98579150-001-01-7;F3111-1201;{5-[(4-Amino(5,6,7-trihydrocyclopenta[1,2-d]pyrimidino[4,5-b]thiophen-2-ylthio))methyl](1,3,4-thiadiazol-2-yl)}phenylamine;10-[(5-anilino-1,3,4-thiadiazol-2-yl)methylsulfanyl]-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-12-amine;10-[(5-anilino-1,3,4-thiadiazol-2-yl)methylsulfanyl]-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(8),2(6),9,11-tetraen-12-amine	False				pluskal_iocb_peptide_Peptide01_C16_id		100	C16	False	
4.7		0	124	P0103440005	92.8		M18	False	0	28	0	0	26	0	2	5	0	0		0.0						CCCCOC(=O)c1ccc(NC(=O)C(Cc2ccccc2)N2C(=O)c3ccccc3C2=O)cc1																							0.0		AKOS000536094		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	4	0	0	0	0	0	0	1	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	2	0		C28H26N2O5	C28H26N2O5			InChI=1S/C28H26N2O5/c1-2-3-17-35-28(34)20-13-15-21(16-14-20)29-25(31)24(18-19-9-5-4-6-10-19)30-26(32)22-11-7-8-12-23(22)27(30)33/h4-16,24H,2-3,17-18H2,1H3,(H,29,31)	CMVCKHUZAZQELZ-UHFFFAOYSA-N	butyl 4-[[2-(1,3-dioxoisoindolin-2-yl)-3-phenyl-propanoyl]amino]benzoate	3111893	CCCCOC(=O)c1ccc(NC(=O)C(Cc2ccccc2)N2C(=O)c3ccccc3C2=O)cc1	butyl 4-[[2-(1,3-dioxoisoindol-2-yl)-3-phenylpropanoyl]amino]benzoate			3.890050000000003														470.52982		470.184172	5	1	10	4			48										False	Alkaloids				Peptide01			Compound(3111893)	3111893	4.9	505			[#6]-[#6]-[#6]-[#6]-[#8]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#7]-[#6](=[#8])-[#6](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#7]2-[#6](=[#8])-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3-[#6]-2=[#8]):[#6]:[#6]:1	CCCCOC(=O)c1ccc(NC(=O)C(Cc2ccccc2)N2C(=O)c3ccccc3C2=O)cc1	CMVCKHUZAZQELZ		parent_pubchem_cid	AKOS000536094;AKOS016323546;butyl 4-[[2-(1,3-dioxoisoindolin-2-yl)-3-phenyl-propanoyl]amino]benzoate					pluskal_iocb_peptide_Peptide01_C16_id		100	C16		
3.3		0	212	P7020532050	112.9		M19	False	0	21	0	1	23	0	2	4	0	2		0.0						Cc1c(F)ccc(S(=O)(=O)C2CS(=O)(=O)CC2NCCc2c[nH]c3ccccc23)c1																							0.0		HMS3463N18		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	0		C21H23FN2O4S2	C21H23FN2O4S2			InChI=1S/C21H23FN2O4S2/c1-14-10-16(6-7-18(14)22)30(27,28)21-13-29(25,26)12-20(21)23-9-8-15-11-24-19-5-3-2-4-17(15)19/h2-7,10-11,20-21,23-24H,8-9,12-13H2,1H3/t20-,21-/m0/s1	GIIOHVYOXYGJNX-SFTDATJTSA-N	rac-(3S,4R)-4-(4-fluoro-3-methyl-phenyl)sulfonyl-N-[2-(1H-indol-3-yl)ethyl]-1,1-dioxo-thiolan-3-amine	20996492	Cc1c(F)ccc(S(=O)(=O)[C@H]2CS(=O)(=O)C[C@@H]2NCCc2c[nH]c3ccccc23)c1	(3S,4R)-4-(4-fluoro-3-methylphenyl)sulfonyl-N-[2-(1H-indol-3-yl)ethyl]-1,1-dioxothiolan-3-amine			1.74117													MCULE-7848528508	450.55486		450.108327	5	2	6	4			44										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(20996492)	20996492	3.1	506			[#6]-[#6]1:[#6](-[#9]):[#6]:[#6]:[#6](-[#16](=[#8])(=[#8])-[#6@H]2-[#6]-[#16](=[#8])(=[#8])-[#6]-[#6@@H]-2-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:1	Cc1c(F)ccc(S(=O)(=O)[C@H]2CS(=O)(=O)C[C@@H]2NCCc2c[nH]c3ccccc23)c1	GIIOHVYOXYGJNX		parent_pubchem_cid	HMS3463N18;MFCD10089181;AKOS004926374;CCG-156966;3-[(4-FLUORO-3-METHYLPHENYL)SULFONYL]-4-{[2-(1H-INDOL-3-YL)ETHYL]AMINO}TETRAHYDRO-1H-1LAMBDA~6~-THIOPHENE-1,1-DIONE;rac-(3S,4R)-4-(4-fluoro-3-methyl-phenyl)sulfonyl-N-[2-(1H-indol-3-yl)ethyl]-1,1-dioxo-thiolan-3-amine		21256546.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=21256546		pluskal_iocb_peptide_Peptide01_C16_id		100	C16		ZINC000019797178
2.6		0	300	P3459742	99.8		M20	False	0	22	0	0	19	0	5	2	0	0		0.0						O=C(NC(Cc1ccccc1)C(=O)Nc1nc2ccccc2[nH]1)c1cnccc1																							0.0		AKOS016400244		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0		C22H19N5O2	C22H19N5O2			InChI=1S/C22H19N5O2/c28-20(16-9-6-12-23-14-16)24-19(13-15-7-2-1-3-8-15)21(29)27-22-25-17-10-4-5-11-18(17)26-22/h1-12,14,19H,13H2,(H,24,28)(H2,25,26,27,29)/t19-/m0/s1	PURAVYJPAHGXEY-IBGZPJMESA-N	N-[rac-(1S)-2-(1H-benzimidazol-2-ylamino)-1-benzyl-2-oxo-ethyl]pyridine-3-carboxamide	29130543	O=C(N[C@@H](Cc1ccccc1)C(=O)Nc1nc2ccccc2[nH]1)c1cnccc1	N-[(2S)-1-(1H-benzimidazol-2-ylamino)-1-oxo-3-phenylpropan-2-yl]pyridine-3-carboxamide			2.0192499999999995													MCULE-5526197695	385.42903		385.153875	4	3	6	4			44									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(29130543)	29130543	2.9	507			[#8]=[#6](-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#7]-[#6]1:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#7H]:1)-[#6]1:[#6]:[#7]:[#6]:[#6]:[#6]:1	O=C(N[C@@H](Cc1ccccc1)C(=O)Nc1nc2ccccc2[nH]1)c1cnccc1	PURAVYJPAHGXEY		parent_pubchem_cid	AKOS016400244;N-[rac-(1S)-2-(1H-benzimidazol-2-ylamino)-1-benzyl-2-oxo-ethyl]pyridine-3-carboxamide		20289900.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=20289900		pluskal_iocb_peptide_Peptide01_C16_id		100	C16		ZINC000020720772
2.6		0	44	P7119561854	128.0		M21	False	0	23	0	0	19	0	3	5	0	1		0.0						CN1C(=O)c2cccc3c(S(=O)(=O)NC(Cc4c[nH]c5ccccc45)C(=O)O)ccc1c23																							0.0		N-[(1-methyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)sulfonyl]tryptophan		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	1	0		C23H19N3O5S	C23H19N3O5S			InChI=1S/C23H19N3O5S/c1-26-19-9-10-20(15-6-4-7-16(21(15)19)22(26)27)32(30,31)25-18(23(28)29)11-13-12-24-17-8-3-2-5-14(13)17/h2-10,12,18,24-25H,11H2,1H3,(H,28,29)	KCBJTDNGWZJUGQ-UHFFFAOYSA-N	3-(1H-indol-3-yl)-2-[(1-methyl-2-oxo-benzo[cd]indol-6-yl)sulfonylamino]propanoic acid	3158613	CN1C(=O)c2cccc3c(S(=O)(=O)NC(Cc4c[nH]c5ccccc45)C(=O)O)ccc1c23	3-(1H-indol-3-yl)-2-[(1-methyl-2-oxobenzo[cd]indol-6-yl)sulfonylamino]propanoic acid			1.4304199999999994													MCULE-5724271913	449.48898		449.104542	5	3	6	5			45										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(3158613)	3158613	2.9	508			[#6]-[#7]1-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]3:[#6](-[#16](=[#8])(=[#8])-[#7]-[#6](-[#6]-[#6]4:[#6]:[#7H]:[#6]5:[#6]:[#6]:[#6]:[#6]:[#6]:4:5)-[#6](=[#8])-[#8]):[#6]:[#6]:[#6]-1:[#6]:2:3	CN1C(=O)c2cccc3c(S(=O)(=O)NC(Cc4c[nH]c5ccccc45)C(=O)O)ccc1c23	KCBJTDNGWZJUGQ		parent_pubchem_cid	N-[(1-methyl-2-oxo-1,2-dihydrobenzo[cd]indol-6-yl)sulfonyl]tryptophan;BAS 09620733;AKOS000594045;AKOS016382179;CCG-120454;AQ-390/42869016;SR-01000324195;SR-01000324195-1;3-(1H-indol-3-yl)-2-[(1-methyl-2-oxobenzo[cd]indol-6-yl)sulfonylamino]propanoic acid;3-(1H-indol-3-yl)-2-[(1-methyl-2-oxo-benzo[cd]indol-6-yl)sulfonylamino]propanoic acid		23637839.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23637839		pluskal_iocb_peptide_Peptide01_C16_id		100	C16		
4.7		0	132	P0111051076	96.1		M22	False	0	24	0	0	25	0	1	4	0	1		0.0						COc1ccc(C(=O)CC(Sc2ccccc2N)c2cc(OC)c(OC)cc2)cc1																							0.0		Oprea1_819411		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	2	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0		C24H25NO4S	C24H25NO4S			InChI=1S/C24H25NO4S/c1-27-18-11-8-16(9-12-18)20(26)15-24(30-23-7-5-4-6-19(23)25)17-10-13-21(28-2)22(14-17)29-3/h4-14,24H,15,25H2,1-3H3	NOXANQCYEKBZRH-UHFFFAOYSA-N	3-(2-aminophenyl)sulfanyl-3-(3,4-dimethoxyphenyl)-1-(4-methoxyphenyl)propan-1-one	4051912	COc1ccc(C(=O)CC(Sc2ccccc2N)c2cc(OC)c(OC)cc2)cc1	3-(2-aminophenyl)sulfanyl-3-(3,4-dimethoxyphenyl)-1-(4-methoxyphenyl)propan-1-one			3.4157300000000026													MCULE-9478684380	423.53515		423.150429	6	1	9	3			45										False	Alkaloids	Tyrosine alkaloids			Peptide01			Compound(4051912)	4051912	4.5	509			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](=[#8])-[#6]-[#6](-[#16]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#7])-[#6]2:[#6]:[#6](-[#8]-[#6]):[#6](-[#8]-[#6]):[#6]:[#6]:2):[#6]:[#6]:1	COc1ccc(C(=O)CC(Sc2ccccc2N)c2cc(OC)c(OC)cc2)cc1	NOXANQCYEKBZRH		parent_pubchem_cid	Oprea1_819411;MFCD00267962;AKOS002322482;AKOS016323506;3-(2-aminophenyl)sulfanyl-3-(3,4-dimethoxyphenyl)-1-(4-methoxyphenyl)propan-1-one		24313024.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24313024		pluskal_iocb_peptide_Peptide01_C16_id		100	C16		
2.6		0	220	P7020432029	142.4		M23	False	0	22	0	0	25	0	3	6	0	2		0.0						COc1c(S(=O)(=O)NCCc2c[nH]c3ccccc23)cc(N2C(=O)C(C)(C)CS2(=O)=O)cc1																							0.0		AKOS005577204		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	0		C22H25N3O6S2	C22H25N3O6S2			InChI=1S/C22H25N3O6S2/c1-22(2)14-32(27,28)25(21(22)26)16-8-9-19(31-3)20(12-16)33(29,30)24-11-10-15-13-23-18-7-5-4-6-17(15)18/h4-9,12-13,23-24H,10-11,14H2,1-3H3	RKGVXWBSCTVFBN-UHFFFAOYSA-N	5-(4,4-dimethyl-1,1,3-trioxo-1,2-thiazolidin-2-yl)-N-[2-(1H-indol-3-yl)ethyl]-2-methoxy-benzenesulfonamide	17599011	COc1c(S(=O)(=O)NCCc2c[nH]c3ccccc23)cc(N2C(=O)C(C)(C)CS2(=O)=O)cc1	5-(4,4-dimethyl-1,1,3-trioxo-1,2-thiazolidin-2-yl)-N-[2-(1H-indol-3-yl)ethyl]-2-methoxybenzenesulfonamide			0.9659400000000004													MCULE-2271388900	491.58905		491.118478	6	2	7	4			44									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(17599011)	17599011	2.5	510			[#6]-[#8]-[#6]1:[#6](-[#16](=[#8])(=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6](-[#7]2-[#6](=[#8])-[#6](-[#6])(-[#6])-[#6]-[#16]-2(=[#8])=[#8]):[#6]:[#6]:1	COc1c(S(=O)(=O)NCCc2c[nH]c3ccccc23)cc(N2C(=O)C(C)(C)CS2(=O)=O)cc1	RKGVXWBSCTVFBN		parent_pubchem_cid	AKOS005577204;5-(4,4-dimethyl-1,1,3-trioxo-1,2-thiazolidin-2-yl)-N-[2-(1H-indol-3-yl)ethyl]-2-methoxy-benzenesulfonamide		2185961.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=2185961		pluskal_iocb_peptide_Peptide01_C16_id		100	C16		ZINC000013693807
2.5		0	308	P7126245	124.4		M24	False	0	19	0	0	16	0	4	4	0	0		0.0						Cc1cc(Nc2ccccc2C(=O)O)nc(Nc2ccccc2C(=O)O)n1								Benzoyl derivatives;Aniline and substituted anilines;Aminopyrimidines and derivatives;Imidolactams;Dicarboxylic acids and derivatives;Vinylogous amides;Heteroaromatic compounds;Amino acids;Secondary amines;Carboxylic acids;Azacyclic compounds;Organopnictogen compounds;Organooxygen compounds;Organic oxides;Hydrocarbon derivatives	Amines;Amino acids;Amino acids and derivatives;Amino acids, peptides, and analogues;Aminopyrimidines and derivatives;Aniline and substituted anilines;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Benzoic acids;Benzoic acids and derivatives;Benzoyl derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Diazines;Dicarboxylic acids and derivatives;Heteroaromatic compounds;Hydrocarbon derivatives;Imidolactams;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Pyrimidines and pyrimidine derivatives;Secondary amines;Vinylogous amides	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as benzoic acids. These are organic Compounds containing a benzene ring which bears at least one carboxyl group.	Benzoic acids			Organic compounds	Aromatic heteromonocyclic compounds	carbonyl compound (CHEBI:36586);anilines (CHEBI:22562);aminopyrimidine (CHEBI:38338);heterocyclic compound (CHEBI:5686);dicarboximide (CHEBI:35356);dicarboxylic acid (CHEBI:35692);enone (CHEBI:51689);enamine (CHEBI:47989);organic aromatic compound (CHEBI:33659);amino acid (CHEBI:33709);secondary amine (CHEBI:32863);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);organonitrogen heterocyclic compound (CHEBI:38101);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organooxygen compound (CHEBI:36963);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);benzoic acids (CHEBI:22723);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);organic heterocyclic compound (CHEBI:24532);diazines (CHEBI:38313);pyrimidines (CHEBI:39447);peptide (CHEBI:16670);organonitrogen compound (CHEBI:35352);nitrogen molecular entity (CHEBI:51143);amine (CHEBI:32952);oxygen molecular entity (CHEBI:25806)	Dicarboxylic acids (FA0117)	Benzoic acids and derivatives	Benzoic acid;Benzoyl;Aniline or substituted anilines;Aminopyrimidine;Dicarboxylic acid or derivatives;Pyrimidine;Imidolactam;Heteroaromatic compound;Vinylogous amide;Amino acid or derivatives;Amino acid;Carboxylic acid derivative;Carboxylic acid;Azacycle;Secondary amine;Organoheterocyclic compound;Hydrocarbon derivative;Organic nitrogen compound;Amine;Organic oxide;Organonitrogen compound;Organooxygen compound;Organic oxygen compound;Organopnictogen compound;Aromatic heteromonocyclic compound	Benzenoids	0.0		Oprea1_669972		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	2	2	0	0	0	0	0	0	0	0	0	0	1	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0		C19H16N4O4	C19H16N4O4			InChI=1S/C19H16N4O4/c1-11-10-16(21-14-8-4-2-6-12(14)17(24)25)23-19(20-11)22-15-9-5-3-7-13(15)18(26)27/h2-10H,1H3,(H,24,25)(H,26,27)(H2,20,21,22,23)	IEOOGHVXFIFRSY-UHFFFAOYSA-N	2-[[2-(2-carboxyanilino)-6-methyl-pyrimidin-4-yl]amino]benzoic acid	1931869	Cc1cc(Nc2ccccc2C(=O)O)nc(Nc2ccccc2C(=O)O)n1	2-[[2-(2-carboxyanilino)-6-methylpyrimidin-4-yl]amino]benzoic acid			1.98205													MCULE-6584240991	364.36377		364.117155	8	4	6	3			44									Anthranillic acid derivatives	False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(1931869)	1931869	4.5	511			[#6]-[#6]1:[#6]:[#6](-[#7]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6](=[#8])-[#8]):[#7]:[#6](-[#7]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6](=[#8])-[#8]):[#7]:1	Cc1cc(Nc2ccccc2C(=O)O)nc(Nc2ccccc2C(=O)O)n1	IEOOGHVXFIFRSY		parent_pubchem_cid	Oprea1_669972;MFCD00355629;AKOS003631041;AKOS022103671;2-[[2-(2-carboxyanilino)-6-methyl-pyrimidin-4-yl]amino]benzoic acid		23616875.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23616875		pluskal_iocb_peptide_Peptide01_C16_id		100	C16		ZINC000002315199
3.2		0	52	P7114830130	91.9		M25	False	0	16	0	3	14	0	1	4	0	1		0.0						O=C(O)C(Cc1ccccc1)NS(=O)(=O)c1ccccc1C(F)(F)F																							0.0		AKOS002217829		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0		C16H14F3NO4S	C16H14F3NO4S			InChI=1S/C16H14F3NO4S/c17-16(18,19)12-8-4-5-9-14(12)25(23,24)20-13(15(21)22)10-11-6-2-1-3-7-11/h1-9,13,20H,10H2,(H,21,22)	OBPSPXVWEQDGSQ-UHFFFAOYSA-N	3-phenyl-2-[[2-(trifluoromethyl)phenyl]sulfonylamino]propanoic acid	4106230	O=C(O)C(Cc1ccccc1)NS(=O)(=O)c1ccccc1C(F)(F)F	3-phenyl-2-[[2-(trifluoromethyl)phenyl]sulfonylamino]propanoic acid			2.4621700000000004													MCULE-2294056544	373.35348		373.059564	4	2	7	2			45										False					Peptide01			Compound(4106230)	4106230	3.4	512			[#8]=[#6](-[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#16](=[#8])(=[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#6](-[#9])(-[#9])-[#9]	O=C(O)C(Cc1ccccc1)NS(=O)(=O)c1ccccc1C(F)(F)F	OBPSPXVWEQDGSQ		parent_pubchem_cid	AKOS002217829;AKOS016054933;3-phenyl-2-[[2-(trifluoromethyl)phenyl]sulfonylamino]propanoic acid		23800331.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23800331		pluskal_iocb_peptide_Peptide01_C17_id		100	C17		
4.4		0	140	P7014790900	122.5		M26	False	0	25	0	0	25	0	3	6	0	0		0.0						CCOc1cc(NC(=O)c2cc([N+](=O)[O-])c(C)cc2)c(OCC)cc1NC(=O)c1ccccc1																							0.0		AKOS002253610		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	1		C25H25N3O6	C25H25N3O6			InChI=1S/C25H25N3O6/c1-4-33-22-15-20(27-25(30)18-12-11-16(3)21(13-18)28(31)32)23(34-5-2)14-19(22)26-24(29)17-9-7-6-8-10-17/h6-15H,4-5H2,1-3H3,(H,26,29)(H,27,30)	VEPPXKHXDKTZIX-UHFFFAOYSA-N	N-(4-benzamido-2,5-diethoxy-phenyl)-4-methyl-3-nitro-benzamide	3646713	CCOc1cc(NC(=O)c2cc([N+](=O)[O-])c(C)cc2)c(OCC)cc1NC(=O)c1ccccc1	N-(4-benzamido-2,5-diethoxyphenyl)-4-methyl-3-nitrobenzamide			2.9744400000000013													MCULE-4119180715	463.4945		463.174336	6	2	9	3			44										False	Alkaloids				Peptide01			Compound(3646713)	3646713	4.5	513			[#6]-[#6]-[#8]-[#6]1:[#6]:[#6](-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6](-[#7+](=[#8])-[#8-]):[#6](-[#6]):[#6]:[#6]:2):[#6](-[#8]-[#6]-[#6]):[#6]:[#6]:1-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	CCOc1cc(NC(=O)c2cc([N+](=O)[O-])c(C)cc2)c(OCC)cc1NC(=O)c1ccccc1	VEPPXKHXDKTZIX		parent_pubchem_cid	AKOS002253610;N-(4-benzamido-2,5-diethoxy-phenyl)-4-methyl-3-nitro-benzamide		9178069.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=9178069		pluskal_iocb_peptide_Peptide01_C17_id		100	C17		ZINC000000959463
2.8		0	228	P7020542774	79.3		M27	False	0	19	0	0	20	0	4	2	0	0	-1.0	0.0						Oc1cccc(Nc2nc3ccccc3c(NCC3CCCO3)n2)c1		3.67		0.0	3.73	CHEMBL532641																	0.0		GNF-Pf-2034		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0		C19H20N4O2	C19H20N4O2			InChI=1S/C19H20N4O2/c24-14-6-3-5-13(11-14)21-19-22-17-9-2-1-8-16(17)18(23-19)20-12-15-7-4-10-25-15/h1-3,5-6,8-9,11,15,24H,4,7,10,12H2,(H2,20,21,22,23)	PEQMTEMWXRAERG-UHFFFAOYSA-N	3-[[4-(tetrahydrofuran-2-ylmethylamino)quinazolin-2-yl]amino]phenol	644989	Oc1cccc(Nc2nc3ccccc3c(NCC3CCCO3)n2)c1	3-[[4-(oxolan-2-ylmethylamino)quinazolin-2-yl]amino]phenol			1.63724													MCULE-3420237672	336.39685	NEUTRAL	336.158626	6	3	5	4	0.0		30									Quinazoline alkaloids	False	Alkaloids	Anthranilic acid alkaloids	False	False	Peptide01		-1.0	Compound(644989)	644989	3.8	514			[#8]-[#6]1:[#6]:[#6]:[#6]:[#6](-[#7]-[#6]2:[#7]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3:[#6](-[#7]-[#6]-[#6]3-[#6]-[#6]-[#6]-[#8]-3):[#7]:2):[#6]:1	Oc1cccc(Nc2nc3ccccc3c(NCC3CCCO3)n2)c1	PEQMTEMWXRAERG		parent_pubchem_cid	GNF-Pf-2034;797027-80-6;BAS 07396056;3-({4-[(oxolan-2-ylmethyl)amino]quinazolin-2-yl}amino)phenol;TimTec1_007899;CHEMBL532641;3-[[4-(oxolan-2-ylmethylamino)quinazolin-2-yl]amino]phenol;HMS1556H01;MFCD05241002;AKOS000642428;IDI1_033553;NCGC00073054-02;NS-05530;3-(4-((Tetrahydrofuran-2-yl)methylamino)quinazolin-2-ylamino)phenol;3-[(4-{[(oxolan-2-yl)methyl]amino}quinazolin-2-yl)amino]phenol;3-((4-(((Tetrahydrofuran-2-yl)methyl)amino)quinazolin-2-yl)amino)phenol;3-[[4-(tetrahydrofuran-2-ylmethylamino)quinazolin-2-yl]amino]phenol	False	271428.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=271428		pluskal_iocb_peptide_Peptide01_C17_id		100	C17	False	
2.7		0	316	P1098874	127.2		M28	False	0	20	0	0	17	0	5	4	0	0	-1.0	0.0						O=C(Cn1nnc2ccccc2c1=O)NC(Cc1c[nH]c2ccccc12)C(=O)O		1.08		0.0	2.71	CHEMBL1418136																	0.0		SMR000221686		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C20H17N5O4	C20H17N5O4			InChI=1S/C20H17N5O4/c26-18(11-25-19(27)14-6-2-4-8-16(14)23-24-25)22-17(20(28)29)9-12-10-21-15-7-3-1-5-13(12)15/h1-8,10,17,21H,9,11H2,(H,22,26)(H,28,29)/t17-/m0/s1	DFGRIUZMNPKDKO-KRWDZBQOSA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[[2-(4-oxo-1,2,3-benzotriazin-3-yl)acetyl]amino]propanoic acid	1856838	O=C(Cn1nnc2ccccc2c1=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	(2S)-3-(1H-indol-3-yl)-2-[[2-(4-oxo-1,2,3-benzotriazin-3-yl)acetyl]amino]propanoic acid			1.0732399999999993													MCULE-2344377147	391.38959	ACID	391.128054	6	3	6	4	0.0		29									Quinazoline alkaloids	False	Alkaloids	Anthranilic acid alkaloids	False	False	Peptide01		-1.0	Compound(1856838)	1856838	2.6	515			[#8]=[#6](-[#6]-[#7]1:[#7]:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	O=C(Cn1nnc2ccccc2c1=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	DFGRIUZMNPKDKO		parent_pubchem_cid	SMR000221686;MLS000332364;(S)-3-(1H-Indol-3-yl)-2-[2-(4-oxo-4H-benzo[d][1,2,3]triazin-3-yl)-acetylamino]-propionic acid;CHEMBL1418136;BDBM53802;cid_1856838;HMS2620L15;AKOS005533856;(2S)-3-(1H-indol-3-yl)-2-[[2-(4-oxo-1,2,3-benzotriazin-3-yl)acetyl]amino]propanoic acid;(2S)-3-(1H-indol-3-yl)-2-[[1-oxo-2-(4-oxo-1,2,3-benzotriazin-3-yl)ethyl]amino]propanoic acid;(2S)-3-(1H-indol-3-yl)-2-[[2-(4-keto-1,2,3-benzotriazin-3-yl)acetyl]amino]propionic acid;(2S)-3-(1H-indol-3-yl)-2-[2-(4-oxidanylidene-1,2,3-benzotriazin-3-yl)ethanoylamino]propanoic acid;(S)-3-(1H-indol-3-yl)-2-(2-(4-oxobenzo[d][1,2,3]triazin-3(4H)-yl)acetamido)propanoic acid;3-(1H-INDOL-3-YL)-2-[2-(4-OXO-3,4-DIHYDRO-1,2,3-BENZOTRIAZIN-3-YL)ACETAMIDO]PROPANOIC ACID;rac-(2S)-3-(1H-indol-3-yl)-2-[[2-(4-oxo-1,2,3-benzotriazin-3-yl)acetyl]amino]propanoic acid	False	887387.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=887387		pluskal_iocb_peptide_Peptide01_C17_id		100	C17	False	ZINC000002224947
5.0		0	60	P7114420570	69.0		M29	False	0	20	0	0	19	0	3	0	0	1		0.0						Cc1cc(NC(c2cccs2)c2c(C)[nH]c3ccccc23)ncc1																							0.0		526189-17-3		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0		C20H19N3S	C20H19N3S			InChI=1S/C20H19N3S/c1-13-9-10-21-18(12-13)23-20(17-8-5-11-24-17)19-14(2)22-16-7-4-3-6-15(16)19/h3-12,20,22H,1-2H3,(H,21,23)	FCEQYQWAOQUKPG-UHFFFAOYSA-N	4-methyl-N-[(2-methyl-1H-indol-3-yl)-(2-thienyl)methyl]pyridin-2-amine	4615890	Cc1cc(NC(c2cccs2)c2c(C)[nH]c3ccccc23)ncc1	4-methyl-N-[(2-methyl-1H-indol-3-yl)-thiophen-2-ylmethyl]pyridin-2-amine			4.414870000000003													MCULE-1267343964	333.45853		333.129969	2	2	4	4			45										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(4615890)	4615890	5.0	516			[#6]-[#6]1:[#6]:[#6](-[#7]-[#6](-[#6]2:[#6]:[#6]:[#6]:[#16]:2)-[#6]2:[#6](-[#6]):[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#7]:[#6]:[#6]:1	Cc1cc(NC(c2cccs2)c2c(C)[nH]c3ccccc23)ncc1	FCEQYQWAOQUKPG		parent_pubchem_cid	526189-17-3;4-methyl-N-((2-methyl-1H-indol-3-yl)(thiophen-2-yl)methyl)pyridin-2-amine;4-methyl-N-[(2-methyl-1H-indol-3-yl)(thiophen-2-yl)methyl]pyridin-2-amine;Oprea1_526784;Oprea1_608403;4-methyl-N-[(2-methyl-1H-indol-3-yl)-thiophen-2-ylmethyl]pyridin-2-amine;AKOS000808830;AKOS016074744;Z57301512;F1217-0205;4-methyl-N-[(2-methyl-1H-indol-3-yl)-(2-thienyl)methyl]pyridin-2-amine		24644411.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24644411		pluskal_iocb_peptide_Peptide01_C17_id		100	C17		
4.1		0	148	P7015592665	76.7		M30	False	0	24	0	0	24	0	2	4	0	0		0.0						CCOc1cc(NC(=O)c2ccccc2)c(OCC)cc1NC(=O)c1ccccc1																							0.0		Oprea1_624802		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C24H24N2O4	C24H24N2O4			InChI=1S/C24H24N2O4/c1-3-29-21-15-20(26-24(28)18-13-9-6-10-14-18)22(30-4-2)16-19(21)25-23(27)17-11-7-5-8-12-17/h5-16H,3-4H2,1-2H3,(H,25,27)(H,26,28)	OWJCBUDAZCWXDD-UHFFFAOYSA-N	N-(4-benzamido-2,5-diethoxy-phenyl)benzamide	1147279	CCOc1cc(NC(=O)c2ccccc2)c(OCC)cc1NC(=O)c1ccccc1	N-(4-benzamido-2,5-diethoxyphenyl)benzamide			3.1931400000000014													MCULE-6073909302	404.46988		404.173607	4	2	8	3			44										False	Alkaloids				Peptide01			Compound(1147279)	1147279	4.3	517			[#6]-[#6]-[#8]-[#6]1:[#6]:[#6](-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6](-[#8]-[#6]-[#6]):[#6]:[#6]:1-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	CCOc1cc(NC(=O)c2ccccc2)c(OCC)cc1NC(=O)c1ccccc1	OWJCBUDAZCWXDD		parent_pubchem_cid	Oprea1_624802;AKOS000658229;N-(4-benzamido-2,5-diethoxy-phenyl)benzamide		9288295.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=9288295		pluskal_iocb_peptide_Peptide01_C17_id		100	C17		ZINC000000892304
3.3		0	236	P7020692445	64.3		M31	False	0	18	0	0	22	0	2	2	0	0		0.0						CC(C)CC(N)C(=O)Nc1ccc(Oc2ccccc2)cc1																							0.0		(2S)-2-amino-4-methyl-N-(4-phenoxyphenyl)pentanamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0		C18H22N2O2	C18H22N2O2			InChI=1S/C18H22N2O2/c1-13(2)12-17(19)18(21)20-14-8-10-16(11-9-14)22-15-6-4-3-5-7-15/h3-11,13,17H,12,19H2,1-2H3,(H,20,21)/t17-/m0/s1	MTSPMSPHSCYSRY-KRWDZBQOSA-N	rac-(2S)-2-amino-4-methyl-N-(4-phenoxyphenyl)pentanamide	22691089	CC(C)C[C@H](N)C(=O)Nc1ccc(Oc2ccccc2)cc1	(2S)-2-amino-4-methyl-N-(4-phenoxyphenyl)pentanamide			2.4853700000000005													MCULE-8842547470	298.38824		298.168128	3	2	6	2			44										False					Peptide01			Compound(22691089)	22691089	3.4	518			[#6]-[#6](-[#6])-[#6]-[#6@H](-[#7])-[#6](=[#8])-[#7]-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6]:[#6]:1	CC(C)C[C@H](N)C(=O)Nc1ccc(Oc2ccccc2)cc1	MTSPMSPHSCYSRY		parent_pubchem_cid	(2S)-2-amino-4-methyl-N-(4-phenoxyphenyl)pentanamide;MFCD09725075;AKOS015949089;NS-05046;(S)-2-Amino-4-methyl-N-(4-phenoxyphenyl)pentanamide;1217713-86-4;rac-(2S)-2-amino-4-methyl-N-(4-phenoxyphenyl)pentanamide		24081256.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24081256		pluskal_iocb_peptide_Peptide01_C17_id		100	C17		ZINC000011961349
5.0		0	324	P3460752	100.2		M32	False	0	28	0	0	44	0	4	3	0	0		0.0						CC(C)C(NC(=O)c1c(C(=O)NC2CCCCCCC2)cncc1)C(=O)NC1CCCCCCC1																							0.0		AKOS016355510		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0		C28H44N4O3	C28H44N4O3			InChI=1S/C28H44N4O3/c1-20(2)25(28(35)31-22-15-11-7-4-8-12-16-22)32-26(33)23-17-18-29-19-24(23)27(34)30-21-13-9-5-3-6-10-14-21/h17-22,25H,3-16H2,1-2H3,(H,30,34)(H,31,35)(H,32,33)/t25-/m0/s1	LMRIVBNSYWNQKU-VWLOTQADSA-N	N3-cyclooctyl-N4-[rac-(1S)-1-(cyclooctylcarbamoyl)-2-methyl-propyl]pyridine-3,4-dicarboxamide	39889954	CC(C)[C@H](NC(=O)c1c(C(=O)NC2CCCCCCC2)cncc1)C(=O)NC1CCCCCCC1	3-N-cyclooctyl-4-N-[(2S)-1-(cyclooctylamino)-3-methyl-1-oxobutan-2-yl]pyridine-3,4-dicarboxamide			4.798380000000003													MCULE-3495533184	484.68788		484.341341	4	3	7	3			44										False	Alkaloids				Peptide01			Compound(39889954)	39889954	5.9	519			[#6]-[#6](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#6]1:[#6](-[#6](=[#8])-[#7]-[#6]2-[#6]-[#6]-[#6]-[#6]-[#6]-[#6]-[#6]-2):[#6]:[#7]:[#6]:[#6]:1)-[#6](=[#8])-[#7]-[#6]1-[#6]-[#6]-[#6]-[#6]-[#6]-[#6]-[#6]-1	CC(C)[C@H](NC(=O)c1c(C(=O)NC2CCCCCCC2)cncc1)C(=O)NC1CCCCCCC1	LMRIVBNSYWNQKU		parent_pubchem_cid	AKOS016355510;N3-CYCLOOCTYL-N4-[1-(CYCLOOCTYLCARBAMOYL)-2-METHYLPROPYL]PYRIDINE-3,4-DICARBOXAMIDE;N3-cyclooctyl-N4-[rac-(1S)-1-(cyclooctylcarbamoyl)-2-methyl-propyl]pyridine-3,4-dicarboxamide		6255753.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=6255753		pluskal_iocb_peptide_Peptide01_C17_id		100	C17		ZINC000032646460
3.0		0	68	P1045967	66.4		M33	False	0	17	0	0	17	0	1	3	0	0		0.0						Cc1ccc(C(=O)NC(Cc2ccccc2)C(=O)O)cc1																							0.0		Oprea1_048489		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C17H17NO3	C17H17NO3			InChI=1S/C17H17NO3/c1-12-7-9-14(10-8-12)16(19)18-15(17(20)21)11-13-5-3-2-4-6-13/h2-10,15H,11H2,1H3,(H,18,19)(H,20,21)	JIPRMDMHNPGKNW-UHFFFAOYSA-N	2-[(4-methylbenzoyl)amino]-3-phenyl-propanoic acid	14186389	Cc1ccc(C(=O)NC(Cc2ccccc2)C(=O)O)cc1	2-[(4-methylbenzoyl)amino]-3-phenylpropanoic acid			2.25659													MCULE-8823549911	283.32994		283.120843	3	2	5	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(14186389)	14186389	1.9	520		SCHEMBL4682004	[#6]-[#6]1:[#6]:[#6]:[#6](-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#8]):[#6]:[#6]:1	Cc1ccc(C(=O)NC(Cc2ccccc2)C(=O)O)cc1	JIPRMDMHNPGKNW		parent_pubchem_cid	Oprea1_048489;SCHEMBL4682004;AKOS000127145;AKOS016050924;2-[(4-methylbenzoyl)amino]-3-phenyl-propanoic acid		24603278.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24603278		pluskal_iocb_peptide_Peptide01_C18_id		100	C18		
4.8		0	156	P0115090780	46.2		M34	False	0	23	0	0	21	0	1	2	0	0		0.0						CC(=O)c1cc(NC(=O)c2ccccc2CCc2ccccc2)ccc1																							0.0		MFCD01034749		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C23H21NO2	C23H21NO2			InChI=1S/C23H21NO2/c1-17(25)20-11-7-12-21(16-20)24-23(26)22-13-6-5-10-19(22)15-14-18-8-3-2-4-9-18/h2-13,16H,14-15H2,1H3,(H,24,26)	UAQKIOJOMDKNBX-UHFFFAOYSA-N	N-(3-acetylphenyl)-2-(2-phenylethyl)benzamide	723985	CC(=O)c1cc(NC(=O)c2ccccc2CCc2ccccc2)ccc1	N-(3-acetylphenyl)-2-(2-phenylethyl)benzamide			4.327250000000003													MCULE-3961156332	343.42932		343.157229	2	1	6	3			43										False	Alkaloids				Peptide01			Compound(723985)	723985	4.4	521			[#6]-[#6](=[#8])-[#6]1:[#6]:[#6](-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6]-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6]:[#6]:[#6]:1	CC(=O)c1cc(NC(=O)c2ccccc2CCc2ccccc2)ccc1	UAQKIOJOMDKNBX		parent_pubchem_cid	MFCD01034749;AKOS002261965;SR-01000408681;SR-01000408681-1;N-(3-acetylphenyl)-2-(2-phenylethyl)benzamide		11056718.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=11056718		pluskal_iocb_peptide_Peptide01_C18_id		100	C18		ZINC000000129759
1.2		0	244	P1098079	95.9		M35	False	0	22	0	0	23	0	1	5	0	0		0.0						CC(C)CC(NCc1c2oc(=O)cc(-c3ccccc3)c2ccc1O)C(=O)O								Leucine and derivatives;7-hydroxycoumarins;1-benzopyrans;D-alpha-amino acids;Pyranones and derivatives;1-hydroxy-2-unsubstituted benzenoids;Aralkylamines;Benzene and substituted derivatives;Heteroaromatic compounds;Amino acids;Lactones;Dialkylamines;Carboxylic acids;Oxacyclic compounds;Monocarboxylic acids and derivatives;Hydrocarbon derivatives;Organopnictogen compounds;Carbonyl compounds;Organic oxides	1-benzopyrans;1-hydroxy-2-unsubstituted benzenoids;7-hydroxycoumarins;Alpha amino acids;Alpha amino acids and derivatives;Amines;Amino acids;Amino acids and derivatives;Amino acids, peptides, and analogues;Aralkylamines;Benzene and substituted derivatives;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;D-alpha-amino acids;Dialkylamines;Heteroaromatic compounds;Hydrocarbon derivatives;Hydroxycoumarins;Lactones;Leucine and derivatives;Monocarboxylic acids and derivatives;Neoflavones;Neoflavonoids;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenols;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Secondary amines	Neoflavonoids	2.1	This compound belongs to the class of organic compounds known as neoflavones. These are neoflavonoids with a structure based on the 4-phenylcoumarin skeleton.	Neoflavones			Organic compounds	Aromatic heteropolycyclic compounds	leucine derivative (CHEBI:47003);hydroxycoumarin (CHEBI:37912);1-benzopyran (CHEBI:38443);D-alpha-amino acid (CHEBI:16733);pyranone (CHEBI:37963);phenols (CHEBI:33853);aralkylamine (CHEBI:18000);benzenes (CHEBI:22712);organic aromatic compound (CHEBI:33659);amino acid (CHEBI:33709);lactone (CHEBI:25000);secondary amino compound (CHEBI:50995);carboxylic acid (CHEBI:33575);oxacycle (CHEBI:38104);monocarboxylic acid (CHEBI:25384);organic molecule (CHEBI:72695);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);carbonyl compound (CHEBI:36586);organic oxide (CHEBI:25701);neoflavonoid (CHEBI:71971);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organonitrogen compound (CHEBI:35352);organooxygen compound (CHEBI:36963);coumarins (CHEBI:23403);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);alpha-amino acid (CHEBI:33704);pyrans (CHEBI:26407);benzenoid aromatic compound (CHEBI:33836);nitrogen molecular entity (CHEBI:51143);amine (CHEBI:32952);secondary amine (CHEBI:32863);oxygen molecular entity (CHEBI:25806);carboxylic acid anion (CHEBI:29067);peptide (CHEBI:16670)	Benzopyranoids (PK1311);Neoflavonoids (PK1210)	Neoflavones	4-phenylcoumarin;Leucine or derivatives;7-hydroxycoumarin;Hydroxycoumarin;Coumarin;Alpha-amino acid;Alpha-amino acid or derivatives;D-alpha-amino acid;Benzopyran;1-benzopyran;1-hydroxy-2-unsubstituted benzenoid;Pyranone;Aralkylamine;Monocyclic benzene moiety;Pyran;Benzenoid;Heteroaromatic compound;Amino acid;Lactone;Amino acid or derivatives;Oxacycle;Carboxylic acid derivative;Carboxylic acid;Organoheterocyclic compound;Secondary aliphatic amine;Secondary amine;Monocarboxylic acid or derivatives;Organic oxygen compound;Carbonyl group;Organic nitrogen compound;Organopnictogen compound;Amine;Organic oxide;Organooxygen compound;Hydrocarbon derivative;Organonitrogen compound;Aromatic heteropolycyclic compound	Phenylpropanoids and polyketides	0.0		2-{[(7-hydroxy-2-oxo-4-phenyl-2H-chromen-8-yl)methyl]amino}-4-methylpentanoic acid		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C22H23NO5	C22H23NO5			InChI=1S/C22H23NO5/c1-13(2)10-18(22(26)27)23-12-17-19(24)9-8-15-16(11-20(25)28-21(15)17)14-6-4-3-5-7-14/h3-9,11,13,18,23-24H,10,12H2,1-2H3,(H,26,27)/t18-/m1/s1	KKAMOXGUTPOGNY-GOSISDBHSA-N	rac-(2R)-2-[(7-hydroxy-2-oxo-4-phenyl-chromen-8-yl)methylamino]-4-methyl-pentanoic acid	5428868	CC(C)C[C@@H](NCc1c2oc(=O)cc(-c3ccccc3)c2ccc1O)C(=O)O	(2R)-2-[(7-hydroxy-2-oxo-4-phenylchromen-8-yl)methylamino]-4-methylpentanoic acid			3.3288300000000013													MCULE-4810790420	381.43231		381.157623	6	3	7	3			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(5428868)	5428868	1.7	522			[#6]-[#6](-[#6])-[#6]-[#6@@H](-[#7]-[#6]-[#6]1:[#6]2:[#8]:[#6](=[#8]):[#6]:[#6](-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#6]:2:[#6]:[#6]:[#6]:1-[#8])-[#6](=[#8])-[#8]	CC(C)C[C@@H](NCc1c2oc(=O)cc(-c3ccccc3)c2ccc1O)C(=O)O	KKAMOXGUTPOGNY		parent_pubchem_cid	2-{[(7-hydroxy-2-oxo-4-phenyl-2H-chromen-8-yl)methyl]amino}-4-methylpentanoic acid;STL460509;AKOS016376012;N-[(7-hydroxy-2-oxo-4-phenyl-2H-chromen-8-yl)methyl]-D-leucine;rac-(2R)-2-[(7-hydroxy-2-oxo-4-phenyl-chromen-8-yl)methylamino]-4-methyl-pentanoic acid		13445171.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=13445171		pluskal_iocb_peptide_Peptide01_C18_id		100	C18		ZINC000004026331
2.5		0	332	P1647346	52.7		M36	False	0	19	0	0	29	0	3	2	0	0		0.0						CCN(CC)C(=O)NC(Cc1ccccc1)C(=O)N1CCCCC1																							0.0		AKOS027475301		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0		C19H29N3O2	C19H29N3O2			InChI=1S/C19H29N3O2/c1-3-21(4-2)19(24)20-17(15-16-11-7-5-8-12-16)18(23)22-13-9-6-10-14-22/h5,7-8,11-12,17H,3-4,6,9-10,13-15H2,1-2H3,(H,20,24)/t17-/m0/s1	AVDUVLWDZJBEOB-KRWDZBQOSA-N	1,1-diethyl-3-[rac-(1S)-1-benzyl-2-oxo-2-(1-piperidyl)ethyl]urea	110347393	CCN(CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCCCC1	1,1-diethyl-3-[(2S)-1-oxo-3-phenyl-1-piperidin-1-ylpropan-2-yl]urea			2.606890000000001														331.46188		331.225977	2	1	6	2			45									Piperidine alkaloids	False	Alkaloids	Lysine alkaloids			Peptide01			Compound(110347393)	110347393	2.6	523			[#6]-[#6]-[#7](-[#6]-[#6])-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#7]1-[#6]-[#6]-[#6]-[#6]-[#6]-1	CCN(CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCCCC1	AVDUVLWDZJBEOB		parent_pubchem_cid	AKOS027475301;1,1-diethyl-3-[rac-(1S)-1-benzyl-2-oxo-2-(1-piperidyl)ethyl]urea		12834743.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=12834743		pluskal_iocb_peptide_Peptide01_C18_id		100	C18		ZINC000041247081
4.2		0	76	P7211730794	91.9		M37	False	0	19	0	0	23	0	1	4	0	1		0.0						Cc1cc(C)c(C)c(S(=O)(=O)NC(Cc2ccccc2)C(=O)O)c1C																							0.0		((2,3,5,6-tetramethylphenyl)sulfonyl)phenylalanine		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0		C19H23NO4S	C19H23NO4S			InChI=1S/C19H23NO4S/c1-12-10-13(2)15(4)18(14(12)3)25(23,24)20-17(19(21)22)11-16-8-6-5-7-9-16/h5-10,17,20H,11H2,1-4H3,(H,21,22)	STQXOMYIGNWPDF-UHFFFAOYSA-N	3-phenyl-2-[(2,3,5,6-tetramethylphenyl)sulfonylamino]propanoic acid	3308469	Cc1cc(C)c(C)c(S(=O)(=O)NC(Cc2ccccc2)C(=O)O)c1C	3-phenyl-2-[(2,3,5,6-tetramethylphenyl)sulfonylamino]propanoic acid			2.5129200000000003													MCULE-2096178712	361.46346		361.134779	4	2	6	2			44										False					Peptide01			Compound(3308469)	3308469	3.9	524			[#6]-[#6]1:[#6]:[#6](-[#6]):[#6](-[#6]):[#6](-[#16](=[#8])(=[#8])-[#7]-[#6](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#8]):[#6]:1-[#6]	Cc1cc(C)c(C)c(S(=O)(=O)NC(Cc2ccccc2)C(=O)O)c1C	STQXOMYIGNWPDF		parent_pubchem_cid	((2,3,5,6-tetramethylphenyl)sulfonyl)phenylalanine;381687-95-2;N-(2,3,5,6-Tetramethylphenylsulfonyl)-DL-phenylalanine;3-phenyl-2-[(2,3,5,6-tetramethylphenyl)sulfonylamino]propanoic Acid;Oprea1_850933;AKOS000805769;AKOS016074106;EN300-240213;SR-01000471416;SR-01000471416-1;Z45636854;F0915-2860;3-phenyl-2-(2,3,5,6-tetramethylbenzenesulfonamido)propanoic acid		24811520.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24811520		pluskal_iocb_peptide_Peptide01_C18_id		100	C18		
3.3		0	164	P7020554642	84.2		M38	False	0	20	0	0	25	0	3	3	0	0		0.0						Cc1cc(NC(=O)C(Cc2ccccc2)NC(=O)C2CCCCC2)no1																							0.0		AKOS005581257		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C20H25N3O3	C20H25N3O3			InChI=1S/C20H25N3O3/c1-14-12-18(23-26-14)22-20(25)17(13-15-8-4-2-5-9-15)21-19(24)16-10-6-3-7-11-16/h2,4-5,8-9,12,16-17H,3,6-7,10-11,13H2,1H3,(H,21,24)(H,22,23,25)/t17-/m0/s1	XNTBEJRNGVPLHM-KRWDZBQOSA-N	N-[(1S)-1-benzyl-2-[(5-methylisoxazol-3-yl)amino]-2-oxo-ethyl]cyclohexanecarboxamide	24315155	Cc1cc(NC(=O)[C@H](Cc2ccccc2)NC(=O)C2CCCCC2)no1	N-[(2S)-1-[(5-methyl-1,2-oxazol-3-yl)amino]-1-oxo-3-phenylpropan-2-yl]cyclohexanecarboxamide			2.7392900000000013													MCULE-4452388315	355.44055		355.189592	3	2	6	3			44										False					Peptide01			Compound(24315155)	24315155	3.7	525			[#6]-[#6]1:[#6]:[#6](-[#7]-[#6](=[#8])-[#6@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#7]-[#6](=[#8])-[#6]2-[#6]-[#6]-[#6]-[#6]-[#6]-2):[#7]:[#8]:1	Cc1cc(NC(=O)[C@H](Cc2ccccc2)NC(=O)C2CCCCC2)no1	XNTBEJRNGVPLHM		parent_pubchem_cid	AKOS005581257;N-[(1S)-1-benzyl-2-[(5-methylisoxazol-3-yl)amino]-2-oxo-ethyl]cyclohexanecarboxamide		18002699.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=18002699		pluskal_iocb_peptide_Peptide01_C18_id		100	C18		ZINC000012028712
4.3		0	252	P1301171	76.5		M39	False	0	24	0	0	24	0	2	4	0	0		0.0						CCOc1c(OC)cc(C(CNC(=O)c2ccco2)c2c[nH]c3ccccc23)cc1																							0.0		AKOS001533404		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C24H24N2O4	C24H24N2O4			InChI=1S/C24H24N2O4/c1-3-29-21-11-10-16(13-23(21)28-2)18(14-26-24(27)22-9-6-12-30-22)19-15-25-20-8-5-4-7-17(19)20/h4-13,15,18,25H,3,14H2,1-2H3,(H,26,27)	MLXJIFHITMIZBZ-UHFFFAOYSA-N	N-[2-(4-ethoxy-3-methoxy-phenyl)-2-(1H-indol-3-yl)ethyl]furan-2-carboxamide	17010907	CCOc1c(OC)cc(C(CNC(=O)c2ccco2)c2c[nH]c3ccccc23)cc1	N-[2-(4-ethoxy-3-methoxyphenyl)-2-(1H-indol-3-yl)ethyl]furan-2-carboxamide			3.2127300000000014													MCULE-5918553026	404.46988		404.173607	3	2	8	4			45										False	Alkaloids				Peptide01			Compound(17010907)	17010907	4.4	526			[#6]-[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]):[#6]:[#6](-[#6](-[#6]-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#8]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	CCOc1c(OC)cc(C(CNC(=O)c2ccco2)c2c[nH]c3ccccc23)cc1	MLXJIFHITMIZBZ		parent_pubchem_cid	AKOS001533404;AKOS016325318;N-[2-(4-ethoxy-3-methoxyphenyl)-2-(1H-indol-3-yl)ethyl]furan-2-carboxamide;N-[2-(4-ethoxy-3-methoxy-phenyl)-2-(1H-indol-3-yl)ethyl]furan-2-carboxamide		22753093.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22753093		pluskal_iocb_peptide_Peptide01_C18_id		100	C18		
1.0		0	340	P7008502	95.9		M40	False	0	14	0	0	14	0	6	1	0	0		0.0						OCCNc1nc(Nc2ccccc2)nc2nccnc12																							0.0		2-{[2-(phenylamino)pteridin-4-yl]amino}ethan-1-ol		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0		C14H14N6O	C14H14N6O			InChI=1S/C14H14N6O/c21-9-8-17-13-11-12(16-7-6-15-11)19-14(20-13)18-10-4-2-1-3-5-10/h1-7,21H,8-9H2,(H2,16,17,18,19,20)	BCJAUNBFAQZCPN-UHFFFAOYSA-N	2-[(2-anilinopteridin-4-yl)amino]ethanol	39343463	OCCNc1nc(Nc2ccccc2)nc2nccnc12	2-[(2-anilinopteridin-4-yl)amino]ethanol			-0.0026500000000009													MCULE-8502725104	282.30728		282.122909	7	3	5	3			44									Pyrazine and Piperazine alkaloids	False	Alkaloids	Tetramate alkaloids;Peptide alkaloids			Peptide01			Compound(39343463)	39343463	1.3	527			[#8]-[#6]-[#6]-[#7]-[#6]1:[#7]:[#6](-[#7]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#7]:[#6]2:[#7]:[#6]:[#6]:[#7]:[#6]:1:2	OCCNc1nc(Nc2ccccc2)nc2nccnc12	BCJAUNBFAQZCPN		parent_pubchem_cid	2-{[2-(phenylamino)pteridin-4-yl]amino}ethan-1-ol;1144430-84-1;2-((2-(phenylamino)pteridin-4-yl)amino)ethanol;2-{[2-(phenylamino)pteridin-4-yl]amino}ethanol;STK656875;STL318687;AKOS002337439;AKOS022141230;NCGC00302507-01;AB01300498-01;2-{[(2E)-2-(phenylimino)-1,2-dihydropteridin-4-yl]amino}ethanol;2-[(2-anilinopteridin-4-yl)amino]ethanol		4760390.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=4760390		pluskal_iocb_peptide_Peptide01_C18_id		100	C18		ZINC000032097425
1.9		0	84	P4798630	75.6		M41	False	0	19	0	0	26	0	6	2	0	0		0.0						Cc1c(C)c(Nc2nc(N3CCOCC3)nc(N3CCOCC3)n2)ccc1																							0.0		AKOS016394232		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	2		C19H26N6O2	C19H26N6O2			InChI=1S/C19H26N6O2/c1-14-4-3-5-16(15(14)2)20-17-21-18(24-6-10-26-11-7-24)23-19(22-17)25-8-12-27-13-9-25/h3-5H,6-13H2,1-2H3,(H,20,21,22,23)	NJTLKCNQQGKANH-UHFFFAOYSA-N	N-(2,3-dimethylphenyl)-4,6-dimorpholino-1,3,5-triazin-2-amine	7589319	Cc1c(C)c(Nc2nc(N3CCOCC3)nc(N3CCOCC3)n2)ccc1	N-(2,3-dimethylphenyl)-4,6-dimorpholin-4-yl-1,3,5-triazin-2-amine			0.2733800000000015													MCULE-3746857055	370.45807		370.211724	8	1	4	4			44										False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(7589319)	7589319	2.7	528			[#6]-[#6]1:[#6](-[#6]):[#6](-[#7]-[#6]2:[#7]:[#6](-[#7]3-[#6]-[#6]-[#8]-[#6]-[#6]-3):[#7]:[#6](-[#7]3-[#6]-[#6]-[#8]-[#6]-[#6]-3):[#7]:2):[#6]:[#6]:[#6]:1	Cc1c(C)c(Nc2nc(N3CCOCC3)nc(N3CCOCC3)n2)ccc1	NJTLKCNQQGKANH		parent_pubchem_cid	AKOS016394232;N-(2,3-dimethylphenyl)-4,6-dimorpholino-1,3,5-triazin-2-amine		16760609.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=16760609		pluskal_iocb_peptide_Peptide01_C19_id		100	C19		ZINC000005255830
2.3		0	172	P7020554640	84.2		M42	False	0	17	0	0	21	0	3	3	0	0		0.0						Cc1cc(NC(=O)C(Cc2ccccc2)NC(=O)C(C)C)no1																							0.0		AKOS005586935		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C17H21N3O3	C17H21N3O3			InChI=1S/C17H21N3O3/c1-11(2)16(21)18-14(10-13-7-5-4-6-8-13)17(22)19-15-9-12(3)23-20-15/h4-9,11,14H,10H2,1-3H3,(H,18,21)(H,19,20,22)/t14-/m0/s1	KXSNMBPYLXBZNL-AWEZNQCLSA-N	N-[(1S)-1-benzyl-2-[(5-methylisoxazol-3-yl)amino]-2-oxo-ethyl]-2-methyl-propanamide	24315153	Cc1cc(NC(=O)[C@H](Cc2ccccc2)NC(=O)C(C)C)no1	2-methyl-N-[(2S)-1-[(5-methyl-1,2-oxazol-3-yl)amino]-1-oxo-3-phenylpropan-2-yl]propanamide			1.81499													MCULE-2770831697	315.37522		315.158292	3	2	6	2			44										False					Peptide01			Compound(24315153)	24315153	2.7	529			[#6]-[#6]1:[#6]:[#6](-[#7]-[#6](=[#8])-[#6@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#7]-[#6](=[#8])-[#6](-[#6])-[#6]):[#7]:[#8]:1	Cc1cc(NC(=O)[C@H](Cc2ccccc2)NC(=O)C(C)C)no1	KXSNMBPYLXBZNL		parent_pubchem_cid	AKOS005586935;1134368-62-9;(S)-2-Isobutyramido-N-(5-methylisoxazol-3-yl)-3-phenylpropanamide;N-[(1S)-1-benzyl-2-[(5-methylisoxazol-3-yl)amino]-2-oxo-ethyl]-2-methyl-propanamide		5107589.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=5107589		pluskal_iocb_peptide_Peptide01_C19_id		100	C19		ZINC000012028706
4.9		0	260	P1305485	54.1		M43	False	0	25	0	0	24	0	2	2	0	0		0.0						Cc1ccc(OCC(=O)NCC(c2ccccc2)c2c[nH]c3ccccc23)cc1																							0.0		N-[2-(1H-indol-3-yl)-2-phenylethyl]-2-(4-methylphenoxy)acetamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C25H24N2O2	C25H24N2O2			InChI=1S/C25H24N2O2/c1-18-11-13-20(14-12-18)29-17-25(28)27-15-22(19-7-3-2-4-8-19)23-16-26-24-10-6-5-9-21(23)24/h2-14,16,22,26H,15,17H2,1H3,(H,27,28)	SHSPJZIQQHQSHD-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]-2-(4-methylphenoxy)acetamide	17014632	Cc1ccc(OCC(=O)NCC(c2ccccc2)c2c[nH]c3ccccc23)cc1	N-[2-(1H-indol-3-yl)-2-phenylethyl]-2-(4-methylphenoxy)acetamide			3.7484600000000015													MCULE-6214568252	384.48223		384.183778	2	2	7	4			45										False	Alkaloids				Peptide01			Compound(17014632)	17014632	5.1	530			[#6]-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]-[#6](=[#8])-[#7]-[#6]-[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	Cc1ccc(OCC(=O)NCC(c2ccccc2)c2c[nH]c3ccccc23)cc1	SHSPJZIQQHQSHD		parent_pubchem_cid	N-[2-(1H-indol-3-yl)-2-phenylethyl]-2-(4-methylphenoxy)acetamide;AKOS002335619;AKOS016326696;N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]-2-(4-methylphenoxy)acetamide		23024213.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23024213		pluskal_iocb_peptide_Peptide01_C19_id		100	C19		
3.5		0	348	P4798610	75.2		M44	False	0	21	0	0	24	0	6	1	0	0		0.0						Cc1ccccc1Nc1nc(Nc2ccccc2C)nc(N2CCOCC2)n1																							0.0		AKOS005455124		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1		C21H24N6O	C21H24N6O			InChI=1S/C21H24N6O/c1-15-7-3-5-9-17(15)22-19-24-20(23-18-10-6-4-8-16(18)2)26-21(25-19)27-11-13-28-14-12-27/h3-10H,11-14H2,1-2H3,(H2,22,23,24,25,26)	XSZAOTWWOIYVJP-UHFFFAOYSA-N	6-morpholino-N2,N4-bis(o-tolyl)-1,3,5-triazine-2,4-diamine	1213346	Cc1ccccc1Nc1nc(Nc2ccccc2C)nc(N2CCOCC2)n1	2-N,4-N-bis(2-methylphenyl)-6-morpholin-4-yl-1,3,5-triazine-2,4-diamine			1.7997699999999996													MCULE-1954529554	376.46503		376.201159	7	2	5	4			44										False	Alkaloids				Peptide01			Compound(1213346)	1213346	4.5	531			[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#7]-[#6]1:[#7]:[#6](-[#7]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6]):[#7]:[#6](-[#7]2-[#6]-[#6]-[#8]-[#6]-[#6]-2):[#7]:1	Cc1ccccc1Nc1nc(Nc2ccccc2C)nc(N2CCOCC2)n1	XSZAOTWWOIYVJP		parent_pubchem_cid	AKOS005455124;AB00692561-01;SR-01000255270;SR-01000255270-1;N2,N4-BIS(2-METHYLPHENYL)-6-(MORPHOLIN-4-YL)-1,3,5-TRIAZINE-2,4-DIAMINE;6-morpholino-N2,N4-bis(o-tolyl)-1,3,5-triazine-2,4-diamine		9581103.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=9581103		pluskal_iocb_peptide_Peptide01_C19_id		100	C19		ZINC000000986401
1.8		0	356	P1094971	139.3		N1	False	0	24	0	0	28	0	4	6	0	0		0.0						O=C(O)C(Cc1ccccc1)NC(=O)N1CCN(C(=O)NC(Cc2ccccc2)C(=O)O)CC1																							0.0		AKOS005533539		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	4	0	2	0	0	0	0	0	0	0	0	4	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C24H28N4O6	C24H28N4O6			InChI=1S/C24H28N4O6/c29-21(30)19(15-17-7-3-1-4-8-17)25-23(33)27-11-13-28(14-12-27)24(34)26-20(22(31)32)16-18-9-5-2-6-10-18/h1-10,19-20H,11-16H2,(H,25,33)(H,26,34)(H,29,30)(H,31,32)/t19-,20-/m0/s1	AAJNUQCUXATYLI-PMACEKPBSA-N	rac-(2S)-3-phenyl-2-[[4-[[rac-(1S)-1-carboxy-2-phenyl-ethyl]carbamoyl]piperazine-1-carbonyl]amino]propanoic acid	17578630	O=C(O)[C@H](Cc1ccccc1)NC(=O)N1CCN(C(=O)N[C@@H](Cc2ccccc2)C(=O)O)CC1	(2S)-2-[[4-[[(1S)-1-carboxy-2-phenylethyl]carbamoyl]piperazine-1-carbonyl]amino]-3-phenylpropanoic acid			1.3055800000000006													MCULE-9547734895	468.51396		468.200885	6	4	8	3			44										False	Amino acids and Peptides	Small peptides			Peptide01			Compound(17578630)	17578630	1.8	532			[#8]=[#6](-[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#7]1-[#6]-[#6]-[#7](-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#8])-[#6]-[#6]-1	O=C(O)[C@H](Cc1ccccc1)NC(=O)N1CCN(C(=O)N[C@@H](Cc2ccccc2)C(=O)O)CC1	AAJNUQCUXATYLI		parent_pubchem_cid	AKOS005533539;(2S)-2-({[4-({[(1S)-1-BENZYL-2-HYDROXY-2-OXOETHYL]AMINO}CARBONYL)PIPERAZINO]CARBONYL}AMINO)-3-PHENYLPROPANOIC ACID;rac-(2S)-3-phenyl-2-[[4-[[rac-(1S)-1-carboxy-2-phenyl-ethyl]carbamoyl]piperazine-1-carbonyl]amino]propanoic acid		24251176.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24251176		pluskal_iocb_peptide_Peptide01_C19_id		100	C19		ZINC000009216197
3.7		0	444	P2196136	143.8		N2	False	0	20	1	0	25	0	4	3	0	2		0.0						CCCSc1ncc(Cl)c(C(=O)NC(CCSC)C(=O)Nc2cc(OC)ccc2)n1																							0.0		AKOS016027396		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C20H25ClN4O3S2	C20H25ClN4O3S2			InChI=1S/C20H25ClN4O3S2/c1-4-9-30-20-22-12-15(21)17(25-20)19(27)24-16(8-10-29-3)18(26)23-13-6-5-7-14(11-13)28-2/h5-7,11-12,16H,4,8-10H2,1-3H3,(H,23,26)(H,24,27)	YRGRJSSYXJANTL-UHFFFAOYSA-N	5-chloro-N-[1-[(3-methoxyphenyl)carbamoyl]-3-methylsulfanyl-propyl]-2-propylsulfanyl-pyrimidine-4-carboxamide	52988689	CCCSc1ncc(Cl)c(C(=O)NC(CCSC)C(=O)Nc2cc(OC)ccc2)n1	5-chloro-N-[1-(3-methoxyanilino)-4-methylsulfanyl-1-oxobutan-2-yl]-2-propylsulfanylpyrimidine-4-carboxamide			3.125160000000001													MCULE-5586101920	469.02825		468.10566	7	2	11	2			45										False	Alkaloids				Peptide01			Compound(52988689)	52988689	4.1	533			[#6]-[#6]-[#6]-[#16]-[#6]1:[#7]:[#6]:[#6](-[#17]):[#6](-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]-[#16]-[#6])-[#6](=[#8])-[#7]-[#6]2:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:[#6]:2):[#7]:1	CCCSc1ncc(Cl)c(C(=O)NC(CCSC)C(=O)Nc2cc(OC)ccc2)n1	YRGRJSSYXJANTL		parent_pubchem_cid	AKOS016027396;5-chloro-N-[1-[(3-methoxyphenyl)carbamoyl]-3-methylsulfanyl-propyl]-2-propylsulfanyl-pyrimidine-4-carboxamide		23990531.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23990531		pluskal_iocb_peptide_Peptide01_C19_id		100	C19		
4.9		0	532	P2190663	67.7		N3	False	0	27	0	0	22	0	2	2	0	1		0.0						O=C(C1=C(c2ccccc2)SCCO1)N(Cc1cccc2ccccc12)c1ccccn1																							0.0		N-(naphthalen-1-ylmethyl)-3-phenyl-N-(pyridin-2-yl)-5,6-dihydro-1,4-oxathiine-2-carboxamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0		C27H22N2O2S	C27H22N2O2S			InChI=1S/C27H22N2O2S/c30-27(25-26(32-18-17-31-25)21-10-2-1-3-11-21)29(24-15-6-7-16-28-24)19-22-13-8-12-20-9-4-5-14-23(20)22/h1-16H,17-19H2	YOGUTBPPMCRVEP-UHFFFAOYSA-N	N-(1-naphthylmethyl)-5-phenyl-N-(2-pyridyl)-2,3-dihydro-1,4-oxathiine-6-carboxamide	29139924	O=C(C1=C(c2ccccc2)SCCO1)N(Cc1cccc2ccccc12)c1ccccn1	N-(naphthalen-1-ylmethyl)-5-phenyl-N-pyridin-2-yl-2,3-dihydro-1,4-oxathiine-6-carboxamide			4.981750000000004													MCULE-6700262578	438.55259		438.140199	4	0	5	5			44										False	Shikimates and Phenylpropanoids				Peptide01			Compound(29139924)	29139924	5.6	534			[#8]=[#6](-[#6]1=[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#16]-[#6]-[#6]-[#8]-1)-[#7](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6]1:[#6]:[#6]:[#6]:[#6]:[#7]:1	O=C(C1=C(c2ccccc2)SCCO1)N(Cc1cccc2ccccc12)c1ccccn1	YOGUTBPPMCRVEP		parent_pubchem_cid	N-(naphthalen-1-ylmethyl)-3-phenyl-N-(pyridin-2-yl)-5,6-dihydro-1,4-oxathiine-2-carboxamide;1018067-59-8;AKOS005575329;N-(1-naphthylmethyl)-5-phenyl-N-(2-pyridyl)-2,3-dihydro-1,4-oxathiine-6-carboxamide		11275602.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=11275602		pluskal_iocb_peptide_Peptide01_C19_id		100	C19		ZINC000020745242
4.6		0	620	P1305503	54.1		N4	False	0	24	0	0	22	0	2	2	0	0		0.0						COc1ccc(C(=O)NCC(c2ccccc2)c2c[nH]c3ccccc23)cc1																							0.0		N-[2-(1H-indol-3-yl)-2-phenylethyl]-4-methoxybenzamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C24H22N2O2	C24H22N2O2			InChI=1S/C24H22N2O2/c1-28-19-13-11-18(12-14-19)24(27)26-15-21(17-7-3-2-4-8-17)22-16-25-23-10-6-5-9-20(22)23/h2-14,16,21,25H,15H2,1H3,(H,26,27)	KRONRNGAWUGYEB-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]-4-methoxy-benzamide	17014649	COc1ccc(C(=O)NCC(c2ccccc2)c2c[nH]c3ccccc23)cc1	N-[2-(1H-indol-3-yl)-2-phenylethyl]-4-methoxybenzamide			3.683440000000002													MCULE-8479556721	370.45514		370.168128	2	2	6	4			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(17014649)	17014649	4.7	535			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](=[#8])-[#7]-[#6]-[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	COc1ccc(C(=O)NCC(c2ccccc2)c2c[nH]c3ccccc23)cc1	KRONRNGAWUGYEB		parent_pubchem_cid	N-[2-(1H-indol-3-yl)-2-phenylethyl]-4-methoxybenzamide;HMS3456C12;AKOS002334868;AKOS016326714;N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]-4-methoxy-benzamide		24215991.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24215991		pluskal_iocb_peptide_Peptide01_C19_id		100	C19		
2.0		0	364	P6237108	129.6		N5	False	0	25	0	0	30	0	4	6	0	0		0.0						COc1c(OC)cc2c(=O)n(CC(=O)NC(C(=O)NCCc3ccc(O)cc3)C(C)C)cnc2c1								Valine and derivatives;Alpha amino acid amides;Quinazolines;Anisoles;Pyrimidones;1-hydroxy-2-unsubstituted benzenoids;Alkyl aryl ethers;N-acyl amines;Benzene and substituted derivatives;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactams;Azacyclic compounds;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organonitrogen compounds	1-hydroxy-2-unsubstituted benzenoids;Alkyl aryl ethers;Alpha amino acid amides;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Anisoles;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Benzodiazines;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Diazanaphthalenes;Diazines;Ethers;Fatty Acyls;Fatty amides;Heteroaromatic compounds;Hydrocarbon derivatives;Lactams;Lipids and lipid-like molecules;N-acyl amines;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenol ethers;Phenols;Pyrimidines and pyrimidine derivatives;Pyrimidones;Quinazolines;Secondary carboxylic acid amides;Valine and derivatives	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acyl-alpha amino acids and derivatives. These are compounds containing an alpha amino acid (or a derivative thereof) which bears an acyl group at its terminal nitrogen atom.	N-acyl-alpha amino acids and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	valine derivative (CHEBI:27267);amino acid amide (CHEBI:22475);quinazolines (CHEBI:38530);methoxybenzene (CHEBI:51683);pyrimidone (CHEBI:38337);phenols (CHEBI:33853);aromatic ether (CHEBI:35618);fatty amide (CHEBI:29348);benzenes (CHEBI:22712);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactam (CHEBI:24995);organonitrogen heterocyclic compound (CHEBI:38101);carbonyl compound (CHEBI:36586);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);N-acyl-amino acid (CHEBI:51569);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);organooxygen compound (CHEBI:36963);organic heterocyclic compound (CHEBI:24532);azaarene (CHEBI:50893);benzenoid aromatic compound (CHEBI:33836);diazines (CHEBI:38313);pyrimidines (CHEBI:39447);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ether (CHEBI:25698);lipid (CHEBI:18059);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);amino acid (CHEBI:33709);peptide (CHEBI:16670)	N-acyl amines (FA0802);Fatty Acyls (FA);Fatty amides (FA08)	Amino acids, peptides, and analogues	Valine or derivatives;N-acyl-alpha amino acid or derivatives;Alpha-amino acid amide;Quinazoline;Anisole;Phenol ether;Alkyl aryl ether;1-hydroxy-2-unsubstituted benzenoid;Phenol;Pyrimidone;Monocyclic benzene moiety;Fatty amide;N-acyl-amine;Pyrimidine;Fatty acyl;Benzenoid;Heteroaromatic compound;Lactam;Carboxamide group;Secondary carboxylic acid amide;Ether;Azacycle;Organoheterocyclic compound;Organooxygen compound;Organonitrogen compound;Hydrocarbon derivative;Organic oxide;Organic oxygen compound;Organic nitrogen compound;Carbonyl group;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		SCHEMBL22796498		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1	0		C25H30N4O6	C25H30N4O6			InChI=1S/C25H30N4O6/c1-15(2)23(24(32)26-10-9-16-5-7-17(30)8-6-16)28-22(31)13-29-14-27-19-12-21(35-4)20(34-3)11-18(19)25(29)33/h5-8,11-12,14-15,23,30H,9-10,13H2,1-4H3,(H,26,32)(H,28,31)/t23-/m0/s1	NZNUESWBQPUJHN-QHCPKHFHSA-N	rac-(2S)-2-[[2-(6,7-dimethoxy-4-oxo-quinazolin-3-yl)acetyl]amino]-N-[2-(4-hydroxyphenyl)ethyl]-3-methyl-butanamide	29147853	COc1c(OC)cc2c(=O)n(CC(=O)N[C@H](C(=O)NCCc3ccc(O)cc3)C(C)C)cnc2c1	(2S)-2-[[2-(6,7-dimethoxy-4-oxoquinazolin-3-yl)acetyl]amino]-N-[2-(4-hydroxyphenyl)ethyl]-3-methylbutanamide			0.648530000000002													MCULE-1519554419	482.54105		482.216535	7	3	10	3			43										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(29147853)	29147853	2.5	536		SCHEMBL22796498	[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]):[#6]:[#6]2:[#6](=[#8]):[#7](-[#6]-[#6](=[#8])-[#7]-[#6@H](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]3:[#6]:[#6]:[#6](-[#8]):[#6]:[#6]:3)-[#6](-[#6])-[#6]):[#6]:[#7]:[#6]:2:[#6]:1	COc1c(OC)cc2c(=O)n(CC(=O)N[C@H](C(=O)NCCc3ccc(O)cc3)C(C)C)cnc2c1	NZNUESWBQPUJHN		parent_pubchem_cid	SCHEMBL22796498;AKOS016376599;rac-(2S)-2-[[2-(6,7-dimethoxy-4-oxo-quinazolin-3-yl)acetyl]amino]-N-[2-(4-hydroxyphenyl)ethyl]-3-methyl-butanamide		5908959.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=5908959		pluskal_iocb_peptide_Peptide01_C20_id		100	C20		ZINC000020762178
3.9		0	452	P2195428	67.4		N6	False	0	22	0	0	28	0	2	3	0	0		0.0						COc1ccc(C(=O)NC(CC(C)C)C(=O)NCc2ccc(C)cc2)cc1																							0.0		AKOS015861394		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C22H28N2O3	C22H28N2O3			InChI=1S/C22H28N2O3/c1-15(2)13-20(22(26)23-14-17-7-5-16(3)6-8-17)24-21(25)18-9-11-19(27-4)12-10-18/h5-12,15,20H,13-14H2,1-4H3,(H,23,26)(H,24,25)	LLKWRODRJPIGCR-UHFFFAOYSA-N	4-methoxy-N-[3-methyl-1-(p-tolylmethylcarbamoyl)butyl]benzamide	51065895	COc1ccc(C(=O)NC(CC(C)C)C(=O)NCc2ccc(C)cc2)cc1	4-methoxy-N-[4-methyl-1-[(4-methylphenyl)methylamino]-1-oxopentan-2-yl]benzamide			2.837980000000001													MCULE-7977616044	368.48006		368.209993	3	2	8	2			45									Dipeptides;Phenylalanine-derived alkaloids	False	Alkaloids;Amino acids and Peptides	Pseudoalkaloids;Small peptides			Peptide01			Compound(51065895)	51065895	4.1	537			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](=[#8])-[#7]-[#6](-[#6]-[#6](-[#6])-[#6])-[#6](=[#8])-[#7]-[#6]-[#6]2:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:2):[#6]:[#6]:1	COc1ccc(C(=O)NC(CC(C)C)C(=O)NCc2ccc(C)cc2)cc1	LLKWRODRJPIGCR		parent_pubchem_cid	AKOS015861394;4-methoxy-N-[3-methyl-1-(p-tolylmethylcarbamoyl)butyl]benzamide		23776568.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23776568		pluskal_iocb_peptide_Peptide01_C20_id		100	C20		
2.1		0	540	P2194120	93.7		N7	False	0	19	0	0	28	0	2	5	0	0		0.0						COC(=O)C(CC(C)C)NC(=O)CCCNC(=O)c1ccc(OC)cc1																							0.0		STL217591		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C19H28N2O5	C19H28N2O5			InChI=1S/C19H28N2O5/c1-13(2)12-16(19(24)26-4)21-17(22)6-5-11-20-18(23)14-7-9-15(25-3)10-8-14/h7-10,13,16H,5-6,11-12H2,1-4H3,(H,20,23)(H,21,22)	SEMJWBOACJNLDZ-UHFFFAOYSA-N	methyl 2-[4-[(4-methoxybenzoyl)amino]butanoylamino]-4-methyl-pentanoate	51064931	COC(=O)C(CC(C)C)NC(=O)CCCNC(=O)c1ccc(OC)cc1	methyl 2-[4-[(4-methoxybenzoyl)amino]butanoylamino]-4-methylpentanoate			1.39198													MCULE-6560887323	364.44541		364.199822	5	2	11	1			45									Simple amide alkaloids	False	Alkaloids	Peptide alkaloids			Peptide01			Compound(51064931)	51064931	2.4	538			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=[#8])-[#6]-[#6]-[#6]-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:1	COC(=O)C(CC(C)C)NC(=O)CCCNC(=O)c1ccc(OC)cc1	SEMJWBOACJNLDZ		parent_pubchem_cid	STL217591;AKOS015860377;methyl N-(4-{[(4-methoxyphenyl)carbonyl]amino}butanoyl)leucinate;methyl 2-[4-[(4-methoxybenzoyl)amino]butanoylamino]-4-methyl-pentanoate		24066455.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24066455		pluskal_iocb_peptide_Peptide01_C20_id		100	C20		
4.6		0	628	P1307046	81.9		N8	False	0	23	0	0	19	0	3	3	0	0		0.0						CN(C(=O)c1cc([N+](=O)[O-])ccc1)C(c1ccccc1)c1c[nH]c2ccccc12																							0.0		STL208071		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	1		C23H19N3O3	C23H19N3O3			InChI=1S/C23H19N3O3/c1-25(23(27)17-10-7-11-18(14-17)26(28)29)22(16-8-3-2-4-9-16)20-15-24-21-13-6-5-12-19(20)21/h2-15,22,24H,1H3	CPPHHQDBWSERPQ-UHFFFAOYSA-N	N-[1H-indol-3-yl(phenyl)methyl]-N-methyl-3-nitro-benzamide	43843060	CN(C(=O)c1cc([N+](=O)[O-])ccc1)C(c1ccccc1)c1c[nH]c2ccccc12	N-[1H-indol-3-yl(phenyl)methyl]-N-methyl-3-nitrobenzamide			3.964540000000002													MCULE-3089632803	385.42618		385.142641	3	1	5	4			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(43843060)	43843060	4.5	539			[#6]-[#7](-[#6](=[#8])-[#6]1:[#6]:[#6](-[#7+](=[#8])-[#8-]):[#6]:[#6]:[#6]:1)-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CN(C(=O)c1cc([N+](=O)[O-])ccc1)C(c1ccccc1)c1c[nH]c2ccccc12	CPPHHQDBWSERPQ		parent_pubchem_cid	STL208071;AKOS001544255;AKOS016329102;N-[1H-indol-3-yl(phenyl)methyl]-N-methyl-3-nitrobenzamide;N-[(1H-INDOL-3-YL)(PHENYL)METHYL]-N-METHYL-3-NITROBENZAMIDE;N-[1H-indol-3-yl(phenyl)methyl]-N-methyl-3-nitro-benzamide		23874869.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23874869		pluskal_iocb_peptide_Peptide01_C20_id		100	C20		
3.7		0	372	P11184226	75.6		N9	False	0	22	0	0	25	0	1	4	0	0		0.0						CC1(C)CCc2c(ccc(CC(=O)NC(Cc3ccccc3)C(=O)O)c2)O1																							0.0		AKOS027472144		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C22H25NO4	C22H25NO4			InChI=1S/C22H25NO4/c1-22(2)11-10-17-12-16(8-9-19(17)27-22)14-20(24)23-18(21(25)26)13-15-6-4-3-5-7-15/h3-9,12,18H,10-11,13-14H2,1-2H3,(H,23,24)(H,25,26)/t18-/m0/s1	GDFUWOLSIAGNHX-SFHVURJKSA-N	rac-(2S)-2-[[2-(2,2-dimethylchroman-6-yl)acetyl]amino]-3-phenyl-propanoic acid	75491112	CC1(C)CCc2c(ccc(CC(=O)N[C@@H](Cc3ccccc3)C(=O)O)c2)O1	(2S)-2-[[2-(2,2-dimethyl-3,4-dihydrochromen-6-yl)acetyl]amino]-3-phenylpropanoic acid			2.5182600000000006														367.44885		367.178358	4	2	6	3			45										False	Shikimates and Phenylpropanoids				Peptide01			Compound(75491112)	75491112	3.7	540			[#6]-[#6]1(-[#6])-[#6]-[#6]-[#6]2:[#6](:[#6]:[#6]:[#6](-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3)-[#6](=[#8])-[#8]):[#6]:2)-[#8]-1	CC1(C)CCc2c(ccc(CC(=O)N[C@@H](Cc3ccccc3)C(=O)O)c2)O1	GDFUWOLSIAGNHX		parent_pubchem_cid	AKOS027472144;N-[(2,2-dimethyl-3,4-dihydro-2H-1-benzopyran-6-yl)acetyl]-L-phenylalanine;rac-(2S)-2-[[2-(2,2-dimethylchroman-6-yl)acetyl]amino]-3-phenyl-propanoic acid		80415524.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=80415524		pluskal_iocb_peptide_Peptide01_C20_id		100	C20		ZINC000096221017
1.4		0	460	P2195422	141.3		N10	False	0	16	0	0	21	0	3	6	0	0		0.0						CC(C)CC(NC(=O)CCNC(=O)c1ccc([N+](=O)[O-])cc1)C(=O)O																							0.0		STL218884		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	1		C16H21N3O6	C16H21N3O6			InChI=1S/C16H21N3O6/c1-10(2)9-13(16(22)23)18-14(20)7-8-17-15(21)11-3-5-12(6-4-11)19(24)25/h3-6,10,13H,7-9H2,1-2H3,(H,17,21)(H,18,20)(H,22,23)	MMTFGJFXCGKQIT-UHFFFAOYSA-N	4-methyl-2-[3-[(4-nitrobenzoyl)amino]propanoylamino]pentanoic acid	51065891	CC(C)CC(NC(=O)CCNC(=O)c1ccc([N+](=O)[O-])cc1)C(=O)O	4-methyl-2-[3-[(4-nitrobenzoyl)amino]propanoylamino]pentanoic acid			0.8948799999999997													MCULE-3352522256	351.36227		351.143035	6	3	9	1			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51065891)	51065891	1.6	541			[#6]-[#6](-[#6])-[#6]-[#6](-[#7]-[#6](=[#8])-[#6]-[#6]-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#7+](=[#8])-[#8-]):[#6]:[#6]:1)-[#6](=[#8])-[#8]	CC(C)CC(NC(=O)CCNC(=O)c1ccc([N+](=O)[O-])cc1)C(=O)O	MMTFGJFXCGKQIT		parent_pubchem_cid	STL218884;AKOS015861375;N-[(4-nitrophenyl)carbonyl]-beta-alanylleucine;4-methyl-2-[3-[(4-nitrobenzoyl)amino]propanoylamino]pentanoic acid		22861685.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22861685		pluskal_iocb_peptide_Peptide01_C20_id		100	C20		
4.7		0	548	P4355625	61.9		N11	False	0	22	0	0	17	0	3	1	0	0		0.0						N#Cc1c(NCCc2ccccc2)oc(-c2cccc3ccccc23)n1																							0.0		AKOS005183526		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C22H17N3O	C22H17N3O			InChI=1S/C22H17N3O/c23-15-20-22(24-14-13-16-7-2-1-3-8-16)26-21(25-20)19-12-6-10-17-9-4-5-11-18(17)19/h1-12,24H,13-14H2	DMZHUZQJEJSATH-UHFFFAOYSA-N	2-(1-naphthyl)-5-(2-phenylethylamino)oxazole-4-carbonitrile	945975	N#Cc1c(NCCc2ccccc2)oc(-c2cccc3ccccc23)n1	2-naphthalen-1-yl-5-(2-phenylethylamino)-1,3-oxazole-4-carbonitrile			3.722610000000002													MCULE-1943101206	339.40029		339.137162	3	1	5	4			44										False					Peptide01			Compound(945975)	945975	6.1	542			[#7]#[#6]-[#6]1:[#6](-[#7]-[#6]-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#8]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#7]:1	N#Cc1c(NCCc2ccccc2)oc(-c2cccc3ccccc23)n1	DMZHUZQJEJSATH		parent_pubchem_cid	AKOS005183526;NCGC00316729-01;AB01310435-01;Z1213743877;2-(1-naphthyl)-5-(2-phenylethylamino)oxazole-4-carbonitrile		5901639.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=5901639		pluskal_iocb_peptide_Peptide01_C20_id		100	C20		ZINC000000544380
4.0		0	636	P1307426	64.3		N12	False	0	18	0	0	20	0	2	1	0	1		0.0						CCCC(=O)N(C)C(c1cccs1)c1c[nH]c2ccccc12																							0.0		AKOS002292647		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C18H20N2OS	C18H20N2OS			InChI=1S/C18H20N2OS/c1-3-7-17(21)20(2)18(16-10-6-11-22-16)14-12-19-15-9-5-4-8-13(14)15/h4-6,8-12,18-19H,3,7H2,1-2H3	CEYFLFHOHMMVEJ-UHFFFAOYSA-N	N-[1H-indol-3-yl(2-thienyl)methyl]-N-methyl-butanamide	43843126	CCCC(=O)N(C)C(c1cccs1)c1c[nH]c2ccccc12	N-[1H-indol-3-yl(thiophen-2-yl)methyl]-N-methylbutanamide			4.039460000000003													MCULE-6339582407	312.4369		312.129634	1	1	5	3			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(43843126)	43843126	3.6	543			[#6]-[#6]-[#6]-[#6](=[#8])-[#7](-[#6])-[#6](-[#6]1:[#6]:[#6]:[#6]:[#16]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CCCC(=O)N(C)C(c1cccs1)c1c[nH]c2ccccc12	CEYFLFHOHMMVEJ		parent_pubchem_cid	AKOS002292647;AKOS016329176;N-[1H-indol-3-yl(2-thienyl)methyl]-N-methyl-butanamide		23355208.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23355208		pluskal_iocb_peptide_Peptide01_C20_id		100	C20		
4.8		0	380	P1098250	101.9		N13	False	0	25	0	0	27	0	1	6	0	0		0.0						CCCc1cc(=O)oc2c1ccc(OC(C)C(=O)NC(Cc1ccccc1)C(=O)O)c2C																							0.0		EiM07-16928		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C25H27NO6	C25H27NO6			InChI=1S/C25H27NO6/c1-4-8-18-14-22(27)32-23-15(2)21(12-11-19(18)23)31-16(3)24(28)26-20(25(29)30)13-17-9-6-5-7-10-17/h5-7,9-12,14,16,20H,4,8,13H2,1-3H3,(H,26,28)(H,29,30)/t16?,20-/m0/s1	LRKOUHQRTLNNGO-FZCLLLDFSA-N	rac-(2S)-2-[2-(8-methyl-2-oxo-4-propyl-chromen-7-yl)oxypropanoylamino]-3-phenyl-propanoic acid	16399267	CCCc1cc(=O)oc2c1ccc(OC(C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)c2C	(2S)-2-[2-(8-methyl-2-oxo-4-propylchromen-7-yl)oxypropanoylamino]-3-phenylpropanoic acid			3.478250000000002													MCULE-5278925292	437.49704		437.183838	6	2	9	3			45									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(16399267)	16399267	4.5	544			[#6]-[#6]-[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6](-[#6])-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]):[#6]:2-[#6]	CCCc1cc(=O)oc2c1ccc(OC(C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)c2C	LRKOUHQRTLNNGO		parent_pubchem_cid	EiM07-16928;AKOS004937381;2-{2-[(8-METHYL-2-OXO-4-PROPYL-2H-CHROMEN-7-YL)OXY]PROPANAMIDO}-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[2-(8-methyl-2-oxo-4-propyl-chromen-7-yl)oxypropanoylamino]-3-phenyl-propanoic acid		23225103.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23225103		pluskal_iocb_peptide_Peptide01_C21_id		100	C21		
2.1		0	468	P2195431	93.7		N14	False	0	19	0	0	28	0	2	5	0	0		0.0						COC(=O)CCCNC(=O)C(CC(C)C)NC(=O)c1ccc(OC)cc1																							0.0		STL218892		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C19H28N2O5	C19H28N2O5			InChI=1S/C19H28N2O5/c1-13(2)12-16(19(24)20-11-5-6-17(22)26-4)21-18(23)14-7-9-15(25-3)10-8-14/h7-10,13,16H,5-6,11-12H2,1-4H3,(H,20,24)(H,21,23)	SPYJSKIQMYRHCV-UHFFFAOYSA-N	methyl 4-[[2-[(4-methoxybenzoyl)amino]-4-methyl-pentanoyl]amino]butanoate	51065898	COC(=O)CCCNC(=O)C(CC(C)C)NC(=O)c1ccc(OC)cc1	methyl 4-[[2-[(4-methoxybenzoyl)amino]-4-methylpentanoyl]amino]butanoate			1.39198													MCULE-3891669036	364.44541		364.199822	5	2	11	1			45									Simple amide alkaloids	False	Alkaloids	Peptide alkaloids			Peptide01			Compound(51065898)	51065898	2.4	545			[#6]-[#8]-[#6](=[#8])-[#6]-[#6]-[#6]-[#7]-[#6](=[#8])-[#6](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:1	COC(=O)CCCNC(=O)C(CC(C)C)NC(=O)c1ccc(OC)cc1	SPYJSKIQMYRHCV		parent_pubchem_cid	STL218892;AKOS015861418;methyl 4-({N-[(4-methoxyphenyl)carbonyl]leucyl}amino)butanoate;methyl 4-[[2-[(4-methoxybenzoyl)amino]-4-methyl-pentanoyl]amino]butanoate		24583616.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24583616		pluskal_iocb_peptide_Peptide01_C21_id		100	C21		
3.9		0	556	P7006438	74.8		N15	False	0	25	0	0	24	0	4	3	0	0		0.0						N#Cc1c(N2CCN(Cc3cc4c(cc3)OCO4)CC2)oc(C2CC2c2ccccc2)n1																							0.0		AKOS024254886		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2		C25H24N4O3	C25H24N4O3			InChI=1S/C25H24N4O3/c26-14-21-25(32-24(27-21)20-13-19(20)18-4-2-1-3-5-18)29-10-8-28(9-11-29)15-17-6-7-22-23(12-17)31-16-30-22/h1-7,12,19-20H,8-11,13,15-16H2	SEHURMBCXDCBHO-UHFFFAOYSA-N	5-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-2-(2-phenylcyclopropyl)oxazole-4-carbonitrile	73253959	N#Cc1c(N2CCN(Cc3cc4c(cc3)OCO4)CC2)oc(C2CC2c2ccccc2)n1	5-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-2-(2-phenylcyclopropyl)-1,3-oxazole-4-carbonitrile			2.344010000000001													MCULE-3456032293	428.49503		428.184841	6	0	5	6			45										False	Alkaloids				Peptide01			Compound(73253959)	73253959	3.9	546			[#7]#[#6]-[#6]1:[#6](-[#7]2-[#6]-[#6]-[#7](-[#6]-[#6]3:[#6]:[#6]4:[#6](:[#6]:[#6]:3)-[#8]-[#6]-[#8]-4)-[#6]-[#6]-2):[#8]:[#6](-[#6]2-[#6]-[#6]-2-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#7]:1	N#Cc1c(N2CCN(Cc3cc4c(cc3)OCO4)CC2)oc(C2CC2c2ccccc2)n1	SEHURMBCXDCBHO		parent_pubchem_cid	AKOS024254886;5-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-2-(2-phenylcyclopropyl)oxazole-4-carbonitrile		69862735.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=69862735		pluskal_iocb_peptide_Peptide01_C21_id		100	C21		
4.4		0	644	P1306155	63.4		N16	False	0	25	0	0	24	0	2	3	0	0		0.0						COc1ccc(C(CNC(=O)COc2ccccc2)c2c[nH]c3ccccc23)cc1																							0.0		N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-phenoxyacetamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C25H24N2O3	C25H24N2O3			InChI=1S/C25H24N2O3/c1-29-19-13-11-18(12-14-19)22(23-16-26-24-10-6-5-9-21(23)24)15-27-25(28)17-30-20-7-3-2-4-8-20/h2-14,16,22,26H,15,17H2,1H3,(H,27,28)	AGAAPCKBMLBWNN-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-phenoxy-acetamide	43003885	COc1ccc(C(CNC(=O)COc2ccccc2)c2c[nH]c3ccccc23)cc1	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-phenoxyacetamide			3.040940000000001													MCULE-4918156355	400.48163		400.178693	3	2	8	4			45										False	Alkaloids				Peptide01			Compound(43003885)	43003885	4.7	547			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6]-[#7]-[#6](=[#8])-[#6]-[#8]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	COc1ccc(C(CNC(=O)COc2ccccc2)c2c[nH]c3ccccc23)cc1	AGAAPCKBMLBWNN		parent_pubchem_cid	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-phenoxyacetamide;912891-16-8;HMS3456A22;AKOS002289822;AKOS016329368;Z30425535;N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-phenoxy-acetamide		23265843.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23265843		pluskal_iocb_peptide_Peptide01_C21_id		100	C21		
3.0		0	388	P1108248	138.0		N17	False	0	23	0	0	20	0	2	7	0	0	-1.0	0.0						CC(Oc1cc2c(cc1)ccc(=O)o2)C(=O)NC(Cc1c[nH]c2c1cc(O)cc2)C(=O)O		2.56		0.0	2.59	CHEMBL1590008		N-acyl-alpha amino acids;Coumarins and derivatives;1-benzopyrans;3-alkylindoles;Hydroxyindoles;Pyranones and derivatives;1-hydroxy-2-unsubstituted benzenoids;Alkyl aryl ethers;Substituted pyrroles;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactones;Oxacyclic compounds;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organonitrogen compounds;Organopnictogen compounds	1-benzopyrans;1-hydroxy-2-unsubstituted benzenoids;3-alkylindoles;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Hydroxyindoles;Indoles;Indoles and derivatives;Lactones;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;N-acylserotonins;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenols;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Pyrroles;Secondary carboxylic acid amides;Serotonins;Substituted pyrroles;Tryptamines and derivatives	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acylserotonins. These are aromatic heterocyclic compounds containing a serotonin, in which the amine group is acylated.	N-acylserotonins		Serotonins	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-amino acid (CHEBI:51569);coumarins (CHEBI:23403);1-benzopyran (CHEBI:38443);indoles (CHEBI:24828);hydroxyindoles (CHEBI:84729);pyranone (CHEBI:37963);phenols (CHEBI:33853);aromatic ether (CHEBI:35618);pyrroles (CHEBI:26455);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactone (CHEBI:25000);oxacycle (CHEBI:38104);carbonyl compound (CHEBI:36586);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);organonitrogen heterocyclic compound (CHEBI:38101);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);amino acid (CHEBI:33709);peptide (CHEBI:16670);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);pyrans (CHEBI:26407);benzenoid aromatic compound (CHEBI:33836);oxygen molecular entity (CHEBI:25806);ether (CHEBI:25698);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);tryptamines (CHEBI:27162)	Benzopyranoids (PK1311)	Tryptamines and derivatives	N-acylserotonin;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;Coumarin;Alpha-amino acid or derivatives;Benzopyran;Hydroxyindole;3-alkylindole;1-benzopyran;Indole;Alkyl aryl ether;1-hydroxy-2-unsubstituted benzenoid;Pyranone;Benzenoid;Substituted pyrrole;Pyran;Heteroaromatic compound;Pyrrole;Secondary carboxylic acid amide;Carboxamide group;Lactone;Azacycle;Oxacycle;Carboxylic acid derivative;Monocarboxylic acid or derivatives;Carboxylic acid;Ether;Organic oxygen compound;Organic oxide;Hydrocarbon derivative;Organic nitrogen compound;Organonitrogen compound;Carbonyl group;Organopnictogen compound;Organooxygen compound;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		MLS001140885		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C23H20N2O7	C23H20N2O7			InChI=1S/C23H20N2O7/c1-12(31-16-5-2-13-3-7-21(27)32-20(13)10-16)22(28)25-19(23(29)30)8-14-11-24-18-6-4-15(26)9-17(14)18/h2-7,9-12,19,24,26H,8H2,1H3,(H,25,28)(H,29,30)	HQVRAAHWGUMKGD-UHFFFAOYSA-N	3-(5-hydroxy-1H-indol-3-yl)-2-[2-(2-oxochromen-7-yl)oxypropanoylamino]propanoic acid	4834644	CC(Oc1cc2c(cc1)ccc(=O)o2)C(=O)NC(Cc1c[nH]c2c1cc(O)cc2)C(=O)O	3-(5-hydroxy-1H-indol-3-yl)-2-[2-(2-oxochromen-7-yl)oxypropanoylamino]propanoic acid			1.6228199999999997													MCULE-5498932238	436.42505	ACID	436.127051	7	4	7	4	1.0		30									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins	False	False	Peptide01		-1.0	Compound(4834644)	4834644	3.0	548			[#6]-[#6](-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#6]:[#6]:[#6](=[#8]):[#8]:2)-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:1:[#6]:[#6](-[#8]):[#6]:[#6]:2)-[#6](=[#8])-[#8]	CC(Oc1cc2c(cc1)ccc(=O)o2)C(=O)NC(Cc1c[nH]c2c1cc(O)cc2)C(=O)O	HQVRAAHWGUMKGD		parent_pubchem_cid	MLS001140885;CHEMBL1590008;HMS2270M14;STL464260;AKOS016376893;SMR000650329;AB00864632-06;5-hydroxy-N-{2-[(2-oxo-2H-chromen-7-yl)oxy]propanoyl}tryptophan;3-(5-hydroxy-1H-indol-3-yl)-2-(2-((2-oxo-2H-chromen-7-yl)oxy)propanamido)propanoic acid;3-(5-hydroxy-1H-indol-3-yl)-2-[2-(2-oxochromen-7-yl)oxypropanoylamino]propanoic acid	False	873903.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=873903		pluskal_iocb_peptide_Peptide01_C21_id		100	C21	False	
1.8		0	476	P2195426	93.7		N18	False	0	20	0	0	22	0	2	5	0	0		0.0						COC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)c1ccc(OC)cc1																							0.0		AKOS015861385		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C20H22N2O5	C20H22N2O5			InChI=1S/C20H22N2O5/c1-26-16-10-8-15(9-11-16)19(24)21-13-18(23)22-17(20(25)27-2)12-14-6-4-3-5-7-14/h3-11,17H,12-13H2,1-2H3,(H,21,24)(H,22,23)	WXKSMXFYAIIOSN-UHFFFAOYSA-N	methyl 2-[[2-[(4-methoxybenzoyl)amino]acetyl]amino]-3-phenyl-propanoate	51065893	COC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)c1ccc(OC)cc1	methyl 2-[[2-[(4-methoxybenzoyl)amino]acetyl]amino]-3-phenylpropanoate			0.7536699999999998													MCULE-7625596864	370.40874		370.152872	5	2	9	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51065893)	51065893	2.0	549			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:1	COC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)c1ccc(OC)cc1	WXKSMXFYAIIOSN		parent_pubchem_cid	AKOS015861385;methyl 2-[[2-[(4-methoxybenzoyl)amino]acetyl]amino]-3-phenyl-propanoate		24261914.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24261914		pluskal_iocb_peptide_Peptide01_C21_id		100	C21		
4.7		0	564	P2190591	45.3		N19	False	0	24	0	0	22	0	2	2	0	0		0.0						COc1ccc(C(=O)N(C)C(c2ccccc2)c2c[nH]c3ccccc23)cc1																							0.0		AKOS004934483		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C24H22N2O2	C24H22N2O2			InChI=1S/C24H22N2O2/c1-26(24(27)18-12-14-19(28-2)15-13-18)23(17-8-4-3-5-9-17)21-16-25-22-11-7-6-10-20(21)22/h3-16,23,25H,1-2H3	HFIHNFAZPHEXFI-UHFFFAOYSA-N	N-[1H-indol-3-yl(phenyl)methyl]-4-methoxy-N-methyl-benzamide	45133011	COc1ccc(C(=O)N(C)C(c2ccccc2)c2c[nH]c3ccccc23)cc1	N-[1H-indol-3-yl(phenyl)methyl]-4-methoxy-N-methylbenzamide			3.9831400000000015													MCULE-3662237939	370.45514		370.168128	2	1	5	4			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(45133011)	45133011	4.7	550			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](=[#8])-[#7](-[#6])-[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	COc1ccc(C(=O)N(C)C(c2ccccc2)c2c[nH]c3ccccc23)cc1	HFIHNFAZPHEXFI		parent_pubchem_cid	AKOS004934483;N-[(1H-INDOL-3-YL)(PHENYL)METHYL]-4-METHOXY-N-METHYLBENZAMIDE;N-[1H-indol-3-yl(phenyl)methyl]-4-methoxy-N-methyl-benzamide		23921609.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23921609		pluskal_iocb_peptide_Peptide01_C21_id		100	C21		
4.9		0	652	P1301175	72.6		N20	False	0	27	0	0	28	0	2	4	0	0		0.0						CCOc1c(OC)cc(C(CNC(=O)c2ccccc2OC)c2c[nH]c3ccccc23)cc1																							0.0		AKOS001533234		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C27H28N2O4	C27H28N2O4			InChI=1S/C27H28N2O4/c1-4-33-25-14-13-18(15-26(25)32-3)21(22-17-28-23-11-7-5-9-19(22)23)16-29-27(30)20-10-6-8-12-24(20)31-2/h5-15,17,21,28H,4,16H2,1-3H3,(H,29,30)	SKOWYWXIGFWKMZ-UHFFFAOYSA-N	N-[2-(4-ethoxy-3-methoxy-phenyl)-2-(1H-indol-3-yl)ethyl]-2-methoxy-benzamide	17010911	CCOc1c(OC)cc(C(CNC(=O)c2ccccc2OC)c2c[nH]c3ccccc23)cc1	N-[2-(4-ethoxy-3-methoxyphenyl)-2-(1H-indol-3-yl)ethyl]-2-methoxybenzamide			3.1659200000000007													MCULE-1822342610	444.53521		444.204907	4	2	9	4			45										False	Alkaloids				Peptide01			Compound(17010911)	17010911	5.0	551			[#6]-[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]):[#6]:[#6](-[#6](-[#6]-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#8]-[#6])-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	CCOc1c(OC)cc(C(CNC(=O)c2ccccc2OC)c2c[nH]c3ccccc23)cc1	SKOWYWXIGFWKMZ		parent_pubchem_cid	AKOS001533234;AKOS016325321;N-[2-(4-ethoxy-3-methoxyphenyl)-2-(1H-indol-3-yl)ethyl]-2-methoxybenzamide;N-[2-(4-ethoxy-3-methoxy-phenyl)-2-(1H-indol-3-yl)ethyl]-2-methoxy-benzamide		23924192.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23924192		pluskal_iocb_peptide_Peptide01_C21_id		100	C21		
4.0		0	396	P7129707	58.2		N21	False	0	22	0	0	32	0	2	2	0	0		0.0						CC(C)C1CCC(C(=O)NC(Cc2ccccc2)C(=O)NC2CC2)CC1																							0.0		AKOS024459954		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C22H32N2O2	C22H32N2O2			InChI=1S/C22H32N2O2/c1-15(2)17-8-10-18(11-9-17)21(25)24-20(22(26)23-19-12-13-19)14-16-6-4-3-5-7-16/h3-7,15,17-20H,8-14H2,1-2H3,(H,23,26)(H,24,25)/t17?,18?,20-/m1/s1	ZBMUNASDLXOVJQ-AFMYVXGZSA-N	4-isopropyl-N-[rac-(1R)-1-benzyl-2-(cyclopropylamino)-2-oxo-ethyl]cyclohexanecarboxamide	71691796	CC(C)C1CCC(C(=O)N[C@H](Cc2ccccc2)C(=O)NC2CC2)CC1	N-[(2R)-1-(cyclopropylamino)-1-oxo-3-phenylpropan-2-yl]-4-propan-2-ylcyclohexane-1-carboxamide			3.400190000000001														356.51254		356.246378	2	2	7	3			45										False	Terpenoids	Sesquiterpenoids			Peptide01			Compound(71691796)	71691796	4.6	552			[#6]-[#6](-[#6])-[#6]1-[#6]-[#6]-[#6](-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#7]-[#6]2-[#6]-[#6]-2)-[#6]-[#6]-1	CC(C)C1CCC(C(=O)N[C@H](Cc2ccccc2)C(=O)NC2CC2)CC1	ZBMUNASDLXOVJQ		parent_pubchem_cid	AKOS024459954;4-isopropyl-N-[rac-(1R)-1-benzyl-2-(cyclopropylamino)-2-oxo-ethyl]cyclohexanecarboxamide		43047212.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=43047212		pluskal_iocb_peptide_Peptide01_C22_id		100	C22		ZINC000072405445
2.1		0	484	P2195376	93.7		N22	False	0	21	0	0	24	0	2	5	0	0		0.0						COC(=O)C(Cc1ccccc1)NC(=O)CCNC(=O)c1cc(OC)ccc1																							0.0		AKOS015861480		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C21H24N2O5	C21H24N2O5			InChI=1S/C21H24N2O5/c1-27-17-10-6-9-16(14-17)20(25)22-12-11-19(24)23-18(21(26)28-2)13-15-7-4-3-5-8-15/h3-10,14,18H,11-13H2,1-2H3,(H,22,25)(H,23,24)	ZPQUNYVTGWOHGQ-UHFFFAOYSA-N	methyl 2-[3-[(3-methoxybenzoyl)amino]propanoylamino]-3-phenyl-propanoate	51065845	COC(=O)C(Cc1ccccc1)NC(=O)CCNC(=O)c1cc(OC)ccc1	methyl 2-[3-[(3-methoxybenzoyl)amino]propanoylamino]-3-phenylpropanoate			1.1437699999999993													MCULE-4905602391	384.43583		384.168522	5	2	10	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51065845)	51065845	2.3	553			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]-[#6]-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:[#6]:1	COC(=O)C(Cc1ccccc1)NC(=O)CCNC(=O)c1cc(OC)ccc1	ZPQUNYVTGWOHGQ		parent_pubchem_cid	AKOS015861480;methyl 2-[3-[(3-methoxybenzoyl)amino]propanoylamino]-3-phenyl-propanoate		24069948.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24069948		pluskal_iocb_peptide_Peptide01_C22_id		100	C22		
4.5		0	572	P4357720	74.8		N23	False	0	27	0	0	24	0	4	3	0	0	-1.0	0.0						N#Cc1c(N2CCN(Cc3cc4c(cc3)OCO4)CC2)oc(Cc2cccc3ccccc23)n1		4.34		0.0	4.5	CHEMBL1586072																	0.0		SMR000045258		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2		C27H24N4O3	C27H24N4O3			InChI=1S/C27H24N4O3/c28-16-23-27(34-26(29-23)15-21-6-3-5-20-4-1-2-7-22(20)21)31-12-10-30(11-13-31)17-19-8-9-24-25(14-19)33-18-32-24/h1-9,14H,10-13,15,17-18H2	LGEGMRVMGQEHDS-UHFFFAOYSA-N	5-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-2-(1-naphthylmethyl)oxazole-4-carbonitrile	664315	N#Cc1c(N2CCN(Cc3cc4c(cc3)OCO4)CC2)oc(Cc2cccc3ccccc23)n1	5-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-2-(naphthalen-1-ylmethyl)-1,3-oxazole-4-carbonitrile			2.38849													MCULE-4370858576	452.51733	NEUTRAL	452.184841	6	0	5	6	0.0		29										False	Alkaloids		False	False	Peptide01		-1.0	Compound(664315)	664315	5.2	554			[#7]#[#6]-[#6]1:[#6](-[#7]2-[#6]-[#6]-[#7](-[#6]-[#6]3:[#6]:[#6]4:[#6](:[#6]:[#6]:3)-[#8]-[#6]-[#8]-4)-[#6]-[#6]-2):[#8]:[#6](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#7]:1	N#Cc1c(N2CCN(Cc3cc4c(cc3)OCO4)CC2)oc(Cc2cccc3ccccc23)n1	LGEGMRVMGQEHDS		parent_pubchem_cid	SMR000045258;MLS000083505;MLS000829630;CHEMBL1586072;HMS2176D13;AKOS005184955;5-{4-[(2H-1,3-BENZODIOXOL-5-YL)METHYL]PIPERAZIN-1-YL}-2-[(NAPHTHALEN-1-YL)METHYL]-1,3-OXAZOLE-4-CARBONITRILE;5-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-2-(1-naphthylmethyl)oxazole-4-carbonitrile	False	993931.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=993931		pluskal_iocb_peptide_Peptide01_C22_id		100	C22	False	ZINC000002235400
4.4		0	660	P1301380	63.4		N24	False	0	23	0	0	28	0	2	3	0	0		0.0						CCCC(=O)NCC(c1cc(OC)c(OCC)cc1)c1c[nH]c2ccccc12																							0.0		N-[2-(4-ethoxy-3-methoxyphenyl)-2-(1H-indol-3-yl)ethyl]butanamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C23H28N2O3	C23H28N2O3			InChI=1S/C23H28N2O3/c1-4-8-23(26)25-14-18(19-15-24-20-10-7-6-9-17(19)20)16-11-12-21(28-5-2)22(13-16)27-3/h6-7,9-13,15,18,24H,4-5,8,14H2,1-3H3,(H,25,26)	DMDMHOSEISFCQH-UHFFFAOYSA-N	N-[2-(4-ethoxy-3-methoxy-phenyl)-2-(1H-indol-3-yl)ethyl]butanamide	17011076	CCCC(=O)NCC(c1cc(OC)c(OCC)cc1)c1c[nH]c2ccccc12	N-[2-(4-ethoxy-3-methoxyphenyl)-2-(1H-indol-3-yl)ethyl]butanamide			3.160740000000001													MCULE-2296697669	380.49121		380.209993	3	2	9	3			45										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(17011076)	17011076	4.2	555			[#6]-[#6]-[#6]-[#6](=[#8])-[#7]-[#6]-[#6](-[#6]1:[#6]:[#6](-[#8]-[#6]):[#6](-[#8]-[#6]-[#6]):[#6]:[#6]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CCCC(=O)NCC(c1cc(OC)c(OCC)cc1)c1c[nH]c2ccccc12	DMDMHOSEISFCQH		parent_pubchem_cid	N-[2-(4-ethoxy-3-methoxyphenyl)-2-(1H-indol-3-yl)ethyl]butanamide;AKOS002326819;AKOS016325601;N-[2-(4-ethoxy-3-methoxy-phenyl)-2-(1H-indol-3-yl)ethyl]butanamide		23509889.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23509889		pluskal_iocb_peptide_Peptide01_C22_id		100	C22		
0.8		0	404	P1095018	106.9		N25	False	0	14	0	0	16	0	2	5	0	0		0.0						CC(NC(=O)N1Cc2ccccc2CC1C(=O)O)C(=O)O																							0.0		AKOS004937369		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	2	0	0	0	0	0	0	0	0	3	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C14H16N2O5	C14H16N2O5			InChI=1S/C14H16N2O5/c1-8(12(17)18)15-14(21)16-7-10-5-3-2-4-9(10)6-11(16)13(19)20/h2-5,8,11H,6-7H2,1H3,(H,15,21)(H,17,18)(H,19,20)/t8-,11-/m0/s1	YBQVTWAORGPJPA-KWQFWETISA-N	rac-(3S)-2-[[rac-(1S)-1-carboxyethyl]carbamoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid	11910969	C[C@H](NC(=O)N1Cc2ccccc2C[C@H]1C(=O)O)C(=O)O	(3S)-2-[[(1S)-1-carboxyethyl]carbamoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid			0.5711799999999997													MCULE-6795793682	292.29402		292.105922	5	3	3	2			44									Aminoacids;Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(11910969)	11910969	0.7	556			[#6]-[#6@H](-[#7]-[#6](=[#8])-[#7]1-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6]-[#6@H]-1-[#6](=[#8])-[#8])-[#6](=[#8])-[#8]	C[C@H](NC(=O)N1Cc2ccccc2C[C@H]1C(=O)O)C(=O)O	YBQVTWAORGPJPA		parent_pubchem_cid	AKOS004937369;(3S)-2-({[(1S)-1-CARBOXYETHYL]AMINO}CARBONYL)-1,2,3,4-TETRAHYDRO-3-ISOQUINOLINECARBOXYLIC ACID;rac-(3S)-2-[[rac-(1S)-1-carboxyethyl]carbamoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid		23946357.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23946357		pluskal_iocb_peptide_Peptide01_C22_id		100	C22		ZINC000005352763
1.8		0	492	P2195269	93.7		N26	False	0	18	0	0	26	0	2	5	0	0		0.0						COC(=O)CCNC(=O)C(CC(C)C)NC(=O)c1ccc(OC)cc1																							0.0		AKOS015861307		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C18H26N2O5	C18H26N2O5			InChI=1S/C18H26N2O5/c1-12(2)11-15(18(23)19-10-9-16(21)25-4)20-17(22)13-5-7-14(24-3)8-6-13/h5-8,12,15H,9-11H2,1-4H3,(H,19,23)(H,20,22)	VVBCNHFJWFMFSG-UHFFFAOYSA-N	methyl 3-[[2-[(4-methoxybenzoyl)amino]-4-methyl-pentanoyl]amino]propanoate	51065774	COC(=O)CCNC(=O)C(CC(C)C)NC(=O)c1ccc(OC)cc1	methyl 3-[[2-[(4-methoxybenzoyl)amino]-4-methylpentanoyl]amino]propanoate			1.0018800000000003													MCULE-6943509203	350.41832		350.184172	5	2	10	1			45									Simple amide alkaloids	False	Alkaloids	Peptide alkaloids			Peptide01			Compound(51065774)	51065774	2.1	557			[#6]-[#8]-[#6](=[#8])-[#6]-[#6]-[#7]-[#6](=[#8])-[#6](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:1	COC(=O)CCNC(=O)C(CC(C)C)NC(=O)c1ccc(OC)cc1	VVBCNHFJWFMFSG		parent_pubchem_cid	AKOS015861307;methyl 3-[[2-[(4-methoxybenzoyl)amino]-4-methyl-pentanoyl]amino]propanoate		23958560.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23958560		pluskal_iocb_peptide_Peptide01_C22_id		100	C22		
4.4		0	580	P1305409	72.6		N27	False	0	26	0	0	26	0	2	4	0	0		0.0						COc1ccc(OCC(=O)NCC(c2ccc(OC)cc2)c2c[nH]c3ccccc23)cc1																							0.0		N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-(4-methoxyphenoxy)acetamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C26H26N2O4	C26H26N2O4			InChI=1S/C26H26N2O4/c1-30-19-9-7-18(8-10-19)23(24-16-27-25-6-4-3-5-22(24)25)15-28-26(29)17-32-21-13-11-20(31-2)12-14-21/h3-14,16,23,27H,15,17H2,1-2H3,(H,28,29)	CBWIDXBMZCXKKP-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-(4-methoxyphenoxy)acetamide	17014559	COc1ccc(OCC(=O)NCC(c2ccc(OC)cc2)c2c[nH]c3ccccc23)cc1	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-(4-methoxyphenoxy)acetamide			2.58713													MCULE-7758613761	430.50812		430.189257	4	2	9	4			44										False	Alkaloids				Peptide01			Compound(17014559)	17014559	4.7	558			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]-[#6](=[#8])-[#7]-[#6]-[#6](-[#6]2:[#6]:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	COc1ccc(OCC(=O)NCC(c2ccc(OC)cc2)c2c[nH]c3ccccc23)cc1	CBWIDXBMZCXKKP		parent_pubchem_cid	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-(4-methoxyphenoxy)acetamide;HMS3456E22;STL207516;AKOS002334755;AKOS016326653		24630132.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24630132		pluskal_iocb_peptide_Peptide01_C22_id		100	C22		
4.7		0	668	P1305566	36.1		N28	False	0	21	0	0	24	0	2	1	0	0		0.0						Cc1ccc(C(c2c[nH]c3ccccc23)N(C)C(=O)C(C)C)cc1																							0.0		AKOS001912036		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C21H24N2O	C21H24N2O			InChI=1S/C21H24N2O/c1-14(2)21(24)23(4)20(16-11-9-15(3)10-12-16)18-13-22-19-8-6-5-7-17(18)19/h5-14,20,22H,1-4H3	FLBQMTQVBLHZPH-UHFFFAOYSA-N	N-[1H-indol-3-yl(p-tolyl)methyl]-N,2-dimethyl-propanamide	17014705	Cc1ccc(C(c2c[nH]c3ccccc23)N(C)C(=O)C(C)C)cc1	N-[1H-indol-3-yl-(4-methylphenyl)methyl]-N,2-dimethylpropanamide			4.087570000000003													MCULE-1666609417	320.43823		320.188863	1	1	4	3			45										False					Peptide01			Compound(17014705)	17014705	4.4	559			[#6]-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#7](-[#6])-[#6](=[#8])-[#6](-[#6])-[#6]):[#6]:[#6]:1	Cc1ccc(C(c2c[nH]c3ccccc23)N(C)C(=O)C(C)C)cc1	FLBQMTQVBLHZPH		parent_pubchem_cid	AKOS001912036;AKOS016326737;NCGC00277588-01;AB01282173-01;N-[(1H-INDOL-3-YL)(4-METHYLPHENYL)METHYL]-N,2-DIMETHYLPROPANAMIDE;N-[1H-indol-3-yl(p-tolyl)methyl]-N,2-dimethyl-propanamide		24746601.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24746601		pluskal_iocb_peptide_Peptide01_C22_id		100	C22		
4.7		0	412	P1100025	117.7		N29	False	0	29	0	0	24	0	2	6	0	0		0.0						CC(Oc1cc2c(cc1)c(-c1ccccc1)cc(=O)o2)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)O																							0.0		EiM07-19711		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C29H24N2O6	C29H24N2O6			InChI=1S/C29H24N2O6/c1-17(28(33)31-25(29(34)35)13-19-16-30-24-10-6-5-9-21(19)24)36-20-11-12-22-23(18-7-3-2-4-8-18)15-27(32)37-26(22)14-20/h2-12,14-17,25,30H,13H2,1H3,(H,31,33)(H,34,35)/t17?,25-/m0/s1	BAUJIQPZQUOMNX-HHPDBAQJSA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[2-(2-oxo-4-phenyl-chromen-7-yl)oxypropanoylamino]propanoic acid	24280078	CC(Oc1cc2c(cc1)c(-c1ccccc1)cc(=O)o2)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	(2S)-3-(1H-indol-3-yl)-2-[2-(2-oxo-4-phenylchromen-7-yl)oxypropanoylamino]propanoic acid			3.666610000000002														496.52443		496.163436	6	3	8	5			46										False	Shikimates and Phenylpropanoids				Peptide01			Compound(24280078)	24280078	4.5	560			[#6]-[#6](-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1):[#6]:[#6](=[#8]):[#8]:2)-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	CC(Oc1cc2c(cc1)c(-c1ccccc1)cc(=O)o2)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	BAUJIQPZQUOMNX		parent_pubchem_cid	EiM07-19711;AKOS016376888;(2S)-3-(1H-INDOL-3-YL)-2-({2-[(2-OXO-4-PHENYL-2H-CHROMEN-7-YL)OXY]PROPANOYL}AMINO)PROPANOIC ACID;rac-(2S)-3-(1H-indol-3-yl)-2-[2-(2-oxo-4-phenyl-chromen-7-yl)oxypropanoylamino]propanoic acid		24567420.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24567420		pluskal_iocb_peptide_Peptide01_C23_id		100	C23		
1.8		0	500	P1380625	91.7		N30	False	0	13	0	0	17	0	1	3	0	1		0.0						CSCCC(NC(=O)c1ccc(C)cc1)C(=O)O																							0.0		methyl-N-(4-methylbenzoyl)homocysteine		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C13H17NO3S	C13H17NO3S			InChI=1S/C13H17NO3S/c1-9-3-5-10(6-4-9)12(15)14-11(13(16)17)7-8-18-2/h3-6,11H,7-8H2,1-2H3,(H,14,15)(H,16,17)	ROAVZYTYQIFLQA-UHFFFAOYSA-N	2-[(4-methylbenzoyl)amino]-4-methylsulfanyl-butanoic acid	10858461	CSCCC(NC(=O)c1ccc(C)cc1)C(=O)O	2-[(4-methylbenzoyl)amino]-4-methylsulfanylbutanoic acid			1.8217													MCULE-1745861640	267.34934		267.092914	4	2	6	1			44									Aminoacids;Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(10858461)	10858461	2.2	561		SCHEMBL9830233	[#6]-[#16]-[#6]-[#6]-[#6](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:1)-[#6](=[#8])-[#8]	CSCCC(NC(=O)c1ccc(C)cc1)C(=O)O	ROAVZYTYQIFLQA		parent_pubchem_cid	methyl-N-(4-methylbenzoyl)homocysteine;SCHEMBL9830233;STL218344;AKOS000129150;AKOS016338209;N-[(4-methylphenyl)carbonyl]methionine;AG-205/07963050;2-[(4-methylbenzoyl)amino]-4-methylsulfanylbutanoic acid;2-[(4-methylbenzoyl)amino]-4-methylsulfanyl-butanoic acid		23516749.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23516749		pluskal_iocb_peptide_Peptide01_C23_id		100	C23		
4.9		0	588	P1301244	72.6		N31	False	0	27	0	0	28	0	2	4	0	0		0.0						CCOc1c(OC)cc(C(CNC(=O)c2cc(OC)ccc2)c2c[nH]c3ccccc23)cc1																							0.0		AKOS002326816		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C27H28N2O4	C27H28N2O4			InChI=1S/C27H28N2O4/c1-4-33-25-13-12-18(15-26(25)32-3)22(23-17-28-24-11-6-5-10-21(23)24)16-29-27(30)19-8-7-9-20(14-19)31-2/h5-15,17,22,28H,4,16H2,1-3H3,(H,29,30)	WVWKURXDNSVORV-UHFFFAOYSA-N	N-[2-(4-ethoxy-3-methoxy-phenyl)-2-(1H-indol-3-yl)ethyl]-3-methoxy-benzamide	17010962	CCOc1c(OC)cc(C(CNC(=O)c2cc(OC)ccc2)c2c[nH]c3ccccc23)cc1	N-[2-(4-ethoxy-3-methoxyphenyl)-2-(1H-indol-3-yl)ethyl]-3-methoxybenzamide			3.1659200000000007													MCULE-3958680376	444.53521		444.204907	4	2	9	4			45										False	Alkaloids				Peptide01			Compound(17010962)	17010962	5.0	562			[#6]-[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]):[#6]:[#6](-[#6](-[#6]-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:[#6]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	CCOc1c(OC)cc(C(CNC(=O)c2cc(OC)ccc2)c2c[nH]c3ccccc23)cc1	WVWKURXDNSVORV		parent_pubchem_cid	AKOS002326816;AKOS016325491;N-[2-(4-ethoxy-3-methoxyphenyl)-2-(1H-indol-3-yl)ethyl]-3-methoxybenzamide;N-[2-(4-ethoxy-3-methoxy-phenyl)-2-(1H-indol-3-yl)ethyl]-3-methoxy-benzamide		23516265.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23516265		pluskal_iocb_peptide_Peptide01_C23_id		100	C23		
1.0		0	676	P1157561	131.0		N32	False	0	19	0	0	24	0	4	4	0	1		0.0						CSCCC(NC(=O)N1CCN(C(=O)c2c[nH]c3ccccc23)CC1)C(=O)O																							0.0		MFCD09849662		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C19H24N4O4S	C19H24N4O4S			InChI=1S/C19H24N4O4S/c1-28-11-6-16(18(25)26)21-19(27)23-9-7-22(8-10-23)17(24)14-12-20-15-5-3-2-4-13(14)15/h2-5,12,16,20H,6-11H2,1H3,(H,21,27)(H,25,26)/t16-/m0/s1	TUKYOPWJVWAFPH-INIZCTEOSA-N	rac-(2S)-2-[[4-(1H-indole-3-carbonyl)piperazine-1-carbonyl]amino]-4-methylsulfanyl-butanoic acid	17594412	CSCC[C@H](NC(=O)N1CCN(C(=O)c2c[nH]c3ccccc23)CC1)C(=O)O	(2S)-2-[[4-(1H-indole-3-carbonyl)piperazine-1-carbonyl]amino]-4-methylsulfanylbutanoic acid			1.3584699999999994													MCULE-3384813317	404.49153		404.151826	5	3	6	3			44										False	Amino acids and Peptides				Peptide01			Compound(17594412)	17594412	1.2	563			[#6]-[#16]-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#7]1-[#6]-[#6]-[#7](-[#6](=[#8])-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6]-[#6]-1)-[#6](=[#8])-[#8]	CSCC[C@H](NC(=O)N1CCN(C(=O)c2c[nH]c3ccccc23)CC1)C(=O)O	TUKYOPWJVWAFPH		parent_pubchem_cid	MFCD09849662;N-{[4-(1H-indol-3-ylcarbonyl)piperazin-1-yl]carbonyl}-L-methionine;AKOS004937304;(2S)-2-({[4-(1H-INDOL-3-YLCARBONYL)PIPERAZINO]CARBONYL}AMINO)-4-(METHYLSULFANYL)BUTANOIC ACID;(2S)-2-[[4-(1H-indole-3-carbonyl)piperazine-1-carbonyl]amino]-4-methylsulfanylbutanoic acid;rac-(2S)-2-[[4-(1H-indole-3-carbonyl)piperazine-1-carbonyl]amino]-4-methylsulfanyl-butanoic acid		23206730.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23206730		pluskal_iocb_peptide_Peptide01_C23_id		100	C23		ZINC000013682718
2.4		0	420	P6240979	134.4		N33	False	0	22	0	0	22	0	4	4	0	0		0.0						NC(=O)NCCCC(NC(=O)c1cc(-c2ccccc2)nc2ccccc12)C(=O)O								Quinoline carboxamides;N-acyl-alpha amino acids;Phenylpyridines;Pyridinecarboxylic acids and derivatives;Benzene and substituted derivatives;Heteroaromatic compounds;Ureas;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenylpyridines;Phenylquinolines;Pyridinecarboxylic acids and derivatives;Pyridines and derivatives;Quinoline carboxamides;Quinolines and derivatives;Secondary carboxylic acid amides;Ureas	Quinolines and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylquinolines. These are heterocyclic compounds containing a quinoline moiety substituted with a phenyl group.	Phenylquinolines			Organic compounds	Aromatic heteropolycyclic compounds	quinolines (CHEBI:26513);carboxamide (CHEBI:37622);N-acyl-amino acid (CHEBI:51569);phenylpyridine (CHEBI:38193);aromatic carboxylic acid (CHEBI:33859);pyridinemonocarboxylic acid (CHEBI:26420);benzenes (CHEBI:22712);organic aromatic compound (CHEBI:33659);ureas (CHEBI:47857);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);pyridines (CHEBI:26421);benzenoid aromatic compound (CHEBI:33836);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806)		Phenylquinolines	Phenylquinoline;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;Quinoline-4-carboxamide;2-phenylpyridine;Alpha-amino acid or derivatives;Pyridine carboxylic acid or derivatives;Monocyclic benzene moiety;Pyridine;Benzenoid;Heteroaromatic compound;Carboxamide group;Secondary carboxylic acid amide;Urea;Azacycle;Monocarboxylic acid or derivatives;Carboxylic acid;Carboxylic acid derivative;Hydrocarbon derivative;Organooxygen compound;Organonitrogen compound;Organic oxide;Organic oxygen compound;Carbonyl group;Organic nitrogen compound;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		EiM08-12208		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C22H22N4O4	C22H22N4O4			InChI=1S/C22H22N4O4/c23-22(30)24-12-6-11-18(21(28)29)26-20(27)16-13-19(14-7-2-1-3-8-14)25-17-10-5-4-9-15(16)17/h1-5,7-10,13,18H,6,11-12H2,(H,26,27)(H,28,29)(H3,23,24,30)/t18-/m1/s1	PGWHNYBYPYMEQU-GOSISDBHSA-N	rac-(2R)-2-[(2-phenylquinoline-4-carbonyl)amino]-5-ureido-pentanoic acid	49652077	NC(=O)NCCC[C@@H](NC(=O)c1cc(-c2ccccc2)nc2ccccc12)C(=O)O	(2R)-5-(carbamoylamino)-2-[(2-phenylquinoline-4-carbonyl)amino]pentanoic acid			1.6701499999999994													MCULE-3675318422	406.44504		406.164105	5	4	8	3			44									Polyamines	False	Alkaloids	Ornithine alkaloids			Peptide01			Compound(49652077)	49652077	2.2	564			[#7]-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]-[#6@@H](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	NC(=O)NCCC[C@@H](NC(=O)c1cc(-c2ccccc2)nc2ccccc12)C(=O)O	PGWHNYBYPYMEQU		parent_pubchem_cid	EiM08-12208;AKOS016398014;rac-(2R)-2-[(2-phenylquinoline-4-carbonyl)amino]-5-ureido-pentanoic acid		23259142.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23259142		pluskal_iocb_peptide_Peptide01_C23_id		100	C23		ZINC000040309084
3.2		0	508	P2194100	84.5		N34	False	0	21	0	0	32	0	2	4	0	0		0.0						COC(=O)C(CC(C)C)NC(=O)CCNC(=O)c1ccc(C(C)(C)C)cc1																							0.0		AKOS006458559		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C21H32N2O4	C21H32N2O4			InChI=1S/C21H32N2O4/c1-14(2)13-17(20(26)27-6)23-18(24)11-12-22-19(25)15-7-9-16(10-8-15)21(3,4)5/h7-10,14,17H,11-13H2,1-6H3,(H,22,25)(H,23,24)	LYEIQHXATYUJLP-UHFFFAOYSA-N	methyl 2-[3-[(4-tert-butylbenzoyl)amino]propanoylamino]-4-methyl-pentanoate	51064920	COC(=O)C(CC(C)C)NC(=O)CCNC(=O)c1ccc(C(C)(C)C)cc1	methyl 2-[3-[(4-tert-butylbenzoyl)amino]propanoylamino]-4-methylpentanoate			2.698480000000001													MCULE-6955247867	376.50019		376.236208	4	2	10	1			45									Simple amide alkaloids	False	Alkaloids;Amino acids and Peptides	Peptide alkaloids			Peptide01			Compound(51064920)	51064920	3.8	565			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=[#8])-[#6]-[#6]-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6])(-[#6])-[#6]):[#6]:[#6]:1	COC(=O)C(CC(C)C)NC(=O)CCNC(=O)c1ccc(C(C)(C)C)cc1	LYEIQHXATYUJLP		parent_pubchem_cid	AKOS006458559;methyl 2-[3-[(4-tert-butylbenzoyl)amino]propanoylamino]-4-methyl-pentanoate		23454934.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23454934		pluskal_iocb_peptide_Peptide01_C23_id		100	C23		
4.9		0	596	P1680687	62.8		N35	False	0	25	0	0	33	0	1	3	0	1		0.0						CC(C)c1ccc(CN(C(=O)c2ccc(C(C)(C)C)cc2)C2CCS(=O)(=O)C2)cc1																							0.0		4-tert-butyl-N-(1,1-dioxidotetrahydrothiophen-3-yl)-N-[4-(propan-2-yl)benzyl]benzamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0		C25H33NO3S	C25H33NO3S			InChI=1S/C25H33NO3S/c1-18(2)20-8-6-19(7-9-20)16-26(23-14-15-30(28,29)17-23)24(27)21-10-12-22(13-11-21)25(3,4)5/h6-13,18,23H,14-17H2,1-5H3	QSGAQKWTHIIAIA-UHFFFAOYSA-N	4-tert-butyl-N-(1,1-dioxothiolan-3-yl)-N-[(4-isopropylphenyl)methyl]benzamide	4680961	CC(C)c1ccc(CN(C(=O)c2ccc(C(C)(C)C)cc2)C2CCS(=O)(=O)C2)cc1	4-tert-butyl-N-(1,1-dioxothiolan-3-yl)-N-[(4-propan-2-ylphenyl)methyl]benzamide			4.718160000000005													MCULE-7712502244	427.61066		427.218115	3	0	6	3			45										False	Terpenoids				Peptide01			Compound(4680961)	4680961	5.2	566			[#6]-[#6](-[#6])-[#6]1:[#6]:[#6]:[#6](-[#6]-[#7](-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6](-[#6](-[#6])(-[#6])-[#6]):[#6]:[#6]:2)-[#6]2-[#6]-[#6]-[#16](=[#8])(=[#8])-[#6]-2):[#6]:[#6]:1	CC(C)c1ccc(CN(C(=O)c2ccc(C(C)(C)C)cc2)C2CCS(=O)(=O)C2)cc1	QSGAQKWTHIIAIA		parent_pubchem_cid	4-tert-butyl-N-(1,1-dioxidotetrahydrothiophen-3-yl)-N-[4-(propan-2-yl)benzyl]benzamide;620558-18-1;AKOS002233360;AKOS016082985;Z57786016;4-tert-butyl-N-(1,1-dioxothiolan-3-yl)-N-[(4-isopropylphenyl)methyl]benzamide		22842674.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22842674		pluskal_iocb_peptide_Peptide01_C23_id		100	C23		
0.6		0	684	P6666772	100.5		N36	False	0	12	0	0	13	0	3	4	0	0		0.0						CC(C)CC(C(=O)O)N1C(=O)c2nccnc2C1=O																							0.0		126310-30-3		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0		C12H13N3O4	C12H13N3O4			InChI=1S/C12H13N3O4/c1-6(2)5-7(12(18)19)15-10(16)8-9(11(15)17)14-4-3-13-8/h3-4,6-7H,5H2,1-2H3,(H,18,19)/t7-/m0/s1	IFDOROCVHPBJQP-ZETCQYMHSA-N	rac-(2S)-2-(5,7-dioxopyrrolo[3,4-b]pyrazin-6-yl)-4-methyl-pentanoic acid	14582908	CC(C)C[C@@H](C(=O)O)N1C(=O)c2nccnc2C1=O	(2S)-2-(5,7-dioxopyrrolo[3,4-b]pyrazin-6-yl)-4-methylpentanoic acid			0.4624800000000001													MCULE-9489855255	263.25511		263.090606	6	1	4	2			44									Pyrazine and Piperazine alkaloids	False	Alkaloids;Amino acids and Peptides	Tetramate alkaloids			Peptide01			Compound(14582908)	14582908	0.7	567			[#6]-[#6](-[#6])-[#6]-[#6@@H](-[#6](=[#8])-[#8])-[#7]1-[#6](=[#8])-[#6]2:[#7]:[#6]:[#6]:[#7]:[#6]:2-[#6]-1=[#8]	CC(C)C[C@@H](C(=O)O)N1C(=O)c2nccnc2C1=O	IFDOROCVHPBJQP		parent_pubchem_cid	126310-30-3;(2S)-2-{5,7-dioxo-5H,6H,7H-pyrrolo[3,4-b]pyrazin-6-yl}-4-methylpentanoic acid;(2S)-2-(5,7-dioxopyrrolo[3,4-b]pyrazin-6-yl)-4-methylpentanoic acid;MFCD20535508;AKOS016376014;NS-04112;EN300-302500;(2S)-2-{5,7-dioxo-5H,6H,7H-pyrrolo[3,4-b]pyrazin-6-yl}-4-methylpentanoicacid;rac-(2S)-2-(5,7-dioxopyrrolo[3,4-b]pyrazin-6-yl)-4-methyl-pentanoic acid		24717100.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24717100		pluskal_iocb_peptide_Peptide01_C23_id		100	C23		ZINC000072220570
0.7		0	428	P1098938	141.1		N37	False	0	17	0	0	21	0	3	5	0	1		0.0						CSCCC(NC(=O)CCCn1c(=O)[nH]c2ccccc2c1=O)C(=O)O																							0.0		AKOS016387108		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	4	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0		C17H21N3O5S	C17H21N3O5S			InChI=1S/C17H21N3O5S/c1-26-10-8-13(16(23)24)18-14(21)7-4-9-20-15(22)11-5-2-3-6-12(11)19-17(20)25/h2-3,5-6,13H,4,7-10H2,1H3,(H,18,21)(H,19,25)(H,23,24)/t13-/m0/s1	BRHOSTJKUCXEGM-ZDUSSCGKSA-N	rac-(2S)-2-[4-(2,4-dioxo-1H-quinazolin-3-yl)butanoylamino]-4-methylsulfanyl-butanoic acid	1780875	CSCC[C@H](NC(=O)CCCn1c(=O)[nH]c2ccccc2c1=O)C(=O)O	(2S)-2-[4-(2,4-dioxo-1H-quinazolin-3-yl)butanoylamino]-4-methylsulfanylbutanoic acid			2.16386													MCULE-1587689542	379.43802		379.120192	6	3	9	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(1780875)	1780875	0.9	568			[#6]-[#16]-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#6]-[#6]-[#7]1:[#6](=[#8]):[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8])-[#6](=[#8])-[#8]	CSCC[C@H](NC(=O)CCCn1c(=O)[nH]c2ccccc2c1=O)C(=O)O	BRHOSTJKUCXEGM		parent_pubchem_cid	AKOS016387108;AKOS037496723;(S)-2-(4-(2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)butanamido)-4-(methylthio)butanoic acid;2-[4-(2,4-DIOXO-1,2,3,4-TETRAHYDROQUINAZOLIN-3-YL)BUTANAMIDO]-4-(METHYLSULFANYL)BUTANOIC ACID;rac-(2S)-2-[4-(2,4-dioxo-1H-quinazolin-3-yl)butanoylamino]-4-methylsulfanyl-butanoic acid		22883731.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22883731		pluskal_iocb_peptide_Peptide01_C24_id		100	C24		ZINC000002126235
4.4		0	516	P2195066	118.5		N38	False	0	23	1	0	23	0	4	3	0	1		0.0						CCOc1ccc(NC(=O)C(Cc2ccccc2)NC(=O)c2nc(SC)ncc2Cl)cc1																							0.0		AKOS015861020		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C23H23ClN4O3S	C23H23ClN4O3S			InChI=1S/C23H23ClN4O3S/c1-3-31-17-11-9-16(10-12-17)26-21(29)19(13-15-7-5-4-6-8-15)27-22(30)20-18(24)14-25-23(28-20)32-2/h4-12,14,19H,3,13H2,1-2H3,(H,26,29)(H,27,30)	YDVDDHRPQWEMBO-UHFFFAOYSA-N	N-[1-benzyl-2-(4-ethoxyanilino)-2-oxo-ethyl]-5-chloro-2-methylsulfanyl-pyrimidine-4-carboxamide	51065606	CCOc1ccc(NC(=O)C(Cc2ccccc2)NC(=O)c2nc(SC)ncc2Cl)cc1	5-chloro-N-[1-(4-ethoxyanilino)-1-oxo-3-phenylpropan-2-yl]-2-methylsulfanylpyrimidine-4-carboxamide			3.169950000000001													MCULE-4960270619	470.98176		470.117939	6	2	9	3			45										False					Peptide01			Compound(51065606)	51065606	4.5	569			[#6]-[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#7]-[#6](=[#8])-[#6](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#7]-[#6](=[#8])-[#6]2:[#7]:[#6](-[#16]-[#6]):[#7]:[#6]:[#6]:2-[#17]):[#6]:[#6]:1	CCOc1ccc(NC(=O)C(Cc2ccccc2)NC(=O)c2nc(SC)ncc2Cl)cc1	YDVDDHRPQWEMBO		parent_pubchem_cid	AKOS015861020;N-[1-benzyl-2-(4-ethoxyanilino)-2-oxo-ethyl]-5-chloro-2-methylsulfanyl-pyrimidine-4-carboxamide		23398758.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23398758		pluskal_iocb_peptide_Peptide01_C24_id		100	C24		
4.7		0	604	P1305820	36.1		N39	False	0	23	0	0	20	0	2	1	0	0	-1.0	0.0						CN(C(=O)c1ccccc1)C(c1ccccc1)c1c[nH]c2ccccc12		5.03		0.0	4.88	CHEMBL1719080																	0.0		N-[1H-indol-3-yl(phenyl)methyl]-N-methylbenzamide		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C23H20N2O	C23H20N2O			InChI=1S/C23H20N2O/c1-25(23(26)18-12-6-3-7-13-18)22(17-10-4-2-5-11-17)20-16-24-21-15-9-8-14-19(20)21/h2-16,22,24H,1H3	BADJSIINBZIQES-UHFFFAOYSA-N	N-[1H-indol-3-yl(phenyl)methyl]-N-methyl-benzamide	13013141	CN(C(=O)c1ccccc1)C(c1ccccc1)c1c[nH]c2ccccc12	N-[1H-indol-3-yl(phenyl)methyl]-N-methylbenzamide			4.436950000000003													MCULE-9811748079	340.42865	NEUTRAL	340.157563	1	1	4	4	0.0		29									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids	False	False	Peptide01		-1.0	Compound(13013141)	13013141	4.7	570			[#6]-[#7](-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CN(C(=O)c1ccccc1)C(c1ccccc1)c1c[nH]c2ccccc12	BADJSIINBZIQES		parent_pubchem_cid	N-[1H-indol-3-yl(phenyl)methyl]-N-methylbenzamide;MLS-0435775.0001;59836-48-5;CHEMBL1719080;BDBM67414;cid_13013141;STK518557;AKOS001911586;AKOS016328284;CCG-154597;N-[(1H-indol-3-yl)(phenyl)methyl]-N-methylbenzamide;N-[1H-indol-3-yl(phenyl)methyl]-N-methyl-benzamide;Z1213699262	False	1019750.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=1019750		pluskal_iocb_peptide_Peptide01_C24_id		100	C24	False	
3.3		0	692	P6237113	75.1		N40	False	0	20	0	0	21	0	5	1	0	0		0.0						CC(C)CC(NC(=O)c1c[nH]c2ccccc12)c1nnc2ccccn12																							0.0		N-[3-methyl-1-([1,2,4]triazolo[4,3-a]pyridin-3-yl)butyl]-1H-indole-3-carboxamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	3	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C20H21N5O	C20H21N5O			InChI=1S/C20H21N5O/c1-13(2)11-17(19-24-23-18-9-5-6-10-25(18)19)22-20(26)15-12-21-16-8-4-3-7-14(15)16/h3-10,12-13,17,21H,11H2,1-2H3,(H,22,26)	BHUZXDHVVYPFTH-UHFFFAOYSA-N	N-[3-methyl-1-([1,2,4]triazolo[4,3-a]pyridin-3-yl)butyl]-1H-indole-3-carboxamide	42652673	CC(C)CC(NC(=O)c1c[nH]c2ccccc12)c1nnc2ccccn12	N-[3-methyl-1-([1,2,4]triazolo[4,3-a]pyridin-3-yl)butyl]-1H-indole-3-carboxamide			2.975750000000001													MCULE-1539389314	347.42327		347.17461	3	2	5	4			44										False	Alkaloids				Peptide01			Compound(42652673)	42652673	3.8	571			[#6]-[#6](-[#6])-[#6]-[#6](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6]1:[#7]:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#7]:1:2	CC(C)CC(NC(=O)c1c[nH]c2ccccc12)c1nnc2ccccn12	BHUZXDHVVYPFTH		parent_pubchem_cid	N-[3-methyl-1-([1,2,4]triazolo[4,3-a]pyridin-3-yl)butyl]-1H-indole-3-carboxamide;1081118-91-3;STL234739;AKOS016375810		23152244.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23152244		pluskal_iocb_peptide_Peptide01_C24_id		100	C24		
1.8		0	436	P11184881	131.6		N41	False	0	23	0	0	22	0	4	5	0	0		0.0						Cn1c(=O)c(=O)[nH]c2c1ccc(CCC(=O)NC(Cc1c[nH]c3ccccc13)C(=O)O)c2																							0.0		AKOS027472536		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0		C23H22N4O5	C23H22N4O5			InChI=1S/C23H22N4O5/c1-27-19-8-6-13(10-17(19)26-21(29)22(27)30)7-9-20(28)25-18(23(31)32)11-14-12-24-16-5-3-2-4-15(14)16/h2-6,8,10,12,18,24H,7,9,11H2,1H3,(H,25,28)(H,26,29)(H,31,32)/t18-/m0/s1	YPGAWXCHXSGMGI-SFHVURJKSA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[3-(1-methyl-2,3-dioxo-4H-quinoxalin-6-yl)propanoylamino]propanoic acid	91639981	Cn1c(=O)c(=O)[nH]c2c1ccc(CCC(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)O)c2	(2S)-3-(1H-indol-3-yl)-2-[3-(1-methyl-2,3-dioxo-4H-quinoxalin-6-yl)propanoylamino]propanoic acid			2.28632														434.45559		434.15902	5	4	7	4			45										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(91639981)	91639981	1.8	572			[#6]-[#7]1:[#6](=[#8]):[#6](=[#8]):[#7H]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#6]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:1:3)-[#6](=[#8])-[#8]):[#6]:2	Cn1c(=O)c(=O)[nH]c2c1ccc(CCC(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)O)c2	YPGAWXCHXSGMGI		parent_pubchem_cid	AKOS027472536;rac-(2S)-3-(1H-indol-3-yl)-2-[3-(1-methyl-2,3-dioxo-4H-quinoxalin-6-yl)propanoylamino]propanoic acid		93540619.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=93540619		pluskal_iocb_peptide_Peptide01_C24_id		100	C24		ZINC000218273560
1.2		0	524	P2194868	160.9		N42	False	0	15	1	0	21	0	4	4	0	2		0.0						COC(=O)CCNC(=O)C(CCSC)NC(=O)c1nc(SC)ncc1Cl																							0.0		AKOS015861142		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C15H21ClN4O4S2	C15H21ClN4O4S2			InChI=1S/C15H21ClN4O4S2/c1-24-11(21)4-6-17-13(22)10(5-7-25-2)19-14(23)12-9(16)8-18-15(20-12)26-3/h8,10H,4-7H2,1-3H3,(H,17,22)(H,19,23)	YOQQHHZTAUNAFC-UHFFFAOYSA-N	methyl 3-[[2-[(5-chloro-2-methylsulfanyl-pyrimidine-4-carbonyl)amino]-4-methylsulfanyl-butanoyl]amino]propanoate	51065473	COC(=O)CCNC(=O)C(CCSC)NC(=O)c1nc(SC)ncc1Cl	methyl 3-[[2-[(5-chloro-2-methylsulfanylpyrimidine-4-carbonyl)amino]-4-methylsulfanylbutanoyl]amino]propanoate			1.21998													MCULE-4236918612	420.94002		420.069275	8	2	11	1			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51065473)	51065473	1.5	573			[#6]-[#8]-[#6](=[#8])-[#6]-[#6]-[#7]-[#6](=[#8])-[#6](-[#6]-[#6]-[#16]-[#6])-[#7]-[#6](=[#8])-[#6]1:[#7]:[#6](-[#16]-[#6]):[#7]:[#6]:[#6]:1-[#17]	COC(=O)CCNC(=O)C(CCSC)NC(=O)c1nc(SC)ncc1Cl	YOQQHHZTAUNAFC		parent_pubchem_cid	AKOS015861142;methyl 3-[[2-[(5-chloro-2-methylsulfanyl-pyrimidine-4-carbonyl)amino]-4-methylsulfanyl-butanoyl]amino]propanoate		24720994.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24720994		pluskal_iocb_peptide_Peptide01_C24_id		100	C24		
4.9		0	612	P1305405	63.3		N43	False	0	26	0	0	26	0	2	3	0	0		0.0						COc1ccc(C(CNC(=O)COc2ccccc2C)c2c[nH]c3ccccc23)cc1																							0.0		N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-(2-methylphenoxy)acetamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C26H26N2O3	C26H26N2O3			InChI=1S/C26H26N2O3/c1-18-7-3-6-10-25(18)31-17-26(29)28-15-22(19-11-13-20(30-2)14-12-19)23-16-27-24-9-5-4-8-21(23)24/h3-14,16,22,27H,15,17H2,1-2H3,(H,28,29)	ZAFOTLLTCMCNQD-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-(2-methylphenoxy)acetamide	17014555	COc1ccc(C(CNC(=O)COc2ccccc2C)c2c[nH]c3ccccc23)cc1	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-(2-methylphenoxy)acetamide			3.2946500000000016													MCULE-1623804735	414.50872		414.194343	3	2	8	4			44										False	Alkaloids				Peptide01			Compound(17014555)	17014555	5.1	574			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6]-[#7]-[#6](=[#8])-[#6]-[#8]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6])-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	COc1ccc(C(CNC(=O)COc2ccccc2C)c2c[nH]c3ccccc23)cc1	ZAFOTLLTCMCNQD		parent_pubchem_cid	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-(2-methylphenoxy)acetamide;STL207512;AKOS002334439;AKOS016326649		23430147.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23430147		pluskal_iocb_peptide_Peptide01_C24_id		100	C24		
1.9		0	700	P5970155	66.8		N44	False	0	13	0	0	15	0	1	4	0	0	-1.0	0.0						O=C(O)C1CCCN1C(=O)OCc1ccccc1		1.87		0.0	1.86	CHEMBL3276375		Benzyloxycarbonyls;Pyrrolidine carboxylic acids;Carbamate esters;Organic carbonic acids and derivatives;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Benzyloxycarbonyls;Carbamate esters;Carbamic acids and derivatives;Carbonyl compounds;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Hydrocarbon derivatives;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Proline and derivatives;Pyrrolidine carboxylic acids;Pyrrolidine carboxylic acids and derivatives;Pyrrolidines	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as proline and derivatives. These are compounds containing proline or a derivative thereof resulting from reaction of proline at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Proline and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteromonocyclic compounds	carboxylic ester (CHEBI:33308);carboxylic acid (CHEBI:33575);pyrrolidinecarboxylic acid (CHEBI:46767);carbamate ester (CHEBI:23003);organooxygen compound (CHEBI:36963);carbonyl compound (CHEBI:36586);carboxylic acid anion (CHEBI:29067);organonitrogen heterocyclic compound (CHEBI:38101);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);proline derivative (CHEBI:26273);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);organic heterocyclic compound (CHEBI:24532);pyrrolidines (CHEBI:38260);amino acid (CHEBI:33709);peptide (CHEBI:16670);carbon oxoacid (CHEBI:35605);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806)		Amino acids, peptides, and analogues	Proline or derivatives;Benzyloxycarbonyl;Pyrrolidine carboxylic acid;Pyrrolidine carboxylic acid or derivatives;Monocyclic benzene moiety;Benzenoid;Pyrrolidine;Carbamic acid ester;Carbonic acid derivative;Carboxylic acid;Monocarboxylic acid or derivatives;Azacycle;Organoheterocyclic compound;Organooxygen compound;Organonitrogen compound;Organopnictogen compound;Organic nitrogen compound;Organic oxide;Hydrocarbon derivative;Organic oxygen compound;Carbonyl group;Aromatic heteromonocyclic compound	Organic acids and derivatives	0.0		Z-Pro-OH	DTXSID40150856	2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	1	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C13H15NO4	C13H15NO4			InChI=1S/C13H15NO4/c15-12(16)11-7-4-8-14(11)13(17)18-9-10-5-2-1-3-6-10/h1-3,5-6,11H,4,7-9H2,(H,15,16)/t11-/m0/s1	JXGVXCZADZNAMJ-NSHDSACASA-N	(2S)-1-benzyloxycarbonylpyrrolidine-2-carboxylic acid	101987	O=C(O)[C@@H]1CCCN1C(=O)OCc1ccccc1	(2S)-1-phenylmethoxycarbonylpyrrolidine-2-carboxylic acid			1.81749													MCULE-8200556524	249.2688	ACID	249.100108	4	1	4	2	1.0		25									Dipeptides	False	Amino acids and Peptides	Small peptides	False	False	Peptide01		-1.0	Compound(101987)	101987	1.7	575		SCHEMBL29553	[#8]=[#6](-[#8])-[#6@@H]1-[#6]-[#6]-[#6]-[#7]-1-[#6](=[#8])-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	O=C(O)[C@@H]1CCCN1C(=O)OCc1ccccc1	JXGVXCZADZNAMJ		parent_pubchem_cid	Z-Pro-OH;1148-11-4;N-Benzyloxycarbonyl-L-proline;Carbobenzoxyproline;Z-L-Proline;N-Carbobenzoxy-L-proline;N-CBZ-L-PROLINE;Benzyloxycarbonyl-L-proline;Carbobenzoxy-S-proline;Benzyloxycarbonylproline;Carbobenzyloxy-L-proline;Carbobenzoxy-L-proline;114-11-4;CBZ-L-PROLINE;N-Benzyloxycarbonylproline;(2S)-1-phenylmethoxycarbonylpyrrolidine-2-carboxylic acid;1-(Benzyloxycarbonyl)proline;L-CBZ-PROLINE;CBZ-PRO-OH;((benzyloxy)carbonyl)-L-proline;1-Carbobenzoxy-L-proline;Cbz-Pro;(S)-1-((Benzyloxy)carbonyl)pyrrolidine-2-carboxylic acid;N-(Carbobenzyloxy)-L-proline;N-(Benzyloxycarbonyl)-L-proline;CBZ-L-PRO-OH;MFCD00003170;H2BS8M5FPP;1,2-Pyrrolidinedicarboxylic acid, 1-(phenylmethyl) ester, (S)-;L-1,2-Pyrrolidinedicarboxylic acid 1-benzyl ester;1,2-Pyrrolidinedicarboxylic acid, 1-benzyl ester, L-;(2S)-1-[(Benzyloxy)carbonyl]pyrrolidine-2-carboxylic acid;1-(Benzyloxycarbonyl)-L-proline;(S)-1-(benzyloxycarbonyl)pyrrolidine-2-carboxylic acid;(S)-N-CBZ-pyrrolidine-2-carboxylic acid;N-Carbobenzyloxy-l-Proline;1,2-PYRROLIDINEDICARBOXYLIC ACID, 1-(PHENYLMETHYL) ESTER, (2S)-;(2S)-1,2-PYRROLIDINEDICARBOXYLIC ACID 1-(PHENYLMETHYL) ESTER;Z-Pro;EINECS 214-557-4;(S)-1-[(benzyloxy)carbonyl]pyrrolidine-2-carboxylic acid;cbz-proline;n-cbz-proline;carbobenzyloxyproline;N-carbobenzoxyproline;Z-ProOH;N-carbobenzoxy-l-pro;benzyloxycarbonyl proline;1-[(BENZYLOXY)CARBONYL]-L-PROLINE;UNII-H2BS8M5FPP;Z-L-PRO-OH;N-benzyloxycarbonyl-proline;N-benzoxycarbonyl-L-Proline;SCHEMBL29553;Z-Pro-OH, 99%;1-Benzyloxycarbonyl-L-proline;N-benzyloxylcarbonyl-L-proline;1(benzyloxycarbonyl)-L-proline;(2S)-1-benzyloxycarbonylpyrrolidine-2-carboxylic acid;(-)-N-carbobenzyloxy-l-proline;CHEMBL3276375;N-benzyloxycarbonyl-(S)-proline;N-phenylmethyloxycarbonyl proline;DTXSID40150856;N-Benzyloxycarbonylproline, (L)-;HY-Y0588;(s)-(-)-n-benzyloxycarbonylproline;AKOS005144267;AKOS015856042;CS-W020583;N-[(phenyl-methoxy)carbonyl]-L-proline;AC-24081;AS-12747;N-(BENZYLOXYCARBONYL)-(S)-PROLINE;N-ALPHA-BENZYLOXYCARBONYL-L-PROLINE;EN300-103583;M03066;(S)-1-carbobenzoxypyrrolidine-2-carboxylic acid;J-300226;Q-101711;(S)-pyrrolidine-1,2-dicarboxylic acid 1-benzyl ester;Q27896112;(2s)-1-(benzyloxycarbonyl)pyrrolidine-2-carboxylic acid;(S)-1-(benzyloxycarbonyl) pyrrolidine-2-carboxylic acid;(s)-1-(benzyloxycarbonyl)-pyrrolidine-2-carboxylic acid;F8880-9008;Z756430268;(2S)-1-(phenylmethoxycarbonyl)pyrrolidine-2-carboxylic acid;(S)-1-((benzyloxy) carbonyl) pyrrolidine-2-carboxylic acid;(S)-1-((benzyloxy)carbonyl) pyrrolidine-2-carboxylic acid;(S)-1,2-Pyrrolidinedicarboxylic Acid 1-(Phenylmethyl) Ester	False	23928734.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23928734	H2BS8M5FPP	pluskal_iocb_peptide_Peptide01_C24_id		100	C24	False	ZINC000000105333
0.6		0	708	P6240025	126.5		O1	False	0	16	0	0	20	0	4	4	0	0		0.0						NC(=O)NCCCC(NC(=O)Cn1ccc2ccccc21)C(=O)O								N-alkylindoles;Indoles;Substituted pyrroles;Benzenoids;Heteroaromatic compounds;Ureas;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;N-alkylindoles;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Ureas	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom.	N-acyl-alpha amino acids		Amino acids and derivatives;Alpha amino acids and derivatives;N-acyl-alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	indoles (CHEBI:24828);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);organic aromatic compound (CHEBI:33659);ureas (CHEBI:47857);carboxamide (CHEBI:37622);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);N-acyl-amino acid (CHEBI:51569);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806)		Amino acids, peptides, and analogues	N-acyl-alpha-amino acid;N-alkylindole;Indole;Indole or derivatives;Substituted pyrrole;Benzenoid;Pyrrole;Heteroaromatic compound;Carboxamide group;Secondary carboxylic acid amide;Urea;Monocarboxylic acid or derivatives;Carboxylic acid;Azacycle;Organoheterocyclic compound;Carbonyl group;Hydrocarbon derivative;Organooxygen compound;Organonitrogen compound;Organic oxide;Organic oxygen compound;Organic nitrogen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		EiM08-11096		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C16H20N4O4	C16H20N4O4			InChI=1S/C16H20N4O4/c17-16(24)18-8-3-5-12(15(22)23)19-14(21)10-20-9-7-11-4-1-2-6-13(11)20/h1-2,4,6-7,9,12H,3,5,8,10H2,(H,19,21)(H,22,23)(H3,17,18,24)/t12-/m1/s1	VPRWPHRUEDMXIY-GFCCVEGCSA-N	rac-(2R)-2-[(2-indol-1-ylacetyl)amino]-5-ureido-pentanoic acid	45490518	NC(=O)NCCC[C@@H](NC(=O)Cn1ccc2ccccc21)C(=O)O	(2R)-5-(carbamoylamino)-2-[(2-indol-1-ylacetyl)amino]pentanoic acid			0.2307800000000006													MCULE-7899858971	332.3622		332.148455	4	4	8	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(45490518)	45490518	0.5	576			[#7]-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]-[#6@@H](-[#7]-[#6](=[#8])-[#6]-[#7]1:[#6]:[#6]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	NC(=O)NCCC[C@@H](NC(=O)Cn1ccc2ccccc21)C(=O)O	VPRWPHRUEDMXIY		parent_pubchem_cid	EiM08-11096;AKOS016398007;(2R)-5-[(AMINOCARBONYL)AMINO]-2-{[2-(1H-INDOL-1-YL)ACETYL]AMINO}PENTANOIC ACID;rac-(2R)-2-[(2-indol-1-ylacetyl)amino]-5-ureido-pentanoic acid		22740700.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22740700		pluskal_iocb_peptide_Peptide01_D1_id		100	D1		ZINC000036369875
0.6		0	796	P6241978	143.5		O2	False	0	19	0	0	24	0	4	5	0	0		0.0						CC(=O)c1cn(CCC(=O)NC(CCCNC(N)=O)C(=O)O)c2ccccc12								N-alkylindoles;Indoles;Aryl alkyl ketones;Substituted pyrroles;Benzenoids;Vinylogous amides;Heteroaromatic compounds;Ureas;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Aryl alkyl ketones;Aryl ketones;Azacyclic compounds;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Ketones;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;N-alkylindoles;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Ureas;Vinylogous amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom.	N-acyl-alpha amino acids		Amino acids and derivatives;Alpha amino acids and derivatives;N-acyl-alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	indoles (CHEBI:24828);aromatic ketone (CHEBI:76224);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);enone (CHEBI:51689);enamine (CHEBI:47989);organic aromatic compound (CHEBI:33659);ureas (CHEBI:47857);carboxamide (CHEBI:37622);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);N-acyl-amino acid (CHEBI:51569);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);organooxygen compound (CHEBI:36963);carbonyl compound (CHEBI:36586);ketone (CHEBI:17087);organic acid (CHEBI:64709);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)		Amino acids, peptides, and analogues	N-acyl-alpha-amino acid;N-alkylindole;Indole;Indole or derivatives;Aryl alkyl ketone;Aryl ketone;Substituted pyrrole;Benzenoid;Pyrrole;Heteroaromatic compound;Vinylogous amide;Carboxamide group;Ketone;Secondary carboxylic acid amide;Urea;Monocarboxylic acid or derivatives;Azacycle;Carboxylic acid;Organoheterocyclic compound;Hydrocarbon derivative;Organooxygen compound;Organonitrogen compound;Organic oxide;Carbonyl group;Organic oxygen compound;Organic nitrogen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS016375060		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	4	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C19H24N4O5	C19H24N4O5			InChI=1S/C19H24N4O5/c1-12(24)14-11-23(16-7-3-2-5-13(14)16)10-8-17(25)22-15(18(26)27)6-4-9-21-19(20)28/h2-3,5,7,11,15H,4,6,8-10H2,1H3,(H,22,25)(H,26,27)(H3,20,21,28)/t15-/m1/s1	KSROGWRNPUBFLA-OAHLLOKOSA-N	rac-(2R)-2-[3-(3-acetylindol-1-yl)propanoylamino]-5-ureido-pentanoic acid	49652324	CC(=O)c1cn(CCC(=O)N[C@H](CCCNC(N)=O)C(=O)O)c2ccccc12	(2R)-2-[3-(3-acetylindol-1-yl)propanoylamino]-5-(carbamoylamino)pentanoic acid			0.7687700000000014													MCULE-5575891833	388.42693		388.17467	5	4	10	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(49652324)	49652324	0.0	577			[#6]-[#6](=[#8])-[#6]1:[#6]:[#7](-[#6]-[#6]-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#8])-[#6](=[#8])-[#8]):[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CC(=O)c1cn(CCC(=O)N[C@H](CCCNC(N)=O)C(=O)O)c2ccccc12	KSROGWRNPUBFLA		parent_pubchem_cid	AKOS016375060;N~2~-[3-(3-ACETYL-1H-INDOL-1-YL)PROPANOYL]-N~5~-(AMINOCARBONYL)-D-ORNITHINE;rac-(2R)-2-[3-(3-acetylindol-1-yl)propanoylamino]-5-ureido-pentanoic acid		22894389.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22894389		pluskal_iocb_peptide_Peptide01_D1_id		100	D1		ZINC000040310006
3.3		0	884	P1107554	127.0		O3	False	0	25	0	0	24	0	2	7	0	0		0.0						COc1c(OC)cc2c(C)c(CC(=O)NC(Cc3c[nH]c4ccccc34)C(=O)O)c(=O)oc2c1																							0.0		AKOS016378796		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C25H24N2O7	C25H24N2O7			InChI=1S/C25H24N2O7/c1-13-16-9-21(32-2)22(33-3)11-20(16)34-25(31)17(13)10-23(28)27-19(24(29)30)8-14-12-26-18-7-5-4-6-15(14)18/h4-7,9,11-12,19,26H,8,10H2,1-3H3,(H,27,28)(H,29,30)/t19-/m1/s1	MFRVMJLCZUJXMN-LJQANCHMSA-N	rac-(2R)-2-[[2-(6,7-dimethoxy-4-methyl-2-oxo-chromen-3-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid	24280475	COc1c(OC)cc2c(C)c(CC(=O)N[C@H](Cc3c[nH]c4ccccc34)C(=O)O)c(=O)oc2c1	(2R)-2-[[2-(6,7-dimethoxy-4-methyl-2-oxochromen-3-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid			1.9086199999999995													MCULE-2463027077	464.47923		464.158351	7	3	8	4			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(24280475)	24280475	2.7	578			[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]):[#6]:[#6]2:[#6](-[#6]):[#6](-[#6]-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6]3:[#6]:[#7H]:[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]:3:4)-[#6](=[#8])-[#8]):[#6](=[#8]):[#8]:[#6]:2:[#6]:1	COc1c(OC)cc2c(C)c(CC(=O)N[C@H](Cc3c[nH]c4ccccc34)C(=O)O)c(=O)oc2c1	MFRVMJLCZUJXMN		parent_pubchem_cid	AKOS016378796;rac-(2R)-2-[[2-(6,7-dimethoxy-4-methyl-2-oxo-chromen-3-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid		24816469.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24816469		pluskal_iocb_peptide_Peptide01_D1_id		100	D1		ZINC000011865470
1.3		0	972	P3460032	112.9		O4	False	0	13	0	0	15	0	1	6	0	0	-1.0	0.0						O=C(O)CCC(NC(=O)OCc1ccccc1)C(=O)O		1.23		0.0	1.23	CHEMBL1899104		Benzyloxycarbonyls;Dicarboxylic acids and derivatives;Carbamate esters;Organic carbonic acids and derivatives;Carboxylic acids;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Benzene and substituted derivatives;Benzenoids;Benzyloxycarbonyls;Carbamate esters;Carbamic acids and derivatives;Carbonyl compounds;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Dicarboxylic acids and derivatives;Glutamic acid and derivatives;Hydrocarbon derivatives;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as glutamic acid and derivatives. These are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Glutamic acid and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic homomonocyclic compounds	carboxylic ester (CHEBI:33308);dicarboxylic acid (CHEBI:35692);carbamate ester (CHEBI:23003);organooxygen compound (CHEBI:36963);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);glutamic acid derivative (CHEBI:24315);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);amino acid (CHEBI:33709);peptide (CHEBI:16670);carbon oxoacid (CHEBI:35605);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806)	Dicarboxylic acids (FA0117)	Amino acids, peptides, and analogues	Glutamic acid or derivatives;Benzyloxycarbonyl;Monocyclic benzene moiety;Dicarboxylic acid or derivatives;Benzenoid;Carbamic acid ester;Carbonic acid derivative;Carboxylic acid;Organooxygen compound;Organonitrogen compound;Organic oxide;Organopnictogen compound;Carbonyl group;Organic oxygen compound;Organic nitrogen compound;Hydrocarbon derivative;Aromatic homomonocyclic compound	Organic acids and derivatives	0.0		N-[(Benzyloxy)carbonyl]glutamic acid		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	1	0	3	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C13H15NO6	C13H15NO6			InChI=1S/C13H15NO6/c15-11(16)7-6-10(12(17)18)14-13(19)20-8-9-4-2-1-3-5-9/h1-5,10H,6-8H2,(H,14,19)(H,15,16)(H,17,18)	PVFCXMDXBIEMQG-UHFFFAOYSA-N	2-(benzyloxycarbonylamino)pentanedioic acid	219352	O=C(O)CCC(NC(=O)OCc1ccccc1)C(=O)O	2-(phenylmethoxycarbonylamino)pentanedioic acid			1.17609													MCULE-7742481336	281.2676	ACID	281.089937	6	3	8	1	0.0		28									Dipeptides	False	Amino acids and Peptides	Small peptides	False	False	Peptide01		-1.0	Compound(219352)	219352	0.9	579		SCHEMBL910232	[#8]=[#6](-[#8])-[#6]-[#6]-[#6](-[#7]-[#6](=[#8])-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	O=C(O)CCC(NC(=O)OCc1ccccc1)C(=O)O	PVFCXMDXBIEMQG		parent_pubchem_cid	N-[(Benzyloxy)carbonyl]glutamic acid;Z-DL-GLU-OH;5619-01-2;Z-Glu-OH;2-(phenylmethoxycarbonylamino)pentanedioic acid;63648-73-7;2-{[(benzyloxy)carbonyl]amino}pentanedioic acid;Cbz-Glu-OH;Glutamic acid, N-benzyl ester, L-;Cbz-DL-Glutamic acid;2-([(Benzyloxy)carbonyl]amino)pentanedioic acid;Na-CBZ-L-glutamic acid;(S)-2-(((BENZYLOXY)CARBONYL)AMINO)PENTANEDIOIC ACID;MFCD00002801;MFCD00063193;N-[(benzyloxy)carbonyl]-L-glutamic acid;N-[(Phenylmethoxycarbonyl]-L-glutamic acid;Cbz-D-Glu-OH;NCIOpen2_005607;MLS000080799;SCHEMBL910232;carbobenzoxy-d,l-glutamic acid;NSC555;CHEMBL1899104;NSC-555;HMS2166F10;HMS3308L19;NSC88494;BBL013083;NSC-88494;NSC156967;NSC169149;NSC169154;STK315384;AKOS000121020;AKOS016037667;CARBOBENZYLOXY-DL-GLUTAMIC ACID;AB00277;CCG-250924;NSC-156967;NSC-169149;NSC-169154;AC-12398;DS-13899;SMR000037962;SY006648;SY038045;2-(benzyloxycarbonylamino)pentanedioic acid;AM20050441;FT-0629943;FT-0629953;EN300-20859;A834450	False	1117478.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=1117478		pluskal_iocb_peptide_Peptide01_D1_id		100	D1	False	
3.5		0	716	P6248094	94.9		O5	False	0	23	0	0	26	0	2	4	0	1		0.0						COC(=O)C(CCSC)NC(=O)Cn1ccc2c1ccc(OCc1ccccc1)c2								Alpha amino acid esters;N-acyl-alpha amino acids and derivatives;N-alkylindoles;Indoles;Phenol ethers;Alkyl aryl ethers;Fatty acid esters;Substituted pyrroles;Benzene and substituted derivatives;Methyl esters;Heteroaromatic compounds;Secondary carboxylic acid amides;Sulfenyl compounds;Azacyclic compounds;Dialkylthioethers;Monocarboxylic acids and derivatives;Carbonyl compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	Alkyl aryl ethers;Alpha amino acid esters;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids and derivatives;Chemical entities;Dialkylthioethers;Ethers;Fatty Acyls;Fatty acid esters;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Lipids and lipid-like molecules;Methionine and derivatives;Methyl esters;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids and derivatives;N-alkylindoles;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Organosulfur compounds;Phenol ethers;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Sulfenyl compounds;Thioethers	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as methionine and derivatives. These are compounds containing methionine or a derivative thereof resulting from reaction of methionine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Methionine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	alpha-amino acid ester (CHEBI:46874);N-acyl-amino acid (CHEBI:51569);indoles (CHEBI:24828);aromatic ether (CHEBI:35618);fatty acid ester (CHEBI:35748);pyrroles (CHEBI:26455);benzenes (CHEBI:22712);carboxylic ester (CHEBI:33308);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organosulfur compound (CHEBI:33261);organonitrogen heterocyclic compound (CHEBI:38101);aliphatic sulfide (CHEBI:22327);monocarboxylic acid (CHEBI:25384);carbonyl compound (CHEBI:36586);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);alpha-amino acid (CHEBI:33704);methionine derivative (CHEBI:25230);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);organooxygen compound (CHEBI:36963);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ether (CHEBI:25698);lipid (CHEBI:18059);amide (CHEBI:32988);organic sulfide (CHEBI:16385);nitrogen molecular entity (CHEBI:51143);amino acid (CHEBI:33709);peptide (CHEBI:16670)	Fatty esters (FA07);Fatty Acyls (FA)	Amino acids, peptides, and analogues	Methionine or derivatives;Alpha-amino acid ester;N-acyl-alpha amino acid or derivatives;N-alkylindole;Indole;Indole or derivatives;Phenol ether;Alkyl aryl ether;Fatty acid ester;Monocyclic benzene moiety;Fatty acyl;Benzenoid;Substituted pyrrole;Heteroaromatic compound;Pyrrole;Methyl ester;Secondary carboxylic acid amide;Carboxamide group;Carboxylic acid ester;Sulfenyl compound;Dialkylthioether;Thioether;Organoheterocyclic compound;Monocarboxylic acid or derivatives;Azacycle;Ether;Organic oxygen compound;Hydrocarbon derivative;Organic nitrogen compound;Organonitrogen compound;Organooxygen compound;Carbonyl group;Organic oxide;Organosulfur compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS016382686		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C23H26N2O4S	C23H26N2O4S			InChI=1S/C23H26N2O4S/c1-28-23(27)20(11-13-30-2)24-22(26)15-25-12-10-18-14-19(8-9-21(18)25)29-16-17-6-4-3-5-7-17/h3-10,12,14,20H,11,13,15-16H2,1-2H3,(H,24,26)/t20-/m0/s1	DEKMYYBWDNWYPT-FQEVSTJZSA-N	methyl rac-(2S)-2-[[2-(5-benzyloxyindol-1-yl)acetyl]amino]-4-methylsulfanyl-butanoate	71692226	COC(=O)[C@H](CCSC)NC(=O)Cn1ccc2c1ccc(OCc1ccccc1)c2	methyl (2S)-4-methylsulfanyl-2-[[2-(5-phenylmethoxyindol-1-yl)acetyl]amino]butanoate			2.6856600000000004													MCULE-4554061460	426.53867		426.161328	5	1	11	3			44										False	Alkaloids				Peptide01			Compound(71692226)	71692226	3.9	580			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]-[#16]-[#6])-[#7]-[#6](=[#8])-[#6]-[#7]1:[#6]:[#6]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1):[#6]:2	COC(=O)[C@H](CCSC)NC(=O)Cn1ccc2c1ccc(OCc1ccccc1)c2	DEKMYYBWDNWYPT		parent_pubchem_cid	AKOS016382686;methyl N-{[5-(benzyloxy)-1H-indol-1-yl]acetyl}-L-methioninate;methyl rac-(2S)-2-[[2-(5-benzyloxyindol-1-yl)acetyl]amino]-4-methylsulfanyl-butanoate		68853404.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=68853404		pluskal_iocb_peptide_Peptide01_D1_id		100	D1		ZINC000072325952
2.7		0	804	P6244739	97.7		O6	False	0	20	0	0	20	0	6	2	0	0		0.0						COc1c(-n2cnnn2)cc(NC(=O)CCCc2c[nH]c3ccccc23)cc1																							0.0		4-(1H-indol-3-yl)-N-[4-methoxy-3-(1H-tetrazol-1-yl)phenyl]butanamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	4	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C20H20N6O2	C20H20N6O2			InChI=1S/C20H20N6O2/c1-28-19-10-9-15(11-18(19)26-13-22-24-25-26)23-20(27)8-4-5-14-12-21-17-7-3-2-6-16(14)17/h2-3,6-7,9-13,21H,4-5,8H2,1H3,(H,23,27)	ACOMKJHFCVKGEM-UHFFFAOYSA-N	4-(1H-indol-3-yl)-N-[4-methoxy-3-(tetrazol-1-yl)phenyl]butanamide	45493095	COc1c(-n2cnnn2)cc(NC(=O)CCCc2c[nH]c3ccccc23)cc1	4-(1H-indol-3-yl)-N-[4-methoxy-3-(tetrazol-1-yl)phenyl]butanamide			1.5974399999999989													MCULE-7227004260	376.4214		376.164774	5	2	7	4			44										False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(45493095)	45493095	2.7	581			[#6]-[#8]-[#6]1:[#6](-[#7]2:[#6]:[#7]:[#7]:[#7]:2):[#6]:[#6](-[#7]-[#6](=[#8])-[#6]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	COc1c(-n2cnnn2)cc(NC(=O)CCCc2c[nH]c3ccccc23)cc1	ACOMKJHFCVKGEM		parent_pubchem_cid	4-(1H-indol-3-yl)-N-[4-methoxy-3-(1H-tetrazol-1-yl)phenyl]butanamide;1190248-76-0;EiM08-17311;STK933373;AKOS005662968;4-(1H-indol-3-yl)-N-[4-methoxy-3-(tetrazol-1-yl)phenyl]butanamide		7639424.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=7639424		pluskal_iocb_peptide_Peptide01_D1_id		100	D1		ZINC000036358458
2.3		0	892	P3462532	89.6		O7	False	0	22	0	0	19	0	3	4	0	0		0.0						O=C(NC(Cc1ccccc1)C(=O)Nc1cc2c(cc1)OCO2)c1cnccc1																							0.0		AKOS016399976		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C22H19N3O4	C22H19N3O4			InChI=1S/C22H19N3O4/c26-21(16-7-4-10-23-13-16)25-18(11-15-5-2-1-3-6-15)22(27)24-17-8-9-19-20(12-17)29-14-28-19/h1-10,12-13,18H,11,14H2,(H,24,27)(H,25,26)/t18-/m0/s1	GEDKVCCYJOHXLK-SFHVURJKSA-N	N-[rac-(1S)-2-(1,3-benzodioxol-5-ylamino)-1-benzyl-2-oxo-ethyl]pyridine-3-carboxamide	29135721	O=C(N[C@@H](Cc1ccccc1)C(=O)Nc1cc2c(cc1)OCO2)c1cnccc1	N-[(2S)-1-(1,3-benzodioxol-5-ylamino)-1-oxo-3-phenylpropan-2-yl]pyridine-3-carboxamide			1.3752499999999996													MCULE-6780210813	389.41443		389.137556	5	2	6	4			44									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(29135721)	29135721	2.8	582			[#8]=[#6](-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#7]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1)-[#8]-[#6]-[#8]-2)-[#6]1:[#6]:[#7]:[#6]:[#6]:[#6]:1	O=C(N[C@@H](Cc1ccccc1)C(=O)Nc1cc2c(cc1)OCO2)c1cnccc1	GEDKVCCYJOHXLK		parent_pubchem_cid	AKOS016399976;N-(2H-1,3-BENZODIOXOL-5-YL)-3-PHENYL-2-[(PYRIDIN-3-YL)FORMAMIDO]PROPANAMIDE;N-[rac-(1S)-2-(1,3-benzodioxol-5-ylamino)-1-benzyl-2-oxo-ethyl]pyridine-3-carboxamide		15365677.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=15365677		pluskal_iocb_peptide_Peptide01_D1_id		100	D1		ZINC000020735063
4.2		0	980	P6248294	62.7		O8	False	0	21	0	0	20	0	4	1	0	0		0.0						Cc1c(C(=O)NCCc2c[nH]c3ccccc23)n(-c2ccccc2)nc1																							0.0		N-[2-(1H-indol-3-yl)ethyl]-4-methyl-1-phenyl-1H-pyrazole-5-carboxamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C21H20N4O	C21H20N4O			InChI=1S/C21H20N4O/c1-15-13-24-25(17-7-3-2-4-8-17)20(15)21(26)22-12-11-16-14-23-19-10-6-5-9-18(16)19/h2-10,13-14,23H,11-12H2,1H3,(H,22,26)	JUYVQWKMOFLAEU-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)ethyl]-4-methyl-2-phenyl-pyrazole-3-carboxamide	71946702	Cc1c(C(=O)NCCc2c[nH]c3ccccc23)n(-c2ccccc2)nc1	N-[2-(1H-indol-3-yl)ethyl]-4-methyl-2-phenylpyrazole-3-carboxamide			2.851960000000001													MCULE-7413278511	344.41975		344.163711	2	2	5	4			44									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(71946702)	71946702	3.9	583			[#6]-[#6]1:[#6](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#7](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#7]:[#6]:1	Cc1c(C(=O)NCCc2c[nH]c3ccccc23)n(-c2ccccc2)nc1	JUYVQWKMOFLAEU		parent_pubchem_cid	N-[2-(1H-indol-3-yl)ethyl]-4-methyl-1-phenyl-1H-pyrazole-5-carboxamide;EiM08-25743;STL472076;AKOS016390604;N-[2-(1H-indol-3-yl)ethyl]-4-methyl-2-phenyl-pyrazole-3-carboxamide		69317582.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=69317582		pluskal_iocb_peptide_Peptide01_D1_id		100	D1		ZINC000094993190
1.1		0	724	P3460015	130.8		O9	False	0	21	0	0	30	0	4	5	0	0	-1.0	0.0						CC(C)CC(NC(=O)C1CCCN1C(=O)OCc1ccccc1)C(=O)NCC(N)=O		0.92		0.0	0.66	CHEMBL2371664																	0.0		Z-Pro-leu-gly-NH2		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	4	0	2	0	0	0	0	0	0	1	0	4	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C21H30N4O5	C21H30N4O5			InChI=1S/C21H30N4O5/c1-14(2)11-16(19(27)23-12-18(22)26)24-20(28)17-9-6-10-25(17)21(29)30-13-15-7-4-3-5-8-15/h3-5,7-8,14,16-17H,6,9-13H2,1-2H3,(H2,22,26)(H,23,27)(H,24,28)/t16-,17-/m0/s1	OHIXEKXBUUHYHX-IRXDYDNUSA-N	benzyl rac-(2S)-2-[[rac-(1S)-1-[(2-amino-2-oxo-ethyl)carbamoyl]-3-methyl-butyl]carbamoyl]pyrrolidine-1-carboxylate	7272433	CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)OCc1ccccc1)C(=O)NCC(N)=O	benzyl (2S)-2-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]pyrrolidine-1-carboxylate			0.8652900000000017													MCULE-2578015581	418.49705	NEUTRAL	418.22162	5	3	10	2	0.0		28									Tripeptides	False	Amino acids and Peptides	Small peptides	False	False	Peptide01		-1.0	Compound(7272433)	7272433	1.5	584		SCHEMBL1372348	[#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6@@H]1-[#6]-[#6]-[#6]-[#7]-1-[#6](=[#8])-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#7]-[#6]-[#6](-[#7])=[#8]	CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)OCc1ccccc1)C(=O)NCC(N)=O	OHIXEKXBUUHYHX		parent_pubchem_cid	Z-Pro-leu-gly-NH2;14485-80-4;MFCD00057240;benzyl (2S)-2-{[(1S)-1-[(carbamoylmethyl)carbamoyl]-3-methylbutyl]carbamoyl}pyrrolidine-1-carboxylate;1-[(benzyloxy)carbonyl]-L-prolyl-L-leucylglycinamide;N-Cbz-Pro-Leu-Gly amide;SCHEMBL1372348;CHEMBL2371664;Glycinamide,1-((phenylmethoxy)carbonyl)-L-prolyl-L-leucyl-;AKOS016010222;benzyl (2S)-2-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]pyrrolidine-1-carboxylate;LS-09782;CS-0334070;benzyloxycarbonyl-l-prolyl-l-leucyl-glycinamide;Glycinamide,1-[(phenylmethoxy)carbonyl]-L-prolyl-L-leucyl-(9ci);(S)-benzyl 2-((S)-1-(2-amino-2-oxoethylamino)-4-methyl-1-oxopentan-2-ylcarbamoyl)pyrrolidine-1-carboxylate;Benzyl (S)-2-(((S)-1-((2-amino-2-oxoethyl)amino)-4-methyl-1-oxopentan-2-yl)carbamoyl)pyrrolidine-1-carboxylate;BENZYL 2-({1-[(CARBAMOYLMETHYL)CARBAMOYL]-3-METHYLBUTYL}CARBAMOYL)PYRROLIDINE-1-CARBOXYLATE;benzyl rac-(2S)-2-[[rac-(1S)-1-[(2-amino-2-oxo-ethyl)carbamoyl]-3-methyl-butyl]carbamoyl]pyrrolidine-1-carboxylate	False	7869580.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=7869580		pluskal_iocb_peptide_Peptide01_D2_id		100	D2	False	ZINC000004536040
3.0		0	812	P6240941	80.6		O10	False	0	21	0	0	22	0	2	4	0	0		0.0						O=C(O)CCCNC(=O)Cn1ccc2c1cc(OCc1ccccc1)cc2								N-alkylindoles;Indoles;Phenol ethers;Alkyl aryl ethers;Substituted pyrroles;Benzene and substituted derivatives;Heteroaromatic compounds;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alkyl aryl ethers;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Ethers;Gamma amino acids and derivatives;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Monocarboxylic acids and derivatives;N-alkylindoles;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenol ethers;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as gamma amino acids and derivatives. These are amino acids having a (-NH2) group attached to the gamma carbon atom.	Gamma amino acids and derivatives		Amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	indoles (CHEBI:24828);aromatic ether (CHEBI:35618);pyrroles (CHEBI:26455);benzenes (CHEBI:22712);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);organooxygen compound (CHEBI:36963);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ether (CHEBI:25698);organic acid (CHEBI:64709);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)		Amino acids, peptides, and analogues	Gamma amino acid or derivatives;N-alkylindole;Indole;Indole or derivatives;Phenol ether;Alkyl aryl ether;Monocyclic benzene moiety;Benzenoid;Substituted pyrrole;Heteroaromatic compound;Pyrrole;Carboxamide group;Secondary carboxylic acid amide;Carboxylic acid;Ether;Azacycle;Organoheterocyclic compound;Monocarboxylic acid or derivatives;Hydrocarbon derivative;Organic nitrogen compound;Organic oxygen compound;Carbonyl group;Organic oxide;Organonitrogen compound;Organooxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		4-({[6-(benzyloxy)-1H-indol-1-yl]acetyl}amino)butanoic acid		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C21H22N2O4	C21H22N2O4			InChI=1S/C21H22N2O4/c24-20(22-11-4-7-21(25)26)14-23-12-10-17-8-9-18(13-19(17)23)27-15-16-5-2-1-3-6-16/h1-3,5-6,8-10,12-13H,4,7,11,14-15H2,(H,22,24)(H,25,26)	PYLUFXDVCZMVDD-UHFFFAOYSA-N	4-[[2-(6-benzyloxyindol-1-yl)acetyl]amino]butanoic acid	49656872	O=C(O)CCCNC(=O)Cn1ccc2c1cc(OCc1ccccc1)cc2	4-[[2-(6-phenylmethoxyindol-1-yl)acetyl]amino]butanoic acid			2.2557599999999995													MCULE-5371046259	366.42049		366.157957	4	2	9	3			44										False	Alkaloids				Peptide01			Compound(49656872)	49656872	2.8	585			[#8]=[#6](-[#8])-[#6]-[#6]-[#6]-[#7]-[#6](=[#8])-[#6]-[#7]1:[#6]:[#6]:[#6]2:[#6]:1:[#6]:[#6](-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1):[#6]:[#6]:2	O=C(O)CCCNC(=O)Cn1ccc2c1cc(OCc1ccccc1)cc2	PYLUFXDVCZMVDD		parent_pubchem_cid	4-({[6-(benzyloxy)-1H-indol-1-yl]acetyl}amino)butanoic acid;1219547-65-5;EiM08-12168;STK943537;AKOS005672589;4-({2-[6-(BENZYLOXY)-1H-INDOL-1-YL]ACETYL}AMINO)BUTANOIC ACID;4-[[2-(6-benzyloxyindol-1-yl)acetyl]amino]butanoic acid		23307190.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23307190		pluskal_iocb_peptide_Peptide01_D2_id		100	D2		ZINC000040287405
3.5		0	900	P6666707	65.2		O11	False	0	24	0	0	25	0	3	2	0	0		0.0						CC(C)Cn1cc(C(=O)NCCc2c[nH]c3ccccc23)c2ccccc2c1=O								3-alkylindoles;Pyridinecarboxylic acids and derivatives;Pyridinones;Substituted pyrroles;Benzenoids;Vinylogous amides;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactams;Azacyclic compounds;Organooxygen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	3-alkylindoles;Azacyclic compounds;Benzenoids;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Hydropyridines;Indoles;Indoles and derivatives;Isoquinolines and derivatives;Isoquinolones and derivatives;Lactams;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Pyridinecarboxylic acids and derivatives;Pyridines and derivatives;Pyridinones;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Vinylogous amides	Isoquinolines and derivatives	2.1	This compound belongs to the class of organic compounds known as isoquinolones and derivatives. These are aromatic polycyclic compounds containing a ketone bearing isoquinoline moiety.	Isoquinolones and derivatives			Organic compounds	Aromatic heteropolycyclic compounds	indoles (CHEBI:24828);aromatic carboxylic acid (CHEBI:33859);pyridinemonocarboxylic acid (CHEBI:26420);pyridone (CHEBI:38183);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);enone (CHEBI:51689);enamine (CHEBI:47989);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactam (CHEBI:24995);organonitrogen heterocyclic compound (CHEBI:38101);organooxygen compound (CHEBI:36963);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);isoquinolines (CHEBI:24922);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);pyridines (CHEBI:26421);dihydropyridine (CHEBI:50075);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143)		Isoquinolones and derivatives	Isoquinolone;3-alkylindole;Indole;Indole or derivatives;Pyridine carboxylic acid or derivatives;Pyridinone;Pyridine;Benzenoid;Substituted pyrrole;Heteroaromatic compound;Vinylogous amide;Pyrrole;Carboxamide group;Lactam;Secondary carboxylic acid amide;Azacycle;Carboxylic acid derivative;Organooxygen compound;Organonitrogen compound;Organic oxide;Organic oxygen compound;Organic nitrogen compound;Hydrocarbon derivative;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		1401589-27-2		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C24H25N3O2	C24H25N3O2			InChI=1S/C24H25N3O2/c1-16(2)14-27-15-21(19-8-3-4-9-20(19)24(27)29)23(28)25-12-11-17-13-26-22-10-6-5-7-18(17)22/h3-10,13,15-16,26H,11-12,14H2,1-2H3,(H,25,28)	WEDAXIBVRVTBOF-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)ethyl]-2-isobutyl-1-oxo-isoquinoline-4-carboxamide	71753690	CC(C)Cn1cc(C(=O)NCCc2c[nH]c3ccccc23)c2ccccc2c1=O	N-[2-(1H-indol-3-yl)ethyl]-2-(2-methylpropyl)-1-oxoisoquinoline-4-carboxamide			4.044930000000003													MCULE-1211479875	387.48575		387.194677	2	2	6	4			44										False	Alkaloids				Peptide01			Compound(71753690)	71753690	3.9	586			[#6]-[#6](-[#6])-[#6]-[#7]1:[#6]:[#6](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8]	CC(C)Cn1cc(C(=O)NCCc2c[nH]c3ccccc23)c2ccccc2c1=O	WEDAXIBVRVTBOF		parent_pubchem_cid	1401589-27-2;N~4~-[2-(1H-indol-3-yl)ethyl]-2-isobutyl-1-oxo-1,2-dihydro-4-isoquinolinecarboxamide;EiM08-25749;AKOS016375667;N-[2-(1H-indol-3-yl)ethyl]-2-(2-methylpropyl)-1-oxo-1,2-dihydroisoquinoline-4-carboxamide;N-[2-(1H-indol-3-yl)ethyl]-2-isobutyl-1-oxo-isoquinoline-4-carboxamide		69434131.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=69434131		pluskal_iocb_peptide_Peptide01_D2_id		100	D2		ZINC000079188772
3.1		0	988	P7138703	75.6		O12	False	0	17	0	0	17	0	1	4	0	0	-1.0	0.0						O=C(NC(Cc1ccccc1)C(=O)O)OCc1ccccc1		2.61		0.0	3.24	CHEMBL66143		Phenylpropanoic acids;Benzyloxycarbonyls;Amphetamines and derivatives;Carbamate esters;Organic carbonic acids and derivatives;Monocarboxylic acids and derivatives;Carboxylic acids;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Benzene and substituted derivatives;Benzenoids;Benzyloxycarbonyls;Carbamate esters;Carbamic acids and derivatives;Carbonyl compounds;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Hydrocarbon derivatives;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenethylamines;Phenylalanine and derivatives;Phenylpropanoic acids;Phenylpropanoids and polyketides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic homomonocyclic compounds	benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);carboxylic ester (CHEBI:33308);amphetamines (CHEBI:35338);carbamate ester (CHEBI:23003);organooxygen compound (CHEBI:36963);carbonyl compound (CHEBI:36586);carboxylic acid anion (CHEBI:29067);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);primary amine (CHEBI:32877);amino acid (CHEBI:33709);peptide (CHEBI:16670);carbon oxoacid (CHEBI:35605);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806)		Amino acids, peptides, and analogues	Phenylalanine or derivatives;3-phenylpropanoic-acid;Amphetamine or derivatives;Benzyloxycarbonyl;Monocyclic benzene moiety;Benzenoid;Carbamic acid ester;Carbonic acid derivative;Carboxylic acid;Monocarboxylic acid or derivatives;Organic nitrogen compound;Organonitrogen compound;Organooxygen compound;Hydrocarbon derivative;Organic oxide;Carbonyl group;Organopnictogen compound;Organic oxygen compound;Aromatic homomonocyclic compound	Organic acids and derivatives	0.0		1161-13-3	DTXSID30151276	2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	1	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C17H17NO4	C17H17NO4			InChI=1S/C17H17NO4/c19-16(20)15(11-13-7-3-1-4-8-13)18-17(21)22-12-14-9-5-2-6-10-14/h1-10,15H,11-12H2,(H,18,21)(H,19,20)/t15-/m0/s1	RRONHWAVOYADJL-HNNXBMFYSA-N	rac-(2S)-2-(benzyloxycarbonylamino)-3-phenyl-propanoic acid	70878	O=C(N[C@@H](Cc1ccccc1)C(=O)O)OCc1ccccc1	(2S)-3-phenyl-2-(phenylmethoxycarbonylamino)propanoic acid			2.4992800000000006													MCULE-1543516037	299.32934	ACID	299.115758	4	2	7	2	1.0		27									Dipeptides	False	Amino acids and Peptides	Small peptides	False	False	Peptide01		-1.0	Compound(70878)	70878	2.1	587		SCHEMBL220648	[#8]=[#6](-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8])-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	O=C(N[C@@H](Cc1ccccc1)C(=O)O)OCc1ccccc1	RRONHWAVOYADJL		parent_pubchem_cid	1161-13-3;Z-Phe-OH;N-CBZ-L-PHENYLALANINE;Carbobenzoxyphenylalanine;Z-L-Phenylalanine;N-Carbobenzoxy-L-phenylalanine;Cbz-Phe-OH;CBZ-L-Phenylalanine;Carbobenzoxy-L-phenylalanine;N-(Carbobenzyloxy)-L-phenylalanine;(Benzyloxycarbonyl)phenylalanine;(2S)-2-{[(Benzyloxy)carbonyl]amino}-3-phenylpropanoic acid;L-N-Carboxy-3-phenylalanine N-benzyl ester;N-(benzyloxycarbonyl)-L-phenylalanine;((benzyloxy)carbonyl)-L-phenylalanine;(S)-2-(Benzyloxycarbonylamino)-3-phenylpropanoicacid;CHEMBL66143;L-Phenylalanine, N-((phenylmethoxy)carbonyl)-;Alanine, N-carboxy-3-phenyl-, N-benzyl ester, L-;N-[(Benzyloxy)carbonyl]phenylalanine;(2S)-3-phenyl-2-(phenylmethoxycarbonylamino)propanoic acid;L-Phenylalanine, N-[(phenylmethoxy)carbonyl]-;NSC 402059;N-Carbobenzyloxy-L-phenylalanine;MFCD00020418;Cbz-Phe;CBZ-L-phenylalaine;n-benzyloxycarbonyl-l-phenylalanine;EINECS 214-599-3;N-Benzyloxycarbonyl-L-3-phenylalanine;N-((Phenylmethoxy)carbonyl)-L-phenylalanine;Phenylalanine, N-[(phenylmethoxy)carbonyl]-;N-[(Benzyloxy)carbonyl]phenylalanine #;ZPheOH;N-Cbz-phenylalanine;N-CBz phenylalanine;Z-Phe;Z-PheOH;Z-L-Phe-OH;CBZ-L-PHE;Z-(L)-Phe-OH;N-carbobenzoxy-phenylalanine;benzyloxycarbonylphenylalanine;Z-Phe-OH, 99%;SCHEMBL220648;N-benzyloxycarbonylphenylalanine;benzyloxycarbonyl-L-phenylalanine;DTXSID30151276;n-benzyloxycarbonyl-s-phenylalanine;n-benzyloxycarbonyl-l-phenyl alanine;BDBM50043796;AKOS010373384;AKOS015839335;N-Benzyloxycarbonyl-(L)-Phenylalanine;AC-7045;AM82160;CS-W012139;HY-W011423;nalpha-benzyloxycarbonyl-l-phenylalanine;N-alpha-Benzyloxycarbonyl-L-phenylalanine;Nalpha -Benzyloxycarbonyl-L-phenylalanine;AS-12743;BP-13289;C0660;D71210;EN300-121295;M03068;Nalpha -[(phenylmethoxy)carbonyl]-L-phenylalanine;J-300211;(S)-2-Benzyloxycarbonylamino-3-phenyl-propionic acid;(S)-2-(((benzyloxy)carbonyl)amino)-3-phenylpropanoic acid;rac-(2S)-2-(benzyloxycarbonylamino)-3-phenyl-propanoic acid	False	442767.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=442767		pluskal_iocb_peptide_Peptide01_D2_id		100	D2	False	ZINC000000038519
2.3		0	732	P6248078	105.7		O13	False	0	23	0	0	24	0	4	4	0	0		0.0						O=C(O)C(Cc1ccccc1)NC(=O)N1CCN(C(=O)c2c[nH]c3ccccc23)CC1																							0.0		MFCD09855589		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C23H24N4O4	C23H24N4O4			InChI=1S/C23H24N4O4/c28-21(18-15-24-19-9-5-4-8-17(18)19)26-10-12-27(13-11-26)23(31)25-20(22(29)30)14-16-6-2-1-3-7-16/h1-9,15,20,24H,10-14H2,(H,25,31)(H,29,30)/t20-/m0/s1	NLPWVGKIOKVIOE-FQEVSTJZSA-N	rac-(2S)-2-[[4-(1H-indole-3-carbonyl)piperazine-1-carbonyl]amino]-3-phenyl-propanoic acid	17600222	O=C(O)[C@H](Cc1ccccc1)NC(=O)N1CCN(C(=O)c2c[nH]c3ccccc23)CC1	(2S)-2-[[4-(1H-indole-3-carbonyl)piperazine-1-carbonyl]amino]-3-phenylpropanoic acid			1.7933599999999996													MCULE-2928324586	420.47213		420.179755	4	3	5	4			44										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(17600222)	17600222	2.2	588			[#8]=[#6](-[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#7]1-[#6]-[#6]-[#7](-[#6](=[#8])-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6]-[#6]-1	O=C(O)[C@H](Cc1ccccc1)NC(=O)N1CCN(C(=O)c2c[nH]c3ccccc23)CC1	NLPWVGKIOKVIOE		parent_pubchem_cid	MFCD09855589;AKOS005562696;(2S)-2-({[4-(1H-INDOL-3-YLCARBONYL)PIPERAZINO]CARBONYL}AMINO)-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[[4-(1H-indole-3-carbonyl)piperazine-1-carbonyl]amino]-3-phenyl-propanoic acid		24745131.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24745131		pluskal_iocb_peptide_Peptide01_D2_id		100	D2		ZINC000013722981
2.7		0	820	P6240002	88.4		O14	False	0	21	0	0	20	0	2	4	0	0		0.0						CC(=O)c1cn(CC(=O)NC(Cc2ccccc2)C(=O)O)c2ccccc12								N-acyl-L-alpha-amino acids;Phenylpropanoic acids;Amphetamines and derivatives;N-alkylindoles;Indoles;Aryl alkyl ketones;Substituted pyrroles;Vinylogous amides;Heteroaromatic compounds;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Aryl alkyl ketones;Aryl ketones;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Ketones;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;N-alkylindoles;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenethylamines;Phenylalanine and derivatives;Phenylpropanoic acids;Phenylpropanoids and polyketides;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Vinylogous amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-L-alpha-amino acid (CHEBI:48927);benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);amphetamines (CHEBI:35338);indoles (CHEBI:24828);aromatic ketone (CHEBI:76224);pyrroles (CHEBI:26455);enone (CHEBI:51689);enamine (CHEBI:47989);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);monocarboxylic acid (CHEBI:25384);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);carbonyl compound (CHEBI:36586);organooxygen compound (CHEBI:36963);N-acyl-amino acid (CHEBI:51569);benzenoid aromatic compound (CHEBI:33836);primary amine (CHEBI:32877);organic heterocyclic compound (CHEBI:24532);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ketone (CHEBI:17087);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)		Amino acids, peptides, and analogues	Phenylalanine or derivatives;N-acyl-alpha amino acid or derivatives;N-acyl-alpha-amino acid;N-acyl-l-alpha-amino acid;3-phenylpropanoic-acid;Amphetamine or derivatives;N-alkylindole;Indole;Indole or derivatives;Aryl alkyl ketone;Aryl ketone;Monocyclic benzene moiety;Benzenoid;Substituted pyrrole;Heteroaromatic compound;Vinylogous amide;Pyrrole;Carboxamide group;Ketone;Secondary carboxylic acid amide;Organoheterocyclic compound;Azacycle;Monocarboxylic acid or derivatives;Carboxylic acid;Hydrocarbon derivative;Organic oxide;Organic nitrogen compound;Carbonyl group;Organonitrogen compound;Organooxygen compound;Organic oxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		EiM08-11072		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C21H20N2O4	C21H20N2O4			InChI=1S/C21H20N2O4/c1-14(24)17-12-23(19-10-6-5-9-16(17)19)13-20(25)22-18(21(26)27)11-15-7-3-2-4-8-15/h2-10,12,18H,11,13H2,1H3,(H,22,25)(H,26,27)/t18-/m0/s1	LWMVLYKZVQOGNL-SFHVURJKSA-N	rac-(2S)-2-[[2-(3-acetylindol-1-yl)acetyl]amino]-3-phenyl-propanoic acid	45490469	CC(=O)c1cn(CC(=O)N[C@@H](Cc2ccccc2)C(=O)O)c2ccccc12	(2S)-2-[[2-(3-acetylindol-1-yl)acetyl]amino]-3-phenylpropanoic acid			2.11816													MCULE-1657512300	364.40455		364.142307	4	2	7	3			44										False					Peptide01			Compound(45490469)	45490469	2.7	589			[#6]-[#6](=[#8])-[#6]1:[#6]:[#7](-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#8]):[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CC(=O)c1cn(CC(=O)N[C@@H](Cc2ccccc2)C(=O)O)c2ccccc12	LWMVLYKZVQOGNL		parent_pubchem_cid	EiM08-11072;AKOS016375010;(2S)-2-{[2-(3-ACETYL-1H-INDOL-1-YL)ACETYL]AMINO}-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[[2-(3-acetylindol-1-yl)acetyl]amino]-3-phenyl-propanoic acid		22683564.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22683564		pluskal_iocb_peptide_Peptide01_D2_id		100	D2		ZINC000036369821
4.4		0	908	P7565544	86.0		O15	False	1	17	0	0	18	0	3	1	0	1		0.0						CC(C)c1c(C(=O)NCCc2c[nH]c3ccccc23)nc(Br)s1								Thiazolecarboxamides;2-heteroaryl carboxamides;2,4,5-trisubstituted thiazoles;Substituted pyrroles;Benzenoids;Aryl bromides;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Organooxygen compounds;Organonitrogen compounds;Organobromides;Organic oxides;Hydrocarbon derivatives	2,4,5-trisubstituted thiazoles;2-heteroaryl carboxamides;3-alkylindoles;Aryl bromides;Aryl halides;Azacyclic compounds;Azoles;Benzenoids;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organobromides;Organohalogen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Thiazolecarboxamides;Thiazolecarboxylic acids and derivatives;Thiazoles	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as 3-alkylindoles. These are compounds containing an indole moiety that carries an alkyl chain at the 3-position.	3-alkylindoles			Organic compounds	Aromatic heteropolycyclic compounds	aromatic amide (CHEBI:62733);thiazoles (CHEBI:48901);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);organobromine compound (CHEBI:37141);organonitrogen heterocyclic compound (CHEBI:38101);organooxygen compound (CHEBI:36963);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);indoles (CHEBI:24828);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);azole (CHEBI:68452);aromatic carboxylic acid (CHEBI:33859);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);organohalogen compound (CHEBI:36684);haloarene (CHEBI:50887);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143)		Indoles	3-alkylindole;2-heteroaryl carboxamide;2,4,5-trisubstituted 1,3-thiazole;Thiazolecarboxylic acid or derivatives;Thiazolecarboxamide;Aryl bromide;Aryl halide;Benzenoid;Substituted pyrrole;Azole;Heteroaromatic compound;Thiazole;Pyrrole;Carboxamide group;Secondary carboxylic acid amide;Azacycle;Carboxylic acid derivative;Organobromide;Organohalogen compound;Organic nitrogen compound;Hydrocarbon derivative;Organic oxide;Organic oxygen compound;Organonitrogen compound;Organooxygen compound;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		1435997-27-5		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C17H18BrN3OS	C17H18BrN3OS			InChI=1S/C17H18BrN3OS/c1-10(2)15-14(21-17(18)23-15)16(22)19-8-7-11-9-20-13-6-4-3-5-12(11)13/h3-6,9-10,20H,7-8H2,1-2H3,(H,19,22)	SNPCOSNUOZWXGX-UHFFFAOYSA-N	2-bromo-N-[2-(1H-indol-3-yl)ethyl]-5-isopropyl-thiazole-4-carboxamide	71754697	CC(C)c1c(C(=O)NCCc2c[nH]c3ccccc23)nc(Br)s1	2-bromo-N-[2-(1H-indol-3-yl)ethyl]-5-propan-2-yl-1,3-thiazole-4-carboxamide			3.890250000000002													MCULE-7096182831	392.32051		391.035395	2	2	5	3			44									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(71754697)	71754697	4.8	590			[#6]-[#6](-[#6])-[#6]1:[#6](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#7]:[#6](-[#35]):[#16]:1	CC(C)c1c(C(=O)NCCc2c[nH]c3ccccc23)nc(Br)s1	SNPCOSNUOZWXGX		parent_pubchem_cid	1435997-27-5;2-bromo-N-[2-(1H-indol-3-yl)ethyl]-5-isopropyl-1,3-thiazole-4-carboxamide;EiM08-29017;AKOS025144363;2-bromo-N-[2-(1H-indol-3-yl)ethyl]-5-(propan-2-yl)-1,3-thiazole-4-carboxamide;2-bromo-N-[2-(1H-indol-3-yl)ethyl]-5-isopropyl-thiazole-4-carboxamide		69351213.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=69351213		pluskal_iocb_peptide_Peptide01_D2_id		100	D2		ZINC000085876340
3.2		0	996	P6245629	103.5		O16	False	0	20	0	2	20	0	4	3	0	1		0.0						COC(=O)C(CCSC)NC(=O)c1c(-n2cccc2)n(-c2c(F)cc(F)cc2)nc1																							0.0		AKOS016382696		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	2		C20H20F2N4O3S	C20H20F2N4O3S			InChI=1S/C20H20F2N4O3S/c1-29-20(28)16(7-10-30-2)24-18(27)14-12-23-26(19(14)25-8-3-4-9-25)17-6-5-13(21)11-15(17)22/h3-6,8-9,11-12,16H,7,10H2,1-2H3,(H,24,27)/t16-/m0/s1	AEPFGJLCYYNHBG-INIZCTEOSA-N	methyl rac-(2S)-2-[[1-(2,4-difluorophenyl)-5-pyrrol-1-yl-pyrazole-4-carbonyl]amino]-4-methylsulfanyl-butanoate	51052636	COC(=O)[C@H](CCSC)NC(=O)c1c(-n2cccc2)n(-c2c(F)cc(F)cc2)nc1	methyl (2S)-2-[[1-(2,4-difluorophenyl)-5-pyrrol-1-ylpyrazole-4-carbonyl]amino]-4-methylsulfanylbutanoate			2.530970000000001													MCULE-4470691352	434.4682		434.122418	5	1	9	3			44										False	Alkaloids				Peptide01			Compound(51052636)	51052636	3.1	591			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]-[#16]-[#6])-[#7]-[#6](=[#8])-[#6]1:[#6](-[#7]2:[#6]:[#6]:[#6]:[#6]:2):[#7](-[#6]2:[#6](-[#9]):[#6]:[#6](-[#9]):[#6]:[#6]:2):[#7]:[#6]:1	COC(=O)[C@H](CCSC)NC(=O)c1c(-n2cccc2)n(-c2c(F)cc(F)cc2)nc1	AEPFGJLCYYNHBG		parent_pubchem_cid	AKOS016382696;methyl rac-(2S)-2-[[1-(2,4-difluorophenyl)-5-pyrrol-1-yl-pyrazole-4-carbonyl]amino]-4-methylsulfanyl-butanoate		15726293.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=15726293		pluskal_iocb_peptide_Peptide01_D2_id		100	D2		ZINC000049544286
2.6		0	740	P6240448	98.0		O17	False	0	18	0	0	20	0	4	1	0	1		0.0						Cc1c(C(=O)NCCc2c[nH]c3ccccc23)sc(NC2CC2)n1								Thiazolecarboxamides;2-heteroaryl carboxamides;2,4,5-trisubstituted thiazoles;Secondary alkylarylamines;Substituted pyrroles;Benzenoids;2-amino-1,3-thiazoles;Heteroaromatic compounds;Secondary carboxylic acid amides;Amino acids and derivatives;Azacyclic compounds;Organooxygen compounds;Organic oxides;Hydrocarbon derivatives	2,4,5-trisubstituted thiazoles;2-amino-1,3-thiazoles;2-heteroaryl carboxamides;3-alkylindoles;Amines;Amino acids and derivatives;Amino acids, peptides, and analogues;Aminothiazoles;Azacyclic compounds;Azoles;Benzenoids;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Pyrroles;Secondary alkylarylamines;Secondary amines;Secondary carboxylic acid amides;Substituted pyrroles;Thiazolecarboxamides;Thiazolecarboxylic acids and derivatives;Thiazoles	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as 3-alkylindoles. These are compounds containing an indole moiety that carries an alkyl chain at the 3-position.	3-alkylindoles			Organic compounds	Aromatic heteropolycyclic compounds	aromatic amide (CHEBI:62733);thiazoles (CHEBI:48901);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);secondary amine (CHEBI:32863);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);1,3-thiazole (CHEBI:38418);organonitrogen compound (CHEBI:35352);organooxygen compound (CHEBI:36963);organonitrogen heterocyclic compound (CHEBI:38101);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);indoles (CHEBI:24828);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);azole (CHEBI:68452);aromatic carboxylic acid (CHEBI:33859);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);amine (CHEBI:32952);carbonyl compound (CHEBI:36586);oxygen molecular entity (CHEBI:25806)		Indoles	3-alkylindole;2-heteroaryl carboxamide;2,4,5-trisubstituted 1,3-thiazole;Thiazolecarboxamide;Thiazolecarboxylic acid or derivatives;Secondary aliphatic/aromatic amine;Substituted pyrrole;Benzenoid;1,3-thiazol-2-amine;Azole;Pyrrole;Thiazole;Heteroaromatic compound;Secondary carboxylic acid amide;Amino acid or derivatives;Carboxamide group;Secondary amine;Carboxylic acid derivative;Azacycle;Organic nitrogen compound;Organic oxygen compound;Organooxygen compound;Organonitrogen compound;Organic oxide;Hydrocarbon derivative;Amine;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		2-(cyclopropylamino)-N-[2-(1H-indol-3-yl)ethyl]-4-methyl-1,3-thiazole-5-carboxamide		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	0	0	0	0	0	0	0		C18H20N4OS	C18H20N4OS			InChI=1S/C18H20N4OS/c1-11-16(24-18(21-11)22-13-6-7-13)17(23)19-9-8-12-10-20-15-5-3-2-4-14(12)15/h2-5,10,13,20H,6-9H2,1H3,(H,19,23)(H,21,22)	KSQXIXWKDKFVFO-UHFFFAOYSA-N	2-(cyclopropylamino)-N-[2-(1H-indol-3-yl)ethyl]-4-methyl-thiazole-5-carboxamide	45492232	Cc1c(C(=O)NCCc2c[nH]c3ccccc23)sc(NC2CC2)n1	2-(cyclopropylamino)-N-[2-(1H-indol-3-yl)ethyl]-4-methyl-1,3-thiazole-5-carboxamide			2.506460000000001													MCULE-9947708251	340.4503		340.135782	3	3	6	4			44										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(45492232)	45492232	3.9	592			[#6]-[#6]1:[#6](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#16]:[#6](-[#7]-[#6]2-[#6]-[#6]-2):[#7]:1	Cc1c(C(=O)NCCc2c[nH]c3ccccc23)sc(NC2CC2)n1	KSQXIXWKDKFVFO		parent_pubchem_cid	2-(cyclopropylamino)-N-[2-(1H-indol-3-yl)ethyl]-4-methyl-1,3-thiazole-5-carboxamide;1190280-02-4;EiM08-11652;AKOS005660437;2-(cyclopropylamino)-N-[2-(1H-indol-3-yl)ethyl]-4-methyl-thiazole-5-carboxamide		17753920.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=17753920		pluskal_iocb_peptide_Peptide01_D3_id		100	D3		ZINC000036357334
3.4		0	828	P11184223	75.6		O18	False	0	19	0	0	27	0	1	4	0	0		0.0						CC(C)CC(NC(=O)Cc1cc2c(cc1)OC(C)(C)CC2)C(=O)O																							0.0		AKOS027472141		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C19H27NO4	C19H27NO4			InChI=1S/C19H27NO4/c1-12(2)9-15(18(22)23)20-17(21)11-13-5-6-16-14(10-13)7-8-19(3,4)24-16/h5-6,10,12,15H,7-9,11H2,1-4H3,(H,20,21)(H,22,23)/t15-/m0/s1	SYMIFDQPTIUFBO-HNNXBMFYSA-N	rac-(2S)-2-[[2-(2,2-dimethylchroman-6-yl)acetyl]amino]-4-methyl-pentanoic acid	75491857	CC(C)C[C@H](NC(=O)Cc1cc2c(cc1)OC(C)(C)CC2)C(=O)O	(2S)-2-[[2-(2,2-dimethyl-3,4-dihydrochromen-6-yl)acetyl]amino]-4-methylpentanoic acid			2.37637														333.43134		333.194008	4	2	6	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(75491857)	75491857	3.4	593			[#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1)-[#8]-[#6](-[#6])(-[#6])-[#6]-[#6]-2)-[#6](=[#8])-[#8]	CC(C)C[C@H](NC(=O)Cc1cc2c(cc1)OC(C)(C)CC2)C(=O)O	SYMIFDQPTIUFBO		parent_pubchem_cid	AKOS027472141;N-[(2,2-dimethyl-3,4-dihydro-2H-1-benzopyran-6-yl)acetyl]-L-leucine;rac-(2S)-2-[[2-(2,2-dimethylchroman-6-yl)acetyl]amino]-4-methyl-pentanoic acid		80416269.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=80416269		pluskal_iocb_peptide_Peptide01_D3_id		100	D3		ZINC000096221925
1.9		0	916	P6236797	99.0		O19	False	0	18	0	1	16	0	5	3	0	0		0.0						COC(=O)C(Cc1ccccc1)NC(=O)c1c(-n2cnnn2)cc(F)cc1																							0.0		AKOS016382600		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	4	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C18H16FN5O3	C18H16FN5O3			InChI=1S/C18H16FN5O3/c1-27-18(26)15(9-12-5-3-2-4-6-12)21-17(25)14-8-7-13(19)10-16(14)24-11-20-22-23-24/h2-8,10-11,15H,9H2,1H3,(H,21,25)/t15-/m0/s1	PJHGONSCPFUNLK-HNNXBMFYSA-N	methyl rac-(2S)-2-[[4-fluoro-2-(tetrazol-1-yl)benzoyl]amino]-3-phenyl-propanoate	29135327	COC(=O)[C@H](Cc1ccccc1)NC(=O)c1c(-n2cnnn2)cc(F)cc1	methyl (2S)-2-[[4-fluoro-2-(tetrazol-1-yl)benzoyl]amino]-3-phenylpropanoate			1.0160699999999994													MCULE-1467940301	369.35832		369.123718	6	1	7	3			44										False	Alkaloids				Peptide01			Compound(29135327)	29135327	2.5	594			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]1:[#6](-[#7]2:[#6]:[#7]:[#7]:[#7]:2):[#6]:[#6](-[#9]):[#6]:[#6]:1	COC(=O)[C@H](Cc1ccccc1)NC(=O)c1c(-n2cnnn2)cc(F)cc1	PJHGONSCPFUNLK		parent_pubchem_cid	AKOS016382600;methyl rac-(2S)-2-[[4-fluoro-2-(tetrazol-1-yl)benzoyl]amino]-3-phenyl-propanoate		7058016.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=7058016		pluskal_iocb_peptide_Peptide01_D3_id		100	D3		ZINC000020733823
3.6		0	1004	P6241031	85.6		O20	False	0	22	0	0	24	0	2	3	0	1		0.0						COC(=O)C(CCSC)NC(=O)c1cc2c(cc1)ccn2Cc1ccccc1								Alpha amino acid esters;N-acyl-alpha amino acids and derivatives;Indolecarboxamides and derivatives;N-alkylindoles;Indoles;Fatty acid esters;Substituted pyrroles;Benzene and substituted derivatives;Methyl esters;Heteroaromatic compounds;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Sulfenyl compounds;Dialkylthioethers;Azacyclic compounds;Organonitrogen compounds;Hydrocarbon derivatives;Carbonyl compounds;Organic oxides	Alpha amino acid esters;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids and derivatives;Chemical entities;Dialkylthioethers;Fatty Acyls;Fatty acid esters;Heteroaromatic compounds;Hydrocarbon derivatives;Indolecarboxamides and derivatives;Indolecarboxylic acids and derivatives;Indoles;Indoles and derivatives;Lipids and lipid-like molecules;Methionine and derivatives;Methyl esters;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids and derivatives;N-alkylindoles;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Organosulfur compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Sulfenyl compounds;Thioethers	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as methionine and derivatives. These are compounds containing methionine or a derivative thereof resulting from reaction of methionine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Methionine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	alpha-amino acid ester (CHEBI:46874);N-acyl-amino acid (CHEBI:51569);indolecarboxamide (CHEBI:46921);indoles (CHEBI:24828);fatty acid ester (CHEBI:35748);pyrroles (CHEBI:26455);benzenes (CHEBI:22712);carboxylic ester (CHEBI:33308);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);monocarboxylic acid (CHEBI:25384);organosulfur compound (CHEBI:33261);aliphatic sulfide (CHEBI:22327);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);organic oxide (CHEBI:25701);alpha-amino acid (CHEBI:33704);methionine derivative (CHEBI:25230);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);organooxygen compound (CHEBI:36963);organic heterocyclic compound (CHEBI:24532);indolyl carboxylic acid (CHEBI:46867);lipid (CHEBI:18059);benzenoid aromatic compound (CHEBI:33836);amide (CHEBI:32988);organic sulfide (CHEBI:16385);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806);amino acid (CHEBI:33709);peptide (CHEBI:16670)	Fatty esters (FA07);Fatty Acyls (FA)	Amino acids, peptides, and analogues	Methionine or derivatives;Alpha-amino acid ester;N-acyl-alpha amino acid or derivatives;Indolecarboxamide derivative;Indolecarboxylic acid derivative;N-alkylindole;Indole;Indole or derivatives;Fatty acid ester;Monocyclic benzene moiety;Fatty acyl;Substituted pyrrole;Benzenoid;Methyl ester;Pyrrole;Heteroaromatic compound;Carboxamide group;Carboxylic acid ester;Secondary carboxylic acid amide;Organoheterocyclic compound;Dialkylthioether;Sulfenyl compound;Thioether;Azacycle;Monocarboxylic acid or derivatives;Hydrocarbon derivative;Organic oxide;Organic oxygen compound;Organosulfur compound;Carbonyl group;Organic nitrogen compound;Organonitrogen compound;Organooxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS016382711		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C22H24N2O3S	C22H24N2O3S			InChI=1S/C22H24N2O3S/c1-27-22(26)19(11-13-28-2)23-21(25)18-9-8-17-10-12-24(20(17)14-18)15-16-6-4-3-5-7-16/h3-10,12,14,19H,11,13,15H2,1-2H3,(H,23,25)/t19-/m0/s1	IBGQXFHOMCAGLA-IBGZPJMESA-N	methyl rac-(2S)-2-[(1-benzylindole-6-carbonyl)amino]-4-methylsulfanyl-butanoate	45490661	COC(=O)[C@H](CCSC)NC(=O)c1cc2c(cc1)ccn2Cc1ccccc1	methyl (2S)-2-[(1-benzylindole-6-carbonyl)amino]-4-methylsulfanylbutanoate			3.176260000000002													MCULE-4601487799	396.51218		396.150764	4	1	9	3			44										False	Alkaloids				Peptide01			Compound(45490661)	45490661	3.8	595			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]-[#16]-[#6])-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#6]:[#6]:[#7]:2-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	COC(=O)[C@H](CCSC)NC(=O)c1cc2c(cc1)ccn2Cc1ccccc1	IBGQXFHOMCAGLA		parent_pubchem_cid	AKOS016382711;methyl rac-(2S)-2-[(1-benzylindole-6-carbonyl)amino]-4-methylsulfanyl-butanoate		11035078.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=11035078		pluskal_iocb_peptide_Peptide01_D3_id		100	D3		ZINC000036370036
4.0		0	748	P6240992	92.2		O21	False	0	24	0	0	19	0	3	3	0	0		0.0						O=C(NC(Cc1ccccc1)C(=O)O)c1cc(-c2ccccn2)nc2ccccc12								Quinoline carboxamides;N-acyl-alpha amino acids;Bipyridines and oligopyridines;Phenylpropanoic acids;Amphetamines and derivatives;Pyridinecarboxylic acids and derivatives;Heteroaromatic compounds;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Bipyridines and oligopyridines;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenethylamines;Phenylalanine and derivatives;Phenylpropanoic acids;Phenylpropanoids and polyketides;Pyridinecarboxylic acids and derivatives;Pyridines and derivatives;Quinoline carboxamides;Quinolines and derivatives;Secondary carboxylic acid amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	quinolines (CHEBI:26513);carboxamide (CHEBI:37622);N-acyl-amino acid (CHEBI:51569);bipyridines (CHEBI:50511);benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);amphetamines (CHEBI:35338);aromatic carboxylic acid (CHEBI:33859);pyridinemonocarboxylic acid (CHEBI:26420);organic aromatic compound (CHEBI:33659);monocarboxylic acid (CHEBI:25384);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);pyridines (CHEBI:26421);benzenoid aromatic compound (CHEBI:33836);primary amine (CHEBI:32877);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806)		Amino acids, peptides, and analogues	Phenylalanine or derivatives;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;Quinoline-4-carboxamide;Bipyridine;3-phenylpropanoic-acid;Amphetamine or derivatives;Quinoline;Pyridine carboxylic acid or derivatives;Monocyclic benzene moiety;Benzenoid;Pyridine;Heteroaromatic compound;Carboxamide group;Secondary carboxylic acid amide;Carboxylic acid;Monocarboxylic acid or derivatives;Azacycle;Organoheterocyclic compound;Organic nitrogen compound;Hydrocarbon derivative;Carbonyl group;Organic oxygen compound;Organic oxide;Organonitrogen compound;Organooxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS016402584		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C24H19N3O3	C24H19N3O3			InChI=1S/C24H19N3O3/c28-23(27-22(24(29)30)14-16-8-2-1-3-9-16)18-15-21(20-12-6-7-13-25-20)26-19-11-5-4-10-17(18)19/h1-13,15,22H,14H2,(H,27,28)(H,29,30)/t22-/m0/s1	BTRMWWXHEANDJQ-QFIPXVFZSA-N	rac-(2S)-3-phenyl-2-[[2-(2-pyridyl)quinoline-4-carbonyl]amino]propanoic acid	49652215	O=C(N[C@@H](Cc1ccccc1)C(=O)O)c1cc(-c2ccccn2)nc2ccccc12	(2S)-3-phenyl-2-[(2-pyridin-2-ylquinoline-4-carbonyl)amino]propanoic acid			2.804640000000001													MCULE-5734432238	397.43733		397.142641	5	2	6	4			44									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(49652215)	49652215	3.7	596			[#8]=[#6](-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8])-[#6]1:[#6]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#7]:2):[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	O=C(N[C@@H](Cc1ccccc1)C(=O)O)c1cc(-c2ccccn2)nc2ccccc12	BTRMWWXHEANDJQ		parent_pubchem_cid	AKOS016402584;rac-(2S)-3-phenyl-2-[[2-(2-pyridyl)quinoline-4-carbonyl]amino]propanoic acid		22947424.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22947424		pluskal_iocb_peptide_Peptide01_D3_id		100	D3		ZINC000040309579
2.8		0	836	P7564214	67.8		O22	False	0	22	0	0	18	0	4	1	0	0		0.0						O=C(NCCc1ccncc1)c1cc(-c2ccncc2)nc2ccccc12																							0.0		2-(pyridin-4-yl)-N-[2-(pyridin-4-yl)ethyl]quinoline-4-carboxamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C22H18N4O	C22H18N4O			InChI=1S/C22H18N4O/c27-22(25-14-7-16-5-10-23-11-6-16)19-15-21(17-8-12-24-13-9-17)26-20-4-2-1-3-18(19)20/h1-6,8-13,15H,7,14H2,(H,25,27)	TVBWJGDGJUETKL-UHFFFAOYSA-N	2-(4-pyridyl)-N-[2-(4-pyridyl)ethyl]quinoline-4-carboxamide	60174886	O=C(NCCc1ccncc1)c1cc(-c2ccncc2)nc2ccccc12	2-pyridin-4-yl-N-(2-pyridin-4-ylethyl)quinoline-4-carboxamide			2.7464400000000007													MCULE-6187374992	354.41496		354.148061	4	1	5	4			44									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(60174886)	60174886	2.9	597			[#8]=[#6](-[#7]-[#6]-[#6]-[#6]1:[#6]:[#6]:[#7]:[#6]:[#6]:1)-[#6]1:[#6]:[#6](-[#6]2:[#6]:[#6]:[#7]:[#6]:[#6]:2):[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	O=C(NCCc1ccncc1)c1cc(-c2ccncc2)nc2ccccc12	TVBWJGDGJUETKL		parent_pubchem_cid	2-(pyridin-4-yl)-N-[2-(pyridin-4-yl)ethyl]quinoline-4-carboxamide;1401536-55-7;EiM08-26553;AKOS025143728;2-(4-PYRIDYL)-N-[2-(4-PYRIDYL)ETHYL]-4-QUINOLINECARBOXAMIDE;2-(4-pyridyl)-N-[2-(4-pyridyl)ethyl]quinoline-4-carboxamide		67544342.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=67544342		pluskal_iocb_peptide_Peptide01_D3_id		100	D3		ZINC000079478284
4.7		0	924	P11185686	71.9		O23	False	0	27	0	0	26	0	4	2	0	0		0.0						COCCn1cc(C(=O)NC(Cc2ccccc2)c2nc3ccccc3[nH]2)c2ccccc21																							0.0		AKOS025257455		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C27H26N4O2	C27H26N4O2			InChI=1S/C27H26N4O2/c1-33-16-15-31-18-21(20-11-5-8-14-25(20)31)27(32)30-24(17-19-9-3-2-4-10-19)26-28-22-12-6-7-13-23(22)29-26/h2-14,18,24H,15-17H2,1H3,(H,28,29)(H,30,32)	XRZIQQKJAHJZBK-UHFFFAOYSA-N	N-[1-(1H-benzimidazol-2-yl)-2-phenyl-ethyl]-1-(2-methoxyethyl)indole-3-carboxamide	91821463	COCCn1cc(C(=O)NC(Cc2ccccc2)c2nc3ccccc3[nH]2)c2ccccc21	N-[1-(1H-benzimidazol-2-yl)-2-phenylethyl]-1-(2-methoxyethyl)indole-3-carboxamide			3.856830000000002														438.53387		438.205576	3	2	8	5			46										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(91821463)	91821463	4.1	598			[#6]-[#8]-[#6]-[#6]-[#7]1:[#6]:[#6](-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]2:[#7]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3:[#7H]:2):[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	COCCn1cc(C(=O)NC(Cc2ccccc2)c2nc3ccccc3[nH]2)c2ccccc21	XRZIQQKJAHJZBK		parent_pubchem_cid	AKOS025257455;N-[1-(1H-benzimidazol-2-yl)-2-phenyl-ethyl]-1-(2-methoxyethyl)indole-3-carboxamide		100825174.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=100825174		pluskal_iocb_peptide_Peptide01_D3_id		100	D3		
4.0		0	1012	P7129705	71.1		O24	False	0	25	0	0	33	0	3	2	0	0		0.0						CC(C)C1CCC(C(=O)NC(Cc2ccccc2)C(=O)NCc2cnccc2)CC1																							0.0		AKOS024459952		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C25H33N3O2	C25H33N3O2			InChI=1S/C25H33N3O2/c1-18(2)21-10-12-22(13-11-21)24(29)28-23(15-19-7-4-3-5-8-19)25(30)27-17-20-9-6-14-26-16-20/h3-9,14,16,18,21-23H,10-13,15,17H2,1-2H3,(H,27,30)(H,28,29)/t21?,22?,23-/m1/s1	IZDINJZJGVNKAW-XPPIMPSXSA-N	4-isopropyl-N-[rac-(1R)-1-benzyl-2-oxo-2-(3-pyridylmethylamino)ethyl]cyclohexanecarboxamide	71692026	CC(C)C1CCC(C(=O)N[C@H](Cc2ccccc2)C(=O)NCc2cnccc2)CC1	N-[(2R)-1-oxo-3-phenyl-1-(pyridin-3-ylmethylamino)propan-2-yl]-4-propan-2-ylcyclohexane-1-carboxamide			3.7782800000000014														407.56066		407.257277	3	2	8	3			46										False	Alkaloids				Peptide01			Compound(71692026)	71692026	4.4	599			[#6]-[#6](-[#6])-[#6]1-[#6]-[#6]-[#6](-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#7]-[#6]-[#6]2:[#6]:[#7]:[#6]:[#6]:[#6]:2)-[#6]-[#6]-1	CC(C)C1CCC(C(=O)N[C@H](Cc2ccccc2)C(=O)NCc2cnccc2)CC1	IZDINJZJGVNKAW		parent_pubchem_cid	AKOS024459952;4-isopropyl-N-[rac-(1R)-1-benzyl-2-oxo-2-(3-pyridylmethylamino)ethyl]cyclohexanecarboxamide		62599984.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=62599984		pluskal_iocb_peptide_Peptide01_D3_id		100	D3		
3.6		0	756	P6237429	65.2		O25	False	0	22	0	0	23	0	3	2	0	0		0.0						CC(C)CC(C(=O)Nc1cc2c(cc1)[nH]cc2)N1Cc2ccccc2C1=O																							0.0		AKOS016376002		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C22H23N3O2	C22H23N3O2			InChI=1S/C22H23N3O2/c1-14(2)11-20(25-13-16-5-3-4-6-18(16)22(25)27)21(26)24-17-7-8-19-15(12-17)9-10-23-19/h3-10,12,14,20,23H,11,13H2,1-2H3,(H,24,26)/t20-/m0/s1	QOEMUEBFZAMTFO-FQEVSTJZSA-N	rac-(2S)-N-(1H-indol-5-yl)-4-methyl-2-(1-oxoisoindolin-2-yl)pentanamide	39378046	CC(C)C[C@@H](C(=O)Nc1cc2c(cc1)[nH]cc2)N1Cc2ccccc2C1=O	(2S)-N-(1H-indol-5-yl)-4-methyl-2-(3-oxo-1H-isoindol-2-yl)pentanamide			3.258650000000001													MCULE-1035743829	361.44751		361.179027	2	2	5	4			44									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(39378046)	39378046	3.7	600			[#6]-[#6](-[#6])-[#6]-[#6@@H](-[#6](=[#8])-[#7]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#7H]:[#6]:[#6]:2)-[#7]1-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6]-1=[#8]	CC(C)C[C@@H](C(=O)Nc1cc2c(cc1)[nH]cc2)N1Cc2ccccc2C1=O	QOEMUEBFZAMTFO		parent_pubchem_cid	AKOS016376002;N-(1H-INDOL-5-YL)-4-METHYL-2-(1-OXO-2,3-DIHYDRO-1H-ISOINDOL-2-YL)PENTANAMIDE;rac-(2S)-N-(1H-indol-5-yl)-4-methyl-2-(1-oxoisoindolin-2-yl)pentanamide		12148078.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=12148078		pluskal_iocb_peptide_Peptide01_D4_id		100	D4		ZINC000032124210
3.2		0	844	P7564213	67.8		O26	False	0	22	0	0	18	0	4	1	0	0		0.0						O=C(NCCc1ccncc1)c1cc(-c2ccccn2)nc2ccccc12																							0.0		2-(pyridin-2-yl)-N-[2-(pyridin-4-yl)ethyl]quinoline-4-carboxamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C22H18N4O	C22H18N4O			InChI=1S/C22H18N4O/c27-22(25-14-10-16-8-12-23-13-9-16)18-15-21(20-7-3-4-11-24-20)26-19-6-2-1-5-17(18)19/h1-9,11-13,15H,10,14H2,(H,25,27)	YMMUWMFAQUETLK-UHFFFAOYSA-N	2-(2-pyridyl)-N-[2-(4-pyridyl)ethyl]quinoline-4-carboxamide	60174970	O=C(NCCc1ccncc1)c1cc(-c2ccccn2)nc2ccccc12	2-pyridin-2-yl-N-(2-pyridin-4-ylethyl)quinoline-4-carboxamide			2.7464400000000007													MCULE-4448075942	354.41496		354.148061	4	1	5	4			44									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(60174970)	60174970	3.0	601			[#8]=[#6](-[#7]-[#6]-[#6]-[#6]1:[#6]:[#6]:[#7]:[#6]:[#6]:1)-[#6]1:[#6]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#7]:2):[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	O=C(NCCc1ccncc1)c1cc(-c2ccccn2)nc2ccccc12	YMMUWMFAQUETLK		parent_pubchem_cid	2-(pyridin-2-yl)-N-[2-(pyridin-4-yl)ethyl]quinoline-4-carboxamide;1401605-66-0;EiM08-26552;AKOS025143727;2-(2-PYRIDYL)-N-[2-(4-PYRIDYL)ETHYL]-4-QUINOLINECARBOXAMIDE;2-(2-pyridyl)-N-[2-(4-pyridyl)ethyl]quinoline-4-carboxamide		53103541.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=53103541		pluskal_iocb_peptide_Peptide01_D4_id		100	D4		ZINC000079476840
4.7		0	932	P11185728	78.1		O27	False	0	28	0	0	28	0	4	2	0	0		0.0						CC(C)C(C(=O)NC(Cc1ccccc1)c1nc2ccccc2[nH]1)N1Cc2ccccc2C1=O																							0.0		STL425697		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C28H28N4O2	C28H28N4O2			InChI=1S/C28H28N4O2/c1-18(2)25(32-17-20-12-6-7-13-21(20)28(32)34)27(33)31-24(16-19-10-4-3-5-11-19)26-29-22-14-8-9-15-23(22)30-26/h3-15,18,24-25H,16-17H2,1-2H3,(H,29,30)(H,31,33)	VROXTLJPYRTTSU-UHFFFAOYSA-N	N-[1-(1H-benzimidazol-2-yl)-2-phenyl-ethyl]-3-methyl-2-(1-oxoisoindolin-2-yl)butanamide	91823494	CC(C)C(C(=O)NC(Cc1ccccc1)c1nc2ccccc2[nH]1)N1Cc2ccccc2C1=O	N-[1-(1H-benzimidazol-2-yl)-2-phenylethyl]-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanamide			3.996240000000003														452.56096		452.221226	3	2	7	5			46										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(91823494)	91823494	4.8	602			[#6]-[#6](-[#6])-[#6](-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#7H]:1)-[#7]1-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6]-1=[#8]	CC(C)C(C(=O)NC(Cc1ccccc1)c1nc2ccccc2[nH]1)N1Cc2ccccc2C1=O	VROXTLJPYRTTSU		parent_pubchem_cid	STL425697;AKOS025260594;N-[1-(1H-benzimidazol-2-yl)-2-phenylethyl]-3-methyl-2-(1-oxo-1,3-dihydro-2H-isoindol-2-yl)butanamide;N-[1-(1H-benzimidazol-2-yl)-2-phenyl-ethyl]-3-methyl-2-(1-oxoisoindolin-2-yl)butanamide		100827197.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=100827197		pluskal_iocb_peptide_Peptide01_D4_id		100	D4		
1.9		0	1020	P11184277	144.7		O28	False	0	23	0	0	21	0	7	3	0	0		0.0						O=C(CC1NC(=O)c2ccccc2NC1=O)Nc1n[nH]c(CCc2c[nH]c3ccccc23)n1																							0.0		AKOS027472172		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	3	0	0	3	0	0	0	0	0	0	0	0	0	3	0	1	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	3	2	0	0	0	0	0	0	0	0	0	0		C23H21N7O3	C23H21N7O3			InChI=1S/C23H21N7O3/c31-20(11-18-22(33)25-17-8-4-2-6-15(17)21(32)26-18)28-23-27-19(29-30-23)10-9-13-12-24-16-7-3-1-5-14(13)16/h1-8,12,18,24H,9-11H2,(H,25,33)(H,26,32)(H2,27,28,29,30,31)/t18-/m0/s1	URNVCQHOXBBQFU-SFHVURJKSA-N	N-[5-[2-(1H-indol-3-yl)ethyl]-1H-1,2,4-triazol-3-yl]-2-[rac-(3S)-2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl]acetamide	91637975	O=C(C[C@@H]1NC(=O)c2ccccc2NC1=O)Nc1n[nH]c(CCc2c[nH]c3ccccc23)n1	2-[(3S)-2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl]-N-[5-[2-(1H-indol-3-yl)ethyl]-1H-1,2,4-triazol-3-yl]acetamide			0.7967300000000004														443.46892		443.170588	5	5	6	5			45									Benzodiazepine alkaloids	False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(91637975)	91637975	1.8	603			[#8]=[#6](-[#6]-[#6@@H]1-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#7]-[#6]-1=[#8])-[#7]-[#6]1:[#7]:[#7H]:[#6](-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#7]:1	O=C(C[C@@H]1NC(=O)c2ccccc2NC1=O)Nc1n[nH]c(CCc2c[nH]c3ccccc23)n1	URNVCQHOXBBQFU		parent_pubchem_cid	AKOS027472172;N-[5-[2-(1H-indol-3-yl)ethyl]-1H-1,2,4-triazol-3-yl]-2-[rac-(3S)-2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl]acetamide		92151611.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=92151611		pluskal_iocb_peptide_Peptide01_D4_id		100	D4		ZINC000217828526
3.6		0	764	P6240993	92.2		O29	False	0	23	0	0	17	0	3	3	0	0		0.0						O=C(NC(C(=O)O)c1ccccc1)c1cc(-c2ccccn2)nc2ccccc12																							0.0		AKOS005663520		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C23H17N3O3	C23H17N3O3			InChI=1S/C23H17N3O3/c27-22(26-21(23(28)29)15-8-2-1-3-9-15)17-14-20(19-12-6-7-13-24-19)25-18-11-5-4-10-16(17)18/h1-14,21H,(H,26,27)(H,28,29)/t21-/m1/s1	RMIFFJDFFNVBAC-OAQYLSRUSA-N	rac-(2R)-2-phenyl-2-[[2-(2-pyridyl)quinoline-4-carbonyl]amino]acetic acid	49654985	O=C(N[C@@H](C(=O)O)c1ccccc1)c1cc(-c2ccccn2)nc2ccccc12	(2R)-2-phenyl-2-[(2-pyridin-2-ylquinoline-4-carbonyl)amino]acetic acid			2.934640000000001													MCULE-9721575670	383.41024		383.126991	5	2	5	4			44										False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(49654985)	49654985	3.4	604			[#8]=[#6](-[#7]-[#6@@H](-[#6](=[#8])-[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#7]:2):[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	O=C(N[C@@H](C(=O)O)c1ccccc1)c1cc(-c2ccccn2)nc2ccccc12	RMIFFJDFFNVBAC		parent_pubchem_cid	AKOS005663520;(2R)-2-PHENYL-2-({[2-(2-PYRIDYL)-4-QUINOLYL]CARBONYL}AMINO)ETHANOIC ACID;rac-(2R)-2-phenyl-2-[[2-(2-pyridyl)quinoline-4-carbonyl]amino]acetic acid		23927846.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23927846		pluskal_iocb_peptide_Peptide01_D4_id		100	D4		ZINC000040283456
3.9		0	852	P1159617	71.3		O30	False	1	20	0	0	19	0	2	3	0	0		0.0						O=C(CCn1ccc2c1ccc(Br)c2)NC(Cc1ccccc1)C(=O)O																							0.0		AKOS005535169		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C20H19BrN2O3	C20H19BrN2O3			InChI=1S/C20H19BrN2O3/c21-16-6-7-18-15(13-16)8-10-23(18)11-9-19(24)22-17(20(25)26)12-14-4-2-1-3-5-14/h1-8,10,13,17H,9,11-12H2,(H,22,24)(H,25,26)/t17-/m0/s1	QOVVUHKUNBUJQS-KRWDZBQOSA-N	rac-(2S)-2-[3-(5-bromoindol-1-yl)propanoylamino]-3-phenyl-propanoic acid	28935259	O=C(CCn1ccc2c1ccc(Br)c2)N[C@@H](Cc1ccccc1)C(=O)O	(2S)-2-[3-(5-bromoindol-1-yl)propanoylamino]-3-phenylpropanoic acid			3.1228700000000007													MCULE-2423295969	415.29003		414.057905	3	2	7	3			44										False					Peptide01			Compound(28935259)	28935259	3.5	605			[#8]=[#6](-[#6]-[#6]-[#7]1:[#6]:[#6]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#35]):[#6]:2)-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	O=C(CCn1ccc2c1ccc(Br)c2)N[C@@H](Cc1ccccc1)C(=O)O	QOVVUHKUNBUJQS		parent_pubchem_cid	AKOS005535169;(2S)-2-{[3-(5-BROMO-1H-INDOL-1-YL)PROPANOYL]AMINO}-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[3-(5-bromoindol-1-yl)propanoylamino]-3-phenyl-propanoic acid		24252017.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24252017		pluskal_iocb_peptide_Peptide01_D4_id		100	D4		ZINC000020427467
4.7		0	940	P11185693	62.7		O31	False	0	25	0	0	22	0	4	1	0	0		0.0						O=C(Cn1ccc2ccccc21)NC(Cc1ccccc1)c1nc2ccccc2[nH]1																							0.0		AKOS025258872		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C25H22N4O	C25H22N4O			InChI=1S/C25H22N4O/c30-24(17-29-15-14-19-10-4-7-13-23(19)29)26-22(16-18-8-2-1-3-9-18)25-27-20-11-5-6-12-21(20)28-25/h1-15,22H,16-17H2,(H,26,30)(H,27,28)	BAVOQCXAZBBXAU-UHFFFAOYSA-N	N-[1-(1H-benzimidazol-2-yl)-2-phenyl-ethyl]-2-indol-1-yl-acetamide	91822372	O=C(Cn1ccc2ccccc21)NC(Cc1ccccc1)c1nc2ccccc2[nH]1	N-[1-(1H-benzimidazol-2-yl)-2-phenylethyl]-2-indol-1-ylacetamide			3.6515400000000025														394.48029		394.179361	2	2	6	5			46									Quinazoline alkaloids	False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(91822372)	91822372	4.5	606			[#8]=[#6](-[#6]-[#7]1:[#6]:[#6]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#7H]:1	O=C(Cn1ccc2ccccc21)NC(Cc1ccccc1)c1nc2ccccc2[nH]1	BAVOQCXAZBBXAU		parent_pubchem_cid	AKOS025258872;N-[1-(1H-benzimidazol-2-yl)-2-phenyl-ethyl]-2-indol-1-yl-acetamide		100826078.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=100826078		pluskal_iocb_peptide_Peptide01_D4_id		100	D4		
2.8		0	1028	P7567761	82.7		O32	False	0	23	0	0	23	0	5	1	0	0		0.0						O=C(CCNc1ncccn1)NCC(c1ccccc1)c1c[nH]c2ccccc12																							0.0		1293740-90-5		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	0	0	0	0	0	0	0		C23H23N5O	C23H23N5O			InChI=1S/C23H23N5O/c29-22(11-14-26-23-24-12-6-13-25-23)28-15-19(17-7-2-1-3-8-17)20-16-27-21-10-5-4-9-18(20)21/h1-10,12-13,16,19,27H,11,14-15H2,(H,28,29)(H,24,25,26)	QEIOAIKZSNTMRZ-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]-3-(pyrimidin-2-ylamino)propanamide	55790822	O=C(CCNc1ncccn1)NCC(c1ccccc1)c1c[nH]c2ccccc12	N-[2-(1H-indol-3-yl)-2-phenylethyl]-3-(pyrimidin-2-ylamino)propanamide			2.78975														385.47266		385.19026	4	3	8	4			46										False	Alkaloids				Peptide01			Compound(55790822)	55790822	3.9	607			[#8]=[#6](-[#6]-[#6]-[#7]-[#6]1:[#7]:[#6]:[#6]:[#6]:[#7]:1)-[#7]-[#6]-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	O=C(CCNc1ncccn1)NCC(c1ccccc1)c1c[nH]c2ccccc12	QEIOAIKZSNTMRZ		parent_pubchem_cid	1293740-90-5;N-[2-(1H-indol-3-yl)-2-phenylethyl]-3-(2-pyrimidinylamino)propanamide;EiM08-36393;AKOS007098213;N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]-3-(pyrimidin-2-ylamino)propanamide		42341368.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=42341368		pluskal_iocb_peptide_Peptide01_D4_id		100	D4		
4.0		0	772	P6240560	65.2		O33	False	0	27	0	0	25	0	3	2	0	0		0.0						CN1C(=O)c2ccccc2C(C(=O)NCCc2c[nH]c3ccccc23)C1c1ccccc1								Tetrahydroisoquinolines;3-alkylindoles;Substituted pyrroles;Benzene and substituted derivatives;Tertiary carboxylic acid amides;Heteroaromatic compounds;Tertiary amines;Secondary carboxylic acid amides;Lactams;Amino acids and derivatives;Azacyclic compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	3-alkylindoles;Amines;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Isoquinolines and derivatives;Isoquinolones and derivatives;Lactams;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Tertiary amines;Tertiary carboxylic acid amides;Tetrahydroisoquinolines	Isoquinolines and derivatives	2.1	This compound belongs to the class of organic compounds known as isoquinolones and derivatives. These are aromatic polycyclic compounds containing a ketone bearing isoquinoline moiety.	Isoquinolones and derivatives			Organic compounds	Aromatic heteropolycyclic compounds	isoquinolines (CHEBI:24922);indoles (CHEBI:24828);pyrroles (CHEBI:26455);benzenes (CHEBI:22712);carboxamide (CHEBI:37622);organic aromatic compound (CHEBI:33659);tertiary amine (CHEBI:32876);lactam (CHEBI:24995);organonitrogen compound (CHEBI:35352);organooxygen compound (CHEBI:36963);organonitrogen heterocyclic compound (CHEBI:38101);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);amine (CHEBI:32952);oxygen molecular entity (CHEBI:25806);amino acid (CHEBI:33709);peptide (CHEBI:16670)		Isoquinolones and derivatives	Isoquinolone;Tetrahydroisoquinoline;3-alkylindole;Indole;Indole or derivatives;Monocyclic benzene moiety;Substituted pyrrole;Benzenoid;Pyrrole;Heteroaromatic compound;Tertiary carboxylic acid amide;Amino acid or derivatives;Secondary carboxylic acid amide;Lactam;Carboxamide group;Tertiary amine;Carboxylic acid derivative;Azacycle;Amine;Organooxygen compound;Organonitrogen compound;Hydrocarbon derivative;Organic oxide;Organic oxygen compound;Carbonyl group;Organic nitrogen compound;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		1190289-80-5		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C27H25N3O2	C27H25N3O2			InChI=1S/C27H25N3O2/c1-30-25(18-9-3-2-4-10-18)24(21-12-5-6-13-22(21)27(30)32)26(31)28-16-15-19-17-29-23-14-8-7-11-20(19)23/h2-14,17,24-25,29H,15-16H2,1H3,(H,28,31)	ZZLUIIQVQDYYEW-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)ethyl]-2-methyl-1-oxo-3-phenyl-3,4-dihydroisoquinoline-4-carboxamide	45490449	CN1C(=O)c2ccccc2C(C(=O)NCCc2c[nH]c3ccccc23)C1c1ccccc1	N-[2-(1H-indol-3-yl)ethyl]-2-methyl-1-oxo-3-phenyl-3,4-dihydroisoquinoline-4-carboxamide			3.790040000000002													MCULE-7849222780	423.5192		423.194677	2	2	5	5			45										False	Alkaloids				Peptide01			Compound(45490449)	45490449	4.0	608			[#6]-[#7]1-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6]-1-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	CN1C(=O)c2ccccc2C(C(=O)NCCc2c[nH]c3ccccc23)C1c1ccccc1	ZZLUIIQVQDYYEW		parent_pubchem_cid	1190289-80-5;N-[2-(1H-indol-3-yl)ethyl]-2-methyl-1-oxo-3-phenyl-1,2,3,4-tetrahydroisoquinoline-4-carboxamide;EiM08-11781;AKOS016382022;N-[2-(1H-INDOL-3-YL)ETHYL]-2-METHYL-1-OXO-3-PHENYL-1,2,3,4-TETRAHYDRO-4-ISOQUINOLINECARBOXAMIDE;N-[2-(1H-indol-3-yl)ethyl]-2-methyl-1-oxo-3-phenyl-3,4-dihydroisoquinoline-4-carboxamide		23863627.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23863627		pluskal_iocb_peptide_Peptide01_D5_id		100	D5		
4.0		0	860	P1159616	123.3		O34	False	0	22	0	1	18	0	3	3	0	1		0.0						Cc1c(C(=O)NC(Cc2c[nH]c3ccccc23)C(=O)O)sc(-c2ccc(F)cc2)n1								Indolyl carboxylic acids and derivatives;3-alkylindoles;Thiazolecarboxamides;2,4,5-trisubstituted thiazoles;2-heteroaryl carboxamides;Fluorobenzenes;Substituted pyrroles;Aryl fluorides;Heteroaromatic compounds;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organofluorides;Organonitrogen compounds	2,4,5-trisubstituted thiazoles;2-heteroaryl carboxamides;3-alkylindoles;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Aryl fluorides;Aryl halides;Azacyclic compounds;Azoles;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Fluorobenzenes;Halobenzenes;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Indolyl carboxylic acids and derivatives;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organofluorides;Organohalogen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Thiazolecarboxamides;Thiazolecarboxylic acids and derivatives;Thiazoles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom.	N-acyl-alpha amino acids		Amino acids and derivatives;Alpha amino acids and derivatives;N-acyl-alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	indolyl carboxylic acid (CHEBI:46867);indoles (CHEBI:24828);aromatic amide (CHEBI:62733);thiazoles (CHEBI:48901);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organofluorine compound (CHEBI:37143);pyrroles (CHEBI:26455);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);organonitrogen heterocyclic compound (CHEBI:38101);carbonyl compound (CHEBI:36586);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);N-acyl-amino acid (CHEBI:51569);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);azole (CHEBI:68452);aromatic carboxylic acid (CHEBI:33859);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);amide (CHEBI:32988);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);organohalogen compound (CHEBI:36684);haloarene (CHEBI:50887);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143)		Amino acids, peptides, and analogues	N-acyl-alpha-amino acid;Indolyl carboxylic acid derivative;3-alkylindole;Indole;Indole or derivatives;2-heteroaryl carboxamide;2,4,5-trisubstituted 1,3-thiazole;Thiazolecarboxamide;Thiazolecarboxylic acid or derivatives;Fluorobenzene;Halobenzene;Aryl fluoride;Aryl halide;Monocyclic benzene moiety;Substituted pyrrole;Benzenoid;Thiazole;Azole;Pyrrole;Heteroaromatic compound;Secondary carboxylic acid amide;Carboxamide group;Organoheterocyclic compound;Monocarboxylic acid or derivatives;Azacycle;Carboxylic acid;Organooxygen compound;Organic oxygen compound;Organic oxide;Hydrocarbon derivative;Carbonyl group;Organic nitrogen compound;Organohalogen compound;Organofluoride;Organonitrogen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		STK718898		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C22H18FN3O3S	C22H18FN3O3S			InChI=1S/C22H18FN3O3S/c1-12-19(30-21(25-12)13-6-8-15(23)9-7-13)20(27)26-18(22(28)29)10-14-11-24-17-5-3-2-4-16(14)17/h2-9,11,18,24H,10H2,1H3,(H,26,27)(H,28,29)/t18-/m0/s1	TWNDEHIWNWPPSV-SFHVURJKSA-N	rac-(2S)-2-[[2-(4-fluorophenyl)-4-methyl-thiazole-5-carbonyl]amino]-3-(1H-indol-3-yl)propanoic acid	28935256	Cc1c(C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)sc(-c2ccc(F)cc2)n1	(2S)-2-[[2-(4-fluorophenyl)-4-methyl-1,3-thiazole-5-carbonyl]amino]-3-(1H-indol-3-yl)propanoic acid			3.192050000000002													MCULE-2126924220	423.46946		423.105291	4	3	6	4			44										False	Alkaloids				Peptide01			Compound(28935256)	28935256	3.6	609			[#6]-[#6]1:[#6](-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6](=[#8])-[#8]):[#16]:[#6](-[#6]2:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:2):[#7]:1	Cc1c(C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)sc(-c2ccc(F)cc2)n1	TWNDEHIWNWPPSV		parent_pubchem_cid	STK718898;AKOS005535141;N-{[2-(4-fluorophenyl)-4-methyl-1,3-thiazol-5-yl]carbonyl}-L-tryptophan;rac-(2S)-2-[[2-(4-fluorophenyl)-4-methyl-thiazole-5-carbonyl]amino]-3-(1H-indol-3-yl)propanoic acid		24101623.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24101623		pluskal_iocb_peptide_Peptide01_D5_id		100	D5		ZINC000020427463
1.2		0	948	P3460176	102.1		O35	False	0	18	0	0	18	0	4	3	0	0		0.0						O=C(O)CCC(=O)N1CCc2c(nc[nH]2)C1c1c2cc[nH]c2ccc1								Indoles;Imidazopiperidines;Benzenoids;Tertiary carboxylic acid amides;Pyrroles;Imidazoles;Heteroaromatic compounds;Tertiary amines;Amino acids;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Amines;Amino acids;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Azoles;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Imidazoles;Imidazopiperidines;Imidazopyridines;Indoles;Indoles and derivatives;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Pyrroles;Tertiary amines;Tertiary carboxylic acid amides	Imidazopyridines	2.1	This compound belongs to the class of organic compounds known as imidazopyridines. These are organic polycyclic compounds containing an imidazole ring fused to a pyridine ring. Imidazole is 5-membered ring consisting of three carbon atoms, and two nitrogen centers at the 1- and 3-positions. Pyridine is a 6-membered ring consisting of five carbon atoms and one nitrogen center.	Imidazopyridines			Organic compounds	Aromatic heteropolycyclic compounds	indoles (CHEBI:24828);organonitrogen heterocyclic compound (CHEBI:38101);benzenoid aromatic compound (CHEBI:33836);carboxamide (CHEBI:37622);pyrroles (CHEBI:26455);imidazoles (CHEBI:24780);organic aromatic compound (CHEBI:33659);tertiary amine (CHEBI:32876);amino acid (CHEBI:33709);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);imidazopyridine (CHEBI:46908);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);amide (CHEBI:32988);azole (CHEBI:68452);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);amine (CHEBI:32952);oxygen molecular entity (CHEBI:25806);carboxylic acid anion (CHEBI:29067);peptide (CHEBI:16670)			Imidazopiperidine;Imidazopyridine;Indole;Indole or derivatives;Benzenoid;Azole;Imidazole;Heteroaromatic compound;Tertiary carboxylic acid amide;Pyrrole;Amino acid or derivatives;Carboxamide group;Amino acid;Tertiary amine;Carboxylic acid derivative;Carboxylic acid;Azacycle;Monocarboxylic acid or derivatives;Hydrocarbon derivative;Organic nitrogen compound;Amine;Organic oxide;Carbonyl group;Organooxygen compound;Organonitrogen compound;Organic oxygen compound;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		1071914-00-5		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	1	0		C18H18N4O3	C18H18N4O3			InChI=1S/C18H18N4O3/c23-15(4-5-16(24)25)22-9-7-14-17(21-10-20-14)18(22)12-2-1-3-13-11(12)6-8-19-13/h1-3,6,8,10,18-19H,4-5,7,9H2,(H,20,21)(H,24,25)	CKBVXYJEFWFZOL-UHFFFAOYSA-N	4-[4-(1H-indol-4-yl)-3,4,6,7-tetrahydroimidazo[4,5-c]pyridin-5-yl]-4-oxo-butanoic acid	42648445	O=C(O)CCC(=O)N1CCc2c(nc[nH]2)C1c1c2cc[nH]c2ccc1	4-[4-(1H-indol-4-yl)-1,4,6,7-tetrahydroimidazo[4,5-c]pyridin-5-yl]-4-oxobutanoic acid			1.6373499999999994													MCULE-6742419447	338.36916		338.13789	4	3	4	4			45										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(42648445)	42648445	0.7	610			[#8]=[#6](-[#8])-[#6]-[#6]-[#6](=[#8])-[#7]1-[#6]-[#6]-[#6]2:[#6](:[#7]:[#6]:[#7H]:2)-[#6]-1-[#6]1:[#6]2:[#6]:[#6]:[#7H]:[#6]:2:[#6]:[#6]:[#6]:1	O=C(O)CCC(=O)N1CCc2c(nc[nH]2)C1c1c2cc[nH]c2ccc1	CKBVXYJEFWFZOL		parent_pubchem_cid	1071914-00-5;4-(4-(1H-indol-4-yl)-6,7-dihydro-3H-imidazo[4,5-c]pyridin-5(4H)-yl)-4-oxobutanoic acid;4-[4-(1H-indol-4-yl)-3H,4H,5H,6H,7H-imidazo[4,5-c]pyridin-5-yl]-4-oxobutanoic acid;4-[4-(1H-indol-4-yl)-1,4,6,7-tetrahydroimidazo[4,5-c]pyridin-5-yl]-4-oxobutanoic acid;MFCD11501582;AKOS015955914;NS-05549;CS-0269017;EN300-303199;4-[4-(1H-indol-4-yl)-3H,4H,5H,6H,7H-imidazo[4,5-c]pyridin-5-yl]-4-oxobutanoicacid;4-(4-(1h-Indol-4-yl)-3,4,6,7-tetrahydro-5h-imidazo[4,5-c]pyridin-5-yl)-4-oxobutanoic acid;4-[4-(1H-indol-4-yl)-3,4,6,7-tetrahydroimidazo[4,5-c]pyridin-5-yl]-4-oxo-butanoic acid		22801753.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22801753		pluskal_iocb_peptide_Peptide01_D5_id		100	D5		
3.8		0	1036	P7129734	76.0		O36	False	0	23	0	0	32	0	4	2	0	0		0.0						CC(C)C1CCC(C(=O)NC(Cc2ccccc2)C(=O)Nc2cn(C)nc2)CC1																							0.0		AKOS024459978		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	1		C23H32N4O2	C23H32N4O2			InChI=1S/C23H32N4O2/c1-16(2)18-9-11-19(12-10-18)22(28)26-21(13-17-7-5-4-6-8-17)23(29)25-20-14-24-27(3)15-20/h4-8,14-16,18-19,21H,9-13H2,1-3H3,(H,25,29)(H,26,28)/t18?,19?,21-/m1/s1	PDXIBFNEIYICGG-GZNCHQMQSA-N	4-isopropyl-N-[rac-(1R)-1-benzyl-2-[(1-methylpyrazol-4-yl)amino]-2-oxo-ethyl]cyclohexanecarboxamide	71691712	CC(C)C1CCC(C(=O)N[C@H](Cc2ccccc2)C(=O)Nc2cn(C)nc2)CC1	N-[(2R)-1-[(1-methylpyrazol-4-yl)amino]-1-oxo-3-phenylpropan-2-yl]-4-propan-2-ylcyclohexane-1-carboxamide			3.1131800000000016														396.53709		396.252526	3	2	7	3			45									Eudesmane sesquiterpenoids	False	Terpenoids	Sesquiterpenoids			Peptide01			Compound(71691712)	71691712	3.9	611			[#6]-[#6](-[#6])-[#6]1-[#6]-[#6]-[#6](-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#7]-[#6]2:[#6]:[#7](-[#6]):[#7]:[#6]:2)-[#6]-[#6]-1	CC(C)C1CCC(C(=O)N[C@H](Cc2ccccc2)C(=O)Nc2cn(C)nc2)CC1	PDXIBFNEIYICGG		parent_pubchem_cid	AKOS024459978;4-isopropyl-N-[rac-(1R)-1-benzyl-2-[(1-methylpyrazol-4-yl)amino]-2-oxo-ethyl]cyclohexanecarboxamide		68073855.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=68073855		pluskal_iocb_peptide_Peptide01_D5_id		100	D5		ZINC000072404143
1.1		0	780	P6237066	171.9		O37	False	0	18	0	0	22	0	4	5	0	1		0.0						COc1ccccc1-c1nc(CC(=O)NC(CCCNC(N)=O)C(=O)O)cs1																							0.0		SCHEMBL21560227		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	1	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C18H22N4O5S	C18H22N4O5S			InChI=1S/C18H22N4O5S/c1-27-14-7-3-2-5-12(14)16-21-11(10-28-16)9-15(23)22-13(17(24)25)6-4-8-20-18(19)26/h2-3,5,7,10,13H,4,6,8-9H2,1H3,(H,22,23)(H,24,25)(H3,19,20,26)/t13-/m1/s1	BKNCDZFERPKIPA-CYBMUJFWSA-N	rac-(2R)-2-[[2-[2-(2-methoxyphenyl)thiazol-4-yl]acetyl]amino]-5-ureido-pentanoic acid	29129788	COc1ccccc1-c1nc(CC(=O)N[C@H](CCCNC(N)=O)C(=O)O)cs1	(2R)-5-(carbamoylamino)-2-[[2-[2-(2-methoxyphenyl)-1,3-thiazol-4-yl]acetyl]amino]pentanoic acid			0.4819600000000011													MCULE-6527012365	406.46384		406.131091	6	4	10	2			43									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(29129788)	29129788	0.9	612		SCHEMBL21560227	[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#6]1:[#7]:[#6](-[#6]-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#8])-[#6](=[#8])-[#8]):[#6]:[#16]:1	COc1ccccc1-c1nc(CC(=O)N[C@H](CCCNC(N)=O)C(=O)O)cs1	BKNCDZFERPKIPA		parent_pubchem_cid	SCHEMBL21560227;AKOS016386081;rac-(2R)-2-[[2-[2-(2-methoxyphenyl)thiazol-4-yl]acetyl]amino]-5-ureido-pentanoic acid		22995662.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22995662		pluskal_iocb_peptide_Peptide01_D5_id		100	D5		ZINC000020719429
3.6		0	868	P7130023	63.4		O38	False	0	23	0	1	25	0	2	3	0	0		0.0						COc1ccc(C2(C(=O)NCCc3c[nH]c4c3cc(F)cc4)CCOCC2)cc1																							0.0		N-[2-(5-fluoro-1H-indol-3-yl)ethyl]-4-(4-methoxyphenyl)tetrahydro-2H-pyran-4-carboxamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C23H25FN2O3	C23H25FN2O3			InChI=1S/C23H25FN2O3/c1-28-19-5-2-17(3-6-19)23(9-12-29-13-10-23)22(27)25-11-8-16-15-26-21-7-4-18(24)14-20(16)21/h2-7,14-15,26H,8-13H2,1H3,(H,25,27)	NXVANTDDIIGCDD-UHFFFAOYSA-N	N-[2-(5-fluoro-1H-indol-3-yl)ethyl]-4-(4-methoxyphenyl)tetrahydropyran-4-carboxamide	60180873	COc1ccc(C2(C(=O)NCCc3c[nH]c4c3cc(F)cc4)CCOCC2)cc1	N-[2-(5-fluoro-1H-indol-3-yl)ethyl]-4-(4-methoxyphenyl)oxane-4-carboxamide			2.722450000000001													MCULE-7247484386	396.4657		396.184921	3	2	6	4			44										False					Peptide01			Compound(60180873)	60180873	3.5	613			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6]2(-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]3:[#6]:[#7H]:[#6]4:[#6]:3:[#6]:[#6](-[#9]):[#6]:[#6]:4)-[#6]-[#6]-[#8]-[#6]-[#6]-2):[#6]:[#6]:1	COc1ccc(C2(C(=O)NCCc3c[nH]c4c3cc(F)cc4)CCOCC2)cc1	NXVANTDDIIGCDD		parent_pubchem_cid	N-[2-(5-fluoro-1H-indol-3-yl)ethyl]-4-(4-methoxyphenyl)tetrahydro-2H-pyran-4-carboxamide;1351696-72-4;EiM08-24774;AKOS022118565;N-[2-(5-fluoro-1H-indol-3-yl)ethyl]-4-(4-methoxyphenyl)oxane-4-carboxamide;N-[2-(5-fluoro-1H-indol-3-yl)ethyl]-4-(4-methoxyphenyl)tetrahydropyran-4-carboxamide		23418705.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23418705		pluskal_iocb_peptide_Peptide01_D5_id		100	D5		ZINC000072402195
1.9		0	956	P6235913	91.9		O39	False	0	12	0	0	17	0	1	4	0	1		0.0						CC(C)CC(NS(=O)(=O)c1ccccc1)C(=O)O																							0.0		68305-76-0		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0		C12H17NO4S	C12H17NO4S			InChI=1S/C12H17NO4S/c1-9(2)8-11(12(14)15)13-18(16,17)10-6-4-3-5-7-10/h3-7,9,11,13H,8H2,1-2H3,(H,14,15)/t11-/m0/s1	FLJPDKBVKGRHQC-NSHDSACASA-N	rac-(2S)-2-(benzenesulfonamido)-4-methyl-pentanoic acid	744876	CC(C)C[C@H](NS(=O)(=O)c1ccccc1)C(=O)O	(2S)-2-(benzenesulfonamido)-4-methylpentanoic acid			1.35619													MCULE-5254267961	271.33759		271.087829	4	2	6	1			43										False					Peptide01			Compound(744876)	744876	2.2	614		SCHEMBL5191083	[#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#16](=[#8])(=[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	CC(C)C[C@H](NS(=O)(=O)c1ccccc1)C(=O)O	FLJPDKBVKGRHQC		parent_pubchem_cid	68305-76-0;(Phenylsulfonyl)-L-leucine;(2S)-2-(benzenesulfonamido)-4-methylpentanoic acid;SCHEMBL5191083;MFCD09749741;AKOS001656149;CCG-110548;SR-01000480146;SR-01000480146-1;(2S)-4-METHYL-2-[(PHENYLSULFONYL)AMINO]PENTANOIC ACID;rac-(2S)-2-(benzenesulfonamido)-4-methyl-pentanoic acid		22723792.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22723792		pluskal_iocb_peptide_Peptide01_D5_id		100	D5		ZINC000000186516
4.5		0	1044	P1094972	61.9		O40	False	0	28	0	0	31	0	3	3	0	0		0.0						COC(=O)C(Cc1ccccc1)NC(=O)N1CCN(C(c2ccccc2)c2ccccc2)CC1																							0.0		AKOS005533540		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1		C28H31N3O3	C28H31N3O3			InChI=1S/C28H31N3O3/c1-34-27(32)25(21-22-11-5-2-6-12-22)29-28(33)31-19-17-30(18-20-31)26(23-13-7-3-8-14-23)24-15-9-4-10-16-24/h2-16,25-26H,17-21H2,1H3,(H,29,33)/t25-/m0/s1	INOGDZRAJLMPBW-VWLOTQADSA-N	methyl rac-(2S)-2-[(4-benzhydrylpiperazine-1-carbonyl)amino]-3-phenyl-propanoate	17579736	COC(=O)[C@H](Cc1ccccc1)NC(=O)N1CCN(C(c2ccccc2)c2ccccc2)CC1	methyl (2S)-2-[(4-benzhydrylpiperazine-1-carbonyl)amino]-3-phenylpropanoate			3.7233700000000014													MCULE-7721348264	457.57757		457.236542	4	1	8	4			44										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(17579736)	17579736	4.5	615			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#7]1-[#6]-[#6]-[#7](-[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]-[#6]-1	COC(=O)[C@H](Cc1ccccc1)NC(=O)N1CCN(C(c2ccccc2)c2ccccc2)CC1	INOGDZRAJLMPBW		parent_pubchem_cid	AKOS005533540;methyl rac-(2S)-2-[(4-benzhydrylpiperazine-1-carbonyl)amino]-3-phenyl-propanoate		14330032.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=14330032		pluskal_iocb_peptide_Peptide01_D5_id		100	D5		ZINC000020403780
1.1		0	788	P6241966	126.5		O41	False	0	17	0	0	22	0	4	4	0	0		0.0						Cc1c2ccn(CC(=O)NC(CCCNC(N)=O)C(=O)O)c2ccc1								N-alkylindoles;Indoles;Substituted pyrroles;Benzenoids;Heteroaromatic compounds;Ureas;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;N-alkylindoles;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Ureas	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom.	N-acyl-alpha amino acids		Amino acids and derivatives;Alpha amino acids and derivatives;N-acyl-alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	indoles (CHEBI:24828);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);organic aromatic compound (CHEBI:33659);ureas (CHEBI:47857);carboxamide (CHEBI:37622);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);N-acyl-amino acid (CHEBI:51569);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806)		Amino acids, peptides, and analogues	N-acyl-alpha-amino acid;N-alkylindole;Indole;Indole or derivatives;Substituted pyrrole;Benzenoid;Pyrrole;Heteroaromatic compound;Carboxamide group;Secondary carboxylic acid amide;Urea;Monocarboxylic acid or derivatives;Carboxylic acid;Azacycle;Organoheterocyclic compound;Carbonyl group;Hydrocarbon derivative;Organooxygen compound;Organonitrogen compound;Organic oxide;Organic oxygen compound;Organic nitrogen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS016394083		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C17H22N4O4	C17H22N4O4			InChI=1S/C17H22N4O4/c1-11-4-2-6-14-12(11)7-9-21(14)10-15(22)20-13(16(23)24)5-3-8-19-17(18)25/h2,4,6-7,9,13H,3,5,8,10H2,1H3,(H,20,22)(H,23,24)(H3,18,19,25)/t13-/m1/s1	GLQWOMRSYSSFQS-CYBMUJFWSA-N	rac-(2R)-2-[[2-(4-methylindol-1-yl)acetyl]amino]-5-ureido-pentanoic acid	49652376	Cc1c2ccn(CC(=O)N[C@H](CCCNC(N)=O)C(=O)O)c2ccc1	(2R)-5-(carbamoylamino)-2-[[2-(4-methylindol-1-yl)acetyl]amino]pentanoic acid			0.4844900000000012													MCULE-4749187161	346.38929		346.164105	4	4	8	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(49652376)	49652376	0.9	616			[#6]-[#6]1:[#6]2:[#6]:[#6]:[#7](-[#6]-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#8])-[#6](=[#8])-[#8]):[#6]:2:[#6]:[#6]:[#6]:1	Cc1c2ccn(CC(=O)N[C@H](CCCNC(N)=O)C(=O)O)c2ccc1	GLQWOMRSYSSFQS		parent_pubchem_cid	AKOS016394083;rac-(2R)-2-[[2-(4-methylindol-1-yl)acetyl]amino]-5-ureido-pentanoic acid		23858877.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23858877		pluskal_iocb_peptide_Peptide01_D6_id		100	D6		ZINC000040310193
4.0		0	876	P7130767	74.4		O42	False	0	25	0	0	29	0	3	3	0	0		0.0						COc1cc2c(cc1)[nH]cc2CCNC(=O)C(CC(C)C)N1Cc2ccccc2C1=O																							0.0		EiM08-27871		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C25H29N3O3	C25H29N3O3			InChI=1S/C25H29N3O3/c1-16(2)12-23(28-15-18-6-4-5-7-20(18)25(28)30)24(29)26-11-10-17-14-27-22-9-8-19(31-3)13-21(17)22/h4-9,13-14,16,23,27H,10-12,15H2,1-3H3,(H,26,29)/t23-/m0/s1	WGOJSLIWWSPMRS-QHCPKHFHSA-N	rac-(2S)-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-4-methyl-2-(1-oxoisoindolin-2-yl)pentanamide	71753661	COc1cc2c(cc1)[nH]cc2CCNC(=O)[C@H](CC(C)C)N1Cc2ccccc2C1=O	(2S)-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-4-methyl-2-(3-oxo-1H-isoindol-2-yl)pentanamide			2.8509400000000005													MCULE-3869624413	419.52818		419.220892	3	2	8	4			44										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(71753661)	71753661	4.1	617			[#6]-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#7H]:[#6]:[#6]:2-[#6]-[#6]-[#7]-[#6](=[#8])-[#6@H](-[#6]-[#6](-[#6])-[#6])-[#7]1-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6]-1=[#8]	COc1cc2c(cc1)[nH]cc2CCNC(=O)[C@H](CC(C)C)N1Cc2ccccc2C1=O	WGOJSLIWWSPMRS		parent_pubchem_cid	EiM08-27871;AKOS024460758;(2S)-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-4-methyl-2-(1-oxo-1,3-dihydro-2H-isoindol-2-yl)pentanamide;rac-(2S)-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-4-methyl-2-(1-oxoisoindolin-2-yl)pentanamide		69150577.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=69150577		pluskal_iocb_peptide_Peptide01_D6_id		100	D6		ZINC000079188617
4.9		0	964	P1108852	90.9		O43	False	0	29	0	0	27	0	1	6	0	0		0.0						CC(C)OC(=O)C(Cc1ccccc1)NC(=O)COc1cc2c(cc1)c(-c1ccccc1)cc(=O)o2																							0.0		EiM07-30168		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C29H27NO6	C29H27NO6			InChI=1S/C29H27NO6/c1-19(2)35-29(33)25(15-20-9-5-3-6-10-20)30-27(31)18-34-22-13-14-23-24(21-11-7-4-8-12-21)17-28(32)36-26(23)16-22/h3-14,16-17,19,25H,15,18H2,1-2H3,(H,30,31)/t25-/m1/s1	QHDCMIDPMGNRER-RUZDIDTESA-N	isopropyl rac-(2R)-2-[[2-(2-oxo-4-phenyl-chromen-7-yl)oxyacetyl]amino]-3-phenyl-propanoate	24280744	CC(C)OC(=O)[C@@H](Cc1ccccc1)NC(=O)COc1cc2c(cc1)c(-c1ccccc1)cc(=O)o2	propan-2-yl (2R)-2-[[2-(2-oxo-4-phenylchromen-7-yl)oxyacetyl]amino]-3-phenylpropanoate			4.092230000000003													MCULE-4614408390	485.54164		485.183838	6	1	10	4			44										False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(24280744)	24280744	5.1	618			[#6]-[#6](-[#6])-[#8]-[#6](=[#8])-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1):[#6]:[#6](=[#8]):[#8]:2	CC(C)OC(=O)[C@@H](Cc1ccccc1)NC(=O)COc1cc2c(cc1)c(-c1ccccc1)cc(=O)o2	QHDCMIDPMGNRER		parent_pubchem_cid	EiM07-30168;AKOS016376121;PROPAN-2-YL 2-{2-[(2-OXO-4-PHENYL-2H-CHROMEN-7-YL)OXY]ACETAMIDO}-3-PHENYLPROPANOATE;isopropyl rac-(2R)-2-[[2-(2-oxo-4-phenyl-chromen-7-yl)oxyacetyl]amino]-3-phenyl-propanoate		4974377.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=4974377		pluskal_iocb_peptide_Peptide01_D6_id		100	D6		ZINC000011865721
2.3		0	1052	P6248079	105.7		O44	False	0	20	0	0	26	0	4	4	0	0		0.0						CCC(C)C(NC(=O)N1CCN(C(=O)c2cc3ccccc3[nH]2)CC1)C(=O)O																							0.0		MFCD20535494		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C20H26N4O4	C20H26N4O4			InChI=1S/C20H26N4O4/c1-3-13(2)17(19(26)27)22-20(28)24-10-8-23(9-11-24)18(25)16-12-14-6-4-5-7-15(14)21-16/h4-7,12-13,17,21H,3,8-11H2,1-2H3,(H,22,28)(H,26,27)/t13-,17+/m1/s1	HSQQYSDKJAJVKL-DYVFJYSZSA-N	rac-(2S,3R)-2-[[4-(1H-indole-2-carbonyl)piperazine-1-carbonyl]amino]-3-methyl-pentanoic acid	42108632	CC[C@@H](C)[C@H](NC(=O)N1CCN(C(=O)c2cc3ccccc3[nH]2)CC1)C(=O)O	(2S,3R)-2-[[4-(1H-indole-2-carbonyl)piperazine-1-carbonyl]amino]-3-methylpentanoic acid			1.65147													MCULE-9005700559	386.45462		386.195405	4	3	5	3			44									Carboline alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(42108632)	42108632	2.3	619			[#6]-[#6]-[#6@@H](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#7]1-[#6]-[#6]-[#7](-[#6](=[#8])-[#6]2:[#6]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3:[#7H]:2)-[#6]-[#6]-1)-[#6](=[#8])-[#8]	CC[C@@H](C)[C@H](NC(=O)N1CCN(C(=O)c2cc3ccccc3[nH]2)CC1)C(=O)O	HSQQYSDKJAJVKL		parent_pubchem_cid	MFCD20535494;AKOS016387012;rac-(2S,3R)-2-[[4-(1H-indole-2-carbonyl)piperazine-1-carbonyl]amino]-3-methyl-pentanoic acid		24401630.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24401630		pluskal_iocb_peptide_Peptide01_D6_id		100	D6		ZINC000011692334
2.4		0	1060	P11184857	121.1		P1	False	0	21	0	0	18	0	4	4	0	0		0.0						O=C(CCc1nc(-c2ccc3cc[nH]c3c2)no1)NC(C(=O)O)c1ccccc1																							0.0		AKOS027472518		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	2	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C21H18N4O4	C21H18N4O4			InChI=1S/C21H18N4O4/c26-17(23-19(21(27)28)14-4-2-1-3-5-14)8-9-18-24-20(25-29-18)15-7-6-13-10-11-22-16(13)12-15/h1-7,10-12,19,22H,8-9H2,(H,23,26)(H,27,28)/t19-/m0/s1	ROBUUFFKYVMDKV-IBGZPJMESA-N	rac-(2S)-2-[3-[3-(1H-indol-6-yl)-1,2,4-oxadiazol-5-yl]propanoylamino]-2-phenyl-acetic acid	91639378	O=C(CCc1nc(-c2ccc3cc[nH]c3c2)no1)N[C@H](C(=O)O)c1ccccc1	(2S)-2-[3-[3-(1H-indol-6-yl)-1,2,4-oxadiazol-5-yl]propanoylamino]-2-phenylacetic acid			2.17474														390.40201		390.132805	5	3	7	4			45										False	Alkaloids				Peptide01			Compound(91639378)	91639378	2.8	620			[#8]=[#6](-[#6]-[#6]-[#6]1:[#7]:[#6](-[#6]2:[#6]:[#6]3:[#6](:[#6]:[#6]:[#7H]:3):[#6]:[#6]:2):[#7]:[#8]:1)-[#7]-[#6@H](-[#6](=[#8])-[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	O=C(CCc1nc(-c2ccc3cc[nH]c3c2)no1)N[C@H](C(=O)O)c1ccccc1	ROBUUFFKYVMDKV		parent_pubchem_cid	AKOS027472518;(2S)-2-({3-[3-(1H-INDOL-6-YL)-1,2,4-OXADIAZOL-5-YL]PROPANOYL}AMINO)-2-PHENYLETHANOIC ACID;rac-(2S)-2-[3-[3-(1H-indol-6-yl)-1,2,4-oxadiazol-5-yl]propanoylamino]-2-phenyl-acetic acid		94461421.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=94461421		pluskal_iocb_peptide_Peptide01_D6_id		100	D6		ZINC000218204417
4.7		0	1148	P1098565	117.7		P2	False	0	27	0	0	26	0	2	6	0	0		0.0						Cc1c2oc(=O)c3c(CCCC3)c2ccc1OCC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)O																							0.0		EiM07-17243		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C27H26N2O6	C27H26N2O6			InChI=1S/C27H26N2O6/c1-15-23(11-10-19-18-7-2-3-8-20(18)27(33)35-25(15)19)34-14-24(30)29-22(26(31)32)12-16-13-28-21-9-5-4-6-17(16)21/h4-6,9-11,13,22,28H,2-3,7-8,12,14H2,1H3,(H,29,30)(H,31,32)/t22-/m0/s1	OQRCXPBLWJEGKS-QFIPXVFZSA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[[2-[(4-methyl-6-oxo-7,8,9,10-tetrahydrobenzo[c]chromen-3-yl)oxy]acetyl]amino]propanoic acid	1762784	Cc1c2oc(=O)c3c(CCCC3)c2ccc1OCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	(2S)-3-(1H-indol-3-yl)-2-[[2-[(4-methyl-6-oxo-7,8,9,10-tetrahydrobenzo[c]chromen-3-yl)oxy]acetyl]amino]propanoic acid			3.01422													MCULE-8138269660	474.51807		474.179087	6	3	7	5			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(1762784)	1762784	4.2	621			[#6]-[#6]1:[#6]2:[#8]:[#6](=[#8]):[#6]3:[#6](-[#6]-[#6]-[#6]-[#6]-3):[#6]:2:[#6]:[#6]:[#6]:1-[#8]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	Cc1c2oc(=O)c3c(CCCC3)c2ccc1OCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	OQRCXPBLWJEGKS		parent_pubchem_cid	EiM07-17243;AKOS016390390;3-(1H-INDOL-3-YL)-2-[2-({4-METHYL-6-OXO-6H,7H,8H,9H,10H-CYCLOHEXA[C]CHROMEN-3-YL}OXY)ACETAMIDO]PROPANOIC ACID;rac-(2S)-3-(1H-indol-3-yl)-2-[[2-[(4-methyl-6-oxo-7,8,9,10-tetrahydrobenzo[c]chromen-3-yl)oxy]acetyl]amino]propanoic acid		24221778.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24221778		pluskal_iocb_peptide_Peptide01_D6_id		100	D6		ZINC000002107703
4.2		0	1236	P2125921	93.7		P3	False	0	20	0	0	16	0	2	4	0	1	-1.0	0.0						O=S(=O)(c1ccccc1)c1c(NCc2ccccc2)oc(-c2ccco2)n1		4.38		0.0	3.84	CHEMBL1364742																	0.0		4-(benzenesulfonyl)-N-benzyl-2-(furan-2-yl)-1,3-oxazol-5-amine		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0		C20H16N2O4S	C20H16N2O4S			InChI=1S/C20H16N2O4S/c23-27(24,16-10-5-2-6-11-16)20-19(21-14-15-8-3-1-4-9-15)26-18(22-20)17-12-7-13-25-17/h1-13,21H,14H2	APNPHLHLCJBKOJ-UHFFFAOYSA-N	4-(benzenesulfonyl)-N-benzyl-2-(2-furyl)oxazol-5-amine	1244674	O=S(=O)(c1ccccc1)c1c(NCc2ccccc2)oc(-c2ccco2)n1	4-(benzenesulfonyl)-N-benzyl-2-(furan-2-yl)-1,3-oxazol-5-amine			3.3481400000000017													MCULE-1403860259	380.42552	NEUTRAL	380.083078	4	1	6	4	0.0		29										False	Shikimates and Phenylpropanoids		False	False	Peptide01		-1.0	Compound(1244674)	1244674	4.6	622			[#8]=[#16](=[#8])(-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6](-[#7]-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#8]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#8]:2):[#7]:1	O=S(=O)(c1ccccc1)c1c(NCc2ccccc2)oc(-c2ccco2)n1	APNPHLHLCJBKOJ		parent_pubchem_cid	4-(benzenesulfonyl)-N-benzyl-2-(furan-2-yl)-1,3-oxazol-5-amine;475042-14-9;SMR000144290;MLS000538248;CHEMBL1364742;2-(2-furyl)-5-[benzylamino]-4-(phenylsulfonyl)-1,3-oxazole;HMS2446J20;AKOS002326273;Z57362589;F1790-0010;N-benzyl-2-(furan-2-yl)-4-(phenylsulfonyl)oxazol-5-amine;N-benzyl-2-(2-furyl)-4-(phenylsulfonyl)-1,3-oxazol-5-amine;4-(benzenesulfonyl)-N-benzyl-2-(2-furyl)oxazol-5-amine	False	994013.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=994013		pluskal_iocb_peptide_Peptide01_D6_id		100	D6	False	ZINC000001052845
2.8		0	1068	P1090468	109.5		P5	False	0	21	0	0	21	0	3	5	0	0		0.0						COC(=O)c1ccccc1NC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)OC																							0.0		STL457184		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C21H21N3O5	C21H21N3O5			InChI=1S/C21H21N3O5/c1-28-19(25)15-8-4-6-10-17(15)23-21(27)24-18(20(26)29-2)11-13-12-22-16-9-5-3-7-14(13)16/h3-10,12,18,22H,11H2,1-2H3,(H2,23,24,27)/t18-/m0/s1	XICFDKXZTOTYHA-SFHVURJKSA-N	methyl 2-[[rac-(1S)-1-(1H-indol-3-ylmethyl)-2-methoxy-2-oxo-ethyl]carbamoylamino]benzoate	24279068	COC(=O)c1ccccc1NC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)OC	methyl 2-[[(2S)-3-(1H-indol-3-yl)-1-methoxy-1-oxopropan-2-yl]carbamoylamino]benzoate			1.94185													MCULE-4233846020	395.41862		395.148121	5	3	8	3			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(24279068)	24279068	3.2	623			[#6]-[#8]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#7]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]-[#6]	COC(=O)c1ccccc1NC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)OC	XICFDKXZTOTYHA		parent_pubchem_cid	STL457184;AKOS016382731;methyl N-{[2-(methoxycarbonyl)phenyl]carbamoyl}-L-tryptophanate;METHYL 2-[({[(1S)-1-(1H-INDOL-3-YLMETHYL)-2-METHOXY-2-OXOETHYL]AMINO}CARBONYL)AMINO]BENZOATE;methyl 2-[[rac-(1S)-1-(1H-indol-3-ylmethyl)-2-methoxy-2-oxo-ethyl]carbamoylamino]benzoate		4714088.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=4714088		pluskal_iocb_peptide_Peptide01_D6_id		100	D6		ZINC000011766771
3.5		0	1156	P1158167	96.4		P6	False	0	24	0	0	23	0	3	4	0	0		0.0						COc1cc2c(cc1)cc(C(=O)NC(Cc1ccccc1)C(=O)NCc1ccco1)[nH]2																							0.0		STL226513		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0		C24H23N3O4	C24H23N3O4			InChI=1S/C24H23N3O4/c1-30-18-10-9-17-13-22(26-20(17)14-18)24(29)27-21(12-16-6-3-2-4-7-16)23(28)25-15-19-8-5-11-31-19/h2-11,13-14,21,26H,12,15H2,1H3,(H,25,28)(H,27,29)/t21-/m0/s1	SNEAHXVJWJDZQP-NRFANRHFSA-N	6-methoxy-N-[rac-(1S)-1-benzyl-2-(2-furylmethylamino)-2-oxo-ethyl]-1H-indole-2-carboxamide	17600064	COc1cc2c(cc1)cc(C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccco1)[nH]2	N-[(2S)-1-(furan-2-ylmethylamino)-1-oxo-3-phenylpropan-2-yl]-6-methoxy-1H-indole-2-carboxamide			2.37204													MCULE-1900933963	417.46861		417.168856	3	3	8	4			44										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(17600064)	17600064	3.6	624			[#6]-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#6]:[#6](-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#7]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#8]:1):[#7H]:2	COc1cc2c(cc1)cc(C(=O)N[C@@H](Cc1ccccc1)C(=O)NCc1ccco1)[nH]2	SNEAHXVJWJDZQP		parent_pubchem_cid	STL226513;AKOS004937036;N-(furan-2-ylmethyl)-Nalpha-[(6-methoxy-1H-indol-2-yl)carbonyl]-L-phenylalaninamide;6-methoxy-N-[rac-(1S)-1-benzyl-2-(2-furylmethylamino)-2-oxo-ethyl]-1H-indole-2-carboxamide		10037575.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=10037575		pluskal_iocb_peptide_Peptide01_D7_id		100	D7		ZINC000013722423
5.0		0	1244	P6466088	80.4		P7	False	0	26	0	0	28	0	2	4	0	0		0.0						Cc1cc(=O)oc2c1cc(CCC(=O)NCCc1c[nH]c3ccccc13)c(OC(C)C)c2								1-benzopyrans;3-alkylindoles;Phenol ethers;Pyranones and derivatives;Alkyl aryl ethers;Substituted pyrroles;Fatty amides;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactones;Azacyclic compounds;Oxacyclic compounds;Organic oxides;Carbonyl compounds;Organonitrogen compounds;Hydrocarbon derivatives	1-benzopyrans;3-alkylindoles;Alkyl aryl ethers;Azacyclic compounds;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;Ethers;Fatty Acyls;Fatty amides;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Lactones;Lipids and lipid-like molecules;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenol ethers;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Coumarins and derivatives	2.1	This compound belongs to the class of organic compounds known as coumarins and derivatives. These are polycyclic aromatic compounds containing a 1-benzopyran moiety with a ketone group at the C2 carbon atom (1-benzopyran-2-one).	Coumarins and derivatives			Organic compounds	Aromatic heteropolycyclic compounds	1-benzopyran (CHEBI:38443);indoles (CHEBI:24828);aromatic ether (CHEBI:35618);pyranone (CHEBI:37963);pyrroles (CHEBI:26455);fatty amide (CHEBI:29348);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactone (CHEBI:25000);organonitrogen heterocyclic compound (CHEBI:38101);oxacycle (CHEBI:38104);organic oxide (CHEBI:25701);carbonyl compound (CHEBI:36586);organonitrogen compound (CHEBI:35352);organic molecule (CHEBI:72695);coumarins (CHEBI:23403);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);benzenoid aromatic compound (CHEBI:33836);pyrans (CHEBI:26407);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);organooxygen compound (CHEBI:36963);ether (CHEBI:25698);lipid (CHEBI:18059);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)	Fatty amides (FA08);Benzopyranoids (PK1311);Fatty Acyls (FA)		Coumarin;Benzopyran;1-benzopyran;3-alkylindole;Indole;Indole or derivatives;Phenol ether;Alkyl aryl ether;Pyranone;Fatty amide;Pyran;Substituted pyrrole;Fatty acyl;Benzenoid;Pyrrole;Heteroaromatic compound;Carboxamide group;Secondary carboxylic acid amide;Lactone;Azacycle;Oxacycle;Organoheterocyclic compound;Carboxylic acid derivative;Ether;Organooxygen compound;Organic nitrogen compound;Organic oxide;Hydrocarbon derivative;Organonitrogen compound;Organic oxygen compound;Carbonyl group;Aromatic heteropolycyclic compound	Phenylpropanoids and polyketides	0.0		N-[2-(1H-indol-3-yl)ethyl]-3-[4-methyl-2-oxo-7-(propan-2-yloxy)-2H-chromen-6-yl]propanamide		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C26H28N2O4	C26H28N2O4			InChI=1S/C26H28N2O4/c1-16(2)31-23-14-24-21(17(3)12-26(30)32-24)13-18(23)8-9-25(29)27-11-10-19-15-28-22-7-5-4-6-20(19)22/h4-7,12-16,28H,8-11H2,1-3H3,(H,27,29)	PIRGTIQAZVTIKZ-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)ethyl]-3-(7-isopropoxy-4-methyl-2-oxo-chromen-6-yl)propanamide	42506616	Cc1cc(=O)oc2c1cc(CCC(=O)NCCc1c[nH]c3ccccc13)c(OC(C)C)c2	N-[2-(1H-indol-3-yl)ethyl]-3-(4-methyl-2-oxo-7-propan-2-yloxychromen-6-yl)propanamide			4.077930000000003													MCULE-9295336758	432.52406		432.204907	4	2	8	4			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(42506616)	42506616	4.2	625			[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6](-[#6]-[#6]-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:1:3):[#6](-[#8]-[#6](-[#6])-[#6]):[#6]:2	Cc1cc(=O)oc2c1cc(CCC(=O)NCCc1c[nH]c3ccccc13)c(OC(C)C)c2	PIRGTIQAZVTIKZ		parent_pubchem_cid	N-[2-(1H-indol-3-yl)ethyl]-3-[4-methyl-2-oxo-7-(propan-2-yloxy)-2H-chromen-6-yl]propanamide;1010871-13-2;AKOS005176962;N-(2-(1H-indol-3-yl)ethyl)-3-(7-isopropoxy-4-methyl-2-oxo-2H-chromen-6-yl)propanamide;N-[2-(1H-indol-3-yl)ethyl]-3-(7-isopropoxy-4-methyl-2-oxo-chromen-6-yl)propanamide		10892291.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=10892291		pluskal_iocb_peptide_Peptide01_D7_id		100	D7		ZINC000012296380
2.4		0	1076	P1094984	94.2		P9	False	0	16	0	0	21	0	3	3	0	0		0.0						CC(C)C(NC(=O)NCCc1c[nH]c2ccccc12)C(=O)O																							0.0		N-{[2-(1H-indol-3-yl)ethyl]carbamoyl}-L-valine		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C16H21N3O3	C16H21N3O3			InChI=1S/C16H21N3O3/c1-10(2)14(15(20)21)19-16(22)17-8-7-11-9-18-13-6-4-3-5-12(11)13/h3-6,9-10,14,18H,7-8H2,1-2H3,(H,20,21)(H2,17,19,22)/t14-/m0/s1	BHEOONAHJPDLMN-AWEZNQCLSA-N	rac-(2S)-2-[2-(1H-indol-3-yl)ethylcarbamoylamino]-3-methyl-butanoic acid	1758205	CC(C)[C@H](NC(=O)NCCc1c[nH]c2ccccc12)C(=O)O	(2S)-2-[2-(1H-indol-3-yl)ethylcarbamoylamino]-3-methylbutanoic acid			1.6356699999999995													MCULE-3864588086	303.36407		303.158292	3	4	6	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(1758205)	1758205	2.6	626			[#6]-[#6](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	CC(C)[C@H](NC(=O)NCCc1c[nH]c2ccccc12)C(=O)O	BHEOONAHJPDLMN		parent_pubchem_cid	N-{[2-(1H-indol-3-yl)ethyl]carbamoyl}-L-valine;HMS3468N15;(2S)-2-[2-(1H-indol-3-yl)ethylcarbamoylamino]-3-methylbutanoic acid;AKOS004937527;956045-60-6;(2S)-2-[({[2-(1H-INDOL-3-YL)ETHYL]AMINO}CARBONYL)AMINO]-3-METHYLBUTANOIC ACID;rac-(2S)-2-[2-(1H-indol-3-yl)ethylcarbamoylamino]-3-methyl-butanoic acid		24737032.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24737032		pluskal_iocb_peptide_Peptide01_D7_id		100	D7		ZINC000002102995
3.3		0	1164	P1157901	91.9		P10	False	0	23	0	0	24	0	2	5	0	0		0.0						COc1c(OC)cc2CN(C(=O)CCc3c[nH]c4ccccc34)C(C(=O)O)Cc2c1								Tetrahydroisoquinolines;3-alkylindoles;Alpha amino acids and derivatives;Anisoles;Alkyl aryl ethers;Substituted pyrroles;Heteroaromatic compounds;Tertiary carboxylic acid amides;Amino acids;Tertiary amines;Carboxylic acids;Azacyclic compounds;Monocarboxylic acids and derivatives;Hydrocarbon derivatives;Carbonyl compounds;Organic oxides	3-alkylindoles;Alkyl aryl ethers;Alpha amino acids and derivatives;Amines;Amino acids;Amino acids and derivatives;Amino acids, peptides, and analogues;Anisoles;Azacyclic compounds;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenol ethers;Pyrroles;Substituted pyrroles;Tertiary amines;Tertiary carboxylic acid amides;Tetrahydroisoquinolines;Tryptamines and derivatives	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as tryptamines and derivatives. These are compounds containing the tryptamine backbone, which is structurally characterized by an indole ring substituted at the 3-position by an ethanamine.	Tryptamines and derivatives			Organic compounds	Aromatic heteropolycyclic compounds	isoquinolines (CHEBI:24922);indoles (CHEBI:24828);organonitrogen compound (CHEBI:35352);organooxygen compound (CHEBI:36963);methoxybenzene (CHEBI:51683);aromatic ether (CHEBI:35618);pyrroles (CHEBI:26455);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);amino acid (CHEBI:33709);tertiary amine (CHEBI:32876);carboxylic acid (CHEBI:33575);organonitrogen heterocyclic compound (CHEBI:38101);monocarboxylic acid (CHEBI:25384);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);organic oxide (CHEBI:25701);tryptamines (CHEBI:27162);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);organic acid (CHEBI:64709);benzenoid aromatic compound (CHEBI:33836);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ether (CHEBI:25698);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);amine (CHEBI:32952);carboxylic acid anion (CHEBI:29067);peptide (CHEBI:16670)		Tryptamines and derivatives	Triptan;Alpha-amino acid or derivatives;Tetrahydroisoquinoline;3-alkylindole;Indole;Anisole;Phenol ether;Alkyl aryl ether;Benzenoid;Substituted pyrrole;Heteroaromatic compound;Tertiary carboxylic acid amide;Pyrrole;Amino acid;Amino acid or derivatives;Tertiary amine;Carboxamide group;Azacycle;Carboxylic acid derivative;Carboxylic acid;Ether;Monocarboxylic acid or derivatives;Hydrocarbon derivative;Organooxygen compound;Carbonyl group;Amine;Organic oxide;Organic oxygen compound;Organic nitrogen compound;Organonitrogen compound;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		AKOS016384173		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C23H24N2O5	C23H24N2O5			InChI=1S/C23H24N2O5/c1-29-20-10-15-9-19(23(27)28)25(13-16(15)11-21(20)30-2)22(26)8-7-14-12-24-18-6-4-3-5-17(14)18/h3-6,10-12,19,24H,7-9,13H2,1-2H3,(H,27,28)	VYPZDXUVRGZVSW-UHFFFAOYSA-N	2-[3-(1H-indol-3-yl)propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid	43912851	COc1c(OC)cc2CN(C(=O)CCc3c[nH]c4ccccc34)C(C(=O)O)Cc2c1	2-[3-(1H-indol-3-yl)propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid			1.6384299999999994													MCULE-9727433902	408.45813		408.168522	5	2	6	4			45										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(43912851)	43912851	2.8	627			[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]):[#6]:[#6]2-[#6]-[#7](-[#6](=[#8])-[#6]-[#6]-[#6]3:[#6]:[#7H]:[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]:3:4)-[#6](-[#6](=[#8])-[#8])-[#6]-[#6]:2:[#6]:1	COc1c(OC)cc2CN(C(=O)CCc3c[nH]c4ccccc34)C(C(=O)O)Cc2c1	VYPZDXUVRGZVSW		parent_pubchem_cid	AKOS016384173;2-[3-(1H-indol-3-yl)propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid		23115487.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23115487		pluskal_iocb_peptide_Peptide01_D7_id		100	D7		
3.0		0	1252	P7008317	58.9		P11	False	0	16	0	0	20	0	6	0	0	0		0.0						CCN(CC)c1nc(Nc2ccccc2)c2cnn(C)c2n1																							0.0		STK890880		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	2		C16H20N6	C16H20N6			InChI=1S/C16H20N6/c1-4-22(5-2)16-19-14(18-12-9-7-6-8-10-12)13-11-17-21(3)15(13)20-16/h6-11H,4-5H2,1-3H3,(H,18,19,20)	MGQUEXMSZMHHMJ-UHFFFAOYSA-N	N6,N6-diethyl-1-methyl-N4-phenyl-pyrazolo[3,4-d]pyrimidine-4,6-diamine	16456635	CCN(CC)c1nc(Nc2ccccc2)c2cnn(C)c2n1	6-N,6-N-diethyl-1-methyl-4-N-phenylpyrazolo[3,4-d]pyrimidine-4,6-diamine			1.3828499999999997													MCULE-2390784417	296.378		296.174945	5	1	5	3			44										False	Alkaloids				Peptide01			Compound(16456635)	16456635	3.2	628			[#6]-[#6]-[#7](-[#6]-[#6])-[#6]1:[#7]:[#6](-[#7]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6]2:[#6]:[#7]:[#7](-[#6]):[#6]:2:[#7]:1	CCN(CC)c1nc(Nc2ccccc2)c2cnn(C)c2n1	MGQUEXMSZMHHMJ		parent_pubchem_cid	STK890880;AKOS002311368;CCG-313774;N~6~,N~6~-diethyl-1-methyl-N~4~-phenyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine;N6,N6-diethyl-1-methyl-N4-phenyl-pyrazolo[3,4-d]pyrimidine-4,6-diamine		8818123.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=8818123		pluskal_iocb_peptide_Peptide01_D7_id		100	D7		ZINC000009212209
3.0		0	1084	P1094929	110.9		P13	False	0	22	0	0	25	0	3	6	0	0		0.0						COC(=O)c1cc(OC)c(OC)cc1NC(=O)NCCc1c[nH]c2c1cc(OC)cc2								M-methoxybenzoic acids and derivatives;3-alkylindoles;Benzoic acid esters;Dimethoxybenzenes;N-phenylureas;Methoxyanilines;Anisoles;Benzoyl derivatives;Phenoxy compounds;Alkyl aryl ethers;Substituted pyrroles;Methyl esters;Vinylogous amides;Heteroaromatic compounds;Ureas;Azacyclic compounds;Monocarboxylic acids and derivatives;Organopnictogen compounds;Hydrocarbon derivatives;Carbonyl compounds;Organonitrogen compounds;Organic oxides	3-alkylindoles;Alkyl aryl ethers;Aniline and substituted anilines;Anisoles;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Benzoic acid esters;Benzoic acids and derivatives;Benzoyl derivatives;Carbonyl compounds;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids and derivatives;Chemical entities;Dimethoxybenzenes;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;M-methoxybenzoic acids and derivatives;Methoxyanilines;Methoxybenzenes;Methoxybenzoic acids and derivatives;Methyl esters;Monocarboxylic acids and derivatives;N-phenylureas;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;P-methoxybenzoic acids and derivatives;Phenol ethers;Phenoxy compounds;Pyrroles;Substituted pyrroles;Ureas;Vinylogous amides	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as p-methoxybenzoic acids and derivatives. These are benzoic acids in which the hydrogen atom at position 4 of the benzene ring is replaced by a methoxy group.	P-methoxybenzoic acids and derivatives		Methoxybenzoic acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	methoxybenzoic acid (CHEBI:25238);indoles (CHEBI:24828);benzoate ester (CHEBI:36054);dimethoxybenzene (CHEBI:51681);ureas (CHEBI:47857);substituted aniline (CHEBI:48975);methoxybenzene (CHEBI:51683);carbonyl compound (CHEBI:36586);benzenes (CHEBI:22712);aromatic ether (CHEBI:35618);pyrroles (CHEBI:26455);carboxylic ester (CHEBI:33308);enone (CHEBI:51689);enamine (CHEBI:47989);organic aromatic compound (CHEBI:33659);organonitrogen heterocyclic compound (CHEBI:38101);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organic molecule (CHEBI:72695);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);organic heterocyclic compound (CHEBI:24532);anilines (CHEBI:22562);oxygen molecular entity (CHEBI:25806);organooxygen compound (CHEBI:36963);ether (CHEBI:25698);nitrogen molecular entity (CHEBI:51143)		Benzoic acids and derivatives	M-methoxybenzoic acid or derivatives;P-methoxybenzoic acid or derivatives;Benzoate ester;N-phenylurea;3-alkylindole;Dimethoxybenzene;O-dimethoxybenzene;Indole;Indole or derivatives;Methoxyaniline;Methoxybenzene;Benzoyl;Anisole;Phenol ether;Phenoxy compound;Alkyl aryl ether;Substituted pyrrole;Heteroaromatic compound;Vinylogous amide;Methyl ester;Pyrrole;Carboxylic acid ester;Urea;Carbonic acid derivative;Monocarboxylic acid or derivatives;Ether;Azacycle;Carboxylic acid derivative;Organoheterocyclic compound;Organic oxygen compound;Organopnictogen compound;Hydrocarbon derivative;Organic oxide;Carbonyl group;Organic nitrogen compound;Organonitrogen compound;Organooxygen compound;Aromatic heteropolycyclic compound	Benzenoids	0.0		methyl 4,5-dimethoxy-2-({[2-(5-methoxy-1H-indol-3-yl)ethyl]carbamoyl}amino)benzoate		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C22H25N3O6	C22H25N3O6			InChI=1S/C22H25N3O6/c1-28-14-5-6-17-15(9-14)13(12-24-17)7-8-23-22(27)25-18-11-20(30-3)19(29-2)10-16(18)21(26)31-4/h5-6,9-12,24H,7-8H2,1-4H3,(H2,23,25,27)	LLGYSUNWUDJQKV-UHFFFAOYSA-N	methyl 4,5-dimethoxy-2-[2-(5-methoxy-1H-indol-3-yl)ethylcarbamoylamino]benzoate	1767878	COC(=O)c1cc(OC)c(OC)cc1NC(=O)NCCc1c[nH]c2c1cc(OC)cc2	methyl 4,5-dimethoxy-2-[2-(5-methoxy-1H-indol-3-yl)ethylcarbamoylamino]benzoate			1.0388200000000012													MCULE-8008293908	427.46105		427.174336	6	3	9	3			44									Anthranillic acid derivatives	False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(1767878)	1767878	3.3	629			[#6]-[#8]-[#6](=[#8])-[#6]1:[#6]:[#6](-[#8]-[#6]):[#6](-[#8]-[#6]):[#6]:[#6]:1-[#7]-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:1:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:2	COC(=O)c1cc(OC)c(OC)cc1NC(=O)NCCc1c[nH]c2c1cc(OC)cc2	LLGYSUNWUDJQKV		parent_pubchem_cid	methyl 4,5-dimethoxy-2-({[2-(5-methoxy-1H-indol-3-yl)ethyl]carbamoyl}amino)benzoate;859143-05-8;AKOS016382601;methyl 4,5-dimethoxy-2-[2-(5-methoxy-1H-indol-3-yl)ethylcarbamoylamino]benzoate		2472251.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=2472251		pluskal_iocb_peptide_Peptide01_D7_id		100	D7		ZINC000002112958
4.1		0	1172	P1098356	117.7		P14	False	0	25	0	0	24	0	2	6	0	0	-1.0	0.0						Cc1c(C)c2c(oc1=O)c(C)c(OCC(=O)NC(Cc1c[nH]c3ccccc13)C(=O)O)cc2		3.39		0.0	3.53	CHEMBL1318613		Coumarins and derivatives;1-benzopyrans;3-alkylindoles;Pyranones and derivatives;Alkyl aryl ethers;Substituted pyrroles;Benzenoids;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactones;Oxacyclic compounds;Monocarboxylic acids and derivatives;Azacyclic compounds;Carboxylic acids;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organonitrogen compounds;Organopnictogen compounds	1-benzopyrans;3-alkylindoles;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Lactones;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acyl-l-alpha-amino acids. These are n-acylated alpha amino acids which have the L-configuration of the alpha-carbon atom.	N-acyl-L-alpha-amino acids		Amino acids and derivatives;Alpha amino acids and derivatives;N-acyl-alpha amino acids and derivatives;N-acyl-alpha amino acids	Organic compounds	Aromatic heteropolycyclic compounds	coumarins (CHEBI:23403);1-benzopyran (CHEBI:38443);indoles (CHEBI:24828);pyranone (CHEBI:37963);aromatic ether (CHEBI:35618);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactone (CHEBI:25000);oxacycle (CHEBI:38104);carbonyl compound (CHEBI:36586);organonitrogen heterocyclic compound (CHEBI:38101);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);N-acyl-L-alpha-amino acid (CHEBI:48927);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);pyrans (CHEBI:26407);oxygen molecular entity (CHEBI:25806);ether (CHEBI:25698);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);amino acid (CHEBI:33709);peptide (CHEBI:16670);N-acyl-amino acid (CHEBI:51569)	Benzopyranoids (PK1311)	Amino acids, peptides, and analogues	N-acyl-l-alpha-amino acid;Coumarin;Benzopyran;1-benzopyran;3-alkylindole;Indole;Indole or derivatives;Alkyl aryl ether;Pyranone;Pyran;Substituted pyrrole;Benzenoid;Heteroaromatic compound;Pyrrole;Secondary carboxylic acid amide;Carboxamide group;Lactone;Organoheterocyclic compound;Oxacycle;Azacycle;Carboxylic acid;Monocarboxylic acid or derivatives;Ether;Organic nitrogen compound;Organic oxide;Hydrocarbon derivative;Organopnictogen compound;Organonitrogen compound;Organooxygen compound;Carbonyl group;Organic oxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		MLS001146454		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C25H24N2O6	C25H24N2O6			InChI=1S/C25H24N2O6/c1-13-14(2)25(31)33-23-15(3)21(9-8-17(13)23)32-12-22(28)27-20(24(29)30)10-16-11-26-19-7-5-4-6-18(16)19/h4-9,11,20,26H,10,12H2,1-3H3,(H,27,28)(H,29,30)/t20-/m0/s1	WADHQNBEDDSGQE-FQEVSTJZSA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[[2-(3,4,8-trimethyl-2-oxo-chromen-7-yl)oxyacetyl]amino]propanoic acid	1798666	Cc1c(C)c2c(oc1=O)c(C)c(OCC(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)O)cc2	(2S)-3-(1H-indol-3-yl)-2-[[2-(3,4,8-trimethyl-2-oxochromen-7-yl)oxyacetyl]amino]propanoic acid			2.7522600000000006													MCULE-9197446303	448.47983	ACID	448.163436	6	3	7	4	1.0		29									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins	False	False	Peptide01		-1.0	Compound(1798666)	1798666	3.6	630			[#6]-[#6]1:[#6](-[#6]):[#6]2:[#6](:[#8]:[#6]:1=[#8]):[#6](-[#6]):[#6](-[#8]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:1:3)-[#6](=[#8])-[#8]):[#6]:[#6]:2	Cc1c(C)c2c(oc1=O)c(C)c(OCC(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)O)cc2	WADHQNBEDDSGQE		parent_pubchem_cid	MLS001146454;CHEMBL1318613;HMS2269J08;EiM07-17034;STL460768;AKOS004937182;SMR000646803;AB00864457-06;N-{[(3,4,8-trimethyl-2-oxo-2H-chromen-7-yl)oxy]acetyl}-L-tryptophan;rac-(2S)-3-(1H-indol-3-yl)-2-[[2-(3,4,8-trimethyl-2-oxo-chromen-7-yl)oxyacetyl]amino]propanoic acid	False	977930.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=977930		pluskal_iocb_peptide_Peptide01_D7_id		100	D7	False	ZINC000002146363
2.0		0	1260	P7008463	71.3		P15	False	0	21	0	0	29	0	7	1	0	0		0.0						COCCCNc1c2cnn(C)c2nc(N2CCN(Cc3ccccc3)CC2)n1																							0.0		AKOS005586700		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	3		C21H29N7O	C21H29N7O			InChI=1S/C21H29N7O/c1-26-20-18(15-23-26)19(22-9-6-14-29-2)24-21(25-20)28-12-10-27(11-13-28)16-17-7-4-3-5-8-17/h3-5,7-8,15H,6,9-14,16H2,1-2H3,(H,22,24,25)	ULDGVCOHLHVJQA-UHFFFAOYSA-N	6-(4-benzylpiperazin-1-yl)-N-(3-methoxypropyl)-1-methyl-pyrazolo[3,4-d]pyrimidin-4-amine	39038197	COCCCNc1c2cnn(C)c2nc(N2CCN(Cc3ccccc3)CC2)n1	6-(4-benzylpiperazin-1-yl)-N-(3-methoxypropyl)-1-methylpyrazolo[3,4-d]pyrimidin-4-amine			0.8895500000000012													MCULE-3896945806	395.51158		395.243359	7	1	8	4			44										False	Alkaloids				Peptide01			Compound(39038197)	39038197	2.5	631			[#6]-[#8]-[#6]-[#6]-[#6]-[#7]-[#6]1:[#6]2:[#6]:[#7]:[#7](-[#6]):[#6]:2:[#7]:[#6](-[#7]2-[#6]-[#6]-[#7](-[#6]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3)-[#6]-[#6]-2):[#7]:1	COCCCNc1c2cnn(C)c2nc(N2CCN(Cc3ccccc3)CC2)n1	ULDGVCOHLHVJQA		parent_pubchem_cid	AKOS005586700;6-(4-benzylpiperazin-1-yl)-N-(3-methoxypropyl)-1-methyl-pyrazolo[3,4-d]pyrimidin-4-amine		21581962.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=21581962		pluskal_iocb_peptide_Peptide01_D7_id		100	D7		ZINC000031811599
4.7		0	1092	P1098551	117.7		P17	False	0	27	0	0	26	0	2	6	0	0		0.0						CC(Oc1cc2c(cc1)c1c(CCCC1)c(=O)o2)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)O																							0.0		AKOS016376816		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C27H26N2O6	C27H26N2O6			InChI=1S/C27H26N2O6/c1-15(25(30)29-23(26(31)32)12-16-14-28-22-9-5-4-6-18(16)22)34-17-10-11-20-19-7-2-3-8-21(19)27(33)35-24(20)13-17/h4-6,9-11,13-15,23,28H,2-3,7-8,12H2,1H3,(H,29,30)(H,31,32)/t15?,23-/m0/s1	DXICFGQSCWLYEU-GMTBNIFVSA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[2-[(6-oxo-7,8,9,10-tetrahydrobenzo[c]chromen-3-yl)oxy]propanoylamino]propanoic acid	16397217	CC(Oc1cc2c(cc1)c1c(CCCC1)c(=O)o2)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	(2S)-3-(1H-indol-3-yl)-2-[2-[(6-oxo-7,8,9,10-tetrahydrobenzo[c]chromen-3-yl)oxy]propanoylamino]propanoic acid			3.1490100000000005													MCULE-5205159315	474.51807		474.179087	6	3	7	5			45									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(16397217)	16397217	4.3	632			[#6]-[#6](-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#6]1:[#6](-[#6]-[#6]-[#6]-[#6]-1):[#6](=[#8]):[#8]:2)-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	CC(Oc1cc2c(cc1)c1c(CCCC1)c(=O)o2)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	DXICFGQSCWLYEU		parent_pubchem_cid	AKOS016376816;(2S)-3-(1H-INDOL-3-YL)-2-({2-[(6-OXO-7,8,9,10-TETRAHYDRO-6H-BENZO[C]CHROMEN-3-YL)OXY]PROPANOYL}AMINO)PROPANOIC ACID;(2S)-3-(1H-indol-3-yl)-2-(2-((6-oxo-7,8,9,10-tetrahydro-6H-benzo[c]chromen-3-yl)oxy)propanamido)propanoic acid;rac-(2S)-3-(1H-indol-3-yl)-2-[2-[(6-oxo-7,8,9,10-tetrahydrobenzo[c]chromen-3-yl)oxy]propanoylamino]propanoic acid		24720808.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24720808		pluskal_iocb_peptide_Peptide01_D8_id		100	D8		
3.8		0	1180	P3461230	117.7		P18	False	0	25	0	0	24	0	2	6	0	0		0.0						COc1cc2c(cc1CCC(=O)NC(Cc1c[nH]c3ccccc13)C(=O)O)c(C)cc(=O)o2																							0.0		EiM08-08814		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C25H24N2O6	C25H24N2O6			InChI=1S/C25H24N2O6/c1-14-9-24(29)33-22-12-21(32-2)15(10-18(14)22)7-8-23(28)27-20(25(30)31)11-16-13-26-19-6-4-3-5-17(16)19/h3-6,9-10,12-13,20,26H,7-8,11H2,1-2H3,(H,27,28)(H,30,31)/t20-/m0/s1	HJSQDKDGHIOANW-FQEVSTJZSA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[3-(7-methoxy-4-methyl-2-oxo-chromen-6-yl)propanoylamino]propanoic acid	51703570	COc1cc2c(cc1CCC(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)O)c(C)cc(=O)o2	(2S)-3-(1H-indol-3-yl)-2-[3-(7-methoxy-4-methyl-2-oxochromen-6-yl)propanoylamino]propanoic acid			2.75253													MCULE-1808197167	448.47983		448.163436	6	3	8	4			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(51703570)	51703570	3.0	633			[#6]-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1-[#6]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:1:3)-[#6](=[#8])-[#8]):[#6](-[#6]):[#6]:[#6](=[#8]):[#8]:2	COc1cc2c(cc1CCC(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)O)c(C)cc(=O)o2	HJSQDKDGHIOANW		parent_pubchem_cid	EiM08-08814;AKOS016377322;3-(1H-INDOL-3-YL)-2-[3-(7-METHOXY-4-METHYL-2-OXO-2H-CHROMEN-6-YL)PROPANAMIDO]PROPANOIC ACID;rac-(2S)-3-(1H-indol-3-yl)-2-[3-(7-methoxy-4-methyl-2-oxo-chromen-6-yl)propanoylamino]propanoic acid		23724642.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23724642		pluskal_iocb_peptide_Peptide01_D8_id		100	D8		ZINC000035686286
3.1		0	1268	P7008529	84.9		P19	False	0	20	0	0	18	0	6	1	0	0		0.0						COc1ccc(Nc2nc3nccnc3c(NCc3ccccc3)n2)cc1																							0.0		{2-[(4-methoxyphenyl)amino]pteridin-4-yl}benzylamine		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0		C20H18N6O	C20H18N6O			InChI=1S/C20H18N6O/c1-27-16-9-7-15(8-10-16)24-20-25-18-17(21-11-12-22-18)19(26-20)23-13-14-5-3-2-4-6-14/h2-12H,13H2,1H3,(H2,22,23,24,25,26)	OMBFKKYJKGTEPY-UHFFFAOYSA-N	N4-benzyl-N2-(4-methoxyphenyl)pteridine-2,4-diamine	45495852	COc1ccc(Nc2nc3nccnc3c(NCc3ccccc3)n2)cc1	4-N-benzyl-2-N-(4-methoxyphenyl)pteridine-2,4-diamine			1.6967299999999994													MCULE-9229651673	358.40606		358.154209	7	2	6	4			44										False	Alkaloids				Peptide01			Compound(45495852)	45495852	3.5	634			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#7]-[#6]2:[#7]:[#6]3:[#7]:[#6]:[#6]:[#7]:[#6]:3:[#6](-[#7]-[#6]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#7]:2):[#6]:[#6]:1	COc1ccc(Nc2nc3nccnc3c(NCc3ccccc3)n2)cc1	OMBFKKYJKGTEPY		parent_pubchem_cid	{2-[(4-methoxyphenyl)amino]pteridin-4-yl}benzylamine;1190263-72-9;AKOS002337643;CCG-330108;N4-benzyl-N2-(4-methoxyphenyl)pteridine-2,4-diamine		9510282.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=9510282		pluskal_iocb_peptide_Peptide01_D8_id		100	D8		ZINC000036366545
4.8		0	1100	P1098423	101.9		P21	False	0	28	0	0	25	0	1	6	0	0	-1.0	0.0						Cc1c(Cc2ccccc2)c(=O)oc2c1ccc(OCC(=O)NC(Cc1ccccc1)C(=O)O)c2		3.88		0.0	4.5	CHEMBL1321057		N-acyl-L-alpha-amino acids;Phenylpropanoic acids;Coumarins and derivatives;1-benzopyrans;Amphetamines and derivatives;Pyranones and derivatives;Alkyl aryl ethers;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactones;Oxacyclic compounds;Carboxylic acids;Monocarboxylic acids and derivatives;Organopnictogen compounds;Carbonyl compounds;Organic oxides;Organonitrogen compounds;Hydrocarbon derivatives	1-benzopyrans;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Benzene and substituted derivatives;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Lactones;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenethylamines;Phenylalanine and derivatives;Phenylpropanoic acids;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Secondary carboxylic acid amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-L-alpha-amino acid (CHEBI:48927);benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);coumarins (CHEBI:23403);1-benzopyran (CHEBI:38443);amphetamines (CHEBI:35338);pyranone (CHEBI:37963);aromatic ether (CHEBI:35618);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactone (CHEBI:25000);oxacycle (CHEBI:38104);carboxylic acid anion (CHEBI:29067);carbonyl compound (CHEBI:36586);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);organic molecule (CHEBI:72695);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);amino acid (CHEBI:33709);peptide (CHEBI:16670);N-acyl-amino acid (CHEBI:51569);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);benzenoid aromatic compound (CHEBI:33836);primary amine (CHEBI:32877);pyrans (CHEBI:26407);oxygen molecular entity (CHEBI:25806);ether (CHEBI:25698);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)	Benzopyranoids (PK1311)	Amino acids, peptides, and analogues	Phenylalanine or derivatives;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;N-acyl-l-alpha-amino acid;Coumarin;3-phenylpropanoic-acid;Benzopyran;1-benzopyran;Amphetamine or derivatives;Alkyl aryl ether;Pyranone;Monocyclic benzene moiety;Benzenoid;Pyran;Heteroaromatic compound;Carboxamide group;Lactone;Secondary carboxylic acid amide;Monocarboxylic acid or derivatives;Ether;Organoheterocyclic compound;Carboxylic acid;Oxacycle;Organic oxygen compound;Organic nitrogen compound;Hydrocarbon derivative;Organic oxide;Carbonyl group;Organopnictogen compound;Organonitrogen compound;Organooxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		SMR000646745		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C28H25NO6	C28H25NO6			InChI=1S/C28H25NO6/c1-18-22-13-12-21(16-25(22)35-28(33)23(18)14-19-8-4-2-5-9-19)34-17-26(30)29-24(27(31)32)15-20-10-6-3-7-11-20/h2-13,16,24H,14-15,17H2,1H3,(H,29,30)(H,31,32)/t24-/m0/s1	KTZOKINREVUDBT-DEOSSOPVSA-N	rac-(2S)-2-[[2-(3-benzyl-4-methyl-2-oxo-chromen-7-yl)oxyacetyl]amino]-3-phenyl-propanoic acid	1798481	Cc1c(Cc2ccccc2)c(=O)oc2c1ccc(OCC(=O)N[C@@H](Cc1ccccc1)C(=O)O)c2	(2S)-2-[[2-(3-benzyl-4-methyl-2-oxochromen-7-yl)oxyacetyl]amino]-3-phenylpropanoic acid			3.6733400000000014													MCULE-6698251648	471.51455	ACID	471.168188	6	2	9	4	1.0		29									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins	False	False	Peptide01		-1.0	Compound(1798481)	1798481	4.7	635			[#6]-[#6]1:[#6](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]):[#6]:2	Cc1c(Cc2ccccc2)c(=O)oc2c1ccc(OCC(=O)N[C@@H](Cc1ccccc1)C(=O)O)c2	KTZOKINREVUDBT		parent_pubchem_cid	SMR000646745;MLS001146569;MLS003901477;CHEMBL1321057;HMS2267I18;EiM07-17101;STK921382;AKOS016378769;AB00864217-06;N-{[(3-benzyl-4-methyl-2-oxo-2H-chromen-7-yl)oxy]acetyl}-L-phenylalanine;rac-(2S)-2-[[2-(3-benzyl-4-methyl-2-oxo-chromen-7-yl)oxyacetyl]amino]-3-phenyl-propanoic acid	False	877407.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=877407		pluskal_iocb_peptide_Peptide01_D8_id		100	D8	False	ZINC000002146041
3.6		0	1188	P3461219	83.2		P22	False	0	22	0	0	25	0	3	3	0	0		0.0						COc1ccc(CNC(=O)C(NC(=O)c2cc3ccccc3[nH]2)C(C)C)cc1																							0.0		EiM08-08769		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0		C22H25N3O3	C22H25N3O3			InChI=1S/C22H25N3O3/c1-14(2)20(22(27)23-13-15-8-10-17(28-3)11-9-15)25-21(26)19-12-16-6-4-5-7-18(16)24-19/h4-12,14,20,24H,13H2,1-3H3,(H,23,27)(H,25,26)/t20-/m1/s1	OJAZBYDGFBZNCH-HXUWFJFHSA-N	N-[rac-(1R)-1-[(4-methoxyphenyl)methylcarbamoyl]-2-methyl-propyl]-1H-indole-2-carboxamide	51703552	COc1ccc(CNC(=O)[C@H](NC(=O)c2cc3ccccc3[nH]2)C(C)C)cc1	N-[(2R)-1-[(4-methoxyphenyl)methylamino]-3-methyl-1-oxobutan-2-yl]-1H-indole-2-carboxamide			2.24705													MCULE-5865992217	379.46285		379.189592	3	3	7	3			44										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(51703552)	51703552	3.8	636			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6]-[#7]-[#6](=[#8])-[#6@H](-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3:[#7H]:2)-[#6](-[#6])-[#6]):[#6]:[#6]:1	COc1ccc(CNC(=O)[C@H](NC(=O)c2cc3ccccc3[nH]2)C(C)C)cc1	OJAZBYDGFBZNCH		parent_pubchem_cid	EiM08-08769;AKOS016376747;2-[(1H-INDOL-2-YL)FORMAMIDO]-N-[(4-METHOXYPHENYL)METHYL]-3-METHYLBUTANAMIDE;N-[rac-(1R)-1-[(4-methoxyphenyl)methylcarbamoyl]-2-methyl-propyl]-1H-indole-2-carboxamide		18454512.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=18454512		pluskal_iocb_peptide_Peptide01_D8_id		100	D8		ZINC000035686273
3.4		0	1276	P11640537	121.0		P23	False	0	24	0	0	26	0	6	3	0	0		0.0						CC(C)(C)OC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NNc1ncnc2ccccc12																							0.0		AKOS038555059		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	1	0	2	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0		C24H26N6O3	C24H26N6O3			InChI=1S/C24H26N6O3/c1-24(2,3)33-23(32)28-20(12-15-13-25-18-10-6-4-8-16(15)18)22(31)30-29-21-17-9-5-7-11-19(17)26-14-27-21/h4-11,13-14,20,25H,12H2,1-3H3,(H,28,32)(H,30,31)(H,26,27,29)	YMFDLTJWISIJJK-UHFFFAOYSA-N	tert-butyl N-[1-(1H-indol-3-ylmethyl)-2-oxo-2-(2-quinazolin-4-ylhydrazino)ethyl]carbamate	132932716	CC(C)(C)OC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NNc1ncnc2ccccc12	tert-butyl N-[3-(1H-indol-3-yl)-1-oxo-1-(2-quinazolin-4-ylhydrazinyl)propan-2-yl]carbamate			2.39804														446.51322		446.206639	6	4	8	4			46									Quinazoline alkaloids	False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(132932716)	132932716	4.8	637			[#6]-[#6](-[#6])(-[#6])-[#8]-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#7]-[#7]-[#6]1:[#7]:[#6]:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CC(C)(C)OC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NNc1ncnc2ccccc12	YMFDLTJWISIJJK		parent_pubchem_cid	AKOS038555059;tert-butyl N-[1-(1H-indol-3-ylmethyl)-2-oxo-2-(2-quinazolin-4-ylhydrazino)ethyl]carbamate		163766241.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=163766241		pluskal_iocb_peptide_Peptide01_D8_id		100	D8		
2.4		0	1108	P1098873	111.4		P25	False	0	18	0	0	16	0	4	4	0	0	-1.0	0.0						O=C(Cn1nnc2ccccc2c1=O)NC(Cc1ccccc1)C(=O)O		0.6		0.0	2.61	CHEMBL1894728																	0.0		(2S)-2-[[2-(4-oxo-1,2,3-benzotriazin-3-yl)acetyl]amino]-3-phenylpropanoic acid		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C18H16N4O4	C18H16N4O4			InChI=1S/C18H16N4O4/c23-16(19-15(18(25)26)10-12-6-2-1-3-7-12)11-22-17(24)13-8-4-5-9-14(13)20-21-22/h1-9,15H,10-11H2,(H,19,23)(H,25,26)/t15-/m0/s1	ICGFHVUHHPOZQA-HNNXBMFYSA-N	rac-(2S)-2-[[2-(4-oxo-1,2,3-benzotriazin-3-yl)acetyl]amino]-3-phenyl-propanoic acid	1970084	O=C(Cn1nnc2ccccc2c1=O)N[C@@H](Cc1ccccc1)C(=O)O	(2S)-2-[[2-(4-oxo-1,2,3-benzotriazin-3-yl)acetyl]amino]-3-phenylpropanoic acid			1.0203599999999993													MCULE-7153903952	352.35262	ACID	352.117155	6	2	6	3	0.0		29										False	Amino acids and Peptides		False	False	Peptide01		-1.0	Compound(1970084)	1970084	2.5	638			[#8]=[#6](-[#6]-[#7]1:[#7]:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	O=C(Cn1nnc2ccccc2c1=O)N[C@@H](Cc1ccccc1)C(=O)O	ICGFHVUHHPOZQA		parent_pubchem_cid	(2S)-2-[[2-(4-oxo-1,2,3-benzotriazin-3-yl)acetyl]amino]-3-phenylpropanoic acid;958984-65-1;MLS000762420;CHEMBL1894728;DTXSID601331115;HMS2742A07;AKOS005533832;SMR000415992;(S)-2-(2-(4-oxobenzo[d][1,2,3]triazin-3(4H)-yl)acetamido)-3-phenylpropanoic acid;(S)-2-[2-(4-Oxo-4H-benzo[d][1,2,3]triazin-3-yl)-acetylamino]-3-phenyl-propionic acid;2-[2-(4-OXO-3,4-DIHYDRO-1,2,3-BENZOTRIAZIN-3-YL)ACETAMIDO]-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[[2-(4-oxo-1,2,3-benzotriazin-3-yl)acetyl]amino]-3-phenyl-propanoic acid	False	1118957.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=1118957		pluskal_iocb_peptide_Peptide01_D8_id		100	D8	False	ZINC000002357771
1.0		0	1196	P6235934	95.9		P26	False	0	19	0	0	25	0	1	5	0	0		0.0						CCCc1cc(=O)oc2c1ccc(O)c2CNC(CC(C)C)C(=O)O								7-hydroxycoumarins;1-benzopyrans;D-alpha-amino acids;Pyranones and derivatives;1-hydroxy-2-unsubstituted benzenoids;Aralkylamines;Heteroaromatic compounds;Amino acids;Lactones;Oxacyclic compounds;Monocarboxylic acids and derivatives;Carboxylic acids;Dialkylamines;Hydrocarbon derivatives;Carbonyl compounds;Organic oxides;Organopnictogen compounds	1-benzopyrans;1-hydroxy-2-unsubstituted benzenoids;7-hydroxycoumarins;Alpha amino acids;Alpha amino acids and derivatives;Amines;Amino acids;Amino acids and derivatives;Amino acids, peptides, and analogues;Aralkylamines;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;D-alpha-amino acids;Dialkylamines;Heteroaromatic compounds;Hydrocarbon derivatives;Hydroxycoumarins;Lactones;Leucine and derivatives;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenols;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Secondary amines	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as leucine and derivatives. These are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Leucine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	hydroxycoumarin (CHEBI:37912);1-benzopyran (CHEBI:38443);D-alpha-amino acid (CHEBI:16733);pyranone (CHEBI:37963);phenols (CHEBI:33853);aralkylamine (CHEBI:18000);organic aromatic compound (CHEBI:33659);amino acid (CHEBI:33709);lactone (CHEBI:25000);oxacycle (CHEBI:38104);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);secondary amino compound (CHEBI:50995);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);organic oxide (CHEBI:25701);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);leucine derivative (CHEBI:47003);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);coumarins (CHEBI:23403);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);organic acid (CHEBI:64709);organonitrogen compound (CHEBI:35352);alpha-amino acid (CHEBI:33704);pyrans (CHEBI:26407);benzenoid aromatic compound (CHEBI:33836);nitrogen molecular entity (CHEBI:51143);amine (CHEBI:32952);secondary amine (CHEBI:32863);oxygen molecular entity (CHEBI:25806);carboxylic acid anion (CHEBI:29067);peptide (CHEBI:16670)	Benzopyranoids (PK1311)	Amino acids, peptides, and analogues	Leucine or derivatives;7-hydroxycoumarin;Hydroxycoumarin;Coumarin;Alpha-amino acid;Benzopyran;D-alpha-amino acid;1-benzopyran;1-hydroxy-2-unsubstituted benzenoid;Aralkylamine;Pyranone;Benzenoid;Pyran;Heteroaromatic compound;Amino acid;Lactone;Carboxylic acid;Secondary aliphatic amine;Oxacycle;Monocarboxylic acid or derivatives;Organoheterocyclic compound;Secondary amine;Hydrocarbon derivative;Organic oxygen compound;Organic oxide;Organic nitrogen compound;Amine;Organonitrogen compound;Organooxygen compound;Organopnictogen compound;Carbonyl group;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		2-{[(7-HYDROXY-2-OXO-4-PROPYL-2H-CHROMEN-8-YL)METHYL]AMINO}-4-METHYLPENTANOIC ACID		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C19H25NO5	C19H25NO5			InChI=1S/C19H25NO5/c1-4-5-12-9-17(22)25-18-13(12)6-7-16(21)14(18)10-20-15(19(23)24)8-11(2)3/h6-7,9,11,15,20-21H,4-5,8,10H2,1-3H3,(H,23,24)/t15-/m1/s1	IQZDVXSHBFSQBL-OAHLLOKOSA-N	rac-(2R)-2-[(7-hydroxy-2-oxo-4-propyl-chromen-8-yl)methylamino]-4-methyl-pentanoic acid	5417021	CCCc1cc(=O)oc2c1ccc(O)c2CN[C@H](CC(C)C)C(=O)O	(2R)-2-[(7-hydroxy-2-oxo-4-propylchromen-8-yl)methylamino]-4-methylpentanoic acid			2.9396400000000007													MCULE-7537206669	347.4148		347.173273	6	3	8	2			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(5417021)	5417021	1.4	639			[#6]-[#6]-[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]):[#6]:2-[#6]-[#7]-[#6@H](-[#6]-[#6](-[#6])-[#6])-[#6](=[#8])-[#8]	CCCc1cc(=O)oc2c1ccc(O)c2CN[C@H](CC(C)C)C(=O)O	IQZDVXSHBFSQBL		parent_pubchem_cid	2-{[(7-HYDROXY-2-OXO-4-PROPYL-2H-CHROMEN-8-YL)METHYL]AMINO}-4-METHYLPENTANOIC ACID;EiM07-17286;AKOS016376011;rac-(2R)-2-[(7-hydroxy-2-oxo-4-propyl-chromen-8-yl)methylamino]-4-methyl-pentanoic acid		18237826.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=18237826		pluskal_iocb_peptide_Peptide01_D8_id		100	D8		ZINC000004039855
2.6		0	1284	P11569546	103.4		P27	False	0	19	0	0	19	0	3	2	0	1		0.0						O=C(Cc1csc(-c2ccccn2)n1)NC(CO)Cc1ccccc1																							0.0		AKOS027474369		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C19H19N3O2S	C19H19N3O2S			InChI=1S/C19H19N3O2S/c23-12-15(10-14-6-2-1-3-7-14)21-18(24)11-16-13-25-19(22-16)17-8-4-5-9-20-17/h1-9,13,15,23H,10-12H2,(H,21,24)/t15-/m0/s1	YFFNYRYAYAGABL-HNNXBMFYSA-N	2-[2-(2-pyridyl)thiazol-4-yl]-N-[rac-(1S)-1-benzyl-2-hydroxy-ethyl]acetamide	91640147	O=C(Cc1csc(-c2ccccn2)n1)N[C@H](CO)Cc1ccccc1	N-[(2S)-1-hydroxy-3-phenylpropan-2-yl]-2-(2-pyridin-2-yl-1,3-thiazol-4-yl)acetamide			1.97796														353.44618		353.119798	4	2	7	3			45									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(91640147)	91640147	2.2	640			[#8]=[#6](-[#6]-[#6]1:[#6]:[#16]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#7]:2):[#7]:1)-[#7]-[#6@H](-[#6]-[#8])-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	O=C(Cc1csc(-c2ccccn2)n1)N[C@H](CO)Cc1ccccc1	YFFNYRYAYAGABL		parent_pubchem_cid	AKOS027474369;2-[2-(2-pyridyl)thiazol-4-yl]-N-[rac-(1S)-1-benzyl-2-hydroxy-ethyl]acetamide		94134261.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=94134261		pluskal_iocb_peptide_Peptide01_D9_id		100	D9		ZINC000120501028
3.0		0	1116	P1157904	100.7		P29	False	0	17	0	0	22	0	2	5	0	0		0.0						CCCCC(NC(=O)c1cc2c(OC)ccc(OC)c2[nH]1)C(=O)O																							0.0		STK717297		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C17H22N2O5	C17H22N2O5			InChI=1S/C17H22N2O5/c1-4-5-6-11(17(21)22)19-16(20)12-9-10-13(23-2)7-8-14(24-3)15(10)18-12/h7-9,11,18H,4-6H2,1-3H3,(H,19,20)(H,21,22)	OPLIOEGOJSQEKG-UHFFFAOYSA-N	2-[(4,7-dimethoxy-1H-indole-2-carbonyl)amino]hexanoic acid	16420303	CCCCC(NC(=O)c1cc2c(OC)ccc(OC)c2[nH]1)C(=O)O	2-[(4,7-dimethoxy-1H-indole-2-carbonyl)amino]hexanoic acid			1.1503499999999998													MCULE-9708263798	334.37529		334.152872	5	3	8	2			45										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(16420303)	16420303	3.0	641			[#6]-[#6]-[#6]-[#6]-[#6](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]2:[#6](-[#8]-[#6]):[#6]:[#6]:[#6](-[#8]-[#6]):[#6]:2:[#7H]:1)-[#6](=[#8])-[#8]	CCCCC(NC(=O)c1cc2c(OC)ccc(OC)c2[nH]1)C(=O)O	OPLIOEGOJSQEKG		parent_pubchem_cid	STK717297;AKOS005533631;N-[(4,7-dimethoxy-1H-indol-2-yl)carbonyl]norleucine;2-[(4,7-DIMETHOXY-1H-INDOL-2-YL)FORMAMIDO]HEXANOIC ACID;2-[(4,7-dimethoxy-1H-indole-2-carbonyl)amino]hexanoic acid		23190844.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23190844		pluskal_iocb_peptide_Peptide01_D9_id		100	D9		
4.9		0	1204	P1098313	101.9		P30	False	0	25	0	0	27	0	1	6	0	0		0.0						CCCCc1cc(=O)oc2c1ccc(OC(C)C(=O)NC(C(=O)O)c1ccccc1)c2C																							0.0		AKOS004937248		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C25H27NO6	C25H27NO6			InChI=1S/C25H27NO6/c1-4-5-9-18-14-21(27)32-23-15(2)20(13-12-19(18)23)31-16(3)24(28)26-22(25(29)30)17-10-7-6-8-11-17/h6-8,10-14,16,22H,4-5,9H2,1-3H3,(H,26,28)(H,29,30)/t16?,22-/m0/s1	RVDSMTWQSNUNLV-XLDIYJRPSA-N	rac-(2S)-2-[2-(4-butyl-8-methyl-2-oxo-chromen-7-yl)oxypropanoylamino]-2-phenyl-acetic acid	16399738	CCCCc1cc(=O)oc2c1ccc(OC(C)C(=O)N[C@H](C(=O)O)c1ccccc1)c2C	(2S)-2-[2-(4-butyl-8-methyl-2-oxochromen-7-yl)oxypropanoylamino]-2-phenylacetic acid			3.998350000000002													MCULE-1140867038	437.49704		437.183838	6	2	9	3			45									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(16399738)	16399738	4.7	642			[#6]-[#6]-[#6]-[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6](-[#6])-[#6](=[#8])-[#7]-[#6@H](-[#6](=[#8])-[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1):[#6]:2-[#6]	CCCCc1cc(=O)oc2c1ccc(OC(C)C(=O)N[C@H](C(=O)O)c1ccccc1)c2C	RVDSMTWQSNUNLV		parent_pubchem_cid	AKOS004937248;2-{2-[(4-BUTYL-8-METHYL-2-OXO-2H-CHROMEN-7-YL)OXY]PROPANAMIDO}-2-PHENYLACETIC ACID;rac-(2S)-2-[2-(4-butyl-8-methyl-2-oxo-chromen-7-yl)oxypropanoylamino]-2-phenyl-acetic acid		22996930.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22996930		pluskal_iocb_peptide_Peptide01_D9_id		100	D9		
2.1		0	1292	P11570107	82.0		P31	False	0	20	0	0	25	0	3	3	0	0		0.0						O=C(Cn1nc2CCCCCc2cc1=O)NC(CO)Cc1ccccc1																							0.0		AKOS027474826		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C20H25N3O3	C20H25N3O3			InChI=1S/C20H25N3O3/c24-14-17(11-15-7-3-1-4-8-15)21-19(25)13-23-20(26)12-16-9-5-2-6-10-18(16)22-23/h1,3-4,7-8,12,17,24H,2,5-6,9-11,13-14H2,(H,21,25)/t17-/m0/s1	CSLIXMAUQZQTPQ-KRWDZBQOSA-N	2-(3-oxo-6,7,8,9-tetrahydro-5H-cyclohepta[c]pyridazin-2-yl)-N-[rac-(1S)-1-benzyl-2-hydroxy-ethyl]acetamide	110205671	O=C(Cn1nc2CCCCCc2cc1=O)N[C@H](CO)Cc1ccccc1	N-[(2S)-1-hydroxy-3-phenylpropan-2-yl]-2-(3-oxo-6,7,8,9-tetrahydro-5H-cyclohepta[c]pyridazin-2-yl)acetamide			1.9677599999999995														355.44055		355.189592	4	2	6	3			45										False					Peptide01			Compound(110205671)	110205671	1.9	643			[#8]=[#6](-[#6]-[#7]1:[#7]:[#6]2-[#6]-[#6]-[#6]-[#6]-[#6]-[#6]:2:[#6]:[#6]:1=[#8])-[#7]-[#6@H](-[#6]-[#8])-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	O=C(Cn1nc2CCCCCc2cc1=O)N[C@H](CO)Cc1ccccc1	CSLIXMAUQZQTPQ		parent_pubchem_cid	AKOS027474826;N-(1-HYDROXY-3-PHENYLPROPAN-2-YL)-2-{3-OXO-2H,3H,5H,6H,7H,8H,9H-CYCLOHEPTA[C]PYRIDAZIN-2-YL}ACETAMIDE;2-(3-oxo-6,7,8,9-tetrahydro-5H-cyclohepta[c]pyridazin-2-yl)-N-[rac-(1S)-1-benzyl-2-hydroxy-ethyl]acetamide		117133880.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=117133880		pluskal_iocb_peptide_Peptide01_D9_id		100	D9		ZINC000252481805
4.7		0	1124	P1098248	101.9		P33	False	0	22	0	0	29	0	1	6	0	0		0.0						CCCCC(NC(=O)C(C)Oc1c(C)c2c(cc1)c(CCC)cc(=O)o2)C(=O)O								Coumarins and derivatives;1-benzopyrans;Medium-chain fatty acids;Pyranones and derivatives;Alkyl aryl ethers;Amino fatty acids;Heterocyclic fatty acids;Benzenoids;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactones;Oxacyclic compounds;Monocarboxylic acids and derivatives;Carboxylic acids;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organonitrogen compounds;Organopnictogen compounds	1-benzopyrans;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amino fatty acids;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;Ethers;Fatty Acyls;Fatty acids and conjugates;Heteroaromatic compounds;Heterocyclic fatty acids;Hydrocarbon derivatives;Lactones;Lipids and lipid-like molecules;Medium-chain fatty acids;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Secondary carboxylic acid amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom.	N-acyl-alpha amino acids		Amino acids and derivatives;Alpha amino acids and derivatives;N-acyl-alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	coumarins (CHEBI:23403);1-benzopyran (CHEBI:38443);medium-chain fatty acid (CHEBI:59554);pyranone (CHEBI:37963);aromatic ether (CHEBI:35618);amino fatty acid (CHEBI:59650);heterocyclic fatty acid (CHEBI:48847);benzenoid aromatic compound (CHEBI:33836);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactone (CHEBI:25000);oxacycle (CHEBI:38104);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);carbonyl compound (CHEBI:36586);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);N-acyl-amino acid (CHEBI:51569);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);lipid (CHEBI:18059);pyrans (CHEBI:26407);oxygen molecular entity (CHEBI:25806);ether (CHEBI:25698);organic acid (CHEBI:64709);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);carboxylic acid anion (CHEBI:29067);amino acid (CHEBI:33709);peptide (CHEBI:16670)	Fatty Acids and Conjugates (FA01);Amino fatty acids (FA0110);Heterocyclic fatty acids (FA0115);Benzopyranoids (PK1311);Fatty Acyls (FA)	Amino acids, peptides, and analogues	N-acyl-alpha-amino acid;Coumarin;Benzopyran;1-benzopyran;Medium-chain fatty acid;Alkyl aryl ether;Amino fatty acid;Heterocyclic fatty acid;Pyranone;Benzenoid;Fatty acyl;Fatty acid;Pyran;Heteroaromatic compound;Carboxamide group;Lactone;Secondary carboxylic acid amide;Monocarboxylic acid or derivatives;Oxacycle;Ether;Carboxylic acid;Organoheterocyclic compound;Organonitrogen compound;Organopnictogen compound;Organic oxygen compound;Carbonyl group;Organic oxide;Organooxygen compound;Organic nitrogen compound;Hydrocarbon derivative;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		N-{2-[(8-methyl-2-oxo-4-propyl-2H-chromen-7-yl)oxy]propanoyl}norleucine		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C22H29NO6	C22H29NO6			InChI=1S/C22H29NO6/c1-5-7-9-17(22(26)27)23-21(25)14(4)28-18-11-10-16-15(8-6-2)12-19(24)29-20(16)13(18)3/h10-12,14,17H,5-9H2,1-4H3,(H,23,25)(H,26,27)	MAZNTMSQDCJWIO-UHFFFAOYSA-N	2-[2-(8-methyl-2-oxo-4-propyl-chromen-7-yl)oxypropanoylamino]hexanoic acid	3373490	CCCCC(NC(=O)C(C)Oc1c(C)c2c(cc1)c(CCC)cc(=O)o2)C(=O)O	2-[2-(8-methyl-2-oxo-4-propylchromen-7-yl)oxypropanoylamino]hexanoic acid			3.4804600000000017													MCULE-3358826869	403.47953		403.199488	6	2	10	2			45									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(3373490)	3373490	4.3	644			[#6]-[#6]-[#6]-[#6]-[#6](-[#7]-[#6](=[#8])-[#6](-[#6])-[#8]-[#6]1:[#6](-[#6]):[#6]2:[#6](:[#6]:[#6]:1):[#6](-[#6]-[#6]-[#6]):[#6]:[#6](=[#8]):[#8]:2)-[#6](=[#8])-[#8]	CCCCC(NC(=O)C(C)Oc1c(C)c2c(cc1)c(CCC)cc(=O)o2)C(=O)O	MAZNTMSQDCJWIO		parent_pubchem_cid	N-{2-[(8-methyl-2-oxo-4-propyl-2H-chromen-7-yl)oxy]propanoyl}norleucine;1008202-80-9;EiM07-16926;AKOS016390215;2-{2-[(8-METHYL-2-OXO-4-PROPYL-2H-CHROMEN-7-YL)OXY]PROPANAMIDO}HEXANOIC ACID;2-[2-(8-methyl-2-oxo-4-propyl-chromen-7-yl)oxypropanoylamino]hexanoic acid		23138625.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23138625		pluskal_iocb_peptide_Peptide01_D9_id		100	D9		
3.9		0	1212	P7565952	59.1		P34	False	0	22	0	0	23	0	3	2	0	0		0.0						COCCn1c(C(=O)NCCc2c[nH]c3ccccc23)cc2ccccc21								N-alkylindoles;3-alkylindoles;Pyrrole carboxamides;2-heteroaryl carboxamides;Substituted pyrroles;Benzenoids;Heteroaromatic compounds;Secondary carboxylic acid amides;Dialkyl ethers;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	2-heteroaryl carboxamides;3-alkylindoles;Azacyclic compounds;Benzenoids;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Dialkyl ethers;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Indolecarboxamides and derivatives;Indolecarboxylic acids and derivatives;Indoles;Indoles and derivatives;N-alkylindoles;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Pyrrole carboxamides;Pyrrole carboxylic acids and derivatives;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as indolecarboxamides and derivatives. These are compounds containing a carboxamide group attached to an indole.	Indolecarboxamides and derivatives			Organic compounds	Aromatic heteropolycyclic compounds	indoles (CHEBI:24828);pyrroles (CHEBI:26455);carboxamide (CHEBI:37622);organic aromatic compound (CHEBI:33659);benzenoid aromatic compound (CHEBI:33836);ether (CHEBI:25698);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);indolecarboxamide (CHEBI:46921);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);organooxygen compound (CHEBI:36963);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143);indolyl carboxylic acid (CHEBI:46867)		Indolecarboxylic acids and derivatives	Indolecarboxamide derivative;N-alkylindole;3-alkylindole;Indole;2-heteroaryl carboxamide;Pyrrole-2-carboxamide;Pyrrole-2-carboxylic acid or derivatives;Benzenoid;Substituted pyrrole;Heteroaromatic compound;Pyrrole;Carboxamide group;Secondary carboxylic acid amide;Ether;Dialkyl ether;Carboxylic acid derivative;Azacycle;Hydrocarbon derivative;Organic oxide;Organooxygen compound;Organonitrogen compound;Organic oxygen compound;Organic nitrogen compound;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		N-[2-(1H-indol-3-yl)ethyl]-1-(2-methoxyethyl)-1H-indole-2-carboxamide		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C22H23N3O2	C22H23N3O2			InChI=1S/C22H23N3O2/c1-27-13-12-25-20-9-5-2-6-16(20)14-21(25)22(26)23-11-10-17-15-24-19-8-4-3-7-18(17)19/h2-9,14-15,24H,10-13H2,1H3,(H,23,26)	LFOWBFBGLMRIJH-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)ethyl]-1-(2-methoxyethyl)indole-2-carboxamide	71754954	COCCn1c(C(=O)NCCc2c[nH]c3ccccc23)cc2ccccc21	N-[2-(1H-indol-3-yl)ethyl]-1-(2-methoxyethyl)indole-2-carboxamide			2.775240000000001													MCULE-2625581765	361.44751		361.179027	2	2	7	4			44									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(71754954)	71754954	3.5	645			[#6]-[#8]-[#6]-[#6]-[#7]1:[#6](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	COCCn1c(C(=O)NCCc2c[nH]c3ccccc23)cc2ccccc21	LFOWBFBGLMRIJH		parent_pubchem_cid	N-[2-(1H-indol-3-yl)ethyl]-1-(2-methoxyethyl)-1H-indole-2-carboxamide;1435999-81-7;EiM08-29853;AKOS025144505;N-[2-(1H-indol-3-yl)ethyl]-1-(2-methoxyethyl)indole-2-carboxamide		69156689.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=69156689		pluskal_iocb_peptide_Peptide01_D9_id		100	D9		ZINC000085877890
3.7		0	1132	P1098329	117.7		P37	False	0	24	0	0	22	0	2	6	0	0	-1.0	0.0						Cc1c(C)c2c(cc(OCC(=O)NC(Cc3c[nH]c4ccccc34)C(=O)O)cc2)oc1=O		3.08		0.0	3.02	CHEMBL1877548		Indolyl carboxylic acids and derivatives;Coumarins and derivatives;1-benzopyrans;3-alkylindoles;Pyranones and derivatives;Alkyl aryl ethers;Substituted pyrroles;Benzenoids;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactones;Oxacyclic compounds;Monocarboxylic acids and derivatives;Azacyclic compounds;Carboxylic acids;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organonitrogen compounds;Organopnictogen compounds	1-benzopyrans;3-alkylindoles;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Indolyl carboxylic acids and derivatives;Lactones;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acyl-l-alpha-amino acids. These are n-acylated alpha amino acids which have the L-configuration of the alpha-carbon atom.	N-acyl-L-alpha-amino acids		Amino acids and derivatives;Alpha amino acids and derivatives;N-acyl-alpha amino acids and derivatives;N-acyl-alpha amino acids	Organic compounds	Aromatic heteropolycyclic compounds	indolyl carboxylic acid (CHEBI:46867);coumarins (CHEBI:23403);1-benzopyran (CHEBI:38443);indoles (CHEBI:24828);pyranone (CHEBI:37963);aromatic ether (CHEBI:35618);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactone (CHEBI:25000);oxacycle (CHEBI:38104);carbonyl compound (CHEBI:36586);organonitrogen heterocyclic compound (CHEBI:38101);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);N-acyl-L-alpha-amino acid (CHEBI:48927);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);organooxygen compound (CHEBI:36963);benzopyran (CHEBI:22727);pyrans (CHEBI:26407);oxygen molecular entity (CHEBI:25806);ether (CHEBI:25698);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);amino acid (CHEBI:33709);peptide (CHEBI:16670);N-acyl-amino acid (CHEBI:51569)	Benzopyranoids (PK1311)	Amino acids, peptides, and analogues	N-acyl-l-alpha-amino acid;Indolyl carboxylic acid derivative;Coumarin;Benzopyran;1-benzopyran;3-alkylindole;Indole;Indole or derivatives;Alkyl aryl ether;Pyranone;Pyran;Substituted pyrrole;Benzenoid;Pyrrole;Heteroaromatic compound;Carboxamide group;Secondary carboxylic acid amide;Lactone;Organoheterocyclic compound;Azacycle;Carboxylic acid;Ether;Oxacycle;Monocarboxylic acid or derivatives;Organic oxide;Carbonyl group;Organopnictogen compound;Hydrocarbon derivative;Organic nitrogen compound;Organic oxygen compound;Organonitrogen compound;Organooxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		MLS001076813		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C24H22N2O6	C24H22N2O6			InChI=1S/C24H22N2O6/c1-13-14(2)24(30)32-21-10-16(7-8-17(13)21)31-12-22(27)26-20(23(28)29)9-15-11-25-19-6-4-3-5-18(15)19/h3-8,10-11,20,25H,9,12H2,1-2H3,(H,26,27)(H,28,29)/t20-/m0/s1	RBUPUMFZZDPXIV-FQEVSTJZSA-N	rac-(2S)-2-[[2-(3,4-dimethyl-2-oxo-chromen-7-yl)oxyacetyl]amino]-3-(1H-indol-3-yl)propanoic acid	1784691	Cc1c(C)c2c(cc(OCC(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)O)cc2)oc1=O	(2S)-2-[[2-(3,4-dimethyl-2-oxochromen-7-yl)oxyacetyl]amino]-3-(1H-indol-3-yl)propanoic acid			2.49855													MCULE-4481982306	434.45274	ACID	434.147786	6	3	7	4	1.0		29									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins	False	False	Peptide01		-1.0	Compound(1784691)	1784691	3.2	646			[#6]-[#6]1:[#6](-[#6]):[#6]2:[#6](:[#6]:[#6](-[#8]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]3:[#6]:[#7H]:[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]:3:4)-[#6](=[#8])-[#8]):[#6]:[#6]:2):[#8]:[#6]:1=[#8]	Cc1c(C)c2c(cc(OCC(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)O)cc2)oc1=O	RBUPUMFZZDPXIV		parent_pubchem_cid	MLS001076813;CHEMBL1877548;HMS2269H20;EiM07-17007;STL460741;AKOS004937383;SMR000646599;AB00864062-06;N-{[(3,4-dimethyl-2-oxo-2H-chromen-7-yl)oxy]acetyl}-L-tryptophan;rac-(2S)-2-[[2-(3,4-dimethyl-2-oxo-chromen-7-yl)oxyacetyl]amino]-3-(1H-indol-3-yl)propanoic acid	False	1114811.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=1114811		pluskal_iocb_peptide_Peptide01_D9_id		100	D9	False	ZINC000002129737
2.0		0	1220	P1006087	108.7		P38	False	0	19	0	0	21	0	3	4	0	1		0.0						COc1c(NC(C)=O)cc(S(=O)(=O)NCCc2c[nH]c3ccccc23)cc1																							0.0		STK983501		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	1	0	0	0	0	0	0	0		C19H21N3O4S	C19H21N3O4S			InChI=1S/C19H21N3O4S/c1-13(23)22-18-11-15(7-8-19(18)26-2)27(24,25)21-10-9-14-12-20-17-6-4-3-5-16(14)17/h3-8,11-12,20-21H,9-10H2,1-2H3,(H,22,23)	GIKCUEHLDPVECM-UHFFFAOYSA-N	N-[5-[2-(1H-indol-3-yl)ethylsulfamoyl]-2-methoxy-phenyl]acetamide	24283545	COc1c(NC(C)=O)cc(S(=O)(=O)NCCc2c[nH]c3ccccc23)cc1	N-[5-[2-(1H-indol-3-yl)ethylsulfamoyl]-2-methoxyphenyl]acetamide			1.2217400000000007													MCULE-9822372530	387.46092		387.125277	4	3	7	3			44										False	Alkaloids				Peptide01			Compound(24283545)	24283545	2.1	647			[#6]-[#8]-[#6]1:[#6](-[#7]-[#6](-[#6])=[#8]):[#6]:[#6](-[#16](=[#8])(=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	COc1c(NC(C)=O)cc(S(=O)(=O)NCCc2c[nH]c3ccccc23)cc1	GIKCUEHLDPVECM		parent_pubchem_cid	STK983501;AKOS005646945;Z45689437;N-(5-{[2-(1H-indol-3-yl)ethyl]sulfamoyl}-2-methoxyphenyl)acetamide;N-[5-[2-(1H-indol-3-yl)ethylsulfamoyl]-2-methoxy-phenyl]acetamide		17785872.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=17785872		pluskal_iocb_peptide_Peptide01_D9_id		100	D9		ZINC000011689590
2.7		0	1140	P1157877	124.6		P41	False	0	23	1	0	22	0	3	5	0	0		0.0						CCC(NC(=O)C(Cc1cc(=O)[nH]c2ccccc12)NC(=O)c1ccc(Cl)cc1)C(=O)O																							0.0		SCHEMBL16713748		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	2	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0		C23H22ClN3O5	C23H22ClN3O5			InChI=1S/C23H22ClN3O5/c1-2-17(23(31)32)26-22(30)19(27-21(29)13-7-9-15(24)10-8-13)11-14-12-20(28)25-18-6-4-3-5-16(14)18/h3-10,12,17,19H,2,11H2,1H3,(H,25,28)(H,26,30)(H,27,29)(H,31,32)	OTGCNLMXRLINMR-UHFFFAOYSA-N	2-[[2-[(4-chlorobenzoyl)amino]-3-(2-oxo-1H-quinolin-4-yl)propanoyl]amino]butanoic acid	16417804	CCC(NC(=O)C(Cc1cc(=O)[nH]c2ccccc12)NC(=O)c1ccc(Cl)cc1)C(=O)O	2-[[2-[(4-chlorobenzoyl)amino]-3-(2-oxo-1H-quinolin-4-yl)propanoyl]amino]butanoic acid			2.8640500000000007													MCULE-6699344073	455.90189		455.124798	5	4	8	3			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(16417804)	16417804	2.6	648		SCHEMBL16713748	[#6]-[#6]-[#6](-[#7]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6](=[#8]):[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#17]):[#6]:[#6]:1)-[#6](=[#8])-[#8]	CCC(NC(=O)C(Cc1cc(=O)[nH]c2ccccc12)NC(=O)c1ccc(Cl)cc1)C(=O)O	OTGCNLMXRLINMR		parent_pubchem_cid	SCHEMBL16713748;EiM07-18179;AKOS005560342;AKOS016379468;2-{2-[(4-CHLOROPHENYL)FORMAMIDO]-3-(2-OXO-1,2-DIHYDROQUINOLIN-4-YL)PROPANAMIDO}BUTANOIC ACID;2-[[2-[(4-chlorobenzoyl)amino]-3-(2-oxo-1H-quinolin-4-yl)propanoyl]amino]butanoic acid		24513640.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24513640		pluskal_iocb_peptide_Peptide01_D10_id		100	D10		
1.5		0	1228	P1437143	82.3		P42	False	0	19	0	0	25	0	7	1	0	0		0.0						Cc1ccccc1Nc1c2cnn(C)c2nc(N2CCN(CCO)CC2)n1																							0.0		887213-16-3		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	3		C19H25N7O	C19H25N7O			InChI=1S/C19H25N7O/c1-14-5-3-4-6-16(14)21-17-15-13-20-24(2)18(15)23-19(22-17)26-9-7-25(8-10-26)11-12-27/h3-6,13,27H,7-12H2,1-2H3,(H,21,22,23)	KOXUUBHWOZPUOW-UHFFFAOYSA-N	2-[4-[1-methyl-4-(2-methylanilino)pyrazolo[3,4-d]pyrimidin-6-yl]piperazin-1-yl]ethanol	7162545	Cc1ccccc1Nc1c2cnn(C)c2nc(N2CCN(CCO)CC2)n1	2-[4-[1-methyl-4-(2-methylanilino)pyrazolo[3,4-d]pyrimidin-6-yl]piperazin-1-yl]ethanol			-0.0953399999999988													MCULE-3878623032	367.4574		367.212058	7	2	5	4			43										False	Alkaloids				Peptide01			Compound(7162545)	7162545	2.0	649			[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#7]-[#6]1:[#6]2:[#6]:[#7]:[#7](-[#6]):[#6]:2:[#7]:[#6](-[#7]2-[#6]-[#6]-[#7](-[#6]-[#6]-[#8])-[#6]-[#6]-2):[#7]:1	Cc1ccccc1Nc1c2cnn(C)c2nc(N2CCN(CCO)CC2)n1	KOXUUBHWOZPUOW		parent_pubchem_cid	887213-16-3;2-(4-(1-methyl-4-(o-tolylamino)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)piperazin-1-yl)ethanol;2-[4-[1-methyl-4-(2-methylanilino)pyrazolo[3,4-d]pyrimidin-6-yl]piperazin-1-yl]ethanol;STK890931;AKOS002312677;CCG-330066;SR-01000019776;SR-01000019776-1;F2031-0505;2-(4-{1-METHYL-4-[(2-METHYLPHENYL)AMINO]-1H-PYRAZOLO[3,4-D]PYRIMIDIN-6-YL}PIPERAZIN-1-YL)ETHAN-1-OL;2-(4-{1-methyl-4-[(2-methylphenyl)amino]-1H-pyrazolo[3,4-d]pyrimidin-6-yl}piperazin-1-yl)ethanol		16969989.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=16969989		pluskal_iocb_peptide_Peptide01_D10_id		100	D10		ZINC000021928594
2.1		0	5	P2125460	75.6		Q1	False	0	13	0	0	17	0	1	4	0	0	-1.0	0.0						CC(C)(C)OC(=O)NC(C(=O)O)c1ccccc1		2.34		0.0	2.28	CHEMBL5022501																	0.0		Boc-Phg-OH	DTXSID30451804	2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	1	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C13H17NO4	C13H17NO4			InChI=1S/C13H17NO4/c1-13(2,3)18-12(17)14-10(11(15)16)9-7-5-4-6-8-9/h4-8,10H,1-3H3,(H,14,17)(H,15,16)/t10-/m0/s1	HOBFSNNENNQQIU-JTQLQIEISA-N	rac-(2S)-2-(tert-butoxycarbonylamino)-2-phenyl-acetic acid	11010409	CC(C)(C)OC(=O)N[C@H](C(=O)O)c1ccccc1	(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-2-phenylacetic acid			2.2822900000000006													MCULE-6719743124	251.28474	ACID	251.115758	4	2	5	1	1.0		27										False			False	False	Peptide01		-1.0	Compound(11010409)	11010409	2.2	650		SCHEMBL264362	[#6]-[#6](-[#6])(-[#6])-[#8]-[#6](=[#8])-[#7]-[#6@H](-[#6](=[#8])-[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	CC(C)(C)OC(=O)N[C@H](C(=O)O)c1ccccc1	HOBFSNNENNQQIU		parent_pubchem_cid	Boc-Phg-OH;2900-27-8;Boc-L-Phenylglycine;(S)-2-((tert-Butoxycarbonyl)amino)-2-phenylacetic acid;Boc-L-Phg-OH;(S)-BOC-L-PHENYLGLYCINE;(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-2-phenylacetic acid;N-(tert-Butoxycarbonyl)-L-2-phenylglycine;(S)-2-(tert-butoxycarbonylamino)-2-phenylacetic acid;Boc-L-alpha-phenylglycine;N-BOC-L-ALPHA-PHENYLGLYCINE;MFCD00065588;Boc-L-a-phenylglycine;N-Boc-L-phenyl glycine;N-Boc-L-2-phenylglycine;SCHEMBL264362;CHEMBL5022501;DTXSID30451804;HOBFSNNENNQQIU-JTQLQIEISA-N;(2S)-2-{[(tert-butoxy)carbonyl]amino}-2-phenylacetic acid;AKOS015924161;Boc-Phg-OH, >=99.0% (T);CS-W012629;HY-W011913;AS-12739;(S)-N-tert-butoxycarbonyl-2-phenylglycine;B3211;N-alpha-(t-Butyloxycarbonyl)-L-phenylglycine;EN300-30946;M03228;(S)-Tert-Butoxycarbonylamino-Phenyl-Acetic Acid;A819716;(S)-2-tert-butoxycarbonylamino-2-phenylacetic acid;J-017350;(s)-2-[(t-butoxycarbonyl)amino]-2-phenylacetic acid;(2s)-[(tert-butoxycarbonyl)amino](phenyl)ethanoic acid;Z317062680;rac-(2S)-2-(tert-butoxycarbonylamino)-2-phenyl-acetic acid	False	24037984.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24037984		pluskal_iocb_peptide_Peptide01_D10_id		100	D10	False	ZINC000002168269
4.2		0	93	P7111550027	80.4		Q2	False	0	20	2	0	18	0	2	4	0	0	-1.0	0.0						COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)COc1c(Cl)cc(Cl)cc1		3.75		0.0	3.87	CHEMBL1449116																	0.0		CHEMBL1449116		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C20H18Cl2N2O4	C20H18Cl2N2O4			InChI=1S/C20H18Cl2N2O4/c1-27-20(26)17(8-12-10-23-16-5-3-2-4-14(12)16)24-19(25)11-28-18-7-6-13(21)9-15(18)22/h2-7,9-10,17,23H,8,11H2,1H3,(H,24,25)	UOFFMXOFBLMMIF-UHFFFAOYSA-N	methyl 2-[[2-(2,4-dichlorophenoxy)acetyl]amino]-3-(1H-indol-3-yl)propanoate	3734903	COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)COc1c(Cl)cc(Cl)cc1	methyl 2-[[2-(2,4-dichlorophenoxy)acetyl]amino]-3-(1H-indol-3-yl)propanoate			2.808460000000001													MCULE-1008259303	421.28346	NEUTRAL	420.064362	4	2	8	3	0.0		30									Dipeptides	False	Shikimates and Phenylpropanoids	Small peptides	False	False	Peptide01		-1.0	Compound(3734903)	3734903	4.4	651			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#6](=[#8])-[#6]-[#8]-[#6]1:[#6](-[#17]):[#6]:[#6](-[#17]):[#6]:[#6]:1	COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)COc1c(Cl)cc(Cl)cc1	UOFFMXOFBLMMIF		parent_pubchem_cid	CHEMBL1449116;HMS1797L22;AKOS001656512;AKOS016312424;NCGC00099124-01;METHYL 2-[2-(2,4-DICHLOROPHENOXY)ACETAMIDO]-3-(1H-INDOL-3-YL)PROPANOATE;methyl 2-[[2-(2,4-dichlorophenoxy)acetyl]amino]-3-(1H-indol-3-yl)propanoate	False	688671.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=688671		pluskal_iocb_peptide_Peptide01_D10_id		100	D10	False	
4.6		0	181	P7020350948	70.9		Q3	False	0	21	0	0	18	0	2	3	0	0		0.0						O=C(O)c1ccccc1NN=Cc1ccccc1OCc1ccccc1																							0.0		MFCD02245998		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C21H18N2O3	C21H18N2O3			InChI=1S/C21H18N2O3/c24-21(25)18-11-5-6-12-19(18)23-22-14-17-10-4-7-13-20(17)26-15-16-8-2-1-3-9-16/h1-14,23H,15H2,(H,24,25)/b22-14+	LUBOSQIBAGDMFD-HYARGMPZSA-N	2-[(2E)-2-[(2-benzyloxyphenyl)methylene]hydrazino]benzoic acid	22694071	O=C(O)c1ccccc1N/N=C/c1ccccc1OCc1ccccc1	2-[(2E)-2-[(2-phenylmethoxyphenyl)methylidene]hydrazinyl]benzoic acid			3.402650000000002														346.38921		346.131742	5	2	7	3			45									Chalcones	False	Shikimates and Phenylpropanoids	Flavonoids			Peptide01			Compound(22694071)	22694071	5.1	652			[#8]=[#6](-[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#7]/[#7]=[#6]/[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	O=C(O)c1ccccc1N/N=C/c1ccccc1OCc1ccccc1	LUBOSQIBAGDMFD		parent_pubchem_cid	MFCD02245998;AKOS016370761;2-[(2E)-2-[(2-benzyloxyphenyl)methylene]hydrazino]benzoic acid		24329679.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24329679		pluskal_iocb_peptide_Peptide01_D10_id		100	D10		ZINC000011903689
4.1		0	269	P7119880252	32.7		Q4	False	0	19	0	0	29	0	1	2	0	0		0.0						C=CCc1ccccc1OCC(O)CN1C(C)CCCC1C																							0.0		1-(2,6-dimethylpiperidyl)-3-(2-prop-2-enylphenoxy)propan-2-ol		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1		C19H29NO2	C19H29NO2			InChI=1S/C19H29NO2/c1-4-8-17-11-5-6-12-19(17)22-14-18(21)13-20-15(2)9-7-10-16(20)3/h4-6,11-12,15-16,18,21H,1,7-10,13-14H2,2-3H3	WKGNRPVVXGGWCM-UHFFFAOYSA-N	1-(2-allylphenoxy)-3-(2,6-dimethyl-1-piperidyl)propan-2-ol	2770392	C=CCc1ccccc1OCC(O)CN1C(C)CCCC1C	1-(2,6-dimethylpiperidin-1-yl)-3-(2-prop-2-enylphenoxy)propan-2-ol			2.900580000000001													MCULE-9060868596	303.44848		303.219829	3	1	7	2			45									Piperidine alkaloids	False	Alkaloids	Lysine alkaloids			Peptide01			Compound(2770392)	2770392	4.5	653			[#6]=[#6]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#8]-[#6]-[#6](-[#8])-[#6]-[#7]1-[#6](-[#6])-[#6]-[#6]-[#6]-[#6]-1-[#6]	C=CCc1ccccc1OCC(O)CN1C(C)CCCC1C	WKGNRPVVXGGWCM		parent_pubchem_cid	1-(2,6-dimethylpiperidyl)-3-(2-prop-2-enylphenoxy)propan-2-ol;110808-03-2;Oprea1_352642;Oprea1_704072;STK547644;AKOS000581080;AKOS016287410;EU-0039713;1-(2,6-dimethylpiperidin-1-yl)-3-[2-(prop-2-en-1-yl)phenoxy]propan-2-ol;1-(2-allylphenoxy)-3-(2,6-dimethyl-1-piperidyl)propan-2-ol		23817519.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23817519		pluskal_iocb_peptide_Peptide01_D10_id		100	D10		
4.3		0	13	P7020664170	55.8		Q5	False	0	19	0	0	22	0	0	4	0	0		0.0						COc1c(OCCCc2ccccc2)cc(CCC(=O)O)cc1																							0.0		MFCD09707091		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C19H22O4	C19H22O4			InChI=1S/C19H22O4/c1-22-17-11-9-16(10-12-19(20)21)14-18(17)23-13-5-8-15-6-3-2-4-7-15/h2-4,6-7,9,11,14H,5,8,10,12-13H2,1H3,(H,20,21)	UMKOCBBZVRFCDQ-UHFFFAOYSA-N	3-[4-methoxy-3-(3-phenylpropoxy)phenyl]propanoic acid	20987608	COc1c(OCCCc2ccccc2)cc(CCC(=O)O)cc1	3-[4-methoxy-3-(3-phenylpropoxy)phenyl]propanoic acid			2.6897600000000006													MCULE-2825368335	314.38479		314.151809	4	1	9	2			43										False	Shikimates and Phenylpropanoids				Peptide01			Compound(20987608)	20987608	3.9	654			[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]-[#6]-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6]:[#6](-[#6]-[#6]-[#6](=[#8])-[#8]):[#6]:[#6]:1	COc1c(OCCCc2ccccc2)cc(CCC(=O)O)cc1	UMKOCBBZVRFCDQ		parent_pubchem_cid	MFCD09707091;STL451235;AKOS016384929;3-[4-methoxy-3-(3-phenylpropoxy)phenyl]propanoic acid		51533058.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=51533058		pluskal_iocb_peptide_Peptide01_D10_id		100	D10		ZINC000011994039
3.7		0	101	P7210750026	92.8		Q6	False	0	25	0	0	28	0	2	5	0	0		0.0						CCOC(=O)C(CC(C)C)NC(=O)C(Cc1ccccc1)N1C(=O)c2ccccc2C1=O																							0.0		CBMicro_003803		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	2	0	0	0	0	0	0	0	0	4	0	0	0	0	0	0	1	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	2	0		C25H28N2O5	C25H28N2O5			InChI=1S/C25H28N2O5/c1-4-32-25(31)20(14-16(2)3)26-22(28)21(15-17-10-6-5-7-11-17)27-23(29)18-12-8-9-13-19(18)24(27)30/h5-13,16,20-21H,4,14-15H2,1-3H3,(H,26,28)	MICRODNJZKNSMX-UHFFFAOYSA-N	ethyl 2-[[2-(1,3-dioxoisoindolin-2-yl)-3-phenyl-propanoyl]amino]-4-methyl-pentanoate	5220793	CCOC(=O)C(CC(C)C)NC(=O)C(Cc1ccccc1)N1C(=O)c2ccccc2C1=O	ethyl 2-[[2-(1,3-dioxoisoindol-2-yl)-3-phenylpropanoyl]amino]-4-methylpentanoate			2.823770000000001													MCULE-6869597542	436.51231		436.199822	5	1	10	3			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(5220793)	5220793	4.2	655			[#6]-[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]1-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6]-1=[#8]	CCOC(=O)C(CC(C)C)NC(=O)C(Cc1ccccc1)N1C(=O)c2ccccc2C1=O	MICRODNJZKNSMX		parent_pubchem_cid	CBMicro_003803;SMSF0019108;AKOS002378950;CB05598;BIM-0003584.P001;SR-01000231336;SR-01000231336-1;ETHYL 2-{[2-(1,3-DIOXO-1,3-DIHYDRO-2H-ISOINDOL-2-YL)-3-PHENYLPROPANOYL]AMINO}-4-METHYLPENTANOATE;ethyl 2-[[2-(1,3-dioxoisoindolin-2-yl)-3-phenyl-propanoyl]amino]-4-methyl-pentanoate		22995802.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22995802		pluskal_iocb_peptide_Peptide01_D10_id		100	D10		
4.8		0	189	P7014751240	101.6		Q7	False	0	21	0	0	17	0	3	3	0	1		0.0						COC(=O)c1c(C)c2c(Nc3ccc(Oc4ccccc4)cc3)ncnc2s1																							0.0		AKOS002253250		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C21H17N3O3S	C21H17N3O3S			InChI=1S/C21H17N3O3S/c1-13-17-19(22-12-23-20(17)28-18(13)21(25)26-2)24-14-8-10-16(11-9-14)27-15-6-4-3-5-7-15/h3-12H,1-2H3,(H,22,23,24)	KOVKWTFYWXJUNN-UHFFFAOYSA-N	methyl 5-methyl-4-(4-phenoxyanilino)thieno[2,3-d]pyrimidine-6-carboxylate	7453530	COC(=O)c1c(C)c2c(Nc3ccc(Oc4ccccc4)cc3)ncnc2s1	methyl 5-methyl-4-(4-phenoxyanilino)thieno[2,3-d]pyrimidine-6-carboxylate			3.098340000000001													MCULE-4703078859	391.45194		391.099062	6	1	6	4			44										False	Alkaloids				Peptide01			Compound(7453530)	7453530	5.5	656			[#6]-[#8]-[#6](=[#8])-[#6]1:[#6](-[#6]):[#6]2:[#6](-[#7]-[#6]3:[#6]:[#6]:[#6](-[#8]-[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]:4):[#6]:[#6]:3):[#7]:[#6]:[#7]:[#6]:2:[#16]:1	COC(=O)c1c(C)c2c(Nc3ccc(Oc4ccccc4)cc3)ncnc2s1	KOVKWTFYWXJUNN		parent_pubchem_cid	AKOS002253250;methyl 5-methyl-4-(4-phenoxyanilino)thieno[2,3-d]pyrimidine-6-carboxylate		16037036.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=16037036		pluskal_iocb_peptide_Peptide01_D11_id		100	D11		ZINC000005008972
4.1		0	277	P1584410	75.2		Q8	False	0	19	2	1	17	0	6	1	0	0		0.0						Fc1c(Cl)cc(Nc2nc(N3CCOCC3)nc(Nc3cc(Cl)ccc3)n2)cc1																							0.0		898630-60-9		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1		C19H17Cl2FN6O	C19H17Cl2FN6O			InChI=1S/C19H17Cl2FN6O/c20-12-2-1-3-13(10-12)23-17-25-18(24-14-4-5-16(22)15(21)11-14)27-19(26-17)28-6-8-29-9-7-28/h1-5,10-11H,6-9H2,(H2,23,24,25,26,27)	UEKRAIRTUUNEFR-UHFFFAOYSA-N	N2-(3-chloro-4-fluoro-phenyl)-N4-(3-chlorophenyl)-6-morpholino-1,3,5-triazine-2,4-diamine	18580163	Fc1c(Cl)cc(Nc2nc(N3CCOCC3)nc(Nc3cc(Cl)ccc3)n2)cc1	2-N-(3-chloro-4-fluorophenyl)-4-N-(3-chlorophenyl)-6-morpholin-4-yl-1,3,5-triazine-2,4-diamine			2.7382500000000007													MCULE-2821686791	435.29134		434.082493	7	2	5	4			44										False	Alkaloids				Peptide01			Compound(18580163)	18580163	5.2	657			[#9]-[#6]1:[#6](-[#17]):[#6]:[#6](-[#7]-[#6]2:[#7]:[#6](-[#7]3-[#6]-[#6]-[#8]-[#6]-[#6]-3):[#7]:[#6](-[#7]-[#6]3:[#6]:[#6](-[#17]):[#6]:[#6]:[#6]:3):[#7]:2):[#6]:[#6]:1	Fc1c(Cl)cc(Nc2nc(N3CCOCC3)nc(Nc3cc(Cl)ccc3)n2)cc1	UEKRAIRTUUNEFR		parent_pubchem_cid	898630-60-9;N2-(3-CHLORO-4-FLUOROPHENYL)-N4-(3-CHLOROPHENYL)-6-(MORPHOLIN-4-YL)-1,3,5-TRIAZINE-2,4-DIAMINE;C19H17Cl2FN6O;AKOS016397648;F2703-0288;N2-(3-chloro-4-fluorophenyl)-N4-(3-chlorophenyl)-6-morpholino-1,3,5-triazine-2,4-diamine;2-N-(3-chloro-4-fluorophenyl)-4-N-(3-chlorophenyl)-6-morpholin-4-yl-1,3,5-triazine-2,4-diamine;N2-(3-chloro-4-fluoro-phenyl)-N4-(3-chlorophenyl)-6-morpholino-1,3,5-triazine-2,4-diamine		5048409.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=5048409		pluskal_iocb_peptide_Peptide01_D11_id		100	D11		ZINC000009762062
2.6		0	21	P3460175	89.0	2 HCl	Q9	False	0	21	0	0	30	0	2	4	0	0		0.0						COc1c(OC)cc(Cc2cc(OC)c(OC)cc2CCN)c(CCN)c1																							0.0		MFCD13967167		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0		C21H32Cl2N2O4	C21H30N2O4			InChI=1S/C21H30N2O4/c1-24-18-10-14(5-7-22)16(12-20(18)26-3)9-17-13-21(27-4)19(25-2)11-15(17)6-8-23/h10-13H,5-9,22-23H2,1-4H3	XCYTZOCEXQDONL-UHFFFAOYSA-N	2-[2-[[2-(2-aminoethyl)-4,5-dimethoxy-phenyl]methyl]-4,5-dimethoxy-phenyl]ethanamine;dihydrochloride	37912166	COc1c(OC)cc(Cc2cc(OC)c(OC)cc2CCN)c(CCN)c1	2-[2-[[2-(2-aminoethyl)-4,5-dimethoxyphenyl]methyl]-4,5-dimethoxyphenyl]ethanamine			0.2457200000000031													MCULE-2546496867	447.40619		374.220557	6	2	10	2			43									Phenylethylamines	False	Alkaloids	Tyrosine alkaloids			Peptide01			Compound(37912166)	37912166	2.4	658			[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]):[#6]:[#6](-[#6]-[#6]2:[#6]:[#6](-[#8]-[#6]):[#6](-[#8]-[#6]):[#6]:[#6]:2-[#6]-[#6]-[#7]):[#6](-[#6]-[#6]-[#7]):[#6]:1	COc1c(OC)cc(Cc2cc(OC)c(OC)cc2CCN)c(CCN)c1	XCYTZOCEXQDONL		parent_pubchem_cid	"MFCD13967167;STL484231;AKOS021648932;2,2'-[methanediylbis(4,5-dimethoxybenzene-2,1-diyl)]diethanamine;""2-[2-[[2-(2-aminoethyl)-4,5-dimethoxy-phenyl]methyl]-4,5-dimethoxy-phenyl]ethanamine;dihydrochloride"""		23606139.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23606139		pluskal_iocb_peptide_Peptide01_D11_id		100	D11		ZINC000030769045
2.8		0	109	P0120630209	66.4		Q10	False	0	16	0	1	14	0	1	3	0	0		0.0						O=C(NC(Cc1ccccc1)C(=O)O)c1ccc(F)cc1																							0.0		2-[(4-fluorophenyl)formamido]-3-phenylpropanoic acid		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C16H14FNO3	C16H14FNO3			InChI=1S/C16H14FNO3/c17-13-8-6-12(7-9-13)15(19)18-14(16(20)21)10-11-4-2-1-3-5-11/h1-9,14H,10H2,(H,18,19)(H,20,21)	ATEOULBATLXMHD-UHFFFAOYSA-N	2-[(4-fluorobenzoyl)amino]-3-phenyl-propanoic acid	4129338	O=C(NC(Cc1ccccc1)C(=O)O)c1ccc(F)cc1	2-[(4-fluorobenzoyl)amino]-3-phenylpropanoic acid			2.14198													MCULE-3756968149	287.29328		287.095772	3	2	5	2			44									Dipeptides	False	Amino acids and Peptides;Shikimates and Phenylpropanoids	Small peptides			Peptide01			Compound(4129338)	4129338	2.9	659		SCHEMBL2975803	[#8]=[#6](-[#7]-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8])-[#6]1:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:1	O=C(NC(Cc1ccccc1)C(=O)O)c1ccc(F)cc1	ATEOULBATLXMHD		parent_pubchem_cid	2-[(4-fluorophenyl)formamido]-3-phenylpropanoic acid;92010-72-5;2-[(4-fluorobenzoyl)amino]-3-phenylpropanoic acid;Oprea1_359856;SCHEMBL2975803;AKOS000134327;AKOS016044990;Z85881018;2-[(4-fluorobenzoyl)amino]-3-phenyl-propanoic acid		23870072.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23870072		pluskal_iocb_peptide_Peptide01_D11_id		100	D11		
3.8		0	197	P1113404	83.1		Q11	False	0	24	0	0	21	0	3	1	0	1		0.0						O=C(NCCc1csc(-c2cnccc2)n1)C(c1ccccc1)c1ccccc1								Phenylacetamides;2,4-disubstituted thiazoles;Pyridines and derivatives;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	2,4-disubstituted thiazoles;Azacyclic compounds;Azoles;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Diphenylmethanes;Heteroaromatic compounds;Hydrocarbon derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenylacetamides;Pyridines and derivatives;Secondary carboxylic acid amides;Thiazoles	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as diphenylmethanes. These are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups.	Diphenylmethanes			Organic compounds	Aromatic heteromonocyclic compounds	acetamides (CHEBI:22160);thiazoles (CHEBI:48901);pyridines (CHEBI:26421);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);diarylmethane (CHEBI:51614);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);organic heterocyclic compound (CHEBI:24532);azole (CHEBI:68452);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);organooxygen compound (CHEBI:36963);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806)		Diphenylmethanes	Diphenylmethane;Phenylacetamide;2,4-disubstituted 1,3-thiazole;Pyridine;Azole;Heteroaromatic compound;Thiazole;Carboxamide group;Secondary carboxylic acid amide;Carboxylic acid derivative;Azacycle;Organoheterocyclic compound;Hydrocarbon derivative;Organooxygen compound;Organonitrogen compound;Organic oxide;Organic nitrogen compound;Carbonyl group;Organic oxygen compound;Aromatic heteromonocyclic compound	Benzenoids	0.0		AKOS005584886		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C24H21N3OS	C24H21N3OS			InChI=1S/C24H21N3OS/c28-23(22(18-8-3-1-4-9-18)19-10-5-2-6-11-19)26-15-13-21-17-29-24(27-21)20-12-7-14-25-16-20/h1-12,14,16-17,22H,13,15H2,(H,26,28)	YZIPZLYLZBPJEU-UHFFFAOYSA-N	2,2-diphenyl-N-[2-[2-(3-pyridyl)thiazol-4-yl]ethyl]acetamide	28466472	O=C(NCCc1csc(-c2cnccc2)n1)C(c1ccccc1)c1ccccc1	2,2-diphenyl-N-[2-(2-pyridin-3-yl-1,3-thiazol-4-yl)ethyl]acetamide			4.151750000000003													MCULE-3269364381	399.51847		399.140533	3	1	7	4			44									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(28466472)	28466472	4.4	660			[#8]=[#6](-[#7]-[#6]-[#6]-[#6]1:[#6]:[#16]:[#6](-[#6]2:[#6]:[#7]:[#6]:[#6]:[#6]:2):[#7]:1)-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	O=C(NCCc1csc(-c2cnccc2)n1)C(c1ccccc1)c1ccccc1	YZIPZLYLZBPJEU		parent_pubchem_cid	AKOS005584886;2,2-diphenyl-N-(2-(2-(pyridin-3-yl)thiazol-4-yl)ethyl)acetamide;2,2-diphenyl-N-[2-[2-(3-pyridyl)thiazol-4-yl]ethyl]acetamide		11577262.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=11577262		pluskal_iocb_peptide_Peptide01_D11_id		100	D11		ZINC000019942443
2.5		0	285	P7126274	124.4		Q12	False	0	19	0	0	16	0	4	4	0	0		0.0						Cc1cc(Nc2ccccc2C(=O)O)nc(Nc2cccc(C(=O)O)c2)n1																							0.0		AKOS024459043		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	2	2	0	0	0	0	0	0	0	0	0	0	1	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0		C19H16N4O4	C19H16N4O4			InChI=1S/C19H16N4O4/c1-11-9-16(22-15-8-3-2-7-14(15)18(26)27)23-19(20-11)21-13-6-4-5-12(10-13)17(24)25/h2-10H,1H3,(H,24,25)(H,26,27)(H2,20,21,22,23)	KSMTVFGHZLZWLD-UHFFFAOYSA-N	2-[[2-(3-carboxyanilino)-6-methyl-pyrimidin-4-yl]amino]benzoic acid	90489135	Cc1cc(Nc2ccccc2C(=O)O)nc(Nc2cccc(C(=O)O)c2)n1	2-[[2-(3-carboxyanilino)-6-methylpyrimidin-4-yl]amino]benzoic acid			1.98205													MCULE-4500574361	364.36377		364.117155	8	4	6	3			44									Anthranillic acid derivatives	False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(90489135)	90489135	4.0	661			[#6]-[#6]1:[#6]:[#6](-[#7]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6](=[#8])-[#8]):[#7]:[#6](-[#7]-[#6]2:[#6]:[#6]:[#6]:[#6](-[#6](=[#8])-[#8]):[#6]:2):[#7]:1	Cc1cc(Nc2ccccc2C(=O)O)nc(Nc2cccc(C(=O)O)c2)n1	KSMTVFGHZLZWLD		parent_pubchem_cid	AKOS024459043;2-[[2-(3-carboxyanilino)-6-methyl-pyrimidin-4-yl]amino]benzoic acid		99993856.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=99993856		pluskal_iocb_peptide_Peptide01_D11_id		100	D11		ZINC000170621824
4.7		0	29	P7117310037	158.9		Q13	False	0	22	0	0	18	0	4	4	0	2		0.0						COC(=O)Nc1c(-c2ccccc2)nc(-c2nc(-c3ccccc3)c(NC(=O)OC)s2)s1																							0.0		Oprea1_655863		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	2	2	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C22H18N4O4S2	C22H18N4O4S2			InChI=1S/C22H18N4O4S2/c1-29-21(27)25-17-15(13-9-5-3-6-10-13)23-19(31-17)20-24-16(14-11-7-4-8-12-14)18(32-20)26-22(28)30-2/h3-12H,1-2H3,(H,25,27)(H,26,28)	XFPQZAZPQGKJOI-UHFFFAOYSA-N	methyl N-[2-[5-(methoxycarbonylamino)-4-phenyl-thiazol-2-yl]-4-phenyl-thiazol-5-yl]carbamate	1583606	COC(=O)Nc1c(-c2ccccc2)nc(-c2nc(-c3ccccc3)c(NC(=O)OC)s2)s1	methyl N-[2-[5-(methoxycarbonylamino)-4-phenyl-1,3-thiazol-2-yl]-4-phenyl-1,3-thiazol-5-yl]carbamate			4.055920000000002													MCULE-9802448878	466.54116		466.076947	6	2	7	4			44										False	Alkaloids				Peptide01			Compound(1583606)	1583606	4.8	662			[#6]-[#8]-[#6](=[#8])-[#7]-[#6]1:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#7]:[#6](-[#6]2:[#7]:[#6](-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#6](-[#7]-[#6](=[#8])-[#8]-[#6]):[#16]:2):[#16]:1	COC(=O)Nc1c(-c2ccccc2)nc(-c2nc(-c3ccccc3)c(NC(=O)OC)s2)s1	XFPQZAZPQGKJOI		parent_pubchem_cid	Oprea1_655863;AKOS002386095;methyl N-(2-{5-[(methoxycarbonyl)amino]-4-phenyl-1,3-thiazol-2-yl}-4-phenyl-1,3-thiazol-5-yl)carbamate;methyl N-[2-[5-(methoxycarbonylamino)-4-phenyl-thiazol-2-yl]-4-phenyl-thiazol-5-yl]carbamate		15451966.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=15451966		pluskal_iocb_peptide_Peptide01_D11_id		100	D11		ZINC000001797357
3.3		0	117	P1108731	107.6		Q14	False	1	17	0	0	15	0	2	4	0	1		0.0						O=C(O)C(Cc1c[nH]c2ccccc12)NS(=O)(=O)c1ccc(Br)cc1																							0.0		Oprea1_805305		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0		C17H15BrN2O4S	C17H15BrN2O4S			InChI=1S/C17H15BrN2O4S/c18-12-5-7-13(8-6-12)25(23,24)20-16(17(21)22)9-11-10-19-15-4-2-1-3-14(11)15/h1-8,10,16,19-20H,9H2,(H,21,22)/t16-/m0/s1	BFYSIYWEMZAFCB-INIZCTEOSA-N	rac-(2S)-2-[(4-bromophenyl)sulfonylamino]-3-(1H-indol-3-yl)propanoic acid	1150308	O=C(O)[C@H](Cc1c[nH]c2ccccc12)NS(=O)(=O)c1ccc(Br)cc1	(2S)-2-[(4-bromophenyl)sulfonylamino]-3-(1H-indol-3-yl)propanoic acid			2.31346													MCULE-2895184073	423.2881		421.99359	4	3	6	3			43										False	Shikimates and Phenylpropanoids				Peptide01			Compound(1150308)	1150308	2.6	663		SCHEMBL22500283	[#8]=[#6](-[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#16](=[#8])(=[#8])-[#6]1:[#6]:[#6]:[#6](-[#35]):[#6]:[#6]:1	O=C(O)[C@H](Cc1c[nH]c2ccccc12)NS(=O)(=O)c1ccc(Br)cc1	BFYSIYWEMZAFCB		parent_pubchem_cid	Oprea1_805305;SCHEMBL22500283;STK921499;AKOS016402493;N-[(4-bromophenyl)sulfonyl]-L-tryptophan;2-(4-BROMOBENZENESULFONAMIDO)-3-(1H-INDOL-3-YL)PROPANOIC ACID;rac-(2S)-2-[(4-bromophenyl)sulfonylamino]-3-(1H-indol-3-yl)propanoic acid		53085113.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=53085113		pluskal_iocb_peptide_Peptide01_D11_id		100	D11		ZINC000000896684
2.2		0	205	P0108610020	112.4	HCl	Q15	False	0	18	0	0	15	0	3	4	0	0		0.0						O=C(O)CC(Nc1nc(-c2ccccc2)nc2ccccc12)C(=O)O																							0.0		ChemDiv1_004230		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C18H16ClN3O4	C18H15N3O4			InChI=1S/C18H15N3O4/c22-15(23)10-14(18(24)25)20-17-12-8-4-5-9-13(12)19-16(21-17)11-6-2-1-3-7-11/h1-9,14H,10H2,(H,22,23)(H,24,25)(H,19,20,21)	ICUYCGSTIAGCGT-UHFFFAOYSA-N	2-[(2-phenylquinazolin-4-yl)amino]butanedioic acid;hydrochloride	4053823	O=C(O)CC(Nc1nc(-c2ccccc2)nc2ccccc12)C(=O)O	2-[(2-phenylquinazolin-4-yl)amino]butanedioic acid			1.44755													MCULE-3599294893	373.79892		337.106256	7	3	6	3			44										False	Alkaloids				Peptide01			Compound(4053823)	4053823	3.5	664			[#8]=[#6](-[#8])-[#6]-[#6](-[#7]-[#6]1:[#7]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	O=C(O)CC(Nc1nc(-c2ccccc2)nc2ccccc12)C(=O)O	ICUYCGSTIAGCGT		parent_pubchem_cid	"ChemDiv1_004230;Oprea1_797800;HMS599A06;CCG-16891;STK962872;N-(2-phenylquinazolin-4-yl)aspartic acid;""2-[(2-phenylquinazolin-4-yl)amino]butanedioic acid;hydrochloride"""		61646750.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=61646750		pluskal_iocb_peptide_Peptide01_D12_id		100	D12		
4.2		0	293	P6543363	87.1		Q16	False	0	19	0	0	18	0	4	2	0	0		0.0						Cc1cc(C)cc(Nc2nccc(Nc3ccc(C(=O)O)cc3)n2)c1																							0.0		AKOS016760505		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0		C19H18N4O2	C19H18N4O2			InChI=1S/C19H18N4O2/c1-12-9-13(2)11-16(10-12)22-19-20-8-7-17(23-19)21-15-5-3-14(4-6-15)18(24)25/h3-11H,1-2H3,(H,24,25)(H2,20,21,22,23)	AUTPNIOBVYNBJF-UHFFFAOYSA-N	4-[[2-(3,5-dimethylanilino)pyrimidin-4-yl]amino]benzoic acid	84505946	Cc1cc(C)cc(Nc2nccc(Nc3ccc(C(=O)O)cc3)n2)c1	4-[[2-(3,5-dimethylanilino)pyrimidin-4-yl]amino]benzoic acid			2.59227													MCULE-4828674255	334.38091		334.142976	6	3	5	3			44									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(84505946)	84505946	4.2	665			[#6]-[#6]1:[#6]:[#6](-[#6]):[#6]:[#6](-[#7]-[#6]2:[#7]:[#6]:[#6]:[#6](-[#7]-[#6]3:[#6]:[#6]:[#6](-[#6](=[#8])-[#8]):[#6]:[#6]:3):[#7]:2):[#6]:1	Cc1cc(C)cc(Nc2nccc(Nc3ccc(C(=O)O)cc3)n2)c1	AUTPNIOBVYNBJF		parent_pubchem_cid	AKOS016760505;4-[[2-(3,5-dimethylanilino)pyrimidin-4-yl]amino]benzoic acid		89937981.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=89937981		pluskal_iocb_peptide_Peptide01_D12_id		100	D12		ZINC000096693796
4.8		0	37	P7114840950	83.2		Q17	False	0	26	0	0	27	0	7	0	0	0		0.0						Nc1cc(Nc2nc(N3CCCCC3)nc(N(c3ccccc3)c3ccccc3)n2)ccc1																							0.0		Oprea1_454885		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	2		C26H27N7	C26H27N7			InChI=1S/C26H27N7/c27-20-11-10-12-21(19-20)28-24-29-25(32-17-8-3-9-18-32)31-26(30-24)33(22-13-4-1-5-14-22)23-15-6-2-7-16-23/h1-2,4-7,10-16,19H,3,8-9,17-18,27H2,(H,28,29,30,31)	XQVPMQPAYNYUKO-UHFFFAOYSA-N	N4-(3-aminophenyl)-N2,N2-diphenyl-6-(1-piperidyl)-1,3,5-triazine-2,4-diamine	1582823	Nc1cc(Nc2nc(N3CCCCC3)nc(N(c3ccccc3)c3ccccc3)n2)ccc1	2-N-(3-aminophenyl)-4-N,4-N-diphenyl-6-piperidin-1-yl-1,3,5-triazine-2,4-diamine			2.9932300000000014													MCULE-8571250561	437.55199		437.232794	7	2	6	5			44										False	Alkaloids				Peptide01			Compound(1582823)	1582823	6.0	666			[#7]-[#6]1:[#6]:[#6](-[#7]-[#6]2:[#7]:[#6](-[#7]3-[#6]-[#6]-[#6]-[#6]-[#6]-3):[#7]:[#6](-[#7](-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3)-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#7]:2):[#6]:[#6]:[#6]:1	Nc1cc(Nc2nc(N3CCCCC3)nc(N(c3ccccc3)c3ccccc3)n2)ccc1	XQVPMQPAYNYUKO		parent_pubchem_cid	Oprea1_454885;AKOS001725808;2-N-(3-aminophenyl)-4-N,4-N-diphenyl-6-piperidin-1-yl-1,3,5-triazine-2,4-diamine;AS-871/13360368;SR-01000526838;SR-01000526838-1;N-[4-(3-aminoanilino)-6-piperidino-1,3,5-triazin-2-yl]-N,N-diphenylamine;N-[4-(3-aminoanilino)-6-(1-piperidinyl)-1,3,5-triazin-2-yl]-N,N-diphenylamine;N4-(3-AMINOPHENYL)-N2,N2-DIPHENYL-6-(PIPERIDIN-1-YL)-1,3,5-TRIAZINE-2,4-DIAMINE;N4-(3-aminophenyl)-N2,N2-diphenyl-6-(1-piperidyl)-1,3,5-triazine-2,4-diamine		18238349.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=18238349		pluskal_iocb_peptide_Peptide01_D12_id		100	D12		ZINC000001796023
4.4		0	125	P0103420058	80.4		Q18	False	0	22	1	0	23	0	2	4	0	0	-1.0	0.0						CCOC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)COc1cc(C)c(Cl)cc1		3.8		0.0	4.13	CHEMBL1513915																	0.0		CHEMBL1513915		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C22H23ClN2O4	C22H23ClN2O4			InChI=1S/C22H23ClN2O4/c1-3-28-22(27)20(11-15-12-24-19-7-5-4-6-17(15)19)25-21(26)13-29-16-8-9-18(23)14(2)10-16/h4-10,12,20,24H,3,11,13H2,1-2H3,(H,25,26)	UZLVUDITSQQQCS-UHFFFAOYSA-N	ethyl 2-[[2-(4-chloro-3-methyl-phenoxy)acetyl]amino]-3-(1H-indol-3-yl)propanoate	2787534	CCOC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)COc1cc(C)c(Cl)cc1	ethyl 2-[[2-(4-chloro-3-methylphenoxy)acetyl]amino]-3-(1H-indol-3-yl)propanoate			2.798870000000001													MCULE-5047200380	414.89261	NEUTRAL	414.134635	4	2	9	3	0.0		30									Dipeptides	False	Shikimates and Phenylpropanoids	Small peptides	False	False	Peptide01		-1.0	Compound(2787534)	2787534	4.5	667			[#6]-[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#6](=[#8])-[#6]-[#8]-[#6]1:[#6]:[#6](-[#6]):[#6](-[#17]):[#6]:[#6]:1	CCOC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)COc1cc(C)c(Cl)cc1	UZLVUDITSQQQCS		parent_pubchem_cid	CHEMBL1513915;HMS1795G08;AKOS001596524;AKOS016311826;NCGC00098208-01;ethyl 2-[[2-(4-chloro-3-methyl-phenoxy)acetyl]amino]-3-(1H-indol-3-yl)propanoate	False	709160.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=709160		pluskal_iocb_peptide_Peptide01_D12_id		100	D12	False	
3.7		0	213	P1098147	117.7		Q19	False	0	24	0	0	22	0	2	6	0	0		0.0						CCc1cc(=O)oc2c1ccc(OCC(=O)NC(Cc1c[nH]c3ccccc13)C(=O)O)c2																							0.0		EiM07-16825		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C24H22N2O6	C24H22N2O6			InChI=1S/C24H22N2O6/c1-2-14-10-23(28)32-21-11-16(7-8-18(14)21)31-13-22(27)26-20(24(29)30)9-15-12-25-19-6-4-3-5-17(15)19/h3-8,10-12,20,25H,2,9,13H2,1H3,(H,26,27)(H,29,30)/t20-/m0/s1	SPWALZPBOHMQGX-FQEVSTJZSA-N	rac-(2S)-2-[[2-(4-ethyl-2-oxo-chromen-7-yl)oxyacetyl]amino]-3-(1H-indol-3-yl)propanoic acid	1795346	CCc1cc(=O)oc2c1ccc(OCC(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)O)c2	(2S)-2-[[2-(4-ethyl-2-oxochromen-7-yl)oxyacetyl]amino]-3-(1H-indol-3-yl)propanoic acid			2.4988200000000003													MCULE-5372361956	434.45274		434.147786	6	3	8	4			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(1795346)	1795346	3.3	668			[#6]-[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:1:3)-[#6](=[#8])-[#8]):[#6]:2	CCc1cc(=O)oc2c1ccc(OCC(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)O)c2	SPWALZPBOHMQGX		parent_pubchem_cid	EiM07-16825;AKOS004937376;956044-15-8;(2-((4-ethyl-2-oxo-2H-chromen-7-yl)oxy)acetyl)-L-tryptophan;(2S)-2-({2-[(4-ETHYL-2-OXO-2H-CHROMEN-7-YL)OXY]ACETYL}AMINO)-3-(1H-INDOL-3-YL)PROPANOIC ACID;rac-(2S)-2-[[2-(4-ethyl-2-oxo-chromen-7-yl)oxyacetyl]amino]-3-(1H-indol-3-yl)propanoic acid		24302089.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24302089		pluskal_iocb_peptide_Peptide01_D12_id		100	D12		ZINC000002139647
1.9		0	301	P4798607	75.6		Q20	False	0	19	0	0	26	0	6	2	0	0		0.0						Cc1cc(Nc2nc(N3CCOCC3)nc(N3CCOCC3)n2)c(C)cc1																							0.0		AKOS016391340		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	2		C19H26N6O2	C19H26N6O2			InChI=1S/C19H26N6O2/c1-14-3-4-15(2)16(13-14)20-17-21-18(24-5-9-26-10-6-24)23-19(22-17)25-7-11-27-12-8-25/h3-4,13H,5-12H2,1-2H3,(H,20,21,22,23)	CQXLUOBEGPYZJL-UHFFFAOYSA-N	N-(2,5-dimethylphenyl)-4,6-dimorpholino-1,3,5-triazin-2-amine	7589322	Cc1cc(Nc2nc(N3CCOCC3)nc(N3CCOCC3)n2)c(C)cc1	N-(2,5-dimethylphenyl)-4,6-dimorpholin-4-yl-1,3,5-triazin-2-amine			0.2733800000000015													MCULE-5714378957	370.45807		370.211724	8	1	4	4			44										False	Alkaloids				Peptide01			Compound(7589322)	7589322	2.7	669			[#6]-[#6]1:[#6]:[#6](-[#7]-[#6]2:[#7]:[#6](-[#7]3-[#6]-[#6]-[#8]-[#6]-[#6]-3):[#7]:[#6](-[#7]3-[#6]-[#6]-[#8]-[#6]-[#6]-3):[#7]:2):[#6](-[#6]):[#6]:[#6]:1	Cc1cc(Nc2nc(N3CCOCC3)nc(N3CCOCC3)n2)c(C)cc1	CQXLUOBEGPYZJL		parent_pubchem_cid	AKOS016391340;N-(2,5-dimethylphenyl)-4,6-dimorpholino-1,3,5-triazin-2-amine		9643332.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=9643332		pluskal_iocb_peptide_Peptide01_D12_id		100	D12		ZINC000005255833
4.1		0	45	P7114890212	40.7		Q21	False	0	21	0	0	19	0	3	0	0	0		0.0						Cc1c(C(Nc2ccccc2)c2cnccc2)c2ccccc2[nH]1																							0.0		514186-37-9		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0		C21H19N3	C21H19N3			InChI=1S/C21H19N3/c1-15-20(18-11-5-6-12-19(18)23-15)21(16-8-7-13-22-14-16)24-17-9-3-2-4-10-17/h2-14,21,23-24H,1H3	MVCXIXUUVBTJDM-UHFFFAOYSA-N	N-[(2-methyl-1H-indol-3-yl)-(3-pyridyl)methyl]aniline	4119196	Cc1c(C(Nc2ccccc2)c2cnccc2)c2ccccc2[nH]1	N-[(2-methyl-1H-indol-3-yl)-pyridin-3-ylmethyl]aniline			4.099660000000002													MCULE-3532567273	313.40568		313.157898	2	2	4	4			45										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(4119196)	4119196	4.6	670			[#6]-[#6]1:[#6](-[#6](-[#7]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]2:[#6]:[#7]:[#6]:[#6]:[#6]:2):[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#7H]:1	Cc1c(C(Nc2ccccc2)c2cnccc2)c2ccccc2[nH]1	MVCXIXUUVBTJDM		parent_pubchem_cid	514186-37-9;N-[(2-methyl-1H-indol-3-yl)(pyridin-3-yl)methyl]aniline;N-((2-methyl-1H-indol-3-yl)(pyridin-3-yl)methyl)aniline;F1310-0266;N-[(2-methyl-1H-indol-3-yl)-pyridin-3-ylmethyl]aniline;STK964199;AKOS000806564;AKOS016055475;Z56971124;N-[(2-methyl-1H-indol-3-yl)-(3-pyridyl)methyl]aniline		22827823.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22827823		pluskal_iocb_peptide_Peptide01_D12_id		100	D12		
4.2		0	133	P0103040320	117.7		Q22	False	0	28	0	0	22	0	2	6	0	0	-1.0	0.0						O=C(COc1cc2c(cc1)c(-c1ccccc1)cc(=O)o2)NC(Cc1c[nH]c2ccccc12)C(=O)O		4.13		0.0	3.76	CHEMBL1716074		N-acyl-alpha amino acids;Coumarins and derivatives;1-benzopyrans;3-alkylindoles;Pyranones and derivatives;Alkyl aryl ethers;Substituted pyrroles;Benzene and substituted derivatives;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactones;Oxacyclic compounds;Monocarboxylic acids and derivatives;Azacyclic compounds;Carboxylic acids;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organonitrogen compounds;Organopnictogen compounds	1-benzopyrans;3-alkylindoles;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Lactones;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Neoflavones;Neoflavonoids;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Neoflavonoids	2.1	This compound belongs to the class of organic compounds known as neoflavones. These are neoflavonoids with a structure based on the 4-phenylcoumarin skeleton.	Neoflavones			Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-amino acid (CHEBI:51569);coumarins (CHEBI:23403);1-benzopyran (CHEBI:38443);indoles (CHEBI:24828);pyranone (CHEBI:37963);aromatic ether (CHEBI:35618);pyrroles (CHEBI:26455);benzenes (CHEBI:22712);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactone (CHEBI:25000);oxacycle (CHEBI:38104);carbonyl compound (CHEBI:36586);organonitrogen heterocyclic compound (CHEBI:38101);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);neoflavonoid (CHEBI:71971);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);amino acid (CHEBI:33709);peptide (CHEBI:16670);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);pyrans (CHEBI:26407);oxygen molecular entity (CHEBI:25806);ether (CHEBI:25698);benzenoid aromatic compound (CHEBI:33836);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)	Benzopyranoids (PK1311);Neoflavonoids (PK1210)	Neoflavones	4-phenylcoumarin;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;Coumarin;Alpha-amino acid or derivatives;Benzopyran;3-alkylindole;1-benzopyran;Indole;Indole or derivatives;Alkyl aryl ether;Pyranone;Monocyclic benzene moiety;Benzenoid;Pyran;Substituted pyrrole;Pyrrole;Heteroaromatic compound;Secondary carboxylic acid amide;Carboxamide group;Lactone;Carboxylic acid derivative;Carboxylic acid;Ether;Organoheterocyclic compound;Azacycle;Monocarboxylic acid or derivatives;Oxacycle;Organic oxygen compound;Organic nitrogen compound;Organic oxide;Organooxygen compound;Hydrocarbon derivative;Organopnictogen compound;Carbonyl group;Organonitrogen compound;Aromatic heteropolycyclic compound	Phenylpropanoids and polyketides	0.0		Oprea1_641199		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C28H22N2O6	C28H22N2O6			InChI=1S/C28H22N2O6/c31-26(30-24(28(33)34)12-18-15-29-23-9-5-4-8-20(18)23)16-35-19-10-11-21-22(17-6-2-1-3-7-17)14-27(32)36-25(21)13-19/h1-11,13-15,24,29H,12,16H2,(H,30,31)(H,33,34)	AUVNQHSNKVZPBG-UHFFFAOYSA-N	3-(1H-indol-3-yl)-2-[[2-(2-oxo-4-phenyl-chromen-7-yl)oxyacetyl]amino]propanoic acid	3622216	O=C(COc1cc2c(cc1)c(-c1ccccc1)cc(=O)o2)NC(Cc1c[nH]c2ccccc12)C(=O)O	3-(1H-indol-3-yl)-2-[[2-(2-oxo-4-phenylchromen-7-yl)oxyacetyl]amino]propanoic acid			3.2781100000000007													MCULE-5099168685	482.49734	ACID	482.147786	6	3	8	5	1.0		30										False	Shikimates and Phenylpropanoids		False	False	Peptide01		-1.0	Compound(3622216)	3622216	4.1	671			[#8]=[#6](-[#6]-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1):[#6]:[#6](=[#8]):[#8]:2)-[#7]-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	O=C(COc1cc2c(cc1)c(-c1ccccc1)cc(=O)o2)NC(Cc1c[nH]c2ccccc12)C(=O)O	AUVNQHSNKVZPBG		parent_pubchem_cid	Oprea1_641199;MLS002253007;CHEMBL1716074;HMS3090G05;AKOS002345309;SMR001315337;Z24126177;3-(1H-indol-3-yl)-2-[[2-(2-oxo-4-phenyl-chromen-7-yl)oxyacetyl]amino]propanoic acid	False	1028884.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=1028884		pluskal_iocb_peptide_Peptide01_D12_id		100	D12	False	
3.9		0	221	P1108202	138.0		Q23	False	0	25	0	0	24	0	2	7	0	0		0.0						CCc1cc(=O)oc2c1ccc(OCC(=O)NC(Cc1c[nH]c3c1cc(O)cc3)C(=O)O)c2C								N-acyl-alpha amino acids;Indolyl carboxylic acids and derivatives;Coumarins and derivatives;1-benzopyrans;Hydroxyindoles;3-alkylindoles;Phenol ethers;Pyranones and derivatives;Alkyl aryl ethers;1-hydroxy-2-unsubstituted benzenoids;Substituted pyrroles;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactones;Monocarboxylic acids and derivatives;Carboxylic acids;Oxacyclic compounds;Azacyclic compounds;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organonitrogen compounds	1-benzopyrans;1-hydroxy-2-unsubstituted benzenoids;3-alkylindoles;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Hydroxyindoles;Indoles;Indoles and derivatives;Indolyl carboxylic acids and derivatives;Lactones;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;N-acylserotonins;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenol ethers;Phenols;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Pyrroles;Secondary carboxylic acid amides;Serotonins;Substituted pyrroles;Tryptamines and derivatives	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acylserotonins. These are aromatic heterocyclic compounds containing a serotonin, in which the amine group is acylated.	N-acylserotonins		Serotonins	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-amino acid (CHEBI:51569);indolyl carboxylic acid (CHEBI:46867);coumarins (CHEBI:23403);1-benzopyran (CHEBI:38443);hydroxyindoles (CHEBI:84729);indoles (CHEBI:24828);aromatic ether (CHEBI:35618);pyranone (CHEBI:37963);phenols (CHEBI:33853);pyrroles (CHEBI:26455);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactone (CHEBI:25000);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);oxacycle (CHEBI:38104);organonitrogen heterocyclic compound (CHEBI:38101);carbonyl compound (CHEBI:36586);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);benzenoid aromatic compound (CHEBI:33836);pyrans (CHEBI:26407);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ether (CHEBI:25698);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);tryptamines (CHEBI:27162);carboxylic acid anion (CHEBI:29067);amino acid (CHEBI:33709);peptide (CHEBI:16670)	Benzopyranoids (PK1311)	Tryptamines and derivatives	N-acylserotonin;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;Indolyl carboxylic acid derivative;Coumarin;Alpha-amino acid or derivatives;1-benzopyran;3-alkylindole;Benzopyran;Hydroxyindole;Indole;Phenol ether;1-hydroxy-2-unsubstituted benzenoid;Pyranone;Phenol;Alkyl aryl ether;Benzenoid;Substituted pyrrole;Pyran;Pyrrole;Heteroaromatic compound;Lactone;Secondary carboxylic acid amide;Carboxamide group;Carboxylic acid derivative;Carboxylic acid;Oxacycle;Ether;Azacycle;Monocarboxylic acid or derivatives;Organic oxygen compound;Organic nitrogen compound;Organic oxide;Carbonyl group;Organooxygen compound;Organonitrogen compound;Hydrocarbon derivative;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		1214101-41-3		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C25H24N2O7	C25H24N2O7			InChI=1S/C25H24N2O7/c1-3-14-9-23(30)34-24-13(2)21(7-5-17(14)24)33-12-22(29)27-20(25(31)32)8-15-11-26-19-6-4-16(28)10-18(15)19/h4-7,9-11,20,26,28H,3,8,12H2,1-2H3,(H,27,29)(H,31,32)	AKGUUTOJDVYTKL-UHFFFAOYSA-N	2-[[2-(4-ethyl-8-methyl-2-oxo-chromen-7-yl)oxyacetyl]amino]-3-(5-hydroxy-1H-indol-3-yl)propanoic acid	4835822	CCc1cc(=O)oc2c1ccc(OCC(=O)NC(Cc1c[nH]c3c1cc(O)cc3)C(=O)O)c2C	2-[[2-(4-ethyl-8-methyl-2-oxochromen-7-yl)oxyacetyl]amino]-3-(5-hydroxy-1H-indol-3-yl)propanoic acid			1.99572													MCULE-3515756266	464.47923		464.158351	7	4	8	4			45									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(4835822)	4835822	3.3	672			[#6]-[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6]-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]3:[#6]:1:[#6]:[#6](-[#8]):[#6]:[#6]:3)-[#6](=[#8])-[#8]):[#6]:2-[#6]	CCc1cc(=O)oc2c1ccc(OCC(=O)NC(Cc1c[nH]c3c1cc(O)cc3)C(=O)O)c2C	AKGUUTOJDVYTKL		parent_pubchem_cid	1214101-41-3;N-{[(4-ethyl-8-methyl-2-oxo-2H-chromen-7-yl)oxy]acetyl}-5-hydroxytryptophan;2-(2-((4-ethyl-8-methyl-2-oxo-2H-chromen-7-yl)oxy)acetamido)-3-(5-hydroxy-1H-indol-3-yl)propanoic acid;2-{2-[(4-ETHYL-8-METHYL-2-OXO-2H-CHROMEN-7-YL)OXY]ACETAMIDO}-3-(5-HYDROXY-1H-INDOL-3-YL)PROPANOIC ACID;EiM07-29404;STL464220;AKOS016390190;2-[[2-(4-ethyl-8-methyl-2-oxo-chromen-7-yl)oxyacetyl]amino]-3-(5-hydroxy-1H-indol-3-yl)propanoic acid		24073721.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24073721		pluskal_iocb_peptide_Peptide01_D13_id		100	D13		
3.9		0	309	P7126246	90.4		Q24	False	0	23	0	0	25	0	5	2	0	0		0.0						Cc1cc(Nc2ccccc2C(=O)O)nc(Nc2ccc(N3CCCCC3)cc2)n1																							0.0		AKOS025142292		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1		C23H25N5O2	C23H25N5O2			InChI=1S/C23H25N5O2/c1-16-15-21(26-20-8-4-3-7-19(20)22(29)30)27-23(24-16)25-17-9-11-18(12-10-17)28-13-5-2-6-14-28/h3-4,7-12,15H,2,5-6,13-14H2,1H3,(H,29,30)(H2,24,25,26,27)	WOCBKNXKPPFANO-UHFFFAOYSA-N	2-[[6-methyl-2-[4-(1-piperidyl)anilino]pyrimidin-4-yl]amino]benzoic acid	91900822	Cc1cc(Nc2ccccc2C(=O)O)nc(Nc2ccc(N3CCCCC3)cc2)n1	2-[[6-methyl-2-(4-piperidin-1-ylanilino)pyrimidin-4-yl]amino]benzoic acid			2.9482500000000016														403.488		403.200825	7	3	6	4			45										False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(91900822)	91900822	5.4	673			[#6]-[#6]1:[#6]:[#6](-[#7]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6](=[#8])-[#8]):[#7]:[#6](-[#7]-[#6]2:[#6]:[#6]:[#6](-[#7]3-[#6]-[#6]-[#6]-[#6]-[#6]-3):[#6]:[#6]:2):[#7]:1	Cc1cc(Nc2ccccc2C(=O)O)nc(Nc2ccc(N3CCCCC3)cc2)n1	WOCBKNXKPPFANO		parent_pubchem_cid	AKOS025142292;2-[[6-methyl-2-[4-(1-piperidyl)anilino]pyrimidin-4-yl]amino]benzoic acid		101553126.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=101553126		pluskal_iocb_peptide_Peptide01_D13_id		100	D13		ZINC000170621799
0.1		0	53	P7114510238	124.5		Q25	False	0	17	0	0	19	0	5	4	0	0		0.0						CC1=C(C(N)=O)C(c2cc3c(cc2)OCO3)n2nc(CCCO)nc2N1																							0.0		Oprea1_850982		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	3	0	0	1	0	0	0	0	1	0	0	0	0	1	0	1	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	1		C17H19N5O4	C17H19N5O4			InChI=1S/C17H19N5O4/c1-9-14(16(18)24)15(10-4-5-11-12(7-10)26-8-25-11)22-17(19-9)20-13(21-22)3-2-6-23/h4-5,7,15,23H,2-3,6,8H2,1H3,(H2,18,24)(H,19,20,21)	PSHBMOISPANOCB-UHFFFAOYSA-N	7-(1,3-benzodioxol-5-yl)-2-(3-hydroxypropyl)-5-methyl-4,7-dihydro-[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxamide	4248150	CC1=C(C(N)=O)C(c2cc3c(cc2)OCO3)n2nc(CCCO)nc2N1	7-(1,3-benzodioxol-5-yl)-2-(3-hydroxypropyl)-5-methyl-4,7-dihydro-[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxamide			-0.70895													MCULE-5673541997	357.37208		357.143704	7	3	5	4			45										False	Alkaloids				Peptide01			Compound(4248150)	4248150	0.9	674			[#6]-[#6]1=[#6](-[#6](-[#7])=[#8])-[#6](-[#6]2:[#6]:[#6]3:[#6](:[#6]:[#6]:2)-[#8]-[#6]-[#8]-3)-[#7]2:[#7]:[#6](-[#6]-[#6]-[#6]-[#8]):[#7]:[#6]:2-[#7]-1	CC1=C(C(N)=O)C(c2cc3c(cc2)OCO3)n2nc(CCCO)nc2N1	PSHBMOISPANOCB		parent_pubchem_cid	Oprea1_850982;AKOS002380087;AKOS016378272;Z1222312968;7-(1,3-benzodioxol-5-yl)-2-(3-hydroxypropyl)-5-methyl-4,7-dihydro-[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxamide		23092009.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23092009		pluskal_iocb_peptide_Peptide01_D13_id		100	D13		
3.2		0	141	P0103180019	107.6		Q26	False	0	17	1	0	15	0	2	4	0	1	-1.0	0.0						O=C(O)C(Cc1c[nH]c2ccccc12)NS(=O)(=O)c1ccc(Cl)cc1		2.8		0.0	3.21	CHEMBL1545762																	0.0		2-(4-chlorobenzenesulfonamido)-3-(1H-indol-3-yl)propanoic acid		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0		C17H15ClN2O4S	C17H15ClN2O4S			InChI=1S/C17H15ClN2O4S/c18-12-5-7-13(8-6-12)25(23,24)20-16(17(21)22)9-11-10-19-15-4-2-1-3-14(11)15/h1-8,10,16,19-20H,9H2,(H,21,22)	IEFVFKOHASQYES-UHFFFAOYSA-N	2-[(4-chlorophenyl)sulfonylamino]-3-(1H-indol-3-yl)propanoic acid	2787483	O=C(O)C(Cc1c[nH]c2ccccc12)NS(=O)(=O)c1ccc(Cl)cc1	2-[(4-chlorophenyl)sulfonylamino]-3-(1H-indol-3-yl)propanoic acid			2.2043600000000003													MCULE-6356237452	378.8371	ACID	378.044106	4	3	6	3	0.0		30										False	Shikimates and Phenylpropanoids		False	False	Peptide01		-1.0	Compound(2787483)	2787483	2.6	675			[#8]=[#6](-[#8])-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#16](=[#8])(=[#8])-[#6]1:[#6]:[#6]:[#6](-[#17]):[#6]:[#6]:1	O=C(O)C(Cc1c[nH]c2ccccc12)NS(=O)(=O)c1ccc(Cl)cc1	IEFVFKOHASQYES		parent_pubchem_cid	2-(4-chlorobenzenesulfonamido)-3-(1H-indol-3-yl)propanoic acid;MLS000775911;SMR000371031;N-[(4-chlorophenyl)sulfonyl]tryptophan;SR-01000404569;2-(4-Chloro-benzenesulfonylamino)-3-(1H-indol-3-yl)-propionic acid;C17H15ClN2O4S;Oprea1_361233;CHEMBL1545762;HMS2692F12;2-(4-Chloro-benzenesulfonylamino)-3-(1H-indol-3-yl)propionic acid;BBL028890;MFCD00709349;STL025267;AKOS000116572;AKOS016044995;((4-Chlorophenyl)sulfonyl)-DL-tryptophan;VS-09017;EU-0002039;EN300-05215;SR-01000404569-1;SR-01000404569-3;Z45636969;2-(4-chlorophenylsulfonamido)-3-(1H-indol-3-yl)propanoic acid;2-[(4-chlorophenyl)sulfonylamino]-3-(1H-indol-3-yl)propanoic acid	False	816889.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=816889		pluskal_iocb_peptide_Peptide01_D13_id		100	D13	False	
3.6		0	229	P1182552	133.5		Q27	False	0	22	0	0	22	0	4	3	0	2		0.0						O=C(NCCc1c[nH]c2ccccc12)c1nn(C2CCS(=O)(=O)C2)c(-c2cccs2)c1																							0.0		AKOS004932985		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	1	0	0	0	0	0	0	1		C22H22N4O3S2	C22H22N4O3S2			InChI=1S/C22H22N4O3S2/c27-22(23-9-7-15-13-24-18-5-2-1-4-17(15)18)19-12-20(21-6-3-10-30-21)26(25-19)16-8-11-31(28,29)14-16/h1-6,10,12-13,16,24H,7-9,11,14H2,(H,23,27)	SDVIBAGEZPWWFT-UHFFFAOYSA-N	1-(1,1-dioxothiolan-3-yl)-N-[2-(1H-indol-3-yl)ethyl]-5-(2-thienyl)pyrazole-3-carboxamide	50753461	O=C(NCCc1c[nH]c2ccccc12)c1nn(C2CCS(=O)(=O)C2)c(-c2cccs2)c1	1-(1,1-dioxothiolan-3-yl)-N-[2-(1H-indol-3-yl)ethyl]-5-thiophen-2-ylpyrazole-3-carboxamide			2.5071400000000006													MCULE-6536468151	454.57364		454.113333	4	2	6	5			45										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(50753461)	50753461	2.8	676			[#8]=[#6](-[#7]-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6]1:[#7]:[#7](-[#6]2-[#6]-[#6]-[#16](=[#8])(=[#8])-[#6]-2):[#6](-[#6]2:[#6]:[#6]:[#6]:[#16]:2):[#6]:1	O=C(NCCc1c[nH]c2ccccc12)c1nn(C2CCS(=O)(=O)C2)c(-c2cccs2)c1	SDVIBAGEZPWWFT		parent_pubchem_cid	AKOS004932985;1-(11-DIOXO-1LAMBDA6-THIOLAN-3-YL)-N-[2-(1H-INDOL-3-YL)ETHYL]-5-(THIOPHEN-2-YL)-1H-PYRAZOLE-3-CARBOXAMIDE;1-(1,1-dioxothiolan-3-yl)-N-[2-(1H-indol-3-yl)ethyl]-5-(2-thienyl)pyrazole-3-carboxamide		24804574.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24804574		pluskal_iocb_peptide_Peptide01_D13_id		100	D13		
2.5		0	317	P1108684	116.9		Q28	False	0	18	0	0	18	0	2	5	0	1		0.0						COc1ccc(S(=O)(=O)NC(Cc2c[nH]c3ccccc23)C(=O)O)cc1																							0.0		N-[(4-methoxyphenyl)sulfonyl]tryptophan		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0		C18H18N2O5S	C18H18N2O5S			InChI=1S/C18H18N2O5S/c1-25-13-6-8-14(9-7-13)26(23,24)20-17(18(21)22)10-12-11-19-16-5-3-2-4-15(12)16/h2-9,11,17,19-20H,10H2,1H3,(H,21,22)/t17-/m0/s1	VBZKTKSXUUPPES-KRWDZBQOSA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[(4-methoxyphenyl)sulfonylamino]propanoic acid	7440506	COc1ccc(S(=O)(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)cc1	(2S)-3-(1H-indol-3-yl)-2-[(4-methoxyphenyl)sulfonylamino]propanoic acid			1.0971499999999994													MCULE-4250934915	374.41856		374.093643	5	3	7	3			44										False					Peptide01			Compound(7440506)	7440506	1.9	677			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#16](=[#8])(=[#8])-[#7]-[#6@@H](-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6](=[#8])-[#8]):[#6]:[#6]:1	COc1ccc(S(=O)(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)cc1	VBZKTKSXUUPPES		parent_pubchem_cid	N-[(4-methoxyphenyl)sulfonyl]tryptophan;Oprea1_074747;(2S)-3-(1H-indol-3-yl)-2-[(4-methoxyphenyl)sulfonylamino]propanoic acid;AKOS016385917;AQ-390/40881367;3-(1H-INDOL-3-YL)-2-(4-METHOXYBENZENESULFONAMIDO)PROPANOIC ACID;rac-(2S)-3-(1H-indol-3-yl)-2-[(4-methoxyphenyl)sulfonylamino]propanoic acid		54812960.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=54812960		pluskal_iocb_peptide_Peptide01_D13_id		100	D13		ZINC000004980060
2.1		0	61	P7114011380	101.9		Q29	False	0	16	0	0	21	0	1	6	0	0	-1.0	0.0						CC(C)(C)OC(=O)NC(CC(=O)OCc1ccccc1)C(=O)O		2.1		0.0	2.14	CHEMBL1299590		Benzyloxycarbonyls;Fatty acid esters;Dicarboxylic acids and derivatives;Carbamate esters;Organic carbonic acids and derivatives;Carboxylic acid esters;Carboxylic acids;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Aspartic acid and derivatives;Benzene and substituted derivatives;Benzenoids;Benzyloxycarbonyls;Carbamate esters;Carbamic acids and derivatives;Carbonyl compounds;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Dicarboxylic acids and derivatives;Fatty Acyls;Fatty acid esters;Hydrocarbon derivatives;Lipids and lipid-like molecules;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as aspartic acid and derivatives. These are compounds containing an aspartic acid or a derivative thereof resulting from reaction of aspartic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Aspartic acid and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic homomonocyclic compounds	carboxylic ester (CHEBI:33308);fatty acid ester (CHEBI:35748);dicarboxylic acid (CHEBI:35692);carbamate ester (CHEBI:23003);organooxygen compound (CHEBI:36963);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);aspartic acid derivative (CHEBI:22661);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);lipid (CHEBI:18059);amino acid (CHEBI:33709);peptide (CHEBI:16670);carbon oxoacid (CHEBI:35605);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806)	Fatty esters (FA07);Dicarboxylic acids (FA0117);Fatty Acyls (FA)	Amino acids, peptides, and analogues	Aspartic acid or derivatives;Benzyloxycarbonyl;Fatty acid ester;Monocyclic benzene moiety;Dicarboxylic acid or derivatives;Fatty acyl;Benzenoid;Carbamic acid ester;Carboxylic acid ester;Carbonic acid derivative;Carboxylic acid;Organooxygen compound;Hydrocarbon derivative;Organic oxide;Organopnictogen compound;Carbonyl group;Organic oxygen compound;Organic nitrogen compound;Organonitrogen compound;Aromatic homomonocyclic compound	Organic acids and derivatives	0.0		Boc-Asp(OBzl)-OH	DTXSID40884402	2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	1	0	3	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C16H21NO6	C16H21NO6			InChI=1S/C16H21NO6/c1-16(2,3)23-15(21)17-12(14(19)20)9-13(18)22-10-11-7-5-4-6-8-11/h4-8,12H,9-10H2,1-3H3,(H,17,21)(H,19,20)/t12-/m0/s1	SOHLZANWVLCPHK-LBPRGKRZSA-N	rac-(2S)-4-benzyloxy-2-(tert-butoxycarbonylamino)-4-oxo-butanoic acid	1581888	CC(C)(C)OC(=O)N[C@@H](CC(=O)OCc1ccccc1)C(=O)O	(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-4-oxo-4-phenylmethoxybutanoic acid			2.04309													MCULE-8241395602	323.34887	ACID	323.136887	6	2	9	1	1.0		27									Dipeptides	False	Amino acids and Peptides	Small peptides	False	False	Peptide01		-1.0	Compound(1581888)	1581888	1.9	678		SCHEMBL344669	[#6]-[#6](-[#6])(-[#6])-[#8]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6](=[#8])-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	CC(C)(C)OC(=O)N[C@@H](CC(=O)OCc1ccccc1)C(=O)O	SOHLZANWVLCPHK		parent_pubchem_cid	Boc-Asp(OBzl)-OH;7536-58-5;Boc-L-aspartic acid 4-benzyl ester;(S)-4-(Benzyloxy)-2-((tert-butoxycarbonyl)amino)-4-oxobutanoic acid;N-Boc-L-aspartic Acid 4-Benzyl Ester;(2S)-4-(benzyloxy)-2-[(tert-butoxycarbonyl)amino]-4-oxobutanoic acid;Boc-L-Asp(OBn)-OH;Boc-L-Aspartic acid-4-benzyl ester;(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-4-oxo-4-phenylmethoxybutanoic acid;N-(tert-Butoxycarbonyl)-L-aspartic acid 4-benzyl ester;L-Aspartic acid, N-[(1,1-dimethylethoxy)carbonyl]-, 4-(phenylmethyl) ester;Aspartic acid, N-carboxy-, 4-benzyl N-tert-butyl ester, L-;MFCD00065564;4-(benzyloxy)-2-{[(tert-butoxy)carbonyl]amino}-4-oxobutanoic acid;Boc-L-Asp(OBzl)-OH;N-tert-Butoxycarbonyl-L-aspartic acid .beta.-benzyl ester;(2S)-4-(benzyloxy)-2-{[(tert-butoxy)carbonyl]amino}-4-oxobutanoic acid;t-Butyloxycarbonylaspartic acid alpha-benzyl ester;Boc-L-asparticacid4-benzylester;4-Benzyl N-(tert-Butoxycarbonyl)-L-aspartate;NSC-118538;51186-58-4;boc-aspartic acid beta-benzyl ester;Boc-Asp(Bzl)-OH;BOC-Asp(OBzl);Boc-Asp(OBn)-OH;Boc-Asp-(OBzl)-OH;N-alpha-t-BOC-L-aspartic-beta-benzyl ester;LQ5UR33F4Q;SCHEMBL84710;4-Benzyl N-Boc-L-aspartate;MLS000686264;SCHEMBL344669;CHEMBL1299590;DTXSID40884402;HMS2629N19;Boc-L-aspartic acid b-benzyl ester;HY-Z0615;STK014529;AKOS000491316;AKOS015922891;NCGC00245870-01;NCGC00245870-02;AC-15060;AS-14197;beta-Benzyl N-tert-butoxycarbonylaspartate;SMR000313107;B1628;CS-0020431;EN300-204848;F14855;M03266;AB00620016-07;N-Alpha-t-Boc-L-aspartic acid beta-benzyl ester;SR-01000084220;N-(t-butoxycarbonyl)-L-aspartic acid 4-benzyl ester;N-(tert-butoxycarbonyl)aspartic acid-4-benzyl ester;o-Benzyl-N-(tert-butoxycarbonyl)-4-oxohomoserine #;Q-101783;SR-01000084220-1;N-(t-butyloxycarbonyl)-L-aspartic acid 4-benzyl ester;(S)-2-t-butoxycarbonylamino-succinic acid 4-benzyl ester;(S)-2-tert-butoxycarbonylamino-succinic acid 4-benzyl ester;Boc-Asp(OBzl)-OH, >=99.0% (sum of enantiomers, HPLC);N-alpha-t-Butyloxycarbonyl-L-aspartic acid beta-benzyl ester;(s)-4-(benzyloxy)-2-(tert-butoxycarbonylamino)-4-oxobutanoic acid;N-((1,1-Dimethylethoxy)carbonyl)-L-aspartic acid, 4-(phenylmethyl)ester;(2S)-4-(benzyloxy)-2-[(tert-butoxycarbonyl)amino]-4-oxobutanoic acid (non-preferred name);rac-(2S)-4-benzyloxy-2-(tert-butoxycarbonylamino)-4-oxo-butanoic acid	False	903722.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=903722		pluskal_iocb_peptide_Peptide01_D13_id		100	D13	False	ZINC000001794854
3.8		0	149	P0120630186	66.5		Q30	False	0	23	0	0	24	0	2	3	0	0		0.0						O=C(NC1CCCCC1)C(Cc1ccccc1)N1C(=O)c2ccccc2C1=O																							0.0		N-cyclohexyl-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-phenylpropanamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	2	0		C23H24N2O3	C23H24N2O3			InChI=1S/C23H24N2O3/c26-21(24-17-11-5-2-6-12-17)20(15-16-9-3-1-4-10-16)25-22(27)18-13-7-8-14-19(18)23(25)28/h1,3-4,7-10,13-14,17,20H,2,5-6,11-12,15H2,(H,24,26)	YOFNWFOOKXAPNR-UHFFFAOYSA-N	N-cyclohexyl-2-(1,3-dioxoisoindolin-2-yl)-3-phenyl-propanamide	2787191	O=C(NC1CCCCC1)C(Cc1ccccc1)N1C(=O)c2ccccc2C1=O	N-cyclohexyl-2-(1,3-dioxoisoindol-2-yl)-3-phenylpropanamide			3.178670000000001													MCULE-9760535357	376.45933		376.178693	3	1	5	4			44										False	Alkaloids				Peptide01			Compound(2787191)	2787191	4.0	679		SCHEMBL3455646	[#8]=[#6](-[#7]-[#6]1-[#6]-[#6]-[#6]-[#6]-[#6]-1)-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]1-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6]-1=[#8]	O=C(NC1CCCCC1)C(Cc1ccccc1)N1C(=O)c2ccccc2C1=O	YOFNWFOOKXAPNR		parent_pubchem_cid	N-cyclohexyl-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-phenylpropanamide;294655-18-8;Cambridge id 5140196;Oprea1_162310;Oprea1_434438;SCHEMBL3455646;AKOS000574673;AKOS016311592;AB00074332-01;F3096-1338;N-cyclohexyl-2-(1,3-dioxoisoindolin-2-yl)-3-phenylpropanamide;N~1~-CYCLOHEXYL-2-(1,3-DIOXO-1,3-DIHYDRO-2H-ISOINDOL-2-YL)-3-PHENYLPROPANAMIDE;N-cyclohexyl-2-(1,3-dioxoisoindolin-2-yl)-3-phenyl-propanamide		23947942.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23947942		pluskal_iocb_peptide_Peptide01_D13_id		100	D13		
3.7		0	237	P1000523	121.5		Q31	False	0	20	0	0	14	0	2	6	0	0		0.0						O=C(Nc1ccc(Oc2ccccc2)cc1)c1c(C(=O)O)c([N+](=O)[O-])ccc1								Diphenylethers;Nitrobenzoic acids and derivatives;Diarylethers;Nitrobenzenes;Benzoic acids;Benzamides;Phenoxy compounds;Phenol ethers;Nitroaromatic compounds;Benzoyl derivatives;Secondary carboxylic acid amides;Propargyl-type 1,3-dipolar organic compounds;Organic oxoazanium compounds;Monocarboxylic acids and derivatives;Carboxylic acids;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	Allyl-type 1,3-dipolar organic compounds;Anilides;Aromatic anilides;Benzamides;Benzanilides;Benzene and substituted derivatives;Benzenoids;Benzoic acids;Benzoic acids and derivatives;Benzoyl derivatives;C-nitro compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Diarylethers;Diphenylethers;Ethers;Hydrocarbon derivatives;Monocarboxylic acids and derivatives;Nitroaromatic compounds;Nitrobenzenes;Nitrobenzoic acids and derivatives;Organic 1,3-dipolar compounds;Organic acids and derivatives;Organic compounds;Organic nitro compounds;Organic nitrogen compounds;Organic oxides;Organic oxoazanium compounds;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenol ethers;Phenoxy compounds;Propargyl-type 1,3-dipolar organic compounds;Secondary carboxylic acid amides	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as benzanilides. These are aromatic compounds containing an anilide group in which the carboxamide group is substituted with a benzene ring. They have the general structure RNC(=O)R', where R,R'= benzene.	Benzanilides		Aromatic anilides	Organic compounds	Aromatic homomonocyclic compounds	aromatic ether (CHEBI:35618);nitrobenzoic acid (CHEBI:25553);nitrobenzenes (CHEBI:48109);benzoic acids (CHEBI:22723);benzamides (CHEBI:22702);benzenes (CHEBI:22712);aromatic compound (CHEBI:33655);carbonyl compound (CHEBI:36586);carboxamide (CHEBI:37622);dipolar compound (CHEBI:51151);nitrogen molecular entity (CHEBI:51143);organooxygen compound (CHEBI:36963);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);anilide (CHEBI:13248);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);oxygen molecular entity (CHEBI:25806);ether (CHEBI:25698);nitro compound (CHEBI:35715);amide (CHEBI:32988)		Anilides	Benzanilide;Diphenylether;Nitrobenzoate;Diaryl ether;Nitrobenzene;Benzoic acid;Benzoic acid or derivatives;Benzamide;Phenoxy compound;Nitroaromatic compound;Phenol ether;Benzoyl;Organic nitro compound;Secondary carboxylic acid amide;C-nitro compound;Carboxamide group;Organic 1,3-dipolar compound;Propargyl-type 1,3-dipolar organic compound;Allyl-type 1,3-dipolar organic compound;Organic oxoazanium;Monocarboxylic acid or derivatives;Ether;Carboxylic acid;Carboxylic acid derivative;Organic nitrogen compound;Organic oxygen compound;Organopnictogen compound;Organic oxide;Hydrocarbon derivative;Organooxygen compound;Organonitrogen compound;Aromatic homomonocyclic compound	Benzenoids	0.0		683249-53-8		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C20H14N2O6	C20H14N2O6			InChI=1S/C20H14N2O6/c23-19(16-7-4-8-17(22(26)27)18(16)20(24)25)21-13-9-11-15(12-10-13)28-14-5-2-1-3-6-14/h1-12H,(H,21,23)(H,24,25)	QNWFAURSCKVMKF-UHFFFAOYSA-N	2-nitro-6-[(4-phenoxyphenyl)carbamoyl]benzoic acid	16645473	O=C(Nc1ccc(Oc2ccccc2)cc1)c1c(C(=O)O)c([N+](=O)[O-])ccc1	2-nitro-6-[(4-phenoxyphenyl)carbamoyl]benzoic acid			2.54214													MCULE-3241987773	378.34438		378.085186	6	2	6	3			43										False	Shikimates and Phenylpropanoids				Peptide01			Compound(16645473)	16645473	3.6	680			[#8]=[#6](-[#7]-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6]:[#6]:1)-[#6]1:[#6](-[#6](=[#8])-[#8]):[#6](-[#7+](=[#8])-[#8-]):[#6]:[#6]:[#6]:1	O=C(Nc1ccc(Oc2ccccc2)cc1)c1c(C(=O)O)c([N+](=O)[O-])ccc1	QNWFAURSCKVMKF		parent_pubchem_cid	683249-53-8;2-nitro-6-((4-phenoxyphenyl)carbamoyl)benzoic acid;2-nitro-6-[(4-phenoxyphenyl)carbamoyl]benzoic acid;Oprea1_290095;Oprea1_513887;AKOS001425243;F1107-0305;Z283687034		23724544.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23724544		pluskal_iocb_peptide_Peptide01_D14_id		100	D14		ZINC000011565766
2.4		0	325	P3460720	126.5		Q32	False	0	22	0	0	24	0	4	4	0	0		0.0						NC(=O)NCCCC(NC(=O)Cn1c(-c2ccccc2)cc2ccccc21)C(=O)O																							0.0		EiM08-07336		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C22H24N4O4	C22H24N4O4			InChI=1S/C22H24N4O4/c23-22(30)24-12-6-10-17(21(28)29)25-20(27)14-26-18-11-5-4-9-16(18)13-19(26)15-7-2-1-3-8-15/h1-5,7-9,11,13,17H,6,10,12,14H2,(H,25,27)(H,28,29)(H3,23,24,30)/t17-/m1/s1	YGUBFAWPPZARGU-QGZVFWFLSA-N	rac-(2R)-2-[[2-(2-phenylindol-1-yl)acetyl]amino]-5-ureido-pentanoic acid	39333675	NC(=O)NCCC[C@@H](NC(=O)Cn1c(-c2ccccc2)cc2ccccc21)C(=O)O	(2R)-5-(carbamoylamino)-2-[[2-(2-phenylindol-1-yl)acetyl]amino]pentanoic acid			1.5177600000000002													MCULE-6678183938	408.46098		408.179755	4	4	9	3			44										False	Alkaloids				Peptide01			Compound(39333675)	39333675	2.2	681			[#7]-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]-[#6@@H](-[#7]-[#6](=[#8])-[#6]-[#7]1:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	NC(=O)NCCC[C@@H](NC(=O)Cn1c(-c2ccccc2)cc2ccccc21)C(=O)O	YGUBFAWPPZARGU		parent_pubchem_cid	EiM08-07336;STK656781;AKOS005587391;N~5~-carbamoyl-N~2~-[(2-phenyl-1H-indol-1-yl)acetyl]-D-ornithine;(2R)-5-[(AMINOCARBONYL)AMINO]-2-{[2-(2-PHENYL-1H-INDOL-1-YL)ACETYL]AMINO}PENTANOIC ACID;rac-(2R)-2-[[2-(2-phenylindol-1-yl)acetyl]amino]-5-ureido-pentanoic acid		23897400.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23897400		pluskal_iocb_peptide_Peptide01_D14_id		100	D14		ZINC000032088901
1.4		0	69	P7210740628	115.2		Q33	False	0	20	0	0	18	0	2	6	0	0		0.0						O=C(O)c1ccccc1C(=O)N1CCN(C(=O)c2ccccc2C(=O)O)CC1								Benzoic acids;Benzoyl derivatives;Piperazines;Dicarboxylic acids and derivatives;Tertiary carboxylic acid amides;Carboxylic acids;Azacyclic compounds;Organopnictogen compounds;Organooxygen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	Azacyclic compounds;Benzamides;Benzene and substituted derivatives;Benzenoids;Benzoic acids;Benzoic acids and derivatives;Benzoyl derivatives;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Diazinanes;Dicarboxylic acids and derivatives;Hydrocarbon derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Piperazines;Tertiary carboxylic acid amides	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as benzamides. These are organic compounds containing a carboxamido substituent attached to a benzene ring.	Benzamides			Organic compounds	Aromatic heteromonocyclic compounds	benzoic acids (CHEBI:22723);carbonyl compound (CHEBI:36586);piperazines (CHEBI:26144);dicarboxylic acid (CHEBI:35692);carboxamide (CHEBI:37622);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);organonitrogen heterocyclic compound (CHEBI:38101);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organooxygen compound (CHEBI:36963);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);benzamides (CHEBI:22702);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);organic heterocyclic compound (CHEBI:24532);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);nitrogen molecular entity (CHEBI:51143)	Dicarboxylic acids (FA0117)	Benzoic acids and derivatives	Benzamide;Benzoic acid;Benzoyl;Piperazine;1,4-diazinane;Dicarboxylic acid or derivatives;Tertiary carboxylic acid amide;Carboxamide group;Carboxylic acid derivative;Azacycle;Organoheterocyclic compound;Carboxylic acid;Organic nitrogen compound;Organonitrogen compound;Organooxygen compound;Hydrocarbon derivative;Organic oxide;Organopnictogen compound;Organic oxygen compound;Aromatic heteromonocyclic compound	Benzenoids	0.0		195526-67-1		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	4	2	0	0	0	0	0	0	0	0	2	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0		C20H18N2O6	C20H18N2O6			InChI=1S/C20H18N2O6/c23-17(13-5-1-3-7-15(13)19(25)26)21-9-11-22(12-10-21)18(24)14-6-2-4-8-16(14)20(27)28/h1-8H,9-12H2,(H,25,26)(H,27,28)	GQKZKPFUFFDRPX-UHFFFAOYSA-N	2-[4-(2-carboxybenzoyl)piperazine-1-carbonyl]benzoic acid	990038	O=C(O)c1ccccc1C(=O)N1CCN(C(=O)c2ccccc2C(=O)O)CC1	2-[4-(2-carboxybenzoyl)piperazine-1-carbonyl]benzoic acid			1.46236													MCULE-1750000298	382.37626		382.116486	6	2	4	3			42										False	Alkaloids				Peptide01			Compound(990038)	990038	1.4	682		SCHEMBL16026538	[#8]=[#6](-[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#6](=[#8])-[#7]1-[#6]-[#6]-[#7](-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6](=[#8])-[#8])-[#6]-[#6]-1	O=C(O)c1ccccc1C(=O)N1CCN(C(=O)c2ccccc2C(=O)O)CC1	GQKZKPFUFFDRPX		parent_pubchem_cid	195526-67-1;2-[4-(2-carboxybenzoyl)piperazine-1-carbonyl]benzoic acid;2-{[4-(2-carboxybenzoyl)-1-piperazinyl]carbonyl}benzoic acid;2,2'-(Piperazine-1,4-dicarbonyl)dibenzoic acid;CBMicro_041791;1,4-bis(2-carboxybenzoyl)piperazine;Oprea1_374962;Oprea1_753582;SCHEMBL16026538;STK025412;AKOS000486470;BIM-0041820.P001;CS-0358908;SR-01000493561;2,2'-(piperazine-1,4-diyldicarbonyl)dibenzoic acid;SR-01000493561-1		22993624.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22993624		pluskal_iocb_peptide_Peptide01_D14_id		100	D14		ZINC000004394109
2.3		0	157	P7016240116	114.5		Q34	False	0	22	0	0	19	0	3	5	0	1	-1.0	0.0						COc1c(NC(=O)c2ccccc2)cc(OC)c(NC2=NS(=O)(=O)c3ccccc23)c1		3.52		0.0	3.03	CHEMBL4960437																	0.0		CHEMBL4960437		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	1	0	0	0	0	0	0	0		C22H19N3O5S	C22H19N3O5S			InChI=1S/C22H19N3O5S/c1-29-18-13-17(24-22(26)14-8-4-3-5-9-14)19(30-2)12-16(18)23-21-15-10-6-7-11-20(15)31(27,28)25-21/h3-13H,1-2H3,(H,23,25)(H,24,26)	ZOFWCEZQCXHZBE-UHFFFAOYSA-N	N-[4-[(1,1-dioxo-1,2-benzothiazol-3-yl)amino]-2,5-dimethoxy-phenyl]benzamide	1178266	COc1c(NC(=O)c2ccccc2)cc(OC)c(NC2=NS(=O)(=O)c3ccccc23)c1	N-[4-[(1,1-dioxo-1,2-benzothiazol-3-yl)amino]-2,5-dimethoxyphenyl]benzamide			1.61363													MCULE-4117428544	437.47783	NEUTRAL	437.104542	7	2	6	4	0.0		29										False	Alkaloids	Tyrosine alkaloids	False	False	Peptide01		-1.0	Compound(1178266)	1178266	2.8	683			[#6]-[#8]-[#6]1:[#6](-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6]:[#6](-[#8]-[#6]):[#6](-[#7]-[#6]2=[#7]-[#16](=[#8])(=[#8])-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]-2:3):[#6]:1	COc1c(NC(=O)c2ccccc2)cc(OC)c(NC2=NS(=O)(=O)c3ccccc23)c1	ZOFWCEZQCXHZBE		parent_pubchem_cid	CHEMBL4960437;AKOS001712332;SR-01000150715;SR-01000150715-1;N-{4-[(1,1-dioxido-1,2-benzisothiazol-3-yl)amino]-2,5-dimethoxyphenyl}benzamide;N-[4-[(1,1-dioxo-1,2-benzothiazol-3-yl)amino]-2,5-dimethoxy-phenyl]benzamide	False	2065051.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=2065051		pluskal_iocb_peptide_Peptide01_D14_id		100	D14	False	ZINC000000936111
2.1		0	245	P1037847	64.3		Q35	False	0	14	0	0	22	0	2	2	0	0		0.0						CC(C)(C)OC(=O)NC(CN)Cc1ccccc1								Aralkylamines;Carbamate esters;Organic oxides;Monoalkylamines;Hydrocarbon derivatives;Carbonyl compounds	Amines;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Aralkylamines;Benzene and substituted derivatives;Benzenoids;Carbamate esters;Carbamic acids and derivatives;Carbonyl compounds;Carboxylic acids and derivatives;Chemical entities;Hydrocarbon derivatives;Monoalkylamines;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenethylamines;Primary amines	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as amphetamines and derivatives. These are organic compounds containing or derived from 1-phenylpropan-2-amine.	Amphetamines and derivatives			Organic compounds	Aromatic homomonocyclic compounds	aralkylamine (CHEBI:18000);carbamate ester (CHEBI:23003);organic oxide (CHEBI:25701);alkylamine (CHEBI:13759);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);amphetamines (CHEBI:35338);chemical entity (CHEBI:24431);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);amine (CHEBI:32952);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);organooxygen compound (CHEBI:36963);carbon oxoacid (CHEBI:35605);oxygen molecular entity (CHEBI:25806);primary amine (CHEBI:32877);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);amino acid (CHEBI:33709);peptide (CHEBI:16670)		Phenethylamines	Amphetamine or derivatives;Aralkylamine;Carbamic acid ester;Organic nitrogen compound;Organic oxygen compound;Organic oxide;Hydrocarbon derivative;Primary amine;Organooxygen compound;Organonitrogen compound;Primary aliphatic amine;Carbonyl group;Amine;Aromatic homomonocyclic compound	Benzenoids	0.0		146552-72-9	DTXSID40439673	2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0		C14H22N2O2	C14H22N2O2			InChI=1S/C14H22N2O2/c1-14(2,3)18-13(17)16-12(10-15)9-11-7-5-4-6-8-11/h4-8,12H,9-10,15H2,1-3H3,(H,16,17)/t12-/m0/s1	LHZRJEOMDFKIJM-LBPRGKRZSA-N	tert-butyl N-[(1S)-1-(aminomethyl)-2-phenyl-ethyl]carbamate	10422234	CC(C)(C)OC(=O)N[C@H](CN)Cc1ccccc1	tert-butyl N-[(2S)-1-amino-3-phenylpropan-2-yl]carbamate			2.02639													MCULE-5603801612	250.34364		250.168128	3	2	6	1			42									Phenylalanine-derived alkaloids;Phenylethylamines	False	Alkaloids	Tyrosine alkaloids;Pseudoalkaloids			Peptide01			Compound(10422234)	10422234	2.0	684		SCHEMBL272844	[#6]-[#6](-[#6])(-[#6])-[#8]-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#7])-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	CC(C)(C)OC(=O)N[C@H](CN)Cc1ccccc1	LHZRJEOMDFKIJM		parent_pubchem_cid	146552-72-9;(S)-tert-Butyl (1-amino-3-phenylpropan-2-yl)carbamate;TERT-BUTYL N-[(2S)-1-AMINO-3-PHENYLPROPAN-2-YL]CARBAMATE;Carbamic acid, N-[(1S)-1-(aminomethyl)-2-phenylethyl]-, 1,1-dimethylethyl ester;MFCD09885896;(2S)-2-(tert-butoxycarbonylamino)-3-phenylpropylamine;(S)-2-(Boc-amino)-3-phenylpropylamine;Carbamic acid,[(1S)-1-(aminomethyl)-2-phenylethyl]-, 1,1-dimethylethyl ester;V2GLQ7NR6F;SCHEMBL272844;DTXSID40439673;LHZRJEOMDFKIJM-LBPRGKRZSA-N;WFA55272;AKOS015945927;DS-5696;C72784;EN300-6201461;(S)-tert-Butyl(1-amino-3-phenylpropan-2-yl)carbamate;tert-Butyl ((S)-1-amino-3-phenylpropan-2-yl)carbamate;((S)-2-Amino-1-benzyl-ethyl)-carbamic acid tert-butyl ester;((S)-1-aminomethyl-2-phenyl-ethyl)-carbamic acid tert-butyl ester;1,1-dimethylethyl [(1S)-2-amino-1-(phenylmethyl)ethyl]carbamate;tert-butyl N-[(1S)-1-(aminomethyl)-2-phenyl-ethyl]carbamate		34618493.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=34618493		pluskal_iocb_peptide_Peptide01_D14_id		100	D14		ZINC000011593547
1.8		0	333	P1647345	52.7		Q36	False	0	17	0	0	25	0	3	2	0	0	-1.0	0.0						CN(C)C(=O)NC(Cc1ccccc1)C(=O)N1CCCCC1		1.88		0.0	1.5	CHEMBL4926568																	0.0		CHEMBL4926568		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0		C17H25N3O2	C17H25N3O2			InChI=1S/C17H25N3O2/c1-19(2)17(22)18-15(13-14-9-5-3-6-10-14)16(21)20-11-7-4-8-12-20/h3,5-6,9-10,15H,4,7-8,11-13H2,1-2H3,(H,18,22)/t15-/m0/s1	NCFDHJXHUVOVIO-HNNXBMFYSA-N	1,1-dimethyl-3-[rac-(1S)-1-benzyl-2-oxo-2-(1-piperidyl)ethyl]urea	110347392	CN(C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCCCC1	1,1-dimethyl-3-[(2S)-1-oxo-3-phenyl-1-piperidin-1-ylpropan-2-yl]urea			1.82669														303.4077	NEUTRAL	303.194677	2	1	4	2	0.0		30									Piperidine alkaloids	False	Alkaloids;Amino acids and Peptides	Lysine alkaloids	False	False	Peptide01		-1.0	Compound(110347392)	110347392	1.9	685			[#6]-[#7](-[#6])-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#7]1-[#6]-[#6]-[#6]-[#6]-[#6]-1	CN(C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCCCC1	NCFDHJXHUVOVIO		parent_pubchem_cid	CHEMBL4926568;AKOS027475300;1,1-dimethyl-3-[rac-(1S)-1-benzyl-2-oxo-2-(1-piperidyl)ethyl]urea	False	6808032.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=6808032		pluskal_iocb_peptide_Peptide01_D14_id		100	D14	False	ZINC000041247078
4.7		0	77	P0129663884	37.3		Q37	False	0	24	0	0	25	0	3	2	0	0		0.0						COc1ccccc1N1CCN(N=Cc2cc(Oc3ccccc3)ccc2)CC1																							0.0		AKOS000555223		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2		C24H25N3O2	C24H25N3O2			InChI=1S/C24H25N3O2/c1-28-24-13-6-5-12-23(24)26-14-16-27(17-15-26)25-19-20-8-7-11-22(18-20)29-21-9-3-2-4-10-21/h2-13,18-19H,14-17H2,1H3/b25-19-	ROULWRMXSWNHGI-PLRJNAJWSA-N	(Z)-N-[4-(2-methoxyphenyl)piperazin-1-yl]-1-(3-phenoxyphenyl)methanimine	5540426	COc1ccccc1N1CCN(/N=C\c2cc(Oc3ccccc3)ccc2)CC1	(Z)-N-[4-(2-methoxyphenyl)piperazin-1-yl]-1-(3-phenoxyphenyl)methanimine			2.8210500000000014														387.48575		387.194677	5	0	6	4			45										False					Peptide01			Compound(5540426)	5540426	5.2	686			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#7]1-[#6]-[#6]-[#7](/[#7]=[#6]\[#6]2:[#6]:[#6](-[#8]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#6]:[#6]:[#6]:2)-[#6]-[#6]-1	COc1ccccc1N1CCN(/N=C\c2cc(Oc3ccccc3)ccc2)CC1	ROULWRMXSWNHGI		parent_pubchem_cid	AKOS000555223;(Z)-N-[4-(2-methoxyphenyl)piperazin-1-yl]-1-(3-phenoxyphenyl)methanimine		17211237.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=17211237		pluskal_iocb_peptide_Peptide01_D14_id		100	D14		ZINC000004482738
3.5		0	165	P7020554654	84.2		Q38	False	0	20	1	0	18	0	3	3	0	0		0.0						Cc1cc(NC(=O)C(Cc2ccccc2)NC(=O)c2ccccc2Cl)no1																							0.0		AKOS005591477		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C20H18ClN3O3	C20H18ClN3O3			InChI=1S/C20H18ClN3O3/c1-13-11-18(24-27-13)23-20(26)17(12-14-7-3-2-4-8-14)22-19(25)15-9-5-6-10-16(15)21/h2-11,17H,12H2,1H3,(H,22,25)(H,23,24,26)/t17-/m0/s1	HWOAUGQTFDWNRW-KRWDZBQOSA-N	N-[(1S)-1-benzyl-2-[(5-methylisoxazol-3-yl)amino]-2-oxo-ethyl]-2-chloro-benzamide	24315167	Cc1cc(NC(=O)[C@H](Cc2ccccc2)NC(=O)c2ccccc2Cl)no1	2-chloro-N-[(2S)-1-[(5-methyl-1,2-oxazol-3-yl)amino]-1-oxo-3-phenylpropan-2-yl]benzamide			3.071480000000001													MCULE-2542600479	383.83776		383.103669	3	2	6	3			44										False					Peptide01			Compound(24315167)	24315167	3.9	687			[#6]-[#6]1:[#6]:[#6](-[#7]-[#6](=[#8])-[#6@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#17]):[#7]:[#8]:1	Cc1cc(NC(=O)[C@H](Cc2ccccc2)NC(=O)c2ccccc2Cl)no1	HWOAUGQTFDWNRW		parent_pubchem_cid	AKOS005591477;N-[(1S)-1-benzyl-2-[(5-methylisoxazol-3-yl)amino]-2-oxo-ethyl]-2-chloro-benzamide		17996477.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=17996477		pluskal_iocb_peptide_Peptide01_D14_id		100	D14		ZINC000012028751
4.9		0	253	P1301183	76.5		Q39	False	1	24	0	0	23	0	2	4	0	0		0.0						CCOc1c(OC)cc(C(CNC(=O)c2ccc(Br)o2)c2c[nH]c3ccccc23)cc1																							0.0		AKOS001533489		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C24H23BrN2O4	C24H23BrN2O4			InChI=1S/C24H23BrN2O4/c1-3-30-20-9-8-15(12-22(20)29-2)17(13-27-24(28)21-10-11-23(25)31-21)18-14-26-19-7-5-4-6-16(18)19/h4-12,14,17,26H,3,13H2,1-2H3,(H,27,28)	PAZBSRFVUKUHBZ-UHFFFAOYSA-N	5-bromo-N-[2-(4-ethoxy-3-methoxy-phenyl)-2-(1H-indol-3-yl)ethyl]furan-2-carboxamide	17010918	CCOc1c(OC)cc(C(CNC(=O)c2ccc(Br)o2)c2c[nH]c3ccccc23)cc1	5-bromo-N-[2-(4-ethoxy-3-methoxyphenyl)-2-(1H-indol-3-yl)ethyl]furan-2-carboxamide			3.9752300000000016													MCULE-1103023951	483.36591		482.084119	3	2	8	4			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(17010918)	17010918	5.5	688			[#6]-[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]):[#6]:[#6](-[#6](-[#6]-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6](-[#35]):[#8]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	CCOc1c(OC)cc(C(CNC(=O)c2ccc(Br)o2)c2c[nH]c3ccccc23)cc1	PAZBSRFVUKUHBZ		parent_pubchem_cid	AKOS001533489;AKOS016325387;5-bromo-N-[2-(4-ethoxy-3-methoxyphenyl)-2-(1H-indol-3-yl)ethyl]furan-2-carboxamide;5-bromo-N-[2-(4-ethoxy-3-methoxy-phenyl)-2-(1H-indol-3-yl)ethyl]furan-2-carboxamide		23750933.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23750933		pluskal_iocb_peptide_Peptide01_D15_id		100	D15		
5.0		0	341	P6052646	63.0		Q40	False	0	24	0	0	21	0	3	2	0	0		0.0						O=C(NCCc1c[nH]c2ccccc12)c1cc2c(cco2)n1Cc1ccccc1								Pyrrole carboxamides;Furopyrroles;2-heteroaryl carboxamides;Substituted pyrroles;Benzene and substituted derivatives;Heteroaromatic compounds;Furans;Secondary carboxylic acid amides;Oxacyclic compounds;Azacyclic compounds;Organooxygen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	2-heteroaryl carboxamides;3-alkylindoles;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Furans;Furopyrroles;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Oxacyclic compounds;Pyrrole carboxamides;Pyrrole carboxylic acids and derivatives;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as 3-alkylindoles. These are compounds containing an indole moiety that carries an alkyl chain at the 3-position.	3-alkylindoles			Organic compounds	Aromatic heteropolycyclic compounds	pyrroles (CHEBI:26455);carboxamide (CHEBI:37622);furopyrrole (CHEBI:64471);organic aromatic compound (CHEBI:33659);benzenes (CHEBI:22712);furans (CHEBI:24129);oxacycle (CHEBI:38104);organonitrogen heterocyclic compound (CHEBI:38101);organooxygen compound (CHEBI:36963);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);indoles (CHEBI:24828);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);benzenoid aromatic compound (CHEBI:33836);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143)		Indoles	3-alkylindole;2-heteroaryl carboxamide;Furopyrrole;Pyrrole-2-carboxamide;Pyrrole-2-carboxylic acid or derivatives;Monocyclic benzene moiety;Benzenoid;Substituted pyrrole;Furan;Heteroaromatic compound;Pyrrole;Carboxamide group;Secondary carboxylic acid amide;Oxacycle;Carboxylic acid derivative;Azacycle;Hydrocarbon derivative;Organooxygen compound;Organonitrogen compound;Organic oxide;Organic oxygen compound;Organic nitrogen compound;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		AKOS005660571		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C24H21N3O2	C24H21N3O2			InChI=1S/C24H21N3O2/c28-24(25-12-10-18-15-26-20-9-5-4-8-19(18)20)22-14-23-21(11-13-29-23)27(22)16-17-6-2-1-3-7-17/h1-9,11,13-15,26H,10,12,16H2,(H,25,28)	JDVZHPMRYWGCKX-UHFFFAOYSA-N	4-benzyl-N-[2-(1H-indol-3-yl)ethyl]furo[3,2-b]pyrrole-5-carboxamide	45494332	O=C(NCCc1c[nH]c2ccccc12)c1cc2c(cco2)n1Cc1ccccc1	4-benzyl-N-[2-(1H-indol-3-yl)ethyl]furo[3,2-b]pyrrole-5-carboxamide			3.715430000000003													MCULE-1207088805	383.45387		383.163377	1	2	6	5			44									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(45494332)	45494332	4.4	689			[#8]=[#6](-[#7]-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:[#8]:2):[#7]:1-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	O=C(NCCc1c[nH]c2ccccc12)c1cc2c(cco2)n1Cc1ccccc1	JDVZHPMRYWGCKX		parent_pubchem_cid	AKOS005660571;4-benzyl-N-[2-(1H-indol-3-yl)ethyl]furo[3,2-b]pyrrole-5-carboxamide		4240003.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=4240003		pluskal_iocb_peptide_Peptide01_D15_id		100	D15		ZINC000036360042
4.9		0	85	P7211130005	66.9		Q41	False	0	26	0	0	23	0	1	5	0	0		0.0						COc1cc(C(=O)OC(c2ccccc2)c2nccc3ccccc23)cc(OC)c1OC																							0.0		Oprea1_269585		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C26H23NO5	C26H23NO5			InChI=1S/C26H23NO5/c1-29-21-15-19(16-22(30-2)25(21)31-3)26(28)32-24(18-10-5-4-6-11-18)23-20-12-8-7-9-17(20)13-14-27-23/h4-16,24H,1-3H3	AJJHWJZAMWDEKK-UHFFFAOYSA-N	[1-isoquinolyl(phenyl)methyl] 3,4,5-trimethoxybenzoate	3478939	COc1cc(C(=O)OC(c2ccccc2)c2nccc3ccccc23)cc(OC)c1OC	[isoquinolin-1-yl(phenyl)methyl] 3,4,5-trimethoxybenzoate			3.2272200000000018													MCULE-2139393056	429.47691		429.157623	6	0	8	4			45									Isoquinoline alkaloids	False	Alkaloids	Tyrosine alkaloids			Peptide01			Compound(3478939)	3478939	5.1	690			[#6]-[#8]-[#6]1:[#6]:[#6](-[#6](=[#8])-[#8]-[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]2:[#7]:[#6]:[#6]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6](-[#8]-[#6]):[#6]:1-[#8]-[#6]	COc1cc(C(=O)OC(c2ccccc2)c2nccc3ccccc23)cc(OC)c1OC	AJJHWJZAMWDEKK		parent_pubchem_cid	Oprea1_269585;Oprea1_856965;isoquinolin-1-yl(phenyl)methyl 3,4,5-trimethoxybenzoate;STK976725;AKOS000808239;AKOS016290573;SR-01000445580;SR-01000445580-1;Z56174639;[1-isoquinolyl(phenyl)methyl] 3,4,5-trimethoxybenzoate		24451548.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24451548		pluskal_iocb_peptide_Peptide01_D15_id		100	D15		
2.9		0	173	P7020554647	84.2		Q42	False	0	20	0	0	19	0	3	3	0	0		0.0						Cc1cc(NC(=O)C(Cc2ccccc2)NC(=O)c2ccccc2)no1																							0.0		STK659762		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C20H19N3O3	C20H19N3O3			InChI=1S/C20H19N3O3/c1-14-12-18(23-26-14)22-20(25)17(13-15-8-4-2-5-9-15)21-19(24)16-10-6-3-7-11-16/h2-12,17H,13H2,1H3,(H,21,24)(H,22,23,25)/t17-/m0/s1	WJDFWUVDGLRKRN-KRWDZBQOSA-N	N-[(1S)-1-benzyl-2-[(5-methylisoxazol-3-yl)amino]-2-oxo-ethyl]benzamide	24315160	Cc1cc(NC(=O)[C@H](Cc2ccccc2)NC(=O)c2ccccc2)no1	N-[(2S)-1-[(5-methyl-1,2-oxazol-3-yl)amino]-1-oxo-3-phenylpropan-2-yl]benzamide			2.4180800000000007													MCULE-9951337668	349.39273		349.142641	3	2	6	3			44										False					Peptide01			Compound(24315160)	24315160	3.3	691			[#6]-[#6]1:[#6]:[#6](-[#7]-[#6](=[#8])-[#6@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#7]:[#8]:1	Cc1cc(NC(=O)[C@H](Cc2ccccc2)NC(=O)c2ccccc2)no1	WJDFWUVDGLRKRN		parent_pubchem_cid	STK659762;AKOS005590110;N-(5-methyl-1,2-oxazol-3-yl)-Nalpha-(phenylcarbonyl)-L-phenylalaninamide;N-[(1S)-1-benzyl-2-[(5-methylisoxazol-3-yl)amino]-2-oxo-ethyl]benzamide		3714980.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=3714980		pluskal_iocb_peptide_Peptide01_D15_id		100	D15		ZINC000012028729
4.4		0	261	P1305487	63.4		Q43	False	0	25	0	0	24	0	2	3	0	0		0.0						COc1ccc(OCC(=O)NCC(c2ccccc2)c2c[nH]c3ccccc23)cc1																							0.0		HMS3456K14		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C25H24N2O3	C25H24N2O3			InChI=1S/C25H24N2O3/c1-29-19-11-13-20(14-12-19)30-17-25(28)27-15-22(18-7-3-2-4-8-18)23-16-26-24-10-6-5-9-21(23)24/h2-14,16,22,26H,15,17H2,1H3,(H,27,28)	OFMDGDNFSFVBTC-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]-2-(4-methoxyphenoxy)acetamide	17014634	COc1ccc(OCC(=O)NCC(c2ccccc2)c2c[nH]c3ccccc23)cc1	N-[2-(1H-indol-3-yl)-2-phenylethyl]-2-(4-methoxyphenoxy)acetamide			3.040940000000001													MCULE-4059021211	400.48163		400.178693	3	2	8	4			45										False	Alkaloids				Peptide01			Compound(17014634)	17014634	4.7	692			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]-[#6](=[#8])-[#7]-[#6]-[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	COc1ccc(OCC(=O)NCC(c2ccccc2)c2c[nH]c3ccccc23)cc1	OFMDGDNFSFVBTC		parent_pubchem_cid	HMS3456K14;N-[2-(1H-indol-3-yl)-2-phenylethyl]-2-(4-methoxyphenoxy)acetamide;AKOS002335722;AKOS016326698;N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]-2-(4-methoxyphenoxy)acetamide		23604687.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23604687		pluskal_iocb_peptide_Peptide01_D15_id		100	D15		
3.7		0	349	P4799301	84.4		Q44	False	0	21	1	0	23	0	6	2	0	0		0.0						COc1ccc(Nc2nc(Nc3c(C)ccc(Cl)c3)nc(N3CCOCC3)n2)cc1																							0.0		946209-04-7		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1		C21H23ClN6O2	C21H23ClN6O2			InChI=1S/C21H23ClN6O2/c1-14-3-4-15(22)13-18(14)24-20-25-19(23-16-5-7-17(29-2)8-6-16)26-21(27-20)28-9-11-30-12-10-28/h3-8,13H,9-12H2,1-2H3,(H2,23,24,25,26,27)	BLIJYYDMRNNJLZ-UHFFFAOYSA-N	N2-(5-chloro-2-methyl-phenyl)-N4-(4-methoxyphenyl)-6-morpholino-1,3,5-triazine-2,4-diamine	42477758	COc1ccc(Nc2nc(Nc3c(C)ccc(Cl)c3)nc(N3CCOCC3)n2)cc1	2-N-(5-chloro-2-methylphenyl)-4-N-(4-methoxyphenyl)-6-morpholin-4-yl-1,3,5-triazine-2,4-diamine			1.7456499999999997													MCULE-1000619933	426.90946		426.157102	8	2	6	4			44										False	Alkaloids				Peptide01			Compound(42477758)	42477758	4.8	693			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#7]-[#6]2:[#7]:[#6](-[#7]-[#6]3:[#6](-[#6]):[#6]:[#6]:[#6](-[#17]):[#6]:3):[#7]:[#6](-[#7]3-[#6]-[#6]-[#8]-[#6]-[#6]-3):[#7]:2):[#6]:[#6]:1	COc1ccc(Nc2nc(Nc3c(C)ccc(Cl)c3)nc(N3CCOCC3)n2)cc1	BLIJYYDMRNNJLZ		parent_pubchem_cid	946209-04-7;N2-(5-chloro-2-methylphenyl)-N4-(4-methoxyphenyl)-6-morpholino-1,3,5-triazine-2,4-diamine;N2-(5-CHLORO-2-METHYLPHENYL)-N4-(4-METHOXYPHENYL)-6-(MORPHOLIN-4-YL)-1,3,5-TRIAZINE-2,4-DIAMINE;AKOS016392459;F2490-0361;2-N-(5-chloro-2-methylphenyl)-4-N-(4-methoxyphenyl)-6-morpholin-4-yl-1,3,5-triazine-2,4-diamine;N2-(5-chloro-2-methyl-phenyl)-N4-(4-methoxyphenyl)-6-morpholino-1,3,5-triazine-2,4-diamine		16286076.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=16286076		pluskal_iocb_peptide_Peptide01_D15_id		100	D15		ZINC000012235173
2.4		0	357	P6248730	117.2		R1	False	0	15	0	0	23	0	1	4	0	2		0.0						CSCCC(NS(=O)(=O)c1ccc(C(C)(C)C)cc1)C(=O)O								Benzenesulfonamides;Phenylpropanes;Benzenesulfonyl compounds;Thia fatty acids;Organosulfonamides;Aminosulfonyl compounds;Sulfenyl compounds;Monocarboxylic acids and derivatives;Dialkylthioethers;Carboxylic acids;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Aminosulfonyl compounds;Benzene and substituted derivatives;Benzenesulfonamides;Benzenesulfonyl compounds;Benzenoids;Carbonyl compounds;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Dialkylthioethers;Fatty Acyls;Fatty acids and conjugates;Hydrocarbon derivatives;Lipids and lipid-like molecules;Methionine and derivatives;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organic sulfonic acids and derivatives;Organonitrogen compounds;Organooxygen compounds;Organosulfonamides;Organosulfonic acids and derivatives;Organosulfur compounds;Phenylpropanes;Sulfenyl compounds;Sulfonyls;Thia fatty acids;Thioethers	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as methionine and derivatives. These are compounds containing methionine or a derivative thereof resulting from reaction of methionine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Methionine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic homomonocyclic compounds	sulfonamide (CHEBI:35358);alkylbenzene (CHEBI:38976);benzenes (CHEBI:22712);organosulfur compound (CHEBI:33261);thia fatty acid (CHEBI:59643);organonitrogen compound (CHEBI:35352);monocarboxylic acid (CHEBI:25384);aliphatic sulfide (CHEBI:22327);carboxylic acid (CHEBI:33575);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);alpha-amino acid (CHEBI:33704);methionine derivative (CHEBI:25230);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);lipid (CHEBI:18059);organooxygen compound (CHEBI:36963);organic acid (CHEBI:64709);sulfonic acid derivative (CHEBI:33552);organic molecular entity (CHEBI:50860);sulfone (CHEBI:35850);organic sulfide (CHEBI:16385);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806)	Thia fatty acids (FA0113);Fatty Acyls (FA);Fatty Acids and Conjugates (FA01)	Amino acids, peptides, and analogues	Methionine or derivatives;Benzenesulfonamide;Phenylpropane;Benzenesulfonyl group;Thia fatty acid;Monocyclic benzene moiety;Fatty acyl;Benzenoid;Organosulfonic acid amide;Organic sulfonic acid or derivatives;Organosulfonic acid or derivatives;Aminosulfonyl compound;Sulfonyl;Carboxylic acid;Monocarboxylic acid or derivatives;Dialkylthioether;Sulfenyl compound;Thioether;Organosulfur compound;Organooxygen compound;Organonitrogen compound;Organic nitrogen compound;Organic oxide;Hydrocarbon derivative;Organic oxygen compound;Carbonyl group;Aromatic homomonocyclic compound	Organic acids and derivatives	0.0		((4-(tert-butyl)phenyl)sulfonyl)methionine		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0		C15H23NO4S2	C15H23NO4S2			InChI=1S/C15H23NO4S2/c1-15(2,3)11-5-7-12(8-6-11)22(19,20)16-13(14(17)18)9-10-21-4/h5-8,13,16H,9-10H2,1-4H3,(H,17,18)	VMWPZNUUHUVDSP-UHFFFAOYSA-N	2-[(4-tert-butylphenyl)sulfonylamino]-4-methylsulfanyl-butanoic acid	44669181	CSCCC(NS(=O)(=O)c1ccc(C(C)(C)C)cc1)C(=O)O	2-[(4-tert-butylphenyl)sulfonylamino]-4-methylsulfanylbutanoic acid			2.30598													MCULE-9932844607	345.48286		345.10685	5	2	8	1			45										False					Peptide01			Compound(44669181)	44669181	3.2	694			[#6]-[#16]-[#6]-[#6]-[#6](-[#7]-[#16](=[#8])(=[#8])-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6])(-[#6])-[#6]):[#6]:[#6]:1)-[#6](=[#8])-[#8]	CSCCC(NS(=O)(=O)c1ccc(C(C)(C)C)cc1)C(=O)O	VMWPZNUUHUVDSP		parent_pubchem_cid	((4-(tert-butyl)phenyl)sulfonyl)methionine;1393654-69-7;2-[(4-tert-butylphenyl)sulfonylamino]-4-methylsulfanylbutanoic acid;AKOS000813599;AKOS016387098;F9995-0700;2-[(4-tert-butylphenyl)sulfonylamino]-4-methylsulfanyl-butanoic acid		22942265.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22942265		pluskal_iocb_peptide_Peptide01_D15_id		100	D15		
0.4		0	445	P2195935	130.0		R2	False	0	15	0	0	20	0	2	5	0	1		0.0						COc1ccc(C(=O)NCC(=O)NC(CCSC)C(=O)O)cc1																							0.0		SCHEMBL9830091		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C15H20N2O5S	C15H20N2O5S			InChI=1S/C15H20N2O5S/c1-22-11-5-3-10(4-6-11)14(19)16-9-13(18)17-12(15(20)21)7-8-23-2/h3-6,12H,7-9H2,1-2H3,(H,16,19)(H,17,18)(H,20,21)	OBLDFJBGOLAETJ-UHFFFAOYSA-N	2-[[2-[(4-methoxybenzoyl)amino]acetyl]amino]-4-methylsulfanyl-butanoic acid	20132361	COc1ccc(C(=O)NCC(=O)NC(CCSC)C(=O)O)cc1	2-[[2-[(4-methoxybenzoyl)amino]acetyl]amino]-4-methylsulfanylbutanoic acid			0.2303800000000008													MCULE-3218174721	340.40105		340.109293	6	3	9	1			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(20132361)	20132361	1.2	695		SCHEMBL9830091	[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](=[#8])-[#7]-[#6]-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]-[#16]-[#6])-[#6](=[#8])-[#8]):[#6]:[#6]:1	COc1ccc(C(=O)NCC(=O)NC(CCSC)C(=O)O)cc1	OBLDFJBGOLAETJ		parent_pubchem_cid	SCHEMBL9830091;AKOS015861819;2-[[2-[(4-methoxybenzoyl)amino]acetyl]amino]-4-methylsulfanyl-butanoic acid		24035481.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24035481		pluskal_iocb_peptide_Peptide01_D15_id		100	D15		
4.3		0	533	P2195085	109.3		R3	False	0	21	1	1	18	0	4	2	0	1		0.0						CSc1ncc(Cl)c(C(=O)NC(Cc2ccccc2)C(=O)Nc2ccc(F)cc2)n1																							0.0		AKOS015861176		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C21H18ClFN4O2S	C21H18ClFN4O2S			InChI=1S/C21H18ClFN4O2S/c1-30-21-24-12-16(22)18(27-21)20(29)26-17(11-13-5-3-2-4-6-13)19(28)25-15-9-7-14(23)8-10-15/h2-10,12,17H,11H2,1H3,(H,25,28)(H,26,29)	FRUWYQSYVKOWAI-UHFFFAOYSA-N	N-[1-benzyl-2-(4-fluoroanilino)-2-oxo-ethyl]-5-chloro-2-methylsulfanyl-pyrimidine-4-carboxamide	51065622	CSc1ncc(Cl)c(C(=O)NC(Cc2ccccc2)C(=O)Nc2ccc(F)cc2)n1	5-chloro-N-[1-(4-fluoroanilino)-1-oxo-3-phenylpropan-2-yl]-2-methylsulfanylpyrimidine-4-carboxamide			3.3727600000000013													MCULE-9017066317	444.91861		444.082303	5	2	7	3			45										False					Peptide01			Compound(51065622)	51065622	4.3	696			[#6]-[#16]-[#6]1:[#7]:[#6]:[#6](-[#17]):[#6](-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#7]-[#6]2:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:2):[#7]:1	CSc1ncc(Cl)c(C(=O)NC(Cc2ccccc2)C(=O)Nc2ccc(F)cc2)n1	FRUWYQSYVKOWAI		parent_pubchem_cid	AKOS015861176;N-[1-benzyl-2-(4-fluoroanilino)-2-oxo-ethyl]-5-chloro-2-methylsulfanyl-pyrimidine-4-carboxamide		23834757.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23834757		pluskal_iocb_peptide_Peptide01_D16_id		100	D16		
4.2		0	621	P1304018	107.9		R4	False	0	25	0	0	19	0	3	5	0	0		0.0						O=C1c2c(c(-c3ccccc3O)n[nH]2)C(c2ccc(O)cc2)N1Cc1cc2c(cc1)OCO2																							0.0		AKOS002332926		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	0	2	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C25H19N3O5	C25H19N3O5			InChI=1S/C25H19N3O5/c29-16-8-6-15(7-9-16)24-21-22(17-3-1-2-4-18(17)30)26-27-23(21)25(31)28(24)12-14-5-10-19-20(11-14)33-13-32-19/h1-11,24,29-30H,12-13H2,(H,26,27)	MBNYXWWYELYPEF-UHFFFAOYSA-N	5-(1,3-benzodioxol-5-ylmethyl)-3-(2-hydroxyphenyl)-4-(4-hydroxyphenyl)-1,4-dihydropyrrolo[3,4-c]pyrazol-6-one	135888188	O=C1c2c(c(-c3ccccc3O)n[nH]2)C(c2ccc(O)cc2)N1Cc1cc2c(cc1)OCO2	5-(1,3-benzodioxol-5-ylmethyl)-3-(2-hydroxyphenyl)-4-(4-hydroxyphenyl)-1,4-dihydropyrrolo[3,4-c]pyrazol-6-one			1.5135													MCULE-4700305986	441.44728		441.132471	6	3	4	6			45										False	Alkaloids				Peptide01			Compound(135888188)	135888188	3.5	697			[#8]=[#6]1-[#6]2:[#6](:[#6](-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3-[#8]):[#7]:[#7H]:2)-[#6](-[#6]2:[#6]:[#6]:[#6](-[#8]):[#6]:[#6]:2)-[#7]-1-[#6]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1)-[#8]-[#6]-[#8]-2	O=C1c2c(c(-c3ccccc3O)n[nH]2)C(c2ccc(O)cc2)N1Cc1cc2c(cc1)OCO2	MBNYXWWYELYPEF		parent_pubchem_cid	AKOS002332926;AKOS016325019;5-(benzo[d][1,3]dioxol-5-ylmethyl)-3-(2-hydroxyphenyl)-4-(4-hydroxyphenyl)-4,5-dihydropyrrolo[3,4-c]pyrazol-6(1h)-one;5-(1,3-benzodioxol-5-ylmethyl)-3-(2-hydroxyphenyl)-4-(4-hydroxyphenyl)-1,4-dihydropyrrolo[3,4-c]pyrazol-6-one		24419827.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24419827		pluskal_iocb_peptide_Peptide01_D16_id		100	D16		
3.3		0	365	P1107425	112.9		R5	False	0	22	0	0	21	0	1	6	0	0		0.0						Cc1c(CCC(=O)NC(Cc2ccccc2)C(=O)O)c(=O)oc2c1ccc(O)c2																							0.0		AKOS004937843		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C22H21NO6	C22H21NO6			InChI=1S/C22H21NO6/c1-13-16-8-7-15(24)12-19(16)29-22(28)17(13)9-10-20(25)23-18(21(26)27)11-14-5-3-2-4-6-14/h2-8,12,18,24H,9-11H2,1H3,(H,23,25)(H,26,27)/t18-/m1/s1	DJSBYOCVGPTSDU-GOSISDBHSA-N	rac-(2R)-2-[3-(7-hydroxy-4-methyl-2-oxo-chromen-3-yl)propanoylamino]-3-phenyl-propanoic acid	24280406	Cc1c(CCC(=O)N[C@H](Cc2ccccc2)C(=O)O)c(=O)oc2c1ccc(O)c2	(2R)-2-[3-(7-hydroxy-4-methyl-2-oxochromen-3-yl)propanoylamino]-3-phenylpropanoic acid			2.39665													MCULE-7401051192	395.41577		395.136887	6	3	7	3			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(24280406)	24280406	2.6	698			[#6]-[#6]1:[#6](-[#6]-[#6]-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#8]):[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]):[#6]:2	Cc1c(CCC(=O)N[C@H](Cc2ccccc2)C(=O)O)c(=O)oc2c1ccc(O)c2	DJSBYOCVGPTSDU		parent_pubchem_cid	AKOS004937843;rac-(2R)-2-[3-(7-hydroxy-4-methyl-2-oxo-chromen-3-yl)propanoylamino]-3-phenyl-propanoic acid		22940210.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22940210		pluskal_iocb_peptide_Peptide01_D16_id		100	D16		ZINC000011865405
4.6		0	453	P2195368	109.3		R6	False	0	23	1	0	23	0	4	2	0	1		0.0						CSc1ncc(Cl)c(C(=O)NC(Cc2ccccc2)C(=O)NCc2ccc(C)cc2)n1																							0.0		AKOS015861449		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C23H23ClN4O2S	C23H23ClN4O2S			InChI=1S/C23H23ClN4O2S/c1-15-8-10-17(11-9-15)13-25-21(29)19(12-16-6-4-3-5-7-16)27-22(30)20-18(24)14-26-23(28-20)31-2/h3-11,14,19H,12-13H2,1-2H3,(H,25,29)(H,27,30)	WYQXAKSATMQYJT-UHFFFAOYSA-N	N-[1-benzyl-2-oxo-2-(p-tolylmethylamino)ethyl]-5-chloro-2-methylsulfanyl-pyrimidine-4-carboxamide	51065837	CSc1ncc(Cl)c(C(=O)NC(Cc2ccccc2)C(=O)NCc2ccc(C)cc2)n1	5-chloro-N-[1-[(4-methylphenyl)methylamino]-1-oxo-3-phenylpropan-2-yl]-2-methylsulfanylpyrimidine-4-carboxamide			3.4909700000000017													MCULE-4448469792	454.98236		454.123025	5	2	8	3			45									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(51065837)	51065837	4.5	699			[#6]-[#16]-[#6]1:[#7]:[#6]:[#6](-[#17]):[#6](-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#7]-[#6]-[#6]2:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:2):[#7]:1	CSc1ncc(Cl)c(C(=O)NC(Cc2ccccc2)C(=O)NCc2ccc(C)cc2)n1	WYQXAKSATMQYJT		parent_pubchem_cid	AKOS015861449;N-[1-benzyl-2-oxo-2-(p-tolylmethylamino)ethyl]-5-chloro-2-methylsulfanyl-pyrimidine-4-carboxamide		23992256.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23992256		pluskal_iocb_peptide_Peptide01_D16_id		100	D16		
1.8		0	541	P2194165	93.7		R7	False	0	18	0	0	26	0	2	5	0	0		0.0						COC(=O)C(CC(C)C)NC(=O)CCNC(=O)c1ccc(OC)cc1																							0.0		STL217637		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C18H26N2O5	C18H26N2O5			InChI=1S/C18H26N2O5/c1-12(2)11-15(18(23)25-4)20-16(21)9-10-19-17(22)13-5-7-14(24-3)8-6-13/h5-8,12,15H,9-11H2,1-4H3,(H,19,22)(H,20,21)	VPJGZDBIUDOXKS-UHFFFAOYSA-N	methyl 2-[3-[(4-methoxybenzoyl)amino]propanoylamino]-4-methyl-pentanoate	51064959	COC(=O)C(CC(C)C)NC(=O)CCNC(=O)c1ccc(OC)cc1	methyl 2-[3-[(4-methoxybenzoyl)amino]propanoylamino]-4-methylpentanoate			1.0018800000000003													MCULE-8442976368	350.41832		350.184172	5	2	10	1			45									Simple amide alkaloids	False	Alkaloids	Peptide alkaloids			Peptide01			Compound(51064959)	51064959	2.1	700			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=[#8])-[#6]-[#6]-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:1	COC(=O)C(CC(C)C)NC(=O)CCNC(=O)c1ccc(OC)cc1	VPJGZDBIUDOXKS		parent_pubchem_cid	STL217637;AKOS015860393;methyl N-[(4-methoxyphenyl)carbonyl]-beta-alanylleucinate;methyl 2-[3-[(4-methoxybenzoyl)amino]propanoylamino]-4-methyl-pentanoate		23936100.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23936100		pluskal_iocb_peptide_Peptide01_D16_id		100	D16		
4.9		0	629	P1301240	63.4		R8	False	0	26	0	0	26	0	2	3	0	0		0.0						CCOc1c(OC)cc(C(CNC(=O)c2ccccc2)c2c[nH]c3ccccc23)cc1																							0.0		N-[2-(4-ethoxy-3-methoxyphenyl)-2-(1H-indol-3-yl)ethyl]benzamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C26H26N2O3	C26H26N2O3			InChI=1S/C26H26N2O3/c1-3-31-24-14-13-19(15-25(24)30-2)21(16-28-26(29)18-9-5-4-6-10-18)22-17-27-23-12-8-7-11-20(22)23/h4-15,17,21,27H,3,16H2,1-2H3,(H,28,29)	UVCVDKPRUSJHPG-UHFFFAOYSA-N	N-[2-(4-ethoxy-3-methoxy-phenyl)-2-(1H-indol-3-yl)ethyl]benzamide	17010959	CCOc1c(OC)cc(C(CNC(=O)c2ccccc2)c2c[nH]c3ccccc23)cc1	N-[2-(4-ethoxy-3-methoxyphenyl)-2-(1H-indol-3-yl)ethyl]benzamide			3.6197300000000014													MCULE-1243709785	414.50872		414.194343	3	2	8	4			45										False	Alkaloids				Peptide01			Compound(17010959)	17010959	5.0	701			[#6]-[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]):[#6]:[#6](-[#6](-[#6]-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	CCOc1c(OC)cc(C(CNC(=O)c2ccccc2)c2c[nH]c3ccccc23)cc1	UVCVDKPRUSJHPG		parent_pubchem_cid	N-[2-(4-ethoxy-3-methoxyphenyl)-2-(1H-indol-3-yl)ethyl]benzamide;AKOS002326714;AKOS016325488;N-[2-(4-ethoxy-3-methoxy-phenyl)-2-(1H-indol-3-yl)ethyl]benzamide		23890501.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23890501		pluskal_iocb_peptide_Peptide01_D16_id		100	D16		
1.2		0	373	P5970151	75.6		R9	False	0	13	0	0	17	0	1	4	0	0	-1.0	0.0						CCOC(=O)C(Cc1ccc(O)cc1)NC(C)=O	28828.0	1.0		0.0	1.1	CHEMBL3278820		Phenylalanine and derivatives;N-acyl-alpha amino acids and derivatives;Alpha amino acid esters;Amphetamines and derivatives;Fatty acid esters;1-hydroxy-2-unsubstituted benzenoids;Acetamides;Secondary carboxylic acid amides;Carboxylic acid esters;Monocarboxylic acids and derivatives;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	1-hydroxy-2-unsubstituted benzenoids;Acetamides;Alpha amino acid esters;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids and derivatives;Chemical entities;Fatty Acyls;Fatty acid esters;Hydrocarbon derivatives;Lipids and lipid-like molecules;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenethylamines;Phenols;Phenylalanine and derivatives;Secondary carboxylic acid amides;Tyrosine and derivatives	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as tyrosine and derivatives. These are compounds containing tyrosine or a derivative thereof resulting from reaction of tyrosine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Tyrosine and derivatives	CHEBI (CHEBI:28828):['ethyl ester', 'phenols', 'acetamides', 'L-tyrosine derivative']	Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic homomonocyclic compounds	phenylalanine derivative (CHEBI:25985);N-acyl-amino acid (CHEBI:51569);alpha-amino acid ester (CHEBI:46874);amphetamines (CHEBI:35338);fatty acid ester (CHEBI:35748);phenols (CHEBI:33853);acetamides (CHEBI:22160);carboxamide (CHEBI:37622);carboxylic ester (CHEBI:33308);carbonyl compound (CHEBI:36586);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);tyrosine derivative (CHEBI:62761);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);amino acid (CHEBI:33709);peptide (CHEBI:16670);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);primary amine (CHEBI:32877);lipid (CHEBI:18059);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806)	Fatty esters (FA07);Fatty Acyls (FA)	Amino acids, peptides, and analogues	Tyrosine or derivatives;Phenylalanine or derivatives;Alpha-amino acid ester;N-acyl-alpha amino acid or derivatives;Amphetamine or derivatives;1-hydroxy-2-unsubstituted benzenoid;Fatty acid ester;Phenol;Fatty acyl;Benzenoid;Monocyclic benzene moiety;Acetamide;Secondary carboxylic acid amide;Carboxamide group;Carboxylic acid ester;Monocarboxylic acid or derivatives;Organic oxide;Organic oxygen compound;Organic nitrogen compound;Organonitrogen compound;Organooxygen compound;Carbonyl group;Hydrocarbon derivative;Organopnictogen compound;Aromatic homomonocyclic compound	Organic acids and derivatives	0.0		840-97-1	DTXSID20877256	2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C13H17NO4	C13H17NO4			InChI=1S/C13H17NO4/c1-3-18-13(17)12(14-9(2)15)8-10-4-6-11(16)7-5-10/h4-7,12,16H,3,8H2,1-2H3,(H,14,15)/t12-/m0/s1	SKAWDTAMLOJQNK-LBPRGKRZSA-N	ethyl (2S)-2-acetamido-3-(4-hydroxyphenyl)propanoate	13289	CCOC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O	ethyl (2S)-2-acetamido-3-(4-hydroxyphenyl)propanoate	C01657		0.48538													MCULE-6383679429	251.28474	NEUTRAL	251.115758	4	2	6	1	1.0		24									Dipeptides	False	Amino acids and Peptides	Small peptides	False	False	Peptide01		-1.0	Compound(13289)	13289	0.7	702		SCHEMBL468756	[#6]-[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#6]:[#6](-[#8]):[#6]:[#6]:1)-[#7]-[#6](-[#6])=[#8]	CCOC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O	SKAWDTAMLOJQNK		parent_pubchem_cid	840-97-1;Ethyl N-acetyl-L-tyrosinate;Ac-Tyr-OEt;N-ACETYL-L-TYROSINE ETHYL ESTER;(S)-Ethyl 2-acetamido-3-(4-hydroxyphenyl)propanoate;ethyl (2S)-2-acetamido-3-(4-hydroxyphenyl)propanoate;N-Acetyl-L-tyrosine ethyl ester monohydrate;L-Tyrosine, N-acetyl-, ethyl ester;Ethyl N-alpha-acetyl-tyrosinate;Ethyl acetyl-l-tyrosinate;acetyltyrosine ethyl ester;CHEBI:28828;N-Acetyltyrosine ethyl ester;Ethyl acetyltyrosine;EINECS 212-663-5;MFCD00002389;NSC 64725;NSC 87506;Ethyl acetyltyrosinate;Tyrosine, N-acetyl-, ethyl ester, L-;L-ATEE;Acetyl-L-tyrosine ethyl ester;N-Acetyl-L-tyrosyl ethyl ester;N-Acetyltyrosine ethyl ester monohydrate;L-Tyrosine, N-acetyl-, ethyl ester, monohydrate;L-Tyrosine, N-acetyl-, ethyl ester, hydrate (1:1);Ac-Tyr.OEt;N-Acetyl-L-Tyrosineethylestermonohydrate;N-Acetyl-L-tyrosine ethyl;N-acetyl tyrosine ethylester;n-acetyl tyrosine ethyl ester;SCHEMBL468756;CHEMBL3278820;DTXSID20877256;SKAWDTAMLOJQNK-LBPRGKRZSA-N;AMY25349;AKOS016844077;HY-W236261;AS-68931;A0118;CS-0298722;Ethyl N-acetyl-L-tyrosinate (Ac-L-Tyr-OEt);C01657;D87592;EN300-302678;(S)-Ethyl2-acetamido-3-(4-hydroxyphenyl)propanoate;W-106602;Q27103918	False	1066930.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=1066930		pluskal_iocb_peptide_Peptide01_D16_id		100	D16	False	ZINC000001529249
2.6		0	461	P2195235	84.5		R10	False	0	21	0	0	24	0	2	4	0	0		0.0						COC(=O)CCNC(=O)C(Cc1ccccc1)NC(=O)c1ccc(C)cc1								Phenylalanine and derivatives;N-acyl-alpha amino acids and derivatives;Hippuric acids and derivatives;Alpha amino acid amides;Beta amino acids and derivatives;Amphetamines and derivatives;p-Toluamides;Benzoyl derivatives;Fatty amides;Methyl esters;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acid amides;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Benzamides;Benzene and substituted derivatives;Benzenoids;Benzoic acids and derivatives;Benzoyl derivatives;Beta amino acids and derivatives;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids and derivatives;Chemical entities;Fatty Acyls;Fatty amides;Hippuric acids and derivatives;Hybrid peptides;Hydrocarbon derivatives;Lipids and lipid-like molecules;Methyl esters;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Peptidomimetics;Phenethylamines;Phenylalanine and derivatives;Secondary carboxylic acid amides;Toluamides;Toluenes;p-Toluamides	Peptidomimetics	2.1	This compound belongs to the class of organic compounds known as hybrid peptides. These are compounds containing at least two different types of amino acids (alpha, beta, gamma, delta) linked to each other through a peptide bond.	Hybrid peptides			Organic compounds	Aromatic homomonocyclic compounds	phenylalanine derivative (CHEBI:25985);N-acyl-amino acid (CHEBI:51569);benzamides (CHEBI:22702);N-acylglycine (CHEBI:16180);phenols (CHEBI:33853);amino acid amide (CHEBI:22475);organonitrogen compound (CHEBI:35352);organooxygen compound (CHEBI:36963);amphetamines (CHEBI:35338);carbonyl compound (CHEBI:36586);fatty amide (CHEBI:29348);carboxylic ester (CHEBI:33308);carboxamide (CHEBI:37622);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);peptide (CHEBI:16670);chemical entity (CHEBI:24431);amino acid (CHEBI:33709);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);primary amine (CHEBI:32877);toluenes (CHEBI:27024);lipid (CHEBI:18059);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806);peptidomimetic (CHEBI:63175)	Fatty amides (FA08);Fatty Acyls (FA)	Hybrid peptides	Hybrid peptide;Phenylalanine or derivatives;N-acyl-alpha amino acid or derivatives;Hippuric acid or derivatives;Alpha-amino acid amide;Beta amino acid or derivatives;Amphetamine or derivatives;Alpha-amino acid or derivatives;N-substituted-alpha-amino acid;P-toluamide;Toluamide;Benzoic acid or derivatives;Benzamide;Benzoyl;Toluene;Fatty acyl;Benzenoid;Fatty amide;Monocyclic benzene moiety;Methyl ester;Secondary carboxylic acid amide;Carboxylic acid ester;Carboxamide group;Monocarboxylic acid or derivatives;Carboxylic acid derivative;Organic nitrogen compound;Organic oxygen compound;Organopnictogen compound;Organic oxide;Hydrocarbon derivative;Organooxygen compound;Organonitrogen compound;Carbonyl group;Aromatic homomonocyclic compound	Organic acids and derivatives	0.0		AKOS015861314		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C21H24N2O4	C21H24N2O4			InChI=1S/C21H24N2O4/c1-15-8-10-17(11-9-15)20(25)23-18(14-16-6-4-3-5-7-16)21(26)22-13-12-19(24)27-2/h3-11,18H,12-14H2,1-2H3,(H,22,26)(H,23,25)	AMSKNBCNDMHFOW-UHFFFAOYSA-N	methyl 3-[[2-[(4-methylbenzoyl)amino]-3-phenyl-propanoyl]amino]propanoate	51065743	COC(=O)CCNC(=O)C(Cc1ccccc1)NC(=O)c1ccc(C)cc1	methyl 3-[[2-[(4-methylbenzoyl)amino]-3-phenylpropanoyl]amino]propanoate			1.8512899999999988													MCULE-3630452506	368.43643		368.173607	4	2	9	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51065743)	51065743	2.7	703			[#6]-[#8]-[#6](=[#8])-[#6]-[#6]-[#7]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:1	COC(=O)CCNC(=O)C(Cc1ccccc1)NC(=O)c1ccc(C)cc1	AMSKNBCNDMHFOW		parent_pubchem_cid	AKOS015861314;methyl 3-[[2-[(4-methylbenzoyl)amino]-3-phenyl-propanoyl]amino]propanoate		22813726.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22813726		pluskal_iocb_peptide_Peptide01_D16_id		100	D16		
4.9		0	549	P2195876	118.5		R11	False	0	24	1	0	25	0	4	3	0	1		0.0						CCCSc1ncc(Cl)c(C(=O)NC(Cc2ccccc2)C(=O)Nc2ccc(OC)cc2)n1																							0.0		AKOS015861838		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C24H25ClN4O3S	C24H25ClN4O3S			InChI=1S/C24H25ClN4O3S/c1-3-13-33-24-26-15-19(25)21(29-24)23(31)28-20(14-16-7-5-4-6-8-16)22(30)27-17-9-11-18(32-2)12-10-17/h4-12,15,20H,3,13-14H2,1-2H3,(H,27,30)(H,28,31)	FBWNJXXFJVLEHB-UHFFFAOYSA-N	N-[1-benzyl-2-(4-methoxyanilino)-2-oxo-ethyl]-5-chloro-2-propylsulfanyl-pyrimidine-4-carboxamide	52988634	CCCSc1ncc(Cl)c(C(=O)NC(Cc2ccccc2)C(=O)Nc2ccc(OC)cc2)n1	5-chloro-N-[1-(4-methoxyanilino)-1-oxo-3-phenylpropan-2-yl]-2-propylsulfanylpyrimidine-4-carboxamide			3.5600500000000013													MCULE-7821695423	485.00885		484.133589	6	2	10	3			45										False					Peptide01			Compound(52988634)	52988634	5.0	704			[#6]-[#6]-[#6]-[#16]-[#6]1:[#7]:[#6]:[#6](-[#17]):[#6](-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#7]-[#6]2:[#6]:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:2):[#7]:1	CCCSc1ncc(Cl)c(C(=O)NC(Cc2ccccc2)C(=O)Nc2ccc(OC)cc2)n1	FBWNJXXFJVLEHB		parent_pubchem_cid	AKOS015861838;N-[1-benzyl-2-(4-methoxyanilino)-2-oxo-ethyl]-5-chloro-2-propylsulfanyl-pyrimidine-4-carboxamide		24042202.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24042202		pluskal_iocb_peptide_Peptide01_D17_id		100	D17		
5.0		0	637	P1308372	54.6		R12	False	0	26	0	0	26	0	2	3	0	0		0.0						CCN(C(=O)c1cc(OC)ccc1)C(c1ccc(OC)cc1)c1c[nH]c2ccccc12																							0.0		AKOS002297839		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C26H26N2O3	C26H26N2O3			InChI=1S/C26H26N2O3/c1-4-28(26(29)19-8-7-9-21(16-19)31-3)25(18-12-14-20(30-2)15-13-18)23-17-27-24-11-6-5-10-22(23)24/h5-17,25,27H,4H2,1-3H3	NNLVYGSAQRIDLM-UHFFFAOYSA-N	N-ethyl-N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-3-methoxy-benzamide	43843353	CCN(C(=O)c1cc(OC)ccc1)C(c1ccc(OC)cc1)c1c[nH]c2ccccc12	N-ethyl-N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-3-methoxybenzamide			3.919430000000003													MCULE-3387605979	414.50872		414.194343	3	1	7	4			45										False	Alkaloids				Peptide01			Compound(43843353)	43843353	5.0	705			[#6]-[#6]-[#7](-[#6](=[#8])-[#6]1:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:[#6]:1)-[#6](-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CCN(C(=O)c1cc(OC)ccc1)C(c1ccc(OC)cc1)c1c[nH]c2ccccc12	NNLVYGSAQRIDLM		parent_pubchem_cid	AKOS002297839;AKOS016330253;N-ethyl-N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-3-methoxy-benzamide		24605478.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24605478		pluskal_iocb_peptide_Peptide01_D17_id		100	D17		
1.0		0	381	P1107480	168.1		R13	False	0	19	0	0	23	0	3	7	0	0	-1.0	0.0						Cc1cc(O)c2c(C)c(CC(=O)NC(CCCNC(N)=O)C(=O)O)c(=O)oc2c1		0.68		0.0	0.18	CHEMBL1163263		Hydroxycoumarins;1-benzopyrans;Pyranones and derivatives;1-hydroxy-2-unsubstituted benzenoids;1-hydroxy-4-unsubstituted benzenoids;Heteroaromatic compounds;Ureas;Secondary carboxylic acid amides;Lactones;Oxacyclic compounds;Carboxylic acids;Monocarboxylic acids and derivatives;Carbonyl compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	1-benzopyrans;1-hydroxy-2-unsubstituted benzenoids;1-hydroxy-4-unsubstituted benzenoids;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;Heteroaromatic compounds;Hydrocarbon derivatives;Hydroxycoumarins;Lactones;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenols;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Secondary carboxylic acid amides;Ureas	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom.	N-acyl-alpha amino acids		Amino acids and derivatives;Alpha amino acids and derivatives;N-acyl-alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	hydroxycoumarin (CHEBI:37912);1-benzopyran (CHEBI:38443);pyranone (CHEBI:37963);phenols (CHEBI:33853);organic aromatic compound (CHEBI:33659);ureas (CHEBI:47857);carboxamide (CHEBI:37622);lactone (CHEBI:25000);oxacycle (CHEBI:38104);carboxylic acid (CHEBI:33575);monocarboxylic acid (CHEBI:25384);carbonyl compound (CHEBI:36586);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);N-acyl-amino acid (CHEBI:51569);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);coumarins (CHEBI:23403);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);pyrans (CHEBI:26407);benzenoid aromatic compound (CHEBI:33836);organic acid (CHEBI:64709);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143);carboxylic acid anion (CHEBI:29067);amino acid (CHEBI:33709);peptide (CHEBI:16670)	Benzopyranoids (PK1311)	Amino acids, peptides, and analogues	N-acyl-alpha-amino acid;Hydroxycoumarin;Coumarin;Benzopyran;1-benzopyran;1-hydroxy-4-unsubstituted benzenoid;1-hydroxy-2-unsubstituted benzenoid;Phenol;Pyranone;Pyran;Benzenoid;Heteroaromatic compound;Secondary carboxylic acid amide;Lactone;Carboxamide group;Urea;Organoheterocyclic compound;Oxacycle;Monocarboxylic acid or derivatives;Carboxylic acid;Organooxygen compound;Organonitrogen compound;Hydrocarbon derivative;Organic oxide;Organic oxygen compound;Carbonyl group;Organic nitrogen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		CHEMBL1163263		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C19H23N3O7	C19H23N3O7			InChI=1S/C19H23N3O7/c1-9-6-13(23)16-10(2)11(18(27)29-14(16)7-9)8-15(24)22-12(17(25)26)4-3-5-21-19(20)28/h6-7,12,23H,3-5,8H2,1-2H3,(H,22,24)(H,25,26)(H3,20,21,28)/t12-/m1/s1	IGODCUREOYTJPM-GFCCVEGCSA-N	rac-(2R)-2-[[2-(5-hydroxy-4,7-dimethyl-2-oxo-chromen-3-yl)acetyl]amino]-5-ureido-pentanoic acid	24280444	Cc1cc(O)c2c(C)c(CC(=O)N[C@H](CCCNC(N)=O)C(=O)O)c(=O)oc2c1	(2R)-5-(carbamoylamino)-2-[[2-(5-hydroxy-4,7-dimethyl-2-oxochromen-3-yl)acetyl]amino]pentanoic acid			0.5207700000000007													MCULE-7805483758	405.41106	ACID	405.1536	7	5	8	2	1.0		29									Dipeptides;Simple coumarins	False	Amino acids and Peptides;Shikimates and Phenylpropanoids	Coumarins;Small peptides	False	False	Peptide01		-1.0	Compound(24280444)	24280444	0.1	706			[#6]-[#6]1:[#6]:[#6](-[#8]):[#6]2:[#6](-[#6]):[#6](-[#6]-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#8])-[#6](=[#8])-[#8]):[#6](=[#8]):[#8]:[#6]:2:[#6]:1	Cc1cc(O)c2c(C)c(CC(=O)N[C@H](CCCNC(N)=O)C(=O)O)c(=O)oc2c1	IGODCUREOYTJPM		parent_pubchem_cid	CHEMBL1163263;BDBM50320641;AKOS016392233;(R)-2-(2-(5-hydroxy-4,7-dimethyl-2-oxo-2H-chromen-3-yl)acetamido)-5-ureidopentanoic acid;5-(CARBAMOYLAMINO)-2-[2-(5-HYDROXY-4,7-DIMETHYL-2-OXO-2H-CHROMEN-3-YL)ACETAMIDO]PENTANOIC ACID;rac-(2R)-2-[[2-(5-hydroxy-4,7-dimethyl-2-oxo-chromen-3-yl)acetyl]amino]-5-ureido-pentanoic acid	False	605744.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=605744		pluskal_iocb_peptide_Peptide01_D17_id		100	D17	False	ZINC000011865442
3.5		0	469	P2195700	84.5		R14	False	0	22	0	0	34	0	2	4	0	0		0.0						COC(=O)CCCNC(=O)C(CC(C)C)NC(=O)c1ccc(C(C)(C)C)cc1																							0.0		AKOS015861644		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C22H34N2O4	C22H34N2O4			InChI=1S/C22H34N2O4/c1-15(2)14-18(21(27)23-13-7-8-19(25)28-6)24-20(26)16-9-11-17(12-10-16)22(3,4)5/h9-12,15,18H,7-8,13-14H2,1-6H3,(H,23,27)(H,24,26)	RPZJJSJMMQZIJV-UHFFFAOYSA-N	methyl 4-[[2-[(4-tert-butylbenzoyl)amino]-4-methyl-pentanoyl]amino]butanoate	52988569	COC(=O)CCCNC(=O)C(CC(C)C)NC(=O)c1ccc(C(C)(C)C)cc1	methyl 4-[[2-[(4-tert-butylbenzoyl)amino]-4-methylpentanoyl]amino]butanoate			3.088580000000001													MCULE-5455699274	390.52728		390.251858	4	2	11	1			45									Tripeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(52988569)	52988569	4.1	707			[#6]-[#8]-[#6](=[#8])-[#6]-[#6]-[#6]-[#7]-[#6](=[#8])-[#6](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6])(-[#6])-[#6]):[#6]:[#6]:1	COC(=O)CCCNC(=O)C(CC(C)C)NC(=O)c1ccc(C(C)(C)C)cc1	RPZJJSJMMQZIJV		parent_pubchem_cid	AKOS015861644;methyl 4-[[2-[(4-tert-butylbenzoyl)amino]-4-methyl-pentanoyl]amino]butanoate		24014805.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24014805		pluskal_iocb_peptide_Peptide01_D17_id		100	D17		
4.6		0	557	P2190592	45.3		R15	False	0	24	0	0	22	0	2	2	0	0		0.0						CN(C(=O)COc1ccccc1)C(c1ccccc1)c1c[nH]c2ccccc12																							0.0		AKOS004934495		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C24H22N2O2	C24H22N2O2			InChI=1S/C24H22N2O2/c1-26(23(27)17-28-19-12-6-3-7-13-19)24(18-10-4-2-5-11-18)21-16-25-22-15-9-8-14-20(21)22/h2-16,24-25H,17H2,1H3	JEHBARLSZOCDGF-UHFFFAOYSA-N	N-[1H-indol-3-yl(phenyl)methyl]-N-methyl-2-phenoxy-acetamide	45133012	CN(C(=O)COc1ccccc1)C(c1ccccc1)c1c[nH]c2ccccc12	N-[1H-indol-3-yl(phenyl)methyl]-N-methyl-2-phenoxyacetamide			3.794450000000002													MCULE-6467942001	370.45514		370.168128	2	1	6	4			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(45133012)	45133012	4.7	708			[#6]-[#7](-[#6](=[#8])-[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CN(C(=O)COc1ccccc1)C(c1ccccc1)c1c[nH]c2ccccc12	JEHBARLSZOCDGF		parent_pubchem_cid	AKOS004934495;N-[(1H-INDOL-3-YL)(PHENYL)METHYL]-N-METHYL-2-PHENOXYACETAMIDE;N-[1H-indol-3-yl(phenyl)methyl]-N-methyl-2-phenoxy-acetamide		23761325.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23761325		pluskal_iocb_peptide_Peptide01_D17_id		100	D17		
4.6		0	645	P1305257	54.1		R16	False	0	24	0	0	22	0	2	2	0	0		0.0						COc1ccc(C(CNC(=O)c2ccccc2)c2c[nH]c3ccccc23)cc1																							0.0		N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]benzamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C24H22N2O2	C24H22N2O2			InChI=1S/C24H22N2O2/c1-28-19-13-11-17(12-14-19)21(15-26-24(27)18-7-3-2-4-8-18)22-16-25-23-10-6-5-9-20(22)23/h2-14,16,21,25H,15H2,1H3,(H,26,27)	REVXWUIMWFLUGN-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]benzamide	17014414	COc1ccc(C(CNC(=O)c2ccccc2)c2c[nH]c3ccccc23)cc1	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]benzamide			3.683440000000002													MCULE-9825642930	370.45514		370.168128	2	2	6	4			44									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(17014414)	17014414	4.7	709			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6]-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	COc1ccc(C(CNC(=O)c2ccccc2)c2c[nH]c3ccccc23)cc1	REVXWUIMWFLUGN		parent_pubchem_cid	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]benzamide;STL207373;AKOS002335168;AKOS016326570		23116010.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23116010		pluskal_iocb_peptide_Peptide01_D17_id		100	D17		
2.4		0	389	P3463177	137.9		R17	False	0	23	0	0	22	0	4	4	0	1		0.0						COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)CSCc1nc(=O)c2ccccc2[nH]1																							0.0		methyl rac-(2S)-3-(1H-indol-3-yl)-2-[[2-[(4-oxo-3H-quinazolin-2-yl)methylsulfanyl]acetyl]amino]propanoate		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	0	0	0	0	0	0	0		C23H22N4O4S	C23H22N4O4S			InChI=1S/C23H22N4O4S/c1-31-23(30)19(10-14-11-24-17-8-4-2-6-15(14)17)26-21(28)13-32-12-20-25-18-9-5-3-7-16(18)22(29)27-20/h2-9,11,19,24H,10,12-13H2,1H3,(H,26,28)(H,25,27,29)/t19-/m0/s1	WWYPPSIJXVIHEV-IBGZPJMESA-N	methyl rac-(2S)-3-(1H-indol-3-yl)-2-[[2-[(4-oxo-3H-quinazolin-2-yl)methylsulfanyl]acetyl]amino]propanoate	45494227	COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CSCc1nc(=O)c2ccccc2[nH]1	methyl (2S)-3-(1H-indol-3-yl)-2-[[2-[(4-oxo-1H-quinazolin-2-yl)methylsulfanyl]acetyl]amino]propanoate			2.47173													MCULE-8972161935	450.52019		450.136176	6	3	9	4			44										False	Alkaloids				Peptide01			Compound(45494227)	45494227	2.8	710			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#6](=[#8])-[#6]-[#16]-[#6]-[#6]1:[#7]:[#6](=[#8]):[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#7H]:1	COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CSCc1nc(=O)c2ccccc2[nH]1	WWYPPSIJXVIHEV		parent_pubchem_cid	methyl rac-(2S)-3-(1H-indol-3-yl)-2-[[2-[(4-oxo-3H-quinazolin-2-yl)methylsulfanyl]acetyl]amino]propanoate		18134515.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=18134515		pluskal_iocb_peptide_Peptide01_D17_id		100	D17		ZINC000035686421
4.2		0	477	P2195223	84.5		R18	False	0	23	1	0	27	0	2	4	0	0		0.0						COC(=O)C(Cc1ccccc1)NC(=O)C(CC(C)C)NC(=O)c1ccc(Cl)cc1																							0.0		AKOS015861271		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	2	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C23H27ClN2O4	C23H27ClN2O4			InChI=1S/C23H27ClN2O4/c1-15(2)13-19(25-21(27)17-9-11-18(24)12-10-17)22(28)26-20(23(29)30-3)14-16-7-5-4-6-8-16/h4-12,15,19-20H,13-14H2,1-3H3,(H,25,27)(H,26,28)	ONARDHPIQUUUGO-UHFFFAOYSA-N	methyl 2-[[2-[(4-chlorobenzoyl)amino]-4-methyl-pentanoyl]amino]-3-phenyl-propanoate	51065732	COC(=O)C(Cc1ccccc1)NC(=O)C(CC(C)C)NC(=O)c1ccc(Cl)cc1	methyl 2-[[2-[(4-chlorobenzoyl)amino]-4-methylpentanoyl]amino]-3-phenylpropanoate			3.275580000000001													MCULE-2072976929	430.93564		430.165935	4	2	10	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51065732)	51065732	4.8	711			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#17]):[#6]:[#6]:1	COC(=O)C(Cc1ccccc1)NC(=O)C(CC(C)C)NC(=O)c1ccc(Cl)cc1	ONARDHPIQUUUGO		parent_pubchem_cid	AKOS015861271;methyl 2-[[2-[(4-chlorobenzoyl)amino]-4-methyl-pentanoyl]amino]-3-phenyl-propanoate		23502239.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23502239		pluskal_iocb_peptide_Peptide01_D17_id		100	D17		
4.5		0	565	P1310506	110.2		R19	False	0	21	0	0	17	0	3	3	0	1		0.0						CN(C(=O)c1cc([N+](=O)[O-])ccc1)C(c1cccs1)c1c[nH]c2ccccc12																							0.0		STL211260		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	1		C21H17N3O3S	C21H17N3O3S			InChI=1S/C21H17N3O3S/c1-23(21(25)14-6-4-7-15(12-14)24(26)27)20(19-10-5-11-28-19)17-13-22-18-9-3-2-8-16(17)18/h2-13,20,22H,1H3	OXKCAMMVDXPMDC-UHFFFAOYSA-N	N-[1H-indol-3-yl(2-thienyl)methyl]-N-methyl-3-nitro-benzamide	43843852	CN(C(=O)c1cc([N+](=O)[O-])ccc1)C(c1cccs1)c1c[nH]c2ccccc12	N-[1H-indol-3-yl(thiophen-2-yl)methyl]-N-methyl-3-nitrobenzamide			4.026040000000003													MCULE-5751543906	391.45194		391.099062	3	1	5	4			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(43843852)	43843852	4.2	712			[#6]-[#7](-[#6](=[#8])-[#6]1:[#6]:[#6](-[#7+](=[#8])-[#8-]):[#6]:[#6]:[#6]:1)-[#6](-[#6]1:[#6]:[#6]:[#6]:[#16]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CN(C(=O)c1cc([N+](=O)[O-])ccc1)C(c1cccs1)c1c[nH]c2ccccc12	OXKCAMMVDXPMDC		parent_pubchem_cid	STL211260;AKOS002280874;AKOS016330463;N-[1H-indol-3-yl(thiophen-2-yl)methyl]-N-methyl-3-nitrobenzamide;N-[1H-indol-3-yl(2-thienyl)methyl]-N-methyl-3-nitro-benzamide		23854603.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23854603		pluskal_iocb_peptide_Peptide01_D18_id		100	D18		
4.9		0	653	P1308378	63.8		R20	False	0	27	0	0	28	0	2	4	0	0		0.0						CCN(C(=O)COc1ccc(OC)cc1)C(c1ccc(OC)cc1)c1c[nH]c2ccccc12																							0.0		AKOS002297994		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C27H28N2O4	C27H28N2O4			InChI=1S/C27H28N2O4/c1-4-29(26(30)18-33-22-15-13-21(32-3)14-16-22)27(19-9-11-20(31-2)12-10-19)24-17-28-25-8-6-5-7-23(24)25/h5-17,27-28H,4,18H2,1-3H3	HFNRXEJBQQCPRW-UHFFFAOYSA-N	N-ethyl-N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-2-(4-methoxyphenoxy)acetamide	43843359	CCN(C(=O)COc1ccc(OC)cc1)C(c1ccc(OC)cc1)c1c[nH]c2ccccc12	N-ethyl-N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-2-(4-methoxyphenoxy)acetamide			3.276930000000001													MCULE-9479305251	444.53521		444.204907	4	1	9	4			45										False	Alkaloids				Peptide01			Compound(43843359)	43843359	5.0	713			[#6]-[#6]-[#7](-[#6](=[#8])-[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:1)-[#6](-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CCN(C(=O)COc1ccc(OC)cc1)C(c1ccc(OC)cc1)c1c[nH]c2ccccc12	HFNRXEJBQQCPRW		parent_pubchem_cid	AKOS002297994;AKOS016330259;N-ethyl-N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-2-(4-methoxyphenoxy)acetamide		23979096.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23979096		pluskal_iocb_peptide_Peptide01_D18_id		100	D18		
1.7		0	397	P7008308	82.3		R21	False	0	18	0	0	23	0	7	1	0	0	-1.0	0.0						Cn1ncc2c(Nc3ccccc3)nc(N3CCN(CCO)CC3)nc21		1.22		0.0	1.84	CHEMBL3918057																	0.0		CHEMBL3918057		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	3		C18H23N7O	C18H23N7O			InChI=1S/C18H23N7O/c1-23-17-15(13-19-23)16(20-14-5-3-2-4-6-14)21-18(22-17)25-9-7-24(8-10-25)11-12-26/h2-6,13,26H,7-12H2,1H3,(H,20,21,22)	RDMAPOWZOOQNMR-UHFFFAOYSA-N	2-[4-(4-anilino-1-methyl-pyrazolo[3,4-d]pyrimidin-6-yl)piperazin-1-yl]ethanol	16456626	Cn1ncc2c(Nc3ccccc3)nc(N3CCN(CCO)CC3)nc21	2-[4-(4-anilino-1-methylpyrazolo[3,4-d]pyrimidin-6-yl)piperazin-1-yl]ethanol			-0.3490499999999996													MCULE-9031665473	353.43031	NEUTRAL	353.196408	7	2	5	4	0.0		29										False	Alkaloids		False	False	Peptide01		-1.0	Compound(16456626)	16456626	1.6	714			[#6]-[#7]1:[#7]:[#6]:[#6]2:[#6](-[#7]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#7]:[#6](-[#7]3-[#6]-[#6]-[#7](-[#6]-[#6]-[#8])-[#6]-[#6]-3):[#7]:[#6]:1:2	Cn1ncc2c(Nc3ccccc3)nc(N3CCN(CCO)CC3)nc21	RDMAPOWZOOQNMR		parent_pubchem_cid	CHEMBL3918057;AKOS001906571;CCG-170400;2-[4-(4-anilino-1-methyl-pyrazolo[3,4-d]pyrimidin-6-yl)piperazin-1-yl]ethanol	False	2287211.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=2287211		pluskal_iocb_peptide_Peptide01_D18_id		100	D18	False	ZINC000020560364
5.0		0	485	P2195762	84.5		R22	False	0	27	0	0	36	0	2	4	0	0		0.0						COC(=O)C(Cc1ccccc1)NC(=O)C(CC(C)C)NC(=O)c1ccc(C(C)(C)C)cc1																							0.0		AKOS015861861		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	2	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C27H36N2O4	C27H36N2O4			InChI=1S/C27H36N2O4/c1-18(2)16-22(28-24(30)20-12-14-21(15-13-20)27(3,4)5)25(31)29-23(26(32)33-6)17-19-10-8-7-9-11-19/h7-15,18,22-23H,16-17H2,1-6H3,(H,28,30)(H,29,31)	NPRORWLVQOCGTA-UHFFFAOYSA-N	methyl 2-[[2-[(4-tert-butylbenzoyl)amino]-4-methyl-pentanoyl]amino]-3-phenyl-propanoate	52988595	COC(=O)C(Cc1ccccc1)NC(=O)C(CC(C)C)NC(=O)c1ccc(C(C)(C)C)cc1	methyl 2-[[2-[(4-tert-butylbenzoyl)amino]-4-methylpentanoyl]amino]-3-phenylpropanoate			3.864970000000002													MCULE-4804183269	452.59897		452.267508	4	2	11	2			45									Dipeptides;Tripeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(52988595)	52988595	5.9	715			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6])(-[#6])-[#6]):[#6]:[#6]:1	COC(=O)C(Cc1ccccc1)NC(=O)C(CC(C)C)NC(=O)c1ccc(C(C)(C)C)cc1	NPRORWLVQOCGTA		parent_pubchem_cid	AKOS015861861;methyl 2-[[2-[(4-tert-butylbenzoyl)amino]-4-methyl-pentanoyl]amino]-3-phenyl-propanoate		23160738.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23160738		pluskal_iocb_peptide_Peptide01_D18_id		100	D18		
4.5		0	573	P4356063	74.8		R23	False	0	26	0	0	22	0	4	3	0	0		0.0						N#Cc1c(N2CCN(Cc3cc4c(cc3)OCO4)CC2)oc(-c2cccc3ccccc23)n1																							0.0		AKOS005184388		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2		C26H22N4O3	C26H22N4O3			InChI=1S/C26H22N4O3/c27-15-22-26(33-25(28-22)21-7-3-5-19-4-1-2-6-20(19)21)30-12-10-29(11-13-30)16-18-8-9-23-24(14-18)32-17-31-23/h1-9,14H,10-13,16-17H2	LRHJBFSYXMNCTB-UHFFFAOYSA-N	5-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-2-(1-naphthyl)oxazole-4-carbonitrile	2030343	N#Cc1c(N2CCN(Cc3cc4c(cc3)OCO4)CC2)oc(-c2cccc3ccccc23)n1	5-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-2-naphthalen-1-yl-1,3-oxazole-4-carbonitrile			2.19409													MCULE-1082947976	438.49024		438.169191	6	0	4	6			44										False	Alkaloids	Tyrosine alkaloids			Peptide01			Compound(2030343)	2030343	4.9	716			[#7]#[#6]-[#6]1:[#6](-[#7]2-[#6]-[#6]-[#7](-[#6]-[#6]3:[#6]:[#6]4:[#6](:[#6]:[#6]:3)-[#8]-[#6]-[#8]-4)-[#6]-[#6]-2):[#8]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#7]:1	N#Cc1c(N2CCN(Cc3cc4c(cc3)OCO4)CC2)oc(-c2cccc3ccccc23)n1	LRHJBFSYXMNCTB		parent_pubchem_cid	AKOS005184388;Z1213744895;5-{4-[(2H-1,3-benzodioxol-5-yl)methyl]piperazin-1-yl}-2-(naphthalen-1-yl)-1,3-oxazole-4-carbonitrile;5-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-2-(1-naphthyl)oxazole-4-carbonitrile		22665095.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22665095		pluskal_iocb_peptide_Peptide01_D18_id		100	D18		ZINC000002434071
5.0		0	661	P1306935	64.3		R24	False	0	20	0	0	24	0	2	1	0	1		0.0						CCC(CC)C(=O)N(C)C(c1cccs1)c1c[nH]c2ccccc12																							0.0		AKOS001544593		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C20H24N2OS	C20H24N2OS			InChI=1S/C20H24N2OS/c1-4-14(5-2)20(23)22(3)19(18-11-8-12-24-18)16-13-21-17-10-7-6-9-15(16)17/h6-14,19,21H,4-5H2,1-3H3	LVQDZAKRVNULSR-UHFFFAOYSA-N	2-ethyl-N-[1H-indol-3-yl(2-thienyl)methyl]-N-methyl-butanamide	20895194	CCC(CC)C(=O)N(C)C(c1cccs1)c1c[nH]c2ccccc12	2-ethyl-N-[1H-indol-3-yl(thiophen-2-yl)methyl]-N-methylbutanamide			4.675560000000004													MCULE-4282268724	340.49108		340.160934	1	1	6	3			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(20895194)	20895194	4.5	717			[#6]-[#6]-[#6](-[#6]-[#6])-[#6](=[#8])-[#7](-[#6])-[#6](-[#6]1:[#6]:[#6]:[#6]:[#16]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CCC(CC)C(=O)N(C)C(c1cccs1)c1c[nH]c2ccccc12	LVQDZAKRVNULSR		parent_pubchem_cid	AKOS001544593;AKOS016329530;CCG-154611;2-ETHYL-N-[(1H-INDOL-3-YL)(THIOPHEN-2-YL)METHYL]-N-METHYLBUTANAMIDE;2-ethyl-N-[1H-indol-3-yl(2-thienyl)methyl]-N-methyl-butanamide		24647972.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24647972		pluskal_iocb_peptide_Peptide01_D18_id		100	D18		
2.5		0	405	P1157914	120.9		R25	False	0	19	0	0	18	0	2	6	0	0		0.0						COc1c2cc(C(=O)NC(C(=O)O)c3ccc(O)cc3)[nH]c2c(OC)cc1																							0.0		AKOS004937114		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C19H18N2O6	C19H18N2O6			InChI=1S/C19H18N2O6/c1-26-14-7-8-15(27-2)17-12(14)9-13(20-17)18(23)21-16(19(24)25)10-3-5-11(22)6-4-10/h3-9,16,20,22H,1-2H3,(H,21,23)(H,24,25)/t16-/m1/s1	ZJYIPRGQCKJXFI-MRXNPFEDSA-N	rac-(2R)-2-[(4,7-dimethoxy-1H-indole-2-carbonyl)amino]-2-(4-hydroxyphenyl)acetic acid	16408453	COc1c2cc(C(=O)N[C@@H](C(=O)O)c3ccc(O)cc3)[nH]c2c(OC)cc1	(2R)-2-[(4,7-dimethoxy-1H-indole-2-carbonyl)amino]-2-(4-hydroxyphenyl)acetic acid			0.5213299999999996													MCULE-6045428898	370.36511		370.116486	6	4	6	3			44									Carbazole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(16408453)	16408453	2.5	718			[#6]-[#8]-[#6]1:[#6]2:[#6]:[#6](-[#6](=[#8])-[#7]-[#6@@H](-[#6](=[#8])-[#8])-[#6]3:[#6]:[#6]:[#6](-[#8]):[#6]:[#6]:3):[#7H]:[#6]:2:[#6](-[#8]-[#6]):[#6]:[#6]:1	COc1c2cc(C(=O)N[C@@H](C(=O)O)c3ccc(O)cc3)[nH]c2c(OC)cc1	ZJYIPRGQCKJXFI		parent_pubchem_cid	AKOS004937114;(2R)-2-{[(4,7-DIMETHOXY-1H-INDOL-2-YL)CARBONYL]AMINO}-2-(4-HYDROXYPHENYL)ETHANOIC ACID;rac-(2R)-2-[(4,7-dimethoxy-1H-indole-2-carbonyl)amino]-2-(4-hydroxyphenyl)acetic acid		24302721.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24302721		pluskal_iocb_peptide_Peptide01_D18_id		100	D18		ZINC000008764217
4.2		0	493	P2194104	117.5		R26	False	0	18	1	0	20	0	3	3	0	1		0.0						CC(C)CC(NC(=O)c1nc(SCc2ccccc2)ncc1Cl)C(=O)O								N-acyl-alpha amino acids;Pyrimidinecarboxylic acids and derivatives;2-heteroaryl carboxamides;Alkylarylthioethers;Halopyrimidines;Aryl chlorides;Benzene and substituted derivatives;Vinylogous halides;Heteroaromatic compounds;Secondary carboxylic acid amides;Sulfenyl compounds;Monocarboxylic acids and derivatives;Azacyclic compounds;Carboxylic acids;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organochlorides;Organonitrogen compounds	2-heteroaryl carboxamides;Alkylarylthioethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Aryl chlorides;Aryl halides;Aryl thioethers;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Diazines;Halopyrimidines;Heteroaromatic compounds;Hydrocarbon derivatives;Leucine and derivatives;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organochlorides;Organohalogen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organosulfur compounds;Pyrimidinecarboxylic acids and derivatives;Pyrimidines and pyrimidine derivatives;Secondary carboxylic acid amides;Sulfenyl compounds;Thioethers;Vinyl halides;Vinylogous halides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as leucine and derivatives. These are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Leucine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteromonocyclic compounds	N-acyl-amino acid (CHEBI:51569);pyrimidinecarboxylic acid (CHEBI:78574);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);aryl sulfide (CHEBI:35683);pyrimidines (CHEBI:39447);organohalogen compound (CHEBI:36684);organochlorine compound (CHEBI:36683);benzenes (CHEBI:22712);organosulfur compound (CHEBI:33261);monocarboxylic acid (CHEBI:25384);organonitrogen heterocyclic compound (CHEBI:38101);carboxylic acid (CHEBI:33575);carbonyl compound (CHEBI:36586);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);leucine derivative (CHEBI:47003);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);organic heterocyclic compound (CHEBI:24532);diazines (CHEBI:38313);amide (CHEBI:32988);organic sulfide (CHEBI:16385);haloarene (CHEBI:50887);benzenoid aromatic compound (CHEBI:33836);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143)		Amino acids, peptides, and analogues	Leucine or derivatives;N-acyl-alpha amino acid or derivatives;N-acyl-alpha-amino acid;Pyrimidine-6-carboxylic acid or derivatives;2-heteroaryl carboxamide;Aryl thioether;Alkylarylthioether;Halopyrimidine;Pyrimidine;Aryl chloride;Aryl halide;Benzenoid;Monocyclic benzene moiety;Vinylogous halide;Heteroaromatic compound;Secondary carboxylic acid amide;Carboxamide group;Carboxylic acid;Azacycle;Monocarboxylic acid or derivatives;Organoheterocyclic compound;Sulfenyl compound;Thioether;Carbonyl group;Organic oxide;Organic oxygen compound;Organic nitrogen compound;Organohalogen compound;Organochloride;Organonitrogen compound;Organooxygen compound;Organosulfur compound;Hydrocarbon derivative;Aromatic heteromonocyclic compound	Organic acids and derivatives	0.0		STL217574		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C18H20ClN3O3S	C18H20ClN3O3S			InChI=1S/C18H20ClN3O3S/c1-11(2)8-14(17(24)25)21-16(23)15-13(19)9-20-18(22-15)26-10-12-6-4-3-5-7-12/h3-7,9,11,14H,8,10H2,1-2H3,(H,21,23)(H,24,25)	NNFQTNDLIJDYTQ-UHFFFAOYSA-N	2-[(2-benzylsulfanyl-5-chloro-pyrimidine-4-carbonyl)amino]-4-methyl-pentanoic acid	49756819	CC(C)CC(NC(=O)c1nc(SCc2ccccc2)ncc1Cl)C(=O)O	2-[(2-benzylsulfanyl-5-chloropyrimidine-4-carbonyl)amino]-4-methylpentanoic acid			3.4339700000000013													MCULE-7086781793	393.8954		393.09139	6	2	8	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(49756819)	49756819	4.1	719			[#6]-[#6](-[#6])-[#6]-[#6](-[#7]-[#6](=[#8])-[#6]1:[#7]:[#6](-[#16]-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#7]:[#6]:[#6]:1-[#17])-[#6](=[#8])-[#8]	CC(C)CC(NC(=O)c1nc(SCc2ccccc2)ncc1Cl)C(=O)O	NNFQTNDLIJDYTQ		parent_pubchem_cid	STL217574;AKOS005136571;N-{[2-(benzylsulfanyl)-5-chloropyrimidin-4-yl]carbonyl}leucine;2-[(2-benzylsulfanyl-5-chloro-pyrimidine-4-carbonyl)amino]-4-methyl-pentanoic acid		22628659.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22628659		pluskal_iocb_peptide_Peptide01_D18_id		100	D18		
5.0		0	581	P1306102	54.6		R27	False	0	26	0	0	26	0	2	3	0	0		0.0						COc1ccccc1OCC(=O)N(C)C(c1ccc(C)cc1)c1c[nH]c2ccccc12																							0.0		N-[1H-indol-3-yl(4-methylphenyl)methyl]-2-(2-methoxyphenoxy)-N-methylacetamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C26H26N2O3	C26H26N2O3			InChI=1S/C26H26N2O3/c1-18-12-14-19(15-13-18)26(21-16-27-22-9-5-4-8-20(21)22)28(2)25(29)17-31-24-11-7-6-10-23(24)30-3/h4-16,26-27H,17H2,1-3H3	RMSAEMKDHBFJQK-UHFFFAOYSA-N	N-[1H-indol-3-yl(p-tolyl)methyl]-2-(2-methoxyphenoxy)-N-methyl-acetamide	20895161	COc1ccccc1OCC(=O)N(C)C(c1ccc(C)cc1)c1c[nH]c2ccccc12	N-[1H-indol-3-yl-(4-methylphenyl)methyl]-2-(2-methoxyphenoxy)-N-methylacetamide			3.594350000000002													MCULE-5795397927	414.50872		414.194343	3	1	7	4			45										False	Alkaloids				Peptide01			Compound(20895161)	20895161	5.1	720			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#8]-[#6]-[#6](=[#8])-[#7](-[#6])-[#6](-[#6]1:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	COc1ccccc1OCC(=O)N(C)C(c1ccc(C)cc1)c1c[nH]c2ccccc12	RMSAEMKDHBFJQK		parent_pubchem_cid	N-[1H-indol-3-yl(4-methylphenyl)methyl]-2-(2-methoxyphenoxy)-N-methylacetamide;912890-98-3;AKOS001544336;AKOS016329324;Z1213699889;N-[(1H-indol-3-yl)(4-methylphenyl)methyl]-2-(2-methoxyphenoxy)-N-methylacetamide;N-[1H-indol-3-yl(p-tolyl)methyl]-2-(2-methoxyphenoxy)-N-methyl-acetamide		24742262.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24742262		pluskal_iocb_peptide_Peptide01_D19_id		100	D19		
4.7		0	669	P1303111	60.9		R28	False	0	26	0	0	24	0	2	4	0	0		0.0						COc1cc(C(=O)N(Cc2cccc3ccccc23)c2ccccn2)cc(OC)c1OC																							0.0		AKOS002331376		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0		C26H24N2O4	C26H24N2O4			InChI=1S/C26H24N2O4/c1-30-22-15-20(16-23(31-2)25(22)32-3)26(29)28(24-13-6-7-14-27-24)17-19-11-8-10-18-9-4-5-12-21(18)19/h4-16H,17H2,1-3H3	YIDOLWBJCRFCEK-UHFFFAOYSA-N	3,4,5-trimethoxy-N-(1-naphthylmethyl)-N-(2-pyridyl)benzamide	17012537	COc1cc(C(=O)N(Cc2cccc3ccccc23)c2ccccn2)cc(OC)c1OC	3,4,5-trimethoxy-N-(naphthalen-1-ylmethyl)-N-pyridin-2-ylbenzamide			2.801920000000001													MCULE-1230249457	428.49218		428.173607	5	0	7	4			44										False	Alkaloids				Peptide01			Compound(17012537)	17012537	4.9	721			[#6]-[#8]-[#6]1:[#6]:[#6](-[#6](=[#8])-[#7](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6]2:[#6]:[#6]:[#6]:[#6]:[#7]:2):[#6]:[#6](-[#8]-[#6]):[#6]:1-[#8]-[#6]	COc1cc(C(=O)N(Cc2cccc3ccccc23)c2ccccn2)cc(OC)c1OC	YIDOLWBJCRFCEK		parent_pubchem_cid	AKOS002331376;3,4,5-TRIMETHOXY-N-[(NAPHTHALEN-1-YL)METHYL]-N-(PYRIDIN-2-YL)BENZAMIDE;3,4,5-trimethoxy-N-(1-naphthylmethyl)-N-(2-pyridyl)benzamide		14066977.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=14066977		pluskal_iocb_peptide_Peptide01_D19_id		100	D19		ZINC000027662776
2.9		0	413	P11185520	78.0		R29	False	0	15	0	0	25	0	3	2	0	0		0.0						CCC(C)C(CO)NC(=O)c1n[nH]c2c1CCCCC2																							0.0		AKOS027473022		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C15H25N3O2	C15H25N3O2			InChI=1S/C15H25N3O2/c1-3-10(2)13(9-19)16-15(20)14-11-7-5-4-6-8-12(11)17-18-14/h10,13,19H,3-9H2,1-2H3,(H,16,20)(H,17,18)/t10-,13-/m1/s1	UZMZSUZCRGUKAU-ZWNOBZJWSA-N	N-[rac-(1S,2R)-1-(hydroxymethyl)-2-methyl-butyl]-2,4,5,6,7,8-hexahydrocyclohepta[c]pyrazole-3-carboxamide	110204626	CC[C@@H](C)[C@@H](CO)NC(=O)c1n[nH]c2c1CCCCC2	N-[(2S,3R)-1-hydroxy-3-methylpentan-2-yl]-1,4,5,6,7,8-hexahydrocyclohepta[c]pyrazole-3-carboxamide			1.65127														279.3854		279.194677	3	3	5	2			45										False	Alkaloids				Peptide01			Compound(110204626)	110204626	2.7	722			[#6]-[#6]-[#6@@H](-[#6])-[#6@@H](-[#6]-[#8])-[#7]-[#6](=[#8])-[#6]1:[#7]:[#7H]:[#6]2:[#6]:1-[#6]-[#6]-[#6]-[#6]-[#6]-2	CC[C@@H](C)[C@@H](CO)NC(=O)c1n[nH]c2c1CCCCC2	UZMZSUZCRGUKAU		parent_pubchem_cid	AKOS027473022;AKOS032421549;AO-022/43512695;N-[(2S3R)-1-HYDROXY-3-METHYLPENTAN-2-YL]-1H4H5H6H7H8H-CYCLOHEPTA[C]PYRAZOLE-3-CARBOXAMIDE;N-[1-(hydroxymethyl)-2-methylbutyl]-1,4,5,6,7,8-hexahydrocyclohepta[c]pyrazole-3-carboxamide;N-[rac-(1S,2R)-1-(hydroxymethyl)-2-methyl-butyl]-2,4,5,6,7,8-hexahydrocyclohepta[c]pyrazole-3-carboxamide		117132837.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=117132837		pluskal_iocb_peptide_Peptide01_D19_id		100	D19		ZINC000252503211
2.9		0	501	P1045801	66.4		R30	False	0	13	1	0	16	0	1	3	0	0	-1.0	0.0						CC(C)CC(NC(=O)c1ccc(Cl)cc1)C(=O)O		2.57		0.0	2.95	CHEMBL1448650																	0.0		2-[(4-chlorophenyl)formamido]-4-methylpentanoic acid		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C13H16ClNO3	C13H16ClNO3			InChI=1S/C13H16ClNO3/c1-8(2)7-11(13(17)18)15-12(16)9-3-5-10(14)6-4-9/h3-6,8,11H,7H2,1-2H3,(H,15,16)(H,17,18)	GBFHNWPMWRSODC-UHFFFAOYSA-N	2-[(4-chlorobenzoyl)amino]-4-methyl-pentanoic acid	4994387	CC(C)CC(NC(=O)c1ccc(Cl)cc1)C(=O)O	2-[(4-chlorobenzoyl)amino]-4-methylpentanoic acid			2.514390000000001													MCULE-8720181956	269.73037	ACID	269.081871	3	2	5	1	0.0		30									Dipeptides	False	Amino acids and Peptides	Small peptides	False	False	Peptide01		-1.0	Compound(4994387)	4994387	3.1	723			[#6]-[#6](-[#6])-[#6]-[#6](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#17]):[#6]:[#6]:1)-[#6](=[#8])-[#8]	CC(C)CC(NC(=O)c1ccc(Cl)cc1)C(=O)O	GBFHNWPMWRSODC		parent_pubchem_cid	2-[(4-chlorophenyl)formamido]-4-methylpentanoic acid;1008697-93-5;2-(4-Chloro-benzoylamino)-4-methyl-pentanoic acid;2-[(4-chlorobenzoyl)amino]-4-methylpentanoic acid;MLS000571593;CHEMBL1448650;HMS2404B03;AKOS000114594;AKOS016050250;SMR000151055;CS-0218131;EN300-00204;SR-01000034955;2-[(4-chlorophenyl)formamido]-4-methylpentanoicacid;SR-01000034955-1;Z56846775;2-[(4-chlorobenzoyl)amino]-4-methyl-pentanoic acid	False	908697.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=908697		pluskal_iocb_peptide_Peptide01_D19_id		100	D19	False	
4.1		0	589	P1692478	98.7		R31	False	0	25	0	0	21	0	3	4	0	0		0.0						O=C1c2c(c(-c3ccccc3O)n[nH]2)C(c2cc(Oc3ccccc3)ccc2)N1CCO																							0.0		AKOS001846800		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	1	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C25H21N3O4	C25H21N3O4			InChI=1S/C25H21N3O4/c29-14-13-28-24(16-7-6-10-18(15-16)32-17-8-2-1-3-9-17)21-22(26-27-23(21)25(28)31)19-11-4-5-12-20(19)30/h1-12,15,24,29-30H,13-14H2,(H,26,27)	XORCUXPFDRQOOR-UHFFFAOYSA-N	5-(2-hydroxyethyl)-3-(2-hydroxyphenyl)-4-(3-phenoxyphenyl)-1,4-dihydropyrrolo[3,4-c]pyrazol-6-one	4970665	O=C1c2c(c(-c3ccccc3O)n[nH]2)C(c2cc(Oc3ccccc3)ccc2)N1CCO	5-(2-hydroxyethyl)-3-(2-hydroxyphenyl)-4-(3-phenoxyphenyl)-1,4-dihydropyrrolo[3,4-c]pyrazol-6-one			2.1807200000000004													MCULE-4619725189	427.46382		427.153206	5	3	6	5			45										False	Alkaloids				Peptide01			Compound(4970665)	4970665	3.4	724			[#8]=[#6]1-[#6]2:[#6](:[#6](-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3-[#8]):[#7]:[#7H]:2)-[#6](-[#6]2:[#6]:[#6](-[#8]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#6]:[#6]:[#6]:2)-[#7]-1-[#6]-[#6]-[#8]	O=C1c2c(c(-c3ccccc3O)n[nH]2)C(c2cc(Oc3ccccc3)ccc2)N1CCO	XORCUXPFDRQOOR		parent_pubchem_cid	AKOS001846800;AKOS005628330;AKOS016306235;CCG-145153;Z1213668413;5-(2-hydroxyethyl)-3-(2-hydroxyphenyl)-4-(3-phenoxyphenyl)-1H,4H,5H,6H-pyrrolo[3,4-c]pyrazol-6-one;5-(2-hydroxyethyl)-3-(2-hydroxyphenyl)-4-(3-phenoxyphenyl)-1,4-dihydropyrrolo[3,4-c]pyrazol-6-one		23759645.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23759645		pluskal_iocb_peptide_Peptide01_D19_id		100	D19		
2.4		0	677	P3460064	95.9		R32	False	0	20	0	0	28	0	2	5	0	0	-1.0	0.0						CC(C)(C)OC(=O)N1CCC(C(=O)NC(Cc2ccccc2)C(=O)O)CC1		2.45		0.0	2.28	CHEMBL1494032																	0.0		1099537-24-2		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	1	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C20H28N2O5	C20H28N2O5			InChI=1S/C20H28N2O5/c1-20(2,3)27-19(26)22-11-9-15(10-12-22)17(23)21-16(18(24)25)13-14-7-5-4-6-8-14/h4-8,15-16H,9-13H2,1-3H3,(H,21,23)(H,24,25)/t16-/m0/s1	FKCVTDVCCAOPGT-INIZCTEOSA-N	rac-(2S)-2-[(1-tert-butoxycarbonylpiperidine-4-carbonyl)amino]-3-phenyl-propanoic acid	7061454	CC(C)(C)OC(=O)N1CCC(C(=O)N[C@@H](Cc2ccccc2)C(=O)O)CC1	(2S)-2-[[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidine-4-carbonyl]amino]-3-phenylpropanoic acid			2.3908900000000006													MCULE-2994593868	376.45656	ACID	376.199822	5	2	7	2	0.0		29									Dipeptides	False	Amino acids and Peptides	Small peptides	False	False	Peptide01		-1.0	Compound(7061454)	7061454	2.5	725			[#6]-[#6](-[#6])(-[#6])-[#8]-[#6](=[#8])-[#7]1-[#6]-[#6]-[#6](-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#8])-[#6]-[#6]-1	CC(C)(C)OC(=O)N1CCC(C(=O)N[C@@H](Cc2ccccc2)C(=O)O)CC1	FKCVTDVCCAOPGT		parent_pubchem_cid	1099537-24-2;N-{[1-(tert-butoxycarbonyl)piperidin-4-yl]carbonyl}-L-phenylalanine;N-([1-(tert-Butoxycarbonyl)piperidin-4-yl]carbonyl)-l-phenylalanine;MFCD04012875;(2S)-2-[[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidine-4-carbonyl]amino]-3-phenylpropanoic acid;MLS000552071;CHEMBL1494032;HMS2158M17;AKOS005535532;SMR000145796;VS-12162;(2S)-2-({1-[(tert-butoxy)carbonyl]piperidin-4-yl}formamido)-3-phenylpropanoic acid;4-((S)-1-Carboxy-2-phenyl-ethylcarbamoyl)-piperidine-1-carboxylic acid tert-butyl ester;rac-(2S)-2-[(1-tert-butoxycarbonylpiperidine-4-carbonyl)amino]-3-phenyl-propanoic acid	False	926672.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=926672		pluskal_iocb_peptide_Peptide01_D19_id		100	D19	False	ZINC000003882133
3.5		0	421	P6237115	75.1		R33	False	0	22	0	0	25	0	5	1	0	0		0.0						Cc1c(CC(=O)NC(CC(C)C)c2nnc3ccccn23)c2ccccc2[nH]1																							0.0		2-(2-methyl-1H-indol-3-yl)-N-[3-methyl-1-([1,2,4]triazolo[4,3-a]pyridin-3-yl)butyl]acetamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	3	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C22H25N5O	C22H25N5O			InChI=1S/C22H25N5O/c1-14(2)12-19(22-26-25-20-10-6-7-11-27(20)22)24-21(28)13-17-15(3)23-18-9-5-4-8-16(17)18/h4-11,14,19,23H,12-13H2,1-3H3,(H,24,28)	ZXEGXWGRLXIFAJ-UHFFFAOYSA-N	2-(2-methyl-1H-indol-3-yl)-N-[3-methyl-1-([1,2,4]triazolo[4,3-a]pyridin-3-yl)butyl]acetamide	42652677	Cc1c(CC(=O)NC(CC(C)C)c2nnc3ccccn23)c2ccccc2[nH]1	2-(2-methyl-1H-indol-3-yl)-N-[3-methyl-1-([1,2,4]triazolo[4,3-a]pyridin-3-yl)butyl]acetamide			3.158360000000001													MCULE-4883010240	375.47745		375.20591	3	2	6	4			44										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(42652677)	42652677	4.2	726			[#6]-[#6]1:[#6](-[#6]-[#6](=[#8])-[#7]-[#6](-[#6]-[#6](-[#6])-[#6])-[#6]2:[#7]:[#7]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#7]:2:3):[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#7H]:1	Cc1c(CC(=O)NC(CC(C)C)c2nnc3ccccn23)c2ccccc2[nH]1	ZXEGXWGRLXIFAJ		parent_pubchem_cid	2-(2-methyl-1H-indol-3-yl)-N-[3-methyl-1-([1,2,4]triazolo[4,3-a]pyridin-3-yl)butyl]acetamide;1081118-96-8;STL236009;AKOS016387925		23029687.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23029687		pluskal_iocb_peptide_Peptide01_D19_id		100	D19		
1.7		0	509	P2193951	103.0		R34	False	0	19	0	0	28	0	2	6	0	0		0.0						COC(=O)C(CC(C)C)NC(=O)CCNC(=O)c1cc(OC)c(OC)cc1																							0.0		AKOS015860069		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C19H28N2O6	C19H28N2O6			InChI=1S/C19H28N2O6/c1-12(2)10-14(19(24)27-5)21-17(22)8-9-20-18(23)13-6-7-15(25-3)16(11-13)26-4/h6-7,11-12,14H,8-10H2,1-5H3,(H,20,23)(H,21,22)	IVSKUTOMKBGCKL-UHFFFAOYSA-N	methyl 2-[3-[(3,4-dimethoxybenzoyl)amino]propanoylamino]-4-methyl-pentanoate	51064818	COC(=O)C(CC(C)C)NC(=O)CCNC(=O)c1cc(OC)c(OC)cc1	methyl 2-[3-[(3,4-dimethoxybenzoyl)amino]propanoylamino]-4-methylpentanoate			0.5480700000000014													MCULE-9681634733	380.44481		380.194737	6	2	11	1			45									Simple amide alkaloids	False	Alkaloids	Peptide alkaloids			Peptide01			Compound(51064818)	51064818	2.0	727			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=[#8])-[#6]-[#6]-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6](-[#8]-[#6]):[#6](-[#8]-[#6]):[#6]:[#6]:1	COC(=O)C(CC(C)C)NC(=O)CCNC(=O)c1cc(OC)c(OC)cc1	IVSKUTOMKBGCKL		parent_pubchem_cid	AKOS015860069;methyl 2-[3-[(3,4-dimethoxybenzoyl)amino]propanoylamino]-4-methyl-pentanoate		24104412.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24104412		pluskal_iocb_peptide_Peptide01_D19_id		100	D19		
4.7		0	597	P1305819	45.3		R35	False	0	24	0	0	22	0	2	2	0	0		0.0						COc1cccc(C(=O)N(C)C(c2ccccc2)c2c[nH]c3ccccc23)c1																							0.0		N-[1H-indol-3-yl(phenyl)methyl]-3-methoxy-N-methylbenzamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C24H22N2O2	C24H22N2O2			InChI=1S/C24H22N2O2/c1-26(24(27)18-11-8-12-19(15-18)28-2)23(17-9-4-3-5-10-17)21-16-25-22-14-7-6-13-20(21)22/h3-16,23,25H,1-2H3	ZRRRLQKUKVFHHE-UHFFFAOYSA-N	N-[1H-indol-3-yl(phenyl)methyl]-3-methoxy-N-methyl-benzamide	20895153	COc1cccc(C(=O)N(C)C(c2ccccc2)c2c[nH]c3ccccc23)c1	N-[1H-indol-3-yl(phenyl)methyl]-3-methoxy-N-methylbenzamide			3.9831400000000032													MCULE-6402194330	370.45514		370.168128	2	1	5	4			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(20895153)	20895153	4.7	728			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6](-[#6](=[#8])-[#7](-[#6])-[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:1	COc1cccc(C(=O)N(C)C(c2ccccc2)c2c[nH]c3ccccc23)c1	ZRRRLQKUKVFHHE		parent_pubchem_cid	N-[1H-indol-3-yl(phenyl)methyl]-3-methoxy-N-methylbenzamide;905768-37-8;AKOS001911698;AKOS016328283;Z1213699261;N-[(1H-indol-3-yl)(phenyl)methyl]-3-methoxy-N-methylbenzamide;N-[1H-indol-3-yl(phenyl)methyl]-3-methoxy-N-methyl-benzamide		22672260.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22672260		pluskal_iocb_peptide_Peptide01_D20_id		100	D20		
1.9		0	685	P1157887	107.5		R36	False	0	14	0	0	16	0	2	3	0	1		0.0						CSCCC(NC(=O)c1cc2ccccc2[nH]1)C(=O)O																							0.0		AKOS010397678		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C14H16N2O3S	C14H16N2O3S			InChI=1S/C14H16N2O3S/c1-20-7-6-11(14(18)19)16-13(17)12-8-9-4-2-3-5-10(9)15-12/h2-5,8,11,15H,6-7H2,1H3,(H,16,17)(H,18,19)/t11-/m0/s1	DPWVVNUFSDKJMV-NSHDSACASA-N	rac-(2S)-2-(1H-indole-2-carbonylamino)-4-methylsulfanyl-butanoic acid	16409640	CSCC[C@H](NC(=O)c1cc2ccccc2[nH]1)C(=O)O	(2S)-2-(1H-indole-2-carbonylamino)-4-methylsulfanylbutanoic acid			1.6208699999999998													MCULE-3076068948	292.35922		292.088163	4	3	6	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(16409640)	16409640	2.7	729			[#6]-[#16]-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#7H]:1)-[#6](=[#8])-[#8]	CSCC[C@H](NC(=O)c1cc2ccccc2[nH]1)C(=O)O	DPWVVNUFSDKJMV		parent_pubchem_cid	AKOS010397678;rac-(2S)-2-(1H-indole-2-carbonylamino)-4-methylsulfanyl-butanoic acid		22773422.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22773422		pluskal_iocb_peptide_Peptide01_D20_id		100	D20		ZINC000012898352
3.6		0	429	P1108300	128.7		R37	False	0	24	0	0	22	0	2	6	0	0		0.0						Cc1cc(O)c2c(C)c(CC(=O)NC(Cc3c[nH]c4ccccc34)C(=O)O)c(=O)oc2c1																							0.0		SCHEMBL13780691		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C24H22N2O6	C24H22N2O6			InChI=1S/C24H22N2O6/c1-12-7-19(27)22-13(2)16(24(31)32-20(22)8-12)10-21(28)26-18(23(29)30)9-14-11-25-17-6-4-3-5-15(14)17/h3-8,11,18,25,27H,9-10H2,1-2H3,(H,26,28)(H,29,30)/t18-/m0/s1	ARJHYIXJSHLFBK-SFHVURJKSA-N	rac-(2S)-2-[[2-(5-hydroxy-4,7-dimethyl-2-oxo-chromen-3-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid	6851248	Cc1cc(O)c2c(C)c(CC(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)O)c(=O)oc2c1	(2S)-2-[[2-(5-hydroxy-4,7-dimethyl-2-oxochromen-3-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid			2.31314													MCULE-4289634789	434.45274		434.147786	6	4	6	4			43									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(6851248)	6851248	2.8	730		SCHEMBL13780691	[#6]-[#6]1:[#6]:[#6](-[#8]):[#6]2:[#6](-[#6]):[#6](-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]3:[#6]:[#7H]:[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]:3:4)-[#6](=[#8])-[#8]):[#6](=[#8]):[#8]:[#6]:2:[#6]:1	Cc1cc(O)c2c(C)c(CC(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)O)c(=O)oc2c1	ARJHYIXJSHLFBK		parent_pubchem_cid	SCHEMBL13780691;EiM07-29504;AKOS016390739;Z2327398579;2-[2-(5-HYDROXY-4,7-DIMETHYL-2-OXO-2H-CHROMEN-3-YL)ACETAMIDO]-3-(1H-INDOL-3-YL)PROPANOIC ACID;rac-(2S)-2-[[2-(5-hydroxy-4,7-dimethyl-2-oxo-chromen-3-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid		23289423.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23289423		pluskal_iocb_peptide_Peptide01_D20_id		100	D20		ZINC000002114556
3.6		0	517	P2195735	96.5		R38	False	0	27	0	0	29	0	3	4	0	0		0.0						CCOc1ccc(NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)c2ccc(C)cc2)cc1																							0.0		AKOS015861881		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0		C27H29N3O4	C27H29N3O4			InChI=1S/C27H29N3O4/c1-3-34-23-15-13-22(14-16-23)29-27(33)24(17-20-7-5-4-6-8-20)30-25(31)18-28-26(32)21-11-9-19(2)10-12-21/h4-16,24H,3,17-18H2,1-2H3,(H,28,32)(H,29,33)(H,30,31)	PFJDWRYQWVIVDU-UHFFFAOYSA-N	N-[2-[[1-benzyl-2-(4-ethoxyanilino)-2-oxo-ethyl]amino]-2-oxo-ethyl]-4-methyl-benzamide	52988585	CCOc1ccc(NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)c2ccc(C)cc2)cc1	N-[2-[[1-(4-ethoxyanilino)-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]-4-methylbenzamide			2.482570000000001													MCULE-6604142152	459.54988		459.215806	4	3	10	3			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(52988585)	52988585	4.1	731			[#6]-[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#7]-[#6](=[#8])-[#6](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#7]-[#6](=[#8])-[#6]-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:2):[#6]:[#6]:1	CCOc1ccc(NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)c2ccc(C)cc2)cc1	PFJDWRYQWVIVDU		parent_pubchem_cid	AKOS015861881;N-[2-[[1-benzyl-2-(4-ethoxyanilino)-2-oxo-ethyl]amino]-2-oxo-ethyl]-4-methyl-benzamide		23384327.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23384327		pluskal_iocb_peptide_Peptide01_D20_id		100	D20		
4.6		0	605	P1306109	81.9		R39	False	0	23	0	0	19	0	3	3	0	0		0.0						CN(C(=O)c1ccc([N+](=O)[O-])cc1)C(c1ccccc1)c1c[nH]c2ccccc12																							0.0		STK518806		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	1		C23H19N3O3	C23H19N3O3			InChI=1S/C23H19N3O3/c1-25(23(27)17-11-13-18(14-12-17)26(28)29)22(16-7-3-2-4-8-16)20-15-24-21-10-6-5-9-19(20)21/h2-15,22,24H,1H3	ZTKGSOOEJZYTKI-UHFFFAOYSA-N	N-[1H-indol-3-yl(phenyl)methyl]-N-methyl-4-nitro-benzamide	43842815	CN(C(=O)c1ccc([N+](=O)[O-])cc1)C(c1ccccc1)c1c[nH]c2ccccc12	N-[1H-indol-3-yl(phenyl)methyl]-N-methyl-4-nitrobenzamide			3.964540000000002													MCULE-9299019459	385.42618		385.142641	3	1	5	4			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(43842815)	43842815	4.5	732			[#6]-[#7](-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#7+](=[#8])-[#8-]):[#6]:[#6]:1)-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CN(C(=O)c1ccc([N+](=O)[O-])cc1)C(c1ccccc1)c1c[nH]c2ccccc12	ZTKGSOOEJZYTKI		parent_pubchem_cid	STK518806;AKOS001544228;AKOS016329329;N-[1H-indol-3-yl(phenyl)methyl]-N-methyl-4-nitrobenzamide;N-[(1H-INDOL-3-YL)(PHENYL)METHYL]-N-METHYL-4-NITROBENZAMIDE;N-[1H-indol-3-yl(phenyl)methyl]-N-methyl-4-nitro-benzamide		22710622.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22710622		pluskal_iocb_peptide_Peptide01_D20_id		100	D20		
2.7		0	693	P6239350	112.5		R40	False	0	15	0	0	19	0	3	3	0	1		0.0						Cc1c(C(=O)NC(CC(C)C)C(=O)O)sc(-n2cccc2)n1																							0.0		EiM08-09945		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C15H19N3O3S	C15H19N3O3S			InChI=1S/C15H19N3O3S/c1-9(2)8-11(14(20)21)17-13(19)12-10(3)16-15(22-12)18-6-4-5-7-18/h4-7,9,11H,8H2,1-3H3,(H,17,19)(H,20,21)/t11-/m0/s1	CDXDHLSJAVROBM-NSHDSACASA-N	rac-(2S)-4-methyl-2-[(4-methyl-2-pyrrol-1-yl-thiazole-5-carbonyl)amino]pentanoic acid	45494255	Cc1c(C(=O)N[C@@H](CC(C)C)C(=O)O)sc(-n2cccc2)n1	(2S)-4-methyl-2-[(4-methyl-2-pyrrol-1-yl-1,3-thiazole-5-carbonyl)amino]pentanoic acid			2.1718900000000003													MCULE-5261223056	321.40098		321.114712	4	2	6	2			44									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(45494255)	45494255	3.0	733			[#6]-[#6]1:[#6](-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=[#8])-[#8]):[#16]:[#6](-[#7]2:[#6]:[#6]:[#6]:[#6]:2):[#7]:1	Cc1c(C(=O)N[C@@H](CC(C)C)C(=O)O)sc(-n2cccc2)n1	CDXDHLSJAVROBM		parent_pubchem_cid	EiM08-09945;AKOS005666259;(2S)-4-METHYL-2-({[4-METHYL-2-(1H-PYRROL-1-YL)-1,3-THIAZOL-5-YL]CARBONYL}AMINO)PENTANOIC ACID;rac-(2S)-4-methyl-2-[(4-methyl-2-pyrrol-1-yl-thiazole-5-carbonyl)amino]pentanoic acid		24202306.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24202306		pluskal_iocb_peptide_Peptide01_D20_id		100	D20		ZINC000036359947
0.9		0	437	P1090574	72.9		R41	False	0	23	0	2	27	0	3	3	0	0		0.0						CC(C)C(NC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)C(=O)O																							0.0		N-({4-[bis(4-fluorophenyl)methyl]piperazin-1-yl}carbonyl)-L-valine		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1		C23H27F2N3O3	C23H27F2N3O3			InChI=1S/C23H27F2N3O3/c1-15(2)20(22(29)30)26-23(31)28-13-11-27(12-14-28)21(16-3-7-18(24)8-4-16)17-5-9-19(25)10-6-17/h3-10,15,20-21H,11-14H2,1-2H3,(H,26,31)(H,29,30)/t20-/m0/s1	FOWRIOVPQVITMR-FQEVSTJZSA-N	rac-(2S)-2-[[4-[bis(4-fluorophenyl)methyl]piperazine-1-carbonyl]amino]-3-methyl-butanoic acid	17580403	CC(C)[C@H](NC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)C(=O)O	(2S)-2-[[4-[bis(4-fluorophenyl)methyl]piperazine-1-carbonyl]amino]-3-methylbutanoic acid			3.3811800000000014													MCULE-6406590068	431.48674		431.202048	4	2	6	3			44										False	Alkaloids				Peptide01			Compound(17580403)	17580403	1.4	734			[#6]-[#6](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#7]1-[#6]-[#6]-[#7](-[#6](-[#6]2:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:2)-[#6]2:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:2)-[#6]-[#6]-1)-[#6](=[#8])-[#8]	CC(C)[C@H](NC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)C(=O)O	FOWRIOVPQVITMR		parent_pubchem_cid	N-({4-[bis(4-fluorophenyl)methyl]piperazin-1-yl}carbonyl)-L-valine;MFCD07639603;STK716551;AKOS005533433;(2S)-2-[({4-[BIS(4-FLUOROPHENYL)METHYL]PIPERAZINO}CARBONYL)AMINO]-3-METHYLBUTANOIC ACID;rac-(2S)-2-[[4-[bis(4-fluorophenyl)methyl]piperazine-1-carbonyl]amino]-3-methyl-butanoic acid		12925140.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=12925140		pluskal_iocb_peptide_Peptide01_D20_id		100	D20		ZINC000011767257
2.5		0	525	P2194867	135.6		R42	False	0	19	1	0	21	0	4	4	0	1		0.0						COC(=O)CCNC(=O)C(Cc1ccccc1)NC(=O)c1nc(SC)ncc1Cl																							0.0		STL218339		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C19H21ClN4O4S	C19H21ClN4O4S			InChI=1S/C19H21ClN4O4S/c1-28-15(25)8-9-21-17(26)14(10-12-6-4-3-5-7-12)23-18(27)16-13(20)11-22-19(24-16)29-2/h3-7,11,14H,8-10H2,1-2H3,(H,21,26)(H,23,27)	XEBZQHJVQMTHKG-UHFFFAOYSA-N	methyl 3-[[2-[(5-chloro-2-methylsulfanyl-pyrimidine-4-carbonyl)amino]-3-phenyl-propanoyl]amino]propanoate	51065472	COC(=O)CCNC(=O)C(Cc1ccccc1)NC(=O)c1nc(SC)ncc1Cl	methyl 3-[[2-[(5-chloro-2-methylsulfanylpyrimidine-4-carbonyl)amino]-3-phenylpropanoyl]amino]propanoate			1.6548699999999994													MCULE-7772909696	436.92062		436.097204	7	2	10	2			45										False	Alkaloids				Peptide01			Compound(51065472)	51065472	2.4	735			[#6]-[#8]-[#6](=[#8])-[#6]-[#6]-[#7]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]1:[#7]:[#6](-[#16]-[#6]):[#7]:[#6]:[#6]:1-[#17]	COC(=O)CCNC(=O)C(Cc1ccccc1)NC(=O)c1nc(SC)ncc1Cl	XEBZQHJVQMTHKG		parent_pubchem_cid	STL218339;AKOS015861137;methyl N-{[5-chloro-2-(methylsulfanyl)pyrimidin-4-yl]carbonyl}phenylalanyl-beta-alaninate;methyl 3-[[2-[(5-chloro-2-methylsulfanyl-pyrimidine-4-carbonyl)amino]-3-phenyl-propanoyl]amino]propanoate		24765825.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24765825		pluskal_iocb_peptide_Peptide01_D20_id		100	D20		
4.5		0	613	P1305423	67.3		R43	False	1	22	0	0	19	0	2	3	0	0		0.0						COc1ccc(C(CNC(=O)c2ccc(Br)o2)c2c[nH]c3ccccc23)cc1																							0.0		5-bromo-N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]furan-2-carboxamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C22H19BrN2O3	C22H19BrN2O3			InChI=1S/C22H19BrN2O3/c1-27-15-8-6-14(7-9-15)17(12-25-22(26)20-10-11-21(23)28-20)18-13-24-19-5-3-2-4-16(18)19/h2-11,13,17,24H,12H2,1H3,(H,25,26)	UBUKYMNYGUVPPJ-UHFFFAOYSA-N	5-bromo-N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]furan-2-carboxamide	17014571	COc1ccc(C(CNC(=O)c2ccc(Br)o2)c2c[nH]c3ccccc23)cc1	5-bromo-N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]furan-2-carboxamide			4.038940000000003													MCULE-5066635994	439.31233		438.057905	2	2	6	4			44									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(17014571)	17014571	5.1	736			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6]-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6](-[#35]):[#8]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	COc1ccc(C(CNC(=O)c2ccc(Br)o2)c2c[nH]c3ccccc23)cc1	UBUKYMNYGUVPPJ		parent_pubchem_cid	5-bromo-N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]furan-2-carboxamide;STL207530;AKOS002335615;AKOS016326667		22749980.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22749980		pluskal_iocb_peptide_Peptide01_D21_id		100	D21		
3.2		0	701	P6241454	126.0		R44	False	0	19	0	0	24	0	2	5	0	1		0.0						COc1c(OC)cc(-c2nc(C)c(C(=O)NC(CC(C)C)C(=O)O)s2)cc1								N-acyl-alpha amino acids;Dimethoxybenzenes;Thiazolecarboxamides;Phenoxy compounds;2,4,5-trisubstituted thiazoles;2-heteroaryl carboxamides;Anisoles;Alkyl aryl ethers;Heteroaromatic compounds;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Azacyclic compounds;Carboxylic acids;Hydrocarbon derivatives;Organic oxides;Carbonyl compounds;Organonitrogen compounds	2,4,5-trisubstituted thiazoles;2-heteroaryl carboxamides;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Anisoles;Azacyclic compounds;Azoles;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Dimethoxybenzenes;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Leucine and derivatives;Methoxybenzenes;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenol ethers;Phenoxy compounds;Secondary carboxylic acid amides;Thiazolecarboxamides;Thiazolecarboxylic acids and derivatives;Thiazoles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as leucine and derivatives. These are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Leucine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteromonocyclic compounds	N-acyl-amino acid (CHEBI:51569);dimethoxybenzene (CHEBI:51681);aromatic amide (CHEBI:62733);thiazoles (CHEBI:48901);benzenes (CHEBI:22712);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);methoxybenzene (CHEBI:51683);aromatic ether (CHEBI:35618);monocarboxylic acid (CHEBI:25384);organonitrogen heterocyclic compound (CHEBI:38101);carboxylic acid (CHEBI:33575);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);carbonyl compound (CHEBI:36586);organonitrogen compound (CHEBI:35352);leucine derivative (CHEBI:47003);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);benzenoid aromatic compound (CHEBI:33836);organic heterocyclic compound (CHEBI:24532);azole (CHEBI:68452);aromatic carboxylic acid (CHEBI:33859);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ether (CHEBI:25698);nitrogen molecular entity (CHEBI:51143)		Amino acids, peptides, and analogues	Leucine or derivatives;N-acyl-alpha amino acid or derivatives;N-acyl-alpha-amino acid;Dimethoxybenzene;O-dimethoxybenzene;Phenoxy compound;Methoxybenzene;2,4,5-trisubstituted 1,3-thiazole;2-heteroaryl carboxamide;Thiazolecarboxylic acid or derivatives;Thiazolecarboxamide;Phenol ether;Anisole;Alkyl aryl ether;Monocyclic benzene moiety;Benzenoid;Azole;Heteroaromatic compound;Thiazole;Carboxamide group;Secondary carboxylic acid amide;Azacycle;Organoheterocyclic compound;Carboxylic acid;Ether;Monocarboxylic acid or derivatives;Organic oxygen compound;Carbonyl group;Organic nitrogen compound;Organic oxide;Hydrocarbon derivative;Organooxygen compound;Organonitrogen compound;Aromatic heteromonocyclic compound	Organic acids and derivatives	0.0		EiM08-12818		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C19H24N2O5S	C19H24N2O5S			InChI=1S/C19H24N2O5S/c1-10(2)8-13(19(23)24)21-17(22)16-11(3)20-18(27-16)12-6-7-14(25-4)15(9-12)26-5/h6-7,9-10,13H,8H2,1-5H3,(H,21,22)(H,23,24)/t13-/m0/s1	GRKLFFXYTMGEEM-ZDUSSCGKSA-N	rac-(2S)-2-[[2-(3,4-dimethoxyphenyl)-4-methyl-thiazole-5-carbonyl]amino]-4-methyl-pentanoic acid	25621316	COc1c(OC)cc(-c2nc(C)c(C(=O)N[C@@H](CC(C)C)C(=O)O)s2)cc1	(2S)-2-[[2-(3,4-dimethoxyphenyl)-4-methyl-1,3-thiazole-5-carbonyl]amino]-4-methylpentanoic acid			1.95056													MCULE-3063111791	392.47753		392.140593	6	2	8	2			44										False	Alkaloids				Peptide01			Compound(25621316)	25621316	3.9	737			[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]):[#6]:[#6](-[#6]2:[#7]:[#6](-[#6]):[#6](-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=[#8])-[#8]):[#16]:2):[#6]:[#6]:1	COc1c(OC)cc(-c2nc(C)c(C(=O)N[C@@H](CC(C)C)C(=O)O)s2)cc1	GRKLFFXYTMGEEM		parent_pubchem_cid	EiM08-12818;AKOS016388504;(2S)-2-({[2-(3,4-DIMETHOXYPHENYL)-4-METHYL-1,3-THIAZOL-5-YL]CARBONYL}AMINO)-4-METHYLPENTANOIC ACID;rac-(2S)-2-[[2-(3,4-dimethoxyphenyl)-4-methyl-thiazole-5-carbonyl]amino]-4-methyl-pentanoic acid		24522635.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24522635		pluskal_iocb_peptide_Peptide01_D21_id		100	D21		ZINC000012941027
1.7		0	709	P6242856	107.5		S1	False	0	15	0	0	16	0	2	3	0	1		0.0						Cc1nc(CC(=O)NC(Cc2ccccc2)C(=O)O)cs1								N-acyl-L-alpha-amino acids;Phenylpropanoic acids;Amphetamines and derivatives;2,4-disubstituted thiazoles;Heteroaromatic compounds;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	2,4-disubstituted thiazoles;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Azacyclic compounds;Azoles;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenethylamines;Phenylalanine and derivatives;Phenylpropanoic acids;Phenylpropanoids and polyketides;Secondary carboxylic acid amides;Thiazoles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteromonocyclic compounds	N-acyl-L-alpha-amino acid (CHEBI:48927);benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);amphetamines (CHEBI:35338);thiazoles (CHEBI:48901);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);monocarboxylic acid (CHEBI:25384);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);N-acyl-amino acid (CHEBI:51569);benzenoid aromatic compound (CHEBI:33836);primary amine (CHEBI:32877);organic heterocyclic compound (CHEBI:24532);azole (CHEBI:68452);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806)		Amino acids, peptides, and analogues	Phenylalanine or derivatives;N-acyl-alpha-amino acid;N-acyl-l-alpha-amino acid;N-acyl-alpha amino acid or derivatives;3-phenylpropanoic-acid;Amphetamine or derivatives;2,4-disubstituted 1,3-thiazole;Monocyclic benzene moiety;Benzenoid;Azole;Heteroaromatic compound;Thiazole;Carboxamide group;Secondary carboxylic acid amide;Azacycle;Monocarboxylic acid or derivatives;Carboxylic acid;Organoheterocyclic compound;Organooxygen compound;Organonitrogen compound;Organic oxygen compound;Hydrocarbon derivative;Carbonyl group;Organic oxide;Organic nitrogen compound;Aromatic heteromonocyclic compound	Organic acids and derivatives	0.0		EiM08-15093		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C15H16N2O3S	C15H16N2O3S			InChI=1S/C15H16N2O3S/c1-10-16-12(9-21-10)8-14(18)17-13(15(19)20)7-11-5-3-2-4-6-11/h2-6,9,13H,7-8H2,1H3,(H,17,18)(H,19,20)/t13-/m0/s1	FIYGBFCFMCAOHL-ZDUSSCGKSA-N	rac-(2S)-2-[[2-(2-methylthiazol-4-yl)acetyl]amino]-3-phenyl-propanoic acid	51052338	Cc1nc(CC(=O)N[C@@H](Cc2ccccc2)C(=O)O)cs1	(2S)-2-[[2-(2-methyl-1,3-thiazol-4-yl)acetyl]amino]-3-phenylpropanoic acid			1.6419899999999998													MCULE-6988286242	304.37037		304.088163	4	2	6	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51052338)	51052338	2.2	738			[#6]-[#6]1:[#7]:[#6](-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#8]):[#6]:[#16]:1	Cc1nc(CC(=O)N[C@@H](Cc2ccccc2)C(=O)O)cs1	FIYGBFCFMCAOHL		parent_pubchem_cid	EiM08-15093;AKOS010373932;(2S)-2-{[2-(2-METHYL-1,3-THIAZOL-4-YL)ACETYL]AMINO}-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[[2-(2-methylthiazol-4-yl)acetyl]amino]-3-phenyl-propanoic acid		22696112.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22696112		pluskal_iocb_peptide_Peptide01_D21_id		100	D21		ZINC000037430631
4.0		0	797	P6241977	80.6		S2	False	0	23	0	0	26	0	2	4	0	0		0.0						CC(C)C(NC(=O)CCn1ccc2c1ccc(OCc1ccccc1)c2)C(=O)O								N-acyl-L-alpha-amino acids;N-alkylindoles;Indoles;Phenol ethers;Alkyl aryl ethers;Substituted pyrroles;Benzene and substituted derivatives;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Carboxylic acids;Monocarboxylic acids and derivatives;Carbonyl compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;N-alkylindoles;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenol ethers;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Valine and derivatives	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as valine and derivatives. These are compounds containing valine or a derivative thereof resulting from reaction of valine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Valine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-L-alpha-amino acid (CHEBI:48927);indoles (CHEBI:24828);aromatic ether (CHEBI:35618);pyrroles (CHEBI:26455);benzenes (CHEBI:22712);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organonitrogen heterocyclic compound (CHEBI:38101);carboxylic acid (CHEBI:33575);monocarboxylic acid (CHEBI:25384);carbonyl compound (CHEBI:36586);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);valine derivative (CHEBI:27267);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);N-acyl-amino acid (CHEBI:51569);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ether (CHEBI:25698);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)		Amino acids, peptides, and analogues	N-acyl-alpha-amino acid;Valine or derivatives;N-acyl-alpha amino acid or derivatives;N-acyl-l-alpha-amino acid;N-alkylindole;Indole;Indole or derivatives;Phenol ether;Alkyl aryl ether;Monocyclic benzene moiety;Benzenoid;Substituted pyrrole;Heteroaromatic compound;Pyrrole;Secondary carboxylic acid amide;Carboxamide group;Azacycle;Organoheterocyclic compound;Carboxylic acid;Ether;Monocarboxylic acid or derivatives;Organic nitrogen compound;Carbonyl group;Organic oxygen compound;Organooxygen compound;Organic oxide;Hydrocarbon derivative;Organonitrogen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS016376593		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C23H26N2O4	C23H26N2O4			InChI=1S/C23H26N2O4/c1-16(2)22(23(27)28)24-21(26)11-13-25-12-10-18-14-19(8-9-20(18)25)29-15-17-6-4-3-5-7-17/h3-10,12,14,16,22H,11,13,15H2,1-2H3,(H,24,26)(H,27,28)/t22-/m0/s1	NGJZBGUHMWJGBJ-QFIPXVFZSA-N	rac-(2S)-2-[3-(5-benzyloxyindol-1-yl)propanoylamino]-3-methyl-butanoic acid	49652494	CC(C)[C@H](NC(=O)CCn1ccc2c1ccc(OCc1ccccc1)c2)C(=O)O	(2S)-3-methyl-2-[3-(5-phenylmethoxyindol-1-yl)propanoylamino]butanoic acid			2.8902600000000005													MCULE-8826129668	394.47467		394.189257	4	2	9	3			44										False	Alkaloids				Peptide01			Compound(49652494)	49652494	3.6	739			[#6]-[#6](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#6]-[#7]1:[#6]:[#6]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1):[#6]:2)-[#6](=[#8])-[#8]	CC(C)[C@H](NC(=O)CCn1ccc2c1ccc(OCc1ccccc1)c2)C(=O)O	NGJZBGUHMWJGBJ		parent_pubchem_cid	AKOS016376593;(2S)-2-({3-[5-(BENZYLOXY)-1H-INDOL-1-YL]PROPANOYL}AMINO)-3-METHYLBUTANOIC ACID;rac-(2S)-2-[3-(5-benzyloxyindol-1-yl)propanoylamino]-3-methyl-butanoic acid		23540026.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23540026		pluskal_iocb_peptide_Peptide01_D21_id		100	D21		ZINC000040312601
2.8		0	885	P7566157	99.7		S3	False	0	22	0	0	27	0	7	1	0	0		0.0						Cc1cc(C)nc(N2CCCC(C(=O)Nc3n[nH]c(CCc4ccccc4)n3)C2)n1																							0.0		1-(4,6-dimethylpyrimidin-2-yl)-N-[3-(2-phenylethyl)-1H-1,2,4-triazol-5-yl]piperidine-3-carboxamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	3	0	0	1	0	0	0	0	0	0	0	0	0	1	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C22H27N7O	C22H27N7O			InChI=1S/C22H27N7O/c1-15-13-16(2)24-22(23-15)29-12-6-9-18(14-29)20(30)26-21-25-19(27-28-21)11-10-17-7-4-3-5-8-17/h3-5,7-8,13,18H,6,9-12,14H2,1-2H3,(H2,25,26,27,28,30)	QOULQTGGCHAOQU-UHFFFAOYSA-N	1-(4,6-dimethylpyrimidin-2-yl)-N-[5-(2-phenylethyl)-1H-1,2,4-triazol-3-yl]piperidine-3-carboxamide	71706141	Cc1cc(C)nc(N2CCCC(C(=O)Nc3n[nH]c(CCc4ccccc4)n3)C2)n1	1-(4,6-dimethylpyrimidin-2-yl)-N-[5-(2-phenylethyl)-1H-1,2,4-triazol-3-yl]piperidine-3-carboxamide			1.87178													MCULE-6263223445	405.50679		405.227708	6	2	6	4			45										False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(71706141)	71706141	3.4	740			[#6]-[#6]1:[#6]:[#6](-[#6]):[#7]:[#6](-[#7]2-[#6]-[#6]-[#6]-[#6](-[#6](=[#8])-[#7]-[#6]3:[#7]:[#7H]:[#6](-[#6]-[#6]-[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]:4):[#7]:3)-[#6]-2):[#7]:1	Cc1cc(C)nc(N2CCCC(C(=O)Nc3n[nH]c(CCc4ccccc4)n3)C2)n1	QOULQTGGCHAOQU		parent_pubchem_cid	1-(4,6-dimethylpyrimidin-2-yl)-N-[3-(2-phenylethyl)-1H-1,2,4-triazol-5-yl]piperidine-3-carboxamide;1401538-07-5;EiM08-30159;AKOS022125604;AKOS025144588;1-(4,6-DIMETHYL-2-PYRIMIDINYL)-N-[5-(2-PHENYLETHYL)-1H-1,2,4-TRIAZOL-3-YL]-3-PIPERIDINECARBOXAMIDE;1-(4,6-dimethylpyrimidin-2-yl)-N-[5-(2-phenylethyl)-1H-1,2,4-triazol-3-yl]piperidine-3-carboxamide		57593696.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=57593696		pluskal_iocb_peptide_Peptide01_D21_id		100	D21		
1.8		0	973	P3460082	81.4		S4	False	0	14	0	0	20	0	2	3	0	0		0.0						CC(C)(C)OC(=O)NC(Cc1ccccc1)C(N)=O								Amphetamines and derivatives;Fatty amides;Carbamate esters;Primary carboxylic acid amides;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Benzene and substituted derivatives;Benzenoids;Carbamate esters;Carbamic acids and derivatives;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Fatty Acyls;Fatty amides;Hydrocarbon derivatives;Lipids and lipid-like molecules;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenethylamines;Phenylalanine and derivatives;Primary carboxylic acid amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic homomonocyclic compounds	amphetamines (CHEBI:35338);fatty amide (CHEBI:29348);carbamate ester (CHEBI:23003);carboxamide (CHEBI:37622);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);primary amine (CHEBI:32877);lipid (CHEBI:18059);organooxygen compound (CHEBI:36963);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);carbon oxoacid (CHEBI:35605);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806);amino acid (CHEBI:33709);peptide (CHEBI:16670)	Fatty amides (FA08);Fatty Acyls (FA)	Amino acids, peptides, and analogues	Phenylalanine or derivatives;Amphetamine or derivatives;Monocyclic benzene moiety;Fatty amide;Fatty acyl;Benzenoid;Carbamic acid ester;Carboxamide group;Primary carboxylic acid amide;Organooxygen compound;Organonitrogen compound;Organic oxide;Organic nitrogen compound;Carbonyl group;Organic oxygen compound;Hydrocarbon derivative;Aromatic homomonocyclic compound	Organic acids and derivatives	0.0		35150-06-2	DTXSID10427249	2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	1	0	2	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C14H20N2O3	C14H20N2O3			InChI=1S/C14H20N2O3/c1-14(2,3)19-13(18)16-11(12(15)17)9-10-7-5-4-6-8-10/h4-8,11H,9H2,1-3H3,(H2,15,17)(H,16,18)/t11-/m0/s1	DHUPSFPAFRFQRO-NSHDSACASA-N	tert-butyl N-[rac-(1S)-2-amino-1-benzyl-2-oxo-ethyl]carbamate	7020416	CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(N)=O	tert-butyl N-[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]carbamate			1.55299													MCULE-2150281714	264.3271		264.147393	3	2	6	1			42									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(7020416)	7020416	1.3	741		SCHEMBL4420859	[#6]-[#6](-[#6])(-[#6])-[#8]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](-[#7])=[#8]	CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(N)=O	DHUPSFPAFRFQRO		parent_pubchem_cid	35150-06-2;Boc-L-phenylalaninamide;(S)-tert-Butyl (1-amino-1-oxo-3-phenylpropan-2-yl)carbamate;Boc-L-phenylalanine amide;tert-butyl (S)-(1-amino-1-oxo-3-phenylpropan-2-yl)carbamate;tert-butyl N-[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]carbamate;N-(tert-butoxycarbonyl)-L-phenylalaninamide;(S)-tert-butyl 1-amino-1-oxo-3-phenylpropan-2-ylcarbamate;MFCD00272775;tert-butyl N-[(1S)-1-carbamoyl-2-phenylethyl]carbamate;Boc-Phe-NH2;BocPheNH2;N-(tert-Butoxycarbonyl)phenylalanine amide;(S)-N-(tert-Butoxycarbonyl)phenylalanine amide;Nalpha-(tert-butoxycarbonyl)-L-phenylalaninamide;SCHEMBL4420859;DTXSID10427249;DHUPSFPAFRFQRO-NSHDSACASA-N;AKOS005175184;AKOS015836431;CS-15658;NS-00105;CS-0010981;D71973;EN300-263517;(S)-2-Phenyl-1-carbamoyl-ethyl-carbamic Acid tert-butyl Ester;rac-tert-butyl N-[(1R)-1-carbamoyl-2-phenylethyl]carbamate;CarbaMic acid, N-[(1S)-2-aMino-2-oxo-1-(phenylMethyl)ethyl]-, 1,1-diMethylethyl ester;tert-butyl N-[rac-(1S)-2-amino-1-benzyl-2-oxo-ethyl]carbamate		2668271.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=2668271		pluskal_iocb_peptide_Peptide01_D21_id		100	D21		ZINC000002564484
3.9		0	717	P6240794	71.3		S5	False	1	20	0	0	19	0	2	3	0	0		0.0						O=C(CCn1ccc2c1cccc2Br)NC(Cc1ccccc1)C(=O)O								N-acyl-L-alpha-amino acids;Phenylpropanoic acids;Amphetamines and derivatives;N-alkylindoles;Indoles;Substituted pyrroles;Aryl bromides;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Carboxylic acids;Monocarboxylic acids and derivatives;Organobromides;Carbonyl compounds;Organic oxides;Hydrocarbon derivatives;Organonitrogen compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Aryl bromides;Aryl halides;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;N-alkylindoles;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organobromides;Organohalogen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenethylamines;Phenylalanine and derivatives;Phenylpropanoic acids;Phenylpropanoids and polyketides;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-L-alpha-amino acid (CHEBI:48927);benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);amphetamines (CHEBI:35338);indoles (CHEBI:24828);pyrroles (CHEBI:26455);organobromine compound (CHEBI:37141);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organonitrogen heterocyclic compound (CHEBI:38101);monocarboxylic acid (CHEBI:25384);carbonyl compound (CHEBI:36586);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);organonitrogen compound (CHEBI:35352);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);N-acyl-amino acid (CHEBI:51569);benzenoid aromatic compound (CHEBI:33836);primary amine (CHEBI:32877);organic heterocyclic compound (CHEBI:24532);organohalogen compound (CHEBI:36684);haloarene (CHEBI:50887);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143)		Amino acids, peptides, and analogues	Phenylalanine or derivatives;N-acyl-l-alpha-amino acid;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;3-phenylpropanoic-acid;Amphetamine or derivatives;N-alkylindole;Indole;Indole or derivatives;Aryl bromide;Aryl halide;Monocyclic benzene moiety;Benzenoid;Substituted pyrrole;Heteroaromatic compound;Pyrrole;Secondary carboxylic acid amide;Carboxamide group;Organoheterocyclic compound;Monocarboxylic acid or derivatives;Azacycle;Carboxylic acid;Organonitrogen compound;Organobromide;Organohalogen compound;Organic nitrogen compound;Carbonyl group;Hydrocarbon derivative;Organic oxide;Organic oxygen compound;Organooxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS016402507		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C20H19BrN2O3	C20H19BrN2O3			InChI=1S/C20H19BrN2O3/c21-16-7-4-8-18-15(16)9-11-23(18)12-10-19(24)22-17(20(25)26)13-14-5-2-1-3-6-14/h1-9,11,17H,10,12-13H2,(H,22,24)(H,25,26)/t17-/m0/s1	XEXCPYUXIPQUCV-KRWDZBQOSA-N	rac-(2S)-2-[3-(4-bromoindol-1-yl)propanoylamino]-3-phenyl-propanoic acid	49652538	O=C(CCn1ccc2c1cccc2Br)N[C@@H](Cc1ccccc1)C(=O)O	(2S)-2-[3-(4-bromoindol-1-yl)propanoylamino]-3-phenylpropanoic acid			3.1228700000000007													MCULE-1589680670	415.29003		414.057905	3	2	7	3			44										False	Alkaloids				Peptide01			Compound(49652538)	49652538	3.5	742			[#8]=[#6](-[#6]-[#6]-[#7]1:[#6]:[#6]:[#6]2:[#6]:1:[#6]:[#6]:[#6]:[#6]:2-[#35])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	O=C(CCn1ccc2c1cccc2Br)N[C@@H](Cc1ccccc1)C(=O)O	XEXCPYUXIPQUCV		parent_pubchem_cid	AKOS016402507;(2S)-2-{[3-(4-BROMO-1H-INDOL-1-YL)PROPANOYL]AMINO}-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[3-(4-bromoindol-1-yl)propanoylamino]-3-phenyl-propanoic acid		24115381.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24115381		pluskal_iocb_peptide_Peptide01_D21_id		100	D21		ZINC000040312756
3.1		0	805	P6243581	99.1		S6	False	0	25	0	0	21	0	3	4	0	0		0.0						O=C(Cn1nc(-c2cc3ccccc3cc2)ccc1=O)NC(Cc1ccccc1)C(=O)O																							0.0		AKOS016402529		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C25H21N3O4	C25H21N3O4			InChI=1S/C25H21N3O4/c29-23(26-22(25(31)32)14-17-6-2-1-3-7-17)16-28-24(30)13-12-21(27-28)20-11-10-18-8-4-5-9-19(18)15-20/h1-13,15,22H,14,16H2,(H,26,29)(H,31,32)/t22-/m0/s1	JYUMYAWRTZYTJG-QFIPXVFZSA-N	rac-(2S)-2-[[2-[3-(2-naphthyl)-6-oxo-pyridazin-1-yl]acetyl]amino]-3-phenyl-propanoic acid	51053665	O=C(Cn1nc(-c2cc3ccccc3cc2)ccc1=O)N[C@@H](Cc1ccccc1)C(=O)O	(2S)-2-[[2-(3-naphthalen-2-yl-6-oxopyridazin-1-yl)acetyl]amino]-3-phenylpropanoic acid			2.9123400000000004													MCULE-1314409603	427.46382		427.153206	5	2	7	4			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51053665)	51053665	3.6	743			[#8]=[#6](-[#6]-[#7]1:[#7]:[#6](-[#6]2:[#6]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3:[#6]:[#6]:2):[#6]:[#6]:[#6]:1=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	O=C(Cn1nc(-c2cc3ccccc3cc2)ccc1=O)N[C@@H](Cc1ccccc1)C(=O)O	JYUMYAWRTZYTJG		parent_pubchem_cid	AKOS016402529;(2S)-2-({2-[3-(2-NAPHTHYL)-6-OXO-1(6H)-PYRIDAZINYL]ACETYL}AMINO)-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[[2-[3-(2-naphthyl)-6-oxo-pyridazin-1-yl]acetyl]amino]-3-phenyl-propanoic acid		23233005.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23233005		pluskal_iocb_peptide_Peptide01_D21_id		100	D21		ZINC000049547541
4.1		0	893	P1107948	138.2		S7	False	0	24	0	0	25	0	1	6	0	1		0.0						Cc1c(CCC(=O)NC(CSCc2ccccc2)C(=O)O)c(=O)oc2c1ccc(O)c2C																							0.0		AKOS016390267		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C24H25NO6S	C24H25NO6S			InChI=1S/C24H25NO6S/c1-14-17-8-10-20(26)15(2)22(17)31-24(30)18(14)9-11-21(27)25-19(23(28)29)13-32-12-16-6-4-3-5-7-16/h3-8,10,19,26H,9,11-13H2,1-2H3,(H,25,27)(H,28,29)/t19-/m1/s1	SKIXMKPOJFKOBJ-LJQANCHMSA-N	rac-(2S)-3-benzylsulfanyl-2-[3-(7-hydroxy-4,8-dimethyl-2-oxo-chromen-3-yl)propanoylamino]propanoic acid	24280548	Cc1c(CCC(=O)N[C@H](CSCc2ccccc2)C(=O)O)c(=O)oc2c1ccc(O)c2C	(2S)-3-benzylsulfanyl-2-[3-(7-hydroxy-4,8-dimethyl-2-oxochromen-3-yl)propanoylamino]propanoic acid			3.341060000000001													MCULE-9131367407	455.53395		455.140259	7	3	9	3			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(24280548)	24280548	3.1	744			[#6]-[#6]1:[#6](-[#6]-[#6]-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#16]-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#8]):[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]):[#6]:2-[#6]	Cc1c(CCC(=O)N[C@H](CSCc2ccccc2)C(=O)O)c(=O)oc2c1ccc(O)c2C	SKIXMKPOJFKOBJ		parent_pubchem_cid	AKOS016390267;3-(BENZYLSULFANYL)-2-[3-(7-HYDROXY-4,8-DIMETHYL-2-OXO-2H-CHROMEN-3-YL)PROPANAMIDO]PROPANOIC ACID;rac-(2S)-3-benzylsulfanyl-2-[3-(7-hydroxy-4,8-dimethyl-2-oxo-chromen-3-yl)propanoylamino]propanoic acid		23357642.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23357642		pluskal_iocb_peptide_Peptide01_D22_id		100	D22		ZINC000011865554
2.9		0	981	P6667625	93.9		S8	False	0	22	0	1	20	0	5	2	0	0		0.0						O=C(NCCc1c[nH]c2ccccc12)C1CC(=O)N(c2n[nH]c3c2c(F)ccc3)C1																							0.0		AKOS016400637		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	0	0	0	0	0	1	0		C22H20FN5O2	C22H20FN5O2			InChI=1S/C22H20FN5O2/c23-16-5-3-7-18-20(16)21(27-26-18)28-12-14(10-19(28)29)22(30)24-9-8-13-11-25-17-6-2-1-4-15(13)17/h1-7,11,14,25H,8-10,12H2,(H,24,30)(H,26,27)	GCPAYUHHLFWKQF-UHFFFAOYSA-N	1-(4-fluoro-1H-indazol-3-yl)-N-[2-(1H-indol-3-yl)ethyl]-5-oxo-pyrrolidine-3-carboxamide	75465614	O=C(NCCc1c[nH]c2ccccc12)C1CC(=O)N(c2n[nH]c3c2c(F)ccc3)C1	1-(4-fluoro-1H-indazol-3-yl)-N-[2-(1H-indol-3-yl)ethyl]-5-oxopyrrolidine-3-carboxamide			1.6029399999999996													MCULE-4747686628	405.4354		405.160103	3	3	5	5			45									Carboline alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(75465614)	75465614	2.4	745			[#8]=[#6](-[#7]-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6]1-[#6]-[#6](=[#8])-[#7](-[#6]2:[#7]:[#7H]:[#6]3:[#6]:2:[#6](-[#9]):[#6]:[#6]:[#6]:3)-[#6]-1	O=C(NCCc1c[nH]c2ccccc12)C1CC(=O)N(c2n[nH]c3c2c(F)ccc3)C1	GCPAYUHHLFWKQF		parent_pubchem_cid	AKOS016400637;1-(4-fluoro-1H-indazol-3-yl)-N-[2-(1H-indol-3-yl)ethyl]-5-oxopyrrolidine-3-carboxamide;NCGC00423761-01;1-(4-fluoro-1H-indazol-3-yl)-N-[2-(1H-indol-3-yl)ethyl]-5-oxo-pyrrolidine-3-carboxamide		80390414.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=80390414		pluskal_iocb_peptide_Peptide01_D22_id		100	D22		
2.6		0	725	P3460076	111.7		S9	False	0	22	0	0	29	0	3	5	0	0		0.0						CC(C)(C)OC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)N1CCC(C(=O)O)CC1																							0.0		1-[N-(tert-butoxycarbonyl)-L-tryptophyl]piperidine-4-carboxylic acid		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	1	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C22H29N3O5	C22H29N3O5			InChI=1S/C22H29N3O5/c1-22(2,3)30-21(29)24-18(12-15-13-23-17-7-5-4-6-16(15)17)19(26)25-10-8-14(9-11-25)20(27)28/h4-7,13-14,18,23H,8-12H2,1-3H3,(H,24,29)(H,27,28)/t18-/m0/s1	IBKKEOYSFHLJFO-SFHVURJKSA-N	1-[rac-(2S)-2-(tert-butoxycarbonylamino)-3-(1H-indol-3-yl)propanoyl]piperidine-4-carboxylic acid	1778189	CC(C)(C)OC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC(C(=O)O)CC1	1-[(2S)-3-(1H-indol-3-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoyl]piperidine-4-carboxylic acid			2.4437700000000007													MCULE-3378395800	415.49353		415.210721	5	3	7	3			44										False	Amino acids and Peptides				Peptide01			Compound(1778189)	1778189	2.4	746			[#6]-[#6](-[#6])(-[#6])-[#8]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#7]1-[#6]-[#6]-[#6](-[#6](=[#8])-[#8])-[#6]-[#6]-1	CC(C)(C)OC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC(C(=O)O)CC1	IBKKEOYSFHLJFO		parent_pubchem_cid	1-[N-(tert-butoxycarbonyl)-L-tryptophyl]piperidine-4-carboxylic acid;MFCD05668002;AKOS016375507;1-[rac-(2S)-2-(tert-butoxycarbonylamino)-3-(1H-indol-3-yl)propanoyl]piperidine-4-carboxylic acid		23558721.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23558721		pluskal_iocb_peptide_Peptide01_D22_id		100	D22		ZINC000002123419
2.5		0	813	P6243170	115.6		S10	False	0	22	0	0	26	0	4	3	0	1		0.0						CC(=O)N(CC1CCCO1)c1nc(C)c(C(=O)NCCc2c[nH]c3ccccc23)s1								Thiazolecarboxamides;2,4,5-trisubstituted thiazoles;2-heteroaryl carboxamides;Substituted pyrroles;Benzenoids;Tertiary carboxylic acid amides;Oxolanes;Acetamides;Heteroaromatic compounds;Tertiary amines;Secondary carboxylic acid amides;Amino acids and derivatives;Oxacyclic compounds;Dialkyl ethers;Azacyclic compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	2,4,5-trisubstituted thiazoles;2-heteroaryl carboxamides;3-alkylindoles;Acetamides;Amines;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Azoles;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Dialkyl ethers;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Oxacyclic compounds;Oxolanes;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Tertiary amines;Tertiary carboxylic acid amides;Thiazolecarboxamides;Thiazolecarboxylic acids and derivatives;Thiazoles	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as 3-alkylindoles. These are compounds containing an indole moiety that carries an alkyl chain at the 3-position.	3-alkylindoles			Organic compounds	Aromatic heteropolycyclic compounds	aromatic amide (CHEBI:62733);thiazoles (CHEBI:48901);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);oxolanes (CHEBI:26912);acetamides (CHEBI:22160);tertiary amine (CHEBI:32876);organonitrogen compound (CHEBI:35352);organooxygen compound (CHEBI:36963);oxacycle (CHEBI:38104);ether (CHEBI:25698);organonitrogen heterocyclic compound (CHEBI:38101);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);indoles (CHEBI:24828);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);azole (CHEBI:68452);aromatic carboxylic acid (CHEBI:33859);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);amine (CHEBI:32952);oxygen molecular entity (CHEBI:25806)		Indoles	3-alkylindole;2-heteroaryl carboxamide;2,4,5-trisubstituted 1,3-thiazole;Thiazolecarboxamide;Thiazolecarboxylic acid or derivatives;Substituted pyrrole;Benzenoid;Tertiary carboxylic acid amide;Azole;Thiazole;Heteroaromatic compound;Pyrrole;Acetamide;Oxolane;Secondary carboxylic acid amide;Amino acid or derivatives;Carboxamide group;Tertiary amine;Carboxylic acid derivative;Dialkyl ether;Ether;Oxacycle;Azacycle;Amine;Organic nitrogen compound;Hydrocarbon derivative;Carbonyl group;Organic oxygen compound;Organonitrogen compound;Organooxygen compound;Organic oxide;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		1232802-43-5		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C22H26N4O3S	C22H26N4O3S			InChI=1S/C22H26N4O3S/c1-14-20(30-22(25-14)26(15(2)27)13-17-6-5-11-29-17)21(28)23-10-9-16-12-24-19-8-4-3-7-18(16)19/h3-4,7-8,12,17,24H,5-6,9-11,13H2,1-2H3,(H,23,28)	LUMRJCWREDZCSL-UHFFFAOYSA-N	2-[acetyl(tetrahydrofuran-2-ylmethyl)amino]-N-[2-(1H-indol-3-yl)ethyl]-4-methyl-thiazole-5-carboxamide	51043702	CC(=O)N(CC1CCCO1)c1nc(C)c(C(=O)NCCc2c[nH]c3ccccc23)s1	2-[acetyl(oxolan-2-ylmethyl)amino]-N-[2-(1H-indol-3-yl)ethyl]-4-methyl-1,3-thiazole-5-carboxamide			2.464060000000001													MCULE-6459621495	426.54152		426.172562	4	2	7	4			45										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(51043702)	51043702	3.1	747			[#6]-[#6](=[#8])-[#7](-[#6]-[#6]1-[#6]-[#6]-[#6]-[#8]-1)-[#6]1:[#7]:[#6](-[#6]):[#6](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#16]:1	CC(=O)N(CC1CCCO1)c1nc(C)c(C(=O)NCCc2c[nH]c3ccccc23)s1	LUMRJCWREDZCSL		parent_pubchem_cid	1232802-43-5;2-[acetyl(tetrahydro-2-furanylmethyl)amino]-N-[2-(1H-indol-3-yl)ethyl]-4-methyl-1,3-thiazole-5-carboxamide;AKOS005665803;N-(2-(1H-indol-3-yl)ethyl)-4-methyl-2-(N-((tetrahydrofuran-2-yl)methyl)acetamido)thiazole-5-carboxamide;N-[2-(1H-INDOL-3-YL)ETHYL]-4-METHYL-2-{N-[(OXOLAN-2-YL)METHYL]ACETAMIDO}-1,3-THIAZOLE-5-CARBOXAMIDE;2-[acetyl(tetrahydrofuran-2-ylmethyl)amino]-N-[2-(1H-indol-3-yl)ethyl]-4-methyl-thiazole-5-carboxamide		23993020.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23993020		pluskal_iocb_peptide_Peptide01_D22_id		100	D22		
2.2		0	901	P6242843	99.1		S11	False	0	21	0	0	19	0	3	4	0	0		0.0						O=C(Cn1nc(-c2ccccc2)ccc1=O)NC(Cc1ccccc1)C(=O)O																							0.0		STK928191		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C21H19N3O4	C21H19N3O4			InChI=1S/C21H19N3O4/c25-19(22-18(21(27)28)13-15-7-3-1-4-8-15)14-24-20(26)12-11-17(23-24)16-9-5-2-6-10-16/h1-12,18H,13-14H2,(H,22,25)(H,27,28)/t18-/m0/s1	LKJKVBRKEPZVNM-SFHVURJKSA-N	rac-(2S)-2-[[2-(6-oxo-3-phenyl-pyridazin-1-yl)acetyl]amino]-3-phenyl-propanoic acid	51044055	O=C(Cn1nc(-c2ccccc2)ccc1=O)N[C@@H](Cc1ccccc1)C(=O)O	(2S)-2-[[2-(6-oxo-3-phenylpyridazin-1-yl)acetyl]amino]-3-phenylpropanoic acid			2.18756													MCULE-8868913547	377.40328		377.137556	5	2	7	3			44										False	Amino acids and Peptides				Peptide01			Compound(51044055)	51044055	2.4	748			[#8]=[#6](-[#6]-[#7]1:[#7]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6]:[#6]:[#6]:1=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	O=C(Cn1nc(-c2ccccc2)ccc1=O)N[C@@H](Cc1ccccc1)C(=O)O	LKJKVBRKEPZVNM		parent_pubchem_cid	STK928191;AKOS005658340;N-[(6-oxo-3-phenylpyridazin-1(6H)-yl)acetyl]-L-phenylalanine;(2S)-2-({2-[6-OXO-3-PHENYL-1(6H)-PYRIDAZINYL]ACETYL}AMINO)-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[[2-(6-oxo-3-phenyl-pyridazin-1-yl)acetyl]amino]-3-phenyl-propanoic acid		24794381.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24794381		pluskal_iocb_peptide_Peptide01_D22_id		100	D22		ZINC000049546959
1.4		0	989	P7138808	75.1		S12	False	0	13	0	0	13	0	3	2	0	0	-1.0	0.0						O=C(O)C(Cc1ccccc1)Nc1ncccn1		1.58		0.0	1.33	CHEMBL4907863		Phenylpropanoic acids;L-alpha-amino acids;Amphetamines and derivatives;Secondary alkylarylamines;Aminopyrimidines and derivatives;Heteroaromatic compounds;Amino acids;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids;Alpha amino acids and derivatives;Amines;Amino acids;Amino acids and derivatives;Amino acids, peptides, and analogues;Aminopyrimidines and derivatives;Amphetamines and derivatives;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Diazines;Heteroaromatic compounds;Hydrocarbon derivatives;L-alpha-amino acids;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenethylamines;Phenylalanine and derivatives;Phenylpropanoic acids;Phenylpropanoids and polyketides;Pyrimidines and pyrimidine derivatives;Secondary alkylarylamines;Secondary amines	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteromonocyclic compounds	benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);L-alpha-amino acid (CHEBI:15705);amphetamines (CHEBI:35338);secondary amine (CHEBI:32863);aminopyrimidine (CHEBI:38338);organic aromatic compound (CHEBI:33659);amino acid (CHEBI:33709);monocarboxylic acid (CHEBI:25384);organonitrogen heterocyclic compound (CHEBI:38101);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);organic acid (CHEBI:64709);organonitrogen compound (CHEBI:35352);alpha-amino acid (CHEBI:33704);benzenoid aromatic compound (CHEBI:33836);primary amine (CHEBI:32877);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);amine (CHEBI:32952);organic heterocyclic compound (CHEBI:24532);diazines (CHEBI:38313);pyrimidines (CHEBI:39447);oxygen molecular entity (CHEBI:25806)		Amino acids, peptides, and analogues	Phenylalanine or derivatives;3-phenylpropanoic-acid;Amphetamine or derivatives;L-alpha-amino acid;Aminopyrimidine;Secondary aliphatic/aromatic amine;Monocyclic benzene moiety;Pyrimidine;Benzenoid;Heteroaromatic compound;Amino acid;Azacycle;Carboxylic acid;Monocarboxylic acid or derivatives;Organoheterocyclic compound;Secondary amine;Organonitrogen compound;Organic nitrogen compound;Hydrocarbon derivative;Carbonyl group;Organooxygen compound;Organic oxygen compound;Amine;Organic oxide;Aromatic heteromonocyclic compound	Organic acids and derivatives	0.0		SCHEMBL2501414		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C13H13N3O2	C13H13N3O2			InChI=1S/C13H13N3O2/c17-12(18)11(9-10-5-2-1-3-6-10)16-13-14-7-4-8-15-13/h1-8,11H,9H2,(H,17,18)(H,14,15,16)/t11-/m0/s1	IVJZYRZYVLZTQK-NSHDSACASA-N	rac-(2S)-3-phenyl-2-(pyrimidin-2-ylamino)propanoic acid	38999788	O=C(O)[C@H](Cc1ccccc1)Nc1ncccn1	(2S)-3-phenyl-2-(pyrimidin-2-ylamino)propanoic acid			1.14908													MCULE-2262956141	243.26746	ACID	243.100777	5	2	5	2	1.0		28									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids	False	False	Peptide01		-1.0	Compound(38999788)	38999788	2.1	749		SCHEMBL2501414	[#8]=[#6](-[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6]1:[#7]:[#6]:[#6]:[#6]:[#7]:1	O=C(O)[C@H](Cc1ccccc1)Nc1ncccn1	IVJZYRZYVLZTQK		parent_pubchem_cid	SCHEMBL2501414;CHEMBL4907863;AKOS024462005;rac-(2S)-3-phenyl-2-(pyrimidin-2-ylamino)propanoic acid	False	43323356.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=43323356		pluskal_iocb_peptide_Peptide01_D22_id		100	D22	False	ZINC000031775774
1.4		0	733	P6666356	111.7		S13	False	0	17	0	0	19	0	3	5	0	0		0.0						COc1cc2c(cc1)[nH]cc2CCN1C(=O)NC(CCC(=O)O)C1=O																							0.0		AKOS016384013		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C17H19N3O5	C17H19N3O5			InChI=1S/C17H19N3O5/c1-25-11-2-3-13-12(8-11)10(9-18-13)6-7-20-16(23)14(19-17(20)24)4-5-15(21)22/h2-3,8-9,14,18H,4-7H2,1H3,(H,19,24)(H,21,22)/t14-/m0/s1	XQJOSFMJFDVWFF-AWEZNQCLSA-N	3-[rac-(4S)-1-[2-(5-methoxy-1H-indol-3-yl)ethyl]-2,5-dioxo-imidazolidin-4-yl]propanoic acid	16409313	COc1cc2c(cc1)[nH]cc2CCN1C(=O)N[C@@H](CCC(=O)O)C1=O	3-[(4S)-1-[2-(5-methoxy-1H-indol-3-yl)ethyl]-2,5-dioxoimidazolidin-4-yl]propanoic acid			0.5586599999999999													MCULE-3292002775	345.35808		345.132471	5	3	7	3			44										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(16409313)	16409313	1.1	750			[#6]-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#7H]:[#6]:[#6]:2-[#6]-[#6]-[#7]1-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]-[#6](=[#8])-[#8])-[#6]-1=[#8]	COc1cc2c(cc1)[nH]cc2CCN1C(=O)N[C@@H](CCC(=O)O)C1=O	XQJOSFMJFDVWFF		parent_pubchem_cid	AKOS016384013;3-[rac-(4S)-1-[2-(5-methoxy-1H-indol-3-yl)ethyl]-2,5-dioxo-imidazolidin-4-yl]propanoic acid		23624355.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23624355		pluskal_iocb_peptide_Peptide01_D22_id		100	D22		ZINC000008765233
1.7		0	821	P3463231	120.8		S14	False	0	20	0	0	19	0	5	4	0	1		0.0						O=C(Cc1c[nH]c2ccccc12)N1CCN(S(=O)(=O)c2cccc3nonc23)CC1																							0.0		1010904-99-0		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	1	1		C20H19N5O4S	C20H19N5O4S			InChI=1S/C20H19N5O4S/c26-19(12-14-13-21-16-5-2-1-4-15(14)16)24-8-10-25(11-9-24)30(27,28)18-7-3-6-17-20(18)23-29-22-17/h1-7,13,21H,8-12H2	ATDZUPRXLBFCMS-UHFFFAOYSA-N	1-[4-(2,1,3-benzoxadiazol-4-ylsulfonyl)piperazin-1-yl]-2-(1H-indol-3-yl)ethanone	42571258	O=C(Cc1c[nH]c2ccccc12)N1CCN(S(=O)(=O)c2cccc3nonc23)CC1	1-[4-(2,1,3-benzoxadiazol-4-ylsulfonyl)piperazin-1-yl]-2-(1H-indol-3-yl)ethanone			0.7601399999999998													MCULE-4660519185	425.46953		425.115775	5	1	4	5			43									Carboline alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(42571258)	42571258	1.3	751			[#8]=[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]1-[#6]-[#6]-[#7](-[#16](=[#8])(=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]3:[#7]:[#8]:[#7]:[#6]:2:3)-[#6]-[#6]-1	O=C(Cc1c[nH]c2ccccc12)N1CCN(S(=O)(=O)c2cccc3nonc23)CC1	ATDZUPRXLBFCMS		parent_pubchem_cid	1010904-99-0;Ethanone, 1-[4-(2,1,3-benzoxadiazol-4-ylsulfonyl)-1-piperazinyl]-2-(1H-indol-3-yl)-;DTXSID301135184;STK634237;AKOS005566179;1-[4-(2,1,3-Benzoxadiazol-4-ylsulfonyl)-1-piperazinyl]-2-(1H-indol-3-yl)ethanone;1-[4-(2,1,3-benzoxadiazol-4-ylsulfonyl)piperazin-1-yl]-2-(1H-indol-3-yl)ethanone		6547222.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=6547222		pluskal_iocb_peptide_Peptide01_D22_id		100	D22		ZINC000012391515
3.6		0	909	P7130770	74.4		S15	False	0	24	0	0	27	0	3	3	0	0		0.0						COc1cc2c(cc1)[nH]cc2CCNC(=O)C(C(C)C)N1Cc2ccccc2C1=O																							0.0		EiM08-27874		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C24H27N3O3	C24H27N3O3			InChI=1S/C24H27N3O3/c1-15(2)22(27-14-17-6-4-5-7-19(17)24(27)29)23(28)25-11-10-16-13-26-21-9-8-18(30-3)12-20(16)21/h4-9,12-13,15,22,26H,10-11,14H2,1-3H3,(H,25,28)/t22-/m0/s1	IDJNUCOSDLYMNB-QFIPXVFZSA-N	rac-(2S)-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-3-methyl-2-(1-oxoisoindolin-2-yl)butanamide	71753666	COc1cc2c(cc1)[nH]cc2CCNC(=O)[C@H](C(C)C)N1Cc2ccccc2C1=O	(2S)-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanamide			2.46084													MCULE-7358685592	405.50109		405.205242	3	2	7	4			44										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(71753666)	71753666	3.7	752			[#6]-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#7H]:[#6]:[#6]:2-[#6]-[#6]-[#7]-[#6](=[#8])-[#6@H](-[#6](-[#6])-[#6])-[#7]1-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6]-1=[#8]	COc1cc2c(cc1)[nH]cc2CCNC(=O)[C@H](C(C)C)N1Cc2ccccc2C1=O	IDJNUCOSDLYMNB		parent_pubchem_cid	EiM08-27874;AKOS024460759;(2S)-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-3-methyl-2-(1-oxo-1,3-dihydro-2H-isoindol-2-yl)butanamide;rac-(2S)-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-3-methyl-2-(1-oxoisoindolin-2-yl)butanamide		69040846.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=69040846		pluskal_iocb_peptide_Peptide01_D23_id		100	D23		ZINC000079188637
2.3		0	997	P6237106	109.3		S16	False	0	25	0	0	30	0	4	5	0	0		0.0						COc1c(OC)cc2c(=O)n(CC(=O)NC(C(=O)NCCc3ccccc3)C(C)C)cnc2c1								Valine and derivatives;Alpha amino acid amides;Quinazolines;Anisoles;Alkyl aryl ethers;Pyrimidones;Benzene and substituted derivatives;N-acyl amines;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactams;Azacyclic compounds;Hydrocarbon derivatives;Carbonyl compounds;Organic oxides;Organonitrogen compounds	Alkyl aryl ethers;Alpha amino acid amides;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Anisoles;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Benzodiazines;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Diazanaphthalenes;Diazines;Ethers;Fatty Acyls;Fatty amides;Heteroaromatic compounds;Hydrocarbon derivatives;Lactams;Lipids and lipid-like molecules;N-acyl amines;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenol ethers;Pyrimidines and pyrimidine derivatives;Pyrimidones;Quinazolines;Secondary carboxylic acid amides;Valine and derivatives	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acyl-alpha amino acids and derivatives. These are compounds containing an alpha amino acid (or a derivative thereof) which bears an acyl group at its terminal nitrogen atom.	N-acyl-alpha amino acids and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	valine derivative (CHEBI:27267);amino acid amide (CHEBI:22475);quinazolines (CHEBI:38530);methoxybenzene (CHEBI:51683);aromatic ether (CHEBI:35618);pyrimidone (CHEBI:38337);benzenes (CHEBI:22712);fatty amide (CHEBI:29348);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactam (CHEBI:24995);organonitrogen heterocyclic compound (CHEBI:38101);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);N-acyl-amino acid (CHEBI:51569);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);organooxygen compound (CHEBI:36963);organic heterocyclic compound (CHEBI:24532);azaarene (CHEBI:50893);benzenoid aromatic compound (CHEBI:33836);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ether (CHEBI:25698);diazines (CHEBI:38313);pyrimidines (CHEBI:39447);lipid (CHEBI:18059);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);amino acid (CHEBI:33709);peptide (CHEBI:16670)	N-acyl amines (FA0802);Fatty Acyls (FA);Fatty amides (FA08)	Amino acids, peptides, and analogues	Valine or derivatives;N-acyl-alpha amino acid or derivatives;Alpha-amino acid amide;Quinazoline;Anisole;Phenol ether;Alkyl aryl ether;Pyrimidone;Monocyclic benzene moiety;Fatty amide;N-acyl-amine;Pyrimidine;Fatty acyl;Benzenoid;Heteroaromatic compound;Lactam;Carboxamide group;Secondary carboxylic acid amide;Ether;Azacycle;Organoheterocyclic compound;Organooxygen compound;Organonitrogen compound;Hydrocarbon derivative;Organic oxide;Organic oxygen compound;Organic nitrogen compound;Carbonyl group;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS016376600		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1	0		C25H30N4O5	C25H30N4O5			InChI=1S/C25H30N4O5/c1-16(2)23(24(31)26-11-10-17-8-6-5-7-9-17)28-22(30)14-29-15-27-19-13-21(34-4)20(33-3)12-18(19)25(29)32/h5-9,12-13,15-16,23H,10-11,14H2,1-4H3,(H,26,31)(H,28,30)/t23-/m0/s1	UQCFSAHFZOYLNO-QHCPKHFHSA-N	rac-(2S)-2-[[2-(6,7-dimethoxy-4-oxo-quinazolin-3-yl)acetyl]amino]-3-methyl-N-(2-phenylethyl)butanamide	29147352	COc1c(OC)cc2c(=O)n(CC(=O)N[C@H](C(=O)NCCc3ccccc3)C(C)C)cnc2c1	(2S)-2-[[2-(6,7-dimethoxy-4-oxoquinazolin-3-yl)acetyl]amino]-3-methyl-N-(2-phenylethyl)butanamide			1.4053400000000014													MCULE-4320973529	466.54165		466.22162	6	2	10	3			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(29147352)	29147352	2.8	753			[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]):[#6]:[#6]2:[#6](=[#8]):[#7](-[#6]-[#6](=[#8])-[#7]-[#6@H](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3)-[#6](-[#6])-[#6]):[#6]:[#7]:[#6]:2:[#6]:1	COc1c(OC)cc2c(=O)n(CC(=O)N[C@H](C(=O)NCCc3ccccc3)C(C)C)cnc2c1	UQCFSAHFZOYLNO		parent_pubchem_cid	AKOS016376600;rac-(2S)-2-[[2-(6,7-dimethoxy-4-oxo-quinazolin-3-yl)acetyl]amino]-3-methyl-N-(2-phenylethyl)butanamide		12714346.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=12714346		pluskal_iocb_peptide_Peptide01_D23_id		100	D23		ZINC000020761133
2.1		0	741	P6236784	91.5		S17	False	0	22	0	0	21	0	3	4	0	0		0.0						COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)CN1Cc2ccccc2C1=O																							0.0		AKOS016382724		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C22H21N3O4	C22H21N3O4			InChI=1S/C22H21N3O4/c1-29-22(28)19(10-15-11-23-18-9-5-4-7-16(15)18)24-20(26)13-25-12-14-6-2-3-8-17(14)21(25)27/h2-9,11,19,23H,10,12-13H2,1H3,(H,24,26)/t19-/m0/s1	BWPDYIKQJFULIU-IBGZPJMESA-N	methyl rac-(2S)-3-(1H-indol-3-yl)-2-[[2-(1-oxoisoindolin-2-yl)acetyl]amino]propanoate	29148538	COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN1Cc2ccccc2C1=O	methyl (2S)-3-(1H-indol-3-yl)-2-[[2-(3-oxo-1H-isoindol-2-yl)acetyl]amino]propanoate			1.4316499999999996													MCULE-7352934444	391.43037		391.153206	4	2	7	4			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(29148538)	29148538	2.3	754			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#6](=[#8])-[#6]-[#7]1-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6]-1=[#8]	COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN1Cc2ccccc2C1=O	BWPDYIKQJFULIU		parent_pubchem_cid	AKOS016382724;methyl rac-(2S)-3-(1H-indol-3-yl)-2-[[2-(1-oxoisoindolin-2-yl)acetyl]amino]propanoate		15817112.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=15817112		pluskal_iocb_peptide_Peptide01_D23_id		100	D23		ZINC000020763603
2.6		0	829	P1159385	114.8		S18	False	0	20	1	0	17	0	6	3	0	0		0.0						COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c1c(-n2cnnn2)cc(Cl)cc1																							0.0		AKOS004938022		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	4	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C20H17ClN6O3	C20H17ClN6O3			InChI=1S/C20H17ClN6O3/c1-30-20(29)17(8-12-10-22-16-5-3-2-4-14(12)16)24-19(28)15-7-6-13(21)9-18(15)27-11-23-25-26-27/h2-7,9-11,17,22H,8H2,1H3,(H,24,28)/t17-/m0/s1	BZXHCKPXYHNDQZ-KRWDZBQOSA-N	methyl rac-(2S)-2-[[4-chloro-2-(tetrazol-1-yl)benzoyl]amino]-3-(1H-indol-3-yl)propanoate	28934780	COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1c(-n2cnnn2)cc(Cl)cc1	methyl (2S)-2-[[4-chloro-2-(tetrazol-1-yl)benzoyl]amino]-3-(1H-indol-3-yl)propanoate			1.5832499999999994													MCULE-1854741413	424.84989		424.105066	6	2	7	4			44									Imidazole alkaloids;Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids;Histidine alkaloids			Peptide01			Compound(28934780)	28934780	3.2	755			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#6](=[#8])-[#6]1:[#6](-[#7]2:[#6]:[#7]:[#7]:[#7]:2):[#6]:[#6](-[#17]):[#6]:[#6]:1	COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1c(-n2cnnn2)cc(Cl)cc1	BZXHCKPXYHNDQZ		parent_pubchem_cid	AKOS004938022;METHYL (2S)-2-{[4-CHLORO-2-(1H-1,2,3,4-TETRAAZOL-1-YL)BENZOYL]AMINO}-3-(1H-INDOL-3-YL)PROPANOATE;methyl rac-(2S)-2-[[4-chloro-2-(tetrazol-1-yl)benzoyl]amino]-3-(1H-indol-3-yl)propanoate		13296439.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=13296439		pluskal_iocb_peptide_Peptide01_D23_id		100	D23		ZINC000020426751
1.4		0	917	P6243652	99.1		S19	False	0	16	0	0	23	0	3	4	0	0		0.0						CC(C)CC(NC(=O)Cn1nc2CCCCc2cc1=O)C(=O)O																							0.0		AKOS016376060		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C16H23N3O4	C16H23N3O4			InChI=1S/C16H23N3O4/c1-10(2)7-13(16(22)23)17-14(20)9-19-15(21)8-11-5-3-4-6-12(11)18-19/h8,10,13H,3-7,9H2,1-2H3,(H,17,20)(H,22,23)/t13-/m0/s1	MVCOXKYLMOQRCV-ZDUSSCGKSA-N	rac-(2S)-4-methyl-2-[[2-(3-oxo-5,6,7,8-tetrahydrocinnolin-2-yl)acetyl]amino]pentanoic acid	51054161	CC(C)C[C@H](NC(=O)Cn1nc2CCCCc2cc1=O)C(=O)O	(2S)-4-methyl-2-[[2-(3-oxo-5,6,7,8-tetrahydrocinnolin-2-yl)acetyl]amino]pentanoic acid			1.5280699999999998													MCULE-5560826604	321.37941		321.168856	5	2	6	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51054161)	51054161	1.3	756			[#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#7]1:[#7]:[#6]2-[#6]-[#6]-[#6]-[#6]-[#6]:2:[#6]:[#6]:1=[#8])-[#6](=[#8])-[#8]	CC(C)C[C@H](NC(=O)Cn1nc2CCCCc2cc1=O)C(=O)O	MVCOXKYLMOQRCV		parent_pubchem_cid	AKOS016376060;NCGC00422972-01;4-METHYL-2-[2-(3-OXO-2,3,5,6,7,8-HEXAHYDROCINNOLIN-2-YL)ACETAMIDO]PENTANOIC ACID;rac-(2S)-4-methyl-2-[[2-(3-oxo-5,6,7,8-tetrahydrocinnolin-2-yl)acetyl]amino]pentanoic acid		22858079.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22858079		pluskal_iocb_peptide_Peptide01_D23_id		100	D23		ZINC000049549140
1.4		0	1005	P11185523	54.3		S20	False	0	12	0	0	20	0	2	2	0	0		0.0						CC(C)C(CO)NC(=O)C(C)n1cccc1																							0.0		AKOS027473025		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C12H20N2O2	C12H20N2O2			InChI=1S/C12H20N2O2/c1-9(2)11(8-15)13-12(16)10(3)14-6-4-5-7-14/h4-7,9-11,15H,8H2,1-3H3,(H,13,16)/t10-,11+/m0/s1	LNGRBWJNFUZLNN-WDEREUQCSA-N	rac-(2S)-2-pyrrol-1-yl-N-[rac-(1S)-1-(hydroxymethyl)-2-methyl-propyl]propanamide	121595447	CC(C)[C@@H](CO)NC(=O)[C@H](C)n1cccc1	(2S)-N-[(2S)-1-hydroxy-3-methylbutan-2-yl]-2-pyrrol-1-ylpropanamide			1.1821999999999997														224.3054		224.152478	2	2	5	1			45									Simple amide alkaloids	False	Alkaloids	Peptide alkaloids			Peptide01			Compound(121595447)	121595447	1.2	757			[#6]-[#6](-[#6])-[#6@@H](-[#6]-[#8])-[#7]-[#6](=[#8])-[#6@H](-[#6])-[#7]1:[#6]:[#6]:[#6]:[#6]:1	CC(C)[C@@H](CO)NC(=O)[C@H](C)n1cccc1	LNGRBWJNFUZLNN		parent_pubchem_cid	AKOS027473025;rac-(2S)-2-pyrrol-1-yl-N-[rac-(1S)-1-(hydroxymethyl)-2-methyl-propyl]propanamide		147966419.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=147966419		pluskal_iocb_peptide_Peptide01_D23_id		100	D23		ZINC000334160750
1.4		0	749	P6237497	113.6		S21	False	0	22	0	0	23	0	3	5	0	0		0.0						COC(=O)C(Cc1ccccc1)NC(=O)CCC1NC(=O)c2ccccc2NC1=O								Alpha amino acid esters;N-acyl-alpha amino acids and derivatives;1,4-benzodiazepines;Amphetamines and derivatives;Fatty acid esters;Fatty amides;Vinylogous amides;Methyl esters;Secondary carboxylic acid amides;Lactams;Monocarboxylic acids and derivatives;Azacyclic compounds;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organonitrogen compounds	1,4-benzodiazepines;Alpha amino acid esters;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Benzodiazepines;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids and derivatives;Chemical entities;Fatty Acyls;Fatty acid esters;Fatty amides;Hydrocarbon derivatives;Lactams;Lipids and lipid-like molecules;Methyl esters;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenethylamines;Phenylalanine and derivatives;Secondary carboxylic acid amides;Vinylogous amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	alpha-amino acid ester (CHEBI:46874);N-acyl-amino acid (CHEBI:51569);benzodiazepine (CHEBI:22720);amphetamines (CHEBI:35338);fatty acid ester (CHEBI:35748);fatty amide (CHEBI:29348);enone (CHEBI:51689);enamine (CHEBI:47989);carboxylic ester (CHEBI:33308);carboxamide (CHEBI:37622);lactam (CHEBI:24995);monocarboxylic acid (CHEBI:25384);organonitrogen heterocyclic compound (CHEBI:38101);carbonyl compound (CHEBI:36586);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);organooxygen compound (CHEBI:36963);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);primary amine (CHEBI:32877);lipid (CHEBI:18059);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143);amino acid (CHEBI:33709);peptide (CHEBI:16670)	Fatty esters (FA07);Fatty amides (FA08);Fatty Acyls (FA)	Amino acids, peptides, and analogues	Phenylalanine or derivatives;Alpha-amino acid ester;N-acyl-alpha amino acid or derivatives;Benzodiazepine;1,4-benzodiazepine;Amphetamine or derivatives;Fatty acid ester;Monocyclic benzene moiety;Fatty acyl;Fatty amide;Benzenoid;Vinylogous amide;Methyl ester;Carboxamide group;Carboxylic acid ester;Lactam;Secondary carboxylic acid amide;Organoheterocyclic compound;Azacycle;Monocarboxylic acid or derivatives;Organic oxygen compound;Organic nitrogen compound;Carbonyl group;Hydrocarbon derivative;Organic oxide;Organonitrogen compound;Organooxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS016382737		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	2	0	0	0	0	0	0	0	0	4	0	0	0	0	0	0	1	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0		C22H23N3O5	C22H23N3O5			InChI=1S/C22H23N3O5/c1-30-22(29)18(13-14-7-3-2-4-8-14)23-19(26)12-11-17-21(28)24-16-10-6-5-9-15(16)20(27)25-17/h2-10,17-18H,11-13H2,1H3,(H,23,26)(H,24,28)(H,25,27)/t17-,18+/m1/s1	WNRQIPPPHSITPJ-MSOLQXFVSA-N	methyl rac-(2S)-3-phenyl-2-[3-[rac-(3R)-2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl]propanoylamino]propanoate	39377613	COC(=O)[C@H](Cc1ccccc1)NC(=O)CC[C@H]1NC(=O)c2ccccc2NC1=O	methyl (2S)-2-[3-[(3R)-2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl]propanoylamino]-3-phenylpropanoate			0.9277699999999982													MCULE-3193550400	409.44571		409.163771	5	3	8	3			44									Benzodiazepine alkaloids	False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(39377613)	39377613	1.7	758			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]-[#6]-[#6@H]1-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#7]-[#6]-1=[#8]	COC(=O)[C@H](Cc1ccccc1)NC(=O)CC[C@H]1NC(=O)c2ccccc2NC1=O	WNRQIPPPHSITPJ		parent_pubchem_cid	AKOS016382737;METHYL 2-[3-(2,5-DIOXO-2,3,4,5-TETRAHYDRO-1H-1,4-BENZODIAZEPIN-3-YL)PROPANAMIDO]-3-PHENYLPROPANOATE;methyl rac-(2S)-3-phenyl-2-[3-[rac-(3R)-2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl]propanoylamino]propanoate		2075754.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=2075754		pluskal_iocb_peptide_Peptide01_D23_id		100	D23		ZINC000032123886
4.7		0	837	P1108086	105.8		S22	False	0	27	0	0	27	0	1	6	0	0		0.0						Cc1c(-c2ccccc2)c2c(cc3oc(=O)c(CC(=O)NC(CC(C)C)C(=O)O)c(C)c3c2)o1																							0.0		EiM07-29288		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C27H27NO6	C27H27NO6			InChI=1S/C27H27NO6/c1-14(2)10-21(26(30)31)28-24(29)12-19-15(3)18-11-20-23(13-22(18)34-27(19)32)33-16(4)25(20)17-8-6-5-7-9-17/h5-9,11,13-14,21H,10,12H2,1-4H3,(H,28,29)(H,30,31)/t21-/m1/s1	RBNZAJLTRMBCKF-OAQYLSRUSA-N	rac-(2R)-2-[[2-(2,5-dimethyl-7-oxo-3-phenyl-furo[3,2-g]chromen-6-yl)acetyl]amino]-4-methyl-pentanoic acid	24280599	Cc1c(-c2ccccc2)c2c(cc3oc(=O)c(CC(=O)N[C@H](CC(C)C)C(=O)O)c(C)c3c2)o1	(2R)-2-[[2-(2,5-dimethyl-7-oxo-3-phenylfuro[3,2-g]chromen-6-yl)acetyl]amino]-4-methylpentanoic acid			4.479940000000004													MCULE-5989828049	461.51934		461.183838	5	2	7	4			44									Furocoumarins;Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(24280599)	24280599	4.8	759			[#6]-[#6]1:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6]2:[#6](:[#6]:[#6]3:[#8]:[#6](=[#8]):[#6](-[#6]-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6](-[#6])-[#6])-[#6](=[#8])-[#8]):[#6](-[#6]):[#6]:3:[#6]:2):[#8]:1	Cc1c(-c2ccccc2)c2c(cc3oc(=O)c(CC(=O)N[C@H](CC(C)C)C(=O)O)c(C)c3c2)o1	RBNZAJLTRMBCKF		parent_pubchem_cid	EiM07-29288;AKOS016376023;rac-(2R)-2-[[2-(2,5-dimethyl-7-oxo-3-phenyl-furo[3,2-g]chromen-6-yl)acetyl]amino]-4-methyl-pentanoic acid		24045256.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24045256		pluskal_iocb_peptide_Peptide01_D23_id		100	D23		ZINC000011865597
3.8		0	925	P11185753	57.8		S23	False	0	19	0	0	21	0	3	1	0	0		0.0						CC(C)C(=O)NC(Cc1ccccc1)c1nc2ccccc2[nH]1																							0.0		AKOS027473183		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C19H21N3O	C19H21N3O			InChI=1S/C19H21N3O/c1-13(2)19(23)22-17(12-14-8-4-3-5-9-14)18-20-15-10-6-7-11-16(15)21-18/h3-11,13,17H,12H2,1-2H3,(H,20,21)(H,22,23)	PFECIIXPCNIQRC-UHFFFAOYSA-N	N-[1-(1H-benzimidazol-2-yl)-2-phenyl-ethyl]-2-methyl-propanamide	51154300	CC(C)C(=O)NC(Cc1ccccc1)c1nc2ccccc2[nH]1	N-[1-(1H-benzimidazol-2-yl)-2-phenylethyl]-2-methylpropanamide			3.081060000000001														307.39872		307.168462	2	2	5	3			46										False	Alkaloids				Peptide01			Compound(51154300)	51154300	3.7	760			[#6]-[#6](-[#6])-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#7H]:1	CC(C)C(=O)NC(Cc1ccccc1)c1nc2ccccc2[nH]1	PFECIIXPCNIQRC		parent_pubchem_cid	AKOS027473183;N-[1-(1H-1,3-BENZIMIDAZOL-2-YL)-2-PHENYLETHYL]-2-METHYLPROPANAMIDE;N-[1-(1H-benzimidazol-2-yl)-2-phenyl-ethyl]-2-methyl-propanamide		60898090.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=60898090		pluskal_iocb_peptide_Peptide01_D24_id		100	D24		
3.1		0	1013	P7567851	71.3		S24	False	0	19	0	0	18	0	2	3	0	0		0.0						Cn1ccc2c1cc(C(=O)NC(Cc1ccccc1)C(=O)O)cc2																							0.0		EiM08-36791		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C19H18N2O3	C19H18N2O3			InChI=1S/C19H18N2O3/c1-21-10-9-14-7-8-15(12-17(14)21)18(22)20-16(19(23)24)11-13-5-3-2-4-6-13/h2-10,12,16H,11H2,1H3,(H,20,22)(H,23,24)/t16-/m0/s1	FCSKIEZLPKEYIE-INIZCTEOSA-N	rac-(2S)-2-[(1-methylindole-6-carbonyl)amino]-3-phenyl-propanoic acid	91637902	Cn1ccc2c1cc(C(=O)N[C@@H](Cc1ccccc1)C(=O)O)cc2	(2S)-2-[(1-methylindole-6-carbonyl)amino]-3-phenylpropanoic acid			2.06616														322.36691		322.131742	3	2	5	3			45										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(91637902)	91637902	2.9	761			[#6]-[#7]1:[#6]:[#6]:[#6]2:[#6]:1:[#6]:[#6](-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]):[#6]:[#6]:2	Cn1ccc2c1cc(C(=O)N[C@@H](Cc1ccccc1)C(=O)O)cc2	FCSKIEZLPKEYIE		parent_pubchem_cid	EiM08-36791;AKOS025146047;(2S)-2-{[(1-METHYL-1H-INDOL-6-YL)CARBONYL]AMINO}-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[(1-methylindole-6-carbonyl)amino]-3-phenyl-propanoic acid		94786038.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=94786038		pluskal_iocb_peptide_Peptide01_D24_id		100	D24		ZINC000170625475
3.2		0	757	P6239986	105.9		S25	False	0	22	0	0	24	0	2	4	0	1		0.0						CSCCC(NC(=O)Cn1ccc2c1ccc(OCc1ccccc1)c2)C(=O)O																							0.0		AKOS005671284		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C22H24N2O4S	C22H24N2O4S			InChI=1S/C22H24N2O4S/c1-29-12-10-19(22(26)27)23-21(25)14-24-11-9-17-13-18(7-8-20(17)24)28-15-16-5-3-2-4-6-16/h2-9,11,13,19H,10,12,14-15H2,1H3,(H,23,25)(H,26,27)/t19-/m0/s1	RKWMNKXXJVYMAI-IBGZPJMESA-N	rac-(2S)-2-[[2-(5-benzyloxyindol-1-yl)acetyl]amino]-4-methylsulfanyl-butanoic acid	45493634	CSCC[C@H](NC(=O)Cn1ccc2c1ccc(OCc1ccccc1)c2)C(=O)O	(2S)-4-methylsulfanyl-2-[[2-(5-phenylmethoxyindol-1-yl)acetyl]amino]butanoic acid			2.5972599999999995													MCULE-9384225092	412.51158		412.145678	5	2	10	3			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(45493634)	45493634	3.5	762			[#6]-[#16]-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#7]1:[#6]:[#6]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1):[#6]:2)-[#6](=[#8])-[#8]	CSCC[C@H](NC(=O)Cn1ccc2c1ccc(OCc1ccccc1)c2)C(=O)O	RKWMNKXXJVYMAI		parent_pubchem_cid	AKOS005671284;(2S)-2-({2-[5-(BENZYLOXY)-1H-INDOL-1-YL]ACETYL}AMINO)-4-(METHYLSULFANYL)BUTANOIC ACID;rac-(2S)-2-[[2-(5-benzyloxyindol-1-yl)acetyl]amino]-4-methylsulfanyl-butanoic acid		24071426.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24071426		pluskal_iocb_peptide_Peptide01_D24_id		100	D24		ZINC000036359156
2.5		0	845	P11184225	100.9		S26	False	0	18	0	0	25	0	1	4	0	1		0.0						CSCCC(NC(=O)Cc1cc2c(cc1)OC(C)(C)CC2)C(=O)O																							0.0		AKOS027472143		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C18H25NO4S	C18H25NO4S			InChI=1S/C18H25NO4S/c1-18(2)8-6-13-10-12(4-5-15(13)23-18)11-16(20)19-14(17(21)22)7-9-24-3/h4-5,10,14H,6-9,11H2,1-3H3,(H,19,20)(H,21,22)/t14-/m0/s1	BHTDCRNCGQVYRH-AWEZNQCLSA-N	rac-(2S)-2-[[2-(2,2-dimethylchroman-6-yl)acetyl]amino]-4-methylsulfanyl-butanoic acid	75492159	CSCC[C@H](NC(=O)Cc1cc2c(cc1)OC(C)(C)CC2)C(=O)O	(2S)-2-[[2-(2,2-dimethyl-3,4-dihydrochromen-6-yl)acetyl]amino]-4-methylsulfanylbutanoic acid			2.0833699999999995														351.46825		351.150429	5	2	7	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(75492159)	75492159	2.8	763			[#6]-[#16]-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1)-[#8]-[#6](-[#6])(-[#6])-[#6]-[#6]-2)-[#6](=[#8])-[#8]	CSCC[C@H](NC(=O)Cc1cc2c(cc1)OC(C)(C)CC2)C(=O)O	BHTDCRNCGQVYRH		parent_pubchem_cid	AKOS027472143;N-[(2,2-dimethyl-3,4-dihydro-2H-1-benzopyran-6-yl)acetyl]-L-methionine;rac-(2S)-2-[[2-(2,2-dimethylchroman-6-yl)acetyl]amino]-4-methylsulfanyl-butanoic acid		80416571.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=80416571		pluskal_iocb_peptide_Peptide01_D24_id		100	D24		ZINC000096222349
1.9		0	933	P6236162	99.0		S27	False	0	18	0	1	16	0	5	3	0	0		0.0						COC(=O)C(Cc1ccccc1)NC(=O)c1c(-n2cnnn2)ccc(F)c1																							0.0		AKOS005577787		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	4	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C18H16FN5O3	C18H16FN5O3			InChI=1S/C18H16FN5O3/c1-27-18(26)15(9-12-5-3-2-4-6-12)21-17(25)14-10-13(19)7-8-16(14)24-11-20-22-23-24/h2-8,10-11,15H,9H2,1H3,(H,21,25)/t15-/m0/s1	IOVPMJIJEPVPLD-HNNXBMFYSA-N	methyl rac-(2S)-2-[[5-fluoro-2-(tetrazol-1-yl)benzoyl]amino]-3-phenyl-propanoate	42580732	COC(=O)[C@H](Cc1ccccc1)NC(=O)c1c(-n2cnnn2)ccc(F)c1	methyl (2S)-2-[[5-fluoro-2-(tetrazol-1-yl)benzoyl]amino]-3-phenylpropanoate			1.0160699999999991													MCULE-5396176204	369.35832		369.123718	6	1	7	3			44										False	Alkaloids				Peptide01			Compound(42580732)	42580732	2.5	764			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]1:[#6](-[#7]2:[#6]:[#7]:[#7]:[#7]:2):[#6]:[#6]:[#6](-[#9]):[#6]:1	COC(=O)[C@H](Cc1ccccc1)NC(=O)c1c(-n2cnnn2)ccc(F)c1	IOVPMJIJEPVPLD		parent_pubchem_cid	AKOS005577787;methyl rac-(2S)-2-[[5-fluoro-2-(tetrazol-1-yl)benzoyl]amino]-3-phenyl-propanoate		15934379.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=15934379		pluskal_iocb_peptide_Peptide01_D24_id		100	D24		ZINC000012407197
2.9		0	1021	P11184296	120.4		S28	False	0	18	0	0	23	0	3	3	0	1		0.0						CCCc1nccc(-c2nc(CC(=O)NC(C(=O)O)C(C)C)cs2)c1																							0.0		AKOS027472187		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C18H23N3O3S	C18H23N3O3S			InChI=1S/C18H23N3O3S/c1-4-5-13-8-12(6-7-19-13)17-20-14(10-25-17)9-15(22)21-16(11(2)3)18(23)24/h6-8,10-11,16H,4-5,9H2,1-3H3,(H,21,22)(H,23,24)/t16-/m0/s1	UVHMFJKPOXBUSL-INIZCTEOSA-N	rac-(2S)-3-methyl-2-[[2-[2-(2-propyl-4-pyridyl)thiazol-4-yl]acetyl]amino]butanoic acid	100216659	CCCc1nccc(-c2nc(CC(=O)N[C@H](C(=O)O)C(C)C)cs2)c1	(2S)-3-methyl-2-[[2-[2-(2-propylpyridin-4-yl)-1,3-thiazol-4-yl]acetyl]amino]butanoic acid			2.4360600000000003														361.46631		361.146013	5	2	8	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(100216659)	100216659	2.9	765			[#6]-[#6]-[#6]-[#6]1:[#7]:[#6]:[#6]:[#6](-[#6]2:[#7]:[#6](-[#6]-[#6](=[#8])-[#7]-[#6@H](-[#6](=[#8])-[#8])-[#6](-[#6])-[#6]):[#6]:[#16]:2):[#6]:1	CCCc1nccc(-c2nc(CC(=O)N[C@H](C(=O)O)C(C)C)cs2)c1	UVHMFJKPOXBUSL		parent_pubchem_cid	AKOS027472187;rac-(2S)-3-methyl-2-[[2-[2-(2-propyl-4-pyridyl)thiazol-4-yl]acetyl]amino]butanoic acid		102189499.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=102189499		pluskal_iocb_peptide_Peptide01_D24_id		100	D24		ZINC000223241709
3.4		0	765	P6240044	107.5		S29	False	0	20	0	0	18	0	2	3	0	1		0.0						O=C(Cc1csc(-c2ccccc2)n1)NC(Cc1ccccc1)C(=O)O																							0.0		SCHEMBL20255500		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C20H18N2O3S	C20H18N2O3S			InChI=1S/C20H18N2O3S/c23-18(22-17(20(24)25)11-14-7-3-1-4-8-14)12-16-13-26-19(21-16)15-9-5-2-6-10-15/h1-10,13,17H,11-12H2,(H,22,23)(H,24,25)/t17-/m0/s1	DLOACPLYNCPRDL-KRWDZBQOSA-N	rac-(2S)-3-phenyl-2-[[2-(2-phenylthiazol-4-yl)acetyl]amino]propanoic acid	45491724	O=C(Cc1csc(-c2ccccc2)n1)N[C@@H](Cc1ccccc1)C(=O)O	(2S)-3-phenyl-2-[[2-(2-phenyl-1,3-thiazol-4-yl)acetyl]amino]propanoic acid			2.6752600000000006													MCULE-2490083487	366.44206		366.103813	4	2	7	3			43										False					Peptide01			Compound(45491724)	45491724	3.4	766		SCHEMBL20255500	[#8]=[#6](-[#6]-[#6]1:[#6]:[#16]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#7]:1)-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	O=C(Cc1csc(-c2ccccc2)n1)N[C@@H](Cc1ccccc1)C(=O)O	DLOACPLYNCPRDL		parent_pubchem_cid	SCHEMBL20255500;AKOS005667133;(2S)-3-PHENYL-2-{[2-(2-PHENYL-1,3-THIAZOL-4-YL)ACETYL]AMINO}PROPANOIC ACID;rac-(2S)-3-phenyl-2-[[2-(2-phenylthiazol-4-yl)acetyl]amino]propanoic acid		24122920.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24122920		pluskal_iocb_peptide_Peptide01_D24_id		100	D24		ZINC000036354854
4.2		0	853	P7130045	86.0		S30	False	0	21	0	0	19	0	3	1	0	1		0.0						Cc1nc(-c2ccccc2)c(C(=O)NCCc2c[nH]c3ccccc23)s1								Thiazolecarboxamides;2-heteroaryl carboxamides;2,4,5-trisubstituted thiazoles;Substituted pyrroles;Benzene and substituted derivatives;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Organooxygen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	2,4,5-trisubstituted thiazoles;2-heteroaryl carboxamides;3-alkylindoles;Azacyclic compounds;Azoles;Benzene and substituted derivatives;Benzenoids;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Thiazolecarboxamides;Thiazolecarboxylic acids and derivatives;Thiazoles	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as 3-alkylindoles. These are compounds containing an indole moiety that carries an alkyl chain at the 3-position.	3-alkylindoles			Organic compounds	Aromatic heteropolycyclic compounds	aromatic amide (CHEBI:62733);thiazoles (CHEBI:48901);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);pyrroles (CHEBI:26455);benzenes (CHEBI:22712);organonitrogen heterocyclic compound (CHEBI:38101);organooxygen compound (CHEBI:36963);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);indoles (CHEBI:24828);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);azole (CHEBI:68452);aromatic carboxylic acid (CHEBI:33859);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);benzenoid aromatic compound (CHEBI:33836);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143)		Indoles	3-alkylindole;2-heteroaryl carboxamide;2,4,5-trisubstituted 1,3-thiazole;Thiazolecarboxylic acid or derivatives;Thiazolecarboxamide;Monocyclic benzene moiety;Benzenoid;Substituted pyrrole;Azole;Heteroaromatic compound;Pyrrole;Thiazole;Carboxamide group;Secondary carboxylic acid amide;Carboxylic acid derivative;Azacycle;Organonitrogen compound;Organic nitrogen compound;Hydrocarbon derivative;Organic oxide;Organic oxygen compound;Organooxygen compound;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		N-[2-(1H-indol-3-yl)ethyl]-2-methyl-4-phenyl-1,3-thiazole-5-carboxamide		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C21H19N3OS	C21H19N3OS			InChI=1S/C21H19N3OS/c1-14-24-19(15-7-3-2-4-8-15)20(26-14)21(25)22-12-11-16-13-23-18-10-6-5-9-17(16)18/h2-10,13,23H,11-12H2,1H3,(H,22,25)	DWLIZLTULPIDMD-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)ethyl]-2-methyl-4-phenyl-thiazole-5-carboxamide	9441805	Cc1nc(-c2ccccc2)c(C(=O)NCCc2c[nH]c3ccccc23)s1	N-[2-(1H-indol-3-yl)ethyl]-2-methyl-4-phenyl-1,3-thiazole-5-carboxamide			3.599750000000002													MCULE-9311071113	361.46908		361.124883	2	2	5	4			44										False	Alkaloids				Peptide01			Compound(9441805)	9441805	4.7	767			[#6]-[#6]1:[#7]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#16]:1	Cc1nc(-c2ccccc2)c(C(=O)NCCc2c[nH]c3ccccc23)s1	DWLIZLTULPIDMD		parent_pubchem_cid	N-[2-(1H-indol-3-yl)ethyl]-2-methyl-4-phenyl-1,3-thiazole-5-carboxamide;920623-89-8;EiM08-24876;AKOS024460222;Z108839720;N-[2-(1H-indol-3-yl)ethyl]-2-methyl-4-phenyl-thiazole-5-carboxamide		1709112.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=1709112		pluskal_iocb_peptide_Peptide01_D24_id		100	D24		ZINC000008316312
3.0		0	941	P3460799	91.5		S31	False	0	24	1	0	24	0	3	4	0	0		0.0						COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C1CC(=O)N(Cc2ccc(Cl)cc2)C1								N-acyl-alpha amino acids and derivatives;Alpha amino acid esters;Indolyl carboxylic acids and derivatives;3-alkylindoles;Pyrrolidinecarboxamides;Fatty acid esters;Chlorobenzenes;Substituted pyrroles;Pyrrolidine-2-ones;N-alkylpyrrolidines;Aryl chlorides;Tertiary carboxylic acid amides;Methyl esters;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactams;Monocarboxylic acids and derivatives;Azacyclic compounds;Organopnictogen compounds;Organonitrogen compounds;Organochlorides;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	3-alkylindoles;Alpha amino acid esters;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Aryl chlorides;Aryl halides;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids and derivatives;Chemical entities;Chlorobenzenes;Fatty Acyls;Fatty acid esters;Halobenzenes;Heteroaromatic compounds;Hybrid peptides;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Indolyl carboxylic acids and derivatives;Lactams;Lipids and lipid-like molecules;Methyl esters;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids and derivatives;N-alkylpyrrolidines;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organochlorides;Organohalogen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Peptidomimetics;Pyrroles;Pyrrolidine carboxylic acids and derivatives;Pyrrolidine-2-ones;Pyrrolidinecarboxamides;Pyrrolidines;Pyrrolidones;Secondary carboxylic acid amides;Substituted pyrroles;Tertiary carboxylic acid amides	Peptidomimetics	2.1	This compound belongs to the class of organic compounds known as hybrid peptides. These are compounds containing at least two different types of amino acids (alpha, beta, gamma, delta) linked to each other through a peptide bond.	Hybrid peptides			Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-amino acid (CHEBI:51569);alpha-amino acid ester (CHEBI:46874);indolyl carboxylic acid (CHEBI:46867);indoles (CHEBI:24828);pyrrolidinecarboxamide (CHEBI:46770);fatty acid ester (CHEBI:35748);organochlorine compound (CHEBI:36683);pyrroles (CHEBI:26455);pyrrolidin-2-ones (CHEBI:74223);N-alkylpyrrolidine (CHEBI:46775);carboxamide (CHEBI:37622);carboxylic ester (CHEBI:33308);organic aromatic compound (CHEBI:33659);lactam (CHEBI:24995);carbonyl compound (CHEBI:36586);organonitrogen heterocyclic compound (CHEBI:38101);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);peptide (CHEBI:16670);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);amino acid (CHEBI:33709);organic heterocyclic compound (CHEBI:24532);pyrrolidines (CHEBI:38260);lipid (CHEBI:18059);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);organohalogen compound (CHEBI:36684);pyrrolidinone (CHEBI:38275);haloarene (CHEBI:50887);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806);peptidomimetic (CHEBI:63175)	Fatty esters (FA07);Fatty Acyls (FA)	Hybrid peptides	Hybrid peptide;N-acyl-alpha amino acid or derivatives;Alpha-amino acid ester;Indolyl carboxylic acid derivative;3-alkylindole;Alpha-amino acid or derivatives;Indole or derivatives;Indole;Pyrrolidine-3-carboxamide;Pyrrolidine carboxylic acid or derivatives;Halobenzene;Fatty acid ester;Chlorobenzene;Fatty acyl;Benzenoid;N-alkylpyrrolidine;Substituted pyrrole;2-pyrrolidone;Pyrrolidone;Monocyclic benzene moiety;Aryl halide;Aryl chloride;Heteroaromatic compound;Methyl ester;Tertiary carboxylic acid amide;Pyrrolidine;Pyrrole;Secondary carboxylic acid amide;Lactam;Carboxylic acid ester;Carboxamide group;Azacycle;Organoheterocyclic compound;Monocarboxylic acid or derivatives;Carboxylic acid derivative;Organic nitrogen compound;Organic oxygen compound;Organopnictogen compound;Organic oxide;Hydrocarbon derivative;Organooxygen compound;Organonitrogen compound;Organochloride;Organohalogen compound;Carbonyl group;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS016382152		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C24H24ClN3O4	C24H24ClN3O4			InChI=1S/C24H24ClN3O4/c1-32-24(31)21(10-16-12-26-20-5-3-2-4-19(16)20)27-23(30)17-11-22(29)28(14-17)13-15-6-8-18(25)9-7-15/h2-9,12,17,21,26H,10-11,13-14H2,1H3,(H,27,30)	GCVMXXHWPZAWEF-UHFFFAOYSA-N	methyl 2-[[1-[(4-chlorophenyl)methyl]-5-oxo-pyrrolidine-3-carbonyl]amino]-3-(1H-indol-3-yl)propanoate	56725832	COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C1CC(=O)N(Cc2ccc(Cl)cc2)C1	methyl 2-[[1-[(4-chlorophenyl)methyl]-5-oxopyrrolidine-3-carbonyl]amino]-3-(1H-indol-3-yl)propanoate			2.5324600000000004													MCULE-6171467233	453.92958		453.145534	4	2	8	4			45										False	Amino acids and Peptides				Peptide01			Compound(56725832)	56725832	2.9	768			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#6](=[#8])-[#6]1-[#6]-[#6](=[#8])-[#7](-[#6]-[#6]2:[#6]:[#6]:[#6](-[#17]):[#6]:[#6]:2)-[#6]-1	COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C1CC(=O)N(Cc2ccc(Cl)cc2)C1	GCVMXXHWPZAWEF		parent_pubchem_cid	AKOS016382152;methyl 2-[[1-[(4-chlorophenyl)methyl]-5-oxo-pyrrolidine-3-carbonyl]amino]-3-(1H-indol-3-yl)propanoate		22921322.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22921322		pluskal_iocb_peptide_Peptide01_E1_id		100	E1		
3.4		0	1029	P6245619	103.5		S32	False	0	20	1	0	21	0	4	3	0	1		0.0						COC(=O)C(CCSC)NC(=O)c1c(-n2cccc2)n(-c2ccc(Cl)cc2)nc1																							0.0		AKOS016382691		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	2		C20H21ClN4O3S	C20H21ClN4O3S			InChI=1S/C20H21ClN4O3S/c1-28-20(27)17(9-12-29-2)23-18(26)16-13-22-25(15-7-5-14(21)6-8-15)19(16)24-10-3-4-11-24/h3-8,10-11,13,17H,9,12H2,1-2H3,(H,23,26)/t17-/m0/s1	DOFUQMGOWLMGLE-KRWDZBQOSA-N	methyl rac-(2S)-2-[[1-(4-chlorophenyl)-5-pyrrol-1-yl-pyrazole-4-carbonyl]amino]-4-methylsulfanyl-butanoate	51052503	COC(=O)[C@H](CCSC)NC(=O)c1c(-n2cccc2)n(-c2ccc(Cl)cc2)nc1	methyl (2S)-2-[[1-(4-chlorophenyl)-5-pyrrol-1-ylpyrazole-4-carbonyl]amino]-4-methylsulfanylbutanoate			2.9061700000000013													MCULE-3624826628	432.93237		432.102289	5	1	9	3			44										False	Alkaloids				Peptide01			Compound(51052503)	51052503	3.5	769			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]-[#16]-[#6])-[#7]-[#6](=[#8])-[#6]1:[#6](-[#7]2:[#6]:[#6]:[#6]:[#6]:2):[#7](-[#6]2:[#6]:[#6]:[#6](-[#17]):[#6]:[#6]:2):[#7]:[#6]:1	COC(=O)[C@H](CCSC)NC(=O)c1c(-n2cccc2)n(-c2ccc(Cl)cc2)nc1	DOFUQMGOWLMGLE		parent_pubchem_cid	AKOS016382691;methyl rac-(2S)-2-[[1-(4-chlorophenyl)-5-pyrrol-1-yl-pyrazole-4-carbonyl]amino]-4-methylsulfanyl-butanoate		10133860.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=10133860		pluskal_iocb_peptide_Peptide01_E1_id		100	E1		ZINC000049543893
1.2		0	773	P7138705	104.3		S33	False	0	14	0	0	15	0	3	4	0	0		0.0						O=C(NC(Cc1cnc[nH]1)C(=O)O)OCc1ccccc1								Benzyloxycarbonyls;Imidazolyl carboxylic acids and derivatives;Heteroaromatic compounds;Carbamate esters;Organic carbonic acids and derivatives;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Azoles;Benzene and substituted derivatives;Benzenoids;Benzyloxycarbonyls;Carbamate esters;Carbamic acids and derivatives;Carbonyl compounds;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Histidine and derivatives;Hydrocarbon derivatives;Imidazoles;Imidazolyl carboxylic acids and derivatives;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Substituted imidazoles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as histidine and derivatives. These are compounds containing cysteine or a derivative thereof resulting from reaction of cysteine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Histidine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteromonocyclic compounds	carboxylic ester (CHEBI:33308);imidazolyl carboxylic acid (CHEBI:38307);organic aromatic compound (CHEBI:33659);carbamate ester (CHEBI:23003);organooxygen compound (CHEBI:36963);carbonyl compound (CHEBI:36586);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);organonitrogen heterocyclic compound (CHEBI:38101);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);histidine derivative (CHEBI:24599);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);organic heterocyclic compound (CHEBI:24532);azole (CHEBI:68452);imidazoles (CHEBI:24780);amino acid (CHEBI:33709);peptide (CHEBI:16670);carbon oxoacid (CHEBI:35605);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806)		Amino acids, peptides, and analogues	Histidine or derivatives;Benzyloxycarbonyl;Imidazolyl carboxylic acid derivative;Monocyclic benzene moiety;Benzenoid;Azole;Imidazole;Heteroaromatic compound;Carbamic acid ester;Carbonic acid derivative;Carboxylic acid;Monocarboxylic acid or derivatives;Azacycle;Organoheterocyclic compound;Organic nitrogen compound;Hydrocarbon derivative;Organic oxide;Carbonyl group;Organic oxygen compound;Organonitrogen compound;Organooxygen compound;Organopnictogen compound;Aromatic heteromonocyclic compound	Organic acids and derivatives	0.0		Z-His-OH		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	2	1	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C14H15N3O4	C14H15N3O4			InChI=1S/C14H15N3O4/c18-13(19)12(6-11-7-15-9-16-11)17-14(20)21-8-10-4-2-1-3-5-10/h1-5,7,9,12H,6,8H2,(H,15,16)(H,17,20)(H,18,19)/t12-/m0/s1	WCOJOHPAKJFUDF-LBPRGKRZSA-N	rac-(2S)-2-(benzyloxycarbonylamino)-3-(1H-imidazol-4-yl)propanoic acid	736313	O=C(N[C@@H](Cc1cnc[nH]1)C(=O)O)OCc1ccccc1	(2S)-3-(1H-imidazol-5-yl)-2-(phenylmethoxycarbonylamino)propanoic acid			1.2223799999999998													MCULE-4620948899	289.29335		289.106256	5	3	7	2			43									Dipeptides	False	Alkaloids;Amino acids and Peptides	Small peptides			Peptide01			Compound(736313)	736313	1.2	770		SCHEMBL254638	[#8]=[#6](-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7]:[#6]:[#7H]:1)-[#6](=[#8])-[#8])-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	O=C(N[C@@H](Cc1cnc[nH]1)C(=O)O)OCc1ccccc1	WCOJOHPAKJFUDF		parent_pubchem_cid	Z-His-OH;14997-58-1;N-Cbz-L-histidine;L-Histidine, N-[(phenylmethoxy)carbonyl]-;CBZ-histidine;Nalpha-Cbz-L-histidine;Nalpha-Carbobenzoxy-L-histidine;Cbz-His-OH;(2S)-3-(1H-imidazol-5-yl)-2-(phenylmethoxycarbonylamino)propanoic acid;N-[(Benzyloxy)carbonyl]-L-histidine;MFCD00065960;(s)-2-(((benzyloxy)carbonyl)amino)-3-(1h-imidazol-5-yl)propanoic acid;Cbz-L-histidine;Cbz-His;Histidine, N-[(phenylmethoxy)carbonyl]-;N-(alpha)-Carbobenzoxy-L-histidine;N-alpha-benzyloxycarbonyl-L-histidine;benzyloxycarbonyl-L-histidine;N-CBZ-L-HISTIDINE-OH;Z-His-OH, 99%;SCHEMBL254638;SCHEMBL9230979;((Benzyloxy)carbonyl)-L-histidine;DTXSID501280353;Nalpha -benzyloxycarbonyl-histidine;AMY31373;(2S)-2-{[(benzyloxy)carbonyl]amino}-3-(1H-imidazol-4-yl)propanoic acid;(S)-2-(BENZYLOXYCARBONYLAMINO)-3-(1H-IMIDAZOL-4-YL)PROPANOIC ACID;AKOS015909985;AKOS015924085;CS-W013996;FD21657;HY-W013280;N-[(Phenylmethoxy)carbonyl]-L-histidine;AC-17159;AS-49151;B0265;EN300-121289;A808989;W-108080;rac-(2S)-2-(benzyloxycarbonylamino)-3-(1H-imidazol-4-yl)propanoic acid		19030098.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=19030098		pluskal_iocb_peptide_Peptide01_E1_id		100	E1		ZINC000095890228
0.5		0	861	P1100516	168.1		S34	False	0	18	0	0	21	0	3	7	0	0	-1.0	0.0						Cc1c(CC(=O)NC(CCCNC(N)=O)C(=O)O)c(=O)oc2c1ccc(O)c2		0.37		0.0	-0.33	CHEMBL1164009		7-hydroxycoumarins;1-benzopyrans;Pyranones and derivatives;1-hydroxy-2-unsubstituted benzenoids;Heteroaromatic compounds;Ureas;Secondary carboxylic acid amides;Lactones;Oxacyclic compounds;Monocarboxylic acids and derivatives;Carboxylic acids;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	1-benzopyrans;1-hydroxy-2-unsubstituted benzenoids;7-hydroxycoumarins;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;Heteroaromatic compounds;Hydrocarbon derivatives;Hydroxycoumarins;Lactones;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenols;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Secondary carboxylic acid amides;Ureas	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom.	N-acyl-alpha amino acids		Amino acids and derivatives;Alpha amino acids and derivatives;N-acyl-alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	hydroxycoumarin (CHEBI:37912);1-benzopyran (CHEBI:38443);pyranone (CHEBI:37963);phenols (CHEBI:33853);organic aromatic compound (CHEBI:33659);ureas (CHEBI:47857);carboxamide (CHEBI:37622);lactone (CHEBI:25000);oxacycle (CHEBI:38104);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);N-acyl-amino acid (CHEBI:51569);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);coumarins (CHEBI:23403);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);pyrans (CHEBI:26407);benzenoid aromatic compound (CHEBI:33836);organic acid (CHEBI:64709);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806);carboxylic acid anion (CHEBI:29067);amino acid (CHEBI:33709);peptide (CHEBI:16670)	Benzopyranoids (PK1311)	Amino acids, peptides, and analogues	N-acyl-alpha-amino acid;7-hydroxycoumarin;Hydroxycoumarin;Coumarin;Benzopyran;1-benzopyran;1-hydroxy-2-unsubstituted benzenoid;Phenol;Pyranone;Pyran;Benzenoid;Heteroaromatic compound;Urea;Secondary carboxylic acid amide;Carboxamide group;Lactone;Oxacycle;Organoheterocyclic compound;Carboxylic acid;Monocarboxylic acid or derivatives;Organic oxide;Organic oxygen compound;Organic nitrogen compound;Organooxygen compound;Carbonyl group;Hydrocarbon derivative;Organonitrogen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		CHEMBL1164009		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C18H21N3O7	C18H21N3O7			InChI=1S/C18H21N3O7/c1-9-11-5-4-10(22)7-14(11)28-17(26)12(9)8-15(23)21-13(16(24)25)3-2-6-20-18(19)27/h4-5,7,13,22H,2-3,6,8H2,1H3,(H,21,23)(H,24,25)(H3,19,20,27)/t13-/m1/s1	DLSPEGRJURWCRI-CYBMUJFWSA-N	rac-(2R)-2-[[2-(7-hydroxy-4-methyl-2-oxo-chromen-3-yl)acetyl]amino]-5-ureido-pentanoic acid	24280127	Cc1c(CC(=O)N[C@H](CCCNC(N)=O)C(=O)O)c(=O)oc2c1ccc(O)c2	(2R)-5-(carbamoylamino)-2-[[2-(7-hydroxy-4-methyl-2-oxochromen-3-yl)acetyl]amino]pentanoic acid			0.2670600000000013													MCULE-2652504518	391.38397	ACID	391.13795	7	5	8	2	1.0		29									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins	False	False	Peptide01		-1.0	Compound(24280127)	24280127	-0.2	771			[#6]-[#6]1:[#6](-[#6]-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#8])-[#6](=[#8])-[#8]):[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]):[#6]:2	Cc1c(CC(=O)N[C@H](CCCNC(N)=O)C(=O)O)c(=O)oc2c1ccc(O)c2	DLSPEGRJURWCRI		parent_pubchem_cid	CHEMBL1164009;BDBM50320642;AKOS016379141;(R)-2-(2-(7-hydroxy-4-methyl-2-oxo-2H-chromen-3-yl)acetamido)-5-ureidopentanoic acid;5-(CARBAMOYLAMINO)-2-[2-(7-HYDROXY-4-METHYL-2-OXO-2H-CHROMEN-3-YL)ACETAMIDO]PENTANOIC ACID;rac-(2R)-2-[[2-(7-hydroxy-4-methyl-2-oxo-chromen-3-yl)acetyl]amino]-5-ureido-pentanoic acid	False	40007.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=40007		pluskal_iocb_peptide_Peptide01_E1_id		100	E1	False	ZINC000011867572
2.1		0	949	P6243731	81.9		S35	False	0	19	0	0	21	0	5	2	0	0		0.0						COc1ccc(CCNC(=O)C(Cc2ccccc2)n2cnnn2)cc1																							0.0		AKOS016384778		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	4	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C19H21N5O2	C19H21N5O2			InChI=1S/C19H21N5O2/c1-26-17-9-7-15(8-10-17)11-12-20-19(25)18(24-14-21-22-23-24)13-16-5-3-2-4-6-16/h2-10,14,18H,11-13H2,1H3,(H,20,25)/t18-/m0/s1	YEJPYLOSZBVZBD-SFHVURJKSA-N	rac-(2S)-N-[2-(4-methoxyphenyl)ethyl]-3-phenyl-2-(tetrazol-1-yl)propanamide	51054807	COc1ccc(CCNC(=O)[C@H](Cc2ccccc2)n2cnnn2)cc1	(2S)-N-[2-(4-methoxyphenyl)ethyl]-3-phenyl-2-(tetrazol-1-yl)propanamide			1.2525699999999995													MCULE-1576876699	351.41152		351.169525	5	1	8	3			44										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(51054807)	51054807	2.9	772			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6]-[#6]-[#7]-[#6](=[#8])-[#6@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#7]2:[#6]:[#7]:[#7]:[#7]:2):[#6]:[#6]:1	COc1ccc(CCNC(=O)[C@H](Cc2ccccc2)n2cnnn2)cc1	YEJPYLOSZBVZBD		parent_pubchem_cid	AKOS016384778;rac-(2S)-N-[2-(4-methoxyphenyl)ethyl]-3-phenyl-2-(tetrazol-1-yl)propanamide		17384091.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=17384091		pluskal_iocb_peptide_Peptide01_E1_id		100	E1		ZINC000025527661
4.0		0	1037	P1157524	97.3		S36	False	0	25	0	0	32	0	2	6	0	0		0.0						COc1ccc(C2c3cc(OC)c(OC)cc3CCN2C(=O)NC(CC(C)C)C(=O)O)cc1																							0.0		AKOS016376086		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C25H32N2O6	C25H32N2O6			InChI=1S/C25H32N2O6/c1-15(2)12-20(24(28)29)26-25(30)27-11-10-17-13-21(32-4)22(33-5)14-19(17)23(27)16-6-8-18(31-3)9-7-16/h6-9,13-15,20,23H,10-12H2,1-5H3,(H,26,30)(H,28,29)/t20-,23?/m0/s1	IUFXPBVRSZEFGW-AJZOCDQUSA-N	rac-(2S)-2-[[6,7-dimethoxy-1-(4-methoxyphenyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]amino]-4-methyl-pentanoic acid	16407230	COc1ccc(C2c3cc(OC)c(OC)cc3CCN2C(=O)N[C@@H](CC(C)C)C(=O)O)cc1	(2S)-2-[[6,7-dimethoxy-1-(4-methoxyphenyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]amino]-4-methylpentanoic acid			2.3174399999999995													MCULE-8523010990	456.54359		456.226037	6	2	8	3			45									Isoquinoline alkaloids	False	Alkaloids	Tyrosine alkaloids			Peptide01			Compound(16407230)	16407230	4.0	773			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6]2-[#6]3:[#6]:[#6](-[#8]-[#6]):[#6](-[#8]-[#6]):[#6]:[#6]:3-[#6]-[#6]-[#7]-2-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=[#8])-[#8]):[#6]:[#6]:1	COc1ccc(C2c3cc(OC)c(OC)cc3CCN2C(=O)N[C@@H](CC(C)C)C(=O)O)cc1	IUFXPBVRSZEFGW		parent_pubchem_cid	AKOS016376086;N-{[6,7-dimethoxy-1-(4-methoxyphenyl)-3,4-dihydroisoquinolin-2(1H)-yl]carbonyl}-L-leucine;956940-57-1;(2S)-2-({[6,7-DIMETHOXY-1-(4-METHOXYPHENYL)-3,4-DIHYDRO-2(1H)-ISOQUINOLINYL]CARBONYL}AMINO)-4-METHYLPENTANOIC ACID;(2S)-2-[[6,7-dimethoxy-1-(4-methoxyphenyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]amino]-4-methylpentanoic acid;rac-(2S)-2-[[6,7-dimethoxy-1-(4-methoxyphenyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]amino]-4-methyl-pentanoic acid		24287172.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24287172		pluskal_iocb_peptide_Peptide01_E1_id		100	E1		
3.8		0	781	P6236783	91.5		S37	False	0	26	0	0	29	0	3	4	0	0		0.0						COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CC(C)C)N1Cc2ccccc2C1=O																							0.0		EiM08-03966		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	2	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C26H29N3O4	C26H29N3O4			InChI=1S/C26H29N3O4/c1-16(2)12-23(29-15-17-8-4-5-10-20(17)25(29)31)24(30)28-22(26(32)33-3)13-18-14-27-21-11-7-6-9-19(18)21/h4-11,14,16,22-23,27H,12-13,15H2,1-3H3,(H,28,30)/t22-,23-/m0/s1	QQWIQRRKEOUHOX-GOTSBHOMSA-N	methyl rac-(2S)-3-(1H-indol-3-yl)-2-[[rac-(2S)-4-methyl-2-(1-oxoisoindolin-2-yl)pentanoyl]amino]propanoate	29148493	COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)N1Cc2ccccc2C1=O	methyl (2S)-3-(1H-indol-3-yl)-2-[[(2S)-4-methyl-2-(3-oxo-1H-isoindol-2-yl)pentanoyl]amino]propanoate			2.84635													MCULE-2085443292	447.53873		447.215806	4	2	9	4			44										False	Alkaloids;Amino acids and Peptides	Pseudoalkaloids			Peptide01			Compound(29148493)	29148493	4.1	774			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#6](=[#8])-[#6@H](-[#6]-[#6](-[#6])-[#6])-[#7]1-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6]-1=[#8]	COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)N1Cc2ccccc2C1=O	QQWIQRRKEOUHOX		parent_pubchem_cid	EiM08-03966;AKOS016375999;methyl rac-(2S)-3-(1H-indol-3-yl)-2-[[rac-(2S)-4-methyl-2-(1-oxoisoindolin-2-yl)pentanoyl]amino]propanoate		8816627.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=8816627		pluskal_iocb_peptide_Peptide01_E1_id		100	E1		ZINC000020763515
1.5		0	869	P6243668	99.1		S38	False	0	16	0	0	23	0	3	4	0	0		0.0						CC(C)C(NC(=O)Cn1nc2CCCCCc2cc1=O)C(=O)O																							0.0		AKOS016376623		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C16H23N3O4	C16H23N3O4			InChI=1S/C16H23N3O4/c1-10(2)15(16(22)23)17-13(20)9-19-14(21)8-11-6-4-3-5-7-12(11)18-19/h8,10,15H,3-7,9H2,1-2H3,(H,17,20)(H,22,23)/t15-/m0/s1	KCRRTSPBAVBYCI-HNNXBMFYSA-N	rac-(2S)-3-methyl-2-[[2-(3-oxo-6,7,8,9-tetrahydro-5H-cyclohepta[c]pyridazin-2-yl)acetyl]amino]butanoic acid	51053334	CC(C)[C@H](NC(=O)Cn1nc2CCCCCc2cc1=O)C(=O)O	(2S)-3-methyl-2-[[2-(3-oxo-6,7,8,9-tetrahydro-5H-cyclohepta[c]pyridazin-2-yl)acetyl]amino]butanoic acid			1.5280699999999994													MCULE-4827332853	321.37941		321.168856	5	2	5	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51053334)	51053334	1.5	775			[#6]-[#6](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#7]1:[#7]:[#6]2-[#6]-[#6]-[#6]-[#6]-[#6]-[#6]:2:[#6]:[#6]:1=[#8])-[#6](=[#8])-[#8]	CC(C)[C@H](NC(=O)Cn1nc2CCCCCc2cc1=O)C(=O)O	KCRRTSPBAVBYCI		parent_pubchem_cid	AKOS016376623;NCGC00422740-01;3-METHYL-2-(2-{3-OXO-2H,3H,5H,6H,7H,8H,9H-CYCLOHEPTA[C]PYRIDAZIN-2-YL}ACETAMIDO)BUTANOIC ACID;rac-(2S)-3-methyl-2-[[2-(3-oxo-6,7,8,9-tetrahydro-5H-cyclohepta[c]pyridazin-2-yl)acetyl]amino]butanoic acid		24174733.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24174733		pluskal_iocb_peptide_Peptide01_E1_id		100	E1		ZINC000049546476
1.4		0	957	P3459747	79.3		S39	False	0	15	0	0	14	0	2	3	0	0	-1.0	0.0						O=C(NC(Cc1ccccc1)C(=O)O)c1cnccc1		1.51		0.0	0.79	CHEMBL63715																	0.0		3-phenyl-2-[(pyridin-3-yl)formamido]propanoic acid		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C15H14N2O3	C15H14N2O3			InChI=1S/C15H14N2O3/c18-14(12-7-4-8-16-10-12)17-13(15(19)20)9-11-5-2-1-3-6-11/h1-8,10,13H,9H2,(H,17,18)(H,19,20)/t13-/m0/s1	KSZPRUJKMRILRZ-ZDUSSCGKSA-N	rac-(2S)-3-phenyl-2-(pyridine-3-carbonylamino)propanoic acid	5307679	O=C(N[C@@H](Cc1ccccc1)C(=O)O)c1cnccc1	(2S)-3-phenyl-2-(pyridine-3-carbonylamino)propanoic acid			1.3978800000000002													MCULE-3889199704	270.29043	ACID	270.100442	4	2	5	2	0.0		28									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids	False	False	Peptide01		-1.0	Compound(5307679)	5307679	1.7	776		SCHEMBL3497405	[#8]=[#6](-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8])-[#6]1:[#6]:[#7]:[#6]:[#6]:[#6]:1	O=C(N[C@@H](Cc1ccccc1)C(=O)O)c1cnccc1	KSZPRUJKMRILRZ		parent_pubchem_cid	3-phenyl-2-[(pyridin-3-yl)formamido]propanoic acid;MLS000120702;CHEMBL63715;SCHEMBL3497405;HMS2266L06;AKOS001503378;SMR000097545;SR-01000105389;SR-01000105389-1;rac-(2S)-3-phenyl-2-(pyridine-3-carbonylamino)propanoic acid	False	417116.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=417116		pluskal_iocb_peptide_Peptide01_E2_id		100	E2	False	ZINC000001581830
3.9		0	1045	P6241009	85.6		S40	False	0	22	0	0	24	0	2	3	0	1		0.0						COC(=O)C(CCSC)NC(=O)c1cc2ccccc2n1Cc1ccccc1																							0.0		AKOS005667361		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C22H24N2O3S	C22H24N2O3S			InChI=1S/C22H24N2O3S/c1-27-22(26)18(12-13-28-2)23-21(25)20-14-17-10-6-7-11-19(17)24(20)15-16-8-4-3-5-9-16/h3-11,14,18H,12-13,15H2,1-2H3,(H,23,25)/t18-/m0/s1	SSKMZXCYCIHGCO-SFHVURJKSA-N	methyl rac-(2S)-2-[(1-benzylindole-2-carbonyl)amino]-4-methylsulfanyl-butanoate	45493424	COC(=O)[C@H](CCSC)NC(=O)c1cc2ccccc2n1Cc1ccccc1	methyl (2S)-2-[(1-benzylindole-2-carbonyl)amino]-4-methylsulfanylbutanoate			3.176260000000002													MCULE-3611436002	396.51218		396.150764	4	1	9	3			44										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(45493424)	45493424	4.2	777			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]-[#16]-[#6])-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#7]:1-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	COC(=O)[C@H](CCSC)NC(=O)c1cc2ccccc2n1Cc1ccccc1	SSKMZXCYCIHGCO		parent_pubchem_cid	AKOS005667361;methyl rac-(2S)-2-[(1-benzylindole-2-carbonyl)amino]-4-methylsulfanyl-butanoate		6925145.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=6925145		pluskal_iocb_peptide_Peptide01_E2_id		100	E2		ZINC000036358885
3.4		0	789	P11184224	75.6		S41	False	0	19	0	0	27	0	1	4	0	0		0.0						CCC(C)C(NC(=O)Cc1cc2c(cc1)OC(C)(C)CC2)C(=O)O																							0.0		AKOS027472142		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C19H27NO4	C19H27NO4			InChI=1S/C19H27NO4/c1-5-12(2)17(18(22)23)20-16(21)11-13-6-7-15-14(10-13)8-9-19(3,4)24-15/h6-7,10,12,17H,5,8-9,11H2,1-4H3,(H,20,21)(H,22,23)/t12-,17+/m1/s1	ZJYOXWYWXNGDPU-PXAZEXFGSA-N	rac-(2S,3R)-2-[[2-(2,2-dimethylchroman-6-yl)acetyl]amino]-3-methyl-pentanoic acid	75491235	CC[C@@H](C)[C@H](NC(=O)Cc1cc2c(cc1)OC(C)(C)CC2)C(=O)O	(2S,3R)-2-[[2-(2,2-dimethyl-3,4-dihydrochromen-6-yl)acetyl]amino]-3-methylpentanoic acid			2.37637														333.43134		333.194008	4	2	6	2			45										False					Peptide01			Compound(75491235)	75491235	3.4	778			[#6]-[#6]-[#6@@H](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1)-[#8]-[#6](-[#6])(-[#6])-[#6]-[#6]-2)-[#6](=[#8])-[#8]	CC[C@@H](C)[C@H](NC(=O)Cc1cc2c(cc1)OC(C)(C)CC2)C(=O)O	ZJYOXWYWXNGDPU		parent_pubchem_cid	AKOS027472142;N-[(2,2-dimethyl-3,4-dihydro-2H-1-benzopyran-6-yl)acetyl]isoleucine;rac-(2S,3R)-2-[[2-(2,2-dimethylchroman-6-yl)acetyl]amino]-3-methyl-pentanoic acid		80415647.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=80415647		pluskal_iocb_peptide_Peptide01_E2_id		100	E2		ZINC000096221182
3.7		0	877	P1107505	101.9		S42	False	0	21	0	0	27	0	1	6	0	0		0.0						COc1c(C)c2c(cc1)c(C)c(CCC(=O)NC(CC(C)C)C(=O)O)c(=O)o2								N-acyl-alpha amino acids;Coumarins and derivatives;1-benzopyrans;Anisoles;Pyranones and derivatives;Alkyl aryl ethers;Fatty amides;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactones;Oxacyclic compounds;Monocarboxylic acids and derivatives;Carboxylic acids;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organonitrogen compounds	1-benzopyrans;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Anisoles;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;Ethers;Fatty Acyls;Fatty amides;Heteroaromatic compounds;Hydrocarbon derivatives;Lactones;Leucine and derivatives;Lipids and lipid-like molecules;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Oxacyclic compounds;Phenol ethers;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Secondary carboxylic acid amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as leucine and derivatives. These are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Leucine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-amino acid (CHEBI:51569);coumarins (CHEBI:23403);1-benzopyran (CHEBI:38443);methoxybenzene (CHEBI:51683);pyranone (CHEBI:37963);aromatic ether (CHEBI:35618);fatty amide (CHEBI:29348);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactone (CHEBI:25000);oxacycle (CHEBI:38104);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);carbonyl compound (CHEBI:36586);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);leucine derivative (CHEBI:47003);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);benzenoid aromatic compound (CHEBI:33836);pyrans (CHEBI:26407);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ether (CHEBI:25698);lipid (CHEBI:18059);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)	Fatty amides (FA08);Benzopyranoids (PK1311);Fatty Acyls (FA)	Amino acids, peptides, and analogues	Leucine or derivatives;N-acyl-alpha amino acid or derivatives;N-acyl-alpha-amino acid;Coumarin;Benzopyran;1-benzopyran;Anisole;Phenol ether;Alkyl aryl ether;Pyranone;Fatty acyl;Fatty amide;Pyran;Benzenoid;Heteroaromatic compound;Lactone;Secondary carboxylic acid amide;Carboxamide group;Carboxylic acid;Oxacycle;Ether;Organoheterocyclic compound;Monocarboxylic acid or derivatives;Organic oxygen compound;Organic nitrogen compound;Hydrocarbon derivative;Organic oxide;Organooxygen compound;Carbonyl group;Organonitrogen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		EiM07-28543		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C21H27NO6	C21H27NO6			InChI=1S/C21H27NO6/c1-11(2)10-16(20(24)25)22-18(23)9-7-15-12(3)14-6-8-17(27-5)13(4)19(14)28-21(15)26/h6,8,11,16H,7,9-10H2,1-5H3,(H,22,23)(H,24,25)/t16-/m1/s1	CQNDWRCAXXGMFD-MRXNPFEDSA-N	rac-(2R)-2-[3-(7-methoxy-4,8-dimethyl-2-oxo-chromen-3-yl)propanoylamino]-4-methyl-pentanoic acid	24280453	COc1c(C)c2c(cc1)c(C)c(CCC(=O)N[C@H](CC(C)C)C(=O)O)c(=O)o2	(2R)-2-[3-(7-methoxy-4,8-dimethyl-2-oxochromen-3-yl)propanoylamino]-4-methylpentanoic acid			2.811470000000001													MCULE-6578413357	389.45244		389.183838	6	2	8	2			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(24280453)	24280453	3.0	779			[#6]-[#8]-[#6]1:[#6](-[#6]):[#6]2:[#6](:[#6]:[#6]:1):[#6](-[#6]):[#6](-[#6]-[#6]-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6](-[#6])-[#6])-[#6](=[#8])-[#8]):[#6](=[#8]):[#8]:2	COc1c(C)c2c(cc1)c(C)c(CCC(=O)N[C@H](CC(C)C)C(=O)O)c(=O)o2	CQNDWRCAXXGMFD		parent_pubchem_cid	EiM07-28543;AKOS004937860;rac-(2R)-2-[3-(7-methoxy-4,8-dimethyl-2-oxo-chromen-3-yl)propanoylamino]-4-methyl-pentanoic acid		23347476.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23347476		pluskal_iocb_peptide_Peptide01_E2_id		100	E2		ZINC000006825372
2.1		0	965	P11185657	88.5		S43	False	0	20	0	0	20	0	6	1	0	0		0.0						O=C(NCCc1c[nH]c2ccccc12)C(Cn1cnnn1)c1ccccc1																							0.0		STL476931		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	4	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C20H20N6O	C20H20N6O			InChI=1S/C20H20N6O/c27-20(21-11-10-16-12-22-19-9-5-4-8-17(16)19)18(13-26-14-23-24-25-26)15-6-2-1-3-7-15/h1-9,12,14,18,22H,10-11,13H2,(H,21,27)	ZFAZLKBSSWBGQY-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)ethyl]-2-phenyl-3-(tetrazol-1-yl)propanamide	118986107	O=C(NCCc1c[nH]c2ccccc12)C(Cn1cnnn1)c1ccccc1	N-[2-(1H-indol-3-yl)ethyl]-2-phenyl-3-(tetrazol-1-yl)propanamide			1.7592599999999992														360.422		360.169859	4	2	7	4			46									Quinazoline alkaloids	False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(118986107)	118986107	2.5	780			[#8]=[#6](-[#7]-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](-[#6]-[#7]1:[#6]:[#7]:[#7]:[#7]:1)-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	O=C(NCCc1c[nH]c2ccccc12)C(Cn1cnnn1)c1ccccc1	ZFAZLKBSSWBGQY		parent_pubchem_cid	STL476931;AKOS027473142;N-[2-(1H-indol-3-yl)ethyl]-2-phenyl-3-(1H-tetrazol-1-yl)propanamide;N-[2-(1H-indol-3-yl)ethyl]-2-phenyl-3-(tetrazol-1-yl)propanamide		145498479.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=145498479		pluskal_iocb_peptide_Peptide01_E2_id		100	E2		
2.5		0	1053	P11184856	121.1		S44	False	0	19	0	0	22	0	4	4	0	0		0.0						CCC(C)C(NC(=O)CCc1nc(-c2ccc3cc[nH]c3c2)no1)C(=O)O																							0.0		AKOS027472517		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	2	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C19H22N4O4	C19H22N4O4			InChI=1S/C19H22N4O4/c1-3-11(2)17(19(25)26)21-15(24)6-7-16-22-18(23-27-16)13-5-4-12-8-9-20-14(12)10-13/h4-5,8-11,17,20H,3,6-7H2,1-2H3,(H,21,24)(H,25,26)/t11-,17+/m1/s1	ULUVSAUIWNKOPX-DIFFPNOSSA-N	rac-(2S,3R)-2-[3-[3-(1H-indol-6-yl)-1,2,4-oxadiazol-5-yl]propanoylamino]-3-methyl-pentanoic acid	91639263	CC[C@@H](C)[C@H](NC(=O)CCc1nc(-c2ccc3cc[nH]c3c2)no1)C(=O)O	(2S,3R)-2-[3-[3-(1H-indol-6-yl)-1,2,4-oxadiazol-5-yl]propanoylamino]-3-methylpentanoic acid			1.90285														370.41159		370.164105	5	3	8	3			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(91639263)	91639263	2.8	781			[#6]-[#6]-[#6@@H](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#6]-[#6]1:[#7]:[#6](-[#6]2:[#6]:[#6]3:[#6](:[#6]:[#6]:[#7H]:3):[#6]:[#6]:2):[#7]:[#8]:1)-[#6](=[#8])-[#8]	CC[C@@H](C)[C@H](NC(=O)CCc1nc(-c2ccc3cc[nH]c3c2)no1)C(=O)O	ULUVSAUIWNKOPX		parent_pubchem_cid	AKOS027472517;(2S,3R)-2-({3-[3-(1H-INDOL-6-YL)-1,2,4-OXADIAZOL-5-YL]PROPANOYL}AMINO)-3-METHYLPENTANOIC ACID;rac-(2S,3R)-2-[3-[3-(1H-indol-6-yl)-1,2,4-oxadiazol-5-yl]propanoylamino]-3-methyl-pentanoic acid		96393922.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=96393922		pluskal_iocb_peptide_Peptide01_E2_id		100	E2		ZINC000218187551
2.1		0	1061	P11569425	74.4		T1	False	0	22	0	0	27	0	3	3	0	0		0.0						COCCCn1c(C)cc(C)c(C(=O)NCCc2c[nH]c3ccccc23)c1=O								Nicotinamides;Pyridinones;Methylpyridines;Dihydropyridines;Substituted pyrroles;Benzenoids;Vinylogous amides;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactams;Dialkyl ethers;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	3-alkylindoles;Azacyclic compounds;Benzenoids;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Dialkyl ethers;Dihydropyridines;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Hydropyridines;Indoles;Indoles and derivatives;Lactams;Methylpyridines;Nicotinamides;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Pyridinecarboxamides;Pyridinecarboxylic acids and derivatives;Pyridines and derivatives;Pyridinones;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Vinylogous amides	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as 3-alkylindoles. These are compounds containing an indole moiety that carries an alkyl chain at the 3-position.	3-alkylindoles			Organic compounds	Aromatic heteropolycyclic compounds	pyridinecarboxamide (CHEBI:25529);pyridone (CHEBI:38183);methylpyridines (CHEBI:25340);dihydropyridine (CHEBI:50075);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);enone (CHEBI:51689);enamine (CHEBI:47989);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactam (CHEBI:24995);ether (CHEBI:25698);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);indoles (CHEBI:24828);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);pyridines (CHEBI:26421);aromatic carboxylic acid (CHEBI:33859);pyridinemonocarboxylic acid (CHEBI:26420);organothiophosphorus compound (CHEBI:25716);phosphoramide (CHEBI:17102);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);organooxygen compound (CHEBI:36963);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143)		Indoles	3-alkylindole;Nicotinamide;Pyridine carboxylic acid or derivatives;Dihydropyridine;Methylpyridine;Pyridinone;Hydropyridine;Pyridine;Substituted pyrrole;Benzenoid;Pyrrole;Vinylogous amide;Heteroaromatic compound;Secondary carboxylic acid amide;Carboxamide group;Lactam;Carboxylic acid derivative;Azacycle;Dialkyl ether;Ether;Hydrocarbon derivative;Organic oxygen compound;Organic nitrogen compound;Organonitrogen compound;Organooxygen compound;Organic oxide;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		1630824-44-0		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C22H27N3O3	C22H27N3O3			InChI=1S/C22H27N3O3/c1-15-13-16(2)25(11-6-12-28-3)22(27)20(15)21(26)23-10-9-17-14-24-19-8-5-4-7-18(17)19/h4-5,7-8,13-14,24H,6,9-12H2,1-3H3,(H,23,26)	CBAUIEJZZDCZLG-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)ethyl]-1-(3-methoxypropyl)-4,6-dimethyl-2-oxo-pyridine-3-carboxamide	91639622	COCCCn1c(C)cc(C)c(C(=O)NCCc2c[nH]c3ccccc23)c1=O	N-[2-(1H-indol-3-yl)ethyl]-1-(3-methoxypropyl)-4,6-dimethyl-2-oxopyridine-3-carboxamide			3.208070000000001														381.47879		381.205242	3	2	8	3			45									Quinoline alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(91639622)	91639622	3.0	782			[#6]-[#8]-[#6]-[#6]-[#6]-[#7]1:[#6](-[#6]):[#6]:[#6](-[#6]):[#6](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:1=[#8]	COCCCn1c(C)cc(C)c(C(=O)NCCc2c[nH]c3ccccc23)c1=O	CBAUIEJZZDCZLG		parent_pubchem_cid	1630824-44-0;N-[2-(1H-indol-3-yl)ethyl]-1-(3-methoxypropyl)-4,6-dimethyl-2-oxo-1,2-dihydropyridine-3-carboxamide;EiM08-37668;AKOS025256627;N-[2-(1H-INDOL-3-YL)ETHYL]-1-(3-METHOXYPROPYL)-4,6-DIMETHYL-2-OXO-1,2-DIHYDRO-3-PYRIDINECARBOXAMIDE;N-[2-(1H-indol-3-yl)ethyl]-1-(3-methoxypropyl)-4,6-dimethyl-2-oxo-pyridine-3-carboxamide		95209182.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=95209182		pluskal_iocb_peptide_Peptide01_E2_id		100	E2		ZINC000218236073
2.3		0	1149	P6238552	130.6		T2	False	0	21	0	0	22	0	4	4	0	1		0.0						CSCCC(NC(=O)C1COc2ccccc2O1)C(=O)Nc1nc2ccccc2[nH]1																							0.0		EiM08-08786		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0		C21H22N4O4S	C21H22N4O4S			InChI=1S/C21H22N4O4S/c1-30-11-10-15(19(26)25-21-23-13-6-2-3-7-14(13)24-21)22-20(27)18-12-28-16-8-4-5-9-17(16)29-18/h2-9,15,18H,10-12H2,1H3,(H,22,27)(H2,23,24,25,26)/t15-,18?/m1/s1	UREICCCUUVWLGW-NNJIEVJOSA-N	N-[rac-(1R)-1-(1H-benzimidazol-2-ylcarbamoyl)-3-methylsulfanyl-propyl]-2,3-dihydro-1,4-benzodioxine-3-carboxamide	75366499	CSCC[C@@H](NC(=O)C1COc2ccccc2O1)C(=O)Nc1nc2ccccc2[nH]1	N-[(2R)-1-(1H-benzimidazol-2-ylamino)-4-methylsulfanyl-1-oxobutan-2-yl]-2,3-dihydro-1,4-benzodioxine-3-carboxamide			0.84545														426.49789		426.136176	6	3	7	4			46										False	Alkaloids				Peptide01			Compound(75366499)	75366499	2.9	783			[#6]-[#16]-[#6]-[#6]-[#6@@H](-[#7]-[#6](=[#8])-[#6]1-[#6]-[#8]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#8]-1)-[#6](=[#8])-[#7]-[#6]1:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#7H]:1	CSCC[C@@H](NC(=O)C1COc2ccccc2O1)C(=O)Nc1nc2ccccc2[nH]1	UREICCCUUVWLGW		parent_pubchem_cid	EiM08-08786;AKOS016387106;N-(1H-1,3-BENZODIAZOL-2-YL)-2-[(2,3-DIHYDRO-1,4-BENZODIOXIN-2-YL)FORMAMIDO]-4-(METHYLSULFANYL)BUTANAMIDE;N-[rac-(1R)-1-(1H-benzimidazol-2-ylcarbamoyl)-3-methylsulfanyl-propyl]-2,3-dihydro-1,4-benzodioxine-3-carboxamide		80293208.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=80293208		pluskal_iocb_peptide_Peptide01_E2_id		100	E2		
4.5		0	1237	P2125972	93.7		T3	False	0	21	0	0	18	0	2	4	0	1		0.0						O=S(=O)(c1ccccc1)c1c(NCCc2ccccc2)oc(-c2ccco2)n1																							0.0		823829-40-9		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0		C21H18N2O4S	C21H18N2O4S			InChI=1S/C21H18N2O4S/c24-28(25,17-10-5-2-6-11-17)21-20(22-14-13-16-8-3-1-4-9-16)27-19(23-21)18-12-7-15-26-18/h1-12,15,22H,13-14H2	CLELMSQRQWVWOU-UHFFFAOYSA-N	4-(benzenesulfonyl)-2-(2-furyl)-N-(2-phenylethyl)oxazol-5-amine	1244677	O=S(=O)(c1ccccc1)c1c(NCCc2ccccc2)oc(-c2ccco2)n1	4-(benzenesulfonyl)-2-(furan-2-yl)-N-(2-phenylethyl)-1,3-oxazol-5-amine			3.390640000000002													MCULE-3408642931	394.45261		394.098728	4	1	7	4			44										False					Peptide01			Compound(1244677)	1244677	5.1	784			[#8]=[#16](=[#8])(-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6](-[#7]-[#6]-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#8]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#8]:2):[#7]:1	O=S(=O)(c1ccccc1)c1c(NCCc2ccccc2)oc(-c2ccco2)n1	CLELMSQRQWVWOU		parent_pubchem_cid	823829-40-9;2-(furan-2-yl)-N-phenethyl-4-(phenylsulfonyl)oxazol-5-amine;4-(benzenesulfonyl)-2-(furan-2-yl)-N-(2-phenylethyl)-1,3-oxazol-5-amine;STL011577;AKOS002326329;Z57362594;F1790-0012;2-(furan-2-yl)-N-(2-phenylethyl)-4-(phenylsulfonyl)-1,3-oxazol-5-amine;4-(benzenesulfonyl)-2-(2-furyl)-N-(2-phenylethyl)oxazol-5-amine		12032905.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=12032905		pluskal_iocb_peptide_Peptide01_E3_id		100	E3		ZINC000001052851
2.5		0	1069	P11184859	121.1		T5	False	0	19	0	0	22	0	4	4	0	0		0.0						CCC(C)C(NC(=O)CCc1nc(-c2c3cc[nH]c3ccc2)no1)C(=O)O																							0.0		AKOS027472519		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	2	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C19H22N4O4	C19H22N4O4			InChI=1S/C19H22N4O4/c1-3-11(2)17(19(25)26)21-15(24)7-8-16-22-18(23-27-16)13-5-4-6-14-12(13)9-10-20-14/h4-6,9-11,17,20H,3,7-8H2,1-2H3,(H,21,24)(H,25,26)/t11-,17+/m1/s1	VEWGJRXPIOULQD-DIFFPNOSSA-N	rac-(2S,3R)-2-[3-[3-(1H-indol-4-yl)-1,2,4-oxadiazol-5-yl]propanoylamino]-3-methyl-pentanoic acid	91640602	CC[C@@H](C)[C@H](NC(=O)CCc1nc(-c2c3cc[nH]c3ccc2)no1)C(=O)O	(2S,3R)-2-[3-[3-(1H-indol-4-yl)-1,2,4-oxadiazol-5-yl]propanoylamino]-3-methylpentanoic acid			1.90285														370.41159		370.164105	5	3	8	3			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(91640602)	91640602	2.8	785			[#6]-[#6]-[#6@@H](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#6]-[#6]1:[#7]:[#6](-[#6]2:[#6]3:[#6]:[#6]:[#7H]:[#6]:3:[#6]:[#6]:[#6]:2):[#7]:[#8]:1)-[#6](=[#8])-[#8]	CC[C@@H](C)[C@H](NC(=O)CCc1nc(-c2c3cc[nH]c3ccc2)no1)C(=O)O	VEWGJRXPIOULQD		parent_pubchem_cid	AKOS027472519;rac-(2S,3R)-2-[3-[3-(1H-indol-4-yl)-1,2,4-oxadiazol-5-yl]propanoylamino]-3-methyl-pentanoic acid		93050865.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=93050865		pluskal_iocb_peptide_Peptide01_E3_id		100	E3		ZINC000218338786
4.4		0	1157	P1157761	99.2		T6	False	0	23	0	0	25	0	5	3	0	0		0.0						COc1cc2c(cc1)[nH]cc2CCNC(=O)C(C(C)C)n1nnc2ccccc2c1=O																							0.0		EiM07-17980		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C23H25N5O3	C23H25N5O3			InChI=1S/C23H25N5O3/c1-14(2)21(28-23(30)17-6-4-5-7-20(17)26-27-28)22(29)24-11-10-15-13-25-19-9-8-16(31-3)12-18(15)19/h4-9,12-14,21,25H,10-11H2,1-3H3,(H,24,29)/t21-/m0/s1	YDRNQVRUUPFOEQ-NRFANRHFSA-N	rac-(2S)-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-3-methyl-2-(4-oxo-1,2,3-benzotriazin-3-yl)butanamide	40854724	COc1cc2c(cc1)[nH]cc2CCNC(=O)[C@H](C(C)C)n1nnc2ccccc2c1=O	(2S)-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-3-methyl-2-(4-oxo-1,2,3-benzotriazin-3-yl)butanamide			2.3633299999999995													MCULE-1416299002	419.4874		419.19574	5	2	7	4			44										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(40854724)	40854724	4.3	786			[#6]-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#7H]:[#6]:[#6]:2-[#6]-[#6]-[#7]-[#6](=[#8])-[#6@H](-[#6](-[#6])-[#6])-[#7]1:[#7]:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8]	COc1cc2c(cc1)[nH]cc2CCNC(=O)[C@H](C(C)C)n1nnc2ccccc2c1=O	YDRNQVRUUPFOEQ		parent_pubchem_cid	EiM07-17980;AKOS016376515;N-[2-(5-METHOXY-1H-INDOL-3-YL)ETHYL]-3-METHYL-2-(4-OXO-3,4-DIHYDRO-1,2,3-BENZOTRIAZIN-3-YL)BUTANAMIDE;rac-(2S)-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-3-methyl-2-(4-oxo-1,2,3-benzotriazin-3-yl)butanamide		12832780.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=12832780		pluskal_iocb_peptide_Peptide01_E3_id		100	E3		ZINC000008879382
3.6		0	1245	P6666216	65.2		T7	False	0	22	0	0	23	0	3	2	0	0		0.0						CC(C)CC(C(=O)Nc1c2cc[nH]c2ccc1)N1Cc2ccccc2C1=O								Isoindolones;Isoindoles;Indoles;N-arylamides;Fatty amides;Benzenoids;Tertiary carboxylic acid amides;Pyrroles;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactams;Azacyclic compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Fatty Acyls;Fatty amides;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Isoindoles;Isoindoles and derivatives;Isoindolines;Isoindolones;Lactams;Leucine and derivatives;Lipids and lipid-like molecules;N-arylamides;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Pyrroles;Secondary carboxylic acid amides;Tertiary carboxylic acid amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as leucine and derivatives. These are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Leucine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	isoindoles (CHEBI:24897);indoles (CHEBI:24828);aromatic amide (CHEBI:62733);fatty amide (CHEBI:29348);benzenoid aromatic compound (CHEBI:33836);carboxamide (CHEBI:37622);pyrroles (CHEBI:26455);organic aromatic compound (CHEBI:33659);lactam (CHEBI:24995);organonitrogen heterocyclic compound (CHEBI:38101);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);leucine derivative (CHEBI:47003);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);lipid (CHEBI:18059);organooxygen compound (CHEBI:36963);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);amino acid (CHEBI:33709);peptide (CHEBI:16670)	Fatty amides (FA08);Fatty Acyls (FA)	Amino acids, peptides, and analogues	Leucine or derivatives;Isoindolone;Indole;Indole or derivatives;Isoindoline;Isoindole;Isoindole or derivatives;N-arylamide;Fatty amide;Fatty acyl;Benzenoid;Tertiary carboxylic acid amide;Pyrrole;Heteroaromatic compound;Secondary carboxylic acid amide;Lactam;Carboxamide group;Azacycle;Organoheterocyclic compound;Organooxygen compound;Organonitrogen compound;Hydrocarbon derivative;Organic oxide;Organic oxygen compound;Organic nitrogen compound;Carbonyl group;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		STL352244		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C22H23N3O2	C22H23N3O2			InChI=1S/C22H23N3O2/c1-14(2)12-20(25-13-15-6-3-4-7-16(15)22(25)27)21(26)24-19-9-5-8-18-17(19)10-11-23-18/h3-11,14,20,23H,12-13H2,1-2H3,(H,24,26)	KACDYNZGEBSQKD-UHFFFAOYSA-N	N-(1H-indol-4-yl)-4-methyl-2-(1-oxoisoindolin-2-yl)pentanamide	71710582	CC(C)CC(C(=O)Nc1c2cc[nH]c2ccc1)N1Cc2ccccc2C1=O	N-(1H-indol-4-yl)-4-methyl-2-(3-oxo-1H-isoindol-2-yl)pentanamide			3.258650000000002													MCULE-7245207973	361.44751		361.179027	2	2	5	4			44									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(71710582)	71710582	3.7	787			[#6]-[#6](-[#6])-[#6]-[#6](-[#6](=[#8])-[#7]-[#6]1:[#6]2:[#6]:[#6]:[#7H]:[#6]:2:[#6]:[#6]:[#6]:1)-[#7]1-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6]-1=[#8]	CC(C)CC(C(=O)Nc1c2cc[nH]c2ccc1)N1Cc2ccccc2C1=O	KACDYNZGEBSQKD		parent_pubchem_cid	STL352244;AKOS016375540;N-(1H-indol-4-yl)-4-methyl-2-(1-oxoisoindolin-2-yl)pentanamide;N-(1H-indol-4-yl)-4-methyl-2-(1-oxo-1,3-dihydro-2H-isoindol-2-yl)pentanamide		22935792.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22935792		pluskal_iocb_peptide_Peptide01_E3_id		100	E3		
1.8		0	1077	P1122711	94.9		T9	False	0	14	0	0	20	0	2	3	0	1		0.0						CCN(C(=O)NC(CCSC)C(=O)O)c1ccccc1																							0.0		956943-60-5		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C14H20N2O3S	C14H20N2O3S			InChI=1S/C14H20N2O3S/c1-3-16(11-7-5-4-6-8-11)14(19)15-12(13(17)18)9-10-20-2/h4-8,12H,3,9-10H2,1-2H3,(H,15,19)(H,17,18)/t12-/m0/s1	LZXCOCVNRNAJDL-LBPRGKRZSA-N	rac-(2S)-2-[[ethyl(phenyl)carbamoyl]amino]-4-methylsulfanyl-butanoic acid	16419539	CCN(C(=O)N[C@@H](CCSC)C(=O)O)c1ccccc1	(2S)-2-[[ethyl(phenyl)carbamoyl]amino]-4-methylsulfanylbutanoic acid			2.04819													MCULE-3887796844	296.3911		296.119463	4	2	7	1			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(16419539)	16419539	2.1	788			[#6]-[#6]-[#7](-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]-[#16]-[#6])-[#6](=[#8])-[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	CCN(C(=O)N[C@@H](CCSC)C(=O)O)c1ccccc1	LZXCOCVNRNAJDL		parent_pubchem_cid	956943-60-5;N-[ethyl(phenyl)carbamoyl]-L-methionine;(Ethyl(phenyl)carbamoyl)-L-methionine;AKOS005533322;(2S)-2-[[ethyl(phenyl)carbamoyl]amino]-4-methylsulfanylbutanoic acid;(2S)-2-{[(ETHYLANILINO)CARBONYL]AMINO}-4-(METHYLSULFANYL)BUTANOIC ACID;rac-(2S)-2-[[ethyl(phenyl)carbamoyl]amino]-4-methylsulfanyl-butanoic acid		24163043.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24163043		pluskal_iocb_peptide_Peptide01_E3_id		100	E3		ZINC000009418362
4.4		0	1165	P1157763	89.9		T10	False	0	22	0	0	23	0	5	2	0	0		0.0						CC(C)C(C(=O)NCCc1c[nH]c2ccccc12)n1nnc2ccccc2c1=O																							0.0		EiM07-17983		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C22H23N5O2	C22H23N5O2			InChI=1S/C22H23N5O2/c1-14(2)20(27-22(29)17-8-4-6-10-19(17)25-26-27)21(28)23-12-11-15-13-24-18-9-5-3-7-16(15)18/h3-10,13-14,20,24H,11-12H2,1-2H3,(H,23,28)/t20-/m0/s1	ZDNBSOUWFJZXPL-FQEVSTJZSA-N	rac-(2S)-N-[2-(1H-indol-3-yl)ethyl]-3-methyl-2-(4-oxo-1,2,3-benzotriazin-3-yl)butanamide	25582676	CC(C)[C@@H](C(=O)NCCc1c[nH]c2ccccc12)n1nnc2ccccc2c1=O	(2S)-N-[2-(1H-indol-3-yl)ethyl]-3-methyl-2-(4-oxo-1,2,3-benzotriazin-3-yl)butanamide			2.817140000000001													MCULE-7966798637	389.46091		389.185175	4	2	6	4			44										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(25582676)	25582676	4.4	789			[#6]-[#6](-[#6])-[#6@@H](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]1:[#7]:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8]	CC(C)[C@@H](C(=O)NCCc1c[nH]c2ccccc12)n1nnc2ccccc2c1=O	ZDNBSOUWFJZXPL		parent_pubchem_cid	EiM07-17983;AKOS004937004;N-[2-(1H-INDOL-3-YL)ETHYL]-3-METHYL-2-(4-OXO-1,2,3-BENZOTRIAZIN-3(4H)-YL)BUTANAMIDE;rac-(2S)-N-[2-(1H-indol-3-yl)ethyl]-3-methyl-2-(4-oxo-1,2,3-benzotriazin-3-yl)butanamide		11837404.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=11837404		pluskal_iocb_peptide_Peptide01_E3_id		100	E3		ZINC000012893063
4.6		0	1253	P7008339	67.7		T11	False	0	20	0	0	20	0	6	0	0	0		0.0						Cc1ccc(Nc2nc(Nc3ccccc3C)c3cnn(C)c3n2)cc1																							0.0		AKOS002312280		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1		C20H20N6	C20H20N6			InChI=1S/C20H20N6/c1-13-8-10-15(11-9-13)22-20-24-18(16-12-21-26(3)19(16)25-20)23-17-7-5-4-6-14(17)2/h4-12H,1-3H3,(H2,22,23,24,25)	MRUQHBNEJNPCAY-UHFFFAOYSA-N	1-methyl-N4-(o-tolyl)-N6-(p-tolyl)pyrazolo[3,4-d]pyrimidine-4,6-diamine	8546000	Cc1ccc(Nc2nc(Nc3ccccc3C)c3cnn(C)c3n2)cc1	1-methyl-4-N-(2-methylphenyl)-6-N-(4-methylphenyl)pyrazolo[3,4-d]pyrimidine-4,6-diamine			2.4070600000000004													MCULE-9710441807	344.4226		344.174945	5	2	4	4			44										False	Alkaloids				Peptide01			Compound(8546000)	8546000	4.7	790			[#6]-[#6]1:[#6]:[#6]:[#6](-[#7]-[#6]2:[#7]:[#6](-[#7]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3-[#6]):[#6]3:[#6]:[#7]:[#7](-[#6]):[#6]:3:[#7]:2):[#6]:[#6]:1	Cc1ccc(Nc2nc(Nc3ccccc3C)c3cnn(C)c3n2)cc1	MRUQHBNEJNPCAY		parent_pubchem_cid	AKOS002312280;1-METHYL-N4-(2-METHYLPHENYL)-N6-(4-METHYLPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDINE-4,6-DIAMINE;1-methyl-N4-(o-tolyl)-N6-(p-tolyl)pyrazolo[3,4-d]pyrimidine-4,6-diamine		10378696.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=10378696		pluskal_iocb_peptide_Peptide01_E3_id		100	E3		ZINC000007448535
3.8		0	1085	P6668366	92.0		T13	False	0	24	0	0	26	0	4	3	0	0		0.0						COc1ccc(-c2n[nH]c(C)c2CC(=O)NCCc2c[nH]c3c2cc(OC)cc3)cc1								3-alkylindoles;Phenoxy compounds;Methoxybenzenes;Anisoles;Alkyl aryl ethers;Substituted pyrroles;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	3-alkylindoles;Alkyl aryl ethers;Anisoles;Azacyclic compounds;Azoles;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Methoxybenzenes;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenol ethers;Phenoxy compounds;Phenylpyrazoles;Pyrazoles;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Azoles	2.1	This compound belongs to the class of organic compounds known as phenylpyrazoles. These are compounds containing a phenylpyrazole skeleton, which consists of a pyrazole bound to a phenyl group.	Phenylpyrazoles			Organic compounds	Aromatic heteropolycyclic compounds	indoles (CHEBI:24828);benzenes (CHEBI:22712);methoxybenzene (CHEBI:51683);aromatic ether (CHEBI:35618);pyrroles (CHEBI:26455);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);ring assembly (CHEBI:36820);pyrazoles (CHEBI:26410);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);organooxygen compound (CHEBI:36963);ether (CHEBI:25698);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);azole (CHEBI:68452)		Pyrazoles	Phenylpyrazole;3-alkylindole;Indole;Indole or derivatives;Anisole;Phenoxy compound;Phenol ether;Methoxybenzene;Alkyl aryl ether;Benzenoid;Substituted pyrrole;Monocyclic benzene moiety;Heteroaromatic compound;Pyrrole;Secondary carboxylic acid amide;Carboxamide group;Azacycle;Carboxylic acid derivative;Ether;Hydrocarbon derivative;Organic nitrogen compound;Organonitrogen compound;Organooxygen compound;Carbonyl group;Organic oxygen compound;Organic oxide;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		AKOS016388057		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	0	0	0	0	0	0	0		C24H26N4O3	C24H26N4O3			InChI=1S/C24H26N4O3/c1-15-20(24(28-27-15)16-4-6-18(30-2)7-5-16)13-23(29)25-11-10-17-14-26-22-9-8-19(31-3)12-21(17)22/h4-9,12,14,26H,10-11,13H2,1-3H3,(H,25,29)(H,27,28)	OOJRQWZAHRNORE-UHFFFAOYSA-N	N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-2-[5-(4-methoxyphenyl)-3-methyl-1H-pyrazol-4-yl]acetamide	71709190	COc1ccc(-c2n[nH]c(C)c2CC(=O)NCCc2c[nH]c3c2cc(OC)cc3)cc1	N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-2-[3-(4-methoxyphenyl)-5-methyl-1H-pyrazol-4-yl]acetamide			1.88763													MCULE-3120556137	418.49982		418.200491	4	3	8	4			44										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(71709190)	71709190	3.5	791			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6]2:[#7]:[#7H]:[#6](-[#6]):[#6]:2-[#6]-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:2:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:3):[#6]:[#6]:1	COc1ccc(-c2n[nH]c(C)c2CC(=O)NCCc2c[nH]c3c2cc(OC)cc3)cc1	OOJRQWZAHRNORE		parent_pubchem_cid	AKOS016388057;AKOS032417442;N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-2-[5-(4-methoxyphenyl)-3-methyl-1H-pyrazol-4-yl]acetamide		45357922.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=45357922		pluskal_iocb_peptide_Peptide01_E3_id		100	E3		ZINC000095479910
3.4		0	1173	P1098863	99.1		T14	False	0	25	0	0	27	0	3	4	0	0		0.0						O=C(NC(Cc1ccccc1)C(=O)O)C1CCC(Cn2cnc3ccccc3c2=O)CC1																							0.0		STK716938		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0		C25H27N3O4	C25H27N3O4			InChI=1S/C25H27N3O4/c29-23(27-22(25(31)32)14-17-6-2-1-3-7-17)19-12-10-18(11-13-19)15-28-16-26-21-9-5-4-8-20(21)24(28)30/h1-9,16,18-19,22H,10-15H2,(H,27,29)(H,31,32)/t18?,19?,22-/m0/s1	DWQIWIVOLGFWKS-AJTFCVKESA-N	rac-(2S)-2-[[4-[(4-oxoquinazolin-3-yl)methyl]cyclohexanecarbonyl]amino]-3-phenyl-propanoic acid	17577467	O=C(N[C@@H](Cc1ccccc1)C(=O)O)C1CCC(Cn2cnc3ccccc3c2=O)CC1	(2S)-2-[[4-[(4-oxoquinazolin-3-yl)methyl]cyclohexanecarbonyl]amino]-3-phenylpropanoic acid			3.431760000000001														433.51164		433.200156	5	2	7	4			45									Quinazoline alkaloids	False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(17577467)	17577467	3.2	792			[#8]=[#6](-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8])-[#6]1-[#6]-[#6]-[#6](-[#6]-[#7]2:[#6]:[#7]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3:[#6]:2=[#8])-[#6]-[#6]-1	O=C(N[C@@H](Cc1ccccc1)C(=O)O)C1CCC(Cn2cnc3ccccc3c2=O)CC1	DWQIWIVOLGFWKS		parent_pubchem_cid	STK716938;AKOS004937077;AKOS032395067;(S)-2-(4-((4-oxoquinazolin-3(4H)-yl)methyl)cyclohexanecarboxamido)-3-phenylpropanoic acid;N-({trans-4-[(4-oxoquinazolin-3(4H)-yl)methyl]cyclohexyl}carbonyl)-L-phenylalanine;2-({4-[(4-OXO-3,4-DIHYDROQUINAZOLIN-3-YL)METHYL]CYCLOHEXYL}FORMAMIDO)-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[[4-[(4-oxoquinazolin-3-yl)methyl]cyclohexanecarbonyl]amino]-3-phenyl-propanoic acid		52829151.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=52829151		pluskal_iocb_peptide_Peptide01_E4_id		100	E4		ZINC000011867189
4.6		0	1261	P7008466	67.7		T15	False	0	21	0	0	22	0	6	0	0	0		0.0						Cc1ccc(CNc2nc(Nc3ccc(C)cc3)c3cnn(C)c3n2)cc1																							0.0		STK890653		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1		C21H22N6	C21H22N6			InChI=1S/C21H22N6/c1-14-4-8-16(9-5-14)12-22-21-25-19(18-13-23-27(3)20(18)26-21)24-17-10-6-15(2)7-11-17/h4-11,13H,12H2,1-3H3,(H2,22,24,25,26)	QGMUFMQHQLIBMU-UHFFFAOYSA-N	1-methyl-N4-(p-tolyl)-N6-(p-tolylmethyl)pyrazolo[3,4-d]pyrimidine-4,6-diamine	16456415	Cc1ccc(CNc2nc(Nc3ccc(C)cc3)c3cnn(C)c3n2)cc1	1-methyl-4-N-(4-methylphenyl)-6-N-[(4-methylphenyl)methyl]pyrazolo[3,4-d]pyrimidine-4,6-diamine			2.6014600000000003													MCULE-1707160721	358.44969		358.190595	5	2	5	4			44										False	Alkaloids				Peptide01			Compound(16456415)	16456415	4.6	793			[#6]-[#6]1:[#6]:[#6]:[#6](-[#6]-[#7]-[#6]2:[#7]:[#6](-[#7]-[#6]3:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:3):[#6]3:[#6]:[#7]:[#7](-[#6]):[#6]:3:[#7]:2):[#6]:[#6]:1	Cc1ccc(CNc2nc(Nc3ccc(C)cc3)c3cnn(C)c3n2)cc1	QGMUFMQHQLIBMU		parent_pubchem_cid	STK890653;AKOS001909753;CCG-170573;1-methyl-N~6~-(4-methylbenzyl)-N~4~-(4-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine;1-METHYL-N4-(4-METHYLPHENYL)-N6-[(4-METHYLPHENYL)METHYL]-1H-PYRAZOLO[3,4-D]PYRIMIDINE-4,6-DIAMINE;1-methyl-N4-(p-tolyl)-N6-(p-tolylmethyl)pyrazolo[3,4-d]pyrimidine-4,6-diamine		14318543.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=14318543		pluskal_iocb_peptide_Peptide01_E4_id		100	E4		ZINC000009273239
4.0		0	1093	P6241077	98.9		T17	False	0	19	0	0	16	0	4	1	0	1		0.0						O=C(NCCc1c[nH]c2ccccc12)c1c(-c2ccccc2)nns1								2-heteroaryl carboxamides;Substituted pyrroles;Benzene and substituted derivatives;Thiadiazoles;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Organooxygen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	2-heteroaryl carboxamides;3-alkylindoles;Azacyclic compounds;Azoles;Benzene and substituted derivatives;Benzenoids;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Thiadiazoles	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as 3-alkylindoles. These are compounds containing an indole moiety that carries an alkyl chain at the 3-position.	3-alkylindoles			Organic compounds	Aromatic heteropolycyclic compounds	organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);pyrroles (CHEBI:26455);benzenes (CHEBI:22712);thiadiazoles (CHEBI:38099);organonitrogen heterocyclic compound (CHEBI:38101);organooxygen compound (CHEBI:36963);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);indoles (CHEBI:24828);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);azole (CHEBI:68452);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143)		Indoles	3-alkylindole;2-heteroaryl carboxamide;Monocyclic benzene moiety;Benzenoid;Substituted pyrrole;Azole;Heteroaromatic compound;Thiadiazole;Pyrrole;Carboxamide group;Secondary carboxylic acid amide;Carboxylic acid derivative;Azacycle;Organic nitrogen compound;Organooxygen compound;Organonitrogen compound;Hydrocarbon derivative;Organic oxide;Organic oxygen compound;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		EiM08-12314		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C19H16N4OS	C19H16N4OS			InChI=1S/C19H16N4OS/c24-19(18-17(22-23-25-18)13-6-2-1-3-7-13)20-11-10-14-12-21-16-9-5-4-8-15(14)16/h1-9,12,21H,10-11H2,(H,20,24)	DZUBLQRMRSZSLZ-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)ethyl]-4-phenyl-thiadiazole-5-carboxamide	45491427	O=C(NCCc1c[nH]c2ccccc12)c1c(-c2ccccc2)nns1	N-[2-(1H-indol-3-yl)ethyl]-4-phenylthiadiazole-5-carboxamide			2.741040000000001													MCULE-6870865777	348.42957		348.104482	3	2	5	4			44									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(45491427)	45491427	3.8	794			[#8]=[#6](-[#7]-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6]1:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#7]:[#7]:[#16]:1	O=C(NCCc1c[nH]c2ccccc12)c1c(-c2ccccc2)nns1	DZUBLQRMRSZSLZ		parent_pubchem_cid	EiM08-12314;AKOS005665158;N-[2-(1H-indol-3-yl)ethyl]-4-phenyl-thiadiazole-5-carboxamide		11762086.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=11762086		pluskal_iocb_peptide_Peptide01_E4_id		100	E4		ZINC000036354199
3.4		0	1181	P1098714	95.3		T18	False	0	20	0	0	16	0	2	4	0	0		0.0						O=C(NC(Cc1c[nH]c2ccccc12)C(=O)O)c1cc2ccccc2o1								Indolyl carboxylic acids and derivatives;3-alkylindoles;Benzofurans;2-heteroaryl carboxamides;Furoic acid and derivatives;Substituted pyrroles;Benzenoids;Heteroaromatic compounds;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Oxacyclic compounds;Carbonyl compounds;Organic oxides;Organonitrogen compounds;Hydrocarbon derivatives	2-heteroaryl carboxamides;3-alkylindoles;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzenoids;Benzofurans;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Furans;Furoic acid and derivatives;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Indolyl carboxylic acids and derivatives;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Oxacyclic compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom.	N-acyl-alpha amino acids		Amino acids and derivatives;Alpha amino acids and derivatives;N-acyl-alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	indolyl carboxylic acid (CHEBI:46867);indoles (CHEBI:24828);benzofurans (CHEBI:35259);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);furans (CHEBI:24129);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);organonitrogen heterocyclic compound (CHEBI:38101);oxacycle (CHEBI:38104);carbonyl compound (CHEBI:36586);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);organic molecule (CHEBI:72695);N-acyl-amino acid (CHEBI:51569);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143)	Benzofuranoids (PK1310)	Amino acids, peptides, and analogues	N-acyl-alpha-amino acid;Indolyl carboxylic acid derivative;3-alkylindole;Benzofuran;Indole;Indole or derivatives;2-heteroaryl carboxamide;Furoic acid or derivatives;Substituted pyrrole;Benzenoid;Furan;Heteroaromatic compound;Pyrrole;Secondary carboxylic acid amide;Carboxamide group;Monocarboxylic acid or derivatives;Carboxylic acid;Oxacycle;Azacycle;Organoheterocyclic compound;Carbonyl group;Organooxygen compound;Organonitrogen compound;Organic nitrogen compound;Hydrocarbon derivative;Organic oxide;Organic oxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		SCHEMBL1711017		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C20H16N2O4	C20H16N2O4			InChI=1S/C20H16N2O4/c23-19(18-10-12-5-1-4-8-17(12)26-18)22-16(20(24)25)9-13-11-21-15-7-3-2-6-14(13)15/h1-8,10-11,16,21H,9H2,(H,22,23)(H,24,25)/t16-/m0/s1	HXQIEAOUNVXAQY-INIZCTEOSA-N	rac-(2S)-2-(benzofuran-2-carbonylamino)-3-(1H-indol-3-yl)propanoic acid	24279928	O=C(N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)c1cc2ccccc2o1	(2S)-2-(1-benzofuran-2-carbonylamino)-3-(1H-indol-3-yl)propanoic acid			2.373540000000001													MCULE-8467081068	348.36152		348.111007	3	3	5	4			43									Dipeptides	False	Shikimates and Phenylpropanoids	Small peptides			Peptide01			Compound(24279928)	24279928	3.0	795		SCHEMBL1711017	[#8]=[#6](-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8])-[#6]1:[#6]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#8]:1	O=C(N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)c1cc2ccccc2o1	HXQIEAOUNVXAQY		parent_pubchem_cid	SCHEMBL1711017;HXQIEAOUNVXAQY-INIZCTEOSA-N;AKOS016402492;Nalpha-(Benzofuran-2-Carbonyl)-L-Tryptophan;rac-(2S)-2-(benzofuran-2-carbonylamino)-3-(1H-indol-3-yl)propanoic acid		23511741.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23511741		pluskal_iocb_peptide_Peptide01_E4_id		100	E4		ZINC000011866894
1.1		0	1269	P7008532	103.3		T19	False	0	17	0	0	18	0	6	3	0	0		0.0						COCCNc1nc(NCc2cc3c(cc2)OCO3)nc2nccnc12																							0.0		N~2~-(1,3-benzodioxol-5-ylmethyl)-N~4~-(2-methoxyethyl)pteridine-2,4-diamine		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0		C17H18N6O3	C17H18N6O3			InChI=1S/C17H18N6O3/c1-24-7-6-20-16-14-15(19-5-4-18-14)22-17(23-16)21-9-11-2-3-12-13(8-11)26-10-25-12/h2-5,8H,6-7,9-10H2,1H3,(H2,19,20,21,22,23)	BABWOMOEULFMAA-UHFFFAOYSA-N	N2-(1,3-benzodioxol-5-ylmethyl)-N4-(2-methoxyethyl)pteridine-2,4-diamine	39348746	COCCNc1nc(NCc2cc3c(cc2)OCO3)nc2nccnc12	2-N-(1,3-benzodioxol-5-ylmethyl)-4-N-(2-methoxyethyl)pteridine-2,4-diamine			-0.3502699999999987													MCULE-4189187891	354.37141		354.144038	9	2	7	4			44										False	Alkaloids	Pseudoalkaloids			Peptide01			Compound(39348746)	39348746	1.6	796			[#6]-[#8]-[#6]-[#6]-[#7]-[#6]1:[#7]:[#6](-[#7]-[#6]-[#6]2:[#6]:[#6]3:[#6](:[#6]:[#6]:2)-[#8]-[#6]-[#8]-3):[#7]:[#6]2:[#7]:[#6]:[#6]:[#7]:[#6]:1:2	COCCNc1nc(NCc2cc3c(cc2)OCO3)nc2nccnc12	BABWOMOEULFMAA		parent_pubchem_cid	N~2~-(1,3-benzodioxol-5-ylmethyl)-N~4~-(2-methoxyethyl)pteridine-2,4-diamine;1144465-98-4;AKOS002337618;Z1013695856;N2-(1,3-benzodioxol-5-ylmethyl)-N4-(2-methoxyethyl)pteridine-2,4-diamine		7842981.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=7842981		pluskal_iocb_peptide_Peptide01_E4_id		100	E4		ZINC000032102097
3.2		0	1101	P1098911	127.2		T21	False	0	21	0	0	19	0	5	4	0	0	-1.0	0.0						CC(C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)O)n1nnc2ccccc2c1=O		1.65		0.0	3.28	CHEMBL1705764																	0.0		MLS000332393		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C21H19N5O4	C21H19N5O4			InChI=1S/C21H19N5O4/c1-12(26-20(28)15-7-3-5-9-17(15)24-25-26)19(27)23-18(21(29)30)10-13-11-22-16-8-4-2-6-14(13)16/h2-9,11-12,18,22H,10H2,1H3,(H,23,27)(H,29,30)/t12-,18-/m0/s1	NTYVDUWYWLFUGG-SGTLLEGYSA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[[rac-(2S)-2-(4-oxo-1,2,3-benzotriazin-3-yl)propanoyl]amino]propanoic acid	1970916	C[C@@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)n1nnc2ccccc2c1=O	(2S)-3-(1H-indol-3-yl)-2-[[(2S)-2-(4-oxo-1,2,3-benzotriazin-3-yl)propanoyl]amino]propanoic acid			1.63424													MCULE-6716930228	405.41668	ACID	405.143704	6	3	6	4	0.0		29									Dipeptides;Quinazoline alkaloids	False	Alkaloids;Amino acids and Peptides	Anthranilic acid alkaloids;Small peptides	False	False	Peptide01		-1.0	Compound(1970916)	1970916	3.0	797			[#6]-[#6@@H](-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8])-[#7]1:[#7]:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8]	C[C@@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)n1nnc2ccccc2c1=O	NTYVDUWYWLFUGG		parent_pubchem_cid	MLS000332393;CHEMBL1705764;HMS2743L20;EiM07-17609;STK716986;AKOS004937128;SMR000221727;N-[(2S)-2-(4-oxo-1,2,3-benzotriazin-3(4H)-yl)propanoyl]-L-tryptophan;(2S)-3-(1H-INDOL-3-YL)-2-({(2S)-2-[4-OXO-1,2,3-BENZOTRIAZIN-3(4H)-YL]PROPANOYL}AMINO)PROPANOIC ACID;(S)-3-(1H-Indol-3-yl)-2-[(S)-2-(4-oxo-4H-benzo[d][1,2,3]triazin-3-yl)-propionylamino]-propionic acid;rac-(2S)-3-(1H-indol-3-yl)-2-[[rac-(2S)-2-(4-oxo-1,2,3-benzotriazin-3-yl)propanoyl]amino]propanoic acid	False	1021757.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=1021757		pluskal_iocb_peptide_Peptide01_E4_id		100	E4	False	ZINC000002358641
3.3		0	1189	P3461197	133.6		T22	False	0	23	0	0	22	0	4	4	0	1		0.0						COc1c2cc(C(=O)NC(Cc3ccccc3)C(=O)Nc3nccs3)[nH]c2c(OC)cc1																							0.0		AKOS016385145		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0		C23H22N4O4S	C23H22N4O4S			InChI=1S/C23H22N4O4S/c1-30-18-8-9-19(31-2)20-15(18)13-17(25-20)21(28)26-16(12-14-6-4-3-5-7-14)22(29)27-23-24-10-11-32-23/h3-11,13,16,25H,12H2,1-2H3,(H,26,28)(H,24,27,29)/t16-/m1/s1	GTGNMBQVIYZMRL-MRXNPFEDSA-N	4,7-dimethoxy-N-[rac-(1R)-1-benzyl-2-oxo-2-(thiazol-2-ylamino)ethyl]-1H-indole-2-carboxamide	51703547	COc1c2cc(C(=O)N[C@H](Cc3ccccc3)C(=O)Nc3nccs3)[nH]c2c(OC)cc1	4,7-dimethoxy-N-[(2R)-1-oxo-3-phenyl-1-(1,3-thiazol-2-ylamino)propan-2-yl]-1H-indole-2-carboxamide			1.778129999999999													MCULE-7242026960	450.52019		450.136176	5	3	8	4			44										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(51703547)	51703547	3.9	798			[#6]-[#8]-[#6]1:[#6]2:[#6]:[#6](-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3)-[#6](=[#8])-[#7]-[#6]3:[#7]:[#6]:[#6]:[#16]:3):[#7H]:[#6]:2:[#6](-[#8]-[#6]):[#6]:[#6]:1	COc1c2cc(C(=O)N[C@H](Cc3ccccc3)C(=O)Nc3nccs3)[nH]c2c(OC)cc1	GTGNMBQVIYZMRL		parent_pubchem_cid	AKOS016385145;2-[(4,7-DIMETHOXY-1H-INDOL-2-YL)FORMAMIDO]-3-PHENYL-N-(1,3-THIAZOL-2-YL)PROPANAMIDE;4,7-dimethoxy-N-[rac-(1R)-1-benzyl-2-oxo-2-(thiazol-2-ylamino)ethyl]-1H-indole-2-carboxamide		4681909.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=4681909		pluskal_iocb_peptide_Peptide01_E4_id		100	E4		ZINC000035686269
1.8		0	1277	P11569947	82.0		T23	False	0	17	0	0	27	0	3	3	0	0		0.0						CCC(C)C(CO)NC(=O)Cn1nc2CCCCCc2cc1=O																							0.0		AKOS027474674		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C17H27N3O3	C17H27N3O3			InChI=1S/C17H27N3O3/c1-3-12(2)15(11-21)18-16(22)10-20-17(23)9-13-7-5-4-6-8-14(13)19-20/h9,12,15,21H,3-8,10-11H2,1-2H3,(H,18,22)/t12-,15-/m1/s1	CSFXAAIHHGBJLK-IUODEOHRSA-N	2-(3-oxo-6,7,8,9-tetrahydro-5H-cyclohepta[c]pyridazin-2-yl)-N-[rac-(1S,2R)-1-(hydroxymethyl)-2-methyl-butyl]acetamide	110204598	CC[C@@H](C)[C@@H](CO)NC(=O)Cn1nc2CCCCCc2cc1=O	N-[(2S,3R)-1-hydroxy-3-methylpentan-2-yl]-2-(3-oxo-6,7,8,9-tetrahydro-5H-cyclohepta[c]pyridazin-2-yl)acetamide			1.82587														321.42304		321.205242	4	2	6	2			45										False	Alkaloids				Peptide01			Compound(110204598)	110204598	1.6	799			[#6]-[#6]-[#6@@H](-[#6])-[#6@@H](-[#6]-[#8])-[#7]-[#6](=[#8])-[#6]-[#7]1:[#7]:[#6]2-[#6]-[#6]-[#6]-[#6]-[#6]-[#6]:2:[#6]:[#6]:1=[#8]	CC[C@@H](C)[C@@H](CO)NC(=O)Cn1nc2CCCCCc2cc1=O	CSFXAAIHHGBJLK		parent_pubchem_cid	AKOS027474674;2-(3-oxo-6,7,8,9-tetrahydro-5H-cyclohepta[c]pyridazin-2-yl)-N-[rac-(1S,2R)-1-(hydroxymethyl)-2-methyl-butyl]acetamide		117132810.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=117132810		pluskal_iocb_peptide_Peptide01_E4_id		100	E4		ZINC000252481800
2.4		0	1109	P1098852	114.9		T25	False	0	23	0	0	22	0	4	4	0	0		0.0						O=C(CCCn1cnc2ccccc2c1=O)NC(Cc1c[nH]c2ccccc12)C(=O)O																							0.0		AKOS016402460		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C23H22N4O4	C23H22N4O4			InChI=1S/C23H22N4O4/c28-21(10-5-11-27-14-25-19-9-4-2-7-17(19)22(27)29)26-20(23(30)31)12-15-13-24-18-8-3-1-6-16(15)18/h1-4,6-9,13-14,20,24H,5,10-12H2,(H,26,28)(H,30,31)/t20-/m0/s1	HGXQVKUTPHBTPA-FQEVSTJZSA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[4-(4-oxoquinazolin-3-yl)butanoylamino]propanoic acid	1782928	O=C(CCCn1cnc2ccccc2c1=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	(2S)-3-(1H-indol-3-yl)-2-[4-(4-oxoquinazolin-3-yl)butanoylamino]propanoic acid			2.4584400000000004													MCULE-5760610509	418.45619		418.164105	5	3	8	4			44									Quinazoline alkaloids	False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(1782928)	1782928	2.2	800			[#8]=[#6](-[#6]-[#6]-[#6]-[#7]1:[#6]:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	O=C(CCCn1cnc2ccccc2c1=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	HGXQVKUTPHBTPA		parent_pubchem_cid	AKOS016402460;Z2327401924;(S)-3-(1H-indol-3-yl)-2-(4-(4-oxoquinazolin-3(4H)-yl)butanamido)propanoic acid;rac-(2S)-3-(1H-indol-3-yl)-2-[4-(4-oxoquinazolin-3-yl)butanoylamino]propanoic acid		24780653.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24780653		pluskal_iocb_peptide_Peptide01_E5_id		100	E5		ZINC000002128187
2.4		0	1197	P1099248	83.1		T26	False	0	18	0	0	19	0	1	6	0	0		0.0						COC(=O)c1cc(OC)c(OC)cc1NC(=O)c1cc(OC)ccc1								M-methoxybenzoic acids and derivatives;P-methoxybenzoic acids and derivatives;Benzoic acid esters;Dimethoxybenzenes;Benzamides;Methoxyanilines;Anisoles;Phenoxy compounds;Benzoyl derivatives;Alkyl aryl ethers;Methyl esters;Vinylogous amides;Secondary carboxylic acid amides;Hydrocarbon derivatives;Organic oxides;Organonitrogen compounds	Alkyl aryl ethers;Anilides;Aniline and substituted anilines;Anisoles;Aromatic anilides;Benzamides;Benzanilides;Benzene and substituted derivatives;Benzenoids;Benzoic acid esters;Benzoic acids and derivatives;Benzoyl derivatives;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids and derivatives;Chemical entities;Dimethoxybenzenes;Ethers;Hydrocarbon derivatives;M-methoxybenzoic acids and derivatives;Methoxyanilines;Methoxybenzenes;Methoxybenzoic acids and derivatives;Methyl esters;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;P-methoxybenzoic acids and derivatives;Phenol ethers;Phenoxy compounds;Secondary carboxylic acid amides;Vinylogous amides	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as benzanilides. These are aromatic compounds containing an anilide group in which the carboxamide group is substituted with a benzene ring. They have the general structure RNC(=O)R', where R,R'= benzene.	Benzanilides		Aromatic anilides	Organic compounds	Aromatic homomonocyclic compounds	methoxybenzoic acid (CHEBI:25238);benzoate ester (CHEBI:36054);dimethoxybenzene (CHEBI:51681);benzamides (CHEBI:22702);substituted aniline (CHEBI:48975);methoxybenzene (CHEBI:51683);benzenes (CHEBI:22712);carbonyl compound (CHEBI:36586);aromatic ether (CHEBI:35618);carboxylic ester (CHEBI:33308);enone (CHEBI:51689);enamine (CHEBI:47989);carboxamide (CHEBI:37622);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);anilide (CHEBI:13248);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);benzoic acids (CHEBI:22723);organooxygen compound (CHEBI:36963);anilines (CHEBI:22562);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ether (CHEBI:25698);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)		Anilides	Benzanilide;M-methoxybenzoic acid or derivatives;P-methoxybenzoic acid or derivatives;Benzoate ester;Dimethoxybenzene;O-dimethoxybenzene;Methoxyaniline;Benzamide;Benzoic acid or derivatives;Methoxybenzene;Anisole;Phenol ether;Phenoxy compound;Benzoyl;Alkyl aryl ether;Vinylogous amide;Methyl ester;Secondary carboxylic acid amide;Carboxamide group;Carboxylic acid ester;Carboxylic acid derivative;Ether;Hydrocarbon derivative;Organonitrogen compound;Organooxygen compound;Organic oxide;Organic oxygen compound;Organic nitrogen compound;Aromatic homomonocyclic compound	Benzenoids	0.0		methyl 4,5-dimethoxy-2-[(3-methoxybenzoyl)amino]benzoate		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C18H19NO6	C18H19NO6			InChI=1S/C18H19NO6/c1-22-12-7-5-6-11(8-12)17(20)19-14-10-16(24-3)15(23-2)9-13(14)18(21)25-4/h5-10H,1-4H3,(H,19,20)	VJOSFTWDRPXKAV-UHFFFAOYSA-N	methyl 4,5-dimethoxy-2-[(3-methoxybenzoyl)amino]benzoate	8031345	COC(=O)c1cc(OC)c(OC)cc1NC(=O)c1cc(OC)ccc1	methyl 4,5-dimethoxy-2-[(3-methoxybenzoyl)amino]benzoate			0.8740399999999997													MCULE-7683839429	345.35523		345.121237	6	1	7	2			43									Anthranillic acid derivatives	False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(8031345)	8031345	3.1	801			[#6]-[#8]-[#6](=[#8])-[#6]1:[#6]:[#6](-[#8]-[#6]):[#6](-[#8]-[#6]):[#6]:[#6]:1-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:[#6]:1	COC(=O)c1cc(OC)c(OC)cc1NC(=O)c1cc(OC)ccc1	VJOSFTWDRPXKAV		parent_pubchem_cid	methyl 4,5-dimethoxy-2-[(3-methoxybenzoyl)amino]benzoate;903311-10-4;EiM07-18285;STK710785;AKOS001312504;Z28738044;METHYL 4,5-DIMETHOXY-2-(3-METHOXYBENZAMIDO)BENZOATE;methyl 4,5-dimethoxy-2-{[(3-methoxyphenyl)carbonyl]amino}benzoate		2600807.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=2600807		pluskal_iocb_peptide_Peptide01_E5_id		100	E5		ZINC000006662877
2.7		0	1285	P11570322	54.3		T27	False	0	16	0	0	22	0	2	2	0	0		0.0						CCC(C)C(CO)NC(=O)c1cc2c(cc1)ccn2C																							0.0		AKOS027475007		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C16H22N2O2	C16H22N2O2			InChI=1S/C16H22N2O2/c1-4-11(2)14(10-19)17-16(20)13-6-5-12-7-8-18(3)15(12)9-13/h5-9,11,14,19H,4,10H2,1-3H3,(H,17,20)/t11-,14-/m1/s1	ZQECNAFXKLSDPU-BXUZGUMPSA-N	1-methyl-N-[rac-(1S,2R)-1-(hydroxymethyl)-2-methyl-butyl]indole-6-carboxamide	110205640	CC[C@@H](C)[C@@H](CO)NC(=O)c1cc2c(cc1)ccn2C	N-[(2S,3R)-1-hydroxy-3-methylpentan-2-yl]-1-methylindole-6-carboxamide			1.83197														274.36594		274.168128	2	2	5	2			45										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(110205640)	110205640	2.3	802			[#6]-[#6]-[#6@@H](-[#6])-[#6@@H](-[#6]-[#8])-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#6]:[#6]:[#7]:2-[#6]	CC[C@@H](C)[C@@H](CO)NC(=O)c1cc2c(cc1)ccn2C	ZQECNAFXKLSDPU		parent_pubchem_cid	AKOS027475007;1-methyl-N-[rac-(1S,2R)-1-(hydroxymethyl)-2-methyl-butyl]indole-6-carboxamide		117133849.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=117133849		pluskal_iocb_peptide_Peptide01_E5_id		100	E5		ZINC000253415101
3.2		0	1117	P1098864	119.3		T29	False	0	25	0	0	27	0	3	5	0	0		0.0						O=C(NC(Cc1ccc(O)cc1)C(=O)O)C1CCC(Cn2cnc3ccccc3c2=O)CC1																							0.0		STK716940		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0		C25H27N3O5	C25H27N3O5			InChI=1S/C25H27N3O5/c29-19-11-7-16(8-12-19)13-22(25(32)33)27-23(30)18-9-5-17(6-10-18)14-28-15-26-21-4-2-1-3-20(21)24(28)31/h1-4,7-8,11-12,15,17-18,22,29H,5-6,9-10,13-14H2,(H,27,30)(H,32,33)/t17?,18?,22-/m0/s1	SGGNUWMCYCOYSD-IRZJEQJZSA-N	rac-(2S)-3-(4-hydroxyphenyl)-2-[[4-[(4-oxoquinazolin-3-yl)methyl]cyclohexanecarbonyl]amino]propanoic acid	2031451	O=C(N[C@@H](Cc1ccc(O)cc1)C(=O)O)C1CCC(Cn2cnc3ccccc3c2=O)CC1	(2S)-3-(4-hydroxyphenyl)-2-[[4-[(4-oxoquinazolin-3-yl)methyl]cyclohexanecarbonyl]amino]propanoic acid			2.67495														449.51104		449.195071	6	3	7	4			45									Quinazoline alkaloids	False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(2031451)	2031451	2.9	803			[#8]=[#6](-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6](-[#8]):[#6]:[#6]:1)-[#6](=[#8])-[#8])-[#6]1-[#6]-[#6]-[#6](-[#6]-[#7]2:[#6]:[#7]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3:[#6]:2=[#8])-[#6]-[#6]-1	O=C(N[C@@H](Cc1ccc(O)cc1)C(=O)O)C1CCC(Cn2cnc3ccccc3c2=O)CC1	SGGNUWMCYCOYSD		parent_pubchem_cid	STK716940;AKOS004937094;AKOS032395538;N-({TRANS-4-[(4-OXO-3(4H)-QUINAZOLINYL)METHYL]CYCLOHEXYL}CARBONYL)-L-TYROSINE;N-({trans-4-[(4-oxoquinazolin-3(4H)-yl)methyl]cyclohexyl}carbonyl)-L-tyrosine;(S)-3-(4-hydroxyphenyl)-2-(4-((4-oxoquinazolin-3(4H)-yl)methyl)cyclohexanecarboxamido)propanoic acid;rac-(2S)-3-(4-hydroxyphenyl)-2-[[4-[(4-oxoquinazolin-3-yl)methyl]cyclohexanecarbonyl]amino]propanoic acid		60351872.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=60351872		pluskal_iocb_peptide_Peptide01_E5_id		100	E5		ZINC000002435175
4.1		0	1205	P3463129	117.7		T30	False	0	25	0	0	24	0	2	6	0	0		0.0						CCc1cc(=O)oc2c1ccc(OC(C)C(=O)NC(Cc1c[nH]c3ccccc13)C(=O)O)c2																							0.0		AKOS016376912		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C25H24N2O6	C25H24N2O6			InChI=1S/C25H24N2O6/c1-3-15-11-23(28)33-22-12-17(8-9-19(15)22)32-14(2)24(29)27-21(25(30)31)10-16-13-26-20-7-5-4-6-18(16)20/h4-9,11-14,21,26H,3,10H2,1-2H3,(H,27,29)(H,30,31)/t14?,21-/m0/s1	IGAYEPRLKCNKLH-YNNZGITBSA-N	rac-(2S)-2-[2-(4-ethyl-2-oxo-chromen-7-yl)oxypropanoylamino]-3-(1H-indol-3-yl)propanoic acid	16397162	CCc1cc(=O)oc2c1ccc(OC(C)C(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)O)c2	(2S)-2-[2-(4-ethyl-2-oxochromen-7-yl)oxypropanoylamino]-3-(1H-indol-3-yl)propanoic acid			2.8873200000000008														448.47983		448.163436	6	3	8	4			46									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(16397162)	16397162	3.7	804			[#6]-[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6](-[#6])-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:1:3)-[#6](=[#8])-[#8]):[#6]:2	CCc1cc(=O)oc2c1ccc(OC(C)C(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)O)c2	IGAYEPRLKCNKLH		parent_pubchem_cid	AKOS016376912;(2S)-2-(2-((4-ethyl-2-oxo-2H-chromen-7-yl)oxy)propanamido)-3-(1H-indol-3-yl)propanoic acid;2-{2-[(4-ETHYL-2-OXO-2H-CHROMEN-7-YL)OXY]PROPANAMIDO}-3-(1H-INDOL-3-YL)PROPANOIC ACID;rac-(2S)-2-[2-(4-ethyl-2-oxo-chromen-7-yl)oxypropanoylamino]-3-(1H-indol-3-yl)propanoic acid		23119838.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23119838		pluskal_iocb_peptide_Peptide01_E5_id		100	E5		
1.6		0	1293	P11569966	78.4		T31	False	0	18	0	0	30	0	4	2	0	0		0.0						CCC(C)C(CO)NC(=O)C1CCCN(c2nc(C)cc(C)n2)C1																							0.0		AKOS027474693		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C18H30N4O2	C18H30N4O2			InChI=1S/C18H30N4O2/c1-5-12(2)16(11-23)21-17(24)15-7-6-8-22(10-15)18-19-13(3)9-14(4)20-18/h9,12,15-16,23H,5-8,10-11H2,1-4H3,(H,21,24)/t12-,15?,16-/m1/s1	ZBBGVWUNSAXLKC-IATLWXBXSA-N	1-(4,6-dimethylpyrimidin-2-yl)-N-[rac-(1S,2R)-1-(hydroxymethyl)-2-methyl-butyl]piperidine-3-carboxamide	110204121	CC[C@@H](C)[C@@H](CO)NC(=O)C1CCCN(c2nc(C)cc(C)n2)C1	1-(4,6-dimethylpyrimidin-2-yl)-N-[(2S,3R)-1-hydroxy-3-methylpentan-2-yl]piperidine-3-carboxamide			1.34301														334.4654		334.236876	5	2	6	2			46									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(110204121)	110204121	2.3	805			[#6]-[#6]-[#6@@H](-[#6])-[#6@@H](-[#6]-[#8])-[#7]-[#6](=[#8])-[#6]1-[#6]-[#6]-[#6]-[#7](-[#6]2:[#7]:[#6](-[#6]):[#6]:[#6](-[#6]):[#7]:2)-[#6]-1	CC[C@@H](C)[C@@H](CO)NC(=O)C1CCCN(c2nc(C)cc(C)n2)C1	ZBBGVWUNSAXLKC		parent_pubchem_cid	AKOS027474693;1-(4,6-dimethylpyrimidin-2-yl)-N-[rac-(1S,2R)-1-(hydroxymethyl)-2-methyl-butyl]piperidine-3-carboxamide		117132334.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=117132334		pluskal_iocb_peptide_Peptide01_E5_id		100	E5		
4.3		0	1125	P1098188	101.9		T33	False	0	24	0	0	25	0	1	6	0	0		0.0						CCc1cc(=O)oc2c1ccc(OC(C)C(=O)NC(Cc1ccccc1)C(=O)O)c2C																							0.0		EiM07-16866		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C24H25NO6	C24H25NO6			InChI=1S/C24H25NO6/c1-4-17-13-21(26)31-22-14(2)20(11-10-18(17)22)30-15(3)23(27)25-19(24(28)29)12-16-8-6-5-7-9-16/h5-11,13,15,19H,4,12H2,1-3H3,(H,25,27)(H,28,29)/t15?,19-/m0/s1	DYMMQMVMCMFSOO-FUBQLUNQSA-N	rac-(2S)-2-[2-(4-ethyl-8-methyl-2-oxo-chromen-7-yl)oxypropanoylamino]-3-phenyl-propanoic acid	16398830	CCc1cc(=O)oc2c1ccc(OC(C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)c2C	(2S)-2-[2-(4-ethyl-8-methyl-2-oxochromen-7-yl)oxypropanoylamino]-3-phenylpropanoic acid			3.0881500000000006													MCULE-5804050251	423.46995		423.168188	6	2	8	3			45									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(16398830)	16398830	3.9	806			[#6]-[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6](-[#6])-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]):[#6]:2-[#6]	CCc1cc(=O)oc2c1ccc(OC(C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)c2C	DYMMQMVMCMFSOO		parent_pubchem_cid	EiM07-16866;AKOS004937313;2-{2-[(4-ETHYL-8-METHYL-2-OXO-2H-CHROMEN-7-YL)OXY]PROPANAMIDO}-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[2-(4-ethyl-8-methyl-2-oxo-chromen-7-yl)oxypropanoylamino]-3-phenyl-propanoic acid		22988239.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22988239		pluskal_iocb_peptide_Peptide01_E5_id		100	E5		
3.9		0	1213	P7565951	68.3		T34	False	0	23	0	0	25	0	3	3	0	0		0.0						COCCn1c(C(=O)NCCc2c[nH]c3c2cc(OC)cc3)cc2ccccc21								N-alkylindoles;3-alkylindoles;Pyrrole carboxamides;Anisoles;2-heteroaryl carboxamides;Alkyl aryl ethers;Substituted pyrroles;Heteroaromatic compounds;Secondary carboxylic acid amides;Dialkyl ethers;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	2-heteroaryl carboxamides;3-alkylindoles;Alkyl aryl ethers;Anisoles;Azacyclic compounds;Benzenoids;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Dialkyl ethers;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Indolecarboxamides and derivatives;Indolecarboxylic acids and derivatives;Indoles;Indoles and derivatives;N-alkylindoles;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenol ethers;Pyrrole carboxamides;Pyrrole carboxylic acids and derivatives;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as indolecarboxamides and derivatives. These are compounds containing a carboxamide group attached to an indole.	Indolecarboxamides and derivatives			Organic compounds	Aromatic heteropolycyclic compounds	indoles (CHEBI:24828);pyrroles (CHEBI:26455);carboxamide (CHEBI:37622);methoxybenzene (CHEBI:51683);organic aromatic compound (CHEBI:33659);aromatic ether (CHEBI:35618);ether (CHEBI:25698);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);indolecarboxamide (CHEBI:46921);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);organooxygen compound (CHEBI:36963);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143);indolyl carboxylic acid (CHEBI:46867)		Indolecarboxylic acids and derivatives	Indolecarboxamide derivative;N-alkylindole;3-alkylindole;Indole;2-heteroaryl carboxamide;Anisole;Pyrrole-2-carboxylic acid or derivatives;Pyrrole-2-carboxamide;Phenol ether;Alkyl aryl ether;Benzenoid;Substituted pyrrole;Heteroaromatic compound;Pyrrole;Carboxamide group;Secondary carboxylic acid amide;Carboxylic acid derivative;Dialkyl ether;Ether;Azacycle;Organic oxygen compound;Organic nitrogen compound;Hydrocarbon derivative;Organic oxide;Organonitrogen compound;Organooxygen compound;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		1-(2-methoxyethyl)-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-1H-indole-2-carboxamide		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C23H25N3O3	C23H25N3O3			InChI=1S/C23H25N3O3/c1-28-12-11-26-21-6-4-3-5-16(21)13-22(26)23(27)24-10-9-17-15-25-20-8-7-18(29-2)14-19(17)20/h3-8,13-15,25H,9-12H2,1-2H3,(H,24,27)	DKNDVEAVFHIHOM-UHFFFAOYSA-N	1-(2-methoxyethyl)-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]indole-2-carboxamide	71754729	COCCn1c(C(=O)NCCc2c[nH]c3c2cc(OC)cc3)cc2ccccc21	1-(2-methoxyethyl)-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]indole-2-carboxamide			2.3214300000000003													MCULE-6073118518	391.474		391.189592	3	2	8	4			44									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(71754729)	71754729	3.5	807			[#6]-[#8]-[#6]-[#6]-[#7]1:[#6](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:2:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:3):[#6]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	COCCn1c(C(=O)NCCc2c[nH]c3c2cc(OC)cc3)cc2ccccc21	DKNDVEAVFHIHOM		parent_pubchem_cid	1-(2-methoxyethyl)-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-1H-indole-2-carboxamide;1435991-64-2;EiM08-29852;AKOS025144504;N-[2-(5-METHOXY-1H-INDOL-3-YL)ETHYL]-1-(2-METHOXYETHYL)-1H-INDOLE-2-CARBOXAMIDE;1-(2-methoxyethyl)-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]indole-2-carboxamide		69213634.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=69213634		pluskal_iocb_peptide_Peptide01_E5_id		100	E5		ZINC000085876508
1.6		0	1133	P1157630	115.8		T37	False	0	17	0	0	21	0	3	5	0	0		0.0						CCC(C)C(NC(=O)C(C)n1c(=O)[nH]c2ccccc2c1=O)C(=O)O																							0.0		EiM07-17663		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	4	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0		C17H21N3O5	C17H21N3O5			InChI=1S/C17H21N3O5/c1-4-9(2)13(16(23)24)19-14(21)10(3)20-15(22)11-7-5-6-8-12(11)18-17(20)25/h5-10,13H,4H2,1-3H3,(H,18,25)(H,19,21)(H,23,24)/t9-,10+,13+/m1/s1	HVAJXHGXQQGHGI-NRUUGDAUSA-N	rac-(2S,3R)-3-methyl-2-[[rac-(2S)-2-(2,4-dioxo-1H-quinazolin-3-yl)propanoyl]amino]pentanoic acid	1793401	CC[C@@H](C)[C@H](NC(=O)[C@H](C)n1c(=O)[nH]c2ccccc2c1=O)C(=O)O	(2S,3R)-2-[[(2S)-2-(2,4-dioxo-1H-quinazolin-3-yl)propanoyl]amino]-3-methylpentanoic acid			2.2376599999999995													MCULE-7064216477	347.37402		347.148121	5	3	6	2			44									Dipeptides	False	Alkaloids;Amino acids and Peptides	Small peptides			Peptide01			Compound(1793401)	1793401	1.7	808			[#6]-[#6]-[#6@@H](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#6@H](-[#6])-[#7]1:[#6](=[#8]):[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8])-[#6](=[#8])-[#8]	CC[C@@H](C)[C@H](NC(=O)[C@H](C)n1c(=O)[nH]c2ccccc2c1=O)C(=O)O	HVAJXHGXQQGHGI		parent_pubchem_cid	EiM07-17663;STL461255;AKOS016380808;N-[(2S)-2-(2,4-dioxo-1,4-dihydroquinazolin-3(2H)-yl)propanoyl]-L-isoleucine;2-[2-(2,4-DIOXO-1,2,3,4-TETRAHYDROQUINAZOLIN-3-YL)PROPANAMIDO]-3-METHYLPENTANOIC ACID;rac-(2S,3R)-3-methyl-2-[[rac-(2S)-2-(2,4-dioxo-1H-quinazolin-3-yl)propanoyl]amino]pentanoic acid		23086497.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23086497		pluskal_iocb_peptide_Peptide01_E6_id		100	E6		ZINC000002137889
4.0		0	1221	P1006427	123.0		T38	False	0	22	0	0	24	0	6	2	0	1		0.0						COc1cc2c(cc1)c(CCNC(=O)C(C)Sc1nnnn1-c1cccc(C)c1)c[nH]2								3-alkylindoles;Anisoles;Toluenes;Alkylarylthioethers;Alkyl aryl ethers;Substituted pyrroles;Heteroaromatic compounds;Secondary carboxylic acid amides;Sulfenyl compounds;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	3-alkylindoles;Alkyl aryl ethers;Alkylarylthioethers;Anisoles;Aryl thioethers;Azacyclic compounds;Azoles;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organosulfur compounds;Phenol ethers;Phenyltetrazoles and derivatives;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Sulfenyl compounds;Tetrazoles;Thioethers;Toluenes	Azoles	2.1	This compound belongs to the class of organic compounds known as phenyltetrazoles and derivatives. These are compounds containing a phenyltetrazole skeleton, which consists of a tetrazole bound to a phenyl group.	Phenyltetrazoles and derivatives			Organic compounds	Aromatic heteropolycyclic compounds	indoles (CHEBI:24828);methoxybenzene (CHEBI:51683);toluenes (CHEBI:27024);aryl sulfide (CHEBI:35683);aromatic ether (CHEBI:35618);pyrroles (CHEBI:26455);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organosulfur compound (CHEBI:33261);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);tetrazoles (CHEBI:35689);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);organic sulfide (CHEBI:16385);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);organooxygen compound (CHEBI:36963);ether (CHEBI:25698);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);azole (CHEBI:68452)		Tetrazoles	Phenyltetrazole;3-alkylindole;Indole;Indole or derivatives;Aryl thioether;Anisole;Phenol ether;Alkyl aryl ether;Alkylarylthioether;Toluene;Monocyclic benzene moiety;Benzenoid;Substituted pyrrole;Heteroaromatic compound;Pyrrole;Carboxamide group;Secondary carboxylic acid amide;Sulfenyl compound;Azacycle;Ether;Carboxylic acid derivative;Thioether;Organic oxygen compound;Organosulfur compound;Organooxygen compound;Organonitrogen compound;Organic nitrogen compound;Hydrocarbon derivative;Carbonyl group;Organic oxide;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		902330-18-1		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	4	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C22H24N6O2S	C22H24N6O2S			InChI=1S/C22H24N6O2S/c1-14-5-4-6-17(11-14)28-22(25-26-27-28)31-15(2)21(29)23-10-9-16-13-24-20-12-18(30-3)7-8-19(16)20/h4-8,11-13,15,24H,9-10H2,1-3H3,(H,23,29)	ZBTWCRLSJBHKON-UHFFFAOYSA-N	N-[2-(6-methoxy-1H-indol-3-yl)ethyl]-2-[1-(m-tolyl)tetrazol-5-yl]sulfanyl-propanamide	4974929	COc1cc2c(cc1)c(CCNC(=O)C(C)Sc1nnnn1-c1cccc(C)c1)c[nH]2	N-[2-(6-methoxy-1H-indol-3-yl)ethyl]-2-[1-(3-methylphenyl)tetrazol-5-yl]sulfanylpropanamide			2.0018499999999992													MCULE-9268874182	436.53958		436.168145	6	2	8	4			45										False	Alkaloids				Peptide01			Compound(4974929)	4974929	4.2	809			[#6]-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#6](-[#6]-[#6]-[#7]-[#6](=[#8])-[#6](-[#6])-[#16]-[#6]1:[#7]:[#7]:[#7]:[#7]:1-[#6]1:[#6]:[#6]:[#6]:[#6](-[#6]):[#6]:1):[#6]:[#7H]:2	COc1cc2c(cc1)c(CCNC(=O)C(C)Sc1nnnn1-c1cccc(C)c1)c[nH]2	ZBTWCRLSJBHKON		parent_pubchem_cid	902330-18-1;N-[2-(6-methoxy-1H-indol-3-yl)ethyl]-2-{[1-(3-methylphenyl)-1H-tetrazol-5-yl]sulfanyl}propanamide;AKOS002309838;AKOS016247722;N-[2-(6-methoxy-1H-indol-3-yl)ethyl]-2-[1-(m-tolyl)tetrazol-5-yl]sulfanyl-propanamide		22952911.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22952911		pluskal_iocb_peptide_Peptide01_E6_id		100	E6		
0.9		0	1141	P6235932	95.9		T41	False	0	21	0	0	21	0	1	5	0	0		0.0						CCc1cc(=O)oc2c1ccc(O)c2CNC(Cc1ccccc1)C(=O)O								7-hydroxycoumarins;Phenylpropanoic acids;1-benzopyrans;Amphetamines and derivatives;D-alpha-amino acids;Pyranones and derivatives;1-hydroxy-2-unsubstituted benzenoids;Aralkylamines;Heteroaromatic compounds;Carboxylic acid salts;Amino acids;Lactones;Oxacyclic compounds;Dialkylamines;Monocarboxylic acids and derivatives;Carboxylic acids;Hydrocarbon derivatives;Carbonyl compounds;Organic oxides;Organic salts;Organic zwitterions;Organopnictogen compounds	1-benzopyrans;1-hydroxy-2-unsubstituted benzenoids;7-hydroxycoumarins;Alpha amino acids;Alpha amino acids and derivatives;Amines;Amino acids;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Aralkylamines;Benzene and substituted derivatives;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acid derivatives;Carboxylic acid salts;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;D-alpha-amino acids;Dialkylamines;Heteroaromatic compounds;Hydrocarbon derivatives;Hydroxycoumarins;Lactones;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organic salts;Organic zwitterions;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenethylamines;Phenols;Phenylalanine and derivatives;Phenylpropanoic acids;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Secondary amines	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	hydroxycoumarin (CHEBI:37912);benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);1-benzopyran (CHEBI:38443);amphetamines (CHEBI:35338);D-alpha-amino acid (CHEBI:16733);pyranone (CHEBI:37963);phenols (CHEBI:33853);aralkylamine (CHEBI:18000);organic aromatic compound (CHEBI:33659);organic salt (CHEBI:24868);amino acid (CHEBI:33709);lactone (CHEBI:25000);oxacycle (CHEBI:38104);secondary amino compound (CHEBI:50995);monocarboxylic acid (CHEBI:25384);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);organic oxide (CHEBI:25701);zwitterion (CHEBI:27369);organic molecular entity (CHEBI:50860);pnictogen molecular entity (CHEBI:33302);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);coumarins (CHEBI:23403);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);benzenoid aromatic compound (CHEBI:33836);primary amine (CHEBI:32877);organic acid (CHEBI:64709);organonitrogen compound (CHEBI:35352);alpha-amino acid (CHEBI:33704);pyrans (CHEBI:26407);nitrogen molecular entity (CHEBI:51143);amine (CHEBI:32952);secondary amine (CHEBI:32863);oxygen molecular entity (CHEBI:25806);carboxylic acid anion (CHEBI:29067);peptide (CHEBI:16670)	Benzopyranoids (PK1311)	Amino acids, peptides, and analogues	Phenylalanine or derivatives;7-hydroxycoumarin;Hydroxycoumarin;Coumarin;3-phenylpropanoic-acid;Alpha-amino acid;Amphetamine or derivatives;Benzopyran;D-alpha-amino acid;1-benzopyran;1-hydroxy-2-unsubstituted benzenoid;Aralkylamine;Pyranone;Monocyclic benzene moiety;Pyran;Benzenoid;Heteroaromatic compound;Amino acid;Carboxylic acid salt;Lactone;Secondary amine;Organoheterocyclic compound;Oxacycle;Carboxylic acid;Monocarboxylic acid or derivatives;Secondary aliphatic amine;Organic zwitterion;Organic nitrogen compound;Hydrocarbon derivative;Organonitrogen compound;Organooxygen compound;Carbonyl group;Organic salt;Organic oxide;Organopnictogen compound;Amine;Organic oxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS016379399		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C21H21NO5	C21H21NO5			InChI=1S/C21H21NO5/c1-2-14-11-19(24)27-20-15(14)8-9-18(23)16(20)12-22-17(21(25)26)10-13-6-4-3-5-7-13/h3-9,11,17,22-23H,2,10,12H2,1H3,(H,25,26)/t17-/m1/s1	KFSANEVZNCAVEL-QGZVFWFLSA-N	rac-(2R)-2-[(4-ethyl-7-hydroxy-2-oxo-chromen-8-yl)methylamino]-3-phenyl-propanoic acid	5580374	CCc1cc(=O)oc2c1ccc(O)c2CN[C@H](Cc1ccccc1)C(=O)O	(2R)-2-[(4-ethyl-7-hydroxy-2-oxochromen-8-yl)methylamino]-3-phenylpropanoic acid			2.6914300000000004													MCULE-8748733499	367.40522		367.141973	6	3	7	3			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(11963721)	11963721	1.1	810			[#6]-[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]):[#6]:2-[#6]-[#7]-[#6@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	CCc1cc(=O)oc2c1ccc(O)c2CN[C@H](Cc1ccccc1)C(=O)O	KFSANEVZNCAVEL		parent_pubchem_cid	AKOS016379399;N-[(4-ETHYL-7-HYDROXY-2-OXO-2H-CHROMEN-8-YL)METHYL]-D-PHENYLALANINE;rac-(2R)-2-[(4-ethyl-7-hydroxy-2-oxo-chromen-8-yl)methylamino]-3-phenyl-propanoic acid		2930690.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=2930690		pluskal_iocb_peptide_Peptide01_E6_id		100	E6		ZINC000002139623
1.0		0	1229	P1437146	82.3		T42	False	0	19	0	0	25	0	7	1	0	0		0.0						Cn1ncc2c(NCc3ccccc3)nc(N3CCN(CCO)CC3)nc21																							0.0		897758-17-7		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	3		C19H25N7O	C19H25N7O			InChI=1S/C19H25N7O/c1-24-18-16(14-21-24)17(20-13-15-5-3-2-4-6-15)22-19(23-18)26-9-7-25(8-10-26)11-12-27/h2-6,14,27H,7-13H2,1H3,(H,20,22,23)	DZIXSBIUYIXPQH-UHFFFAOYSA-N	2-[4-[4-(benzylamino)-1-methyl-pyrazolo[3,4-d]pyrimidin-6-yl]piperazin-1-yl]ethanol	7216343	Cn1ncc2c(NCc3ccccc3)nc(N3CCN(CCO)CC3)nc21	2-[4-[4-(benzylamino)-1-methylpyrazolo[3,4-d]pyrimidin-6-yl]piperazin-1-yl]ethanol			-0.1546499999999993													MCULE-3239832328	367.4574		367.212058	7	2	6	4			43									Purine alkaloids	False	Alkaloids	Pseudoalkaloids			Peptide01			Compound(7216343)	7216343	1.6	811		SCHEMBL13943747	[#6]-[#7]1:[#7]:[#6]:[#6]2:[#6](-[#7]-[#6]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#7]:[#6](-[#7]3-[#6]-[#6]-[#7](-[#6]-[#6]-[#8])-[#6]-[#6]-3):[#7]:[#6]:1:2	Cn1ncc2c(NCc3ccccc3)nc(N3CCN(CCO)CC3)nc21	DZIXSBIUYIXPQH		parent_pubchem_cid	897758-17-7;2-(4-(4-(benzylamino)-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)piperazin-1-yl)ethanol;SCHEMBL13943747;HMS1656M03;AKOS002313301;CCG-186679;2-[4-[4-(benzylamino)-1-methylpyrazolo[3,4-d]pyrimidin-6-yl]piperazin-1-yl]ethanol;F2031-0893;2-{4-[4-(BENZYLAMINO)-1-METHYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-6-YL]PIPERAZIN-1-YL}ETHAN-1-OL;2-[4-[4-(benzylamino)-1-methyl-pyrazolo[3,4-d]pyrimidin-6-yl]piperazin-1-yl]ethanol		16876951.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=16876951		pluskal_iocb_peptide_Peptide01_E6_id		100	E6		ZINC000021929056
-0.5		0	6	P1276838	49.3		U1	False	0	12	0	0	17	0	1	2	0	0		0.0						CC(C)C(NCc1ccccc1)C(=O)O								Alpha amino acids;Phenylmethylamines;Benzylamines;Aralkylamines;Amino acids;Monocarboxylic acids and derivatives;Dialkylamines;Carboxylic acids;Organopnictogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids;Alpha amino acids and derivatives;Amines;Amino acids;Amino acids and derivatives;Amino acids, peptides, and analogues;Aralkylamines;Benzene and substituted derivatives;Benzenoids;Benzylamines;Carbonyl compounds;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Dialkylamines;Hydrocarbon derivatives;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenylmethylamines;Secondary amines;Valine and derivatives	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as valine and derivatives. These are compounds containing valine or a derivative thereof resulting from reaction of valine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Valine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic homomonocyclic compounds	alpha-amino acid (CHEBI:33704);aromatic amine (CHEBI:33860);aralkylamine (CHEBI:18000);amino acid (CHEBI:33709);carbonyl compound (CHEBI:36586);secondary amino compound (CHEBI:50995);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);valine derivative (CHEBI:27267);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);peptide (CHEBI:16670);organonitrogen compound (CHEBI:35352);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);nitrogen molecular entity (CHEBI:51143);amine (CHEBI:32952);secondary amine (CHEBI:32863);oxygen molecular entity (CHEBI:25806)		Amino acids, peptides, and analogues	Valine or derivatives;Alpha-amino acid;Benzylamine;Phenylmethylamine;Aralkylamine;Monocyclic benzene moiety;Benzenoid;Amino acid;Secondary amine;Monocarboxylic acid or derivatives;Secondary aliphatic amine;Carboxylic acid;Organic nitrogen compound;Organic oxide;Organooxygen compound;Organonitrogen compound;Carbonyl group;Organopnictogen compound;Organic oxygen compound;Amine;Hydrocarbon derivative;Aromatic homomonocyclic compound	Organic acids and derivatives	0.0		2-(benzylamino)-3-methylbutanoic acid		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C12H17NO2	C12H17NO2			InChI=1S/C12H17NO2/c1-9(2)11(12(14)15)13-8-10-6-4-3-5-7-10/h3-7,9,11,13H,8H2,1-2H3,(H,14,15)	FJBAOZHBRMLMCP-UHFFFAOYSA-N	2-(benzylamino)-3-methyl-butanoic acid	98172	CC(C)C(NCc1ccccc1)C(=O)O	2-(benzylamino)-3-methylbutanoic acid			1.83069													MCULE-2775757228	207.27479		207.125929	3	2	5	1			44										False	Amino acids and Peptides	Small peptides			Peptide01			Compound(98172)	98172	-0.6	812		SCHEMBL8349459	[#6]-[#6](-[#6])-[#6](-[#7]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	CC(C)C(NCc1ccccc1)C(=O)O	FJBAOZHBRMLMCP		parent_pubchem_cid	2-(benzylamino)-3-methylbutanoic acid;16975-39-6;15363-84-5;N-Benzylvaline;Benzylvaline;N-Benzylvaline #;Valine, N-benzyl-;NSC 86091;L-Valine, N-(phenylmethyl)-;SCHEMBL8349459;FJBAOZHBRMLMCP-UHFFFAOYSA-N;NSC86091;MFCD00448597;NSC-86091;2-(benzylamino)-3-methylbutanoicacid;AKOS000126237;AKOS016283962;NCGC00327341-01;CS-0273371;EN300-58095;AB01322027-02;2-(benzylamino)-3-methyl-butanoic acid		24048508.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24048508		pluskal_iocb_peptide_Peptide01_E6_id		100	E6		
3.8		0	94	P0110420176	71.2		U2	False	1	19	0	0	17	0	2	3	0	0		0.0						COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c1ccc(Br)cc1								Alpha amino acid esters;N-acyl-alpha amino acids and derivatives;Indolyl carboxylic acids and derivatives;3-alkylindoles;4-halobenzoic acids and derivatives;Benzoyl derivatives;Fatty acid esters;Bromobenzenes;Substituted pyrroles;Aryl bromides;Methyl esters;Heteroaromatic compounds;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Azacyclic compounds;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organobromides;Organonitrogen compounds	3-alkylindoles;4-halobenzoic acids and derivatives;Alpha amino acid esters;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Aryl bromides;Aryl halides;Azacyclic compounds;Benzamides;Benzene and substituted derivatives;Benzenoids;Benzoic acids and derivatives;Benzoyl derivatives;Bromobenzenes;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids and derivatives;Chemical entities;Fatty Acyls;Fatty acid esters;Halobenzenes;Halobenzoic acids and derivatives;Heteroaromatic compounds;Hippuric acids and derivatives;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Indolyl carboxylic acids and derivatives;Lipids and lipid-like molecules;Methyl esters;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organobromides;Organohalogen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as hippuric acids and derivatives. These are compounds containing a hippuric acid or a derivative, with a structure characterized the presence of a benzoyl group linked to the N-terminal of a glycine.	Hippuric acids and derivatives		Benzamides	Organic compounds	Aromatic heteropolycyclic compounds	alpha-amino acid ester (CHEBI:46874);N-acyl-amino acid (CHEBI:51569);indolyl carboxylic acid (CHEBI:46867);indoles (CHEBI:24828);carbonyl compound (CHEBI:36586);organohalogen compound (CHEBI:36684);fatty acid ester (CHEBI:35748);organobromine compound (CHEBI:37141);pyrroles (CHEBI:26455);carboxylic ester (CHEBI:33308);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);monocarboxylic acid (CHEBI:25384);organonitrogen heterocyclic compound (CHEBI:38101);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);N-acylglycine (CHEBI:16180);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);organooxygen compound (CHEBI:36963);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);benzoic acids (CHEBI:22723);lipid (CHEBI:18059);haloarene (CHEBI:50887);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143);benzamides (CHEBI:22702);phenols (CHEBI:33853);amino acid (CHEBI:33709);peptide (CHEBI:16670)	Fatty esters (FA07);Fatty Acyls (FA)	Benzoic acids and derivatives	Alpha-amino acid ester;Hippuric acid or derivatives;N-acyl-alpha amino acid or derivatives;Indolyl carboxylic acid derivative;Alpha-amino acid or derivatives;4-halobenzoic acid or derivatives;3-alkylindole;Halobenzoic acid or derivatives;Indole;Indole or derivatives;Benzoyl;Bromobenzene;Fatty acid ester;Halobenzene;Substituted pyrrole;Fatty acyl;Aryl bromide;Aryl halide;Pyrrole;Heteroaromatic compound;Methyl ester;Secondary carboxylic acid amide;Carboxamide group;Carboxylic acid ester;Azacycle;Organoheterocyclic compound;Carboxylic acid derivative;Monocarboxylic acid or derivatives;Organooxygen compound;Carbonyl group;Organic oxygen compound;Organic nitrogen compound;Hydrocarbon derivative;Organonitrogen compound;Organobromide;Organohalogen compound;Organic oxide;Aromatic heteropolycyclic compound	Benzenoids	0.0		Oprea1_689610		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C19H17BrN2O3	C19H17BrN2O3			InChI=1S/C19H17BrN2O3/c1-25-19(24)17(22-18(23)12-6-8-14(20)9-7-12)10-13-11-21-16-5-3-2-4-15(13)16/h2-9,11,17,21H,10H2,1H3,(H,22,23)	OZCVNYGMHQVRGC-UHFFFAOYSA-N	methyl 2-[(4-bromobenzoyl)amino]-3-(1H-indol-3-yl)propanoate	4137996	COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c1ccc(Br)cc1	methyl 2-[(4-bromobenzoyl)amino]-3-(1H-indol-3-yl)propanoate			2.9066600000000014													MCULE-5618459221	401.26294		400.042255	3	2	6	3			45										False					Peptide01			Compound(4137996)	4137996	3.7	813			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#35]):[#6]:[#6]:1	COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c1ccc(Br)cc1	OZCVNYGMHQVRGC		parent_pubchem_cid	Oprea1_689610;AKOS001613413;AKOS016311681;NCGC00674403-01;METHYL 2-[(4-BROMOPHENYL)FORMAMIDO]-3-(1H-INDOL-3-YL)PROPANOATE;methyl 2-[(4-bromobenzoyl)amino]-3-(1H-indol-3-yl)propanoate		24428748.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24428748		pluskal_iocb_peptide_Peptide01_E6_id		100	E6		
4.6		0	182	P7020351203	80.2		U3	False	0	22	0	0	20	0	2	4	0	0		0.0						COc1c(OCc2ccccc2)ccc(C=NNc2ccccc2C(=O)O)c1																							0.0		MFCD09057498		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C22H20N2O4	C22H20N2O4			InChI=1S/C22H20N2O4/c1-27-21-13-17(11-12-20(21)28-15-16-7-3-2-4-8-16)14-23-24-19-10-6-5-9-18(19)22(25)26/h2-14,24H,15H2,1H3,(H,25,26)/b23-14+	SLESQPKCDPJSKX-OEAKJJBVSA-N	2-[(2E)-2-[(4-benzyloxy-3-methoxy-phenyl)methylene]hydrazino]benzoic acid	22694079	COc1c(OCc2ccccc2)ccc(/C=N/Nc2ccccc2C(=O)O)c1	2-[(2E)-2-[(3-methoxy-4-phenylmethoxyphenyl)methylidene]hydrazinyl]benzoic acid			2.948840000000001														376.4157		376.142307	6	2	8	3			45										False					Peptide01			Compound(22694079)	22694079	5.1	814			[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6]:[#6]:[#6](/[#6]=[#7]/[#7]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6](=[#8])-[#8]):[#6]:1	COc1c(OCc2ccccc2)ccc(/C=N/Nc2ccccc2C(=O)O)c1	SLESQPKCDPJSKX		parent_pubchem_cid	MFCD09057498;AKOS016360971;2-[(2E)-2-[(4-benzyloxy-3-methoxy-phenyl)methylene]hydrazino]benzoic acid		24477400.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24477400		pluskal_iocb_peptide_Peptide01_E6_id		100	E6		ZINC000011903704
1.8		0	270	P5404829	78.4		U4	False	0	12	0	0	16	0	2	3	0	0		0.0						CC(C)C(NC(=O)Nc1ccccc1)C(=O)O																							0.0		2-[(anilinocarbonyl)amino]-3-methylbutanoic acid	DTXSID30387932	2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C12H16N2O3	C12H16N2O3			InChI=1S/C12H16N2O3/c1-8(2)10(11(15)16)14-12(17)13-9-6-4-3-5-7-9/h3-8,10H,1-2H3,(H,15,16)(H2,13,14,17)	IIJAEFRNONKHQP-UHFFFAOYSA-N	3-methyl-2-(phenylcarbamoylamino)butanoic acid	2944809	CC(C)C(NC(=O)Nc1ccccc1)C(=O)O	3-methyl-2-(phenylcarbamoylamino)butanoic acid			1.53669													MCULE-8460848874	236.27292		236.116092	3	3	4	1			42									Aminoacids;Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(2944809)	2944809	1.9	815		SCHEMBL20335126	[#6]-[#6](-[#6])-[#6](-[#7]-[#6](=[#8])-[#7]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	CC(C)C(NC(=O)Nc1ccccc1)C(=O)O	IIJAEFRNONKHQP		parent_pubchem_cid	2-[(anilinocarbonyl)amino]-3-methylbutanoic acid;84860-35-5;3-methyl-2-(phenylcarbamoylamino)butanoic Acid;N-(anilinocarbonyl)valine;3-methyl-2-[(phenylcarbamoyl)amino]butanoic acid;SCHEMBL20335126;DTXSID30387932;MFCD00483843;AKOS000263984;AKOS016302487;3-Methyl-2-(3-phenylureido)butanoicacid;LS-07770;3-Methyl-2-(3-phenylureido)butanoic acid;CS-0221303;EN300-08820;SR-01000267839;SR-01000267839-1;Z55928884		24573657.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24573657		pluskal_iocb_peptide_Peptide01_E6_id		100	E6		
0.6		0	14	P7135560	104.1		U5	False	0	11	0	0	17	0	1	6	0	0		0.0						CC(C)(C)OC(=O)N1CCC(C(=O)O)C1C(=O)O																							0.0		1706428-51-4		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	1	0	3	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C11H17NO6	C11H17NO6			InChI=1S/C11H17NO6/c1-11(2,3)18-10(17)12-5-4-6(8(13)14)7(12)9(15)16/h6-7H,4-5H2,1-3H3,(H,13,14)(H,15,16)	DYMWLRVGPQDELA-UHFFFAOYSA-N	1-tert-butoxycarbonylpyrrolidine-2,3-dicarboxylic acid	67220718	CC(C)(C)OC(=O)N1CCC(C(=O)O)C1C(=O)O	1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2,3-dicarboxylic acid			0.7811999999999998													MCULE-6468304723	259.26124		259.105587	6	2	4	1			44									Aminoacids	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(67220718)	67220718	0.4	816		SCHEMBL1943658	[#6]-[#6](-[#6])(-[#6])-[#8]-[#6](=[#8])-[#7]1-[#6]-[#6]-[#6](-[#6](=[#8])-[#8])-[#6]-1-[#6](=[#8])-[#8]	CC(C)(C)OC(=O)N1CCC(C(=O)O)C1C(=O)O	DYMWLRVGPQDELA		parent_pubchem_cid	1706428-51-4;1-(TERT-BUTOXYCARBONYL)PYRROLIDINE-2,3-DICARBOXYLIC ACID;SCHEMBL1943658;1-[(tert-butoxy)carbonyl]pyrrolidine-2,3-dicarboxylic acid;AKOS024461910;EN300-749142;1-(TERT-BUTOXYCARBONYL)PYRROLIDINE-2,3-DICARBOXYLICACID;1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2,3-dicarboxylic acid;1-tert-butoxycarbonylpyrrolidine-2,3-dicarboxylic acid		56779549.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=56779549		pluskal_iocb_peptide_Peptide01_E7_id		100	E7		
3.8		0	102	P1158295	110.2		U6	False	0	27	0	0	25	0	5	3	0	0		0.0						COc1cc2c(cc1)[nH]cc2CCNC(=O)CCc1c(C)c(C#N)c2[nH]c3ccccc3n2c1=O																							0.0		EiM07-18656		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	2	0	0	0	0	0	0	0	0	1	0		C27H25N5O3	C27H25N5O3			InChI=1S/C27H25N5O3/c1-16-19(27(34)32-24-6-4-3-5-23(24)31-26(32)21(16)14-28)8-10-25(33)29-12-11-17-15-30-22-9-7-18(35-2)13-20(17)22/h3-7,9,13,15,30-31H,8,10-12H2,1-2H3,(H,29,33)	OXQJLJKNTKNRIK-UHFFFAOYSA-N	3-(4-cyano-3-methyl-1-oxo-5H-pyrido[1,2-a]benzimidazol-2-yl)-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]propanamide	17591861	COc1cc2c(cc1)[nH]cc2CCNC(=O)CCc1c(C)c(C#N)c2[nH]c3ccccc3n2c1=O	3-(4-cyano-3-methyl-1-oxo-5H-pyrido[1,2-a]benzimidazol-2-yl)-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]propanamide			2.8898900000000003														467.532		467.19574	5	3	7	5			45									Carbazole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(17591861)	17591861	2.7	817			[#6]-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#7H]:[#6]:[#6]:2-[#6]-[#6]-[#7]-[#6](=[#8])-[#6]-[#6]-[#6]1:[#6](-[#6]):[#6](-[#6]#[#7]):[#6]2:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3:[#7]:2:[#6]:1=[#8]	COc1cc2c(cc1)[nH]cc2CCNC(=O)CCc1c(C)c(C#N)c2[nH]c3ccccc3n2c1=O	OXQJLJKNTKNRIK		parent_pubchem_cid	EiM07-18656;AKOS005555254;AKOS016377782;3-(4-cyano-3-methyl-1-oxo-1,5-dihydropyrido[1,2-a]benzimidazol-2-yl)-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]propanamide;3-(4-cyano-3-methyl-1-oxo-5H-pyrido[1,2-a]benzimidazol-2-yl)-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]propanamide		24314031.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24314031		pluskal_iocb_peptide_Peptide01_E7_id		100	E7		ZINC000101478157
2.1		0	190	P7020090678	83.6		U7	False	0	17	0	0	22	0	4	2	0	1		0.0						Cc1cc(C)nc(Nc2ccc(S(=O)(=O)N3CCCCC3)cc2)n1																							0.0		AKOS002359711		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	1		C17H22N4O2S	C17H22N4O2S			InChI=1S/C17H22N4O2S/c1-13-12-14(2)19-17(18-13)20-15-6-8-16(9-7-15)24(22,23)21-10-4-3-5-11-21/h6-9,12H,3-5,10-11H2,1-2H3,(H,18,19,20)	BJHBWKDYJUPVOO-UHFFFAOYSA-N	4,6-dimethyl-N-[4-(1-piperidylsulfonyl)phenyl]pyrimidin-2-amine	1649291	Cc1cc(C)nc(Nc2ccc(S(=O)(=O)N3CCCCC3)cc2)n1	4,6-dimethyl-N-(4-piperidin-1-ylsulfonylphenyl)pyrimidin-2-amine			2.03299													MCULE-1145748855	346.45449		346.146347	5	1	4	3			44										False	Alkaloids	Lysine alkaloids			Peptide01			Compound(1649291)	1649291	2.9	818			[#6]-[#6]1:[#6]:[#6](-[#6]):[#7]:[#6](-[#7]-[#6]2:[#6]:[#6]:[#6](-[#16](=[#8])(=[#8])-[#7]3-[#6]-[#6]-[#6]-[#6]-[#6]-3):[#6]:[#6]:2):[#7]:1	Cc1cc(C)nc(Nc2ccc(S(=O)(=O)N3CCCCC3)cc2)n1	BJHBWKDYJUPVOO		parent_pubchem_cid	AKOS002359711;4,6-dimethyl-N-[4-(1-piperidylsulfonyl)phenyl]pyrimidin-2-amine		4396768.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=4396768		pluskal_iocb_peptide_Peptide01_E7_id		100	E7		ZINC000001921706
4.4		0	278	P1583189	75.2		U8	False	0	21	1	1	22	0	6	1	0	0		0.0						Cc1cc(C)cc(Nc2nc(N3CCOCC3)nc(Nc3cc(Cl)c(F)cc3)n2)c1																							0.0		898630-65-4		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1		C21H22ClFN6O	C21H22ClFN6O			InChI=1S/C21H22ClFN6O/c1-13-9-14(2)11-16(10-13)25-20-26-19(24-15-3-4-18(23)17(22)12-15)27-21(28-20)29-5-7-30-8-6-29/h3-4,9-12H,5-8H2,1-2H3,(H2,24,25,26,27,28)	AINLQMYUCLAXPC-UHFFFAOYSA-N	N2-(3-chloro-4-fluoro-phenyl)-N4-(3,5-dimethylphenyl)-6-morpholino-1,3,5-triazine-2,4-diamine	18580189	Cc1cc(C)cc(Nc2nc(N3CCOCC3)nc(Nc3cc(Cl)c(F)cc3)n2)c1	4-N-(3-chloro-4-fluorophenyl)-2-N-(3,5-dimethylphenyl)-6-morpholin-4-yl-1,3,5-triazine-2,4-diamine			2.59227													MCULE-1893523523	428.90049		428.152765	7	2	5	4			44										False	Alkaloids				Peptide01			Compound(18580189)	18580189	5.3	819			[#6]-[#6]1:[#6]:[#6](-[#6]):[#6]:[#6](-[#7]-[#6]2:[#7]:[#6](-[#7]3-[#6]-[#6]-[#8]-[#6]-[#6]-3):[#7]:[#6](-[#7]-[#6]3:[#6]:[#6](-[#17]):[#6](-[#9]):[#6]:[#6]:3):[#7]:2):[#6]:1	Cc1cc(C)cc(Nc2nc(N3CCOCC3)nc(Nc3cc(Cl)c(F)cc3)n2)c1	AINLQMYUCLAXPC		parent_pubchem_cid	898630-65-4;N2-(3-CHLORO-4-FLUOROPHENYL)-N4-(3,5-DIMETHYLPHENYL)-6-(MORPHOLIN-4-YL)-1,3,5-TRIAZINE-2,4-DIAMINE;N2-(3-chloro-4-fluorophenyl)-N4-(3,5-dimethylphenyl)-6-morpholino-1,3,5-triazine-2,4-diamine;AKOS016391811;F2703-0338;4-N-(3-chloro-4-fluorophenyl)-2-N-(3,5-dimethylphenyl)-6-morpholin-4-yl-1,3,5-triazine-2,4-diamine;N2-(3-chloro-4-fluoro-phenyl)-N4-(3,5-dimethylphenyl)-6-morpholino-1,3,5-triazine-2,4-diamine		13070256.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=13070256		pluskal_iocb_peptide_Peptide01_E7_id		100	E7		ZINC000009708874
3.8		0	22	P7119360829	146.1		U9	False	0	21	0	0	15	0	5	1	0	1	-1.0	0.0						N#Cc1c(N)nc2c(C(N)=O)c(Nc3ccccc3)sc2c1-c1ccccc1		4.26		0.0	5.04	CHEMBL600819																	0.0		5-amino-6-cyano-7-phenyl-2-(phenylamino)thieno[3,2-b]pyridine-3-carboxamide		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	1	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	1	0	0	0	0	0	0	0	0	0	0		C21H15N5OS	C21H15N5OS			InChI=1S/C21H15N5OS/c22-11-14-15(12-7-3-1-4-8-12)18-17(26-19(14)23)16(20(24)27)21(28-18)25-13-9-5-2-6-10-13/h1-10,25H,(H2,23,26)(H2,24,27)	VJCANGHIFSKRFF-UHFFFAOYSA-N	5-amino-2-anilino-6-cyano-7-phenyl-thieno[3,2-b]pyridine-3-carboxamide	2982214	N#Cc1c(N)nc2c(C(N)=O)c(Nc3ccccc3)sc2c1-c1ccccc1	5-amino-2-anilino-6-cyano-7-phenylthieno[3,2-b]pyridine-3-carboxamide			2.19999													MCULE-6638158453	385.4506	NEUTRAL	385.099731	5	3	4	4	0.0		29										False	Alkaloids		False	False	Peptide01		-1.0	Compound(2982214)	2982214	4.8	820			[#7]#[#6]-[#6]1:[#6](-[#7]):[#7]:[#6]2:[#6](-[#6](-[#7])=[#8]):[#6](-[#7]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#16]:[#6]:2:[#6]:1-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	N#Cc1c(N)nc2c(C(N)=O)c(Nc3ccccc3)sc2c1-c1ccccc1	VJCANGHIFSKRFF		parent_pubchem_cid	5-amino-6-cyano-7-phenyl-2-(phenylamino)thieno[3,2-b]pyridine-3-carboxamide;836664-59-6;CHEMBL600819;BDBM50306767;STK952910;5-amino-2-anilino-6-cyano-7-phenylthieno[3,2-b]pyridine-3-carboxamide;AKOS002205405;VU0608742-1;AB00683839-01;SR-01000300016;SR-01000300016-1;F3284-8549;5-amino-2-anilino-6-cyano-7-phenyl-thieno[3,2-b]pyridine-3-carboxamide	False	604790.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=604790		pluskal_iocb_peptide_Peptide01_E7_id		100	E7	False	ZINC000019881424
0.4		0	110	P0120630228	104.3		U10	False	0	14	0	0	15	0	3	4	0	0	-1.0	0.0						COc1ccc(C(=O)NC(Cc2cnc[nH]2)C(=O)O)cc1		0.84		0.0	-0.66	CHEMBL264955		N-acyl-alpha amino acids;Hippuric acids;Phenoxy compounds;Anisoles;Methoxybenzenes;Imidazolyl carboxylic acids and derivatives;Benzoyl derivatives;Alkyl aryl ethers;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Monocarboxylic acids and derivatives;Carboxylic acids;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organonitrogen compounds;Organopnictogen compounds	Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Anisoles;Azacyclic compounds;Azoles;Benzamides;Benzene and substituted derivatives;Benzenoids;Benzoic acids and derivatives;Benzoyl derivatives;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Ethers;Heteroaromatic compounds;Hippuric acids;Hippuric acids and derivatives;Histidine and derivatives;Hydrocarbon derivatives;Imidazoles;Imidazolyl carboxylic acids and derivatives;Methoxybenzenes;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenol ethers;Phenoxy compounds;Secondary carboxylic acid amides;Substituted imidazoles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as histidine and derivatives. These are compounds containing cysteine or a derivative thereof resulting from reaction of cysteine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Histidine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteromonocyclic compounds	N-acyl-amino acid (CHEBI:51569);N-acylglycine (CHEBI:16180);benzenes (CHEBI:22712);methoxybenzene (CHEBI:51683);imidazolyl carboxylic acid (CHEBI:38307);carbonyl compound (CHEBI:36586);aromatic ether (CHEBI:35618);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organonitrogen heterocyclic compound (CHEBI:38101);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);histidine derivative (CHEBI:24599);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);amino acid (CHEBI:33709);peptide (CHEBI:16670);benzenoid aromatic compound (CHEBI:33836);benzamides (CHEBI:22702);phenols (CHEBI:33853);organic heterocyclic compound (CHEBI:24532);azole (CHEBI:68452);imidazoles (CHEBI:24780);oxygen molecular entity (CHEBI:25806);ether (CHEBI:25698);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)		Amino acids, peptides, and analogues	Histidine or derivatives;Hippuric acid or derivatives;Hippuric acid;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;Benzamide;Benzoic acid or derivatives;Anisole;Phenoxy compound;Benzoyl;Imidazolyl carboxylic acid derivative;Phenol ether;Methoxybenzene;Alkyl aryl ether;Monocyclic benzene moiety;Benzenoid;Heteroaromatic compound;Azole;Imidazole;Secondary carboxylic acid amide;Carboxamide group;Azacycle;Organoheterocyclic compound;Monocarboxylic acid or derivatives;Carboxylic acid;Ether;Carbonyl group;Organic oxide;Hydrocarbon derivative;Organooxygen compound;Organic nitrogen compound;Organonitrogen compound;Organic oxygen compound;Organopnictogen compound;Aromatic heteromonocyclic compound	Organic acids and derivatives	0.0		3-(1H-imidazol-5-yl)-2-(4-methoxybenzamido)propanoic acid		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	2	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C14H15N3O4	C14H15N3O4			InChI=1S/C14H15N3O4/c1-21-11-4-2-9(3-5-11)13(18)17-12(14(19)20)6-10-7-15-8-16-10/h2-5,7-8,12H,6H2,1H3,(H,15,16)(H,17,18)(H,19,20)	LMLSSYWZBJKKEA-UHFFFAOYSA-N	3-(1H-imidazol-5-yl)-2-[(4-methoxybenzoyl)amino]propanoic acid	2787196	COc1ccc(C(=O)NC(Cc2cnc[nH]2)C(=O)O)cc1	3-(1H-imidazol-5-yl)-2-[(4-methoxybenzoyl)amino]propanoic acid			0.2721699999999993													MCULE-5021830008	289.29335	ACID	289.106256	5	3	6	2	1.0		28									Imidazole alkaloids	False	Alkaloids	Histidine alkaloids	False	False	Peptide01		-1.0	Compound(2787196)	2787196	0.9	821		SCHEMBL9830731	[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]2:[#6]:[#7]:[#6]:[#7H]:2)-[#6](=[#8])-[#8]):[#6]:[#6]:1	COc1ccc(C(=O)NC(Cc2cnc[nH]2)C(=O)O)cc1	LMLSSYWZBJKKEA		parent_pubchem_cid	3-(1H-imidazol-5-yl)-2-(4-methoxybenzamido)propanoic acid;CBMicro_000245;Oprea1_134567;N-(4-methoxybenzoyl)histidine;CHEMBL264955;SCHEMBL9830731;3-(1H-imidazol-5-yl)-2-[(4-methoxybenzoyl)amino]propanoic acid;SMSF0005536;MFCD00708117;AKOS000127481;AKOS000273927;AKOS016040213;CB01417;BIM-0000031.P001;F3096-1355	False	594617.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=594617		pluskal_iocb_peptide_Peptide01_E7_id		100	E7	False	
4.1		0	198	P1113407	83.1		U11	False	0	25	0	0	23	0	3	1	0	1		0.0						O=C(CC(c1ccccc1)c1ccccc1)NCCc1csc(-c2cnccc2)n1								2,4-disubstituted thiazoles;Pyridines and derivatives;Fatty amides;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	2,4-disubstituted thiazoles;Azacyclic compounds;Azoles;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Diphenylmethanes;Fatty Acyls;Fatty amides;Heteroaromatic compounds;Hydrocarbon derivatives;Lipids and lipid-like molecules;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Pyridines and derivatives;Secondary carboxylic acid amides;Thiazoles	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as diphenylmethanes. These are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups.	Diphenylmethanes			Organic compounds	Aromatic heteromonocyclic compounds	thiazoles (CHEBI:48901);pyridines (CHEBI:26421);fatty amide (CHEBI:29348);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);diarylmethane (CHEBI:51614);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);azole (CHEBI:68452);lipid (CHEBI:18059);organooxygen compound (CHEBI:36963);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712)	Fatty amides (FA08);Fatty Acyls (FA)	Diphenylmethanes	Diphenylmethane;2,4-disubstituted 1,3-thiazole;Fatty amide;Fatty acyl;Pyridine;Azole;Heteroaromatic compound;Thiazole;Carboxamide group;Secondary carboxylic acid amide;Carboxylic acid derivative;Azacycle;Organoheterocyclic compound;Hydrocarbon derivative;Organic nitrogen compound;Organic oxide;Carbonyl group;Organonitrogen compound;Organooxygen compound;Organic oxygen compound;Aromatic heteromonocyclic compound	Benzenoids	0.0		AKOS005588665		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C25H23N3OS	C25H23N3OS			InChI=1S/C25H23N3OS/c29-24(16-23(19-8-3-1-4-9-19)20-10-5-2-6-11-20)27-15-13-22-18-30-25(28-22)21-12-7-14-26-17-21/h1-12,14,17-18,23H,13,15-16H2,(H,27,29)	SINPULRVLTZZDZ-UHFFFAOYSA-N	3,3-diphenyl-N-[2-[2-(3-pyridyl)thiazol-4-yl]ethyl]propanamide	28466474	O=C(CC(c1ccccc1)c1ccccc1)NCCc1csc(-c2cnccc2)n1	3,3-diphenyl-N-[2-(2-pyridin-3-yl-1,3-thiazol-4-yl)ethyl]propanamide			4.541850000000003													MCULE-4589958204	413.54556		413.156183	3	1	8	4			44									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(28466474)	28466474	4.5	822			[#8]=[#6](-[#6]-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6]-[#6]-[#6]1:[#6]:[#16]:[#6](-[#6]2:[#6]:[#7]:[#6]:[#6]:[#6]:2):[#7]:1	O=C(CC(c1ccccc1)c1ccccc1)NCCc1csc(-c2cnccc2)n1	SINPULRVLTZZDZ		parent_pubchem_cid	AKOS005588665;3,3-diphenyl-N-(2-(2-(pyridin-3-yl)thiazol-4-yl)ethyl)propanamide;3,3-diphenyl-N-[2-[2-(3-pyridyl)thiazol-4-yl]ethyl]propanamide		7124085.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=7124085		pluskal_iocb_peptide_Peptide01_E7_id		100	E7		ZINC000019942445
2.0		0	286	P7126269	144.7		U12	False	0	19	0	0	16	0	4	5	0	0		0.0						O=C(O)Cc1ccc(Nc2nccc(Nc3cc(C(=O)O)c(O)cc3)n2)cc1																							0.0		AKOS024459039		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	2	2	0	0	0	0	0	0	0	0	0	0	1	0	0	0	3	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0		C19H16N4O5	C19H16N4O5			InChI=1S/C19H16N4O5/c24-15-6-5-13(10-14(15)18(27)28)21-16-7-8-20-19(23-16)22-12-3-1-11(2-4-12)9-17(25)26/h1-8,10,24H,9H2,(H,25,26)(H,27,28)(H2,20,21,22,23)	QHKDSLZGYPEIJY-UHFFFAOYSA-N	5-[[2-[4-(carboxymethyl)anilino]pyrimidin-4-yl]amino]-2-hydroxy-benzoic acid	90489131	O=C(O)Cc1ccc(Nc2nccc(Nc3cc(C(=O)O)c(O)cc3)n2)cc1	5-[[2-[4-(carboxymethyl)anilino]pyrimidin-4-yl]amino]-2-hydroxybenzoic acid			0.9004299999999998													MCULE-8239063264	380.36317		380.11207	9	5	7	3			44										False	Alkaloids				Peptide01			Compound(90489131)	90489131	3.1	823			[#8]=[#6](-[#8])-[#6]-[#6]1:[#6]:[#6]:[#6](-[#7]-[#6]2:[#7]:[#6]:[#6]:[#6](-[#7]-[#6]3:[#6]:[#6](-[#6](=[#8])-[#8]):[#6](-[#8]):[#6]:[#6]:3):[#7]:2):[#6]:[#6]:1	O=C(O)Cc1ccc(Nc2nccc(Nc3cc(C(=O)O)c(O)cc3)n2)cc1	QHKDSLZGYPEIJY		parent_pubchem_cid	AKOS024459039;5-[[2-[4-(carboxymethyl)anilino]pyrimidin-4-yl]amino]-2-hydroxy-benzoic acid		99993852.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=99993852		pluskal_iocb_peptide_Peptide01_E7_id		100	E7		ZINC000170621820
2.6		0	30	P1090434	75.6		U13	False	0	14	0	0	25	0	1	4	0	0		0.0						CC(C)(C)OC(=O)NCC1(CC(=O)O)CCCCC1								Carbamate esters;Organic carbonic acids and derivatives;Monocarboxylic acids and derivatives;Carboxylic acids;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Amino acids and derivatives;Amino acids, peptides, and analogues;Carbamate esters;Carbamic acids and derivatives;Carbonyl compounds;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Gamma amino acids and derivatives;Hydrocarbon derivatives;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as gamma amino acids and derivatives. These are amino acids having a (-NH2) group attached to the gamma carbon atom.	Gamma amino acids and derivatives		Amino acids and derivatives	Organic compounds	Aliphatic homomonocyclic compounds	carbamate ester (CHEBI:23003);organooxygen compound (CHEBI:36963);carbonyl compound (CHEBI:36586);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);chemical entity (CHEBI:24431);amino acid (CHEBI:33709);peptide (CHEBI:16670);carbon oxoacid (CHEBI:35605);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806)		Amino acids, peptides, and analogues	Gamma amino acid or derivatives;Carbamic acid ester;Carbonic acid derivative;Monocarboxylic acid or derivatives;Carboxylic acid;Organic nitrogen compound;Organic oxygen compound;Organopnictogen compound;Organic oxide;Hydrocarbon derivative;Organooxygen compound;Organonitrogen compound;Carbonyl group;Aliphatic homomonocyclic compound	Organic acids and derivatives	0.0		227626-60-0	DTXSID70373152	2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	1	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C14H25NO4	C14H25NO4			InChI=1S/C14H25NO4/c1-13(2,3)19-12(18)15-10-14(9-11(16)17)7-5-4-6-8-14/h4-10H2,1-3H3,(H,15,18)(H,16,17)	YOOHANJKYCQHED-UHFFFAOYSA-N	2-[1-[(tert-butoxycarbonylamino)methyl]cyclohexyl]acetic acid	2755941	CC(C)(C)OC(=O)NCC1(CC(=O)O)CCCCC1	2-[1-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]cyclohexyl]acetic acid			2.936300000000002													MCULE-4894457444	271.35965		271.178358	4	2	6	1			42										False					Peptide01			Compound(2755941)	2755941	2.7	824		SCHEMBL1076767	[#6]-[#6](-[#6])(-[#6])-[#8]-[#6](=[#8])-[#7]-[#6]-[#6]1(-[#6]-[#6](=[#8])-[#8])-[#6]-[#6]-[#6]-[#6]-[#6]-1	CC(C)(C)OC(=O)NCC1(CC(=O)O)CCCCC1	YOOHANJKYCQHED		parent_pubchem_cid	"227626-60-0;2-(1-(((tert-Butoxycarbonyl)amino)methyl)cyclohexyl)acetic acid;(1-{[(tert-butoxycarbonyl)amino]methyl}cyclohexyl)acetic acid;[1-(n-boc-aminomethyl)-cyclohexyl]-acetic acid;[1-(Tert-Butoxycarbonylamino-Methyl)-Cyclohexyl]-Acetic Acid;2-[1-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]cyclohexyl]acetic Acid;[1-(N-Boc-aminomethyl)cyclohexyl]acetic acid;MFCD03839829;(1-{[(tert-Butoxycarbonyl)amino]methyl}-cyclohexyl)acetic acid;2-[1-[(Boc-amino)methyl]cyclohexyl]acetic acid;boc-gabapentin;(1-(((tert-butoxycarbonyl)amino)methyl)cyclohexyl)acetic acid;N-rt-Butyloxycarbonyl Gabapentin;SCHEMBL1076767;DTXSID70373152;YOOHANJKYCQHED-UHFFFAOYSA-N;AKOS005175128;BS-11768;SY064308;2-n-boc-aminomethyl-2-cyclohexylacetic acid;CS-0154395;FT-0684281;A13940;EN300-137107;Z839048550;1-(N-tert-butoxycarbonylaminomethyl) cyclohexan acetic acid;1-(n-tert-butoxycarbonylaminomethyl)cyclohexan acetic acid;1-(tert-butoxycarbonylamino-methyl)-cyclohexyl-acetic acid;1-[(tert-Butoxycarbonyl)aminomethyl]-1-Cyclohexane Acetic Acid;2-(1-(((tert-Butoxycarbonyl)amino)methyl)cyclohexyl)aceticacid;2-(1-((tert-butoxycarbonylamino)methyl)cyclohexyl)ethanoic acid;2-[1-({[(tert-butoxy)carbonyl]amino}methyl)cyclohexyl]acetic acid;[1-(tert-Butoxycarbonylamino-methyl)-cyclohexyl]-acetic acid, AldrichCPR;""3-(tert-butoxycarbonyl)-2-cyclohexylpropanoic acid;[1-(N-BOC-AMINOMETHYL)-CYCLOHEXYL]-ACETIC ACID"";2-[1-[(tert-butoxycarbonylamino)methyl]cyclohexyl]acetic acid"		24581600.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24581600		pluskal_iocb_peptide_Peptide01_E8_id		100	E8		ZINC000002512920
2.5		0	118	P7211800051	121.9		U14	False	0	19	0	0	21	0	1	5	0	1		0.0						CC(=O)NC(CSC(CC(=O)c1ccc(C)cc1)c1ccco1)C(=O)O																							0.0		STL487181		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C19H21NO5S	C19H21NO5S			InChI=1S/C19H21NO5S/c1-12-5-7-14(8-6-12)16(22)10-18(17-4-3-9-25-17)26-11-15(19(23)24)20-13(2)21/h3-9,15,18H,10-11H2,1-2H3,(H,20,21)(H,23,24)	YOGOGWMOYMTWKT-UHFFFAOYSA-N	2-acetamido-3-[1-(2-furyl)-3-oxo-3-(p-tolyl)propyl]sulfanyl-propanoic acid	3858772	CC(=O)NC(CSC(CC(=O)c1ccc(C)cc1)c1ccco1)C(=O)O	2-acetamido-3-[1-(furan-2-yl)-3-(4-methylphenyl)-3-oxopropyl]sulfanylpropanoic acid			3.060490000000001													MCULE-4091096259	375.44692		375.114044	5	2	9	2			45										False					Peptide01			Compound(3858772)	3858772	2.1	825			[#6]-[#6](=[#8])-[#7]-[#6](-[#6]-[#16]-[#6](-[#6]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:1)-[#6]1:[#6]:[#6]:[#6]:[#8]:1)-[#6](=[#8])-[#8]	CC(=O)NC(CSC(CC(=O)c1ccc(C)cc1)c1ccco1)C(=O)O	YOGOGWMOYMTWKT		parent_pubchem_cid	STL487181;AKOS000808747;AKOS016374413;SR-01000115952;SR-01000115952-1;N-acetyl-S-[1-(furan-2-yl)-3-(4-methylphenyl)-3-oxopropyl]cysteine;2-acetamido-3-[1-(2-furyl)-3-oxo-3-(p-tolyl)propyl]sulfanyl-propanoic acid		24622810.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24622810		pluskal_iocb_peptide_Peptide01_E8_id		100	E8		
1.8		0	206	P7020531683	115.5		U15	False	0	18	0	0	19	0	1	6	0	2		0.0						O=S1(=O)CC(NCc2cc3c(cc2)OCO3)C(S(=O)(=O)c2ccccc2)C1																							0.0		HMS3463J06		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0		C18H19NO6S2	C18H19NO6S2			InChI=1S/C18H19NO6S2/c20-26(21)10-15(18(11-26)27(22,23)14-4-2-1-3-5-14)19-9-13-6-7-16-17(8-13)25-12-24-16/h1-8,15,18-19H,9-12H2/t15-,18-/m0/s1	KVYJONOKKHYVOV-YJBOKZPZSA-N	rac-(3S,4R)-4-(benzenesulfonyl)-N-(1,3-benzodioxol-5-ylmethyl)-1,1-dioxo-thiolan-3-amine	20897752	O=S1(=O)C[C@H](NCc2cc3c(cc2)OCO3)[C@@H](S(=O)(=O)c2ccccc2)C1	(3S,4R)-4-(benzenesulfonyl)-N-(1,3-benzodioxol-5-ylmethyl)-1,1-dioxothiolan-3-amine			0.0568600000000014													MCULE-2474165509	409.48323		409.065379	7	1	5	4			44										False	Shikimates and Phenylpropanoids				Peptide01			Compound(20897752)	20897752	1.9	826			[#8]=[#16]1(=[#8])-[#6]-[#6@H](-[#7]-[#6]-[#6]2:[#6]:[#6]3:[#6](:[#6]:[#6]:2)-[#8]-[#6]-[#8]-3)-[#6@@H](-[#16](=[#8])(=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]-1	O=S1(=O)C[C@H](NCc2cc3c(cc2)OCO3)[C@@H](S(=O)(=O)c2ccccc2)C1	KVYJONOKKHYVOV		parent_pubchem_cid	HMS3463J06;MFCD10567724;AKOS001564648;CCG-156697;(3R4S)-3-(BENZENESULFONYL)-4-{[(2H-13-BENZODIOXOL-5-YL)METHYL]AMINO}-1LAMBDA6-THIOLANE-11-DIONE;rac-(3S,4R)-4-(benzenesulfonyl)-N-(1,3-benzodioxol-5-ylmethyl)-1,1-dioxo-thiolan-3-amine		17060592.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=17060592		pluskal_iocb_peptide_Peptide01_E8_id		100	E8		ZINC000013371268
3.2		0	294	P6543458	96.4		U16	False	0	18	0	0	16	0	4	3	0	0		0.0						COc1ccc(Nc2nccc(Nc3cccc(C(=O)O)c3)n2)cc1																							0.0		MFCD29050629		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0		C18H16N4O3	C18H16N4O3			InChI=1S/C18H16N4O3/c1-25-15-7-5-13(6-8-15)21-18-19-10-9-16(22-18)20-14-4-2-3-12(11-14)17(23)24/h2-11H,1H3,(H,23,24)(H2,19,20,21,22)	LYULDTTVWMMWBJ-UHFFFAOYSA-N	3-[[2-(4-methoxyanilino)pyrimidin-4-yl]amino]benzoic acid	84506685	COc1ccc(Nc2nccc(Nc3cccc(C(=O)O)c3)n2)cc1	3-[[2-(4-methoxyanilino)pyrimidin-4-yl]amino]benzoic acid			1.6310399999999998													MCULE-2203701682	336.35322		336.12224	7	3	6	3			44									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(84506685)	84506685	3.5	827			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#7]-[#6]2:[#7]:[#6]:[#6]:[#6](-[#7]-[#6]3:[#6]:[#6]:[#6]:[#6](-[#6](=[#8])-[#8]):[#6]:3):[#7]:2):[#6]:[#6]:1	COc1ccc(Nc2nccc(Nc3cccc(C(=O)O)c3)n2)cc1	LYULDTTVWMMWBJ		parent_pubchem_cid	MFCD29050629;AKOS016761271;3-[[2-(4-methoxyanilino)pyrimidin-4-yl]amino]benzoic acid		89938713.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=89938713		pluskal_iocb_peptide_Peptide01_E8_id		100	E8		ZINC000096693898
1.8		0	38	P7020530653	142.4		U17	False	0	20	0	0	21	0	3	6	0	2		0.0						COc1c(S(=O)(=O)NCCc2c[nH]c3ccccc23)cc(N2C(=O)CCS2(=O)=O)cc1								3-alkylindoles;Benzenesulfonamides;Benzenesulfonyl compounds;Methoxyanilines;Phenoxy compounds;Anisoles;Methoxybenzenes;Alkyl aryl ethers;Gamma sultams;Substituted pyrroles;Organosulfonamides;Aminosulfonyl compounds;Heteroaromatic compounds;Carboxylic acids and derivatives;Azacyclic compounds;Carbonyl compounds;Organic oxides;Organonitrogen compounds;Hydrocarbon derivatives	3-alkylindoles;Alkyl aryl ethers;Aminosulfonyl compounds;Aniline and substituted anilines;Anisoles;Azacyclic compounds;Azolidines;Benzene and substituted derivatives;Benzenesulfonamides;Benzenesulfonyl compounds;Benzenoids;Carbonyl compounds;Carboxylic acids and derivatives;Chemical entities;Ethers;Gamma sultams;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Methoxyanilines;Methoxybenzenes;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organic sulfonic acids and derivatives;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organosulfonamides;Organosulfonic acids and derivatives;Organosulfur compounds;Phenol ethers;Phenoxy compounds;Pyrroles;Substituted pyrroles;Sulfanilides;Sulfonyls;Thiazolidinediones;Thiazolidines;Thiazolidinones	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as sulfanilides. These are organic aromatic compounds containing a sulfanilide moiety, with the general structure RS(=O)(=O)NC1=CC=CC=C1.	Sulfanilides			Organic compounds	Aromatic heteropolycyclic compounds	indoles (CHEBI:24828);sulfonamide (CHEBI:35358);benzenes (CHEBI:22712);organosulfur compound (CHEBI:33261);substituted aniline (CHEBI:48975);methoxybenzene (CHEBI:51683);aromatic ether (CHEBI:35618);sultam (CHEBI:46950);pyrroles (CHEBI:26455);organonitrogen compound (CHEBI:35352);organic aromatic compound (CHEBI:33659);carboxylic acid (CHEBI:33575);organonitrogen heterocyclic compound (CHEBI:38101);carbonyl compound (CHEBI:36586);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);anilines (CHEBI:22562);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);organooxygen compound (CHEBI:36963);ether (CHEBI:25698);thiazolidines (CHEBI:35622);thiazolidinone (CHEBI:48891);thiazolidenediones (CHEBI:50990);organic acid (CHEBI:64709);sulfonic acid derivative (CHEBI:33552);sulfone (CHEBI:35850);nitrogen molecular entity (CHEBI:51143)		Sulfanilides	Benzenesulfonamide;Sulfanilide;3-alkylindole;Indole;Indole or derivatives;Benzenesulfonyl group;Methoxyaniline;Anisole;Phenoxy compound;Phenol ether;Methoxybenzene;Thiazolidinedione;Gamma-sultam;Alkyl aryl ether;Organosulfonic acid amide;Substituted pyrrole;Heteroaromatic compound;Aminosulfonyl compound;Thiazolidine;Sulfonyl;Organosulfonic acid or derivatives;Organic sulfonic acid or derivatives;Pyrrole;Azacycle;Organoheterocyclic compound;Carboxylic acid derivative;Ether;Organic oxide;Organic nitrogen compound;Hydrocarbon derivative;Carbonyl group;Organic oxygen compound;Organonitrogen compound;Organooxygen compound;Organosulfur compound;Aromatic heteropolycyclic compound	Benzenoids	0.0		HMS3463E04		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	0		C20H21N3O6S2	C20H21N3O6S2			InChI=1S/C20H21N3O6S2/c1-29-18-7-6-15(23-20(24)9-11-30(23,25)26)12-19(18)31(27,28)22-10-8-14-13-21-17-5-3-2-4-16(14)17/h2-7,12-13,21-22H,8-11H2,1H3	PWCXRQDWBLTWBF-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)ethyl]-2-methoxy-5-(1,1,3-trioxo-1,2-thiazolidin-2-yl)benzenesulfonamide	20996069	COc1c(S(=O)(=O)NCCc2c[nH]c3ccccc23)cc(N2C(=O)CCS2(=O)=O)cc1	N-[2-(1H-indol-3-yl)ethyl]-2-methoxy-5-(1,1,3-trioxo-1,2-thiazolidin-2-yl)benzenesulfonamide			0.3298400000000008													MCULE-6616457373	463.53487		463.087177	6	2	7	4			44									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(20996069)	20996069	1.6	828			[#6]-[#8]-[#6]1:[#6](-[#16](=[#8])(=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6](-[#7]2-[#6](=[#8])-[#6]-[#6]-[#16]-2(=[#8])=[#8]):[#6]:[#6]:1	COc1c(S(=O)(=O)NCCc2c[nH]c3ccccc23)cc(N2C(=O)CCS2(=O)=O)cc1	PWCXRQDWBLTWBF		parent_pubchem_cid	HMS3463E04;AKOS004926867;5-(1,1-DIOXIDO-3-OXO-2-ISOTHIAZOLIDINYL)-N-[2-(1H-INDOL-3-YL)ETHYL]-2-METHOXYBENZENESULFONAMIDE;N-[2-(1H-indol-3-yl)ethyl]-2-methoxy-5-(1,1,3-trioxo-1,2-thiazolidin-2-yl)benzenesulfonamide		17440109.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=17440109		pluskal_iocb_peptide_Peptide01_E8_id		100	E8		ZINC000011906123
4.9		0	126	P0110490026	58.6		U18	False	0	25	0	0	21	0	1	3	0	0		0.0						COc1ccccc1C(=O)NC(c1ccccc1)c1c(O)ccc2ccccc12																							0.0		N-[(2-hydroxynaphthyl)phenylmethyl](2-methoxyphenyl)carboxamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C25H21NO3	C25H21NO3			InChI=1S/C25H21NO3/c1-29-22-14-8-7-13-20(22)25(28)26-24(18-10-3-2-4-11-18)23-19-12-6-5-9-17(19)15-16-21(23)27/h2-16,24,27H,1H3,(H,26,28)	QEGFNJKRANLPDR-UHFFFAOYSA-N	N-[(2-hydroxy-1-naphthyl)-phenyl-methyl]-2-methoxy-benzamide	2787112	COc1ccccc1C(=O)NC(c1ccccc1)c1c(O)ccc2ccccc12	N-[(2-hydroxynaphthalen-1-yl)-phenylmethyl]-2-methoxybenzamide			3.5560300000000025													MCULE-2765748219	383.45102		383.152144	3	2	5	4			45										False					Peptide01			Compound(2787112)	2787112	5.8	829			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#6](=[#8])-[#7]-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6](-[#8]):[#6]:[#6]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	COc1ccccc1C(=O)NC(c1ccccc1)c1c(O)ccc2ccccc12	QEGFNJKRANLPDR		parent_pubchem_cid	N-[(2-hydroxynaphthyl)phenylmethyl](2-methoxyphenyl)carboxamide;303794-91-4;N-((2-hydroxynaphthalen-1-yl)(phenyl)methyl)-2-methoxybenzamide;N-[(2-hydroxynaphthalen-1-yl)(phenyl)methyl]-2-methoxybenzamide;Oprea1_872623;MFCD00707924;STL331860;AKOS002260879;AKOS016311567;SR-01000404390;SR-01000404390-1;F3284-0633;N-[(2-hydroxy-1-naphthyl)-phenyl-methyl]-2-methoxy-benzamide		24188919.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24188919		pluskal_iocb_peptide_Peptide01_E8_id		100	E8		
2.4		0	214	P7020554872	123.4		U19	False	0	20	0	0	23	0	1	6	0	2		0.0						CC(C)Oc1ccccc1NC(=O)c1ccc(S(=O)(=O)C2CCS(=O)(=O)C2)cc1																							0.0		STK655787		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	2	0	0	0	0	0	0	0		C20H23NO6S2	C20H23NO6S2			InChI=1S/C20H23NO6S2/c1-14(2)27-19-6-4-3-5-18(19)21-20(22)15-7-9-16(10-8-15)29(25,26)17-11-12-28(23,24)13-17/h3-10,14,17H,11-13H2,1-2H3,(H,21,22)	CJDZNSGUVUZSMR-UHFFFAOYSA-N	4-(1,1-dioxothiolan-3-yl)sulfonyl-N-(2-isopropoxyphenyl)benzamide	24315383	CC(C)Oc1ccccc1NC(=O)c1ccc(S(=O)(=O)C2CCS(=O)(=O)C2)cc1	4-(1,1-dioxothiolan-3-yl)sulfonyl-N-(2-propan-2-yloxyphenyl)benzamide			1.6811599999999998													MCULE-1424782707	437.53741		437.096679	6	1	6	3			45										False					Peptide01			Compound(24315383)	24315383	2.3	830			[#6]-[#6](-[#6])-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#16](=[#8])(=[#8])-[#6]2-[#6]-[#6]-[#16](=[#8])(=[#8])-[#6]-2):[#6]:[#6]:1	CC(C)Oc1ccccc1NC(=O)c1ccc(S(=O)(=O)C2CCS(=O)(=O)C2)cc1	CJDZNSGUVUZSMR		parent_pubchem_cid	STK655787;AKOS005586328;4-[(1,1-dioxidotetrahydrothiophen-3-yl)sulfonyl]-N-[2-(propan-2-yloxy)phenyl]benzamide;4-(1,1-dioxothiolan-3-yl)sulfonyl-N-(2-isopropoxyphenyl)benzamide		23613825.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23613825		pluskal_iocb_peptide_Peptide01_E8_id		100	E8		
1.5		0	302	P4802985	84.9		U20	False	0	18	1	0	23	0	6	3	0	0		0.0						COc1c(Nc2nc(N3CCOCC3)nc(N3CCOCC3)n2)cc(Cl)cc1																							0.0		Cambridge id 7278467		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	2		C18H23ClN6O3	C18H23ClN6O3			InChI=1S/C18H23ClN6O3/c1-26-15-3-2-13(19)12-14(15)20-16-21-17(24-4-8-27-9-5-24)23-18(22-16)25-6-10-28-11-7-25/h2-3,12H,4-11H2,1H3,(H,20,21,22,23)	IZNBBPMTGBAWDW-UHFFFAOYSA-N	N-(5-chloro-2-methoxy-phenyl)-4,6-dimorpholino-1,3,5-triazin-2-amine	1292910	COc1c(Nc2nc(N3CCOCC3)nc(N3CCOCC3)n2)cc(Cl)cc1	N-(5-chloro-2-methoxyphenyl)-4,6-dimorpholin-4-yl-1,3,5-triazin-2-amine			-0.0344499999999978													MCULE-3328308288	406.87541		406.152016	9	1	5	4			44										False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(1292910)	1292910	2.6	831			[#6]-[#8]-[#6]1:[#6](-[#7]-[#6]2:[#7]:[#6](-[#7]3-[#6]-[#6]-[#8]-[#6]-[#6]-3):[#7]:[#6](-[#7]3-[#6]-[#6]-[#8]-[#6]-[#6]-3):[#7]:2):[#6]:[#6](-[#17]):[#6]:[#6]:1	COc1c(Nc2nc(N3CCOCC3)nc(N3CCOCC3)n2)cc(Cl)cc1	IZNBBPMTGBAWDW		parent_pubchem_cid	Cambridge id 7278467;STL301248;AKOS022118153;SR-01000257269;SR-01000257269-1;N-(5-chloro-2-methoxyphenyl)-4,6-di(morpholin-4-yl)-1,3,5-triazin-2-amine;N-(5-chloro-2-methoxy-phenyl)-4,6-dimorpholino-1,3,5-triazin-2-amine		12591280.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=12591280		pluskal_iocb_peptide_Peptide01_E8_id		100	E8		ZINC000001115051
2.2		0	46	P1029336	134.4		U21	False	0	16	0	0	20	0	8	1	0	1	-1.0	0.0						CCNc1nc2nnc(SCC(=O)Nc3ccccc3)n2c(NCC)n1		2.11		0.0	1.1	CHEMBL1889341																	0.0		MLS000679022		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	3	0	0	1	0	0	0	0	0	0	0	0	0	1	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	0	0	0	0	0	0	1		C16H20N8OS	C16H20N8OS			InChI=1S/C16H20N8OS/c1-3-17-13-20-14(18-4-2)24-15(21-13)22-23-16(24)26-10-12(25)19-11-8-6-5-7-9-11/h5-9H,3-4,10H2,1-2H3,(H,19,25)(H2,17,18,20,21,22)	LIGWQMUAAZGCGR-UHFFFAOYSA-N	2-[[5,7-bis(ethylamino)-[1,2,4]triazolo[4,3-a][1,3,5]triazin-3-yl]sulfanyl]-N-phenyl-acetamide	4531633	CCNc1nc2nnc(SCC(=O)Nc3ccccc3)n2c(NCC)n1	2-[[5,7-bis(ethylamino)-[1,2,4]triazolo[4,3-a][1,3,5]triazin-3-yl]sulfanyl]-N-phenylacetamide			0.6496499999999992													MCULE-9196453006	372.4548	NEUTRAL	372.148078	8	3	8	3	0.0		29										False	Alkaloids		False	False	Peptide01		-1.0	Compound(4531633)	4531633	3.4	832			[#6]-[#6]-[#7]-[#6]1:[#7]:[#6]2:[#7]:[#7]:[#6](-[#16]-[#6]-[#6](=[#8])-[#7]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#7]:2:[#6](-[#7]-[#6]-[#6]):[#7]:1	CCNc1nc2nnc(SCC(=O)Nc3ccccc3)n2c(NCC)n1	LIGWQMUAAZGCGR		parent_pubchem_cid	MLS000679022;CHEMBL1889341;HMS2739I16;AKOS016380172;SMR000323415;SR-01000444070;SR-01000444070-1;2-[[5,7-bis(ethylamino)-[1,2,4]triazolo[4,3-a][1,3,5]triazin-3-yl]sulfanyl]-N-phenyl-acetamide	False	1132234.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=1132234		pluskal_iocb_peptide_Peptide01_E9_id		100	E9	False	ZINC000000624200
3.0		0	134	P7566289	82.7		U22	False	0	23	0	1	22	0	5	1	0	0		0.0						O=C(CCNc1ncccn1)NCC(c1ccc(F)cc1)c1c[nH]c2ccccc12																							0.0		1401568-10-2		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	0	0	0	0	0	0	0		C23H22FN5O	C23H22FN5O			InChI=1S/C23H22FN5O/c24-17-8-6-16(7-9-17)19(20-15-28-21-5-2-1-4-18(20)21)14-29-22(30)10-13-27-23-25-11-3-12-26-23/h1-9,11-12,15,19,28H,10,13-14H2,(H,29,30)(H,25,26,27)	RRDRUFXLWPDXSN-UHFFFAOYSA-N	N-[2-(4-fluorophenyl)-2-(1H-indol-3-yl)ethyl]-3-(pyrimidin-2-ylamino)propanamide	71707775	O=C(CCNc1ncccn1)NCC(c1ccc(F)cc1)c1c[nH]c2ccccc12	N-[2-(4-fluorophenyl)-2-(1H-indol-3-yl)ethyl]-3-(pyrimidin-2-ylamino)propanamide			2.9288500000000006													MCULE-3489968873	403.46309		403.180839	4	3	8	4			45										False	Alkaloids				Peptide01			Compound(71707775)	71707775	4.0	833			[#8]=[#6](-[#6]-[#6]-[#7]-[#6]1:[#7]:[#6]:[#6]:[#6]:[#7]:1)-[#7]-[#6]-[#6](-[#6]1:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	O=C(CCNc1ncccn1)NCC(c1ccc(F)cc1)c1c[nH]c2ccccc12	RRDRUFXLWPDXSN		parent_pubchem_cid	1401568-10-2;N-[2-(4-fluorophenyl)-2-(1H-indol-3-yl)ethyl]-3-(2-pyrimidinylamino)propanamide;EiM08-30655;AKOS022135113;N-[2-(4-FLUOROPHENYL)-2-(1H-INDOL-3-YL)ETHYL]-3-[(PYRIMIDIN-2-YL)AMINO]PROPANAMIDE;N-[2-(4-fluorophenyl)-2-(1H-indol-3-yl)ethyl]-3-(pyrimidin-2-ylamino)propanamide		63225401.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=63225401		pluskal_iocb_peptide_Peptide01_E9_id		100	E9		
4.2		0	222	P1098492	117.7		U23	False	0	26	0	0	24	0	2	6	0	0		0.0						Cc1c2oc(=O)c3c(CCC3)c2ccc1OCC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)O																							0.0		EiM07-17170		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C26H24N2O6	C26H24N2O6			InChI=1S/C26H24N2O6/c1-14-22(10-9-18-17-6-4-7-19(17)26(32)34-24(14)18)33-13-23(29)28-21(25(30)31)11-15-12-27-20-8-3-2-5-16(15)20/h2-3,5,8-10,12,21,27H,4,6-7,11,13H2,1H3,(H,28,29)(H,30,31)/t21-/m0/s1	MYRTWMRQFUVQHY-NRFANRHFSA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[[2-[(6-methyl-4-oxo-2,3-dihydro-1H-cyclopenta[c]chromen-7-yl)oxy]acetyl]amino]propanoic acid	1748544	Cc1c2oc(=O)c3c(CCC3)c2ccc1OCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	(2S)-3-(1H-indol-3-yl)-2-[[2-[(6-methyl-4-oxo-2,3-dihydro-1H-cyclopenta[c]chromen-7-yl)oxy]acetyl]amino]propanoic acid			2.6241200000000005													MCULE-3993462744	460.49098		460.163436	6	3	7	5			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(1748544)	1748544	3.7	834			[#6]-[#6]1:[#6]2:[#8]:[#6](=[#8]):[#6]3:[#6](-[#6]-[#6]-[#6]-3):[#6]:2:[#6]:[#6]:[#6]:1-[#8]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	Cc1c2oc(=O)c3c(CCC3)c2ccc1OCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	MYRTWMRQFUVQHY		parent_pubchem_cid	EiM07-17170;AKOS016390332;3-(1H-INDOL-3-YL)-2-[2-({6-METHYL-4-OXO-1H,2H,3H,4H-CYCLOPENTA[C]CHROMEN-7-YL}OXY)ACETAMIDO]PROPANOIC ACID;rac-(2S)-3-(1H-indol-3-yl)-2-[[2-[(6-methyl-4-oxo-2,3-dihydro-1H-cyclopenta[c]chromen-7-yl)oxy]acetyl]amino]propanoic acid		24098194.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24098194		pluskal_iocb_peptide_Peptide01_E9_id		100	E9		ZINC000002091508
2.8		0	310	P7126247	87.1		U24	False	0	17	0	1	13	0	4	2	0	0	-1.0	0.0						O=C(O)c1ccccc1Nc1nc(Nc2ccccc2)ncc1F		3.8		0.0	5.16	CHEMBL244793																	0.0		Kinome_1261		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0		C17H13FN4O2	C17H13FN4O2			InChI=1S/C17H13FN4O2/c18-13-10-19-17(20-11-6-2-1-3-7-11)22-15(13)21-14-9-5-4-8-12(14)16(23)24/h1-10H,(H,23,24)(H2,19,20,21,22)	HBJUFAHIACMPFY-UHFFFAOYSA-N	2-[(2-anilino-5-fluoro-pyrimidin-4-yl)amino]benzoic acid	23647269	O=C(O)c1ccccc1Nc1nc(Nc2ccccc2)ncc1F	2-[(2-anilino-5-fluoropyrimidin-4-yl)amino]benzoic acid			2.2239499999999994														324.31716	ACID	324.102254	6	3	5	3	0.0		30									Anthranillic acid derivatives	False	Alkaloids	Anthranilic acid alkaloids	False	False	Peptide01		-1.0	Compound(23647269)	23647269	4.1	835			[#8]=[#6](-[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#7]-[#6]1:[#7]:[#6](-[#7]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#7]:[#6]:[#6]:1-[#9]	O=C(O)c1ccccc1Nc1nc(Nc2ccccc2)ncc1F	HBJUFAHIACMPFY		parent_pubchem_cid	Kinome_1261;Bisanilinopyrimidine, 3m;4-anilinopyrimidine 14a;CHEMBL244793;BDBM16011;AKOS025142293;2-{[5-fluoro-2-(phenylamino)pyrimidin-4-yl]amino}benzoic acid;2-[(2-anilino-5-fluoro-pyrimidin-4-yl)amino]benzoic acid	False	309655.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=309655		pluskal_iocb_peptide_Peptide01_E9_id		100	E9	False	ZINC000014960343
2.5		0	54	P7114490075	86.6		U25	False	0	16	0	0	17	0	1	4	0	0		0.0						CC(C)C(NC(=O)c1cc2ccccc2cc1O)C(=O)O																							0.0		IFLab2_000104		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C16H17NO4	C16H17NO4			InChI=1S/C16H17NO4/c1-9(2)14(16(20)21)17-15(19)12-7-10-5-3-4-6-11(10)8-13(12)18/h3-9,14,18H,1-2H3,(H,17,19)(H,20,21)	PAQNBUMFNNCFQV-UHFFFAOYSA-N	2-[(3-hydroxynaphthalene-2-carbonyl)amino]-3-methyl-butanoic acid	3982562	CC(C)C(NC(=O)c1cc2ccccc2cc1O)C(=O)O	2-[(3-hydroxynaphthalene-2-carbonyl)amino]-3-methylbutanoic acid			1.4388599999999998													MCULE-7847336050	287.31819		287.115758	4	3	4	2			45										False					Peptide01			Compound(3982562)	3982562	3.6	836			[#6]-[#6](-[#6])-[#6](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:[#6]:1-[#8])-[#6](=[#8])-[#8]	CC(C)C(NC(=O)c1cc2ccccc2cc1O)C(=O)O	PAQNBUMFNNCFQV		parent_pubchem_cid	IFLab2_000104;Oprea1_241726;(3-hydroxy-2-naphthoyl)valine;IFLab1_006058;HMS1429D08;AKOS002286179;AKOS016054809;IDI1_019130;SR-01000013298;SR-01000013298-1;F1574-0033;2-[(3-hydroxynaphthalene-2-carbonyl)amino]-3-methyl-butanoic acid		23971138.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23971138		pluskal_iocb_peptide_Peptide01_E9_id		100	E9		
4.6		0	142	P7014791102	76.7		U26	False	0	26	0	0	28	0	2	4	0	0		0.0						CCOc1cc(NC(=O)c2ccccc2)c(OCC)cc1NC(=O)CCc1ccccc1																							0.0		Oprea1_573715		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C26H28N2O4	C26H28N2O4			InChI=1S/C26H28N2O4/c1-3-31-23-18-22(28-26(30)20-13-9-6-10-14-20)24(32-4-2)17-21(23)27-25(29)16-15-19-11-7-5-8-12-19/h5-14,17-18H,3-4,15-16H2,1-2H3,(H,27,29)(H,28,30)	BFYQKYUCINVHJM-UHFFFAOYSA-N	N-[2,5-diethoxy-4-(3-phenylpropanoylamino)phenyl]benzamide	1080028	CCOc1cc(NC(=O)c2ccccc2)c(OCC)cc1NC(=O)CCc1ccccc1	N-[2,5-diethoxy-4-(3-phenylpropanoylamino)phenyl]benzamide			3.5121400000000023													MCULE-7828606785	432.52406		432.204907	4	2	10	3			44									Simple amide alkaloids	False	Alkaloids	Peptide alkaloids			Peptide01			Compound(1080028)	1080028	4.5	837			[#6]-[#6]-[#8]-[#6]1:[#6]:[#6](-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6](-[#8]-[#6]-[#6]):[#6]:[#6]:1-[#7]-[#6](=[#8])-[#6]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	CCOc1cc(NC(=O)c2ccccc2)c(OCC)cc1NC(=O)CCc1ccccc1	BFYQKYUCINVHJM		parent_pubchem_cid	Oprea1_573715;AKOS000669883;N-[2,5-diethoxy-4-(3-phenylpropanoylamino)phenyl]benzamide		2933608.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=2933608		pluskal_iocb_peptide_Peptide01_E9_id		100	E9		ZINC000000794456
4.6		0	230	P1182670	105.2		U27	False	0	26	0	0	28	0	4	3	0	1		0.0						Cc1c(C)cc(-c2cc(C(=O)NCCc3c[nH]c4ccccc34)nn2C2CCS(=O)(=O)C2)cc1																							0.0		AKOS004933128		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	1	0	0	0	0	0	0	1		C26H28N4O3S	C26H28N4O3S			InChI=1S/C26H28N4O3S/c1-17-7-8-19(13-18(17)2)25-14-24(29-30(25)21-10-12-34(32,33)16-21)26(31)27-11-9-20-15-28-23-6-4-3-5-22(20)23/h3-8,13-15,21,28H,9-12,16H2,1-2H3,(H,27,31)	YJEZZDPAHQKFGY-UHFFFAOYSA-N	5-(3,4-dimethylphenyl)-1-(1,1-dioxothiolan-3-yl)-N-[2-(1H-indol-3-yl)ethyl]pyrazole-3-carboxamide	50753531	Cc1c(C)cc(-c2cc(C(=O)NCCc3c[nH]c4ccccc34)nn2C2CCS(=O)(=O)C2)cc1	5-(3,4-dimethylphenyl)-1-(1,1-dioxothiolan-3-yl)-N-[2-(1H-indol-3-yl)ethyl]pyrazole-3-carboxamide			2.9530600000000016													MCULE-8570419316	476.60206		476.188212	4	2	6	5			45										False					Peptide01			Compound(50753531)	50753531	3.8	838			[#6]-[#6]1:[#6](-[#6]):[#6]:[#6](-[#6]2:[#6]:[#6](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]3:[#6]:[#7H]:[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]:3:4):[#7]:[#7]:2-[#6]2-[#6]-[#6]-[#16](=[#8])(=[#8])-[#6]-2):[#6]:[#6]:1	Cc1c(C)cc(-c2cc(C(=O)NCCc3c[nH]c4ccccc34)nn2C2CCS(=O)(=O)C2)cc1	YJEZZDPAHQKFGY		parent_pubchem_cid	AKOS004933128;5-(3,4-DIMETHYLPHENYL)-1-(1,1-DIOXIDOTETRAHYDRO-3-THIOPHENYL)-N-[2-(1H-INDOL-3-YL)ETHYL]-1H-PYRAZOLE-3-CARBOXAMIDE;5-(3,4-dimethylphenyl)-1-(1,1-dioxothiolan-3-yl)-N-[2-(1H-indol-3-yl)ethyl]pyrazole-3-carboxamide		24313936.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24313936		pluskal_iocb_peptide_Peptide01_E9_id		100	E9		
2.8		0	318	P1108713	107.6		U28	False	0	17	0	1	15	0	2	4	0	1		0.0						O=C(O)C(Cc1c[nH]c2ccccc12)NS(=O)(=O)c1ccc(F)cc1																							0.0		L-Tryptophan, N-((4-fluorophenyl)sulfonyl)-	DTXSID80235318	2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0		C17H15FN2O4S	C17H15FN2O4S			InChI=1S/C17H15FN2O4S/c18-12-5-7-13(8-6-12)25(23,24)20-16(17(21)22)9-11-10-19-15-4-2-1-3-14(11)15/h1-8,10,16,19-20H,9H2,(H,21,22)/t16-/m0/s1	LEMVXFLDSISVNM-INIZCTEOSA-N	rac-(2S)-2-[(4-fluorophenyl)sulfonylamino]-3-(1H-indol-3-yl)propanoic acid	1091373	O=C(O)[C@H](Cc1c[nH]c2ccccc12)NS(=O)(=O)c1ccc(F)cc1	(2S)-2-[(4-fluorophenyl)sulfonylamino]-3-(1H-indol-3-yl)propanoic acid			1.6900600000000003													MCULE-2983160602	362.3825		362.073656	4	3	6	3			42										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(1091373)	1091373	2.0	839		SCHEMBL7468980	[#8]=[#6](-[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#16](=[#8])(=[#8])-[#6]1:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:1	O=C(O)[C@H](Cc1c[nH]c2ccccc12)NS(=O)(=O)c1ccc(F)cc1	LEMVXFLDSISVNM		parent_pubchem_cid	L-Tryptophan, N-((4-fluorophenyl)sulfonyl)-;N-((4-Fluorophenyl)sulfonyl)-L-tryptophan;B-539;85979-02-8;Oprea1_804818;SCHEMBL7468980;DTXSID80235318;LEMVXFLDSISVNM-INIZCTEOSA-N;AKOS016402494;(S)-2-(4-Fluoro-benzenesulfonylamino)-3-(1H-Indol-3-yl)-propionic acid;(2S)-2-{[(4-FLUOROPHENYL)SULFONYL]AMINO}-3-(1H-INDOL-3-YL)PROPANOIC ACID;rac-(2S)-2-[(4-fluorophenyl)sulfonylamino]-3-(1H-indol-3-yl)propanoic acid		24844163.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24844163		pluskal_iocb_peptide_Peptide01_E9_id		100	E9		ZINC000000811636
1.9		0	62	P7114011384	100.9		U29	False	0	13	0	0	17	0	1	4	0	1	-1.0	0.0						CSCCC(NC(=O)OCc1ccccc1)C(=O)O		2.12		0.0	2.24	CHEMBL1713556		Benzyloxycarbonyls;Thia fatty acids;Carbamate esters;Organic carbonic acids and derivatives;Sulfenyl compounds;Monocarboxylic acids and derivatives;Dialkylthioethers;Carboxylic acids;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Benzene and substituted derivatives;Benzenoids;Benzyloxycarbonyls;Carbamate esters;Carbamic acids and derivatives;Carbonyl compounds;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Dialkylthioethers;Fatty Acyls;Fatty acids and conjugates;Hydrocarbon derivatives;Lipids and lipid-like molecules;Methionine and derivatives;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Organosulfur compounds;Sulfenyl compounds;Thia fatty acids;Thioethers	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as methionine and derivatives. These are compounds containing methionine or a derivative thereof resulting from reaction of methionine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Methionine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic homomonocyclic compounds	carboxylic ester (CHEBI:33308);thia fatty acid (CHEBI:59643);carbamate ester (CHEBI:23003);organooxygen compound (CHEBI:36963);organosulfur compound (CHEBI:33261);carbonyl compound (CHEBI:36586);aliphatic sulfide (CHEBI:22327);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);alpha-amino acid (CHEBI:33704);methionine derivative (CHEBI:25230);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);lipid (CHEBI:18059);monocarboxylic acid (CHEBI:25384);amino acid (CHEBI:33709);peptide (CHEBI:16670);carbon oxoacid (CHEBI:35605);organic sulfide (CHEBI:16385);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806)	Thia fatty acids (FA0113);Fatty Acyls (FA);Fatty Acids and Conjugates (FA01)	Amino acids, peptides, and analogues	Methionine or derivatives;Benzyloxycarbonyl;Thia fatty acid;Monocyclic benzene moiety;Fatty acyl;Benzenoid;Carbamic acid ester;Carbonic acid derivative;Carboxylic acid;Monocarboxylic acid or derivatives;Thioether;Sulfenyl compound;Dialkylthioether;Organosulfur compound;Organooxygen compound;Organonitrogen compound;Organopnictogen compound;Organic nitrogen compound;Organic oxide;Organic oxygen compound;Hydrocarbon derivative;Carbonyl group;Aromatic homomonocyclic compound	Organic acids and derivatives	0.0		1152-62-1		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	1	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C13H17NO4S	C13H17NO4S			InChI=1S/C13H17NO4S/c1-19-8-7-11(12(15)16)14-13(17)18-9-10-5-3-2-4-6-10/h2-6,11H,7-9H2,1H3,(H,14,17)(H,15,16)/t11-/m0/s1	FPKHNNQXKZMOJJ-NSHDSACASA-N	rac-(2S)-2-(benzyloxycarbonylamino)-4-methylsulfanyl-butanoic acid	1550857	CSCC[C@H](NC(=O)OCc1ccccc1)C(=O)O	(2S)-4-methylsulfanyl-2-(phenylmethoxycarbonylamino)butanoic acid			2.06439													MCULE-7489099679	283.34874	ACID	283.087829	5	2	8	1	0.0		28									Dipeptides	False	Amino acids and Peptides	Small peptides	False	False	Peptide01		-1.0	Compound(1550857)	1550857	2.1	840		SCHEMBL1157282	[#6]-[#16]-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	CSCC[C@H](NC(=O)OCc1ccccc1)C(=O)O	FPKHNNQXKZMOJJ		parent_pubchem_cid	"1152-62-1;Z-Met-OH;N-CBZ-L-METHIONINE;Z-L-Methionine;Cbz-L-Methionine;CBZ-MET-OH;(2S)-4-methylsulfanyl-2-(phenylmethoxycarbonylamino)butanoic acid;L-Methionine, N-[(phenylmethoxy)carbonyl]-;MFCD00065124;N-[(benzyloxy)carbonyl]-L-methionine;N-Carbobenzoxy-L-methionine;N-Carbobenzyloxy-L-methionine;N-Cbz methionine;BENZYLOXYCARBONYL-L-METHIONINE;(S)-Cbz methionine;N-[(Benzyloxy)carbonyl](methyl)homocysteine #;Z-L-Methionine, 97%;Z-L-MET-OH;MLS000521452;N-Benzyloxycarbonyl methionine;SCHEMBL1157282;CHEMBL1713556;DTXSID901306173;HMS2453O15;((Benzyloxy)carbonyl)-L-methionine;(2S)-2-{[(benzyloxy)carbonyl]amino}-4-(methylsulfanyl)butanoic acid;BBL012095;STK730616;AKOS001661703;AKOS015923286;AM81984;CCG-114114;CS-W014002;HY-W013286;N-BENZYLOXYCARBONYL-L-METHIONINE;N-ALPHA-CARBOBENZOXY-L-METHIONINE;NCGC00245950-01;AS-35009;N-[(Phenylmethoxy)carbonyl]-L-methionine;SMR000131860;Z-Met-OH, puriss., >=99.0% (T);N-ALPHA-BENZYLOXYCARBONYL-L-METHIONINE;N-{[(Phenylmethyl)oxy]carbonyl}-L-methionine;EN300-5014673;A803399;SR-01000084222;J-300199;Q-101650;SR-01000084222-1;(S)-2-(benzyloxycarbonylamino)-4-(methylthio)butanoic acid;""(2S)-2-(benzyloxycarbonylamino)-4-methylsulfanyl-butanoic acid;N-Cbz-L-Methionine"";rac-(2S)-2-(benzyloxycarbonylamino)-4-methylsulfanyl-butanoic acid"	False	1042387.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=1042387		pluskal_iocb_peptide_Peptide01_E10_id		100	E10	False	ZINC000001675889
2.2		0	150	P0110420194	95.3		U30	False	0	16	0	0	14	0	2	4	0	0	-1.0	0.0						O=C(NC(Cc1c[nH]c2ccccc12)C(=O)O)c1ccco1		2.19		0.0	1.91	CHEMBL1731838		Indolyl carboxylic acids and derivatives;3-alkylindoles;2-heteroaryl carboxamides;Furoic acid and derivatives;Substituted pyrroles;Benzenoids;Heteroaromatic compounds;Secondary carboxylic acid amides;Oxacyclic compounds;Azacyclic compounds;Monocarboxylic acids and derivatives;Carboxylic acids;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organonitrogen compounds;Organopnictogen compounds	2-heteroaryl carboxamides;3-alkylindoles;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Furans;Furoic acid and derivatives;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Indolyl carboxylic acids and derivatives;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom.	N-acyl-alpha amino acids		Amino acids and derivatives;Alpha amino acids and derivatives;N-acyl-alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	indolyl carboxylic acid (CHEBI:46867);indoles (CHEBI:24828);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);furans (CHEBI:24129);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);oxacycle (CHEBI:38104);organonitrogen heterocyclic compound (CHEBI:38101);carbonyl compound (CHEBI:36586);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);N-acyl-amino acid (CHEBI:51569);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);organooxygen compound (CHEBI:36963);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);nitrogen molecular entity (CHEBI:51143);amino acid (CHEBI:33709);peptide (CHEBI:16670)		Amino acids, peptides, and analogues	N-acyl-alpha-amino acid;Indolyl carboxylic acid derivative;3-alkylindole;Indole;Indole or derivatives;2-heteroaryl carboxamide;Furoic acid or derivatives;Substituted pyrrole;Benzenoid;Heteroaromatic compound;Furan;Pyrrole;Carboxamide group;Secondary carboxylic acid amide;Oxacycle;Monocarboxylic acid or derivatives;Organoheterocyclic compound;Carboxylic acid;Azacycle;Carbonyl group;Organooxygen compound;Organonitrogen compound;Organic oxide;Organopnictogen compound;Organic oxygen compound;Organic nitrogen compound;Hydrocarbon derivative;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		2-[(Furan-2-carbonyl)-amino]-3-(1H-indol-3-yl)-propionic acid		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C16H14N2O4	C16H14N2O4			InChI=1S/C16H14N2O4/c19-15(14-6-3-7-22-14)18-13(16(20)21)8-10-9-17-12-5-2-1-4-11(10)12/h1-7,9,13,17H,8H2,(H,18,19)(H,20,21)	MZLDSYCNJZQTAJ-UHFFFAOYSA-N	2-(furan-2-carbonylamino)-3-(1H-indol-3-yl)propanoic acid	2785192	O=C(NC(Cc1c[nH]c2ccccc12)C(=O)O)c1ccco1	2-(furan-2-carbonylamino)-3-(1H-indol-3-yl)propanoic acid			1.6487600000000004													MCULE-9380003177	298.30098	ACID	298.095357	3	3	5	3	1.0		30									Dipeptides	False	Amino acids and Peptides	Small peptides	False	False	Peptide01		-1.0	Compound(2785192)	2785192	1.6	841			[#8]=[#6](-[#7]-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8])-[#6]1:[#6]:[#6]:[#6]:[#8]:1	O=C(NC(Cc1c[nH]c2ccccc12)C(=O)O)c1ccco1	MZLDSYCNJZQTAJ		parent_pubchem_cid	2-[(Furan-2-carbonyl)-amino]-3-(1H-indol-3-yl)-propionic acid;293324-78-4;MLS000026919;Oprea1_446959;Oprea1_666776;CHEMBL1731838;N-(furan-2-ylcarbonyl)tryptophan;HMS2383J21;MFCD00408251;STK086251;AKOS000132048;AKOS016044839;SMR000122904;2-(furan-2-carbonylamino)-3-(1H-indol-3-yl)propanoic acid	False	1032242.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=1032242		pluskal_iocb_peptide_Peptide01_E10_id		100	E10	False	
0.5		0	238	P7119880230	174.9		U31	False	0	15	0	0	22	0	2	8	0	2		0.0						Cc1c(N(C)S(C)(=O)=O)c(C)c(S(=O)(=O)NC(CCC(=O)O)C(=O)O)cc1																							0.0		AKOS002315563		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	1		C15H22N2O8S2	C15H22N2O8S2			InChI=1S/C15H22N2O8S2/c1-9-5-7-12(10(2)14(9)17(3)26(4,22)23)27(24,25)16-11(15(20)21)6-8-13(18)19/h5,7,11,16H,6,8H2,1-4H3,(H,18,19)(H,20,21)	SDRWFRIOIIPJCM-UHFFFAOYSA-N	2-[[2,4-dimethyl-3-[methyl(methylsulfonyl)amino]phenyl]sulfonylamino]pentanedioic acid	18592816	Cc1c(N(C)S(C)(=O)=O)c(C)c(S(=O)(=O)NC(CCC(=O)O)C(=O)O)cc1	2-[[2,4-dimethyl-3-[methyl(methylsulfonyl)amino]phenyl]sulfonylamino]pentanedioic acid			-0.3024999999999975													MCULE-7441134863	422.47919		422.081758	8	3	9	1			45									Aminoacids	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(18592816)	18592816	0.2	842			[#6]-[#6]1:[#6](-[#7](-[#6])-[#16](-[#6])(=[#8])=[#8]):[#6](-[#6]):[#6](-[#16](=[#8])(=[#8])-[#7]-[#6](-[#6]-[#6]-[#6](=[#8])-[#8])-[#6](=[#8])-[#8]):[#6]:[#6]:1	Cc1c(N(C)S(C)(=O)=O)c(C)c(S(=O)(=O)NC(CCC(=O)O)C(=O)O)cc1	SDRWFRIOIIPJCM		parent_pubchem_cid	AKOS002315563;AKOS016323743;2-[[2,4-dimethyl-3-[methyl(methylsulfonyl)amino]phenyl]sulfonylamino]pentanedioic acid		23830664.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23830664		pluskal_iocb_peptide_Peptide01_E10_id		100	E10		
-0.5		0	326	P6242859	162.6		U32	False	0	12	0	0	18	0	4	4	0	1		0.0						Cc1nc(CC(=O)NC(CCCNC(N)=O)C(=O)O)cs1																							0.0		AKOS005665763		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	1	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C12H18N4O4S	C12H18N4O4S			InChI=1S/C12H18N4O4S/c1-7-15-8(6-21-7)5-10(17)16-9(11(18)19)3-2-4-14-12(13)20/h6,9H,2-5H2,1H3,(H,16,17)(H,18,19)(H3,13,14,20)/t9-/m1/s1	RIHMNQDPKIZXNN-SECBINFHSA-N	rac-(2R)-2-[[2-(2-methylthiazol-4-yl)acetyl]amino]-5-ureido-pentanoic acid	51043673	Cc1nc(CC(=O)N[C@H](CCCNC(N)=O)C(=O)O)cs1	(2R)-5-(carbamoylamino)-2-[[2-(2-methyl-1,3-thiazol-4-yl)acetyl]amino]pentanoic acid			-0.0974999999999993													MCULE-7550587502	314.36566		314.104876	5	4	8	1			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51043673)	51043673	-0.3	843			[#6]-[#6]1:[#7]:[#6](-[#6]-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#8])-[#6](=[#8])-[#8]):[#6]:[#16]:1	Cc1nc(CC(=O)N[C@H](CCCNC(N)=O)C(=O)O)cs1	RIHMNQDPKIZXNN		parent_pubchem_cid	AKOS005665763;rac-(2R)-2-[[2-(2-methylthiazol-4-yl)acetyl]amino]-5-ureido-pentanoic acid		23423520.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23423520		pluskal_iocb_peptide_Peptide01_E10_id		100	E10		ZINC000044901679
4.0		0	70	P1108204	137.9		U33	False	0	28	0	0	22	0	2	7	0	0		0.0						O=C(COc1cc2c(cc1)c(-c1ccccc1)cc(=O)o2)NC(Cc1c[nH]c2c1cc(O)cc2)C(=O)O								N-acylserotonins;N-acyl-alpha amino acids;Coumarins and derivatives;1-benzopyrans;3-alkylindoles;Hydroxyindoles;1-hydroxy-2-unsubstituted benzenoids;Pyranones and derivatives;Alkyl aryl ethers;Substituted pyrroles;Benzene and substituted derivatives;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactones;Carboxylic acids;Azacyclic compounds;Oxacyclic compounds;Monocarboxylic acids and derivatives;Organic oxides;Hydrocarbon derivatives;Organonitrogen compounds;Carbonyl compounds;Organopnictogen compounds	1-benzopyrans;1-hydroxy-2-unsubstituted benzenoids;3-alkylindoles;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Hydroxyindoles;Indoles;Indoles and derivatives;Lactones;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;N-acylserotonins;Neoflavones;Neoflavonoids;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenols;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Pyrroles;Secondary carboxylic acid amides;Serotonins;Substituted pyrroles;Tryptamines and derivatives	Neoflavonoids	2.1	This compound belongs to the class of organic compounds known as neoflavones. These are neoflavonoids with a structure based on the 4-phenylcoumarin skeleton.	Neoflavones			Organic compounds	Aromatic heteropolycyclic compounds	hydroxyindoles (CHEBI:84729);N-acyl-amino acid (CHEBI:51569);coumarins (CHEBI:23403);1-benzopyran (CHEBI:38443);indoles (CHEBI:24828);phenols (CHEBI:33853);pyranone (CHEBI:37963);aromatic ether (CHEBI:35618);pyrroles (CHEBI:26455);benzenes (CHEBI:22712);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactone (CHEBI:25000);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);organonitrogen heterocyclic compound (CHEBI:38101);oxacycle (CHEBI:38104);carbonyl compound (CHEBI:36586);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);organonitrogen compound (CHEBI:35352);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);neoflavonoid (CHEBI:71971);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);tryptamines (CHEBI:27162);organooxygen compound (CHEBI:36963);amino acid (CHEBI:33709);peptide (CHEBI:16670);benzopyran (CHEBI:22727);benzenoid aromatic compound (CHEBI:33836);pyrans (CHEBI:26407);oxygen molecular entity (CHEBI:25806);ether (CHEBI:25698);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)	Benzopyranoids (PK1311);Neoflavonoids (PK1210)	Neoflavones	4-phenylcoumarin;N-acylserotonin;N-acyl-alpha amino acid or derivatives;N-acyl-alpha-amino acid;Serotonin;Coumarin;Alpha-amino acid or derivatives;Benzopyran;Hydroxyindole;3-alkylindole;1-benzopyran;Indole;Indole or derivatives;Alkyl aryl ether;1-hydroxy-2-unsubstituted benzenoid;Pyranone;Monocyclic benzene moiety;Benzenoid;Pyran;Substituted pyrrole;Heteroaromatic compound;Pyrrole;Carboxamide group;Secondary carboxylic acid amide;Lactone;Carboxylic acid derivative;Carboxylic acid;Oxacycle;Ether;Azacycle;Organoheterocyclic compound;Monocarboxylic acid or derivatives;Organic oxygen compound;Organic nitrogen compound;Organopnictogen compound;Organic oxide;Carbonyl group;Organooxygen compound;Hydrocarbon derivative;Organonitrogen compound;Aromatic heteropolycyclic compound	Phenylpropanoids and polyketides	0.0		EiM07-29406		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C28H22N2O7	C28H22N2O7			InChI=1S/C28H22N2O7/c31-18-6-9-23-22(11-18)17(14-29-23)10-24(28(34)35)30-26(32)15-36-19-7-8-20-21(16-4-2-1-3-5-16)13-27(33)37-25(20)12-19/h1-9,11-14,24,29,31H,10,15H2,(H,30,32)(H,34,35)	ZKIUZXSOQMYIAW-UHFFFAOYSA-N	3-(5-hydroxy-1H-indol-3-yl)-2-[[2-(2-oxo-4-phenyl-chromen-7-yl)oxyacetyl]amino]propanoic acid	4833841	O=C(COc1cc2c(cc1)c(-c1ccccc1)cc(=O)o2)NC(Cc1c[nH]c2c1cc(O)cc2)C(=O)O	3-(5-hydroxy-1H-indol-3-yl)-2-[[2-(2-oxo-4-phenylchromen-7-yl)oxyacetyl]amino]propanoic acid			2.5213													MCULE-5130489782	498.49674		498.142701	7	4	8	5			45										False	Shikimates and Phenylpropanoids				Peptide01			Compound(4833841)	4833841	3.8	844			[#8]=[#6](-[#6]-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1):[#6]:[#6](=[#8]):[#8]:2)-[#7]-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:1:[#6]:[#6](-[#8]):[#6]:[#6]:2)-[#6](=[#8])-[#8]	O=C(COc1cc2c(cc1)c(-c1ccccc1)cc(=O)o2)NC(Cc1c[nH]c2c1cc(O)cc2)C(=O)O	ZKIUZXSOQMYIAW		parent_pubchem_cid	EiM07-29406;AKOS016401691;3-(5-HYDROXY-1H-INDOL-3-YL)-2-{2-[(2-OXO-4-PHENYL-2H-CHROMEN-7-YL)OXY]ACETAMIDO}PROPANOIC ACID;3-(5-hydroxy-1H-indol-3-yl)-2-[[2-(2-oxo-4-phenyl-chromen-7-yl)oxyacetyl]amino]propanoic acid		24183117.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24183117		pluskal_iocb_peptide_Peptide01_E10_id		100	E10		
3.6		0	158	P0105620067	83.1		U34	False	0	21	0	0	25	0	1	6	0	0		0.0						COc1cc(C(=O)Nc2ccc(C(=O)OCC(C)C)cc2)cc(OC)c1OC																							0.0		301306-49-0		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C21H25NO6	C21H25NO6			InChI=1S/C21H25NO6/c1-13(2)12-28-21(24)14-6-8-16(9-7-14)22-20(23)15-10-17(25-3)19(27-5)18(11-15)26-4/h6-11,13H,12H2,1-5H3,(H,22,23)	CVZFGUFGHBUTRH-UHFFFAOYSA-N	isobutyl 4-[(3,4,5-trimethoxybenzoyl)amino]benzoate	983552	COc1cc(C(=O)Nc2ccc(C(=O)OCC(C)C)cc2)cc(OC)c1OC	2-methylpropyl 4-[(3,4,5-trimethoxybenzoyl)amino]benzoate			1.90024													MCULE-1669711526	387.4365		387.168188	6	1	9	2			43										False	Shikimates and Phenylpropanoids				Peptide01			Compound(983552)	983552	3.9	845			[#6]-[#8]-[#6]1:[#6]:[#6](-[#6](=[#8])-[#7]-[#6]2:[#6]:[#6]:[#6](-[#6](=[#8])-[#8]-[#6]-[#6](-[#6])-[#6]):[#6]:[#6]:2):[#6]:[#6](-[#8]-[#6]):[#6]:1-[#8]-[#6]	COc1cc(C(=O)Nc2ccc(C(=O)OCC(C)C)cc2)cc(OC)c1OC	CVZFGUFGHBUTRH		parent_pubchem_cid	301306-49-0;isobutyl 4-(3,4,5-trimethoxybenzamido)benzoate;2-METHYLPROPYL 4-(3,4,5-TRIMETHOXYBENZAMIDO)BENZOATE;Oprea1_592651;Oprea1_798222;2-methylpropyl 4-[(3,4,5-trimethoxybenzoyl)amino]benzoate;AKOS002270823;VU0508949-1;isobutyl 4-[(3,4,5-trimethoxybenzoyl)amino]benzoate;F3095-0968		12156343.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=12156343		pluskal_iocb_peptide_Peptide01_E10_id		100	E10		ZINC000000629808
2.4		0	246	P3462623	95.9		U35	False	0	20	0	0	28	0	2	5	0	0	-1.0	0.0						CC(C)(C)OC(=O)NC(Cc1ccccc1)C(=O)N1CCC(C(=O)O)CC1		2.45		0.0	2.28	CHEMBL1705739																	0.0		1-[N-(tert-butoxycarbonyl)-L-phenylalanyl]piperidine-4-carboxylic acid		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	1	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0		C20H28N2O5	C20H28N2O5			InChI=1S/C20H28N2O5/c1-20(2,3)27-19(26)21-16(13-14-7-5-4-6-8-14)17(23)22-11-9-15(10-12-22)18(24)25/h4-8,15-16H,9-13H2,1-3H3,(H,21,26)(H,24,25)/t16-/m0/s1	VXHNQGJCBYKWFP-INIZCTEOSA-N	1-[rac-(2S)-2-(tert-butoxycarbonylamino)-3-phenyl-propanoyl]piperidine-4-carboxylic acid	6851158	CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC(C(=O)O)CC1	1-[(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]piperidine-4-carboxylic acid			2.3908900000000006													MCULE-9355414744	376.45656	ACID	376.199822	5	2	7	2	0.0		29									Tripeptides	False	Amino acids and Peptides	Small peptides	False	False	Peptide01		-1.0	Compound(6851158)	6851158	2.5	846			[#6]-[#6](-[#6])(-[#6])-[#8]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#7]1-[#6]-[#6]-[#6](-[#6](=[#8])-[#8])-[#6]-[#6]-1	CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC(C(=O)O)CC1	VXHNQGJCBYKWFP		parent_pubchem_cid	1-[N-(tert-butoxycarbonyl)-L-phenylalanyl]piperidine-4-carboxylic acid;1164466-05-0;MFCD04016898;1-[(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]piperidine-4-carboxylic acid;MLS000551714;CHEMBL1705739;HMS2158O17;AKOS016375517;LS-09786;SMR000145639;CS-0316641;1-((Tert-butoxycarbonyl)-L-phenylalanyl)piperidine-4-carboxylic acid;1-[N-(tert-butoxycarbonyl)-L-phenylalanyl]piperidine-4-carboxylicacid;1-((S)-2-tert-Butoxycarbonylamino-3-phenyl-propionyl)-piperidine-4-carboxylic acid;1-[(2S)-2-{[(tert-butoxy)carbonyl]amino}-3-phenylpropanoyl]piperidine-4-carboxylic acid;1-[rac-(2S)-2-(tert-butoxycarbonylamino)-3-phenyl-propanoyl]piperidine-4-carboxylic acid	False	1018508.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=1018508		pluskal_iocb_peptide_Peptide01_E10_id		100	E10	False	ZINC000003882132
1.5		0	334	P1647347	61.9		U36	False	0	19	0	0	27	0	3	3	0	0	-1.0	0.0						O=C(NC(Cc1ccccc1)C(=O)N1CCCCC1)N1CCOCC1		1.65		0.0	1.28	CHEMBL4950191																	0.0		CHEMBL4950191		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0		C19H27N3O3	C19H27N3O3			InChI=1S/C19H27N3O3/c23-18(21-9-5-2-6-10-21)17(15-16-7-3-1-4-8-16)20-19(24)22-11-13-25-14-12-22/h1,3-4,7-8,17H,2,5-6,9-15H2,(H,20,24)/t17-/m0/s1	OHWVKHQVXLWJRT-KRWDZBQOSA-N	N-[rac-(1S)-1-benzyl-2-oxo-2-(1-piperidyl)ethyl]morpholine-4-carboxamide	110347394	O=C(N[C@@H](Cc1ccccc1)C(=O)N1CCCCC1)N1CCOCC1	N-[(2S)-1-oxo-3-phenyl-1-piperidin-1-ylpropan-2-yl]morpholine-4-carboxamide			1.59729														345.44534	NEUTRAL	345.205242	3	1	4	3	0.0		30										False			False	False	Peptide01		-1.0	Compound(110347394)	110347394	1.5	847			[#8]=[#6](-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#7]1-[#6]-[#6]-[#6]-[#6]-[#6]-1)-[#7]1-[#6]-[#6]-[#8]-[#6]-[#6]-1	O=C(N[C@@H](Cc1ccccc1)C(=O)N1CCCCC1)N1CCOCC1	OHWVKHQVXLWJRT		parent_pubchem_cid	CHEMBL4950191;AKOS027475302;N-[rac-(1S)-1-benzyl-2-oxo-2-(1-piperidyl)ethyl]morpholine-4-carboxamide	False	3760459.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=3760459		pluskal_iocb_peptide_Peptide01_E10_id		100	E10	False	ZINC000041247084
1.0		0	78	P1107423	168.1		U37	False	0	19	0	0	23	0	3	7	0	0		0.0						Cc1c(CCC(=O)NC(CCCNC(N)=O)C(=O)O)c(=O)oc2c1ccc(O)c2																							0.0		STL463429		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C19H23N3O7	C19H23N3O7			InChI=1S/C19H23N3O7/c1-10-12-5-4-11(23)9-15(12)29-18(27)13(10)6-7-16(24)22-14(17(25)26)3-2-8-21-19(20)28/h4-5,9,14,23H,2-3,6-8H2,1H3,(H,22,24)(H,25,26)(H3,20,21,28)/t14-/m1/s1	JKCMWTVELNNQTF-CQSZACIVSA-N	rac-(2R)-2-[3-(7-hydroxy-4-methyl-2-oxo-chromen-3-yl)propanoylamino]-5-ureido-pentanoic acid	24280404	Cc1c(CCC(=O)N[C@H](CCCNC(N)=O)C(=O)O)c(=O)oc2c1ccc(O)c2	(2R)-5-(carbamoylamino)-2-[3-(7-hydroxy-4-methyl-2-oxochromen-3-yl)propanoylamino]pentanoic acid			0.6571600000000011													MCULE-7123109857	405.41106		405.1536	7	5	9	2			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(24280404)	24280404	0.1	848			[#6]-[#6]1:[#6](-[#6]-[#6]-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#8])-[#6](=[#8])-[#8]):[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]):[#6]:2	Cc1c(CCC(=O)N[C@H](CCCNC(N)=O)C(=O)O)c(=O)oc2c1ccc(O)c2	JKCMWTVELNNQTF		parent_pubchem_cid	STL463429;AKOS016379186;N~5~-carbamoyl-N~2~-[3-(7-hydroxy-4-methyl-2-oxo-2H-chromen-3-yl)propanoyl]-D-ornithine;5-(CARBAMOYLAMINO)-2-[3-(7-HYDROXY-4-METHYL-2-OXO-2H-CHROMEN-3-YL)PROPANAMIDO]PENTANOIC ACID;rac-(2R)-2-[3-(7-hydroxy-4-methyl-2-oxo-chromen-3-yl)propanoylamino]-5-ureido-pentanoic acid		24525811.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24525811		pluskal_iocb_peptide_Peptide01_E11_id		100	E11		ZINC000011865403
3.1		0	166	P7020554650	84.2		U38	False	0	20	0	1	18	0	3	3	0	0		0.0						Cc1cc(NC(=O)C(Cc2ccccc2)NC(=O)c2ccc(F)cc2)no1																							0.0		AKOS005585515		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C20H18FN3O3	C20H18FN3O3			InChI=1S/C20H18FN3O3/c1-13-11-18(24-27-13)23-20(26)17(12-14-5-3-2-4-6-14)22-19(25)15-7-9-16(21)10-8-15/h2-11,17H,12H2,1H3,(H,22,25)(H,23,24,26)/t17-/m0/s1	FQNXFCUYEOEERI-KRWDZBQOSA-N	N-[(1S)-1-benzyl-2-[(5-methylisoxazol-3-yl)amino]-2-oxo-ethyl]-4-fluoro-benzamide	24315163	Cc1cc(NC(=O)[C@H](Cc2ccccc2)NC(=O)c2ccc(F)cc2)no1	4-fluoro-N-[(2S)-1-[(5-methyl-1,2-oxazol-3-yl)amino]-1-oxo-3-phenylpropan-2-yl]benzamide			2.5571800000000007													MCULE-7081060619	367.38316		367.13322	3	2	6	3			44										False					Peptide01			Compound(24315163)	24315163	3.4	849			[#6]-[#6]1:[#6]:[#6](-[#7]-[#6](=[#8])-[#6@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:2):[#7]:[#8]:1	Cc1cc(NC(=O)[C@H](Cc2ccccc2)NC(=O)c2ccc(F)cc2)no1	FQNXFCUYEOEERI		parent_pubchem_cid	AKOS005585515;N-[(1S)-1-benzyl-2-[(5-methylisoxazol-3-yl)amino]-2-oxo-ethyl]-4-fluoro-benzamide		15881496.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=15881496		pluskal_iocb_peptide_Peptide01_E11_id		100	E11		ZINC000012028738
4.4		0	254	P1301890	63.4		U39	False	0	23	0	0	28	0	2	3	0	0		0.0						CCOc1c(OC)cc(C(CNC(=O)C(C)C)c2c[nH]c3ccccc23)cc1																							0.0		AKOS001912927		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C23H28N2O3	C23H28N2O3			InChI=1S/C23H28N2O3/c1-5-28-21-11-10-16(12-22(21)27-4)18(13-25-23(26)15(2)3)19-14-24-20-9-7-6-8-17(19)20/h6-12,14-15,18,24H,5,13H2,1-4H3,(H,25,26)	OPZCXBMJABWHLX-UHFFFAOYSA-N	N-[2-(4-ethoxy-3-methoxy-phenyl)-2-(1H-indol-3-yl)ethyl]-2-methyl-propanamide	17011497	CCOc1c(OC)cc(C(CNC(=O)C(C)C)c2c[nH]c3ccccc23)cc1	N-[2-(4-ethoxy-3-methoxyphenyl)-2-(1H-indol-3-yl)ethyl]-2-methylpropanamide			3.0166400000000007													MCULE-1888218006	380.49121		380.209993	3	2	8	3			45										False	Alkaloids				Peptide01			Compound(17011497)	17011497	4.4	850			[#6]-[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]):[#6]:[#6](-[#6](-[#6]-[#7]-[#6](=[#8])-[#6](-[#6])-[#6])-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	CCOc1c(OC)cc(C(CNC(=O)C(C)C)c2c[nH]c3ccccc23)cc1	OPZCXBMJABWHLX		parent_pubchem_cid	AKOS001912927;AKOS016325205;N-[2-(4-ethoxy-3-methoxyphenyl)-2-(1H-indol-3-yl)ethyl]-2-methylpropanamide;N-[2-(4-ethoxy-3-methoxy-phenyl)-2-(1H-indol-3-yl)ethyl]-2-methyl-propanamide		24200606.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24200606		pluskal_iocb_peptide_Peptide01_E11_id		100	E11		
0.3		0	342	P3460024	128.3		U40	False	0	13	0	0	18	0	4	3	0	0	-1.0	0.0						NC(N)=NCCCC(NC(=O)c1ccccc1)C(=O)O	90086.0	0.13		0.0	-1.46	CHEMBL25380		N-acyl-alpha amino acids;Benzoyl derivatives;Secondary carboxylic acid amides;Guanidines;Propargyl-type 1,3-dipolar organic compounds;Monocarboxylic acids and derivatives;Carboxylic acids;Carboximidamides;Organopnictogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Benzamides;Benzene and substituted derivatives;Benzenoids;Benzoic acids and derivatives;Benzoyl derivatives;Carbonyl compounds;Carboximidamides;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Guanidines;Hippuric acids;Hippuric acids and derivatives;Hydrocarbon derivatives;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic 1,3-dipolar compounds;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Propargyl-type 1,3-dipolar organic compounds;Secondary carboxylic acid amides	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as hippuric acids. These are compounds containing hippuric acid, which consists of a of a benzoyl group linked to the N-terminal of a glycine.	Hippuric acids		Benzamides;Hippuric acids and derivatives	Organic compounds	Aromatic homomonocyclic compounds	N-acyl-amino acid (CHEBI:51569);carbonyl compound (CHEBI:36586);carboxamide (CHEBI:37622);guanidines (CHEBI:24436);dipolar compound (CHEBI:51151);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);organonitrogen compound (CHEBI:35352);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);N-acylglycine (CHEBI:16180);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);amino acid (CHEBI:33709);peptide (CHEBI:16670);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806);benzamides (CHEBI:22702);phenols (CHEBI:33853)		Benzoic acids and derivatives	Hippuric acid;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;Alpha-amino acid or derivatives;Benzoyl;Carboxamide group;Guanidine;Secondary carboxylic acid amide;Carboxylic acid derivative;Carboxylic acid;Monocarboxylic acid or derivatives;Organic 1,3-dipolar compound;Propargyl-type 1,3-dipolar organic compound;Carboximidamide;Hydrocarbon derivative;Organic oxide;Organic oxygen compound;Carbonyl group;Organopnictogen compound;Organonitrogen compound;Organooxygen compound;Organic nitrogen compound;Aromatic homomonocyclic compound	Benzenoids	0.0		154-92-7		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C13H18N4O3	C13H18N4O3			InChI=1S/C13H18N4O3/c14-13(15)16-8-4-7-10(12(19)20)17-11(18)9-5-2-1-3-6-9/h1-3,5-6,10H,4,7-8H2,(H,17,18)(H,19,20)(H4,14,15,16)/t10-/m0/s1	RSYYQCDERUOEFI-JTQLQIEISA-N	rac-(2S)-2-benzamido-5-guanidino-pentanoic acid	97369	NC(N)=NCCC[C@H](NC(=O)c1ccccc1)C(=O)O	(2S)-2-benzamido-5-(diaminomethylideneamino)pentanoic acid			-0.1315099999999991													MCULE-6148197286	278.31341	ZWITTERION	278.13789	4	5	8	1	1.0		27									Dipeptides	False	Amino acids and Peptides	Small peptides	False	False	Peptide01		-1.0	Compound(97369)	97369	0.0	851		SCHEMBL188590	[#7]-[#6](-[#7])=[#7]-[#6]-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	NC(N)=NCCC[C@H](NC(=O)c1ccccc1)C(=O)O	RSYYQCDERUOEFI		parent_pubchem_cid	154-92-7;Bz-Arg-OH;N-alpha-Benzoyl-L-arginine;Benzoyl-L-arginine;N-Benzoyl-L-arginine;N2-Benzoyl-L-arginine;Bz-L-Arg-OH;L-Arginine, N2-benzoyl-;N~2~-(Benzenecarbonyl)-L-Arginine;Arginine, N2-benzoyl-;MFCD00001763;bzo-arg-oh;Bz-Arg;EINECS 205-837-7;NSC 118519;(2S)-5-carbamimidamido-2-(phenylformamido)pentanoic acid;N(2)-benzoyl-L-arginine;alpha-N-benzoyl-L-arginine;Nalpha -benzoyl-L-arginine;n(alpha)-benzoyl-l-arginine;CHEMBL25380;L-Arginine, N(2)-benzoyl-;SCHEMBL188590;N- alpha -Benzoyl-L-arginine;N-.alpha.-Benzoyl-L-arginine;CHEBI:90086;N(.alpha.)-Benzolyl-L-arginine;DTXSID801315997;AKOS005175151;CS-W009300;FD10547;HY-W008584;AC-19173;AS-12261;(S)-2-Benzoylamino-5-guanidino-pentanoic acid;EN300-302944;6JY;rac-(2S)-2-benzamido-5-guanidino-pentanoic acid	False	31602.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=31602		pluskal_iocb_peptide_Peptide01_E11_id		100	E11	False	ZINC000001677520
3.7		0	86	P0124040054	118.4		U41	False	0	20	0	0	17	0	5	2	0	1		0.0						Nc1ccc(Nc2nc3ccccc3nc2NS(=O)(=O)c2ccccc2)cc1																							0.0		Oprea1_103828		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	2	0	0	1	0	0	0	0	0	0	0		C20H17N5O2S	C20H17N5O2S			InChI=1S/C20H17N5O2S/c21-14-10-12-15(13-11-14)22-19-20(24-18-9-5-4-8-17(18)23-19)25-28(26,27)16-6-2-1-3-7-16/h1-13H,21H2,(H,22,23)(H,24,25)	CBTHGXMOCMDMFR-UHFFFAOYSA-N	N-[3-(4-aminoanilino)quinoxalin-2-yl]benzenesulfonamide	1575551	Nc1ccc(Nc2nc3ccccc3nc2NS(=O)(=O)c2ccccc2)cc1	N-[3-(4-aminoanilino)quinoxalin-2-yl]benzenesulfonamide			1.69753													MCULE-2502800845	391.45479		391.110296	6	3	5	4			44										False	Alkaloids				Peptide01			Compound(1575551)	1575551	3.3	852			[#7]-[#6]1:[#6]:[#6]:[#6](-[#7]-[#6]2:[#7]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3:[#7]:[#6]:2-[#7]-[#16](=[#8])(=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6]:[#6]:1	Nc1ccc(Nc2nc3ccccc3nc2NS(=O)(=O)c2ccccc2)cc1	CBTHGXMOCMDMFR		parent_pubchem_cid	Oprea1_103828;MFCD00352902;AKOS001058582;Z56851837;N-[3-(4-aminoanilino)quinoxalin-2-yl]benzenesulfonamide		9580400.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=9580400		pluskal_iocb_peptide_Peptide01_E11_id		100	E11		ZINC000001786860
3.4		0	174	P7020556503	76.3	HCl	U42	False	0	21	0	0	26	0	2	4	0	1		0.0						O=S(=O)(CCc1ccccc1)NCC(c1cc2c(cc1)OCO2)N1CCCC1																							0.0		AKOS005591135		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	1		C21H27ClN2O4S	C21H26N2O4S			InChI=1S/C21H26N2O4S/c24-28(25,13-10-17-6-2-1-3-7-17)22-15-19(23-11-4-5-12-23)18-8-9-20-21(14-18)27-16-26-20/h1-3,6-9,14,19,22H,4-5,10-13,15-16H2	KYEOPRCMLYGLKJ-UHFFFAOYSA-N	N-[2-(1,3-benzodioxol-5-yl)-2-pyrrolidin-1-yl-ethyl]-2-phenyl-ethanesulfonamide;hydrochloride	24316767	O=S(=O)(CCc1ccccc1)NCC(c1cc2c(cc1)OCO2)N1CCCC1	N-[2-(1,3-benzodioxol-5-yl)-2-pyrrolidin-1-ylethyl]-2-phenylethanesulfonamide			1.68006													MCULE-7726864658	438.97734		402.161328	5	1	8	4			44									Piperidine alkaloids	False	Alkaloids	Lysine alkaloids			Peptide01			Compound(24316767)	24316767	3.2	853			[#8]=[#16](=[#8])(-[#6]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6]-[#6](-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1)-[#8]-[#6]-[#8]-2)-[#7]1-[#6]-[#6]-[#6]-[#6]-1	O=S(=O)(CCc1ccccc1)NCC(c1cc2c(cc1)OCO2)N1CCCC1	KYEOPRCMLYGLKJ		parent_pubchem_cid	"AKOS005591135;""N-[2-(1,3-benzodioxol-5-yl)-2-pyrrolidin-1-yl-ethyl]-2-phenyl-ethanesulfonamide;hydrochloride"""		23623062.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23623062		pluskal_iocb_peptide_Peptide01_E11_id		100	E11		
4.6		0	262	P1305488	54.1		U43	False	0	24	0	1	21	0	2	2	0	0		0.0						O=C(COc1ccc(F)cc1)NCC(c1ccccc1)c1c[nH]c2ccccc12																							0.0		HMS3456G14		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C24H21FN2O2	C24H21FN2O2			InChI=1S/C24H21FN2O2/c25-18-10-12-19(13-11-18)29-16-24(28)27-14-21(17-6-2-1-3-7-17)22-15-26-23-9-5-4-8-20(22)23/h1-13,15,21,26H,14,16H2,(H,27,28)	TWBMEJZSCRMHDA-UHFFFAOYSA-N	2-(4-fluorophenoxy)-N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]acetamide	17014635	O=C(COc1ccc(F)cc1)NCC(c1ccccc1)c1c[nH]c2ccccc12	2-(4-fluorophenoxy)-N-[2-(1H-indol-3-yl)-2-phenylethyl]acetamide			3.6338500000000016													MCULE-2571785053	388.44557		388.158706	2	2	7	4			45										False	Alkaloids				Peptide01			Compound(17014635)	17014635	4.9	854			[#8]=[#6](-[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:1)-[#7]-[#6]-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	O=C(COc1ccc(F)cc1)NCC(c1ccccc1)c1c[nH]c2ccccc12	TWBMEJZSCRMHDA		parent_pubchem_cid	HMS3456G14;2-(4-fluorophenoxy)-N-[2-(1H-indol-3-yl)-2-phenylethyl]acetamide;AKOS002335723;AKOS016326699;2-(4-fluorophenoxy)-N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]acetamide		24228278.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24228278		pluskal_iocb_peptide_Peptide01_E11_id		100	E11		
3.7		0	350	P6237055	123.3		U44	False	0	22	0	0	19	0	3	3	0	1		0.0						O=C(Cc1csc(-c2ccccc2)n1)NC(Cc1c[nH]c2ccccc12)C(=O)O																							0.0		SCHEMBL20255990		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C22H19N3O3S	C22H19N3O3S			InChI=1S/C22H19N3O3S/c26-20(11-16-13-29-21(24-16)14-6-2-1-3-7-14)25-19(22(27)28)10-15-12-23-18-9-5-4-8-17(15)18/h1-9,12-13,19,23H,10-11H2,(H,25,26)(H,27,28)/t19-/m0/s1	WYYCUXZUXHVWDV-IBGZPJMESA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[[2-(2-phenylthiazol-4-yl)acetyl]amino]propanoic acid	75366476	O=C(Cc1csc(-c2ccccc2)n1)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	(2S)-3-(1H-indol-3-yl)-2-[[2-(2-phenyl-1,3-thiazol-4-yl)acetyl]amino]propanoic acid			2.72814													MCULE-4938291276	405.47903		405.114712	4	3	7	4			43										False	Alkaloids				Peptide01			Compound(75366476)	75366476	2.7	855		SCHEMBL20255990	[#8]=[#6](-[#6]-[#6]1:[#6]:[#16]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#7]:1)-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	O=C(Cc1csc(-c2ccccc2)n1)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	WYYCUXZUXHVWDV		parent_pubchem_cid	SCHEMBL20255990;AKOS016402491;N-[(2-phenyl-1,3-thiazol-4-yl)acetyl]-L-tryptophan;rac-(2S)-3-(1H-indol-3-yl)-2-[[2-(2-phenylthiazol-4-yl)acetyl]amino]propanoic acid		80293186.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=80293186		pluskal_iocb_peptide_Peptide01_E11_id		100	E11		ZINC000094992900
-0.9		0	358	P3461624	65.1		V1	False	0	13	0	0	14	0	2	2	0	0		0.0						O=C(O)C(NC1CC1)c1c[nH]c2ccccc12								Alpha amino acids;3-alkylindoles;Aralkylamines;Substituted pyrroles;Benzenoids;Heteroaromatic compounds;Amino acids;Monocarboxylic acids and derivatives;Dialkylamines;Carboxylic acids;Azacyclic compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	3-alkylindoles;Alpha amino acids;Alpha amino acids and derivatives;Amines;Amino acids;Amino acids and derivatives;Amino acids, peptides, and analogues;Aralkylamines;Azacyclic compounds;Benzenoids;Carbonyl compounds;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Dialkylamines;Heteroaromatic compounds;Hydrocarbon derivatives;Indole-3-acetic acid derivatives;Indoles;Indoles and derivatives;Indolyl carboxylic acids and derivatives;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Pyrroles;Secondary amines;Substituted pyrroles	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as indole-3-acetic acid derivatives. These are compounds containing an acetic acid (or a derivative) linked to the C3 carbon atom of an indole.	Indole-3-acetic acid derivatives			Organic compounds	Aromatic heteropolycyclic compounds	alpha-amino acid (CHEBI:33704);indoles (CHEBI:24828);aralkylamine (CHEBI:18000);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);organic aromatic compound (CHEBI:33659);amino acid (CHEBI:33709);monocarboxylic acid (CHEBI:25384);secondary amino compound (CHEBI:50995);carboxylic acid (CHEBI:33575);organonitrogen heterocyclic compound (CHEBI:38101);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);indole-3-acetic acids (CHEBI:24803);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organonitrogen compound (CHEBI:35352);organooxygen compound (CHEBI:36963);organic heterocyclic compound (CHEBI:24532);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);amine (CHEBI:32952);secondary amine (CHEBI:32863);oxygen molecular entity (CHEBI:25806);indolyl carboxylic acid (CHEBI:46867)		Indolyl carboxylic acids and derivatives	Indole-3-acetic acid derivative;Alpha-amino acid;Alpha-amino acid or derivatives;3-alkylindole;Indole;Aralkylamine;Benzenoid;Substituted pyrrole;Heteroaromatic compound;Pyrrole;Amino acid or derivatives;Amino acid;Carboxylic acid derivative;Carboxylic acid;Secondary aliphatic amine;Azacycle;Monocarboxylic acid or derivatives;Secondary amine;Amine;Organic oxygen compound;Organic nitrogen compound;Hydrocarbon derivative;Organic oxide;Organonitrogen compound;Organooxygen compound;Carbonyl group;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		2-(cyclopropylamino)-2-(1H-indol-3-yl)acetic acid		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0		C13H14N2O2	C13H14N2O2			InChI=1S/C13H14N2O2/c16-13(17)12(15-8-5-6-8)10-7-14-11-4-2-1-3-9(10)11/h1-4,7-8,12,14-15H,5-6H2,(H,16,17)	BCKDAERGQLSGQB-UHFFFAOYSA-N	2-(cyclopropylamino)-2-(1H-indol-3-yl)acetic acid	45492389	O=C(O)C(NC1CC1)c1c[nH]c2ccccc12	2-(cyclopropylamino)-2-(1H-indol-3-yl)acetic acid			1.5624699999999998													MCULE-8574522999	230.26873		230.105528	3	3	4	3			44									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(45492389)	45492389	-0.5	856			[#8]=[#6](-[#8])-[#6](-[#7]-[#6]1-[#6]-[#6]-1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	O=C(O)C(NC1CC1)c1c[nH]c2ccccc12	BCKDAERGQLSGQB		parent_pubchem_cid	2-(cyclopropylamino)-2-(1H-indol-3-yl)acetic acid;1214684-07-7;(cyclopropylamino)(1H-indol-3-yl)acetic acid;MFCD13176346;BBL032275;STK935141;AKOS005664602;NS-02973;EN300-186410;2-(cyclopropylamino)-2-(1H-indol-3-yl)aceticacid;Z1698590753;(Cyclopropylamino)(1H-indol-3-yl)acetic acid (cPr-DL-nTrp-OH)		23687079.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23687079		pluskal_iocb_peptide_Peptide01_E12_id		100	E12		
3.9		0	446	P2196114	134.6		V2	False	0	19	1	1	22	0	4	2	0	2		0.0						CCCSc1ncc(Cl)c(C(=O)NC(CCSC)C(=O)Nc2ccc(F)cc2)n1																							0.0		AKOS016027025		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C19H22ClFN4O2S2	C19H22ClFN4O2S2			InChI=1S/C19H22ClFN4O2S2/c1-3-9-29-19-22-11-14(20)16(25-19)18(27)24-15(8-10-28-2)17(26)23-13-6-4-12(21)5-7-13/h4-7,11,15H,3,8-10H2,1-2H3,(H,23,26)(H,24,27)	PXCRXNJJZOTJLE-UHFFFAOYSA-N	5-chloro-N-[1-[(4-fluorophenyl)carbamoyl]-3-methylsulfanyl-propyl]-2-propylsulfanyl-pyrimidine-4-carboxamide	52988683	CCCSc1ncc(Cl)c(C(=O)NC(CCSC)C(=O)Nc2ccc(F)cc2)n1	5-chloro-N-[1-(4-fluoroanilino)-4-methylsulfanyl-1-oxobutan-2-yl]-2-propylsulfanylpyrimidine-4-carboxamide			3.7180700000000018													MCULE-7157732869	456.99219		456.085674	6	2	10	2			45										False	Alkaloids				Peptide01			Compound(52988683)	52988683	4.2	857			[#6]-[#6]-[#6]-[#16]-[#6]1:[#7]:[#6]:[#6](-[#17]):[#6](-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]-[#16]-[#6])-[#6](=[#8])-[#7]-[#6]2:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:2):[#7]:1	CCCSc1ncc(Cl)c(C(=O)NC(CCSC)C(=O)Nc2ccc(F)cc2)n1	PXCRXNJJZOTJLE		parent_pubchem_cid	AKOS016027025;5-chloro-N-[1-[(4-fluorophenyl)carbamoyl]-3-methylsulfanyl-propyl]-2-propylsulfanyl-pyrimidine-4-carboxamide		24408534.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24408534		pluskal_iocb_peptide_Peptide01_E12_id		100	E12		
4.2		0	534	P2196113	134.6		V3	False	0	20	1	0	25	0	4	2	0	2		0.0						CCCSc1ncc(Cl)c(C(=O)NC(CCSC)C(=O)Nc2ccccc2C)n1																							0.0		AKOS016027466		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C20H25ClN4O2S2	C20H25ClN4O2S2			InChI=1S/C20H25ClN4O2S2/c1-4-10-29-20-22-12-14(21)17(25-20)19(27)24-16(9-11-28-3)18(26)23-15-8-6-5-7-13(15)2/h5-8,12,16H,4,9-11H2,1-3H3,(H,23,26)(H,24,27)	FAAVKTZUPDUPIZ-UHFFFAOYSA-N	5-chloro-N-[3-methylsulfanyl-1-(o-tolylcarbamoyl)propyl]-2-propylsulfanyl-pyrimidine-4-carboxamide	52988682	CCCSc1ncc(Cl)c(C(=O)NC(CCSC)C(=O)Nc2ccccc2C)n1	5-chloro-N-[1-(2-methylanilino)-4-methylsulfanyl-1-oxobutan-2-yl]-2-propylsulfanylpyrimidine-4-carboxamide			3.8326800000000025													MCULE-9659477380	453.02885		452.110746	6	2	10	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(52988682)	52988682	4.5	858			[#6]-[#6]-[#6]-[#16]-[#6]1:[#7]:[#6]:[#6](-[#17]):[#6](-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]-[#16]-[#6])-[#6](=[#8])-[#7]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6]):[#7]:1	CCCSc1ncc(Cl)c(C(=O)NC(CCSC)C(=O)Nc2ccccc2C)n1	FAAVKTZUPDUPIZ		parent_pubchem_cid	AKOS016027466;5-chloro-N-[3-methylsulfanyl-1-(o-tolylcarbamoyl)propyl]-2-propylsulfanyl-pyrimidine-4-carboxamide		22799499.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22799499		pluskal_iocb_peptide_Peptide01_E12_id		100	E12		
4.3		0	622	P1309410	32.8		V4	False	0	26	0	0	30	0	2	2	0	0		0.0						CN(C)c1ccc(CN(CC2CCCO2)C(=O)Cc2cccc3ccccc23)cc1																							0.0		AKOS002297972		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1		C26H30N2O2	C26H30N2O2			InChI=1S/C26H30N2O2/c1-27(2)23-14-12-20(13-15-23)18-28(19-24-10-6-16-30-24)26(29)17-22-9-5-8-21-7-3-4-11-25(21)22/h3-5,7-9,11-15,24H,6,10,16-19H2,1-2H3	IPJLKPWXBCNKLW-UHFFFAOYSA-N	N-[[4-(dimethylamino)phenyl]methyl]-2-(1-naphthyl)-N-(tetrahydrofuran-2-ylmethyl)acetamide	19118887	CN(C)c1ccc(CN(CC2CCCO2)C(=O)Cc2cccc3ccccc23)cc1	N-[[4-(dimethylamino)phenyl]methyl]-2-naphthalen-1-yl-N-(oxolan-2-ylmethyl)acetamide			3.737650000000003													MCULE-9414359544	402.5412		402.230728	3	0	7	4			45										False					Peptide01			Compound(19118887)	19118887	4.6	859			[#6]-[#7](-[#6])-[#6]1:[#6]:[#6]:[#6](-[#6]-[#7](-[#6]-[#6]2-[#6]-[#6]-[#6]-[#8]-2)-[#6](=[#8])-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	CN(C)c1ccc(CN(CC2CCCO2)C(=O)Cc2cccc3ccccc23)cc1	IPJLKPWXBCNKLW		parent_pubchem_cid	AKOS002297972;AKOS016169766;N-[[4-(dimethylamino)phenyl]methyl]-2-(1-naphthyl)-N-(tetrahydrofuran-2-ylmethyl)acetamide		24634272.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24634272		pluskal_iocb_peptide_Peptide01_E12_id		100	E12		
4.6		0	366	P1098220	117.7		V5	False	0	26	0	0	26	0	2	6	0	0		0.0						CCCc1cc(=O)oc2c1ccc(OC(C)C(=O)NC(Cc1c[nH]c3ccccc13)C(=O)O)c2																							0.0		EiM07-16898		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C26H26N2O6	C26H26N2O6			InChI=1S/C26H26N2O6/c1-3-6-16-12-24(29)34-23-13-18(9-10-20(16)23)33-15(2)25(30)28-22(26(31)32)11-17-14-27-21-8-5-4-7-19(17)21/h4-5,7-10,12-15,22,27H,3,6,11H2,1-2H3,(H,28,30)(H,31,32)/t15?,22-/m0/s1	HGIFSZXSOSGFMZ-CEISFSOZSA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[2-(2-oxo-4-propyl-chromen-7-yl)oxypropanoylamino]propanoic acid	16397712	CCCc1cc(=O)oc2c1ccc(OC(C)C(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)O)c2	(2S)-3-(1H-indol-3-yl)-2-[2-(2-oxo-4-propylchromen-7-yl)oxypropanoylamino]propanoic acid			3.277420000000001													MCULE-3668402968	462.50692		462.179087	6	3	9	4			45									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(16397712)	16397712	4.2	860			[#6]-[#6]-[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6](-[#6])-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:1:3)-[#6](=[#8])-[#8]):[#6]:2	CCCc1cc(=O)oc2c1ccc(OC(C)C(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)O)c2	HGIFSZXSOSGFMZ		parent_pubchem_cid	EiM07-16898;AKOS016376914;3-(1H-INDOL-3-YL)-2-{2-[(2-OXO-4-PROPYL-2H-CHROMEN-7-YL)OXY]PROPANAMIDO}PROPANOIC ACID;rac-(2S)-3-(1H-indol-3-yl)-2-[2-(2-oxo-4-propyl-chromen-7-yl)oxypropanoylamino]propanoic acid		24031268.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24031268		pluskal_iocb_peptide_Peptide01_E12_id		100	E12		
3.5		0	454	P2195429	93.7		V6	False	0	24	0	0	30	0	2	5	0	0		0.0						COC(=O)C(Cc1ccccc1)NC(=O)C(CC(C)C)NC(=O)c1ccc(OC)cc1																							0.0		AKOS015861402		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	2	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C24H30N2O5	C24H30N2O5			InChI=1S/C24H30N2O5/c1-16(2)14-20(25-22(27)18-10-12-19(30-3)13-11-18)23(28)26-21(24(29)31-4)15-17-8-6-5-7-9-17/h5-13,16,20-21H,14-15H2,1-4H3,(H,25,27)(H,26,28)	FOMOXFIJVFWWSG-UHFFFAOYSA-N	methyl 2-[[2-[(4-methoxybenzoyl)amino]-4-methyl-pentanoyl]amino]-3-phenyl-propanoate	51065896	COC(=O)C(Cc1ccccc1)NC(=O)C(CC(C)C)NC(=O)c1ccc(OC)cc1	methyl 2-[[2-[(4-methoxybenzoyl)amino]-4-methylpentanoyl]amino]-3-phenylpropanoate			2.1683699999999995													MCULE-1004896703	426.5171		426.215472	5	2	11	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51065896)	51065896	4.2	861			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:1	COC(=O)C(Cc1ccccc1)NC(=O)C(CC(C)C)NC(=O)c1ccc(OC)cc1	FOMOXFIJVFWWSG		parent_pubchem_cid	AKOS015861402;methyl 2-[[2-[(4-methoxybenzoyl)amino]-4-methyl-pentanoyl]amino]-3-phenyl-propanoate		23000943.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23000943		pluskal_iocb_peptide_Peptide01_E12_id		100	E12		
2.3		0	542	P2195230	84.5		V7	False	0	20	0	0	22	0	2	4	0	0		0.0						COC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)c1ccc(C)cc1																							0.0		SCHEMBL16005297		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C20H22N2O4	C20H22N2O4			InChI=1S/C20H22N2O4/c1-14-8-10-16(11-9-14)19(24)21-13-18(23)22-17(20(25)26-2)12-15-6-4-3-5-7-15/h3-11,17H,12-13H2,1-2H3,(H,21,24)(H,22,23)	KHVGOILYQUJJCR-UHFFFAOYSA-N	methyl 2-[[2-[(4-methylbenzoyl)amino]acetyl]amino]-3-phenyl-propanoate	51065738	COC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)c1ccc(C)cc1	methyl 2-[[2-[(4-methylbenzoyl)amino]acetyl]amino]-3-phenylpropanoate			1.461189999999999													MCULE-7915436801	354.40934		354.157957	4	2	8	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51065738)	51065738	2.4	862		SCHEMBL16005297	[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:1	COC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)c1ccc(C)cc1	KHVGOILYQUJJCR		parent_pubchem_cid	SCHEMBL16005297;AKOS015861297;methyl 2-[[2-[(4-methylbenzoyl)amino]acetyl]amino]-3-phenyl-propanoate		24555403.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24555403		pluskal_iocb_peptide_Peptide01_E12_id		100	E12		
4.3		0	630	P1307045	119.4		V8	False	0	22	0	0	19	0	3	4	0	1		0.0						CN(C(=O)COc1ccccc1[N+](=O)[O-])C(c1cccs1)c1c[nH]c2ccccc12																							0.0		STL208070		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	1		C22H19N3O4S	C22H19N3O4S			InChI=1S/C22H19N3O4S/c1-24(21(26)14-29-19-10-5-4-9-18(19)25(27)28)22(20-11-6-12-30-20)16-13-23-17-8-3-2-7-15(16)17/h2-13,22-23H,14H2,1H3	ZUKNGDRXCXRVCI-UHFFFAOYSA-N	N-[1H-indol-3-yl(2-thienyl)methyl]-N-methyl-2-(2-nitrophenoxy)acetamide	43843059	CN(C(=O)COc1ccccc1[N+](=O)[O-])C(c1cccs1)c1c[nH]c2ccccc12	N-[1H-indol-3-yl(thiophen-2-yl)methyl]-N-methyl-2-(2-nitrophenoxy)acetamide			3.3835400000000018													MCULE-1721362682	421.47843		421.109627	4	1	7	4			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(43843059)	43843059	4.3	863			[#6]-[#7](-[#6](=[#8])-[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#7+](=[#8])-[#8-])-[#6](-[#6]1:[#6]:[#6]:[#6]:[#16]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CN(C(=O)COc1ccccc1[N+](=O)[O-])C(c1cccs1)c1c[nH]c2ccccc12	ZUKNGDRXCXRVCI		parent_pubchem_cid	STL208070;AKOS001544474;AKOS016329101;N-[(1H-INDOL-3-YL)(THIOPHEN-2-YL)METHYL]-N-METHYL-2-(2-NITROPHENOXY)ACETAMIDE;N-[1H-indol-3-yl(thiophen-2-yl)methyl]-N-methyl-2-(2-nitrophenoxy)acetamide;N-[1H-indol-3-yl(2-thienyl)methyl]-N-methyl-2-(2-nitrophenoxy)acetamide		23011017.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23011017		pluskal_iocb_peptide_Peptide01_E12_id		100	E12		
4.4		0	374	P1108201	138.0		V9	False	0	26	0	0	26	0	2	7	0	0		0.0						CCc1cc(=O)oc2c1ccc(OC(C)C(=O)NC(Cc1c[nH]c3c1cc(O)cc3)C(=O)O)c2C								N-acyl-alpha amino acids;Indolyl carboxylic acids and derivatives;Coumarins and derivatives;1-benzopyrans;Hydroxyindoles;3-alkylindoles;Phenol ethers;Pyranones and derivatives;Alkyl aryl ethers;1-hydroxy-2-unsubstituted benzenoids;Substituted pyrroles;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactones;Monocarboxylic acids and derivatives;Carboxylic acids;Oxacyclic compounds;Azacyclic compounds;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organonitrogen compounds	1-benzopyrans;1-hydroxy-2-unsubstituted benzenoids;3-alkylindoles;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Hydroxyindoles;Indoles;Indoles and derivatives;Indolyl carboxylic acids and derivatives;Lactones;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;N-acylserotonins;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenol ethers;Phenols;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Pyrroles;Secondary carboxylic acid amides;Serotonins;Substituted pyrroles;Tryptamines and derivatives	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acylserotonins. These are aromatic heterocyclic compounds containing a serotonin, in which the amine group is acylated.	N-acylserotonins		Serotonins	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-amino acid (CHEBI:51569);indolyl carboxylic acid (CHEBI:46867);coumarins (CHEBI:23403);1-benzopyran (CHEBI:38443);hydroxyindoles (CHEBI:84729);indoles (CHEBI:24828);aromatic ether (CHEBI:35618);pyranone (CHEBI:37963);phenols (CHEBI:33853);pyrroles (CHEBI:26455);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactone (CHEBI:25000);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);oxacycle (CHEBI:38104);organonitrogen heterocyclic compound (CHEBI:38101);carbonyl compound (CHEBI:36586);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);benzenoid aromatic compound (CHEBI:33836);pyrans (CHEBI:26407);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ether (CHEBI:25698);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);tryptamines (CHEBI:27162);carboxylic acid anion (CHEBI:29067);amino acid (CHEBI:33709);peptide (CHEBI:16670)	Benzopyranoids (PK1311)	Tryptamines and derivatives	N-acylserotonin;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;Indolyl carboxylic acid derivative;Coumarin;Alpha-amino acid or derivatives;1-benzopyran;3-alkylindole;Benzopyran;Hydroxyindole;Indole;Phenol ether;1-hydroxy-2-unsubstituted benzenoid;Pyranone;Phenol;Alkyl aryl ether;Benzenoid;Substituted pyrrole;Pyran;Pyrrole;Heteroaromatic compound;Lactone;Secondary carboxylic acid amide;Carboxamide group;Carboxylic acid derivative;Carboxylic acid;Oxacycle;Ether;Azacycle;Monocarboxylic acid or derivatives;Organic oxygen compound;Organic nitrogen compound;Organic oxide;Carbonyl group;Organooxygen compound;Organonitrogen compound;Hydrocarbon derivative;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		N-{2-[(4-ethyl-8-methyl-2-oxo-2H-chromen-7-yl)oxy]propanoyl}-5-hydroxytryptophan		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C26H26N2O7	C26H26N2O7			InChI=1S/C26H26N2O7/c1-4-15-10-23(30)35-24-13(2)22(8-6-18(15)24)34-14(3)25(31)28-21(26(32)33)9-16-12-27-20-7-5-17(29)11-19(16)20/h5-8,10-12,14,21,27,29H,4,9H2,1-3H3,(H,28,31)(H,32,33)	SSTKTMCDROXOIL-UHFFFAOYSA-N	2-[2-(4-ethyl-8-methyl-2-oxo-chromen-7-yl)oxypropanoylamino]-3-(5-hydroxy-1H-indol-3-yl)propanoic acid	4836069	CCc1cc(=O)oc2c1ccc(OC(C)C(=O)NC(Cc1c[nH]c3c1cc(O)cc3)C(=O)O)c2C	2-[2-(4-ethyl-8-methyl-2-oxochromen-7-yl)oxypropanoylamino]-3-(5-hydroxy-1H-indol-3-yl)propanoic acid			2.38422													MCULE-3545089077	478.50632		478.174001	7	4	8	4			45									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(4836069)	4836069	3.7	864			[#6]-[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6](-[#6])-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]3:[#6]:1:[#6]:[#6](-[#8]):[#6]:[#6]:3)-[#6](=[#8])-[#8]):[#6]:2-[#6]	CCc1cc(=O)oc2c1ccc(OC(C)C(=O)NC(Cc1c[nH]c3c1cc(O)cc3)C(=O)O)c2C	SSTKTMCDROXOIL		parent_pubchem_cid	N-{2-[(4-ethyl-8-methyl-2-oxo-2H-chromen-7-yl)oxy]propanoyl}-5-hydroxytryptophan;1214214-07-9;EiM07-29403;AKOS016390165;2-[2-(4-ethyl-8-methyl-2-oxo-chromen-7-yl)oxypropanoylamino]-3-(5-hydroxy-1H-indol-3-yl)propanoic acid		23570403.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23570403		pluskal_iocb_peptide_Peptide01_E13_id		100	E13		
4.7		0	462	P2196112	134.6		V10	False	0	21	1	0	27	0	4	2	0	2		0.0						CCCSc1ncc(Cl)c(C(=O)NC(CCSC)C(=O)Nc2c(C)cc(C)cc2)n1																							0.0		AKOS016027331		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C21H27ClN4O2S2	C21H27ClN4O2S2			InChI=1S/C21H27ClN4O2S2/c1-5-9-30-21-23-12-15(22)18(26-21)20(28)25-17(8-10-29-4)19(27)24-16-7-6-13(2)11-14(16)3/h6-7,11-12,17H,5,8-10H2,1-4H3,(H,24,27)(H,25,28)	RECDMPIKFYPMSE-UHFFFAOYSA-N	5-chloro-N-[1-[(2,4-dimethylphenyl)carbamoyl]-3-methylsulfanyl-propyl]-2-propylsulfanyl-pyrimidine-4-carboxamide	52988681	CCCSc1ncc(Cl)c(C(=O)NC(CCSC)C(=O)Nc2c(C)cc(C)cc2)n1	5-chloro-N-[1-(2,4-dimethylanilino)-4-methylsulfanyl-1-oxobutan-2-yl]-2-propylsulfanylpyrimidine-4-carboxamide			4.086390000000003													MCULE-9737737895	467.05594		466.126396	6	2	10	2			45										False	Alkaloids				Peptide01			Compound(52988681)	52988681	4.9	865			[#6]-[#6]-[#6]-[#16]-[#6]1:[#7]:[#6]:[#6](-[#17]):[#6](-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]-[#16]-[#6])-[#6](=[#8])-[#7]-[#6]2:[#6](-[#6]):[#6]:[#6](-[#6]):[#6]:[#6]:2):[#7]:1	CCCSc1ncc(Cl)c(C(=O)NC(CCSC)C(=O)Nc2c(C)cc(C)cc2)n1	RECDMPIKFYPMSE		parent_pubchem_cid	AKOS016027331;5-chloro-N-[1-[(2,4-dimethylphenyl)carbamoyl]-3-methylsulfanyl-propyl]-2-propylsulfanyl-pyrimidine-4-carboxamide		24582694.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24582694		pluskal_iocb_peptide_Peptide01_E13_id		100	E13		
3.2		0	550	P2195812	84.5		V11	False	0	23	0	0	28	0	2	4	0	0		0.0						COC(=O)CNC(=O)C(Cc1ccccc1)NC(=O)c1ccc(C(C)(C)C)cc1																							0.0		STL219268		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C23H28N2O4	C23H28N2O4			InChI=1S/C23H28N2O4/c1-23(2,3)18-12-10-17(11-13-18)21(27)25-19(14-16-8-6-5-7-9-16)22(28)24-15-20(26)29-4/h5-13,19H,14-15H2,1-4H3,(H,24,28)(H,25,27)	UENKXGFXRGDPIE-UHFFFAOYSA-N	methyl 2-[[2-[(4-tert-butylbenzoyl)amino]-3-phenyl-propanoyl]amino]acetate	52988614	COC(=O)CNC(=O)C(Cc1ccccc1)NC(=O)c1ccc(C(C)(C)C)cc1	methyl 2-[[2-[(4-tert-butylbenzoyl)amino]-3-phenylpropanoyl]amino]acetate			2.45027													MCULE-5425666407	396.49061		396.204907	4	2	9	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(52988614)	52988614	3.8	866			[#6]-[#8]-[#6](=[#8])-[#6]-[#7]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6])(-[#6])-[#6]):[#6]:[#6]:1	COC(=O)CNC(=O)C(Cc1ccccc1)NC(=O)c1ccc(C(C)(C)C)cc1	UENKXGFXRGDPIE		parent_pubchem_cid	STL219268;AKOS015861935;methyl N-[(4-tert-butylphenyl)carbonyl]phenylalanylglycinate;methyl 2-[[2-[(4-tert-butylbenzoyl)amino]-3-phenyl-propanoyl]amino]acetate		23098600.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23098600		pluskal_iocb_peptide_Peptide01_E13_id		100	E13		
4.9		0	638	P1307404	54.1		V12	False	0	25	0	0	24	0	2	2	0	0		0.0						CCOc1ccccc1C(=O)NCC(c1ccccc1)c1c[nH]c2ccccc12																							0.0		2-ethoxy-N-[2-(1H-indol-3-yl)-2-phenylethyl]benzamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C25H24N2O2	C25H24N2O2			InChI=1S/C25H24N2O2/c1-2-29-24-15-9-7-13-20(24)25(28)27-16-21(18-10-4-3-5-11-18)22-17-26-23-14-8-6-12-19(22)23/h3-15,17,21,26H,2,16H2,1H3,(H,27,28)	OUJPTRZVDWHVTQ-UHFFFAOYSA-N	2-ethoxy-N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]benzamide	43843123	CCOc1ccccc1C(=O)NCC(c1ccccc1)c1c[nH]c2ccccc12	2-ethoxy-N-[2-(1H-indol-3-yl)-2-phenylethyl]benzamide			4.073540000000002													MCULE-9885913285	384.48223		384.183778	2	2	7	4			45										False	Alkaloids				Peptide01			Compound(43843123)	43843123	5.1	867			[#6]-[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#6](=[#8])-[#7]-[#6]-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CCOc1ccccc1C(=O)NCC(c1ccccc1)c1c[nH]c2ccccc12	OUJPTRZVDWHVTQ		parent_pubchem_cid	2-ethoxy-N-[2-(1H-indol-3-yl)-2-phenylethyl]benzamide;AKOS001533516;AKOS016329172;2-ethoxy-N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]benzamide		22708614.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22708614		pluskal_iocb_peptide_Peptide01_E13_id		100	E13		
2.9		0	382	P1098300	139.2		V13	False	0	21	0	0	25	0	1	8	0	0		0.0						CCCCc1cc(=O)oc2c1ccc(OCC(=O)NC(CCC(=O)O)C(=O)O)c2C								N-acyl-L-alpha-amino acids;Coumarins and derivatives;1-benzopyrans;Pyranones and derivatives;Alkyl aryl ethers;Benzenoids;Dicarboxylic acids and derivatives;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactones;Oxacyclic compounds;Carboxylic acids;Hydrocarbon derivatives;Carbonyl compounds;Organic oxides;Organonitrogen compounds;Organopnictogen compounds	1-benzopyrans;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;Dicarboxylic acids and derivatives;Ethers;Glutamic acid and derivatives;Heteroaromatic compounds;Hydrocarbon derivatives;Lactones;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Secondary carboxylic acid amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as glutamic acid and derivatives. These are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Glutamic acid and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-L-alpha-amino acid (CHEBI:48927);coumarins (CHEBI:23403);1-benzopyran (CHEBI:38443);pyranone (CHEBI:37963);aromatic ether (CHEBI:35618);benzenoid aromatic compound (CHEBI:33836);dicarboxylic acid (CHEBI:35692);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactone (CHEBI:25000);oxacycle (CHEBI:38104);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);glutamic acid derivative (CHEBI:24315);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);amino acid (CHEBI:33709);peptide (CHEBI:16670);N-acyl-amino acid (CHEBI:51569);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);pyrans (CHEBI:26407);oxygen molecular entity (CHEBI:25806);ether (CHEBI:25698);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)	Dicarboxylic acids (FA0117);Benzopyranoids (PK1311)	Amino acids, peptides, and analogues	Glutamic acid or derivatives;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;N-acyl-l-alpha-amino acid;Coumarin;Benzopyran;1-benzopyran;Alkyl aryl ether;Pyranone;Dicarboxylic acid or derivatives;Pyran;Benzenoid;Heteroaromatic compound;Secondary carboxylic acid amide;Carboxamide group;Lactone;Organoheterocyclic compound;Oxacycle;Carboxylic acid;Ether;Carbonyl group;Organic nitrogen compound;Organopnictogen compound;Organic oxygen compound;Organooxygen compound;Organic oxide;Hydrocarbon derivative;Organonitrogen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		EiM07-16978		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	3	2	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C21H25NO8	C21H25NO8			InChI=1S/C21H25NO8/c1-3-4-5-13-10-19(26)30-20-12(2)16(8-6-14(13)20)29-11-17(23)22-15(21(27)28)7-9-18(24)25/h6,8,10,15H,3-5,7,9,11H2,1-2H3,(H,22,23)(H,24,25)(H,27,28)/t15-/m0/s1	BXPINNBJLNOEOY-HNNXBMFYSA-N	rac-(2S)-2-[[2-(4-butyl-8-methyl-2-oxo-chromen-7-yl)oxyacetyl]amino]pentanedioic acid	1780695	CCCCc1cc(=O)oc2c1ccc(OCC(=O)N[C@@H](CCC(=O)O)C(=O)O)c2C	(2S)-2-[[2-(4-butyl-8-methyl-2-oxochromen-7-yl)oxyacetyl]amino]pentanedioic acid			2.1566600000000005													MCULE-8417579224	419.4353		419.158017	8	3	11	2			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(1780695)	1780695	2.5	868			[#6]-[#6]-[#6]-[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]-[#6](=[#8])-[#8])-[#6](=[#8])-[#8]):[#6]:2-[#6]	CCCCc1cc(=O)oc2c1ccc(OCC(=O)N[C@@H](CCC(=O)O)C(=O)O)c2C	BXPINNBJLNOEOY		parent_pubchem_cid	EiM07-16978;AKOS016390303;2-{2-[(4-BUTYL-8-METHYL-2-OXO-2H-CHROMEN-7-YL)OXY]ACETAMIDO}PENTANEDIOIC ACID;rac-(2S)-2-[[2-(4-butyl-8-methyl-2-oxo-chromen-7-yl)oxyacetyl]amino]pentanedioic acid		24402390.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24402390		pluskal_iocb_peptide_Peptide01_E13_id		100	E13		ZINC000002126011
4.2		0	470	P2196148	134.6		V14	False	0	20	1	0	25	0	4	2	0	2		0.0						CCCSc1ncc(Cl)c(C(=O)NC(CCSC)C(=O)Nc2cccc(C)c2)n1																							0.0		AKOS016027266		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C20H25ClN4O2S2	C20H25ClN4O2S2			InChI=1S/C20H25ClN4O2S2/c1-4-9-29-20-22-12-15(21)17(25-20)19(27)24-16(8-10-28-3)18(26)23-14-7-5-6-13(2)11-14/h5-7,11-12,16H,4,8-10H2,1-3H3,(H,23,26)(H,24,27)	MAVPLLTUUMXKHR-UHFFFAOYSA-N	5-chloro-N-[3-methylsulfanyl-1-(m-tolylcarbamoyl)propyl]-2-propylsulfanyl-pyrimidine-4-carboxamide	52988698	CCCSc1ncc(Cl)c(C(=O)NC(CCSC)C(=O)Nc2cccc(C)c2)n1	5-chloro-N-[1-(3-methylanilino)-4-methylsulfanyl-1-oxobutan-2-yl]-2-propylsulfanylpyrimidine-4-carboxamide			3.8326800000000025													MCULE-6724608481	453.02885		452.110746	6	2	10	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(52988698)	52988698	4.5	869			[#6]-[#6]-[#6]-[#16]-[#6]1:[#7]:[#6]:[#6](-[#17]):[#6](-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]-[#16]-[#6])-[#6](=[#8])-[#7]-[#6]2:[#6]:[#6]:[#6]:[#6](-[#6]):[#6]:2):[#7]:1	CCCSc1ncc(Cl)c(C(=O)NC(CCSC)C(=O)Nc2cccc(C)c2)n1	MAVPLLTUUMXKHR		parent_pubchem_cid	AKOS016027266;5-chloro-N-[3-methylsulfanyl-1-(m-tolylcarbamoyl)propyl]-2-propylsulfanyl-pyrimidine-4-carboxamide		24250322.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24250322		pluskal_iocb_peptide_Peptide01_E13_id		100	E13		
4.2		0	558	P7006436	61.9		V15	False	0	21	0	0	19	0	3	1	0	0	-1.0	0.0						N#Cc1c(NCCc2ccccc2)oc(C2CC2c2ccccc2)n1		4.47		0.0	4.06	CHEMBL5017723																	0.0		CHEMBL5017723		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C21H19N3O	C21H19N3O			InChI=1S/C21H19N3O/c22-14-19-21(23-12-11-15-7-3-1-4-8-15)25-20(24-19)18-13-17(18)16-9-5-2-6-10-16/h1-10,17-18,23H,11-13H2	AHITXPXITHQFPL-UHFFFAOYSA-N	2-(2-phenylcyclopropyl)-5-(2-phenylethylamino)oxazole-4-carbonitrile	73253924	N#Cc1c(NCCc2ccccc2)oc(C2CC2c2ccccc2)n1	2-(2-phenylcyclopropyl)-5-(2-phenylethylamino)-1,3-oxazole-4-carbonitrile			3.872530000000003													MCULE-9088072532	329.40508	NEUTRAL	329.152812	3	1	6	4	0.0		30										False	Alkaloids		False	False	Peptide01		-1.0	Compound(73253924)	73253924	5.2	870			[#7]#[#6]-[#6]1:[#6](-[#7]-[#6]-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#8]:[#6](-[#6]2-[#6]-[#6]-2-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#7]:1	N#Cc1c(NCCc2ccccc2)oc(C2CC2c2ccccc2)n1	AHITXPXITHQFPL		parent_pubchem_cid	CHEMBL5017723;AKOS024254885;2-(2-phenylcyclopropyl)-5-(2-phenylethylamino)oxazole-4-carbonitrile	False	69862709.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=69862709		pluskal_iocb_peptide_Peptide01_E13_id		100	E13	False	
4.6		0	646	P1306321	58.0		V16	False	1	21	0	0	17	0	2	2	0	0		0.0						O=C(NCC(c1ccccc1)c1c[nH]c2ccccc12)c1ccc(Br)o1																							0.0		5-bromo-N-[2-(1H-indol-3-yl)-2-phenylethyl]furan-2-carboxamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C21H17BrN2O2	C21H17BrN2O2			InChI=1S/C21H17BrN2O2/c22-20-11-10-19(26-20)21(25)24-12-16(14-6-2-1-3-7-14)17-13-23-18-9-5-4-8-15(17)18/h1-11,13,16,23H,12H2,(H,24,25)	HLKCSSKUMSPVFI-UHFFFAOYSA-N	5-bromo-N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]furan-2-carboxamide	43842889	O=C(NCC(c1ccccc1)c1c[nH]c2ccccc12)c1ccc(Br)o1	5-bromo-N-[2-(1H-indol-3-yl)-2-phenylethyl]furan-2-carboxamide			4.492750000000003													MCULE-6817866760	409.28584		408.04734	1	2	5	4			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(43842889)	43842889	5.2	871			[#8]=[#6](-[#7]-[#6]-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6]1:[#6]:[#6]:[#6](-[#35]):[#8]:1	O=C(NCC(c1ccccc1)c1c[nH]c2ccccc12)c1ccc(Br)o1	HLKCSSKUMSPVFI		parent_pubchem_cid	5-bromo-N-[2-(1H-indol-3-yl)-2-phenylethyl]furan-2-carboxamide;912897-14-4;AKOS002289936;AKOS016329463;Z29961030;5-bromo-N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]furan-2-carboxamide		23705978.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23705978		pluskal_iocb_peptide_Peptide01_E13_id		100	E13		
2.8		0	390	P9080061	66.5		V17	False	0	25	0	0	24	0	2	3	0	0		0.0						O=C(NCc1ccccc1)C(Cc1ccccc1)N1C(=O)C2C3C=CC(C3)C2C1=O								Isoindolones;Amphetamines and derivatives;Pyrrolidine-2-ones;N-substituted carboxylic acid imides;N-alkylpyrrolidines;Fatty amides;Dicarboximides;Secondary carboxylic acid amides;Lactams;Azacyclic compounds;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acid imides;Carboxylic acids and derivatives;Chemical entities;Dicarboximides;Fatty Acyls;Fatty amides;Hydrocarbon derivatives;Isoindoles and derivatives;Isoindolines;Isoindolones;Lactams;Lipids and lipid-like molecules;N-alkylpyrrolidines;N-substituted carboxylic acid imides;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenethylamines;Phenylalanine and derivatives;Pyrrolidine-2-ones;Pyrrolidines;Pyrrolidones;Secondary carboxylic acid amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	isoindoles (CHEBI:24897);amphetamines (CHEBI:35338);pyrrolidin-2-ones (CHEBI:74223);dicarboximide (CHEBI:35356);N-alkylpyrrolidine (CHEBI:46775);fatty amide (CHEBI:29348);carboxamide (CHEBI:37622);lactam (CHEBI:24995);organonitrogen heterocyclic compound (CHEBI:38101);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);primary amine (CHEBI:32877);pyrrolidines (CHEBI:38260);pyrrolidinone (CHEBI:38275);organooxygen compound (CHEBI:36963);lipid (CHEBI:18059);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806);amino acid (CHEBI:33709);peptide (CHEBI:16670)	Fatty amides (FA08);Fatty Acyls (FA)	Amino acids, peptides, and analogues	Phenylalanine or derivatives;Amphetamine or derivatives;Isoindolone;Isoindoline;Isoindole or derivatives;Monocyclic benzene moiety;Fatty amide;Carboxylic acid imide, n-substituted;Pyrrolidone;2-pyrrolidone;N-alkylpyrrolidine;Benzenoid;Fatty acyl;Pyrrolidine;Dicarboximide;Carboxylic acid imide;Lactam;Secondary carboxylic acid amide;Carboxamide group;Azacycle;Organoheterocyclic compound;Hydrocarbon derivative;Organic oxygen compound;Organopnictogen compound;Organic oxide;Organic nitrogen compound;Organonitrogen compound;Organooxygen compound;Carbonyl group;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		Cambridge id 7028743		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	2	0		C25H24N2O3	C25H24N2O3			InChI=1S/C25H24N2O3/c28-23(26-15-17-9-5-2-6-10-17)20(13-16-7-3-1-4-8-16)27-24(29)21-18-11-12-19(14-18)22(21)25(27)30/h1-12,18-22H,13-15H2,(H,26,28)	WFMOHGIYKDRBIU-UHFFFAOYSA-N	N-benzyl-2-(3,5-dioxo-4-azatricyclo[5.2.1.02,6]dec-8-en-4-yl)-3-phenyl-propanamide	2924679	O=C(NCc1ccccc1)C(Cc1ccccc1)N1C(=O)C2C3C=CC(C3)C2C1=O	N-benzyl-2-(3,5-dioxo-4-azatricyclo[5.2.1.02,6]dec-8-en-4-yl)-3-phenylpropanamide			2.6117800000000004													MCULE-8280835008	400.48163		400.178693	3	1	6	5			45										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(2924679)	2924679	3.1	872			[#8]=[#6](-[#7]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]1-[#6](=[#8])-[#6]2-[#6]3-[#6]=[#6]-[#6](-[#6]-3)-[#6]-2-[#6]-1=[#8]	O=C(NCc1ccccc1)C(Cc1ccccc1)N1C(=O)C2C3C=CC(C3)C2C1=O	WFMOHGIYKDRBIU		parent_pubchem_cid	Cambridge id 7028743;AKOS001870104;AKOS016186061;N-benzyl-2-(1,3-dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-methanoisoindol-2-yl)-3-phenylpropanamide;SR-01000250014;SR-01000250014-1;N-benzyl-2-(3,5-dioxo-4-azatricyclo[5.2.1.02,6]dec-8-en-4-yl)-3-phenyl-propanamide		23480487.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23480487		pluskal_iocb_peptide_Peptide01_E14_id		100	E14		
2.8		0	478	P2195224	84.5		V18	False	0	18	1	0	25	0	2	4	0	0		0.0						COC(=O)CCCNC(=O)C(CC(C)C)NC(=O)c1ccc(Cl)cc1																							0.0		AKOS015861278		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C18H25ClN2O4	C18H25ClN2O4			InChI=1S/C18H25ClN2O4/c1-12(2)11-15(18(24)20-10-4-5-16(22)25-3)21-17(23)13-6-8-14(19)9-7-13/h6-9,12,15H,4-5,10-11H2,1-3H3,(H,20,24)(H,21,23)	GXGSFSOTSBILAR-UHFFFAOYSA-N	methyl 4-[[2-[(4-chlorobenzoyl)amino]-4-methyl-pentanoyl]amino]butanoate	51065733	COC(=O)CCCNC(=O)C(CC(C)C)NC(=O)c1ccc(Cl)cc1	methyl 4-[[2-[(4-chlorobenzoyl)amino]-4-methylpentanoyl]amino]butanoate			2.4991900000000005													MCULE-6936427384	368.86395		368.150285	4	2	10	1			45									Simple amide alkaloids	False	Alkaloids	Peptide alkaloids			Peptide01			Compound(51065733)	51065733	3.1	873			[#6]-[#8]-[#6](=[#8])-[#6]-[#6]-[#6]-[#7]-[#6](=[#8])-[#6](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#17]):[#6]:[#6]:1	COC(=O)CCCNC(=O)C(CC(C)C)NC(=O)c1ccc(Cl)cc1	GXGSFSOTSBILAR		parent_pubchem_cid	AKOS015861278;methyl 4-[[2-[(4-chlorobenzoyl)amino]-4-methyl-pentanoyl]amino]butanoate		23855612.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23855612		pluskal_iocb_peptide_Peptide01_E14_id		100	E14		
4.5		0	566	P1310242	110.2		V19	False	0	21	0	0	17	0	3	3	0	1		0.0						CN(C(=O)c1ccccc1[N+](=O)[O-])C(c1cccs1)c1c[nH]c2ccccc12																							0.0		STL210973		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	1		C21H17N3O3S	C21H17N3O3S			InChI=1S/C21H17N3O3S/c1-23(21(25)15-8-3-5-10-18(15)24(26)27)20(19-11-6-12-28-19)16-13-22-17-9-4-2-7-14(16)17/h2-13,20,22H,1H3	SQPAETCAGFKPTK-UHFFFAOYSA-N	N-[1H-indol-3-yl(2-thienyl)methyl]-N-methyl-2-nitro-benzamide	43843749	CN(C(=O)c1ccccc1[N+](=O)[O-])C(c1cccs1)c1c[nH]c2ccccc12	N-[1H-indol-3-yl(thiophen-2-yl)methyl]-N-methyl-2-nitrobenzamide			4.026040000000003													MCULE-9771480094	391.45194		391.099062	3	1	5	4			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(43843749)	43843749	4.2	874			[#6]-[#7](-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#7+](=[#8])-[#8-])-[#6](-[#6]1:[#6]:[#6]:[#6]:[#16]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CN(C(=O)c1ccccc1[N+](=O)[O-])C(c1cccs1)c1c[nH]c2ccccc12	SQPAETCAGFKPTK		parent_pubchem_cid	STL210973;AKOS002280879;AKOS016329043;N-[1H-indol-3-yl(thiophen-2-yl)methyl]-N-methyl-2-nitrobenzamide;N-[1H-indol-3-yl(2-thienyl)methyl]-N-methyl-2-nitro-benzamide		24798815.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24798815		pluskal_iocb_peptide_Peptide01_E14_id		100	E14		
4.9		0	654	P1305502	54.1		V20	False	0	25	0	0	24	0	2	2	0	0		0.0						CCOc1ccc(C(=O)NCC(c2ccccc2)c2c[nH]c3ccccc23)cc1																							0.0		4-ethoxy-N-[2-(1H-indol-3-yl)-2-phenylethyl]benzamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C25H24N2O2	C25H24N2O2			InChI=1S/C25H24N2O2/c1-2-29-20-14-12-19(13-15-20)25(28)27-16-22(18-8-4-3-5-9-18)23-17-26-24-11-7-6-10-21(23)24/h3-15,17,22,26H,2,16H2,1H3,(H,27,28)	PJENWSLHXDSDPO-UHFFFAOYSA-N	4-ethoxy-N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]benzamide	17014648	CCOc1ccc(C(=O)NCC(c2ccccc2)c2c[nH]c3ccccc23)cc1	4-ethoxy-N-[2-(1H-indol-3-yl)-2-phenylethyl]benzamide			4.073540000000003													MCULE-5798057765	384.48223		384.183778	2	2	7	4			45										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(17014648)	17014648	5.1	875			[#6]-[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](=[#8])-[#7]-[#6]-[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	CCOc1ccc(C(=O)NCC(c2ccccc2)c2c[nH]c3ccccc23)cc1	PJENWSLHXDSDPO		parent_pubchem_cid	4-ethoxy-N-[2-(1H-indol-3-yl)-2-phenylethyl]benzamide;AKOS002334760;AKOS016326713;4-ethoxy-N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]benzamide		24539890.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24539890		pluskal_iocb_peptide_Peptide01_E14_id		100	E14		
3.8		0	398	P7008311	62.1		V21	False	0	23	0	0	25	0	7	0	0	0		0.0						Cn1ncc2c(Nc3ccccc3)nc(N3CCN(Cc4ccccc4)CC3)nc21																							0.0		AKOS001906572		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	3		C23H25N7	C23H25N7			InChI=1S/C23H25N7/c1-28-22-20(16-24-28)21(25-19-10-6-3-7-11-19)26-23(27-22)30-14-12-29(13-15-30)17-18-8-4-2-5-9-18/h2-11,16H,12-15,17H2,1H3,(H,25,26,27)	JOVJDUGAPNDIGB-UHFFFAOYSA-N	6-(4-benzylpiperazin-1-yl)-1-methyl-N-phenyl-pyrazolo[3,4-d]pyrimidin-4-amine	16456629	Cn1ncc2c(Nc3ccccc3)nc(N3CCN(Cc4ccccc4)CC3)nc21	6-(4-benzylpiperazin-1-yl)-1-methyl-N-phenylpyrazolo[3,4-d]pyrimidin-4-amine			1.80414													MCULE-1380897753	399.5026		399.217144	6	1	5	5			44										False	Alkaloids				Peptide01			Compound(16456629)	16456629	3.8	876			[#6]-[#7]1:[#7]:[#6]:[#6]2:[#6](-[#7]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#7]:[#6](-[#7]3-[#6]-[#6]-[#7](-[#6]-[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]:4)-[#6]-[#6]-3):[#7]:[#6]:1:2	Cn1ncc2c(Nc3ccccc3)nc(N3CCN(Cc4ccccc4)CC3)nc21	JOVJDUGAPNDIGB		parent_pubchem_cid	AKOS001906572;CCG-170401;6-(4-benzylpiperazin-1-yl)-1-methyl-N-phenyl-pyrazolo[3,4-d]pyrimidin-4-amine		18236074.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=18236074		pluskal_iocb_peptide_Peptide01_E14_id		100	E14		ZINC000015682330
4.7		0	486	P2195418	58.2		V22	False	0	25	0	0	26	0	2	2	0	0		0.0						Cc1ccc(CNC(=O)C(Cc2ccccc2)NC(=O)c2ccc(C)cc2)cc1																							0.0		AKOS015861500		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C25H26N2O2	C25H26N2O2			InChI=1S/C25H26N2O2/c1-18-8-12-21(13-9-18)17-26-25(29)23(16-20-6-4-3-5-7-20)27-24(28)22-14-10-19(2)11-15-22/h3-15,23H,16-17H2,1-2H3,(H,26,29)(H,27,28)	PDKCBHUCVGPMEE-UHFFFAOYSA-N	N-[1-benzyl-2-oxo-2-(p-tolylmethylamino)ethyl]-4-methyl-benzamide	51065887	Cc1ccc(CNC(=O)C(Cc2ccccc2)NC(=O)c2ccc(C)cc2)cc1	4-methyl-N-[1-[(4-methylphenyl)methylamino]-1-oxo-3-phenylpropan-2-yl]benzamide			3.6873900000000015													MCULE-9873594931	386.49817		386.199428	2	2	7	3			45										False	Amino acids and Peptides				Peptide01			Compound(51065887)	51065887	4.4	877			[#6]-[#6]1:[#6]:[#6]:[#6](-[#6]-[#7]-[#6](=[#8])-[#6](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:2):[#6]:[#6]:1	Cc1ccc(CNC(=O)C(Cc2ccccc2)NC(=O)c2ccc(C)cc2)cc1	PDKCBHUCVGPMEE		parent_pubchem_cid	AKOS015861500;N-[1-benzyl-2-oxo-2-(p-tolylmethylamino)ethyl]-4-methyl-benzamide		23071325.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23071325		pluskal_iocb_peptide_Peptide01_E14_id		100	E14		
4.3		0	574	P4351727	83.4		V23	False	0	19	0	0	16	0	4	2	0	0		0.0						CCc1nc(C#N)c(NN=Cc2cc(Oc3ccccc3)ccc2)o1																							0.0		AKOS005180065		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C19H16N4O2	C19H16N4O2			InChI=1S/C19H16N4O2/c1-2-18-22-17(12-20)19(25-18)23-21-13-14-7-6-10-16(11-14)24-15-8-4-3-5-9-15/h3-11,13,23H,2H2,1H3/b21-13+	CYPBEOKNYRJLEU-FYJGNVAPSA-N	2-ethyl-5-[(2E)-2-[(3-phenoxyphenyl)methylene]hydrazino]oxazole-4-carbonitrile	44615472	CCc1nc(C#N)c(N/N=C/c2cc(Oc3ccccc3)ccc2)o1	2-ethyl-5-[(2E)-2-[(3-phenoxyphenyl)methylidene]hydrazinyl]-1,3-oxazole-4-carbonitrile			2.8774200000000016													MCULE-6249039429	332.36497		332.127326	5	1	6	3			44										False	Alkaloids				Peptide01			Compound(44615472)	44615472	5.3	878			[#6]-[#6]-[#6]1:[#7]:[#6](-[#6]#[#7]):[#6](-[#7]/[#7]=[#6]/[#6]2:[#6]:[#6](-[#8]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#6]:[#6]:[#6]:2):[#8]:1	CCc1nc(C#N)c(N/N=C/c2cc(Oc3ccccc3)ccc2)o1	CYPBEOKNYRJLEU		parent_pubchem_cid	AKOS005180065;2-ethyl-5-[(2E)-2-[(3-phenoxyphenyl)methylene]hydrazino]oxazole-4-carbonitrile		14564842.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=14564842		pluskal_iocb_peptide_Peptide01_E14_id		100	E14		ZINC000028467641
5.0		0	662	P1307204	54.6		V24	False	0	26	0	0	26	0	2	3	0	0		0.0						COc1ccc(OCC(=O)N(C)C(c2ccc(C)cc2)c2c[nH]c3ccccc23)cc1																							0.0		AKOS002295799		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C26H26N2O3	C26H26N2O3			InChI=1S/C26H26N2O3/c1-18-8-10-19(11-9-18)26(23-16-27-24-7-5-4-6-22(23)24)28(2)25(29)17-31-21-14-12-20(30-3)13-15-21/h4-16,26-27H,17H2,1-3H3	PDFAESAAYUNARB-UHFFFAOYSA-N	N-[1H-indol-3-yl(p-tolyl)methyl]-2-(4-methoxyphenoxy)-N-methyl-acetamide	43843090	COc1ccc(OCC(=O)N(C)C(c2ccc(C)cc2)c2c[nH]c3ccccc23)cc1	N-[1H-indol-3-yl-(4-methylphenyl)methyl]-2-(4-methoxyphenoxy)-N-methylacetamide			3.594350000000002													MCULE-6954811516	414.50872		414.194343	3	1	7	4			45										False	Alkaloids				Peptide01			Compound(43843090)	43843090	5.1	879			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]-[#6](=[#8])-[#7](-[#6])-[#6](-[#6]2:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	COc1ccc(OCC(=O)N(C)C(c2ccc(C)cc2)c2c[nH]c3ccccc23)cc1	PDFAESAAYUNARB		parent_pubchem_cid	AKOS002295799;AKOS016329375;N-[1H-indol-3-yl(p-tolyl)methyl]-2-(4-methoxyphenoxy)-N-methyl-acetamide		22974741.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22974741		pluskal_iocb_peptide_Peptide01_E14_id		100	E14		
3.0		0	406	P3460414	106.5		V25	False	0	21	0	0	21	0	3	3	0	1		0.0						COC(=O)C(CCSC)NC(=O)c1cc(-c2ccccn2)nc2ccccc12								Quinoline carboxamides;Alpha amino acid esters;N-acyl-alpha amino acids and derivatives;Bipyridines and oligopyridines;Pyridinecarboxylic acids and derivatives;Fatty acid esters;Benzenoids;Methyl esters;Heteroaromatic compounds;Secondary carboxylic acid amides;Sulfenyl compounds;Azacyclic compounds;Monocarboxylic acids and derivatives;Dialkylthioethers;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organonitrogen compounds	Alpha amino acid esters;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzenoids;Bipyridines and oligopyridines;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids and derivatives;Chemical entities;Dialkylthioethers;Fatty Acyls;Fatty acid esters;Heteroaromatic compounds;Hydrocarbon derivatives;Lipids and lipid-like molecules;Methionine and derivatives;Methyl esters;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Organosulfur compounds;Pyridinecarboxylic acids and derivatives;Pyridines and derivatives;Quinoline carboxamides;Quinolines and derivatives;Secondary carboxylic acid amides;Sulfenyl compounds;Thioethers	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as methionine and derivatives. These are compounds containing methionine or a derivative thereof resulting from reaction of methionine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Methionine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	quinolines (CHEBI:26513);carboxamide (CHEBI:37622);alpha-amino acid ester (CHEBI:46874);N-acyl-amino acid (CHEBI:51569);bipyridines (CHEBI:50511);aromatic carboxylic acid (CHEBI:33859);pyridinemonocarboxylic acid (CHEBI:26420);fatty acid ester (CHEBI:35748);benzenoid aromatic compound (CHEBI:33836);carboxylic ester (CHEBI:33308);organic aromatic compound (CHEBI:33659);organosulfur compound (CHEBI:33261);organonitrogen heterocyclic compound (CHEBI:38101);monocarboxylic acid (CHEBI:25384);aliphatic sulfide (CHEBI:22327);carbonyl compound (CHEBI:36586);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);alpha-amino acid (CHEBI:33704);methionine derivative (CHEBI:25230);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);organooxygen compound (CHEBI:36963);pyridines (CHEBI:26421);lipid (CHEBI:18059);amide (CHEBI:32988);organic sulfide (CHEBI:16385);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143);amino acid (CHEBI:33709);peptide (CHEBI:16670)	Fatty esters (FA07);Fatty Acyls (FA)	Amino acids, peptides, and analogues	Methionine or derivatives;Alpha-amino acid ester;N-acyl-alpha amino acid or derivatives;Quinoline-4-carboxamide;Bipyridine;Quinoline;Pyridine carboxylic acid or derivatives;Fatty acid ester;Fatty acyl;Benzenoid;Pyridine;Heteroaromatic compound;Methyl ester;Carboxamide group;Carboxylic acid ester;Secondary carboxylic acid amide;Azacycle;Monocarboxylic acid or derivatives;Organoheterocyclic compound;Dialkylthioether;Sulfenyl compound;Thioether;Organic oxygen compound;Organic nitrogen compound;Organonitrogen compound;Organooxygen compound;Organosulfur compound;Carbonyl group;Organic oxide;Hydrocarbon derivative;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS016382709		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C21H21N3O3S	C21H21N3O3S			InChI=1S/C21H21N3O3S/c1-27-21(26)18(10-12-28-2)24-20(25)15-13-19(17-9-5-6-11-22-17)23-16-8-4-3-7-14(15)16/h3-9,11,13,18H,10,12H2,1-2H3,(H,24,25)/t18-/m0/s1	DPAWJGWKUJMMIH-SFHVURJKSA-N	methyl rac-(2S)-4-methylsulfanyl-2-[[2-(2-pyridyl)quinoline-4-carbonyl]amino]butanoate	39378144	COC(=O)[C@H](CCSC)NC(=O)c1cc(-c2ccccn2)nc2ccccc12	methyl (2S)-4-methylsulfanyl-2-[(2-pyridin-2-ylquinoline-4-carbonyl)amino]butanoate			2.4581500000000007													MCULE-4156361853	395.48382		395.130363	6	1	8	3			44									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(39378144)	39378144	3.1	880			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]-[#16]-[#6])-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#7]:2):[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	COC(=O)[C@H](CCSC)NC(=O)c1cc(-c2ccccn2)nc2ccccc12	DPAWJGWKUJMMIH		parent_pubchem_cid	AKOS016382709;methyl rac-(2S)-4-methylsulfanyl-2-[[2-(2-pyridyl)quinoline-4-carbonyl]amino]butanoate		10484388.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=10484388		pluskal_iocb_peptide_Peptide01_E15_id		100	E15		ZINC000032124292
2.5		0	494	P1045972	75.6		V26	False	0	17	0	0	17	0	1	4	0	0		0.0						COc1ccc(C(=O)NC(Cc2ccccc2)C(=O)O)cc1								N-acyl-alpha amino acids;Hippuric acids;Phenylpropanoic acids;Amphetamines and derivatives;Phenoxy compounds;Methoxybenzenes;Anisoles;Benzoyl derivatives;Alkyl aryl ethers;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organonitrogen compounds	Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Anisoles;Benzamides;Benzene and substituted derivatives;Benzenoids;Benzoic acids and derivatives;Benzoyl derivatives;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Ethers;Hippuric acids;Hippuric acids and derivatives;Hydrocarbon derivatives;Methoxybenzenes;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenethylamines;Phenol ethers;Phenoxy compounds;Phenylalanine and derivatives;Phenylpropanoic acids;Phenylpropanoids and polyketides;Secondary carboxylic acid amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic homomonocyclic compounds	N-acyl-amino acid (CHEBI:51569);N-acylglycine (CHEBI:16180);benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);amphetamines (CHEBI:35338);methoxybenzene (CHEBI:51683);carbonyl compound (CHEBI:36586);aromatic ether (CHEBI:35618);carboxamide (CHEBI:37622);monocarboxylic acid (CHEBI:25384);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);benzenoid aromatic compound (CHEBI:33836);benzoic acids (CHEBI:22723);benzamides (CHEBI:22702);primary amine (CHEBI:32877);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ether (CHEBI:25698);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);carboxylic acid anion (CHEBI:29067);amino acid (CHEBI:33709);peptide (CHEBI:16670);phenols (CHEBI:33853)		Amino acids, peptides, and analogues	Phenylalanine or derivatives;Hippuric acid or derivatives;Hippuric acid;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;3-phenylpropanoic-acid;Amphetamine or derivatives;Benzamide;Benzoic acid or derivatives;Anisole;Phenoxy compound;Benzoyl;Methoxybenzene;Phenol ether;Alkyl aryl ether;Monocyclic benzene moiety;Benzenoid;Carboxamide group;Secondary carboxylic acid amide;Monocarboxylic acid or derivatives;Ether;Carboxylic acid;Hydrocarbon derivative;Organic oxide;Carbonyl group;Organic oxygen compound;Organonitrogen compound;Organooxygen compound;Organic nitrogen compound;Aromatic homomonocyclic compound	Organic acids and derivatives	0.0		2-(4-Methoxy-benzoylamino)-3-phenyl-propionic acid		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C17H17NO4	C17H17NO4			InChI=1S/C17H17NO4/c1-22-14-9-7-13(8-10-14)16(19)18-15(17(20)21)11-12-5-3-2-4-6-12/h2-10,15H,11H2,1H3,(H,18,19)(H,20,21)	BHFKERBWGWXNFK-UHFFFAOYSA-N	2-[(4-methoxybenzoyl)amino]-3-phenyl-propanoic acid	3574399	COc1ccc(C(=O)NC(Cc2ccccc2)C(=O)O)cc1	2-[(4-methoxybenzoyl)amino]-3-phenylpropanoic acid			1.54907													MCULE-1964984512	299.32934		299.115758	4	2	6	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(3574399)	3574399	2.8	881		SCHEMBL3719426	[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#8]):[#6]:[#6]:1	COc1ccc(C(=O)NC(Cc2ccccc2)C(=O)O)cc1	BHFKERBWGWXNFK		parent_pubchem_cid	2-(4-Methoxy-benzoylamino)-3-phenyl-propionic acid;103678-74-6;2-[(4-methoxybenzoyl)amino]-3-phenylpropanoic acid;Oprea1_360071;SCHEMBL3719426;AKOS000127466;AKOS016051000;A1-00732;2-[(4-methoxybenzoyl)amino]-3-phenyl-propanoic acid		24272978.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24272978		pluskal_iocb_peptide_Peptide01_E15_id		100	E15		
4.8		0	582	P1306927	64.3		V27	False	0	21	0	1	17	0	2	1	0	1		0.0						CN(C(=O)c1ccccc1F)C(c1cccs1)c1c[nH]c2ccccc12																							0.0		AKOS001911127		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C21H17FN2OS	C21H17FN2OS			InChI=1S/C21H17FN2OS/c1-24(21(25)15-8-2-4-9-17(15)22)20(19-11-6-12-26-19)16-13-23-18-10-5-3-7-14(16)18/h2-13,20,23H,1H3	ZVZOTNZGFIERAU-UHFFFAOYSA-N	2-fluoro-N-[1H-indol-3-yl(2-thienyl)methyl]-N-methyl-benzamide	20895191	CN(C(=O)c1ccccc1F)C(c1cccs1)c1c[nH]c2ccccc12	2-fluoro-N-[1H-indol-3-yl(thiophen-2-yl)methyl]-N-methylbenzamide			4.637550000000004													MCULE-2817812777	364.44484		364.104562	1	1	4	4			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(20895191)	20895191	4.5	882			[#6]-[#7](-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#9])-[#6](-[#6]1:[#6]:[#6]:[#6]:[#16]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CN(C(=O)c1ccccc1F)C(c1cccs1)c1c[nH]c2ccccc12	ZVZOTNZGFIERAU		parent_pubchem_cid	AKOS001911127;AKOS016329522;CCG-154609;2-fluoro-N-[1H-indol-3-yl(2-thienyl)methyl]-N-methyl-benzamide		23237911.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23237911		pluskal_iocb_peptide_Peptide01_E15_id		100	E15		
4.4		0	670	P1306943	82.8		V28	False	0	23	0	0	22	0	2	3	0	1		0.0						COc1ccc(OCC(=O)N(C)C(c2cccs2)c2c[nH]c3ccccc23)cc1																							0.0		STL208010		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C23H22N2O3S	C23H22N2O3S			InChI=1S/C23H22N2O3S/c1-25(22(26)15-28-17-11-9-16(27-2)10-12-17)23(21-8-5-13-29-21)19-14-24-20-7-4-3-6-18(19)20/h3-14,23-24H,15H2,1-2H3	MIVQZWRFVZBWGD-UHFFFAOYSA-N	N-[1H-indol-3-yl(2-thienyl)methyl]-2-(4-methoxyphenoxy)-N-methyl-acetamide	20895183	COc1ccc(OCC(=O)N(C)C(c2cccs2)c2c[nH]c3ccccc23)cc1	N-[1H-indol-3-yl(thiophen-2-yl)methyl]-2-(4-methoxyphenoxy)-N-methylacetamide			3.402140000000001													MCULE-5924728164	406.50739		406.135114	3	1	7	4			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(20895183)	20895183	4.4	883			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]-[#6](=[#8])-[#7](-[#6])-[#6](-[#6]2:[#6]:[#6]:[#6]:[#16]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	COc1ccc(OCC(=O)N(C)C(c2cccs2)c2c[nH]c3ccccc23)cc1	MIVQZWRFVZBWGD		parent_pubchem_cid	STL208010;AKOS001911009;AKOS016329597;CCG-154607;N-[(1H-INDOL-3-YL)(THIOPHEN-2-YL)METHYL]-2-(4-METHOXYPHENOXY)-N-METHYLACETAMIDE;N-[1H-indol-3-yl(thiophen-2-yl)methyl]-2-(4-methoxyphenoxy)-N-methylacetamide;N-[1H-indol-3-yl(2-thienyl)methyl]-2-(4-methoxyphenoxy)-N-methyl-acetamide		24246283.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24246283		pluskal_iocb_peptide_Peptide01_E15_id		100	E15		
-0.4		0	414	P6237910	162.6		V29	False	0	12	0	0	18	0	4	4	0	1		0.0						Cc1nc(C)c(C(=O)NC(CCCNC(N)=O)C(=O)O)s1																							0.0		AKOS005582887		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	1	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C12H18N4O4S	C12H18N4O4S			InChI=1S/C12H18N4O4S/c1-6-9(21-7(2)15-6)10(17)16-8(11(18)19)4-3-5-14-12(13)20/h8H,3-5H2,1-2H3,(H,16,17)(H,18,19)(H3,13,14,20)/t8-/m1/s1	YAMKNFSZLXCIML-MRVPVSSYSA-N	rac-(2R)-2-[(2,4-dimethylthiazole-5-carbonyl)amino]-5-ureido-pentanoic acid	39341359	Cc1nc(C)c(C(=O)N[C@H](CCCNC(N)=O)C(=O)O)s1	(2R)-5-(carbamoylamino)-2-[(2,4-dimethyl-1,3-thiazole-5-carbonyl)amino]pentanoic acid			0.2273100000000009													MCULE-6207999239	314.36566		314.104876	5	4	7	1			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(39341359)	39341359	0.4	884			[#6]-[#6]1:[#7]:[#6](-[#6]):[#6](-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#8])-[#6](=[#8])-[#8]):[#16]:1	Cc1nc(C)c(C(=O)N[C@H](CCCNC(N)=O)C(=O)O)s1	YAMKNFSZLXCIML		parent_pubchem_cid	AKOS005582887;rac-(2R)-2-[(2,4-dimethylthiazole-5-carbonyl)amino]-5-ureido-pentanoic acid		23404200.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23404200		pluskal_iocb_peptide_Peptide01_E15_id		100	E15		ZINC000032095884
2.2		0	502	P2195934	95.5		V30	False	0	16	1	0	21	0	2	4	0	0		0.0						CC(C)CC(NC(=O)c1ccc(Cl)cc1)C(=O)NCCC(=O)O																							0.0		AKOS015861818		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C16H21ClN2O4	C16H21ClN2O4			InChI=1S/C16H21ClN2O4/c1-10(2)9-13(16(23)18-8-7-14(20)21)19-15(22)11-3-5-12(17)6-4-11/h3-6,10,13H,7-9H2,1-2H3,(H,18,23)(H,19,22)(H,20,21)	HEHVNXDIGCEEGO-UHFFFAOYSA-N	3-[[2-[(4-chlorobenzoyl)amino]-4-methyl-pentanoyl]amino]propanoic acid	52988659	CC(C)CC(NC(=O)c1ccc(Cl)cc1)C(=O)NCCC(=O)O	3-[[2-[(4-chlorobenzoyl)amino]-4-methylpentanoyl]amino]propanoic acid			2.02069													MCULE-9250105707	340.80977		340.118985	4	3	8	1			45									Simple amide alkaloids	False	Alkaloids	Peptide alkaloids			Peptide01			Compound(52988659)	52988659	2.4	885			[#6]-[#6](-[#6])-[#6]-[#6](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#17]):[#6]:[#6]:1)-[#6](=[#8])-[#7]-[#6]-[#6]-[#6](=[#8])-[#8]	CC(C)CC(NC(=O)c1ccc(Cl)cc1)C(=O)NCCC(=O)O	HEHVNXDIGCEEGO		parent_pubchem_cid	AKOS015861818;3-[[2-[(4-chlorobenzoyl)amino]-4-methyl-pentanoyl]amino]propanoic acid		23097078.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23097078		pluskal_iocb_peptide_Peptide01_E15_id		100	E15		
3.6		0	590	P1680035	64.6		V31	False	0	19	0	0	21	0	1	4	0	0		0.0						COC(=O)c1ccccc1NC(=O)c1ccc(OCC(C)C)cc1																							0.0		Oprea1_633345		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C19H21NO4	C19H21NO4			InChI=1S/C19H21NO4/c1-13(2)12-24-15-10-8-14(9-11-15)18(21)20-17-7-5-4-6-16(17)19(22)23-3/h4-11,13H,12H2,1-3H3,(H,20,21)	FBKDECASHOOOGQ-UHFFFAOYSA-N	methyl 2-[(4-isobutoxybenzoyl)amino]benzoate	1121870	COC(=O)c1ccccc1NC(=O)c1ccc(OCC(C)C)cc1	methyl 2-[[4-(2-methylpropoxy)benzoyl]amino]benzoate			2.8078600000000007													MCULE-7621600493	327.38352		327.147058	4	1	7	2			44									Anthranillic acid derivatives	False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(1121870)	1121870	4.6	886			[#6]-[#8]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]-[#6](-[#6])-[#6]):[#6]:[#6]:1	COC(=O)c1ccccc1NC(=O)c1ccc(OCC(C)C)cc1	FBKDECASHOOOGQ		parent_pubchem_cid	Oprea1_633345;STK729983;AKOS002236759;methyl 2-({[4-(2-methylpropoxy)phenyl]carbonyl}amino)benzoate;methyl 2-[(4-isobutoxybenzoyl)amino]benzoate		5051610.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=5051610		pluskal_iocb_peptide_Peptide01_E15_id		100	E15		ZINC000000859584
4.7		0	678	P3458905	36.1		V32	False	0	25	0	0	22	0	2	1	0	0		0.0						O=C(C(c1ccccc1)c1ccccc1)N1CCc2c(C1)c1ccccc1[nH]2																							0.0		2,2-diphenyl-1-(1,3,4,5-tetrahydro-2H-pyrido[4,3-b]indol-2-yl)ethanone		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C25H22N2O	C25H22N2O			InChI=1S/C25H22N2O/c28-25(24(18-9-3-1-4-10-18)19-11-5-2-6-12-19)27-16-15-23-21(17-27)20-13-7-8-14-22(20)26-23/h1-14,24,26H,15-17H2	QOVYGBXGFMXQKF-UHFFFAOYSA-N	2,2-diphenyl-1-(1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)ethanone	42569278	O=C(C(c1ccccc1)c1ccccc1)N1CCc2c(C1)c1ccccc1[nH]2	2,2-diphenyl-1-(1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)ethanone			4.237440000000003													MCULE-3440746701	366.46689		366.173213	1	1	3	5			44									Carboline alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(42569278)	42569278	4.7	887			[#8]=[#6](-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]1-[#6]-[#6]-[#6]2:[#6](-[#6]-1):[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1:[#7H]:2	O=C(C(c1ccccc1)c1ccccc1)N1CCc2c(C1)c1ccccc1[nH]2	QOVYGBXGFMXQKF		parent_pubchem_cid	2,2-diphenyl-1-(1,3,4,5-tetrahydro-2H-pyrido[4,3-b]indol-2-yl)ethanone;1010938-94-9;AKOS005535230;2,2-diphenyl-1-(1,3,4,5-tetrahydro-2H-pyrido[4,3-b]indol-2-yl)ethan-1-one;2,2-diphenyl-1-(1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)ethanone		4023258.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=4023258		pluskal_iocb_peptide_Peptide01_E15_id		100	E15		ZINC000012389467
3.6		0	422	P6238758	83.8		V33	False	0	21	0	0	22	0	4	2	0	0		0.0						Cc1noc2c1c(C(=O)NCCc1c[nH]c3ccccc13)cc(C(C)C)n2								Pyridinecarboxamides;Isoxazolopyridines;Substituted pyrroles;Benzenoids;Isoxazoles;Heteroaromatic compounds;Secondary carboxylic acid amides;Oxacyclic compounds;Azacyclic compounds;Organooxygen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	3-alkylindoles;Azacyclic compounds;Azoles;Benzenoids;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Isoxazoles;Isoxazolopyridines;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Pyridinecarboxamides;Pyridinecarboxylic acids and derivatives;Pyridines and derivatives;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as 3-alkylindoles. These are compounds containing an indole moiety that carries an alkyl chain at the 3-position.	3-alkylindoles			Organic compounds	Aromatic heteropolycyclic compounds	organothiophosphorus compound (CHEBI:25716);phosphoramide (CHEBI:17102);oxacycle (CHEBI:38104);organic heterobicyclic compound (CHEBI:27171);organonitrogen heterocyclic compound (CHEBI:38101);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);isoxazoles (CHEBI:55373);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organooxygen compound (CHEBI:36963);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);indoles (CHEBI:24828);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);pyridines (CHEBI:26421);aromatic carboxylic acid (CHEBI:33859);pyridinemonocarboxylic acid (CHEBI:26420);azole (CHEBI:68452);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143);pyrimidinecarboxamide (CHEBI:48438)		Indoles	3-alkylindole;1,2-oxazolopyridine;Pyridinecarboxamide;Pyridine carboxylic acid or derivatives;Pyridine;Substituted pyrrole;Benzenoid;Azole;Isoxazole;Pyrrole;Heteroaromatic compound;Carboxamide group;Secondary carboxylic acid amide;Carboxylic acid derivative;Oxacycle;Azacycle;Hydrocarbon derivative;Organic oxide;Organic oxygen compound;Organooxygen compound;Organonitrogen compound;Organic nitrogen compound;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		1190285-01-8		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C21H22N4O2	C21H22N4O2			InChI=1S/C21H22N4O2/c1-12(2)18-10-16(19-13(3)25-27-21(19)24-18)20(26)22-9-8-14-11-23-17-7-5-4-6-15(14)17/h4-7,10-12,23H,8-9H2,1-3H3,(H,22,26)	ZOMVHYMSDGBUIQ-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)ethyl]-6-isopropyl-3-methyl-isoxazolo[5,4-b]pyridine-4-carboxamide	45490639	Cc1noc2c1c(C(=O)NCCc1c[nH]c3ccccc13)cc(C(C)C)n2	N-[2-(1H-indol-3-yl)ethyl]-3-methyl-6-propan-2-yl-[1,2]oxazolo[5,4-b]pyridine-4-carboxamide			3.0327400000000013													MCULE-8166697376	362.43509		362.174276	3	2	5	4			44										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(45490639)	45490639	3.9	888			[#6]-[#6]1:[#7]:[#8]:[#6]2:[#6]:1:[#6](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:1:3):[#6]:[#6](-[#6](-[#6])-[#6]):[#7]:2	Cc1noc2c1c(C(=O)NCCc1c[nH]c3ccccc13)cc(C(C)C)n2	ZOMVHYMSDGBUIQ		parent_pubchem_cid	1190285-01-8;N-[2-(1H-indol-3-yl)ethyl]-6-isopropyl-3-methylisoxazolo[5,4-b]pyridine-4-carboxamide;EiM08-09198;AKOS016389562;N-[2-(1H-INDOL-3-YL)ETHYL]-3-METHYL-6-(PROPAN-2-YL)-[1,2]OXAZOLO[5,4-B]PYRIDINE-4-CARBOXAMIDE;N-[2-(1H-indol-3-yl)ethyl]-6-isopropyl-3-methyl-isoxazolo[5,4-b]pyridine-4-carboxamide		17265173.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=17265173		pluskal_iocb_peptide_Peptide01_E16_id		100	E16		ZINC000036370010
2.1		0	510	P2193980	103.0		V34	False	0	22	0	0	26	0	2	6	0	0		0.0						COC(=O)C(Cc1ccccc1)NC(=O)CCNC(=O)c1cc(OC)c(OC)cc1																							0.0		AKOS015860227		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C22H26N2O6	C22H26N2O6			InChI=1S/C22H26N2O6/c1-28-18-10-9-16(14-19(18)29-2)21(26)23-12-11-20(25)24-17(22(27)30-3)13-15-7-5-4-6-8-15/h4-10,14,17H,11-13H2,1-3H3,(H,23,26)(H,24,25)	ILEXIIWBLQYCTA-UHFFFAOYSA-N	methyl 2-[3-[(3,4-dimethoxybenzoyl)amino]propanoylamino]-3-phenyl-propanoate	51064837	COC(=O)C(Cc1ccccc1)NC(=O)CCNC(=O)c1cc(OC)c(OC)cc1	methyl 2-[3-[(3,4-dimethoxybenzoyl)amino]propanoylamino]-3-phenylpropanoate			0.6899600000000004													MCULE-3219523602	414.46232		414.179087	6	2	11	2			45										False	Amino acids and Peptides				Peptide01			Compound(51064837)	51064837	2.3	889			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]-[#6]-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6](-[#8]-[#6]):[#6](-[#8]-[#6]):[#6]:[#6]:1	COC(=O)C(Cc1ccccc1)NC(=O)CCNC(=O)c1cc(OC)c(OC)cc1	ILEXIIWBLQYCTA		parent_pubchem_cid	AKOS015860227;methyl 2-[3-[(3,4-dimethoxybenzoyl)amino]propanoylamino]-3-phenyl-propanoate		24077275.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24077275		pluskal_iocb_peptide_Peptide01_E16_id		100	E16		
4.5		0	598	P1307055	110.2		V35	False	0	21	0	0	17	0	3	3	0	1		0.0						CN(C(=O)c1ccc([N+](=O)[O-])cc1)C(c1cccs1)c1c[nH]c2ccccc12																							0.0		STL208080		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	1		C21H17N3O3S	C21H17N3O3S			InChI=1S/C21H17N3O3S/c1-23(21(25)14-8-10-15(11-9-14)24(26)27)20(19-7-4-12-28-19)17-13-22-18-6-3-2-5-16(17)18/h2-13,20,22H,1H3	XFNNZVHLPCFHJN-UHFFFAOYSA-N	N-[1H-indol-3-yl(2-thienyl)methyl]-N-methyl-4-nitro-benzamide	43843065	CN(C(=O)c1ccc([N+](=O)[O-])cc1)C(c1cccs1)c1c[nH]c2ccccc12	N-[1H-indol-3-yl(thiophen-2-yl)methyl]-N-methyl-4-nitrobenzamide			4.026040000000003													MCULE-2378707787	391.45194		391.099062	3	1	5	4			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(43843065)	43843065	4.2	890			[#6]-[#7](-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#7+](=[#8])-[#8-]):[#6]:[#6]:1)-[#6](-[#6]1:[#6]:[#6]:[#6]:[#16]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CN(C(=O)c1ccc([N+](=O)[O-])cc1)C(c1cccs1)c1c[nH]c2ccccc12	XFNNZVHLPCFHJN		parent_pubchem_cid	STL208080;AKOS001544475;AKOS016329106;N-[1H-indol-3-yl(thiophen-2-yl)methyl]-N-methyl-4-nitrobenzamide;N-[(1H-INDOL-3-YL)(THIOPHEN-2-YL)METHYL]-N-METHYL-4-NITROBENZAMIDE;N-[1H-indol-3-yl(2-thienyl)methyl]-N-methyl-4-nitro-benzamide		23377858.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23377858		pluskal_iocb_peptide_Peptide01_E16_id		100	E16		
3.2		0	686	P6241992	80.6		V36	False	0	21	0	0	22	0	2	4	0	0		0.0						CC(NC(=O)CCn1ccc2c1cc(OCc1ccccc1)cc2)C(=O)O								Alanine and derivatives;N-alkylindoles;Indoles;Phenol ethers;Alkyl aryl ethers;Substituted pyrroles;Benzene and substituted derivatives;Heteroaromatic compounds;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Azacyclic compounds;Carboxylic acids;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organonitrogen compounds	Alanine and derivatives;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;N-alkylindoles;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenol ethers;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acyl-l-alpha-amino acids. These are n-acylated alpha amino acids which have the L-configuration of the alpha-carbon atom.	N-acyl-L-alpha-amino acids		Amino acids and derivatives;Alpha amino acids and derivatives;N-acyl-alpha amino acids and derivatives;N-acyl-alpha amino acids	Organic compounds	Aromatic heteropolycyclic compounds	alanine derivative (CHEBI:22278);indoles (CHEBI:24828);aromatic ether (CHEBI:35618);pyrroles (CHEBI:26455);benzenes (CHEBI:22712);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);monocarboxylic acid (CHEBI:25384);organonitrogen heterocyclic compound (CHEBI:38101);carboxylic acid (CHEBI:33575);carbonyl compound (CHEBI:36586);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);N-acyl-L-alpha-amino acid (CHEBI:48927);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ether (CHEBI:25698);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);N-acyl-amino acid (CHEBI:51569)		Amino acids, peptides, and analogues	N-acyl-l-alpha-amino acid;Alanine or derivatives;N-alkylindole;Indole;Indole or derivatives;Phenol ether;Alkyl aryl ether;Monocyclic benzene moiety;Substituted pyrrole;Benzenoid;Heteroaromatic compound;Pyrrole;Secondary carboxylic acid amide;Carboxamide group;Monocarboxylic acid or derivatives;Ether;Carboxylic acid;Azacycle;Organoheterocyclic compound;Organic nitrogen compound;Organooxygen compound;Organonitrogen compound;Hydrocarbon derivative;Organic oxide;Carbonyl group;Organic oxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS016386861		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C21H22N2O4	C21H22N2O4			InChI=1S/C21H22N2O4/c1-15(21(25)26)22-20(24)10-12-23-11-9-17-7-8-18(13-19(17)23)27-14-16-5-3-2-4-6-16/h2-9,11,13,15H,10,12,14H2,1H3,(H,22,24)(H,25,26)/t15-/m0/s1	YZGMVTQMTSZFAZ-HNNXBMFYSA-N	rac-(2S)-2-[3-(6-benzyloxyindol-1-yl)propanoylamino]propanoic acid	49652399	C[C@H](NC(=O)CCn1ccc2c1cc(OCc1ccccc1)cc2)C(=O)O	(2S)-2-[3-(6-phenylmethoxyindol-1-yl)propanoylamino]propanoic acid			2.25416													MCULE-2783701713	366.42049		366.157957	4	2	8	3			44										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(49652399)	49652399	2.6	891			[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#6]-[#7]1:[#6]:[#6]:[#6]2:[#6]:1:[#6]:[#6](-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1):[#6]:[#6]:2)-[#6](=[#8])-[#8]	C[C@H](NC(=O)CCn1ccc2c1cc(OCc1ccccc1)cc2)C(=O)O	YZGMVTQMTSZFAZ		parent_pubchem_cid	AKOS016386861;(2S)-2-({3-[6-(BENZYLOXY)-1H-INDOL-1-YL]PROPANOYL}AMINO)PROPANOIC ACID;rac-(2S)-2-[3-(6-benzyloxyindol-1-yl)propanoylamino]propanoic acid		22812559.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22812559		pluskal_iocb_peptide_Peptide01_E16_id		100	E16		ZINC000040310261
3.3		0	430	P1158205	124.4		V37	False	0	22	0	0	20	0	4	3	0	1		0.0						COc1cc2c(cc1)cc(C(=O)NC(Cc1ccccc1)C(=O)Nc1nccs1)[nH]2																							0.0		STK717431		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0		C22H20N4O3S	C22H20N4O3S			InChI=1S/C22H20N4O3S/c1-29-16-8-7-15-12-19(24-17(15)13-16)20(27)25-18(11-14-5-3-2-4-6-14)21(28)26-22-23-9-10-30-22/h2-10,12-13,18,24H,11H2,1H3,(H,25,27)(H,23,26,28)/t18-/m0/s1	XDENBYGOCFAOBG-SFHVURJKSA-N	6-methoxy-N-[rac-(1S)-1-benzyl-2-oxo-2-(thiazol-2-ylamino)ethyl]-1H-indole-2-carboxamide	42581462	COc1cc2c(cc1)cc(C(=O)N[C@@H](Cc1ccccc1)C(=O)Nc1nccs1)[nH]2	6-methoxy-N-[(2S)-1-oxo-3-phenyl-1-(1,3-thiazol-2-ylamino)propan-2-yl]-1H-indole-2-carboxamide			2.23194													MCULE-3585602714	420.4937		420.125612	4	3	7	4			44										False	Alkaloids				Peptide01			Compound(42581462)	42581462	3.9	892			[#6]-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#6]:[#6](-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#7]-[#6]1:[#7]:[#6]:[#6]:[#16]:1):[#7H]:2	COc1cc2c(cc1)cc(C(=O)N[C@@H](Cc1ccccc1)C(=O)Nc1nccs1)[nH]2	XDENBYGOCFAOBG		parent_pubchem_cid	STK717431;AKOS005534096;2-[(6-METHOXY-1H-INDOL-2-YL)FORMAMIDO]-3-PHENYL-N-(1,3-THIAZOL-2-YL)PROPANAMIDE;Nalpha-[(6-methoxy-1H-indol-2-yl)carbonyl]-N-1,3-thiazol-2-yl-L-phenylalaninamide;6-methoxy-N-[rac-(1S)-1-benzyl-2-oxo-2-(thiazol-2-ylamino)ethyl]-1H-indole-2-carboxamide		7293294.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=7293294		pluskal_iocb_peptide_Peptide01_E16_id		100	E16		ZINC000012408404
2.7		0	518	P1045777	66.4		V38	False	0	14	0	0	19	0	1	3	0	0		0.0						Cc1cc(C(=O)NC(CC(C)C)C(=O)O)ccc1																							0.0		SCHEMBL4159712		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C14H19NO3	C14H19NO3			InChI=1S/C14H19NO3/c1-9(2)7-12(14(17)18)15-13(16)11-6-4-5-10(3)8-11/h4-6,8-9,12H,7H2,1-3H3,(H,15,16)(H,17,18)	NXVNYFBAKNMHHU-UHFFFAOYSA-N	4-methyl-2-[(3-methylbenzoyl)amino]pentanoic acid	16770781	Cc1cc(C(=O)NC(CC(C)C)C(=O)O)ccc1	4-methyl-2-[(3-methylbenzoyl)amino]pentanoic acid			2.1147													MCULE-2532781738	249.31243		249.136493	3	2	5	1			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(16770781)	16770781	2.9	893		SCHEMBL4159712	[#6]-[#6]1:[#6]:[#6](-[#6](=[#8])-[#7]-[#6](-[#6]-[#6](-[#6])-[#6])-[#6](=[#8])-[#8]):[#6]:[#6]:[#6]:1	Cc1cc(C(=O)NC(CC(C)C)C(=O)O)ccc1	NXVNYFBAKNMHHU		parent_pubchem_cid	SCHEMBL4159712;AKOS000127124;AKOS016338219;4-methyl-2-[(3-methylbenzoyl)amino]pentanoic acid		24618446.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24618446		pluskal_iocb_peptide_Peptide01_E16_id		100	E16		
4.9		0	606	P1305265	63.4		V39	False	0	26	0	0	26	0	2	3	0	0		0.0						CCOc1ccc(C(=O)NCC(c2ccc(OC)cc2)c2c[nH]c3ccccc23)cc1																							0.0		4-ethoxy-N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]benzamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C26H26N2O3	C26H26N2O3			InChI=1S/C26H26N2O3/c1-3-31-21-14-10-19(11-15-21)26(29)28-16-23(18-8-12-20(30-2)13-9-18)24-17-27-25-7-5-4-6-22(24)25/h4-15,17,23,27H,3,16H2,1-2H3,(H,28,29)	WMHUWISAFFSXMJ-UHFFFAOYSA-N	4-ethoxy-N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]benzamide	17014422	CCOc1ccc(C(=O)NCC(c2ccc(OC)cc2)c2c[nH]c3ccccc23)cc1	4-ethoxy-N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]benzamide			3.6197300000000014													MCULE-7883608871	414.50872		414.194343	3	2	8	4			44										False	Alkaloids				Peptide01			Compound(17014422)	17014422	5.0	894			[#6]-[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](=[#8])-[#7]-[#6]-[#6](-[#6]2:[#6]:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	CCOc1ccc(C(=O)NCC(c2ccc(OC)cc2)c2c[nH]c3ccccc23)cc1	WMHUWISAFFSXMJ		parent_pubchem_cid	4-ethoxy-N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]benzamide;STL207381;AKOS002335608;AKOS016326578		23341948.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23341948		pluskal_iocb_peptide_Peptide01_E16_id		100	E16		
1.8		0	694	P6666814	161.6		V40	False	0	20	0	0	22	0	4	5	0	1		0.0						COc1cc2c(cc1)[nH]cc2CCNC(=O)c1c(C)nc(NC(=O)CCC(=O)O)s1																							0.0		EiM08-26631		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	1	0	0	3	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0		C20H22N4O5S	C20H22N4O5S			InChI=1S/C20H22N4O5S/c1-11-18(30-20(23-11)24-16(25)5-6-17(26)27)19(28)21-8-7-12-10-22-15-4-3-13(29-2)9-14(12)15/h3-4,9-10,22H,5-8H2,1-2H3,(H,21,28)(H,26,27)(H,23,24,25)	RPRGRLYIGSKMKK-UHFFFAOYSA-N	4-[[5-[2-(5-methoxy-1H-indol-3-yl)ethylcarbamoyl]-4-methyl-thiazol-2-yl]amino]-4-oxo-butanoic acid	75465338	COc1cc2c(cc1)[nH]cc2CCNC(=O)c1c(C)nc(NC(=O)CCC(=O)O)s1	4-[[5-[2-(5-methoxy-1H-indol-3-yl)ethylcarbamoyl]-4-methyl-1,3-thiazol-2-yl]amino]-4-oxobutanoic acid			1.2816499999999995													MCULE-5402527848	430.48614		430.131091	6	4	9	3			44										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(75465338)	75465338	2.0	895			[#6]-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#7H]:[#6]:[#6]:2-[#6]-[#6]-[#7]-[#6](=[#8])-[#6]1:[#6](-[#6]):[#7]:[#6](-[#7]-[#6](=[#8])-[#6]-[#6]-[#6](=[#8])-[#8]):[#16]:1	COc1cc2c(cc1)[nH]cc2CCNC(=O)c1c(C)nc(NC(=O)CCC(=O)O)s1	RPRGRLYIGSKMKK		parent_pubchem_cid	EiM08-26631;STL472332;AKOS016388617;4-[(5-{[2-(5-methoxy-1H-indol-3-yl)ethyl]carbamoyl}-4-methyl-1,3-thiazol-2-yl)amino]-4-oxobutanoic acid;4-{[5-({[2-(5-METHOXY-1H-INDOL-3-YL)ETHYL]AMINO}CARBONYL)-4-METHYL-1,3-THIAZOL-2-YL]AMINO}-4-OXOBUTANOIC ACID;4-[[5-[2-(5-methoxy-1H-indol-3-yl)ethylcarbamoyl]-4-methyl-thiazol-2-yl]amino]-4-oxo-butanoic acid		80390139.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=80390139		pluskal_iocb_peptide_Peptide01_E16_id		100	E16		ZINC000096343511
2.8		0	438	P1094958	85.9		V41	False	0	24	0	0	30	0	2	5	0	0		0.0						COC(=O)C(Cc1ccccc1)NC(=O)NCC1(c2ccc(OC)cc2)CCOCC1																							0.0		AKOS005533434		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C24H30N2O5	C24H30N2O5			InChI=1S/C24H30N2O5/c1-29-20-10-8-19(9-11-20)24(12-14-31-15-13-24)17-25-23(28)26-21(22(27)30-2)16-18-6-4-3-5-7-18/h3-11,21H,12-17H2,1-2H3,(H2,25,26,28)/t21-/m0/s1	KHGQXIQAYOHPEM-NRFANRHFSA-N	methyl rac-(2S)-2-[[4-(4-methoxyphenyl)tetrahydropyran-4-yl]methylcarbamoylamino]-3-phenyl-propanoate	7692789	COC(=O)[C@H](Cc1ccccc1)NC(=O)NCC1(c2ccc(OC)cc2)CCOCC1	methyl (2S)-2-[[4-(4-methoxyphenyl)oxan-4-yl]methylcarbamoylamino]-3-phenylpropanoate			2.25507													MCULE-6644456025	426.5171		426.215472	5	2	9	3			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(7692789)	7692789	3.4	896			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#7]-[#6]-[#6]1(-[#6]2:[#6]:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:2)-[#6]-[#6]-[#8]-[#6]-[#6]-1	COC(=O)[C@H](Cc1ccccc1)NC(=O)NCC1(c2ccc(OC)cc2)CCOCC1	KHGQXIQAYOHPEM		parent_pubchem_cid	AKOS005533434;methyl rac-(2S)-2-[[4-(4-methoxyphenyl)tetrahydropyran-4-yl]methylcarbamoylamino]-3-phenyl-propanoate		3044746.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=3044746		pluskal_iocb_peptide_Peptide01_E17_id		100	E17		ZINC000005451008
1.1		0	526	P2194595	120.8		V42	False	0	16	0	0	22	0	2	4	0	1		0.0						CSCCC(NC(=O)CCNC(=O)c1ccc(C)cc1)C(=O)O																							0.0		AKOS015860661		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C16H22N2O4S	C16H22N2O4S			InChI=1S/C16H22N2O4S/c1-11-3-5-12(6-4-11)15(20)17-9-7-14(19)18-13(16(21)22)8-10-23-2/h3-6,13H,7-10H2,1-2H3,(H,17,20)(H,18,19)(H,21,22)	OXEYMGPDKLGFCS-UHFFFAOYSA-N	2-[3-[(4-methylbenzoyl)amino]propanoylamino]-4-methylsulfanyl-butanoic acid	51065252	CSCCC(NC(=O)CCNC(=O)c1ccc(C)cc1)C(=O)O	2-[3-[(4-methylbenzoyl)amino]propanoylamino]-4-methylsulfanylbutanoic acid			1.3279999999999996													MCULE-9935792743	338.42874		338.130028	5	3	9	1			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51065252)	51065252	1.4	897			[#6]-[#16]-[#6]-[#6]-[#6](-[#7]-[#6](=[#8])-[#6]-[#6]-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:1)-[#6](=[#8])-[#8]	CSCCC(NC(=O)CCNC(=O)c1ccc(C)cc1)C(=O)O	OXEYMGPDKLGFCS		parent_pubchem_cid	AKOS015860661;2-[3-[(4-methylbenzoyl)amino]propanoylamino]-4-methylsulfanyl-butanoic acid		23412630.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23412630		pluskal_iocb_peptide_Peptide01_E17_id		100	E17		
4.9		0	614	P1305494	54.1		V43	False	0	25	0	0	24	0	2	2	0	0		0.0						Cc1cc(OCC(=O)NCC(c2ccccc2)c2c[nH]c3ccccc23)ccc1																							0.0		N-[2-(1H-indol-3-yl)-2-phenylethyl]-2-(3-methylphenoxy)acetamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C25H24N2O2	C25H24N2O2			InChI=1S/C25H24N2O2/c1-18-8-7-11-20(14-18)29-17-25(28)27-15-22(19-9-3-2-4-10-19)23-16-26-24-13-6-5-12-21(23)24/h2-14,16,22,26H,15,17H2,1H3,(H,27,28)	BCLVXHSHVTWTQG-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]-2-(3-methylphenoxy)acetamide	17014641	Cc1cc(OCC(=O)NCC(c2ccccc2)c2c[nH]c3ccccc23)ccc1	N-[2-(1H-indol-3-yl)-2-phenylethyl]-2-(3-methylphenoxy)acetamide			3.7484600000000015													MCULE-8872665232	384.48223		384.183778	2	2	7	4			45										False	Alkaloids				Peptide01			Compound(17014641)	17014641	5.1	898			[#6]-[#6]1:[#6]:[#6](-[#8]-[#6]-[#6](=[#8])-[#7]-[#6]-[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:[#6]:1	Cc1cc(OCC(=O)NCC(c2ccccc2)c2c[nH]c3ccccc23)ccc1	BCLVXHSHVTWTQG		parent_pubchem_cid	N-[2-(1H-indol-3-yl)-2-phenylethyl]-2-(3-methylphenoxy)acetamide;AKOS002334332;AKOS016326705;N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]-2-(3-methylphenoxy)acetamide		22837726.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22837726		pluskal_iocb_peptide_Peptide01_E17_id		100	E17		
5.0		0	702	P1158325	44.9		V44	False	0	25	0	0	24	0	2	1	0	0		0.0						O=C(CC(c1ccccc1)c1ccccc1)NCCc1c[nH]c2ccccc12								3-alkylindoles;Substituted pyrroles;Fatty amides;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	3-alkylindoles;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Diphenylmethanes;Fatty Acyls;Fatty amides;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Lipids and lipid-like molecules;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as diphenylmethanes. These are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups.	Diphenylmethanes			Organic compounds	Aromatic heteropolycyclic compounds	indoles (CHEBI:24828);pyrroles (CHEBI:26455);fatty amide (CHEBI:29348);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);diarylmethane (CHEBI:51614);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);lipid (CHEBI:18059);organooxygen compound (CHEBI:36963);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712)	Fatty amides (FA08);Fatty Acyls (FA)	Diphenylmethanes	Diphenylmethane;3-alkylindole;Indole;Indole or derivatives;Fatty amide;Fatty acyl;Substituted pyrrole;Heteroaromatic compound;Pyrrole;Carboxamide group;Secondary carboxylic acid amide;Azacycle;Carboxylic acid derivative;Organoheterocyclic compound;Organooxygen compound;Organonitrogen compound;Hydrocarbon derivative;Organic oxide;Organic oxygen compound;Organic nitrogen compound;Carbonyl group;Aromatic heteropolycyclic compound	Benzenoids	0.0		41260-02-0		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C25H24N2O	C25H24N2O			InChI=1S/C25H24N2O/c28-25(26-16-15-21-18-27-24-14-8-7-13-22(21)24)17-23(19-9-3-1-4-10-19)20-11-5-2-6-12-20/h1-14,18,23,27H,15-17H2,(H,26,28)	FZVDIBAHUKOLBU-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)ethyl]-3,3-diphenyl-propanamide	17590387	O=C(CC(c1ccccc1)c1ccccc1)NCCc1c[nH]c2ccccc12	N-[2-(1H-indol-3-yl)ethyl]-3,3-diphenylpropanamide			4.456250000000003													MCULE-2489262074	368.48283		368.188863	1	2	7	4			44										False	Alkaloids				Peptide01			Compound(17590387)	17590387	5.1	899			[#8]=[#6](-[#6]-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	O=C(CC(c1ccccc1)c1ccccc1)NCCc1c[nH]c2ccccc12	FZVDIBAHUKOLBU		parent_pubchem_cid	41260-02-0;N~1~-[2-(1H-indol-3-yl)ethyl]-3,3-diphenylpropanamide;N-[2-(1H-indol-3-yl)ethyl]-3,3-diphenylpropanamide;AKOS008408110;N-[2-(1H-indol-3-yl)ethyl]-3,3-diphenyl-propanamide		7870718.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=7870718		pluskal_iocb_peptide_Peptide01_E17_id		100	E17		ZINC000009481455
3.7		0	710	P6241390	71.3		W1	False	1	19	0	0	17	0	2	3	0	0		0.0						O=C(Cn1ccc2c1cccc2Br)NC(Cc1ccccc1)C(=O)O								N-acyl-L-alpha-amino acids;Phenylpropanoic acids;Amphetamines and derivatives;N-alkylindoles;Indoles;Substituted pyrroles;Aryl bromides;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Carboxylic acids;Monocarboxylic acids and derivatives;Organobromides;Carbonyl compounds;Organic oxides;Hydrocarbon derivatives;Organonitrogen compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Aryl bromides;Aryl halides;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;N-alkylindoles;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organobromides;Organohalogen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenethylamines;Phenylalanine and derivatives;Phenylpropanoic acids;Phenylpropanoids and polyketides;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-L-alpha-amino acid (CHEBI:48927);benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);amphetamines (CHEBI:35338);indoles (CHEBI:24828);pyrroles (CHEBI:26455);organobromine compound (CHEBI:37141);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organonitrogen heterocyclic compound (CHEBI:38101);monocarboxylic acid (CHEBI:25384);carbonyl compound (CHEBI:36586);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);organonitrogen compound (CHEBI:35352);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);N-acyl-amino acid (CHEBI:51569);benzenoid aromatic compound (CHEBI:33836);primary amine (CHEBI:32877);organic heterocyclic compound (CHEBI:24532);organohalogen compound (CHEBI:36684);haloarene (CHEBI:50887);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143)		Amino acids, peptides, and analogues	Phenylalanine or derivatives;N-acyl-l-alpha-amino acid;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;3-phenylpropanoic-acid;Amphetamine or derivatives;N-alkylindole;Indole;Indole or derivatives;Aryl bromide;Aryl halide;Monocyclic benzene moiety;Benzenoid;Substituted pyrrole;Heteroaromatic compound;Pyrrole;Secondary carboxylic acid amide;Carboxamide group;Organoheterocyclic compound;Monocarboxylic acid or derivatives;Azacycle;Carboxylic acid;Organonitrogen compound;Organobromide;Organohalogen compound;Organic nitrogen compound;Carbonyl group;Hydrocarbon derivative;Organic oxide;Organic oxygen compound;Organooxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS016402564		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C19H17BrN2O3	C19H17BrN2O3			InChI=1S/C19H17BrN2O3/c20-15-7-4-8-17-14(15)9-10-22(17)12-18(23)21-16(19(24)25)11-13-5-2-1-3-6-13/h1-10,16H,11-12H2,(H,21,23)(H,24,25)/t16-/m0/s1	ZQGUAWAMPUIZAM-INIZCTEOSA-N	rac-(2S)-2-[[2-(4-bromoindol-1-yl)acetyl]amino]-3-phenyl-propanoic acid	49652565	O=C(Cn1ccc2c1cccc2Br)N[C@@H](Cc1ccccc1)C(=O)O	(2S)-2-[[2-(4-bromoindol-1-yl)acetyl]amino]-3-phenylpropanoic acid			2.7327700000000004													MCULE-6839383254	401.26294		400.042255	3	2	6	3			44										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(49652565)	49652565	3.7	900			[#8]=[#6](-[#6]-[#7]1:[#6]:[#6]:[#6]2:[#6]:1:[#6]:[#6]:[#6]:[#6]:2-[#35])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	O=C(Cn1ccc2c1cccc2Br)N[C@@H](Cc1ccccc1)C(=O)O	ZQGUAWAMPUIZAM		parent_pubchem_cid	AKOS016402564;(2S)-2-{[2-(4-BROMO-1H-INDOL-1-YL)ACETYL]AMINO}-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[[2-(4-bromoindol-1-yl)acetyl]amino]-3-phenyl-propanoic acid		23247822.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23247822		pluskal_iocb_peptide_Peptide01_E17_id		100	E17		ZINC000040312847
2.8		0	798	P3461816	49.4		W2	False	0	20	0	0	22	0	2	2	0	0		0.0						CC(C)NC(=O)C(Cc1ccccc1)N1Cc2ccccc2C1=O								Isoindolones;Amphetamines and derivatives;Isoindoles;Fatty amides;Tertiary carboxylic acid amides;Tertiary amines;Secondary carboxylic acid amides;Lactams;Azacyclic compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amines;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Fatty Acyls;Fatty amides;Hydrocarbon derivatives;Isoindoles;Isoindoles and derivatives;Isoindolines;Isoindolones;Lactams;Lipids and lipid-like molecules;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenethylamines;Phenylalanine and derivatives;Secondary carboxylic acid amides;Tertiary amines;Tertiary carboxylic acid amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	isoindoles (CHEBI:24897);amphetamines (CHEBI:35338);fatty amide (CHEBI:29348);carboxamide (CHEBI:37622);tertiary amine (CHEBI:32876);lactam (CHEBI:24995);organonitrogen heterocyclic compound (CHEBI:38101);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);primary amine (CHEBI:32877);lipid (CHEBI:18059);organooxygen compound (CHEBI:36963);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);amine (CHEBI:32952);oxygen molecular entity (CHEBI:25806);amino acid (CHEBI:33709);peptide (CHEBI:16670)	Fatty amides (FA08);Fatty Acyls (FA)	Amino acids, peptides, and analogues	Phenylalanine or derivatives;Amphetamine or derivatives;Isoindolone;Isoindoline;Isoindole;Isoindole or derivatives;Monocyclic benzene moiety;Fatty amide;Benzenoid;Fatty acyl;Tertiary carboxylic acid amide;Tertiary amine;Secondary carboxylic acid amide;Lactam;Carboxamide group;Azacycle;Organoheterocyclic compound;Organooxygen compound;Organonitrogen compound;Hydrocarbon derivative;Organic oxide;Organic oxygen compound;Organic nitrogen compound;Carbonyl group;Amine;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS016376202		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0		C20H22N2O2	C20H22N2O2			InChI=1S/C20H22N2O2/c1-14(2)21-19(23)18(12-15-8-4-3-5-9-15)22-13-16-10-6-7-11-17(16)20(22)24/h3-11,14,18H,12-13H2,1-2H3,(H,21,23)/t18-/m0/s1	QJVBCTMKNFGQCN-SFHVURJKSA-N	rac-(2S)-N-isopropyl-2-(1-oxoisoindolin-2-yl)-3-phenyl-propanamide	51607468	CC(C)NC(=O)[C@H](Cc1ccccc1)N1Cc2ccccc2C1=O	(2S)-2-(3-oxo-1H-isoindol-2-yl)-3-phenyl-N-propan-2-ylpropanamide			2.6141700000000005													MCULE-4605870308	322.41054		322.168128	2	1	5	3			44									Phenylalanine-derived alkaloids	False	Alkaloids	Pseudoalkaloids			Peptide01			Compound(51607468)	51607468	3.1	901			[#6]-[#6](-[#6])-[#7]-[#6](=[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]1-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6]-1=[#8]	CC(C)NC(=O)[C@H](Cc1ccccc1)N1Cc2ccccc2C1=O	QJVBCTMKNFGQCN		parent_pubchem_cid	AKOS016376202;rac-(2S)-N-isopropyl-2-(1-oxoisoindolin-2-yl)-3-phenyl-propanamide		9247323.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=9247323		pluskal_iocb_peptide_Peptide01_E17_id		100	E17		ZINC000020531194
3.1		0	886	P6241415	71.3		W3	False	0	20	0	0	20	0	2	3	0	0		0.0						Cc1cc2ccccc2n1CC(=O)NC(Cc1ccccc1)C(=O)O								N-acyl-L-alpha-amino acids;Phenylpropanoic acids;N-alkylindoles;Amphetamines and derivatives;Indoles;Substituted pyrroles;Heteroaromatic compounds;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;N-alkylindoles;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenethylamines;Phenylalanine and derivatives;Phenylpropanoic acids;Phenylpropanoids and polyketides;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-L-alpha-amino acid (CHEBI:48927);benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);indoles (CHEBI:24828);amphetamines (CHEBI:35338);pyrroles (CHEBI:26455);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);monocarboxylic acid (CHEBI:25384);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);N-acyl-amino acid (CHEBI:51569);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);primary amine (CHEBI:32877);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806)		Amino acids, peptides, and analogues	Phenylalanine or derivatives;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;N-acyl-l-alpha-amino acid;3-phenylpropanoic-acid;Amphetamine or derivatives;N-alkylindole;Indole;Indole or derivatives;Benzenoid;Substituted pyrrole;Monocyclic benzene moiety;Pyrrole;Heteroaromatic compound;Secondary carboxylic acid amide;Carboxamide group;Organoheterocyclic compound;Azacycle;Carboxylic acid;Monocarboxylic acid or derivatives;Hydrocarbon derivative;Organic nitrogen compound;Organic oxygen compound;Organic oxide;Carbonyl group;Organonitrogen compound;Organooxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		EiM08-12773		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C20H20N2O3	C20H20N2O3			InChI=1S/C20H20N2O3/c1-14-11-16-9-5-6-10-18(16)22(14)13-19(23)21-17(20(24)25)12-15-7-3-2-4-8-15/h2-11,17H,12-13H2,1H3,(H,21,23)(H,24,25)/t17-/m0/s1	PKLXQSTXIFIWCL-KRWDZBQOSA-N	rac-(2S)-2-[[2-(2-methylindol-1-yl)acetyl]amino]-3-phenyl-propanoic acid	49652260	Cc1cc2ccccc2n1CC(=O)N[C@@H](Cc1ccccc1)C(=O)O	(2S)-2-[[2-(2-methylindol-1-yl)acetyl]amino]-3-phenylpropanoic acid			2.22398													MCULE-1327904956	336.394		336.147392	3	2	6	3			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(49652260)	49652260	3.4	902			[#6]-[#6]1:[#6]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#7]:1-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	Cc1cc2ccccc2n1CC(=O)N[C@@H](Cc1ccccc1)C(=O)O	PKLXQSTXIFIWCL		parent_pubchem_cid	EiM08-12773;AKOS016392422;(2S)-2-{[2-(2-METHYL-1H-INDOL-1-YL)ACETYL]AMINO}-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[[2-(2-methylindol-1-yl)acetyl]amino]-3-phenyl-propanoic acid		23761447.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23761447		pluskal_iocb_peptide_Peptide01_E17_id		100	E17		ZINC000040309767
4.0		0	974	P3461821	67.9		W4	False	0	27	0	0	28	0	2	4	0	0		0.0						COc1c(OC)cc(CCNC(=O)C(Cc2ccccc2)N2Cc3ccccc3C2=O)cc1																							0.0		AKOS001845060		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0		C27H28N2O4	C27H28N2O4			InChI=1S/C27H28N2O4/c1-32-24-13-12-20(17-25(24)33-2)14-15-28-26(30)23(16-19-8-4-3-5-9-19)29-18-21-10-6-7-11-22(21)27(29)31/h3-13,17,23H,14-16,18H2,1-2H3,(H,28,30)/t23-/m0/s1	CAKQIVIFIHXUCX-QHCPKHFHSA-N	rac-(2S)-N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(1-oxoisoindolin-2-yl)-3-phenyl-propanamide	20862777	COc1c(OC)cc(CCNC(=O)[C@H](Cc2ccccc2)N2Cc3ccccc3C2=O)cc1	(2S)-N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(3-oxo-1H-isoindol-2-yl)-3-phenylpropanamide			2.48614													MCULE-2083779143	444.53521		444.204907	4	1	9	4			44									Phenylethylamines	False	Alkaloids	Tyrosine alkaloids			Peptide01			Compound(20862777)	20862777	4.2	903			[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]):[#6]:[#6](-[#6]-[#6]-[#7]-[#6](=[#8])-[#6@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#7]2-[#6]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3-[#6]-2=[#8]):[#6]:[#6]:1	COc1c(OC)cc(CCNC(=O)[C@H](Cc2ccccc2)N2Cc3ccccc3C2=O)cc1	CAKQIVIFIHXUCX		parent_pubchem_cid	AKOS001845060;SR-01000130923;SR-01000130923-1;N-[2-(3,4-DIMETHOXYPHENYL)ETHYL]-2-(1-OXO-2,3-DIHYDRO-1H-ISOINDOL-2-YL)-3-PHENYLPROPANAMIDE;rac-(2S)-N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(1-oxoisoindolin-2-yl)-3-phenyl-propanamide		2210962.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=2210962		pluskal_iocb_peptide_Peptide01_E17_id		100	E17		ZINC000013366280
3.0		0	718	P6666561	65.2		W5	False	0	23	0	0	23	0	3	2	0	0		0.0						CC(C)n1cc(C(=O)NCCc2c[nH]c3ccccc23)c2ccccc2c1=O								3-alkylindoles;Pyridinecarboxylic acids and derivatives;Pyridinones;Substituted pyrroles;Benzenoids;Vinylogous amides;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactams;Azacyclic compounds;Organooxygen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	3-alkylindoles;Azacyclic compounds;Benzenoids;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Hydropyridines;Indoles;Indoles and derivatives;Isoquinolines and derivatives;Isoquinolones and derivatives;Lactams;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Pyridinecarboxylic acids and derivatives;Pyridines and derivatives;Pyridinones;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Vinylogous amides	Isoquinolines and derivatives	2.1	This compound belongs to the class of organic compounds known as isoquinolones and derivatives. These are aromatic polycyclic compounds containing a ketone bearing isoquinoline moiety.	Isoquinolones and derivatives			Organic compounds	Aromatic heteropolycyclic compounds	indoles (CHEBI:24828);aromatic carboxylic acid (CHEBI:33859);pyridinemonocarboxylic acid (CHEBI:26420);pyridone (CHEBI:38183);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);enone (CHEBI:51689);enamine (CHEBI:47989);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactam (CHEBI:24995);organonitrogen heterocyclic compound (CHEBI:38101);organooxygen compound (CHEBI:36963);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);isoquinolines (CHEBI:24922);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);pyridines (CHEBI:26421);dihydropyridine (CHEBI:50075);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143)		Isoquinolones and derivatives	Isoquinolone;3-alkylindole;Indole;Indole or derivatives;Pyridine carboxylic acid or derivatives;Pyridinone;Pyridine;Benzenoid;Substituted pyrrole;Heteroaromatic compound;Vinylogous amide;Pyrrole;Carboxamide group;Lactam;Secondary carboxylic acid amide;Azacycle;Carboxylic acid derivative;Organooxygen compound;Organonitrogen compound;Organic oxide;Organic oxygen compound;Organic nitrogen compound;Hydrocarbon derivative;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		1351680-41-5		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C23H23N3O2	C23H23N3O2			InChI=1S/C23H23N3O2/c1-15(2)26-14-20(18-8-3-4-9-19(18)23(26)28)22(27)24-12-11-16-13-25-21-10-6-5-7-17(16)21/h3-10,13-15,25H,11-12H2,1-2H3,(H,24,27)	TXCPJTURHDXNRO-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)ethyl]-2-isopropyl-1-oxo-isoquinoline-4-carboxamide	71753515	CC(C)n1cc(C(=O)NCCc2c[nH]c3ccccc23)c2ccccc2c1=O	N-[2-(1H-indol-3-yl)ethyl]-1-oxo-2-propan-2-ylisoquinoline-4-carboxamide			3.969830000000002													MCULE-2899516479	373.45866		373.179027	2	2	5	4			44										False	Alkaloids				Peptide01			Compound(71753515)	71753515	3.4	904			[#6]-[#6](-[#6])-[#7]1:[#6]:[#6](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8]	CC(C)n1cc(C(=O)NCCc2c[nH]c3ccccc23)c2ccccc2c1=O	TXCPJTURHDXNRO		parent_pubchem_cid	1351680-41-5;N~4~-[2-(1H-indol-3-yl)ethyl]-2-isopropyl-1-oxo-1,2-dihydro-4-isoquinolinecarboxamide;EiM08-24407;AKOS016375920;N-[2-(1H-indol-3-yl)ethyl]-1-oxo-2-(propan-2-yl)-1,2-dihydroisoquinoline-4-carboxamide;N-[2-(1H-indol-3-yl)ethyl]-2-isopropyl-1-oxo-isoquinoline-4-carboxamide		23552245.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23552245		pluskal_iocb_peptide_Peptide01_E18_id		100	E18		ZINC000072324880
4.6		0	806	P11569323	62.7		W6	False	0	23	0	0	26	0	4	1	0	0		0.0						CC(C)CC(NC(=O)Cc1cn(C)c2ccccc12)c1nc2ccccc2[nH]1																							0.0		AKOS027474175		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C23H26N4O	C23H26N4O			InChI=1S/C23H26N4O/c1-15(2)12-20(23-25-18-9-5-6-10-19(18)26-23)24-22(28)13-16-14-27(3)21-11-7-4-8-17(16)21/h4-11,14-15,20H,12-13H2,1-3H3,(H,24,28)(H,25,26)/t20-/m0/s1	ICEVNGNJFACUCY-FQEVSTJZSA-N	2-(1-methylindol-3-yl)-N-[rac-(1S)-1-(1H-benzimidazol-2-yl)-3-methyl-butyl]acetamide	99003537	CC(C)C[C@H](NC(=O)Cc1cn(C)c2ccccc12)c1nc2ccccc2[nH]1	N-[(1S)-1-(1H-benzimidazol-2-yl)-3-methylbutyl]-2-(1-methylindol-3-yl)acetamide			3.534440000000002														374.48987		374.210661	2	2	6	4			45										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(99003537)	99003537	4.0	905			[#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#6]1:[#6]:[#7](-[#6]):[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6]1:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#7H]:1	CC(C)C[C@H](NC(=O)Cc1cn(C)c2ccccc12)c1nc2ccccc2[nH]1	ICEVNGNJFACUCY		parent_pubchem_cid	AKOS027474175;N-[(1S)-1-(1H-13-BENZODIAZOL-2-YL)-3-METHYLBUTYL]-2-(1-METHYL-1H-INDOL-3-YL)ACETAMIDE;2-(1-methylindol-3-yl)-N-[rac-(1S)-1-(1H-benzimidazol-2-yl)-3-methyl-butyl]acetamide		109841999.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=109841999		pluskal_iocb_peptide_Peptide01_E18_id		100	E18		ZINC000109340260
3.3		0	894	P1100519	127.0		W7	False	0	25	0	0	24	0	2	7	0	0		0.0						COc1cc2c(c(OC)c1)c(C)c(CC(=O)NC(Cc1c[nH]c3ccccc13)C(=O)O)c(=O)o2																							0.0		AKOS016379103		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C25H24N2O7	C25H24N2O7			InChI=1S/C25H24N2O7/c1-13-17(25(31)34-21-10-15(32-2)9-20(33-3)23(13)21)11-22(28)27-19(24(29)30)8-14-12-26-18-7-5-4-6-16(14)18/h4-7,9-10,12,19,26H,8,11H2,1-3H3,(H,27,28)(H,29,30)/t19-/m1/s1	HWNKZTJPSHMSST-LJQANCHMSA-N	rac-(2R)-2-[[2-(5,7-dimethoxy-4-methyl-2-oxo-chromen-3-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid	24280130	COc1cc2c(c(OC)c1)c(C)c(CC(=O)N[C@H](Cc1c[nH]c3ccccc13)C(=O)O)c(=O)o2	(2R)-2-[[2-(5,7-dimethoxy-4-methyl-2-oxochromen-3-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid			1.90862													MCULE-8004700712	464.47923		464.158351	7	3	8	4			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(24280130)	24280130	2.7	906			[#6]-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6](-[#8]-[#6]):[#6]:1):[#6](-[#6]):[#6](-[#6]-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:1:3)-[#6](=[#8])-[#8]):[#6](=[#8]):[#8]:2	COc1cc2c(c(OC)c1)c(C)c(CC(=O)N[C@H](Cc1c[nH]c3ccccc13)C(=O)O)c(=O)o2	HWNKZTJPSHMSST		parent_pubchem_cid	AKOS016379103;2-[2-(5,7-DIMETHOXY-4-METHYL-2-OXO-2H-CHROMEN-3-YL)ACETAMIDO]-3-(1H-INDOL-3-YL)PROPANOIC ACID;rac-(2R)-2-[[2-(5,7-dimethoxy-4-methyl-2-oxo-chromen-3-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid		23569616.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23569616		pluskal_iocb_peptide_Peptide01_E18_id		100	E18		ZINC000011867575
2.7		0	982	P6667642	93.9		W8	False	0	22	0	0	21	0	5	2	0	0		0.0						O=C(NCCc1c[nH]c2ccccc12)C1CC(=O)N(c2n[nH]c3ccccc23)C1																							0.0		AKOS016400686		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	0	0	0	0	0	1	0		C22H21N5O2	C22H21N5O2			InChI=1S/C22H21N5O2/c28-20-11-15(13-27(20)21-17-6-2-4-8-19(17)25-26-21)22(29)23-10-9-14-12-24-18-7-3-1-5-16(14)18/h1-8,12,15,24H,9-11,13H2,(H,23,29)(H,25,26)	AGNZVNGKFKRIFC-UHFFFAOYSA-N	1-(1H-indazol-3-yl)-N-[2-(1H-indol-3-yl)ethyl]-5-oxo-pyrrolidine-3-carboxamide	75465631	O=C(NCCc1c[nH]c2ccccc12)C1CC(=O)N(c2n[nH]c3ccccc23)C1	1-(1H-indazol-3-yl)-N-[2-(1H-indol-3-yl)ethyl]-5-oxopyrrolidine-3-carboxamide			1.4638399999999991													MCULE-9773958904	387.44497		387.169525	3	3	5	5			45										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(75465631)	75465631	2.3	907			[#8]=[#6](-[#7]-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6]1-[#6]-[#6](=[#8])-[#7](-[#6]2:[#7]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6]-1	O=C(NCCc1c[nH]c2ccccc12)C1CC(=O)N(c2n[nH]c3ccccc23)C1	AGNZVNGKFKRIFC		parent_pubchem_cid	AKOS016400686;1-(1H-INDAZOL-3-YL)-N-[2-(1H-INDOL-3-YL)ETHYL]-5-OXO-3-PYRROLIDINECARBOXAMIDE;1-(1H-indazol-3-yl)-N-[2-(1H-indol-3-yl)ethyl]-5-oxo-pyrrolidine-3-carboxamide		80390431.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=80390431		pluskal_iocb_peptide_Peptide01_E18_id		100	E18		
3.6		0	726	P6240990	92.2		W9	False	0	21	0	0	21	0	3	3	0	0		0.0						CC(C)CC(NC(=O)c1cc(-c2ccccn2)nc2ccccc12)C(=O)O								Quinoline carboxamides;N-acyl-alpha amino acids;Bipyridines and oligopyridines;Pyridinecarboxylic acids and derivatives;Benzenoids;Heteroaromatic compounds;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzenoids;Bipyridines and oligopyridines;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Leucine and derivatives;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Pyridinecarboxylic acids and derivatives;Pyridines and derivatives;Quinoline carboxamides;Quinolines and derivatives;Secondary carboxylic acid amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as leucine and derivatives. These are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Leucine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	quinolines (CHEBI:26513);carboxamide (CHEBI:37622);N-acyl-amino acid (CHEBI:51569);bipyridines (CHEBI:50511);aromatic carboxylic acid (CHEBI:33859);pyridinemonocarboxylic acid (CHEBI:26420);benzenoid aromatic compound (CHEBI:33836);organic aromatic compound (CHEBI:33659);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);leucine derivative (CHEBI:47003);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);pyridines (CHEBI:26421);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806)		Amino acids, peptides, and analogues	Leucine or derivatives;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;Quinoline-4-carboxamide;Bipyridine;Quinoline;Pyridine carboxylic acid or derivatives;Pyridine;Benzenoid;Heteroaromatic compound;Secondary carboxylic acid amide;Carboxamide group;Azacycle;Monocarboxylic acid or derivatives;Carboxylic acid;Organoheterocyclic compound;Carbonyl group;Organic oxygen compound;Organooxygen compound;Organonitrogen compound;Hydrocarbon derivative;Organic nitrogen compound;Organic oxide;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS016376006		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C21H21N3O3	C21H21N3O3			InChI=1S/C21H21N3O3/c1-13(2)11-19(21(26)27)24-20(25)15-12-18(17-9-5-6-10-22-17)23-16-8-4-3-7-14(15)16/h3-10,12-13,19H,11H2,1-2H3,(H,24,25)(H,26,27)/t19-/m0/s1	JEQQZJHZNLUVDH-IBGZPJMESA-N	rac-(2S)-4-methyl-2-[[2-(2-pyridyl)quinoline-4-carbonyl]amino]pentanoic acid	49652397	CC(C)C[C@H](NC(=O)c1cc(-c2ccccn2)nc2ccccc12)C(=O)O	(2S)-4-methyl-2-[(2-pyridin-2-ylquinoline-4-carbonyl)amino]pentanoic acid			2.66275													MCULE-7520291016	363.41982		363.158292	5	2	6	3			44									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(49652397)	49652397	3.4	908			[#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#7]:2):[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	CC(C)C[C@H](NC(=O)c1cc(-c2ccccn2)nc2ccccc12)C(=O)O	JEQQZJHZNLUVDH		parent_pubchem_cid	AKOS016376006;(2S)-4-METHYL-2-({[2-(2-PYRIDYL)-4-QUINOLYL]CARBONYL}AMINO)PENTANOIC ACID;rac-(2S)-4-methyl-2-[[2-(2-pyridyl)quinoline-4-carbonyl]amino]pentanoic acid		24331200.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24331200		pluskal_iocb_peptide_Peptide01_E18_id		100	E18		ZINC000040310251
5.0		0	814	P3458813	123.3		W10	False	0	22	2	0	17	0	3	3	0	1		0.0						O=C(Cc1csc(-c2c(Cl)cccc2Cl)n1)NC(Cc1c[nH]c2ccccc12)C(=O)O																							0.0		SCHEMBL20255460		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C22H17Cl2N3O3S	C22H17Cl2N3O3S			InChI=1S/C22H17Cl2N3O3S/c23-15-5-3-6-16(24)20(15)21-26-13(11-31-21)9-19(28)27-18(22(29)30)8-12-10-25-17-7-2-1-4-14(12)17/h1-7,10-11,18,25H,8-9H2,(H,27,28)(H,29,30)/t18-/m0/s1	BVXQBQAHSBWEJC-SFHVURJKSA-N	rac-(2S)-2-[[2-[2-(2,6-dichlorophenyl)thiazol-4-yl]acetyl]amino]-3-(1H-indol-3-yl)propanoic acid	29140070	O=C(Cc1csc(-c2c(Cl)cccc2Cl)n1)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	(2S)-2-[[2-[2-(2,6-dichlorophenyl)-1,3-thiazol-4-yl]acetyl]amino]-3-(1H-indol-3-yl)propanoic acid			4.0349400000000015													MCULE-2297750348	474.36909		473.036768	4	3	7	4			43										False	Alkaloids				Peptide01			Compound(29140070)	29140070	4.2	909		SCHEMBL20255460	[#8]=[#6](-[#6]-[#6]1:[#6]:[#16]:[#6](-[#6]2:[#6](-[#17]):[#6]:[#6]:[#6]:[#6]:2-[#17]):[#7]:1)-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	O=C(Cc1csc(-c2c(Cl)cccc2Cl)n1)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	BVXQBQAHSBWEJC		parent_pubchem_cid	SCHEMBL20255460;AKOS005534940;2-{2-[2-(2,6-DICHLOROPHENYL)-1,3-THIAZOL-4-YL]ACETAMIDO}-3-(1H-INDOL-3-YL)PROPANOIC ACID;rac-(2S)-2-[[2-[2-(2,6-dichlorophenyl)thiazol-4-yl]acetyl]amino]-3-(1H-indol-3-yl)propanoic acid		24224133.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24224133		pluskal_iocb_peptide_Peptide01_E18_id		100	E18		ZINC000020745369
3.4		0	902	P6240052	126.0		W11	False	0	22	0	0	22	0	2	5	0	1		0.0						COc1cccc(-c2nc(CC(=O)NC(Cc3ccccc3)C(=O)O)cs2)c1OC																							0.0		SCHEMBL20255691		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C22H22N2O5S	C22H22N2O5S			InChI=1S/C22H22N2O5S/c1-28-18-10-6-9-16(20(18)29-2)21-23-15(13-30-21)12-19(25)24-17(22(26)27)11-14-7-4-3-5-8-14/h3-10,13,17H,11-12H2,1-2H3,(H,24,25)(H,26,27)/t17-/m0/s1	ZTEAPRDBWLLMHX-KRWDZBQOSA-N	rac-(2S)-2-[[2-[2-(2,3-dimethoxyphenyl)thiazol-4-yl]acetyl]amino]-3-phenyl-propanoic acid	45493502	COc1cccc(-c2nc(CC(=O)N[C@@H](Cc3ccccc3)C(=O)O)cs2)c1OC	(2S)-2-[[2-[2-(2,3-dimethoxyphenyl)-1,3-thiazol-4-yl]acetyl]amino]-3-phenylpropanoic acid			1.7676399999999997													MCULE-8101968231	426.49504		426.124943	6	2	9	3			43										False	Alkaloids	Tyrosine alkaloids			Peptide01			Compound(45493502)	45493502	3.4	910		SCHEMBL20255691	[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6](-[#6]2:[#7]:[#6](-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3)-[#6](=[#8])-[#8]):[#6]:[#16]:2):[#6]:1-[#8]-[#6]	COc1cccc(-c2nc(CC(=O)N[C@@H](Cc3ccccc3)C(=O)O)cs2)c1OC	ZTEAPRDBWLLMHX		parent_pubchem_cid	SCHEMBL20255691;EiM08-11124;AKOS005667710;(2S)-2-({2-[2-(2,3-DIMETHOXYPHENYL)-1,3-THIAZOL-4-YL]ACETYL}AMINO)-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[[2-[2-(2,3-dimethoxyphenyl)thiazol-4-yl]acetyl]amino]-3-phenyl-propanoic acid		23159907.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23159907		pluskal_iocb_peptide_Peptide01_E18_id		100	E18		ZINC000036358981
1.3		0	990	P7138826	112.9		W12	False	0	13	0	0	15	0	1	6	0	0	-1.0	0.0						O=C(O)CCC(NC(=O)OCc1ccccc1)C(=O)O		1.23		0.0	1.23	CHEMBL355760		Benzyloxycarbonyls;Dicarboxylic acids and derivatives;Carbamate esters;Organic carbonic acids and derivatives;Carboxylic acids;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Benzene and substituted derivatives;Benzenoids;Benzyloxycarbonyls;Carbamate esters;Carbamic acids and derivatives;Carbonyl compounds;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Dicarboxylic acids and derivatives;Glutamic acid and derivatives;Hydrocarbon derivatives;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as glutamic acid and derivatives. These are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Glutamic acid and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic homomonocyclic compounds	carboxylic ester (CHEBI:33308);dicarboxylic acid (CHEBI:35692);carbamate ester (CHEBI:23003);organooxygen compound (CHEBI:36963);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);glutamic acid derivative (CHEBI:24315);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);amino acid (CHEBI:33709);peptide (CHEBI:16670);carbon oxoacid (CHEBI:35605);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806)	Dicarboxylic acids (FA0117)	Amino acids, peptides, and analogues	Glutamic acid or derivatives;Benzyloxycarbonyl;Monocyclic benzene moiety;Dicarboxylic acid or derivatives;Benzenoid;Carbamic acid ester;Carbonic acid derivative;Carboxylic acid;Organooxygen compound;Organonitrogen compound;Organic oxide;Organopnictogen compound;Carbonyl group;Organic oxygen compound;Organic nitrogen compound;Hydrocarbon derivative;Aromatic homomonocyclic compound	Organic acids and derivatives	0.0		1155-62-0	DTXSID70883660	2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	1	0	3	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C13H15NO6	C13H15NO6			InChI=1S/C13H15NO6/c15-11(16)7-6-10(12(17)18)14-13(19)20-8-9-4-2-1-3-5-9/h1-5,10H,6-8H2,(H,14,19)(H,15,16)(H,17,18)/t10-/m0/s1	PVFCXMDXBIEMQG-JTQLQIEISA-N	rac-(2S)-2-(benzyloxycarbonylamino)pentanedioic acid	70866	O=C(O)CC[C@H](NC(=O)OCc1ccccc1)C(=O)O	(2S)-2-(phenylmethoxycarbonylamino)pentanedioic acid			1.17609													MCULE-8214046876	281.2676	ACID	281.089937	6	3	8	1	0.0	20199009.0	26									Dipeptides	False	Amino acids and Peptides	Small peptides	False	False	Peptide01		-1.0	Compound(70866)	70866	0.9	911		SCHEMBL910233	[#8]=[#6](-[#8])-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	O=C(O)CC[C@H](NC(=O)OCc1ccccc1)C(=O)O	PVFCXMDXBIEMQG		parent_pubchem_cid	1155-62-0;N-Cbz-L-glutamic acid;N-Carbobenzoxy-L-glutamic acid;Z-Glu-OH;N-Benzyloxycarbonyl-L-glutamic acid;Carbobenzoxy-L-glutamic acid;N-Carbobenzyloxy-l-glutamic acid;L-Glutamic acid, N-[(phenylmethoxy)carbonyl]-;BENZYLOXYCARBONYL-L-GLUTAMIC ACID;N-Benzyloxycarbonylglutamic acid;(2S)-2-(phenylmethoxycarbonylamino)pentanedioic acid;NSC 555;NSC 88494;N-(Benzyloxycarbonyl)-L-glutamic acid;Glutamic acid, N-carboxy-, N-benzyl ester, L-;Cbz-Glu-OH;(S)-2-(((BENZYLOXY)CARBONYL)AMINO)PENTANEDIOIC ACID;N-((Phenylmethoxy)carbonyl)-L-glutamic acid;L-Glutamic acid, N-((phenylmethoxy)carbonyl)-;MFCD00002801;Z-L-Glutamic acid;N-((Phenylmethoxycarbonyl)-L-glutamic acid;63648-73-7;N-(Carbobenzyloxy)-L-glutamic acid;N-[(PHENYLMETHOXY)CARBONYL]-L-GLUTAMIC ACID;Glutamic acid, N-[(phenylmethoxy)carbonyl]-;Cbz-L-Glu;EINECS 214-584-1;n-cbz-glutamic acid;Z-Glu;Z-L-Glu;N-carbobenzoxy glutamic acid;Z-Glu-OH, 99%;SCHEMBL910233;UPCMLD00WCRH4-129;(2S)-2-{[(benzyloxy)carbonyl]amino}pentanedioic acid;CHEMBL355760;BDBM36120;PVFCXMDXBIEMQG-JTQLQIEISA-;DTXSID70883660;((Benzyloxy)carbonyl)-L-glutamic acid;AKOS010397338;AKOS015836890;N-benzyloxycarbonyl-(L)-glutamic acid;CS-W020668;FD21351;N-Benzyloxycarbonylglutamic acid, (L)-;N-[(benzyloxy)carbonyl]-L-glutamic acid;2-Benzyloxycarbonylamino-pentanedioic acid;AC-26243;CS-17392;HY-20165;N-[Phenylmethoxycarbonyl]-L-glutamic acid;(s)-2-(benzyloxycarbonylamino)pentanedioic acid;EN300-149212;M03047;J-300102;Z756446340;N-alpha-BenZyloxycarbonyl-L-glutamic-acid (CbZ-L-Glu-OH);InChI=1/C13H15NO6/c15-11(16)7-6-10(12(17)18)14-13(19)20-8-9-4-2-1-3-5-9/h1-5,10H,6-8H2,(H,14,19)(H,15,16)(H,17,18)/t10-/m0/s1;rac-(2S)-2-(benzyloxycarbonylamino)pentanedioic acid	False	509948.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=509948		pluskal_iocb_peptide_Peptide01_E18_id		100	E18	False	ZINC000001555607
1.9		0	734	P6236307	102.5		W13	False	0	21	0	0	19	0	3	4	0	0		0.0						O=C(CN1Cc2ccccc2C1=O)NC(Cc1c[nH]c2ccccc12)C(=O)O								N-acyl-L-alpha-amino acids;3-alkylindoles;Isoindolones;Isoindoles;Substituted pyrroles;Benzenoids;Tertiary carboxylic acid amides;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactams;Azacyclic compounds;Carboxylic acids;Monocarboxylic acids and derivatives;Carbonyl compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	3-alkylindoles;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Dipeptides;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Isoindoles;Isoindoles and derivatives;Isoindolines;Isoindolones;Lactams;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Peptides;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Tertiary carboxylic acid amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond.	Dipeptides		Peptides	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-L-alpha-amino acid (CHEBI:48927);indoles (CHEBI:24828);isoindoles (CHEBI:24897);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);carboxamide (CHEBI:37622);organic aromatic compound (CHEBI:33659);lactam (CHEBI:24995);organonitrogen heterocyclic compound (CHEBI:38101);carboxylic acid (CHEBI:33575);monocarboxylic acid (CHEBI:25384);carbonyl compound (CHEBI:36586);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);dipeptide (CHEBI:46761);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);N-acyl-amino acid (CHEBI:51569);organic heterocyclic compound (CHEBI:24532);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143);peptide (CHEBI:16670);carboxylic acid anion (CHEBI:29067);amino acid (CHEBI:33709)		Amino acids, peptides, and analogues	Alpha-dipeptide;N-acyl-alpha-amino acid;N-acyl-l-alpha-amino acid;N-acyl-alpha amino acid or derivatives;Alpha-amino acid or derivatives;Isoindolone;3-alkylindole;Indole;Indole or derivatives;Isoindoline;Isoindole;Isoindole or derivatives;Benzenoid;Substituted pyrrole;Pyrrole;Tertiary carboxylic acid amide;Heteroaromatic compound;Lactam;Secondary carboxylic acid amide;Carboxamide group;Carboxylic acid;Azacycle;Organoheterocyclic compound;Monocarboxylic acid or derivatives;Hydrocarbon derivative;Organic oxide;Organic nitrogen compound;Carbonyl group;Organooxygen compound;Organonitrogen compound;Organic oxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS016402464		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C21H19N3O4	C21H19N3O4			InChI=1S/C21H19N3O4/c25-19(12-24-11-13-5-1-2-7-16(13)20(24)26)23-18(21(27)28)9-14-10-22-17-8-4-3-6-15(14)17/h1-8,10,18,22H,9,11-12H2,(H,23,25)(H,27,28)/t18-/m0/s1	GUPDNGGAZSGPES-SFHVURJKSA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[[2-(1-oxoisoindolin-2-yl)acetyl]amino]propanoic acid	29147726	O=C(CN1Cc2ccccc2C1=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	(2S)-3-(1H-indol-3-yl)-2-[[2-(3-oxo-1H-isoindol-2-yl)acetyl]amino]propanoic acid			1.3432499999999998													MCULE-9299775767	377.40328		377.137556	4	3	6	4			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(29147726)	29147726	2.0	912			[#8]=[#6](-[#6]-[#7]1-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6]-1=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	O=C(CN1Cc2ccccc2C1=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	GUPDNGGAZSGPES		parent_pubchem_cid	AKOS016402464;rac-(2S)-3-(1H-indol-3-yl)-2-[[2-(1-oxoisoindolin-2-yl)acetyl]amino]propanoic acid		23984903.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23984903		pluskal_iocb_peptide_Peptide01_E19_id		100	E19		ZINC000020761909
1.3		0	822	P6243191	119.2		W14	False	0	17	0	0	23	0	5	2	0	1		0.0						CC(=O)N(c1nc(C)c(C(=O)NCCc2cnc[nH]2)s1)C1CCCC1								2-heteroaryl carboxamides;2,4,5-trisubstituted thiazoles;Tertiary carboxylic acid amides;Imidazoles;Heteroaromatic compounds;Acetamides;Tertiary amines;Secondary carboxylic acid amides;Amino acids and derivatives;Azacyclic compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	2,4,5-trisubstituted thiazoles;2-heteroaryl carboxamides;Acetamides;Amines;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Azoles;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Imidazoles;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Secondary carboxylic acid amides;Tertiary amines;Tertiary carboxylic acid amides;Thiazolecarboxamides;Thiazolecarboxylic acids and derivatives;Thiazoles	Azoles	2.1	This compound belongs to the class of organic compounds known as thiazolecarboxamides. These are heterocyclic compounds containing a thiazole ring which bears a carboxylic acid amide group.	Thiazolecarboxamides		Thiazolecarboxylic acids and derivatives	Organic compounds	Aromatic heteromonocyclic compounds	organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);thiazoles (CHEBI:48901);imidazoles (CHEBI:24780);acetamides (CHEBI:22160);tertiary amine (CHEBI:32876);organonitrogen compound (CHEBI:35352);organooxygen compound (CHEBI:36963);organonitrogen heterocyclic compound (CHEBI:38101);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);aromatic amide (CHEBI:62733);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);organic heterocyclic compound (CHEBI:24532);azole (CHEBI:68452);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);amine (CHEBI:32952);oxygen molecular entity (CHEBI:25806);aromatic carboxylic acid (CHEBI:33859)		Thiazoles	2-heteroaryl carboxamide;2,4,5-trisubstituted 1,3-thiazole;Thiazolecarboxamide;Imidazole;Tertiary carboxylic acid amide;Heteroaromatic compound;Acetamide;Amino acid or derivatives;Carboxamide group;Secondary carboxylic acid amide;Tertiary amine;Carboxylic acid derivative;Azacycle;Organic nitrogen compound;Organooxygen compound;Organonitrogen compound;Organic oxygen compound;Amine;Carbonyl group;Organic oxide;Hydrocarbon derivative;Aromatic heteromonocyclic compound	Organoheterocyclic compounds	0.0		1232791-18-2		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	3	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C17H23N5O2S	C17H23N5O2S			InChI=1S/C17H23N5O2S/c1-11-15(16(24)19-8-7-13-9-18-10-20-13)25-17(21-11)22(12(2)23)14-5-3-4-6-14/h9-10,14H,3-8H2,1-2H3,(H,18,20)(H,19,24)	NRMJYTXEQJJQGK-UHFFFAOYSA-N	2-[acetyl(cyclopentyl)amino]-N-[2-(1H-imidazol-4-yl)ethyl]-4-methyl-thiazole-5-carboxamide	51048428	CC(=O)N(c1nc(C)c(C(=O)NCCc2cnc[nH]2)s1)C1CCCC1	2-[acetyl(cyclopentyl)amino]-N-[2-(1H-imidazol-5-yl)ethyl]-4-methyl-1,3-thiazole-5-carboxamide			1.89788													MCULE-1639517088	361.46916		361.157246	4	2	6	3			44									Imidazole alkaloids	False	Alkaloids	Histidine alkaloids			Peptide01			Compound(51048428)	51048428	2.1	913			[#6]-[#6](=[#8])-[#7](-[#6]1:[#7]:[#6](-[#6]):[#6](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7]:[#6]:[#7H]:2):[#16]:1)-[#6]1-[#6]-[#6]-[#6]-[#6]-1	CC(=O)N(c1nc(C)c(C(=O)NCCc2cnc[nH]2)s1)C1CCCC1	NRMJYTXEQJJQGK		parent_pubchem_cid	1232791-18-2;2-[acetyl(cyclopentyl)amino]-N-[2-(1H-imidazol-4-yl)ethyl]-4-methyl-1,3-thiazole-5-carboxamide;EiM08-15483;AKOS005667807;2-(N-CYCLOPENTYLACETAMIDO)-N-[2-(1H-IMIDAZOL-4-YL)ETHYL]-4-METHYL-1,3-THIAZOLE-5-CARBOXAMIDE;2-[acetyl(cyclopentyl)amino]-N-[2-(1H-imidazol-4-yl)ethyl]-4-methyl-thiazole-5-carboxamide		20282414.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=20282414		pluskal_iocb_peptide_Peptide01_E19_id		100	E19		ZINC000044903613
1.0		0	910	P1107544	168.1		W15	False	0	19	0	0	23	0	3	7	0	0		0.0						Cc1c(CC(=O)NC(CCCCNC(N)=O)C(=O)O)c(=O)oc2c1ccc(O)c2																							0.0		AKOS016379140		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C19H23N3O7	C19H23N3O7			InChI=1S/C19H23N3O7/c1-10-12-6-5-11(23)8-15(12)29-18(27)13(10)9-16(24)22-14(17(25)26)4-2-3-7-21-19(20)28/h5-6,8,14,23H,2-4,7,9H2,1H3,(H,22,24)(H,25,26)(H3,20,21,28)/t14-/m1/s1	OQRIORVPGMFSJO-CQSZACIVSA-N	rac-(2R)-2-[[2-(7-hydroxy-4-methyl-2-oxo-chromen-3-yl)acetyl]amino]-6-ureido-hexanoic acid	24280470	Cc1c(CC(=O)N[C@H](CCCCNC(N)=O)C(=O)O)c(=O)oc2c1ccc(O)c2	(2R)-6-(carbamoylamino)-2-[[2-(7-hydroxy-4-methyl-2-oxochromen-3-yl)acetyl]amino]hexanoic acid			0.6571600000000011													MCULE-2626030821	405.41106		405.1536	7	5	9	2			44									Dipeptides;Simple coumarins	False	Amino acids and Peptides;Shikimates and Phenylpropanoids	Coumarins;Small peptides			Peptide01			Compound(24280470)	24280470	0.1	914			[#6]-[#6]1:[#6](-[#6]-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#8])-[#6](=[#8])-[#8]):[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]):[#6]:2	Cc1c(CC(=O)N[C@H](CCCCNC(N)=O)C(=O)O)c(=O)oc2c1ccc(O)c2	OQRIORVPGMFSJO		parent_pubchem_cid	AKOS016379140;6-(CARBAMOYLAMINO)-2-[2-(7-HYDROXY-4-METHYL-2-OXO-2H-CHROMEN-3-YL)ACETAMIDO]HEXANOIC ACID;rac-(2R)-2-[[2-(7-hydroxy-4-methyl-2-oxo-chromen-3-yl)acetyl]amino]-6-ureido-hexanoic acid		23008930.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23008930		pluskal_iocb_peptide_Peptide01_E19_id		100	E19		ZINC000011865465
4.5		0	998	P1099331	125.3		W16	False	0	22	0	0	22	0	4	2	0	1		0.0						CCc1cc(-c2c(-c3nc(C)cs3)c(N)n[nH]2)c(O)cc1OCc1ccccc1																							0.0		AKOS004937069		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	1	1	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0		C22H22N4O2S	C22H22N4O2S			InChI=1S/C22H22N4O2S/c1-3-15-9-16(17(27)10-18(15)28-11-14-7-5-4-6-8-14)20-19(21(23)26-25-20)22-24-13(2)12-29-22/h4-10,12,27H,3,11H2,1-2H3,(H3,23,25,26)	PKIVWSCIDQAKPU-UHFFFAOYSA-N	2-[5-amino-4-(4-methylthiazol-2-yl)-1H-pyrazol-3-yl]-5-benzyloxy-4-ethyl-phenol	135898010	CCc1cc(-c2c(-c3nc(C)cs3)c(N)n[nH]2)c(O)cc1OCc1ccccc1	2-[3-amino-4-(4-methyl-1,3-thiazol-2-yl)-1H-pyrazol-5-yl]-4-ethyl-5-phenylmethoxyphenol			2.7082200000000007													MCULE-8519817756	406.51024		406.146347	5	3	6	4			44										False	Alkaloids				Peptide01			Compound(135898010)	135898010	4.5	915			[#6]-[#6]-[#6]1:[#6]:[#6](-[#6]2:[#6](-[#6]3:[#7]:[#6](-[#6]):[#6]:[#16]:3):[#6](-[#7]):[#7]:[#7H]:2):[#6](-[#8]):[#6]:[#6]:1-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	CCc1cc(-c2c(-c3nc(C)cs3)c(N)n[nH]2)c(O)cc1OCc1ccccc1	PKIVWSCIDQAKPU		parent_pubchem_cid	AKOS004937069;2-[5-amino-4-(4-methylthiazol-2-yl)-1H-pyrazol-3-yl]-5-benzyloxy-4-ethyl-phenol		17850894.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=17850894		pluskal_iocb_peptide_Peptide01_E19_id		100	E19		ZINC000011867302
3.7		0	742	P6236256	132.5		W17	False	0	23	0	0	21	0	3	4	0	1		0.0						COc1ccc(-c2nc(CC(=O)NC(Cc3c[nH]c4ccccc34)C(=O)O)cs2)cc1																							0.0		SCHEMBL20255602		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C23H21N3O4S	C23H21N3O4S			InChI=1S/C23H21N3O4S/c1-30-17-8-6-14(7-9-17)22-25-16(13-31-22)11-21(27)26-20(23(28)29)10-15-12-24-19-5-3-2-4-18(15)19/h2-9,12-13,20,24H,10-11H2,1H3,(H,26,27)(H,28,29)/t20-/m0/s1	XNUAIXPEKLRKEP-FQEVSTJZSA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[[2-[2-(4-methoxyphenyl)thiazol-4-yl]acetyl]amino]propanoic acid	29130846	COc1ccc(-c2nc(CC(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)O)cs2)cc1	(2S)-3-(1H-indol-3-yl)-2-[[2-[2-(4-methoxyphenyl)-1,3-thiazol-4-yl]acetyl]amino]propanoic acid			2.27433													MCULE-2113848188	435.50552		435.125277	5	3	8	4			43										False	Alkaloids				Peptide01			Compound(29130846)	29130846	2.7	916		SCHEMBL20255602	[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6]2:[#7]:[#6](-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]3:[#6]:[#7H]:[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]:3:4)-[#6](=[#8])-[#8]):[#6]:[#16]:2):[#6]:[#6]:1	COc1ccc(-c2nc(CC(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)O)cs2)cc1	XNUAIXPEKLRKEP		parent_pubchem_cid	SCHEMBL20255602;STK632378;AKOS005564854;N-{[2-(4-methoxyphenyl)-1,3-thiazol-4-yl]acetyl}-L-tryptophan;rac-(2S)-3-(1H-indol-3-yl)-2-[[2-[2-(4-methoxyphenyl)thiazol-4-yl]acetyl]amino]propanoic acid		23712161.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23712161		pluskal_iocb_peptide_Peptide01_E19_id		100	E19		ZINC000020721448
4.7		0	830	P3460709	107.5		W18	False	0	20	2	0	16	0	2	3	0	1		0.0						O=C(Cc1csc(-c2c(Cl)cccc2Cl)n1)NC(Cc1ccccc1)C(=O)O																							0.0		SCHEMBL21560115		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C20H16Cl2N2O3S	C20H16Cl2N2O3S			InChI=1S/C20H16Cl2N2O3S/c21-14-7-4-8-15(22)18(14)19-23-13(11-28-19)10-17(25)24-16(20(26)27)9-12-5-2-1-3-6-12/h1-8,11,16H,9-10H2,(H,24,25)(H,26,27)/t16-/m0/s1	HOBWIDXOHSSCHB-INIZCTEOSA-N	rac-(2S)-2-[[2-[2-(2,6-dichlorophenyl)thiazol-4-yl]acetyl]amino]-3-phenyl-propanoic acid	39340917	O=C(Cc1csc(-c2c(Cl)cccc2Cl)n1)N[C@@H](Cc1ccccc1)C(=O)O	(2S)-2-[[2-[2-(2,6-dichlorophenyl)-1,3-thiazol-4-yl]acetyl]amino]-3-phenylpropanoic acid			3.9820600000000015													MCULE-3353253382	435.33212		434.025869	4	2	7	3			43										False					Peptide01			Compound(39340917)	39340917	4.7	917		SCHEMBL21560115	[#8]=[#6](-[#6]-[#6]1:[#6]:[#16]:[#6](-[#6]2:[#6](-[#17]):[#6]:[#6]:[#6]:[#6]:2-[#17]):[#7]:1)-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	O=C(Cc1csc(-c2c(Cl)cccc2Cl)n1)N[C@@H](Cc1ccccc1)C(=O)O	HOBWIDXOHSSCHB		parent_pubchem_cid	SCHEMBL21560115;AKOS005585248;(2S)-2-({2-[2-(2,6-DICHLOROPHENYL)-1,3-THIAZOL-4-YL]ACETYL}AMINO)-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[[2-[2-(2,6-dichlorophenyl)thiazol-4-yl]acetyl]amino]-3-phenyl-propanoic acid		24062244.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24062244		pluskal_iocb_peptide_Peptide01_E19_id		100	E19		ZINC000032095581
2.0		0	918	P1159730	114.8		W19	False	0	20	0	0	18	0	6	3	0	0		0.0						COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c1cc(-n2cnnn2)ccc1								Alpha amino acid esters;N-acyl-alpha amino acids and derivatives;Phenyltetrazoles and derivatives;3-alkylindoles;Benzoyl derivatives;Fatty acid esters;Substituted pyrroles;Methyl esters;Heteroaromatic compounds;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Azacyclic compounds;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organonitrogen compounds	3-alkylindoles;Alpha amino acid esters;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Azoles;Benzamides;Benzene and substituted derivatives;Benzenoids;Benzoic acids and derivatives;Benzoyl derivatives;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids and derivatives;Chemical entities;Fatty Acyls;Fatty acid esters;Heteroaromatic compounds;Hippuric acids and derivatives;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Lipids and lipid-like molecules;Methyl esters;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenyltetrazoles and derivatives;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Tetrazoles	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as hippuric acids and derivatives. These are compounds containing a hippuric acid or a derivative, with a structure characterized the presence of a benzoyl group linked to the N-terminal of a glycine.	Hippuric acids and derivatives		Benzamides	Organic compounds	Aromatic heteropolycyclic compounds	alpha-amino acid ester (CHEBI:46874);N-acyl-amino acid (CHEBI:51569);tetrazoles (CHEBI:35689);indoles (CHEBI:24828);carbonyl compound (CHEBI:36586);fatty acid ester (CHEBI:35748);pyrroles (CHEBI:26455);carboxylic ester (CHEBI:33308);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);monocarboxylic acid (CHEBI:25384);organonitrogen heterocyclic compound (CHEBI:38101);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);N-acylglycine (CHEBI:16180);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);organooxygen compound (CHEBI:36963);organic heterocyclic compound (CHEBI:24532);azole (CHEBI:68452);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);lipid (CHEBI:18059);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143);benzoic acids (CHEBI:22723);benzamides (CHEBI:22702);phenols (CHEBI:33853);amino acid (CHEBI:33709);peptide (CHEBI:16670)	Fatty esters (FA07);Fatty Acyls (FA)	Benzoic acids and derivatives	Alpha-amino acid ester;N-acyl-alpha amino acid or derivatives;Hippuric acid or derivatives;Phenyltetrazole;Alpha-amino acid or derivatives;3-alkylindole;Indole or derivatives;Indole;Benzoyl;Fatty acid ester;Fatty acyl;Substituted pyrrole;Azole;Heteroaromatic compound;Methyl ester;Pyrrole;Tetrazole;Carboxylic acid ester;Carboxamide group;Secondary carboxylic acid amide;Azacycle;Carboxylic acid derivative;Organoheterocyclic compound;Monocarboxylic acid or derivatives;Organic oxygen compound;Organic nitrogen compound;Carbonyl group;Hydrocarbon derivative;Organooxygen compound;Organonitrogen compound;Organic oxide;Aromatic heteropolycyclic compound	Benzenoids	0.0		AKOS005535092		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	4	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C20H18N6O3	C20H18N6O3			InChI=1S/C20H18N6O3/c1-29-20(28)18(10-14-11-21-17-8-3-2-7-16(14)17)23-19(27)13-5-4-6-15(9-13)26-12-22-24-25-26/h2-9,11-12,18,21H,10H2,1H3,(H,23,27)/t18-/m0/s1	ZSFRFNGRVYRJOV-SFHVURJKSA-N	methyl rac-(2S)-3-(1H-indol-3-yl)-2-[[3-(tetrazol-1-yl)benzoyl]amino]propanoate	28935446	COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1cc(-n2cnnn2)ccc1	methyl (2S)-3-(1H-indol-3-yl)-2-[[3-(tetrazol-1-yl)benzoyl]amino]propanoate			0.9298499999999996													MCULE-9704335306	390.40486		390.144038	6	2	7	4			44									Imidazole alkaloids;Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids;Histidine alkaloids			Peptide01			Compound(28935446)	28935446	2.5	918			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6](-[#7]2:[#6]:[#7]:[#7]:[#7]:2):[#6]:[#6]:[#6]:1	COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1cc(-n2cnnn2)ccc1	ZSFRFNGRVYRJOV		parent_pubchem_cid	AKOS005535092;METHYL 3-(1H-INDOL-3-YL)-2-{[3-(1H-1,2,3,4-TETRAZOL-1-YL)PHENYL]FORMAMIDO}PROPANOATE;methyl rac-(2S)-3-(1H-indol-3-yl)-2-[[3-(tetrazol-1-yl)benzoyl]amino]propanoate		6746203.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=6746203		pluskal_iocb_peptide_Peptide01_E19_id		100	E19		ZINC000020427691
2.3		0	1006	P1094966	117.3		W20	False	0	26	0	0	32	0	4	6	0	0		0.0						COC(=O)C(Cc1ccccc1)NC(=O)N1CCN(C(=O)NC(Cc2ccccc2)C(=O)OC)CC1																							0.0		AKOS005533483		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	4	0	2	0	0	0	0	0	0	0	0	4	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C26H32N4O6	C26H32N4O6			InChI=1S/C26H32N4O6/c1-35-23(31)21(17-19-9-5-3-6-10-19)27-25(33)29-13-15-30(16-14-29)26(34)28-22(24(32)36-2)18-20-11-7-4-8-12-20/h3-12,21-22H,13-18H2,1-2H3,(H,27,33)(H,28,34)/t21-,22-/m0/s1	KFVWLODQGCNZSF-VXKWHMMOSA-N	methyl rac-(2S)-3-phenyl-2-[[4-[[rac-(1S)-1-benzyl-2-methoxy-2-oxo-ethyl]carbamoyl]piperazine-1-carbonyl]amino]propanoate	17579166	COC(=O)[C@H](Cc1ccccc1)NC(=O)N1CCN(C(=O)N[C@@H](Cc2ccccc2)C(=O)OC)CC1	methyl (2S)-2-[[4-[[(2S)-1-methoxy-1-oxo-3-phenylpropan-2-yl]carbamoyl]piperazine-1-carbonyl]amino]-3-phenylpropanoate			1.4823800000000007													MCULE-3765445841	496.56814		496.232185	6	2	10	3			44										False	Amino acids and Peptides	Small peptides			Peptide01			Compound(17579166)	17579166	2.5	919			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#7]1-[#6]-[#6]-[#7](-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#8]-[#6])-[#6]-[#6]-1	COC(=O)[C@H](Cc1ccccc1)NC(=O)N1CCN(C(=O)N[C@@H](Cc2ccccc2)C(=O)OC)CC1	KFVWLODQGCNZSF		parent_pubchem_cid	AKOS005533483;methyl rac-(2S)-3-phenyl-2-[[4-[[rac-(1S)-1-benzyl-2-methoxy-2-oxo-ethyl]carbamoyl]piperazine-1-carbonyl]amino]propanoate		4063391.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=4063391		pluskal_iocb_peptide_Peptide01_E19_id		100	E19		ZINC000011692318
1.0		0	750	P6248070	105.7		W21	False	0	19	0	0	24	0	4	4	0	0		0.0						O=C(O)CCNC(=O)N1CCN(C(=O)CCc2c[nH]c3ccccc23)CC1								3-alkylindoles;Piperazine carboxamides;Substituted pyrroles;Benzenoids;Tertiary carboxylic acid amides;Heteroaromatic compounds;Ureas;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	3-alkylindoles;Azacyclic compounds;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Diazinanes;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Piperazine carboxamides;Piperazine carboxylic acids and derivatives;Piperazines;Pyrroles;Substituted pyrroles;Tertiary carboxylic acid amides;Tryptamines and derivatives;Ureas	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as tryptamines and derivatives. These are compounds containing the tryptamine backbone, which is structurally characterized by an indole ring substituted at the 3-position by an ethanamine.	Tryptamines and derivatives			Organic compounds	Aromatic heteropolycyclic compounds	indoles (CHEBI:24828);piperazinecarboxamide (CHEBI:46853);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);carboxamide (CHEBI:37622);organic aromatic compound (CHEBI:33659);ureas (CHEBI:47857);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);tryptamines (CHEBI:27162);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);organic heteromonocyclic compound (CHEBI:25693);piperazines (CHEBI:26144);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806)		Tryptamines and derivatives	Triptan;3-alkylindole;Indole;Piperazine-1-carboxamide;1,4-diazinane;Piperazine;Substituted pyrrole;Benzenoid;Heteroaromatic compound;Tertiary carboxylic acid amide;Pyrrole;Urea;Carboxamide group;Azacycle;Carboxylic acid derivative;Carboxylic acid;Monocarboxylic acid or derivatives;Hydrocarbon derivative;Organic nitrogen compound;Organic oxide;Organonitrogen compound;Organooxygen compound;Organic oxygen compound;Carbonyl group;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		N-({4-[3-(1H-indol-3-yl)propanoyl]piperazin-1-yl}carbonyl)-beta-alanine		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C19H24N4O4	C19H24N4O4			InChI=1S/C19H24N4O4/c24-17(6-5-14-13-21-16-4-2-1-3-15(14)16)22-9-11-23(12-10-22)19(27)20-8-7-18(25)26/h1-4,13,21H,5-12H2,(H,20,27)(H,25,26)	GUVAFKOGRWLKTC-UHFFFAOYSA-N	3-[[4-[3-(1H-indol-3-yl)propanoyl]piperazine-1-carbonyl]amino]propanoic acid	17597902	O=C(O)CCNC(=O)N1CCN(C(=O)CCc2c[nH]c3ccccc23)CC1	3-[[4-[3-(1H-indol-3-yl)propanoyl]piperazine-1-carbonyl]amino]propanoic acid			0.9458700000000008													MCULE-5308279384	372.42753		372.179755	4	3	6	3			43									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(17597902)	17597902	0.3	920			[#8]=[#6](-[#8])-[#6]-[#6]-[#7]-[#6](=[#8])-[#7]1-[#6]-[#6]-[#7](-[#6](=[#8])-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6]-[#6]-1	O=C(O)CCNC(=O)N1CCN(C(=O)CCc2c[nH]c3ccccc23)CC1	GUVAFKOGRWLKTC		parent_pubchem_cid	N-({4-[3-(1H-indol-3-yl)propanoyl]piperazin-1-yl}carbonyl)-beta-alanine;951943-03-6;MFCD09853225;STL237464;AKOS016402321;3-[({4-[3-(1H-INDOL-3-YL)PROPANOYL]PIPERAZINO}CARBONYL)AMINO]PROPANOIC ACID;3-[[4-[3-(1H-indol-3-yl)propanoyl]piperazine-1-carbonyl]amino]propanoic acid		22994926.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22994926		pluskal_iocb_peptide_Peptide01_E20_id		100	E20		ZINC000013692209
3.0		0	838	P1108044	161.0		W22	False	0	25	0	0	31	0	3	7	0	0		0.0						Cc1c(CC(=O)NC(CCCNC(N)=O)C(=O)O)c(=O)oc2c(C)c3c(cc12)c(C(C)(C)C)co3																							0.0		AKOS016379060		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C25H31N3O7	C25H31N3O7			InChI=1S/C25H31N3O7/c1-12-14-9-16-17(25(3,4)5)11-34-20(16)13(2)21(14)35-23(32)15(12)10-19(29)28-18(22(30)31)7-6-8-27-24(26)33/h9,11,18H,6-8,10H2,1-5H3,(H,28,29)(H,30,31)(H3,26,27,33)/t18-/m1/s1	JMOWXWVVSVIBKV-GOSISDBHSA-N	rac-(2R)-2-[[2-(3-tert-butyl-5,9-dimethyl-7-oxo-furo[3,2-g]chromen-6-yl)acetyl]amino]-5-ureido-pentanoic acid	24280581	Cc1c(CC(=O)N[C@H](CCCNC(N)=O)C(=O)O)c(=O)oc2c(C)c3c(cc12)c(C(C)(C)C)co3	(2R)-2-[[2-(3-tert-butyl-5,9-dimethyl-7-oxofuro[3,2-g]chromen-6-yl)acetyl]amino]-5-(carbamoylamino)pentanoic acid			2.838150000000001													MCULE-2716497725	485.54172		485.2162	6	4	9	3			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(24280581)	24280581	2.6	921			[#6]-[#6]1:[#6](-[#6]-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#8])-[#6](=[#8])-[#8]):[#6](=[#8]):[#8]:[#6]2:[#6](-[#6]):[#6]3:[#6](:[#6]:[#6]:1:2):[#6](-[#6](-[#6])(-[#6])-[#6]):[#6]:[#8]:3	Cc1c(CC(=O)N[C@H](CCCNC(N)=O)C(=O)O)c(=O)oc2c(C)c3c(cc12)c(C(C)(C)C)co3	JMOWXWVVSVIBKV		parent_pubchem_cid	AKOS016379060;rac-(2R)-2-[[2-(3-tert-butyl-5,9-dimethyl-7-oxo-furo[3,2-g]chromen-6-yl)acetyl]amino]-5-ureido-pentanoic acid		23651066.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23651066		pluskal_iocb_peptide_Peptide01_E20_id		100	E20		ZINC000011865580
0.1		0	926	P10085231	98.7		W23	False	0	14	0	0	21	0	5	3	0	0		0.0						CC(C)C(NC(=O)N1CCN(c2ncccn2)CC1)C(=O)O																							0.0		AKOS025280298		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1		C14H21N5O3	C14H21N5O3			InChI=1S/C14H21N5O3/c1-10(2)11(12(20)21)17-14(22)19-8-6-18(7-9-19)13-15-4-3-5-16-13/h3-5,10-11H,6-9H2,1-2H3,(H,17,22)(H,20,21)	WYNUVWKXIBKXMI-UHFFFAOYSA-N	3-methyl-2-[(4-pyrimidin-2-ylpiperazine-1-carbonyl)amino]butanoic acid	60174511	CC(C)C(NC(=O)N1CCN(c2ncccn2)CC1)C(=O)O	3-methyl-2-[(4-pyrimidin-2-ylpiperazine-1-carbonyl)amino]butanoic acid			0.0367900000000004													MCULE-3030052131	307.35517		307.16444	6	2	4	2			45										False	Alkaloids	Lysine alkaloids			Peptide01			Compound(60174511)	60174511	0.7	922			[#6]-[#6](-[#6])-[#6](-[#7]-[#6](=[#8])-[#7]1-[#6]-[#6]-[#7](-[#6]2:[#7]:[#6]:[#6]:[#6]:[#7]:2)-[#6]-[#6]-1)-[#6](=[#8])-[#8]	CC(C)C(NC(=O)N1CCN(c2ncccn2)CC1)C(=O)O	WYNUVWKXIBKXMI		parent_pubchem_cid	AKOS025280298;3-methyl-2-[(4-pyrimidin-2-ylpiperazine-1-carbonyl)amino]butanoic acid		64775604.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=64775604		pluskal_iocb_peptide_Peptide01_E20_id		100	E20		
2.8		0	1014	P7567849	71.3		W24	False	0	16	0	0	20	0	2	3	0	0		0.0						CCC(C)C(NC(=O)c1cc2c(cc1)ccn2C)C(=O)O																							0.0		AKOS025146045		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C16H20N2O3	C16H20N2O3			InChI=1S/C16H20N2O3/c1-4-10(2)14(16(20)21)17-15(19)12-6-5-11-7-8-18(3)13(11)9-12/h5-10,14H,4H2,1-3H3,(H,17,19)(H,20,21)/t10-,14+/m1/s1	LBKRFFPVBWDSHN-YGRLFVJLSA-N	rac-(2S,3R)-3-methyl-2-[(1-methylindole-6-carbonyl)amino]pentanoic acid	91637583	CC[C@@H](C)[C@H](NC(=O)c1cc2c(cc1)ccn2C)C(=O)O	(2S,3R)-3-methyl-2-[(1-methylindole-6-carbonyl)amino]pentanoic acid			1.92427														288.3494		288.147392	3	2	5	2			45										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(91637583)	91637583	2.6	923			[#6]-[#6]-[#6@@H](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#6]:[#6]:[#7]:2-[#6])-[#6](=[#8])-[#8]	CC[C@@H](C)[C@H](NC(=O)c1cc2c(cc1)ccn2C)C(=O)O	LBKRFFPVBWDSHN		parent_pubchem_cid	AKOS025146045;(2S,3R)-3-METHYL-2-{[(1-METHYL-1H-INDOL-6-YL)CARBONYL]AMINO}PENTANOIC ACID;rac-(2S,3R)-3-methyl-2-[(1-methylindole-6-carbonyl)amino]pentanoic acid		94946446.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=94946446		pluskal_iocb_peptide_Peptide01_E20_id		100	E20		ZINC000170625473
2.3		0	758	P6236895	162.6		W25	False	0	20	0	0	26	0	4	4	0	1		0.0						CC(C)c1ccc(-c2nc(CC(=O)NC(CCCNC(N)=O)C(=O)O)cs2)cc1								Monocyclic monoterpenoids;Aromatic monoterpenoids;Phenylpropanes;Cumenes;2,4-disubstituted thiazoles;Heteroaromatic compounds;Ureas;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	2,4-disubstituted thiazoles;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Aromatic monoterpenoids;Azacyclic compounds;Azoles;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Cumenes;Heteroaromatic compounds;Hydrocarbon derivatives;Lipids and lipid-like molecules;Monocarboxylic acids and derivatives;Monocyclic monoterpenoids;Monoterpenoids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenylpropanes;Prenol lipids;Secondary carboxylic acid amides;Thiazoles;Ureas	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom.	N-acyl-alpha amino acids		Amino acids and derivatives;Alpha amino acids and derivatives;N-acyl-alpha amino acids and derivatives	Organic compounds	Aromatic heteromonocyclic compounds	monoterpenoid (CHEBI:25409);alkylbenzene (CHEBI:38976);thiazoles (CHEBI:48901);organic aromatic compound (CHEBI:33659);ureas (CHEBI:47857);carboxamide (CHEBI:37622);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);N-acyl-amino acid (CHEBI:51569);chemical entity (CHEBI:24431);lipid (CHEBI:18059);ether lipid (CHEBI:64611);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);organic heterocyclic compound (CHEBI:24532);azole (CHEBI:68452);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806)	C10 isoprenoids (monoterpenes) (PR0102);Prenol Lipids (PR)	Amino acids, peptides, and analogues	N-acyl-alpha-amino acid;P-cymene;Aromatic monoterpenoid;Monocyclic monoterpenoid;Monoterpenoid;Phenylpropane;Cumene;2,4-disubstituted 1,3-thiazole;Monocyclic benzene moiety;Benzenoid;Azole;Heteroaromatic compound;Thiazole;Carboxamide group;Urea;Secondary carboxylic acid amide;Azacycle;Organoheterocyclic compound;Carboxylic acid;Monocarboxylic acid or derivatives;Carbonyl group;Organic nitrogen compound;Hydrocarbon derivative;Organic oxygen compound;Organooxygen compound;Organic oxide;Organonitrogen compound;Aromatic heteromonocyclic compound	Organic acids and derivatives	0.0		SCHEMBL21560187		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	1	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C20H26N4O4S	C20H26N4O4S			InChI=1S/C20H26N4O4S/c1-12(2)13-5-7-14(8-6-13)18-23-15(11-29-18)10-17(25)24-16(19(26)27)4-3-9-22-20(21)28/h5-8,11-12,16H,3-4,9-10H2,1-2H3,(H,24,25)(H,26,27)(H3,21,22,28)/t16-/m1/s1	SISZTTCTWSIEMI-MRXNPFEDSA-N	rac-(2R)-2-[[2-[2-(4-isopropylphenyl)thiazol-4-yl]acetyl]amino]-5-ureido-pentanoic acid	29147163	CC(C)c1ccc(-c2nc(CC(=O)N[C@H](CCCNC(N)=O)C(=O)O)cs2)cc1	(2R)-5-(carbamoylamino)-2-[[2-[2-(4-propan-2-ylphenyl)-1,3-thiazol-4-yl]acetyl]amino]pentanoic acid			2.004459999999999													MCULE-6943045464	418.51862		418.167476	5	4	10	2			43										False	Amino acids and Peptides				Peptide01			Compound(29147163)	29147163	2.1	924		SCHEMBL21560187	[#6]-[#6](-[#6])-[#6]1:[#6]:[#6]:[#6](-[#6]2:[#7]:[#6](-[#6]-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#8])-[#6](=[#8])-[#8]):[#6]:[#16]:2):[#6]:[#6]:1	CC(C)c1ccc(-c2nc(CC(=O)N[C@H](CCCNC(N)=O)C(=O)O)cs2)cc1	SISZTTCTWSIEMI		parent_pubchem_cid	SCHEMBL21560187;AKOS016376776;rac-(2R)-2-[[2-[2-(4-isopropylphenyl)thiazol-4-yl]acetyl]amino]-5-ureido-pentanoic acid		24446003.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24446003		pluskal_iocb_peptide_Peptide01_E20_id		100	E20		ZINC000020760756
2.8		0	846	P6245401	99.1		W26	False	0	22	0	0	23	0	3	4	0	0		0.0						CC(C)CC(NC(=O)Cn1nc(-c2cccc3ccccc23)ccc1=O)C(=O)O																							0.0		AKOS016376056		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C22H23N3O4	C22H23N3O4			InChI=1S/C22H23N3O4/c1-14(2)12-19(22(28)29)23-20(26)13-25-21(27)11-10-18(24-25)17-9-5-7-15-6-3-4-8-16(15)17/h3-11,14,19H,12-13H2,1-2H3,(H,23,26)(H,28,29)/t19-/m0/s1	RISRROMVWBINST-IBGZPJMESA-N	rac-(2S)-4-methyl-2-[[2-[3-(1-naphthyl)-6-oxo-pyridazin-1-yl]acetyl]amino]pentanoic acid	52900261	CC(C)C[C@H](NC(=O)Cn1nc(-c2cccc3ccccc23)ccc1=O)C(=O)O	(2S)-4-methyl-2-[[2-(3-naphthalen-1-yl-6-oxopyridazin-1-yl)acetyl]amino]pentanoic acid			2.7704500000000003													MCULE-9026250604	393.44631		393.168856	5	2	7	3			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(52900261)	52900261	3.4	925			[#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#7]1:[#7]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:[#6]:1=[#8])-[#6](=[#8])-[#8]	CC(C)C[C@H](NC(=O)Cn1nc(-c2cccc3ccccc23)ccc1=O)C(=O)O	RISRROMVWBINST		parent_pubchem_cid	AKOS016376056;(2S)-4-METHYL-2-({2-[3-(1-NAPHTHYL)-6-OXO-1(6H)-PYRIDAZINYL]ACETYL}AMINO)PENTANOIC ACID;rac-(2S)-4-methyl-2-[[2-[3-(1-naphthyl)-6-oxo-pyridazin-1-yl]acetyl]amino]pentanoic acid		22653081.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22653081		pluskal_iocb_peptide_Peptide01_E20_id		100	E20		ZINC000061719827
1.5		0	934	P6236874	92.9		W27	False	0	17	0	1	16	0	5	2	0	0		0.0						O=C(NC(CO)Cc1ccccc1)c1c(-n2cnnn2)cc(F)cc1																							0.0		AKOS016401583		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	4	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C17H16FN5O2	C17H16FN5O2			InChI=1S/C17H16FN5O2/c18-13-6-7-15(16(9-13)23-11-19-21-22-23)17(25)20-14(10-24)8-12-4-2-1-3-5-12/h1-7,9,11,14,24H,8,10H2,(H,20,25)	ZZUSRAIWJLJOTL-UHFFFAOYSA-N	N-(1-benzyl-2-hydroxy-ethyl)-4-fluoro-2-(tetrazol-1-yl)benzamide	42650879	O=C(NC(CO)Cc1ccccc1)c1c(-n2cnnn2)cc(F)cc1	4-fluoro-N-(1-hydroxy-3-phenylpropan-2-yl)-2-(tetrazol-1-yl)benzamide			0.8353699999999991													MCULE-9358565918	341.34777		341.128803	5	2	6	3			45										False	Alkaloids				Peptide01			Compound(42650879)	42650879	1.9	926			[#8]=[#6](-[#7]-[#6](-[#6]-[#8])-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6](-[#7]2:[#6]:[#7]:[#7]:[#7]:2):[#6]:[#6](-[#9]):[#6]:[#6]:1	O=C(NC(CO)Cc1ccccc1)c1c(-n2cnnn2)cc(F)cc1	ZZUSRAIWJLJOTL		parent_pubchem_cid	AKOS016401583;N-(1-benzyl-2-hydroxy-ethyl)-4-fluoro-2-(tetrazol-1-yl)benzamide		23699663.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23699663		pluskal_iocb_peptide_Peptide01_E20_id		100	E20		
2.8		0	1022	P11185104	102.5		W28	False	0	23	0	0	21	0	3	4	0	0		0.0						Cc1cc(=O)n(CC(=O)NC(Cc2c[nH]c3ccccc23)C(=O)O)c2ccccc12																							0.0		AKOS027472733		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C23H21N3O4	C23H21N3O4			InChI=1S/C23H21N3O4/c1-14-10-22(28)26(20-9-5-3-6-16(14)20)13-21(27)25-19(23(29)30)11-15-12-24-18-8-4-2-7-17(15)18/h2-10,12,19,24H,11,13H2,1H3,(H,25,27)(H,29,30)/t19-/m0/s1	SLWQCKXHHIBMGQ-IBGZPJMESA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[[2-(4-methyl-2-oxo-1-quinolyl)acetyl]amino]propanoic acid	91637758	Cc1cc(=O)n(CC(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)c2ccccc12	(2S)-3-(1H-indol-3-yl)-2-[[2-(4-methyl-2-oxoquinolin-1-yl)acetyl]amino]propanoic acid			2.536950000000001														403.44152		403.153206	4	3	6	4			45										False					Peptide01			Compound(91637758)	91637758	2.5	927			[#6]-[#6]1:[#6]:[#6](=[#8]):[#7](-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6](=[#8])-[#8]):[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	Cc1cc(=O)n(CC(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)c2ccccc12	SLWQCKXHHIBMGQ		parent_pubchem_cid	AKOS027472733;(2S)-3-(1H-INDOL-3-YL)-2-({2-[4-METHYL-2-OXO-1(2H)-QUINOLINYL]ACETYL}AMINO)PROPANOIC ACID;rac-(2S)-3-(1H-indol-3-yl)-2-[[2-(4-methyl-2-oxo-1-quinolyl)acetyl]amino]propanoic acid		92310616.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=92310616		pluskal_iocb_peptide_Peptide01_E20_id		100	E20		ZINC000217796378
3.8		0	766	P6239985	80.6		W29	False	0	22	0	0	24	0	2	4	0	0		0.0						CC(C)C(NC(=O)Cn1ccc2c1ccc(OCc1ccccc1)c2)C(=O)O																							0.0		AKOS005670042		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C22H24N2O4	C22H24N2O4			InChI=1S/C22H24N2O4/c1-15(2)21(22(26)27)23-20(25)13-24-11-10-17-12-18(8-9-19(17)24)28-14-16-6-4-3-5-7-16/h3-12,15,21H,13-14H2,1-2H3,(H,23,25)(H,26,27)/t21-/m0/s1	MTVFEMFSISSPDY-NRFANRHFSA-N	rac-(2S)-2-[[2-(5-benzyloxyindol-1-yl)acetyl]amino]-3-methyl-butanoic acid	45490783	CC(C)[C@H](NC(=O)Cn1ccc2c1ccc(OCc1ccccc1)c2)C(=O)O	(2S)-3-methyl-2-[[2-(5-phenylmethoxyindol-1-yl)acetyl]amino]butanoic acid			2.50016													MCULE-7815740273	380.44758		380.173607	4	2	8	3			44										False	Alkaloids				Peptide01			Compound(45490783)	45490783	3.9	928			[#6]-[#6](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#7]1:[#6]:[#6]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1):[#6]:2)-[#6](=[#8])-[#8]	CC(C)[C@H](NC(=O)Cn1ccc2c1ccc(OCc1ccccc1)c2)C(=O)O	MTVFEMFSISSPDY		parent_pubchem_cid	AKOS005670042;(2S)-2-({2-[5-(BENZYLOXY)-1H-INDOL-1-YL]ACETYL}AMINO)-3-METHYLBUTANOIC ACID;rac-(2S)-2-[[2-(5-benzyloxyindol-1-yl)acetyl]amino]-3-methyl-butanoic acid		23041125.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23041125		pluskal_iocb_peptide_Peptide01_E21_id		100	E21		ZINC000036352630
2.3		0	854	P7129936	88.5		W30	False	0	18	0	1	15	0	6	1	0	0		0.0						O=C(NCCc1c[nH]c2c1cc(F)cc2)c1ccccc1-n1cnnn1																							0.0		1374541-00-0		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	4	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C18H15FN6O	C18H15FN6O			InChI=1S/C18H15FN6O/c19-13-5-6-16-15(9-13)12(10-21-16)7-8-20-18(26)14-3-1-2-4-17(14)25-11-22-23-24-25/h1-6,9-11,21H,7-8H2,(H,20,26)	HPXKVLPDMGKMAW-UHFFFAOYSA-N	N-[2-(5-fluoro-1H-indol-3-yl)ethyl]-2-(tetrazol-1-yl)benzamide	60175950	O=C(NCCc1c[nH]c2c1cc(F)cc2)c1ccccc1-n1cnnn1	N-[2-(5-fluoro-1H-indol-3-yl)ethyl]-2-(tetrazol-1-yl)benzamide			1.5273500000000002													MCULE-4858743468	350.35825		350.129137	4	2	5	4			44									Imidazole alkaloids;Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids;Histidine alkaloids			Peptide01			Compound(60175950)	60175950	2.7	929			[#8]=[#6](-[#7]-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:1:[#6]:[#6](-[#9]):[#6]:[#6]:2)-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#7]1:[#6]:[#7]:[#7]:[#7]:1	O=C(NCCc1c[nH]c2c1cc(F)cc2)c1ccccc1-n1cnnn1	HPXKVLPDMGKMAW		parent_pubchem_cid	1374541-00-0;N-[2-(5-fluoro-1H-indol-3-yl)ethyl]-2-(1H-1,2,3,4-tetraazol-1-yl)benzamide;EiM08-24604;AKOS024460133;N-[2-(5-fluoro-1H-indol-3-yl)ethyl]-2-(tetrazol-1-yl)benzamide		63516345.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=63516345		pluskal_iocb_peptide_Peptide01_E21_id		100	E21		ZINC000072406002
3.9		0	942	P6666409	56.4		W31	False	0	25	0	0	27	0	3	2	0	0		0.0						CC(C)CC(C(=O)N1CCc2c(C1)c1ccccc1[nH]2)N1Cc2ccccc2C1=O								Isoindolones;3-alkylindoles;Isoindoles;Benzenoids;Tertiary carboxylic acid amides;Pyrroles;Heteroaromatic compounds;Lactams;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	3-alkylindoles;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Isoindoles;Isoindoles and derivatives;Isoindolines;Isoindolones;Lactams;Leucine and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Pyrroles;Tertiary carboxylic acid amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as leucine and derivatives. These are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Leucine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	isoindoles (CHEBI:24897);indoles (CHEBI:24828);benzenoid aromatic compound (CHEBI:33836);carboxamide (CHEBI:37622);pyrroles (CHEBI:26455);organic aromatic compound (CHEBI:33659);lactam (CHEBI:24995);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);leucine derivative (CHEBI:47003);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);organooxygen compound (CHEBI:36963);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806);amino acid (CHEBI:33709);peptide (CHEBI:16670)		Amino acids, peptides, and analogues	Leucine or derivatives;Isoindolone;3-alkylindole;Indole;Indole or derivatives;Isoindoline;Isoindole;Isoindole or derivatives;Benzenoid;Heteroaromatic compound;Pyrrole;Tertiary carboxylic acid amide;Lactam;Carboxamide group;Azacycle;Organoheterocyclic compound;Organooxygen compound;Organonitrogen compound;Hydrocarbon derivative;Organic oxide;Organic oxygen compound;Organic nitrogen compound;Carbonyl group;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS016375541		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	2	0		C25H27N3O2	C25H27N3O2			InChI=1S/C25H27N3O2/c1-16(2)13-23(28-14-17-7-3-4-8-18(17)24(28)29)25(30)27-12-11-22-20(15-27)19-9-5-6-10-21(19)26-22/h3-10,16,23,26H,11-15H2,1-2H3	GUSPRKBVHWDTTD-UHFFFAOYSA-N	2-[3-methyl-1-(1,3,4,5-tetrahydropyrido[4,3-b]indole-2-carbonyl)butyl]isoindolin-1-one	71753350	CC(C)CC(C(=O)N1CCc2c(C1)c1ccccc1[nH]2)N1Cc2ccccc2C1=O	2-[4-methyl-1-oxo-1-(1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)pentan-2-yl]-3H-isoindol-1-one			3.476040000000002													MCULE-1978164352	401.51284		401.210327	2	1	4	5			45									Carboline alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(71753350)	71753350	3.9	930			[#6]-[#6](-[#6])-[#6]-[#6](-[#6](=[#8])-[#7]1-[#6]-[#6]-[#6]2:[#6](-[#6]-1):[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1:[#7H]:2)-[#7]1-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6]-1=[#8]	CC(C)CC(C(=O)N1CCc2c(C1)c1ccccc1[nH]2)N1Cc2ccccc2C1=O	GUSPRKBVHWDTTD		parent_pubchem_cid	AKOS016375541;2-(1-(3,4-dihydro-1H-pyrido[4,3-b]indol-2(5H)-yl)-4-methyl-1-oxopentan-2-yl)isoindolin-1-one;2-[3-METHYL-1-(1,3,4,5-TETRAHYDRO-2H-PYRIDO[4,3-B]INDOL-2-YLCARBONYL)BUTYL]-1-ISOINDOLINONE;2-[3-methyl-1-(1,3,4,5-tetrahydropyrido[4,3-b]indole-2-carbonyl)butyl]isoindolin-1-one		23811455.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23811455		pluskal_iocb_peptide_Peptide01_E21_id		100	E21		
2.8		0	1030	P7567724	103.5		W32	False	0	24	0	1	25	0	4	4	0	0		0.0						COc1ccccc1CN1C(=O)NC(CCC(=O)NCCc2c[nH]c3c2cc(F)cc3)C1=O																							0.0		AKOS025145929		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	4	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C24H25FN4O4	C24H25FN4O4			InChI=1S/C24H25FN4O4/c1-33-21-5-3-2-4-16(21)14-29-23(31)20(28-24(29)32)8-9-22(30)26-11-10-15-13-27-19-7-6-17(25)12-18(15)19/h2-7,12-13,20,27H,8-11,14H2,1H3,(H,26,30)(H,28,32)/t20-/m0/s1	AQUGTQBXJZHCNG-FQEVSTJZSA-N	N-[2-(5-fluoro-1H-indol-3-yl)ethyl]-3-[rac-(4S)-1-[(2-methoxyphenyl)methyl]-2,5-dioxo-imidazolidin-4-yl]propanamide	75489351	COc1ccccc1CN1C(=O)N[C@@H](CCC(=O)NCCc2c[nH]c3c2cc(F)cc3)C1=O	N-[2-(5-fluoro-1H-indol-3-yl)ethyl]-3-[(4S)-1-[(2-methoxyphenyl)methyl]-2,5-dioxoimidazolidin-4-yl]propanamide			1.87485														452.48965		452.185984	4	3	9	4			45										False	Alkaloids				Peptide01			Compound(75489351)	75489351	2.4	931			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#6]-[#7]1-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:2:[#6]:[#6](-[#9]):[#6]:[#6]:3)-[#6]-1=[#8]	COc1ccccc1CN1C(=O)N[C@@H](CCC(=O)NCCc2c[nH]c3c2cc(F)cc3)C1=O	AQUGTQBXJZHCNG		parent_pubchem_cid	AKOS025145929;(S)-N-(2-(5-fluoro-1H-indol-3-yl)ethyl)-3-(1-(2-methoxybenzyl)-2,5-dioxoimidazolidin-4-yl)propanamide;N-[2-(5-FLUORO-1H-INDOL-3-YL)ETHYL]-3-{1-[(2-METHOXYPHENYL)METHYL]-2,5-DIOXOIMIDAZOLIDIN-4-YL}PROPANAMIDE;N-[2-(5-fluoro-1H-indol-3-yl)ethyl]-3-[rac-(4S)-1-[(2-methoxyphenyl)methyl]-2,5-dioxo-imidazolidin-4-yl]propanamide		80413783.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=80413783		pluskal_iocb_peptide_Peptide01_E21_id		100	E21		ZINC000096230765
0.8		0	774	P3463464	80.9		W33	False	0	10	0	0	16	0	4	2	0	0		0.0						O=C(O)CC1(Cn2cnnn2)CCCCC1								Heteroaromatic compounds;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Azacyclic compounds;Azoles;Carbonyl compounds;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Tetrazoles	Azoles	2.1	This compound belongs to the class of organic compounds known as tetrazoles. These are organic compounds containing a tetrazole ring, which is a five-member aromatic heterocycle made up of four nitrogen atoms and a one carbon atom.	Tetrazoles			Organic compounds	Aromatic heteromonocyclic compounds	organic aromatic compound (CHEBI:33659);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);tetrazoles (CHEBI:35689);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);organic acid (CHEBI:64709);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806);organooxygen compound (CHEBI:36963);azole (CHEBI:68452)		Tetrazoles	Heteroaromatic compound;Tetrazole;Azacycle;Monocarboxylic acid or derivatives;Carboxylic acid;Carboxylic acid derivative;Organic nitrogen compound;Organic oxygen compound;Organic oxide;Hydrocarbon derivative;Organooxygen compound;Organonitrogen compound;Carbonyl group;Aromatic heteromonocyclic compound	Organoheterocyclic compounds	0.0		[1-(1H-tetrazol-1-ylmethyl)cyclohexyl]acetic acid		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	4	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1		C10H16N4O2	C10H16N4O2			InChI=1S/C10H16N4O2/c15-9(16)6-10(4-2-1-3-5-10)7-14-8-11-12-13-14/h8H,1-7H2,(H,15,16)	ANSFBWSCPNYMFA-UHFFFAOYSA-N	2-[1-(tetrazol-1-ylmethyl)cyclohexyl]acetic acid	45495403	O=C(O)CC1(Cn2cnnn2)CCCCC1	2-[1-(tetrazol-1-ylmethyl)cyclohexyl]acetic acid			1.0982999999999994													MCULE-1011422282	224.26462		224.127326	5	1	4	2			43										False					Peptide01			Compound(45495403)	45495403	1.2	932			[#8]=[#6](-[#8])-[#6]-[#6]1(-[#6]-[#7]2:[#6]:[#7]:[#7]:[#7]:2)-[#6]-[#6]-[#6]-[#6]-[#6]-1	O=C(O)CC1(Cn2cnnn2)CCCCC1	ANSFBWSCPNYMFA		parent_pubchem_cid	[1-(1H-tetrazol-1-ylmethyl)cyclohexyl]acetic acid;1189749-68-5;2-[1-(tetrazol-1-ylmethyl)cyclohexyl]acetic acid;2-{1-[(1H-1,2,3,4-tetrazol-1-yl)methyl]cyclohexyl}acetic acid;MFCD13176375;BBL032289;STK652602;AKOS005174929;VS-11135;CS-0214668;EN300-186537;2-[1-(1H-1,2,3,4-tetrazol-1-ylmethyl)cyclohexyl]acetic acid;2-{1-[(1H-1,2,3,4-tetrazol-1-yl)methyl]cyclohexyl}aceticacid		22973202.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22973202		pluskal_iocb_peptide_Peptide01_E21_id		100	E21		ZINC000036047667
4.9		0	862	P1108031	105.8		W34	False	0	29	0	0	23	0	1	6	0	0		0.0						Cc1c(CC(=O)NC(Cc2ccccc2)C(=O)O)c(=O)oc2cc3c(cc12)c(-c1ccccc1)co3																							0.0		AKOS016378920		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C29H23NO6	C29H23NO6			InChI=1S/C29H23NO6/c1-17-20-13-22-23(19-10-6-3-7-11-19)16-35-25(22)15-26(20)36-29(34)21(17)14-27(31)30-24(28(32)33)12-18-8-4-2-5-9-18/h2-11,13,15-16,24H,12,14H2,1H3,(H,30,31)(H,32,33)/t24-/m1/s1	NFSKLRPVOPSCRF-XMMPIXPASA-N	rac-(2R)-2-[[2-(5-methyl-7-oxo-3-phenyl-furo[3,2-g]chromen-6-yl)acetyl]amino]-3-phenyl-propanoic acid	24280574	Cc1c(CC(=O)N[C@H](Cc2ccccc2)C(=O)O)c(=O)oc2cc3c(cc12)c(-c1ccccc1)co3	(2R)-2-[[2-(5-methyl-7-oxo-3-phenylfuro[3,2-g]chromen-6-yl)acetyl]amino]-3-phenylpropanoic acid			4.368120000000003													MCULE-3395693747	481.50976		481.152537	5	2	7	5			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(24280574)	24280574	4.7	933			[#6]-[#6]1:[#6](-[#6]-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#8]):[#6](=[#8]):[#8]:[#6]2:[#6]:[#6]3:[#6](:[#6]:[#6]:1:2):[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1):[#6]:[#8]:3	Cc1c(CC(=O)N[C@H](Cc2ccccc2)C(=O)O)c(=O)oc2cc3c(cc12)c(-c1ccccc1)co3	NFSKLRPVOPSCRF		parent_pubchem_cid	AKOS016378920;rac-(2R)-2-[[2-(5-methyl-7-oxo-3-phenyl-furo[3,2-g]chromen-6-yl)acetyl]amino]-3-phenyl-propanoic acid		24104212.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24104212		pluskal_iocb_peptide_Peptide01_E21_id		100	E21		ZINC000011865574
2.2		0	950	P1094968	94.7		W35	False	0	21	0	0	28	0	4	4	0	0		0.0						CCC(C)C(NC(=O)N1CCN(C(=O)c2c[nH]c3ccccc23)CC1)C(=O)OC																							0.0		AKOS005533502		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C21H28N4O4	C21H28N4O4			InChI=1S/C21H28N4O4/c1-4-14(2)18(20(27)29-3)23-21(28)25-11-9-24(10-12-25)19(26)16-13-22-17-8-6-5-7-15(16)17/h5-8,13-14,18,22H,4,9-12H2,1-3H3,(H,23,28)/t14?,18-/m0/s1	HXNMAHHBUDFEQE-IBYPIGCZSA-N	methyl rac-(2S)-2-[[4-(1H-indole-3-carbonyl)piperazine-1-carbonyl]amino]-3-methyl-pentanoate	16415508	CCC(C)[C@H](NC(=O)N1CCN(C(=O)c2c[nH]c3ccccc23)CC1)C(=O)OC	methyl (2S)-2-[[4-(1H-indole-3-carbonyl)piperazine-1-carbonyl]amino]-3-methylpentanoate			1.7398699999999998														400.48171		400.211055	4	2	6	3			46									Carboline alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(16415508)	16415508	2.3	934			[#6]-[#6]-[#6](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#7]1-[#6]-[#6]-[#7](-[#6](=[#8])-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6]-[#6]-1)-[#6](=[#8])-[#8]-[#6]	CCC(C)[C@H](NC(=O)N1CCN(C(=O)c2c[nH]c3ccccc23)CC1)C(=O)OC	HXNMAHHBUDFEQE		parent_pubchem_cid	AKOS005533502;methyl rac-(2S)-2-[[4-(1H-indole-3-carbonyl)piperazine-1-carbonyl]amino]-3-methyl-pentanoate		24518971.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24518971		pluskal_iocb_peptide_Peptide01_E21_id		100	E21		
1.4		0	1038	P1090531	121.0		W36	False	0	17	0	0	18	0	2	5	0	1		0.0						CC(=O)Nc1ccc(S(=O)(=O)NC(Cc2ccccc2)C(=O)O)cc1																							0.0		87661-71-0		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	1	0	0	0	0	0	0	0		C17H18N2O5S	C17H18N2O5S			InChI=1S/C17H18N2O5S/c1-12(20)18-14-7-9-15(10-8-14)25(23,24)19-16(17(21)22)11-13-5-3-2-4-6-13/h2-10,16,19H,11H2,1H3,(H,18,20)(H,21,22)/t16-/m0/s1	FBRYNDBSABMBDI-INIZCTEOSA-N	rac-(2S)-2-[(4-acetamidophenyl)sulfonylamino]-3-phenyl-propanoic acid	983566	CC(=O)Nc1ccc(S(=O)(=O)N[C@@H](Cc2ccccc2)C(=O)O)cc1	(2S)-2-[(4-acetamidophenyl)sulfonylamino]-3-phenylpropanoic acid			1.075869999999999													MCULE-9462108751	362.40741		362.093643	5	3	7	2			43									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(983566)	983566	1.6	935		SCHEMBL5189116	[#6]-[#6](=[#8])-[#7]-[#6]1:[#6]:[#6]:[#6](-[#16](=[#8])(=[#8])-[#7]-[#6@@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#8]):[#6]:[#6]:1	CC(=O)Nc1ccc(S(=O)(=O)N[C@@H](Cc2ccccc2)C(=O)O)cc1	FBRYNDBSABMBDI		parent_pubchem_cid	87661-71-0;2-(4-ACETAMIDOBENZENESULFONAMIDO)-3-PHENYLPROPANOIC ACID;SCHEMBL5189116;FBRYNDBSABMBDI-INIZCTEOSA-N;DTXSID601226003;2-(4-ACETYLAMINO-BENZENESULFONYLAMINO)-3-PHENYL-PROPIONIC ACID;AKOS015955401;Nalpha-(4-acetamidobenzenesulfonyl)-L-phenylalanine;N-[[4-(Acetylamino)phenyl]sulfonyl]-L-phenylalanine;rac-(2S)-2-[(4-acetamidophenyl)sulfonylamino]-3-phenyl-propanoic acid		22854358.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22854358		pluskal_iocb_peptide_Peptide01_E21_id		100	E21		ZINC000000629828
3.2		0	782	P6666934	88.5		W37	False	0	20	1	0	25	0	6	1	0	0		0.0						O=C(CC1(Cn2cnnn2)CCCCC1)NCCc1c[nH]c2c1cc(Cl)cc2								Substituted pyrroles;Fatty amides;Benzenoids;Aryl chlorides;Tetrazoles;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Organonitrogen compounds;Organochlorides;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	3-alkylindoles;Aryl chlorides;Aryl halides;Azacyclic compounds;Azoles;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Fatty Acyls;Fatty amides;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Lipids and lipid-like molecules;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organochlorides;Organohalogen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Tetrazoles	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as 3-alkylindoles. These are compounds containing an indole moiety that carries an alkyl chain at the 3-position.	3-alkylindoles			Organic compounds	Aromatic heteropolycyclic compounds	pyrroles (CHEBI:26455);fatty amide (CHEBI:29348);benzenoid aromatic compound (CHEBI:33836);organochlorine compound (CHEBI:36683);tetrazoles (CHEBI:35689);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);indoles (CHEBI:24828);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);lipid (CHEBI:18059);organooxygen compound (CHEBI:36963);organohalogen compound (CHEBI:36684);haloarene (CHEBI:50887);azole (CHEBI:68452);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806)	Fatty amides (FA08);Fatty Acyls (FA)	Indoles	3-alkylindole;Aryl chloride;Aryl halide;Fatty amide;Substituted pyrrole;Benzenoid;Fatty acyl;Azole;Pyrrole;Tetrazole;Heteroaromatic compound;Secondary carboxylic acid amide;Carboxamide group;Carboxylic acid derivative;Azacycle;Organic nitrogen compound;Organooxygen compound;Organonitrogen compound;Organochloride;Organohalogen compound;Organic oxide;Carbonyl group;Hydrocarbon derivative;Organic oxygen compound;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		1401541-07-8		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	4	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C20H25ClN6O	C20H25ClN6O			InChI=1S/C20H25ClN6O/c21-16-4-5-18-17(10-16)15(12-23-18)6-9-22-19(28)11-20(7-2-1-3-8-20)13-27-14-24-25-26-27/h4-5,10,12,14,23H,1-3,6-9,11,13H2,(H,22,28)	BQXTWTHOJJKCSO-UHFFFAOYSA-N	N-[2-(5-chloro-1H-indol-3-yl)ethyl]-2-[1-(tetrazol-1-ylmethyl)cyclohexyl]acetamide	71703702	O=C(CC1(Cn2cnnn2)CCCCC1)NCCc1c[nH]c2c1cc(Cl)cc2	N-[2-(5-chloro-1H-indol-3-yl)ethyl]-2-[1-(tetrazol-1-ylmethyl)cyclohexyl]acetamide			3.0241700000000007													MCULE-2403811456	400.91485		400.177837	4	2	7	4			44										False	Alkaloids				Peptide01			Compound(71703702)	71703702	3.7	936			[#8]=[#6](-[#6]-[#6]1(-[#6]-[#7]2:[#6]:[#7]:[#7]:[#7]:2)-[#6]-[#6]-[#6]-[#6]-[#6]-1)-[#7]-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:1:[#6]:[#6](-[#17]):[#6]:[#6]:2	O=C(CC1(Cn2cnnn2)CCCCC1)NCCc1c[nH]c2c1cc(Cl)cc2	BQXTWTHOJJKCSO		parent_pubchem_cid	1401541-07-8;N-[2-(5-chloro-1H-indol-3-yl)ethyl]-2-[1-(1H-1,2,3,4-tetraazol-1-ylmethyl)cyclohexyl]acetamide;EiM08-27208;AKOS016398625;N-[2-(5-CHLORO-1H-INDOL-3-YL)ETHYL]-2-{1-[(1H-1,2,3,4-TETRAZOL-1-YL)METHYL]CYCLOHEXYL}ACETAMIDE;N-[2-(5-chloro-1H-indol-3-yl)ethyl]-2-[1-(tetrazol-1-ylmethyl)cyclohexyl]acetamide		51585280.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=51585280		pluskal_iocb_peptide_Peptide01_E22_id		100	E22		ZINC000079480413
1.7		0	870	P6242000	113.7		W38	False	0	18	0	0	22	0	2	4	0	1	-1.0	0.0						CSCCC(NC(=O)CCn1cc(C(C)=O)c2ccccc21)C(=O)O		2.56		0.0	1.68	CHEMBL3438434		N-acyl-L-alpha-amino acids;N-alkylindoles;Indoles;Aryl alkyl ketones;Thia fatty acids;Substituted pyrroles;Benzenoids;Vinylogous amides;Heteroaromatic compounds;Secondary carboxylic acid amides;Dialkylthioethers;Carboxylic acids;Sulfenyl compounds;Azacyclic compounds;Monocarboxylic acids and derivatives;Organic oxides;Hydrocarbon derivatives;Organonitrogen compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Aryl alkyl ketones;Aryl ketones;Azacyclic compounds;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Dialkylthioethers;Fatty Acyls;Fatty acids and conjugates;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Ketones;Lipids and lipid-like molecules;Methionine and derivatives;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;N-alkylindoles;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Organosulfur compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Sulfenyl compounds;Thia fatty acids;Thioethers;Vinylogous amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as methionine and derivatives. These are compounds containing methionine or a derivative thereof resulting from reaction of methionine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Methionine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-L-alpha-amino acid (CHEBI:48927);indoles (CHEBI:24828);aromatic ketone (CHEBI:76224);thia fatty acid (CHEBI:59643);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);enone (CHEBI:51689);enamine (CHEBI:47989);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);aliphatic sulfide (CHEBI:22327);carboxylic acid (CHEBI:33575);organosulfur compound (CHEBI:33261);organonitrogen heterocyclic compound (CHEBI:38101);monocarboxylic acid (CHEBI:25384);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);organonitrogen compound (CHEBI:35352);alpha-amino acid (CHEBI:33704);methionine derivative (CHEBI:25230);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);carbonyl compound (CHEBI:36586);organooxygen compound (CHEBI:36963);N-acyl-amino acid (CHEBI:51569);organic heterocyclic compound (CHEBI:24532);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ketone (CHEBI:17087);lipid (CHEBI:18059);amide (CHEBI:32988);organic sulfide (CHEBI:16385);nitrogen molecular entity (CHEBI:51143);carboxylic acid anion (CHEBI:29067);amino acid (CHEBI:33709);peptide (CHEBI:16670)	Thia fatty acids (FA0113);Fatty Acyls (FA);Fatty Acids and Conjugates (FA01)	Amino acids, peptides, and analogues	Methionine or derivatives;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;N-acyl-l-alpha-amino acid;N-alkylindole;Indole;Indole or derivatives;Aryl ketone;Aryl alkyl ketone;Thia fatty acid;Substituted pyrrole;Benzenoid;Fatty acyl;Heteroaromatic compound;Vinylogous amide;Pyrrole;Carboxamide group;Secondary carboxylic acid amide;Ketone;Azacycle;Organoheterocyclic compound;Sulfenyl compound;Thioether;Dialkylthioether;Carboxylic acid;Monocarboxylic acid or derivatives;Carbonyl group;Organic oxide;Hydrocarbon derivative;Organonitrogen compound;Organic oxygen compound;Organic nitrogen compound;Organooxygen compound;Organosulfur compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		CHEMBL3438434		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C18H22N2O4S	C18H22N2O4S			InChI=1S/C18H22N2O4S/c1-12(21)14-11-20(16-6-4-3-5-13(14)16)9-7-17(22)19-15(18(23)24)8-10-25-2/h3-6,11,15H,7-10H2,1-2H3,(H,19,22)(H,23,24)/t15-/m0/s1	OTVRPAYVXOGAPS-HNNXBMFYSA-N	rac-(2S)-2-[3-(3-acetylindol-1-yl)propanoylamino]-4-methylsulfanyl-butanoic acid	49652469	CSCC[C@H](NC(=O)CCn1cc(C(C)=O)c2ccccc21)C(=O)O	(2S)-2-[3-(3-acetylindol-1-yl)propanoylamino]-4-methylsulfanylbutanoic acid			2.07337													MCULE-9813610036	362.45104	ACID	362.130028	5	2	9	2	1.0		29										False			False	False	Peptide01		-1.0	Compound(49652469)	49652469	1.5	937			[#6]-[#16]-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#6]-[#7]1:[#6]:[#6](-[#6](-[#6])=[#8]):[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	CSCC[C@H](NC(=O)CCn1cc(C(C)=O)c2ccccc21)C(=O)O	OTVRPAYVXOGAPS		parent_pubchem_cid	CHEMBL3438434;EiM08-13468;AKOS016375061;(2S)-2-{[3-(3-ACETYL-1H-INDOL-1-YL)PROPANOYL]AMINO}-4-(METHYLSULFANYL)BUTANOIC ACID;rac-(2S)-2-[3-(3-acetylindol-1-yl)propanoylamino]-4-methylsulfanyl-butanoic acid	False	23470631.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23470631		pluskal_iocb_peptide_Peptide01_E22_id		100	E22	False	ZINC000040312516
0.3		0	958	P3460034	118.7		W39	False	0	12	0	0	14	0	2	5	0	0		0.0						NC(=O)CC(NC(=O)OCc1ccccc1)C(=O)O								Benzyloxycarbonyls;Fatty amides;Carbamate esters;Primary carboxylic acid amides;Organic carbonic acids and derivatives;Monocarboxylic acids and derivatives;Carboxylic acids;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Asparagine and derivatives;Benzene and substituted derivatives;Benzenoids;Benzyloxycarbonyls;Carbamate esters;Carbamic acids and derivatives;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Fatty Acyls;Fatty amides;Hydrocarbon derivatives;Lipids and lipid-like molecules;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Primary carboxylic acid amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as asparagine and derivatives. These are compounds containing asparagine or a derivative thereof resulting from reaction of asparagine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Asparagine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic homomonocyclic compounds	carboxylic ester (CHEBI:33308);fatty amide (CHEBI:29348);carbamate ester (CHEBI:23003);carboxamide (CHEBI:37622);organooxygen compound (CHEBI:36963);carbonyl compound (CHEBI:36586);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);asparagine derivative (CHEBI:22654);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);lipid (CHEBI:18059);amino acid (CHEBI:33709);peptide (CHEBI:16670);carbon oxoacid (CHEBI:35605);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806)	Fatty amides (FA08);Fatty Acyls (FA)	Amino acids, peptides, and analogues	Asparagine or derivatives;Benzyloxycarbonyl;Monocyclic benzene moiety;Fatty amide;Fatty acyl;Benzenoid;Carbamic acid ester;Carboxamide group;Primary carboxylic acid amide;Carbonic acid derivative;Carboxylic acid;Monocarboxylic acid or derivatives;Organic nitrogen compound;Organonitrogen compound;Organooxygen compound;Hydrocarbon derivative;Organic oxide;Organopnictogen compound;Carbonyl group;Organic oxygen compound;Aromatic homomonocyclic compound	Organic acids and derivatives	0.0		2304-96-3	DTXSID90883824	2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	1	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C12H14N2O5	C12H14N2O5			InChI=1S/C12H14N2O5/c13-10(15)6-9(11(16)17)14-12(18)19-7-8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H2,13,15)(H,14,18)(H,16,17)/t9-/m0/s1	FUCKRCGERFLLHP-VIFPVBQESA-N	rac-(2S)-4-amino-2-(benzyloxycarbonylamino)-4-oxo-butanoic acid	75314	NC(=O)C[C@H](NC(=O)OCc1ccccc1)C(=O)O	(2S)-4-amino-4-oxo-2-(phenylmethoxycarbonylamino)butanoic acid			0.186689999999999													MCULE-6267936143	266.25578		266.090272	5	3	7	1			42									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(75314)	75314	-0.1	938		SCHEMBL722757	[#7]-[#6](=[#8])-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	NC(=O)C[C@H](NC(=O)OCc1ccccc1)C(=O)O	FUCKRCGERFLLHP		parent_pubchem_cid	2304-96-3;Z-Asn-OH;N-Cbz-L-asparagine;Cbz-Asn-OH;N-Benzyloxycarbonyl-L-asparagine;CBZ asparagine;Z-L-Asparagine;N-Carbobenzoxy-L-asparagine;Carbobenzoxy-L-asparagine;Carbobenzoxy-L-asparagin;N-(Benzyloxycarbonyl)-L-asparagine;L-Asparagine, N2-[(phenylmethoxy)carbonyl]-;Asparagine, N-(benzyloxy)carbonyl-;NSC 59837;NSC 88498;Asparagine, N2-[(phenylmethoxy)carbonyl]-;(2S)-2-{[(benzyloxy)carbonyl]amino}-3-carbamoylpropanoic acid;(2S)-4-amino-4-oxo-2-(phenylmethoxycarbonylamino)butanoic acid;EINECS 218-969-5;Asparagine, N(2)-carboxy-, N(2)-benzyl ester, L-;C12H14N2O5;L-Asparagine, N2-((phenylmethoxy)carbonyl)-;MFCD00008035;Carbobenzyloxy-L-asparagine;CBZ-L-Asparagine;N~2~-[(benzyloxy)carbonyl]-L-asparagine;N2-((Phenylmethoxy)carbonyl)-L-asparagine;N2-[(PHENYLMETHOXY)CARBONYL]-L-ASPARAGINE;benzyloxycarbonyl-L-asparagine;Nalpha-Cbz-L-asparagine;N2-[(Phenylmehtoxy)carbonyl]-L-asparagine;benzyloxycarbonylasparagine;(S)-4-AMINO-2-(((BENZYLOXY)CARBONYL)AMINO)-4-OXOBUTANOIC ACID;Z-Asn-OH, 99%;N-CBZ-L-ASPARAGINE-OH;SCHEMBL722757;4-AMINO-2-([(BENZYLOXY)CARBONYL]AMINO)-4-OXOBUTANOIC ACID;Nalpha-Carbobenzoxy-L-asparagine;DTXSID90883824;((Benzyloxy)carbonyl)-L-asparagine;AMY31304;BBL033973;Nalpha-benzyloxycarbonyl-L-asparagine;STK719863;AKOS005174933;AKOS015924197;CS-W008233;HY-W008233;AC-13403;AC-17141;Asparagine, N2-carboxy-, N-benzyl ester;DS-13753;N2-[(BENZYLOXY)CARBONYL]-L-ASPARAGINE;EN300-102792;J-300053;Q-101669;N-alpha-BenZyloxycarbonyl-L-asparagine (CbZ-L-Asn-OH);(S)-4-amino-2-(benzyloxycarbonylamino)-4-oxobutanoic acid;(2S)-4-amino-2-{[(benzyloxy)carbonyl]amino}-4-oxobutanoic acid;rac-(2S)-4-amino-2-(benzyloxycarbonylamino)-4-oxo-butanoic acid		24758732.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24758732		pluskal_iocb_peptide_Peptide01_E22_id		100	E22		ZINC000001689810
2.1		0	1046	P11184842	134.2		W40	False	0	20	0	0	18	0	4	5	0	0		0.0						O=C(CCc1nc(-c2ccco2)no1)NC(Cc1c[nH]c2ccccc12)C(=O)O																							0.0		AKOS027472507		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	2	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C20H18N4O5	C20H18N4O5			InChI=1S/C20H18N4O5/c25-17(7-8-18-23-19(24-29-18)16-6-3-9-28-16)22-15(20(26)27)10-12-11-21-14-5-2-1-4-13(12)14/h1-6,9,11,15,21H,7-8,10H2,(H,22,25)(H,26,27)/t15-/m0/s1	OWWSANSNNQTDAN-HNNXBMFYSA-N	rac-(2S)-2-[3-[3-(2-furyl)-1,2,4-oxadiazol-5-yl]propanoylamino]-3-(1H-indol-3-yl)propanoic acid	91640211	O=C(CCc1nc(-c2ccco2)no1)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	(2S)-2-[3-[3-(furan-2-yl)-1,2,4-oxadiazol-5-yl]propanoylamino]-3-(1H-indol-3-yl)propanoic acid			1.63774														394.39026		394.12772	5	3	8	4			45										False	Alkaloids				Peptide01			Compound(91640211)	91640211	2.2	939			[#8]=[#6](-[#6]-[#6]-[#6]1:[#7]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#8]:2):[#7]:[#8]:1)-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	O=C(CCc1nc(-c2ccco2)no1)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	OWWSANSNNQTDAN		parent_pubchem_cid	AKOS027472507;(2S)-2-({3-[3-(2-FURYL)-1,2,4-OXADIAZOL-5-YL]PROPANOYL}AMINO)-3-(1H-INDOL-3-YL)PROPANOIC ACID;rac-(2S)-2-[3-[3-(2-furyl)-1,2,4-oxadiazol-5-yl]propanoylamino]-3-(1H-indol-3-yl)propanoic acid		100343018.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=100343018		pluskal_iocb_peptide_Peptide01_E22_id		100	E22		ZINC000218295853
3.2		0	790	P3462495	71.1		W41	False	0	22	1	0	20	0	3	2	0	0		0.0						O=C(NC(Cc1ccccc1)C(=O)NCc1ccccc1Cl)c1cnccc1																							0.0		AKOS016400211		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C22H20ClN3O2	C22H20ClN3O2			InChI=1S/C22H20ClN3O2/c23-19-11-5-4-9-17(19)15-25-22(28)20(13-16-7-2-1-3-8-16)26-21(27)18-10-6-12-24-14-18/h1-12,14,20H,13,15H2,(H,25,28)(H,26,27)/t20-/m0/s1	XGCDEPRHDUOIKI-FQEVSTJZSA-N	N-[rac-(1S)-1-benzyl-2-[(2-chlorophenyl)methylamino]-2-oxo-ethyl]pyridine-3-carboxamide	29127381	O=C(N[C@@H](Cc1ccccc1)C(=O)NCc1ccccc1Cl)c1cnccc1	N-[(2S)-1-[(2-chlorophenyl)methylamino]-1-oxo-3-phenylpropan-2-yl]pyridine-3-carboxamide			3.2283700000000017													MCULE-5561554676	393.8766		393.124405	3	2	7	3			44									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(29127381)	29127381	3.6	940			[#8]=[#6](-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#7]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#17])-[#6]1:[#6]:[#7]:[#6]:[#6]:[#6]:1	O=C(N[C@@H](Cc1ccccc1)C(=O)NCc1ccccc1Cl)c1cnccc1	XGCDEPRHDUOIKI		parent_pubchem_cid	AKOS016400211;N-[(2-CHLOROPHENYL)METHYL]-3-PHENYL-2-[(PYRIDIN-3-YL)FORMAMIDO]PROPANAMIDE;N-[rac-(1S)-1-benzyl-2-[(2-chlorophenyl)methylamino]-2-oxo-ethyl]pyridine-3-carboxamide		18031919.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=18031919		pluskal_iocb_peptide_Peptide01_E22_id		100	E22		ZINC000020715075
3.8		0	878	P1108331	117.7		W42	False	0	25	0	0	24	0	2	6	0	0		0.0						COc1c2c(C)c(CC(=O)NC(Cc3c[nH]c4ccccc34)C(=O)O)c(=O)oc2cc(C)c1																							0.0		AKOS016383011		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C25H24N2O6	C25H24N2O6			InChI=1S/C25H24N2O6/c1-13-8-20(32-3)23-14(2)17(25(31)33-21(23)9-13)11-22(28)27-19(24(29)30)10-15-12-26-18-7-5-4-6-16(15)18/h4-9,12,19,26H,10-11H2,1-3H3,(H,27,28)(H,29,30)/t19-/m1/s1	HWOIOGRALMIXSA-LJQANCHMSA-N	rac-(2R)-3-(1H-indol-3-yl)-2-[[2-(5-methoxy-4,7-dimethyl-2-oxo-chromen-3-yl)acetyl]amino]propanoic acid	24280643	COc1c2c(C)c(CC(=O)N[C@H](Cc3c[nH]c4ccccc34)C(=O)O)c(=O)oc2cc(C)c1	(2R)-3-(1H-indol-3-yl)-2-[[2-(5-methoxy-4,7-dimethyl-2-oxochromen-3-yl)acetyl]amino]propanoic acid			2.616140000000001													MCULE-1940755604	448.47983		448.163436	6	3	7	4			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(24280643)	24280643	3.1	941			[#6]-[#8]-[#6]1:[#6]2:[#6](-[#6]):[#6](-[#6]-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6]3:[#6]:[#7H]:[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]:3:4)-[#6](=[#8])-[#8]):[#6](=[#8]):[#8]:[#6]:2:[#6]:[#6](-[#6]):[#6]:1	COc1c2c(C)c(CC(=O)N[C@H](Cc3c[nH]c4ccccc34)C(=O)O)c(=O)oc2cc(C)c1	HWOIOGRALMIXSA		parent_pubchem_cid	AKOS016383011;3-(1H-INDOL-3-YL)-2-[2-(5-METHOXY-4,7-DIMETHYL-2-OXO-2H-CHROMEN-3-YL)ACETAMIDO]PROPANOIC ACID;rac-(2R)-3-(1H-indol-3-yl)-2-[[2-(5-methoxy-4,7-dimethyl-2-oxo-chromen-3-yl)acetyl]amino]propanoic acid		23056883.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23056883		pluskal_iocb_peptide_Peptide01_E22_id		100	E22		ZINC000011865643
3.4		0	966	P11185737	103.1		W43	False	0	28	0	1	25	0	4	3	0	0		0.0						O=C(CCC1NC(=O)c2ccccc2NC1=O)NCC(c1ccc(F)cc1)c1c[nH]c2ccccc12																							0.0		AKOS027473174		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	0	0		C28H25FN4O3	C28H25FN4O3			InChI=1S/C28H25FN4O3/c29-18-11-9-17(10-12-18)21(22-16-30-23-7-3-1-5-19(22)23)15-31-26(34)14-13-25-28(36)32-24-8-4-2-6-20(24)27(35)33-25/h1-12,16,21,25,30H,13-15H2,(H,31,34)(H,32,36)(H,33,35)	BFWVMGXQMZZAQB-UHFFFAOYSA-N	3-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)-N-[2-(4-fluorophenyl)-2-(1H-indol-3-yl)ethyl]propanamide	118986124	O=C(CCC1NC(=O)c2ccccc2NC1=O)NCC(c1ccc(F)cc1)c1c[nH]c2ccccc12	3-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)-N-[2-(4-fluorophenyl)-2-(1H-indol-3-yl)ethyl]propanamide			3.112840000000001														484.53485		484.191069	3	4	7	5			46										False	Alkaloids				Peptide01			Compound(118986124)	118986124	3.5	942			[#8]=[#6](-[#6]-[#6]-[#6]1-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#7]-[#6]-1=[#8])-[#7]-[#6]-[#6](-[#6]1:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	O=C(CCC1NC(=O)c2ccccc2NC1=O)NCC(c1ccc(F)cc1)c1c[nH]c2ccccc12	BFWVMGXQMZZAQB		parent_pubchem_cid	AKOS027473174;3-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)-N-[2-(4-fluorophenyl)-2-(1H-indol-3-yl)ethyl]propanamide		145498496.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=145498496		pluskal_iocb_peptide_Peptide01_E22_id		100	E22		
0.2		0	1054	P3463275	65.1		W44	False	0	15	0	0	20	0	2	2	0	0		0.0						CC(C)CCNC(C(=O)O)c1c[nH]c2ccccc12								Alpha amino acids;3-alkylindoles;Aralkylamines;Substituted pyrroles;Benzenoids;Heteroaromatic compounds;Amino acids;Monocarboxylic acids and derivatives;Dialkylamines;Carboxylic acids;Azacyclic compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	3-alkylindoles;Alpha amino acids;Alpha amino acids and derivatives;Amines;Amino acids;Amino acids and derivatives;Amino acids, peptides, and analogues;Aralkylamines;Azacyclic compounds;Benzenoids;Carbonyl compounds;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Dialkylamines;Heteroaromatic compounds;Hydrocarbon derivatives;Indole-3-acetic acid derivatives;Indoles;Indoles and derivatives;Indolyl carboxylic acids and derivatives;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Pyrroles;Secondary amines;Substituted pyrroles	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as indole-3-acetic acid derivatives. These are compounds containing an acetic acid (or a derivative) linked to the C3 carbon atom of an indole.	Indole-3-acetic acid derivatives			Organic compounds	Aromatic heteropolycyclic compounds	alpha-amino acid (CHEBI:33704);indoles (CHEBI:24828);aralkylamine (CHEBI:18000);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);organic aromatic compound (CHEBI:33659);amino acid (CHEBI:33709);monocarboxylic acid (CHEBI:25384);secondary amino compound (CHEBI:50995);carboxylic acid (CHEBI:33575);organonitrogen heterocyclic compound (CHEBI:38101);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);indole-3-acetic acids (CHEBI:24803);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organonitrogen compound (CHEBI:35352);organooxygen compound (CHEBI:36963);organic heterocyclic compound (CHEBI:24532);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);amine (CHEBI:32952);secondary amine (CHEBI:32863);oxygen molecular entity (CHEBI:25806);indolyl carboxylic acid (CHEBI:46867);carboxylic acid anion (CHEBI:29067);peptide (CHEBI:16670)		Indolyl carboxylic acids and derivatives	Indole-3-acetic acid derivative;Alpha-amino acid;Alpha-amino acid or derivatives;3-alkylindole;Indole;Aralkylamine;Benzenoid;Substituted pyrrole;Heteroaromatic compound;Pyrrole;Amino acid or derivatives;Amino acid;Carboxylic acid derivative;Carboxylic acid;Secondary aliphatic amine;Azacycle;Monocarboxylic acid or derivatives;Secondary amine;Amine;Organic oxygen compound;Organic nitrogen compound;Hydrocarbon derivative;Organic oxide;Organonitrogen compound;Organooxygen compound;Carbonyl group;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		1H-indol-3-yl[(3-methylbutyl)amino]acetic acid		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0		C15H20N2O2	C15H20N2O2			InChI=1S/C15H20N2O2/c1-10(2)7-8-16-14(15(18)19)12-9-17-13-6-4-3-5-11(12)13/h3-6,9-10,14,16-17H,7-8H2,1-2H3,(H,18,19)	CSSNEFYHYSDKOT-UHFFFAOYSA-N	2-(1H-indol-3-yl)-2-(isopentylamino)acetic acid	45490487	CC(C)CCNC(C(=O)O)c1c[nH]c2ccccc12	2-(1H-indol-3-yl)-2-(3-methylbutylamino)acetic acid			2.4461700000000004													MCULE-1476010519	260.33885		260.152478	3	3	6	2			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(45490487)	45490487	0.6	943			[#6]-[#6](-[#6])-[#6]-[#6]-[#7]-[#6](-[#6](=[#8])-[#8])-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CC(C)CCNC(C(=O)O)c1c[nH]c2ccccc12	CSSNEFYHYSDKOT		parent_pubchem_cid	1H-indol-3-yl[(3-methylbutyl)amino]acetic acid;1214860-66-8;MFCD13176345;2-(1H-indol-3-yl)-2-(3-methylbutylamino)acetic acid;2-(1H-indol-3-yl)-2-[(3-methylbutyl)amino]acetic acid;AKOS005720744;NS-04031;1H-indol-3-yl[(3-methylbutyl)amino]aceticacid;EN300-302372;2-(1H-indol-3-yl)-2-(isopentylamino)acetic acid		22875033.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22875033		pluskal_iocb_peptide_Peptide01_E22_id		100	E22		
3.4		0	1062	P11185789	78.4		X1	False	0	22	0	0	34	0	2	3	0	0		0.0						CC(CO)NC(=O)C(Cc1ccccc1)NC(=O)C1CCC(C(C)C)CC1																							0.0		AKOS027473219		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C22H34N2O3	C22H34N2O3			InChI=1S/C22H34N2O3/c1-15(2)18-9-11-19(12-10-18)21(26)24-20(22(27)23-16(3)14-25)13-17-7-5-4-6-8-17/h4-8,15-16,18-20,25H,9-14H2,1-3H3,(H,23,27)(H,24,26)/t16-,18?,19?,20-/m0/s1	ITLCVOOZAVDUID-ACAXCVFMSA-N	4-isopropyl-N-[rac-(1S)-1-benzyl-2-oxo-2-[[rac-(1S)-2-hydroxy-1-methyl-ethyl]amino]ethyl]cyclohexanecarboxamide	121595458	CC(C)C1CCC(C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C)CO)CC1	N-[(2S)-1-[[(2S)-1-hydroxypropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-4-propan-2-ylcyclohexane-1-carboxamide			2.61859														374.52788		374.256943	3	3	8	2			45										False	Terpenoids	Sesquiterpenoids			Peptide01			Compound(121595458)	121595458	3.8	944			[#6]-[#6](-[#6])-[#6]1-[#6]-[#6]-[#6](-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#7]-[#6@@H](-[#6])-[#6]-[#8])-[#6]-[#6]-1	CC(C)C1CCC(C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C)CO)CC1	ITLCVOOZAVDUID		parent_pubchem_cid	AKOS027473219;4-isopropyl-N-[rac-(1S)-1-benzyl-2-oxo-2-[[rac-(1S)-2-hydroxy-1-methyl-ethyl]amino]ethyl]cyclohexanecarboxamide		147966430.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=147966430		pluskal_iocb_peptide_Peptide01_E23_id		100	E23		ZINC000334160618
4.9		0	1150	P1098578	101.9		X2	False	0	26	0	0	27	0	1	6	0	0	-1.0	0.0						Cc1c2oc(=O)c3c(CCCC3)c2ccc1OC(C)C(=O)NC(Cc1ccccc1)C(=O)O		3.56		0.0	4.43	CHEMBL1493961		N-acyl-L-alpha-amino acids;Phenylpropanoic acids;Coumarins and derivatives;1-benzopyrans;Amphetamines and derivatives;Phenol ethers;Pyranones and derivatives;Alkyl aryl ethers;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactones;Oxacyclic compounds;Carboxylic acids;Monocarboxylic acids and derivatives;Carbonyl compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	1-benzopyrans;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Benzene and substituted derivatives;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Lactones;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenethylamines;Phenol ethers;Phenylalanine and derivatives;Phenylpropanoic acids;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Secondary carboxylic acid amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	chemical entity (CHEBI:24431);aromatic ether (CHEBI:35618);organic molecular entity (CHEBI:50860);monocarboxylic acid (CHEBI:25384);carboxylic acid anion (CHEBI:29067);organonitrogen compound (CHEBI:35352);ether (CHEBI:25698);amphetamines (CHEBI:35338);N-acyl-amino acid (CHEBI:51569);primary amine (CHEBI:32877);oxacycle (CHEBI:38104);pyranone (CHEBI:37963);benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);amino acid (CHEBI:33709);peptide (CHEBI:16670);lactone (CHEBI:25000);coumarins (CHEBI:23403);N-acyl-L-alpha-amino acid (CHEBI:48927);organooxygen compound (CHEBI:36963);carboxamide (CHEBI:37622);phenylalanine derivative (CHEBI:25985);pyrans (CHEBI:26407);amide (CHEBI:32988);organic aromatic compound (CHEBI:33659);benzenoid aromatic compound (CHEBI:33836);organic acid (CHEBI:64709);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);1-benzopyran (CHEBI:38443);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806);organic oxide (CHEBI:25701)	Benzopyranoids (PK1311)	Amino acids, peptides, and analogues	Phenylalanine or derivatives;N-acyl-alpha-amino acid;N-acyl-l-alpha-amino acid;N-acyl-alpha amino acid or derivatives;Coumarin;3-phenylpropanoic-acid;Amphetamine or derivatives;Benzopyran;1-benzopyran;Phenol ether;Pyranone;Alkyl aryl ether;Benzenoid;Pyran;Monocyclic benzene moiety;Heteroaromatic compound;Secondary carboxylic acid amide;Carboxamide group;Lactone;Organoheterocyclic compound;Oxacycle;Carboxylic acid;Ether;Monocarboxylic acid or derivatives;Organooxygen compound;Carbonyl group;Organic oxide;Organic nitrogen compound;Organonitrogen compound;Organic oxygen compound;Hydrocarbon derivative;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		MLS001142935		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C26H27NO6	C26H27NO6			InChI=1S/C26H27NO6/c1-15-22(13-12-19-18-10-6-7-11-20(18)26(31)33-23(15)19)32-16(2)24(28)27-21(25(29)30)14-17-8-4-3-5-9-17/h3-5,8-9,12-13,16,21H,6-7,10-11,14H2,1-2H3,(H,27,28)(H,29,30)/t16?,21-/m0/s1	QVTYWGMYZTWEPJ-MRNPHLECSA-N	rac-(2S)-2-[2-[(4-methyl-6-oxo-7,8,9,10-tetrahydrobenzo[c]chromen-3-yl)oxy]propanoylamino]-3-phenyl-propanoic acid	16399388	Cc1c2oc(=O)c3c(CCCC3)c2ccc1OC(C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O	(2S)-2-[2-[(4-methyl-6-oxo-7,8,9,10-tetrahydrobenzo[c]chromen-3-yl)oxy]propanoylamino]-3-phenylpropanoic acid			3.3498400000000013													MCULE-8739848884	449.50819	ACID	449.183838	6	2	7	4	1.0		30									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins	False	False	Peptide01		-1.0	Compound(16399388)	16399388	4.5	945			[#6]-[#6]1:[#6]2:[#8]:[#6](=[#8]):[#6]3:[#6](-[#6]-[#6]-[#6]-[#6]-3):[#6]:2:[#6]:[#6]:[#6]:1-[#8]-[#6](-[#6])-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	Cc1c2oc(=O)c3c(CCCC3)c2ccc1OC(C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O	QVTYWGMYZTWEPJ		parent_pubchem_cid	MLS001142935;CHEMBL1493961;HMS2270O05;EiM07-17256;STL460966;AKOS004937485;SMR000647483;AB00864201-06;N-{2-[(4-methyl-6-oxo-7,8,9,10-tetrahydro-6H-benzo[c]chromen-3-yl)oxy]propanoyl}-L-phenylalanine;rac-(2S)-2-[2-[(4-methyl-6-oxo-7,8,9,10-tetrahydrobenzo[c]chromen-3-yl)oxy]propanoylamino]-3-phenyl-propanoic acid	False	802544.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=802544		pluskal_iocb_peptide_Peptide01_E23_id		100	E23	False	
2.2		0	1238	P6248729	117.2		X3	False	0	14	0	0	21	0	1	4	0	2		0.0						CSCCC(NS(=O)(=O)c1ccc(C(C)C)cc1)C(=O)O								Benzenesulfonamides;Phenylpropanes;Cumenes;Benzenesulfonyl compounds;Thia fatty acids;Organosulfonamides;Aminosulfonyl compounds;Sulfenyl compounds;Monocarboxylic acids and derivatives;Dialkylthioethers;Carboxylic acids;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Aminosulfonyl compounds;Benzene and substituted derivatives;Benzenesulfonamides;Benzenesulfonyl compounds;Benzenoids;Carbonyl compounds;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Cumenes;Dialkylthioethers;Fatty Acyls;Fatty acids and conjugates;Hydrocarbon derivatives;Lipids and lipid-like molecules;Methionine and derivatives;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organic sulfonic acids and derivatives;Organonitrogen compounds;Organooxygen compounds;Organosulfonamides;Organosulfonic acids and derivatives;Organosulfur compounds;Phenylpropanes;Sulfenyl compounds;Sulfonyls;Thia fatty acids;Thioethers	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as methionine and derivatives. These are compounds containing methionine or a derivative thereof resulting from reaction of methionine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Methionine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic homomonocyclic compounds	sulfonamide (CHEBI:35358);alkylbenzene (CHEBI:38976);benzenes (CHEBI:22712);organosulfur compound (CHEBI:33261);thia fatty acid (CHEBI:59643);organonitrogen compound (CHEBI:35352);monocarboxylic acid (CHEBI:25384);aliphatic sulfide (CHEBI:22327);carboxylic acid (CHEBI:33575);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);alpha-amino acid (CHEBI:33704);methionine derivative (CHEBI:25230);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);lipid (CHEBI:18059);organooxygen compound (CHEBI:36963);organic acid (CHEBI:64709);sulfonic acid derivative (CHEBI:33552);organic molecular entity (CHEBI:50860);sulfone (CHEBI:35850);organic sulfide (CHEBI:16385);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806)	Thia fatty acids (FA0113);Fatty Acyls (FA);Fatty Acids and Conjugates (FA01)	Amino acids, peptides, and analogues	Methionine or derivatives;Benzenesulfonamide;Cumene;Benzenesulfonyl group;Phenylpropane;Thia fatty acid;Monocyclic benzene moiety;Fatty acyl;Organosulfonic acid amide;Benzenoid;Organic sulfonic acid or derivatives;Organosulfonic acid or derivatives;Sulfonyl;Aminosulfonyl compound;Dialkylthioether;Monocarboxylic acid or derivatives;Carboxylic acid;Sulfenyl compound;Thioether;Organic nitrogen compound;Hydrocarbon derivative;Organosulfur compound;Organooxygen compound;Organonitrogen compound;Organic oxide;Organic oxygen compound;Carbonyl group;Aromatic homomonocyclic compound	Organic acids and derivatives	0.0		STK982299		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0		C14H21NO4S2	C14H21NO4S2			InChI=1S/C14H21NO4S2/c1-10(2)11-4-6-12(7-5-11)21(18,19)15-13(14(16)17)8-9-20-3/h4-7,10,13,15H,8-9H2,1-3H3,(H,16,17)	OCJXGOIZYLVVRW-UHFFFAOYSA-N	2-[(4-isopropylphenyl)sulfonylamino]-4-methylsulfanyl-butanoic acid	43237776	CSCCC(NS(=O)(=O)c1ccc(C(C)C)cc1)C(=O)O	4-methylsulfanyl-2-[(4-propan-2-ylphenyl)sulfonylamino]butanoic acid			2.13188													MCULE-3813632073	331.45577		331.0912	5	2	8	1			45										False	Amino acids and Peptides				Peptide01			Compound(43237776)	43237776	2.6	946			[#6]-[#16]-[#6]-[#6]-[#6](-[#7]-[#16](=[#8])(=[#8])-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6])-[#6]):[#6]:[#6]:1)-[#6](=[#8])-[#8]	CSCCC(NS(=O)(=O)c1ccc(C(C)C)cc1)C(=O)O	OCJXGOIZYLVVRW		parent_pubchem_cid	STK982299;AKOS005647131;N-{[4-(propan-2-yl)phenyl]sulfonyl}methionine;AQ-390/43490624;N-[(4-isopropylphenyl)sulfonyl](methyl)homocysteine;2-[(4-isopropylphenyl)sulfonylamino]-4-methylsulfanyl-butanoic acid		23613783.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23613783		pluskal_iocb_peptide_Peptide01_E23_id		100	E23		
2.4		0	1070	P11184288	135.0		X5	False	0	21	0	0	20	0	6	4	0	0		0.0						Cn1nnc(-c2ccc(OCC(=O)NC(Cc3c[nH]c4ccccc34)C(=O)O)cc2)n1																							0.0		AKOS027472183		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	4	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C21H20N6O4	C21H20N6O4			InChI=1S/C21H20N6O4/c1-27-25-20(24-26-27)13-6-8-15(9-7-13)31-12-19(28)23-18(21(29)30)10-14-11-22-17-5-3-2-4-16(14)17/h2-9,11,18,22H,10,12H2,1H3,(H,23,28)(H,29,30)/t18-/m0/s1	WINFQPYGJBPATB-SFHVURJKSA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[[2-[4-(2-methyltetrazol-5-yl)phenoxy]acetyl]amino]propanoic acid	91640040	Cn1nnc(-c2ccc(OCC(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)O)cc2)n1	(2S)-3-(1H-indol-3-yl)-2-[[2-[4-(2-methyltetrazol-5-yl)phenoxy]acetyl]amino]propanoic acid			0.2237400000000008														420.43135		420.154603	7	3	8	4			45										False	Alkaloids				Peptide01			Compound(91640040)	91640040	2.0	947			[#6]-[#7]1:[#7]:[#7]:[#6](-[#6]2:[#6]:[#6]:[#6](-[#8]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]3:[#6]:[#7H]:[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]:3:4)-[#6](=[#8])-[#8]):[#6]:[#6]:2):[#7]:1	Cn1nnc(-c2ccc(OCC(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)O)cc2)n1	WINFQPYGJBPATB		parent_pubchem_cid	AKOS027472183;(2S)-3-(1H-INDOL-3-YL)-2-({2-[4-(2-METHYL-2H-1,2,3,4-TETRAAZOL-5-YL)PHENOXY]ACETYL}AMINO)PROPANOIC ACID;rac-(2S)-3-(1H-indol-3-yl)-2-[[2-[4-(2-methyltetrazol-5-yl)phenoxy]acetyl]amino]propanoic acid		95106443.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=95106443		pluskal_iocb_peptide_Peptide01_E23_id		100	E23		ZINC000218279167
3.4		0	1158	P1157881	82.2		X6	False	0	20	1	0	19	0	2	3	0	0		0.0						O=C(O)CC(CNC(=O)Cc1c[nH]c2ccccc12)c1ccc(Cl)cc1								Phenylpropanoic acids;3-alkylindoles;Chlorobenzenes;Substituted pyrroles;Aryl chlorides;Heteroaromatic compounds;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organonitrogen compounds;Organochlorides;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	3-alkylindoles;Amino acids and derivatives;Amino acids, peptides, and analogues;Aryl chlorides;Aryl halides;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Chlorobenzenes;Gamma amino acids and derivatives;Halobenzenes;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organochlorides;Organohalogen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenylpropanoic acids;Phenylpropanoids and polyketides;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as gamma amino acids and derivatives. These are amino acids having a (-NH2) group attached to the gamma carbon atom.	Gamma amino acids and derivatives		Amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);indoles (CHEBI:24828);organochlorine compound (CHEBI:36683);pyrroles (CHEBI:26455);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);monocarboxylic acid (CHEBI:25384);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);organooxygen compound (CHEBI:36963);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);organohalogen compound (CHEBI:36684);haloarene (CHEBI:50887);organic acid (CHEBI:64709);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806)		Amino acids, peptides, and analogues	Gamma amino acid or derivatives;3-phenylpropanoic-acid;3-alkylindole;Indole;Indole or derivatives;Chlorobenzene;Halobenzene;Aryl chloride;Aryl halide;Monocyclic benzene moiety;Substituted pyrrole;Benzenoid;Pyrrole;Heteroaromatic compound;Secondary carboxylic acid amide;Carboxamide group;Azacycle;Organoheterocyclic compound;Monocarboxylic acid or derivatives;Carboxylic acid;Carbonyl group;Organic oxide;Organic oxygen compound;Organic nitrogen compound;Hydrocarbon derivative;Organohalogen compound;Organochloride;Organonitrogen compound;Organooxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS005533928		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C20H19ClN2O3	C20H19ClN2O3			InChI=1S/C20H19ClN2O3/c21-16-7-5-13(6-8-16)14(10-20(25)26)11-23-19(24)9-15-12-22-18-4-2-1-3-17(15)18/h1-8,12,14,22H,9-11H2,(H,23,24)(H,25,26)	XZVGHCZWECWKNL-UHFFFAOYSA-N	3-(4-chlorophenyl)-4-[[2-(1H-indol-3-yl)acetyl]amino]butanoic acid	43912848	O=C(O)CC(CNC(=O)Cc1c[nH]c2ccccc12)c1ccc(Cl)cc1	3-(4-chlorophenyl)-4-[[2-(1H-indol-3-yl)acetyl]amino]butanoic acid			3.200660000000001													MCULE-2856775711	370.83903		370.10842	3	3	7	3			45										False					Peptide01			Compound(43912848)	43912848	3.0	948			[#8]=[#6](-[#8])-[#6]-[#6](-[#6]-[#7]-[#6](=[#8])-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6]1:[#6]:[#6]:[#6](-[#17]):[#6]:[#6]:1	O=C(O)CC(CNC(=O)Cc1c[nH]c2ccccc12)c1ccc(Cl)cc1	XZVGHCZWECWKNL		parent_pubchem_cid	AKOS005533928;3-(4-CHLOROPHENYL)-4-[2-(1H-INDOL-3-YL)ACETAMIDO]BUTANOIC ACID;3-(4-chlorophenyl)-4-[[2-(1H-indol-3-yl)acetyl]amino]butanoic acid		23595893.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23595893		pluskal_iocb_peptide_Peptide01_E23_id		100	E23		
4.3		0	1246	P7008231	62.1		X7	False	0	24	0	0	27	0	7	0	0	0		0.0						Cc1cc(Nc2c3cnn(C)c3nc(N3CCN(Cc4ccccc4)CC3)n2)ccc1																							0.0		6-(4-benzylpiperazin-1-yl)-1-methyl-N-(3-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	3		C24H27N7	C24H27N7			InChI=1S/C24H27N7/c1-18-7-6-10-20(15-18)26-22-21-16-25-29(2)23(21)28-24(27-22)31-13-11-30(12-14-31)17-19-8-4-3-5-9-19/h3-10,15-16H,11-14,17H2,1-2H3,(H,26,27,28)	DXCDMKVDMNZFNQ-UHFFFAOYSA-N	6-(4-benzylpiperazin-1-yl)-1-methyl-N-(m-tolyl)pyrazolo[3,4-d]pyrimidin-4-amine	16456471	Cc1cc(Nc2c3cnn(C)c3nc(N3CCN(Cc4ccccc4)CC3)n2)ccc1	6-(4-benzylpiperazin-1-yl)-1-methyl-N-(3-methylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine			2.05785													MCULE-8548415959	413.52969		413.232794	6	1	5	5			44										False	Alkaloids				Peptide01			Compound(16456471)	16456471	4.2	949			[#6]-[#6]1:[#6]:[#6](-[#7]-[#6]2:[#6]3:[#6]:[#7]:[#7](-[#6]):[#6]:3:[#7]:[#6](-[#7]3-[#6]-[#6]-[#7](-[#6]-[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]:4)-[#6]-[#6]-3):[#7]:2):[#6]:[#6]:[#6]:1	Cc1cc(Nc2c3cnn(C)c3nc(N3CCN(Cc4ccccc4)CC3)n2)ccc1	DXCDMKVDMNZFNQ		parent_pubchem_cid	6-(4-benzylpiperazin-1-yl)-1-methyl-N-(3-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine;887213-25-4;AKOS001905745;6-(4-benzylpiperazin-1-yl)-1-methyl-N-(m-tolyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine;F2031-0563;6-(4-benzylpiperazin-1-yl)-1-methyl-N-(3-methylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine;6-(4-benzylpiperazin-1-yl)-1-methyl-N-(m-tolyl)pyrazolo[3,4-d]pyrimidin-4-amine		8479285.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=8479285		pluskal_iocb_peptide_Peptide01_E23_id		100	E23		ZINC000020560415
3.4		0	1078	P7567861	71.3		X9	False	0	19	0	0	18	0	2	3	0	0		0.0						Cn1c(C(=O)NC(Cc2ccccc2)C(=O)O)cc2ccccc21																							0.0		EiM08-36801		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C19H18N2O3	C19H18N2O3			InChI=1S/C19H18N2O3/c1-21-16-10-6-5-9-14(16)12-17(21)18(22)20-15(19(23)24)11-13-7-3-2-4-8-13/h2-10,12,15H,11H2,1H3,(H,20,22)(H,23,24)/t15-/m0/s1	HLBRSTXVYHYUAH-HNNXBMFYSA-N	rac-(2S)-2-[(1-methylindole-2-carbonyl)amino]-3-phenyl-propanoic acid	91636471	Cn1c(C(=O)N[C@@H](Cc2ccccc2)C(=O)O)cc2ccccc21	(2S)-2-[(1-methylindole-2-carbonyl)amino]-3-phenylpropanoic acid			2.06616														322.36691		322.131742	3	2	5	3			45										False	Alkaloids				Peptide01			Compound(91636471)	91636471	3.3	950			[#6]-[#7]1:[#6](-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#8]):[#6]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	Cn1c(C(=O)N[C@@H](Cc2ccccc2)C(=O)O)cc2ccccc21	HLBRSTXVYHYUAH		parent_pubchem_cid	EiM08-36801;AKOS025146057;(2S)-2-{[(1-METHYL-1H-INDOL-2-YL)CARBONYL]AMINO}-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[(1-methylindole-2-carbonyl)amino]-3-phenyl-propanoic acid		91728286.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=91728286		pluskal_iocb_peptide_Peptide01_E23_id		100	E23		ZINC000170625487
4.5		0	1166	P1105819	99.7		X10	False	0	22	0	0	23	0	3	4	0	0	-1.0	0.0						C=C(C)COc1cc(O)c(-c2nc(N)ncc2Oc2ccccc2OCC)cc1		4.58		0.0	4.15	CHEMBL1549606		Diarylethers;Phenoxy compounds;Phenol ethers;Aminopyrimidines and derivatives;Alkyl aryl ethers;1-hydroxy-4-unsubstituted benzenoids;1-hydroxy-2-unsubstituted benzenoids;Heteroaromatic compounds;Azacyclic compounds;Primary amines;Hydrocarbon derivatives;Organic anions	1-hydroxy-2-unsubstituted benzenoids;1-hydroxy-4-unsubstituted benzenoids;Alkyl aryl ethers;Amines;Aminopyrimidines and derivatives;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Chemical entities;Diarylethers;Diazines;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Organic anions;Organic compounds;Organic nitrogen compounds;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenol ethers;Phenols;Phenoxy compounds;Phenylpyrimidines;Primary amines;Pyrimidines and pyrimidine derivatives	Diazines	2.1	This compound belongs to the class of organic compounds known as phenylpyrimidines. These are polycyclic aromatic compounds containing a benzene ring linked to a pyrimidine ring through a CC or CN bond.  Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions.	Phenylpyrimidines			Organic compounds	Aromatic heteromonocyclic compounds	aromatic ether (CHEBI:35618);benzenes (CHEBI:22712);aminopyrimidine (CHEBI:38338);phenols (CHEBI:33853);organic aromatic compound (CHEBI:33659);organonitrogen heterocyclic compound (CHEBI:38101);primary amine (CHEBI:32877);organic molecule (CHEBI:72695);organic anion (CHEBI:25696);pyrimidines (CHEBI:39447);chemical entity (CHEBI:24431);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);organooxygen compound (CHEBI:36963);ether (CHEBI:25698);benzenoid aromatic compound (CHEBI:33836);organic heterocyclic compound (CHEBI:24532);diazines (CHEBI:38313);nitrogen molecular entity (CHEBI:51143);organonitrogen compound (CHEBI:35352);amine (CHEBI:32952)		Pyrimidines and pyrimidine derivatives	4-phenylpyrimidine;Diaryl ether;Phenoxy compound;Phenol ether;1-hydroxy-4-unsubstituted benzenoid;Aminopyrimidine;Alkyl aryl ether;1-hydroxy-2-unsubstituted benzenoid;Phenol;Monocyclic benzene moiety;Benzenoid;Heteroaromatic compound;Ether;Azacycle;Primary amine;Organic nitrogen compound;Organooxygen compound;Organonitrogen compound;Amine;Hydrocarbon derivative;Organic oxygen compound;Organic anion;Aromatic heteromonocyclic compound	Organoheterocyclic compounds	0.0		862200-20-2		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0		C22H23N3O4	C22H23N3O4			InChI=1S/C22H23N3O4/c1-4-27-18-7-5-6-8-19(18)29-20-12-24-22(23)25-21(20)16-10-9-15(11-17(16)26)28-13-14(2)3/h5-12,26H,2,4,13H2,1,3H3,(H2,23,24,25)	DCQWFQSQTHYGSR-UHFFFAOYSA-N	2-[2-amino-5-(2-ethoxyphenoxy)pyrimidin-4-yl]-5-(2-methylallyloxy)phenol	665670	C=C(C)COc1cc(O)c(-c2nc(N)ncc2Oc2ccccc2OCC)cc1	2-[2-amino-5-(2-ethoxyphenoxy)pyrimidin-4-yl]-5-(2-methylprop-2-enoxy)phenol			1.5046199999999994													MCULE-2883051063	393.44631	NEUTRAL	393.168856	7	2	8	3	1.0		29										False	Alkaloids		False	False	Peptide01		-1.0	Compound(665670)	665670	4.3	951			[#6]=[#6](-[#6])-[#6]-[#8]-[#6]1:[#6]:[#6](-[#8]):[#6](-[#6]2:[#7]:[#6](-[#7]):[#7]:[#6]:[#6]:2-[#8]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#8]-[#6]-[#6]):[#6]:[#6]:1	C=C(C)COc1cc(O)c(-c2nc(N)ncc2Oc2ccccc2OCC)cc1	DCQWFQSQTHYGSR		parent_pubchem_cid	862200-20-2;2-(2-amino-5-(2-ethoxyphenoxy)pyrimidin-4-yl)-5-((2-methylallyl)oxy)phenol;2-[2-amino-5-(2-ethoxyphenoxy)pyrimidin-4-yl]-5-[(2-methylprop-2-en-1-yl)oxy]phenol;SMR000046824;MLS000042425;MLS002584287;CHEMBL1549606;HMS2287J18;AKOS002226462;F3385-1518;2-[2-amino-5-(2-ethoxyphenoxy)pyrimidin-4-yl]-5-(2-methylprop-2-enoxy)phenol;2-[2-amino-5-(2-ethoxyphenoxy)pyrimidin-4-yl]-5-(2-methylallyloxy)phenol	False	916652.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=916652		pluskal_iocb_peptide_Peptide01_E23_id		100	E23	False	ZINC000013127161
0.4		0	1254	P7008350	79.5		X11	False	0	14	0	0	22	0	6	2	0	0		0.0						CCN(CCO)c1nc(N2CCOCC2)c2cnn(C)c2n1																							0.0		897619-69-1		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3		C14H22N6O2	C14H22N6O2			InChI=1S/C14H22N6O2/c1-3-19(4-7-21)14-16-12-11(10-15-18(12)2)13(17-14)20-5-8-22-9-6-20/h10,21H,3-9H2,1-2H3	BJJTVIIMZACDJQ-UHFFFAOYSA-N	2-[ethyl-(1-methyl-4-morpholino-pyrazolo[3,4-d]pyrimidin-6-yl)amino]ethanol	7216438	CCN(CCO)c1nc(N2CCOCC2)c2cnn(C)c2n1	2-[ethyl-(1-methyl-4-morpholin-4-ylpyrazolo[3,4-d]pyrimidin-6-yl)amino]ethanol			-1.1711399999999974													MCULE-5283260467	306.37044		306.180424	7	1	5	3			44										False	Alkaloids	Pseudoalkaloids			Peptide01			Compound(7216438)	7216438	0.4	952			[#6]-[#6]-[#7](-[#6]-[#6]-[#8])-[#6]1:[#7]:[#6](-[#7]2-[#6]-[#6]-[#8]-[#6]-[#6]-2):[#6]2:[#6]:[#7]:[#7](-[#6]):[#6]:2:[#7]:1	CCN(CCO)c1nc(N2CCOCC2)c2cnn(C)c2n1	BJJTVIIMZACDJQ		parent_pubchem_cid	897619-69-1;2-(ethyl(1-methyl-4-morpholino-1H-pyrazolo[3,4-d]pyrimidin-6-yl)amino)ethanol;AKOS002312514;2-[ethyl-(1-methyl-4-morpholin-4-ylpyrazolo[3,4-d]pyrimidin-6-yl)amino]ethanol;F2031-1108;2-(ethyl(1-methyl-4-morpholino-1H-pyrazolo[3,4-d]pyrimidin-6-yl)amino)ethan-1-ol;2-[ethyl-(1-methyl-4-morpholino-pyrazolo[3,4-d]pyrimidin-6-yl)amino]ethanol		12164924.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=12164924		pluskal_iocb_peptide_Peptide01_E24_id		100	E24		ZINC000004375086
5.0		0	1086	P6667569	65.2		X13	False	0	28	0	0	33	0	3	2	0	0		0.0						CCCCN1C(=O)c2ccccc2C(C(=O)NCCc2c[nH]c3ccccc23)C12CCCC2																							0.0		EiM08-30567		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C28H33N3O2	C28H33N3O2			InChI=1S/C28H33N3O2/c1-2-3-18-31-27(33)23-12-5-4-11-22(23)25(28(31)15-8-9-16-28)26(32)29-17-14-20-19-30-24-13-7-6-10-21(20)24/h4-7,10-13,19,25,30H,2-3,8-9,14-18H2,1H3,(H,29,32)	MEHLZIKREJFBQD-UHFFFAOYSA-N	2-butyl-N-[2-(1H-indol-3-yl)ethyl]-1-oxo-spiro[4H-isoquinoline-3,1'-cyclopentane]-4-carboxamide	75465575	CCCCN1C(=O)c2ccccc2C(C(=O)NCCc2c[nH]c3ccccc23)C12CCCC2	2-butyl-N-[2-(1H-indol-3-yl)ethyl]-1-oxospiro[4H-isoquinoline-3,1'-cyclopentane]-4-carboxamide			4.586550000000004													MCULE-6685680767	443.59411		443.257277	2	2	7	5			45										False	Alkaloids				Peptide01			Compound(75465575)	75465575	4.8	953			[#6]-[#6]-[#6]-[#6]-[#7]1-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6]-12-[#6]-[#6]-[#6]-[#6]-2	CCCCN1C(=O)c2ccccc2C(C(=O)NCCc2c[nH]c3ccccc23)C12CCCC2	MEHLZIKREJFBQD		parent_pubchem_cid	EiM08-30567;AKOS016358327;2'-BUTYL-{N}-[2-(1{H}-INDOL-3-YL)ETHYL]-1'-OXO-1',4'-DIHYDRO-2'{H}-SPIRO[CYCLOPENTANE-1,3'-ISOQUINOLINE]-4'-CARBOXAMIDE;2-butyl-N-[2-(1H-indol-3-yl)ethyl]-1-oxo-spiro[4H-isoquinoline-3,1'-cyclopentane]-4-carboxamide		80390375.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=80390375		pluskal_iocb_peptide_Peptide01_E24_id		100	E24		
4.1		0	1174	P1098204	117.7		X14	False	0	25	0	0	24	0	2	6	0	0	-1.0	0.0						CCCc1cc(=O)oc2c1ccc(OCC(=O)NC(Cc1c[nH]c3ccccc13)C(=O)O)c2		3.42		0.0	3.51	CHEMBL1592594		Coumarins and derivatives;1-benzopyrans;3-alkylindoles;Pyranones and derivatives;Alkyl aryl ethers;Substituted pyrroles;Benzenoids;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactones;Oxacyclic compounds;Monocarboxylic acids and derivatives;Azacyclic compounds;Carboxylic acids;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organonitrogen compounds;Organopnictogen compounds	1-benzopyrans;3-alkylindoles;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Lactones;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acyl-l-alpha-amino acids. These are n-acylated alpha amino acids which have the L-configuration of the alpha-carbon atom.	N-acyl-L-alpha-amino acids		Amino acids and derivatives;Alpha amino acids and derivatives;N-acyl-alpha amino acids and derivatives;N-acyl-alpha amino acids	Organic compounds	Aromatic heteropolycyclic compounds	coumarins (CHEBI:23403);1-benzopyran (CHEBI:38443);indoles (CHEBI:24828);pyranone (CHEBI:37963);aromatic ether (CHEBI:35618);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactone (CHEBI:25000);oxacycle (CHEBI:38104);carbonyl compound (CHEBI:36586);organonitrogen heterocyclic compound (CHEBI:38101);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);N-acyl-L-alpha-amino acid (CHEBI:48927);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);pyrans (CHEBI:26407);oxygen molecular entity (CHEBI:25806);ether (CHEBI:25698);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);amino acid (CHEBI:33709);peptide (CHEBI:16670);N-acyl-amino acid (CHEBI:51569)	Benzopyranoids (PK1311)	Amino acids, peptides, and analogues	N-acyl-l-alpha-amino acid;Coumarin;Benzopyran;1-benzopyran;3-alkylindole;Indole;Indole or derivatives;Alkyl aryl ether;Pyranone;Pyran;Substituted pyrrole;Benzenoid;Heteroaromatic compound;Pyrrole;Secondary carboxylic acid amide;Carboxamide group;Lactone;Organoheterocyclic compound;Oxacycle;Azacycle;Carboxylic acid;Monocarboxylic acid or derivatives;Ether;Organic nitrogen compound;Organic oxide;Hydrocarbon derivative;Organopnictogen compound;Organonitrogen compound;Organooxygen compound;Carbonyl group;Organic oxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		MLS001075490		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C25H24N2O6	C25H24N2O6			InChI=1S/C25H24N2O6/c1-2-5-15-11-24(29)33-22-12-17(8-9-19(15)22)32-14-23(28)27-21(25(30)31)10-16-13-26-20-7-4-3-6-18(16)20/h3-4,6-9,11-13,21,26H,2,5,10,14H2,1H3,(H,27,28)(H,30,31)/t21-/m0/s1	SAOMPGOZGMMAQF-NRFANRHFSA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[[2-(2-oxo-4-propyl-chromen-7-yl)oxyacetyl]amino]propanoic acid	1761970	CCCc1cc(=O)oc2c1ccc(OCC(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)O)c2	(2S)-3-(1H-indol-3-yl)-2-[[2-(2-oxo-4-propylchromen-7-yl)oxyacetyl]amino]propanoic acid			2.8889200000000006													MCULE-4658508988	448.47983	ACID	448.163436	6	3	9	4	1.0		29									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins	False	False	Peptide01		-1.0	Compound(1761970)	1761970	3.8	954			[#6]-[#6]-[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:1:3)-[#6](=[#8])-[#8]):[#6]:2	CCCc1cc(=O)oc2c1ccc(OCC(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)O)c2	SAOMPGOZGMMAQF		parent_pubchem_cid	MLS001075490;CHEMBL1592594;HMS2267I10;EiM07-16882;STL460619;AKOS004937445;SMR000646280;AB00864207-06;N-{[(2-oxo-4-propyl-2H-chromen-7-yl)oxy]acetyl}-L-tryptophan;rac-(2S)-3-(1H-indol-3-yl)-2-[[2-(2-oxo-4-propyl-chromen-7-yl)oxyacetyl]amino]propanoic acid	False	863429.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=863429		pluskal_iocb_peptide_Peptide01_E24_id		100	E24	False	ZINC000002106981
4.3		0	1262	P7008477	62.1		X15	False	0	24	0	0	27	0	7	0	0	0		0.0						Cc1ccc(Nc2c3cnn(C)c3nc(N3CCN(Cc4ccccc4)CC3)n2)cc1																							0.0		AKOS001910386		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	3		C24H27N7	C24H27N7			InChI=1S/C24H27N7/c1-18-8-10-20(11-9-18)26-22-21-16-25-29(2)23(21)28-24(27-22)31-14-12-30(13-15-31)17-19-6-4-3-5-7-19/h3-11,16H,12-15,17H2,1-2H3,(H,26,27,28)	QPYPEPPNCMRCEK-UHFFFAOYSA-N	6-(4-benzylpiperazin-1-yl)-1-methyl-N-(p-tolyl)pyrazolo[3,4-d]pyrimidin-4-amine	16456428	Cc1ccc(Nc2c3cnn(C)c3nc(N3CCN(Cc4ccccc4)CC3)n2)cc1	6-(4-benzylpiperazin-1-yl)-1-methyl-N-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine			2.05785													MCULE-1565946209	413.52969		413.232794	6	1	5	5			44										False	Alkaloids				Peptide01			Compound(16456428)	16456428	4.2	955			[#6]-[#6]1:[#6]:[#6]:[#6](-[#7]-[#6]2:[#6]3:[#6]:[#7]:[#7](-[#6]):[#6]:3:[#7]:[#6](-[#7]3-[#6]-[#6]-[#7](-[#6]-[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]:4)-[#6]-[#6]-3):[#7]:2):[#6]:[#6]:1	Cc1ccc(Nc2c3cnn(C)c3nc(N3CCN(Cc4ccccc4)CC3)n2)cc1	QPYPEPPNCMRCEK		parent_pubchem_cid	AKOS001910386;6-(4-benzylpiperazin-1-yl)-1-methyl-N-(4-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine;6-(4-benzylpiperazin-1-yl)-1-methyl-N-(p-tolyl)pyrazolo[3,4-d]pyrimidin-4-amine		17566841.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=17566841		pluskal_iocb_peptide_Peptide01_E24_id		100	E24		ZINC000020560419
4.7		0	1094	P1158040	39.3		X17	False	0	27	0	0	27	0	3	1	0	0		0.0						O=C(Cc1c[nH]c2ccccc12)N1CCN(C(c2ccccc2)c2ccccc2)CC1																							0.0		921106-05-0		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	1		C27H27N3O	C27H27N3O			InChI=1S/C27H27N3O/c31-26(19-23-20-28-25-14-8-7-13-24(23)25)29-15-17-30(18-16-29)27(21-9-3-1-4-10-21)22-11-5-2-6-12-22/h1-14,20,27-28H,15-19H2	KYMOTTJXKAHOBT-UHFFFAOYSA-N	1-(4-benzhydrylpiperazin-1-yl)-2-(1H-indol-3-yl)ethanone	16419353	O=C(Cc1c[nH]c2ccccc12)N1CCN(C(c2ccccc2)c2ccccc2)CC1	1-(4-benzhydrylpiperazin-1-yl)-2-(1H-indol-3-yl)ethanone			4.051650000000003													MCULE-1412515621	409.53574		409.215412	2	1	5	5			44										False	Alkaloids				Peptide01			Compound(16419353)	16419353	4.3	956			[#8]=[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]1-[#6]-[#6]-[#7](-[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]-[#6]-1	O=C(Cc1c[nH]c2ccccc12)N1CCN(C(c2ccccc2)c2ccccc2)CC1	KYMOTTJXKAHOBT		parent_pubchem_cid	921106-05-0;1-(4-benzhydrylpiperazino)-2-(1H-indol-3-yl)-1-ethanone;AKOS005533931;NCGC00278569-01;AB01279883-01;1-[4-(DIPHENYLMETHYL)PIPERAZIN-1-YL]-2-(1H-INDOL-3-YL)ETHAN-1-ONE;1-(4-benzhydrylpiperazin-1-yl)-2-(1H-indol-3-yl)ethanone		9843674.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=9843674		pluskal_iocb_peptide_Peptide01_E24_id		100	E24		ZINC000020426427
1.4		0	1182	P6235935	95.9		X18	False	0	22	0	0	23	0	1	5	0	0		0.0						CCCc1cc(=O)oc2c1ccc(O)c2CNC(Cc1ccccc1)C(=O)O								7-hydroxycoumarins;Phenylpropanoic acids;1-benzopyrans;Amphetamines and derivatives;D-alpha-amino acids;Pyranones and derivatives;1-hydroxy-2-unsubstituted benzenoids;Aralkylamines;Heteroaromatic compounds;Carboxylic acid salts;Amino acids;Lactones;Oxacyclic compounds;Dialkylamines;Monocarboxylic acids and derivatives;Carboxylic acids;Hydrocarbon derivatives;Carbonyl compounds;Organic oxides;Organic salts;Organic zwitterions;Organopnictogen compounds	1-benzopyrans;1-hydroxy-2-unsubstituted benzenoids;7-hydroxycoumarins;Alpha amino acids;Alpha amino acids and derivatives;Amines;Amino acids;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Aralkylamines;Benzene and substituted derivatives;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acid derivatives;Carboxylic acid salts;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;D-alpha-amino acids;Dialkylamines;Heteroaromatic compounds;Hydrocarbon derivatives;Hydroxycoumarins;Lactones;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organic salts;Organic zwitterions;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenethylamines;Phenols;Phenylalanine and derivatives;Phenylpropanoic acids;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Secondary amines	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	hydroxycoumarin (CHEBI:37912);benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);1-benzopyran (CHEBI:38443);amphetamines (CHEBI:35338);D-alpha-amino acid (CHEBI:16733);pyranone (CHEBI:37963);phenols (CHEBI:33853);aralkylamine (CHEBI:18000);organic aromatic compound (CHEBI:33659);organic salt (CHEBI:24868);amino acid (CHEBI:33709);lactone (CHEBI:25000);oxacycle (CHEBI:38104);secondary amino compound (CHEBI:50995);monocarboxylic acid (CHEBI:25384);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);organic oxide (CHEBI:25701);zwitterion (CHEBI:27369);organic molecular entity (CHEBI:50860);pnictogen molecular entity (CHEBI:33302);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);coumarins (CHEBI:23403);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);benzenoid aromatic compound (CHEBI:33836);primary amine (CHEBI:32877);organic acid (CHEBI:64709);organonitrogen compound (CHEBI:35352);alpha-amino acid (CHEBI:33704);pyrans (CHEBI:26407);nitrogen molecular entity (CHEBI:51143);amine (CHEBI:32952);secondary amine (CHEBI:32863);oxygen molecular entity (CHEBI:25806);carboxylic acid anion (CHEBI:29067);peptide (CHEBI:16670)	Benzopyranoids (PK1311)	Amino acids, peptides, and analogues	Phenylalanine or derivatives;7-hydroxycoumarin;Hydroxycoumarin;Coumarin;3-phenylpropanoic-acid;Alpha-amino acid;Amphetamine or derivatives;Benzopyran;D-alpha-amino acid;1-benzopyran;1-hydroxy-2-unsubstituted benzenoid;Aralkylamine;Pyranone;Monocyclic benzene moiety;Pyran;Benzenoid;Heteroaromatic compound;Amino acid;Carboxylic acid salt;Lactone;Secondary amine;Organoheterocyclic compound;Oxacycle;Carboxylic acid;Monocarboxylic acid or derivatives;Secondary aliphatic amine;Organic zwitterion;Organic nitrogen compound;Hydrocarbon derivative;Organonitrogen compound;Organooxygen compound;Carbonyl group;Organic salt;Organic oxide;Organopnictogen compound;Amine;Organic oxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		2-{[(7-HYDROXY-2-OXO-4-PROPYL-2H-CHROMEN-8-YL)METHYL]AMINO}-3-PHENYLPROPANOIC ACID		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C22H23NO5	C22H23NO5			InChI=1S/C22H23NO5/c1-2-6-15-12-20(25)28-21-16(15)9-10-19(24)17(21)13-23-18(22(26)27)11-14-7-4-3-5-8-14/h3-5,7-10,12,18,23-24H,2,6,11,13H2,1H3,(H,26,27)/t18-/m1/s1	ANIBAKNMKNJZIG-GOSISDBHSA-N	rac-(2R)-2-[(7-hydroxy-2-oxo-4-propyl-chromen-8-yl)methylamino]-3-phenyl-propanoic acid	5576376	CCCc1cc(=O)oc2c1ccc(O)c2CN[C@H](Cc1ccccc1)C(=O)O	(2R)-2-[(7-hydroxy-2-oxo-4-propylchromen-8-yl)methylamino]-3-phenylpropanoic acid			3.0815300000000008													MCULE-8859410804	381.43231		381.157623	6	3	8	3			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(11963713)	11963713	1.7	957			[#6]-[#6]-[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]):[#6]:2-[#6]-[#7]-[#6@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	CCCc1cc(=O)oc2c1ccc(O)c2CN[C@H](Cc1ccccc1)C(=O)O	ANIBAKNMKNJZIG		parent_pubchem_cid	2-{[(7-HYDROXY-2-OXO-4-PROPYL-2H-CHROMEN-8-YL)METHYL]AMINO}-3-PHENYLPROPANOIC ACID;AKOS016379535;rac-(2R)-2-[(7-hydroxy-2-oxo-4-propyl-chromen-8-yl)methylamino]-3-phenyl-propanoic acid		9868986.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=9868986		pluskal_iocb_peptide_Peptide01_E24_id		100	E24		ZINC000002121312
1.4		0	1270	P7009484	88.3		X19	False	0	17	0	0	20	0	6	2	0	0		0.0						OCCNc1nc(N2CCOCC2)c2cnn(-c3ccccc3)c2n1																							0.0		AKOS005652003		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	2		C17H20N6O2	C17H20N6O2			InChI=1S/C17H20N6O2/c24-9-6-18-17-20-15(22-7-10-25-11-8-22)14-12-19-23(16(14)21-17)13-4-2-1-3-5-13/h1-5,12,24H,6-11H2,(H,18,20,21)	ZPDZAZRNRJAZIC-UHFFFAOYSA-N	2-[(4-morpholino-1-phenyl-pyrazolo[3,4-d]pyrimidin-6-yl)amino]ethanol	51045408	OCCNc1nc(N2CCOCC2)c2cnn(-c3ccccc3)c2n1	2-[(4-morpholin-4-yl-1-phenylpyrazolo[3,4-d]pyrimidin-6-yl)amino]ethanol			-0.3233499999999982													MCULE-1156684896	340.38795		340.164774	7	2	5	4			44										False	Alkaloids				Peptide01			Compound(51045408)	51045408	1.6	958			[#8]-[#6]-[#6]-[#7]-[#6]1:[#7]:[#6](-[#7]2-[#6]-[#6]-[#8]-[#6]-[#6]-2):[#6]2:[#6]:[#7]:[#7](-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#6]:2:[#7]:1	OCCNc1nc(N2CCOCC2)c2cnn(-c3ccccc3)c2n1	ZPDZAZRNRJAZIC		parent_pubchem_cid	AKOS005652003;2-[(4-morpholino-1-phenyl-pyrazolo[3,4-d]pyrimidin-6-yl)amino]ethanol		5990757.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=5990757		pluskal_iocb_peptide_Peptide01_E24_id		100	E24		ZINC000044928568
4.7		0	1102	P1098591	117.7		X21	False	0	27	0	0	26	0	2	6	0	0		0.0						Cc1cc2c(c(OCC(=O)NC(Cc3c[nH]c4ccccc34)C(=O)O)c1)c1c(CCCC1)c(=O)o2																							0.0		EiM07-17269		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C27H26N2O6	C27H26N2O6			InChI=1S/C27H26N2O6/c1-15-10-22(25-18-7-2-3-8-19(18)27(33)35-23(25)11-15)34-14-24(30)29-21(26(31)32)12-16-13-28-20-9-5-4-6-17(16)20/h4-6,9-11,13,21,28H,2-3,7-8,12,14H2,1H3,(H,29,30)(H,31,32)/t21-/m0/s1	JTIQGLKRCIOWFG-NRFANRHFSA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[[2-[(3-methyl-6-oxo-7,8,9,10-tetrahydrobenzo[c]chromen-1-yl)oxy]acetyl]amino]propanoic acid	1792394	Cc1cc2c(c(OCC(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)O)c1)c1c(CCCC1)c(=O)o2	(2S)-3-(1H-indol-3-yl)-2-[[2-[(3-methyl-6-oxo-7,8,9,10-tetrahydrobenzo[c]chromen-1-yl)oxy]acetyl]amino]propanoic acid			3.0142200000000017													MCULE-9245926172	474.51807		474.179087	6	3	7	5			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(1792394)	1792394	4.2	959			[#6]-[#6]1:[#6]:[#6]2:[#6](:[#6](-[#8]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]3:[#6]:[#7H]:[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]:3:4)-[#6](=[#8])-[#8]):[#6]:1):[#6]1:[#6](-[#6]-[#6]-[#6]-[#6]-1):[#6](=[#8]):[#8]:2	Cc1cc2c(c(OCC(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)O)c1)c1c(CCCC1)c(=O)o2	JTIQGLKRCIOWFG		parent_pubchem_cid	EiM07-17269;AKOS016392300;(2S)-3-(1H-indol-3-yl)-2-({2-[(3-methyl-6-oxo-7,8,9,10-tetrahydro-6H-benzo[c]chromen-1-yl)oxy]acetyl}amino)propanoic acid;rac-(2S)-3-(1H-indol-3-yl)-2-[[2-[(3-methyl-6-oxo-7,8,9,10-tetrahydrobenzo[c]chromen-1-yl)oxy]acetyl]amino]propanoic acid		24524447.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24524447		pluskal_iocb_peptide_Peptide01_E24_id		100	E24		ZINC000002136974
1.6		0	1190	P3461239	163.8		X22	False	0	20	0	0	26	0	4	6	0	0		0.0						CCc1cc(=O)oc2c1ccc(OC(C)C(=O)NC(CCCN=C(N)N)C(=O)O)c2																							0.0		EiM08-08824		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C20H26N4O6	C20H26N4O6			InChI=1S/C20H26N4O6/c1-3-12-9-17(25)30-16-10-13(6-7-14(12)16)29-11(2)18(26)24-15(19(27)28)5-4-8-23-20(21)22/h6-7,9-11,15H,3-5,8H2,1-2H3,(H,24,26)(H,27,28)(H4,21,22,23)/t11?,15-/m0/s1	BHKCVEJTFUBLCJ-MHTVFEQDSA-N	rac-(2S)-2-[2-(4-ethyl-2-oxo-chromen-7-yl)oxypropanoylamino]-5-guanidino-pentanoic acid	56726571	CCc1cc(=O)oc2c1ccc(OC(C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)c2	(2S)-5-(diaminomethylideneamino)-2-[2-(4-ethyl-2-oxochromen-7-yl)oxypropanoylamino]pentanoic acid			0.7000500000000014														418.45342		418.185235	7	5	11	2			46									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(56726571)	56726571	0.8	960			[#6]-[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6](-[#6])-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]=[#6](-[#7])-[#7])-[#6](=[#8])-[#8]):[#6]:2	CCc1cc(=O)oc2c1ccc(OC(C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)c2	BHKCVEJTFUBLCJ		parent_pubchem_cid	EiM08-08824;AKOS016376819;5-CARBAMIMIDAMIDO-2-{2-[(4-ETHYL-2-OXO-2H-CHROMEN-7-YL)OXY]PROPANAMIDO}PENTANOIC ACID;rac-(2S)-2-[2-(4-ethyl-2-oxo-chromen-7-yl)oxypropanoylamino]-5-guanidino-pentanoic acid		23705382.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23705382		pluskal_iocb_peptide_Peptide01_F1_id		100	F1		
4.4		0	1278	P11569570	65.1		X23	False	0	20	1	0	23	0	2	2	0	0		0.0						CC(C(=O)NC(CO)C(C)C)c1cc2c(cc1)c1c(ccc(Cl)c1)[nH]2																							0.0		AKOS027474391		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C20H23ClN2O2	C20H23ClN2O2			InChI=1S/C20H23ClN2O2/c1-11(2)19(10-24)23-20(25)12(3)13-4-6-15-16-9-14(21)5-7-17(16)22-18(15)8-13/h4-9,11-12,19,22,24H,10H2,1-3H3,(H,23,25)/t12?,19-/m1/s1	SMDLETALVZXPND-FKWGRNQDSA-N	2-(6-chloro-9H-carbazol-2-yl)-N-[rac-(1S)-1-(hydroxymethyl)-2-methyl-propyl]propanamide	91639178	CC(C(=O)N[C@H](CO)C(C)C)c1cc2c(cc1)c1c(ccc(Cl)c1)[nH]2	2-(6-chloro-9H-carbazol-2-yl)-N-[(2S)-1-hydroxy-3-methylbutan-2-yl]propanamide			3.299550000000001														358.87151		358.144806	2	3	5	3			46									Carbazole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(91639178)	91639178	4.5	961			[#6]-[#6](-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#8])-[#6](-[#6])-[#6])-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#6]1:[#6](:[#6]:[#6]:[#6](-[#17]):[#6]:1):[#7H]:2	CC(C(=O)N[C@H](CO)C(C)C)c1cc2c(cc1)c1c(ccc(Cl)c1)[nH]2	SMDLETALVZXPND		parent_pubchem_cid	AKOS027474391;2-(6-chloro-9H-carbazol-2-yl)-N-[rac-(1S)-1-(hydroxymethyl)-2-methyl-propyl]propanamide		94399970.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=94399970		pluskal_iocb_peptide_Peptide01_F1_id		100	F1		
2.2		0	1110	P1098878	131.7		X25	False	0	18	0	0	16	0	4	5	0	0		0.0						O=C(Cn1nnc2ccccc2c1=O)NC(Cc1ccc(O)cc1)C(=O)O																							0.0		STK716954		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C18H16N4O5	C18H16N4O5			InChI=1S/C18H16N4O5/c23-12-7-5-11(6-8-12)9-15(18(26)27)19-16(24)10-22-17(25)13-3-1-2-4-14(13)20-21-22/h1-8,15,23H,9-10H2,(H,19,24)(H,26,27)/t15-/m0/s1	HXBAZAGNVYQNJL-HNNXBMFYSA-N	rac-(2S)-3-(4-hydroxyphenyl)-2-[[2-(4-oxo-1,2,3-benzotriazin-3-yl)acetyl]amino]propanoic acid	1834587	O=C(Cn1nnc2ccccc2c1=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O	(2S)-3-(4-hydroxyphenyl)-2-[[2-(4-oxo-1,2,3-benzotriazin-3-yl)acetyl]amino]propanoic acid			0.2635499999999993													MCULE-6574443809	368.35202		368.11207	7	3	6	3			44										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(1834587)	1834587	2.1	962			[#8]=[#6](-[#6]-[#7]1:[#7]:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6](-[#8]):[#6]:[#6]:1)-[#6](=[#8])-[#8]	O=C(Cn1nnc2ccccc2c1=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O	HXBAZAGNVYQNJL		parent_pubchem_cid	STK716954;AKOS004937112;N-[(4-oxo-1,2,3-benzotriazin-3(4H)-yl)acetyl]-L-tyrosine;(S)-3-(4-hydroxyphenyl)-2-(2-(4-oxobenzo[d][1,2,3]triazin-3(4H)-yl)acetamido)propanoic acid;rac-(2S)-3-(4-hydroxyphenyl)-2-[[2-(4-oxo-1,2,3-benzotriazin-3-yl)acetyl]amino]propanoic acid		23918264.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23918264		pluskal_iocb_peptide_Peptide01_F1_id		100	F1		ZINC000002200816
2.9		0	1198	P7565805	82.7		X26	False	0	21	0	0	19	0	5	1	0	0		0.0						O=C(NCCc1c[nH]c2ccccc12)c1cc(Nc2ncccn2)ccc1								3-alkylindoles;Benzamides;Benzoyl derivatives;Aniline and substituted anilines;Aminopyrimidines and derivatives;Substituted pyrroles;Heteroaromatic compounds;Secondary carboxylic acid amides;Amino acids and derivatives;Secondary amines;Azacyclic compounds;Organooxygen compounds;Organic oxides;Hydrocarbon derivatives	3-alkylindoles;Amines;Amino acids and derivatives;Amino acids, peptides, and analogues;Aminobenzoic acids and derivatives;Aminopyrimidines and derivatives;Aniline and substituted anilines;Azacyclic compounds;Benzamides;Benzene and substituted derivatives;Benzenoids;Benzoic acids and derivatives;Benzoyl derivatives;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Diazines;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Pyrimidines and pyrimidine derivatives;Pyrroles;Secondary amines;Secondary carboxylic acid amides;Substituted pyrroles	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as aminobenzoic acids and derivatives. These are benzoic acids (or derivative thereof) containing an amine group attached to the benzene moiety.	Aminobenzoic acids and derivatives			Organic compounds	Aromatic heteropolycyclic compounds	indoles (CHEBI:24828);benzamides (CHEBI:22702);carbonyl compound (CHEBI:36586);anilines (CHEBI:22562);aminopyrimidine (CHEBI:38338);pyrroles (CHEBI:26455);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organonitrogen compound (CHEBI:35352);organooxygen compound (CHEBI:36963);secondary amine (CHEBI:32863);organonitrogen heterocyclic compound (CHEBI:38101);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);benzenes (CHEBI:22712);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);benzoic acids (CHEBI:22723);diazines (CHEBI:38313);pyrimidines (CHEBI:39447);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);amine (CHEBI:32952);oxygen molecular entity (CHEBI:25806)		Benzoic acids and derivatives	Aminobenzoic acid or derivatives;3-alkylindole;Benzamide;Indole;Indole or derivatives;Benzoyl;Aniline or substituted anilines;Aminopyrimidine;Pyrimidine;Substituted pyrrole;Pyrrole;Heteroaromatic compound;Secondary carboxylic acid amide;Amino acid or derivatives;Carboxamide group;Secondary amine;Organoheterocyclic compound;Azacycle;Carboxylic acid derivative;Amine;Organonitrogen compound;Hydrocarbon derivative;Organic oxide;Organic oxygen compound;Organic nitrogen compound;Organooxygen compound;Aromatic heteropolycyclic compound	Benzenoids	0.0		1435983-72-4		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	0	0	0	0	0	0	0		C21H19N5O	C21H19N5O			InChI=1S/C21H19N5O/c27-20(22-12-9-16-14-25-19-8-2-1-7-18(16)19)15-5-3-6-17(13-15)26-21-23-10-4-11-24-21/h1-8,10-11,13-14,25H,9,12H2,(H,22,27)(H,23,24,26)	SIDSSMIIAZVHHX-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)ethyl]-3-(pyrimidin-2-ylamino)benzamide	35438640	O=C(NCCc1c[nH]c2ccccc12)c1cc(Nc2ncccn2)ccc1	N-[2-(1H-indol-3-yl)ethyl]-3-(pyrimidin-2-ylamino)benzamide			2.3749400000000005													MCULE-6209132485	357.41848		357.15896	4	3	6	4			43									Carboline alkaloids;Pyridine alkaloids	False	Alkaloids	Tryptophan alkaloids;Nicotinic acid alkaloids			Peptide01			Compound(35438640)	35438640	3.4	963			[#8]=[#6](-[#7]-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6]1:[#6]:[#6](-[#7]-[#6]2:[#7]:[#6]:[#6]:[#6]:[#7]:2):[#6]:[#6]:[#6]:1	O=C(NCCc1c[nH]c2ccccc12)c1cc(Nc2ncccn2)ccc1	SIDSSMIIAZVHHX		parent_pubchem_cid	1435983-72-4;N-[2-(1H-indol-3-yl)ethyl]-3-(2-pyrimidinylamino)benzamide;EiM08-29564;STL320303;AKOS022136111;N-[2-(1H-indol-3-yl)ethyl]-3-(pyrimidin-2-ylamino)benzamide;N-[2-(1H-INDOL-3-YL)ETHYL]-3-[(PYRIMIDIN-2-YL)AMINO]BENZAMIDE		59864725.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=59864725		pluskal_iocb_peptide_Peptide01_F1_id		100	F1		ZINC000028095055
2.9		0	1286	P11570321	90.4		X27	False	0	18	0	0	24	0	2	2	0	1		0.0						CSCCC(CO)NC(=O)c1cc2c(cc1)[nH]c1c2CCCC1																							0.0		EiM08-40300		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C18H24N2O2S	C18H24N2O2S			InChI=1S/C18H24N2O2S/c1-23-9-8-13(11-21)19-18(22)12-6-7-17-15(10-12)14-4-2-3-5-16(14)20-17/h6-7,10,13,20-21H,2-5,8-9,11H2,1H3,(H,19,22)/t13-/m0/s1	UQFXZVNRIHNPDA-ZDUSSCGKSA-N	N-[rac-(1S)-1-(hydroxymethyl)-3-methylsulfanyl-propyl]-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide	110205744	CSCC[C@@H](CO)NC(=O)c1cc2c(cc1)[nH]c1c2CCCC1	N-[(2S)-1-hydroxy-4-methylsulfanylbutan-2-yl]-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide			2.29795														332.46818		332.155849	3	3	6	3			45									Carboline alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(110205744)	110205744	2.9	964			[#6]-[#16]-[#6]-[#6]-[#6@@H](-[#6]-[#8])-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#7H]:[#6]1:[#6]:2-[#6]-[#6]-[#6]-[#6]-1	CSCC[C@@H](CO)NC(=O)c1cc2c(cc1)[nH]c1c2CCCC1	UQFXZVNRIHNPDA		parent_pubchem_cid	EiM08-40300;AKOS027475006;AO-022/43512875;N-[1-(hydroxymethyl)-3-(methylsulfanyl)propyl]-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide;N-[rac-(1S)-1-(hydroxymethyl)-3-methylsulfanyl-propyl]-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide		117133953.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=117133953		pluskal_iocb_peptide_Peptide01_F1_id		100	F1		ZINC000132188519
2.9		0	1118	P1098948	115.8		X29	False	0	22	0	0	29	0	3	5	0	0		0.0						CC(C)CC(NC(=O)C1CCC(Cn2c(=O)[nH]c3ccccc3c2=O)CC1)C(=O)O																							0.0		AKOS005543995		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	4	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0		C22H29N3O5	C22H29N3O5			InChI=1S/C22H29N3O5/c1-13(2)11-18(21(28)29)23-19(26)15-9-7-14(8-10-15)12-25-20(27)16-5-3-4-6-17(16)24-22(25)30/h3-6,13-15,18H,7-12H2,1-2H3,(H,23,26)(H,24,30)(H,28,29)/t14?,15?,18-/m0/s1	RCISSNOGVFMDHK-JMLCCBQJSA-N	rac-(2S)-2-[[4-[(2,4-dioxo-1H-quinazolin-3-yl)methyl]cyclohexanecarbonyl]amino]-4-methyl-pentanoic acid	8027654	CC(C)C[C@H](NC(=O)C1CCC(Cn2c(=O)[nH]c3ccccc3c2=O)CC1)C(=O)O	(2S)-2-[[4-[(2,4-dioxo-1H-quinazolin-3-yl)methyl]cyclohexanecarbonyl]amino]-4-methylpentanoic acid			3.483060000000002													MCULE-2147766361	415.49353		415.210721	5	3	7	3			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(8027654)	8027654	2.7	965			[#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]1-[#6]-[#6]-[#6](-[#6]-[#7]2:[#6](=[#8]):[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3:[#6]:2=[#8])-[#6]-[#6]-1)-[#6](=[#8])-[#8]	CC(C)C[C@H](NC(=O)C1CCC(Cn2c(=O)[nH]c3ccccc3c2=O)CC1)C(=O)O	RCISSNOGVFMDHK		parent_pubchem_cid	AKOS005543995;AKOS016376089;AKOS032394678;N-({trans-4-[(2,4-dioxo-1,4-dihydroquinazolin-3(2H)-yl)methyl]cyclohexyl}carbonyl)-L-leucine;(S)-2-(4-((2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)methyl)cyclohexanecarboxamido)-4-methylpentanoic acid;rac-(2S)-2-[[4-[(2,4-dioxo-1H-quinazolin-3-yl)methyl]cyclohexanecarbonyl]amino]-4-methyl-pentanoic acid		22722942.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22722942		pluskal_iocb_peptide_Peptide01_F1_id		100	F1		ZINC000006658472
2.9		0	1206	P6238553	89.5		X30	False	0	23	0	0	21	0	3	4	0	0		0.0						O=C(Nc1ccccn1)C(Cc1ccccc1)NC(=O)C1COc2ccccc2O1																							0.0		AKOS016400237		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C23H21N3O4	C23H21N3O4			InChI=1S/C23H21N3O4/c27-22(26-21-12-6-7-13-24-21)17(14-16-8-2-1-3-9-16)25-23(28)20-15-29-18-10-4-5-11-19(18)30-20/h1-13,17,20H,14-15H2,(H,25,28)(H,24,26,27)/t17-,20?/m1/s1	GKSBHTARXJAMEM-DIAVIDTQSA-N	N-[rac-(1R)-1-benzyl-2-oxo-2-(2-pyridylamino)ethyl]-2,3-dihydro-1,4-benzodioxine-3-carboxamide	71695129	O=C(N[C@H](Cc1ccccc1)C(=O)Nc1ccccn1)C1COc2ccccc2O1	N-[(2R)-1-oxo-3-phenyl-1-(pyridin-2-ylamino)propan-2-yl]-2,3-dihydro-1,4-benzodioxine-3-carboxamide			1.227459999999999														403.44152		403.153206	5	2	6	4			46										False	Amino acids and Peptides;Shikimates and Phenylpropanoids				Peptide01			Compound(71695129)	71695129	3.2	966			[#8]=[#6](-[#7]-[#6@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#7]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#7]:1)-[#6]1-[#6]-[#8]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#8]-1	O=C(N[C@H](Cc1ccccc1)C(=O)Nc1ccccn1)C1COc2ccccc2O1	GKSBHTARXJAMEM		parent_pubchem_cid	AKOS016400237;N~2~-[(1R)-1-benzyl-2-oxo-2-(2-pyridylamino)ethyl]-2,3-dihydro-1,4-benzodioxine-2-carboxamide;N-[rac-(1R)-1-benzyl-2-oxo-2-(2-pyridylamino)ethyl]-2,3-dihydro-1,4-benzodioxine-3-carboxamide		64420457.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=64420457		pluskal_iocb_peptide_Peptide01_F1_id		100	F1		
0.1		0	1294	P11570243	108.5		X31	False	0	16	0	0	25	0	7	2	0	0		0.0						CCC(C)C(CO)NC(=O)C1CCN(c2nn3nnnc3cc2)CC1																							0.0		AKOS027474946		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	4	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	2		C16H25N7O2	C16H25N7O2			InChI=1S/C16H25N7O2/c1-3-11(2)13(10-24)17-16(25)12-6-8-22(9-7-12)15-5-4-14-18-20-21-23(14)19-15/h4-5,11-13,24H,3,6-10H2,1-2H3,(H,17,25)/t11?,13-/m1/s1	KIOFFSGXUJZCOC-GLGOKHISSA-N	N-[rac-(1S)-1-(hydroxymethyl)-2-methyl-butyl]-1-(tetrazolo[1,5-b]pyridazin-6-yl)piperidine-4-carboxamide	122714886	CCC(C)[C@@H](CO)NC(=O)C1CCN(c2nn3nnnc3cc2)CC1	N-[(2S)-1-hydroxy-3-methylpentan-2-yl]-1-(tetrazolo[1,5-b]pyridazin-6-yl)piperidine-4-carboxamide			-0.335919999999998														347.42335		347.206973	7	2	6	3			46										False	Alkaloids				Peptide01			Compound(122714886)	122714886	1.2	967			[#6]-[#6]-[#6](-[#6])-[#6@@H](-[#6]-[#8])-[#7]-[#6](=[#8])-[#6]1-[#6]-[#6]-[#7](-[#6]2:[#7]:[#7]3:[#7]:[#7]:[#7]:[#6]:3:[#6]:[#6]:2)-[#6]-[#6]-1	CCC(C)[C@@H](CO)NC(=O)C1CCN(c2nn3nnnc3cc2)CC1	KIOFFSGXUJZCOC		parent_pubchem_cid	AKOS027474946;N-[rac-(1S)-1-(hydroxymethyl)-2-methyl-butyl]-1-(tetrazolo[1,5-b]pyridazin-6-yl)piperidine-4-carboxamide		149118358.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=149118358		pluskal_iocb_peptide_Peptide01_F1_id		100	F1		
0.6		0	1126	P1098875	148.7		X33	False	0	14	0	0	14	0	4	6	0	0		0.0						O=C(O)CCC(NC(=O)Cn1nnc2ccccc2c1=O)C(=O)O																							0.0		AKOS005533857		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	2	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C14H14N4O6	C14H14N4O6			InChI=1S/C14H14N4O6/c19-11(15-10(14(23)24)5-6-12(20)21)7-18-13(22)8-3-1-2-4-9(8)16-17-18/h1-4,10H,5-7H2,(H,15,19)(H,20,21)(H,23,24)/t10-/m0/s1	RDUWCBAWUHFGHR-JTQLQIEISA-N	rac-(2S)-2-[[2-(4-oxo-1,2,3-benzotriazin-3-yl)acetyl]amino]pentanedioic acid	1954112	O=C(O)CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)C(=O)O	(2S)-2-[[2-(4-oxo-1,2,3-benzotriazin-3-yl)acetyl]amino]pentanedioic acid			-0.3028299999999997													MCULE-4406114270	334.29088		334.091334	8	3	7	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(1954112)	1954112	0.4	968			[#8]=[#6](-[#8])-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#7]1:[#7]:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8])-[#6](=[#8])-[#8]	O=C(O)CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)C(=O)O	RDUWCBAWUHFGHR		parent_pubchem_cid	AKOS005533857;(S)-2-(2-(4-oxobenzo[d][1,2,3]triazin-3(4H)-yl)acetamido)pentanedioic acid;2-[2-(4-OXO-3,4-DIHYDRO-1,2,3-BENZOTRIAZIN-3-YL)ACETAMIDO]PENTANEDIOIC ACID;rac-(2S)-2-[[2-(4-oxo-1,2,3-benzotriazin-3-yl)acetyl]amino]pentanedioic acid		23014374.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23014374		pluskal_iocb_peptide_Peptide01_F2_id		100	F2		ZINC000002340494
3.2		0	1214	P1157613	131.7		X34	False	0	20	0	0	20	0	4	5	0	0		0.0						CC(C)C(C(=O)NC(C(=O)O)c1ccc(O)cc1)n1nnc2ccccc2c1=O																							0.0		EiM07-17618		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C20H20N4O5	C20H20N4O5			InChI=1S/C20H20N4O5/c1-11(2)17(24-19(27)14-5-3-4-6-15(14)22-23-24)18(26)21-16(20(28)29)12-7-9-13(25)10-8-12/h3-11,16-17,25H,1-2H3,(H,21,26)(H,28,29)/t16-,17+/m1/s1	YXKOWEPWQPRTLE-SJORKVTESA-N	rac-(2R)-2-(4-hydroxyphenyl)-2-[[rac-(2S)-3-methyl-2-(4-oxo-1,2,3-benzotriazin-3-yl)butanoyl]amino]acetic acid	8070985	CC(C)[C@@H](C(=O)N[C@@H](C(=O)O)c1ccc(O)cc1)n1nnc2ccccc2c1=O	(2R)-2-(4-hydroxyphenyl)-2-[[(2S)-3-methyl-2-(4-oxo-1,2,3-benzotriazin-3-yl)butanoyl]amino]acetic acid			1.5906499999999997													MCULE-3036994538	396.4062		396.14337	7	3	6	3			44									Quinazoline alkaloids	False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(8070985)	8070985	3.2	969			[#6]-[#6](-[#6])-[#6@@H](-[#6](=[#8])-[#7]-[#6@@H](-[#6](=[#8])-[#8])-[#6]1:[#6]:[#6]:[#6](-[#8]):[#6]:[#6]:1)-[#7]1:[#7]:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8]	CC(C)[C@@H](C(=O)N[C@@H](C(=O)O)c1ccc(O)cc1)n1nnc2ccccc2c1=O	YXKOWEPWQPRTLE		parent_pubchem_cid	EiM07-17618;AKOS005533941;rac-(2R)-2-(4-hydroxyphenyl)-2-[[rac-(2S)-3-methyl-2-(4-oxo-1,2,3-benzotriazin-3-yl)butanoyl]amino]acetic acid		23185594.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23185594		pluskal_iocb_peptide_Peptide01_F2_id		100	F2		ZINC000006758977
2.4		0	1134	P1157638	115.8		X37	False	0	21	0	0	21	0	3	5	0	0		0.0						CC(C)C(C(=O)NC(C(=O)O)c1ccccc1)n1c(=O)[nH]c2ccccc2c1=O																							0.0		EiM07-17672		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	4	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0		C21H21N3O5	C21H21N3O5			InChI=1S/C21H21N3O5/c1-12(2)17(18(25)23-16(20(27)28)13-8-4-3-5-9-13)24-19(26)14-10-6-7-11-15(14)22-21(24)29/h3-12,16-17H,1-2H3,(H,22,29)(H,23,25)(H,27,28)/t16-,17-/m0/s1	ZKFAUKUAPRJQGA-IRXDYDNUSA-N	rac-(2S)-2-phenyl-2-[[rac-(2S)-2-(2,4-dioxo-1H-quinazolin-3-yl)-3-methyl-butanoyl]amino]acetic acid	1789998	CC(C)[C@@H](C(=O)N[C@H](C(=O)O)c1ccccc1)n1c(=O)[nH]c2ccccc2c1=O	(2S)-2-[[(2S)-2-(2,4-dioxo-1H-quinazolin-3-yl)-3-methylbutanoyl]amino]-2-phenylacetic acid			3.1456500000000016													MCULE-2918641678	395.41862		395.148121	5	3	6	3			44										False	Amino acids and Peptides				Peptide01			Compound(1789998)	1789998	2.6	970			[#6]-[#6](-[#6])-[#6@@H](-[#6](=[#8])-[#7]-[#6@H](-[#6](=[#8])-[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]1:[#6](=[#8]):[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8]	CC(C)[C@@H](C(=O)N[C@H](C(=O)O)c1ccccc1)n1c(=O)[nH]c2ccccc2c1=O	ZKFAUKUAPRJQGA		parent_pubchem_cid	EiM07-17672;AKOS016376530;(2S)-2-({(2S)-2-[2,4-dioxo-1,4-dihydro-3(2H)-quinazolinyl]-3-methylbutanoyl}amino)-2-phenylethanoic acid;rac-(2S)-2-phenyl-2-[[rac-(2S)-2-(2,4-dioxo-1H-quinazolin-3-yl)-3-methyl-butanoyl]amino]acetic acid		23023829.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23023829		pluskal_iocb_peptide_Peptide01_F2_id		100	F2		ZINC000002134977
4.0		0	1222	P1006803	123.0		X38	False	0	22	0	0	24	0	6	2	0	1		0.0						CCc1ccccc1-n1nnnc1SCC(=O)NCCc1c[nH]c2c1ccc(OC)c2								3-alkylindoles;Anisoles;Alkylarylthioethers;Alkyl aryl ethers;Substituted pyrroles;Benzene and substituted derivatives;Heteroaromatic compounds;Secondary carboxylic acid amides;Sulfenyl compounds;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	3-alkylindoles;Alkyl aryl ethers;Alkylarylthioethers;Anisoles;Aryl thioethers;Azacyclic compounds;Azoles;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organosulfur compounds;Phenol ethers;Phenyltetrazoles and derivatives;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Sulfenyl compounds;Tetrazoles;Thioethers	Azoles	2.1	This compound belongs to the class of organic compounds known as phenyltetrazoles and derivatives. These are compounds containing a phenyltetrazole skeleton, which consists of a tetrazole bound to a phenyl group.	Phenyltetrazoles and derivatives			Organic compounds	Aromatic heteropolycyclic compounds	indoles (CHEBI:24828);methoxybenzene (CHEBI:51683);aryl sulfide (CHEBI:35683);aromatic ether (CHEBI:35618);pyrroles (CHEBI:26455);benzenes (CHEBI:22712);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organosulfur compound (CHEBI:33261);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);tetrazoles (CHEBI:35689);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);organic sulfide (CHEBI:16385);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);organooxygen compound (CHEBI:36963);ether (CHEBI:25698);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);azole (CHEBI:68452)		Tetrazoles	Phenyltetrazole;3-alkylindole;Indole;Indole or derivatives;Aryl thioether;Anisole;Phenol ether;Alkyl aryl ether;Alkylarylthioether;Monocyclic benzene moiety;Benzenoid;Substituted pyrrole;Heteroaromatic compound;Pyrrole;Carboxamide group;Secondary carboxylic acid amide;Sulfenyl compound;Azacycle;Ether;Carboxylic acid derivative;Thioether;Organic oxygen compound;Organosulfur compound;Organooxygen compound;Organonitrogen compound;Organic nitrogen compound;Hydrocarbon derivative;Carbonyl group;Organic oxide;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		2-[1-(2-ethylphenyl)tetrazol-5-yl]sulfanyl-N-[2-(6-methoxy-1H-indol-3-yl)ethyl]acetamide		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	4	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C22H24N6O2S	C22H24N6O2S			InChI=1S/C22H24N6O2S/c1-3-15-6-4-5-7-20(15)28-22(25-26-27-28)31-14-21(29)23-11-10-16-13-24-19-12-17(30-2)8-9-18(16)19/h4-9,12-13,24H,3,10-11,14H2,1-2H3,(H,23,29)	MAIPVLZKDXVBTB-UHFFFAOYSA-N	2-[1-(2-ethylphenyl)tetrazol-5-yl]sulfanyl-N-[2-(6-methoxy-1H-indol-3-yl)ethyl]acetamide	4971264	CCc1ccccc1-n1nnnc1SCC(=O)NCCc1c[nH]c2c1ccc(OC)c2	2-[1-(2-ethylphenyl)tetrazol-5-yl]sulfanyl-N-[2-(6-methoxy-1H-indol-3-yl)ethyl]acetamide			1.86733													MCULE-9476817688	436.53958		436.168145	6	2	9	4			43									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(4971264)	4971264	4.3	971			[#6]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#7]1:[#7]:[#7]:[#7]:[#6]:1-[#16]-[#6]-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6]):[#6]:2	CCc1ccccc1-n1nnnc1SCC(=O)NCCc1c[nH]c2c1ccc(OC)c2	MAIPVLZKDXVBTB		parent_pubchem_cid	2-[1-(2-ethylphenyl)tetrazol-5-yl]sulfanyl-N-[2-(6-methoxy-1H-indol-3-yl)ethyl]acetamide;879567-37-0;2-{[1-(2-ethylphenyl)-1H-tetraazol-5-yl]sulfanyl}-N-[2-(6-methoxy-1H-indol-3-yl)ethyl]acetamide;STK338225;AKOS002314819;2-{[1-(2-ethylphenyl)-1H-tetrazol-5-yl]sulfanyl}-N-[2-(6-methoxy-1H-indol-3-yl)ethyl]acetamide		2002013.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=2002013		pluskal_iocb_peptide_Peptide01_F2_id		100	F2		ZINC000009044467
1.9		0	1142	P1098939	115.8		X41	False	0	21	0	0	21	0	3	5	0	0		0.0						O=C(CCCn1c(=O)[nH]c2ccccc2c1=O)NC(Cc1ccccc1)C(=O)O																							0.0		AKOS016402505		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	4	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0		C21H21N3O5	C21H21N3O5			InChI=1S/C21H21N3O5/c25-18(22-17(20(27)28)13-14-7-2-1-3-8-14)11-6-12-24-19(26)15-9-4-5-10-16(15)23-21(24)29/h1-5,7-10,17H,6,11-13H2,(H,22,25)(H,23,29)(H,27,28)/t17-/m0/s1	PHLLRDPTOWPVOY-KRWDZBQOSA-N	rac-(2S)-2-[4-(2,4-dioxo-1H-quinazolin-3-yl)butanoylamino]-3-phenyl-propanoic acid	1781580	O=C(CCCn1c(=O)[nH]c2ccccc2c1=O)N[C@@H](Cc1ccccc1)C(=O)O	(2S)-2-[4-(2,4-dioxo-1H-quinazolin-3-yl)butanoylamino]-3-phenylpropanoic acid			2.59875													MCULE-7200839160	395.41862		395.148121	5	3	8	3			44										False	Alkaloids				Peptide01			Compound(1781580)	1781580	1.8	972			[#8]=[#6](-[#6]-[#6]-[#6]-[#7]1:[#6](=[#8]):[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	O=C(CCCn1c(=O)[nH]c2ccccc2c1=O)N[C@@H](Cc1ccccc1)C(=O)O	PHLLRDPTOWPVOY		parent_pubchem_cid	AKOS016402505;AKOS037496542;(S)-2-(4-(2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)butanamido)-3-phenylpropanoic acid;2-[4-(2,4-DIOXO-1,2,3,4-TETRAHYDROQUINAZOLIN-3-YL)BUTANAMIDO]-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[4-(2,4-dioxo-1H-quinazolin-3-yl)butanoylamino]-3-phenyl-propanoic acid		23240175.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23240175		pluskal_iocb_peptide_Peptide01_F2_id		100	F2		ZINC000002126962
-0.6		0	1230	P1441073	129.0		X42	False	0	15	0	0	23	0	5	5	0	0		0.0						C=CCOCC(O)Cn1c(NCC(C)O)nc2c1c(=O)[nH]c(=O)n2C																							0.0		7-(3-(allyloxy)-2-hydroxypropyl)-8-((2-hydroxypropyl)amino)-3-methyl-1H-purine-2,6(3H,7H)-dione		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C15H23N5O5	C15H23N5O5			InChI=1S/C15H23N5O5/c1-4-5-25-8-10(22)7-20-11-12(17-14(20)16-6-9(2)21)19(3)15(24)18-13(11)23/h4,9-10,21-22H,1,5-8H2,2-3H3,(H,16,17)(H,18,23,24)	GRBMYOQTSDGWNQ-UHFFFAOYSA-N	7-(3-allyloxy-2-hydroxy-propyl)-8-(2-hydroxypropylamino)-3-methyl-purine-2,6-dione	18590355	C=CCOCC(O)Cn1c(NCC(C)O)nc2c1c(=O)[nH]c(=O)n2C	7-(2-hydroxy-3-prop-2-enoxypropyl)-8-(2-hydroxypropylamino)-3-methylpurine-2,6-dione			-0.2297499999999992													MCULE-2012442534	353.38106		353.169919	7	4	9	2			45									Purine alkaloids	False	Alkaloids	Pseudoalkaloids			Peptide01			Compound(18590355)	18590355	-0.7	973			[#6]=[#6]-[#6]-[#8]-[#6]-[#6](-[#8])-[#6]-[#7]1:[#6](-[#7]-[#6]-[#6](-[#6])-[#8]):[#7]:[#6]2:[#6]:1:[#6](=[#8]):[#7H]:[#6](=[#8]):[#7]:2-[#6]	C=CCOCC(O)Cn1c(NCC(C)O)nc2c1c(=O)[nH]c(=O)n2C	GRBMYOQTSDGWNQ		parent_pubchem_cid	7-(3-(allyloxy)-2-hydroxypropyl)-8-((2-hydroxypropyl)amino)-3-methyl-1H-purine-2,6(3H,7H)-dione;899357-90-5;7-(2-hydroxy-3-prop-2-enoxypropyl)-8-(2-hydroxypropylamino)-3-methylpurine-2,6-dione;MFCD06751498;AKOS024479752;VU0508217-1;SR-01000024967;SR-01000024967-1;F3064-0064;7-(3-allyloxy-2-hydroxy-propyl)-8-(2-hydroxypropylamino)-3-methyl-purine-2,6-dione		22859687.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22859687		pluskal_iocb_peptide_Peptide01_F2_id		100	F2		
1.3		0	7	P1411223	79.7		Y1	False	0	14	0	0	20	0	2	4	0	0		0.0						CC(C)(C)OC(=O)N(CCC(=O)O)Cc1cnccc1																							0.0		3-{[(tert-butoxy)carbonyl][(pyridin-3-yl)methyl]amino}propanoic acid		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	1	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C14H20N2O4	C14H20N2O4			InChI=1S/C14H20N2O4/c1-14(2,3)20-13(19)16(8-6-12(17)18)10-11-5-4-7-15-9-11/h4-5,7,9H,6,8,10H2,1-3H3,(H,17,18)	TWBURXQKKHZJID-UHFFFAOYSA-N	3-[tert-butoxycarbonyl(3-pyridylmethyl)amino]propanoic acid	39380239	CC(C)(C)OC(=O)N(CCC(=O)O)Cc1cnccc1	3-[(2-methylpropan-2-yl)oxycarbonyl-(pyridin-3-ylmethyl)amino]propanoic acid			2.23869													MCULE-9296098087	280.3265		280.142307	5	1	7	1			44									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(39380239)	39380239	1.0	974			[#6]-[#6](-[#6])(-[#6])-[#8]-[#6](=[#8])-[#7](-[#6]-[#6]-[#6](=[#8])-[#8])-[#6]-[#6]1:[#6]:[#7]:[#6]:[#6]:[#6]:1	CC(C)(C)OC(=O)N(CCC(=O)O)Cc1cnccc1	TWBURXQKKHZJID		parent_pubchem_cid	3-{[(tert-butoxy)carbonyl][(pyridin-3-yl)methyl]amino}propanoic acid;1181656-00-7;MFCD11952934;3-((Tert-butoxycarbonyl)(pyridin-3-ylmethyl)amino)propanoic acid;3-[(2-methylpropan-2-yl)oxycarbonyl-(pyridin-3-ylmethyl)amino]propanoic acid;3-{[(tert-butoxy)carbonyl](pyridin-3-ylmethyl)amino}propanoicacid;AKOS015948368;NS-04599;CS-0346059;EN300-1071893;3-{[(t-Butoxy)carbonyl][(pyridin-3-yl)methyl]amino}propanoic acid;3-[tert-butoxycarbonyl(3-pyridylmethyl)amino]propanoic acid		43068240.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=43068240		pluskal_iocb_peptide_Peptide01_F2_id		100	F2		ZINC000032126577
1.8		0	95	P7210750064	137.7		Y2	False	0	12	0	0	16	0	2	6	0	1		0.0						CC(C)CC(NS(=O)(=O)c1ccccc1[N+](=O)[O-])C(=O)O																							0.0		Oprea1_634060		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	1		C12H16N2O6S	C12H16N2O6S			InChI=1S/C12H16N2O6S/c1-8(2)7-9(12(15)16)13-21(19,20)11-6-4-3-5-10(11)14(17)18/h3-6,8-9,13H,7H2,1-2H3,(H,15,16)	VRHVHBIUCNRUOK-UHFFFAOYSA-N	4-methyl-2-[(2-nitrophenyl)sulfonylamino]pentanoic acid	3140382	CC(C)CC(NS(=O)(=O)c1ccccc1[N+](=O)[O-])C(=O)O	4-methyl-2-[(2-nitrophenyl)sulfonylamino]pentanoic acid			0.8837799999999998													MCULE-6564158856	316.33512		316.072907	6	2	7	1			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(3140382)	3140382	2.0	975		SCHEMBL5625012	[#6]-[#6](-[#6])-[#6]-[#6](-[#7]-[#16](=[#8])(=[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#7+](=[#8])-[#8-])-[#6](=[#8])-[#8]	CC(C)CC(NS(=O)(=O)c1ccccc1[N+](=O)[O-])C(=O)O	VRHVHBIUCNRUOK		parent_pubchem_cid	Oprea1_634060;Oprea1_839968;SCHEMBL5625012;VRHVHBIUCNRUOK-UHFFFAOYSA-N;N-[(2-nitrophenyl)sulfonyl]leucine;AKOS000540430;SR-01000313009;SR-01000313009-1;N-(3'-Methyl-1'-carboxybutyl)-2-nitrobenzenesulfonamide;4-methyl-2-[(2-nitrophenyl)sulfonylamino]pentanoic acid		22945726.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22945726		pluskal_iocb_peptide_Peptide01_F2_id		100	F2		
5.0		0	183	P7020521751	80.2		Y3	False	0	23	0	0	22	0	2	4	0	0		0.0						CCOc1c(OCc2ccccc2)ccc(C=NNc2ccccc2C(=O)O)c1																							0.0		2-{2-[4-(benzyloxy)-3-ethoxybenzylidene]hydrazino}benzoic acid		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C23H22N2O4	C23H22N2O4			InChI=1S/C23H22N2O4/c1-2-28-22-14-18(12-13-21(22)29-16-17-8-4-3-5-9-17)15-24-25-20-11-7-6-10-19(20)23(26)27/h3-15,25H,2,16H2,1H3,(H,26,27)/b24-15+	UIJMRJOLKFHDGW-BUVRLJJBSA-N	2-[(2E)-2-[(4-benzyloxy-3-ethoxy-phenyl)methylene]hydrazino]benzoic acid	22694828	CCOc1c(OCc2ccccc2)ccc(/C=N/Nc2ccccc2C(=O)O)c1	2-[(2E)-2-[(3-ethoxy-4-phenylmethoxyphenyl)methylidene]hydrazinyl]benzoic acid			3.338940000000001														390.44279		390.157957	6	2	9	3			45										False					Peptide01			Compound(22694828)	22694828	5.4	976			[#6]-[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6]:[#6]:[#6](/[#6]=[#7]/[#7]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6](=[#8])-[#8]):[#6]:1	CCOc1c(OCc2ccccc2)ccc(/C=N/Nc2ccccc2C(=O)O)c1	UIJMRJOLKFHDGW		parent_pubchem_cid	2-{2-[4-(benzyloxy)-3-ethoxybenzylidene]hydrazino}benzoic acid;MFCD09057657;AKOS016359333;AS-871/43475931;2-[(2E)-2-[(3-ethoxy-4-phenylmethoxyphenyl)methylidene]hydrazinyl]benzoic acid;2-[(2E)-2-[(4-benzyloxy-3-ethoxy-phenyl)methylene]hydrazino]benzoic acid		22737895.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22737895		pluskal_iocb_peptide_Peptide01_F3_id		100	F3		ZINC000011905631
2.2		0	271	P1045775	66.4		Y4	False	0	13	0	0	17	0	1	3	0	0	-1.0	0.0						CC(C)CC(NC(=O)c1ccccc1)C(=O)O		1.92		0.0	2.35	CHEMBL1205692		N-acyl-alpha amino acids;Hippuric acids;Benzoyl derivatives;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Benzamides;Benzene and substituted derivatives;Benzenoids;Benzoic acids and derivatives;Benzoyl derivatives;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Hippuric acids;Hippuric acids and derivatives;Hydrocarbon derivatives;Leucine and derivatives;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Secondary carboxylic acid amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as leucine and derivatives. These are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Leucine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic homomonocyclic compounds	N-acyl-amino acid (CHEBI:51569);N-acylglycine (CHEBI:16180);carbonyl compound (CHEBI:36586);carboxamide (CHEBI:37622);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);leucine derivative (CHEBI:47003);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);amino acid (CHEBI:33709);peptide (CHEBI:16670);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);benzamides (CHEBI:22702);phenols (CHEBI:33853);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806)		Amino acids, peptides, and analogues	Leucine or derivatives;Hippuric acid or derivatives;Hippuric acid;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;Benzamide;Benzoic acid or derivatives;Benzoyl;Monocyclic benzene moiety;Benzenoid;Secondary carboxylic acid amide;Carboxamide group;Monocarboxylic acid or derivatives;Carboxylic acid;Organic nitrogen compound;Hydrocarbon derivative;Organic oxide;Carbonyl group;Organopnictogen compound;Organic oxygen compound;Organonitrogen compound;Organooxygen compound;Aromatic homomonocyclic compound	Organic acids and derivatives	0.0		Benzoyl-dl-leucine		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C13H17NO3	C13H17NO3			InChI=1S/C13H17NO3/c1-9(2)8-11(13(16)17)14-12(15)10-6-4-3-5-7-10/h3-7,9,11H,8H2,1-2H3,(H,14,15)(H,16,17)	POLGZPYHEPOBFG-UHFFFAOYSA-N	2-benzamido-4-methyl-pentanoic acid	294887	CC(C)CC(NC(=O)c1ccccc1)C(=O)O	2-benzamido-4-methylpentanoic acid			1.86099													MCULE-5774822112	235.28534	ACID	235.120843	3	2	5	1	1.0		29									Dipeptides	False	Amino acids and Peptides	Small peptides	False	False	Peptide01		-1.0	Compound(294887)	294887	2.5	977		SCHEMBL2158906	[#6]-[#6](-[#6])-[#6]-[#6](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	CC(C)CC(NC(=O)c1ccccc1)C(=O)O	POLGZPYHEPOBFG		parent_pubchem_cid	Benzoyl-dl-leucine;17966-67-5;2-benzamido-4-methylpentanoic acid;Bz-DL-Leu-OH;N-Benzoyl-dl-leucine;n-benzoyl-leucine;MFCD00038295;N-Benzoylleucine;Leucine,N-benzoyl-;N-Benzoylleucine #;NSC306113;4-methyl-2-(phenylformamido)pentanoic acid;Oprea1_542312;SCHEMBL2158906;CHEMBL1205692;2-benzamido-4-methyl-valeric acid;DTXSID801315078;NSC164029;AKOS000127089;AKOS016844051;HY-W142019;NSC-164029;NSC-306113;AS-56405;Pentanoic acid, 2-benzoylamino-4-methyl-;B0206;CS-0201805;FT-0752476;D88612;2-benzamido-4-methyl-pentanoic acid	False	638096.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=638096		pluskal_iocb_peptide_Peptide01_F3_id		100	F3	False	
2.3		0	15	P7553292	83.2		Y5	False	0	17	0	0	23	0	3	3	0	0		0.0						CNC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C																							0.0		Tert-butyl N-[2-(1H-indol-3-yl)-1-(methylcarbamoyl)ethyl]carbamate		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	1	0	2	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C17H23N3O3	C17H23N3O3			InChI=1S/C17H23N3O3/c1-17(2,3)23-16(22)20-14(15(21)18-4)9-11-10-19-13-8-6-5-7-12(11)13/h5-8,10,14,19H,9H2,1-4H3,(H,18,21)(H,20,22)	ZRYIVAXOMUWFLO-UHFFFAOYSA-N	tert-butyl N-[1-(1H-indol-3-ylmethyl)-2-(methylamino)-2-oxo-ethyl]carbamate	10781745	CNC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C	tert-butyl N-[3-(1H-indol-3-yl)-1-(methylamino)-1-oxopropan-2-yl]carbamate			1.866569999999999														317.39116		317.173942	3	3	6	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(10781745)	10781745	2.2	978		SCHEMBL14300166	[#6]-[#7]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#6](=[#8])-[#8]-[#6](-[#6])(-[#6])-[#6]	CNC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C	ZRYIVAXOMUWFLO		parent_pubchem_cid	Tert-butyl N-[2-(1H-indol-3-yl)-1-(methylcarbamoyl)ethyl]carbamate;2058424-17-0;tert-Butyl (3-(1H-indol-3-yl)-1-(methylamino)-1-oxopropan-2-yl)carbamate;starbld0029093;SCHEMBL14300166;MFCD24394780;tert-butylN-[2-(1H-indol-3-yl)-1-(methylcarbamoyl)ethyl]carbamate;AKOS025142360;NS-05330;tert-butyl N-[3-(1H-indol-3-yl)-1-(methylamino)-1-oxopropan-2-yl]carbamate;tert-butyl N-[1-(1H-indol-3-ylmethyl)-2-(methylamino)-2-oxo-ethyl]carbamate		26124187.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=26124187		pluskal_iocb_peptide_Peptide01_F3_id		100	F3		
2.5		0	103	P1031521	134.4		Y6	False	0	16	0	0	26	0	8	1	0	1		0.0						CCNc1nc2nnc(SCC(=O)NC3CCCCC3)n2c(NCC)n1																							0.0		Oprea1_364859		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	3	0	0	1	0	0	0	0	0	0	0	0	0	1	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	0	0	0	0	0	0	1		C16H26N8OS	C16H26N8OS			InChI=1S/C16H26N8OS/c1-3-17-13-20-14(18-4-2)24-15(21-13)22-23-16(24)26-10-12(25)19-11-8-6-5-7-9-11/h11H,3-10H2,1-2H3,(H,19,25)(H2,17,18,20,21,22)	WFSNAHOKUTXXPH-UHFFFAOYSA-N	2-[[5,7-bis(ethylamino)-[1,2,4]triazolo[4,3-a][1,3,5]triazin-3-yl]sulfanyl]-N-cyclohexyl-acetamide	4174225	CCNc1nc2nnc(SCC(=O)NC3CCCCC3)n2c(NCC)n1	2-[[5,7-bis(ethylamino)-[1,2,4]triazolo[4,3-a][1,3,5]triazin-3-yl]sulfanyl]-N-cyclohexylacetamide			0.8404599999999998													MCULE-5940637041	378.50262		378.195028	8	3	8	3			44										False	Alkaloids				Peptide01			Compound(4174225)	4174225	3.7	979			[#6]-[#6]-[#7]-[#6]1:[#7]:[#6]2:[#7]:[#7]:[#6](-[#16]-[#6]-[#6](=[#8])-[#7]-[#6]3-[#6]-[#6]-[#6]-[#6]-[#6]-3):[#7]:2:[#6](-[#7]-[#6]-[#6]):[#7]:1	CCNc1nc2nnc(SCC(=O)NC3CCCCC3)n2c(NCC)n1	WFSNAHOKUTXXPH		parent_pubchem_cid	Oprea1_364859;AKOS016380149;SR-01000010915;SR-01000010915-1;2-[[5,7-bis(ethylamino)-[1,2,4]triazolo[4,3-a][1,3,5]triazin-3-yl]sulfanyl]-N-cyclohexyl-acetamide		18194073.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=18194073		pluskal_iocb_peptide_Peptide01_F3_id		100	F3		ZINC000006758011
3.4		0	191	P7020720040	123.2		Y7	False	0	27	0	0	21	0	3	6	0	0		0.0						COC(=O)c1cc(NC(=O)c2c(-c3ccccc3)c(-c3ccccc3)n[nH]c2=O)c(C(=O)OC)cc1																							0.0		HMS3451O17		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C27H21N3O6	C27H21N3O6			InChI=1S/C27H21N3O6/c1-35-26(33)18-13-14-19(27(34)36-2)20(15-18)28-24(31)22-21(16-9-5-3-6-10-16)23(29-30-25(22)32)17-11-7-4-8-12-17/h3-15H,1-2H3,(H,28,31)(H,30,32)	ZIQSINITDREYRB-UHFFFAOYSA-N	dimethyl 2-[(6-oxo-3,4-diphenyl-1H-pyridazine-5-carbonyl)amino]benzene-1,4-dicarboxylate	16957830	COC(=O)c1cc(NC(=O)c2c(-c3ccccc3)c(-c3ccccc3)n[nH]c2=O)c(C(=O)OC)cc1	dimethyl 2-[(6-oxo-3,4-diphenyl-1H-pyridazine-5-carbonyl)amino]benzene-1,4-dicarboxylate			3.524510000000001													MCULE-1380234708	483.48492		483.143035	7	2	8	4			44									Anthranillic acid derivatives	False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(16957830)	16957830	4.2	980			[#6]-[#8]-[#6](=[#8])-[#6]1:[#6]:[#6](-[#7]-[#6](=[#8])-[#6]2:[#6](-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#6](-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#7]:[#7H]:[#6]:2=[#8]):[#6](-[#6](=[#8])-[#8]-[#6]):[#6]:[#6]:1	COC(=O)c1cc(NC(=O)c2c(-c3ccccc3)c(-c3ccccc3)n[nH]c2=O)c(C(=O)OC)cc1	ZIQSINITDREYRB		parent_pubchem_cid	HMS3451O17;AKOS001522334;F3308-1346;dimethyl 2-(3-oxo-5,6-diphenyl-2,3-dihydropyridazine-4-carboxamido)terephthalate;1,4-DIMETHYL 2-(3-OXO-5,6-DIPHENYL-2,3-DIHYDROPYRIDAZINE-4-AMIDO)BENZENE-1,4-DICARBOXYLATE;dimethyl 2-[(6-oxo-3,4-diphenyl-1H-pyridazine-5-carbonyl)amino]benzene-1,4-dicarboxylate		22996207.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22996207		pluskal_iocb_peptide_Peptide01_F3_id		100	F3		ZINC000008844298
3.9		0	279	P4792489	120.0		Y8	False	0	28	0	0	24	0	2	7	0	0		0.0						CC(=O)c1c(Nc2ccc(Oc3ccc(Nc4c(C(C)=O)c(=O)cc(C)o4)cc3)cc2)oc(C)cc1=O																							0.0		AKOS016354121		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0		C28H24N2O7	C28H24N2O7			InChI=1S/C28H24N2O7/c1-15-13-23(33)25(17(3)31)27(35-15)29-19-5-9-21(10-6-19)37-22-11-7-20(8-12-22)30-28-26(18(4)32)24(34)14-16(2)36-28/h5-14,29-30H,1-4H3	WZHVVLGHWKDQQM-UHFFFAOYSA-N	3-acetyl-2-[4-[4-[(3-acetyl-6-methyl-4-oxo-pyran-2-yl)amino]phenoxy]anilino]-6-methyl-pyran-4-one	4149429	CC(=O)c1c(Nc2ccc(Oc3ccc(Nc4c(C(C)=O)c(=O)cc(C)o4)cc3)cc2)oc(C)cc1=O	3-acetyl-2-[4-[4-[(3-acetyl-6-methyl-4-oxopyran-2-yl)amino]phenoxy]anilino]-6-methylpyran-4-one			5.028220000000005													MCULE-8577964130	500.51268		500.158351	9	2	8	4			44										False	Polyketides				Peptide01			Compound(4149429)	4149429	5.0	981			[#6]-[#6](=[#8])-[#6]1:[#6](-[#7]-[#6]2:[#6]:[#6]:[#6](-[#8]-[#6]3:[#6]:[#6]:[#6](-[#7]-[#6]4:[#6](-[#6](-[#6])=[#8]):[#6](=[#8]):[#6]:[#6](-[#6]):[#8]:4):[#6]:[#6]:3):[#6]:[#6]:2):[#8]:[#6](-[#6]):[#6]:[#6]:1=[#8]	CC(=O)c1c(Nc2ccc(Oc3ccc(Nc4c(C(C)=O)c(=O)cc(C)o4)cc3)cc2)oc(C)cc1=O	WZHVVLGHWKDQQM		parent_pubchem_cid	AKOS016354121;3-ACETYL-2-(4-{4-[(3-ACETYL-6-METHYL-4-OXO-4H-PYRAN-2-YL)AMINO]PHENOXY}ANILINO)-6-METHYL-4H-PYRAN-4-ONE;3-acetyl-2-[4-[4-[(3-acetyl-6-methyl-4-oxo-pyran-2-yl)amino]phenoxy]anilino]-6-methyl-pyran-4-one		10608321.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=10608321		pluskal_iocb_peptide_Peptide01_F3_id		100	F3		ZINC000015304102
4.5		0	23	P7119250118	107.6		Y9	False	0	21	0	0	24	0	2	4	0	1		0.0						Cc1cc(C)c(C)c(S(=O)(=O)NC(Cc2c[nH]c3ccccc23)C(=O)O)c1C								Alpha amino acids and derivatives;3-alkylindoles;Benzenesulfonyl compounds;Substituted pyrroles;Organosulfonamides;Heteroaromatic compounds;Aminosulfonyl compounds;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	3-alkylindoles;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Aminosulfonyl compounds;Azacyclic compounds;Benzene and substituted derivatives;Benzenesulfonamides;Benzenesulfonyl compounds;Benzenoids;Carbonyl compounds;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organic sulfonic acids and derivatives;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Organosulfonamides;Organosulfonic acids and derivatives;Organosulfur compounds;Pyrroles;Substituted pyrroles;Sulfonyls	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring.	Benzenesulfonamides			Organic compounds	Aromatic heteropolycyclic compounds	organonitrogen compound (CHEBI:35352);organooxygen compound (CHEBI:36963);indoles (CHEBI:24828);benzenes (CHEBI:22712);organosulfur compound (CHEBI:33261);pyrroles (CHEBI:26455);sulfonamide (CHEBI:35358);organic aromatic compound (CHEBI:33659);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);organonitrogen heterocyclic compound (CHEBI:38101);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);sulfonic acid derivative (CHEBI:33552);organic molecular entity (CHEBI:50860);sulfone (CHEBI:35850);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806);carboxylic acid anion (CHEBI:29067);amino acid (CHEBI:33709);peptide (CHEBI:16670)		Benzenesulfonamides	Alpha-amino acid or derivatives;Benzenesulfonamide;3-alkylindole;Indole;Benzenesulfonyl group;Indole or derivatives;Substituted pyrrole;Organosulfonic acid amide;Pyrrole;Heteroaromatic compound;Organic sulfonic acid or derivatives;Organosulfonic acid or derivatives;Sulfonyl;Aminosulfonyl compound;Monocarboxylic acid or derivatives;Azacycle;Carboxylic acid derivative;Carboxylic acid;Organoheterocyclic compound;Organic nitrogen compound;Organosulfur compound;Organooxygen compound;Organonitrogen compound;Hydrocarbon derivative;Organic oxide;Organic oxygen compound;Carbonyl group;Aromatic heteropolycyclic compound	Benzenoids	0.0		N-[(2,3,5,6-tetramethylphenyl)sulfonyl]tryptophan		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0		C21H24N2O4S	C21H24N2O4S			InChI=1S/C21H24N2O4S/c1-12-9-13(2)15(4)20(14(12)3)28(26,27)23-19(21(24)25)10-16-11-22-18-8-6-5-7-17(16)18/h5-9,11,19,22-23H,10H2,1-4H3,(H,24,25)	XKRPVXCCINRLOM-UHFFFAOYSA-N	3-(1H-indol-3-yl)-2-[(2,3,5,6-tetramethylphenyl)sulfonylamino]propanoic acid	5188340	Cc1cc(C)c(C)c(S(=O)(=O)NC(Cc2c[nH]c3ccccc23)C(=O)O)c1C	3-(1H-indol-3-yl)-2-[(2,3,5,6-tetramethylphenyl)sulfonylamino]propanoic acid			2.5658000000000003													MCULE-6314832005	400.50043		400.145678	4	3	6	3			44										False					Peptide01			Compound(5188340)	5188340	3.4	982			[#6]-[#6]1:[#6]:[#6](-[#6]):[#6](-[#6]):[#6](-[#16](=[#8])(=[#8])-[#7]-[#6](-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6](=[#8])-[#8]):[#6]:1-[#6]	Cc1cc(C)c(C)c(S(=O)(=O)NC(Cc2c[nH]c3ccccc23)C(=O)O)c1C	XKRPVXCCINRLOM		parent_pubchem_cid	N-[(2,3,5,6-tetramethylphenyl)sulfonyl]tryptophan;3-(1H-indol-3-yl)-2-[(2,3,5,6-tetramethylphenyl)sulfonylamino]propanoic Acid;MFCD05148196;STK982099;AKOS002376788;AQ-390/42486766		23705775.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23705775		pluskal_iocb_peptide_Peptide01_F3_id		100	F3		
3.1		0	111	P0120630230	82.2		Y10	False	0	18	0	1	15	0	2	3	0	0	-1.0	0.0						O=C(NC(Cc1c[nH]c2ccccc12)C(=O)O)c1ccc(F)cc1		2.73		0.0	2.99	CHEMBL1714211		N-acyl-alpha amino acids;Indolyl carboxylic acids and derivatives;3-alkylindoles;4-halobenzoic acids and derivatives;Benzoyl derivatives;Fluorobenzenes;Substituted pyrroles;Aryl fluorides;Heteroaromatic compounds;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Azacyclic compounds;Carboxylic acids;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organofluorides;Organonitrogen compounds	3-alkylindoles;4-halobenzoic acids and derivatives;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Aryl fluorides;Aryl halides;Azacyclic compounds;Benzamides;Benzene and substituted derivatives;Benzenoids;Benzoic acids and derivatives;Benzoyl derivatives;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Fluorobenzenes;Halobenzenes;Halobenzoic acids and derivatives;Heteroaromatic compounds;Hippuric acids;Hippuric acids and derivatives;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Indolyl carboxylic acids and derivatives;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organofluorides;Organohalogen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as hippuric acids. These are compounds containing hippuric acid, which consists of a of a benzoyl group linked to the N-terminal of a glycine.	Hippuric acids		Benzamides;Hippuric acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-amino acid (CHEBI:51569);indolyl carboxylic acid (CHEBI:46867);indoles (CHEBI:24828);carbonyl compound (CHEBI:36586);organohalogen compound (CHEBI:36684);organofluorine compound (CHEBI:37143);pyrroles (CHEBI:26455);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);monocarboxylic acid (CHEBI:25384);organonitrogen heterocyclic compound (CHEBI:38101);carboxylic acid (CHEBI:33575);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);N-acylglycine (CHEBI:16180);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);benzoic acids (CHEBI:22723);haloarene (CHEBI:50887);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143);benzamides (CHEBI:22702);carboxylic acid anion (CHEBI:29067);amino acid (CHEBI:33709);peptide (CHEBI:16670);phenols (CHEBI:33853)		Benzoic acids and derivatives	Hippuric acid;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;Indolyl carboxylic acid derivative;Alpha-amino acid or derivatives;4-halobenzoic acid or derivatives;Halobenzoic acid or derivatives;3-alkylindole;Indole;Indole or derivatives;Benzoyl;Fluorobenzene;Halobenzene;Aryl fluoride;Substituted pyrrole;Aryl halide;Heteroaromatic compound;Pyrrole;Secondary carboxylic acid amide;Carboxamide group;Carboxylic acid;Carboxylic acid derivative;Azacycle;Organoheterocyclic compound;Monocarboxylic acid or derivatives;Organic oxygen compound;Hydrocarbon derivative;Organohalogen compound;Organic nitrogen compound;Organofluoride;Organonitrogen compound;Carbonyl group;Organooxygen compound;Organic oxide;Aromatic heteropolycyclic compound	Benzenoids	0.0		2-[(4-fluorobenzoyl)amino]-3-(1H-indol-3-yl)propanoic acid	DTXSID00389367	2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C18H15FN2O3	C18H15FN2O3			InChI=1S/C18H15FN2O3/c19-13-7-5-11(6-8-13)17(22)21-16(18(23)24)9-12-10-20-15-4-2-1-3-14(12)15/h1-8,10,16,20H,9H2,(H,21,22)(H,23,24)	IQPJLNVWVQKWMI-UHFFFAOYSA-N	2-[(4-fluorobenzoyl)amino]-3-(1H-indol-3-yl)propanoic acid	3111844	O=C(NC(Cc1c[nH]c2ccccc12)C(=O)O)c1ccc(F)cc1	2-[(4-fluorobenzoyl)amino]-3-(1H-indol-3-yl)propanoic acid			2.1948600000000003													MCULE-8989217778	326.33025	ACID	326.106671	3	3	5	3	0.0		27									Dipeptides	False	Amino acids and Peptides	Small peptides	False	False	Peptide01		-1.0	Compound(3111844)	3111844	2.3	983		SCHEMBL23092632	[#8]=[#6](-[#7]-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8])-[#6]1:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:1	O=C(NC(Cc1c[nH]c2ccccc12)C(=O)O)c1ccc(F)cc1	IQPJLNVWVQKWMI		parent_pubchem_cid	2-[(4-fluorobenzoyl)amino]-3-(1H-indol-3-yl)propanoic acid;39545-02-3;1397321-16-2;(4-fluorobenzoyl)tryptophan;2-(4-fluorobenzamido)-3-(1H-indol-3-yl)propanoic acid;2-[(4-fluorophenyl)formamido]-3-(1H-indol-3-yl)propanoic acid;Oprea1_358520;MLS000716679;N-(4-Fluorobenzoyl)tryptophan;CHEMBL1714211;SCHEMBL23092632;DTXSID00389367;HMS2661N10;AKOS001596573;AKOS016401694;SMR000278196;CS-0270261;EN300-16892;AB00581341-02;SR-01000079087;SR-01000079087-1;Z85881727;F3096-1357	False	1064152.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=1064152		pluskal_iocb_peptide_Peptide01_F3_id		100	F3	False	
4.5		0	199	P1113318	83.1		Y11	False	0	25	0	0	23	0	3	1	0	1		0.0						O=C(CC(c1ccccc1)c1ccccc1)NCCc1csc(-c2ccccn2)n1								2,4-disubstituted thiazoles;Pyridines and derivatives;Fatty amides;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	2,4-disubstituted thiazoles;Azacyclic compounds;Azoles;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Diphenylmethanes;Fatty Acyls;Fatty amides;Heteroaromatic compounds;Hydrocarbon derivatives;Lipids and lipid-like molecules;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Pyridines and derivatives;Secondary carboxylic acid amides;Thiazoles	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as diphenylmethanes. These are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups.	Diphenylmethanes			Organic compounds	Aromatic heteromonocyclic compounds	thiazoles (CHEBI:48901);pyridines (CHEBI:26421);fatty amide (CHEBI:29348);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);diarylmethane (CHEBI:51614);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);azole (CHEBI:68452);lipid (CHEBI:18059);organooxygen compound (CHEBI:36963);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712)	Fatty amides (FA08);Fatty Acyls (FA)	Diphenylmethanes	Diphenylmethane;2,4-disubstituted 1,3-thiazole;Fatty amide;Fatty acyl;Pyridine;Azole;Heteroaromatic compound;Thiazole;Carboxamide group;Secondary carboxylic acid amide;Carboxylic acid derivative;Azacycle;Organoheterocyclic compound;Hydrocarbon derivative;Organic nitrogen compound;Organic oxide;Carbonyl group;Organonitrogen compound;Organooxygen compound;Organic oxygen compound;Aromatic heteromonocyclic compound	Benzenoids	0.0		AKOS005578598		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C25H23N3OS	C25H23N3OS			InChI=1S/C25H23N3OS/c29-24(17-22(19-9-3-1-4-10-19)20-11-5-2-6-12-20)27-16-14-21-18-30-25(28-21)23-13-7-8-15-26-23/h1-13,15,18,22H,14,16-17H2,(H,27,29)	CXUOSPQDJLBZKW-UHFFFAOYSA-N	3,3-diphenyl-N-[2-[2-(2-pyridyl)thiazol-4-yl]ethyl]propanamide	28466356	O=C(CC(c1ccccc1)c1ccccc1)NCCc1csc(-c2ccccn2)n1	3,3-diphenyl-N-[2-(2-pyridin-2-yl-1,3-thiazol-4-yl)ethyl]propanamide			4.541850000000004													MCULE-3017614561	413.54556		413.156183	3	1	8	4			44									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(28466356)	28466356	4.5	984			[#8]=[#6](-[#6]-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6]-[#6]-[#6]1:[#6]:[#16]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#7]:2):[#7]:1	O=C(CC(c1ccccc1)c1ccccc1)NCCc1csc(-c2ccccn2)n1	CXUOSPQDJLBZKW		parent_pubchem_cid	AKOS005578598;3,3-diphenyl-N-(2-(2-(pyridin-2-yl)thiazol-4-yl)ethyl)propanamide;3,3-diphenyl-N-[2-[2-(2-pyridyl)thiazol-4-yl]ethyl]propanamide		3687984.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=3687984		pluskal_iocb_peptide_Peptide01_F4_id		100	F4		ZINC000019942284
2.2		0	287	P7126283	144.7		Y12	False	0	18	0	1	13	0	4	5	0	0		0.0						O=C(O)c1ccc(Nc2nc(Nc3cc(C(=O)O)c(O)cc3)ncc2F)cc1																							0.0		AKOS024459052		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	2	2	0	0	0	0	0	0	0	0	0	0	1	0	0	0	3	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0		C18H13FN4O5	C18H13FN4O5			InChI=1S/C18H13FN4O5/c19-13-8-20-18(22-11-5-6-14(24)12(7-11)17(27)28)23-15(13)21-10-3-1-9(2-4-10)16(25)26/h1-8,24H,(H,25,26)(H,27,28)(H2,20,21,22,23)	PHIFHAMNDTVZOH-UHFFFAOYSA-N	5-[[4-(4-carboxyanilino)-5-fluoro-pyrimidin-2-yl]amino]-2-hydroxy-benzoic acid	90489143	O=C(O)c1ccc(Nc2nc(Nc3cc(C(=O)O)c(O)cc3)ncc2F)cc1	5-[[4-(4-carboxyanilino)-5-fluoropyrimidin-2-yl]amino]-2-hydroxybenzoic acid			1.1106299999999998													MCULE-7211046989	384.32651		384.086998	9	5	6	3			44										False	Alkaloids				Peptide01			Compound(90489143)	90489143	3.3	985			[#8]=[#6](-[#8])-[#6]1:[#6]:[#6]:[#6](-[#7]-[#6]2:[#7]:[#6](-[#7]-[#6]3:[#6]:[#6](-[#6](=[#8])-[#8]):[#6](-[#8]):[#6]:[#6]:3):[#7]:[#6]:[#6]:2-[#9]):[#6]:[#6]:1	O=C(O)c1ccc(Nc2nc(Nc3cc(C(=O)O)c(O)cc3)ncc2F)cc1	PHIFHAMNDTVZOH		parent_pubchem_cid	AKOS024459052;5-[[4-(4-carboxyanilino)-5-fluoro-pyrimidin-2-yl]amino]-2-hydroxy-benzoic acid		99993864.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=99993864		pluskal_iocb_peptide_Peptide01_F4_id		100	F4		ZINC000170621832
4.7		0	31	P7216660597	109.3		Y13	False	0	22	0	3	19	0	4	2	0	1		0.0						CC(=O)Nc1cc(NC(=O)C(C)Sc2nc(-c3ccccc3)cc(C(F)(F)F)n2)ccc1																							0.0		AKOS000557071		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C22H19F3N4O2S	C22H19F3N4O2S			InChI=1S/C22H19F3N4O2S/c1-13(20(31)27-17-10-6-9-16(11-17)26-14(2)30)32-21-28-18(15-7-4-3-5-8-15)12-19(29-21)22(23,24)25/h3-13H,1-2H3,(H,26,30)(H,27,31)	FTXPGPZFXVRDGY-UHFFFAOYSA-N	N-(3-acetamidophenyl)-2-[4-phenyl-6-(trifluoromethyl)pyrimidin-2-yl]sulfanyl-propanamide	3145686	CC(=O)Nc1cc(NC(=O)C(C)Sc2nc(-c3ccccc3)cc(C(F)(F)F)n2)ccc1	N-(3-acetamidophenyl)-2-[4-phenyl-6-(trifluoromethyl)pyrimidin-2-yl]sulfanylpropanamide			3.936140000000002													MCULE-4477827657	460.48153		460.118082	5	2	7	3			45										False	Alkaloids				Peptide01			Compound(3145686)	3145686	4.1	986			[#6]-[#6](=[#8])-[#7]-[#6]1:[#6]:[#6](-[#7]-[#6](=[#8])-[#6](-[#6])-[#16]-[#6]2:[#7]:[#6](-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#6]:[#6](-[#6](-[#9])(-[#9])-[#9]):[#7]:2):[#6]:[#6]:[#6]:1	CC(=O)Nc1cc(NC(=O)C(C)Sc2nc(-c3ccccc3)cc(C(F)(F)F)n2)ccc1	FTXPGPZFXVRDGY		parent_pubchem_cid	AKOS000557071;AKOS016374857;N-(3-acetamidophenyl)-2-[4-phenyl-6-(trifluoromethyl)pyrimidin-2-yl]sulfanyl-propanamide		23227773.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23227773		pluskal_iocb_peptide_Peptide01_F4_id		100	F4		
2.2		0	119	P1557114	75.6	HCl	Y14	False	0	19	0	0	26	0	6	2	0	0		0.0						Cc1cc(C)cc(Nc2nc(N3CCOCC3)nc(N3CCOCC3)n2)c1																							0.0		AKOS022128114		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	2		C19H27ClN6O2	C19H26N6O2			InChI=1S/C19H26N6O2/c1-14-11-15(2)13-16(12-14)20-17-21-18(24-3-7-26-8-4-24)23-19(22-17)25-5-9-27-10-6-25/h11-13H,3-10H2,1-2H3,(H,20,21,22,23)	JBRSLXXJHYNRJF-UHFFFAOYSA-N	N-(3,5-dimethylphenyl)-4,6-dimorpholino-1,3,5-triazin-2-amine;hydrochloride	7192035	Cc1cc(C)cc(Nc2nc(N3CCOCC3)nc(N3CCOCC3)n2)c1	N-(3,5-dimethylphenyl)-4,6-dimorpholin-4-yl-1,3,5-triazin-2-amine			0.273380000000001													MCULE-3610582315	406.91904		370.211724	8	1	4	4			43										False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(7192035)	7192035	2.7	987			[#6]-[#6]1:[#6]:[#6](-[#6]):[#6]:[#6](-[#7]-[#6]2:[#7]:[#6](-[#7]3-[#6]-[#6]-[#8]-[#6]-[#6]-3):[#7]:[#6](-[#7]3-[#6]-[#6]-[#8]-[#6]-[#6]-3):[#7]:2):[#6]:1	Cc1cc(C)cc(Nc2nc(N3CCOCC3)nc(N3CCOCC3)n2)c1	JBRSLXXJHYNRJF		parent_pubchem_cid	"AKOS022128114;""N-(3,5-dimethylphenyl)-4,6-dimorpholino-1,3,5-triazin-2-amine;hydrochloride"""		8996868.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=8996868		pluskal_iocb_peptide_Peptide01_F4_id		100	F4		ZINC000004329672
2.4		0	207	P7020531614	141.1		Y15	False	0	18	0	0	20	0	2	4	0	3		0.0						O=S1(=O)CC(NCCc2c[nH]c3ccccc23)C(S(=O)(=O)c2cccs2)C1																							0.0		MFCD10088988		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	0		C18H20N2O4S3	C18H20N2O4S3			InChI=1S/C18H20N2O4S3/c21-26(22)11-16(17(12-26)27(23,24)18-6-3-9-25-18)19-8-7-13-10-20-15-5-2-1-4-14(13)15/h1-6,9-10,16-17,19-20H,7-8,11-12H2/t16-,17-/m0/s1	XJYDYODGOSSMPJ-IRXDYDNUSA-N	rac-(3S,4R)-N-[2-(1H-indol-3-yl)ethyl]-1,1-dioxo-4-(2-thienylsulfonyl)thiolan-3-amine	20996475	O=S1(=O)C[C@H](NCCc2c[nH]c3ccccc23)[C@@H](S(=O)(=O)c2cccs2)C1	(3S,4R)-N-[2-(1H-indol-3-yl)ethyl]-1,1-dioxo-4-thiophen-2-ylsulfonylthiolan-3-amine			1.40986													MCULE-6207157066	424.5631		424.05852	5	2	6	4			44										False					Peptide01			Compound(20996475)	20996475	2.7	988			[#8]=[#16]1(=[#8])-[#6]-[#6@H](-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6@@H](-[#16](=[#8])(=[#8])-[#6]2:[#6]:[#6]:[#6]:[#16]:2)-[#6]-1	O=S1(=O)C[C@H](NCCc2c[nH]c3ccccc23)[C@@H](S(=O)(=O)c2cccs2)C1	XJYDYODGOSSMPJ		parent_pubchem_cid	MFCD10088988;AKOS001562819;CCG-156642;(3S4R)-3-{[2-(1H-INDOL-3-YL)ETHYL]AMINO}-4-(THIOPHENE-2-SULFONYL)-1LAMBDA6-THIOLANE-11-DIONE;rac-(3S,4R)-N-[2-(1H-indol-3-yl)ethyl]-1,1-dioxo-4-(2-thienylsulfonyl)thiolan-3-amine		20763466.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=20763466		pluskal_iocb_peptide_Peptide01_F4_id		100	F4		ZINC000019796851
2.2		0	295	P7126254	124.4		Y16	False	0	18	0	0	14	0	4	4	0	0	-1.0	0.0						O=C(O)c1cc(Nc2nccc(Nc3ccccc3C(=O)O)n2)ccc1		3.36		0.0	3.31	CHEMBL2170421		Benzoic acids;Benzoyl derivatives;Aniline and substituted anilines;Aminopyrimidines and derivatives;Imidolactams;Vinylogous amides;Heteroaromatic compounds;Amino acids;Secondary amines;Carboxylic acids;Azacyclic compounds;Organooxygen compounds;Organic oxides;Hydrocarbon derivatives	Amines;Amino acids;Amino acids and derivatives;Amino acids, peptides, and analogues;Aminobenzoic acids;Aminobenzoic acids and derivatives;Aminopyrimidines and derivatives;Aniline and substituted anilines;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Benzoic acids;Benzoic acids and derivatives;Benzoyl derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Diazines;Dicarboxylic acids and derivatives;Heteroaromatic compounds;Hydrocarbon derivatives;Imidolactams;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Pyrimidines and pyrimidine derivatives;Secondary amines;Vinylogous amides	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as aminobenzoic acids. These are benzoic acids containing an amine group attached to the benzene moiety.	Aminobenzoic acids		Aminobenzoic acids and derivatives	Organic compounds	Aromatic heteromonocyclic compounds	benzoic acids (CHEBI:22723);carbonyl compound (CHEBI:36586);anilines (CHEBI:22562);aminopyrimidine (CHEBI:38338);heterocyclic compound (CHEBI:5686);dicarboximide (CHEBI:35356);organosulfur compound (CHEBI:33261);enone (CHEBI:51689);enamine (CHEBI:47989);organic aromatic compound (CHEBI:33659);amino acid (CHEBI:33709);secondary amine (CHEBI:32863);carboxylic acid (CHEBI:33575);organonitrogen heterocyclic compound (CHEBI:38101);organooxygen compound (CHEBI:36963);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);aminobenzoic acid (CHEBI:22495);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);organic heterocyclic compound (CHEBI:24532);diazines (CHEBI:38313);pyrimidines (CHEBI:39447);organic acid (CHEBI:64709);organonitrogen compound (CHEBI:35352);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);amine (CHEBI:32952);oxygen molecular entity (CHEBI:25806);carboxylic acid anion (CHEBI:29067);peptide (CHEBI:16670)		Benzoic acids and derivatives	Aminobenzoic acid;Benzoic acid;Benzoyl;Aniline or substituted anilines;Aminopyrimidine;Pyrimidine;Imidolactam;Heteroaromatic compound;Vinylogous amide;Amino acid or derivatives;Amino acid;Secondary amine;Carboxylic acid;Carboxylic acid derivative;Organoheterocyclic compound;Azacycle;Amine;Hydrocarbon derivative;Organooxygen compound;Organonitrogen compound;Organic oxide;Organic oxygen compound;Organic nitrogen compound;Aromatic heteromonocyclic compound	Benzenoids	0.0		Bisanilinopyrimidine, 3q		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	2	2	0	0	0	0	0	0	0	0	0	0	1	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0		C18H14N4O4	C18H14N4O4			InChI=1S/C18H14N4O4/c23-16(24)11-4-3-5-12(10-11)20-18-19-9-8-15(22-18)21-14-7-2-1-6-13(14)17(25)26/h1-10H,(H,23,24)(H,25,26)(H2,19,20,21,22)	CAOQBIMLYDDYEQ-UHFFFAOYSA-N	2-[[2-(3-carboxyanilino)pyrimidin-4-yl]amino]benzoic acid	4663984	O=C(O)c1cc(Nc2nccc(Nc3ccccc3C(=O)O)n2)ccc1	2-[[2-(3-carboxyanilino)pyrimidin-4-yl]amino]benzoic acid			1.72834													MCULE-9122888933	350.33668	ACID	350.101505	8	4	6	3	0.0		29									Anthranillic acid derivatives	False	Alkaloids	Anthranilic acid alkaloids	False	False	Peptide01		-1.0	Compound(4663984)	4663984	3.6	989			[#8]=[#6](-[#8])-[#6]1:[#6]:[#6](-[#7]-[#6]2:[#7]:[#6]:[#6]:[#6](-[#7]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3-[#6](=[#8])-[#8]):[#7]:2):[#6]:[#6]:[#6]:1	O=C(O)c1cc(Nc2nccc(Nc3ccccc3C(=O)O)n2)ccc1	CAOQBIMLYDDYEQ		parent_pubchem_cid	Bisanilinopyrimidine, 3q;Oprea1_696269;CHEMBL2170421;BDBM92802;MFCD01795396;AKOS003631236;SR-01000026929;SR-01000026929-1;Z56772944;2-[[2-(3-carboxyanilino)pyrimidin-4-yl]amino]benzoic acid	False	31981035.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=31981035		pluskal_iocb_peptide_Peptide01_F4_id		100	F4	False	ZINC000005446802
3.3		0	39	P7020532136	112.9		Y17	False	0	20	1	0	21	0	2	4	0	2		0.0						O=S1(=O)CC(NCCc2c[nH]c3ccccc23)C(S(=O)(=O)c2ccc(Cl)cc2)C1																							0.0		HMS3463B20		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	0		C20H21ClN2O4S2	C20H21ClN2O4S2			InChI=1S/C20H21ClN2O4S2/c21-15-5-7-16(8-6-15)29(26,27)20-13-28(24,25)12-19(20)22-10-9-14-11-23-18-4-2-1-3-17(14)18/h1-8,11,19-20,22-23H,9-10,12-13H2/t19-,20-/m0/s1	QLCXZOBMCHHCII-PMACEKPBSA-N	rac-(3S,4R)-4-(4-chlorophenyl)sulfonyl-N-[2-(1H-indol-3-yl)ethyl]-1,1-dioxo-thiolan-3-amine	20996497	O=S1(=O)C[C@H](NCCc2c[nH]c3ccccc23)[C@@H](S(=O)(=O)c2ccc(Cl)cc2)C1	(3S,4R)-4-(4-chlorophenyl)sulfonyl-N-[2-(1H-indol-3-yl)ethyl]-1,1-dioxothiolan-3-amine			2.0017600000000004													MCULE-6727822389	452.98237		452.063127	5	2	6	4			44										False	Alkaloids				Peptide01			Compound(20996497)	20996497	3.3	990			[#8]=[#16]1(=[#8])-[#6]-[#6@H](-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6@@H](-[#16](=[#8])(=[#8])-[#6]2:[#6]:[#6]:[#6](-[#17]):[#6]:[#6]:2)-[#6]-1	O=S1(=O)C[C@H](NCCc2c[nH]c3ccccc23)[C@@H](S(=O)(=O)c2ccc(Cl)cc2)C1	QLCXZOBMCHHCII		parent_pubchem_cid	HMS3463B20;MFCD10043046;AKOS001564637;CCG-157034;(3R4S)-3-(4-CHLOROBENZENESULFONYL)-4-{[2-(1H-INDOL-3-YL)ETHYL]AMINO}-1LAMBDA6-THIOLANE-11-DIONE;rac-(3S,4R)-4-(4-chlorophenyl)sulfonyl-N-[2-(1H-indol-3-yl)ethyl]-1,1-dioxo-thiolan-3-amine		16523730.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=16523730		pluskal_iocb_peptide_Peptide01_F4_id		100	F4		ZINC000019797262
3.2		0	127	P1098685	131.0		Y18	False	0	27	0	0	28	0	2	7	0	0		0.0						Cc1cc2c(c(OCC(=O)NC(Cc3ccccc3)C(=O)NCCC(=O)O)c1)c1c(CCC1)c(=O)o2																							0.0		EiM07-17368		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C27H28N2O7	C27H28N2O7			InChI=1S/C27H28N2O7/c1-16-12-21(25-18-8-5-9-19(18)27(34)36-22(25)13-16)35-15-23(30)29-20(14-17-6-3-2-4-7-17)26(33)28-11-10-24(31)32/h2-4,6-7,12-13,20H,5,8-11,14-15H2,1H3,(H,28,33)(H,29,30)(H,31,32)/t20-/m0/s1	JLNJISAVXHLNJO-FQEVSTJZSA-N	3-[[rac-(2S)-2-[[2-[(7-methyl-4-oxo-2,3-dihydro-1H-cyclopenta[c]chromen-9-yl)oxy]acetyl]amino]-3-phenyl-propanoyl]amino]propanoic acid	24279911	Cc1cc2c(c(OCC(=O)N[C@@H](Cc3ccccc3)C(=O)NCCC(=O)O)c1)c1c(CCC1)c(=O)o2	3-[[(2S)-2-[[2-[(7-methyl-4-oxo-2,3-dihydro-1H-cyclopenta[c]chromen-9-yl)oxy]acetyl]amino]-3-phenylpropanoyl]amino]propanoic acid			2.07754													MCULE-4944463588	492.53341		492.189651	7	3	10	4			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(24279911)	24279911	2.8	991			[#6]-[#6]1:[#6]:[#6]2:[#6](:[#6](-[#8]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3)-[#6](=[#8])-[#7]-[#6]-[#6]-[#6](=[#8])-[#8]):[#6]:1):[#6]1:[#6](-[#6]-[#6]-[#6]-1):[#6](=[#8]):[#8]:2	Cc1cc2c(c(OCC(=O)N[C@@H](Cc3ccccc3)C(=O)NCCC(=O)O)c1)c1c(CCC1)c(=O)o2	JLNJISAVXHLNJO		parent_pubchem_cid	EiM07-17368;AKOS016391557;3-{2-[2-({7-METHYL-4-OXO-1H,2H,3H,4H-CYCLOPENTA[C]CHROMEN-9-YL}OXY)ACETAMIDO]-3-PHENYLPROPANAMIDO}PROPANOIC ACID;3-[[rac-(2S)-2-[[2-[(7-methyl-4-oxo-2,3-dihydro-1H-cyclopenta[c]chromen-9-yl)oxy]acetyl]amino]-3-phenyl-propanoyl]amino]propanoic acid		22672035.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22672035		pluskal_iocb_peptide_Peptide01_F4_id		100	F4		ZINC000011866871
4.8		0	215	P7013540635	76.7		Y19	False	0	26	0	0	28	0	2	4	0	0		0.0						CCOc1ccccc1NC(=O)c1ccc(OCC(=O)Nc2ccccc2C(C)C)cc1																							0.0		Oprea1_258819		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C26H28N2O4	C26H28N2O4			InChI=1S/C26H28N2O4/c1-4-31-24-12-8-7-11-23(24)28-26(30)19-13-15-20(16-14-19)32-17-25(29)27-22-10-6-5-9-21(22)18(2)3/h5-16,18H,4,17H2,1-3H3,(H,27,29)(H,28,30)	SKBAQECNUPQYGL-UHFFFAOYSA-N	N-(2-ethoxyphenyl)-4-[2-(2-isopropylanilino)-2-oxo-ethoxy]benzamide	1193522	CCOc1ccccc1NC(=O)c1ccc(OCC(=O)Nc2ccccc2C(C)C)cc1	N-(2-ethoxyphenyl)-4-[2-oxo-2-(2-propan-2-ylanilino)ethoxy]benzamide			3.6830400000000014													MCULE-3091501850	432.52406		432.204907	4	2	9	3			44										False					Peptide01			Compound(1193522)	1193522	5.1	992			[#6]-[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]-[#6](=[#8])-[#7]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6](-[#6])-[#6]):[#6]:[#6]:1	CCOc1ccccc1NC(=O)c1ccc(OCC(=O)Nc2ccccc2C(C)C)cc1	SKBAQECNUPQYGL		parent_pubchem_cid	Oprea1_258819;AKOS002243273;N-(2-ethoxyphenyl)-4-[2-(2-isopropylanilino)-2-oxo-ethoxy]benzamide		15998102.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=15998102		pluskal_iocb_peptide_Peptide01_F5_id		100	F5		ZINC000000958149
1.5		0	303	P4799057	75.6		Y20	False	0	17	1	0	21	0	6	2	0	0		0.0						Clc1ccccc1Nc1nc(N2CCOCC2)nc(N2CCOCC2)n1																							0.0		AKOS022132921		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	2		C17H21ClN6O2	C17H21ClN6O2			InChI=1S/C17H21ClN6O2/c18-13-3-1-2-4-14(13)19-15-20-16(23-5-9-25-10-6-23)22-17(21-15)24-7-11-26-12-8-24/h1-4H,5-12H2,(H,19,20,21,22)	MWZURHRDINJLTR-UHFFFAOYSA-N	N-(2-chlorophenyl)-4,6-dimorpholino-1,3,5-triazin-2-amine	7589315	Clc1ccccc1Nc1nc(N2CCOCC2)nc(N2CCOCC2)n1	N-(2-chlorophenyl)-4,6-dimorpholin-4-yl-1,3,5-triazin-2-amine			0.4193599999999997													MCULE-9036610514	376.84892		376.141452	8	1	4	4			44										False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(7589315)	7589315	1.2	993			[#17]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#7]-[#6]1:[#7]:[#6](-[#7]2-[#6]-[#6]-[#8]-[#6]-[#6]-2):[#7]:[#6](-[#7]2-[#6]-[#6]-[#8]-[#6]-[#6]-2):[#7]:1	Clc1ccccc1Nc1nc(N2CCOCC2)nc(N2CCOCC2)n1	MWZURHRDINJLTR		parent_pubchem_cid	AKOS022132921;N-(2-chlorophenyl)-4,6-dimorpholino-1,3,5-triazin-2-amine		16641815.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=16641815		pluskal_iocb_peptide_Peptide01_F5_id		100	F5		ZINC000005255826
4.9		0	47	P7114471333	91.5		Y21	False	0	26	0	0	24	0	2	4	0	2		0.0						O=S(=O)(c1ccccc1)N(CCN(c1ccccc1)S(=O)(=O)c1ccccc1)c1ccccc1																							0.0		N-phenyl-N-{2-[(phenylsulfonyl)anilino]ethyl}benzenesulfonamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	2		C26H24N2O4S2	C26H24N2O4S2			InChI=1S/C26H24N2O4S2/c29-33(30,25-17-9-3-10-18-25)27(23-13-5-1-6-14-23)21-22-28(24-15-7-2-8-16-24)34(31,32)26-19-11-4-12-20-26/h1-20H,21-22H2	YSMCDQWBAZNZIB-UHFFFAOYSA-N	N-[2-[N-(benzenesulfonyl)anilino]ethyl]-N-phenyl-benzenesulfonamide	1582115	O=S(=O)(c1ccccc1)N(CCN(c1ccccc1)S(=O)(=O)c1ccccc1)c1ccccc1	N-[2-[N-(benzenesulfonyl)anilino]ethyl]-N-phenylbenzenesulfonamide			3.800160000000004													MCULE-8210814169	492.62018		492.117749	4	0	9	4			44									Chalcones	False	Shikimates and Phenylpropanoids	Flavonoids			Peptide01			Compound(1582115)	1582115	5.0	994			[#8]=[#16](=[#8])(-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7](-[#6]-[#6]-[#7](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#16](=[#8])(=[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	O=S(=O)(c1ccccc1)N(CCN(c1ccccc1)S(=O)(=O)c1ccccc1)c1ccccc1	YSMCDQWBAZNZIB		parent_pubchem_cid	N-phenyl-N-{2-[(phenylsulfonyl)anilino]ethyl}benzenesulfonamide;N-[2-[N-(benzenesulfonyl)anilino]ethyl]-N-phenylbenzenesulfonamide;AKOS000494160;AN-329/03679010;N-[2-[N-(benzenesulfonyl)anilino]ethyl]-N-phenyl-benzenesulfonamide		3875404.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=3875404		pluskal_iocb_peptide_Peptide01_F5_id		100	F5		ZINC000001795174
3.9		0	135	P0111000907	71.2		Y22	False	0	21	0	0	22	0	2	3	0	0		0.0						CCOC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c1ccc(C)cc1								Alpha amino acid esters;N-acyl-alpha amino acids and derivatives;3-alkylindoles;p-Toluamides;Benzoyl derivatives;Fatty acid esters;Substituted pyrroles;Heteroaromatic compounds;Secondary carboxylic acid amides;Carboxylic acid esters;Azacyclic compounds;Monocarboxylic acids and derivatives;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organonitrogen compounds;Organopnictogen compounds	3-alkylindoles;Alpha amino acid esters;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzamides;Benzene and substituted derivatives;Benzenoids;Benzoic acids and derivatives;Benzoyl derivatives;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids and derivatives;Chemical entities;Fatty Acyls;Fatty acid esters;Heteroaromatic compounds;Hippuric acids and derivatives;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Lipids and lipid-like molecules;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Toluamides;Toluenes;p-Toluamides	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as hippuric acids and derivatives. These are compounds containing a hippuric acid or a derivative, with a structure characterized the presence of a benzoyl group linked to the N-terminal of a glycine.	Hippuric acids and derivatives		Benzamides	Organic compounds	Aromatic heteropolycyclic compounds	alpha-amino acid ester (CHEBI:46874);N-acyl-amino acid (CHEBI:51569);indoles (CHEBI:24828);benzamides (CHEBI:22702);carbonyl compound (CHEBI:36586);fatty acid ester (CHEBI:35748);pyrroles (CHEBI:26455);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);carboxylic ester (CHEBI:33308);organonitrogen heterocyclic compound (CHEBI:38101);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);N-acylglycine (CHEBI:16180);phenols (CHEBI:33853);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);amino acid (CHEBI:33709);peptide (CHEBI:16670);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);toluenes (CHEBI:27024);lipid (CHEBI:18059);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);nitrogen molecular entity (CHEBI:51143)	Fatty esters (FA07);Fatty Acyls (FA)	Benzoic acids and derivatives	Alpha-amino acid ester;Hippuric acid or derivatives;N-acyl-alpha amino acid or derivatives;Alpha-amino acid or derivatives;3-alkylindole;P-toluamide;Toluamide;Indole;Indole or derivatives;Benzoyl;Fatty acid ester;Toluene;Fatty acyl;Substituted pyrrole;Heteroaromatic compound;Pyrrole;Carboxylic acid ester;Carboxamide group;Secondary carboxylic acid amide;Organoheterocyclic compound;Monocarboxylic acid or derivatives;Azacycle;Carboxylic acid derivative;Organooxygen compound;Organonitrogen compound;Organic nitrogen compound;Hydrocarbon derivative;Organic oxide;Carbonyl group;Organopnictogen compound;Organic oxygen compound;Aromatic heteropolycyclic compound	Benzenoids	0.0		ST074438		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C21H22N2O3	C21H22N2O3			InChI=1S/C21H22N2O3/c1-3-26-21(25)19(23-20(24)15-10-8-14(2)9-11-15)12-16-13-22-18-7-5-4-6-17(16)18/h4-11,13,19,22H,3,12H2,1-2H3,(H,23,24)	VUXVVLJZRAQTIW-UHFFFAOYSA-N	ethyl 3-(1H-indol-3-yl)-2-[(4-methylbenzoyl)amino]propanoate	2787313	CCOC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c1ccc(C)cc1	ethyl 3-(1H-indol-3-yl)-2-[(4-methylbenzoyl)amino]propanoate			2.7879700000000014													MCULE-7738002863	350.42109		350.163043	3	2	7	3			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(2787313)	2787313	3.8	995			[#6]-[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:1	CCOC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c1ccc(C)cc1	VUXVVLJZRAQTIW		parent_pubchem_cid	ST074438;ethyl 3-(1H-indol-3-yl)-2-[(4-methylbenzoyl)amino]propanoate;AKOS000536740;AKOS016311709;SR-01000404530;SR-01000404530-1		23273372.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23273372		pluskal_iocb_peptide_Peptide01_F5_id		100	F5		
4.3		0	223	P1108203	137.9		Y23	False	0	26	0	0	26	0	2	7	0	0	-1.0	0.0						CCCCc1cc(=O)oc2c1ccc(OCC(=O)NC(Cc1c[nH]c3c1cc(O)cc3)C(=O)O)c2		3.51		0.0	3.65	CHEMBL1397085		N-acyl-alpha amino acids;Indolyl carboxylic acids and derivatives;Coumarins and derivatives;Hydroxyindoles;1-benzopyrans;3-alkylindoles;Alkyl aryl ethers;Pyranones and derivatives;1-hydroxy-2-unsubstituted benzenoids;Substituted pyrroles;Heteroaromatic compounds;Lactones;Secondary carboxylic acid amides;Carboxylic acids;Azacyclic compounds;Monocarboxylic acids and derivatives;Oxacyclic compounds;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organonitrogen compounds;Organopnictogen compounds	1-benzopyrans;1-hydroxy-2-unsubstituted benzenoids;3-alkylindoles;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Hydroxyindoles;Indoles;Indoles and derivatives;Indolyl carboxylic acids and derivatives;Lactones;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;N-acylserotonins;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenols;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Pyrroles;Secondary carboxylic acid amides;Serotonins;Substituted pyrroles;Tryptamines and derivatives	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acylserotonins. These are aromatic heterocyclic compounds containing a serotonin, in which the amine group is acylated.	N-acylserotonins		Serotonins	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-amino acid (CHEBI:51569);indolyl carboxylic acid (CHEBI:46867);coumarins (CHEBI:23403);hydroxyindoles (CHEBI:84729);1-benzopyran (CHEBI:38443);indoles (CHEBI:24828);aromatic ether (CHEBI:35618);pyranone (CHEBI:37963);phenols (CHEBI:33853);pyrroles (CHEBI:26455);organic aromatic compound (CHEBI:33659);lactone (CHEBI:25000);carboxamide (CHEBI:37622);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);organonitrogen heterocyclic compound (CHEBI:38101);carbonyl compound (CHEBI:36586);oxacycle (CHEBI:38104);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);amino acid (CHEBI:33709);peptide (CHEBI:16670);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);oxygen molecular entity (CHEBI:25806);ether (CHEBI:25698);pyrans (CHEBI:26407);benzenoid aromatic compound (CHEBI:33836);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);tryptamines (CHEBI:27162)	Benzopyranoids (PK1311)	Tryptamines and derivatives	N-acylserotonin;N-acyl-alpha amino acid or derivatives;N-acyl-alpha-amino acid;Indolyl carboxylic acid derivative;Coumarin;Benzopyran;Alpha-amino acid or derivatives;Hydroxyindole;3-alkylindole;1-benzopyran;Indole;1-hydroxy-2-unsubstituted benzenoid;Alkyl aryl ether;Pyranone;Benzenoid;Pyran;Substituted pyrrole;Heteroaromatic compound;Pyrrole;Carboxamide group;Secondary carboxylic acid amide;Lactone;Carboxylic acid derivative;Carboxylic acid;Ether;Oxacycle;Azacycle;Monocarboxylic acid or derivatives;Hydrocarbon derivative;Organic oxygen compound;Organic nitrogen compound;Organopnictogen compound;Carbonyl group;Organooxygen compound;Organic oxide;Organonitrogen compound;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		N-{[(4-butyl-2-oxo-2H-chromen-7-yl)oxy]acetyl}-5-hydroxytryptophan		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C26H26N2O7	C26H26N2O7			InChI=1S/C26H26N2O7/c1-2-3-4-15-10-25(31)35-23-12-18(6-7-19(15)23)34-14-24(30)28-22(26(32)33)9-16-13-27-21-8-5-17(29)11-20(16)21/h5-8,10-13,22,27,29H,2-4,9,14H2,1H3,(H,28,30)(H,32,33)	PILODEJWJAFZST-UHFFFAOYSA-N	2-[[2-(4-butyl-2-oxo-chromen-7-yl)oxyacetyl]amino]-3-(5-hydroxy-1H-indol-3-yl)propanoic acid	4836643	CCCCc1cc(=O)oc2c1ccc(OCC(=O)NC(Cc1c[nH]c3c1cc(O)cc3)C(=O)O)c2	2-[[2-(4-butyl-2-oxochromen-7-yl)oxyacetyl]amino]-3-(5-hydroxy-1H-indol-3-yl)propanoic acid			2.5222100000000003													MCULE-7281255296	478.50632	ACID	478.174001	7	4	10	4	1.0		30									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins	False	False	Peptide01		-1.0	Compound(4836643)	4836643	4.0	996			[#6]-[#6]-[#6]-[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6]-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]3:[#6]:1:[#6]:[#6](-[#8]):[#6]:[#6]:3)-[#6](=[#8])-[#8]):[#6]:2	CCCCc1cc(=O)oc2c1ccc(OCC(=O)NC(Cc1c[nH]c3c1cc(O)cc3)C(=O)O)c2	PILODEJWJAFZST		parent_pubchem_cid	N-{[(4-butyl-2-oxo-2H-chromen-7-yl)oxy]acetyl}-5-hydroxytryptophan;1213978-87-0;SMR000650285;MLS001140841;MLS003901595;CHEMBL1397085;HMS2271O14;EiM07-29405;STL464221;AKOS016379671;AB00863988-06;2-[[2-(4-butyl-2-oxo-chromen-7-yl)oxyacetyl]amino]-3-(5-hydroxy-1H-indol-3-yl)propanoic acid	False	662421.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=662421		pluskal_iocb_peptide_Peptide01_F5_id		100	F5	False	
3.1		0	311	P1572651	74.8	HCl	Y24	False	0	15	0	0	22	0	6	0	0	0		0.0						CCNc1nc(NCC)nc(Nc2cc(C)c(C)cc2)n1																							0.0		AKOS022127275		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0		C15H23ClN6	C15H22N6			InChI=1S/C15H22N6/c1-5-16-13-19-14(17-6-2)21-15(20-13)18-12-8-7-10(3)11(4)9-12/h7-9H,5-6H2,1-4H3,(H3,16,17,18,19,20,21)	ZSVAVIOWDWSFCZ-UHFFFAOYSA-N	N2-(3,4-dimethylphenyl)-N4,N6-diethyl-1,3,5-triazine-2,4,6-triamine;hydrochloride	7589382	CCNc1nc(NCC)nc(Nc2cc(C)c(C)cc2)n1	2-N-(3,4-dimethylphenyl)-4-N,6-N-diethyl-1,3,5-triazine-2,4,6-triamine			1.4637799999999996													MCULE-6904697043	322.84376		286.190595	6	3	6	2			43										False	Alkaloids				Peptide01			Compound(7589382)	7589382	3.9	997			[#6]-[#6]-[#7]-[#6]1:[#7]:[#6](-[#7]-[#6]-[#6]):[#7]:[#6](-[#7]-[#6]2:[#6]:[#6](-[#6]):[#6](-[#6]):[#6]:[#6]:2):[#7]:1	CCNc1nc(NCC)nc(Nc2cc(C)c(C)cc2)n1	ZSVAVIOWDWSFCZ		parent_pubchem_cid	"AKOS022127275;""N2-(3,4-dimethylphenyl)-N4,N6-diethyl-1,3,5-triazine-2,4,6-triamine;hydrochloride"""		7497895.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=7497895		pluskal_iocb_peptide_Peptide01_F5_id		100	F5		ZINC000005255905
2.2		0	55	P7212090967	91.9		Y25	False	0	17	0	0	17	0	1	4	0	1		0.0						O=C(O)C(Cc1ccccc1)NS(=O)(=O)C=Cc1ccccc1																							0.0		Cambridge id 7198284		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0		C17H17NO4S	C17H17NO4S			InChI=1S/C17H17NO4S/c19-17(20)16(13-15-9-5-2-6-10-15)18-23(21,22)12-11-14-7-3-1-4-8-14/h1-12,16,18H,13H2,(H,19,20)/b12-11+	JMSZFEPCPCSQMH-VAWYXSNFSA-N	3-phenyl-2-[[(E)-styryl]sulfonylamino]propanoic acid	5736640	O=C(O)C(Cc1ccccc1)NS(=O)(=O)/C=C/c1ccccc1	3-phenyl-2-[[(E)-2-phenylethenyl]sulfonylamino]propanoic acid			2.1631800000000005														331.39334		331.087829	4	2	7	2			46										False	Shikimates and Phenylpropanoids				Peptide01			Compound(5736640)	5736640	2.9	998			[#8]=[#6](-[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#16](=[#8])(=[#8])/[#6]=[#6]/[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	O=C(O)C(Cc1ccccc1)NS(=O)(=O)/C=C/c1ccccc1	JMSZFEPCPCSQMH		parent_pubchem_cid	Cambridge id 7198284;HMS1426I19;AKOS001060338;SR-01000254254;SR-01000254254-1;3-phenyl-2-[[(E)-styryl]sulfonylamino]propanoic acid		24525562.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24525562		pluskal_iocb_peptide_Peptide01_F5_id		100	F5		
4.2		0	143	P0103420052	80.4		Y26	False	0	23	0	0	26	0	2	4	0	0	-1.0	0.0						CCOC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)COc1ccc(CC)cc1		3.4		0.0	3.97	CHEMBL1482423																	0.0		CHEMBL1482423		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C23H26N2O4	C23H26N2O4			InChI=1S/C23H26N2O4/c1-3-16-9-11-18(12-10-16)29-15-22(26)25-21(23(27)28-4-2)13-17-14-24-20-8-6-5-7-19(17)20/h5-12,14,21,24H,3-4,13,15H2,1-2H3,(H,25,26)	HMCFYLGFQXNSOU-UHFFFAOYSA-N	ethyl 2-[[2-(4-ethylphenoxy)acetyl]amino]-3-(1H-indol-3-yl)propanoate	2787532	CCOC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)COc1ccc(CC)cc1	ethyl 2-[[2-(4-ethylphenoxy)acetyl]amino]-3-(1H-indol-3-yl)propanoate			2.39945													MCULE-8884450560	394.47467	NEUTRAL	394.189257	4	2	10	3	0.0		30									Dipeptides	False	Amino acids and Peptides	Small peptides	False	False	Peptide01		-1.0	Compound(2787532)	2787532	4.3	999			[#6]-[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#6](=[#8])-[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6]-[#6]):[#6]:[#6]:1	CCOC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)COc1ccc(CC)cc1	HMCFYLGFQXNSOU		parent_pubchem_cid	CHEMBL1482423;HMS1795E08;ethyl 2-[2-(4-ethylphenoxy)acetamido]-3-(1H-indol-3-yl)propanoate;AKOS000536377;AKOS016311824;NCGC00098206-01;SR-01000404623;SR-01000404623-1;ethyl 2-[[2-(4-ethylphenoxy)acetyl]amino]-3-(1H-indol-3-yl)propanoate	False	705043.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=705043		pluskal_iocb_peptide_Peptide01_F5_id		100	F5	False	
4.1		0	231	P1182420	105.2		Y27	False	0	25	0	0	26	0	4	3	0	1		0.0						Cc1ccc(-c2cc(C(=O)NCCc3c[nH]c4ccccc34)nn2C2CCS(=O)(=O)C2)cc1																							0.0		AKOS004933389		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	1	0	0	0	0	0	0	1		C25H26N4O3S	C25H26N4O3S			InChI=1S/C25H26N4O3S/c1-17-6-8-18(9-7-17)24-14-23(28-29(24)20-11-13-33(31,32)16-20)25(30)26-12-10-19-15-27-22-5-3-2-4-21(19)22/h2-9,14-15,20,27H,10-13,16H2,1H3,(H,26,30)	HJQZEHUWKLTEBJ-UHFFFAOYSA-N	1-(1,1-dioxothiolan-3-yl)-N-[2-(1H-indol-3-yl)ethyl]-5-(p-tolyl)pyrazole-3-carboxamide	50753679	Cc1ccc(-c2cc(C(=O)NCCc3c[nH]c4ccccc34)nn2C2CCS(=O)(=O)C2)cc1	1-(1,1-dioxothiolan-3-yl)-N-[2-(1H-indol-3-yl)ethyl]-5-(4-methylphenyl)pyrazole-3-carboxamide			2.699350000000001													MCULE-4487308174	462.57497		462.172562	4	2	6	5			45										False	Alkaloids				Peptide01			Compound(50753679)	50753679	3.4	1000			[#6]-[#6]1:[#6]:[#6]:[#6](-[#6]2:[#6]:[#6](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]3:[#6]:[#7H]:[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]:3:4):[#7]:[#7]:2-[#6]2-[#6]-[#6]-[#16](=[#8])(=[#8])-[#6]-2):[#6]:[#6]:1	Cc1ccc(-c2cc(C(=O)NCCc3c[nH]c4ccccc34)nn2C2CCS(=O)(=O)C2)cc1	HJQZEHUWKLTEBJ		parent_pubchem_cid	AKOS004933389;1-(11-DIOXO-1LAMBDA6-THIOLAN-3-YL)-N-[2-(1H-INDOL-3-YL)ETHYL]-5-(4-METHYLPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE;1-(1,1-dioxothiolan-3-yl)-N-[2-(1H-indol-3-yl)ethyl]-5-(p-tolyl)pyrazole-3-carboxamide		23928900.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23928900		pluskal_iocb_peptide_Peptide01_F6_id		100	F6		
1.7		0	319	P1159729	99.0		Y28	False	0	18	0	0	17	0	5	3	0	0		0.0						COC(=O)C(Cc1ccccc1)NC(=O)c1cc(-n2cnnn2)ccc1																							0.0		AKOS005535091		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	4	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C18H17N5O3	C18H17N5O3			InChI=1S/C18H17N5O3/c1-26-18(25)16(10-13-6-3-2-4-7-13)20-17(24)14-8-5-9-15(11-14)23-12-19-21-22-23/h2-9,11-12,16H,10H2,1H3,(H,20,24)/t16-/m0/s1	GBPWRJFQYIPTAV-INIZCTEOSA-N	methyl rac-(2S)-3-phenyl-2-[[3-(tetrazol-1-yl)benzoyl]amino]propanoate	28935445	COC(=O)[C@H](Cc1ccccc1)NC(=O)c1cc(-n2cnnn2)ccc1	methyl (2S)-3-phenyl-2-[[3-(tetrazol-1-yl)benzoyl]amino]propanoate			0.8769699999999994													MCULE-8848692148	351.36789		351.133139	6	1	7	3			44										False	Alkaloids				Peptide01			Compound(28935445)	28935445	2.4	1001			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6](-[#7]2:[#6]:[#7]:[#7]:[#7]:2):[#6]:[#6]:[#6]:1	COC(=O)[C@H](Cc1ccccc1)NC(=O)c1cc(-n2cnnn2)ccc1	GBPWRJFQYIPTAV		parent_pubchem_cid	AKOS005535091;METHYL 3-PHENYL-2-{[3-(1H-1,2,3,4-TETRAZOL-1-YL)PHENYL]FORMAMIDO}PROPANOATE;methyl rac-(2S)-3-phenyl-2-[[3-(tetrazol-1-yl)benzoyl]amino]propanoate		12690782.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=12690782		pluskal_iocb_peptide_Peptide01_F6_id		100	F6		ZINC000020427689
3.8		0	63	P7112905285	110.8		Y29	False	0	26	0	0	24	0	2	6	0	0		0.0						CCOC(=O)c1ccccc1NC(=O)c1cc(C(=O)Nc2ccccc2C(=O)OCC)ccc1																							0.0		Oprea1_638930		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	4	0	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C26H24N2O6	C26H24N2O6			InChI=1S/C26H24N2O6/c1-3-33-25(31)19-12-5-7-14-21(19)27-23(29)17-10-9-11-18(16-17)24(30)28-22-15-8-6-13-20(22)26(32)34-4-2/h5-16H,3-4H2,1-2H3,(H,27,29)(H,28,30)	JMRRTKOTYASKOB-UHFFFAOYSA-N	ethyl 2-[[3-[(2-ethoxycarbonylphenyl)carbamoyl]benzoyl]amino]benzoate	4013454	CCOC(=O)c1ccccc1NC(=O)c1cc(C(=O)Nc2ccccc2C(=O)OCC)ccc1	ethyl 2-[[3-[(2-ethoxycarbonylphenyl)carbamoyl]benzoyl]amino]benzoate			3.5645400000000027													MCULE-2285062417	460.49098		460.163436	6	2	10	3			44									Anthranillic acid derivatives	False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(4013454)	4013454	5.1	1002			[#6]-[#6]-[#8]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6](-[#6](=[#8])-[#7]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6](=[#8])-[#8]-[#6]-[#6]):[#6]:[#6]:[#6]:1	CCOC(=O)c1ccccc1NC(=O)c1cc(C(=O)Nc2ccccc2C(=O)OCC)ccc1	JMRRTKOTYASKOB		parent_pubchem_cid	Oprea1_638930;AKOS002321798;ETHYL 2-[(3-{[2-(ETHOXYCARBONYL)ANILINO]CARBONYL}BENZOYL)AMINO]BENZOATE;ethyl 2-[[3-[(2-ethoxycarbonylphenyl)carbamoyl]benzoyl]amino]benzoate		6183885.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=6183885		pluskal_iocb_peptide_Peptide01_F6_id		100	F6		ZINC000008741795
0.4		0	151	P0125160070	103.4		Y30	False	0	14	0	0	11	0	3	4	0	0	-1.0	0.0						O=C(O)C(Cc1cnc[nH]1)N1C(=O)c2ccccc2C1=O		0.7		0.0	-0.71	CHEMBL331687		Phthalimides;Isoindoles;Imidazolyl carboxylic acids and derivatives;N-substituted carboxylic acid imides;Benzenoids;Heteroaromatic compounds;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Azoles;Benzenoids;Carbonyl compounds;Carboxylic acid derivatives;Carboxylic acid imides;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Histidine and derivatives;Hydrocarbon derivatives;Imidazoles;Imidazolyl carboxylic acids and derivatives;Isoindoles;Isoindoles and derivatives;Isoindolines;Isoindolones;Monocarboxylic acids and derivatives;N-substituted carboxylic acid imides;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phthalimides;Substituted imidazoles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as histidine and derivatives. These are compounds containing cysteine or a derivative thereof resulting from reaction of cysteine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Histidine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	phthalimides (CHEBI:82851);isoindoles (CHEBI:24897);imidazolyl carboxylic acid (CHEBI:38307);dicarboximide (CHEBI:35356);benzenoid aromatic compound (CHEBI:33836);organic aromatic compound (CHEBI:33659);carbonyl compound (CHEBI:36586);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);organonitrogen heterocyclic compound (CHEBI:38101);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);histidine derivative (CHEBI:24599);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);azole (CHEBI:68452);imidazoles (CHEBI:24780);organooxygen compound (CHEBI:36963);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806);amino acid (CHEBI:33709);peptide (CHEBI:16670)		Amino acids, peptides, and analogues	Histidine or derivatives;Phthalimide;Isoindolone;Isoindole or derivatives;Isoindole;Isoindoline;Imidazolyl carboxylic acid derivative;Carboxylic acid imide, n-substituted;Benzenoid;Azole;Carboxylic acid imide;Imidazole;Heteroaromatic compound;Monocarboxylic acid or derivatives;Carboxylic acid;Azacycle;Organoheterocyclic compound;Organic nitrogen compound;Organonitrogen compound;Organooxygen compound;Hydrocarbon derivative;Organic oxide;Organopnictogen compound;Organic oxygen compound;Carbonyl group;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		5959-79-5	DTXSID50294073	2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	2	0	0	3	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	2	0		C14H11N3O4	C14H11N3O4			InChI=1S/C14H11N3O4/c18-12-9-3-1-2-4-10(9)13(19)17(12)11(14(20)21)5-8-6-15-7-16-8/h1-4,6-7,11H,5H2,(H,15,16)(H,20,21)	CTUUVOUXZNQMSU-UHFFFAOYSA-N	2-(1,3-dioxoisoindolin-2-yl)-3-(1H-imidazol-4-yl)propanoic acid	261550	O=C(O)C(Cc1cnc[nH]1)N1C(=O)c2ccccc2C1=O	2-(1,3-dioxoisoindol-2-yl)-3-(1H-imidazol-5-yl)propanoic acid			0.5374699999999999													MCULE-4823270662	285.26147	ACID	285.074956	5	2	4	3	0.0		28									Imidazole alkaloids	False	Alkaloids	Histidine alkaloids	False	False	Peptide01		-1.0	Compound(261550)	261550	0.7	1003		SCHEMBL6690700	[#8]=[#6](-[#8])-[#6](-[#6]-[#6]1:[#6]:[#7]:[#6]:[#7H]:1)-[#7]1-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6]-1=[#8]	O=C(O)C(Cc1cnc[nH]1)N1C(=O)c2ccccc2C1=O	CTUUVOUXZNQMSU		parent_pubchem_cid	5959-79-5;NSC93967;2-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-(1H-imidazol-4-yl)propanoic acid;2-(1,3-dioxoisoindol-2-yl)-3-(1H-imidazol-5-yl)propanoic acid;2-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)-3-(1H-imidazol-5-yl)propanoic acid;(S)-2-(1,3-Dioxoisoindolin-2-yl)-3-(1H-imidazol-4-yl)propanoic acid;NSC-93967;N-PHTHALOYL-DL-HISTIDINE;ChemDiv3_000196;Oprea1_116929;Oprea1_671979;Oprea1_841455;CBDivE_002610;CHEMBL331687;SCHEMBL6690700;DTXSID50294073;HMS1473I20;MFCD00023055;STK387462;AKOS000200591;AKOS001061006;AKOS016040283;AKOS016050477;SDCCGMLS-0065495.P001;2-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)-3-(1H-imidazol-4-yl)propanoic acid;IDI1_019514;NCI60_042097;NS-04731;CS-0218153;EN300-00254;2-phthalimido-3-(imidazol-4-yl)propionic acid;Histidine, .alpha.-phthalimido-.alpha.-desamino-;Z56347460;F0827-0155;2-(1,3-dioxoisoindolin-2-yl)-3-(1H-imidazol-5-yl)propanoic acid;1,3-Dihydro-|A-(1H-imidazol-5-ylmethyl)-1,3-dioxo-2H-isoindole-2-acetic acid;2-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-(1H-imidazol-4-yl)propanoic acid #;2-(1,3-dioxoisoindolin-2-yl)-3-(1H-imidazol-4-yl)propanoic acid	False	480028.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=480028		pluskal_iocb_peptide_Peptide01_F6_id		100	F6	False	
2.4		0	239	P7119850022	162.7		Y31	False	0	18	0	0	17	0	3	7	0	1		0.0						COc1c([N+](=O)[O-])cc(S(=O)(=O)NC(Cc2c[nH]c3ccccc23)C(=O)O)cc1																							0.0		1095016-65-1		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	1		C18H17N3O7S	C18H17N3O7S			InChI=1S/C18H17N3O7S/c1-28-17-7-6-12(9-16(17)21(24)25)29(26,27)20-15(18(22)23)8-11-10-19-14-5-3-2-4-13(11)14/h2-7,9-10,15,19-20H,8H2,1H3,(H,22,23)	UHSDHJXMDMOPSP-UHFFFAOYSA-N	3-(1H-indol-3-yl)-2-[(4-methoxy-3-nitro-phenyl)sulfonylamino]propanoic acid	16807422	COc1c([N+](=O)[O-])cc(S(=O)(=O)NC(Cc2c[nH]c3ccccc23)C(=O)O)cc1	3-(1H-indol-3-yl)-2-[(4-methoxy-3-nitrophenyl)sulfonylamino]propanoic acid			0.6247399999999996														419.41609		419.078721	7	3	8	3			46										False					Peptide01			Compound(16807422)	16807422	2.4	1004			[#6]-[#8]-[#6]1:[#6](-[#7+](=[#8])-[#8-]):[#6]:[#6](-[#16](=[#8])(=[#8])-[#7]-[#6](-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6](=[#8])-[#8]):[#6]:[#6]:1	COc1c([N+](=O)[O-])cc(S(=O)(=O)NC(Cc2c[nH]c3ccccc23)C(=O)O)cc1	UHSDHJXMDMOPSP		parent_pubchem_cid	1095016-65-1;3-(1H-indol-3-yl)-2-(4-methoxy-3-nitrophenylsulfonamido)propanoic acid;3-(1H-Indol-3-yl)-2-(4-methoxy-3-nitro-benzenesulfonylamino)-propionic acid;3-(1H-indol-3-yl)-2-[(4-methoxy-3-nitrophenyl)sulfonylamino]propanoic acid;AKOS002384370;AS-871/43476253;SR-01000014176;SR-01000014176-1;F1679-0175;3-(1H-indol-3-yl)-2-[(4-methoxy-3-nitro-phenyl)sulfonylamino]propanoic acid		22832213.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22832213		pluskal_iocb_peptide_Peptide01_F6_id		100	F6		
1.8		0	327	P6243655	99.1		Y32	False	0	19	0	0	21	0	3	4	0	0	-1.0	0.0						O=C(Cn1nc2CCCCc2cc1=O)NC(Cc1ccccc1)C(=O)O		0.93		0.0	1.6	CHEMBL3444012																	0.0		CHEMBL3444012		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C19H21N3O4	C19H21N3O4			InChI=1S/C19H21N3O4/c23-17(20-16(19(25)26)10-13-6-2-1-3-7-13)12-22-18(24)11-14-8-4-5-9-15(14)21-22/h1-3,6-7,11,16H,4-5,8-10,12H2,(H,20,23)(H,25,26)/t16-/m0/s1	LPAVZNSKIJSMMI-INIZCTEOSA-N	rac-(2S)-2-[[2-(3-oxo-5,6,7,8-tetrahydrocinnolin-2-yl)acetyl]amino]-3-phenyl-propanoic acid	51053520	O=C(Cn1nc2CCCCc2cc1=O)N[C@@H](Cc1ccccc1)C(=O)O	(2S)-2-[[2-(3-oxo-5,6,7,8-tetrahydrocinnolin-2-yl)acetyl]amino]-3-phenylpropanoic acid			1.6699599999999994													MCULE-2824622335	355.39692	ACID	355.153206	5	2	6	3	0.0		29									Dipeptides	False	Amino acids and Peptides	Small peptides	False	False	Peptide01		-1.0	Compound(51053520)	51053520	1.6	1005			[#8]=[#6](-[#6]-[#7]1:[#7]:[#6]2-[#6]-[#6]-[#6]-[#6]-[#6]:2:[#6]:[#6]:1=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	O=C(Cn1nc2CCCCc2cc1=O)N[C@@H](Cc1ccccc1)C(=O)O	LPAVZNSKIJSMMI		parent_pubchem_cid	CHEMBL3444012;AKOS016402558;NCGC00422974-01;rac-(2S)-2-[[2-(3-oxo-5,6,7,8-tetrahydrocinnolin-2-yl)acetyl]amino]-3-phenyl-propanoic acid	False	23159795.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23159795		pluskal_iocb_peptide_Peptide01_F6_id		100	F6	False	ZINC000049547046
2.5		0	71	P1094931	93.7		Y33	False	0	19	0	0	20	0	2	5	0	0		0.0						COC(=O)c1ccccc1NC(=O)NC(Cc1ccccc1)C(=O)OC								Alpha amino acid esters;N-carbamoyl-alpha amino acids;Amphetamines and derivatives;Benzoic acid esters;N-phenylureas;Benzoyl derivatives;Fatty acid esters;Dicarboxylic acids and derivatives;Vinylogous amides;Methyl esters;Ureas;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organonitrogen compounds;Organopnictogen compounds	Alpha amino acid esters;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Benzene and substituted derivatives;Benzenoids;Benzoic acid esters;Benzoic acids and derivatives;Benzoyl derivatives;Carbonyl compounds;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids and derivatives;Chemical entities;Dicarboxylic acids and derivatives;Fatty Acyls;Fatty acid esters;Hydrocarbon derivatives;Lipids and lipid-like molecules;Methyl esters;N-acyl-alpha amino acids and derivatives;N-carbamoyl-alpha amino acids;N-carbamoyl-alpha amino acids and derivatives;N-phenylureas;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenethylamines;Phenylalanine and derivatives;Ureas;Vinylogous amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic homomonocyclic compounds	alpha-amino acid ester (CHEBI:46874);N-carbamoyl-amino acid (CHEBI:21689);amphetamines (CHEBI:35338);benzoate ester (CHEBI:36054);ureas (CHEBI:47857);carbonyl compound (CHEBI:36586);fatty acid ester (CHEBI:35748);dicarboxylic acid (CHEBI:35692);enone (CHEBI:51689);enamine (CHEBI:47989);carboxylic ester (CHEBI:33308);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);amino acid (CHEBI:33709);peptide (CHEBI:16670);N-acyl-amino acid (CHEBI:51569);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);primary amine (CHEBI:32877);lipid (CHEBI:18059);oxygen molecular entity (CHEBI:25806);nitrogen molecular entity (CHEBI:51143)	Fatty esters (FA07);Dicarboxylic acids (FA0117);Fatty Acyls (FA)	Amino acids, peptides, and analogues	Phenylalanine or derivatives;Alpha-amino acid ester;N-carbamoyl-alpha-amino acid;N-carbamoyl-alpha-amino acid or derivatives;Amphetamine or derivatives;Benzoate ester;N-phenylurea;Benzoic acid or derivatives;Benzoyl;Fatty acid ester;Monocyclic benzene moiety;Fatty acyl;Benzenoid;Dicarboxylic acid or derivatives;Vinylogous amide;Methyl ester;Urea;Carboxylic acid ester;Carbonic acid derivative;Organic oxygen compound;Carbonyl group;Organic nitrogen compound;Hydrocarbon derivative;Organic oxide;Organopnictogen compound;Organooxygen compound;Organonitrogen compound;Aromatic homomonocyclic compound	Organic acids and derivatives	0.0		AKOS005533556		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C19H20N2O5	C19H20N2O5			InChI=1S/C19H20N2O5/c1-25-17(22)14-10-6-7-11-15(14)20-19(24)21-16(18(23)26-2)12-13-8-4-3-5-9-13/h3-11,16H,12H2,1-2H3,(H2,20,21,24)/t16-/m0/s1	LDPLLYGJCSMNAC-INIZCTEOSA-N	methyl 2-[[rac-(1S)-1-benzyl-2-methoxy-2-oxo-ethyl]carbamoylamino]benzoate	7082771	COC(=O)c1ccccc1NC(=O)N[C@@H](Cc1ccccc1)C(=O)OC	methyl 2-[[(2S)-1-methoxy-1-oxo-3-phenylpropan-2-yl]carbamoylamino]benzoate			1.88897													MCULE-4645186533	356.38165		356.137222	5	2	8	2			44									Anthranillic acid derivatives	False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(7082771)	7082771	3.2	1006			[#6]-[#8]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#7]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]-[#6]	COC(=O)c1ccccc1NC(=O)N[C@@H](Cc1ccccc1)C(=O)OC	LDPLLYGJCSMNAC		parent_pubchem_cid	AKOS005533556;methyl 2-[[rac-(1S)-1-benzyl-2-methoxy-2-oxo-ethyl]carbamoylamino]benzoate		3794523.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=3794523		pluskal_iocb_peptide_Peptide01_F6_id		100	F6		ZINC000004043259
2.7		0	159	P7110950741	100.7		Y34	False	0	20	0	0	20	0	2	5	0	0		0.0						COc1ccc(OCC(=O)NC(Cc2c[nH]c3ccccc23)C(=O)O)cc1								3-alkylindoles;Phenoxy compounds;Anisoles;Methoxybenzenes;Alkyl aryl ethers;Substituted pyrroles;Heteroaromatic compounds;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Azacyclic compounds;Carboxylic acids;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organonitrogen compounds;Organopnictogen compounds	3-alkylindoles;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Anisoles;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Methoxybenzenes;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenol ethers;Phenoxy compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom.	N-acyl-alpha amino acids		Amino acids and derivatives;Alpha amino acids and derivatives;N-acyl-alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	indoles (CHEBI:24828);benzenes (CHEBI:22712);methoxybenzene (CHEBI:51683);aromatic ether (CHEBI:35618);pyrroles (CHEBI:26455);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);carbonyl compound (CHEBI:36586);organonitrogen heterocyclic compound (CHEBI:38101);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);N-acyl-amino acid (CHEBI:51569);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);oxygen molecular entity (CHEBI:25806);organooxygen compound (CHEBI:36963);ether (CHEBI:25698);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);amino acid (CHEBI:33709);peptide (CHEBI:16670)		Amino acids, peptides, and analogues	N-acyl-alpha-amino acid;3-alkylindole;Indole;Indole or derivatives;Phenoxy compound;Anisole;Methoxybenzene;Phenol ether;Alkyl aryl ether;Monocyclic benzene moiety;Benzenoid;Substituted pyrrole;Heteroaromatic compound;Pyrrole;Carboxamide group;Secondary carboxylic acid amide;Carboxylic acid;Ether;Azacycle;Monocarboxylic acid or derivatives;Organoheterocyclic compound;Hydrocarbon derivative;Organic oxygen compound;Organic nitrogen compound;Organic oxide;Organopnictogen compound;Carbonyl group;Organonitrogen compound;Organooxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		Oprea1_066286		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C20H20N2O5	C20H20N2O5			InChI=1S/C20H20N2O5/c1-26-14-6-8-15(9-7-14)27-12-19(23)22-18(20(24)25)10-13-11-21-17-5-3-2-4-16(13)17/h2-9,11,18,21H,10,12H2,1H3,(H,22,23)(H,24,25)	RMEDAXOWLFADFH-UHFFFAOYSA-N	3-(1H-indol-3-yl)-2-[[2-(4-methoxyphenoxy)acetyl]amino]propanoic acid	2792633	COc1ccc(OCC(=O)NC(Cc2c[nH]c3ccccc23)C(=O)O)cc1	3-(1H-indol-3-yl)-2-[[2-(4-methoxyphenoxy)acetyl]amino]propanoic acid			0.95945													MCULE-7954938389	368.3928		368.137222	5	3	8	3			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(2792633)	2792633	2.2	1007			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6](=[#8])-[#8]):[#6]:[#6]:1	COc1ccc(OCC(=O)NC(Cc2c[nH]c3ccccc23)C(=O)O)cc1	RMEDAXOWLFADFH		parent_pubchem_cid	Oprea1_066286;HMS1802L08;MFCD03011498;STL230011;AKOS001694665;AKOS016045059;N-[(4-methoxyphenoxy)acetyl]tryptophan;NCGC00100652-01;3-(1H-indol-3-yl)-2-[[2-(4-methoxyphenoxy)acetyl]amino]propanoic acid		24374342.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24374342		pluskal_iocb_peptide_Peptide01_F6_id		100	F6		
2.4		0	247	P3644477	58.6		Y35	False	0	16	0	0	23	0	1	3	0	0		0.0						COC(=O)C1(NC(CO)Cc2ccccc2)CCCC1																							0.0		AKOS016382424		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C16H23NO3	C16H23NO3			InChI=1S/C16H23NO3/c1-20-15(19)16(9-5-6-10-16)17-14(12-18)11-13-7-3-2-4-8-13/h2-4,7-8,14,17-18H,5-6,9-12H2,1H3	GWYLMNQBOMEKHH-UHFFFAOYSA-N	methyl 1-[(1-benzyl-2-hydroxy-ethyl)amino]cyclopentanecarboxylate	56766466	COC(=O)C1(NC(CO)Cc2ccccc2)CCCC1	methyl 1-[(1-hydroxy-3-phenylpropan-2-yl)amino]cyclopentane-1-carboxylate			1.6106899999999995														277.36661		277.167794	4	2	7	2			48										False					Peptide01			Compound(56766466)	56766466	2.1	1008			[#6]-[#8]-[#6](=[#8])-[#6]1(-[#7]-[#6](-[#6]-[#8])-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]-[#6]-[#6]-[#6]-1	COC(=O)C1(NC(CO)Cc2ccccc2)CCCC1	GWYLMNQBOMEKHH		parent_pubchem_cid	AKOS016382424;methyl 1-[(1-benzyl-2-hydroxy-ethyl)amino]cyclopentanecarboxylate					pluskal_iocb_peptide_Peptide01_F7_id		100	F7		
3.0		0	335	P1652921	49.4		Y36	False	0	19	0	0	28	0	2	2	0	0		0.0						CC(C)CC(NC(=O)Cc1ccccc1)C(=O)N1CCCCC1																							0.0		AKOS027475306		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0		C19H28N2O2	C19H28N2O2			InChI=1S/C19H28N2O2/c1-15(2)13-17(19(23)21-11-7-4-8-12-21)20-18(22)14-16-9-5-3-6-10-16/h3,5-6,9-10,15,17H,4,7-8,11-14H2,1-2H3,(H,20,22)/t17-/m0/s1	DNOBYJATMILVPI-KRWDZBQOSA-N	2-phenyl-N-[rac-(1S)-3-methyl-1-(piperidine-1-carbonyl)butyl]acetamide	110351592	CC(C)C[C@H](NC(=O)Cc1ccccc1)C(=O)N1CCCCC1	N-[(2S)-4-methyl-1-oxo-1-piperidin-1-ylpentan-2-yl]-2-phenylacetamide			2.717790000000001														316.44721		316.215078	2	1	6	2			48									Piperidine alkaloids	False	Alkaloids;Amino acids and Peptides	Lysine alkaloids			Peptide01			Compound(110351592)	110351592	3.2	1009			[#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#7]1-[#6]-[#6]-[#6]-[#6]-[#6]-1	CC(C)C[C@H](NC(=O)Cc1ccccc1)C(=O)N1CCCCC1	DNOBYJATMILVPI		parent_pubchem_cid	AKOS027475306;2-phenyl-N-[rac-(1S)-3-methyl-1-(piperidine-1-carbonyl)butyl]acetamide					pluskal_iocb_peptide_Peptide01_F7_id		100	F7		
5.0		0	79	P0127442801	26.7		Y37	False	0	23	0	0	24	0	2	1	0	0		0.0						Oc1ccc(C2N(Cc3ccccc3)CCN2Cc2ccccc2)cc1																							0.0		4-(1,3-dibenzylimidazolidin-2-yl)phenol		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2		C23H24N2O	C23H24N2O			InChI=1S/C23H24N2O/c26-22-13-11-21(12-14-22)23-24(17-19-7-3-1-4-8-19)15-16-25(23)18-20-9-5-2-6-10-20/h1-14,23,26H,15-18H2	NYHYIUDGOIGOCH-UHFFFAOYSA-N	4-(1,3-dibenzylimidazolidin-2-yl)phenol	722031	Oc1ccc(C2N(Cc3ccccc3)CCN2Cc2ccccc2)cc1	4-(1,3-dibenzylimidazolidin-2-yl)phenol			3.7822600000000026														344.46053		344.188863	3	1	5	4			47										False	Alkaloids				Peptide01			Compound(722031)	722031	4.3	1010			[#8]-[#6]1:[#6]:[#6]:[#6](-[#6]2-[#7](-[#6]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3)-[#6]-[#6]-[#7]-2-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6]:[#6]:1	Oc1ccc(C2N(Cc3ccccc3)CCN2Cc2ccccc2)cc1	NYHYIUDGOIGOCH		parent_pubchem_cid	4-(1,3-dibenzylimidazolidin-2-yl)phenol;Oprea1_162117;Oprea1_702825;STK039673;AKOS000494755;CCG-104888;EU-0035829;SR-01000409373;SR-01000409373-1					pluskal_iocb_peptide_Peptide01_F7_id		100	F7		
3.6		0	167	P7020554652	84.2		Y38	False	1	20	0	0	18	0	3	3	0	0		0.0						Cc1cc(NC(=O)C(Cc2ccccc2)NC(=O)c2cc(Br)ccc2)no1																							0.0		AKOS005586332		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C20H18BrN3O3	C20H18BrN3O3			InChI=1S/C20H18BrN3O3/c1-13-10-18(24-27-13)23-20(26)17(11-14-6-3-2-4-7-14)22-19(25)15-8-5-9-16(21)12-15/h2-10,12,17H,11H2,1H3,(H,22,25)(H,23,24,26)/t17-/m0/s1	NSYWWICCUQGTRU-KRWDZBQOSA-N	N-[(1S)-1-benzyl-2-[(5-methylisoxazol-3-yl)amino]-2-oxo-ethyl]-3-bromo-benzamide	24315165	Cc1cc(NC(=O)[C@H](Cc2ccccc2)NC(=O)c2cc(Br)ccc2)no1	3-bromo-N-[(2S)-1-[(5-methyl-1,2-oxazol-3-yl)amino]-1-oxo-3-phenylpropan-2-yl]benzamide			3.180580000000001													MCULE-9891807252	428.28876		427.053154	3	2	6	3			44										False					Peptide01			Compound(24315165)	24315165	4.0	1011			[#6]-[#6]1:[#6]:[#6](-[#7]-[#6](=[#8])-[#6@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6](-[#35]):[#6]:[#6]:[#6]:2):[#7]:[#8]:1	Cc1cc(NC(=O)[C@H](Cc2ccccc2)NC(=O)c2cc(Br)ccc2)no1	NSYWWICCUQGTRU		parent_pubchem_cid	AKOS005586332;N-[(1S)-1-benzyl-2-[(5-methylisoxazol-3-yl)amino]-2-oxo-ethyl]-3-bromo-benzamide		14908990.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=14908990		pluskal_iocb_peptide_Peptide01_F7_id		100	F7		ZINC000012028746
4.0		0	255	P1305273	54.1		Y39	False	0	21	0	0	24	0	2	2	0	0		0.0						COc1ccc(C(CNC(=O)C(C)C)c2c[nH]c3ccccc23)cc1																							0.0		N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-methylpropanamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C21H24N2O2	C21H24N2O2			InChI=1S/C21H24N2O2/c1-14(2)21(24)23-12-18(15-8-10-16(25-3)11-9-15)19-13-22-20-7-5-4-6-17(19)20/h4-11,13-14,18,22H,12H2,1-3H3,(H,23,24)	MNNWQVZQAQNJCE-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-methyl-propanamide	17014429	COc1ccc(C(CNC(=O)C(C)C)c2c[nH]c3ccccc23)cc1	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-methylpropanamide			3.080350000000001													MCULE-1314286605	336.43763		336.183778	2	2	6	3			45										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(17014429)	17014429	4.1	1012			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6]-[#7]-[#6](=[#8])-[#6](-[#6])-[#6])-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	COc1ccc(C(CNC(=O)C(C)C)c2c[nH]c3ccccc23)cc1	MNNWQVZQAQNJCE		parent_pubchem_cid	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-methylpropanamide;905761-52-6;AKOS002334434;AKOS016326586;Z30425447;N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-methyl-propanamide		24623428.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24623428		pluskal_iocb_peptide_Peptide01_F7_id		100	F7		
1.7		0	343	P7542241	52.7		Y40	False	0	16	0	0	31	0	3	2	0	0		0.0						CCC(CC)C(=O)N1CCC(NC(=O)N(CC)CC)CC1																							0.0		1796489-58-1		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0		C16H31N3O2	C16H31N3O2			InChI=1S/C16H31N3O2/c1-5-13(6-2)15(20)19-11-9-14(10-12-19)17-16(21)18(7-3)8-4/h13-14H,5-12H2,1-4H3,(H,17,21)	PJZFALCDWZIXCJ-UHFFFAOYSA-N	1,1-diethyl-3-[1-(2-ethylbutanoyl)-4-piperidyl]urea	108566158	CCC(CC)C(=O)N1CCC(NC(=O)N(CC)CC)CC1	1,1-diethyl-3-[1-(2-ethylbutanoyl)piperidin-4-yl]urea			2.4650000000000007													MCULE-6955880517	297.44437		297.241627	2	1	6	1			44									Polyamines	False	Alkaloids	Ornithine alkaloids			Peptide01			Compound(108566158)	108566158	2.1	1013			[#6]-[#6]-[#6](-[#6]-[#6])-[#6](=[#8])-[#7]1-[#6]-[#6]-[#6](-[#7]-[#6](=[#8])-[#7](-[#6]-[#6])-[#6]-[#6])-[#6]-[#6]-1	CCC(CC)C(=O)N1CCC(NC(=O)N(CC)CC)CC1	PJZFALCDWZIXCJ		parent_pubchem_cid	1796489-58-1;AKOS027475549;EN300-749223;1,1-Diethyl-3-[1-(2-ethylbutanoyl)piperidin-4-yl]urea;3,3-DIETHYL-1-[1-(2-ETHYLBUTANOYL)PIPERIDIN-4-YL]UREA;1,1-diethyl-3-[1-(2-ethylbutanoyl)-4-piperidyl]urea		115456159.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=115456159		pluskal_iocb_peptide_Peptide01_F7_id		100	F7		ZINC000080084223
1.7		0	87	P1098940	136.0		Y41	False	0	21	0	0	21	0	3	6	0	0		0.0						O=C(CCCn1c(=O)[nH]c2ccccc2c1=O)NC(Cc1ccc(O)cc1)C(=O)O																							0.0		AKOS016402495		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	4	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0		C21H21N3O6	C21H21N3O6			InChI=1S/C21H21N3O6/c25-14-9-7-13(8-10-14)12-17(20(28)29)22-18(26)6-3-11-24-19(27)15-4-1-2-5-16(15)23-21(24)30/h1-2,4-5,7-10,17,25H,3,6,11-12H2,(H,22,26)(H,23,30)(H,28,29)/t17-/m0/s1	OWTFPWHQKXEPHT-KRWDZBQOSA-N	rac-(2S)-2-[4-(2,4-dioxo-1H-quinazolin-3-yl)butanoylamino]-3-(4-hydroxyphenyl)propanoic acid	1787283	O=C(CCCn1c(=O)[nH]c2ccccc2c1=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O	(2S)-2-[4-(2,4-dioxo-1H-quinazolin-3-yl)butanoylamino]-3-(4-hydroxyphenyl)propanoic acid			1.84194													MCULE-2956814509	411.41802		411.143035	6	4	8	3			44										False	Alkaloids				Peptide01			Compound(1787283)	1787283	1.5	1014			[#8]=[#6](-[#6]-[#6]-[#6]-[#7]1:[#6](=[#8]):[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6](-[#8]):[#6]:[#6]:1)-[#6](=[#8])-[#8]	O=C(CCCn1c(=O)[nH]c2ccccc2c1=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O	OWTFPWHQKXEPHT		parent_pubchem_cid	AKOS016402495;AKOS037496761;(S)-2-(4-(2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)butanamido)-3-(4-hydroxyphenyl)propanoic acid;2-[4-(2,4-DIOXO-1,2,3,4-TETRAHYDROQUINAZOLIN-3-YL)BUTANAMIDO]-3-(4-HYDROXYPHENYL)PROPANOIC ACID;rac-(2S)-2-[4-(2,4-dioxo-1H-quinazolin-3-yl)butanoylamino]-3-(4-hydroxyphenyl)propanoic acid		23939524.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23939524		pluskal_iocb_peptide_Peptide01_F7_id		100	F7		ZINC000009046161
2.7		0	175	P7020556581	85.5	HCl	Y42	False	0	21	0	0	26	0	2	5	0	1		0.0						O=S(=O)(CCc1ccccc1)NCC(c1cc2c(cc1)OCO2)N1CCOCC1																							0.0		N-[2-(1,3-benzodioxol-5-yl)-2-morpholino-ethyl]-2-phenyl-ethanesulfonamide;hydrochloride		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	1		C21H27ClN2O5S	C21H26N2O5S			InChI=1S/C21H26N2O5S/c24-29(25,13-8-17-4-2-1-3-5-17)22-15-19(23-9-11-26-12-10-23)18-6-7-20-21(14-18)28-16-27-20/h1-7,14,19,22H,8-13,15-16H2	XUJADAOBPBCONT-UHFFFAOYSA-N	N-[2-(1,3-benzodioxol-5-yl)-2-morpholino-ethyl]-2-phenyl-ethanesulfonamide;hydrochloride	24316826	O=S(=O)(CCc1ccccc1)NCC(c1cc2c(cc1)OCO2)N1CCOCC1	N-[2-(1,3-benzodioxol-5-yl)-2-morpholin-4-ylethyl]-2-phenylethanesulfonamide			0.9164600000000004													MCULE-6641117618	454.97674		418.156243	6	1	8	4			44										False	Alkaloids				Peptide01			Compound(24316826)	24316826	2.3	1015			[#8]=[#16](=[#8])(-[#6]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6]-[#6](-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1)-[#8]-[#6]-[#8]-2)-[#7]1-[#6]-[#6]-[#8]-[#6]-[#6]-1	O=S(=O)(CCc1ccccc1)NCC(c1cc2c(cc1)OCO2)N1CCOCC1	XUJADAOBPBCONT		parent_pubchem_cid	"""N-[2-(1,3-benzodioxol-5-yl)-2-morpholino-ethyl]-2-phenyl-ethanesulfonamide;hydrochloride"""		57506276.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=57506276		pluskal_iocb_peptide_Peptide01_F7_id		100	F7		
4.9		0	263	P1305493	54.1		Y43	False	0	25	0	0	24	0	2	2	0	0		0.0						Cc1ccccc1OCC(=O)NCC(c1ccccc1)c1c[nH]c2ccccc12																							0.0		N-[2-(1H-indol-3-yl)-2-phenylethyl]-2-(2-methylphenoxy)acetamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C25H24N2O2	C25H24N2O2			InChI=1S/C25H24N2O2/c1-18-9-5-8-14-24(18)29-17-25(28)27-15-21(19-10-3-2-4-11-19)22-16-26-23-13-7-6-12-20(22)23/h2-14,16,21,26H,15,17H2,1H3,(H,27,28)	LHESKRNGFNTJPW-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]-2-(2-methylphenoxy)acetamide	17014640	Cc1ccccc1OCC(=O)NCC(c1ccccc1)c1c[nH]c2ccccc12	N-[2-(1H-indol-3-yl)-2-phenylethyl]-2-(2-methylphenoxy)acetamide			3.7484600000000015													MCULE-6015189424	384.48223		384.183778	2	2	7	4			45										False	Alkaloids				Peptide01			Compound(17014640)	17014640	5.1	1016			[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#8]-[#6]-[#6](=[#8])-[#7]-[#6]-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	Cc1ccccc1OCC(=O)NCC(c1ccccc1)c1c[nH]c2ccccc12	LHESKRNGFNTJPW		parent_pubchem_cid	N-[2-(1H-indol-3-yl)-2-phenylethyl]-2-(2-methylphenoxy)acetamide;AKOS002334331;AKOS016326704;N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]-2-(2-methylphenoxy)acetamide		24341903.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24341903		pluskal_iocb_peptide_Peptide01_F8_id		100	F8		
2.5		0	351	P6248847	126.1		Y44	False	0	19	0	0	20	0	2	6	0	1		0.0						COc1cc(S(=O)(=O)NC(Cc2c[nH]c3ccccc23)C(=O)O)c(OC)cc1																							0.0		N-[(2,5-dimethoxyphenyl)sulfonyl]tryptophan		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0		C19H20N2O6S	C19H20N2O6S			InChI=1S/C19H20N2O6S/c1-26-13-7-8-17(27-2)18(10-13)28(24,25)21-16(19(22)23)9-12-11-20-15-6-4-3-5-14(12)15/h3-8,10-11,16,20-21H,9H2,1-2H3,(H,22,23)	DTFMAJGTECLGTR-UHFFFAOYSA-N	2-[(2,5-dimethoxyphenyl)sulfonylamino]-3-(1H-indol-3-yl)propanoic acid	56726554	COc1cc(S(=O)(=O)NC(Cc2c[nH]c3ccccc23)C(=O)O)c(OC)cc1	2-[(2,5-dimethoxyphenyl)sulfonylamino]-3-(1H-indol-3-yl)propanoic acid			0.6433400000000002													MCULE-6329030539	404.44505		404.104207	6	3	8	3			44										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(56726554)	56726554	2.5	1017			[#6]-[#8]-[#6]1:[#6]:[#6](-[#16](=[#8])(=[#8])-[#7]-[#6](-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6](=[#8])-[#8]):[#6](-[#8]-[#6]):[#6]:[#6]:1	COc1cc(S(=O)(=O)NC(Cc2c[nH]c3ccccc23)C(=O)O)c(OC)cc1	DTFMAJGTECLGTR		parent_pubchem_cid	N-[(2,5-dimethoxyphenyl)sulfonyl]tryptophan;AKOS016386418;AQ-390/43490660;2-[(2,5-dimethoxyphenyl)sulfonylamino]-3-(1H-indol-3-yl)propanoic acid		23612646.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23612646		pluskal_iocb_peptide_Peptide01_F8_id		100	F8		
4.7		0	359	P6248791	107.6		Z1	False	0	23	0	0	26	0	2	4	0	1		0.0						O=C(O)C(Cc1c[nH]c2ccccc12)NS(=O)(=O)c1ccc(C2CCCCC2)cc1																							0.0		AKOS016401695		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0		C23H26N2O4S	C23H26N2O4S			InChI=1S/C23H26N2O4S/c26-23(27)22(14-18-15-24-21-9-5-4-8-20(18)21)25-30(28,29)19-12-10-17(11-13-19)16-6-2-1-3-7-16/h4-5,8-13,15-16,22,24-25H,1-3,6-7,14H2,(H,26,27)	LVTRVDMOFYWPFQ-UHFFFAOYSA-N	2-[(4-cyclohexylphenyl)sulfonylamino]-3-(1H-indol-3-yl)propanoic acid	75110456	O=C(O)C(Cc1c[nH]c2ccccc12)NS(=O)(=O)c1ccc(C2CCCCC2)cc1	2-[(4-cyclohexylphenyl)sulfonylamino]-3-(1H-indol-3-yl)propanoic acid			3.5439500000000024													MCULE-4226735295	426.53867		426.161328	4	3	7	4			45										False					Peptide01			Compound(75110456)	75110456	4.3	1018			[#8]=[#6](-[#8])-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#16](=[#8])(=[#8])-[#6]1:[#6]:[#6]:[#6](-[#6]2-[#6]-[#6]-[#6]-[#6]-[#6]-2):[#6]:[#6]:1	O=C(O)C(Cc1c[nH]c2ccccc12)NS(=O)(=O)c1ccc(C2CCCCC2)cc1	LVTRVDMOFYWPFQ		parent_pubchem_cid	AKOS016401695;2-[(4-cyclohexylphenyl)sulfonylamino]-3-(1H-indol-3-yl)propanoic acid		78037549.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=78037549		pluskal_iocb_peptide_Peptide01_F8_id		100	F8		
2.6		0	447	P2195427	67.4		Z2	False	0	21	0	0	26	0	2	3	0	0		0.0						COCCCNC(=O)C(Cc1ccccc1)NC(=O)c1ccc(C)cc1																							0.0		AKOS015861393		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C21H26N2O3	C21H26N2O3			InChI=1S/C21H26N2O3/c1-16-9-11-18(12-10-16)20(24)23-19(15-17-7-4-3-5-8-17)21(25)22-13-6-14-26-2/h3-5,7-12,19H,6,13-15H2,1-2H3,(H,22,25)(H,23,24)	TXKPXWXKXICPCF-UHFFFAOYSA-N	N-[1-benzyl-2-(3-methoxypropylamino)-2-oxo-ethyl]-4-methyl-benzamide	51065894	COCCCNC(=O)C(Cc1ccccc1)NC(=O)c1ccc(C)cc1	N-[1-(3-methoxypropylamino)-1-oxo-3-phenylpropan-2-yl]-4-methylbenzamide			2.3246899999999995													MCULE-2969182512	354.45297		354.194343	3	2	9	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51065894)	51065894	3.1	1019			[#6]-[#8]-[#6]-[#6]-[#6]-[#7]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:1	COCCCNC(=O)C(Cc1ccccc1)NC(=O)c1ccc(C)cc1	TXKPXWXKXICPCF		parent_pubchem_cid	AKOS015861393;N-[1-benzyl-2-(3-methoxypropylamino)-2-oxo-ethyl]-4-methyl-benzamide		24526156.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24526156		pluskal_iocb_peptide_Peptide01_F8_id		100	F8		
3.2		0	535	P2195927	84.5		Z3	False	0	21	0	0	32	0	2	4	0	0		0.0						COC(=O)CCNC(=O)C(CC(C)C)NC(=O)c1ccc(C(C)(C)C)cc1																							0.0		AKOS015861794		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C21H32N2O4	C21H32N2O4			InChI=1S/C21H32N2O4/c1-14(2)13-17(20(26)22-12-11-18(24)27-6)23-19(25)15-7-9-16(10-8-15)21(3,4)5/h7-10,14,17H,11-13H2,1-6H3,(H,22,26)(H,23,25)	GMYDMSXXXWXWSI-UHFFFAOYSA-N	methyl 3-[[2-[(4-tert-butylbenzoyl)amino]-4-methyl-pentanoyl]amino]propanoate	52988656	COC(=O)CCNC(=O)C(CC(C)C)NC(=O)c1ccc(C(C)(C)C)cc1	methyl 3-[[2-[(4-tert-butylbenzoyl)amino]-4-methylpentanoyl]amino]propanoate			2.698480000000001													MCULE-7140542892	376.50019		376.236208	4	2	10	1			45									Tripeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(52988656)	52988656	3.8	1020			[#6]-[#8]-[#6](=[#8])-[#6]-[#6]-[#7]-[#6](=[#8])-[#6](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6])(-[#6])-[#6]):[#6]:[#6]:1	COC(=O)CCNC(=O)C(CC(C)C)NC(=O)c1ccc(C(C)(C)C)cc1	GMYDMSXXXWXWSI		parent_pubchem_cid	AKOS015861794;methyl 3-[[2-[(4-tert-butylbenzoyl)amino]-4-methyl-pentanoyl]amino]propanoate		23313064.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23313064		pluskal_iocb_peptide_Peptide01_F8_id		100	F8		
4.0		0	623	P1307067	64.3		Z4	False	0	18	0	0	20	0	2	1	0	1		0.0						CC(C)C(=O)N(C)C(c1cccs1)c1c[nH]c2ccccc12																							0.0		AKOS001911126		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C18H20N2OS	C18H20N2OS			InChI=1S/C18H20N2OS/c1-12(2)18(21)20(3)17(16-9-6-10-22-16)14-11-19-15-8-5-4-7-13(14)15/h4-12,17,19H,1-3H3	MQABNDKLHCRMMY-UHFFFAOYSA-N	N-[1H-indol-3-yl(2-thienyl)methyl]-N,2-dimethyl-propanamide	20895190	CC(C)C(=O)N(C)C(c1cccs1)c1c[nH]c2ccccc12	N-[1H-indol-3-yl(thiophen-2-yl)methyl]-N,2-dimethylpropanamide			3.895360000000003													MCULE-9107712175	312.4369		312.129634	1	1	4	3			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(20895190)	20895190	3.8	1021			[#6]-[#6](-[#6])-[#6](=[#8])-[#7](-[#6])-[#6](-[#6]1:[#6]:[#6]:[#6]:[#16]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CC(C)C(=O)N(C)C(c1cccs1)c1c[nH]c2ccccc12	MQABNDKLHCRMMY		parent_pubchem_cid	AKOS001911126;AKOS016329115;CCG-154608;N-[(1H-INDOL-3-YL)(THIOPHEN-2-YL)METHYL]-N,2-DIMETHYLPROPANAMIDE;N-[1H-indol-3-yl(2-thienyl)methyl]-N,2-dimethyl-propanamide		22684249.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22684249		pluskal_iocb_peptide_Peptide01_F8_id		100	F8		
1.2		0	367	P11184875	115.8		Z5	False	0	18	0	0	23	0	3	5	0	0		0.0						CCC(C)C(NC(=O)CCc1cc2c(cc1)n(C)c(=O)c(=O)[nH]2)C(=O)O																							0.0		AKOS027472531		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1	0		C18H23N3O5	C18H23N3O5			InChI=1S/C18H23N3O5/c1-4-10(2)15(18(25)26)20-14(22)8-6-11-5-7-13-12(9-11)19-16(23)17(24)21(13)3/h5,7,9-10,15H,4,6,8H2,1-3H3,(H,19,23)(H,20,22)(H,25,26)/t10-,15+/m1/s1	GLSFMMUKXMHICG-BMIGLBTASA-N	rac-(2S,3R)-3-methyl-2-[3-(1-methyl-2,3-dioxo-4H-quinoxalin-6-yl)propanoylamino]pentanoic acid	91640409	CC[C@@H](C)[C@H](NC(=O)CCc1cc2c(cc1)n(C)c(=O)c(=O)[nH]2)C(=O)O	(2S,3R)-3-methyl-2-[3-(1-methyl-2,3-dioxo-4H-quinoxalin-6-yl)propanoylamino]pentanoic acid			2.09155														361.40111		361.163771	5	3	7	2			45									Quinoline alkaloids	False	Alkaloids	Tryptophan alkaloids;Anthranilic acid alkaloids			Peptide01			Compound(91640409)	91640409	1.5	1022			[#6]-[#6]-[#6@@H](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#6]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#7](-[#6]):[#6](=[#8]):[#6](=[#8]):[#7H]:2)-[#6](=[#8])-[#8]	CC[C@@H](C)[C@H](NC(=O)CCc1cc2c(cc1)n(C)c(=O)c(=O)[nH]2)C(=O)O	GLSFMMUKXMHICG		parent_pubchem_cid	AKOS027472531;rac-(2S,3R)-3-methyl-2-[3-(1-methyl-2,3-dioxo-4H-quinoxalin-6-yl)propanoylamino]pentanoic acid		92991664.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=92991664		pluskal_iocb_peptide_Peptide01_F8_id		100	F8		ZINC000218315831
3.5		0	455	P2195696	84.5		Z6	False	0	24	0	0	30	0	2	4	0	0		0.0						COC(=O)CCNC(=O)C(Cc1ccccc1)NC(=O)c1ccc(C(C)(C)C)cc1																							0.0		AKOS015861625		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C24H30N2O4	C24H30N2O4			InChI=1S/C24H30N2O4/c1-24(2,3)19-12-10-18(11-13-19)22(28)26-20(16-17-8-6-5-7-9-17)23(29)25-15-14-21(27)30-4/h5-13,20H,14-16H2,1-4H3,(H,25,29)(H,26,28)	FOKDUBXGOGPURB-UHFFFAOYSA-N	methyl 3-[[2-[(4-tert-butylbenzoyl)amino]-3-phenyl-propanoyl]amino]propanoate	52988566	COC(=O)CCNC(=O)C(Cc1ccccc1)NC(=O)c1ccc(C(C)(C)C)cc1	methyl 3-[[2-[(4-tert-butylbenzoyl)amino]-3-phenylpropanoyl]amino]propanoate			2.84037													MCULE-2337640831	410.5177		410.220557	4	2	10	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(52988566)	52988566	4.0	1023			[#6]-[#8]-[#6](=[#8])-[#6]-[#6]-[#7]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6])(-[#6])-[#6]):[#6]:[#6]:1	COC(=O)CCNC(=O)C(Cc1ccccc1)NC(=O)c1ccc(C(C)(C)C)cc1	FOKDUBXGOGPURB		parent_pubchem_cid	AKOS015861625;methyl 3-[[2-[(4-tert-butylbenzoyl)amino]-3-phenyl-propanoyl]amino]propanoate		24032673.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24032673		pluskal_iocb_peptide_Peptide01_F8_id		100	F8		
5.0		0	543	P1310235	54.6		Z7	False	0	26	0	0	26	0	2	3	0	0		0.0						COc1ccc(C(c2c[nH]c3ccccc23)N(C)C(=O)COc2cccc(C)c2)cc1																							0.0		AKOS002281039		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C26H26N2O3	C26H26N2O3			InChI=1S/C26H26N2O3/c1-18-7-6-8-21(15-18)31-17-25(29)28(2)26(19-11-13-20(30-3)14-12-19)23-16-27-24-10-5-4-9-22(23)24/h4-16,26-27H,17H2,1-3H3	NOGRAFJMUXMYIA-UHFFFAOYSA-N	N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-N-methyl-2-(3-methylphenoxy)acetamide	43843744	COc1ccc(C(c2c[nH]c3ccccc23)N(C)C(=O)COc2cccc(C)c2)cc1	N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-N-methyl-2-(3-methylphenoxy)acetamide			3.594350000000002													MCULE-7635061463	414.50872		414.194343	3	1	7	4			45										False	Alkaloids				Peptide01			Compound(43843744)	43843744	5.1	1024			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#7](-[#6])-[#6](=[#8])-[#6]-[#8]-[#6]2:[#6]:[#6]:[#6]:[#6](-[#6]):[#6]:2):[#6]:[#6]:1	COc1ccc(C(c2c[nH]c3ccccc23)N(C)C(=O)COc2cccc(C)c2)cc1	NOGRAFJMUXMYIA		parent_pubchem_cid	AKOS002281039;AKOS016329038;N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-N-methyl-2-(3-methylphenoxy)acetamide		24603984.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24603984		pluskal_iocb_peptide_Peptide01_F9_id		100	F9		
4.9		0	631	P1307068	73.6		Z8	False	0	23	0	0	22	0	2	2	0	1		0.0						Cc1cc(OCC(=O)N(C)C(c2cccs2)c2c[nH]c3ccccc23)ccc1																							0.0		STL208093		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C23H22N2O2S	C23H22N2O2S			InChI=1S/C23H22N2O2S/c1-16-7-5-8-17(13-16)27-15-22(26)25(2)23(21-11-6-12-28-21)19-14-24-20-10-4-3-9-18(19)20/h3-14,23-24H,15H2,1-2H3	BEWYYFQTACSGFU-UHFFFAOYSA-N	N-[1H-indol-3-yl(2-thienyl)methyl]-N-methyl-2-(3-methylphenoxy)acetamide	20895184	Cc1cc(OCC(=O)N(C)C(c2cccs2)c2c[nH]c3ccccc23)ccc1	N-[1H-indol-3-yl(thiophen-2-yl)methyl]-N-methyl-2-(3-methylphenoxy)acetamide			4.1096600000000025													MCULE-7534852808	390.50799		390.140199	2	1	6	4			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(20895184)	20895184	4.8	1025			[#6]-[#6]1:[#6]:[#6](-[#8]-[#6]-[#6](=[#8])-[#7](-[#6])-[#6](-[#6]2:[#6]:[#6]:[#6]:[#16]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:[#6]:1	Cc1cc(OCC(=O)N(C)C(c2cccs2)c2c[nH]c3ccccc23)ccc1	BEWYYFQTACSGFU		parent_pubchem_cid	STL208093;AKOS001911010;AKOS016329116;N-[(1H-INDOL-3-YL)(THIOPHEN-2-YL)METHYL]-N-METHYL-2-(3-METHYLPHENOXY)ACETAMIDE;N-[1H-indol-3-yl(thiophen-2-yl)methyl]-N-methyl-2-(3-methylphenoxy)acetamide;N-[1H-indol-3-yl(2-thienyl)methyl]-N-methyl-2-(3-methylphenoxy)acetamide		23332873.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23332873		pluskal_iocb_peptide_Peptide01_F9_id		100	F9		
1.1		0	375	P6237059	162.6		Z9	False	0	17	0	0	20	0	4	4	0	1		0.0						NC(=O)NCCCC(NC(=O)Cc1csc(-c2ccccc2)n1)C(=O)O																							0.0		SCHEMBL20255639		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	1	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C17H20N4O4S	C17H20N4O4S			InChI=1S/C17H20N4O4S/c18-17(25)19-8-4-7-13(16(23)24)21-14(22)9-12-10-26-15(20-12)11-5-2-1-3-6-11/h1-3,5-6,10,13H,4,7-9H2,(H,21,22)(H,23,24)(H3,18,19,25)/t13-/m1/s1	SUAREUWTIOWSFF-CYBMUJFWSA-N	rac-(2R)-2-[[2-(2-phenylthiazol-4-yl)acetyl]amino]-5-ureido-pentanoic acid	75366477	NC(=O)NCCC[C@@H](NC(=O)Cc1csc(-c2ccccc2)n1)C(=O)O	(2R)-5-(carbamoylamino)-2-[[2-(2-phenyl-1,3-thiazol-4-yl)acetyl]amino]pentanoic acid			0.9357699999999995													MCULE-8439597568	376.43735		376.120526	5	4	9	2			43									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(75366477)	75366477	0.9	1026		SCHEMBL20255639	[#7]-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]-[#6@@H](-[#7]-[#6](=[#8])-[#6]-[#6]1:[#6]:[#16]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#7]:1)-[#6](=[#8])-[#8]	NC(=O)NCCC[C@@H](NC(=O)Cc1csc(-c2ccccc2)n1)C(=O)O	SUAREUWTIOWSFF		parent_pubchem_cid	SCHEMBL20255639;EiM08-05103;AKOS016398011;N~5~-carbamoyl-N~2~-[(2-phenyl-1,3-thiazol-4-yl)acetyl]-D-ornithine;rac-(2R)-2-[[2-(2-phenylthiazol-4-yl)acetyl]amino]-5-ureido-pentanoic acid		80293187.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=80293187		pluskal_iocb_peptide_Peptide01_F9_id		100	F9		ZINC000094992901
3.8		0	463	P2195695	84.5		Z10	False	0	25	0	0	32	0	2	4	0	0		0.0						COC(=O)CCCNC(=O)C(Cc1ccccc1)NC(=O)c1ccc(C(C)(C)C)cc1																							0.0		AKOS015861618		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C25H32N2O4	C25H32N2O4			InChI=1S/C25H32N2O4/c1-25(2,3)20-14-12-19(13-15-20)23(29)27-21(17-18-9-6-5-7-10-18)24(30)26-16-8-11-22(28)31-4/h5-7,9-10,12-15,21H,8,11,16-17H2,1-4H3,(H,26,30)(H,27,29)	OVQXGMPPEVRBRH-UHFFFAOYSA-N	methyl 4-[[2-[(4-tert-butylbenzoyl)amino]-3-phenyl-propanoyl]amino]butanoate	52988565	COC(=O)CCCNC(=O)C(Cc1ccccc1)NC(=O)c1ccc(C(C)(C)C)cc1	methyl 4-[[2-[(4-tert-butylbenzoyl)amino]-3-phenylpropanoyl]amino]butanoate			3.2304700000000013													MCULE-5908499984	424.54479		424.236208	4	2	11	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(52988565)	52988565	4.4	1027			[#6]-[#8]-[#6](=[#8])-[#6]-[#6]-[#6]-[#7]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6])(-[#6])-[#6]):[#6]:[#6]:1	COC(=O)CCCNC(=O)C(Cc1ccccc1)NC(=O)c1ccc(C(C)(C)C)cc1	OVQXGMPPEVRBRH		parent_pubchem_cid	AKOS015861618;methyl 4-[[2-[(4-tert-butylbenzoyl)amino]-3-phenyl-propanoyl]amino]butanoate		24253411.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24253411		pluskal_iocb_peptide_Peptide01_F9_id		100	F9		
3.9		0	551	P6138277	79.5		Z11	False	0	21	0	0	21	0	1	4	0	0		0.0						Cc1cc2c(cc1C)c(CC(=O)NC(Cc1ccccc1)C(=O)O)co2																							0.0		AKOS016027523		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C21H21NO4	C21H21NO4			InChI=1S/C21H21NO4/c1-13-8-17-16(12-26-19(17)9-14(13)2)11-20(23)22-18(21(24)25)10-15-6-4-3-5-7-15/h3-9,12,18H,10-11H2,1-2H3,(H,22,23)(H,24,25)	WWAQFGPKRXYHBE-UHFFFAOYSA-N	2-[[2-(5,6-dimethylbenzofuran-3-yl)acetyl]amino]-3-phenyl-propanoic acid	60173602	Cc1cc2c(cc1C)c(CC(=O)NC(Cc1ccccc1)C(=O)O)co2	2-[[2-(5,6-dimethyl-1-benzofuran-3-yl)acetyl]amino]-3-phenylpropanoic acid			2.7569800000000004													MCULE-1488055229	351.40582		351.147058	3	2	6	3			45										False	Shikimates and Phenylpropanoids				Peptide01			Compound(60173602)	60173602	3.9	1028			[#6]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1-[#6]):[#6](-[#6]-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]):[#6]:[#8]:2	Cc1cc2c(cc1C)c(CC(=O)NC(Cc1ccccc1)C(=O)O)co2	WWAQFGPKRXYHBE		parent_pubchem_cid	AKOS016027523;2-[[2-(5,6-dimethylbenzofuran-3-yl)acetyl]amino]-3-phenyl-propanoic acid		62090689.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=62090689		pluskal_iocb_peptide_Peptide01_F9_id		100	F9		
4.6		0	639	P1309973	54.6		Z12	False	0	25	0	0	24	0	2	3	0	0		0.0						COc1ccc(C(c2c[nH]c3ccccc23)N(C)C(=O)COc2ccccc2)cc1																							0.0		AKOS001911925		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C25H24N2O3	C25H24N2O3			InChI=1S/C25H24N2O3/c1-27(24(28)17-30-20-8-4-3-5-9-20)25(18-12-14-19(29-2)15-13-18)22-16-26-23-11-7-6-10-21(22)23/h3-16,25-26H,17H2,1-2H3	CANIJABCNRJCFR-UHFFFAOYSA-N	N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-N-methyl-2-phenoxy-acetamide	20895157	COc1ccc(C(c2c[nH]c3ccccc23)N(C)C(=O)COc2ccccc2)cc1	N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-N-methyl-2-phenoxyacetamide			3.3406400000000023													MCULE-1632243904	400.48163		400.178693	3	1	7	4			45										False	Alkaloids				Peptide01			Compound(20895157)	20895157	4.7	1029			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#7](-[#6])-[#6](=[#8])-[#6]-[#8]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6]:[#6]:1	COc1ccc(C(c2c[nH]c3ccccc23)N(C)C(=O)COc2ccccc2)cc1	CANIJABCNRJCFR		parent_pubchem_cid	AKOS001911925;AKOS016330355;N-[(1H-INDOL-3-YL)(4-METHOXYPHENYL)METHYL]-N-METHYL-2-PHENOXYACETAMIDE;N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-N-methyl-2-phenoxy-acetamide		23795224.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23795224		pluskal_iocb_peptide_Peptide01_F9_id		100	F9		
2.4		0	383	P1122589	69.6		Z13	False	0	15	0	0	20	0	2	3	0	0		0.0						CC(C)CC(NC(=O)N1CCc2ccccc21)C(=O)O																							0.0		(Indoline-1-carbonyl)-L-leucine		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C15H20N2O3	C15H20N2O3			InChI=1S/C15H20N2O3/c1-10(2)9-12(14(18)19)16-15(20)17-8-7-11-5-3-4-6-13(11)17/h3-6,10,12H,7-9H2,1-2H3,(H,16,20)(H,18,19)/t12-/m0/s1	ZIGFLLFEYRMVGX-LBPRGKRZSA-N	rac-(2S)-2-(indoline-1-carbonylamino)-4-methyl-pentanoic acid	16419618	CC(C)C[C@H](NC(=O)N1CCc2ccccc21)C(=O)O	(2S)-2-(2,3-dihydroindole-1-carbonylamino)-4-methylpentanoic acid			1.8226800000000003													MCULE-1043290483	276.33825		276.147393	3	2	4	2			44										False	Alkaloids				Peptide01			Compound(16419618)	16419618	2.5	1030			[#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#7]1-[#6]-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]-1:2)-[#6](=[#8])-[#8]	CC(C)C[C@H](NC(=O)N1CCc2ccccc21)C(=O)O	ZIGFLLFEYRMVGX		parent_pubchem_cid	(Indoline-1-carbonyl)-L-leucine;AKOS004937592;(2S)-2-[(2,3-DIHYDRO-1H-INDOL-1-YLCARBONYL)AMINO]-4-METHYLPENTANOIC ACID;rac-(2S)-2-(indoline-1-carbonylamino)-4-methyl-pentanoic acid		23089915.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23089915		pluskal_iocb_peptide_Peptide01_F9_id		100	F9		ZINC000009481446
2.4		0	471	P2195370	118.5		Z14	False	0	18	1	0	21	0	4	3	0	1		0.0						COCCNC(=O)C(Cc1ccccc1)NC(=O)c1nc(SC)ncc1Cl																							0.0		STL218832		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C18H21ClN4O3S	C18H21ClN4O3S			InChI=1S/C18H21ClN4O3S/c1-26-9-8-20-16(24)14(10-12-6-4-3-5-7-12)22-17(25)15-13(19)11-21-18(23-15)27-2/h3-7,11,14H,8-10H2,1-2H3,(H,20,24)(H,22,25)	JATQJDWRKDDGHT-UHFFFAOYSA-N	N-[1-benzyl-2-(2-methoxyethylamino)-2-oxo-ethyl]-5-chloro-2-methylsulfanyl-pyrimidine-4-carboxamide	51065839	COCCNC(=O)C(Cc1ccccc1)NC(=O)c1nc(SC)ncc1Cl	5-chloro-N-[1-(2-methoxyethylamino)-1-oxo-3-phenylpropan-2-yl]-2-methylsulfanylpyrimidine-4-carboxamide			1.738169999999999													MCULE-1086326542	408.91007		408.102289	6	2	9	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51065839)	51065839	2.5	1031			[#6]-[#8]-[#6]-[#6]-[#7]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]1:[#7]:[#6](-[#16]-[#6]):[#7]:[#6]:[#6]:1-[#17]	COCCNC(=O)C(Cc1ccccc1)NC(=O)c1nc(SC)ncc1Cl	JATQJDWRKDDGHT		parent_pubchem_cid	STL218832;AKOS015861457;Nalpha-{[5-chloro-2-(methylsulfanyl)pyrimidin-4-yl]carbonyl}-N-(2-methoxyethyl)phenylalaninamide;N-[1-benzyl-2-(2-methoxyethylamino)-2-oxo-ethyl]-5-chloro-2-methylsulfanyl-pyrimidine-4-carboxamide		23290778.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23290778		pluskal_iocb_peptide_Peptide01_F9_id		100	F9		
4.9		0	559	P1310458	36.4		Z15	False	0	25	0	0	23	0	3	1	0	0		0.0						CN(C)c1ccc(CN(C(=O)c2cccc3ccccc23)c2ccccn2)cc1																							0.0		AKOS002280823		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1		C25H23N3O	C25H23N3O			InChI=1S/C25H23N3O/c1-27(2)21-15-13-19(14-16-21)18-28(24-12-5-6-17-26-24)25(29)23-11-7-9-20-8-3-4-10-22(20)23/h3-17H,18H2,1-2H3	YUMJMVTVLIGWLJ-UHFFFAOYSA-N	N-[[4-(dimethylamino)phenyl]methyl]-N-(2-pyridyl)naphthalene-1-carboxamide	35574860	CN(C)c1ccc(CN(C(=O)c2cccc3ccccc23)c2ccccn2)cc1	N-[[4-(dimethylamino)phenyl]methyl]-N-pyridin-2-ylnaphthalene-1-carboxamide			3.848740000000003													MCULE-4541032432	381.48156		381.184112	3	0	5	4			44										False					Peptide01			Compound(35574860)	35574860	5.1	1032			[#6]-[#7](-[#6])-[#6]1:[#6]:[#6]:[#6](-[#6]-[#7](-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6]2:[#6]:[#6]:[#6]:[#6]:[#7]:2):[#6]:[#6]:1	CN(C)c1ccc(CN(C(=O)c2cccc3ccccc23)c2ccccn2)cc1	YUMJMVTVLIGWLJ		parent_pubchem_cid	AKOS002280823;N-{[4-(DIMETHYLAMINO)PHENYL]METHYL}-N-(PYRIDIN-2-YL)NAPHTHALENE-1-CARBOXAMIDE;N-[[4-(dimethylamino)phenyl]methyl]-N-(2-pyridyl)naphthalene-1-carboxamide		2940015.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=2940015		pluskal_iocb_peptide_Peptide01_F10_id		100	F10		ZINC000028289151
4.8		0	647	P1305270	54.1		Z16	False	0	24	0	1	21	0	2	2	0	0		0.0						COc1ccc(C(CNC(=O)c2ccccc2F)c2c[nH]c3ccccc23)cc1																							0.0		2-fluoro-N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]benzamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C24H21FN2O2	C24H21FN2O2			InChI=1S/C24H21FN2O2/c1-29-17-12-10-16(11-13-17)20(21-15-26-23-9-5-3-6-18(21)23)14-27-24(28)19-7-2-4-8-22(19)25/h2-13,15,20,26H,14H2,1H3,(H,27,28)	VLELJZSJHCYMLT-UHFFFAOYSA-N	2-fluoro-N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]benzamide	17014426	COc1ccc(C(CNC(=O)c2ccccc2F)c2c[nH]c3ccccc23)cc1	2-fluoro-N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]benzamide			3.822540000000002													MCULE-5813609269	388.44557		388.158706	2	2	6	4			44										False	Alkaloids				Peptide01			Compound(17014426)	17014426	4.8	1033			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6]-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#9])-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	COc1ccc(C(CNC(=O)c2ccccc2F)c2c[nH]c3ccccc23)cc1	VLELJZSJHCYMLT		parent_pubchem_cid	2-fluoro-N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]benzamide;STL207386;AKOS002335925;AKOS016326583		23835937.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23835937		pluskal_iocb_peptide_Peptide01_F10_id		100	F10		
1.0		0	391	P7570635	119.5		Z17	False	0	15	0	0	16	0	2	5	0	0		0.0						O=C(O)CCC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)O								3-alkylindoles;Substituted pyrroles;N-acyl amines;Dicarboxylic acids and derivatives;Benzenoids;Heteroaromatic compounds;Secondary carboxylic acid amides;Carboxylic acids;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	3-alkylindoles;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Dicarboxylic acids and derivatives;Fatty Acyls;Fatty amides;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Lipids and lipid-like molecules;N-acyl amines;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom.	N-acyl-alpha amino acids		Amino acids and derivatives;Alpha amino acids and derivatives;N-acyl-alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	indoles (CHEBI:24828);pyrroles (CHEBI:26455);fatty amide (CHEBI:29348);dicarboxylic acid (CHEBI:35692);benzenoid aromatic compound (CHEBI:33836);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);carboxylic acid (CHEBI:33575);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);N-acyl-amino acid (CHEBI:51569);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);lipid (CHEBI:18059);organooxygen compound (CHEBI:36963);organic acid (CHEBI:64709);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806);carboxylic acid anion (CHEBI:29067);amino acid (CHEBI:33709);peptide (CHEBI:16670)	N-acyl amines (FA0802);Dicarboxylic acids (FA0117);Fatty Acyls (FA);Fatty amides (FA08)	Amino acids, peptides, and analogues	N-acyl-alpha-amino acid;3-alkylindole;Indole;Indole or derivatives;Dicarboxylic acid or derivatives;Fatty amide;N-acyl-amine;Substituted pyrrole;Benzenoid;Fatty acyl;Pyrrole;Heteroaromatic compound;Secondary carboxylic acid amide;Carboxamide group;Carboxylic acid;Organoheterocyclic compound;Azacycle;Organooxygen compound;Organonitrogen compound;Organic oxide;Organic oxygen compound;Organic nitrogen compound;Hydrocarbon derivative;Carbonyl group;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		SCHEMBL19051476		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00		2023-12-20T18:17:36+01:00		0	0	1	0	1	0	0	0	0	0	0	0	0	3	2	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C15H16N2O5	C15H16N2O5			InChI=1S/C15H16N2O5/c18-13(5-6-14(19)20)17-12(15(21)22)7-9-8-16-11-4-2-1-3-10(9)11/h1-4,8,12,16H,5-7H2,(H,17,18)(H,19,20)(H,21,22)	SIZZGLHHFQZDEC-UHFFFAOYSA-N	4-[[1-carboxy-2-(1H-indol-3-yl)ethyl]amino]-4-oxo-butanoic acid	3509283	O=C(O)CCC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)O	4-[[1-carboxy-2-(1H-indol-3-yl)ethyl]amino]-4-oxobutanoic acid			0.6614699999999996	10.1111/TPJ.12607	3847.0	3846.0	http://www.wikidata.org/entity/Q311395	Glycine	genus	http://www.wikidata.org/entity/Q46864560	http://www.wikidata.org/entity/Q115948145	N-(3-carboxypropanoyl)tryptophan	http://www.wikidata.org/entity/Q11006	Glycine max	3847.0	MCULE-6243989096	304.30517		304.105922	5	4	7	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(3509283)	3509283	0.0	1034		SCHEMBL19051476	[#8]=[#6](-[#8])-[#6]-[#6]-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	O=C(O)CCC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)O	SIZZGLHHFQZDEC		parent_pubchem_cid	SCHEMBL19051476;N-(3-carboxypropanoyl)tryptophan;STK682688;AKOS001730735;NCGC00297032-01;AB01291232-01;4-{[1-carboxy-2-(1H-indol-3-yl)ethyl]amino}-4-oxobutanoic acid;4-[[1-carboxy-2-(1H-indol-3-yl)ethyl]amino]-4-oxo-butanoic acid		24090904.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24090904		pluskal_iocb_peptide_Peptide01_F10_id		100	F10		
2.4		0	479	P2195225	84.5		Z18	False	0	17	1	0	23	0	2	4	0	0		0.0						COC(=O)CCNC(=O)C(CC(C)C)NC(=O)c1ccc(Cl)cc1																							0.0		STL218691		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C17H23ClN2O4	C17H23ClN2O4			InChI=1S/C17H23ClN2O4/c1-11(2)10-14(17(23)19-9-8-15(21)24-3)20-16(22)12-4-6-13(18)7-5-12/h4-7,11,14H,8-10H2,1-3H3,(H,19,23)(H,20,22)	HHWPNVJKVYUHED-UHFFFAOYSA-N	methyl 3-[[2-[(4-chlorobenzoyl)amino]-4-methyl-pentanoyl]amino]propanoate	51065734	COC(=O)CCNC(=O)C(CC(C)C)NC(=O)c1ccc(Cl)cc1	methyl 3-[[2-[(4-chlorobenzoyl)amino]-4-methylpentanoyl]amino]propanoate			2.10909													MCULE-5570837963	354.83686		354.134635	4	2	9	1			45									Simple amide alkaloids	False	Alkaloids	Peptide alkaloids			Peptide01			Compound(51065734)	51065734	2.7	1035			[#6]-[#8]-[#6](=[#8])-[#6]-[#6]-[#7]-[#6](=[#8])-[#6](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#17]):[#6]:[#6]:1	COC(=O)CCNC(=O)C(CC(C)C)NC(=O)c1ccc(Cl)cc1	HHWPNVJKVYUHED		parent_pubchem_cid	STL218691;AKOS015861279;methyl N-[(4-chlorophenyl)carbonyl]leucyl-beta-alaninate;methyl 3-[[2-[(4-chlorobenzoyl)amino]-4-methyl-pentanoyl]amino]propanoate		24357833.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24357833		pluskal_iocb_peptide_Peptide01_F10_id		100	F10		
3.9		0	567	P2189191	77.5		Z19	False	0	25	0	0	27	0	1	6	0	0		0.0						COc1ccc(OCC(O)CN(C(=O)c2ccc(OC)cc2)c2ccc(OC)cc2)cc1																							0.0		STL213462		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0		C25H27NO6	C25H27NO6			InChI=1S/C25H27NO6/c1-29-21-8-4-18(5-9-21)25(28)26(19-6-10-22(30-2)11-7-19)16-20(27)17-32-24-14-12-23(31-3)13-15-24/h4-15,20,27H,16-17H2,1-3H3	CHOZKLUTVJBLLF-UHFFFAOYSA-N	N-[2-hydroxy-3-(4-methoxyphenoxy)propyl]-4-methoxy-N-(4-methoxyphenyl)benzamide	51064447	COc1ccc(OCC(O)CN(C(=O)c2ccc(OC)cc2)c2ccc(OC)cc2)cc1	N-[2-hydroxy-3-(4-methoxyphenoxy)propyl]-4-methoxy-N-(4-methoxyphenyl)benzamide			1.5141399999999998													MCULE-2748495649	437.49704		437.183838	6	1	10	3			44										False	Shikimates and Phenylpropanoids				Peptide01			Compound(51064447)	51064447	3.9	1036			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]-[#6](-[#8])-[#6]-[#7](-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:2)-[#6]2:[#6]:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:2):[#6]:[#6]:1	COc1ccc(OCC(O)CN(C(=O)c2ccc(OC)cc2)c2ccc(OC)cc2)cc1	CHOZKLUTVJBLLF		parent_pubchem_cid	STL213462;AKOS015858994;N-[2-hydroxy-3-(4-methoxyphenoxy)propyl]-4-methoxy-N-(4-methoxyphenyl)benzamide		24555937.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24555937		pluskal_iocb_peptide_Peptide01_F10_id		100	F10		
4.4		0	655	P1306929	82.8		Z20	False	0	23	0	0	22	0	2	3	0	1		0.0						COc1ccccc1OCC(=O)N(C)C(c1cccs1)c1c[nH]c2ccccc12																							0.0		STL207996		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C23H22N2O3S	C23H22N2O3S			InChI=1S/C23H22N2O3S/c1-25(22(26)15-28-20-11-6-5-10-19(20)27-2)23(21-12-7-13-29-21)17-14-24-18-9-4-3-8-16(17)18/h3-14,23-24H,15H2,1-2H3	UMXDHOYRZISANE-UHFFFAOYSA-N	N-[1H-indol-3-yl(2-thienyl)methyl]-2-(2-methoxyphenoxy)-N-methyl-acetamide	20895180	COc1ccccc1OCC(=O)N(C)C(c1cccs1)c1c[nH]c2ccccc12	N-[1H-indol-3-yl(thiophen-2-yl)methyl]-2-(2-methoxyphenoxy)-N-methylacetamide			3.402140000000002													MCULE-7598833522	406.50739		406.135114	3	1	7	4			45										False	Alkaloids				Peptide01			Compound(20895180)	20895180	4.4	1037			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#8]-[#6]-[#6](=[#8])-[#7](-[#6])-[#6](-[#6]1:[#6]:[#6]:[#6]:[#16]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	COc1ccccc1OCC(=O)N(C)C(c1cccs1)c1c[nH]c2ccccc12	UMXDHOYRZISANE		parent_pubchem_cid	STL207996;AKOS001912613;AKOS016329524;CCG-154606;N-[(1H-INDOL-3-YL)(THIOPHEN-2-YL)METHYL]-2-(2-METHOXYPHENOXY)-N-METHYLACETAMIDE;N-[1H-indol-3-yl(thiophen-2-yl)methyl]-2-(2-methoxyphenoxy)-N-methylacetamide;N-[1H-indol-3-yl(2-thienyl)methyl]-2-(2-methoxyphenoxy)-N-methyl-acetamide		23529627.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23529627		pluskal_iocb_peptide_Peptide01_F10_id		100	F10		
-0.1		0	399	P11569462	110.8		Z21	False	0	16	0	0	24	0	4	4	0	0		0.0						CCC(C)C(CO)NC(=O)CCc1c(C)[nH]c2cc(=O)[nH]n2c1=O																							0.0		N-[1-(hydroxymethyl)-2-methyl-butyl]-3-(5-methyl-2,7-dioxo-1,4-dihydropyrazolo[1,5-a]pyrimidin-6-yl)propanamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C16H24N4O4	C16H24N4O4			InChI=1S/C16H24N4O4/c1-4-9(2)12(8-21)18-14(22)6-5-11-10(3)17-13-7-15(23)19-20(13)16(11)24/h7,9,12,17,21H,4-6,8H2,1-3H3,(H,18,22)(H,19,23)/t9-,12-/m1/s1	HYNYKFOMMSWFBJ-BXKDBHETSA-N	N-[1-(hydroxymethyl)-2-methyl-butyl]-3-(5-methyl-2,7-dioxo-1,4-dihydropyrazolo[1,5-a]pyrimidin-6-yl)propanamide	100018423	CC[C@@H](C)[C@@H](CO)NC(=O)CCc1c(C)[nH]c2cc(=O)[nH]n2c1=O	N-[(2S,3R)-1-hydroxy-3-methylpentan-2-yl]-3-(5-methyl-2,7-dioxo-1,4-dihydropyrazolo[1,5-a]pyrimidin-6-yl)propanamide			1.5562699999999998														336.39408		336.179755	5	4	7	2			45										False	Alkaloids	Peptide alkaloids			Peptide01			Compound(100018423)	100018423	0.1	1038			[#6]-[#6]-[#6@@H](-[#6])-[#6@@H](-[#6]-[#8])-[#7]-[#6](=[#8])-[#6]-[#6]-[#6]1:[#6](-[#6]):[#7H]:[#6]2:[#6]:[#6](=[#8]):[#7H]:[#7]:2:[#6]:1=[#8]	CC[C@@H](C)[C@@H](CO)NC(=O)CCc1c(C)[nH]c2cc(=O)[nH]n2c1=O	HYNYKFOMMSWFBJ		parent_pubchem_cid	N-[1-(hydroxymethyl)-2-methyl-butyl]-3-(5-methyl-2,7-dioxo-1,4-dihydropyrazolo[1,5-a]pyrimidin-6-yl)propanamide		101991569.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=101991569		pluskal_iocb_peptide_Peptide01_F10_id		100	F10		ZINC000218528570
2.1		0	487	P2195275	93.7		Z22	False	0	21	0	0	24	0	2	5	0	0		0.0						COC(=O)CCNC(=O)C(Cc1ccccc1)NC(=O)c1ccc(OC)cc1																							0.0		AKOS015861326		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C21H24N2O5	C21H24N2O5			InChI=1S/C21H24N2O5/c1-27-17-10-8-16(9-11-17)20(25)23-18(14-15-6-4-3-5-7-15)21(26)22-13-12-19(24)28-2/h3-11,18H,12-14H2,1-2H3,(H,22,26)(H,23,25)	RUZIONZEFAYPFX-UHFFFAOYSA-N	methyl 3-[[2-[(4-methoxybenzoyl)amino]-3-phenyl-propanoyl]amino]propanoate	51065780	COC(=O)CCNC(=O)C(Cc1ccccc1)NC(=O)c1ccc(OC)cc1	methyl 3-[[2-[(4-methoxybenzoyl)amino]-3-phenylpropanoyl]amino]propanoate			1.1437699999999993													MCULE-2362246148	384.43583		384.168522	5	2	10	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51065780)	51065780	2.3	1039			[#6]-[#8]-[#6](=[#8])-[#6]-[#6]-[#7]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:1	COC(=O)CCNC(=O)C(Cc1ccccc1)NC(=O)c1ccc(OC)cc1	RUZIONZEFAYPFX		parent_pubchem_cid	AKOS015861326;methyl 3-[[2-[(4-methoxybenzoyl)amino]-3-phenyl-propanoyl]amino]propanoate		23584491.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23584491		pluskal_iocb_peptide_Peptide01_F10_id		100	F10		
4.8		0	575	P1310229	54.6		Z23	False	0	25	0	1	23	0	2	3	0	0		0.0						COc1ccc(C(c2c[nH]c3ccccc23)N(C)C(=O)COc2ccc(F)cc2)cc1																							0.0		AKOS002279014		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C25H23FN2O3	C25H23FN2O3			InChI=1S/C25H23FN2O3/c1-28(24(29)16-31-20-13-9-18(26)10-14-20)25(17-7-11-19(30-2)12-8-17)22-15-27-23-6-4-3-5-21(22)23/h3-15,25,27H,16H2,1-2H3	HTBAKDWSXHLESP-UHFFFAOYSA-N	2-(4-fluorophenoxy)-N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-N-methyl-acetamide	43843738	COc1ccc(C(c2c[nH]c3ccccc23)N(C)C(=O)COc2ccc(F)cc2)cc1	2-(4-fluorophenoxy)-N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-N-methylacetamide			3.4797400000000023													MCULE-4919037373	418.47206		418.169271	3	1	7	4			45										False	Alkaloids				Peptide01			Compound(43843738)	43843738	4.8	1040			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#7](-[#6])-[#6](=[#8])-[#6]-[#8]-[#6]2:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:2):[#6]:[#6]:1	COc1ccc(C(c2c[nH]c3ccccc23)N(C)C(=O)COc2ccc(F)cc2)cc1	HTBAKDWSXHLESP		parent_pubchem_cid	AKOS002279014;AKOS016329032;2-(4-FLUOROPHENOXY)-N-[(1H-INDOL-3-YL)(4-METHOXYPHENYL)METHYL]-N-METHYLACETAMIDE;2-(4-fluorophenoxy)-N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-N-methyl-acetamide		22979233.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22979233		pluskal_iocb_peptide_Peptide01_F11_id		100	F11		
4.6		0	663	P1307044	73.6		Z24	False	0	22	0	1	19	0	2	2	0	1		0.0						CN(C(=O)COc1ccc(F)cc1)C(c1cccs1)c1c[nH]c2ccccc12																							0.0		STL208069		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C22H19FN2O2S	C22H19FN2O2S			InChI=1S/C22H19FN2O2S/c1-25(21(26)14-27-16-10-8-15(23)9-11-16)22(20-7-4-12-28-20)18-13-24-19-6-3-2-5-17(18)19/h2-13,22,24H,14H2,1H3	AFZNMIWQLZFBKP-UHFFFAOYSA-N	2-(4-fluorophenoxy)-N-[1H-indol-3-yl(2-thienyl)methyl]-N-methyl-acetamide	20895178	CN(C(=O)COc1ccc(F)cc1)C(c1cccs1)c1c[nH]c2ccccc12	2-(4-fluorophenoxy)-N-[1H-indol-3-yl(thiophen-2-yl)methyl]-N-methylacetamide			3.995050000000002													MCULE-7850540170	394.47133		394.115127	2	1	6	4			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(20895178)	20895178	4.6	1041			[#6]-[#7](-[#6](=[#8])-[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:1)-[#6](-[#6]1:[#6]:[#6]:[#6]:[#16]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CN(C(=O)COc1ccc(F)cc1)C(c1cccs1)c1c[nH]c2ccccc12	AFZNMIWQLZFBKP		parent_pubchem_cid	STL208069;AKOS001912498;AKOS016329100;CCG-154605;2-(4-FLUOROPHENOXY)-N-[(1H-INDOL-3-YL)(THIOPHEN-2-YL)METHYL]-N-METHYLACETAMIDE;2-(4-fluorophenoxy)-N-[1H-indol-3-yl(thiophen-2-yl)methyl]-N-methylacetamide;2-(4-fluorophenoxy)-N-[1H-indol-3-yl(2-thienyl)methyl]-N-methyl-acetamide		24539347.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24539347		pluskal_iocb_peptide_Peptide01_F11_id		100	F11		
-0.9		0	407	P3460016	113.3		Z25	True	0	13	0	0	24	0	4	3	0	0	-1.0	2.0			melanocyte-stimulating hormone release inhibitor	prolylleucylglycinamide		CC(C)CC(NC(=O)C1CCCN1)C(=O)NCC(N)=O	168693.0	-1.13		0.0	-1.29	CHEMBL317488		Leucine and derivatives;Proline and derivatives;N-acyl-alpha amino acids and derivatives;Alpha amino acid amides;Pyrrolidinecarboxamides;N-acyl amines;Secondary carboxylic acid amides;Primary carboxylic acid amides;Dialkylamines;Azacyclic compounds;Organopnictogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acid amides;Alpha amino acids and derivatives;Amines;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Dialkylamines;Fatty Acyls;Fatty amides;Hydrocarbon derivatives;Leucine and derivatives;Lipids and lipid-like molecules;N-acyl amines;N-acyl-alpha amino acids and derivatives;Oligopeptides;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Peptides;Primary carboxylic acid amides;Proline and derivatives;Pyrrolidine carboxylic acids and derivatives;Pyrrolidinecarboxamides;Pyrrolidines;Secondary amines;Secondary carboxylic acid amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as oligopeptides. These are organic compounds containing a sequence of between three and ten alpha-amino acids joined by peptide bonds.	Oligopeptides		Peptides	Organic compounds	Aliphatic heteromonocyclic compounds	leucine derivative (CHEBI:47003);proline derivative (CHEBI:26273);N-acyl-amino acid (CHEBI:51569);amino acid amide (CHEBI:22475);pyrrolidinecarboxamide (CHEBI:46770);fatty amide (CHEBI:29348);carboxamide (CHEBI:37622);secondary amino compound (CHEBI:50995);organonitrogen heterocyclic compound (CHEBI:38101);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);oligopeptide (CHEBI:25676);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);amino acid (CHEBI:33709);peptide (CHEBI:16670);organonitrogen compound (CHEBI:35352);organic heterocyclic compound (CHEBI:24532);pyrrolidines (CHEBI:38260);lipid (CHEBI:18059);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);amine (CHEBI:32952);secondary amine (CHEBI:32863);oxygen molecular entity (CHEBI:25806)	N-acyl amines (FA0802);Fatty Acyls (FA);Fatty amides (FA08)	Amino acids, peptides, and analogues	Alpha-oligopeptide;Leucine or derivatives;Proline or derivatives;N-acyl-alpha amino acid or derivatives;Alpha-amino acid amide;N-substituted-alpha-amino acid;Alpha-amino acid or derivatives;Pyrrolidine carboxylic acid or derivatives;Pyrrolidine-2-carboxamide;Fatty amide;N-acyl-amine;Fatty acyl;Pyrrolidine;Amino acid or derivatives;Carboxamide group;Primary carboxylic acid amide;Secondary carboxylic acid amide;Azacycle;Secondary aliphatic amine;Organoheterocyclic compound;Secondary amine;Organooxygen compound;Organonitrogen compound;Hydrocarbon derivative;Organic oxide;Organic nitrogen compound;Carbonyl group;Amine;Organic oxygen compound;Organopnictogen compound;Aliphatic heteromonocyclic compound	Organic acids and derivatives	2.0	Phase 2	2002-44-0	DTXSID20173841	2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00		2023-12-20T18:17:36+01:00		0	0	3	0	2	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	0	0		C13H24N4O3	C13H24N4O3		HMDB0005764	InChI=1S/C13H24N4O3/c1-8(2)6-10(12(19)16-7-11(14)18)17-13(20)9-4-3-5-15-9/h8-10,15H,3-7H2,1-2H3,(H2,14,18)(H,16,19)(H,17,20)/t9-,10-/m0/s1	NOOJLZTTWSNHOX-UWVGGRQHSA-N	rac-(2S)-N-[rac-(1S)-1-[(2-amino-2-oxo-ethyl)carbamoyl]-3-methyl-butyl]pyrrolidine-2-carboxamide	92910	CC(C)C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)NCC(N)=O	(2S)-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide			-1.1291999999999969	10.7164/ANTIBIOTICS.44.25	68188.0	1883.0	http://www.wikidata.org/entity/Q1144013	Streptomyces	genus	http://www.wikidata.org/entity/Q34529882	http://www.wikidata.org/entity/Q6811443	melanocyte-inhibiting factor	http://www.wikidata.org/entity/Q19768382	Streptomyces clavifer	68188.0	MCULE-7073107224	284.36123	BASE	284.184841	4	4	7	1	1.0	80021845.0	20									Imidazole alkaloids;Tripeptides	False	Alkaloids;Amino acids and Peptides	Histidine alkaloids;Small peptides	False	False	Peptide01	PD070730	-1.0	Compound(92910)	92910	-1.4	1042		SCHEMBL362530	[#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6@@H]1-[#6]-[#6]-[#6]-[#7]-1)-[#6](=[#8])-[#7]-[#6]-[#6](-[#7])=[#8]	CC(C)C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)NCC(N)=O	NOOJLZTTWSNHOX		parent_pubchem_cid	2002-44-0;MELANOSTATIN;MIF-1;Oxytocin C-terminal tripeptide;MIF-I;7-9-Oxytocin;Melanostatin I (ox);(S)-N-((S)-1-((2-Amino-2-oxoethyl)amino)-4-methyl-1-oxopentan-2-yl)pyrrolidine-2-carboxamide;L-Prolyl-L-leucylglycinamide;Pro-Leu-Gly amide;Prolylleucylglycine amide;MSH-release inhibiting factor I;C13H24N4O3;L-Prolyl-L-leucylglycylamide;Glycinamide, L-prolyl-L-leucyl-;L-Proline-L-leucine-glycine-amide;CHEMBL317488;3KY24B4Q62;Pro-Leu-Gly-NH2;(2S)-N-(carbamoylmethyl)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamide;(2S)-N-(carbamoylmethyl)-4-methyl-2-{[(2S)-pyrrolidin-2-yl]formamido}pentanamide;UNII-3KY24B4Q62;Prolyl-L-leucyl-glycinamide, L-;EINECS 217-902-7;MIF I;L-pro-L-leu-gly-NH2;MELANOSTATIN MIF-I;SCHEMBL362530;MELANOSTATIN MIF-I [MI];DTXSID20173841;CHEBI:168693;MIF-I, (-)-;BBL033793;BDBM50060601;HB1874;MFCD00037866;MFCD08282654;STL372235;2-Pyrrolidinecarboxamide, N-(1-((carbamoylmethyl)carbamoyl)-3-methylbutyl)-;AKOS015955826;MSH RELEASE-INHIBITING FACTOR I;(S)-N-((S)-1-(2-amino-2-oxoethylamino)-4-methyl-1-oxopentan-2-yl)pyrrolidine-2-carboxamide;NS-04720;HY-107663;CS-0029128;A14870;EN300-302728;6-((E)-3-Oxo-3-phenyl-propenyl)-1H-pyrimidine-2,4-dione;(E)-6-(3-oxo-3-phenylprop-1-enyl)pyrimidine-2,4(1H,3H)-dione;(S)-Pyrrolidine-2-carboxylic acid [(S)-1-(carbamoylmethyl-carbamoyl)-3-methyl-butyl]-amide;Pyrrolidine-2-carboxylic acid [1-(carbamoylmethyl-carbamoyl)-3-methyl-butyl]-amide;rac-(2S)-N-[rac-(1S)-1-[(2-amino-2-oxo-ethyl)carbamoyl]-3-methyl-butyl]pyrrolidine-2-carboxamide	False	513533.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=513533	3KY24B4Q62	pluskal_iocb_peptide_Peptide01_F11_id		100	F11	False	ZINC000004899446
3.7		0	495	P2194872	134.6		Z26	False	0	20	1	0	25	0	4	2	0	2		0.0						CCSc1ncc(Cl)c(C(=O)NC(CCSC)C(=O)NCc2ccc(C)cc2)n1																							0.0		AKOS015861159		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C20H25ClN4O2S2	C20H25ClN4O2S2			InChI=1S/C20H25ClN4O2S2/c1-4-29-20-23-12-15(21)17(25-20)19(27)24-16(9-10-28-3)18(26)22-11-14-7-5-13(2)6-8-14/h5-8,12,16H,4,9-11H2,1-3H3,(H,22,26)(H,24,27)	AALLEWUCWSEWPN-UHFFFAOYSA-N	5-chloro-2-ethylsulfanyl-N-[3-methylsulfanyl-1-(p-tolylmethylcarbamoyl)propyl]pyrimidine-4-carboxamide	51065477	CCSc1ncc(Cl)c(C(=O)NC(CCSC)C(=O)NCc2ccc(C)cc2)n1	5-chloro-2-ethylsulfanyl-N-[1-[(4-methylphenyl)methylamino]-4-methylsulfanyl-1-oxobutan-2-yl]pyrimidine-4-carboxamide			3.446180000000002													MCULE-9134828110	453.02885		452.110746	6	2	10	2			45										False	Alkaloids				Peptide01			Compound(51065477)	51065477	3.9	1043			[#6]-[#6]-[#16]-[#6]1:[#7]:[#6]:[#6](-[#17]):[#6](-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]-[#16]-[#6])-[#6](=[#8])-[#7]-[#6]-[#6]2:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:2):[#7]:1	CCSc1ncc(Cl)c(C(=O)NC(CCSC)C(=O)NCc2ccc(C)cc2)n1	AALLEWUCWSEWPN		parent_pubchem_cid	AKOS015861159;5-chloro-2-ethylsulfanyl-N-[3-methylsulfanyl-1-(p-tolylmethylcarbamoyl)propyl]pyrimidine-4-carboxamide		23013118.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23013118		pluskal_iocb_peptide_Peptide01_F11_id		100	F11		
4.5		0	583	P1306341	73.1		Z27	False	0	21	0	0	18	0	2	1	0	1		0.0						O=C(NCC(c1ccccc1)c1c[nH]c2ccccc12)c1cccs1																							0.0		N-[2-(1H-indol-3-yl)-2-phenylethyl]thiophene-2-carboxamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C21H18N2OS	C21H18N2OS			InChI=1S/C21H18N2OS/c24-21(20-11-6-12-25-20)23-13-17(15-7-2-1-3-8-15)18-14-22-19-10-5-4-9-16(18)19/h1-12,14,17,22H,13H2,(H,23,24)	OHCDEUBPASYAPI-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]thiophene-2-carboxamide	4880396	O=C(NCC(c1ccccc1)c1c[nH]c2ccccc12)c1cccs1	N-[2-(1H-indol-3-yl)-2-phenylethyl]thiophene-2-carboxamide			4.198750000000003													MCULE-4241127829	346.45441		346.113984	1	2	5	4			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(4880396)	4880396	4.7	1044			[#8]=[#6](-[#7]-[#6]-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6]1:[#6]:[#6]:[#6]:[#16]:1	O=C(NCC(c1ccccc1)c1c[nH]c2ccccc12)c1cccs1	OHCDEUBPASYAPI		parent_pubchem_cid	N-[2-(1H-indol-3-yl)-2-phenylethyl]thiophene-2-carboxamide;851205-34-0;AKOS001912825;AKOS016329467;NCGC00320931-01;AB01316076-02;N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]thiophene-2-carboxamide		23785779.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23785779		pluskal_iocb_peptide_Peptide01_F11_id		100	F11		
4.6		0	671	P1305254	58.0		Z28	False	0	21	1	0	17	0	2	2	0	0		0.0						O=C(NCC(c1ccccc1Cl)c1c[nH]c2ccccc12)c1ccco1																							0.0		N-[2-(2-chlorophenyl)-2-(1H-indol-3-yl)ethyl]furan-2-carboxamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C21H17ClN2O2	C21H17ClN2O2			InChI=1S/C21H17ClN2O2/c22-18-8-3-1-6-14(18)16(13-24-21(25)20-10-5-11-26-20)17-12-23-19-9-4-2-7-15(17)19/h1-12,16,23H,13H2,(H,24,25)	VNCSZWVYWRDHJA-UHFFFAOYSA-N	N-[2-(2-chlorophenyl)-2-(1H-indol-3-yl)ethyl]furan-2-carboxamide	17014411	O=C(NCC(c1ccccc1Cl)c1c[nH]c2ccccc12)c1ccco1	N-[2-(2-chlorophenyl)-2-(1H-indol-3-yl)ethyl]furan-2-carboxamide			4.383650000000003													MCULE-9064722613	364.83484		364.097855	1	2	5	4			44									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(17014411)	17014411	4.8	1045			[#8]=[#6](-[#7]-[#6]-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#17])-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6]1:[#6]:[#6]:[#6]:[#8]:1	O=C(NCC(c1ccccc1Cl)c1c[nH]c2ccccc12)c1ccco1	VNCSZWVYWRDHJA		parent_pubchem_cid	N-[2-(2-chlorophenyl)-2-(1H-indol-3-yl)ethyl]furan-2-carboxamide;STL207370;AKOS000958635;AKOS016326567		23106343.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23106343		pluskal_iocb_peptide_Peptide01_F11_id		100	F11		
3.1		0	415	P6247964	134.4		Z29	False	0	22	1	0	21	0	4	4	0	0		0.0						NC(=O)NCCCC(NC(=O)c1cc(-c2ccc(Cl)cc2)nc2ccccc12)C(=O)O																							0.0		EiM08-22269		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C22H21ClN4O4	C22H21ClN4O4			InChI=1S/C22H21ClN4O4/c23-14-9-7-13(8-10-14)19-12-16(15-4-1-2-5-17(15)26-19)20(28)27-18(21(29)30)6-3-11-25-22(24)31/h1-2,4-5,7-10,12,18H,3,6,11H2,(H,27,28)(H,29,30)(H3,24,25,31)/t18-/m1/s1	GJDZZCAMKXIUQV-GOSISDBHSA-N	rac-(2R)-2-[[2-(4-chlorophenyl)quinoline-4-carbonyl]amino]-5-ureido-pentanoic acid	71964538	NC(=O)NCCC[C@@H](NC(=O)c1cc(-c2ccc(Cl)cc2)nc2ccccc12)C(=O)O	(2R)-5-(carbamoylamino)-2-[[2-(4-chlorophenyl)quinoline-4-carbonyl]amino]pentanoic acid			2.32355													MCULE-8290377699	440.89007		440.125133	5	4	8	3			44										False	Alkaloids				Peptide01			Compound(71964538)	71964538	2.8	1046			[#7]-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]-[#6@@H](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6](-[#6]2:[#6]:[#6]:[#6](-[#17]):[#6]:[#6]:2):[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	NC(=O)NCCC[C@@H](NC(=O)c1cc(-c2ccc(Cl)cc2)nc2ccccc12)C(=O)O	GJDZZCAMKXIUQV		parent_pubchem_cid	EiM08-22269;AKOS016398012;N~5~-(AMINOCARBONYL)-N~2~-{[2-(4-CHLOROPHENYL)QUINOLIN-4-YL]CARBONYL}-D-ORNITHINE;rac-(2R)-2-[[2-(4-chlorophenyl)quinoline-4-carbonyl]amino]-5-ureido-pentanoic acid		23408347.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23408347		pluskal_iocb_peptide_Peptide01_F11_id		100	F11		ZINC000072401808
0.6		0	503	P2195420	139.3		Z30	False	0	17	0	0	24	0	2	6	0	1		0.0						COc1c(OC)cc(C(=O)NCCC(=O)NC(CCSC)C(=O)O)cc1																							0.0		AKOS015861507		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C17H24N2O6S	C17H24N2O6S			InChI=1S/C17H24N2O6S/c1-24-13-5-4-11(10-14(13)25-2)16(21)18-8-6-15(20)19-12(17(22)23)7-9-26-3/h4-5,10,12H,6-9H2,1-3H3,(H,18,21)(H,19,20)(H,22,23)	QSWAPTUFPSPMQX-UHFFFAOYSA-N	2-[3-[(3,4-dimethoxybenzoyl)amino]propanoylamino]-4-methylsulfanyl-butanoic acid	51065889	COc1c(OC)cc(C(=O)NCCC(=O)NC(CCSC)C(=O)O)cc1	2-[3-[(3,4-dimethoxybenzoyl)amino]propanoylamino]-4-methylsulfanylbutanoic acid			0.1666700000000011													MCULE-1537065613	384.45463		384.135507	7	3	11	1			45									Simple amide alkaloids	False	Alkaloids	Peptide alkaloids			Peptide01			Compound(51065889)	51065889	1.0	1047			[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]):[#6]:[#6](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]-[#16]-[#6])-[#6](=[#8])-[#8]):[#6]:[#6]:1	COc1c(OC)cc(C(=O)NCCC(=O)NC(CCSC)C(=O)O)cc1	QSWAPTUFPSPMQX		parent_pubchem_cid	AKOS015861507;2-[3-[(3,4-dimethoxybenzoyl)amino]propanoylamino]-4-methylsulfanyl-butanoic acid		23685319.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23685319		pluskal_iocb_peptide_Peptide01_F11_id		100	F11		
4.7		0	591	P1680519	62.8		Z31	False	0	24	0	0	31	0	1	3	0	1		0.0						CCc1ccc(CN(C(=O)c2ccc(C(C)(C)C)cc2)C2CCS(=O)(=O)C2)cc1																							0.0		4-tert-butyl-N-(1,1-dioxidotetrahydrothiophen-3-yl)-N-(4-ethylbenzyl)benzamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0		C24H31NO3S	C24H31NO3S			InChI=1S/C24H31NO3S/c1-5-18-6-8-19(9-7-18)16-25(22-14-15-29(27,28)17-22)23(26)20-10-12-21(13-11-20)24(2,3)4/h6-13,22H,5,14-17H2,1-4H3	SAOGSPXMPJKDKB-UHFFFAOYSA-N	4-tert-butyl-N-(1,1-dioxothiolan-3-yl)-N-[(4-ethylphenyl)methyl]benzamide	3698950	CCc1ccc(CN(C(=O)c2ccc(C(C)(C)C)cc2)C2CCS(=O)(=O)C2)cc1	4-tert-butyl-N-(1,1-dioxothiolan-3-yl)-N-[(4-ethylphenyl)methyl]benzamide			4.157160000000004													MCULE-4343806602	413.58357		413.202465	3	0	6	3			45										False	Terpenoids				Peptide01			Compound(3698950)	3698950	4.9	1048			[#6]-[#6]-[#6]1:[#6]:[#6]:[#6](-[#6]-[#7](-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6](-[#6](-[#6])(-[#6])-[#6]):[#6]:[#6]:2)-[#6]2-[#6]-[#6]-[#16](=[#8])(=[#8])-[#6]-2):[#6]:[#6]:1	CCc1ccc(CN(C(=O)c2ccc(C(C)(C)C)cc2)C2CCS(=O)(=O)C2)cc1	SAOGSPXMPJKDKB		parent_pubchem_cid	4-tert-butyl-N-(1,1-dioxidotetrahydrothiophen-3-yl)-N-(4-ethylbenzyl)benzamide;620562-15-4;AKOS002228733;AKOS016082826;Z57387901;4-tert-butyl-N-(1,1-dioxothiolan-3-yl)-N-[(4-ethylphenyl)methyl]benzamide		23959091.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23959091		pluskal_iocb_peptide_Peptide01_F12_id		100	F12		
1.9		0	679	P1090562	105.8		Z32	False	0	18	0	0	27	0	3	5	0	0		0.0						COC(=O)C(Cc1ccccc1)NC(=O)NCCNC(=O)OC(C)(C)C																							0.0		methyl N-({2-[(tert-butoxycarbonyl)amino]ethyl}carbamoyl)-L-phenylalaninate		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	1	0	3	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C18H27N3O5	C18H27N3O5			InChI=1S/C18H27N3O5/c1-18(2,3)26-17(24)20-11-10-19-16(23)21-14(15(22)25-4)12-13-8-6-5-7-9-13/h5-9,14H,10-12H2,1-4H3,(H,20,24)(H2,19,21,23)/t14-/m0/s1	MQSOJQYIEJLBBU-AWEZNQCLSA-N	methyl rac-(2S)-2-[2-(tert-butoxycarbonylamino)ethylcarbamoylamino]-3-phenyl-propanoate	17590969	COC(=O)[C@H](Cc1ccccc1)NC(=O)NCCNC(=O)OC(C)(C)C	methyl (2S)-2-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethylcarbamoylamino]-3-phenylpropanoate			1.5398899999999995													MCULE-5673560207	365.43299		365.195071	5	3	10	1			44									Dipeptides;Tripeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(17590969)	17590969	1.5	1049			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#7]-[#6]-[#6]-[#7]-[#6](=[#8])-[#8]-[#6](-[#6])(-[#6])-[#6]	COC(=O)[C@H](Cc1ccccc1)NC(=O)NCCNC(=O)OC(C)(C)C	MQSOJQYIEJLBBU		parent_pubchem_cid	methyl N-({2-[(tert-butoxycarbonyl)amino]ethyl}carbamoyl)-L-phenylalaninate;MFCD09845361;STK991576;AKOS016382593;methyl (2S)-2-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethylcarbamoylamino]-3-phenylpropanoate;methyl rac-(2S)-2-[2-(tert-butoxycarbonylamino)ethylcarbamoylamino]-3-phenyl-propanoate		14064009.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=14064009		pluskal_iocb_peptide_Peptide01_F12_id		100	F12		ZINC000009486557
3.0		0	423	P6236678	75.1		Z33	False	0	20	0	0	21	0	5	1	0	0		0.0						CC(C)C(NC(=O)Cc1c[nH]c2ccccc12)c1nnc2ccccn12																							0.0		1081128-24-6		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	3	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C20H21N5O	C20H21N5O			InChI=1S/C20H21N5O/c1-13(2)19(20-24-23-17-9-5-6-10-25(17)20)22-18(26)11-14-12-21-16-8-4-3-7-15(14)16/h3-10,12-13,19,21H,11H2,1-2H3,(H,22,26)	NJZTUJDTRLWAAD-UHFFFAOYSA-N	2-(1H-indol-3-yl)-N-[2-methyl-1-([1,2,4]triazolo[4,3-a]pyridin-3-yl)propyl]acetamide	42652463	CC(C)C(NC(=O)Cc1c[nH]c2ccccc12)c1nnc2ccccn12	2-(1H-indol-3-yl)-N-[2-methyl-1-([1,2,4]triazolo[4,3-a]pyridin-3-yl)propyl]acetamide			2.5145500000000007													MCULE-4835377409	347.42327		347.17461	3	2	5	4			44									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(42652463)	42652463	3.4	1050			[#6]-[#6](-[#6])-[#6](-[#7]-[#6](=[#8])-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6]1:[#7]:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#7]:1:2	CC(C)C(NC(=O)Cc1c[nH]c2ccccc12)c1nnc2ccccn12	NJZTUJDTRLWAAD		parent_pubchem_cid	1081128-24-6;2-(1H-indol-3-yl)-N-(2-methyl-1-{[1,2,4]triazolo[4,3-a]pyridin-3-yl}propyl)acetamide;2-(1H-indol-3-yl)-N-[2-methyl-1-([1,2,4]triazolo[4,3-a]pyridin-3-yl)propyl]acetamide;STK639514;AKOS005570798;Z1014196204		24242257.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24242257		pluskal_iocb_peptide_Peptide01_F12_id		100	F12		
4.8		0	511	P2195087	109.3		Z34	False	0	21	2	0	18	0	4	2	0	1		0.0						CSc1ncc(Cl)c(C(=O)NC(Cc2ccccc2)C(=O)Nc2ccc(Cl)cc2)n1																							0.0		STL218546		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C21H18Cl2N4O2S	C21H18Cl2N4O2S			InChI=1S/C21H18Cl2N4O2S/c1-30-21-24-12-16(23)18(27-21)20(29)26-17(11-13-5-3-2-4-6-13)19(28)25-15-9-7-14(22)8-10-15/h2-10,12,17H,11H2,1H3,(H,25,28)(H,26,29)	WVBCOFDJYWEMPK-UHFFFAOYSA-N	N-[1-benzyl-2-(4-chloroanilino)-2-oxo-ethyl]-5-chloro-2-methylsulfanyl-pyrimidine-4-carboxamide	51065624	CSc1ncc(Cl)c(C(=O)NC(Cc2ccccc2)C(=O)Nc2ccc(Cl)cc2)n1	5-chloro-N-[1-(4-chloroanilino)-1-oxo-3-phenylpropan-2-yl]-2-methylsulfanylpyrimidine-4-carboxamide			3.8870600000000017													MCULE-6555392027	461.37321		460.052752	5	2	7	3			45										False					Peptide01			Compound(51065624)	51065624	4.8	1051			[#6]-[#16]-[#6]1:[#7]:[#6]:[#6](-[#17]):[#6](-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#7]-[#6]2:[#6]:[#6]:[#6](-[#17]):[#6]:[#6]:2):[#7]:1	CSc1ncc(Cl)c(C(=O)NC(Cc2ccccc2)C(=O)Nc2ccc(Cl)cc2)n1	WVBCOFDJYWEMPK		parent_pubchem_cid	STL218546;AKOS015861185;Nalpha-{[5-chloro-2-(methylsulfanyl)pyrimidin-4-yl]carbonyl}-N-(4-chlorophenyl)phenylalaninamide;N-[1-benzyl-2-(4-chloroanilino)-2-oxo-ethyl]-5-chloro-2-methylsulfanyl-pyrimidine-4-carboxamide		22898971.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22898971		pluskal_iocb_peptide_Peptide01_F12_id		100	F12		
4.6		0	599	P1307064	73.6		Z35	False	0	22	0	0	20	0	2	2	0	1		0.0						COc1cccc(C(=O)N(C)C(c2cccs2)c2c[nH]c3ccccc23)c1																							0.0		AKOS001912381		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C22H20N2O2S	C22H20N2O2S			InChI=1S/C22H20N2O2S/c1-24(22(25)15-7-5-8-16(13-15)26-2)21(20-11-6-12-27-20)18-14-23-19-10-4-3-9-17(18)19/h3-14,21,23H,1-2H3	YBUJIURDSNYHTH-UHFFFAOYSA-N	N-[1H-indol-3-yl(2-thienyl)methyl]-3-methoxy-N-methyl-benzamide	20895169	COc1cccc(C(=O)N(C)C(c2cccs2)c2c[nH]c3ccccc23)c1	N-[1H-indol-3-yl(thiophen-2-yl)methyl]-3-methoxy-N-methylbenzamide			4.044640000000003													MCULE-6547655959	376.4809		376.124549	2	1	5	4			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(20895169)	20895169	4.4	1052			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6](-[#6](=[#8])-[#7](-[#6])-[#6](-[#6]2:[#6]:[#6]:[#6]:[#16]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:1	COc1cccc(C(=O)N(C)C(c2cccs2)c2c[nH]c3ccccc23)c1	YBUJIURDSNYHTH		parent_pubchem_cid	AKOS001912381;AKOS016329112;N-[(1H-INDOL-3-YL)(THIOPHEN-2-YL)METHYL]-3-METHOXY-N-METHYLBENZAMIDE;N-[1H-indol-3-yl(2-thienyl)methyl]-3-methoxy-N-methyl-benzamide		22713584.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22713584		pluskal_iocb_peptide_Peptide01_F12_id		100	F12		
3.7		0	687	P6243144	106.3		Z36	False	0	24	0	0	24	0	4	2	0	1		0.0						CC(=O)N(Cc1ccccc1)c1nc(C)c(C(=O)NCCc2c[nH]c3ccccc23)s1								Thiazolecarboxamides;2-heteroaryl carboxamides;2,4,5-trisubstituted thiazoles;Substituted pyrroles;Benzene and substituted derivatives;Tertiary carboxylic acid amides;Heteroaromatic compounds;Acetamides;Tertiary amines;Secondary carboxylic acid amides;Amino acids and derivatives;Azacyclic compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	2,4,5-trisubstituted thiazoles;2-heteroaryl carboxamides;3-alkylindoles;Acetamides;Amines;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Azoles;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Tertiary amines;Tertiary carboxylic acid amides;Thiazolecarboxamides;Thiazolecarboxylic acids and derivatives;Thiazoles	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as 3-alkylindoles. These are compounds containing an indole moiety that carries an alkyl chain at the 3-position.	3-alkylindoles			Organic compounds	Aromatic heteropolycyclic compounds	aromatic amide (CHEBI:62733);thiazoles (CHEBI:48901);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);pyrroles (CHEBI:26455);benzenes (CHEBI:22712);acetamides (CHEBI:22160);tertiary amine (CHEBI:32876);organonitrogen compound (CHEBI:35352);organooxygen compound (CHEBI:36963);organonitrogen heterocyclic compound (CHEBI:38101);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);indoles (CHEBI:24828);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);azole (CHEBI:68452);aromatic carboxylic acid (CHEBI:33859);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);benzenoid aromatic compound (CHEBI:33836);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);amine (CHEBI:32952);oxygen molecular entity (CHEBI:25806)		Indoles	3-alkylindole;2-heteroaryl carboxamide;2,4,5-trisubstituted 1,3-thiazole;Thiazolecarboxylic acid or derivatives;Thiazolecarboxamide;Monocyclic benzene moiety;Substituted pyrrole;Benzenoid;Azole;Pyrrole;Heteroaromatic compound;Acetamide;Thiazole;Tertiary carboxylic acid amide;Amino acid or derivatives;Carboxamide group;Secondary carboxylic acid amide;Tertiary amine;Carboxylic acid derivative;Azacycle;Organooxygen compound;Organonitrogen compound;Amine;Carbonyl group;Organic oxide;Organic oxygen compound;Hydrocarbon derivative;Organic nitrogen compound;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		2-[acetyl(benzyl)amino]-N-[2-(1H-indol-3-yl)ethyl]-4-methyl-1,3-thiazole-5-carboxamide		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C24H24N4O2S	C24H24N4O2S			InChI=1S/C24H24N4O2S/c1-16-22(23(30)25-13-12-19-14-26-21-11-7-6-10-20(19)21)31-24(27-16)28(17(2)29)15-18-8-4-3-5-9-18/h3-11,14,26H,12-13,15H2,1-2H3,(H,25,30)	LUYPELYPHBXGQI-UHFFFAOYSA-N	2-[acetyl(benzyl)amino]-N-[2-(1H-indol-3-yl)ethyl]-4-methyl-thiazole-5-carboxamide	51049254	CC(=O)N(Cc1ccccc1)c1nc(C)c(C(=O)NCCc2c[nH]c3ccccc23)s1	2-[acetyl(benzyl)amino]-N-[2-(1H-indol-3-yl)ethyl]-4-methyl-1,3-thiazole-5-carboxamide			3.430550000000002													MCULE-5647494476	432.54848		432.161997	3	2	7	4			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51049254)	51049254	4.2	1053			[#6]-[#6](=[#8])-[#7](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#7]:[#6](-[#6]):[#6](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#16]:1	CC(=O)N(Cc1ccccc1)c1nc(C)c(C(=O)NCCc2c[nH]c3ccccc23)s1	LUYPELYPHBXGQI		parent_pubchem_cid	2-[acetyl(benzyl)amino]-N-[2-(1H-indol-3-yl)ethyl]-4-methyl-1,3-thiazole-5-carboxamide;1224168-84-6;EiM08-15436;AKOS005671376;2-(N-BENZYLACETAMIDO)-N-[2-(1H-INDOL-3-YL)ETHYL]-4-METHYL-1,3-THIAZOLE-5-CARBOXAMIDE;2-[acetyl(benzyl)amino]-N-[2-(1H-indol-3-yl)ethyl]-4-methyl-thiazole-5-carboxamide		14089899.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=14089899		pluskal_iocb_peptide_Peptide01_F12_id		100	F12		ZINC000044921181
3.7		0	431	P3460676	102.8		Z37	False	0	23	0	0	24	0	2	4	0	1		0.0						COC(=O)C(CCSC)NC(=O)c1cc(-c2cc(OC)ccc2)nc2ccccc12																							0.0		EiM08-07043		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C23H24N2O4S	C23H24N2O4S			InChI=1S/C23H24N2O4S/c1-28-16-8-6-7-15(13-16)21-14-18(17-9-4-5-10-19(17)24-21)22(26)25-20(11-12-30-3)23(27)29-2/h4-10,13-14,20H,11-12H2,1-3H3,(H,25,26)/t20-/m0/s1	CYDGJYRQFLZAAM-FQEVSTJZSA-N	methyl rac-(2S)-2-[[2-(3-methoxyphenyl)quinoline-4-carbonyl]amino]-4-methylsulfanyl-butanoate	39889931	COC(=O)[C@H](CCSC)NC(=O)c1cc(-c2cc(OC)ccc2)nc2ccccc12	methyl (2S)-2-[[2-(3-methoxyphenyl)quinoline-4-carbonyl]amino]-4-methylsulfanylbutanoate			2.6093400000000004													MCULE-9018784530	424.52273		424.145678	6	1	9	3			44										False	Alkaloids				Peptide01			Compound(39889931)	39889931	4.1	1054			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]-[#16]-[#6])-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6](-[#6]2:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:[#6]:2):[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	COC(=O)[C@H](CCSC)NC(=O)c1cc(-c2cc(OC)ccc2)nc2ccccc12	CYDGJYRQFLZAAM		parent_pubchem_cid	EiM08-07043;AKOS016383784;METHYL 2-{[2-(3-METHOXYPHENYL)QUINOLIN-4-YL]FORMAMIDO}-4-(METHYLSULFANYL)BUTANOATE;methyl rac-(2S)-2-[[2-(3-methoxyphenyl)quinoline-4-carbonyl]amino]-4-methylsulfanyl-butanoate		3806605.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=3806605		pluskal_iocb_peptide_Peptide01_F12_id		100	F12		ZINC000032646437
4.9		0	519	P2195072	109.3		Z38	False	0	24	1	0	25	0	4	2	0	1		0.0						CCSc1ncc(Cl)c(C(=O)NC(Cc2ccccc2)C(=O)NCc2ccc(C)cc2)n1																							0.0		AKOS015861011		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C24H25ClN4O2S	C24H25ClN4O2S			InChI=1S/C24H25ClN4O2S/c1-3-32-24-27-15-19(25)21(29-24)23(31)28-20(13-17-7-5-4-6-8-17)22(30)26-14-18-11-9-16(2)10-12-18/h4-12,15,20H,3,13-14H2,1-2H3,(H,26,30)(H,28,31)	HMLWRVAUUCPSAK-UHFFFAOYSA-N	N-[1-benzyl-2-oxo-2-(p-tolylmethylamino)ethyl]-5-chloro-2-ethylsulfanyl-pyrimidine-4-carboxamide	51065610	CCSc1ncc(Cl)c(C(=O)NC(Cc2ccccc2)C(=O)NCc2ccc(C)cc2)n1	5-chloro-2-ethylsulfanyl-N-[1-[(4-methylphenyl)methylamino]-1-oxo-3-phenylpropan-2-yl]pyrimidine-4-carboxamide			3.881070000000003													MCULE-1268221676	469.00945		468.138675	5	2	9	3			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51065610)	51065610	4.8	1055			[#6]-[#6]-[#16]-[#6]1:[#7]:[#6]:[#6](-[#17]):[#6](-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#7]-[#6]-[#6]2:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:2):[#7]:1	CCSc1ncc(Cl)c(C(=O)NC(Cc2ccccc2)C(=O)NCc2ccc(C)cc2)n1	HMLWRVAUUCPSAK		parent_pubchem_cid	AKOS015861011;N-[1-benzyl-2-oxo-2-(p-tolylmethylamino)ethyl]-5-chloro-2-ethylsulfanyl-pyrimidine-4-carboxamide		23449111.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23449111		pluskal_iocb_peptide_Peptide01_F12_id		100	F12		
4.9		0	607	P1305264	63.4		Z39	False	0	26	0	0	26	0	2	3	0	0		0.0						CCOc1cccc(C(=O)NCC(c2ccc(OC)cc2)c2c[nH]c3ccccc23)c1																							0.0		3-ethoxy-N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]benzamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C26H26N2O3	C26H26N2O3			InChI=1S/C26H26N2O3/c1-3-31-21-8-6-7-19(15-21)26(29)28-16-23(18-11-13-20(30-2)14-12-18)24-17-27-25-10-5-4-9-22(24)25/h4-15,17,23,27H,3,16H2,1-2H3,(H,28,29)	NCEWEZIJJXIBRG-UHFFFAOYSA-N	3-ethoxy-N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]benzamide	17014421	CCOc1cccc(C(=O)NCC(c2ccc(OC)cc2)c2c[nH]c3ccccc23)c1	3-ethoxy-N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]benzamide			3.6197300000000014													MCULE-7379653700	414.50872		414.194343	3	2	8	4			44										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(17014421)	17014421	5.0	1056			[#6]-[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6](-[#6](=[#8])-[#7]-[#6]-[#6](-[#6]2:[#6]:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:1	CCOc1cccc(C(=O)NCC(c2ccc(OC)cc2)c2c[nH]c3ccccc23)c1	NCEWEZIJJXIBRG		parent_pubchem_cid	3-ethoxy-N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]benzamide;STL207380;AKOS002335502;AKOS016326577		24741024.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24741024		pluskal_iocb_peptide_Peptide01_F13_id		100	F13		
3.7		0	695	P6236293	132.5		Z40	False	0	23	0	0	21	0	3	4	0	1		0.0						COc1cccc(-c2nc(CC(=O)NC(Cc3c[nH]c4ccccc34)C(=O)O)cs2)c1																							0.0		SCHEMBL21560042		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C23H21N3O4S	C23H21N3O4S			InChI=1S/C23H21N3O4S/c1-30-17-6-4-5-14(9-17)22-25-16(13-31-22)11-21(27)26-20(23(28)29)10-15-12-24-19-8-3-2-7-18(15)19/h2-9,12-13,20,24H,10-11H2,1H3,(H,26,27)(H,28,29)/t20-/m0/s1	QXZVNRAIXNWVPT-FQEVSTJZSA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[[2-[2-(3-methoxyphenyl)thiazol-4-yl]acetyl]amino]propanoic acid	29138913	COc1cccc(-c2nc(CC(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)O)cs2)c1	(2S)-3-(1H-indol-3-yl)-2-[[2-[2-(3-methoxyphenyl)-1,3-thiazol-4-yl]acetyl]amino]propanoic acid			2.274329999999999													MCULE-9691845228	435.50552		435.125277	5	3	8	4			43										False	Alkaloids				Peptide01			Compound(29138913)	29138913	3.5	1057		SCHEMBL21560042	[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6](-[#6]2:[#7]:[#6](-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]3:[#6]:[#7H]:[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]:3:4)-[#6](=[#8])-[#8]):[#6]:[#16]:2):[#6]:1	COc1cccc(-c2nc(CC(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)O)cs2)c1	QXZVNRAIXNWVPT		parent_pubchem_cid	SCHEMBL21560042;STK646943;AKOS005577957;N-{[2-(3-methoxyphenyl)-1,3-thiazol-4-yl]acetyl}-L-tryptophan;3-(1H-INDOL-3-YL)-2-{2-[2-(3-METHOXYPHENYL)-1,3-THIAZOL-4-YL]ACETAMIDO}PROPANOIC ACID;rac-(2S)-3-(1H-indol-3-yl)-2-[[2-[2-(3-methoxyphenyl)thiazol-4-yl]acetyl]amino]propanoic acid		24506518.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24506518		pluskal_iocb_peptide_Peptide01_F13_id		100	F13		ZINC000020744380
4.2		0	439	P1094970	61.9		Z41	False	0	25	0	0	33	0	3	3	0	0		0.0						CCC(C)C(NC(=O)N1CCN(C(c2ccccc2)c2ccccc2)CC1)C(=O)OC																							0.0		AKOS005533521		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1		C25H33N3O3	C25H33N3O3			InChI=1S/C25H33N3O3/c1-4-19(2)22(24(29)31-3)26-25(30)28-17-15-27(16-18-28)23(20-11-7-5-8-12-20)21-13-9-6-10-14-21/h5-14,19,22-23H,4,15-18H2,1-3H3,(H,26,30)/t19?,22-/m0/s1	POHILCHOFCRIBO-BPARTEKVSA-N	methyl rac-(2S)-2-[(4-benzhydrylpiperazine-1-carbonyl)amino]-3-methyl-pentanoate	17579217	CCC(C)[C@H](NC(=O)N1CCN(C(c2ccccc2)c2ccccc2)CC1)C(=O)OC	methyl (2S)-2-[(4-benzhydrylpiperazine-1-carbonyl)amino]-3-methylpentanoate			3.5814800000000027														423.56006		423.252192	4	1	8	3			46									Piperidine alkaloids	False	Alkaloids	Lysine alkaloids			Peptide01			Compound(17579217)	17579217	4.2	1058			[#6]-[#6]-[#6](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#7]1-[#6]-[#6]-[#7](-[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]-[#6]-1)-[#6](=[#8])-[#8]-[#6]	CCC(C)[C@H](NC(=O)N1CCN(C(c2ccccc2)c2ccccc2)CC1)C(=O)OC	POHILCHOFCRIBO		parent_pubchem_cid	AKOS005533521;methyl rac-(2S)-2-[(4-benzhydrylpiperazine-1-carbonyl)amino]-3-methyl-pentanoate		23335075.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23335075		pluskal_iocb_peptide_Peptide01_F13_id		100	F13		
1.7		0	527	P2194172	130.3		Z42	False	0	17	0	0	23	0	3	6	0	0		0.0						COC(=O)C(CC(C)C)NC(=O)CCNC(=O)c1ccc([N+](=O)[O-])cc1																							0.0		AKOS015860298		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	1		C17H23N3O6	C17H23N3O6			InChI=1S/C17H23N3O6/c1-11(2)10-14(17(23)26-3)19-15(21)8-9-18-16(22)12-4-6-13(7-5-12)20(24)25/h4-7,11,14H,8-10H2,1-3H3,(H,18,22)(H,19,21)	UFBNHBGFCUAHDT-UHFFFAOYSA-N	methyl 4-methyl-2-[3-[(4-nitrobenzoyl)amino]propanoylamino]pentanoate	51064964	COC(=O)C(CC(C)C)NC(=O)CCNC(=O)c1ccc([N+](=O)[O-])cc1	methyl 4-methyl-2-[3-[(4-nitrobenzoyl)amino]propanoylamino]pentanoate			0.9832800000000004													MCULE-7341306538	365.38936		365.158685	6	2	10	1			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51064964)	51064964	1.9	1059			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=[#8])-[#6]-[#6]-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#7+](=[#8])-[#8-]):[#6]:[#6]:1	COC(=O)C(CC(C)C)NC(=O)CCNC(=O)c1ccc([N+](=O)[O-])cc1	UFBNHBGFCUAHDT		parent_pubchem_cid	AKOS015860298;methyl 4-methyl-2-[3-[(4-nitrobenzoyl)amino]propanoylamino]pentanoate		23067989.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23067989		pluskal_iocb_peptide_Peptide01_F13_id		100	F13		
4.6		0	615	P1305420	80.4		Z43	False	0	27	0	0	22	0	2	4	0	0		0.0						COc1ccc(C(CNC(=O)c2cc3ccccc3oc2=O)c2c[nH]c3ccccc23)cc1																							0.0		AKOS002335397		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C27H22N2O4	C27H22N2O4			InChI=1S/C27H22N2O4/c1-32-19-12-10-17(11-13-19)22(23-16-28-24-8-4-3-7-20(23)24)15-29-26(30)21-14-18-6-2-5-9-25(18)33-27(21)31/h2-14,16,22,28H,15H2,1H3,(H,29,30)	BBEIZUQHNGWGRR-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-oxo-chromene-3-carboxamide	17014569	COc1ccc(C(CNC(=O)c2cc3ccccc3oc2=O)c2c[nH]c3ccccc23)cc1	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-oxochromene-3-carboxamide			4.261310000000003													MCULE-9476391594	438.48739		438.157957	4	2	6	5			45									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(17014569)	17014569	5.5	1060			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6]-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3:[#8]:[#6]:2=[#8])-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	COc1ccc(C(CNC(=O)c2cc3ccccc3oc2=O)c2c[nH]c3ccccc23)cc1	BBEIZUQHNGWGRR		parent_pubchem_cid	AKOS002335397;AKOS016326664;N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-oxo-2H-chromene-3-carboxamide;N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-oxo-chromene-3-carboxamide		23818296.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23818296		pluskal_iocb_peptide_Peptide01_F13_id		100	F13		
2.8		0	703	P6239351	112.5		Z44	False	0	15	0	0	19	0	3	3	0	1		0.0						CCC(C)C(NC(=O)c1c(C)nc(-n2cccc2)s1)C(=O)O																							0.0		EiM08-09946		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C15H19N3O3S	C15H19N3O3S			InChI=1S/C15H19N3O3S/c1-4-9(2)11(14(20)21)17-13(19)12-10(3)16-15(22-12)18-7-5-6-8-18/h5-9,11H,4H2,1-3H3,(H,17,19)(H,20,21)/t9-,11+/m1/s1	NPXICOVRMPLPHB-KOLCDFICSA-N	rac-(2S,3R)-3-methyl-2-[(4-methyl-2-pyrrol-1-yl-thiazole-5-carbonyl)amino]pentanoic acid	45493574	CC[C@@H](C)[C@H](NC(=O)c1c(C)nc(-n2cccc2)s1)C(=O)O	(2S,3R)-3-methyl-2-[(4-methyl-2-pyrrol-1-yl-1,3-thiazole-5-carbonyl)amino]pentanoic acid			2.17189													MCULE-2294901746	321.40098		321.114712	4	2	6	2			44									Dipeptides;Pyridine alkaloids	False	Alkaloids;Amino acids and Peptides	Nicotinic acid alkaloids;Small peptides			Peptide01			Compound(45493574)	45493574	3.0	1061			[#6]-[#6]-[#6@@H](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#6]1:[#6](-[#6]):[#7]:[#6](-[#7]2:[#6]:[#6]:[#6]:[#6]:2):[#16]:1)-[#6](=[#8])-[#8]	CC[C@@H](C)[C@H](NC(=O)c1c(C)nc(-n2cccc2)s1)C(=O)O	NPXICOVRMPLPHB		parent_pubchem_cid	EiM08-09946;AKOS005661724;(2S,3R)-3-METHYL-2-({[4-METHYL-2-(1H-PYRROL-1-YL)-1,3-THIAZOL-5-YL]CARBONYL}AMINO)PENTANOIC ACID;rac-(2S,3R)-3-methyl-2-[(4-methyl-2-pyrrol-1-yl-thiazole-5-carbonyl)amino]pentanoic acid		24772560.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24772560		pluskal_iocb_peptide_Peptide01_F13_id		100	F13		ZINC000036359074
2.3		0	711	P6239999	88.4		AA1	False	0	18	0	0	22	0	2	4	0	0		0.0						CC(=O)c1cn(CC(=O)NC(CC(C)C)C(=O)O)c2ccccc12								N-acyl-L-alpha-amino acids;N-alkylindoles;Indoles;Aryl alkyl ketones;Substituted pyrroles;Benzenoids;Vinylogous amides;Heteroaromatic compounds;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Aryl alkyl ketones;Aryl ketones;Azacyclic compounds;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Ketones;Leucine and derivatives;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;N-alkylindoles;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Vinylogous amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as leucine and derivatives. These are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Leucine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-L-alpha-amino acid (CHEBI:48927);indoles (CHEBI:24828);aromatic ketone (CHEBI:76224);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);enone (CHEBI:51689);enamine (CHEBI:47989);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);leucine derivative (CHEBI:47003);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);carbonyl compound (CHEBI:36586);organooxygen compound (CHEBI:36963);N-acyl-amino acid (CHEBI:51569);organic heterocyclic compound (CHEBI:24532);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ketone (CHEBI:17087);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)		Amino acids, peptides, and analogues	Leucine or derivatives;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;N-acyl-l-alpha-amino acid;N-alkylindole;Indole;Indole or derivatives;Aryl ketone;Aryl alkyl ketone;Substituted pyrrole;Benzenoid;Pyrrole;Heteroaromatic compound;Vinylogous amide;Secondary carboxylic acid amide;Ketone;Carboxamide group;Monocarboxylic acid or derivatives;Carboxylic acid;Azacycle;Organoheterocyclic compound;Carbonyl group;Organooxygen compound;Organonitrogen compound;Hydrocarbon derivative;Organic oxide;Organic oxygen compound;Organic nitrogen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		EiM08-11069		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C18H22N2O4	C18H22N2O4			InChI=1S/C18H22N2O4/c1-11(2)8-15(18(23)24)19-17(22)10-20-9-14(12(3)21)13-6-4-5-7-16(13)20/h4-7,9,11,15H,8,10H2,1-3H3,(H,19,22)(H,23,24)/t15-/m0/s1	MOPZYZVUQWIEBQ-HNNXBMFYSA-N	rac-(2S)-2-[[2-(3-acetylindol-1-yl)acetyl]amino]-4-methyl-pentanoic acid	45490524	CC(=O)c1cn(CC(=O)N[C@@H](CC(C)C)C(=O)O)c2ccccc12	(2S)-2-[[2-(3-acetylindol-1-yl)acetyl]amino]-4-methylpentanoic acid			1.976269999999999													MCULE-6629506417	330.38704		330.157957	4	2	7	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(45490524)	45490524	2.4	1062			[#6]-[#6](=[#8])-[#6]1:[#6]:[#7](-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=[#8])-[#8]):[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CC(=O)c1cn(CC(=O)N[C@@H](CC(C)C)C(=O)O)c2ccccc12	MOPZYZVUQWIEBQ		parent_pubchem_cid	EiM08-11069;AKOS016375006;(2S)-2-{[2-(3-ACETYL-1H-INDOL-1-YL)ACETYL]AMINO}-4-METHYLPENTANOIC ACID;rac-(2S)-2-[[2-(3-acetylindol-1-yl)acetyl]amino]-4-methyl-pentanoic acid		22816674.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22816674		pluskal_iocb_peptide_Peptide01_F13_id		100	F13		ZINC000036369882
4.7		0	799	P6242072	107.5		AA2	False	0	20	2	0	16	0	2	3	0	1		0.0						O=C(Cc1csc(-c2c(Cl)cc(Cl)cc2)n1)NC(Cc1ccccc1)C(=O)O																							0.0		SCHEMBL21560120		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C20H16Cl2N2O3S	C20H16Cl2N2O3S			InChI=1S/C20H16Cl2N2O3S/c21-13-6-7-15(16(22)9-13)19-23-14(11-28-19)10-18(25)24-17(20(26)27)8-12-4-2-1-3-5-12/h1-7,9,11,17H,8,10H2,(H,24,25)(H,26,27)/t17-/m0/s1	NCZJOPZXPJTZSS-KRWDZBQOSA-N	rac-(2S)-2-[[2-[2-(2,4-dichlorophenyl)thiazol-4-yl]acetyl]amino]-3-phenyl-propanoic acid	49657747	O=C(Cc1csc(-c2c(Cl)cc(Cl)cc2)n1)N[C@@H](Cc1ccccc1)C(=O)O	(2S)-2-[[2-[2-(2,4-dichlorophenyl)-1,3-thiazol-4-yl]acetyl]amino]-3-phenylpropanoic acid			3.9820600000000015													MCULE-7642566967	435.33212		434.025869	4	2	7	3			43										False					Peptide01			Compound(49657747)	49657747	4.7	1063		SCHEMBL21560120	[#8]=[#6](-[#6]-[#6]1:[#6]:[#16]:[#6](-[#6]2:[#6](-[#17]):[#6]:[#6](-[#17]):[#6]:[#6]:2):[#7]:1)-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	O=C(Cc1csc(-c2c(Cl)cc(Cl)cc2)n1)N[C@@H](Cc1ccccc1)C(=O)O	NCZJOPZXPJTZSS		parent_pubchem_cid	SCHEMBL21560120;AKOS005668571;(2S)-2-({2-[2-(2,4-DICHLOROPHENYL)-1,3-THIAZOL-4-YL]ACETYL}AMINO)-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[[2-[2-(2,4-dichlorophenyl)thiazol-4-yl]acetyl]amino]-3-phenyl-propanoic acid		23563085.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23563085		pluskal_iocb_peptide_Peptide01_F13_id		100	F13		ZINC000040288554
3.9		0	887	P1108250	138.0		AA3	False	0	25	0	0	24	0	2	7	0	0	-1.0	0.0						Cc1cc(OCC(=O)NC(Cc2c[nH]c3c2cc(O)cc3)C(=O)O)c2c(C)c(C)c(=O)oc2c1		3.1		0.0	3.23	CHEMBL1514556		N-acyl-alpha amino acids;Coumarins and derivatives;1-benzopyrans;3-alkylindoles;Hydroxyindoles;Pyranones and derivatives;1-hydroxy-2-unsubstituted benzenoids;Alkyl aryl ethers;Substituted pyrroles;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactones;Oxacyclic compounds;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organonitrogen compounds;Organopnictogen compounds	1-benzopyrans;1-hydroxy-2-unsubstituted benzenoids;3-alkylindoles;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Hydroxyindoles;Indoles;Indoles and derivatives;Lactones;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;N-acylserotonins;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenols;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Pyrroles;Secondary carboxylic acid amides;Serotonins;Substituted pyrroles;Tryptamines and derivatives	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acylserotonins. These are aromatic heterocyclic compounds containing a serotonin, in which the amine group is acylated.	N-acylserotonins		Serotonins	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-amino acid (CHEBI:51569);coumarins (CHEBI:23403);1-benzopyran (CHEBI:38443);indoles (CHEBI:24828);hydroxyindoles (CHEBI:84729);pyranone (CHEBI:37963);phenols (CHEBI:33853);aromatic ether (CHEBI:35618);pyrroles (CHEBI:26455);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactone (CHEBI:25000);oxacycle (CHEBI:38104);carbonyl compound (CHEBI:36586);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);organonitrogen heterocyclic compound (CHEBI:38101);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);amino acid (CHEBI:33709);peptide (CHEBI:16670);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);pyrans (CHEBI:26407);benzenoid aromatic compound (CHEBI:33836);oxygen molecular entity (CHEBI:25806);ether (CHEBI:25698);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);tryptamines (CHEBI:27162)	Benzopyranoids (PK1311)	Tryptamines and derivatives	N-acylserotonin;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;Coumarin;Alpha-amino acid or derivatives;Benzopyran;Hydroxyindole;3-alkylindole;1-benzopyran;Indole;Alkyl aryl ether;1-hydroxy-2-unsubstituted benzenoid;Pyranone;Benzenoid;Substituted pyrrole;Pyran;Heteroaromatic compound;Pyrrole;Secondary carboxylic acid amide;Carboxamide group;Lactone;Azacycle;Oxacycle;Carboxylic acid derivative;Monocarboxylic acid or derivatives;Carboxylic acid;Ether;Organic oxygen compound;Organic oxide;Hydrocarbon derivative;Organic nitrogen compound;Organonitrogen compound;Carbonyl group;Organopnictogen compound;Organooxygen compound;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		5-hydroxy-N-{[(3,4,7-trimethyl-2-oxo-2H-chromen-5-yl)oxy]acetyl}tryptophan		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C25H24N2O7	C25H24N2O7			InChI=1S/C25H24N2O7/c1-12-6-20(23-13(2)14(3)25(32)34-21(23)7-12)33-11-22(29)27-19(24(30)31)8-15-10-26-18-5-4-16(28)9-17(15)18/h4-7,9-10,19,26,28H,8,11H2,1-3H3,(H,27,29)(H,30,31)	UKCPAGVGBCCKEI-UHFFFAOYSA-N	3-(5-hydroxy-1H-indol-3-yl)-2-[[2-(3,4,7-trimethyl-2-oxo-chromen-5-yl)oxyacetyl]amino]propanoic acid	4833715	Cc1cc(OCC(=O)NC(Cc2c[nH]c3c2cc(O)cc3)C(=O)O)c2c(C)c(C)c(=O)oc2c1	3-(5-hydroxy-1H-indol-3-yl)-2-[[2-(3,4,7-trimethyl-2-oxochromen-5-yl)oxyacetyl]amino]propanoic acid			1.99545													MCULE-7649891374	464.47923	ACID	464.158351	7	4	7	4	1.0		30									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins	False	False	Peptide01		-1.0	Compound(4833715)	4833715	3.2	1064			[#6]-[#6]1:[#6]:[#6](-[#8]-[#6]-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:2:[#6]:[#6](-[#8]):[#6]:[#6]:3)-[#6](=[#8])-[#8]):[#6]2:[#6](-[#6]):[#6](-[#6]):[#6](=[#8]):[#8]:[#6]:2:[#6]:1	Cc1cc(OCC(=O)NC(Cc2c[nH]c3c2cc(O)cc3)C(=O)O)c2c(C)c(C)c(=O)oc2c1	UKCPAGVGBCCKEI		parent_pubchem_cid	5-hydroxy-N-{[(3,4,7-trimethyl-2-oxo-2H-chromen-5-yl)oxy]acetyl}tryptophan;1214794-03-2;SMR000650240;MLS001140974;MLS003901561;CHEMBL1514556;HMS2267H11;STL464262;AKOS016392222;AB00864450-06;3-(5-hydroxy-1H-indol-3-yl)-2-(2-((3,4,7-trimethyl-2-oxo-2H-chromen-5-yl)oxy)acetamido)propanoic acid;3-(5-hydroxy-1H-indol-3-yl)-2-[[2-(3,4,7-trimethyl-2-oxo-chromen-5-yl)oxyacetyl]amino]propanoic acid	False	760628.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=760628		pluskal_iocb_peptide_Peptide01_F14_id		100	F14	False	
1.2		0	975	P1098622	95.9		AA4	False	0	20	0	0	25	0	1	5	0	0		0.0						CCC(C)C(NCc1c2oc(=O)c3c(CCCC3)c2ccc1O)C(=O)O																							0.0		EiM07-17300		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C20H25NO5	C20H25NO5			InChI=1S/C20H25NO5/c1-3-11(2)17(19(23)24)21-10-15-16(22)9-8-13-12-6-4-5-7-14(12)20(25)26-18(13)15/h8-9,11,17,21-22H,3-7,10H2,1-2H3,(H,23,24)/t11-,17+/m0/s1	UYFNOTJIQGIEIF-APPDUMDISA-N	rac-(2R,3S)-2-[(3-hydroxy-6-oxo-7,8,9,10-tetrahydrobenzo[c]chromen-4-yl)methylamino]-3-methyl-pentanoic acid	24279894	CC[C@H](C)[C@@H](NCc1c2oc(=O)c3c(CCCC3)c2ccc1O)C(=O)O	(2R,3S)-2-[(3-hydroxy-6-oxo-7,8,9,10-tetrahydrobenzo[c]chromen-4-yl)methylamino]-3-methylpentanoic acid			2.811230000000001													MCULE-9781963067	359.42595		359.173273	6	3	6	3			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(24279894)	24279894	1.4	1065			[#6]-[#6]-[#6@H](-[#6])-[#6@@H](-[#7]-[#6]-[#6]1:[#6]2:[#8]:[#6](=[#8]):[#6]3:[#6](-[#6]-[#6]-[#6]-[#6]-3):[#6]:2:[#6]:[#6]:[#6]:1-[#8])-[#6](=[#8])-[#8]	CC[C@H](C)[C@@H](NCc1c2oc(=O)c3c(CCCC3)c2ccc1O)C(=O)O	UYFNOTJIQGIEIF		parent_pubchem_cid	EiM07-17300;STK716922;AKOS005533909;N-[(3-hydroxy-6-oxo-7,8,9,10-tetrahydro-6H-benzo[c]chromen-4-yl)methyl]-D-isoleucine;2-[({3-HYDROXY-6-OXO-6H,7H,8H,9H,10H-CYCLOHEXA[C]CHROMEN-4-YL}METHYL)AMINO]-3-METHYLPENTANOIC ACID;rac-(2R,3S)-2-[(3-hydroxy-6-oxo-7,8,9,10-tetrahydrobenzo[c]chromen-4-yl)methylamino]-3-methyl-pentanoic acid		15117026.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=15117026		pluskal_iocb_peptide_Peptide01_F14_id		100	F14		ZINC000011866850
3.9		0	719	P6240027	71.3		AA5	False	1	20	0	0	19	0	2	3	0	0		0.0						O=C(CCn1ccc2c1cc(Br)cc2)NC(Cc1ccccc1)C(=O)O								N-acyl-L-alpha-amino acids;Phenylpropanoic acids;Amphetamines and derivatives;N-alkylindoles;Indoles;Substituted pyrroles;Aryl bromides;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Carboxylic acids;Monocarboxylic acids and derivatives;Organobromides;Carbonyl compounds;Organic oxides;Hydrocarbon derivatives;Organonitrogen compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Aryl bromides;Aryl halides;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;N-alkylindoles;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organobromides;Organohalogen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenethylamines;Phenylalanine and derivatives;Phenylpropanoic acids;Phenylpropanoids and polyketides;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-L-alpha-amino acid (CHEBI:48927);benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);amphetamines (CHEBI:35338);indoles (CHEBI:24828);pyrroles (CHEBI:26455);organobromine compound (CHEBI:37141);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organonitrogen heterocyclic compound (CHEBI:38101);monocarboxylic acid (CHEBI:25384);carbonyl compound (CHEBI:36586);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);organonitrogen compound (CHEBI:35352);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);N-acyl-amino acid (CHEBI:51569);benzenoid aromatic compound (CHEBI:33836);primary amine (CHEBI:32877);organic heterocyclic compound (CHEBI:24532);organohalogen compound (CHEBI:36684);haloarene (CHEBI:50887);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143)		Amino acids, peptides, and analogues	Phenylalanine or derivatives;N-acyl-l-alpha-amino acid;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;3-phenylpropanoic-acid;Amphetamine or derivatives;N-alkylindole;Indole;Indole or derivatives;Aryl bromide;Aryl halide;Monocyclic benzene moiety;Benzenoid;Substituted pyrrole;Heteroaromatic compound;Pyrrole;Secondary carboxylic acid amide;Carboxamide group;Organoheterocyclic compound;Monocarboxylic acid or derivatives;Azacycle;Carboxylic acid;Organonitrogen compound;Organobromide;Organohalogen compound;Organic nitrogen compound;Carbonyl group;Hydrocarbon derivative;Organic oxide;Organic oxygen compound;Organooxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS016402509		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C20H19BrN2O3	C20H19BrN2O3			InChI=1S/C20H19BrN2O3/c21-16-7-6-15-8-10-23(18(15)13-16)11-9-19(24)22-17(20(25)26)12-14-4-2-1-3-5-14/h1-8,10,13,17H,9,11-12H2,(H,22,24)(H,25,26)/t17-/m0/s1	CRUFPYGTYWRPMU-KRWDZBQOSA-N	rac-(2S)-2-[3-(6-bromoindol-1-yl)propanoylamino]-3-phenyl-propanoic acid	45490701	O=C(CCn1ccc2c1cc(Br)cc2)N[C@@H](Cc1ccccc1)C(=O)O	(2S)-2-[3-(6-bromoindol-1-yl)propanoylamino]-3-phenylpropanoic acid			3.1228700000000007													MCULE-1598325437	415.29003		414.057905	3	2	7	3			44										False					Peptide01			Compound(45490701)	45490701	3.5	1066			[#8]=[#6](-[#6]-[#6]-[#7]1:[#6]:[#6]:[#6]2:[#6]:1:[#6]:[#6](-[#35]):[#6]:[#6]:2)-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	O=C(CCn1ccc2c1cc(Br)cc2)N[C@@H](Cc1ccccc1)C(=O)O	CRUFPYGTYWRPMU		parent_pubchem_cid	AKOS016402509;(2S)-2-{[3-(6-BROMO-1H-INDOL-1-YL)PROPANOYL]AMINO}-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[3-(6-bromoindol-1-yl)propanoylamino]-3-phenyl-propanoic acid		24048744.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24048744		pluskal_iocb_peptide_Peptide01_F14_id		100	F14		ZINC000036370084
1.9		0	807	P6236885	162.6		AA6	False	1	17	0	0	19	0	4	4	0	1		0.0						NC(=O)NCCCC(NC(=O)Cc1csc(-c2cc(Br)ccc2)n1)C(=O)O																							0.0		SCHEMBL21560281		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	1	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C17H19BrN4O4S	C17H19BrN4O4S			InChI=1S/C17H19BrN4O4S/c18-11-4-1-3-10(7-11)15-21-12(9-27-15)8-14(23)22-13(16(24)25)5-2-6-20-17(19)26/h1,3-4,7,9,13H,2,5-6,8H2,(H,22,23)(H,24,25)(H3,19,20,26)/t13-/m1/s1	GJYJIOCROWLPGM-CYBMUJFWSA-N	rac-(2R)-2-[[2-[2-(3-bromophenyl)thiazol-4-yl]acetyl]amino]-5-ureido-pentanoic acid	29133252	NC(=O)NCCC[C@@H](NC(=O)Cc1csc(-c2cc(Br)ccc2)n1)C(=O)O	(2R)-2-[[2-[2-(3-bromophenyl)-1,3-thiazol-4-yl]acetyl]amino]-5-(carbamoylamino)pentanoic acid			1.69827													MCULE-7227763975	455.33338		454.031038	5	4	9	2			43									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(29133252)	29133252	1.6	1067		SCHEMBL21560281	[#7]-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]-[#6@@H](-[#7]-[#6](=[#8])-[#6]-[#6]1:[#6]:[#16]:[#6](-[#6]2:[#6]:[#6](-[#35]):[#6]:[#6]:[#6]:2):[#7]:1)-[#6](=[#8])-[#8]	NC(=O)NCCC[C@@H](NC(=O)Cc1csc(-c2cc(Br)ccc2)n1)C(=O)O	GJYJIOCROWLPGM		parent_pubchem_cid	SCHEMBL21560281;AKOS016398009;rac-(2R)-2-[[2-[2-(3-bromophenyl)thiazol-4-yl]acetyl]amino]-5-ureido-pentanoic acid		23708742.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23708742		pluskal_iocb_peptide_Peptide01_F14_id		100	F14		ZINC000020727540
3.2		0	895	P6238601	106.5		AA7	False	0	21	0	1	20	0	3	3	0	1		0.0						COC(=O)C(CCSC)NC(=O)c1c2ccc(F)cc2nc(-c2ccccn2)c1																							0.0		AKOS005589861		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C21H20FN3O3S	C21H20FN3O3S			InChI=1S/C21H20FN3O3S/c1-28-21(27)17(8-10-29-2)25-20(26)15-12-19(16-5-3-4-9-23-16)24-18-11-13(22)6-7-14(15)18/h3-7,9,11-12,17H,8,10H2,1-2H3,(H,25,26)/t17-/m0/s1	PRQSADSCRGOLAP-KRWDZBQOSA-N	methyl rac-(2S)-2-[[7-fluoro-2-(2-pyridyl)quinoline-4-carbonyl]amino]-4-methylsulfanyl-butanoate	39335568	COC(=O)[C@H](CCSC)NC(=O)c1c2ccc(F)cc2nc(-c2ccccn2)c1	methyl (2S)-2-[(7-fluoro-2-pyridin-2-ylquinoline-4-carbonyl)amino]-4-methylsulfanylbutanoate			2.5972500000000007													MCULE-6400804852	413.47425		413.120941	6	1	8	3			44										False	Alkaloids				Peptide01			Compound(39335568)	39335568	3.2	1068			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]-[#16]-[#6])-[#7]-[#6](=[#8])-[#6]1:[#6]2:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:2:[#7]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#7]:2):[#6]:1	COC(=O)[C@H](CCSC)NC(=O)c1c2ccc(F)cc2nc(-c2ccccn2)c1	PRQSADSCRGOLAP		parent_pubchem_cid	AKOS005589861;METHYL 2-{[7-FLUORO-2-(PYRIDIN-2-YL)QUINOLIN-4-YL]FORMAMIDO}-4-(METHYLSULFANYL)BUTANOATE;methyl rac-(2S)-2-[[7-fluoro-2-(2-pyridyl)quinoline-4-carbonyl]amino]-4-methylsulfanyl-butanoate		8281544.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=8281544		pluskal_iocb_peptide_Peptide01_F14_id		100	F14		ZINC000032090524
2.1		0	983	P2517672	75.6		AA8	False	0	12	0	0	15	0	1	4	0	0		0.0						CCC(NC(=O)OCc1ccccc1)C(=O)O																							0.0		2-(benzyloxycarbonylamino)butyric acid		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	1	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C12H15NO4	C12H15NO4			InChI=1S/C12H15NO4/c1-2-10(11(14)15)13-12(16)17-8-9-6-4-3-5-7-9/h3-7,10H,2,8H2,1H3,(H,13,16)(H,14,15)	SZQMTCSQWUYUML-UHFFFAOYSA-N	2-(benzyloxycarbonylamino)butanoic acid	294935	CCC(NC(=O)OCc1ccccc1)C(=O)O	2-(phenylmethoxycarbonylamino)butanoic acid			1.72129													MCULE-3325560646	237.25765		237.100108	4	2	6	1			44									Aminoacids;Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(294935)	294935	2.0	1069		SCHEMBL319160	[#6]-[#6]-[#6](-[#7]-[#6](=[#8])-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	CCC(NC(=O)OCc1ccccc1)C(=O)O	SZQMTCSQWUYUML		parent_pubchem_cid	"2-(benzyloxycarbonylamino)butyric acid;20395-87-3;2-(phenylmethoxycarbonylamino)butanoic acid;2-(((Benzyloxy)carbonyl)amino)butanoic acid;Z-D-Abu-OH;2-Benzyloxycarbonylamino-butyric acid;2-{[(benzyloxy)carbonyl]amino}butanoic acid;Cbz-2-aminobutyric acid;(S)-2-(Cbz-amino)butyric Acid;MFCD00077006;NSC164666;Z-L-2-aminobutyric acid;SCHEMBL319160;MFCD03701339;NSC164085;AKOS009507579;NSC-164085;NSC-164666;LS-14081;SY047077;(s)-2-(benzyloxycarbonylamino)butyric acid;CS-0449702;FT-0656932;EN300-84283;A826065;""2-(benzyloxycarbonylamino)butanoic acid;(S)-2-(Cbz-amino)butyric Acid"";2-(benzyloxycarbonylamino)butanoic acid"		24848774.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24848774		pluskal_iocb_peptide_Peptide01_F14_id		100	F14		
4.0		0	727	P3460019	84.9		AA9	False	0	21	0	0	25	0	1	5	0	0		0.0						CC(C)(C)OC(=O)NC(Cc1ccc(OCc2ccccc2)cc1)C(=O)O								Phenylpropanoic acids;Amphetamines and derivatives;Phenoxy compounds;Phenol ethers;Alkyl aryl ethers;Carbamate esters;Organic carbonic acids and derivatives;Monocarboxylic acids and derivatives;Carboxylic acids;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Benzene and substituted derivatives;Benzenoids;Carbamate esters;Carbamic acids and derivatives;Carbonyl compounds;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Ethers;Hydrocarbon derivatives;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenethylamines;Phenol ethers;Phenoxy compounds;Phenylalanine and derivatives;Phenylpropanoic acids;Phenylpropanoids and polyketides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic homomonocyclic compounds	benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);amphetamines (CHEBI:35338);aromatic ether (CHEBI:35618);carbamate ester (CHEBI:23003);organooxygen compound (CHEBI:36963);carbonyl compound (CHEBI:36586);carboxylic acid anion (CHEBI:29067);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);primary amine (CHEBI:32877);oxygen molecular entity (CHEBI:25806);ether (CHEBI:25698);amino acid (CHEBI:33709);peptide (CHEBI:16670);carbon oxoacid (CHEBI:35605);nitrogen molecular entity (CHEBI:51143)		Amino acids, peptides, and analogues	Phenylalanine or derivatives;3-phenylpropanoic-acid;Amphetamine or derivatives;Phenol ether;Phenoxy compound;Alkyl aryl ether;Monocyclic benzene moiety;Benzenoid;Carbamic acid ester;Carbonic acid derivative;Carboxylic acid;Ether;Monocarboxylic acid or derivatives;Organopnictogen compound;Organonitrogen compound;Organooxygen compound;Organic nitrogen compound;Hydrocarbon derivative;Carbonyl group;Organic oxygen compound;Organic oxide;Aromatic homomonocyclic compound	Organic acids and derivatives	0.0		Boc-Tyr(Bzl)-OH	DTXSID20175567	2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	1	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C21H25NO5	C21H25NO5			InChI=1S/C21H25NO5/c1-21(2,3)27-20(25)22-18(19(23)24)13-15-9-11-17(12-10-15)26-14-16-7-5-4-6-8-16/h4-12,18H,13-14H2,1-3H3,(H,22,25)(H,23,24)/t18-/m0/s1	ZAVSPTOJKOFMTA-SFHVURJKSA-N	rac-(2S)-3-(4-benzyloxyphenyl)-2-(tert-butoxycarbonylamino)propanoic acid	98763	CC(C)(C)OC(=O)N[C@@H](Cc1ccc(OCc2ccccc2)cc1)C(=O)O	(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-(4-phenylmethoxyphenyl)propanoic acid			3.214170000000001													MCULE-9518288094	371.4371		371.173273	5	2	9	2			42									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(98763)	98763	3.3	1070		SCHEMBL193473	[#6]-[#6](-[#6])(-[#6])-[#8]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6]:[#6]:1)-[#6](=[#8])-[#8]	CC(C)(C)OC(=O)N[C@@H](Cc1ccc(OCc2ccccc2)cc1)C(=O)O	ZAVSPTOJKOFMTA		parent_pubchem_cid	Boc-Tyr(Bzl)-OH;2130-96-3;Boc-O-benzyl-L-tyrosine;N-Boc-O-benzyl-L-tyrosine;(S)-3-(4-(Benzyloxy)phenyl)-2-((tert-butoxycarbonyl)amino)propanoic acid;(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-(4-phenylmethoxyphenyl)propanoic acid;MFCD00065597;O-Benzyl-N-((tert-butoxy)carbonyl)-L-tyrosine;N-(tert-Butoxycarbonyl)-O-benzyl-L-tyrosine;(S)-3-(4-(benzyloxy)phenyl)-2-(tert-butoxycarbonylamino)propanoic acid;Boc-Tyr(Bn);Boc-Tyr(OBn);Boc-O-Bzl-L-Tyr;Boc-O-benzyl-L-Tyr;Boc-Tyr(OBn)-OH;Boc-Tyr (Bzl)-OH;Boc-L-Tyr(Bzl)-OH;Tyrosine, N-[(1,1-dimethylethoxy)carbonyl]-O-(phenylmethyl)-;N-Boc-O-Benzyl-tyrosine;O-benzyl-N-(tert-butoxycarbonyl)-L-tyrosine;N-Boc-(O-benzyl)tyrosine;Boc-(O-benzyl)-L-tyrosine;n-alpha-tert-butyloxycarbonyl-o-benzyl-l-tyrosine;SCHEMBL193473;DTXSID20175567;ZAVSPTOJKOFMTA-SFHVURJKSA-N;EINECS 218-349-4;(2S)-3-[4-(benzyloxy)phenyl]-2-[(tert-butoxycarbonyl)amino]propanoic acid;AKOS015839435;AKOS015889900;AM82323;CS-W011789;HY-W011073;NSC 164044;N-tert-Butyloxycarbonyl-O-benzyltyrosine;AC-19284;AS-12176;Boc-Tyr(Bzl)-OH, >=99.0% (T);N-tert-butyloxycarbonyl-O-benzyl-L-tyrosine;Nalpha-t-butoxycarbonyl-O-benzyl-L-tyrosine;B1631;N-tertiarybutoxycarbonyl-O-benzyl-L-tyrosine;Nalpha -t-butoxycarbonyl-O-benzyl-L-tyrosine;N-(tert-butyloxycarbonyl)-O-benzyl-L-tyrosine;nalpha-tert-butoxycarbonyl-o-benzyl-l-tyrosine;EN300-305201;M03335;J-300278;N-(t-butyloxycarbonyl)-4-benzyloxy-L-phenylalanine;Q-101631;N-(tert-butyloxycarbonyl)-O-(phenylmethyl)-L-tyrosine;N-[(1,1-dimethylethoxy)carbonyl]--O-benzyl-L-tyrosine;(S)-3-(4-benzyloxyphenyl)-2-tert-butoxycarbonylaminopropionic acid;(S)-3-(4-(benzyloxy)phenyl)-2-(tert-butoxycarbonyl-amino)propanoic acid;(S)-3-(4-Benzyloxy-phenyl)-2-tert-butoxycarbonylamino-propionic acid;(2S)-3-[4-(benzyloxy)phenyl]-2-{[(tert-butoxy)carbonyl]amino}propanoic acid;rac-(2S)-3-(4-benzyloxyphenyl)-2-(tert-butoxycarbonylamino)propanoic acid		22912276.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22912276		pluskal_iocb_peptide_Peptide01_F14_id		100	F14		ZINC000001640075
3.6		0	815	P11184080	56.3		AA10	False	0	22	1	0	23	0	2	2	0	0		0.0						O=C(CCc1c[nH]c2ccccc12)N1CCC(O)(c2ccc(Cl)cc2)CC1																							0.0		1-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-3-(1H-indol-3-yl)propan-1-one		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C22H23ClN2O2	C22H23ClN2O2			InChI=1S/C22H23ClN2O2/c23-18-8-6-17(7-9-18)22(27)11-13-25(14-12-22)21(26)10-5-16-15-24-20-4-2-1-3-19(16)20/h1-4,6-9,15,24,27H,5,10-14H2	WRFACJRUSCZQCT-UHFFFAOYSA-N	1-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-3-(1H-indol-3-yl)propan-1-one	71700092	O=C(CCc1c[nH]c2ccccc12)N1CCC(O)(c2ccc(Cl)cc2)CC1	1-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-3-(1H-indol-3-yl)propan-1-one			3.7262600000000026													MCULE-6528114040	382.89381		382.144806	2	2	4	4			44										False	Alkaloids				Peptide01			Compound(71700092)	71700092	3.5	1071			[#8]=[#6](-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]1-[#6]-[#6]-[#6](-[#8])(-[#6]2:[#6]:[#6]:[#6](-[#17]):[#6]:[#6]:2)-[#6]-[#6]-1	O=C(CCc1c[nH]c2ccccc12)N1CCC(O)(c2ccc(Cl)cc2)CC1	WRFACJRUSCZQCT		parent_pubchem_cid	1-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-3-(1H-indol-3-yl)propan-1-one;1574467-19-8;EiM08-34892;AKOS022140761;1-[4-(4-CHLOROPHENYL)-4-HYDROXYPIPERIDINO]-3-(1H-INDOL-3-YL)-1-PROPANONE;1-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-3-(1H-indol-3-yl)propan-1-one		52850715.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=52850715		pluskal_iocb_peptide_Peptide01_F14_id		100	F14		ZINC000095471746
2.9		0	903	P11182619	66.0		AA11	False	0	22	0	0	25	0	5	1	0	0		0.0						CN(C)CCCn1cnc2c1ccc(NC(=O)Cc1c[nH]c3ccccc13)c2																							0.0		N-{1-[3-(dimethylamino)propyl]-1H-benzimidazol-5-yl}-2-(1H-indol-3-yl)acetamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	2		C22H25N5O	C22H25N5O			InChI=1S/C22H25N5O/c1-26(2)10-5-11-27-15-24-20-13-17(8-9-21(20)27)25-22(28)12-16-14-23-19-7-4-3-6-18(16)19/h3-4,6-9,13-15,23H,5,10-12H2,1-2H3,(H,25,28)	AOORBOBOZNRMHG-UHFFFAOYSA-N	N-[1-[3-(dimethylamino)propyl]benzimidazol-5-yl]-2-(1H-indol-3-yl)acetamide	71709558	CN(C)CCCn1cnc2c1ccc(NC(=O)Cc1c[nH]c3ccccc13)c2	N-[1-[3-(dimethylamino)propyl]benzimidazol-5-yl]-2-(1H-indol-3-yl)acetamide			2.35834													MCULE-1585312149	375.47745		375.20591	3	2	7	4			44									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(71709558)	71709558	2.7	1072			[#6]-[#7](-[#6])-[#6]-[#6]-[#6]-[#7]1:[#6]:[#7]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#7]-[#6](=[#8])-[#6]-[#6]1:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:1:3):[#6]:2	CN(C)CCCn1cnc2c1ccc(NC(=O)Cc1c[nH]c3ccccc13)c2	AOORBOBOZNRMHG		parent_pubchem_cid	N-{1-[3-(dimethylamino)propyl]-1H-benzimidazol-5-yl}-2-(1H-indol-3-yl)acetamide;1574407-20-7;EiM08-31640;STL319668;AKOS022110036;N-[1-[3-(dimethylamino)propyl]benzimidazol-5-yl]-2-(1H-indol-3-yl)acetamide		68074654.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=68074654		pluskal_iocb_peptide_Peptide01_F15_id		100	F15		ZINC000095480246
1.4		0	991	P7138702	93.4		AA12	False	0	14	0	0	21	0	3	3	0	0		0.0						CC(C)(C)OC(=O)NC(Cc1ccccc1)C(=O)NN								Amphetamines and derivatives;Carbamate esters;Carboxylic acid hydrazides;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Benzene and substituted derivatives;Benzenoids;Carbamate esters;Carbamic acids and derivatives;Carbonyl compounds;Carboxylic acid derivatives;Carboxylic acid hydrazides;Carboxylic acids and derivatives;Chemical entities;Hydrocarbon derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Phenethylamines;Phenylalanine and derivatives	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic homomonocyclic compounds	amphetamines (CHEBI:35338);carbamate ester (CHEBI:23003);carbohydrazide (CHEBI:35363);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);primary amine (CHEBI:32877);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);organooxygen compound (CHEBI:36963);carbon oxoacid (CHEBI:35605);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806)		Amino acids, peptides, and analogues	Phenylalanine or derivatives;Amphetamine or derivatives;Benzenoid;Monocyclic benzene moiety;Carbamic acid ester;Carboxylic acid hydrazide;Organic nitrogen compound;Organic oxygen compound;Organic oxide;Hydrocarbon derivative;Organooxygen compound;Organonitrogen compound;Carbonyl group;Aromatic homomonocyclic compound	Organic acids and derivatives	0.0		30189-48-1		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	1	0	2	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C14H21N3O3	C14H21N3O3			InChI=1S/C14H21N3O3/c1-14(2,3)20-13(19)16-11(12(18)17-15)9-10-7-5-4-6-8-10/h4-8,11H,9,15H2,1-3H3,(H,16,19)(H,17,18)/t11-/m0/s1	GHSCWLGHLYTNJH-NSHDSACASA-N	tert-butyl N-[rac-(1S)-1-benzyl-2-hydrazino-2-oxo-ethyl]carbamate	6710869	CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)NN	tert-butyl N-[(2S)-1-hydrazinyl-1-oxo-3-phenylpropan-2-yl]carbamate			1.0575899999999998													MCULE-8861245989	279.34177		279.158292	4	3	6	1			43									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(6710869)	6710869	1.2	1073		SCHEMBL3004474	[#6]-[#6](-[#6])(-[#6])-[#8]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#7]-[#7]	CC(C)(C)OC(=O)N[C@@H](Cc1ccccc1)C(=O)NN	GHSCWLGHLYTNJH		parent_pubchem_cid	30189-48-1;(S)-tert-Butyl (1-hydrazinyl-1-oxo-3-phenylpropan-2-yl)carbamate;tert-butyl N-(1-benzyl-2-hydrazino-2-oxoethyl)carbamate;MFCD01631238;N-(tert-Butoxycarbonyl)-L-phenylalanine acid hydrazide;Maybridge1_008971;boc-phenylalanine hydrazide;SCHEMBL3004474;HMS566P17;GHSCWLGHLYTNJH-NSHDSACASA-N;AKOS024461962;CCG-255260;DS-3317;CS-0154540;C74548;A919238;J-017822;t-Butyl N-(1-benzyl-2-hydrazino-2-oxoethyl)carbamate;(s)-tert-butyl 1-hydrazinyl-1-oxo-3-phenylpropan-2-ylcarbamate;(S)-tert-Butyl(1-hydrazinyl-1-oxo-3-phenylpropan-2-yl)carbamate;tert-butyl (S)-(1-hydrazinyl-1-oxo-3-phenylpropan-2-yl)carbamate;tert-butyl N-[rac-(1S)-1-benzyl-2-hydrazino-2-oxo-ethyl]carbamate		16581504.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=16581504		pluskal_iocb_peptide_Peptide01_F15_id		100	F15		ZINC000001733335
1.8		0	735	P6668404	80.9		AA13	False	0	13	0	0	22	0	4	2	0	0	-1.0	0.0						CC(C)(C)C1CCC(CC(=O)O)(n2cnnn2)CC1		2.08		0.0	2.11	CHEMBL4900921																	0.0		1524717-40-5		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	4	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1		C13H22N4O2	C13H22N4O2			InChI=1S/C13H22N4O2/c1-12(2,3)10-4-6-13(7-5-10,8-11(18)19)17-9-14-15-16-17/h9-10H,4-8H2,1-3H3,(H,18,19)	NUMIKWGNCAMJLR-UHFFFAOYSA-N	2-[4-tert-butyl-1-(tetrazol-1-yl)cyclohexyl]acetic acid	60181161	CC(C)(C)C1CCC(CC(=O)O)(n2cnnn2)CC1	2-[4-tert-butyl-1-(tetrazol-1-yl)cyclohexyl]acetic acid			2.0794													MCULE-8427319763	266.34589	ACID	266.174276	5	1	4	2	0.0		28										False			False	False	Peptide01		-1.0	Compound(60181161)	60181161	2.0	1074			[#6]-[#6](-[#6])(-[#6])-[#6]1-[#6]-[#6]-[#6](-[#6]-[#6](=[#8])-[#8])(-[#7]2:[#6]:[#7]:[#7]:[#7]:2)-[#6]-[#6]-1	CC(C)(C)C1CCC(CC(=O)O)(n2cnnn2)CC1	NUMIKWGNCAMJLR		parent_pubchem_cid	1524717-40-5;2-[4-tert-butyl-1-(1H-1,2,3,4-tetrazol-1-yl)cyclohexyl]acetic acid;[4-tert-butyl-1-(1H-tetrazol-1-yl)cyclohexyl]acetic acid;2-(4-(tert-butyl)-1-(1H-tetrazol-1-yl)cyclohexyl)acetic acid;2-[4-tert-butyl-1-(tetrazol-1-yl)cyclohexyl]acetic acid;CHEMBL4900921;BBL033247;MFCD22201611;STL251947;AKOS016375186;NS-04210;CS-0272624;EN300-302570	False	55213891.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=55213891		pluskal_iocb_peptide_Peptide01_F15_id		100	F15	False	ZINC000072324033
3.3		0	823	P1108308	127.0		AA14	False	0	25	0	0	24	0	2	7	0	0		0.0						COc1c(OC)c2c(cc1)c(C)c(CC(=O)NC(Cc1c[nH]c3ccccc13)C(=O)O)c(=O)o2																							0.0		EiM07-29512		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C25H24N2O7	C25H24N2O7			InChI=1S/C25H24N2O7/c1-13-15-8-9-20(32-2)23(33-3)22(15)34-25(31)17(13)11-21(28)27-19(24(29)30)10-14-12-26-18-7-5-4-6-16(14)18/h4-9,12,19,26H,10-11H2,1-3H3,(H,27,28)(H,29,30)/t19-/m0/s1	RWIHBMGLWQUKNV-IBGZPJMESA-N	rac-(2S)-2-[[2-(7,8-dimethoxy-4-methyl-2-oxo-chromen-3-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid	1779877	COc1c(OC)c2c(cc1)c(C)c(CC(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)O)c(=O)o2	(2S)-2-[[2-(7,8-dimethoxy-4-methyl-2-oxochromen-3-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid			1.90862													MCULE-9701838330	464.47923		464.158351	7	3	8	4			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(1779877)	1779877	2.7	1075			[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]):[#6]2:[#6](:[#6]:[#6]:1):[#6](-[#6]):[#6](-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:1:3)-[#6](=[#8])-[#8]):[#6](=[#8]):[#8]:2	COc1c(OC)c2c(cc1)c(C)c(CC(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)O)c(=O)o2	RWIHBMGLWQUKNV		parent_pubchem_cid	EiM07-29512;AKOS016379206;2-[2-(7,8-DIMETHOXY-4-METHYL-2-OXO-2H-CHROMEN-3-YL)ACETAMIDO]-3-(1H-INDOL-3-YL)PROPANOIC ACID;rac-(2S)-2-[[2-(7,8-dimethoxy-4-methyl-2-oxo-chromen-3-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid		22747629.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22747629		pluskal_iocb_peptide_Peptide01_F15_id		100	F15		ZINC000002125146
3.3		0	911	P6237114	75.1		AA15	False	0	21	0	0	23	0	5	1	0	0		0.0						CC(C)CC(NC(=O)Cc1c[nH]c2ccccc12)c1nnc2ccccn12																							0.0		2-(1H-indol-3-yl)-N-[3-methyl-1-([1,2,4]triazolo[4,3-a]pyridin-3-yl)butyl]acetamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	3	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C21H23N5O	C21H23N5O			InChI=1S/C21H23N5O/c1-14(2)11-18(21-25-24-19-9-5-6-10-26(19)21)23-20(27)12-15-13-22-17-8-4-3-7-16(15)17/h3-10,13-14,18,22H,11-12H2,1-2H3,(H,23,27)	YSTXEYUSGFGZRY-UHFFFAOYSA-N	2-(1H-indol-3-yl)-N-[3-methyl-1-([1,2,4]triazolo[4,3-a]pyridin-3-yl)butyl]acetamide	42652917	CC(C)CC(NC(=O)Cc1c[nH]c2ccccc12)c1nnc2ccccn12	2-(1H-indol-3-yl)-N-[3-methyl-1-([1,2,4]triazolo[4,3-a]pyridin-3-yl)butyl]acetamide			2.904650000000001													MCULE-2139516314	361.45036		361.19026	3	2	6	4			44										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(42652917)	42652917	3.8	1076			[#6]-[#6](-[#6])-[#6]-[#6](-[#7]-[#6](=[#8])-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6]1:[#7]:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#7]:1:2	CC(C)CC(NC(=O)Cc1c[nH]c2ccccc12)c1nnc2ccccn12	YSTXEYUSGFGZRY		parent_pubchem_cid	2-(1H-indol-3-yl)-N-[3-methyl-1-([1,2,4]triazolo[4,3-a]pyridin-3-yl)butyl]acetamide;1081123-20-7;STL235585;AKOS016375782		23931834.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23931834		pluskal_iocb_peptide_Peptide01_F15_id		100	F15		
3.0		0	999	P11182977	97.7		AA16	False	0	22	1	0	23	0	6	2	0	0		0.0						COc1cc2c(cc1)[nH]cc2CCNC(=O)CC(Cn1cnnn1)c1ccc(Cl)cc1								Anisoles;Chlorobenzenes;Alkyl aryl ethers;Substituted pyrroles;N-acyl amines;Aryl chlorides;Tetrazoles;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Organonitrogen compounds;Organochlorides;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	3-alkylindoles;Alkyl aryl ethers;Anisoles;Aryl chlorides;Aryl halides;Azacyclic compounds;Azoles;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Chlorobenzenes;Ethers;Fatty Acyls;Fatty amides;Halobenzenes;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Lipids and lipid-like molecules;N-acyl amines;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organochlorides;Organohalogen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenol ethers;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Tetrazoles	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as 3-alkylindoles. These are compounds containing an indole moiety that carries an alkyl chain at the 3-position.	3-alkylindoles			Organic compounds	Aromatic heteropolycyclic compounds	methoxybenzene (CHEBI:51683);organochlorine compound (CHEBI:36683);aromatic ether (CHEBI:35618);pyrroles (CHEBI:26455);fatty amide (CHEBI:29348);tetrazoles (CHEBI:35689);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);indoles (CHEBI:24828);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);organohalogen compound (CHEBI:36684);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);organooxygen compound (CHEBI:36963);ether (CHEBI:25698);organic heterocyclic compound (CHEBI:24532);lipid (CHEBI:18059);haloarene (CHEBI:50887);azole (CHEBI:68452);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)	N-acyl amines (FA0802);Fatty Acyls (FA);Fatty amides (FA08)	Indoles	3-alkylindole;Phenol ether;Anisole;Alkyl aryl ether;Chlorobenzene;Halobenzene;Aryl halide;Fatty acyl;Benzenoid;Substituted pyrrole;Monocyclic benzene moiety;N-acyl-amine;Fatty amide;Aryl chloride;Heteroaromatic compound;Azole;Tetrazole;Pyrrole;Secondary carboxylic acid amide;Carboxamide group;Ether;Carboxylic acid derivative;Azacycle;Organonitrogen compound;Organooxygen compound;Organic oxygen compound;Carbonyl group;Organic nitrogen compound;Hydrocarbon derivative;Organic oxide;Organochloride;Organohalogen compound;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		3-(4-chlorophenyl)-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-4-(1H-tetrazol-1-yl)butanamide		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	4	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C22H23ClN6O2	C22H23ClN6O2			InChI=1S/C22H23ClN6O2/c1-31-19-6-7-21-20(11-19)16(12-25-21)8-9-24-22(30)10-17(13-29-14-26-27-28-29)15-2-4-18(23)5-3-15/h2-7,11-12,14,17,25H,8-10,13H2,1H3,(H,24,30)	NGCLBWFRNYUGLC-UHFFFAOYSA-N	3-(4-chlorophenyl)-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-4-(tetrazol-1-yl)butanamide	71704119	COc1cc2c(cc1)[nH]cc2CCNC(=O)CC(Cn1cnnn1)c1ccc(Cl)cc1	3-(4-chlorophenyl)-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-4-(tetrazol-1-yl)butanamide			2.3489499999999994													MCULE-3792354625	438.92061		438.157102	5	2	9	4			45									Imidazole alkaloids	False	Alkaloids	Histidine alkaloids			Peptide01			Compound(71704119)	71704119	3.2	1077			[#6]-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#7H]:[#6]:[#6]:2-[#6]-[#6]-[#7]-[#6](=[#8])-[#6]-[#6](-[#6]-[#7]1:[#6]:[#7]:[#7]:[#7]:1)-[#6]1:[#6]:[#6]:[#6](-[#17]):[#6]:[#6]:1	COc1cc2c(cc1)[nH]cc2CCNC(=O)CC(Cn1cnnn1)c1ccc(Cl)cc1	NGCLBWFRNYUGLC		parent_pubchem_cid	3-(4-chlorophenyl)-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-4-(1H-tetrazol-1-yl)butanamide;1574484-59-5;EiM08-32777;AKOS022115908;3-(4-chlorophenyl)-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-4-(tetrazol-1-yl)butanamide		49347013.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=49347013		pluskal_iocb_peptide_Peptide01_F15_id		100	F15		
3.0		0	743	P6240051	126.0		AA17	False	0	19	0	0	24	0	2	5	0	1		0.0						COc1cccc(-c2nc(CC(=O)NC(CC(C)C)C(=O)O)cs2)c1OC																							0.0		SCHEMBL21560289		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C19H24N2O5S	C19H24N2O5S			InChI=1S/C19H24N2O5S/c1-11(2)8-14(19(23)24)21-16(22)9-12-10-27-18(20-12)13-6-5-7-15(25-3)17(13)26-4/h5-7,10-11,14H,8-9H2,1-4H3,(H,21,22)(H,23,24)/t14-/m0/s1	KZCWXMZVMSWVDU-AWEZNQCLSA-N	rac-(2S)-2-[[2-[2-(2,3-dimethoxyphenyl)thiazol-4-yl]acetyl]amino]-4-methyl-pentanoic acid	45495949	COc1cccc(-c2nc(CC(=O)N[C@@H](CC(C)C)C(=O)O)cs2)c1OC	(2S)-2-[[2-[2-(2,3-dimethoxyphenyl)-1,3-thiazol-4-yl]acetyl]amino]-4-methylpentanoic acid			1.6257499999999996													MCULE-6666124242	392.47753		392.140593	6	2	9	2			43										False	Alkaloids				Peptide01			Compound(45495949)	45495949	3.1	1078		SCHEMBL21560289	[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6](-[#6]2:[#7]:[#6](-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=[#8])-[#8]):[#6]:[#16]:2):[#6]:1-[#8]-[#6]	COc1cccc(-c2nc(CC(=O)N[C@@H](CC(C)C)C(=O)O)cs2)c1OC	KZCWXMZVMSWVDU		parent_pubchem_cid	SCHEMBL21560289;AKOS005669238;(2S)-2-({2-[2-(2,3-DIMETHOXYPHENYL)-1,3-THIAZOL-4-YL]ACETYL}AMINO)-4-METHYLPENTANOIC ACID;rac-(2S)-2-[[2-[2-(2,3-dimethoxyphenyl)thiazol-4-yl]acetyl]amino]-4-methyl-pentanoic acid		24613248.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24613248		pluskal_iocb_peptide_Peptide01_F15_id		100	F15		ZINC000036366774
2.6		0	831	P3463158	91.5		AA18	False	0	23	0	1	22	0	3	4	0	0		0.0						COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C1CC(=O)N(c2ccccc2F)C1								N-acyl-alpha amino acids and derivatives;Alpha amino acid esters;Indolyl carboxylic acids and derivatives;Phenylpyrrolidines;3-alkylindoles;Pyrrolidinecarboxamides;Fluorobenzenes;Fatty acid esters;Substituted pyrroles;Pyrrolidine-2-ones;Aryl fluorides;Tertiary carboxylic acid amides;Methyl esters;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactams;Monocarboxylic acids and derivatives;Azacyclic compounds;Organopnictogen compounds;Organonitrogen compounds;Organofluorides;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	3-alkylindoles;Alpha amino acid esters;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Aryl fluorides;Aryl halides;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids and derivatives;Chemical entities;Fatty Acyls;Fatty acid esters;Fluorobenzenes;Halobenzenes;Heteroaromatic compounds;Hybrid peptides;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Indolyl carboxylic acids and derivatives;Lactams;Lipids and lipid-like molecules;Methyl esters;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organofluorides;Organohalogen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Peptidomimetics;Phenylpyrrolidines;Pyrroles;Pyrrolidine carboxylic acids and derivatives;Pyrrolidine-2-ones;Pyrrolidinecarboxamides;Pyrrolidines;Pyrrolidones;Secondary carboxylic acid amides;Substituted pyrroles;Tertiary carboxylic acid amides	Peptidomimetics	2.1	This compound belongs to the class of organic compounds known as hybrid peptides. These are compounds containing at least two different types of amino acids (alpha, beta, gamma, delta) linked to each other through a peptide bond.	Hybrid peptides			Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-amino acid (CHEBI:51569);alpha-amino acid ester (CHEBI:46874);indolyl carboxylic acid (CHEBI:46867);pyrrolidines (CHEBI:38260);indoles (CHEBI:24828);pyrrolidinecarboxamide (CHEBI:46770);organofluorine compound (CHEBI:37143);fatty acid ester (CHEBI:35748);pyrroles (CHEBI:26455);pyrrolidin-2-ones (CHEBI:74223);carboxamide (CHEBI:37622);carboxylic ester (CHEBI:33308);organic aromatic compound (CHEBI:33659);lactam (CHEBI:24995);carbonyl compound (CHEBI:36586);organonitrogen heterocyclic compound (CHEBI:38101);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);peptide (CHEBI:16670);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);amino acid (CHEBI:33709);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);organohalogen compound (CHEBI:36684);lipid (CHEBI:18059);pyrrolidinone (CHEBI:38275);haloarene (CHEBI:50887);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806);peptidomimetic (CHEBI:63175)	Fatty esters (FA07);Fatty Acyls (FA)	Hybrid peptides	Hybrid peptide;N-acyl-alpha amino acid or derivatives;Alpha-amino acid ester;Indolyl carboxylic acid derivative;1-phenylpyrrolidine;3-alkylindole;Alpha-amino acid or derivatives;Indole or derivatives;Indole;Pyrrolidine-3-carboxamide;Pyrrolidine carboxylic acid or derivatives;Halobenzene;Fluorobenzene;Fatty acid ester;Fatty acyl;Benzenoid;Substituted pyrrole;2-pyrrolidone;Pyrrolidone;Monocyclic benzene moiety;Aryl halide;Aryl fluoride;Heteroaromatic compound;Methyl ester;Tertiary carboxylic acid amide;Pyrrolidine;Pyrrole;Secondary carboxylic acid amide;Lactam;Carboxylic acid ester;Carboxamide group;Azacycle;Organoheterocyclic compound;Monocarboxylic acid or derivatives;Carboxylic acid derivative;Organic nitrogen compound;Organic oxygen compound;Organopnictogen compound;Organic oxide;Hydrocarbon derivative;Organooxygen compound;Organonitrogen compound;Organofluoride;Organohalogen compound;Carbonyl group;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		EiM08-09419		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C23H22FN3O4	C23H22FN3O4			InChI=1S/C23H22FN3O4/c1-31-23(30)19(10-14-12-25-18-8-4-2-6-16(14)18)26-22(29)15-11-21(28)27(13-15)20-9-5-3-7-17(20)24/h2-9,12,15,19,25H,10-11,13H2,1H3,(H,26,29)	UPFKHIAIYIAYQG-UHFFFAOYSA-N	methyl 2-[[1-(2-fluorophenyl)-5-oxo-pyrrolidine-3-carbonyl]amino]-3-(1H-indol-3-yl)propanoate	56726582	COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C1CC(=O)N(c2ccccc2F)C1	methyl 2-[[1-(2-fluorophenyl)-5-oxopyrrolidine-3-carbonyl]amino]-3-(1H-indol-3-yl)propanoate			1.6966599999999994													MCULE-2295309496	423.44789		423.159434	4	2	7	4			45										False	Amino acids and Peptides				Peptide01			Compound(56726582)	56726582	2.4	1079			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#6](=[#8])-[#6]1-[#6]-[#6](=[#8])-[#7](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#9])-[#6]-1	COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C1CC(=O)N(c2ccccc2F)C1	UPFKHIAIYIAYQG		parent_pubchem_cid	EiM08-09419;AKOS016382151;methyl 2-[[1-(2-fluorophenyl)-5-oxo-pyrrolidine-3-carbonyl]amino]-3-(1H-indol-3-yl)propanoate		23869690.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23869690		pluskal_iocb_peptide_Peptide01_F15_id		100	F15		
4.1		0	919	P6236750	107.5		AA19	False	0	20	1	0	17	0	2	3	0	1		0.0						O=C(Cc1csc(-c2ccc(Cl)cc2)n1)NC(Cc1ccccc1)C(=O)O																							0.0		SCHEMBL20255628		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C20H17ClN2O3S	C20H17ClN2O3S			InChI=1S/C20H17ClN2O3S/c21-15-8-6-14(7-9-15)19-22-16(12-27-19)11-18(24)23-17(20(25)26)10-13-4-2-1-3-5-13/h1-9,12,17H,10-11H2,(H,23,24)(H,25,26)/t17-/m0/s1	DJFAVSWKYYGECG-KRWDZBQOSA-N	rac-(2S)-2-[[2-[2-(4-chlorophenyl)thiazol-4-yl]acetyl]amino]-3-phenyl-propanoic acid	29135135	O=C(Cc1csc(-c2ccc(Cl)cc2)n1)N[C@@H](Cc1ccccc1)C(=O)O	(2S)-2-[[2-[2-(4-chlorophenyl)-1,3-thiazol-4-yl]acetyl]amino]-3-phenylpropanoic acid			3.328660000000001													MCULE-3270674469	400.88709		400.064841	4	2	7	3			43										False					Peptide01			Compound(29135135)	29135135	4.1	1080		SCHEMBL20255628	[#8]=[#6](-[#6]-[#6]1:[#6]:[#16]:[#6](-[#6]2:[#6]:[#6]:[#6](-[#17]):[#6]:[#6]:2):[#7]:1)-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	O=C(Cc1csc(-c2ccc(Cl)cc2)n1)N[C@@H](Cc1ccccc1)C(=O)O	DJFAVSWKYYGECG		parent_pubchem_cid	SCHEMBL20255628;AKOS016402568;rac-(2S)-2-[[2-[2-(4-chlorophenyl)thiazol-4-yl]acetyl]amino]-3-phenyl-propanoic acid		24127939.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24127939		pluskal_iocb_peptide_Peptide01_F16_id		100	F16		ZINC000020733213
1.4		0	1007	P1094980	94.7		AA20	False	0	20	0	0	26	0	4	4	0	0		0.0						COC(=O)C(C)NC(=O)N1CCN(C(=O)CCc2c[nH]c3ccccc23)CC1																							0.0		AKOS005533558		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C20H26N4O4	C20H26N4O4			InChI=1S/C20H26N4O4/c1-14(19(26)28-2)22-20(27)24-11-9-23(10-12-24)18(25)8-7-15-13-21-17-6-4-3-5-16(15)17/h3-6,13-14,21H,7-12H2,1-2H3,(H,22,27)/t14-/m0/s1	MATFWHFBQMJLQC-AWEZNQCLSA-N	methyl rac-(2S)-2-[[4-[3-(1H-indol-3-yl)propanoyl]piperazine-1-carbonyl]amino]propanoate	17592729	COC(=O)[C@H](C)NC(=O)N1CCN(C(=O)CCc2c[nH]c3ccccc23)CC1	methyl (2S)-2-[[4-[3-(1H-indol-3-yl)propanoyl]piperazine-1-carbonyl]amino]propanoate			1.0326700000000009													MCULE-9099005750	386.45462		386.195405	4	2	6	3			44										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(17592729)	17592729	1.1	1081			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6])-[#7]-[#6](=[#8])-[#7]1-[#6]-[#6]-[#7](-[#6](=[#8])-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6]-[#6]-1	COC(=O)[C@H](C)NC(=O)N1CCN(C(=O)CCc2c[nH]c3ccccc23)CC1	MATFWHFBQMJLQC		parent_pubchem_cid	AKOS005533558;methyl rac-(2S)-2-[[4-[3-(1H-indol-3-yl)propanoyl]piperazine-1-carbonyl]amino]propanoate		5428862.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=5428862		pluskal_iocb_peptide_Peptide01_F16_id		100	F16		ZINC000008990115
-0.1		0	751	P6239569	119.8		AA21	False	0	23	0	0	29	0	5	4	0	0		0.0						NC(=O)C1CCN(C(=O)CCC(=O)N2CCN(C(=O)c3c[nH]c4ccccc34)CC2)CC1																							0.0		1-{4-[4-(1H-indol-3-ylcarbonyl)piperazin-1-yl]-4-oxobutanoyl}piperidine-4-carboxamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	4	0	0	0	0	0	0	0	0	0	0	4	0	0	0	0	0	0	0	0	0	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	3	0		C23H29N5O4	C23H29N5O4			InChI=1S/C23H29N5O4/c24-22(31)16-7-9-26(10-8-16)20(29)5-6-21(30)27-11-13-28(14-12-27)23(32)18-15-25-19-4-2-1-3-17(18)19/h1-4,15-16,25H,5-14H2,(H2,24,31)	YQAPFFBNVVHJFS-UHFFFAOYSA-N	1-[4-[4-(1H-indole-3-carbonyl)piperazin-1-yl]-4-oxo-butanoyl]piperidine-4-carboxamide	29140875	NC(=O)C1CCN(C(=O)CCC(=O)N2CCN(C(=O)c3c[nH]c4ccccc34)CC2)CC1	1-[4-[4-(1H-indole-3-carbonyl)piperazin-1-yl]-4-oxobutanoyl]piperidine-4-carboxamide			0.4732700000000014													MCULE-8355350271	439.51868		439.221954	4	2	5	4			44									Carboline alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(29140875)	29140875	-0.5	1082			[#7]-[#6](=[#8])-[#6]1-[#6]-[#6]-[#7](-[#6](=[#8])-[#6]-[#6]-[#6](=[#8])-[#7]2-[#6]-[#6]-[#7](-[#6](=[#8])-[#6]3:[#6]:[#7H]:[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]:3:4)-[#6]-[#6]-2)-[#6]-[#6]-1	NC(=O)C1CCN(C(=O)CCC(=O)N2CCN(C(=O)c3c[nH]c4ccccc34)CC2)CC1	YQAPFFBNVVHJFS		parent_pubchem_cid	1-{4-[4-(1H-indol-3-ylcarbonyl)piperazin-1-yl]-4-oxobutanoyl}piperidine-4-carboxamide;1081138-37-5;AKOS005573500;1-[4-[4-(1H-indole-3-carbonyl)piperazin-1-yl]-4-oxo-butanoyl]piperidine-4-carboxamide		11668744.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=11668744		pluskal_iocb_peptide_Peptide01_F16_id		100	F16		ZINC000020746058
3.8		0	839	P1108012	131.1		AA22	False	0	26	0	0	25	0	1	6	0	1		0.0						CSCCC(NC(=O)Cc1c(C)c2cc3c(cc2oc1=O)oc(C)c3-c1ccccc1)C(=O)O																							0.0		AKOS016393793		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C26H25NO6S	C26H25NO6S			InChI=1S/C26H25NO6S/c1-14-17-11-19-22(32-15(2)24(19)16-7-5-4-6-8-16)13-21(17)33-26(31)18(14)12-23(28)27-20(25(29)30)9-10-34-3/h4-8,11,13,20H,9-10,12H2,1-3H3,(H,27,28)(H,29,30)/t20-/m1/s1	RHYGVQJHIBPZQT-HXUWFJFHSA-N	rac-(2R)-2-[[2-(2,5-dimethyl-7-oxo-3-phenyl-furo[3,2-g]chromen-6-yl)acetyl]amino]-4-methylsulfanyl-butanoic acid	24280565	CSCC[C@@H](NC(=O)Cc1c(C)c2cc3c(cc2oc1=O)oc(C)c3-c1ccccc1)C(=O)O	(2R)-2-[[2-(2,5-dimethyl-7-oxo-3-phenylfuro[3,2-g]chromen-6-yl)acetyl]amino]-4-methylsulfanylbutanoic acid			4.1869400000000025													MCULE-1528689843	479.55625		479.140259	6	2	8	4			44									Furocoumarins;Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(24280565)	24280565	4.1	1083			[#6]-[#16]-[#6]-[#6]-[#6@@H](-[#7]-[#6](=[#8])-[#6]-[#6]1:[#6](-[#6]):[#6]2:[#6]:[#6]3:[#6](:[#6]:[#6]:2:[#8]:[#6]:1=[#8]):[#8]:[#6](-[#6]):[#6]:3-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	CSCC[C@@H](NC(=O)Cc1c(C)c2cc3c(cc2oc1=O)oc(C)c3-c1ccccc1)C(=O)O	RHYGVQJHIBPZQT		parent_pubchem_cid	AKOS016393793;rac-(2R)-2-[[2-(2,5-dimethyl-7-oxo-3-phenyl-furo[3,2-g]chromen-6-yl)acetyl]amino]-4-methylsulfanyl-butanoic acid		23548977.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23548977		pluskal_iocb_peptide_Peptide01_F16_id		100	F16		ZINC000011865565
3.0		0	927	P3462922	91.5		AA23	False	0	23	1	0	22	0	3	4	0	0		0.0						COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C1CC(=O)N(c2ccccc2Cl)C1								N-acyl-alpha amino acids and derivatives;Alpha amino acid esters;Indolyl carboxylic acids and derivatives;Phenylpyrrolidines;3-alkylindoles;Pyrrolidinecarboxamides;Fatty acid esters;Chlorobenzenes;Substituted pyrroles;Pyrrolidine-2-ones;Aryl chlorides;Tertiary carboxylic acid amides;Methyl esters;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactams;Monocarboxylic acids and derivatives;Azacyclic compounds;Organopnictogen compounds;Organonitrogen compounds;Organochlorides;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	3-alkylindoles;Alpha amino acid esters;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Aryl chlorides;Aryl halides;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids and derivatives;Chemical entities;Chlorobenzenes;Fatty Acyls;Fatty acid esters;Halobenzenes;Heteroaromatic compounds;Hybrid peptides;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Indolyl carboxylic acids and derivatives;Lactams;Lipids and lipid-like molecules;Methyl esters;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organochlorides;Organohalogen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Peptidomimetics;Phenylpyrrolidines;Pyrroles;Pyrrolidine carboxylic acids and derivatives;Pyrrolidine-2-ones;Pyrrolidinecarboxamides;Pyrrolidines;Pyrrolidones;Secondary carboxylic acid amides;Substituted pyrroles;Tertiary carboxylic acid amides	Peptidomimetics	2.1	This compound belongs to the class of organic compounds known as hybrid peptides. These are compounds containing at least two different types of amino acids (alpha, beta, gamma, delta) linked to each other through a peptide bond.	Hybrid peptides			Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-amino acid (CHEBI:51569);alpha-amino acid ester (CHEBI:46874);indolyl carboxylic acid (CHEBI:46867);pyrrolidines (CHEBI:38260);indoles (CHEBI:24828);pyrrolidinecarboxamide (CHEBI:46770);fatty acid ester (CHEBI:35748);organochlorine compound (CHEBI:36683);pyrroles (CHEBI:26455);pyrrolidin-2-ones (CHEBI:74223);carboxamide (CHEBI:37622);carboxylic ester (CHEBI:33308);organic aromatic compound (CHEBI:33659);lactam (CHEBI:24995);carbonyl compound (CHEBI:36586);organonitrogen heterocyclic compound (CHEBI:38101);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);peptide (CHEBI:16670);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);amino acid (CHEBI:33709);organic heterocyclic compound (CHEBI:24532);lipid (CHEBI:18059);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);organohalogen compound (CHEBI:36684);pyrrolidinone (CHEBI:38275);haloarene (CHEBI:50887);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806);peptidomimetic (CHEBI:63175)	Fatty esters (FA07);Fatty Acyls (FA)	Hybrid peptides	Hybrid peptide;N-acyl-alpha amino acid or derivatives;Alpha-amino acid ester;Indolyl carboxylic acid derivative;1-phenylpyrrolidine;3-alkylindole;Alpha-amino acid or derivatives;Indole or derivatives;Indole;Pyrrolidine-3-carboxamide;Pyrrolidine carboxylic acid or derivatives;Halobenzene;Fatty acid ester;Chlorobenzene;Fatty acyl;Benzenoid;Substituted pyrrole;2-pyrrolidone;Pyrrolidone;Monocyclic benzene moiety;Aryl halide;Aryl chloride;Heteroaromatic compound;Methyl ester;Tertiary carboxylic acid amide;Pyrrolidine;Pyrrole;Secondary carboxylic acid amide;Lactam;Carboxylic acid ester;Carboxamide group;Azacycle;Organoheterocyclic compound;Monocarboxylic acid or derivatives;Carboxylic acid derivative;Organic nitrogen compound;Organic oxygen compound;Organopnictogen compound;Organic oxide;Hydrocarbon derivative;Organooxygen compound;Organonitrogen compound;Organochloride;Organohalogen compound;Carbonyl group;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS016382150		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C23H22ClN3O4	C23H22ClN3O4			InChI=1S/C23H22ClN3O4/c1-31-23(30)19(10-14-12-25-18-8-4-2-6-16(14)18)26-22(29)15-11-21(28)27(13-15)20-9-5-3-7-17(20)24/h2-9,12,15,19,25H,10-11,13H2,1H3,(H,26,29)	LAHWWYBBALPONZ-UHFFFAOYSA-N	methyl 2-[[1-(2-chlorophenyl)-5-oxo-pyrrolidine-3-carbonyl]amino]-3-(1H-indol-3-yl)propanoate	56725834	COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C1CC(=O)N(c2ccccc2Cl)C1	methyl 2-[[1-(2-chlorophenyl)-5-oxopyrrolidine-3-carbonyl]amino]-3-(1H-indol-3-yl)propanoate			2.210959999999999													MCULE-8435994337	439.90249		439.129884	4	2	7	4			45										False	Amino acids and Peptides				Peptide01			Compound(56725834)	56725834	2.9	1084			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#6](=[#8])-[#6]1-[#6]-[#6](=[#8])-[#7](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#17])-[#6]-1	COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C1CC(=O)N(c2ccccc2Cl)C1	LAHWWYBBALPONZ		parent_pubchem_cid	AKOS016382150;methyl 2-[[1-(2-chlorophenyl)-5-oxo-pyrrolidine-3-carbonyl]amino]-3-(1H-indol-3-yl)propanoate		23780001.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23780001		pluskal_iocb_peptide_Peptide01_F16_id		100	F16		
2.8		0	1015	P7567854	71.3		AA24	False	0	16	0	0	20	0	2	3	0	0		0.0						CCC(C)C(NC(=O)c1cc2c(cc1)n(C)cc2)C(=O)O																							0.0		AKOS025146050		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C16H20N2O3	C16H20N2O3			InChI=1S/C16H20N2O3/c1-4-10(2)14(16(20)21)17-15(19)12-5-6-13-11(9-12)7-8-18(13)3/h5-10,14H,4H2,1-3H3,(H,17,19)(H,20,21)/t10-,14+/m1/s1	HLQXKQGHAHTZHI-YGRLFVJLSA-N	rac-(2S,3R)-3-methyl-2-[(1-methylindole-5-carbonyl)amino]pentanoic acid	91637673	CC[C@@H](C)[C@H](NC(=O)c1cc2c(cc1)n(C)cc2)C(=O)O	(2S,3R)-3-methyl-2-[(1-methylindole-5-carbonyl)amino]pentanoic acid			1.92427														288.3494		288.147392	3	2	5	2			45										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(91637673)	91637673	2.6	1085			[#6]-[#6]-[#6@@H](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#7](-[#6]):[#6]:[#6]:2)-[#6](=[#8])-[#8]	CC[C@@H](C)[C@H](NC(=O)c1cc2c(cc1)n(C)cc2)C(=O)O	HLQXKQGHAHTZHI		parent_pubchem_cid	AKOS025146050;rac-(2S,3R)-3-methyl-2-[(1-methylindole-5-carbonyl)amino]pentanoic acid		93432857.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=93432857		pluskal_iocb_peptide_Peptide01_F16_id		100	F16		ZINC000170625477
0.2		0	759	P3463412	65.1		AA25	False	0	17	0	0	16	0	2	2	0	0		0.0						O=C(O)C(NCc1ccccc1)c1c[nH]c2ccccc12								Alpha amino acids;3-alkylindoles;Phenylmethylamines;Benzylamines;Aralkylamines;Substituted pyrroles;Heteroaromatic compounds;Amino acids;Monocarboxylic acids and derivatives;Dialkylamines;Carboxylic acids;Azacyclic compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	3-alkylindoles;Alpha amino acids;Alpha amino acids and derivatives;Amines;Amino acids;Amino acids and derivatives;Amino acids, peptides, and analogues;Aralkylamines;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Benzylamines;Carbonyl compounds;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Dialkylamines;Heteroaromatic compounds;Hydrocarbon derivatives;Indole-3-acetic acid derivatives;Indoles;Indoles and derivatives;Indolyl carboxylic acids and derivatives;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenylmethylamines;Pyrroles;Secondary amines;Substituted pyrroles	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as indole-3-acetic acid derivatives. These are compounds containing an acetic acid (or a derivative) linked to the C3 carbon atom of an indole.	Indole-3-acetic acid derivatives			Organic compounds	Aromatic heteropolycyclic compounds	alpha-amino acid (CHEBI:33704);indoles (CHEBI:24828);aromatic amine (CHEBI:33860);aralkylamine (CHEBI:18000);pyrroles (CHEBI:26455);organic aromatic compound (CHEBI:33659);amino acid (CHEBI:33709);monocarboxylic acid (CHEBI:25384);secondary amino compound (CHEBI:50995);carboxylic acid (CHEBI:33575);organonitrogen heterocyclic compound (CHEBI:38101);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);indole-3-acetic acids (CHEBI:24803);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organonitrogen compound (CHEBI:35352);organooxygen compound (CHEBI:36963);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);amine (CHEBI:32952);secondary amine (CHEBI:32863);oxygen molecular entity (CHEBI:25806);indolyl carboxylic acid (CHEBI:46867);carboxylic acid anion (CHEBI:29067);peptide (CHEBI:16670)		Indolyl carboxylic acids and derivatives	Indole-3-acetic acid derivative;Alpha-amino acid;Alpha-amino acid or derivatives;3-alkylindole;Indole;Benzylamine;Phenylmethylamine;Aralkylamine;Monocyclic benzene moiety;Benzenoid;Substituted pyrrole;Heteroaromatic compound;Pyrrole;Amino acid;Amino acid or derivatives;Azacycle;Carboxylic acid;Carboxylic acid derivative;Monocarboxylic acid or derivatives;Secondary aliphatic amine;Secondary amine;Organic nitrogen compound;Organonitrogen compound;Carbonyl group;Organooxygen compound;Hydrocarbon derivative;Organic oxide;Amine;Organic oxygen compound;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		(benzylamino)(1H-indol-3-yl)acetic acid		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0		C17H16N2O2	C17H16N2O2			InChI=1S/C17H16N2O2/c20-17(21)16(19-10-12-6-2-1-3-7-12)14-11-18-15-9-5-4-8-13(14)15/h1-9,11,16,18-19H,10H2,(H,20,21)	BJDDLDRDCPAFEJ-UHFFFAOYSA-N	2-(benzylamino)-2-(1H-indol-3-yl)acetic acid	19796669	O=C(O)C(NCc1ccccc1)c1c[nH]c2ccccc12	2-(benzylamino)-2-(1H-indol-3-yl)acetic acid			2.545560000000001													MCULE-5623150357	280.32927		280.121178	3	3	5	3			43									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(19796669)	19796669	0.4	1086		SCHEMBL9583647	[#8]=[#6](-[#8])-[#6](-[#7]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	O=C(O)C(NCc1ccccc1)c1c[nH]c2ccccc12	BJDDLDRDCPAFEJ		parent_pubchem_cid	(benzylamino)(1H-indol-3-yl)acetic acid;130361-06-7;2-(benzylamino)-2-(1H-indol-3-yl)acetic acid;MFCD13176347;SCHEMBL9583647;BBL032276;STL146370;AKOS005720770;(benzylamino)(1H-indol-3-yl)aceticacid;NS-04601;CS-0270017;EN300-302787;(BenZylamino)(1H-indol-3-yl)acetic acid (BZl-DL-nTrp-OH)		24000485.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24000485		pluskal_iocb_peptide_Peptide01_F16_id		100	F16		
3.5		0	847	P7130343	74.4		AA26	False	0	25	0	0	27	0	3	3	0	0		0.0						COc1cc2c(cc1)[nH]cc2CCNC(=O)c1cn(CC(C)C)c(=O)c2ccccc12								3-alkylindoles;Pyridinecarboxylic acids and derivatives;Anisoles;Pyridinones;Alkyl aryl ethers;Substituted pyrroles;Vinylogous amides;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactams;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	3-alkylindoles;Alkyl aryl ethers;Anisoles;Azacyclic compounds;Benzenoids;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Hydropyridines;Indoles;Indoles and derivatives;Isoquinolines and derivatives;Isoquinolones and derivatives;Lactams;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenol ethers;Pyridinecarboxylic acids and derivatives;Pyridines and derivatives;Pyridinones;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Vinylogous amides	Isoquinolines and derivatives	2.1	This compound belongs to the class of organic compounds known as isoquinolones and derivatives. These are aromatic polycyclic compounds containing a ketone bearing isoquinoline moiety.	Isoquinolones and derivatives			Organic compounds	Aromatic heteropolycyclic compounds	indoles (CHEBI:24828);aromatic carboxylic acid (CHEBI:33859);pyridinemonocarboxylic acid (CHEBI:26420);methoxybenzene (CHEBI:51683);pyridone (CHEBI:38183);aromatic ether (CHEBI:35618);pyrroles (CHEBI:26455);enone (CHEBI:51689);enamine (CHEBI:47989);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactam (CHEBI:24995);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);isoquinolines (CHEBI:24922);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);pyridines (CHEBI:26421);benzenoid aromatic compound (CHEBI:33836);dihydropyridine (CHEBI:50075);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);organooxygen compound (CHEBI:36963);ether (CHEBI:25698);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)		Isoquinolones and derivatives	Isoquinolone;3-alkylindole;Indole;Indole or derivatives;Pyridine carboxylic acid or derivatives;Anisole;Phenol ether;Alkyl aryl ether;Pyridinone;Pyridine;Benzenoid;Substituted pyrrole;Vinylogous amide;Heteroaromatic compound;Pyrrole;Lactam;Carboxamide group;Secondary carboxylic acid amide;Azacycle;Ether;Carboxylic acid derivative;Organic oxygen compound;Organic nitrogen compound;Organooxygen compound;Organonitrogen compound;Hydrocarbon derivative;Organic oxide;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		1374545-25-1		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C25H27N3O3	C25H27N3O3			InChI=1S/C25H27N3O3/c1-16(2)14-28-15-22(19-6-4-5-7-20(19)25(28)30)24(29)26-11-10-17-13-27-23-9-8-18(31-3)12-21(17)23/h4-9,12-13,15-16,27H,10-11,14H2,1-3H3,(H,26,29)	QEEWFZKSCQOTDM-UHFFFAOYSA-N	2-isobutyl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-1-oxo-isoquinoline-4-carboxamide	71692294	COc1cc2c(cc1)[nH]cc2CCNC(=O)c1cn(CC(C)C)c(=O)c2ccccc12	N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-2-(2-methylpropyl)-1-oxoisoquinoline-4-carboxamide			3.5911200000000028													MCULE-1562321175	417.51224		417.205242	3	2	7	4			44									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(71692294)	71692294	3.9	1087			[#6]-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#7H]:[#6]:[#6]:2-[#6]-[#6]-[#7]-[#6](=[#8])-[#6]1:[#6]:[#7](-[#6]-[#6](-[#6])-[#6]):[#6](=[#8]):[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	COc1cc2c(cc1)[nH]cc2CCNC(=O)c1cn(CC(C)C)c(=O)c2ccccc12	QEEWFZKSCQOTDM		parent_pubchem_cid	1374545-25-1;2-isobutyl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-1-oxo-1,2-dihydro-4-isoquinolinecarboxamide;EiM08-25808;AKOS024460479;N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-2-(2-methylpropyl)-1-oxo-1,2-dihydroisoquinoline-4-carboxamide;2-isobutyl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-1-oxo-isoquinoline-4-carboxamide		47972671.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=47972671		pluskal_iocb_peptide_Peptide01_F16_id		100	F16		ZINC000072326118
2.2		0	935	P3460077	140.8		AA27	False	0	25	0	0	34	0	4	6	0	0		0.0						CC(NC(=O)C1CCN(C(=O)C(Cc2c[nH]c3ccccc23)NC(=O)OC(C)(C)C)CC1)C(=O)O																							0.0		AKOS016386848		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	2	0	0	0	0	0	0	1	0	4	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C25H34N4O6	C25H34N4O6			InChI=1S/C25H34N4O6/c1-15(23(32)33)27-21(30)16-9-11-29(12-10-16)22(31)20(28-24(34)35-25(2,3)4)13-17-14-26-19-8-6-5-7-18(17)19/h5-8,14-16,20,26H,9-13H2,1-4H3,(H,27,30)(H,28,34)(H,32,33)/t15-,20-/m0/s1	MJBGIYBYCIREOE-YWZLYKJASA-N	rac-(2S)-2-[[1-[rac-(2S)-2-(tert-butoxycarbonylamino)-3-(1H-indol-3-yl)propanoyl]piperidine-4-carbonyl]amino]propanoic acid	16400584	C[C@H](NC(=O)C1CCN(C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)OC(C)(C)C)CC1)C(=O)O	(2S)-2-[[1-[(2S)-3-(1H-indol-3-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoyl]piperidine-4-carbonyl]amino]propanoic acid			1.94847													MCULE-7795345638	486.57293		486.247835	6	4	9	3			44									Tripeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(16400584)	16400584	1.7	1088			[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]1-[#6]-[#6]-[#7](-[#6](=[#8])-[#6@H](-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#7]-[#6](=[#8])-[#8]-[#6](-[#6])(-[#6])-[#6])-[#6]-[#6]-1)-[#6](=[#8])-[#8]	C[C@H](NC(=O)C1CCN(C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)OC(C)(C)C)CC1)C(=O)O	MJBGIYBYCIREOE		parent_pubchem_cid	AKOS016386848;rac-(2S)-2-[[1-[rac-(2S)-2-(tert-butoxycarbonylamino)-3-(1H-indol-3-yl)propanoyl]piperidine-4-carbonyl]amino]propanoic acid		24204288.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24204288		pluskal_iocb_peptide_Peptide01_F17_id		100	F17		ZINC000012865190
1.5		0	1023	P11184847	114.9		AA28	False	0	23	0	0	20	0	4	4	0	0		0.0						O=C(Cn1cc(-c2ccccc2)ncc1=O)NC(Cc1c[nH]c2ccccc12)C(=O)O																							0.0		AKOS027472511		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C23H20N4O4	C23H20N4O4			InChI=1S/C23H20N4O4/c28-21(14-27-13-20(25-12-22(27)29)15-6-2-1-3-7-15)26-19(23(30)31)10-16-11-24-18-9-5-4-8-17(16)18/h1-9,11-13,19,24H,10,14H2,(H,26,28)(H,30,31)/t19-/m0/s1	NSFHTHMCPLHZSG-IBGZPJMESA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[[2-(2-oxo-5-phenyl-pyrazin-1-yl)acetyl]amino]propanoic acid	91639262	O=C(Cn1cc(-c2ccccc2)ncc1=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	(2S)-3-(1H-indol-3-yl)-2-[[2-(2-oxo-5-phenylpyrazin-1-yl)acetyl]amino]propanoic acid			2.24044														416.44025		416.148455	5	3	7	4			45										False	Alkaloids				Peptide01			Compound(91639262)	91639262	2.2	1089			[#8]=[#6](-[#6]-[#7]1:[#6]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#7]:[#6]:[#6]:1=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	O=C(Cn1cc(-c2ccccc2)ncc1=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	NSFHTHMCPLHZSG		parent_pubchem_cid	AKOS027472511;rac-(2S)-3-(1H-indol-3-yl)-2-[[2-(2-oxo-5-phenyl-pyrazin-1-yl)acetyl]amino]propanoic acid		94670206.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=94670206		pluskal_iocb_peptide_Peptide01_F17_id		100	F17		ZINC000218187440
2.4		0	767	P11182439	123.2		AA29	False	0	26	0	0	32	0	2	7	0	0		0.0						COc1c(OC)c(OC)c2c(c1)CCC(NC(C)=O)c1cc(=O)c(NC(C(=O)O)C(C)C)ccc1-2																							0.0		(S)-2-(((S)-7-acetamido-1,2,3-trimethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-10-yl)amino)-3-methylbutanoic acid		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C26H32N2O7	C26H32N2O7			InChI=1S/C26H32N2O7/c1-13(2)23(26(31)32)28-19-10-8-16-17(12-20(19)30)18(27-14(3)29)9-7-15-11-21(33-4)24(34-5)25(35-6)22(15)16/h8,10-13,18,23H,7,9H2,1-6H3,(H,27,29)(H,28,30)(H,31,32)/t18-,23-/m0/s1	JZDLAUSYEAFGDD-MBSDFSHPSA-N	rac-(2S)-3-methyl-2-[[rac-(7S)-7-acetamido-1,2,3-trimethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-10-yl]amino]butanoic acid	71827338	COc1c(OC)c(OC)c2c(c1)CC[C@H](NC(C)=O)c1cc(=O)c(N[C@H](C(=O)O)C(C)C)ccc1-2	(2S)-2-[[(7S)-7-acetamido-1,2,3-trimethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-10-yl]amino]-3-methylbutanoic acid			2.0267100000000005													MCULE-1835761532	484.55414		484.220951	8	3	8	3			44									Phenethylisoquinoline alkaloids	False	Alkaloids	Tyrosine alkaloids			Peptide01			Compound(71827338)	71827338	3.0	1090			[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]):[#6](-[#8]-[#6]):[#6]2:[#6](:[#6]:1)-[#6]-[#6]-[#6@H](-[#7]-[#6](-[#6])=[#8])-[#6]1:[#6]:[#6](=[#8]):[#6](-[#7]-[#6@H](-[#6](=[#8])-[#8])-[#6](-[#6])-[#6]):[#6]:[#6]:[#6]-2:1	COc1c(OC)c(OC)c2c(c1)CC[C@H](NC(C)=O)c1cc(=O)c(N[C@H](C(=O)O)C(C)C)ccc1-2	JZDLAUSYEAFGDD		parent_pubchem_cid	(S)-2-(((S)-7-acetamido-1,2,3-trimethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-10-yl)amino)-3-methylbutanoic acid;1491139-78-6;(2S)-2-[[(7S)-7-acetamido-1,2,3-trimethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-10-yl]amino]-3-methylbutanoic acid;(2s)-2-{[(7s)-7-(acetylamino)-1,2,3-trimethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-10-yl]amino}-3-methylbutanoic acid;MFCD26522948;AKOS027471105;rac-(2S)-3-methyl-2-[[rac-(7S)-7-acetamido-1,2,3-trimethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-10-yl]amino]butanoic acid		69041232.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=69041232		pluskal_iocb_peptide_Peptide01_F17_id		100	F17		ZINC000096113661
4.0		0	855	P6241391	87.1		AA30	False	1	21	0	0	18	0	3	3	0	0		0.0						O=C(Cn1ccc2c1cccc2Br)NC(Cc1c[nH]c2ccccc12)C(=O)O																							0.0		AKOS016402475		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C21H18BrN3O3	C21H18BrN3O3			InChI=1S/C21H18BrN3O3/c22-16-5-3-7-19-15(16)8-9-25(19)12-20(26)24-18(21(27)28)10-13-11-23-17-6-2-1-4-14(13)17/h1-9,11,18,23H,10,12H2,(H,24,26)(H,27,28)/t18-/m0/s1	IFTKGFIWJHZLDZ-SFHVURJKSA-N	rac-(2S)-2-[[2-(4-bromoindol-1-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid	49652129	O=C(Cn1ccc2c1cccc2Br)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	(2S)-2-[[2-(4-bromoindol-1-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid			2.7856500000000004													MCULE-9370909101	440.29991		439.053154	3	3	6	4			44									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(49652129)	49652129	3.8	1091			[#8]=[#6](-[#6]-[#7]1:[#6]:[#6]:[#6]2:[#6]:1:[#6]:[#6]:[#6]:[#6]:2-[#35])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	O=C(Cn1ccc2c1cccc2Br)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	IFTKGFIWJHZLDZ		parent_pubchem_cid	AKOS016402475;(2S)-2-{[2-(4-BROMO-1H-INDOL-1-YL)ACETYL]AMINO}-3-(1H-INDOL-3-YL)PROPANOIC ACID;rac-(2S)-2-[[2-(4-bromoindol-1-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid		24528007.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24528007		pluskal_iocb_peptide_Peptide01_F17_id		100	F17		ZINC000040309267
1.6		0	943	P6667583	92.9		AA31	False	0	17	0	0	17	0	5	2	0	0		0.0						O=C(NCCc1ccc(O)cc1)C(c1ccccc1)n1cnnn1								1-hydroxy-2-unsubstituted benzenoids;Tetrazoles;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	1-hydroxy-2-unsubstituted benzenoids;Azacyclic compounds;Azoles;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenols;Phenylacetamides;Secondary carboxylic acid amides;Tetrazoles	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as phenylacetamides. These are amide derivatives of phenylacetic acids.	Phenylacetamides			Organic compounds	Aromatic heteromonocyclic compounds	phenols (CHEBI:33853);tetrazoles (CHEBI:35689);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);acetamides (CHEBI:22160);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);organic heterocyclic compound (CHEBI:24532);azole (CHEBI:68452);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);organooxygen compound (CHEBI:36963);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806);benzenes (CHEBI:22712)		Phenylacetamides	Phenylacetamide;Phenol;1-hydroxy-2-unsubstituted benzenoid;Azole;Tetrazole;Heteroaromatic compound;Secondary carboxylic acid amide;Carboxamide group;Azacycle;Organoheterocyclic compound;Carboxylic acid derivative;Organic oxygen compound;Organic nitrogen compound;Organooxygen compound;Organonitrogen compound;Carbonyl group;Hydrocarbon derivative;Organic oxide;Aromatic heteromonocyclic compound	Benzenoids	0.0		STL310548		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	4	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C17H17N5O2	C17H17N5O2			InChI=1S/C17H17N5O2/c23-15-8-6-13(7-9-15)10-11-18-17(24)16(22-12-19-20-21-22)14-4-2-1-3-5-14/h1-9,12,16,23H,10-11H2,(H,18,24)	VBYKAPAEQOTPJH-UHFFFAOYSA-N	N-[2-(4-hydroxyphenyl)ethyl]-2-phenyl-2-(tetrazol-1-yl)acetamide	71701965	O=C(NCCc1ccc(O)cc1)C(c1ccccc1)n1cnnn1	N-[2-(4-hydroxyphenyl)ethyl]-2-phenyl-2-(tetrazol-1-yl)acetamide			0.7551699999999992													MCULE-2135311476	323.35734		323.138225	5	2	6	3			45										False	Alkaloids				Peptide01			Compound(71701965)	71701965	2.3	1092			[#8]=[#6](-[#7]-[#6]-[#6]-[#6]1:[#6]:[#6]:[#6](-[#8]):[#6]:[#6]:1)-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]1:[#6]:[#7]:[#7]:[#7]:1	O=C(NCCc1ccc(O)cc1)C(c1ccccc1)n1cnnn1	VBYKAPAEQOTPJH		parent_pubchem_cid	STL310548;AKOS016402771;N-[2-(4-hydroxyphenyl)ethyl]-2-phenyl-2-(1H-tetrazol-1-yl)acetamide;N-(4-HYDROXYPHENETHYL)-2-PHENYL-2-(1H-1,2,3,4-TETRAAZOL-1-YL)ACETAMIDE;N-[2-(4-hydroxyphenyl)ethyl]-2-phenyl-2-(tetrazol-1-yl)acetamide		59767532.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=59767532		pluskal_iocb_peptide_Peptide01_F17_id		100	F17		
3.0		0	1031	P6245650	103.5		AA32	False	0	20	0	1	21	0	4	3	0	1		0.0						COC(=O)C(CCSC)NC(=O)c1c(-n2cccc2)n(-c2ccccc2F)nc1																							0.0		AKOS016382697		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	2		C20H21FN4O3S	C20H21FN4O3S			InChI=1S/C20H21FN4O3S/c1-28-20(27)16(9-12-29-2)23-18(26)14-13-22-25(17-8-4-3-7-15(17)21)19(14)24-10-5-6-11-24/h3-8,10-11,13,16H,9,12H2,1-2H3,(H,23,26)/t16-/m0/s1	AJHALYCTPQKQDY-INIZCTEOSA-N	methyl rac-(2S)-2-[[1-(2-fluorophenyl)-5-pyrrol-1-yl-pyrazole-4-carbonyl]amino]-4-methylsulfanyl-butanoate	51052968	COC(=O)[C@H](CCSC)NC(=O)c1c(-n2cccc2)n(-c2ccccc2F)nc1	methyl (2S)-2-[[1-(2-fluorophenyl)-5-pyrrol-1-ylpyrazole-4-carbonyl]amino]-4-methylsulfanylbutanoate			2.39187													MCULE-9257048111	416.47777		416.13184	5	1	9	3			44									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(51052968)	51052968	3.0	1093			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]-[#16]-[#6])-[#7]-[#6](=[#8])-[#6]1:[#6](-[#7]2:[#6]:[#6]:[#6]:[#6]:2):[#7](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#9]):[#7]:[#6]:1	COC(=O)[C@H](CCSC)NC(=O)c1c(-n2cccc2)n(-c2ccccc2F)nc1	AJHALYCTPQKQDY		parent_pubchem_cid	AKOS016382697;methyl rac-(2S)-2-[[1-(2-fluorophenyl)-5-pyrrol-1-yl-pyrazole-4-carbonyl]amino]-4-methylsulfanyl-butanoate		2332745.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=2332745		pluskal_iocb_peptide_Peptide01_F17_id		100	F17		ZINC000049545341
4.2		0	775	P1108026	131.1		AA33	False	0	26	0	0	25	0	1	6	0	1		0.0						CSCCC(NC(=O)Cc1c(C)c2cc3c(cc2oc1=O)occ3-c1ccc(C)cc1)C(=O)O																							0.0		STL464062		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C26H25NO6S	C26H25NO6S			InChI=1S/C26H25NO6S/c1-14-4-6-16(7-5-14)20-13-32-22-12-23-17(10-19(20)22)15(2)18(26(31)33-23)11-24(28)27-21(25(29)30)8-9-34-3/h4-7,10,12-13,21H,8-9,11H2,1-3H3,(H,27,28)(H,29,30)/t21-/m1/s1	SWMBSQOIQMEUOU-OAQYLSRUSA-N	rac-(2R)-2-[[2-[5-methyl-7-oxo-3-(p-tolyl)furo[3,2-g]chromen-6-yl]acetyl]amino]-4-methylsulfanyl-butanoic acid	24280571	CSCC[C@@H](NC(=O)Cc1c(C)c2cc3c(cc2oc1=O)occ3-c1ccc(C)cc1)C(=O)O	(2R)-2-[[2-[5-methyl-3-(4-methylphenyl)-7-oxofuro[3,2-g]chromen-6-yl]acetyl]amino]-4-methylsulfanylbutanoic acid			4.1869400000000025													MCULE-9743477950	479.55625		479.140259	6	2	8	4			44									Furocoumarins;Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(24280571)	24280571	4.1	1094			[#6]-[#16]-[#6]-[#6]-[#6@@H](-[#7]-[#6](=[#8])-[#6]-[#6]1:[#6](-[#6]):[#6]2:[#6]:[#6]3:[#6](:[#6]:[#6]:2:[#8]:[#6]:1=[#8]):[#8]:[#6]:[#6]:3-[#6]1:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:1)-[#6](=[#8])-[#8]	CSCC[C@@H](NC(=O)Cc1c(C)c2cc3c(cc2oc1=O)occ3-c1ccc(C)cc1)C(=O)O	SWMBSQOIQMEUOU		parent_pubchem_cid	STL464062;AKOS016393270;N-{[5-methyl-3-(4-methylphenyl)-7-oxo-7H-furo[3,2-g]chromen-6-yl]acetyl}-D-methionine;rac-(2R)-2-[[2-[5-methyl-7-oxo-3-(p-tolyl)furo[3,2-g]chromen-6-yl]acetyl]amino]-4-methylsulfanyl-butanoic acid		24484733.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24484733		pluskal_iocb_peptide_Peptide01_F17_id		100	F17		ZINC000011865570
3.1		0	863	P1100515	128.7		AA34	False	0	23	0	0	20	0	2	6	0	0		0.0						Cc1c(CC(=O)NC(Cc2c[nH]c3ccccc23)C(=O)O)c(=O)oc2c1ccc(O)c2																							0.0		STL462739		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C23H20N2O6	C23H20N2O6			InChI=1S/C23H20N2O6/c1-12-15-7-6-14(26)9-20(15)31-23(30)17(12)10-21(27)25-19(22(28)29)8-13-11-24-18-5-3-2-4-16(13)18/h2-7,9,11,19,24,26H,8,10H2,1H3,(H,25,27)(H,28,29)/t19-/m1/s1	GCKVKGROCJJERY-LJQANCHMSA-N	rac-(2R)-2-[[2-(7-hydroxy-4-methyl-2-oxo-chromen-3-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid	24280126	Cc1c(CC(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)O)c(=O)oc2c1ccc(O)c2	(2R)-2-[[2-(7-hydroxy-4-methyl-2-oxochromen-3-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid			2.05943													MCULE-6810981556	420.42565		420.132136	6	4	6	4			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(24280126)	24280126	2.4	1095			[#6]-[#6]1:[#6](-[#6]-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6](=[#8])-[#8]):[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]):[#6]:2	Cc1c(CC(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)O)c(=O)oc2c1ccc(O)c2	GCKVKGROCJJERY		parent_pubchem_cid	STL462739;AKOS016379143;N-[(7-hydroxy-4-methyl-2-oxo-2H-chromen-3-yl)acetyl]-D-tryptophan;rac-(2R)-2-[[2-(7-hydroxy-4-methyl-2-oxo-chromen-3-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid		24257954.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24257954		pluskal_iocb_peptide_Peptide01_F17_id		100	F17		ZINC000011867571
2.4		0	951	P1094994	67.4		AA35	False	0	15	0	0	22	0	2	3	0	0		0.0						CCC(C)C(NC(=O)NCc1ccccc1)C(=O)OC																							0.0		AKOS005533385		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C15H22N2O3	C15H22N2O3			InChI=1S/C15H22N2O3/c1-4-11(2)13(14(18)20-3)17-15(19)16-10-12-8-6-5-7-9-12/h5-9,11,13H,4,10H2,1-3H3,(H2,16,17,19)/t11?,13-/m0/s1	SMRRQHSTFSTNQK-YUZLPWPTSA-N	methyl rac-(2S)-2-(benzylcarbamoylamino)-3-methyl-pentanoate	17574766	CCC(C)[C@H](NC(=O)NCc1ccccc1)C(=O)OC	methyl (2S)-2-(benzylcarbamoylamino)-3-methylpentanoate			2.01879														278.35419		278.163043	3	2	7	1			46									Dipeptides;Phenylalanine-derived alkaloids	False	Alkaloids;Amino acids and Peptides	Pseudoalkaloids;Small peptides			Peptide01			Compound(17574766)	17574766	2.5	1096			[#6]-[#6]-[#6](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#7]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]-[#6]	CCC(C)[C@H](NC(=O)NCc1ccccc1)C(=O)OC	SMRRQHSTFSTNQK		parent_pubchem_cid	AKOS005533385;NCGC00342353-01;AB01333926-02;methyl rac-(2S)-2-(benzylcarbamoylamino)-3-methyl-pentanoate		23698098.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23698098		pluskal_iocb_peptide_Peptide01_F18_id		100	F18		
1.9		0	1039	P6248084	105.7		AA36	False	0	19	0	0	24	0	4	4	0	0		0.0						CC(C)C(NC(=O)N1CCN(C(=O)c2cc3ccccc3[nH]2)CC1)C(=O)O																							0.0		N-{[4-(1H-indol-2-ylcarbonyl)piperazin-1-yl]carbonyl}-L-valine		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C19H24N4O4	C19H24N4O4			InChI=1S/C19H24N4O4/c1-12(2)16(18(25)26)21-19(27)23-9-7-22(8-10-23)17(24)15-11-13-5-3-4-6-14(13)20-15/h3-6,11-12,16,20H,7-10H2,1-2H3,(H,21,27)(H,25,26)/t16-/m0/s1	NOEYHTAPSVFRQI-INIZCTEOSA-N	rac-(2S)-2-[[4-(1H-indole-2-carbonyl)piperazine-1-carbonyl]amino]-3-methyl-butanoic acid	17595993	CC(C)[C@H](NC(=O)N1CCN(C(=O)c2cc3ccccc3[nH]2)CC1)C(=O)O	(2S)-2-[[4-(1H-indole-2-carbonyl)piperazine-1-carbonyl]amino]-3-methylbutanoic acid			1.2613699999999997													MCULE-7498532476	372.42753		372.179755	4	3	4	3			44									Carboline alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(17595993)	17595993	1.9	1097			[#6]-[#6](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#7]1-[#6]-[#6]-[#7](-[#6](=[#8])-[#6]2:[#6]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3:[#7H]:2)-[#6]-[#6]-1)-[#6](=[#8])-[#8]	CC(C)[C@H](NC(=O)N1CCN(C(=O)c2cc3ccccc3[nH]2)CC1)C(=O)O	NOEYHTAPSVFRQI		parent_pubchem_cid	N-{[4-(1H-indol-2-ylcarbonyl)piperazin-1-yl]carbonyl}-L-valine;MFCD09851299;AKOS005558677;1014408-24-2;(2S)-2-[[4-(1H-indole-2-carbonyl)piperazine-1-carbonyl]amino]-3-methylbutanoic acid;(2S)-2-({[4-(1H-INDOL-2-YLCARBONYL)PIPERAZINO]CARBONYL}AMINO)-3-METHYLBUTANOIC ACID;rac-(2S)-2-[[4-(1H-indole-2-carbonyl)piperazine-1-carbonyl]amino]-3-methyl-butanoic acid		23470771.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23470771		pluskal_iocb_peptide_Peptide01_F18_id		100	F18		ZINC000013689852
3.1		0	783	P6247862	107.5		AA37	False	0	17	0	0	20	0	2	3	0	1		0.0						CC(C)CC(NC(=O)Cc1csc(-c2ccccc2)n1)C(=O)O																							0.0		SCHEMBL20255589		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C17H20N2O3S	C17H20N2O3S			InChI=1S/C17H20N2O3S/c1-11(2)8-14(17(21)22)19-15(20)9-13-10-23-16(18-13)12-6-4-3-5-7-12/h3-7,10-11,14H,8-9H2,1-2H3,(H,19,20)(H,21,22)/t14-/m0/s1	SRUZEJRSVQBMAC-AWEZNQCLSA-N	rac-(2S)-4-methyl-2-[[2-(2-phenylthiazol-4-yl)acetyl]amino]pentanoic acid	56723910	CC(C)C[C@H](NC(=O)Cc1csc(-c2ccccc2)n1)C(=O)O	(2S)-4-methyl-2-[[2-(2-phenyl-1,3-thiazol-4-yl)acetyl]amino]pentanoic acid			2.533370000000001													MCULE-2245779507	332.42455		332.119463	4	2	7	2			43									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(56723910)	56723910	3.2	1098		SCHEMBL20255589	[#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#6]1:[#6]:[#16]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#7]:1)-[#6](=[#8])-[#8]	CC(C)C[C@H](NC(=O)Cc1csc(-c2ccccc2)n1)C(=O)O	SRUZEJRSVQBMAC		parent_pubchem_cid	SCHEMBL20255589;AKOS016376081;N-[(2-phenyl-1,3-thiazol-4-yl)acetyl]-L-leucine;rac-(2S)-4-methyl-2-[[2-(2-phenylthiazol-4-yl)acetyl]amino]pentanoic acid		23706165.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23706165		pluskal_iocb_peptide_Peptide01_F18_id		100	F18		ZINC000071283361
4.4		0	871	P1109255	123.3		AA38	False	0	22	1	0	18	0	3	3	0	1		0.0						O=C(Cc1csc(-c2ccc(Cl)cc2)n1)NC(Cc1c[nH]c2ccccc12)C(=O)O																							0.0		SCHEMBL20255508		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C22H18ClN3O3S	C22H18ClN3O3S			InChI=1S/C22H18ClN3O3S/c23-15-7-5-13(6-8-15)21-25-16(12-30-21)10-20(27)26-19(22(28)29)9-14-11-24-18-4-2-1-3-17(14)18/h1-8,11-12,19,24H,9-10H2,(H,26,27)(H,28,29)/t19-/m0/s1	BHDZQOHCUXYPKX-IBGZPJMESA-N	rac-(2S)-2-[[2-[2-(4-chlorophenyl)thiazol-4-yl]acetyl]amino]-3-(1H-indol-3-yl)propanoic acid	24280999	O=C(Cc1csc(-c2ccc(Cl)cc2)n1)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	(2S)-2-[[2-[2-(4-chlorophenyl)-1,3-thiazol-4-yl]acetyl]amino]-3-(1H-indol-3-yl)propanoic acid			3.38154													MCULE-1258512528	439.92406		439.07574	4	3	7	4			43										False	Alkaloids				Peptide01			Compound(24280999)	24280999	3.4	1099		SCHEMBL20255508	[#8]=[#6](-[#6]-[#6]1:[#6]:[#16]:[#6](-[#6]2:[#6]:[#6]:[#6](-[#17]):[#6]:[#6]:2):[#7]:1)-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	O=C(Cc1csc(-c2ccc(Cl)cc2)n1)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	BHDZQOHCUXYPKX		parent_pubchem_cid	SCHEMBL20255508;STK967518;AKOS016402476;N-{[2-(4-chlorophenyl)-1,3-thiazol-4-yl]acetyl}-L-tryptophan;2-{2-[2-(4-CHLOROPHENYL)-1,3-THIAZOL-4-YL]ACETAMIDO}-3-(1H-INDOL-3-YL)PROPANOIC ACID;rac-(2S)-2-[[2-[2-(4-chlorophenyl)thiazol-4-yl]acetyl]amino]-3-(1H-indol-3-yl)propanoic acid		23076058.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23076058		pluskal_iocb_peptide_Peptide01_F18_id		100	F18		ZINC000011866055
3.8		0	959	P3460043	101.9		AA39	False	0	24	0	0	27	0	1	6	0	0		0.0						CC(C)(C)OC(=O)CCC(NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O								Fluorenes;Fatty acid esters;Dicarboxylic acids and derivatives;Carbamate esters;Organic carbonic acids and derivatives;Carboxylic acid esters;Carboxylic acids;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Benzenoids;Carbamate esters;Carbamic acids and derivatives;Carbonyl compounds;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Dicarboxylic acids and derivatives;Fatty Acyls;Fatty acid esters;Fluorenes;Glutamic acid and derivatives;Hydrocarbon derivatives;Lipids and lipid-like molecules;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as glutamic acid and derivatives. These are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Glutamic acid and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic homopolycyclic compounds	fluorenes (CHEBI:24059);fatty acid ester (CHEBI:35748);dicarboxylic acid (CHEBI:35692);carbamate ester (CHEBI:23003);organooxygen compound (CHEBI:36963);carboxylic ester (CHEBI:33308);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);glutamic acid derivative (CHEBI:24315);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);lipid (CHEBI:18059);amino acid (CHEBI:33709);peptide (CHEBI:16670);carbon oxoacid (CHEBI:35605);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806)	Fatty esters (FA07);Dicarboxylic acids (FA0117);Fatty Acyls (FA)	Amino acids, peptides, and analogues	Glutamic acid or derivatives;Fluorene;Fatty acid ester;Dicarboxylic acid or derivatives;Fatty acyl;Benzenoid;Carbamic acid ester;Carboxylic acid ester;Carbonic acid derivative;Carboxylic acid;Carbonyl group;Organonitrogen compound;Organooxygen compound;Hydrocarbon derivative;Organic oxide;Organopnictogen compound;Organic oxygen compound;Organic nitrogen compound;Aromatic homopolycyclic compound	Organic acids and derivatives	0.0		Fmoc-Glu(OtBu)-OH		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	1	0	3	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C24H27NO6	C24H27NO6			InChI=1S/C24H27NO6/c1-24(2,3)31-21(26)13-12-20(22(27)28)25-23(29)30-14-19-17-10-6-4-8-15(17)16-9-5-7-11-18(16)19/h4-11,19-20H,12-14H2,1-3H3,(H,25,29)(H,27,28)/t20-/m0/s1	OTKXCALUHMPIGM-FQEVSTJZSA-N	rac-(2S)-5-tert-butoxy-2-(9H-fluoren-9-ylmethoxycarbonylamino)-5-oxo-pentanoic acid	2724637	CC(C)(C)OC(=O)CC[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O	(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-5-[(2-methylpropan-2-yl)oxy]-5-oxopentanoic acid			3.6107600000000017													MCULE-4599051642	425.48589		425.183838	6	2	10	3			43										False	Terpenoids				Peptide01			Compound(2724637)	2724637	3.9	1100		SCHEMBL117964	[#6]-[#6](-[#6])(-[#6])-[#8]-[#6](=[#8])-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#8]-[#6]-[#6]1-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]-1:2)-[#6](=[#8])-[#8]	CC(C)(C)OC(=O)CC[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O	OTKXCALUHMPIGM		parent_pubchem_cid	"Fmoc-Glu(OtBu)-OH;71989-18-9;Fmoc-L-glutamic acid 5-tert-butyl ester;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(tert-butoxy)-5-oxopentanoic acid;N-Fmoc-L-glutamic acid 5-tert-butyl ester;(2S)-5-(tert-butoxy)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-5-oxopentanoic acid;(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-5-[(2-methylpropan-2-yl)oxy]-5-oxopentanoic acid;Fmoc-Glu(tBu);MFCD00037135;Fmoc-L-Glu(OtBu);Fmoc-Glu(OtBu)-OH.nH2O;SCHEMBL117964;Fmoc-Glu(OtBu)-OH,Nonhydrate;5-tert-Butyl N-Fmoc-L-glutamate;OTKXCALUHMPIGM-FQEVSTJZSA-N;DTXSID901167450;AMY31284;BCP18153;HY-Y0134;AKOS015892727;AKOS015924145;CS-W008588;FD21437;AS-14175;PD196607;B3167;Fmoc-Glu(OtBu)-OH, >=98.0% (HPLC);EN300-70200;A837381;J-001102;Q-101758;5-tert-Butyl N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-glutamate;N-(9-Fluorenylmethoxycarbonyl)-L-glutamic acid gamma-tert-butyl ester;N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-glutamic Acid 5-tert-Butyl Ester;(s)-2-(((9h-fluoren-9-yl)methoxy)carbonylamino)-5-tert-butoxy-5-oxopentanoic acid;""5-tert-butoxy-2-(9H-fluoren-9-ylmethoxycarbonylamino)-5-oxo-pentanoic acid;Fmoc-Glu(OtBu)-OH"";rac-(2S)-5-tert-butoxy-2-(9H-fluoren-9-ylmethoxycarbonylamino)-5-oxo-pentanoic acid"		24267248.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24267248		pluskal_iocb_peptide_Peptide01_F18_id		100	F18		ZINC000002384762
2.0		0	1047	P6237109	122.3		AA40	False	0	24	0	0	24	0	4	6	0	0		0.0						COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)Cn1cnc2cc(OC)c(OC)cc2c1=O																							0.0		AKOS016382723		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C24H24N4O6	C24H24N4O6			InChI=1S/C24H24N4O6/c1-32-20-9-16-18(10-21(20)33-2)26-13-28(23(16)30)12-22(29)27-19(24(31)34-3)8-14-11-25-17-7-5-4-6-15(14)17/h4-7,9-11,13,19,25H,8,12H2,1-3H3,(H,27,29)/t19-/m0/s1	XBRFHJQYMWKYRC-IBGZPJMESA-N	methyl rac-(2S)-2-[[2-(6,7-dimethoxy-4-oxo-quinazolin-3-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoate	29148410	COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)Cn1cnc2cc(OC)c(OC)cc2c1=O	methyl (2S)-2-[[2-(6,7-dimethoxy-4-oxoquinazolin-3-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoate			0.8590200000000001													MCULE-9754510301	464.48208		464.169584	7	2	9	4			44									Quinazoline alkaloids	False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(29148410)	29148410	2.2	1101			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#6](=[#8])-[#6]-[#7]1:[#6]:[#7]:[#6]2:[#6]:[#6](-[#8]-[#6]):[#6](-[#8]-[#6]):[#6]:[#6]:2:[#6]:1=[#8]	COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)Cn1cnc2cc(OC)c(OC)cc2c1=O	XBRFHJQYMWKYRC		parent_pubchem_cid	AKOS016382723;METHYL (2S)-2-({2-[6,7-DIMETHOXY-4-OXO-3(4H)-QUINAZOLINYL]ACETYL}AMINO)-3-(1H-INDOL-3-YL)PROPANOATE;methyl rac-(2S)-2-[[2-(6,7-dimethoxy-4-oxo-quinazolin-3-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoate		11894892.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=11894892		pluskal_iocb_peptide_Peptide01_F18_id		100	F18		ZINC000020763335
4.0		0	791	P11184228	91.4		AA41	False	0	24	0	0	26	0	2	4	0	0		0.0						CC1(C)CCc2c(ccc(CC(=O)NC(Cc3c[nH]c4ccccc34)C(=O)O)c2)O1																							0.0		AKOS027472146		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C24H26N2O4	C24H26N2O4			InChI=1S/C24H26N2O4/c1-24(2)10-9-16-11-15(7-8-21(16)30-24)12-22(27)26-20(23(28)29)13-17-14-25-19-6-4-3-5-18(17)19/h3-8,11,14,20,25H,9-10,12-13H2,1-2H3,(H,26,27)(H,28,29)/t20-/m0/s1	QWCFOOKBJCHFFS-FQEVSTJZSA-N	rac-(2S)-2-[[2-(2,2-dimethylchroman-6-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid	75491900	CC1(C)CCc2c(ccc(CC(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)O)c2)O1	(2S)-2-[[2-(2,2-dimethyl-3,4-dihydrochromen-6-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid			2.5711400000000006														406.48582		406.189257	4	3	6	4			45										False					Peptide01			Compound(75491900)	75491900	3.2	1102			[#6]-[#6]1(-[#6])-[#6]-[#6]-[#6]2:[#6](:[#6]:[#6]:[#6](-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]3:[#6]:[#7H]:[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]:3:4)-[#6](=[#8])-[#8]):[#6]:2)-[#8]-1	CC1(C)CCc2c(ccc(CC(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)O)c2)O1	QWCFOOKBJCHFFS		parent_pubchem_cid	AKOS027472146;N-[(2,2-dimethyl-3,4-dihydro-2H-1-benzopyran-6-yl)acetyl]-L-tryptophan;rac-(2S)-2-[[2-(2,2-dimethylchroman-6-yl)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid		80416312.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=80416312		pluskal_iocb_peptide_Peptide01_F18_id		100	F18		ZINC000096221977
3.4		0	879	P3505784	54.1		AA42	False	0	22	0	0	24	0	2	2	0	0		0.0						O=C(NCCc1c[nH]c2ccccc12)C1(c2ccccc2)CCOCC1								Phenylacetamides;Substituted pyrroles;Oxanes;Heteroaromatic compounds;Secondary carboxylic acid amides;Oxacyclic compounds;Dialkyl ethers;Azacyclic compounds;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	3-alkylindoles;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Dialkyl ethers;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Oxanes;Phenylacetamides;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as 3-alkylindoles. These are compounds containing an indole moiety that carries an alkyl chain at the 3-position.	3-alkylindoles			Organic compounds	Aromatic heteropolycyclic compounds	acetamides (CHEBI:22160);pyrroles (CHEBI:26455);oxanes (CHEBI:46942);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);oxacycle (CHEBI:38104);ether (CHEBI:25698);organonitrogen heterocyclic compound (CHEBI:38101);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);indoles (CHEBI:24828);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);organic heterocyclic compound (CHEBI:24532);organooxygen compound (CHEBI:36963);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);nitrogen molecular entity (CHEBI:51143)		Indoles	Phenylacetamide;3-alkylindole;Monocyclic benzene moiety;Oxane;Substituted pyrrole;Benzenoid;Pyrrole;Heteroaromatic compound;Secondary carboxylic acid amide;Carboxamide group;Ether;Dialkyl ether;Carboxylic acid derivative;Azacycle;Oxacycle;Organic nitrogen compound;Hydrocarbon derivative;Organic oxide;Organopnictogen compound;Organic oxygen compound;Organooxygen compound;Organonitrogen compound;Carbonyl group;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		704874-01-1		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C22H24N2O2	C22H24N2O2			InChI=1S/C22H24N2O2/c25-21(22(11-14-26-15-12-22)18-6-2-1-3-7-18)23-13-10-17-16-24-20-9-5-4-8-19(17)20/h1-9,16,24H,10-15H2,(H,23,25)	SNKHZTUIZXPMRN-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)ethyl]-4-phenyl-tetrahydropyran-4-carboxamide	1508773	O=C(NCCc1c[nH]c2ccccc12)C1(c2ccccc2)CCOCC1	N-[2-(1H-indol-3-yl)ethyl]-4-phenyloxane-4-carboxamide			3.037160000000001													MCULE-2390973941	348.44878		348.183778	2	2	5	4			44										False					Peptide01			Compound(1508773)	1508773	3.6	1103			[#8]=[#6](-[#7]-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6]1(-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]-[#6]-[#8]-[#6]-[#6]-1	O=C(NCCc1c[nH]c2ccccc12)C1(c2ccccc2)CCOCC1	SNKHZTUIZXPMRN		parent_pubchem_cid	704874-01-1;N-[2-(1H-indol-3-yl)ethyl]-4-phenyloxane-4-carboxamide;N-(2-(1H-indol-3-yl)ethyl)-4-phenyltetrahydro-2H-pyran-4-carboxamide;F5343-0088;AKOS005598762;VU0642725-1;SR-01000922439;SR-01000922439-1;N-[2-(1H-indol-3-yl)ethyl]-4-phenyl-tetrahydropyran-4-carboxamide		9909067.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=9909067		pluskal_iocb_peptide_Peptide01_F18_id		100	F18		ZINC000001428710
4.7		0	967	P9080062	78.1		AA43	False	0	28	0	0	28	0	4	2	0	0		0.0						CC(C)C(C(=O)NC(Cc1ccccc1)c1nc2ccccc2[nH]1)N1Cc2ccccc2C1=O																							0.0		STL425697		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C28H28N4O2	C28H28N4O2			InChI=1S/C28H28N4O2/c1-18(2)25(32-17-20-12-6-7-13-21(20)28(32)34)27(33)31-24(16-19-10-4-3-5-11-19)26-29-22-14-8-9-15-23(22)30-26/h3-15,18,24-25H,16-17H2,1-2H3,(H,29,30)(H,31,33)	VROXTLJPYRTTSU-UHFFFAOYSA-N	N-[1-(1H-benzimidazol-2-yl)-2-phenyl-ethyl]-3-methyl-2-(1-oxoisoindolin-2-yl)butanamide	91823494	CC(C)C(C(=O)NC(Cc1ccccc1)c1nc2ccccc2[nH]1)N1Cc2ccccc2C1=O	N-[1-(1H-benzimidazol-2-yl)-2-phenylethyl]-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanamide			3.996240000000003														452.56096		452.221226	3	2	7	5			46										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(91823494)	91823494	4.8	1104			[#6]-[#6](-[#6])-[#6](-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#7H]:1)-[#7]1-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6]-1=[#8]	CC(C)C(C(=O)NC(Cc1ccccc1)c1nc2ccccc2[nH]1)N1Cc2ccccc2C1=O	VROXTLJPYRTTSU		parent_pubchem_cid	STL425697;AKOS025260594;N-[1-(1H-benzimidazol-2-yl)-2-phenylethyl]-3-methyl-2-(1-oxo-1,3-dihydro-2H-isoindol-2-yl)butanamide;N-[1-(1H-benzimidazol-2-yl)-2-phenyl-ethyl]-3-methyl-2-(1-oxoisoindolin-2-yl)butanamide		100827197.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=100827197		pluskal_iocb_peptide_Peptide01_F19_id		100	F19		
4.7		0	1055	P1100023	90.9		AA44	False	0	28	0	0	25	0	1	6	0	0		0.0						COC(=O)C(Cc1ccccc1)NC(=O)C(C)Oc1cc2c(cc1)c(-c1ccccc1)cc(=O)o2																							0.0		EiM07-19709		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C28H25NO6	C28H25NO6			InChI=1S/C28H25NO6/c1-18(27(31)29-24(28(32)33-2)15-19-9-5-3-6-10-19)34-21-13-14-22-23(20-11-7-4-8-12-20)17-26(30)35-25(22)16-21/h3-14,16-18,24H,15H2,1-2H3,(H,29,31)/t18?,24-/m0/s1	ZIOIZKBNJBSFQR-LUTIACGYSA-N	methyl rac-(2S)-2-[2-(2-oxo-4-phenyl-chromen-7-yl)oxypropanoylamino]-3-phenyl-propanoate	15432055	COC(=O)[C@H](Cc1ccccc1)NC(=O)C(C)Oc1cc2c(cc1)c(-c1ccccc1)cc(=O)o2	methyl (2S)-2-[2-(2-oxo-4-phenylchromen-7-yl)oxypropanoylamino]-3-phenylpropanoate			3.702130000000003														471.51455		471.168188	6	1	9	4			46									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(15432055)	15432055	4.7	1105			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6](-[#6])-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1):[#6]:[#6](=[#8]):[#8]:2	COC(=O)[C@H](Cc1ccccc1)NC(=O)C(C)Oc1cc2c(cc1)c(-c1ccccc1)cc(=O)o2	ZIOIZKBNJBSFQR		parent_pubchem_cid	EiM07-19709;AKOS016376916;METHYL 2-{2-[(2-OXO-4-PHENYL-2H-CHROMEN-7-YL)OXY]PROPANAMIDO}-3-PHENYLPROPANOATE;methyl rac-(2S)-2-[2-(2-oxo-4-phenyl-chromen-7-yl)oxypropanoylamino]-3-phenyl-propanoate		23335174.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23335174		pluskal_iocb_peptide_Peptide01_F19_id		100	F19		
2.8		0	1063	P11184870	84.2		AB1	False	0	20	0	0	21	0	3	3	0	0		0.0						Cn1cnc2c1ccc(CCC(=O)NC(Cc1ccccc1)C(=O)O)c2																							0.0		AKOS027472527		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	2	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C20H21N3O3	C20H21N3O3			InChI=1S/C20H21N3O3/c1-23-13-21-16-11-15(7-9-18(16)23)8-10-19(24)22-17(20(25)26)12-14-5-3-2-4-6-14/h2-7,9,11,13,17H,8,10,12H2,1H3,(H,22,24)(H,25,26)/t17-/m0/s1	NQVCJGLGXXTPIM-KRWDZBQOSA-N	rac-(2S)-2-[3-(1-methylbenzimidazol-5-yl)propanoylamino]-3-phenyl-propanoic acid	91640674	Cn1cnc2c1ccc(CCC(=O)N[C@@H](Cc1ccccc1)C(=O)O)c2	(2S)-2-[3-(1-methylbenzimidazol-5-yl)propanoylamino]-3-phenylpropanoic acid			1.7801599999999995														351.40867		351.158292	4	2	7	3			45										False	Alkaloids				Peptide01			Compound(91640674)	91640674	2.5	1106			[#6]-[#7]1:[#6]:[#7]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#6]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]):[#6]:2	Cn1cnc2c1ccc(CCC(=O)N[C@@H](Cc1ccccc1)C(=O)O)c2	NQVCJGLGXXTPIM		parent_pubchem_cid	AKOS027472527;rac-(2S)-2-[3-(1-methylbenzimidazol-5-yl)propanoylamino]-3-phenyl-propanoic acid		96015373.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=96015373		pluskal_iocb_peptide_Peptide01_F19_id		100	F19		ZINC000218348451
2.5		0	1151	P1098236	139.2		AB2	False	0	20	0	0	23	0	1	8	0	0		0.0						CCCc1cc(=O)oc2c1ccc(OCC(=O)NC(CCC(=O)O)C(=O)O)c2C																							0.0		EiM07-16914		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	3	2	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C20H23NO8	C20H23NO8			InChI=1S/C20H23NO8/c1-3-4-12-9-18(25)29-19-11(2)15(7-5-13(12)19)28-10-16(22)21-14(20(26)27)6-8-17(23)24/h5,7,9,14H,3-4,6,8,10H2,1-2H3,(H,21,22)(H,23,24)(H,26,27)/t14-/m0/s1	XEQHKXXPOGVUJI-AWEZNQCLSA-N	rac-(2S)-2-[[2-(8-methyl-2-oxo-4-propyl-chromen-7-yl)oxyacetyl]amino]pentanedioic acid	24279862	CCCc1cc(=O)oc2c1ccc(OCC(=O)N[C@@H](CCC(=O)O)C(=O)O)c2C	(2S)-2-[[2-(8-methyl-2-oxo-4-propylchromen-7-yl)oxyacetyl]amino]pentanedioic acid			1.76656													MCULE-1346897047	405.40821		405.142367	8	3	10	2			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(24279862)	24279862	2.0	1107			[#6]-[#6]-[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]-[#6](=[#8])-[#8])-[#6](=[#8])-[#8]):[#6]:2-[#6]	CCCc1cc(=O)oc2c1ccc(OCC(=O)N[C@@H](CCC(=O)O)C(=O)O)c2C	XEQHKXXPOGVUJI		parent_pubchem_cid	EiM07-16914;AKOS016390234;rac-(2S)-2-[[2-(8-methyl-2-oxo-4-propyl-chromen-7-yl)oxyacetyl]amino]pentanedioic acid		23063695.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23063695		pluskal_iocb_peptide_Peptide01_F19_id		100	F19		ZINC000011866787
2.2		0	1239	P6248846	110.3		AB3	False	0	17	0	0	19	0	1	6	0	1		0.0						COc1cc(S(=O)(=O)NC(Cc2ccccc2)C(=O)O)c(OC)cc1																							0.0		N-[(2,5-dimethoxyphenyl)sulfonyl]phenylalanine		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0		C17H19NO6S	C17H19NO6S			InChI=1S/C17H19NO6S/c1-23-13-8-9-15(24-2)16(11-13)25(21,22)18-14(17(19)20)10-12-6-4-3-5-7-12/h3-9,11,14,18H,10H2,1-2H3,(H,19,20)	RAFXOZPWWMVBIR-UHFFFAOYSA-N	2-[(2,5-dimethoxyphenyl)sulfonylamino]-3-phenyl-propanoic acid	16285308	COc1cc(S(=O)(=O)NC(Cc2ccccc2)C(=O)O)c(OC)cc1	2-[(2,5-dimethoxyphenyl)sulfonylamino]-3-phenylpropanoic acid			0.59046													MCULE-2455783600	365.40808		365.093308	6	2	8	2			45										False	Amino acids and Peptides				Peptide01			Compound(16285308)	16285308	2.4	1108			[#6]-[#8]-[#6]1:[#6]:[#6](-[#16](=[#8])(=[#8])-[#7]-[#6](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6](=[#8])-[#8]):[#6](-[#8]-[#6]):[#6]:[#6]:1	COc1cc(S(=O)(=O)NC(Cc2ccccc2)C(=O)O)c(OC)cc1	RAFXOZPWWMVBIR		parent_pubchem_cid	N-[(2,5-dimethoxyphenyl)sulfonyl]phenylalanine;AKOS016386419;AB00746608-01;AQ-390/43490661;Z45636961;2-[(2,5-dimethoxyphenyl)sulfonylamino]-3-phenylpropanoic acid;2-[(2,5-dimethoxyphenyl)sulfonylamino]-3-phenyl-propanoic acid		24794725.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24794725		pluskal_iocb_peptide_Peptide01_F19_id		100	F19		
3.6		0	1071	P1094989	104.5		AB5	False	0	20	0	0	21	0	3	4	0	0		0.0						CC(C)CC(NC(=O)Nc1cccc(-c2nc3ccccc3o2)c1)C(=O)O																							0.0		STK716643		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C20H21N3O4	C20H21N3O4			InChI=1S/C20H21N3O4/c1-12(2)10-16(19(24)25)23-20(26)21-14-7-5-6-13(11-14)18-22-15-8-3-4-9-17(15)27-18/h3-9,11-12,16H,10H2,1-2H3,(H,24,25)(H2,21,23,26)/t16-/m0/s1	PIQQQXGOHJKCFJ-INIZCTEOSA-N	rac-(2S)-2-[[3-(1,3-benzoxazol-2-yl)phenyl]carbamoylamino]-4-methyl-pentanoic acid	8028855	CC(C)C[C@H](NC(=O)Nc1cccc(-c2nc3ccccc3o2)c1)C(=O)O	(2S)-2-[[3-(1,3-benzoxazol-2-yl)phenyl]carbamoylamino]-4-methylpentanoic acid			2.9265500000000007													MCULE-2095615609	367.40807		367.153206	4	3	6	3			44										False					Peptide01			Compound(8028855)	8028855	3.7	1109			[#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#7]-[#6]1:[#6]:[#6]:[#6]:[#6](-[#6]2:[#7]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3:[#8]:2):[#6]:1)-[#6](=[#8])-[#8]	CC(C)C[C@H](NC(=O)Nc1cccc(-c2nc3ccccc3o2)c1)C(=O)O	PIQQQXGOHJKCFJ		parent_pubchem_cid	STK716643;AKOS004937623;N-{[3-(1,3-benzoxazol-2-yl)phenyl]carbamoyl}-L-leucine;N-({[3-(1,3-benzoxazol-2-yl)phenyl]amino}carbonyl)-L-leucine;rac-(2S)-2-[[3-(1,3-benzoxazol-2-yl)phenyl]carbamoylamino]-4-methyl-pentanoic acid		23781060.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23781060		pluskal_iocb_peptide_Peptide01_F19_id		100	F19		ZINC000006660155
4.6		0	1159	P1157760	89.9		AB6	False	0	22	0	1	22	0	5	2	0	0		0.0						CC(C)C(C(=O)NCCc1c[nH]c2c1cc(F)cc2)n1nnc2ccccc2c1=O								3-alkylindoles;Triazinones;Substituted pyrroles;1,2,3-triazines;Aryl fluorides;Benzenoids;N-acyl amines;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactams;Azacyclic compounds;Carbonyl compounds;Organic oxides;Organofluorides;Organonitrogen compounds;Hydrocarbon derivatives	1,2,3-triazines;3-alkylindoles;Aryl fluorides;Aryl halides;Azacyclic compounds;Benzenoids;Benzo-1,2,3-triazines;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Fatty Acyls;Fatty amides;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Lactams;Lipids and lipid-like molecules;N-acyl amines;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organofluorides;Organohalogen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Triazines;Triazinones	Benzo-1,2,3-triazines	2.1	This compound belongs to the class of organic compounds known as benzo-1,2,3-triazines. These are organic compounds containing a 1,2,3-triazine ring fused to a benzene ring.	Benzo-1,2,3-triazines			Organic compounds	Aromatic heteropolycyclic compounds	indoles (CHEBI:24828);triazines (CHEBI:38102);pyrroles (CHEBI:26455);1,2,3-triazines (CHEBI:59099);organofluorine compound (CHEBI:37143);benzenoid aromatic compound (CHEBI:33836);fatty amide (CHEBI:29348);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactam (CHEBI:24995);organonitrogen heterocyclic compound (CHEBI:38101);carbonyl compound (CHEBI:36586);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);organic molecule (CHEBI:72695);benzotriazines (CHEBI:51361);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);organohalogen compound (CHEBI:36684);haloarene (CHEBI:50887);lipid (CHEBI:18059);organooxygen compound (CHEBI:36963);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143)	N-acyl amines (FA0802);Fatty Acyls (FA);Fatty amides (FA08)		Benzo-1,2,3-triazine;3-alkylindole;Indole;Indole or derivatives;Triazinone;Aryl fluoride;Aryl halide;Fatty amide;N-acyl-amine;Substituted pyrrole;Triazine;Benzenoid;Fatty acyl;1,2,3-triazine;Pyrrole;Heteroaromatic compound;Secondary carboxylic acid amide;Carboxamide group;Lactam;Azacycle;Carboxylic acid derivative;Organooxygen compound;Carbonyl group;Organohalogen compound;Organofluoride;Organic oxide;Hydrocarbon derivative;Organic nitrogen compound;Organic oxygen compound;Organonitrogen compound;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		EiM07-17979		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C22H22FN5O2	C22H22FN5O2			InChI=1S/C22H22FN5O2/c1-13(2)20(28-22(30)16-5-3-4-6-19(16)26-27-28)21(29)24-10-9-14-12-25-18-8-7-15(23)11-17(14)18/h3-8,11-13,20,25H,9-10H2,1-2H3,(H,24,29)/t20-/m0/s1	AQANIZXUAISLSH-FQEVSTJZSA-N	rac-(2S)-N-[2-(5-fluoro-1H-indol-3-yl)ethyl]-3-methyl-2-(4-oxo-1,2,3-benzotriazin-3-yl)butanamide	25823803	CC(C)[C@@H](C(=O)NCCc1c[nH]c2c1cc(F)cc2)n1nnc2ccccc2c1=O	(2S)-N-[2-(5-fluoro-1H-indol-3-yl)ethyl]-3-methyl-2-(4-oxo-1,2,3-benzotriazin-3-yl)butanamide			2.956240000000001													MCULE-9577078422	407.45134		407.175753	4	2	6	4			44										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(25823803)	25823803	4.5	1110			[#6]-[#6](-[#6])-[#6@@H](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:1:[#6]:[#6](-[#9]):[#6]:[#6]:2)-[#7]1:[#7]:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8]	CC(C)[C@@H](C(=O)NCCc1c[nH]c2c1cc(F)cc2)n1nnc2ccccc2c1=O	AQANIZXUAISLSH		parent_pubchem_cid	EiM07-17979;AKOS016376514;N-[2-(5-FLUORO-1H-INDOL-3-YL)ETHYL]-3-METHYL-2-(4-OXO-1,2,3-BENZOTRIAZIN-3(4H)-YL)BUTANAMIDE;rac-(2S)-N-[2-(5-fluoro-1H-indol-3-yl)ethyl]-3-methyl-2-(4-oxo-1,2,3-benzotriazin-3-yl)butanamide		8819015.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=8819015		pluskal_iocb_peptide_Peptide01_F19_id		100	F19		ZINC000013625586
4.6		0	1247	P7008268	67.7		AB7	False	0	20	0	0	20	0	6	0	0	0		0.0						Cc1c(C)cc(Nc2nc(Nc3ccccc3)c3cnn(C)c3n2)cc1																							0.0		HMS3475K09		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1		C20H20N6	C20H20N6			InChI=1S/C20H20N6/c1-13-9-10-16(11-14(13)2)23-20-24-18(22-15-7-5-4-6-8-15)17-12-21-26(3)19(17)25-20/h4-12H,1-3H3,(H2,22,23,24,25)	LDKWFDWSUBFQRB-UHFFFAOYSA-N	N6-(3,4-dimethylphenyl)-1-methyl-N4-phenyl-pyrazolo[3,4-d]pyrimidine-4,6-diamine	8545365	Cc1c(C)cc(Nc2nc(Nc3ccccc3)c3cnn(C)c3n2)cc1	6-N-(3,4-dimethylphenyl)-1-methyl-4-N-phenylpyrazolo[3,4-d]pyrimidine-4,6-diamine			2.4070600000000004													MCULE-8641875594	344.4226		344.174945	5	2	4	4			44										False	Alkaloids				Peptide01			Compound(8545365)	8545365	4.7	1111			[#6]-[#6]1:[#6](-[#6]):[#6]:[#6](-[#7]-[#6]2:[#7]:[#6](-[#7]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#6]3:[#6]:[#7]:[#7](-[#6]):[#6]:3:[#7]:2):[#6]:[#6]:1	Cc1c(C)cc(Nc2nc(Nc3ccccc3)c3cnn(C)c3n2)cc1	LDKWFDWSUBFQRB		parent_pubchem_cid	HMS3475K09;AKOS002311385;N6-(3,4-DIMETHYLPHENYL)-1-METHYL-N4-PHENYL-1H-PYRAZOLO[3,4-D]PYRIMIDINE-4,6-DIAMINE;N6-(3,4-dimethylphenyl)-1-methyl-N4-phenyl-pyrazolo[3,4-d]pyrimidine-4,6-diamine		16459443.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=16459443		pluskal_iocb_peptide_Peptide01_F19_id		100	F19		ZINC000007448095
1.9		0	1079	P1094993	119.5		AB9	False	0	16	0	0	21	0	3	3	0	1		0.0						CSCCC(NC(=O)NCCc1c[nH]c2ccccc12)C(=O)O																							0.0		AKOS016387081		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C16H21N3O3S	C16H21N3O3S			InChI=1S/C16H21N3O3S/c1-23-9-7-14(15(20)21)19-16(22)17-8-6-11-10-18-13-5-3-2-4-12(11)13/h2-5,10,14,18H,6-9H2,1H3,(H,20,21)(H2,17,19,22)/t14-/m0/s1	VNCIKPIXOOQEIW-AWEZNQCLSA-N	rac-(2S)-2-[2-(1H-indol-3-yl)ethylcarbamoylamino]-4-methylsulfanyl-butanoic acid	1754927	CSCC[C@H](NC(=O)NCCc1c[nH]c2ccccc12)C(=O)O	(2S)-2-[2-(1H-indol-3-yl)ethylcarbamoylamino]-4-methylsulfanylbutanoic acid			1.73277													MCULE-8230571755	335.42807		335.130363	4	4	8	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(1754927)	1754927	1.5	1112			[#6]-[#16]-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	CSCC[C@H](NC(=O)NCCc1c[nH]c2ccccc12)C(=O)O	VNCIKPIXOOQEIW		parent_pubchem_cid	AKOS016387081;(2S)-2-[({[2-(1H-INDOL-3-YL)ETHYL]AMINO}CARBONYL)AMINO]-4-(METHYLSULFANYL)BUTANOIC ACID;rac-(2S)-2-[2-(1H-indol-3-yl)ethylcarbamoylamino]-4-methylsulfanyl-butanoic acid		24472301.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24472301		pluskal_iocb_peptide_Peptide01_F20_id		100	F20		ZINC000002098904
4.6		0	1167	P1098419	101.9		AB10	False	0	25	0	0	27	0	1	6	0	0		0.0						CCC(C)C(NC(=O)COc1cc2c(cc1)c(C)c(Cc1ccccc1)c(=O)o2)C(=O)O																							0.0		EiM07-17097		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C25H27NO6	C25H27NO6			InChI=1S/C25H27NO6/c1-4-15(2)23(24(28)29)26-22(27)14-31-18-10-11-19-16(3)20(25(30)32-21(19)13-18)12-17-8-6-5-7-9-17/h5-11,13,15,23H,4,12,14H2,1-3H3,(H,26,27)(H,28,29)/t15-,23+/m1/s1	DMWOBBWCACNISE-CMJOXMDJSA-N	rac-(2S,3R)-2-[[2-(3-benzyl-4-methyl-2-oxo-chromen-7-yl)oxyacetyl]amino]-3-methyl-pentanoic acid	6353549	CC[C@@H](C)[C@H](NC(=O)COc1cc2c(cc1)c(C)c(Cc1ccccc1)c(=O)o2)C(=O)O	(2S,3R)-2-[[2-(3-benzyl-4-methyl-2-oxochromen-7-yl)oxyacetyl]amino]-3-methylpentanoic acid			3.531450000000002													MCULE-9681336857	437.49704		437.183838	6	2	9	3			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(6353549)	6353549	4.4	1113			[#6]-[#6]-[#6@@H](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#6](-[#6]):[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1):[#6](=[#8]):[#8]:2)-[#6](=[#8])-[#8]	CC[C@@H](C)[C@H](NC(=O)COc1cc2c(cc1)c(C)c(Cc1ccccc1)c(=O)o2)C(=O)O	DMWOBBWCACNISE		parent_pubchem_cid	EiM07-17097;STL460830;AKOS004937608;N-{[(3-benzyl-4-methyl-2-oxo-2H-chromen-7-yl)oxy]acetyl}-L-isoleucine;2-{2-[(3-BENZYL-4-METHYL-2-OXO-2H-CHROMEN-7-YL)OXY]ACETAMIDO}-3-METHYLPENTANOIC ACID;rac-(2S,3R)-2-[[2-(3-benzyl-4-methyl-2-oxo-chromen-7-yl)oxyacetyl]amino]-3-methyl-pentanoic acid		65378803.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=65378803		pluskal_iocb_peptide_Peptide01_F20_id		100	F20		ZINC000011866814
4.8		0	1255	P7008363	62.1		AB11	False	0	25	0	0	29	0	7	0	0	0		0.0						Cc1c(C)cc(Nc2c3cnn(C)c3nc(N3CCN(Cc4ccccc4)CC3)n2)cc1																							0.0		6-(4-benzylpiperazin-1-yl)-N-(3,4-dimethylphenyl)-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	3		C25H29N7	C25H29N7			InChI=1S/C25H29N7/c1-18-9-10-21(15-19(18)2)27-23-22-16-26-30(3)24(22)29-25(28-23)32-13-11-31(12-14-32)17-20-7-5-4-6-8-20/h4-10,15-16H,11-14,17H2,1-3H3,(H,27,28,29)	KJKXNDKLSWAYAV-UHFFFAOYSA-N	6-(4-benzylpiperazin-1-yl)-N-(3,4-dimethylphenyl)-1-methyl-pyrazolo[3,4-d]pyrimidin-4-amine	16456706	Cc1c(C)cc(Nc2c3cnn(C)c3nc(N3CCN(Cc4ccccc4)CC3)n2)cc1	6-(4-benzylpiperazin-1-yl)-N-(3,4-dimethylphenyl)-1-methylpyrazolo[3,4-d]pyrimidin-4-amine			2.31156													MCULE-9844533485	427.55678		427.248444	6	1	5	5			44										False	Alkaloids				Peptide01			Compound(16456706)	16456706	4.6	1114			[#6]-[#6]1:[#6](-[#6]):[#6]:[#6](-[#7]-[#6]2:[#6]3:[#6]:[#7]:[#7](-[#6]):[#6]:3:[#7]:[#6](-[#7]3-[#6]-[#6]-[#7](-[#6]-[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]:4)-[#6]-[#6]-3):[#7]:2):[#6]:[#6]:1	Cc1c(C)cc(Nc2c3cnn(C)c3nc(N3CCN(Cc4ccccc4)CC3)n2)cc1	KJKXNDKLSWAYAV		parent_pubchem_cid	6-(4-benzylpiperazin-1-yl)-N-(3,4-dimethylphenyl)-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine;878063-94-6;STK890970;AKOS001905838;F2031-0107;6-(4-benzylpiperazin-1-yl)-N-(3,4-dimethylphenyl)-1-methylpyrazolo[3,4-d]pyrimidin-4-amine;6-(4-benzylpiperazin-1-yl)-N-(3,4-dimethylphenyl)-1-methyl-pyrazolo[3,4-d]pyrimidin-4-amine		6984117.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=6984117		pluskal_iocb_peptide_Peptide01_F20_id		100	F20		ZINC000020560375
1.4		0	1087	P1157546	94.9		AB13	False	0	13	0	0	24	0	2	3	0	1		0.0						CSCCC(NC(=O)N1CC(C)CC(C)C1)C(=O)O																							0.0		HMS3468P15		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C13H24N2O3S	C13H24N2O3S			InChI=1S/C13H24N2O3S/c1-9-6-10(2)8-15(7-9)13(18)14-11(12(16)17)4-5-19-3/h9-11H,4-8H2,1-3H3,(H,14,18)(H,16,17)/t9?,10?,11-/m0/s1	OVFIUQGJCHMKMT-ILDUYXDCSA-N	rac-(2S)-2-[(3,5-dimethylpiperidine-1-carbonyl)amino]-4-methylsulfanyl-butanoic acid	16405265	CSCC[C@H](NC(=O)N1CC(C)CC(C)C1)C(=O)O	(2S)-2-[(3,5-dimethylpiperidine-1-carbonyl)amino]-4-methylsulfanylbutanoic acid			1.8802													MCULE-2065972587	288.41183		288.150764	4	2	5	1			45										False	Amino acids and Peptides	Small peptides			Peptide01			Compound(16405265)	16405265	1.9	1115			[#6]-[#16]-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#7]1-[#6]-[#6](-[#6])-[#6]-[#6](-[#6])-[#6]-1)-[#6](=[#8])-[#8]	CSCC[C@H](NC(=O)N1CC(C)CC(C)C1)C(=O)O	OVFIUQGJCHMKMT		parent_pubchem_cid	HMS3468P15;AKOS004937558;rac-(2S)-2-[(3,5-dimethylpiperidine-1-carbonyl)amino]-4-methylsulfanyl-butanoic acid		23092152.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23092152		pluskal_iocb_peptide_Peptide01_F20_id		100	F20		
0.8		0	1175	P1098886	148.7		AB14	False	0	15	0	0	16	0	4	6	0	0		0.0						O=C(O)CCC(NC(=O)CCn1nnc2ccccc2c1=O)C(=O)O																							0.0		AKOS016402340		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	2	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C15H16N4O6	C15H16N4O6			InChI=1S/C15H16N4O6/c20-12(16-11(15(24)25)5-6-13(21)22)7-8-19-14(23)9-3-1-2-4-10(9)17-18-19/h1-4,11H,5-8H2,(H,16,20)(H,21,22)(H,24,25)/t11-/m0/s1	MVRQBONZZWUACJ-NSHDSACASA-N	rac-(2S)-2-[3-(4-oxo-1,2,3-benzotriazin-3-yl)propanoylamino]pentanedioic acid	24279953	O=C(O)CC[C@H](NC(=O)CCn1nnc2ccccc2c1=O)C(=O)O	(2S)-2-[3-(4-oxo-1,2,3-benzotriazin-3-yl)propanoylamino]pentanedioic acid			0.0872700000000003													MCULE-4223477230	348.31797		348.106984	8	3	8	2			44										False					Peptide01			Compound(24279953)	24279953	0.3	1116			[#8]=[#6](-[#8])-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#6]-[#7]1:[#7]:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8])-[#6](=[#8])-[#8]	O=C(O)CC[C@H](NC(=O)CCn1nnc2ccccc2c1=O)C(=O)O	MVRQBONZZWUACJ		parent_pubchem_cid	AKOS016402340;2-[3-(4-OXO-3,4-DIHYDRO-1,2,3-BENZOTRIAZIN-3-YL)PROPANAMIDO]PENTANEDIOIC ACID;rac-(2S)-2-[3-(4-oxo-1,2,3-benzotriazin-3-yl)propanoylamino]pentanedioic acid		23652923.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23652923		pluskal_iocb_peptide_Peptide01_F20_id		100	F20		ZINC000011867197
2.5		0	1263	P7008509	85.3		AB15	False	0	19	0	0	20	0	6	2	0	0		0.0						c1cnc2c(N3CCCCC3)nc(NCc3cc4c(cc3)OCO4)nc2n1																							0.0		N-(1,3-benzodioxol-5-ylmethyl)-4-(piperidin-1-yl)pteridin-2-amine		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1		C19H20N6O2	C19H20N6O2			InChI=1S/C19H20N6O2/c1-2-8-25(9-3-1)18-16-17(21-7-6-20-16)23-19(24-18)22-11-13-4-5-14-15(10-13)27-12-26-14/h4-7,10H,1-3,8-9,11-12H2,(H,21,22,23,24)	RDFGFGHGGSMDAP-UHFFFAOYSA-N	N-(1,3-benzodioxol-5-ylmethyl)-4-(1-piperidyl)pteridin-2-amine	39351126	c1cnc2c(N3CCCCC3)nc(NCc3cc4c(cc3)OCO4)nc2n1	N-(1,3-benzodioxol-5-ylmethyl)-4-piperidin-1-ylpteridin-2-amine			0.5817299999999996													MCULE-4549308045	364.41025		364.164774	8	1	4	5			44										False	Alkaloids	Lysine alkaloids			Peptide01			Compound(39351126)	39351126	2.7	1117			[#6]1:[#6]:[#7]:[#6]2:[#6](-[#7]3-[#6]-[#6]-[#6]-[#6]-[#6]-3):[#7]:[#6](-[#7]-[#6]-[#6]3:[#6]:[#6]4:[#6](:[#6]:[#6]:3)-[#8]-[#6]-[#8]-4):[#7]:[#6]:2:[#7]:1	c1cnc2c(N3CCCCC3)nc(NCc3cc4c(cc3)OCO4)nc2n1	RDFGFGHGGSMDAP		parent_pubchem_cid	N-(1,3-benzodioxol-5-ylmethyl)-4-(piperidin-1-yl)pteridin-2-amine;1144463-12-6;AKOS002337365;CCG-303893;Z1013695800;N-(1,3-benzodioxol-5-ylmethyl)-4-(1-piperidyl)pteridin-2-amine		9125228.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=9125228		pluskal_iocb_peptide_Peptide01_F20_id		100	F20		ZINC000032103885
4.0		0	1095	P1098364	101.9		AB17	False	0	21	0	0	27	0	1	6	0	0		0.0						Cc1c(C)c2c(oc1=O)c(C)c(OC(C)C(=O)NC(CC(C)C)C(=O)O)cc2																							0.0		AKOS004937319		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C21H27NO6	C21H27NO6			InChI=1S/C21H27NO6/c1-10(2)9-16(20(24)25)22-19(23)14(6)27-17-8-7-15-11(3)12(4)21(26)28-18(15)13(17)5/h7-8,10,14,16H,9H2,1-6H3,(H,22,23)(H,24,25)/t14?,16-/m0/s1	CDKWACSMHPTBAQ-WMCAAGNKSA-N	rac-(2S)-4-methyl-2-[2-(3,4,8-trimethyl-2-oxo-chromen-7-yl)oxypropanoylamino]pentanoic acid	16399718	Cc1c(C)c2c(oc1=O)c(C)c(OC(C)C(=O)N[C@@H](CC(C)C)C(=O)O)cc2	(2S)-4-methyl-2-[2-(3,4,8-trimethyl-2-oxochromen-7-yl)oxypropanoylamino]pentanoic acid			2.945990000000001													MCULE-9128927325	389.45244		389.183838	6	2	7	2			45									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(16399718)	16399718	3.6	1118			[#6]-[#6]1:[#6](-[#6]):[#6]2:[#6](:[#8]:[#6]:1=[#8]):[#6](-[#6]):[#6](-[#8]-[#6](-[#6])-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=[#8])-[#8]):[#6]:[#6]:2	Cc1c(C)c2c(oc1=O)c(C)c(OC(C)C(=O)N[C@@H](CC(C)C)C(=O)O)cc2	CDKWACSMHPTBAQ		parent_pubchem_cid	AKOS004937319;(2S)-4-METHYL-2-({2-[(3,4,8-TRIMETHYL-2-OXO-2H-CHROMEN-7-YL)OXY]PROPANOYL}AMINO)PENTANOIC ACID;(2S)-4-methyl-2-(2-((3,4,8-trimethyl-2-oxo-2H-chromen-7-yl)oxy)propanamido)pentanoic acid;rac-(2S)-4-methyl-2-[2-(3,4,8-trimethyl-2-oxo-chromen-7-yl)oxypropanoylamino]pentanoic acid		23680400.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23680400		pluskal_iocb_peptide_Peptide01_F20_id		100	F20		
4.3		0	1183	P1098233	101.9		AB18	False	0	24	0	0	25	0	1	6	0	0		0.0						CCCc1cc(=O)oc2c1ccc(OCC(=O)NC(Cc1ccccc1)C(=O)O)c2C								N-acyl-L-alpha-amino acids;Phenylpropanoic acids;Coumarins and derivatives;1-benzopyrans;Amphetamines and derivatives;Pyranones and derivatives;Alkyl aryl ethers;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactones;Oxacyclic compounds;Carboxylic acids;Monocarboxylic acids and derivatives;Organopnictogen compounds;Carbonyl compounds;Organic oxides;Organonitrogen compounds;Hydrocarbon derivatives	1-benzopyrans;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Benzene and substituted derivatives;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Lactones;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenethylamines;Phenylalanine and derivatives;Phenylpropanoic acids;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Secondary carboxylic acid amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-L-alpha-amino acid (CHEBI:48927);benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);coumarins (CHEBI:23403);1-benzopyran (CHEBI:38443);amphetamines (CHEBI:35338);pyranone (CHEBI:37963);aromatic ether (CHEBI:35618);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactone (CHEBI:25000);oxacycle (CHEBI:38104);carboxylic acid anion (CHEBI:29067);carbonyl compound (CHEBI:36586);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);organic molecule (CHEBI:72695);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);amino acid (CHEBI:33709);peptide (CHEBI:16670);N-acyl-amino acid (CHEBI:51569);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);benzenoid aromatic compound (CHEBI:33836);primary amine (CHEBI:32877);pyrans (CHEBI:26407);oxygen molecular entity (CHEBI:25806);ether (CHEBI:25698);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)	Benzopyranoids (PK1311)	Amino acids, peptides, and analogues	Phenylalanine or derivatives;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;N-acyl-l-alpha-amino acid;Coumarin;3-phenylpropanoic-acid;Benzopyran;1-benzopyran;Amphetamine or derivatives;Alkyl aryl ether;Pyranone;Monocyclic benzene moiety;Benzenoid;Pyran;Heteroaromatic compound;Carboxamide group;Lactone;Secondary carboxylic acid amide;Monocarboxylic acid or derivatives;Ether;Organoheterocyclic compound;Carboxylic acid;Oxacycle;Organic oxygen compound;Organic nitrogen compound;Hydrocarbon derivative;Organic oxide;Carbonyl group;Organopnictogen compound;Organonitrogen compound;Organooxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		EiM07-16911		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C24H25NO6	C24H25NO6			InChI=1S/C24H25NO6/c1-3-7-17-13-22(27)31-23-15(2)20(11-10-18(17)23)30-14-21(26)25-19(24(28)29)12-16-8-5-4-6-9-16/h4-6,8-11,13,19H,3,7,12,14H2,1-2H3,(H,25,26)(H,28,29)/t19-/m0/s1	JUWNHTQEZSYOSE-IBGZPJMESA-N	rac-(2S)-2-[[2-(8-methyl-2-oxo-4-propyl-chromen-7-yl)oxyacetyl]amino]-3-phenyl-propanoic acid	1798674	CCCc1cc(=O)oc2c1ccc(OCC(=O)N[C@@H](Cc1ccccc1)C(=O)O)c2C	(2S)-2-[[2-(8-methyl-2-oxo-4-propylchromen-7-yl)oxyacetyl]amino]-3-phenylpropanoic acid			3.0897500000000013													MCULE-5117618559	423.46995		423.168188	6	2	9	3			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(1798674)	1798674	4.1	1119			[#6]-[#6]-[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]):[#6]:2-[#6]	CCCc1cc(=O)oc2c1ccc(OCC(=O)N[C@@H](Cc1ccccc1)C(=O)O)c2C	JUWNHTQEZSYOSE		parent_pubchem_cid	EiM07-16911;AKOS004937213;(2S)-2-({2-[(8-methyl-2-oxo-4-propyl-2H-chromen-7-yl)oxy]acetyl}amino)-3-phenylpropanoic acid;rac-(2S)-2-[[2-(8-methyl-2-oxo-4-propyl-chromen-7-yl)oxyacetyl]amino]-3-phenyl-propanoic acid		23260506.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23260506		pluskal_iocb_peptide_Peptide01_F20_id		100	F20		ZINC000002146388
2.4		0	1271	P7009516	106.4		AB19	False	0	21	0	1	19	0	6	3	0	0		0.0						OCCNc1c2cnn(-c3ccc(F)cc3)c2nc(NCc2cc3c(cc2)OCO3)n1																							0.0		1207045-32-6		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1		C21H19FN6O3	C21H19FN6O3			InChI=1S/C21H19FN6O3/c22-14-2-4-15(5-3-14)28-20-16(11-25-28)19(23-7-8-29)26-21(27-20)24-10-13-1-6-17-18(9-13)31-12-30-17/h1-6,9,11,29H,7-8,10,12H2,(H2,23,24,26,27)	FAVJIEPAFPSUAG-UHFFFAOYSA-N	2-[[6-(1,3-benzodioxol-5-ylmethylamino)-1-(4-fluorophenyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]ethanol	45497492	OCCNc1c2cnn(-c3ccc(F)cc3)c2nc(NCc2cc3c(cc2)OCO3)n1	2-[[6-(1,3-benzodioxol-5-ylmethylamino)-1-(4-fluorophenyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]ethanol			0.3404199999999999													MCULE-2414711618	422.42238		422.150267	8	3	7	5			43										False	Alkaloids				Peptide01			Compound(45497492)	45497492	3.2	1120			[#8]-[#6]-[#6]-[#7]-[#6]1:[#6]2:[#6]:[#7]:[#7](-[#6]3:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:3):[#6]:2:[#7]:[#6](-[#7]-[#6]-[#6]2:[#6]:[#6]3:[#6](:[#6]:[#6]:2)-[#8]-[#6]-[#8]-3):[#7]:1	OCCNc1c2cnn(-c3ccc(F)cc3)c2nc(NCc2cc3c(cc2)OCO3)n1	FAVJIEPAFPSUAG		parent_pubchem_cid	1207045-32-6;2-((6-((benzo[d][1,3]dioxol-5-ylmethyl)amino)-1-(4-fluorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino)ethanol;2-[[6-(1,3-benzodioxol-5-ylmethylamino)-1-(4-fluorophenyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]ethanol;2-[(6-{[(2H-1,3-benzodioxol-5-yl)methyl]amino}-1-(4-fluorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]ethan-1-ol;STL485844;AKOS024255165;CCG-309457;F2090-1733;2-({6-[(1,3-benzodioxol-5-ylmethyl)amino]-1-(4-fluorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl}amino)ethanol		15989732.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=15989732		pluskal_iocb_peptide_Peptide01_F21_id		100	F21		ZINC000038486260
4.9		0	1103	P1105817	99.7		AB21	False	0	25	0	0	23	0	3	4	0	0		0.0						COc1ccc(Oc2c(C)nc(N)nc2-c2c(O)cc(OCc3ccccc3)cc2)cc1								Diarylethers;Phenoxy compounds;Methoxybenzenes;Anisoles;Aminopyrimidines and derivatives;Alkyl aryl ethers;1-hydroxy-4-unsubstituted benzenoids;1-hydroxy-2-unsubstituted benzenoids;Heteroaromatic compounds;Azacyclic compounds;Primary amines;Organopnictogen compounds;Hydrocarbon derivatives	1-hydroxy-2-unsubstituted benzenoids;1-hydroxy-4-unsubstituted benzenoids;Alkyl aryl ethers;Amines;Aminopyrimidines and derivatives;Anisoles;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Chemical entities;Diarylethers;Diazines;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Methoxybenzenes;Organic compounds;Organic nitrogen compounds;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenol ethers;Phenols;Phenoxy compounds;Phenylpyrimidines;Primary amines;Pyrimidines and pyrimidine derivatives	Diazines	2.1	This compound belongs to the class of organic compounds known as phenylpyrimidines. These are polycyclic aromatic compounds containing a benzene ring linked to a pyrimidine ring through a CC or CN bond.  Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions.	Phenylpyrimidines			Organic compounds	Aromatic heteromonocyclic compounds	aromatic ether (CHEBI:35618);benzenes (CHEBI:22712);methoxybenzene (CHEBI:51683);aminopyrimidine (CHEBI:38338);phenols (CHEBI:33853);organic aromatic compound (CHEBI:33659);organonitrogen heterocyclic compound (CHEBI:38101);primary amine (CHEBI:32877);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organic molecule (CHEBI:72695);pyrimidines (CHEBI:39447);chemical entity (CHEBI:24431);oxygen molecular entity (CHEBI:25806);organooxygen compound (CHEBI:36963);ether (CHEBI:25698);benzenoid aromatic compound (CHEBI:33836);organic heterocyclic compound (CHEBI:24532);diazines (CHEBI:38313);nitrogen molecular entity (CHEBI:51143);organonitrogen compound (CHEBI:35352);amine (CHEBI:32952)		Pyrimidines and pyrimidine derivatives	4-phenylpyrimidine;5-phenylpyrimidine;Diaryl ether;Anisole;Phenol ether;Phenoxy compound;Methoxybenzene;1-hydroxy-4-unsubstituted benzenoid;Aminopyrimidine;1-hydroxy-2-unsubstituted benzenoid;Alkyl aryl ether;Phenol;Monocyclic benzene moiety;Benzenoid;Heteroaromatic compound;Ether;Azacycle;Organopnictogen compound;Organic nitrogen compound;Organic oxygen compound;Organooxygen compound;Organonitrogen compound;Amine;Primary amine;Hydrocarbon derivative;Aromatic heteromonocyclic compound	Organoheterocyclic compounds	0.0		877806-57-0		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0		C25H23N3O4	C25H23N3O4			InChI=1S/C25H23N3O4/c1-16-24(32-19-10-8-18(30-2)9-11-19)23(28-25(26)27-16)21-13-12-20(14-22(21)29)31-15-17-6-4-3-5-7-17/h3-14,29H,15H2,1-2H3,(H2,26,27,28)	WZDIDEYNVACCCN-UHFFFAOYSA-N	2-[2-amino-5-(4-methoxyphenoxy)-6-methyl-pyrimidin-4-yl]-5-benzyloxy-phenol	4262128	COc1ccc(Oc2c(C)nc(N)nc2-c2c(O)cc(OCc3ccccc3)cc2)cc1	2-[2-amino-5-(4-methoxyphenoxy)-6-methylpyrimidin-4-yl]-5-phenylmethoxyphenol			1.93762													MCULE-3732201587	429.47976		429.168856	7	2	7	4			44										False	Alkaloids				Peptide01			Compound(4262128)	4262128	4.5	1121			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]2:[#6](-[#6]):[#7]:[#6](-[#7]):[#7]:[#6]:2-[#6]2:[#6](-[#8]):[#6]:[#6](-[#8]-[#6]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#6]:[#6]:2):[#6]:[#6]:1	COc1ccc(Oc2c(C)nc(N)nc2-c2c(O)cc(OCc3ccccc3)cc2)cc1	WZDIDEYNVACCCN		parent_pubchem_cid	877806-57-0;2-(2-amino-5-(4-methoxyphenoxy)-6-methylpyrimidin-4-yl)-5-(benzyloxy)phenol;2-[2-amino-5-(4-methoxyphenoxy)-6-methylpyrimidin-4-yl]-5-(benzyloxy)phenol;2-[2-amino-5-(4-methoxyphenoxy)-6-methylpyrimidin-4-yl]-5-phenylmethoxyphenol;AKOS002226436;VU0616878-1;F3385-1516;2-[2-amino-5-(4-methoxyphenoxy)-6-methyl-pyrimidin-4-yl]-5-benzyloxy-phenol		10494197.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=10494197		pluskal_iocb_peptide_Peptide01_F21_id		100	F21		ZINC000011865072
1.3		0	1191	P3461231	157.0		AB22	False	0	20	0	0	25	0	3	7	0	0		0.0						COc1cc2c(cc1CCC(=O)NC(CCCNC(N)=O)C(=O)O)c(C)cc(=O)o2																							0.0		EiM08-08815		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C20H25N3O7	C20H25N3O7			InChI=1S/C20H25N3O7/c1-11-8-18(25)30-16-10-15(29-2)12(9-13(11)16)5-6-17(24)23-14(19(26)27)4-3-7-22-20(21)28/h8-10,14H,3-7H2,1-2H3,(H,23,24)(H,26,27)(H3,21,22,28)/t14-/m0/s1	AIFSXXULXLBEPT-AWEZNQCLSA-N	rac-(2S)-2-[3-(7-methoxy-4-methyl-2-oxo-chromen-6-yl)propanoylamino]-5-ureido-pentanoic acid	51703572	COc1cc2c(cc1CCC(=O)N[C@@H](CCCNC(N)=O)C(=O)O)c(C)cc(=O)o2	(2S)-5-(carbamoylamino)-2-[3-(7-methoxy-4-methyl-2-oxochromen-6-yl)propanoylamino]pentanoic acid			0.9601600000000012													MCULE-3357539263	419.43815		419.16925	7	4	10	2			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(51703572)	51703572	0.4	1122			[#6]-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1-[#6]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#8])-[#6](=[#8])-[#8]):[#6](-[#6]):[#6]:[#6](=[#8]):[#8]:2	COc1cc2c(cc1CCC(=O)N[C@@H](CCCNC(N)=O)C(=O)O)c(C)cc(=O)o2	AIFSXXULXLBEPT		parent_pubchem_cid	EiM08-08815;AKOS016377320;rac-(2S)-2-[3-(7-methoxy-4-methyl-2-oxo-chromen-6-yl)propanoylamino]-5-ureido-pentanoic acid		22680136.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22680136		pluskal_iocb_peptide_Peptide01_F21_id		100	F21		ZINC000035686287
0.2		0	1279	P11569495	110.8		AB23	False	0	19	0	0	22	0	4	4	0	0		0.0						Cc1c(CCC(=O)NC(CO)Cc2ccccc2)c(=O)n2[nH]c(=O)cc2[nH]1																							0.0		N-(1-benzyl-2-hydroxy-ethyl)-3-(5-methyl-2,7-dioxo-1,4-dihydropyrazolo[1,5-a]pyrimidin-6-yl)propanamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C19H22N4O4	C19H22N4O4			InChI=1S/C19H22N4O4/c1-12-15(19(27)23-16(20-12)10-18(26)22-23)7-8-17(25)21-14(11-24)9-13-5-3-2-4-6-13/h2-6,10,14,20,24H,7-9,11H2,1H3,(H,21,25)(H,22,26)/t14-/m0/s1	LOCQTTOLJFLEKJ-AWEZNQCLSA-N	N-(1-benzyl-2-hydroxy-ethyl)-3-(5-methyl-2,7-dioxo-1,4-dihydropyrazolo[1,5-a]pyrimidin-6-yl)propanamide	100016917	Cc1c(CCC(=O)N[C@H](CO)Cc2ccccc2)c(=O)n2[nH]c(=O)cc2[nH]1	N-[(2S)-1-hydroxy-3-phenylpropan-2-yl]-3-(5-methyl-2,7-dioxo-1,4-dihydropyrazolo[1,5-a]pyrimidin-6-yl)propanamide			1.6981599999999992														370.41159		370.164105	5	4	7	3			45									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(100016917)	100016917	0.4	1123			[#6]-[#6]1:[#6](-[#6]-[#6]-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#8])-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6](=[#8]):[#7]2:[#7H]:[#6](=[#8]):[#6]:[#6]:2:[#7H]:1	Cc1c(CCC(=O)N[C@H](CO)Cc2ccccc2)c(=O)n2[nH]c(=O)cc2[nH]1	LOCQTTOLJFLEKJ		parent_pubchem_cid	N-(1-benzyl-2-hydroxy-ethyl)-3-(5-methyl-2,7-dioxo-1,4-dihydropyrazolo[1,5-a]pyrimidin-6-yl)propanamide		101990063.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=101990063		pluskal_iocb_peptide_Peptide01_F21_id		100	F21		ZINC000218484208
2.6		0	1111	P1098907	111.4		AB25	False	0	16	0	0	20	0	4	4	0	0		0.0						CCC(C)C(NC(=O)C(C)n1nnc2ccccc2c1=O)C(=O)O																							0.0		EiM07-17605		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C16H20N4O4	C16H20N4O4			InChI=1S/C16H20N4O4/c1-4-9(2)13(16(23)24)17-14(21)10(3)20-15(22)11-7-5-6-8-12(11)18-19-20/h5-10,13H,4H2,1-3H3,(H,17,21)(H,23,24)/t9-,10+,13+/m1/s1	LQWFSQFPJNMSEA-NRUUGDAUSA-N	rac-(2S,3R)-3-methyl-2-[[rac-(2S)-2-(4-oxo-1,2,3-benzotriazin-3-yl)propanoyl]amino]pentanoic acid	1845202	CC[C@@H](C)[C@H](NC(=O)[C@H](C)n1nnc2ccccc2c1=O)C(=O)O	(2S,3R)-3-methyl-2-[[(2S)-2-(4-oxo-1,2,3-benzotriazin-3-yl)propanoyl]amino]pentanoic acid			1.4394699999999996													MCULE-5933583004	332.3622		332.148455	6	2	6	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(1845202)	1845202	2.6	1124			[#6]-[#6]-[#6@@H](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#6@H](-[#6])-[#7]1:[#7]:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8])-[#6](=[#8])-[#8]	CC[C@@H](C)[C@H](NC(=O)[C@H](C)n1nnc2ccccc2c1=O)C(=O)O	LQWFSQFPJNMSEA		parent_pubchem_cid	EiM07-17605;AKOS005533805;NCGC00305378-01;AB01301781-01;3-METHYL-2-[2-(4-OXO-3,4-DIHYDRO-1,2,3-BENZOTRIAZIN-3-YL)PROPANAMIDO]PENTANOIC ACID;rac-(2S,3R)-3-methyl-2-[[rac-(2S)-2-(4-oxo-1,2,3-benzotriazin-3-yl)propanoyl]amino]pentanoic acid		22811212.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22811212		pluskal_iocb_peptide_Peptide01_F21_id		100	F21		ZINC000002212219
2.9		0	1199	P3460769	94.7		AB26	False	0	19	0	0	25	0	3	4	0	0		0.0						CCC(C)C(NC(=O)N1CCc2c(C1)[nH]c1c2cc(OC)cc1)C(=O)O																							0.0		AKOS004938794		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C19H25N3O4	C19H25N3O4			InChI=1S/C19H25N3O4/c1-4-11(2)17(18(23)24)21-19(25)22-8-7-13-14-9-12(26-3)5-6-15(14)20-16(13)10-22/h5-6,9,11,17,20H,4,7-8,10H2,1-3H3,(H,21,25)(H,23,24)/t11-,17+/m1/s1	UCSFIIWHBINDLY-DIFFPNOSSA-N	rac-(2S,3R)-2-[(6-methoxy-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carbonyl)amino]-3-methyl-pentanoic acid	39889971	CC[C@@H](C)[C@H](NC(=O)N1CCc2c(C1)[nH]c1c2cc(OC)cc1)C(=O)O	(2S,3R)-2-[(6-methoxy-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carbonyl)amino]-3-methylpentanoic acid			1.74325													MCULE-2609575988	359.4288		359.184506	4	3	5	3			44									Carboline alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(39889971)	39889971	2.5	1125			[#6]-[#6]-[#6@@H](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#7]1-[#6]-[#6]-[#6]2:[#6](-[#6]-1):[#7H]:[#6]1:[#6]:2:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:1)-[#6](=[#8])-[#8]	CC[C@@H](C)[C@H](NC(=O)N1CCc2c(C1)[nH]c1c2cc(OC)cc1)C(=O)O	UCSFIIWHBINDLY		parent_pubchem_cid	AKOS004938794;rac-(2S,3R)-2-[(6-methoxy-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carbonyl)amino]-3-methyl-pentanoic acid		24261504.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24261504		pluskal_iocb_peptide_Peptide01_F21_id		100	F21		ZINC000032646476
1.8		0	1287	P11570244	98.7		AB27	False	0	22	0	0	25	0	3	4	0	0		0.0						O=C(CC1NC(=O)N(CCc2ccccc2)C1=O)NC(CO)Cc1ccccc1																							0.0		AKOS027474947		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	4	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	1	1	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0		C22H25N3O4	C22H25N3O4			InChI=1S/C22H25N3O4/c26-15-18(13-17-9-5-2-6-10-17)23-20(27)14-19-21(28)25(22(29)24-19)12-11-16-7-3-1-4-8-16/h1-10,18-19,26H,11-15H2,(H,23,27)(H,24,29)/t18-,19?/m0/s1	CROKULRAQZCUKQ-OYKVQYDMSA-N	2-[2,5-dioxo-1-(2-phenylethyl)imidazolidin-4-yl]-N-[rac-(1S)-1-benzyl-2-hydroxy-ethyl]acetamide	110209993	O=C(CC1NC(=O)N(CCc2ccccc2)C1=O)N[C@H](CO)Cc1ccccc1	2-[2,5-dioxo-1-(2-phenylethyl)imidazolidin-4-yl]-N-[(2S)-1-hydroxy-3-phenylpropan-2-yl]acetamide			1.1499799999999998														395.46225		395.184506	4	3	9	3			46									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(110209993)	110209993	1.7	1126			[#8]=[#6](-[#6]-[#6]1-[#7]-[#6](=[#8])-[#7](-[#6]-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]-1=[#8])-[#7]-[#6@H](-[#6]-[#8])-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	O=C(CC1NC(=O)N(CCc2ccccc2)C1=O)N[C@H](CO)Cc1ccccc1	CROKULRAQZCUKQ		parent_pubchem_cid	AKOS027474947;2-[2,5-DIOXO-1-(2-PHENYLETHYL)-4-IMIDAZOLIDINYL]-N-(1-HYDROXY-3-PHENYL-2-PROPANYL)ACETAMIDE;2-[2,5-dioxo-1-(2-phenylethyl)imidazolidin-4-yl]-N-[rac-(1S)-1-benzyl-2-hydroxy-ethyl]acetamide		117138031.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=117138031		pluskal_iocb_peptide_Peptide01_F21_id		100	F21		
2.1		0	1119	P1098618	95.9		AB29	False	0	24	0	0	27	0	1	5	0	0		0.0						Cc1c(Cc2ccccc2)c(=O)oc2c1ccc(O)c2CNC(CC(C)C)C(=O)O																							0.0		EiM07-17296		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C24H27NO5	C24H27NO5			InChI=1S/C24H27NO5/c1-14(2)11-20(23(27)28)25-13-19-21(26)10-9-17-15(3)18(24(29)30-22(17)19)12-16-7-5-4-6-8-16/h4-10,14,20,25-26H,11-13H2,1-3H3,(H,27,28)/t20-/m0/s1	LZVNDAWOTCMIJK-FQEVSTJZSA-N	rac-(2S)-2-[(3-benzyl-7-hydroxy-4-methyl-2-oxo-chromen-8-yl)methylamino]-4-methyl-pentanoic acid	24279893	Cc1c(Cc2ccccc2)c(=O)oc2c1ccc(O)c2CN[C@@H](CC(C)C)C(=O)O	(2S)-2-[(3-benzyl-7-hydroxy-4-methyl-2-oxochromen-8-yl)methylamino]-4-methylpentanoic acid			3.7769400000000015													MCULE-5936501622	409.48649		409.188923	6	3	8	3			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(24279893)	24279893	2.4	1127			[#6]-[#6]1:[#6](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]):[#6]:2-[#6]-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=[#8])-[#8]	Cc1c(Cc2ccccc2)c(=O)oc2c1ccc(O)c2CN[C@@H](CC(C)C)C(=O)O	LZVNDAWOTCMIJK		parent_pubchem_cid	EiM07-17296;AKOS016379118;2-{[(3-BENZYL-7-HYDROXY-4-METHYL-2-OXO-2H-CHROMEN-8-YL)METHYL]AMINO}-4-METHYLPENTANOIC ACID;rac-(2S)-2-[(3-benzyl-7-hydroxy-4-methyl-2-oxo-chromen-8-yl)methylamino]-4-methyl-pentanoic acid		5739769.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=5739769		pluskal_iocb_peptide_Peptide01_F21_id		100	F21		ZINC000011866849
4.8		0	1207	P1098431	101.9		AB30	False	0	25	0	0	27	0	1	6	0	0		0.0						CCCC(NC(=O)COc1c(C)c2c(cc1)c(C)c(Cc1ccccc1)c(=O)o2)C(=O)O								Coumarins and derivatives;1-benzopyrans;Pyranones and derivatives;Alkyl aryl ethers;Benzene and substituted derivatives;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactones;Oxacyclic compounds;Carboxylic acids;Monocarboxylic acids and derivatives;Organopnictogen compounds;Carbonyl compounds;Organic oxides;Organonitrogen compounds;Hydrocarbon derivatives	1-benzopyrans;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Benzene and substituted derivatives;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Lactones;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Secondary carboxylic acid amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom.	N-acyl-alpha amino acids		Amino acids and derivatives;Alpha amino acids and derivatives;N-acyl-alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	coumarins (CHEBI:23403);1-benzopyran (CHEBI:38443);pyranone (CHEBI:37963);aromatic ether (CHEBI:35618);benzenes (CHEBI:22712);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactone (CHEBI:25000);oxacycle (CHEBI:38104);carboxylic acid (CHEBI:33575);monocarboxylic acid (CHEBI:25384);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);carbonyl compound (CHEBI:36586);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);organic molecule (CHEBI:72695);N-acyl-amino acid (CHEBI:51569);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);pyrans (CHEBI:26407);oxygen molecular entity (CHEBI:25806);ether (CHEBI:25698);benzenoid aromatic compound (CHEBI:33836);organic acid (CHEBI:64709);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)	Benzopyranoids (PK1311)	Amino acids, peptides, and analogues	N-acyl-alpha-amino acid;Coumarin;Benzopyran;1-benzopyran;Alkyl aryl ether;Pyranone;Monocyclic benzene moiety;Benzenoid;Pyran;Heteroaromatic compound;Carboxamide group;Lactone;Secondary carboxylic acid amide;Carboxylic acid;Ether;Oxacycle;Monocarboxylic acid or derivatives;Organoheterocyclic compound;Hydrocarbon derivative;Organic nitrogen compound;Organic oxide;Organic oxygen compound;Organopnictogen compound;Carbonyl group;Organonitrogen compound;Organooxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		EiM07-17109		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C25H27NO6	C25H27NO6			InChI=1S/C25H27NO6/c1-4-8-20(24(28)29)26-22(27)14-31-21-12-11-18-15(2)19(13-17-9-6-5-7-10-17)25(30)32-23(18)16(21)3/h5-7,9-12,20H,4,8,13-14H2,1-3H3,(H,26,27)(H,28,29)	OFKJONSDTLMQJR-UHFFFAOYSA-N	2-[[2-(3-benzyl-4,8-dimethyl-2-oxo-chromen-7-yl)oxyacetyl]amino]pentanoic acid	4355254	CCCC(NC(=O)COc1c(C)c2c(cc1)c(C)c(Cc1ccccc1)c(=O)o2)C(=O)O	2-[[2-(3-benzyl-4,8-dimethyl-2-oxochromen-7-yl)oxyacetyl]amino]pentanoic acid			3.5391600000000025													MCULE-8228127167	437.49704		437.183838	6	2	9	3			45									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(4355254)	4355254	4.3	1128			[#6]-[#6]-[#6]-[#6](-[#7]-[#6](=[#8])-[#6]-[#8]-[#6]1:[#6](-[#6]):[#6]2:[#6](:[#6]:[#6]:1):[#6](-[#6]):[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1):[#6](=[#8]):[#8]:2)-[#6](=[#8])-[#8]	CCCC(NC(=O)COc1c(C)c2c(cc1)c(C)c(Cc1ccccc1)c(=O)o2)C(=O)O	OFKJONSDTLMQJR		parent_pubchem_cid	EiM07-17109;AKOS004937184;N-{[(3-benzyl-4,8-dimethyl-2-oxo-2H-chromen-7-yl)oxy]acetyl}norvaline;2-[[2-(3-benzyl-4,8-dimethyl-2-oxochromen-7-yl)oxyacetyl]amino]pentanoic acid;2-{2-[(3-BENZYL-4,8-DIMETHYL-2-OXO-2H-CHROMEN-7-YL)OXY]ACETAMIDO}PENTANOIC ACID;2-[[2-(3-benzyl-4,8-dimethyl-2-oxo-chromen-7-yl)oxyacetyl]amino]pentanoic acid		22961979.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22961979		pluskal_iocb_peptide_Peptide01_F22_id		100	F22		
2.7		0	1295	P11570116	87.1		AB31	False	0	22	0	0	24	0	4	2	0	0		0.0						Cc1cc(C)nc(Nc2ccc(C(=O)NC(CO)Cc3ccccc3)cc2)n1																							0.0		AKOS027474835		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C22H24N4O2	C22H24N4O2			InChI=1S/C22H24N4O2/c1-15-12-16(2)24-22(23-15)26-19-10-8-18(9-11-19)21(28)25-20(14-27)13-17-6-4-3-5-7-17/h3-12,20,27H,13-14H2,1-2H3,(H,25,28)(H,23,24,26)/t20-/m0/s1	FBGVMOYGFJNBNE-FQEVSTJZSA-N	4-[(4,6-dimethylpyrimidin-2-yl)amino]-N-[rac-(1S)-1-benzyl-2-hydroxy-ethyl]benzamide	110205774	Cc1cc(C)nc(Nc2ccc(C(=O)N[C@H](CO)Cc3ccccc3)cc2)n1	4-[(4,6-dimethylpyrimidin-2-yl)amino]-N-[(2S)-1-hydroxy-3-phenylpropan-2-yl]benzamide			2.19038														376.46218		376.189926	5	3	7	3			45										False	Alkaloids	Peptide alkaloids			Peptide01			Compound(110205774)	110205774	3.5	1129			[#6]-[#6]1:[#6]:[#6](-[#6]):[#7]:[#6](-[#7]-[#6]2:[#6]:[#6]:[#6](-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#8])-[#6]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#6]:[#6]:2):[#7]:1	Cc1cc(C)nc(Nc2ccc(C(=O)N[C@H](CO)Cc3ccccc3)cc2)n1	FBGVMOYGFJNBNE		parent_pubchem_cid	AKOS027474835;4-[(4,6-dimethylpyrimidin-2-yl)amino]-N-[rac-(1S)-1-benzyl-2-hydroxy-ethyl]benzamide		117133983.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=117133983		pluskal_iocb_peptide_Peptide01_F22_id		100	F22		ZINC000252483419
4.1		0	1127	P1098174	117.7		AB33	False	0	25	0	0	24	0	2	6	0	0		0.0						CCc1cc(=O)oc2c1ccc(OCC(=O)NC(Cc1c[nH]c3ccccc13)C(=O)O)c2C																							0.0		EiM07-16852		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C25H24N2O6	C25H24N2O6			InChI=1S/C25H24N2O6/c1-3-15-11-23(29)33-24-14(2)21(9-8-18(15)24)32-13-22(28)27-20(25(30)31)10-16-12-26-19-7-5-4-6-17(16)19/h4-9,11-12,20,26H,3,10,13H2,1-2H3,(H,27,28)(H,30,31)/t20-/m0/s1	LLTCJYIEWBIFGU-FQEVSTJZSA-N	rac-(2S)-2-[[2-(4-ethyl-8-methyl-2-oxo-chromen-7-yl)oxyacetyl]amino]-3-(1H-indol-3-yl)propanoic acid	1798814	CCc1cc(=O)oc2c1ccc(OCC(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)O)c2C	(2S)-2-[[2-(4-ethyl-8-methyl-2-oxochromen-7-yl)oxyacetyl]amino]-3-(1H-indol-3-yl)propanoic acid			2.75253													MCULE-7491298997	448.47983		448.163436	6	3	8	4			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(1798814)	1798814	3.7	1130			[#6]-[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:1:3)-[#6](=[#8])-[#8]):[#6]:2-[#6]	CCc1cc(=O)oc2c1ccc(OCC(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)O)c2C	LLTCJYIEWBIFGU		parent_pubchem_cid	EiM07-16852;STL460590;AKOS004937665;N-{[(4-ethyl-8-methyl-2-oxo-2H-chromen-7-yl)oxy]acetyl}-L-tryptophan;(2S)-2-({2-[(4-ETHYL-8-METHYL-2-OXO-2H-CHROMEN-7-YL)OXY]ACETYL}AMINO)-3-(1H-INDOL-3-YL)PROPANOIC ACID;rac-(2S)-2-[[2-(4-ethyl-8-methyl-2-oxo-chromen-7-yl)oxyacetyl]amino]-3-(1H-indol-3-yl)propanoic acid		23623912.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23623912		pluskal_iocb_peptide_Peptide01_F22_id		100	F22		ZINC000002146599
3.8		0	1215	P7014671079	93.4		AB34	False	0	22	0	0	29	0	3	3	0	0		0.0						CC(Oc1ccc(C(=O)Nc2c(C(C)C)cccc2C(C)C)cc1)C(=O)NN																							0.0		MFCD04980312		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C22H29N3O3	C22H29N3O3			InChI=1S/C22H29N3O3/c1-13(2)18-7-6-8-19(14(3)4)20(18)24-22(27)16-9-11-17(12-10-16)28-15(5)21(26)25-23/h6-15H,23H2,1-5H3,(H,24,27)(H,25,26)	BXVOLSBVLSRLHE-UHFFFAOYSA-N	N-(2,6-diisopropylphenyl)-4-(2-hydrazino-1-methyl-2-oxo-ethoxy)benzamide	4137193	CC(Oc1ccc(C(=O)Nc2c(C(C)C)cccc2C(C)C)cc1)C(=O)NN	N-[2,6-di(propan-2-yl)phenyl]-4-(1-hydrazinyl-1-oxopropan-2-yl)oxybenzamide			2.93575													MCULE-8718208015	383.49473		383.220892	4	3	7	2			45										False	Terpenoids				Peptide01			Compound(4137193)	4137193	4.0	1131			[#6]-[#6](-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](=[#8])-[#7]-[#6]2:[#6](-[#6](-[#6])-[#6]):[#6]:[#6]:[#6]:[#6]:2-[#6](-[#6])-[#6]):[#6]:[#6]:1)-[#6](=[#8])-[#7]-[#7]	CC(Oc1ccc(C(=O)Nc2c(C(C)C)cccc2C(C)C)cc1)C(=O)NN	BXVOLSBVLSRLHE		parent_pubchem_cid	MFCD04980312;AKOS002672096;AKOS016045130;N-(2,6-diisopropylphenyl)-4-(2-hydrazino-1-methyl-2-oxo-ethoxy)benzamide		60438223.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=60438223		pluskal_iocb_peptide_Peptide01_F22_id		100	F22		
2.6		0	1135	P1098906	111.4		AB37	False	0	16	0	0	20	0	4	4	0	0		0.0						CC(C)CC(NC(=O)C(C)n1nnc2ccccc2c1=O)C(=O)O																							0.0		STK716981		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C16H20N4O4	C16H20N4O4			InChI=1S/C16H20N4O4/c1-9(2)8-13(16(23)24)17-14(21)10(3)20-15(22)11-6-4-5-7-12(11)18-19-20/h4-7,9-10,13H,8H2,1-3H3,(H,17,21)(H,23,24)/t10-,13-/m0/s1	IOXJSLIGXZBZRC-GWCFXTLKSA-N	rac-(2S)-4-methyl-2-[[rac-(2S)-2-(4-oxo-1,2,3-benzotriazin-3-yl)propanoyl]amino]pentanoic acid	1945783	CC(C)C[C@H](NC(=O)[C@H](C)n1nnc2ccccc2c1=O)C(=O)O	(2S)-4-methyl-2-[[(2S)-2-(4-oxo-1,2,3-benzotriazin-3-yl)propanoyl]amino]pentanoic acid			1.4394699999999996													MCULE-9487822186	332.3622		332.148455	6	2	6	2			44										False	Alkaloids;Amino acids and Peptides	Anthranilic acid alkaloids			Peptide01			Compound(1945783)	1945783	2.6	1132			[#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6@H](-[#6])-[#7]1:[#7]:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8])-[#6](=[#8])-[#8]	CC(C)C[C@H](NC(=O)[C@H](C)n1nnc2ccccc2c1=O)C(=O)O	IOXJSLIGXZBZRC		parent_pubchem_cid	STK716981;AKOS005533777;NCGC00305376-01;AB01301779-01;N-[(2S)-2-(4-oxo-1,2,3-benzotriazin-3(4H)-yl)propanoyl]-L-leucine;(S)-4-methyl-2-((S)-2-(4-oxobenzo[d][1,2,3]triazin-3(4H)-yl)propanamido)pentanoic acid;4-METHYL-2-[2-(4-OXO-3,4-DIHYDRO-1,2,3-BENZOTRIAZIN-3-YL)PROPANAMIDO]PENTANOIC ACID;rac-(2S)-4-methyl-2-[[rac-(2S)-2-(4-oxo-1,2,3-benzotriazin-3-yl)propanoyl]amino]pentanoic acid		24495497.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24495497		pluskal_iocb_peptide_Peptide01_F22_id		100	F22		ZINC000002331310
3.9		0	1223	P1012261	91.9		AB38	False	1	19	0	0	16	0	1	4	0	1		0.0						O=C(O)C(Cc1ccccc1)NS(=O)(=O)c1ccc(Br)c2ccccc12																							0.0		N-[(4-bromo-1-naphthyl)sulfonyl]phenylalanine		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0		C19H16BrNO4S	C19H16BrNO4S			InChI=1S/C19H16BrNO4S/c20-16-10-11-18(15-9-5-4-8-14(15)16)26(24,25)21-17(19(22)23)12-13-6-2-1-3-7-13/h1-11,17,21H,12H2,(H,22,23)	VMEKKOVMEVEEFS-UHFFFAOYSA-N	2-[(4-bromo-1-naphthyl)sulfonylamino]-3-phenyl-propanoic acid	24284182	O=C(O)C(Cc1ccccc1)NS(=O)(=O)c1ccc(Br)c2ccccc12	2-[(4-bromonaphthalen-1-yl)sulfonylamino]-3-phenylpropanoic acid			2.985360000000001													MCULE-2115915913	434.31167		432.998341	4	2	6	3			45										False	Shikimates and Phenylpropanoids				Peptide01			Compound(24284182)	24284182	4.4	1133			[#8]=[#6](-[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#16](=[#8])(=[#8])-[#6]1:[#6]:[#6]:[#6](-[#35]):[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	O=C(O)C(Cc1ccccc1)NS(=O)(=O)c1ccc(Br)c2ccccc12	VMEKKOVMEVEEFS		parent_pubchem_cid	N-[(4-bromo-1-naphthyl)sulfonyl]phenylalanine;AKOS016401526;AQ-390/43490293;2-[(4-bromonaphthalen-1-yl)sulfonylamino]-3-phenylpropanoic acid;2-[(4-bromo-1-naphthyl)sulfonylamino]-3-phenyl-propanoic acid		24459903.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24459903		pluskal_iocb_peptide_Peptide01_F22_id		100	F22		
0.4		0	1143	P1098888	173.3		AB41	False	0	16	0	0	21	0	7	4	0	0		0.0						NC(N)=NCCCC(NC(=O)CCn1nnc2ccccc2c1=O)C(=O)O																							0.0		AKOS016395146		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C16H21N7O4	C16H21N7O4			InChI=1S/C16H21N7O4/c17-16(18)19-8-3-6-12(15(26)27)20-13(24)7-9-23-14(25)10-4-1-2-5-11(10)21-22-23/h1-2,4-5,12H,3,6-9H2,(H,20,24)(H,26,27)(H4,17,18,19)/t12-/m0/s1	SICWCQZDFRBSJI-LBPRGKRZSA-N	rac-(2S)-5-guanidino-2-[3-(4-oxo-1,2,3-benzotriazin-3-yl)propanoylamino]pentanoic acid	24279955	NC(N)=NCCC[C@H](NC(=O)CCn1nnc2ccccc2c1=O)C(=O)O	(2S)-5-(diaminomethylideneamino)-2-[3-(4-oxo-1,2,3-benzotriazin-3-yl)propanoylamino]pentanoic acid			-0.7239299999999984													MCULE-2395743651	375.39027		375.165502	7	5	10	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(24279955)	24279955	-0.4	1134			[#7]-[#6](-[#7])=[#7]-[#6]-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#6]-[#7]1:[#7]:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8])-[#6](=[#8])-[#8]	NC(N)=NCCC[C@H](NC(=O)CCn1nnc2ccccc2c1=O)C(=O)O	SICWCQZDFRBSJI		parent_pubchem_cid	AKOS016395146;5-CARBAMIMIDAMIDO-2-[3-(4-OXO-3,4-DIHYDRO-1,2,3-BENZOTRIAZIN-3-YL)PROPANAMIDO]PENTANOIC ACID;rac-(2S)-5-guanidino-2-[3-(4-oxo-1,2,3-benzotriazin-3-yl)propanoylamino]pentanoic acid		4897826.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=4897826		pluskal_iocb_peptide_Peptide01_F22_id		100	F22		ZINC000011867199
2.0		0	1231	P1559128	82.3		AB42	False	0	20	0	0	27	0	7	1	0	0		0.0						Cc1c(C)cc(Nc2c3cnn(C)c3nc(N3CCN(CCO)CC3)n2)cc1																							0.0		AKOS001905732		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	3		C20H27N7O	C20H27N7O			InChI=1S/C20H27N7O/c1-14-4-5-16(12-15(14)2)22-18-17-13-21-25(3)19(17)24-20(23-18)27-8-6-26(7-9-27)10-11-28/h4-5,12-13,28H,6-11H2,1-3H3,(H,22,23,24)	VXYGYVAHOFTAPE-UHFFFAOYSA-N	2-[4-[4-(3,4-dimethylanilino)-1-methyl-pyrazolo[3,4-d]pyrimidin-6-yl]piperazin-1-yl]ethanol	16456705	Cc1c(C)cc(Nc2c3cnn(C)c3nc(N3CCN(CCO)CC3)n2)cc1	2-[4-[4-(3,4-dimethylanilino)-1-methylpyrazolo[3,4-d]pyrimidin-6-yl]piperazin-1-yl]ethanol			0.1583700000000014													MCULE-1597644614	381.48449		381.227708	7	2	5	4			44										False	Alkaloids				Peptide01			Compound(16456705)	16456705	2.4	1135			[#6]-[#6]1:[#6](-[#6]):[#6]:[#6](-[#7]-[#6]2:[#6]3:[#6]:[#7]:[#7](-[#6]):[#6]:3:[#7]:[#6](-[#7]3-[#6]-[#6]-[#7](-[#6]-[#6]-[#8])-[#6]-[#6]-3):[#7]:2):[#6]:[#6]:1	Cc1c(C)cc(Nc2c3cnn(C)c3nc(N3CCN(CCO)CC3)n2)cc1	VXYGYVAHOFTAPE		parent_pubchem_cid	AKOS001905732;CCG-170424;2-(4-{4-[(3,4-DIMETHYLPHENYL)AMINO]-1-METHYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-6-YL}PIPERAZIN-1-YL)ETHAN-1-OL;2-[4-[4-(3,4-dimethylanilino)-1-methyl-pyrazolo[3,4-d]pyrimidin-6-yl]piperazin-1-yl]ethanol		16728883.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=16728883		pluskal_iocb_peptide_Peptide01_F22_id		100	F22		ZINC000020560373
1.6		0	8	P3463895	58.6		AC1	False	0	14	0	0	21	0	1	3	0	0		0.0						COC(=O)C(Cc1ccccc1)NC(C)(C)CO																							0.0		methyl 2-[(1-hydroxy-2-methylpropan-2-yl)amino]-3-phenylpropanoate		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C14H21NO3	C14H21NO3			InChI=1S/C14H21NO3/c1-14(2,10-16)15-12(13(17)18-3)9-11-7-5-4-6-8-11/h4-8,12,15-16H,9-10H2,1-3H3	LOEFEKVNLXOQFY-UHFFFAOYSA-N	methyl 2-[(2-hydroxy-1,1-dimethyl-ethyl)amino]-3-phenyl-propanoate	56832422	COC(=O)C(Cc1ccccc1)NC(C)(C)CO	methyl 2-[(1-hydroxy-2-methylpropan-2-yl)amino]-3-phenylpropanoate			1.0764899999999995													MCULE-2719166619	251.32837		251.152144	4	2	7	1			45									Aminoacids	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(56832422)	56832422	1.6	1136			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](-[#6])(-[#6])-[#6]-[#8]	COC(=O)C(Cc1ccccc1)NC(C)(C)CO	LOEFEKVNLXOQFY		parent_pubchem_cid	methyl 2-[(1-hydroxy-2-methylpropan-2-yl)amino]-3-phenylpropanoate;1431859-26-5;MFCD19303979;AKOS015947806;NS-03744;methyl 2-[(2-hydroxy-1,1-dimethyl-ethyl)amino]-3-phenyl-propanoate		62286840.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=62286840		pluskal_iocb_peptide_Peptide01_F23_id		100	F23		
2.7		0	96	P7210750003	90.5		AC2	True	0	19	0	0	14	0	2	4	0	0	-1.0	0.5			DNA methyltransferase inhibitor	RG108	DNMT1|DNMT3B	O=C(O)C(Cc1c[nH]c2ccccc12)N1C(=O)c2ccccc2C1=O		2.46		0.0	2.72	CHEMBL383475		Phthalimides;3-alkylindoles;Alpha amino acids and derivatives;Isoindoles;Substituted pyrroles;N-substituted carboxylic acid imides;Benzenoids;Heteroaromatic compounds;Azacyclic compounds;Monocarboxylic acids and derivatives;Carboxylic acids;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organonitrogen compounds;Organopnictogen compounds	3-alkylindoles;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzenoids;Carbonyl compounds;Carboxylic acid derivatives;Carboxylic acid imides;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Indolyl carboxylic acids and derivatives;Isoindoles;Isoindoles and derivatives;Isoindolines;Isoindolones;Monocarboxylic acids and derivatives;N-substituted carboxylic acid imides;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phthalimides;Pyrroles;Substituted pyrroles	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as indolyl carboxylic acids and derivatives. These are compounds containing a carboxylic acid chain (of at least 2 carbon atoms) linked to an indole ring.	Indolyl carboxylic acids and derivatives			Organic compounds	Aromatic heteropolycyclic compounds	phthalimides (CHEBI:82851);indoles (CHEBI:24828);organonitrogen compound (CHEBI:35352);organooxygen compound (CHEBI:36963);isoindoles (CHEBI:24897);pyrroles (CHEBI:26455);dicarboximide (CHEBI:35356);benzenoid aromatic compound (CHEBI:33836);organic aromatic compound (CHEBI:33659);organonitrogen heterocyclic compound (CHEBI:38101);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);carbonyl compound (CHEBI:36586);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);indolyl carboxylic acid (CHEBI:46867);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);organic acid (CHEBI:64709);oxygen molecular entity (CHEBI:25806);nitrogen molecular entity (CHEBI:51143);carboxylic acid anion (CHEBI:29067);amino acid (CHEBI:33709);peptide (CHEBI:16670)		Indolyl carboxylic acids and derivatives	Indolyl carboxylic acid derivative;Phthalimide;Alpha-amino acid or derivatives;Isoindolone;3-alkylindole;Indole;Isoindoline;Isoindole;Isoindole or derivatives;Benzenoid;Substituted pyrrole;Carboxylic acid imide, n-substituted;Carboxylic acid imide;Heteroaromatic compound;Pyrrole;Monocarboxylic acid or derivatives;Azacycle;Carboxylic acid;Carboxylic acid derivative;Hydrocarbon derivative;Organic oxide;Organopnictogen compound;Organic oxygen compound;Organic nitrogen compound;Carbonyl group;Organonitrogen compound;Organooxygen compound;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.5	Preclinical	32675-71-1		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	2	0		C19H14N2O4	C19H14N2O4		HMDB0255797	InChI=1S/C19H14N2O4/c22-17-13-6-1-2-7-14(13)18(23)21(17)16(19(24)25)9-11-10-20-15-8-4-3-5-12(11)15/h1-8,10,16,20H,9H2,(H,24,25)	HPTXLHAHLXOAKV-UHFFFAOYSA-N	2-(1,3-dioxoisoindolin-2-yl)-3-(1H-indol-3-yl)propanoic acid	344265	O=C(O)C(Cc1c[nH]c2ccccc12)N1C(=O)c2ccccc2C1=O	2-(1,3-dioxoisoindol-2-yl)-3-(1H-indol-3-yl)propanoic acid			1.86725													MCULE-9446134990	334.33443	ACID	334.095357	4	2	4	4	0.0		23									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids	False	False	Peptide01	PD055888	-1.0	Compound(344265)	344265	2.6	1137		SCHEMBL562060	[#8]=[#6](-[#8])-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]1-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6]-1=[#8]	O=C(O)C(Cc1c[nH]c2ccccc12)N1C(=O)c2ccccc2C1=O	HPTXLHAHLXOAKV		parent_pubchem_cid	32675-71-1;NSC401077;2-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-3-(1H-indol-3-yl)-propionic acid;NSC 401077;2-(1,3-dioxoisoindol-2-yl)-3-(1H-indol-3-yl)propanoic acid;MLS000757170;CHEMBL383475;NSC-401077;2-(1,3-dioxoisoindolin-2-yl)-3-(1H-indol-3-yl)propanoic acid;2-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-(1H-indol-3-yl)propanoic acid;SMR000413613;(2S)-2-(1,3-dioxoisoindol-2-yl)-3-(1H-indol-3-yl)propanoic acid;Oprea1_410805;Oprea1_475901;(Rac)-RG108;MLS000777218;MLS006011919;SCHEMBL562060;HPTXLHAHLXOAKV-UHFFFAOYSA-N;DTXSID501036239;HMS1762H13;HMS2752N14;HMS3426M03;BDBM50180790;MFCD00379702;MFCD08705332;STK724063;AKOS001035895;AKOS016340696;ES-0018;SB19339;2-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)-3-(1H-indol-3-yl)propanoic acid;NCI60_003759;CS-0137819;EU-0040737;F70732;EN300-6493129;SR-01000456137;SR-01000456137-1;Z56804250;2-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-(1H-indol-3-yl)propanoic acid #	False	192430.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=192430		pluskal_iocb_peptide_Peptide01_F23_id		100	F23	False	
4.1		0	184	P7020526156	80.2		AC3	False	0	19	0	0	22	0	2	4	0	0		0.0						CCOc1c(OC(C)C)ccc(C=NNc2ccccc2C(=O)O)c1																							0.0		MFCD09057669		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C19H22N2O4	C19H22N2O4			InChI=1S/C19H22N2O4/c1-4-24-18-11-14(9-10-17(18)25-13(2)3)12-20-21-16-8-6-5-7-15(16)19(22)23/h5-13,21H,4H2,1-3H3,(H,22,23)/b20-12+	ZFZGTJXFBFFARK-UDWIEESQSA-N	2-[(2E)-2-[(3-ethoxy-4-isopropoxy-phenyl)methylene]hydrazino]benzoic acid	22694844	CCOc1c(OC(C)C)ccc(/C=N/Nc2ccccc2C(=O)O)c1	2-[(2E)-2-[(3-ethoxy-4-propan-2-yloxyphenyl)methylidene]hydrazinyl]benzoic acid			2.6018500000000007														342.39819		342.157957	6	2	8	2			45									Simple phenolic acids	False	Shikimates and Phenylpropanoids	Phenolic acids (C6-C1)			Peptide01			Compound(22694844)	22694844	4.7	1138			[#6]-[#6]-[#8]-[#6]1:[#6](-[#8]-[#6](-[#6])-[#6]):[#6]:[#6]:[#6](/[#6]=[#7]/[#7]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6](=[#8])-[#8]):[#6]:1	CCOc1c(OC(C)C)ccc(/C=N/Nc2ccccc2C(=O)O)c1	ZFZGTJXFBFFARK		parent_pubchem_cid	MFCD09057669;AKOS016359059;2-[(2E)-2-[(3-ethoxy-4-isopropoxy-phenyl)methylene]hydrazino]benzoic acid		24061108.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24061108		pluskal_iocb_peptide_Peptide01_F23_id		100	F23		ZINC000011905654
3.5		0	272	P7119800052	113.7		AC4	False	0	17	0	0	14	0	2	3	0	1	-1.0	0.0						Nc1nc(-c2ccc(Oc3ccccc3)cc2)c(CC(=O)O)s1		3.81		0.0	3.31	CHEMBL1551251																	0.0		2-(2-amino-4-(4-phenoxyphenyl)thiazol-5-yl)acetic acid		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	1	0	1	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0		C17H14N2O3S	C17H14N2O3S			InChI=1S/C17H14N2O3S/c18-17-19-16(14(23-17)10-15(20)21)11-6-8-13(9-7-11)22-12-4-2-1-3-5-12/h1-9H,10H2,(H2,18,19)(H,20,21)	CEXYRFGDYHMRNN-UHFFFAOYSA-N	2-[2-amino-4-(4-phenoxyphenyl)thiazol-5-yl]acetic acid	16462823	Nc1nc(-c2ccc(Oc3ccccc3)cc2)c(CC(=O)O)s1	2-[2-amino-4-(4-phenoxyphenyl)-1,3-thiazol-5-yl]acetic acid			2.07154													MCULE-8374235845	326.37673	ACID	326.072513	5	2	5	3	0.0		29										False			False	False	Peptide01		-1.0	Compound(16462823)	16462823	3.3	1139			[#7]-[#6]1:[#7]:[#6](-[#6]2:[#6]:[#6]:[#6](-[#8]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#6]:[#6]:2):[#6](-[#6]-[#6](=[#8])-[#8]):[#16]:1	Nc1nc(-c2ccc(Oc3ccccc3)cc2)c(CC(=O)O)s1	CEXYRFGDYHMRNN		parent_pubchem_cid	2-(2-amino-4-(4-phenoxyphenyl)thiazol-5-yl)acetic acid;91234-20-7;MLS001215847;CHEMBL1551251;[2-amino-4-(4-phenoxyphenyl)-1,3-thiazol-5-yl]acetic acid;HMS2871N07;STK794586;AKOS002336107;SMR000544792;VU0610885-1;F3325-0074;2-[2-amino-4-(4-phenoxyphenyl)thiazol-5-yl]acetic acid	False	980996.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=980996		pluskal_iocb_peptide_Peptide01_F23_id		100	F23	False	ZINC000006673136
1.1		0	16	P11181192	102.0	HCl	AC5	False	0	23	0	0	23	0	1	5	0	0	-1.0	0.0						NC(C(=O)O)C(O)c1cc(OCc2ccccc2)c(OCc2ccccc2)cc1		3.29		0.0	1.03	CHEMBL4962819		Phenylpropanoic acids;Alpha amino acids;Phenoxy compounds;Phenol ethers;Alkyl aryl ethers;Aralkylamines;Beta hydroxy acids and derivatives;Secondary alcohols;Amino acids;Monocarboxylic acids and derivatives;Carboxylic acids;Carbonyl compounds;Aromatic alcohols;Hydrocarbon derivatives;Monoalkylamines;Organic oxides;Organopnictogen compounds	Alcohols and polyols;Alkyl aryl ethers;Alpha amino acids;Alpha amino acids and derivatives;Amines;Amino acids;Amino acids and derivatives;Amino acids, peptides, and analogues;Aralkylamines;Aromatic alcohols;Benzene and substituted derivatives;Benzenoids;Beta hydroxy acids and derivatives;Carbonyl compounds;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Ethers;Hydrocarbon derivatives;Hydroxy acids and derivatives;Monoalkylamines;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenol ethers;Phenoxy compounds;Phenylalanine and derivatives;Phenylpropanoic acids;Phenylpropanoids and polyketides;Primary amines;Secondary alcohols	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic homomonocyclic compounds	benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);alpha-amino acid (CHEBI:33704);aromatic ether (CHEBI:35618);aralkylamine (CHEBI:18000);3-hydroxy carboxylic acid (CHEBI:61355);secondary alcohol (CHEBI:35681);amino acid (CHEBI:33709);carbonyl compound (CHEBI:36586);carboxylic acid anion (CHEBI:29067);aromatic alcohol (CHEBI:33854);organic molecule (CHEBI:72695);alkylamine (CHEBI:13759);organic oxide (CHEBI:25701);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);peptide (CHEBI:16670);organonitrogen compound (CHEBI:35352);benzenoid aromatic compound (CHEBI:33836);oxygen molecular entity (CHEBI:25806);ether (CHEBI:25698);nitrogen molecular entity (CHEBI:51143);amine (CHEBI:32952);hydroxy carboxylic acid (CHEBI:24669);polyol (CHEBI:26191);organic hydroxy compound (CHEBI:33822);alcohol (CHEBI:30879);primary amine (CHEBI:32877)		Amino acids, peptides, and analogues	Phenylalanine or derivatives;3-phenylpropanoic-acid;Alpha-amino acid;Phenoxy compound;Phenol ether;Alkyl aryl ether;Beta-hydroxy acid;Aralkylamine;Monocyclic benzene moiety;Benzenoid;Hydroxy acid;Amino acid;Secondary alcohol;Carboxylic acid;Ether;Monocarboxylic acid or derivatives;Alcohol;Organonitrogen compound;Organooxygen compound;Primary aliphatic amine;Primary amine;Aromatic alcohol;Hydrocarbon derivative;Carbonyl group;Organic oxide;Organopnictogen compound;Amine;Organic oxygen compound;Organic nitrogen compound;Aromatic homomonocyclic compound	Organic acids and derivatives	0.0		Phenylserine, 3,4-dibenzyloxy-		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0		C23H24ClNO5	C23H23NO5			InChI=1S/C23H23NO5/c24-21(23(26)27)22(25)18-11-12-19(28-14-16-7-3-1-4-8-16)20(13-18)29-15-17-9-5-2-6-10-17/h1-13,21-22,25H,14-15,24H2,(H,26,27)	GZLRNTMXOXBIRR-UHFFFAOYSA-N	2-amino-3-(3,4-dibenzyloxyphenyl)-3-hydroxy-propanoic acid;hydrochloride	417380	NC(C(=O)O)C(O)c1cc(OCc2ccccc2)c(OCc2ccccc2)cc1	2-amino-3-[3,4-bis(phenylmethoxy)phenyl]-3-hydroxypropanoic acid			2.20095													MCULE-7401637061	429.90443	ZWITTERION	393.157623	6	3	9	3	1.0		28										False	Alkaloids		False	False	Peptide01		-1.0	Compound(417380)	417380	0.4	1140		SCHEMBL7281732	[#7]-[#6](-[#6](=[#8])-[#8])-[#6](-[#8])-[#6]1:[#6]:[#6](-[#8]-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6](-[#8]-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6]:[#6]:1	NC(C(=O)O)C(O)c1cc(OCc2ccccc2)c(OCc2ccccc2)cc1	GZLRNTMXOXBIRR		parent_pubchem_cid	"Phenylserine, 3,4-dibenzyloxy-;2-amino-3-[3,4-bis(phenylmethoxy)phenyl]-3-hydroxypropanoic acid;70561-66-9;70543-77-0;NSC90323;SCHEMBL7281732;CHEMBL4962819;DTXSID20990752;NSC17153;NSC-17153;NSC-90323;AKOS024323025;O-Benzyl-3-(benzyloxy)-beta-hydroxytyrosine;3,4-Bis(benzyloxy)-3-hydroxyphenylalanine #;ERYTHRO-3-(3,4-DIBENZYLOXYPHENYL)SERINE;""2-amino-3-(3,4-dibenzyloxyphenyl)-3-hydroxy-propanoic acid;hydrochloride"""	False	23290075.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23290075		pluskal_iocb_peptide_Peptide01_F23_id		100	F23	False	
3.4		0	104	P0110420239	91.4		AC6	False	0	19	1	0	17	0	2	4	0	0		0.0						O=C(COc1ccc(Cl)cc1)NC(Cc1c[nH]c2ccccc12)C(=O)O								Indolyl carboxylic acids and derivatives;3-alkylindoles;Phenoxy compounds;Phenol ethers;Alkyl aryl ethers;Chlorobenzenes;Substituted pyrroles;Aryl chlorides;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Monocarboxylic acids and derivatives;Carboxylic acids;Hydrocarbon derivatives;Carbonyl compounds;Organic oxides;Organochlorides;Organonitrogen compounds;Organopnictogen compounds	3-alkylindoles;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Aryl chlorides;Aryl halides;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Chlorobenzenes;Ethers;Halobenzenes;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Indolyl carboxylic acids and derivatives;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organochlorides;Organohalogen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenol ethers;Phenoxy compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom.	N-acyl-alpha amino acids		Amino acids and derivatives;Alpha amino acids and derivatives;N-acyl-alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	indolyl carboxylic acid (CHEBI:46867);indoles (CHEBI:24828);benzenes (CHEBI:22712);aromatic ether (CHEBI:35618);organochlorine compound (CHEBI:36683);pyrroles (CHEBI:26455);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organonitrogen heterocyclic compound (CHEBI:38101);carbonyl compound (CHEBI:36586);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);N-acyl-amino acid (CHEBI:51569);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);oxygen molecular entity (CHEBI:25806);organooxygen compound (CHEBI:36963);ether (CHEBI:25698);organohalogen compound (CHEBI:36684);haloarene (CHEBI:50887);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);amino acid (CHEBI:33709);peptide (CHEBI:16670)		Amino acids, peptides, and analogues	N-acyl-alpha-amino acid;Indolyl carboxylic acid derivative;3-alkylindole;Indole;Indole or derivatives;Phenoxy compound;Phenol ether;Alkyl aryl ether;Chlorobenzene;Halobenzene;Aryl chloride;Aryl halide;Monocyclic benzene moiety;Substituted pyrrole;Benzenoid;Pyrrole;Heteroaromatic compound;Secondary carboxylic acid amide;Carboxamide group;Organoheterocyclic compound;Azacycle;Monocarboxylic acid or derivatives;Carboxylic acid;Ether;Organic nitrogen compound;Organopnictogen compound;Organic oxide;Organic oxygen compound;Hydrocarbon derivative;Organohalogen compound;Carbonyl group;Organochloride;Organonitrogen compound;Organooxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		Cambridge id 5237317		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C19H17ClN2O4	C19H17ClN2O4			InChI=1S/C19H17ClN2O4/c20-13-5-7-14(8-6-13)26-11-18(23)22-17(19(24)25)9-12-10-21-16-4-2-1-3-15(12)16/h1-8,10,17,21H,9,11H2,(H,22,23)(H,24,25)	IHJCRKSCEDUIKG-UHFFFAOYSA-N	2-[[2-(4-chlorophenoxy)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid	2787070	O=C(COc1ccc(Cl)cc1)NC(Cc1c[nH]c2ccccc12)C(=O)O	2-[[2-(4-chlorophenoxy)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid			2.06666													MCULE-9442551280	372.81134		372.087685	4	3	7	3			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(2787070)	2787070	2.9	1141			[#8]=[#6](-[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#17]):[#6]:[#6]:1)-[#7]-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	O=C(COc1ccc(Cl)cc1)NC(Cc1c[nH]c2ccccc12)C(=O)O	IHJCRKSCEDUIKG		parent_pubchem_cid	Cambridge id 5237317;Oprea1_178533;Oprea1_525743;STK976110;AKOS000536286;AKOS016044840;N-[(4-chlorophenoxy)acetyl]tryptophan;AB00076253-01;2-[[2-(4-chlorophenoxy)acetyl]amino]-3-(1H-indol-3-yl)propanoic acid		23359132.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23359132		pluskal_iocb_peptide_Peptide01_F23_id		100	F23		
-0.3		0	192	P1098846	136.4		AC7	False	0	15	0	0	15	0	3	6	0	0		0.0						O=C(O)CCC(NC(=O)Cn1cnc2ccccc2c1=O)C(=O)O								N-acyl-L-alpha-amino acids;Quinazolines;Pyrimidones;Dicarboxylic acids and derivatives;Benzenoids;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactams;Carboxylic acids;Azacyclic compounds;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzenoids;Benzodiazines;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Diazanaphthalenes;Diazines;Dicarboxylic acids and derivatives;Glutamic acid and derivatives;Heteroaromatic compounds;Hydrocarbon derivatives;Lactams;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Pyrimidines and pyrimidine derivatives;Pyrimidones;Quinazolines;Secondary carboxylic acid amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as glutamic acid and derivatives. These are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Glutamic acid and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-L-alpha-amino acid (CHEBI:48927);quinazolines (CHEBI:38530);pyrimidone (CHEBI:38337);dicarboxylic acid (CHEBI:35692);benzenoid aromatic compound (CHEBI:33836);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactam (CHEBI:24995);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);organonitrogen heterocyclic compound (CHEBI:38101);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);glutamic acid derivative (CHEBI:24315);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);amino acid (CHEBI:33709);peptide (CHEBI:16670);N-acyl-amino acid (CHEBI:51569);organic heterocyclic compound (CHEBI:24532);azaarene (CHEBI:50893);diazines (CHEBI:38313);pyrimidines (CHEBI:39447);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806)	Dicarboxylic acids (FA0117)	Amino acids, peptides, and analogues	Glutamic acid or derivatives;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;N-acyl-l-alpha-amino acid;Diazanaphthalene;Quinazoline;Pyrimidone;Dicarboxylic acid or derivatives;Pyrimidine;Benzenoid;Heteroaromatic compound;Carboxamide group;Lactam;Secondary carboxylic acid amide;Carboxylic acid;Azacycle;Organoheterocyclic compound;Hydrocarbon derivative;Organic oxide;Organooxygen compound;Organonitrogen compound;Organopnictogen compound;Organic oxygen compound;Carbonyl group;Organic nitrogen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS016402341		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	2	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0		C15H15N3O6	C15H15N3O6			InChI=1S/C15H15N3O6/c19-12(17-11(15(23)24)5-6-13(20)21)7-18-8-16-10-4-2-1-3-9(10)14(18)22/h1-4,8,11H,5-7H2,(H,17,19)(H,20,21)(H,23,24)/t11-/m0/s1	UNUYMHYSQOXKRD-NSHDSACASA-N	rac-(2S)-2-[[2-(4-oxoquinazolin-3-yl)acetyl]amino]pentanedioic acid	1791384	O=C(O)CC[C@H](NC(=O)Cn1cnc2ccccc2c1=O)C(=O)O	(2S)-2-[[2-(4-oxoquinazolin-3-yl)acetyl]amino]pentanedioic acid			0.3021699999999997													MCULE-5159631553	333.3033		333.096085	7	3	7	2			44										False					Peptide01			Compound(1791384)	1791384	-0.3	1142			[#8]=[#6](-[#8])-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#7]1:[#6]:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8])-[#6](=[#8])-[#8]	O=C(O)CC[C@H](NC(=O)Cn1cnc2ccccc2c1=O)C(=O)O	UNUYMHYSQOXKRD		parent_pubchem_cid	AKOS016402341;(S)-2-(2-(4-oxoquinazolin-3(4H)-yl)acetamido)pentanedioic acid;2-[2-(4-OXO-3,4-DIHYDROQUINAZOLIN-3-YL)ACETAMIDO]PENTANEDIOIC ACID;rac-(2S)-2-[[2-(4-oxoquinazolin-3-yl)acetyl]amino]pentanedioic acid		23975176.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23975176		pluskal_iocb_peptide_Peptide01_F23_id		100	F23		ZINC000002136133
2.2		0	280	P7126263	124.4		AC8	False	0	18	0	0	14	0	4	4	0	0		0.0						O=C(O)c1ccc(Nc2nc(Nc3cccc(C(=O)O)c3)ncc2)cc1																							0.0		MFCD29050697		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	2	2	0	0	0	0	0	0	0	0	0	0	1	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0		C18H14N4O4	C18H14N4O4			InChI=1S/C18H14N4O4/c23-16(24)11-4-6-13(7-5-11)20-15-8-9-19-18(22-15)21-14-3-1-2-12(10-14)17(25)26/h1-10H,(H,23,24)(H,25,26)(H2,19,20,21,22)	ONNJKVQYOOKKLO-UHFFFAOYSA-N	3-[[4-(4-carboxyanilino)pyrimidin-2-yl]amino]benzoic acid	90489125	O=C(O)c1ccc(Nc2nc(Nc3cccc(C(=O)O)c3)ncc2)cc1	3-[[4-(4-carboxyanilino)pyrimidin-2-yl]amino]benzoic acid			1.72834													MCULE-6686939318	350.33668		350.101505	8	4	6	3			44										False	Alkaloids				Peptide01			Compound(90489125)	90489125	3.0	1143			[#8]=[#6](-[#8])-[#6]1:[#6]:[#6]:[#6](-[#7]-[#6]2:[#7]:[#6](-[#7]-[#6]3:[#6]:[#6]:[#6]:[#6](-[#6](=[#8])-[#8]):[#6]:3):[#7]:[#6]:[#6]:2):[#6]:[#6]:1	O=C(O)c1ccc(Nc2nc(Nc3cccc(C(=O)O)c3)ncc2)cc1	ONNJKVQYOOKKLO		parent_pubchem_cid	MFCD29050697;AKOS024459033;3-[[4-(4-carboxyanilino)pyrimidin-2-yl]amino]benzoic acid		99993846.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=99993846		pluskal_iocb_peptide_Peptide01_F23_id		100	F23		ZINC000170621814
2.1		0	24	P7119250018	121.0		AC9	False	0	20	0	0	16	0	2	5	0	1		0.0						O=C1Nc2c3c1cccc3c(S(=O)(=O)NC(Cc1ccccc1)C(=O)O)cc2																							0.0		AKOS002376815		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	1	0	0	1	0	0	0	0	0	0	0		C20H16N2O5S	C20H16N2O5S			InChI=1S/C20H16N2O5S/c23-19-14-8-4-7-13-17(10-9-15(21-19)18(13)14)28(26,27)22-16(20(24)25)11-12-5-2-1-3-6-12/h1-10,16,22H,11H2,(H,21,23)(H,24,25)	ZDIMOYGQEVMZHV-UHFFFAOYSA-N	2-[(2-oxo-1H-benzo[cd]indol-6-yl)sulfonylamino]-3-phenyl-propanoic acid	5183357	O=C1Nc2c3c1cccc3c(S(=O)(=O)NC(Cc1ccccc1)C(=O)O)cc2	2-[(2-oxo-1H-benzo[cd]indol-6-yl)sulfonylamino]-3-phenylpropanoic acid			1.3532399999999996													MCULE-3840234982	396.42492		396.077993	5	3	6	4			45										False	Alkaloids				Peptide01			Compound(5183357)	5183357	2.6	1144			[#8]=[#6]1-[#7]-[#6]2:[#6]3:[#6]-1:[#6]:[#6]:[#6]:[#6]:3:[#6](-[#16](=[#8])(=[#8])-[#7]-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]):[#6]:[#6]:2	O=C1Nc2c3c1cccc3c(S(=O)(=O)NC(Cc1ccccc1)C(=O)O)cc2	ZDIMOYGQEVMZHV		parent_pubchem_cid	AKOS002376815;2-[(2-oxo-1H-benzo[cd]indol-6-yl)sulfonylamino]-3-phenyl-propanoic acid		22925036.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22925036		pluskal_iocb_peptide_Peptide01_F24_id		100	F24		
3.0		0	112	P0127441036	95.5		AC10	False	0	21	0	0	16	0	2	4	0	0	-1.0	0.0						O=C(Nc1ccccc1)c1ccccc1NC(=O)c1ccccc1C(=O)O		3.89		0.0	3.81	CHEMBL1733315																	0.0		2-{[2-(anilinocarbonyl)anilino]carbonyl}benzoic acid		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C21H16N2O4	C21H16N2O4			InChI=1S/C21H16N2O4/c24-19(15-10-4-5-11-16(15)21(26)27)23-18-13-7-6-12-17(18)20(25)22-14-8-2-1-3-9-14/h1-13H,(H,22,25)(H,23,24)(H,26,27)	MVNHOZLXKLOTDT-UHFFFAOYSA-N	2-[[2-(phenylcarbamoyl)phenyl]carbamoyl]benzoic acid	1008649	O=C(Nc1ccccc1)c1ccccc1NC(=O)c1ccccc1C(=O)O	2-[[2-(phenylcarbamoyl)phenyl]carbamoyl]benzoic acid			2.964050000000001													MCULE-5623236718	360.37267	ACID	360.111007	4	3	5	3	0.0		27									Anthranillic acid derivatives	False	Alkaloids	Anthranilic acid alkaloids	False	False	Peptide01		-1.0	Compound(1008649)	1008649	4.4	1145		SCHEMBL328588	[#8]=[#6](-[#7]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#6](=[#8])-[#8]	O=C(Nc1ccccc1)c1ccccc1NC(=O)c1ccccc1C(=O)O	MVNHOZLXKLOTDT		parent_pubchem_cid	2-{[2-(anilinocarbonyl)anilino]carbonyl}benzoic acid;306324-94-7;2-((2-(Phenylcarbamoyl)phenyl)carbamoyl)benzoic acid;2-[[2-(phenylcarbamoyl)phenyl]carbamoyl]benzoic acid;2-{[2-(phenylcarbamoyl)phenyl]carbamoyl}benzoic acid;CDS1_004013;CBMicro_017517;Oprea1_549009;Oprea1_675014;MLS001178709;DivK1c_005053;SCHEMBL328588;CHEMBL1733315;BDBM223481;DTXSID301170326;HMS2805A20;CCG-6196;STK003244;AKOS000483615;SMR000477052;BIM-0017468.P001;CS-0364012;AB00080778-01;AN-329/10742058;SR-01000405841;US9320734, 439;SR-01000405841-1;2-[[[2-[(Phenylamino)carbonyl]phenyl]amino]carbonyl]benzoic acid	False	1007673.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=1007673		pluskal_iocb_peptide_Peptide01_F24_id		100	F24	False	ZINC000000668345
3.0		0	200	P7020490307	100.3		AC11	False	0	23	0	0	21	0	3	3	0	1		0.0						O=C(Cc1c[nH]c2ccccc12)NCC(c1cnccc1)S(=O)(=O)c1ccccc1																							0.0		AKOS016399656		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	1	0	0	0	0	0	0	0		C23H21N3O3S	C23H21N3O3S			InChI=1S/C23H21N3O3S/c27-23(13-18-15-25-21-11-5-4-10-20(18)21)26-16-22(17-7-6-12-24-14-17)30(28,29)19-8-2-1-3-9-19/h1-12,14-15,22,25H,13,16H2,(H,26,27)	AGONSXWQZSAENM-UHFFFAOYSA-N	N-[2-(benzenesulfonyl)-2-(3-pyridyl)ethyl]-2-(1H-indol-3-yl)acetamide	22694782	O=C(Cc1c[nH]c2ccccc12)NCC(c1cnccc1)S(=O)(=O)c1ccccc1	N-[2-(benzenesulfonyl)-2-pyridin-3-ylethyl]-2-(1H-indol-3-yl)acetamide			2.7909500000000014													MCULE-9826054392	419.50612		419.130363	4	2	7	4			45									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(22694782)	22694782	2.7	1146			[#8]=[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#6]-[#6](-[#6]1:[#6]:[#7]:[#6]:[#6]:[#6]:1)-[#16](=[#8])(=[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	O=C(Cc1c[nH]c2ccccc12)NCC(c1cnccc1)S(=O)(=O)c1ccccc1	AGONSXWQZSAENM		parent_pubchem_cid	AKOS016399656;N-[2-(benzenesulfonyl)-2-(3-pyridyl)ethyl]-2-(1H-indol-3-yl)acetamide		24494672.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24494672		pluskal_iocb_peptide_Peptide01_F24_id		100	F24		
1.2		0	288	P7126273	87.6		AC12	False	0	16	0	0	18	0	4	3	0	0		0.0						Cc1cc(Nc2ccccc2C(=O)O)nc(N2CCOCC2)n1																							0.0		SCHEMBL5310211		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1		C16H18N4O3	C16H18N4O3			InChI=1S/C16H18N4O3/c1-11-10-14(18-13-5-3-2-4-12(13)15(21)22)19-16(17-11)20-6-8-23-9-7-20/h2-5,10H,6-9H2,1H3,(H,21,22)(H,17,18,19)	XDHVAAXRDPUYIN-UHFFFAOYSA-N	2-[(6-methyl-2-morpholino-pyrimidin-4-yl)amino]benzoic acid	16660258	Cc1cc(Nc2ccccc2C(=O)O)nc(N2CCOCC2)n1	2-[(6-methyl-2-morpholin-4-ylpyrimidin-4-yl)amino]benzoic acid			0.8121699999999998													MCULE-1467381633	314.34686		314.13789	7	2	4	3			43									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(16660258)	16660258	2.6	1147		SCHEMBL5310211	[#6]-[#6]1:[#6]:[#6](-[#7]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6](=[#8])-[#8]):[#7]:[#6](-[#7]2-[#6]-[#6]-[#8]-[#6]-[#6]-2):[#7]:1	Cc1cc(Nc2ccccc2C(=O)O)nc(N2CCOCC2)n1	XDHVAAXRDPUYIN		parent_pubchem_cid	SCHEMBL5310211;AKOS000284134;2-[(6-methyl-2-morpholino-pyrimidin-4-yl)amino]benzoic acid		24063422.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24063422		pluskal_iocb_peptide_Peptide01_F24_id		100	F24		ZINC000008702983
1.3		0	32	P1094941	76.7		AC13	False	0	15	0	0	22	0	2	4	0	0		0.0						CCOCCNC(=O)NC(Cc1ccccc1)C(=O)OC																							0.0		AKOS016382594		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C15H22N2O4	C15H22N2O4			InChI=1S/C15H22N2O4/c1-3-21-10-9-16-15(19)17-13(14(18)20-2)11-12-7-5-4-6-8-12/h4-8,13H,3,9-11H2,1-2H3,(H2,16,17,19)/t13-/m0/s1	ANHAVEDRZMNSKO-ZDUSSCGKSA-N	methyl rac-(2S)-2-(2-ethoxyethylcarbamoylamino)-3-phenyl-propanoate	24279682	CCOCCNC(=O)N[C@@H](Cc1ccccc1)C(=O)OC	methyl (2S)-2-(2-ethoxyethylcarbamoylamino)-3-phenylpropanoate			1.0516899999999991													MCULE-3381503911	294.35359		294.157957	4	2	9	1			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(24279682)	24279682	1.0	1148			[#6]-[#6]-[#8]-[#6]-[#6]-[#7]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]-[#6]	CCOCCNC(=O)N[C@@H](Cc1ccccc1)C(=O)OC	ANHAVEDRZMNSKO		parent_pubchem_cid	AKOS016382594;methyl rac-(2S)-2-(2-ethoxyethylcarbamoylamino)-3-phenyl-propanoate		4788830.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=4788830		pluskal_iocb_peptide_Peptide01_F24_id		100	F24		ZINC000011692311
3.1		0	120	P0149760036	127.7		AC14	False	0	20	0	0	20	0	8	0	0	0	-1.0	0.0						Cc1ccc(Nc2c(Nc3ccc(C)cc3)nc3c(N)nnc(N)c3n2)cc1		3.69		0.0	3.73	CHEMBL579968																	0.0		GNF-Pf-285		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	0	0	0	0		C20H20N8	C20H20N8			InChI=1S/C20H20N8/c1-11-3-7-13(8-4-11)23-19-20(24-14-9-5-12(2)6-10-14)26-16-15(25-19)17(21)27-28-18(16)22/h3-10H,1-2H3,(H2,21,27)(H2,22,28)(H,23,25)(H,24,26)	PHRRSLBTVPEKNL-UHFFFAOYSA-N	N2,N3-bis(p-tolyl)pyrazino[2,3-d]pyridazine-2,3,5,8-tetramine	1185324	Cc1ccc(Nc2c(Nc3ccc(C)cc3)nc3c(N)nnc(N)c3n2)cc1	2-N,3-N-bis(4-methylphenyl)pyrazino[2,3-d]pyridazine-2,3,5,8-tetramine			0.8667400000000001													MCULE-6816660020	372.436	NEUTRAL	372.181093	8	4	4	4	0.0		29										False			False	False	Peptide01		-1.0	Compound(1185324)	1185324	2.9	1149			[#6]-[#6]1:[#6]:[#6]:[#6](-[#7]-[#6]2:[#6](-[#7]-[#6]3:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:3):[#7]:[#6]3:[#6](-[#7]):[#7]:[#7]:[#6](-[#7]):[#6]:3:[#7]:2):[#6]:[#6]:1	Cc1ccc(Nc2c(Nc3ccc(C)cc3)nc3c(N)nnc(N)c3n2)cc1	PHRRSLBTVPEKNL		parent_pubchem_cid	GNF-Pf-285;ZINC00946368;Oprea1_053332;CHEMBL579968;DNDI1417733;MFCD02073999;AKOS002347621;SR-01000434608;SR-01000434608-1;N2,N3-bis(p-tolyl)pyrazino[2,3-d]pyridazine-2,3,5,8-tetramine	False	291089.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=291089		pluskal_iocb_peptide_Peptide01_F24_id		100	F24	False	ZINC000000946368
1.5		0	208	P1164646	146.4		AC15	False	0	17	0	0	16	0	4	3	0	1		0.0						Cc1nc(NC(CC(N)=O)C(=O)O)c2cc(-c3ccccc3)sc2n1																							0.0		AKOS016389131		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C17H16N4O3S	C17H16N4O3S			InChI=1S/C17H16N4O3S/c1-9-19-15(21-12(17(23)24)8-14(18)22)11-7-13(25-16(11)20-9)10-5-3-2-4-6-10/h2-7,12H,8H2,1H3,(H2,18,22)(H,23,24)(H,19,20,21)	LKHJTXLHPYVCJJ-UHFFFAOYSA-N	4-amino-2-[(2-methyl-6-phenyl-thieno[2,3-d]pyrimidin-4-yl)amino]-4-oxo-butanoic acid	52984203	Cc1nc(NC(CC(N)=O)C(=O)O)c2cc(-c3ccccc3)sc2n1	4-amino-2-[(2-methyl-6-phenylthieno[2,3-d]pyrimidin-4-yl)amino]-4-oxobutanoic acid			1.1634600000000002													MCULE-7777826897	356.40607		356.094311	6	3	6	3			45										False	Alkaloids				Peptide01			Compound(52984203)	52984203	3.0	1150			[#6]-[#6]1:[#7]:[#6](-[#7]-[#6](-[#6]-[#6](-[#7])=[#8])-[#6](=[#8])-[#8]):[#6]2:[#6]:[#6](-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#16]:[#6]:2:[#7]:1	Cc1nc(NC(CC(N)=O)C(=O)O)c2cc(-c3ccccc3)sc2n1	LKHJTXLHPYVCJJ		parent_pubchem_cid	AKOS016389131;4-amino-2-[(2-methyl-6-phenyl-thieno[2,3-d]pyrimidin-4-yl)amino]-4-oxo-butanoic acid		24114611.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24114611		pluskal_iocb_peptide_Peptide01_F24_id		100	F24		
2.2		0	296	P7126256	124.4		AC16	False	0	18	0	0	14	0	4	4	0	0	-1.0	0.0						O=C(O)c1cc(Nc2nc(Nc3cccc(C(=O)O)c3)ncc2)ccc1		3.36		0.0	2.49	CHEMBL1502891																	0.0		MLS001213333		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	2	2	0	0	0	0	0	0	0	0	0	0	1	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0		C18H14N4O4	C18H14N4O4			InChI=1S/C18H14N4O4/c23-16(24)11-3-1-5-13(9-11)20-15-7-8-19-18(22-15)21-14-6-2-4-12(10-14)17(25)26/h1-10H,(H,23,24)(H,25,26)(H2,19,20,21,22)	UPWHTJMFMSLAHH-UHFFFAOYSA-N	3-[[2-(3-carboxyanilino)pyrimidin-4-yl]amino]benzoic acid	1383261	O=C(O)c1cc(Nc2nc(Nc3cccc(C(=O)O)c3)ncc2)ccc1	3-[[2-(3-carboxyanilino)pyrimidin-4-yl]amino]benzoic acid			1.7283399999999998													MCULE-8260578353	350.33668	ACID	350.101505	8	4	6	3	0.0		27										False	Alkaloids		False	False	Peptide01	PD105408	-1.0	Compound(1383261)	1383261	3.0	1151			[#8]=[#6](-[#8])-[#6]1:[#6]:[#6](-[#7]-[#6]2:[#7]:[#6](-[#7]-[#6]3:[#6]:[#6]:[#6]:[#6](-[#6](=[#8])-[#8]):[#6]:3):[#7]:[#6]:[#6]:2):[#6]:[#6]:[#6]:1	O=C(O)c1cc(Nc2nc(Nc3cccc(C(=O)O)c3)ncc2)ccc1	UPWHTJMFMSLAHH		parent_pubchem_cid	MLS001213333;SMR000542816;Oprea1_752851;CHEMBL1502891;BDBM64116;cid_1383261;3-[[2-(3-carboxyanilino)pyrimidin-4-yl]amino]benzoic acid;HMS2850O19;3-[[2-[(3-carboxyphenyl)amino]pyrimidin-4-yl]amino]benzoic Acid;MFCD01551654;STK569980;AKOS005495412;AKOS024459026;WAY-601448;2,4-di-(m-carboxyphenylamino)pyrimidine;3-[[2-(3-carboxyanilino)-4-pyrimidinyl]amino]benzoic acid;3-{[(2Z)-6-[(3-carboxyphenyl)amino]pyrimidin-2(1H)-ylidene]amino}benzoic acid	False	905370.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=905370		pluskal_iocb_peptide_Peptide01_F24_id		100	F24	False	ZINC000009245306
2.6		0	40	P7020531703	112.9		AC17	False	0	20	0	0	22	0	2	4	0	2		0.0						O=S1(=O)CC(NCCc2c[nH]c3ccccc23)C(S(=O)(=O)c2ccccc2)C1																							0.0		HMS3463N06		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	0		C20H22N2O4S2	C20H22N2O4S2			InChI=1S/C20H22N2O4S2/c23-27(24)13-19(20(14-27)28(25,26)16-6-2-1-3-7-16)21-11-10-15-12-22-18-9-5-4-8-17(15)18/h1-9,12,19-22H,10-11,13-14H2/t19-,20-/m0/s1	VSRPMKJRWLLFOQ-PMACEKPBSA-N	rac-(3S,4R)-4-(benzenesulfonyl)-N-[2-(1H-indol-3-yl)ethyl]-1,1-dioxo-thiolan-3-amine	20996478	O=S1(=O)C[C@H](NCCc2c[nH]c3ccccc23)[C@@H](S(=O)(=O)c2ccccc2)C1	(3S,4R)-4-(benzenesulfonyl)-N-[2-(1H-indol-3-yl)ethyl]-1,1-dioxothiolan-3-amine			1.3483599999999998													MCULE-3362805417	418.53734		418.102099	5	2	6	4			44										False	Alkaloids				Peptide01			Compound(20996478)	20996478	2.6	1152			[#8]=[#16]1(=[#8])-[#6]-[#6@H](-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6@@H](-[#16](=[#8])(=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]-1	O=S1(=O)C[C@H](NCCc2c[nH]c3ccccc23)[C@@H](S(=O)(=O)c2ccccc2)C1	VSRPMKJRWLLFOQ		parent_pubchem_cid	HMS3463N06;AKOS004926385;CCG-156715;(3R4S)-3-(BENZENESULFONYL)-4-{[2-(1H-INDOL-3-YL)ETHYL]AMINO}-1LAMBDA6-THIOLANE-11-DIONE;rac-(3S,4R)-4-(benzenesulfonyl)-N-[2-(1H-indol-3-yl)ethyl]-1,1-dioxo-thiolan-3-amine		15979689.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=15979689		pluskal_iocb_peptide_Peptide01_G1_id		100	G1		ZINC000019796922
0.2		0	128	P7210430710	146.3		AC18	False	0	13	0	0	18	0	2	5	0	2		0.0						CSCCC(NS(=O)(=O)c1ccc(NC(C)=O)cc1)C(=O)O																							0.0		MFCD09749759		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	1	0	0	0	0	0	0	0		C13H18N2O5S2	C13H18N2O5S2			InChI=1S/C13H18N2O5S2/c1-9(16)14-10-3-5-11(6-4-10)22(19,20)15-12(13(17)18)7-8-21-2/h3-6,12,15H,7-8H2,1-2H3,(H,14,16)(H,17,18)/t12-/m0/s1	RJJGSJXGOJEVFB-LBPRGKRZSA-N	rac-(2S)-2-[(4-acetamidophenyl)sulfonylamino]-4-methylsulfanyl-butanoic acid	1583761	CSCC[C@H](NS(=O)(=O)c1ccc(NC(C)=O)cc1)C(=O)O	(2S)-2-[(4-acetamidophenyl)sulfonylamino]-4-methylsulfanylbutanoic acid			0.6409799999999997													MCULE-8984421787	346.42681		346.065714	6	3	8	1			44									Aminoacids;Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(1583761)	1583761	0.7	1153			[#6]-[#16]-[#6]-[#6]-[#6@H](-[#7]-[#16](=[#8])(=[#8])-[#6]1:[#6]:[#6]:[#6](-[#7]-[#6](-[#6])=[#8]):[#6]:[#6]:1)-[#6](=[#8])-[#8]	CSCC[C@H](NS(=O)(=O)c1ccc(NC(C)=O)cc1)C(=O)O	RJJGSJXGOJEVFB		parent_pubchem_cid	MFCD09749759;AKOS002377750;(2S)-2-({[4-(ACETYLAMINO)PHENYL]SULFONYL}AMINO)-4-(METHYLSULFANYL)BUTANOIC ACID;rac-(2S)-2-[(4-acetamidophenyl)sulfonylamino]-4-methylsulfanyl-butanoic acid		23568475.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23568475		pluskal_iocb_peptide_Peptide01_G1_id		100	G1		ZINC000001797611
4.6		0	216	P1098278	117.7		AC19	False	0	26	0	0	26	0	2	6	0	0		0.0						CCCCc1cc(=O)oc2c1ccc(OCC(=O)NC(Cc1c[nH]c3ccccc13)C(=O)O)c2																							0.0		EiM07-16956		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C26H26N2O6	C26H26N2O6			InChI=1S/C26H26N2O6/c1-2-3-6-16-12-25(30)34-23-13-18(9-10-20(16)23)33-15-24(29)28-22(26(31)32)11-17-14-27-21-8-5-4-7-19(17)21/h4-5,7-10,12-14,22,27H,2-3,6,11,15H2,1H3,(H,28,29)(H,31,32)/t22-/m0/s1	XHKLMINRCMVECU-QFIPXVFZSA-N	rac-(2S)-2-[[2-(4-butyl-2-oxo-chromen-7-yl)oxyacetyl]amino]-3-(1H-indol-3-yl)propanoic acid	1792375	CCCCc1cc(=O)oc2c1ccc(OCC(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)O)c2	(2S)-2-[[2-(4-butyl-2-oxochromen-7-yl)oxyacetyl]amino]-3-(1H-indol-3-yl)propanoic acid			3.279020000000001													MCULE-5563487309	462.50692		462.179087	6	3	10	4			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(1792375)	1792375	4.4	1154			[#6]-[#6]-[#6]-[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:1:3)-[#6](=[#8])-[#8]):[#6]:2	CCCCc1cc(=O)oc2c1ccc(OCC(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)O)c2	XHKLMINRCMVECU		parent_pubchem_cid	EiM07-16956;AKOS016379675;2-{2-[(4-BUTYL-2-OXO-2H-CHROMEN-7-YL)OXY]ACETAMIDO}-3-(1H-INDOL-3-YL)PROPANOIC ACID;rac-(2S)-2-[[2-(4-butyl-2-oxo-chromen-7-yl)oxyacetyl]amino]-3-(1H-indol-3-yl)propanoic acid		24455471.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24455471		pluskal_iocb_peptide_Peptide01_G1_id		100	G1		ZINC000002136945
2.3		0	304	P7126238	107.4		AC20	False	0	17	0	0	14	0	4	3	0	0	-1.0	0.0						O=C(O)c1ccccc1Nc1nc(Nc2cc(O)ccc2)ncc1		3.37		0.0	3.39	CHEMBL243088																	0.0		4-anilinopyrimidine 8c		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0		C17H14N4O3	C17H14N4O3			InChI=1S/C17H14N4O3/c22-12-5-3-4-11(10-12)19-17-18-9-8-15(21-17)20-14-7-2-1-6-13(14)16(23)24/h1-10,22H,(H,23,24)(H2,18,19,20,21)	LYNBNVBMAGDJRW-UHFFFAOYSA-N	2-[[2-(3-hydroxyanilino)pyrimidin-4-yl]amino]benzoic acid	23647251	O=C(O)c1ccccc1Nc1nc(Nc2cc(O)ccc2)ncc1	2-[[2-(3-hydroxyanilino)pyrimidin-4-yl]amino]benzoic acid			1.3280399999999997														322.32613	ACID	322.10659	7	4	5	3	0.0		29									Anthranillic acid derivatives	False	Alkaloids	Anthranilic acid alkaloids	False	False	Peptide01	PD121566	-1.0	Compound(23647251)	23647251	4.0	1155			[#8]=[#6](-[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#7]-[#6]1:[#7]:[#6](-[#7]-[#6]2:[#6]:[#6](-[#8]):[#6]:[#6]:[#6]:2):[#7]:[#6]:[#6]:1	O=C(O)c1ccccc1Nc1nc(Nc2cc(O)ccc2)ncc1	LYNBNVBMAGDJRW		parent_pubchem_cid	4-anilinopyrimidine 8c;Kinome_1200;CHEMBL243088;BDBM15993;AKOS025142286;PD121566;2-({2-[(3-hydroxyphenyl)amino]pyrimidin-4-yl}amino)benzoic acid;2-[[2-(3-hydroxyanilino)pyrimidin-4-yl]amino]benzoic acid	False	410196.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=410196		pluskal_iocb_peptide_Peptide01_G1_id		100	G1	False	ZINC000014960274
4.7		0	48	P7020533702	73.6		AC21	False	0	24	0	0	20	0	4	1	0	0		0.0						O=C(NC(Cc1c[nH]c2ccccc12)c1nc2ccccc2[nH]1)c1ccccc1																							0.0		AKOS002287947		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	0	0	0	0	0	0	0		C24H20N4O	C24H20N4O			InChI=1S/C24H20N4O/c29-24(16-8-2-1-3-9-16)28-22(23-26-20-12-6-7-13-21(20)27-23)14-17-15-25-19-11-5-4-10-18(17)19/h1-13,15,22,25H,14H2,(H,26,27)(H,28,29)	UQNMBQAEJAYXSC-UHFFFAOYSA-N	N-[1-(1H-benzimidazol-2-yl)-2-(1H-indol-3-yl)ethyl]benzamide	3582836	O=C(NC(Cc1c[nH]c2ccccc12)c1nc2ccccc2[nH]1)c1ccccc1	N-[1-(1H-benzimidazol-2-yl)-2-(1H-indol-3-yl)ethyl]benzamide			3.7370300000000025													MCULE-1550402350	380.4532		380.163711	2	3	5	5			45										False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(3582836)	3582836	4.4	1156			[#8]=[#6](-[#7]-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6]1:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#7H]:1)-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	O=C(NC(Cc1c[nH]c2ccccc12)c1nc2ccccc2[nH]1)c1ccccc1	UQNMBQAEJAYXSC		parent_pubchem_cid	AKOS002287947;AKOS016309139;CCG-157389;NCGC00675840-01;Z56858050;N-[1-(1H-benzimidazol-2-yl)-2-(1H-indol-3-yl)ethyl]benzamide		24510709.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24510709		pluskal_iocb_peptide_Peptide01_G1_id		100	G1		
3.7		0	136	P0120630233	80.4		AC22	False	1	20	0	0	19	0	2	4	0	0		0.0						COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)COc1ccc(Br)cc1																							0.0		STK369634		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C20H19BrN2O4	C20H19BrN2O4			InChI=1S/C20H19BrN2O4/c1-26-20(25)18(10-13-11-22-17-5-3-2-4-16(13)17)23-19(24)12-27-15-8-6-14(21)7-9-15/h2-9,11,18,22H,10,12H2,1H3,(H,23,24)	JQLOSNMXZRONBE-UHFFFAOYSA-N	methyl 2-[[2-(4-bromophenoxy)acetyl]amino]-3-(1H-indol-3-yl)propanoate	3824569	COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)COc1ccc(Br)cc1	methyl 2-[[2-(4-bromophenoxy)acetyl]amino]-3-(1H-indol-3-yl)propanoate			2.2641600000000004													MCULE-2810780931	431.28943		430.052819	4	2	8	3			45									Dipeptides	False	Amino acids and Peptides;Shikimates and Phenylpropanoids	Small peptides			Peptide01			Compound(3824569)	3824569	3.8	1157			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#6](=[#8])-[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#35]):[#6]:[#6]:1	COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)COc1ccc(Br)cc1	JQLOSNMXZRONBE		parent_pubchem_cid	STK369634;AKOS002346775;AKOS016194049;methyl N-[(4-bromophenoxy)acetyl]tryptophanate;methyl 2-[[2-(4-bromophenoxy)acetyl]amino]-3-(1H-indol-3-yl)propanoate		24183857.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24183857		pluskal_iocb_peptide_Peptide01_G1_id		100	G1		
1.8		0	224	P1098845	114.9		AC23	False	0	21	0	0	18	0	4	4	0	0		0.0						O=C(Cn1cnc2ccccc2c1=O)NC(Cc1c[nH]c2ccccc12)C(=O)O																							0.0		STL461210		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C21H18N4O4	C21H18N4O4			InChI=1S/C21H18N4O4/c26-19(11-25-12-23-17-8-4-2-6-15(17)20(25)27)24-18(21(28)29)9-13-10-22-16-7-3-1-5-14(13)16/h1-8,10,12,18,22H,9,11H2,(H,24,26)(H,28,29)/t18-/m0/s1	DXRKQKIQLKQUJK-SFHVURJKSA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[[2-(4-oxoquinazolin-3-yl)acetyl]amino]propanoic acid	1785176	O=C(Cn1cnc2ccccc2c1=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	(2S)-3-(1H-indol-3-yl)-2-[[2-(4-oxoquinazolin-3-yl)acetyl]amino]propanoic acid			1.6782400000000002													MCULE-3392762578	390.40201		390.132805	5	3	6	4			44									Quinazoline alkaloids	False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(1785176)	1785176	1.9	1158			[#8]=[#6](-[#6]-[#7]1:[#6]:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	O=C(Cn1cnc2ccccc2c1=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	DXRKQKIQLKQUJK		parent_pubchem_cid	STL461210;AKOS016402463;N-[(4-oxoquinazolin-3(4H)-yl)acetyl]-L-tryptophan;(S)-3-(1H-indol-3-yl)-2-(2-(4-oxoquinazolin-3(4H)-yl)acetamido)propanoic acid;3-(1H-INDOL-3-YL)-2-[2-(4-OXO-3,4-DIHYDROQUINAZOLIN-3-YL)ACETAMIDO]PROPANOIC ACID;rac-(2S)-3-(1H-indol-3-yl)-2-[[2-(4-oxoquinazolin-3-yl)acetyl]amino]propanoic acid		23731198.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23731198		pluskal_iocb_peptide_Peptide01_G1_id		100	G1		ZINC000002130102
3.5		0	312	P1581145	74.8	HCl	AC24	False	0	13	2	0	16	0	6	0	0	0		0.0						CCNc1nc(NCC)nc(Nc2cc(Cl)c(Cl)cc2)n1																							0.0		STL483559		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0		C13H17Cl3N6	C13H16Cl2N6			InChI=1S/C13H16Cl2N6/c1-3-16-11-19-12(17-4-2)21-13(20-11)18-8-5-6-9(14)10(15)7-8/h5-7H,3-4H2,1-2H3,(H3,16,17,18,19,20,21)	MDWFGAOBVVGHSE-UHFFFAOYSA-N	N2-(3,4-dichlorophenyl)-N4,N6-diethyl-1,3,5-triazine-2,4,6-triamine;hydrochloride	7589383	CCNc1nc(NCC)nc(Nc2cc(Cl)c(Cl)cc2)n1	2-N-(3,4-dichlorophenyl)-4-N,6-N-diethyl-1,3,5-triazine-2,4,6-triamine			2.26316													MCULE-5873885216	363.67964		326.08135	6	3	6	2			43										False	Alkaloids				Peptide01			Compound(7589383)	7589383	4.5	1159			[#6]-[#6]-[#7]-[#6]1:[#7]:[#6](-[#7]-[#6]-[#6]):[#7]:[#6](-[#7]-[#6]2:[#6]:[#6](-[#17]):[#6](-[#17]):[#6]:[#6]:2):[#7]:1	CCNc1nc(NCC)nc(Nc2cc(Cl)c(Cl)cc2)n1	MDWFGAOBVVGHSE		parent_pubchem_cid	"STL483559;N~2~-(3,4-dichlorophenyl)-N~4~,N~6~-diethyl-1,3,5-triazine-2,4,6-triamine;""N2-(3,4-dichlorophenyl)-N4,N6-diethyl-1,3,5-triazine-2,4,6-triamine;hydrochloride"""		5614574.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=5614574		pluskal_iocb_peptide_Peptide01_G1_id		100	G1		ZINC000005255906
4.0		0	56	P7212570213	77.0		AC25	False	0	20	0	0	25	0	1	5	0	0		0.0						COc1cc(C(=O)Nc2c(C(C)C)cc(O)c(C)c2)cc(OC)c1OC																							0.0		Oprea1_270440		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C20H25NO5	C20H25NO5			InChI=1S/C20H25NO5/c1-11(2)14-10-16(22)12(3)7-15(14)21-20(23)13-8-17(24-4)19(26-6)18(9-13)25-5/h7-11,22H,1-6H3,(H,21,23)	PYNGKZOIYQCOIM-UHFFFAOYSA-N	N-(4-hydroxy-2-isopropyl-5-methyl-phenyl)-3,4,5-trimethoxy-benzamide	1188984	COc1cc(C(=O)Nc2c(C(C)C)cc(O)c(C)c2)cc(OC)c1OC	N-(4-hydroxy-5-methyl-2-propan-2-ylphenyl)-3,4,5-trimethoxybenzamide			1.7077399999999996													MCULE-3466595823	359.42595		359.173273	5	2	6	2			44										False	Alkaloids;Terpenoids				Peptide01			Compound(1188984)	1188984	3.8	1160			[#6]-[#8]-[#6]1:[#6]:[#6](-[#6](=[#8])-[#7]-[#6]2:[#6](-[#6](-[#6])-[#6]):[#6]:[#6](-[#8]):[#6](-[#6]):[#6]:2):[#6]:[#6](-[#8]-[#6]):[#6]:1-[#8]-[#6]	COc1cc(C(=O)Nc2c(C(C)C)cc(O)c(C)c2)cc(OC)c1OC	PYNGKZOIYQCOIM		parent_pubchem_cid	Oprea1_270440;Oprea1_276315;AKOS002272021;N-(4-hydroxy-2-isopropyl-5-methyl-phenyl)-3,4,5-trimethoxy-benzamide		10401920.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=10401920		pluskal_iocb_peptide_Peptide01_G2_id		100	G2		ZINC000000951363
2.4		0	144	P0124050161	83.1		AC26	False	0	17	0	0	25	0	1	6	0	0	-1.0	0.0						COC(=O)C(CC(C)C)NC(=O)c1cc(OC)c(OC)c(OC)c1		2.03		0.0	2.02	CHEMBL1362741																	0.0		MLS000105110		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C17H25NO6	C17H25NO6			InChI=1S/C17H25NO6/c1-10(2)7-12(17(20)24-6)18-16(19)11-8-13(21-3)15(23-5)14(9-11)22-4/h8-10,12H,7H2,1-6H3,(H,18,19)	UJQHKVFHTXFWLE-UHFFFAOYSA-N	methyl 4-methyl-2-[(3,4,5-trimethoxybenzoyl)amino]pentanoate	2787707	COC(=O)C(CC(C)C)NC(=O)c1cc(OC)c(OC)c(OC)c1	methyl 4-methyl-2-[(3,4,5-trimethoxybenzoyl)amino]pentanoate			0.5879600000000016													MCULE-1411640460	339.3919	NEUTRAL	339.168188	6	1	9	1	0.0		30										False	Alkaloids		False	False	Peptide01		-1.0	Compound(2787707)	2787707	2.8	1161			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6](-[#8]-[#6]):[#6](-[#8]-[#6]):[#6](-[#8]-[#6]):[#6]:1	COC(=O)C(CC(C)C)NC(=O)c1cc(OC)c(OC)c(OC)c1	UJQHKVFHTXFWLE		parent_pubchem_cid	MLS000105110;Oprea1_457120;CBDivE_012721;CHEMBL1362741;HMS2373P12;AKOS001595311;AKOS016311822;SMR000055039;methyl N-(3,4,5-trimethoxybenzoyl)leucinate;SR-01000405500;SR-01000405500-1;methyl 4-methyl-2-[(3,4,5-trimethoxybenzoyl)amino]pentanoate	False	859476.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=859476		pluskal_iocb_peptide_Peptide01_G2_id		100	G2	False	
1.8		0	232	P1094943	108.4		AC27	False	0	23	0	0	25	0	3	6	0	0		0.0						O=C(O)C(Cc1ccccc1)NC(=O)N1CCN(C(=O)C2COc3ccccc3O2)CC1																							0.0		AKOS005533574		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0		C23H25N3O6	C23H25N3O6			InChI=1S/C23H25N3O6/c27-21(20-15-31-18-8-4-5-9-19(18)32-20)25-10-12-26(13-11-25)23(30)24-17(22(28)29)14-16-6-2-1-3-7-16/h1-9,17,20H,10-15H2,(H,24,30)(H,28,29)/t17-,20?/m0/s1	HLIVWBCNWLFFAL-DIMJTDRSSA-N	rac-(2S)-2-[[4-(2,3-dihydro-1,4-benzodioxine-3-carbonyl)piperazine-1-carbonyl]amino]-3-phenyl-propanoic acid	17580740	O=C(O)[C@H](Cc1ccccc1)NC(=O)N1CCN(C(=O)C2COc3ccccc3O2)CC1	(2S)-2-[[4-(2,3-dihydro-1,4-benzodioxine-3-carbonyl)piperazine-1-carbonyl]amino]-3-phenylpropanoic acid			0.3965700000000018													MCULE-8371816667	439.4722		439.174336	6	2	5	4			45										False					Peptide01			Compound(17580740)	17580740	1.9	1162			[#8]=[#6](-[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#7]1-[#6]-[#6]-[#7](-[#6](=[#8])-[#6]2-[#6]-[#8]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3-[#8]-2)-[#6]-[#6]-1	O=C(O)[C@H](Cc1ccccc1)NC(=O)N1CCN(C(=O)C2COc3ccccc3O2)CC1	HLIVWBCNWLFFAL		parent_pubchem_cid	AKOS005533574;rac-(2S)-2-[[4-(2,3-dihydro-1,4-benzodioxine-3-carbonyl)piperazine-1-carbonyl]amino]-3-phenyl-propanoic acid		24198861.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24198861		pluskal_iocb_peptide_Peptide01_G2_id		100	G2		
4.4		0	320	P7119250339	109.1		AC28	False	0	26	0	0	26	0	2	4	0	2	-1.0	0.0						O=S(=O)(NCCc1ccccc1)c1c2cccc(S(=O)(=O)NCCc3ccccc3)c2ccc1		3.88		0.0	4.65	CHEMBL1771119																	0.0		CHEMBL1771119		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	0		C26H26N2O4S2	C26H26N2O4S2			InChI=1S/C26H26N2O4S2/c29-33(30,27-19-17-21-9-3-1-4-10-21)25-15-7-14-24-23(25)13-8-16-26(24)34(31,32)28-20-18-22-11-5-2-6-12-22/h1-16,27-28H,17-20H2	XMOBEPYUZXQYKK-UHFFFAOYSA-N	N1,N5-bis(2-phenylethyl)naphthalene-1,5-disulfonamide	2982028	O=S(=O)(NCCc1ccccc1)c1c2cccc(S(=O)(=O)NCCc3ccccc3)c2ccc1	1-N,5-N-bis(2-phenylethyl)naphthalene-1,5-disulfonamide			3.127940000000001													MCULE-1994886867	494.63612	NEUTRAL	494.133399	4	2	10	4	0.0		28										False	Alkaloids		False	False	Peptide01		-1.0	Compound(2982028)	2982028	5.0	1163		SCHEMBL14919628	[#8]=[#16](=[#8])(-[#7]-[#6]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]2:[#6]:[#6]:[#6]:[#6](-[#16](=[#8])(=[#8])-[#7]-[#6]-[#6]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#6]:2:[#6]:[#6]:[#6]:1	O=S(=O)(NCCc1ccccc1)c1c2cccc(S(=O)(=O)NCCc3ccccc3)c2ccc1	XMOBEPYUZXQYKK		parent_pubchem_cid	CHEMBL1771119;SCHEMBL14919628;AKOS002376696;N1,N5-bis(2-phenylethyl)naphthalene-1,5-disulfonamide	False	1091182.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=1091182		pluskal_iocb_peptide_Peptide01_G2_id		100	G2	False	ZINC000008834400
3.1		0	64	P7112896561	110.8		AC29	False	0	24	0	0	20	0	2	6	0	0		0.0						COC(=O)c1ccccc1NC(=O)c1cc(C(=O)Nc2ccccc2C(=O)OC)ccc1																							0.0		Oprea1_409538		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	4	0	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C24H20N2O6	C24H20N2O6			InChI=1S/C24H20N2O6/c1-31-23(29)17-10-3-5-12-19(17)25-21(27)15-8-7-9-16(14-15)22(28)26-20-13-6-4-11-18(20)24(30)32-2/h3-14H,1-2H3,(H,25,27)(H,26,28)	ACPDIIJQNMFHOK-UHFFFAOYSA-N	methyl 2-[[3-[(2-methoxycarbonylphenyl)carbamoyl]benzoyl]amino]benzoate	2832179	COC(=O)c1ccccc1NC(=O)c1cc(C(=O)Nc2ccccc2C(=O)OC)ccc1	methyl 2-[[3-[(2-methoxycarbonylphenyl)carbamoyl]benzoyl]amino]benzoate			2.784340000000001													MCULE-3467970291	432.4368		432.132136	6	2	8	3			44									Anthranillic acid derivatives	False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(2832179)	2832179	4.4	1164			[#6]-[#8]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6](-[#6](=[#8])-[#7]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6](=[#8])-[#8]-[#6]):[#6]:[#6]:[#6]:1	COC(=O)c1ccccc1NC(=O)c1cc(C(=O)Nc2ccccc2C(=O)OC)ccc1	ACPDIIJQNMFHOK		parent_pubchem_cid	Oprea1_409538;AKOS002322303;SR-01000197768;SR-01000197768-1;METHYL 2-[(3-{[2-(METHOXYCARBONYL)ANILINO]CARBONYL}BENZOYL)AMINO]BENZOATE;methyl 2-[[3-[(2-methoxycarbonylphenyl)carbamoyl]benzoyl]amino]benzoate		16537691.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=16537691		pluskal_iocb_peptide_Peptide01_G2_id		100	G2		ZINC000009082873
2.8		0	152	P0110420192	84.3		AC30	False	0	18	0	0	18	0	2	4	0	0	-1.0	0.0						CCOC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c1ccco1		2.67		0.0	2.41	CHEMBL1516422																	0.0		2-[(Furan-2-carbonyl)-amino]-3-(1H-indol-3-yl)-propionic acid ethyl ester		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C18H18N2O4	C18H18N2O4			InChI=1S/C18H18N2O4/c1-2-23-18(22)15(20-17(21)16-8-5-9-24-16)10-12-11-19-14-7-4-3-6-13(12)14/h3-9,11,15,19H,2,10H2,1H3,(H,20,21)	WHEOLGGFCJQGHX-UHFFFAOYSA-N	ethyl 2-(furan-2-carbonylamino)-3-(1H-indol-3-yl)propanoate	653984	CCOC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c1ccco1	ethyl 2-(furan-2-carbonylamino)-3-(1H-indol-3-yl)propanoate			2.12726													MCULE-3731588540	326.35516	NEUTRAL	326.126657	3	2	7	3	0.0		29										False	Shikimates and Phenylpropanoids		False	False	Peptide01		-1.0	Compound(653984)	653984	2.8	1165		SCHEMBL838658	[#6]-[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6]:[#8]:1	CCOC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c1ccco1	WHEOLGGFCJQGHX		parent_pubchem_cid	2-[(Furan-2-carbonyl)-amino]-3-(1H-indol-3-yl)-propionic acid ethyl ester;1309180-69-5;SMR000009164;ethyl N-2-furoyltryptophanate;MLS000029648;SCHEMBL838658;CHEMBL1516422;HMS2287O10;AKOS000536255;AKOS016310816;NCGC00026100-02;SR-01000405543;SR-01000405543-1;F0266-5612;ethyl 2-(furan-2-carboxamido)-3-(1H-indol-3-yl)propanoate;ETHYL 2-[(FURAN-2-YL)FORMAMIDO]-3-(1H-INDOL-3-YL)PROPANOATE;ethyl 2-(furan-2-carbonylamino)-3-(1H-indol-3-yl)propanoate	False	927829.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=927829		pluskal_iocb_peptide_Peptide01_G2_id		100	G2	False	
2.7		0	240	P7119983579	100.9		AC31	False	0	14	0	0	19	0	1	4	0	1		0.0						CSc1ccc(C(NC(=O)OC(C)(C)C)C(=O)O)cc1																							0.0		876756-01-3		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	1	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C14H19NO4S	C14H19NO4S			InChI=1S/C14H19NO4S/c1-14(2,3)19-13(18)15-11(12(16)17)9-5-7-10(20-4)8-6-9/h5-8,11H,1-4H3,(H,15,18)(H,16,17)	AUSHLQBVXGTWOM-UHFFFAOYSA-N	2-(tert-butoxycarbonylamino)-2-(4-methylsulfanylphenyl)acetic acid	16446328	CSc1ccc(C(NC(=O)OC(C)(C)C)C(=O)O)cc1	2-[(2-methylpropan-2-yl)oxycarbonylamino]-2-(4-methylsulfanylphenyl)acetic acid			2.896180000000001													MCULE-9094607254	297.37583		297.103479	5	2	6	1			44										False					Peptide01			Compound(16446328)	16446328	2.7	1166		SCHEMBL3817996	[#6]-[#16]-[#6]1:[#6]:[#6]:[#6](-[#6](-[#7]-[#6](=[#8])-[#8]-[#6](-[#6])(-[#6])-[#6])-[#6](=[#8])-[#8]):[#6]:[#6]:1	CSc1ccc(C(NC(=O)OC(C)(C)C)C(=O)O)cc1	AUSHLQBVXGTWOM		parent_pubchem_cid	876756-01-3;2-{[(tert-butoxy)carbonyl]amino}-2-[4-(methylsulfanyl)phenyl]acetic acid;2-((tert-Butoxycarbonyl)amino)-2-(4-(methylthio)phenyl)acetic acid;tert-butoxycarbonylamino-(4-methylsulfanyl-phenyl)-acetic acid;starbld0014479;SCHEMBL3817996;AUSHLQBVXGTWOM-UHFFFAOYSA-N;MFCD07388840;STK912230;AKOS002265306;AKOS016042040;NS-05019;CS-0205262;Boc-amino-(4-methylsulfanylphenyl)acetic acid;[(tert-butoxycarbonyl)amino][4-(methylsulfanyl)phenyl]acetic acid;2-[(2-methylpropan-2-yl)oxycarbonylamino]-2-(4-methylsulfanylphenyl)acetic acid;2-(tert-butoxycarbonylamino)-2-(4-methylsulfanylphenyl)acetic acid		23619870.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23619870		pluskal_iocb_peptide_Peptide01_G2_id		100	G2		
0.7		0	328	P5625455	103.7		AC32	False	0	13	0	0	15	0	1	5	0	0	-1.0	0.0						O=C(O)CCC(=O)NC(Cc1ccccc1)C(=O)O		0.66		0.0	0.72	CHEMBL446487		N-acyl-alpha amino acids;Phenylpropanoic acids;Amphetamines and derivatives;N-acyl amines;Dicarboxylic acids and derivatives;Secondary carboxylic acid amides;Carboxylic acids;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Dicarboxylic acids and derivatives;Fatty Acyls;Fatty amides;Hydrocarbon derivatives;Lipids and lipid-like molecules;N-acyl amines;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenethylamines;Phenylalanine and derivatives;Phenylpropanoic acids;Phenylpropanoids and polyketides;Secondary carboxylic acid amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic homomonocyclic compounds	N-acyl-amino acid (CHEBI:51569);benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);amphetamines (CHEBI:35338);fatty amide (CHEBI:29348);dicarboxylic acid (CHEBI:35692);carboxamide (CHEBI:37622);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);benzenoid aromatic compound (CHEBI:33836);primary amine (CHEBI:32877);lipid (CHEBI:18059);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806);carboxylic acid anion (CHEBI:29067);amino acid (CHEBI:33709);peptide (CHEBI:16670)	N-acyl amines (FA0802);Dicarboxylic acids (FA0117);Fatty Acyls (FA);Fatty amides (FA08)	Amino acids, peptides, and analogues	Phenylalanine or derivatives;N-acyl-alpha amino acid or derivatives;N-acyl-alpha-amino acid;3-phenylpropanoic-acid;Amphetamine or derivatives;Monocyclic benzene moiety;Dicarboxylic acid or derivatives;Fatty acyl;Benzenoid;Fatty amide;N-acyl-amine;Carboxamide group;Secondary carboxylic acid amide;Carboxylic acid;Organooxygen compound;Hydrocarbon derivative;Organic nitrogen compound;Organic oxide;Carbonyl group;Organic oxygen compound;Organonitrogen compound;Aromatic homomonocyclic compound	Organic acids and derivatives	0.0		CHEMBL446487		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	3	2	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C13H15NO5	C13H15NO5			InChI=1S/C13H15NO5/c15-11(6-7-12(16)17)14-10(13(18)19)8-9-4-2-1-3-5-9/h1-5,10H,6-8H2,(H,14,15)(H,16,17)(H,18,19)	CWAGPBPLOYGROC-UHFFFAOYSA-N	4-[(1-carboxy-2-phenyl-ethyl)amino]-4-oxo-butanoic acid	3131586	O=C(O)CCC(=O)NC(Cc1ccccc1)C(=O)O	4-[(1-carboxy-2-phenylethyl)amino]-4-oxobutanoic acid			0.6085899999999995													MCULE-3967033315	265.2682	ACID	265.095023	5	3	7	1	0.0		29									Dipeptides	False	Amino acids and Peptides	Small peptides	False	False	Peptide01		-1.0	Compound(3131586)	3131586	0.0	1167		SCHEMBL17624790	[#8]=[#6](-[#8])-[#6]-[#6]-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	O=C(O)CCC(=O)NC(Cc1ccccc1)C(=O)O	CWAGPBPLOYGROC		parent_pubchem_cid	CHEMBL446487;SCHEMBL17624790;MFCD00481986;AKOS003245517;FT-0771563;SR-01000430802;SR-01000430802-1;4-[(1-carboxy-2-phenylethyl)amino]-4-oxobutanoic acid;4-[(1-carboxy-2-phenyl-ethyl)amino]-4-oxo-butanoic acid	False	401802.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=401802		pluskal_iocb_peptide_Peptide01_G2_id		100	G2	False	
2.6		0	72	P7211800052	121.9		AC33	False	0	19	0	0	21	0	1	5	0	1	-1.0	0.0						CC(=O)NC(CSC(CC(=O)c1ccco1)c1ccc(C)cc1)C(=O)O		3.22		0.0	2.3	CHEMBL1580187																	0.0		MLS000775909		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C19H21NO5S	C19H21NO5S			InChI=1S/C19H21NO5S/c1-12-5-7-14(8-6-12)18(10-16(22)17-4-3-9-25-17)26-11-15(19(23)24)20-13(2)21/h3-9,15,18H,10-11H2,1-2H3,(H,20,21)(H,23,24)	BRJQWYCYACSFKM-UHFFFAOYSA-N	2-acetamido-3-[3-(2-furyl)-3-oxo-1-(p-tolyl)propyl]sulfanyl-propanoic acid	4055211	CC(=O)NC(CSC(CC(=O)c1ccco1)c1ccc(C)cc1)C(=O)O	2-acetamido-3-[3-(furan-2-yl)-1-(4-methylphenyl)-3-oxopropyl]sulfanylpropanoic acid			3.060490000000001													MCULE-7882574834	375.44692	ACID	375.114044	5	2	9	2	0.0		30										False			False	False	Peptide01		-1.0	Compound(4055211)	4055211	2.4	1168			[#6]-[#6](=[#8])-[#7]-[#6](-[#6]-[#16]-[#6](-[#6]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6]:[#8]:1)-[#6]1:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:1)-[#6](=[#8])-[#8]	CC(=O)NC(CSC(CC(=O)c1ccco1)c1ccc(C)cc1)C(=O)O	BRJQWYCYACSFKM		parent_pubchem_cid	MLS000775909;CHEMBL1580187;HMS2702C03;STL487176;AKOS000808777;AKOS016374415;SMR000371032;N-acetyl-S-[3-(furan-2-yl)-1-(4-methylphenyl)-3-oxopropyl]cysteine;2-acetamido-3-[3-(2-furyl)-3-oxo-1-(p-tolyl)propyl]sulfanyl-propanoic acid	False	696702.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=696702		pluskal_iocb_peptide_Peptide01_G3_id		100	G3	False	
3.5		0	160	P7020556167	90.7		AC34	False	0	21	1	0	22	0	3	3	0	1		0.0						O=C(NCCc1c[nH]c2ccccc12)c1cc(N2CCCCS2(=O)=O)c(Cl)cc1								3-alkylindoles;4-halobenzoic acids and derivatives;Benzamides;Delta sultams;Benzoyl derivatives;Chlorobenzenes;Substituted pyrroles;Organosulfonamides;Aryl chlorides;Organic sulfonamides;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Hydrocarbon derivatives;Organic oxides;Organochlorides;Organonitrogen compounds;Organooxygen compounds	3-alkylindoles;4-halobenzoic acids and derivatives;Aryl chlorides;Aryl halides;Azacyclic compounds;Benzamides;Benzene and substituted derivatives;Benzenoids;Benzoic acids and derivatives;Benzoyl derivatives;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Chlorobenzenes;Delta sultams;Halobenzenes;Halobenzoic acids and derivatives;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organic sulfonamides;Organic sulfonic acids and derivatives;Organochlorides;Organohalogen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organosulfonamides;Organosulfonic acids and derivatives;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Sulfanilides;Thiazinanes	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as sulfanilides. These are organic aromatic compounds containing a sulfanilide moiety, with the general structure RS(=O)(=O)NC1=CC=CC=C1.	Sulfanilides			Organic compounds	Aromatic heteropolycyclic compounds	indoles (CHEBI:24828);carbonyl compound (CHEBI:36586);organohalogen compound (CHEBI:36684);benzamides (CHEBI:22702);sultam (CHEBI:46950);organochlorine compound (CHEBI:36683);pyrroles (CHEBI:26455);sulfonamide (CHEBI:35358);organosulfur compound (CHEBI:33261);organic molecular entity (CHEBI:50860);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organonitrogen heterocyclic compound (CHEBI:38101);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);organooxygen compound (CHEBI:36963);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);benzoic acids (CHEBI:22723);thiazinane (CHEBI:46954);organic acid (CHEBI:64709);sulfonic acid derivative (CHEBI:33552);haloarene (CHEBI:50887);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);nitrogen molecular entity (CHEBI:51143)		Sulfanilides	Sulfanilide;4-halobenzoic acid or derivatives;Halobenzoic acid or derivatives;3-alkylindole;Benzamide;Benzoic acid or derivatives;Indole;Indole or derivatives;Benzoyl;Delta-sultam;Chlorobenzene;Halobenzene;1,2-thiazinane;Organosulfonic acid amide;Organic sulfonic acid amide;Substituted pyrrole;Aryl halide;Aryl chloride;Organosulfonic acid or derivatives;Organic sulfonic acid or derivatives;Heteroaromatic compound;Pyrrole;Secondary carboxylic acid amide;Carboxamide group;Carboxylic acid derivative;Azacycle;Organoheterocyclic compound;Organic oxide;Organochloride;Organonitrogen compound;Organooxygen compound;Organic oxygen compound;Organic nitrogen compound;Hydrocarbon derivative;Organohalogen compound;Aromatic heteropolycyclic compound	Benzenoids	0.0		AKOS005583628		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	1	0	0	0	0	0	0	1		C21H22ClN3O3S	C21H22ClN3O3S			InChI=1S/C21H22ClN3O3S/c22-18-8-7-15(13-20(18)25-11-3-4-12-29(25,27)28)21(26)23-10-9-16-14-24-19-6-2-1-5-17(16)19/h1-2,5-8,13-14,24H,3-4,9-12H2,(H,23,26)	PNPORJRYTAHIER-UHFFFAOYSA-N	4-chloro-3-(1,1-dioxothiazinan-2-yl)-N-[2-(1H-indol-3-yl)ethyl]benzamide	24316467	O=C(NCCc1c[nH]c2ccccc12)c1cc(N2CCCCS2(=O)=O)c(Cl)cc1	4-chloro-3-(1,1-dioxothiazinan-2-yl)-N-[2-(1H-indol-3-yl)ethyl]benzamide			2.8053500000000016													MCULE-1065043024	431.94479		431.10704	3	2	5	4			44										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(24316467)	24316467	3.5	1169			[#8]=[#6](-[#7]-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6]1:[#6]:[#6](-[#7]2-[#6]-[#6]-[#6]-[#6]-[#16]-2(=[#8])=[#8]):[#6](-[#17]):[#6]:[#6]:1	O=C(NCCc1c[nH]c2ccccc12)c1cc(N2CCCCS2(=O)=O)c(Cl)cc1	PNPORJRYTAHIER		parent_pubchem_cid	AKOS005583628;4-chloro-3-(1,1-dioxothiazinan-2-yl)-N-[2-(1H-indol-3-yl)ethyl]benzamide		13611596.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=13611596		pluskal_iocb_peptide_Peptide01_G3_id		100	G3		ZINC000012194954
-0.6		0	248	P3851302	69.6		AC35	False	0	15	0	0	21	0	1	3	0	0		0.0						O=C(O)C1(NC(CO)Cc2ccccc2)CCCC1																							0.0		AKOS016401529		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C15H21NO3	C15H21NO3			InChI=1S/C15H21NO3/c17-11-13(10-12-6-2-1-3-7-12)16-15(14(18)19)8-4-5-9-15/h1-3,6-7,13,16-17H,4-5,8-11H2,(H,18,19)	KDMOUBYUEJHRQB-UHFFFAOYSA-N	1-[(1-benzyl-2-hydroxy-ethyl)amino]cyclopentanecarboxylic acid	56828908	O=C(O)C1(NC(CO)Cc2ccccc2)CCCC1	1-[(1-hydroxy-3-phenylpropan-2-yl)amino]cyclopentane-1-carboxylic acid			1.5222899999999997													MCULE-2734525276	263.33952		263.152144	4	3	6	2			45										False					Peptide01			Compound(56828908)	56828908	-0.5	1170			[#8]=[#6](-[#8])-[#6]1(-[#7]-[#6](-[#6]-[#8])-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]-[#6]-[#6]-[#6]-1	O=C(O)C1(NC(CO)Cc2ccccc2)CCCC1	KDMOUBYUEJHRQB		parent_pubchem_cid	AKOS016401529;1-[(1-benzyl-2-hydroxy-ethyl)amino]cyclopentanecarboxylic acid		62427114.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=62427114		pluskal_iocb_peptide_Peptide01_G3_id		100	G3		
3.5		0	336	P1647327	61.4		AC36	False	0	21	0	0	31	0	3	2	0	0		0.0						O=C(NC1CCCCC1)NC(Cc1ccccc1)C(=O)N1CCCCC1																							0.0		AKOS027475295		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0		C21H31N3O2	C21H31N3O2			InChI=1S/C21H31N3O2/c25-20(24-14-8-3-9-15-24)19(16-17-10-4-1-5-11-17)23-21(26)22-18-12-6-2-7-13-18/h1,4-5,10-11,18-19H,2-3,6-9,12-16H2,(H2,22,23,26)/t19-/m0/s1	FOHAVWMFQBZFQU-IBGZPJMESA-N	1-cyclohexyl-3-[rac-(1S)-1-benzyl-2-oxo-2-(1-piperidyl)ethyl]urea	110347378	O=C(NC1CCCCC1)N[C@@H](Cc1ccccc1)C(=O)N1CCCCC1	1-cyclohexyl-3-[(2S)-1-oxo-3-phenyl-1-piperidin-1-ylpropan-2-yl]urea			3.1873900000000024														357.50012		357.241627	2	2	5	3			45									Piperidine alkaloids	False	Alkaloids	Lysine alkaloids			Peptide01			Compound(110347378)	110347378	3.5	1171			[#8]=[#6](-[#7]-[#6]1-[#6]-[#6]-[#6]-[#6]-[#6]-1)-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#7]1-[#6]-[#6]-[#6]-[#6]-[#6]-1	O=C(NC1CCCCC1)N[C@@H](Cc1ccccc1)C(=O)N1CCCCC1	FOHAVWMFQBZFQU		parent_pubchem_cid	AKOS027475295;1-cyclohexyl-3-[rac-(1S)-1-benzyl-2-oxo-2-(1-piperidyl)ethyl]urea		13138523.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=13138523		pluskal_iocb_peptide_Peptide01_G3_id		100	G3		ZINC000041247037
5.0		0	80	P0127442983	26.7		AC37	False	0	23	0	0	24	0	2	1	0	0		0.0						Oc1ccccc1C1N(Cc2ccccc2)CCN1Cc1ccccc1																							0.0		2-(1,3-dibenzylimidazolidin-2-yl)phenol		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2		C23H24N2O	C23H24N2O			InChI=1S/C23H24N2O/c26-22-14-8-7-13-21(22)23-24(17-19-9-3-1-4-10-19)15-16-25(23)18-20-11-5-2-6-12-20/h1-14,23,26H,15-18H2	WZYDUILDTXZIHH-UHFFFAOYSA-N	2-(1,3-dibenzylimidazolidin-2-yl)phenol	722040	Oc1ccccc1C1N(Cc2ccccc2)CCN1Cc1ccccc1	2-(1,3-dibenzylimidazolidin-2-yl)phenol			3.7822600000000026													MCULE-5568593641	344.46053		344.188863	3	1	5	4			42										False	Alkaloids				Peptide01			Compound(722040)	722040	4.3	1172		SCHEMBL18290563	[#8]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#6]1-[#7](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]-[#6]-[#7]-1-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	Oc1ccccc1C1N(Cc2ccccc2)CCN1Cc1ccccc1	WZYDUILDTXZIHH		parent_pubchem_cid	2-(1,3-dibenzylimidazolidin-2-yl)phenol;2-(1,3-dibenzyl-2-imidazolidinyl)phenol;102656-27-9;ChemDiv3_000953;Oprea1_414062;Oprea1_434006;CBDivE_003854;SCHEMBL18290563;HMS1475L07;STK058211;AKOS000485117;CCG-104890;IDI1_019919;EU-0002539;AB00073708-01;AG-205/32540025;SR-01000409378;SR-01000409378-1;BRD-K34885179-001-01-2;F1443-4817		24037517.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24037517		pluskal_iocb_peptide_Peptide01_G3_id		100	G3		ZINC000019300103
2.2		0	168	P7020554645	97.4		AC38	False	0	18	0	0	17	0	3	4	0	0		0.0						Cc1cc(NC(=O)C(Cc2ccccc2)NC(=O)c2ccco2)no1																							0.0		AKOS005590453		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C18H17N3O4	C18H17N3O4			InChI=1S/C18H17N3O4/c1-12-10-16(21-25-12)20-17(22)14(11-13-6-3-2-4-7-13)19-18(23)15-8-5-9-24-15/h2-10,14H,11H2,1H3,(H,19,23)(H,20,21,22)/t14-/m0/s1	MCLNCIDBNPCLHX-AWEZNQCLSA-N	N-[(1S)-1-benzyl-2-[(5-methylisoxazol-3-yl)amino]-2-oxo-ethyl]furan-2-carboxamide	24315158	Cc1cc(NC(=O)[C@H](Cc2ccccc2)NC(=O)c2ccco2)no1	N-[(2S)-1-[(5-methyl-1,2-oxazol-3-yl)amino]-1-oxo-3-phenylpropan-2-yl]furan-2-carboxamide			2.01108													MCULE-1842223517	339.35389		339.121906	3	2	6	3			44										False					Peptide01			Compound(24315158)	24315158	2.7	1173			[#6]-[#6]1:[#6]:[#6](-[#7]-[#6](=[#8])-[#6@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#8]:2):[#7]:[#8]:1	Cc1cc(NC(=O)[C@H](Cc2ccccc2)NC(=O)c2ccco2)no1	MCLNCIDBNPCLHX		parent_pubchem_cid	AKOS005590453;N-[(1S)-1-benzyl-2-[(5-methylisoxazol-3-yl)amino]-2-oxo-ethyl]furan-2-carboxamide		12623794.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=12623794		pluskal_iocb_peptide_Peptide01_G3_id		100	G3		ZINC000012028725
5.0		0	256	P1305276	44.9		AC39	False	0	21	1	0	23	0	2	1	0	0		0.0						CC(C)CC(=O)NCC(c1ccccc1Cl)c1c[nH]c2ccccc12								Chlorobenzenes;Substituted pyrroles;N-acyl amines;Aryl chlorides;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Organopnictogen compounds;Organonitrogen compounds;Organochlorides;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	3-alkylindoles;Aryl chlorides;Aryl halides;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Chlorobenzenes;Fatty Acyls;Fatty amides;Halobenzenes;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Lipids and lipid-like molecules;N-acyl amines;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organochlorides;Organohalogen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as 3-alkylindoles. These are compounds containing an indole moiety that carries an alkyl chain at the 3-position.	3-alkylindoles			Organic compounds	Aromatic heteropolycyclic compounds	organochlorine compound (CHEBI:36683);pyrroles (CHEBI:26455);fatty amide (CHEBI:29348);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organonitrogen heterocyclic compound (CHEBI:38101);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);indoles (CHEBI:24828);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);organohalogen compound (CHEBI:36684);organic heterocyclic compound (CHEBI:24532);lipid (CHEBI:18059);organooxygen compound (CHEBI:36963);haloarene (CHEBI:50887);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806)	N-acyl amines (FA0802);Fatty Acyls (FA);Fatty amides (FA08)	Indoles	3-alkylindole;Halobenzene;Chlorobenzene;Fatty acyl;Benzenoid;Substituted pyrrole;N-acyl-amine;Fatty amide;Monocyclic benzene moiety;Aryl halide;Aryl chloride;Heteroaromatic compound;Pyrrole;Secondary carboxylic acid amide;Carboxamide group;Azacycle;Carboxylic acid derivative;Organic nitrogen compound;Organic oxygen compound;Organopnictogen compound;Organic oxide;Hydrocarbon derivative;Organooxygen compound;Organonitrogen compound;Organochloride;Organohalogen compound;Carbonyl group;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		N-[2-(2-chlorophenyl)-2-(1H-indol-3-yl)ethyl]-3-methylbutanamide		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C21H23ClN2O	C21H23ClN2O			InChI=1S/C21H23ClN2O/c1-14(2)11-21(25)24-13-17(15-7-3-5-9-19(15)22)18-12-23-20-10-6-4-8-16(18)20/h3-10,12,14,17,23H,11,13H2,1-2H3,(H,24,25)	CKGGMZYKFMJHJM-UHFFFAOYSA-N	N-[2-(2-chlorophenyl)-2-(1H-indol-3-yl)ethyl]-3-methyl-butanamide	17014432	CC(C)CC(=O)NCC(c1ccccc1Cl)c1c[nH]c2ccccc12	N-[2-(2-chlorophenyl)-2-(1H-indol-3-yl)ethyl]-3-methylbutanamide			4.577660000000003													MCULE-6128246034	354.88326		354.149891	1	2	6	3			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(17014432)	17014432	5.0	1174			[#6]-[#6](-[#6])-[#6]-[#6](=[#8])-[#7]-[#6]-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#17])-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CC(C)CC(=O)NCC(c1ccccc1Cl)c1c[nH]c2ccccc12	CKGGMZYKFMJHJM		parent_pubchem_cid	N-[2-(2-chlorophenyl)-2-(1H-indol-3-yl)ethyl]-3-methylbutanamide;HMS3456C18;STL207392;AKOS000958663;AKOS016326589;N-[2-(2-chlorophenyl)-2-(1H-indol-3-yl)ethyl]-3-methyl-butanamide		23544066.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23544066		pluskal_iocb_peptide_Peptide01_G3_id		100	G3		
4.4		0	344	P7119850489	92.3		AC40	False	0	28	0	0	18	0	2	4	0	0		0.0						O=C(Nc1c2C(=O)c3ccccc3C(=O)c2c(NC(=O)c2ccccc2)cc1)c1ccccc1																							0.0		2987-68-0	DTXSID40183987	2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	4	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C28H18N2O4	C28H18N2O4			InChI=1S/C28H18N2O4/c31-25-19-13-7-8-14-20(19)26(32)24-22(30-28(34)18-11-5-2-6-12-18)16-15-21(23(24)25)29-27(33)17-9-3-1-4-10-17/h1-16H,(H,29,33)(H,30,34)	SMYVNUCSIRQQNT-UHFFFAOYSA-N	N-(4-benzamido-9,10-dioxo-1-anthryl)benzamide	72731	O=C(Nc1c2C(=O)c3ccccc3C(=O)c2c(NC(=O)c2ccccc2)cc1)c1ccccc1	N-(4-benzamido-9,10-dioxoanthracen-1-yl)benzamide			3.8771200000000015													MCULE-5157907841	446.46666		446.126657	4	2	4	5			41									Anthraquinones and anthrones	False	Polyketides	Polycyclic aromatic polyketides			Peptide01			Compound(72731)	72731	5.6	1175		SCHEMBL6419867	[#8]=[#6](-[#7]-[#6]1:[#6]2-[#6](=[#8])-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3-[#6](=[#8])-[#6]:2:[#6](-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6]:[#6]:1)-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	O=C(Nc1c2C(=O)c3ccccc3C(=O)c2c(NC(=O)c2ccccc2)cc1)c1ccccc1	SMYVNUCSIRQQNT		parent_pubchem_cid	2987-68-0;Vat Red 42;N,N'-(9,10-Dihydro-9,10-dioxoanthracene-1,4-diyl)bisbenzamide;C.I. Vat Red 42;1,4-Dibenzamidoanthraquinone;Benzadone Red 5G;Indanthren Red 5GK;Romantrene Red F5GK;N-(4-benzamido-9,10-dioxoanthracen-1-yl)benzamide;WNN6WV4DK4;1,4-Bis(benzoylamino)anthraquinone;NSC-7228;C.I. 61650;NSC 7228;EINECS 221-058-5;n,n'-(9,10-dioxo-9,10-dihydroanthracene-1,4-diyl)dibenzamide;UNII-WNN6WV4DK4;1,4-Dibenzoylaminoanthrachinon;SCHEMBL6419867;1,4-bis-benzoylaminoanthraquinone;DTXSID40183987;NSC7228;SMYVNUCSIRQQNT-UHFFFAOYSA-N;AKOS002384306;Benzamide,N'-1,4-anthraquinonylenebis-;N,N'-DIBENZOYL-1,4-DIAMINOANTHRAQUINONE;Benzamide,N'-(9,10-dihydro-9,10-dioxo-1,4-anthracenediyl)bis-;N-[4-(BENZOYLAMINO)-9,10-DIOXO-9,10-DIHYDRO-1-ANTHRACENYL]BENZAMIDE;N-(4-benzamido-9,10-dioxo-1-anthryl)benzamide		9252056.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=9252056	WNN6WV4DK4	pluskal_iocb_peptide_Peptide01_G3_id		100	G3		ZINC000004410897
3.8		0	88	P0120630033	110.0		AC41	False	0	24	0	0	24	0	2	5	0	1		0.0						COC(=O)c1ccccc1NC(=O)C(Cc1ccccc1)NS(=O)(=O)c1ccc(C)cc1																							0.0		Oprea1_007123		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	1	0	0	0	0	0	0	0		C24H24N2O5S	C24H24N2O5S			InChI=1S/C24H24N2O5S/c1-17-12-14-19(15-13-17)32(29,30)26-22(16-18-8-4-3-5-9-18)23(27)25-21-11-7-6-10-20(21)24(28)31-2/h3-15,22,26H,16H2,1-2H3,(H,25,27)	LOULMJACUUZEPJ-UHFFFAOYSA-N	methyl 2-[[3-phenyl-2-(p-tolylsulfonylamino)propanoyl]amino]benzoate	3111842	COC(=O)c1ccccc1NC(=O)C(Cc1ccccc1)NS(=O)(=O)c1ccc(C)cc1	methyl 2-[[2-[(4-methylphenyl)sulfonylamino]-3-phenylpropanoyl]amino]benzoate			2.6571700000000007													MCULE-4731908655	452.53328		452.140593	5	2	9	3			45										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(3111842)	3111842	4.6	1176			[#6]-[#8]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#7]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#16](=[#8])(=[#8])-[#6]1:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:1	COC(=O)c1ccccc1NC(=O)C(Cc1ccccc1)NS(=O)(=O)c1ccc(C)cc1	LOULMJACUUZEPJ		parent_pubchem_cid	Oprea1_007123;Oprea1_314443;AKOS001595369;SR-01000405618;SR-01000405618-1;METHYL 2-[2-(4-METHYLBENZENESULFONAMIDO)-3-PHENYLPROPANAMIDO]BENZOATE;methyl 2-[[3-phenyl-2-(p-tolylsulfonylamino)propanoyl]amino]benzoate		23746766.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23746766		pluskal_iocb_peptide_Peptide01_G4_id		100	G4		
1.4		0	176	P7020554673	135.7		AC42	False	0	18	0	0	20	0	4	5	0	1		0.0						Cc1cc(NC(=O)C(Cc2ccccc2)NS(=O)(=O)c2c(C)onc2C)no1																							0.0		STK654210		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	1	0	0	0	0	0	0	0		C18H20N4O5S	C18H20N4O5S			InChI=1S/C18H20N4O5S/c1-11-9-16(21-26-11)19-18(23)15(10-14-7-5-4-6-8-14)22-28(24,25)17-12(2)20-27-13(17)3/h4-9,15,22H,10H2,1-3H3,(H,19,21,23)/t15-/m0/s1	YKLAAVFJHALIRQ-HNNXBMFYSA-N	(2S)-2-[(3,5-dimethylisoxazol-4-yl)sulfonylamino]-N-(5-methylisoxazol-3-yl)-3-phenyl-propanamide	24315186	Cc1cc(NC(=O)[C@H](Cc2ccccc2)NS(=O)(=O)c2c(C)onc2C)no1	(2S)-2-[(3,5-dimethyl-1,2-oxazol-4-yl)sulfonylamino]-N-(5-methyl-1,2-oxazol-3-yl)-3-phenylpropanamide			1.4086999999999998													MCULE-1792401453	404.4479		404.115441	5	2	7	3			44										False					Peptide01			Compound(24315186)	24315186	2.2	1177			[#6]-[#6]1:[#6]:[#6](-[#7]-[#6](=[#8])-[#6@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#7]-[#16](=[#8])(=[#8])-[#6]2:[#6](-[#6]):[#8]:[#7]:[#6]:2-[#6]):[#7]:[#8]:1	Cc1cc(NC(=O)[C@H](Cc2ccccc2)NS(=O)(=O)c2c(C)onc2C)no1	YKLAAVFJHALIRQ		parent_pubchem_cid	STK654210;AKOS005584810;Nalpha-[(3,5-dimethyl-1,2-oxazol-4-yl)sulfonyl]-N-(5-methyl-1,2-oxazol-3-yl)-L-phenylalaninamide;(2S)-2-[(3,5-dimethylisoxazol-4-yl)sulfonylamino]-N-(5-methylisoxazol-3-yl)-3-phenyl-propanamide		13852215.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=13852215		pluskal_iocb_peptide_Peptide01_G4_id		100	G4		ZINC000012028809
4.6		0	264	P1305500	54.1		AC43	False	0	24	0	0	22	0	2	2	0	0		0.0						COc1ccccc1C(=O)NCC(c1ccccc1)c1c[nH]c2ccccc12																							0.0		N-[2-(1H-indol-3-yl)-2-phenylethyl]-2-methoxybenzamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C24H22N2O2	C24H22N2O2			InChI=1S/C24H22N2O2/c1-28-23-14-8-6-12-19(23)24(27)26-15-20(17-9-3-2-4-10-17)21-16-25-22-13-7-5-11-18(21)22/h2-14,16,20,25H,15H2,1H3,(H,26,27)	AZZVIICXENBKAB-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]-2-methoxy-benzamide	17014646	COc1ccccc1C(=O)NCC(c1ccccc1)c1c[nH]c2ccccc12	N-[2-(1H-indol-3-yl)-2-phenylethyl]-2-methoxybenzamide			3.683440000000002													MCULE-8831530600	370.45514		370.168128	2	2	6	4			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(17014646)	17014646	4.7	1178			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#6](=[#8])-[#7]-[#6]-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	COc1ccccc1C(=O)NCC(c1ccccc1)c1c[nH]c2ccccc12	AZZVIICXENBKAB		parent_pubchem_cid	N-[2-(1H-indol-3-yl)-2-phenylethyl]-2-methoxybenzamide;HMS3456E12;AKOS002334647;AKOS016326711;N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]-2-methoxy-benzamide		23452266.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23452266		pluskal_iocb_peptide_Peptide01_G4_id		100	G4		
0.8		0	352	P6236080	115.8		AC44	False	0	17	0	0	20	0	6	2	0	0		0.0						O=C(CCNc1c2[nH]cnc2ncn1)NC(CO)Cc1ccccc1																							0.0		N-(1-benzyl-2-hydroxy-ethyl)-3-(9H-purin-6-ylamino)propanamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	0	0	0	0	0	0	0	0		C17H20N6O2	C17H20N6O2			InChI=1S/C17H20N6O2/c24-9-13(8-12-4-2-1-3-5-12)23-14(25)6-7-18-16-15-17(20-10-19-15)22-11-21-16/h1-5,10-11,13,24H,6-9H2,(H,23,25)(H2,18,19,20,21,22)/t13-/m1/s1	OLLVHRIVKIQWNF-CYBMUJFWSA-N	N-(1-benzyl-2-hydroxy-ethyl)-3-(9H-purin-6-ylamino)propanamide	42506974	O=C(CCNc1c2[nH]cnc2ncn1)N[C@@H](CO)Cc1ccccc1	N-[(2R)-1-hydroxy-3-phenylpropan-2-yl]-3-(7H-purin-6-ylamino)propanamide			0.0109599999999998													MCULE-6056566135	340.38795		340.164774	6	4	8	3			44									Purine alkaloids	False	Alkaloids	Pseudoalkaloids			Peptide01			Compound(42506974)	42506974	1.6	1179			[#8]=[#6](-[#6]-[#6]-[#7]-[#6]1:[#6]2:[#7H]:[#6]:[#7]:[#6]:2:[#7]:[#6]:[#7]:1)-[#7]-[#6@@H](-[#6]-[#8])-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	O=C(CCNc1c2[nH]cnc2ncn1)N[C@@H](CO)Cc1ccccc1	OLLVHRIVKIQWNF		parent_pubchem_cid	N-(1-benzyl-2-hydroxy-ethyl)-3-(9H-purin-6-ylamino)propanamide		6905226.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=6905226		pluskal_iocb_peptide_Peptide01_G4_id		100	G4		ZINC000012296675
3.3		0	360	P1004953	120.0		AD1	False	0	27	0	0	23	0	5	3	0	0		0.0						N#Cc1c(NCc2ccccc2)oc(CNC(=O)c2ccccc2C(=O)NCc2ccccc2)n1																							0.0		AKOS002311485		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0		C27H23N5O3	C27H23N5O3			InChI=1S/C27H23N5O3/c28-15-23-27(31-17-20-11-5-2-6-12-20)35-24(32-23)18-30-26(34)22-14-8-7-13-21(22)25(33)29-16-19-9-3-1-4-10-19/h1-14,31H,16-18H2,(H,29,33)(H,30,34)	CTGHFIJGHUXBGO-UHFFFAOYSA-N	N1-benzyl-N2-[[5-(benzylamino)-4-cyano-oxazol-2-yl]methyl]phthalamide	16462568	N#Cc1c(NCc2ccccc2)oc(CNC(=O)c2ccccc2C(=O)NCc2ccccc2)n1	1-N-benzyl-2-N-[[5-(benzylamino)-4-cyano-1,3-oxazol-2-yl]methyl]benzene-1,2-dicarboxamide			3.3095100000000013													MCULE-6397781849	465.51606		465.18009	5	3	9	4			44										False	Alkaloids				Peptide01			Compound(16462568)	16462568	4.3	1180			[#7]#[#6]-[#6]1:[#6](-[#7]-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#8]:[#6](-[#6]-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6](=[#8])-[#7]-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#7]:1	N#Cc1c(NCc2ccccc2)oc(CNC(=O)c2ccccc2C(=O)NCc2ccccc2)n1	CTGHFIJGHUXBGO		parent_pubchem_cid	AKOS002311485;Z339407458;N1-benzyl-N2-[[5-(benzylamino)-4-cyano-oxazol-2-yl]methyl]phthalamide		5848692.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=5848692		pluskal_iocb_peptide_Peptide01_G4_id		100	G4		ZINC000011614599
3.2		0	448	P2195430	93.7		AD2	False	0	21	0	0	32	0	2	5	0	0		0.0						COC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)c1ccc(OC)cc1																							0.0		AKOS015861403		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	2	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C21H32N2O5	C21H32N2O5			InChI=1S/C21H32N2O5/c1-13(2)11-17(20(25)23-18(12-14(3)4)21(26)28-6)22-19(24)15-7-9-16(27-5)10-8-15/h7-10,13-14,17-18H,11-12H2,1-6H3,(H,22,24)(H,23,25)	ATVUWTANLDAEFU-UHFFFAOYSA-N	methyl 2-[[2-[(4-methoxybenzoyl)amino]-4-methyl-pentanoyl]amino]-4-methyl-pentanoate	51065897	COC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)c1ccc(OC)cc1	methyl 2-[[2-[(4-methoxybenzoyl)amino]-4-methylpentanoyl]amino]-4-methylpentanoate			2.02648													MCULE-3224712826	392.49959		392.231122	5	2	11	1			45									Tripeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51065897)	51065897	3.9	1181			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=[#8])-[#6](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:1	COC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)c1ccc(OC)cc1	ATVUWTANLDAEFU		parent_pubchem_cid	AKOS015861403;methyl 2-[[2-[(4-methoxybenzoyl)amino]-4-methyl-pentanoyl]amino]-4-methyl-pentanoate		24766746.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24766746		pluskal_iocb_peptide_Peptide01_G4_id		100	G4		
4.2		0	536	P2195095	134.6		AD3	False	0	20	1	0	25	0	4	2	0	2		0.0						CCCSc1ncc(Cl)c(C(=O)NC(CCSC)C(=O)Nc2ccc(C)cc2)n1																							0.0		AKOS015861219		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C20H25ClN4O2S2	C20H25ClN4O2S2			InChI=1S/C20H25ClN4O2S2/c1-4-10-29-20-22-12-15(21)17(25-20)19(27)24-16(9-11-28-3)18(26)23-14-7-5-13(2)6-8-14/h5-8,12,16H,4,9-11H2,1-3H3,(H,23,26)(H,24,27)	VQGYROUKOPJJLA-UHFFFAOYSA-N	5-chloro-N-[3-methylsulfanyl-1-(p-tolylcarbamoyl)propyl]-2-propylsulfanyl-pyrimidine-4-carboxamide	51065631	CCCSc1ncc(Cl)c(C(=O)NC(CCSC)C(=O)Nc2ccc(C)cc2)n1	5-chloro-N-[1-(4-methylanilino)-4-methylsulfanyl-1-oxobutan-2-yl]-2-propylsulfanylpyrimidine-4-carboxamide			3.8326800000000025													MCULE-1393244887	453.02885		452.110746	6	2	10	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51065631)	51065631	4.5	1182			[#6]-[#6]-[#6]-[#16]-[#6]1:[#7]:[#6]:[#6](-[#17]):[#6](-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]-[#16]-[#6])-[#6](=[#8])-[#7]-[#6]2:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:2):[#7]:1	CCCSc1ncc(Cl)c(C(=O)NC(CCSC)C(=O)Nc2ccc(C)cc2)n1	VQGYROUKOPJJLA		parent_pubchem_cid	AKOS015861219;5-chloro-N-[3-methylsulfanyl-1-(p-tolylcarbamoyl)propyl]-2-propylsulfanyl-pyrimidine-4-carboxamide		22968573.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22968573		pluskal_iocb_peptide_Peptide01_G4_id		100	G4		
4.4		0	624	P1305579	63.3		AD4	False	0	25	0	0	24	0	2	3	0	0		0.0						COc1ccccc1OCC(=O)NCC(c1ccccc1)c1c[nH]c2ccccc12																							0.0		HMS3456I14		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C25H24N2O3	C25H24N2O3			InChI=1S/C25H24N2O3/c1-29-23-13-7-8-14-24(23)30-17-25(28)27-15-20(18-9-3-2-4-10-18)21-16-26-22-12-6-5-11-19(21)22/h2-14,16,20,26H,15,17H2,1H3,(H,27,28)	PTTPJFGFKXIRTR-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]-2-(2-methoxyphenoxy)acetamide	17014715	COc1ccccc1OCC(=O)NCC(c1ccccc1)c1c[nH]c2ccccc12	N-[2-(1H-indol-3-yl)-2-phenylethyl]-2-(2-methoxyphenoxy)acetamide			3.040940000000001													MCULE-8319772677	400.48163		400.178693	3	2	8	4			45										False	Alkaloids				Peptide01			Compound(17014715)	17014715	4.7	1183			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#8]-[#6]-[#6](=[#8])-[#7]-[#6]-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	COc1ccccc1OCC(=O)NCC(c1ccccc1)c1c[nH]c2ccccc12	PTTPJFGFKXIRTR		parent_pubchem_cid	HMS3456I14;N-[2-(1H-indol-3-yl)-2-phenylethyl]-2-(2-methoxyphenoxy)acetamide;AKOS002335514;AKOS016326747;N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]-2-(2-methoxyphenoxy)acetamide		23883394.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23883394		pluskal_iocb_peptide_Peptide01_G4_id		100	G4		
2.4		0	368	P11184214	84.9		AD5	False	0	20	0	0	21	0	1	5	0	0		0.0						O=C(Cc1cc2c(cc1)OCCCO2)NC(Cc1ccccc1)C(=O)O																							0.0		AKOS027472134		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C20H21NO5	C20H21NO5			InChI=1S/C20H21NO5/c22-19(21-16(20(23)24)11-14-5-2-1-3-6-14)13-15-7-8-17-18(12-15)26-10-4-9-25-17/h1-3,5-8,12,16H,4,9-11,13H2,(H,21,22)(H,23,24)/t16-/m0/s1	CLVNQSLNSZESJY-INIZCTEOSA-N	rac-(2S)-2-[[2-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)acetyl]amino]-3-phenyl-propanoic acid	75491277	O=C(Cc1cc2c(cc1)OCCCO2)N[C@@H](Cc1ccccc1)C(=O)O	(2S)-2-[[2-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)acetyl]amino]-3-phenylpropanoic acid			1.16826														355.39407		355.141973	5	2	6	3			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(75491277)	75491277	2.8	1184			[#8]=[#6](-[#6]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1)-[#8]-[#6]-[#6]-[#6]-[#8]-2)-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	O=C(Cc1cc2c(cc1)OCCCO2)N[C@@H](Cc1ccccc1)C(=O)O	CLVNQSLNSZESJY		parent_pubchem_cid	AKOS027472134;N-[(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)acetyl]-L-phenylalanine;rac-(2S)-2-[[2-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)acetyl]amino]-3-phenyl-propanoic acid		80415689.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=80415689		pluskal_iocb_peptide_Peptide01_G5_id		100	G5		ZINC000096221226
4.3		0	456	P2195436	109.3		AD6	False	0	19	1	1	22	0	4	2	0	1		0.0						CCSc1ncc(Cl)c(C(=O)NC(CC(C)C)C(=O)Nc2ccc(F)cc2)n1																							0.0		AKOS015861427		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C19H22ClFN4O2S	C19H22ClFN4O2S			InChI=1S/C19H22ClFN4O2S/c1-4-28-19-22-10-14(20)16(25-19)18(27)24-15(9-11(2)3)17(26)23-13-7-5-12(21)6-8-13/h5-8,10-11,15H,4,9H2,1-3H3,(H,23,26)(H,24,27)	RRLGLIQZMFUYHY-UHFFFAOYSA-N	5-chloro-2-ethylsulfanyl-N-[1-[(4-fluorophenyl)carbamoyl]-3-methyl-butyl]pyrimidine-4-carboxamide	51065903	CCSc1ncc(Cl)c(C(=O)NC(CC(C)C)C(=O)Nc2ccc(F)cc2)n1	5-chloro-2-ethylsulfanyl-N-[1-(4-fluoroanilino)-4-methyl-1-oxopentan-2-yl]pyrimidine-4-carboxamide			3.6209700000000025													MCULE-5405591993	424.92819		424.113603	5	2	8	2			45										False	Alkaloids				Peptide01			Compound(51065903)	51065903	4.4	1185			[#6]-[#6]-[#16]-[#6]1:[#7]:[#6]:[#6](-[#17]):[#6](-[#6](=[#8])-[#7]-[#6](-[#6]-[#6](-[#6])-[#6])-[#6](=[#8])-[#7]-[#6]2:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:2):[#7]:1	CCSc1ncc(Cl)c(C(=O)NC(CC(C)C)C(=O)Nc2ccc(F)cc2)n1	RRLGLIQZMFUYHY		parent_pubchem_cid	AKOS015861427;5-chloro-2-ethylsulfanyl-N-[1-[(4-fluorophenyl)carbamoyl]-3-methyl-butyl]pyrimidine-4-carboxamide		23978964.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23978964		pluskal_iocb_peptide_Peptide01_G5_id		100	G5		
5.0		0	544	P11186223	36.1		AD7	False	0	22	0	0	26	0	2	1	0	0		0.0						CCN(C(=O)C(C)C)C(c1ccc(C)cc1)c1c[nH]c2ccccc12																							0.0		AKOS027473433		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C22H26N2O	C22H26N2O			InChI=1S/C22H26N2O/c1-5-24(22(25)15(2)3)21(17-12-10-16(4)11-13-17)19-14-23-20-9-7-6-8-18(19)20/h6-15,21,23H,5H2,1-4H3	KGIXLRSVSSHUJV-UHFFFAOYSA-N	N-ethyl-N-[1H-indol-3-yl(p-tolyl)methyl]-2-methyl-propanamide	121238543	CCN(C(=O)C(C)C)C(c1ccc(C)cc1)c1c[nH]c2ccccc12	N-ethyl-N-[1H-indol-3-yl-(4-methylphenyl)methyl]-2-methylpropanamide			4.477670000000004														334.46532		334.204513	1	1	5	3			46										False					Peptide01			Compound(121238543)	121238543	4.8	1186			[#6]-[#6]-[#7](-[#6](=[#8])-[#6](-[#6])-[#6])-[#6](-[#6]1:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CCN(C(=O)C(C)C)C(c1ccc(C)cc1)c1c[nH]c2ccccc12	KGIXLRSVSSHUJV		parent_pubchem_cid	AKOS027473433;N-ethyl-N-[1H-indol-3-yl(p-tolyl)methyl]-2-methyl-propanamide		147773818.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=147773818		pluskal_iocb_peptide_Peptide01_G5_id		100	G5		
4.8		0	632	P1308226	45.3		AD8	False	0	23	0	0	28	0	2	2	0	0		0.0						CCN(C(=O)CC(C)C)C(c1ccc(OC)cc1)c1c[nH]c2ccccc12																							0.0		AKOS002292609		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C23H28N2O2	C23H28N2O2			InChI=1S/C23H28N2O2/c1-5-25(22(26)14-16(2)3)23(17-10-12-18(27-4)13-11-17)20-15-24-21-9-7-6-8-19(20)21/h6-13,15-16,23-24H,5,14H2,1-4H3	PPPYFVSKSFBIQJ-UHFFFAOYSA-N	N-ethyl-N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-3-methyl-butanamide	43843319	CCN(C(=O)CC(C)C)C(c1ccc(OC)cc1)c1c[nH]c2ccccc12	N-ethyl-N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-3-methylbutanamide			4.160250000000003													MCULE-7358456356	364.49181		364.215078	2	1	7	3			45										False	Alkaloids				Peptide01			Compound(43843319)	43843319	4.6	1187			[#6]-[#6]-[#7](-[#6](=[#8])-[#6]-[#6](-[#6])-[#6])-[#6](-[#6]1:[#6]:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	CCN(C(=O)CC(C)C)C(c1ccc(OC)cc1)c1c[nH]c2ccccc12	PPPYFVSKSFBIQJ		parent_pubchem_cid	AKOS002292609;AKOS016330131;N-ethyl-N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-3-methyl-butanamide		24049464.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24049464		pluskal_iocb_peptide_Peptide01_G5_id		100	G5		
3.5		0	376	P1107419	133.2		AD9	False	0	23	0	0	23	0	1	7	0	0		0.0						Cc1c(CCC(=O)NC(Cc2ccc(O)cc2)C(=O)O)c(=O)oc2c1ccc(O)c2C																							0.0		AKOS016390268		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	3	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C23H23NO7	C23H23NO7			InChI=1S/C23H23NO7/c1-12-16-7-9-19(26)13(2)21(16)31-23(30)17(12)8-10-20(27)24-18(22(28)29)11-14-3-5-15(25)6-4-14/h3-7,9,18,25-26H,8,10-11H2,1-2H3,(H,24,27)(H,28,29)/t18-/m1/s1	TYXJXETWIBYAQJ-GOSISDBHSA-N	rac-(2R)-2-[3-(7-hydroxy-4,8-dimethyl-2-oxo-chromen-3-yl)propanoylamino]-3-(4-hydroxyphenyl)propanoic acid	24280402	Cc1c(CCC(=O)N[C@H](Cc2ccc(O)cc2)C(=O)O)c(=O)oc2c1ccc(O)c2C	(2R)-2-[3-(7-hydroxy-4,8-dimethyl-2-oxochromen-3-yl)propanoylamino]-3-(4-hydroxyphenyl)propanoic acid			1.89355													MCULE-8370791478	425.44226		425.147452	7	4	7	3			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(24280402)	24280402	2.6	1188			[#6]-[#6]1:[#6](-[#6]-[#6]-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6]2:[#6]:[#6]:[#6](-[#8]):[#6]:[#6]:2)-[#6](=[#8])-[#8]):[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]):[#6]:2-[#6]	Cc1c(CCC(=O)N[C@H](Cc2ccc(O)cc2)C(=O)O)c(=O)oc2c1ccc(O)c2C	TYXJXETWIBYAQJ		parent_pubchem_cid	AKOS016390268;2-[3-(7-HYDROXY-4,8-DIMETHYL-2-OXO-2H-CHROMEN-3-YL)PROPANAMIDO]-3-(4-HYDROXYPHENYL)PROPANOIC ACID;rac-(2R)-2-[3-(7-hydroxy-4,8-dimethyl-2-oxo-chromen-3-yl)propanoylamino]-3-(4-hydroxyphenyl)propanoic acid		22628001.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22628001		pluskal_iocb_peptide_Peptide01_G5_id		100	G5		ZINC000011865401
3.7		0	464	P2196137	134.6		AD10	False	0	19	1	0	23	0	4	2	0	2		0.0						CCCSc1ncc(Cl)c(C(=O)NC(CCSC)C(=O)Nc2ccccc2)n1																							0.0		AKOS016027372		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C19H23ClN4O2S2	C19H23ClN4O2S2			InChI=1S/C19H23ClN4O2S2/c1-3-10-28-19-21-12-14(20)16(24-19)18(26)23-15(9-11-27-2)17(25)22-13-7-5-4-6-8-13/h4-8,12,15H,3,9-11H2,1-2H3,(H,22,25)(H,23,26)	TUFHDZBVPGUKSP-UHFFFAOYSA-N	5-chloro-N-[3-methylsulfanyl-1-(phenylcarbamoyl)propyl]-2-propylsulfanyl-pyrimidine-4-carboxamide	52988690	CCCSc1ncc(Cl)c(C(=O)NC(CCSC)C(=O)Nc2ccccc2)n1	N-(1-anilino-4-methylsulfanyl-1-oxobutan-2-yl)-5-chloro-2-propylsulfanylpyrimidine-4-carboxamide			3.5789700000000018													MCULE-1221800884	439.00176		438.095096	6	2	10	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(52988690)	52988690	4.1	1189			[#6]-[#6]-[#6]-[#16]-[#6]1:[#7]:[#6]:[#6](-[#17]):[#6](-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]-[#16]-[#6])-[#6](=[#8])-[#7]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#7]:1	CCCSc1ncc(Cl)c(C(=O)NC(CCSC)C(=O)Nc2ccccc2)n1	TUFHDZBVPGUKSP		parent_pubchem_cid	AKOS016027372;5-chloro-N-[3-methylsulfanyl-1-(phenylcarbamoyl)propyl]-2-propylsulfanyl-pyrimidine-4-carboxamide		24710510.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24710510		pluskal_iocb_peptide_Peptide01_G5_id		100	G5		
3.6		0	552	P6138780	94.1		AD11	False	0	21	0	0	23	0	7	1	0	0		0.0						CCc1nc(C#N)c(N2CCN(c3ncnc(Nc4ccc(C)cc4)c3)CC2)o1																							0.0		AKOS016026434		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	2		C21H23N7O	C21H23N7O			InChI=1S/C21H23N7O/c1-3-20-26-17(13-22)21(29-20)28-10-8-27(9-11-28)19-12-18(23-14-24-19)25-16-6-4-15(2)5-7-16/h4-7,12,14H,3,8-11H2,1-2H3,(H,23,24,25)	GIFYXEOCSAZZGJ-UHFFFAOYSA-N	2-ethyl-5-[4-[6-(4-methylanilino)pyrimidin-4-yl]piperazin-1-yl]oxazole-4-carbonitrile	60173978	CCc1nc(C#N)c(N2CCN(c3ncnc(Nc4ccc(C)cc4)c3)CC2)o1	2-ethyl-5-[4-[6-(4-methylanilino)pyrimidin-4-yl]piperazin-1-yl]-1,3-oxazole-4-carbonitrile			1.590729999999999													MCULE-3413520987	389.46376		389.196408	7	1	5	4			44										False	Alkaloids	Pseudoalkaloids			Peptide01			Compound(60173978)	60173978	4.1	1190			[#6]-[#6]-[#6]1:[#7]:[#6](-[#6]#[#7]):[#6](-[#7]2-[#6]-[#6]-[#7](-[#6]3:[#7]:[#6]:[#7]:[#6](-[#7]-[#6]4:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:4):[#6]:3)-[#6]-[#6]-2):[#8]:1	CCc1nc(C#N)c(N2CCN(c3ncnc(Nc4ccc(C)cc4)c3)CC2)o1	GIFYXEOCSAZZGJ		parent_pubchem_cid	AKOS016026434;2-ethyl-5-[4-[6-(4-methylanilino)pyrimidin-4-yl]piperazin-1-yl]oxazole-4-carbonitrile		67385820.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=67385820		pluskal_iocb_peptide_Peptide01_G5_id		100	G5		ZINC000080345670
4.7		0	640	P1309683	73.0		AD12	False	0	27	0	0	28	0	2	5	0	0		0.0						COc1ccc(C(c2c[nH]c3ccccc23)N(C)C(=O)c2cc(OC)c(OC)c(OC)c2)cc1																							0.0		AKOS001544307		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C27H28N2O5	C27H28N2O5			InChI=1S/C27H28N2O5/c1-29(27(30)18-14-23(32-3)26(34-5)24(15-18)33-4)25(17-10-12-19(31-2)13-11-17)21-16-28-22-9-7-6-8-20(21)22/h6-16,25,28H,1-5H3	ZZRWDOALCQDRAD-UHFFFAOYSA-N	N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-3,4,5-trimethoxy-N-methyl-benzamide	20895159	COc1ccc(C(c2c[nH]c3ccccc23)N(C)C(=O)c2cc(OC)c(OC)c(OC)c2)cc1	N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-3,4,5-trimethoxy-N-methylbenzamide			2.621710000000001													MCULE-6498201711	460.53461		460.199822	5	1	8	4			45										False	Alkaloids				Peptide01			Compound(20895159)	20895159	4.6	1191			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#7](-[#6])-[#6](=[#8])-[#6]2:[#6]:[#6](-[#8]-[#6]):[#6](-[#8]-[#6]):[#6](-[#8]-[#6]):[#6]:2):[#6]:[#6]:1	COc1ccc(C(c2c[nH]c3ccccc23)N(C)C(=O)c2cc(OC)c(OC)c(OC)c2)cc1	ZZRWDOALCQDRAD		parent_pubchem_cid	AKOS001544307;AKOS016329851;N-[(1H-INDOL-3-YL)(4-METHOXYPHENYL)METHYL]-3,4,5-TRIMETHOXY-N-METHYLBENZAMIDE;N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-3,4,5-trimethoxy-N-methyl-benzamide		23552134.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23552134		pluskal_iocb_peptide_Peptide01_G5_id		100	G5		
4.4		0	384	P1158198	88.2		AD13	False	0	26	0	0	30	0	4	3	0	0		0.0						COc1cc2c(cc1)n(C)c(C(=O)NC(C(=O)NCCc1c[nH]c3ccccc13)C(C)C)c2																							0.0		AKOS016376745		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	1		C26H30N4O3	C26H30N4O3			InChI=1S/C26H30N4O3/c1-16(2)24(26(32)27-12-11-17-15-28-21-8-6-5-7-20(17)21)29-25(31)23-14-18-13-19(33-4)9-10-22(18)30(23)3/h5-10,13-16,24,28H,11-12H2,1-4H3,(H,27,32)(H,29,31)/t24-/m0/s1	VWJWZGCPKPVYRD-DEOSSOPVSA-N	5-methoxy-1-methyl-N-[rac-(1S)-1-[2-(1H-indol-3-yl)ethylcarbamoyl]-2-methyl-propyl]indole-2-carboxamide	17571840	COc1cc2c(cc1)n(C)c(C(=O)N[C@H](C(=O)NCCc1c[nH]c3ccccc13)C(C)C)c2	N-[(2S)-1-[2-(1H-indol-3-yl)ethylamino]-3-methyl-1-oxobutan-2-yl]-5-methoxy-1-methylindole-2-carboxamide			2.352830000000001													MCULE-5529317870	446.554		446.231791	3	3	8	4			44									Carbazole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(17571840)	17571840	4.4	1192			[#6]-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#7](-[#6]):[#6](-[#6](=[#8])-[#7]-[#6@H](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:1:3)-[#6](-[#6])-[#6]):[#6]:2	COc1cc2c(cc1)n(C)c(C(=O)N[C@H](C(=O)NCCc1c[nH]c3ccccc13)C(C)C)c2	VWJWZGCPKPVYRD		parent_pubchem_cid	AKOS016376745;5-methoxy-1-methyl-N-[rac-(1S)-1-[2-(1H-indol-3-yl)ethylcarbamoyl]-2-methyl-propyl]indole-2-carboxamide		1368856.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=1368856		pluskal_iocb_peptide_Peptide01_G6_id		100	G6		ZINC000012664566
4.6		0	472	P2195434	109.3		AD14	False	0	21	1	0	27	0	4	2	0	1		0.0						CCSc1ncc(Cl)c(C(=O)NC(CC(C)C)C(=O)NCc2ccc(C)cc2)n1																							0.0		AKOS015861445		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C21H27ClN4O2S	C21H27ClN4O2S			InChI=1S/C21H27ClN4O2S/c1-5-29-21-24-12-16(22)18(26-21)20(28)25-17(10-13(2)3)19(27)23-11-15-8-6-14(4)7-9-15/h6-9,12-13,17H,5,10-11H2,1-4H3,(H,23,27)(H,25,28)	QJHCUGOHUWKHEF-UHFFFAOYSA-N	5-chloro-2-ethylsulfanyl-N-[3-methyl-1-(p-tolylmethylcarbamoyl)butyl]pyrimidine-4-carboxamide	51065901	CCSc1ncc(Cl)c(C(=O)NC(CC(C)C)C(=O)NCc2ccc(C)cc2)n1	5-chloro-2-ethylsulfanyl-N-[4-methyl-1-[(4-methylphenyl)methylamino]-1-oxopentan-2-yl]pyrimidine-4-carboxamide			3.739180000000003													MCULE-3805364723	434.99194		434.154325	5	2	9	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51065901)	51065901	4.6	1193			[#6]-[#6]-[#16]-[#6]1:[#7]:[#6]:[#6](-[#17]):[#6](-[#6](=[#8])-[#7]-[#6](-[#6]-[#6](-[#6])-[#6])-[#6](=[#8])-[#7]-[#6]-[#6]2:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:2):[#7]:1	CCSc1ncc(Cl)c(C(=O)NC(CC(C)C)C(=O)NCc2ccc(C)cc2)n1	QJHCUGOHUWKHEF		parent_pubchem_cid	AKOS015861445;5-chloro-2-ethylsulfanyl-N-[3-methyl-1-(p-tolylmethylcarbamoyl)butyl]pyrimidine-4-carboxamide		22898925.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22898925		pluskal_iocb_peptide_Peptide01_G6_id		100	G6		
5.0		0	560	P2187822	56.2		AD15	False	0	23	0	0	27	0	3	2	0	0		0.0						Cc1cc(OC(C)C(=O)Nc2ccnn2Cc2ccccc2)c(C(C)C)cc1																							0.0		AKOS008703630		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C23H27N3O2	C23H27N3O2			InChI=1S/C23H27N3O2/c1-16(2)20-11-10-17(3)14-21(20)28-18(4)23(27)25-22-12-13-24-26(22)15-19-8-6-5-7-9-19/h5-14,16,18H,15H2,1-4H3,(H,25,27)	RCJJILXARBGJOI-UHFFFAOYSA-N	N-(2-benzylpyrazol-3-yl)-2-(2-isopropyl-5-methyl-phenoxy)propanamide	45155187	Cc1cc(OC(C)C(=O)Nc2ccnn2Cc2ccccc2)c(C(C)C)cc1	N-(2-benzylpyrazol-3-yl)-2-(5-methyl-2-propan-2-ylphenoxy)propanamide			3.762070000000003													MCULE-6918505625	377.49054		377.210327	3	1	7	3			45										False	Terpenoids				Peptide01			Compound(45155187)	45155187	4.9	1194			[#6]-[#6]1:[#6]:[#6](-[#8]-[#6](-[#6])-[#6](=[#8])-[#7]-[#6]2:[#6]:[#6]:[#7]:[#7]:2-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6](-[#6](-[#6])-[#6]):[#6]:[#6]:1	Cc1cc(OC(C)C(=O)Nc2ccnn2Cc2ccccc2)c(C(C)C)cc1	RCJJILXARBGJOI		parent_pubchem_cid	AKOS008703630;N-(1-benzyl-1H-pyrazol-5-yl)-2-[5-methyl-2-(propan-2-yl)phenoxy]propanamide;N-(2-benzylpyrazol-3-yl)-2-(2-isopropyl-5-methyl-phenoxy)propanamide		24673706.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24673706		pluskal_iocb_peptide_Peptide01_G6_id		100	G6		
5.0		0	648	P1308257	70.2		AD16	False	0	25	0	0	22	0	2	1	0	1		0.0						O=C(NCCc1csc(-c2ccccc2)n1)C(c1ccccc1)c1ccccc1																							0.0		2,2-diphenyl-N-[2-(2-phenyl-1,3-thiazol-4-yl)ethyl]acetamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C25H22N2OS	C25H22N2OS			InChI=1S/C25H22N2OS/c28-24(23(19-10-4-1-5-11-19)20-12-6-2-7-13-20)26-17-16-22-18-29-25(27-22)21-14-8-3-9-15-21/h1-15,18,23H,16-17H2,(H,26,28)	JOOYOXJOAVXLEV-UHFFFAOYSA-N	2,2-diphenyl-N-[2-(2-phenylthiazol-4-yl)ethyl]acetamide	35343932	O=C(NCCc1csc(-c2ccccc2)n1)C(c1ccccc1)c1ccccc1	2,2-diphenyl-N-[2-(2-phenyl-1,3-thiazol-4-yl)ethyl]acetamide			4.756750000000004													MCULE-6598012230	398.53089		398.145284	2	1	7	4			44										False	Alkaloids				Peptide01			Compound(35343932)	35343932	5.5	1195			[#8]=[#6](-[#7]-[#6]-[#6]-[#6]1:[#6]:[#16]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#7]:1)-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	O=C(NCCc1csc(-c2ccccc2)n1)C(c1ccccc1)c1ccccc1	JOOYOXJOAVXLEV		parent_pubchem_cid	2,2-diphenyl-N-[2-(2-phenyl-1,3-thiazol-4-yl)ethyl]acetamide;AKOS002291302;2,2-diphenyl-N-[2-(2-phenylthiazol-4-yl)ethyl]acetamide		14722251.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=14722251		pluskal_iocb_peptide_Peptide01_G6_id		100	G6		ZINC000027992571
3.2		0	392	P6248890	91.9		AD17	False	0	19	0	0	17	0	1	4	0	1		0.0						O=C(O)C(Cc1ccccc1)NS(=O)(=O)c1cc2ccccc2cc1								2-naphthalene sulfonic acids and derivatives;2-naphthalene sulfonamides;Phenylpropanoic acids;Amphetamines and derivatives;Organosulfonamides;Aminosulfonyl compounds;Monocarboxylic acids and derivatives;Carboxylic acids;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	2-naphthalene sulfonamides;2-naphthalene sulfonic acids and derivatives;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Aminosulfonyl compounds;Amphetamines and derivatives;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Hydrocarbon derivatives;Monocarboxylic acids and derivatives;Naphthalene sulfonamides;Naphthalene sulfonic acids and derivatives;Naphthalenes;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organic sulfonic acids and derivatives;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Organosulfonamides;Organosulfonic acids and derivatives;Organosulfur compounds;Phenethylamines;Phenylalanine and derivatives;Phenylpropanoic acids;Phenylpropanoids and polyketides;Sulfonyls	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic homopolycyclic compounds	sulfonic acid derivative (CHEBI:33552);naphthalenes (CHEBI:25477);sulfonamide (CHEBI:35358);benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);amphetamines (CHEBI:35338);organosulfur compound (CHEBI:33261);organonitrogen compound (CHEBI:35352);monocarboxylic acid (CHEBI:25384);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);organooxygen compound (CHEBI:36963);primary amine (CHEBI:32877);organic acid (CHEBI:64709);organic molecular entity (CHEBI:50860);sulfone (CHEBI:35850);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806);carboxylic acid anion (CHEBI:29067);amino acid (CHEBI:33709);peptide (CHEBI:16670)		Amino acids, peptides, and analogues	Phenylalanine or derivatives;2-naphthalene sulfonamide;Naphthalene sulfonamide;2-naphthalene sulfonic acid or derivatives;Naphthalene sulfonic acid or derivatives;3-phenylpropanoic-acid;Amphetamine or derivatives;Naphthalene;Benzenoid;Monocyclic benzene moiety;Organosulfonic acid amide;Aminosulfonyl compound;Sulfonyl;Organosulfonic acid or derivatives;Organic sulfonic acid or derivatives;Carboxylic acid;Monocarboxylic acid or derivatives;Organooxygen compound;Organonitrogen compound;Hydrocarbon derivative;Organic oxide;Carbonyl group;Organic oxygen compound;Organosulfur compound;Organic nitrogen compound;Aromatic homopolycyclic compound	Organic acids and derivatives	0.0		90427-55-7	DTXSID50389554	2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0		C19H17NO4S	C19H17NO4S			InChI=1S/C19H17NO4S/c21-19(22)18(12-14-6-2-1-3-7-14)20-25(23,24)17-11-10-15-8-4-5-9-16(15)13-17/h1-11,13,18,20H,12H2,(H,21,22)	RRSYAACXBJFWRS-UHFFFAOYSA-N	2-(2-naphthylsulfonylamino)-3-phenyl-propanoic acid	3125909	O=C(O)C(Cc1ccccc1)NS(=O)(=O)c1cc2ccccc2cc1	2-(naphthalen-2-ylsulfonylamino)-3-phenylpropanoic acid			2.2228600000000007													MCULE-3726839477	355.41564		355.087829	4	2	6	3			42										False	Shikimates and Phenylpropanoids				Peptide01	PD115324		Compound(3125909)	3125909	3.7	1196		SCHEMBL3310154	[#8]=[#6](-[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#16](=[#8])(=[#8])-[#6]1:[#6]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:[#6]:1	O=C(O)C(Cc1ccccc1)NS(=O)(=O)c1cc2ccccc2cc1	RRSYAACXBJFWRS		parent_pubchem_cid	90427-55-7;2-[(2-naphthylsulfonyl)amino]-3-phenylpropanoic acid;2-(naphthalene-2-sulfonamido)-3-phenylpropanoic acid;2-(naphthalen-2-ylsulfonylamino)-3-phenylpropanoic acid;Oprea1_036720;Oprea1_038693;SCHEMBL3310154;DTXSID50389554;RRSYAACXBJFWRS-UHFFFAOYSA-N;MFCD01873085;AKOS001111529;AKOS016051035;WAY-297031;CS-0222902;EN300-11308;SR-01000325948;2-(naphthalene-2-sulfonamido)-3-phenylpropanoicacid;SR-01000325948-1;2-[(2-naphthylsulphonyl)amino]-3-phenylpropanoic acid;Z45636832;2-(2-naphthylsulfonylamino)-3-phenyl-propanoic acid		22639803.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22639803		pluskal_iocb_peptide_Peptide01_G6_id		100	G6		
4.4		0	480	P2195232	84.5		AD18	False	0	27	0	0	28	0	2	4	0	0		0.0						COC(=O)C(Cc1ccccc1)NC(=O)C(Cc1ccccc1)NC(=O)c1ccc(C)cc1																							0.0		AKOS015861305		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	2	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C27H28N2O4	C27H28N2O4			InChI=1S/C27H28N2O4/c1-19-13-15-22(16-14-19)25(30)28-23(17-20-9-5-3-6-10-20)26(31)29-24(27(32)33-2)18-21-11-7-4-8-12-21/h3-16,23-24H,17-18H2,1-2H3,(H,28,30)(H,29,31)	ZUKXHNUNXWJAOJ-UHFFFAOYSA-N	methyl 2-[[2-[(4-methylbenzoyl)amino]-3-phenyl-propanoyl]amino]-3-phenyl-propanoate	51065740	COC(=O)C(Cc1ccccc1)NC(=O)C(Cc1ccccc1)NC(=O)c1ccc(C)cc1	methyl 2-[[2-[(4-methylbenzoyl)amino]-3-phenylpropanoyl]amino]-3-phenylpropanoate			3.017780000000001													MCULE-9544382672	444.53521		444.204907	4	2	10	3			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51065740)	51065740	3.9	1197			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:1	COC(=O)C(Cc1ccccc1)NC(=O)C(Cc1ccccc1)NC(=O)c1ccc(C)cc1	ZUKXHNUNXWJAOJ		parent_pubchem_cid	AKOS015861305;methyl 2-[[2-[(4-methylbenzoyl)amino]-3-phenyl-propanoyl]amino]-3-phenyl-propanoate		22672366.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22672366		pluskal_iocb_peptide_Peptide01_G6_id		100	G6		
4.4		0	568	P1310237	100.4		AD19	False	0	25	0	0	23	0	3	5	0	0		0.0						COc1ccc(C(c2c[nH]c3ccccc23)N(C)C(=O)COc2ccc([N+](=O)[O-])cc2)cc1																							0.0		AKOS002280638		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	1		C25H23N3O5	C25H23N3O5			InChI=1S/C25H23N3O5/c1-27(24(29)16-33-20-13-9-18(10-14-20)28(30)31)25(17-7-11-19(32-2)12-8-17)22-15-26-23-6-4-3-5-21(22)23/h3-15,25-26H,16H2,1-2H3	UDBVNEVBIKYPBL-UHFFFAOYSA-N	N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-N-methyl-2-(4-nitrophenoxy)acetamide	43843746	COc1ccc(C(c2c[nH]c3ccccc23)N(C)C(=O)COc2ccc([N+](=O)[O-])cc2)cc1	N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-N-methyl-2-(4-nitrophenoxy)acetamide			2.8682300000000014													MCULE-4545303376	445.47916		445.163771	5	1	8	4			45										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(43843746)	43843746	4.5	1198			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#7](-[#6])-[#6](=[#8])-[#6]-[#8]-[#6]2:[#6]:[#6]:[#6](-[#7+](=[#8])-[#8-]):[#6]:[#6]:2):[#6]:[#6]:1	COc1ccc(C(c2c[nH]c3ccccc23)N(C)C(=O)COc2ccc([N+](=O)[O-])cc2)cc1	UDBVNEVBIKYPBL		parent_pubchem_cid	AKOS002280638;AKOS016329040;N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-N-methyl-2-(4-nitrophenoxy)acetamide		23699940.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23699940		pluskal_iocb_peptide_Peptide01_G6_id		100	G6		
3.7		0	656	P7119983271	103.5		AD20	False	0	24	0	0	21	0	3	3	0	0		0.0						COc1c(OCc2ccccc2)ccc(C2C(C#N)=C(N)Oc3c2ccc(N)c3)c1																							0.0		AKOS002265356		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0		C24H21N3O3	C24H21N3O3			InChI=1S/C24H21N3O3/c1-28-22-11-16(7-10-20(22)29-14-15-5-3-2-4-6-15)23-18-9-8-17(26)12-21(18)30-24(27)19(23)13-25/h2-12,23H,14,26-27H2,1H3	SGPWVJGKFRCPLI-UHFFFAOYSA-N	2,7-diamino-4-(4-benzyloxy-3-methoxy-phenyl)-4H-chromene-3-carbonitrile	16446119	COc1c(OCc2ccccc2)ccc(C2C(C#N)=C(N)Oc3c2ccc(N)c3)c1	2,7-diamino-4-(3-methoxy-4-phenylmethoxyphenyl)-4H-chromene-3-carbonitrile			2.1426100000000003													MCULE-2449305808	399.45327		399.158292	6	2	5	4			45										False	Alkaloids				Peptide01			Compound(16446119)	16446119	4.0	1199			[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6]:[#6]:[#6](-[#6]2-[#6](-[#6]#[#7])=[#6](-[#7])-[#8]-[#6]3:[#6]-2:[#6]:[#6]:[#6](-[#7]):[#6]:3):[#6]:1	COc1c(OCc2ccccc2)ccc(C2C(C#N)=C(N)Oc3c2ccc(N)c3)c1	SGPWVJGKFRCPLI		parent_pubchem_cid	AKOS002265356;AKOS016309747;2,7-diamino-4-(4-benzyloxy-3-methoxy-phenyl)-4H-chromene-3-carbonitrile		24095740.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24095740		pluskal_iocb_peptide_Peptide01_G6_id		100	G6		
2.2		0	400	P11184213	84.9		AD21	False	0	17	0	0	23	0	1	5	0	0		0.0						CCC(C)C(NC(=O)Cc1cc2c(cc1)OCCCO2)C(=O)O																							0.0		AKOS027472133		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C17H23NO5	C17H23NO5			InChI=1S/C17H23NO5/c1-3-11(2)16(17(20)21)18-15(19)10-12-5-6-13-14(9-12)23-8-4-7-22-13/h5-6,9,11,16H,3-4,7-8,10H2,1-2H3,(H,18,19)(H,20,21)/t11-,16+/m1/s1	FOKBJVQKHDYYOO-BZNIZROVSA-N	rac-(2S,3R)-2-[[2-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)acetyl]amino]-3-methyl-pentanoic acid	75491860	CC[C@@H](C)[C@H](NC(=O)Cc1cc2c(cc1)OCCCO2)C(=O)O	(2S,3R)-2-[[2-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)acetyl]amino]-3-methylpentanoic acid			1.0263699999999998														321.37656		321.157623	5	2	6	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(75491860)	75491860	2.5	1200			[#6]-[#6]-[#6@@H](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1)-[#8]-[#6]-[#6]-[#6]-[#8]-2)-[#6](=[#8])-[#8]	CC[C@@H](C)[C@H](NC(=O)Cc1cc2c(cc1)OCCCO2)C(=O)O	FOKBJVQKHDYYOO		parent_pubchem_cid	AKOS027472133;N-[(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)acetyl]isoleucine;rac-(2S,3R)-2-[[2-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)acetyl]amino]-3-methyl-pentanoic acid		80416272.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=80416272		pluskal_iocb_peptide_Peptide01_G7_id		100	G7		ZINC000096221930
4.0		0	488	P2195276	76.7		AD22	False	0	25	0	0	26	0	2	4	0	0		0.0						CCOc1ccc(NC(=O)C(Cc2ccccc2)NC(=O)c2ccc(OC)cc2)cc1																							0.0		AKOS015861327		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C25H26N2O4	C25H26N2O4			InChI=1S/C25H26N2O4/c1-3-31-22-15-11-20(12-16-22)26-25(29)23(17-18-7-5-4-6-8-18)27-24(28)19-9-13-21(30-2)14-10-19/h4-16,23H,3,17H2,1-2H3,(H,26,29)(H,27,28)	CWSNJEHZKFNNMU-UHFFFAOYSA-N	N-[1-benzyl-2-(4-ethoxyanilino)-2-oxo-ethyl]-4-methoxy-benzamide	51065781	CCOc1ccc(NC(=O)C(Cc2ccccc2)NC(=O)c2ccc(OC)cc2)cc1	N-[1-(4-ethoxyanilino)-1-oxo-3-phenylpropan-2-yl]-4-methoxybenzamide			2.658850000000001													MCULE-4437304012	418.49697		418.189257	4	2	9	3			45										False	Amino acids and Peptides				Peptide01			Compound(51065781)	51065781	4.4	1201			[#6]-[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#7]-[#6](=[#8])-[#6](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:2):[#6]:[#6]:1	CCOc1ccc(NC(=O)C(Cc2ccccc2)NC(=O)c2ccc(OC)cc2)cc1	CWSNJEHZKFNNMU		parent_pubchem_cid	AKOS015861327;N-[1-benzyl-2-(4-ethoxyanilino)-2-oxo-ethyl]-4-methoxy-benzamide		23546520.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23546520		pluskal_iocb_peptide_Peptide01_G7_id		100	G7		
4.9		0	576	P1307059	73.6		AD23	False	0	23	0	0	22	0	2	2	0	1		0.0						Cc1ccccc1OCC(=O)N(C)C(c1cccs1)c1c[nH]c2ccccc12																							0.0		STL208084		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C23H22N2O2S	C23H22N2O2S			InChI=1S/C23H22N2O2S/c1-16-8-3-6-11-20(16)27-15-22(26)25(2)23(21-12-7-13-28-21)18-14-24-19-10-5-4-9-17(18)19/h3-14,23-24H,15H2,1-2H3	CKKSQZPDGZGZFD-UHFFFAOYSA-N	N-[1H-indol-3-yl(2-thienyl)methyl]-N-methyl-2-(2-methylphenoxy)acetamide	20895181	Cc1ccccc1OCC(=O)N(C)C(c1cccs1)c1c[nH]c2ccccc12	N-[1H-indol-3-yl(thiophen-2-yl)methyl]-N-methyl-2-(2-methylphenoxy)acetamide			4.109660000000003													MCULE-6184408764	390.50799		390.140199	2	1	6	4			45									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(20895181)	20895181	4.8	1202			[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#8]-[#6]-[#6](=[#8])-[#7](-[#6])-[#6](-[#6]1:[#6]:[#6]:[#6]:[#16]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	Cc1ccccc1OCC(=O)N(C)C(c1cccs1)c1c[nH]c2ccccc12	CKKSQZPDGZGZFD		parent_pubchem_cid	STL208084;AKOS001910896;AKOS016329107;N-[(1H-INDOL-3-YL)(THIOPHEN-2-YL)METHYL]-N-METHYL-2-(2-METHYLPHENOXY)ACETAMIDE;N-[1H-indol-3-yl(thiophen-2-yl)methyl]-N-methyl-2-(2-methylphenoxy)acetamide;N-[1H-indol-3-yl(2-thienyl)methyl]-N-methyl-2-(2-methylphenoxy)acetamide		23396832.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23396832		pluskal_iocb_peptide_Peptide01_G7_id		100	G7		
4.9		0	664	P7119982260	45.9		AD24	False	0	25	0	0	30	0	2	3	0	0	-1.0	0.0						CC(C)COc1ccc(C(=O)N(Cc2ccc(N(C)C)cc2)Cc2ccco2)cc1		5.22		0.0	4.98	CHEMBL1611607																	0.0		CHEMBL1611607		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1		C25H30N2O3	C25H30N2O3			InChI=1S/C25H30N2O3/c1-19(2)18-30-23-13-9-21(10-14-23)25(28)27(17-24-6-5-15-29-24)16-20-7-11-22(12-8-20)26(3)4/h5-15,19H,16-18H2,1-4H3	LXUSKDRZKJTXGK-UHFFFAOYSA-N	N-[[4-(dimethylamino)phenyl]methyl]-N-(2-furylmethyl)-4-isobutoxy-benzamide	16013240	CC(C)COc1ccc(C(=O)N(Cc2ccc(N(C)C)cc2)Cc2ccco2)cc1	N-[[4-(dimethylamino)phenyl]methyl]-N-(furan-2-ylmethyl)-4-(2-methylpropoxy)benzamide			4.215850000000004													MCULE-7288084392	406.52945	NEUTRAL	406.225643	3	0	9	3	0.0		29										False			False	False	Peptide01		-1.0	Compound(16013240)	16013240	4.9	1203			[#6]-[#6](-[#6])-[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](=[#8])-[#7](-[#6]-[#6]2:[#6]:[#6]:[#6](-[#7](-[#6])-[#6]):[#6]:[#6]:2)-[#6]-[#6]2:[#6]:[#6]:[#6]:[#8]:2):[#6]:[#6]:1	CC(C)COc1ccc(C(=O)N(Cc2ccc(N(C)C)cc2)Cc2ccco2)cc1	LXUSKDRZKJTXGK		parent_pubchem_cid	CHEMBL1611607;HMS1844I17;AKOS001514418;NCGC00115589-01;D062-0237;N-{[4-(DIMETHYLAMINO)PHENYL]METHYL}-N-[(FURAN-2-YL)METHYL]-4-(2-METHYLPROPOXY)BENZAMIDE;N-[[4-(dimethylamino)phenyl]methyl]-N-(2-furylmethyl)-4-isobutoxy-benzamide	False	925920.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=925920		pluskal_iocb_peptide_Peptide01_G7_id		100	G7	False	ZINC000006804325
4.4		0	408	P6236879	123.3		AD25	False	1	22	0	0	18	0	3	3	0	1		0.0						O=C(Cc1csc(-c2cc(Br)ccc2)n1)NC(Cc1c[nH]c2ccccc12)C(=O)O																							0.0		SCHEMBL20255642		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C22H18BrN3O3S	C22H18BrN3O3S			InChI=1S/C22H18BrN3O3S/c23-15-5-3-4-13(8-15)21-25-16(12-30-21)10-20(27)26-19(22(28)29)9-14-11-24-18-7-2-1-6-17(14)18/h1-8,11-12,19,24H,9-10H2,(H,26,27)(H,28,29)/t19-/m0/s1	LAYSXONAXKMGOF-IBGZPJMESA-N	rac-(2S)-2-[[2-[2-(3-bromophenyl)thiazol-4-yl]acetyl]amino]-3-(1H-indol-3-yl)propanoic acid	29147406	O=C(Cc1csc(-c2cc(Br)ccc2)n1)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	(2S)-2-[[2-[2-(3-bromophenyl)-1,3-thiazol-4-yl]acetyl]amino]-3-(1H-indol-3-yl)propanoic acid			3.490640000000001													MCULE-8794940393	484.37506		483.025225	4	3	7	4			43										False	Alkaloids				Peptide01			Compound(29147406)	29147406	4.3	1204		SCHEMBL20255642	[#8]=[#6](-[#6]-[#6]1:[#6]:[#16]:[#6](-[#6]2:[#6]:[#6](-[#35]):[#6]:[#6]:[#6]:2):[#7]:1)-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	O=C(Cc1csc(-c2cc(Br)ccc2)n1)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	LAYSXONAXKMGOF		parent_pubchem_cid	SCHEMBL20255642;AKOS016402477;rac-(2S)-2-[[2-[2-(3-bromophenyl)thiazol-4-yl]acetyl]amino]-3-(1H-indol-3-yl)propanoic acid		23783403.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23783403		pluskal_iocb_peptide_Peptide01_G7_id		100	G7		ZINC000020761248
4.9		0	496	P2194875	68.3		AD26	False	0	26	0	0	22	0	2	3	0	0	-1.0	0.0						COC(=O)C(Cc1ccccc1)NC(=O)c1cc(-c2ccccc2)nc2ccccc12		4.42		0.0	5.09	CHEMBL295270		Phenylquinolines;Alpha amino acid esters;Quinoline carboxamides;N-acyl-alpha amino acids and derivatives;Phenylpyridines;Amphetamines and derivatives;Pyridinecarboxylic acids and derivatives;Fatty acid esters;Methyl esters;Heteroaromatic compounds;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Azacyclic compounds;Hydrocarbon derivatives;Carbonyl compounds;Organonitrogen compounds;Organic oxides	Alpha amino acid esters;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids and derivatives;Chemical entities;Fatty Acyls;Fatty acid esters;Heteroaromatic compounds;Hydrocarbon derivatives;Lipids and lipid-like molecules;Methyl esters;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenethylamines;Phenylalanine and derivatives;Phenylpyridines;Phenylquinolines;Pyridinecarboxylic acids and derivatives;Pyridines and derivatives;Quinoline carboxamides;Quinolines and derivatives;Secondary carboxylic acid amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	quinolines (CHEBI:26513);alpha-amino acid ester (CHEBI:46874);carboxamide (CHEBI:37622);N-acyl-amino acid (CHEBI:51569);phenylpyridine (CHEBI:38193);amphetamines (CHEBI:35338);aromatic carboxylic acid (CHEBI:33859);pyridinemonocarboxylic acid (CHEBI:26420);fatty acid ester (CHEBI:35748);carboxylic ester (CHEBI:33308);organic aromatic compound (CHEBI:33659);monocarboxylic acid (CHEBI:25384);organonitrogen heterocyclic compound (CHEBI:38101);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);organooxygen compound (CHEBI:36963);pyridines (CHEBI:26421);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);primary amine (CHEBI:32877);lipid (CHEBI:18059);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143);amino acid (CHEBI:33709);peptide (CHEBI:16670)	Fatty esters (FA07);Fatty Acyls (FA)	Amino acids, peptides, and analogues	Phenylalanine or derivatives;Phenylquinoline;Alpha-amino acid ester;N-acyl-alpha amino acid or derivatives;Quinoline-4-carboxamide;2-phenylpyridine;Amphetamine or derivatives;Quinoline;Pyridine carboxylic acid or derivatives;Fatty acid ester;Monocyclic benzene moiety;Fatty acyl;Pyridine;Benzenoid;Heteroaromatic compound;Methyl ester;Carboxylic acid ester;Carboxamide group;Secondary carboxylic acid amide;Azacycle;Monocarboxylic acid or derivatives;Organoheterocyclic compound;Organic oxygen compound;Organooxygen compound;Organonitrogen compound;Hydrocarbon derivative;Organic oxide;Carbonyl group;Organic nitrogen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		CHEMBL295270		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C26H22N2O3	C26H22N2O3			InChI=1S/C26H22N2O3/c1-31-26(30)24(16-18-10-4-2-5-11-18)28-25(29)21-17-23(19-12-6-3-7-13-19)27-22-15-9-8-14-20(21)22/h2-15,17,24H,16H2,1H3,(H,28,29)	MHAKERWYUZJBFW-UHFFFAOYSA-N	methyl 3-phenyl-2-[(2-phenylquinoline-4-carbonyl)amino]propanoate	10716491	COC(=O)C(Cc1ccccc1)NC(=O)c1cc(-c2ccccc2)nc2ccccc12	methyl 3-phenyl-2-[(2-phenylquinoline-4-carbonyl)amino]propanoate			3.4980400000000014													MCULE-1339188441	410.47684	NEUTRAL	410.163043	4	1	7	4	0.0		29										False	Alkaloids		False	False	Peptide01		-1.0	Compound(10716491)	10716491	5.0	1205		SCHEMBL7532008	[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	COC(=O)C(Cc1ccccc1)NC(=O)c1cc(-c2ccccc2)nc2ccccc12	MHAKERWYUZJBFW		parent_pubchem_cid	CHEMBL295270;SCHEMBL7532008;BDBM50058259;AKOS015861167;3-Phenyl-2-[(2-phenyl-quinoline-4-carbonyl)-amino]-propionic acid methyl ester;methyl 3-phenyl-2-[(2-phenylquinoline-4-carbonyl)amino]propanoate	False	462364.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=462364		pluskal_iocb_peptide_Peptide01_G7_id		100	G7	False	
5.0		0	584	P1310230	54.6		AD27	False	0	26	0	0	26	0	2	3	0	0		0.0						COc1ccc(C(c2c[nH]c3ccccc23)N(C)C(=O)COc2ccccc2C)cc1																							0.0		AKOS002281637		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C26H26N2O3	C26H26N2O3			InChI=1S/C26H26N2O3/c1-18-8-4-7-11-24(18)31-17-25(29)28(2)26(19-12-14-20(30-3)15-13-19)22-16-27-23-10-6-5-9-21(22)23/h4-16,26-27H,17H2,1-3H3	PWPDIWPYHVXCOS-UHFFFAOYSA-N	N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-N-methyl-2-(2-methylphenoxy)acetamide	43843739	COc1ccc(C(c2c[nH]c3ccccc23)N(C)C(=O)COc2ccccc2C)cc1	N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-N-methyl-2-(2-methylphenoxy)acetamide			3.594350000000002													MCULE-5705120991	414.50872		414.194343	3	1	7	4			45										False	Alkaloids				Peptide01			Compound(43843739)	43843739	5.1	1206			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#7](-[#6])-[#6](=[#8])-[#6]-[#8]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6]):[#6]:[#6]:1	COc1ccc(C(c2c[nH]c3ccccc23)N(C)C(=O)COc2ccccc2C)cc1	PWPDIWPYHVXCOS		parent_pubchem_cid	AKOS002281637;AKOS016329033;N-[(1H-INDOL-3-YL)(4-METHOXYPHENYL)METHYL]-N-METHYL-2-(2-METHYLPHENOXY)ACETAMIDE;N-[1H-indol-3-yl-(4-methoxyphenyl)methyl]-N-methyl-2-(2-methylphenoxy)acetamide		24261650.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24261650		pluskal_iocb_peptide_Peptide01_G7_id		100	G7		
4.8		0	672	P1305271	54.1		AD28	False	0	24	0	1	21	0	2	2	0	0		0.0						COc1ccc(C(CNC(=O)c2ccc(F)cc2)c2c[nH]c3ccccc23)cc1																							0.0		4-fluoro-N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]benzamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C24H21FN2O2	C24H21FN2O2			InChI=1S/C24H21FN2O2/c1-29-19-12-8-16(9-13-19)21(22-15-26-23-5-3-2-4-20(22)23)14-27-24(28)17-6-10-18(25)11-7-17/h2-13,15,21,26H,14H2,1H3,(H,27,28)	CNHLONJADITFHE-UHFFFAOYSA-N	4-fluoro-N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]benzamide	17014427	COc1ccc(C(CNC(=O)c2ccc(F)cc2)c2c[nH]c3ccccc23)cc1	4-fluoro-N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]benzamide			3.822540000000002													MCULE-8914079848	388.44557		388.158706	2	2	6	4			44										False	Alkaloids				Peptide01			Compound(17014427)	17014427	4.8	1207			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6]-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	COc1ccc(C(CNC(=O)c2ccc(F)cc2)c2c[nH]c3ccccc23)cc1	CNHLONJADITFHE		parent_pubchem_cid	4-fluoro-N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]benzamide;STL207387;AKOS002336035;AKOS016326584		22735779.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22735779		pluskal_iocb_peptide_Peptide01_G7_id		100	G7		
2.2		0	416	P3460037	95.9		AD29	False	0	14	0	0	19	0	1	5	0	0	-1.0	0.0						CC(C)(C)OC(=O)NC(Cc1ccc(O)cc1)C(=O)O		1.91		0.0	2.27	CHEMBL65386		Phenylalanine and derivatives;Phenylpropanoic acids;Amphetamines and derivatives;1-hydroxy-2-unsubstituted benzenoids;Carbamate esters;Organic carbonic acids and derivatives;Monocarboxylic acids and derivatives;Carboxylic acids;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	1-hydroxy-2-unsubstituted benzenoids;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Benzene and substituted derivatives;Benzenoids;Carbamate esters;Carbamic acids and derivatives;Carbonyl compounds;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Hydrocarbon derivatives;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenethylamines;Phenols;Phenylalanine and derivatives;Phenylpropanoic acids;Phenylpropanoids and polyketides;Tyrosine and derivatives	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as tyrosine and derivatives. These are compounds containing tyrosine or a derivative thereof resulting from reaction of tyrosine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Tyrosine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic homomonocyclic compounds	phenylalanine derivative (CHEBI:25985);benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);amphetamines (CHEBI:35338);phenols (CHEBI:33853);carbamate ester (CHEBI:23003);organooxygen compound (CHEBI:36963);carbonyl compound (CHEBI:36586);carboxylic acid anion (CHEBI:29067);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);tyrosine derivative (CHEBI:62761);chemical entity (CHEBI:24431);amino acid (CHEBI:33709);peptide (CHEBI:16670);benzenoid aromatic compound (CHEBI:33836);primary amine (CHEBI:32877);carbon oxoacid (CHEBI:35605);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806)		Amino acids, peptides, and analogues	Tyrosine or derivatives;Phenylalanine or derivatives;3-phenylpropanoic-acid;Amphetamine or derivatives;1-hydroxy-2-unsubstituted benzenoid;Phenol;Monocyclic benzene moiety;Benzenoid;Carbamic acid ester;Carbonic acid derivative;Carboxylic acid;Monocarboxylic acid or derivatives;Organooxygen compound;Organonitrogen compound;Organic oxide;Organic oxygen compound;Carbonyl group;Organopnictogen compound;Organic nitrogen compound;Hydrocarbon derivative;Aromatic homomonocyclic compound	Organic acids and derivatives	0.0		Boc-Tyr-OH		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	1	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C14H19NO5	C14H19NO5			InChI=1S/C14H19NO5/c1-14(2,3)20-13(19)15-11(12(17)18)8-9-4-6-10(16)7-5-9/h4-7,11,16H,8H2,1-3H3,(H,15,19)(H,17,18)/t11-/m0/s1	CNBUSIJNWNXLQQ-NSHDSACASA-N	rac-(2S)-2-(tert-butoxycarbonylamino)-3-(4-hydroxyphenyl)propanoic acid	117439	CC(C)(C)OC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O	(2S)-3-(4-hydroxyphenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid			1.39548													MCULE-1908071121	281.31123	ACID	281.126323	5	3	6	1	1.0		28									Dipeptides	False	Amino acids and Peptides;Shikimates and Phenylpropanoids	Small peptides	False	False	Peptide01		-1.0	Compound(117439)	117439	1.5	1208		SCHEMBL231981	[#6]-[#6](-[#6])(-[#6])-[#8]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6](-[#8]):[#6]:[#6]:1)-[#6](=[#8])-[#8]	CC(C)(C)OC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O	CNBUSIJNWNXLQQ		parent_pubchem_cid	Boc-Tyr-OH;Boc-L-tyrosine;3978-80-1;N-Boc-L-tyrosine;N-(tert-Butoxycarbonyl)-L-tyrosine;Boc-Tyr;CHEMBL65386;(S)-2-((tert-butoxycarbonyl)amino)-3-(4-hydroxyphenyl)propanoic acid;MFCD00037179;(S)-2-(TERT-BUTOXYCARBONYLAMINO)-3-(4-HYDROXYPHENYL)PROPANOIC ACID;N-Boc-tyrosine;N-t-BOC-L-Tyrosine;Boc-D-phe(4-OH)-OH;Boc-tyrosine;BocTyrOH;L-Tyrosine, N-[(1,1-dimethylethoxy)carbonyl]-;Boc-(L)-tyrosine;Boc-L-Tyr;N-(tert-Butyloxycarbonyl)-L-tyrosin;BOCTyr-OH;t-butyloxycarbonyltyrosine;Boc-Tyr-OH, 98%;N-tert-butoxycarbonyltyrosine;t-butyloxycarbonyl-L-tyrosine;n-tert-butoxycarbonyl-tyrosine;SCHEMBL231981;(S)-2-tert-Butoxycarbonylamino-3-(4-hydroxy-phenyl)-propionic acid;N-tert-butoxycarbonyl-L-tyrosine;(R)-2-((TERT-BUTOXYCARBONYL)AMINO)-3-(4-HYDROXYPHENYL)PROPANOIC ACID;(S)-N-tert-butoxycarbonyltyrosine;N-tert-butoxy carbonyl-L-tyrosine;DTXSID101317235;N-tertiarybutoxycarbonyl-L-tyrosine;BDBM50043818;N-T-BUTOXYCARBONYL-L-TYROSINE;N-Tertiarybutyloxycarbonyl-L-tyrosine;STL466187;(2S)-2-{[(tert-butoxy)carbonyl]amino}-3-(4-hydroxyphenyl)propanoic acid;AKOS010396897;AKOS015924171;AM82310;CS-W014008;HY-W013292;N-(TERT-BUTOXYCARBONYL)TYROSINE;(TERT-BUTOXYCARBONYL)-L-TYROSINE;AC-16828;AS-12341;PD196901;B1640;N-ALPHA-T-BUTYLOXYCARBONYL-L-TYROSINE;EN300-52852;I10392;M03338;N-(tert-Butoxycarbonyl)-4-hydroxyphenylalanine #;J-300281;J-502158;Q-101769;(S)-2-(tert-butoxycarbonylamino)-3-(4-hydroxyphenyl)propionic acid;(S)-2-tert-butoxycarbonylamino-3-(4-hydroxyphenyl)propionic acid;(S)-2-(tert-butoxycarbonylamino)-3-(4-hydroxyphenyl)-propionic acid;B1C;rac-(2S)-2-(tert-butoxycarbonylamino)-3-(4-hydroxyphenyl)propanoic acid	False	337152.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=337152		pluskal_iocb_peptide_Peptide01_G8_id		100	G8	False	ZINC000002049222
4.6		0	504	P2195763	84.5		AD30	False	0	24	0	0	38	0	2	4	0	0		0.0						COC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)c1ccc(C(C)(C)C)cc1																							0.0		AKOS015861867		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	2	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C24H38N2O4	C24H38N2O4			InChI=1S/C24H38N2O4/c1-15(2)13-19(22(28)26-20(14-16(3)4)23(29)30-8)25-21(27)17-9-11-18(12-10-17)24(5,6)7/h9-12,15-16,19-20H,13-14H2,1-8H3,(H,25,27)(H,26,28)	BGIUKQZUFKBODV-UHFFFAOYSA-N	methyl 2-[[2-[(4-tert-butylbenzoyl)amino]-4-methyl-pentanoyl]amino]-4-methyl-pentanoate	52988596	COC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)c1ccc(C(C)(C)C)cc1	methyl 2-[[2-[(4-tert-butylbenzoyl)amino]-4-methylpentanoyl]amino]-4-methylpentanoate			3.723080000000002													MCULE-8510409830	418.58146		418.283158	4	2	11	1			45									Tripeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(52988596)	52988596	5.6	1209			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=[#8])-[#6](-[#6]-[#6](-[#6])-[#6])-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6])(-[#6])-[#6]):[#6]:[#6]:1	COC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)c1ccc(C(C)(C)C)cc1	BGIUKQZUFKBODV		parent_pubchem_cid	AKOS015861867;CCG-356502;methyl 2-[[2-[(4-tert-butylbenzoyl)amino]-4-methyl-pentanoyl]amino]-4-methyl-pentanoate		23580977.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23580977		pluskal_iocb_peptide_Peptide01_G8_id		100	G8		
4.1		0	592	P4773107	88.5		AD31	False	0	26	0	0	27	0	7	2	0	0		0.0						Cc1cc(Nc2nc(N3CCN(Cc4cc5c(cc4)OCO5)CC3)nc3nccnc23)c(C)cc1																							0.0		STL411690		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	2		C26H27N7O2	C26H27N7O2			InChI=1S/C26H27N7O2/c1-17-3-4-18(2)20(13-17)29-25-23-24(28-8-7-27-23)30-26(31-25)33-11-9-32(10-12-33)15-19-5-6-21-22(14-19)35-16-34-21/h3-8,13-14H,9-12,15-16H2,1-2H3,(H,28,29,30,31)	URCNIBOIVFOBNE-UHFFFAOYSA-N	2-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-N-(2,5-dimethylphenyl)pteridin-4-amine	51699978	Cc1cc(Nc2nc(N3CCN(Cc4cc5c(cc4)OCO5)CC3)nc3nccnc23)c(C)cc1	2-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-N-(2,5-dimethylphenyl)pteridin-4-amine			1.1719400000000009													MCULE-4158150570	469.55079		469.222623	9	1	5	6			43										False	Alkaloids				Peptide01			Compound(51699978)	51699978	4.0	1210			[#6]-[#6]1:[#6]:[#6](-[#7]-[#6]2:[#7]:[#6](-[#7]3-[#6]-[#6]-[#7](-[#6]-[#6]4:[#6]:[#6]5:[#6](:[#6]:[#6]:4)-[#8]-[#6]-[#8]-5)-[#6]-[#6]-3):[#7]:[#6]3:[#7]:[#6]:[#6]:[#7]:[#6]:2:3):[#6](-[#6]):[#6]:[#6]:1	Cc1cc(Nc2nc(N3CCN(Cc4cc5c(cc4)OCO5)CC3)nc3nccnc23)c(C)cc1	URCNIBOIVFOBNE		parent_pubchem_cid	STL411690;AKOS015858169;2-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-N-(2,5-dimethylphenyl)pteridin-4-amine		20176253.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=20176253		pluskal_iocb_peptide_Peptide01_G8_id		100	G8		ZINC000035681978
4.3		0	680	P1090497	88.1		AD32	False	0	27	0	0	28	0	2	5	0	0		0.0						COc1c(OC)cc2c(c1)CCN(C(=O)NC(Cc1ccccc1)C(=O)O)C2c1ccccc1																							0.0		AKOS016384395		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C27H28N2O5	C27H28N2O5			InChI=1S/C27H28N2O5/c1-33-23-16-20-13-14-29(25(19-11-7-4-8-12-19)21(20)17-24(23)34-2)27(32)28-22(26(30)31)15-18-9-5-3-6-10-18/h3-12,16-17,22,25H,13-15H2,1-2H3,(H,28,32)(H,30,31)/t22-,25?/m1/s1	OXAUVGQJEVPWSI-UFUCKMQHSA-N	rac-(2R)-2-[(6,7-dimethoxy-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carbonyl)amino]-3-phenyl-propanoic acid	24279075	COc1c(OC)cc2c(c1)CCN(C(=O)N[C@H](Cc1ccccc1)C(=O)O)C2c1ccccc1	(2R)-2-[(6,7-dimethoxy-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carbonyl)amino]-3-phenylpropanoic acid			2.9131400000000003														460.53461		460.199822	5	2	7	4			46									Isoquinoline alkaloids	False	Alkaloids	Tyrosine alkaloids			Peptide01			Compound(24279075)	24279075	4.3	1211			[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]):[#6]:[#6]2:[#6](:[#6]:1)-[#6]-[#6]-[#7](-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8])-[#6]-2-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	COc1c(OC)cc2c(c1)CCN(C(=O)N[C@H](Cc1ccccc1)C(=O)O)C2c1ccccc1	OXAUVGQJEVPWSI		parent_pubchem_cid	AKOS016384395;rac-(2R)-2-[(6,7-dimethoxy-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carbonyl)amino]-3-phenyl-propanoic acid		23501357.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23501357		pluskal_iocb_peptide_Peptide01_G8_id		100	G8		
3.4		0	424	P6240983	123.1		AD33	False	0	23	0	0	24	0	2	5	0	1		0.0						COc1c(OC)cc(-c2nc3ccccc3c(C(=O)NC(CCSC)C(=O)O)c2)cc1								Methionine and derivatives;Quinoline carboxamides;N-acyl-alpha amino acids;Phenylpyridines;Dimethoxybenzenes;Pyridinecarboxylic acids and derivatives;Phenoxy compounds;Anisoles;Thia fatty acids;Alkyl aryl ethers;Heteroaromatic compounds;Secondary carboxylic acid amides;Sulfenyl compounds;Azacyclic compounds;Carboxylic acids;Dialkylthioethers;Monocarboxylic acids and derivatives;Carbonyl compounds;Organic oxides;Organonitrogen compounds;Hydrocarbon derivatives	Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Anisoles;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Dialkylthioethers;Dimethoxybenzenes;Ethers;Fatty Acyls;Fatty acids and conjugates;Heteroaromatic compounds;Hydrocarbon derivatives;Lipids and lipid-like molecules;Methionine and derivatives;Methoxybenzenes;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organosulfur compounds;Phenol ethers;Phenoxy compounds;Phenylpyridines;Phenylquinolines;Pyridinecarboxylic acids and derivatives;Pyridines and derivatives;Quinoline carboxamides;Quinolines and derivatives;Secondary carboxylic acid amides;Sulfenyl compounds;Thia fatty acids;Thioethers	Quinolines and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylquinolines. These are heterocyclic compounds containing a quinoline moiety substituted with a phenyl group.	Phenylquinolines			Organic compounds	Aromatic heteropolycyclic compounds	alpha-amino acid (CHEBI:33704);methionine derivative (CHEBI:25230);quinolines (CHEBI:26513);carboxamide (CHEBI:37622);N-acyl-amino acid (CHEBI:51569);phenylpyridine (CHEBI:38193);dimethoxybenzene (CHEBI:51681);aromatic carboxylic acid (CHEBI:33859);pyridinemonocarboxylic acid (CHEBI:26420);benzenes (CHEBI:22712);methoxybenzene (CHEBI:51683);thia fatty acid (CHEBI:59643);aromatic ether (CHEBI:35618);organic aromatic compound (CHEBI:33659);organosulfur compound (CHEBI:33261);organonitrogen heterocyclic compound (CHEBI:38101);carboxylic acid (CHEBI:33575);aliphatic sulfide (CHEBI:22327);monocarboxylic acid (CHEBI:25384);carbonyl compound (CHEBI:36586);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);organic molecule (CHEBI:72695);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);organic heterocyclic compound (CHEBI:24532);pyridines (CHEBI:26421);benzenoid aromatic compound (CHEBI:33836);lipid (CHEBI:18059);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ether (CHEBI:25698);amide (CHEBI:32988);organic sulfide (CHEBI:16385);nitrogen molecular entity (CHEBI:51143)	Thia fatty acids (FA0113);Fatty Acyls (FA);Fatty Acids and Conjugates (FA01)	Phenylquinolines	Phenylquinoline;Methionine or derivatives;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;Quinoline-4-carboxamide;2-phenylpyridine;Alpha-amino acid or derivatives;O-dimethoxybenzene;Dimethoxybenzene;Pyridine carboxylic acid or derivatives;Phenoxy compound;Anisole;Phenol ether;Methoxybenzene;Alkyl aryl ether;Thia fatty acid;Monocyclic benzene moiety;Fatty acyl;Benzenoid;Pyridine;Heteroaromatic compound;Secondary carboxylic acid amide;Carboxamide group;Thioether;Dialkylthioether;Azacycle;Sulfenyl compound;Carboxylic acid derivative;Carboxylic acid;Monocarboxylic acid or derivatives;Ether;Organic oxide;Hydrocarbon derivative;Organonitrogen compound;Organooxygen compound;Carbonyl group;Organic nitrogen compound;Organosulfur compound;Organic oxygen compound;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		AKOS016387092		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C23H24N2O5S	C23H24N2O5S			InChI=1S/C23H24N2O5S/c1-29-20-9-8-14(12-21(20)30-2)19-13-16(15-6-4-5-7-17(15)24-19)22(26)25-18(23(27)28)10-11-31-3/h4-9,12-13,18H,10-11H2,1-3H3,(H,25,26)(H,27,28)/t18-/m0/s1	KCEXMQXOFIDLNK-SFHVURJKSA-N	rac-(2S)-2-[[2-(3,4-dimethoxyphenyl)quinoline-4-carbonyl]amino]-4-methylsulfanyl-butanoic acid	49652453	COc1c(OC)cc(-c2nc3ccccc3c(C(=O)N[C@@H](CCSC)C(=O)O)c2)cc1	(2S)-2-[[2-(3,4-dimethoxyphenyl)quinoline-4-carbonyl]amino]-4-methylsulfanylbutanoic acid			2.06713													MCULE-7633924466	440.52213		440.140593	7	2	9	3			44										False	Alkaloids				Peptide01			Compound(49652453)	49652453	3.7	1212			[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]):[#6]:[#6](-[#6]2:[#7]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3:[#6](-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]-[#16]-[#6])-[#6](=[#8])-[#8]):[#6]:2):[#6]:[#6]:1	COc1c(OC)cc(-c2nc3ccccc3c(C(=O)N[C@@H](CCSC)C(=O)O)c2)cc1	KCEXMQXOFIDLNK		parent_pubchem_cid	AKOS016387092;Z2327394136;(2S)-2-({[2-(3,4-DIMETHOXYPHENYL)-4-QUINOLYL]CARBONYL}AMINO)-4-(METHYLSULFANYL)BUTANOIC ACID;rac-(2S)-2-[[2-(3,4-dimethoxyphenyl)quinoline-4-carbonyl]amino]-4-methylsulfanyl-butanoic acid		23026190.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23026190		pluskal_iocb_peptide_Peptide01_G8_id		100	G8		ZINC000040312460
3.0		0	512	P2195189	92.7		AD34	False	0	20	0	0	24	0	2	3	0	1		0.0						COc1ccc(NC(=O)C(CCSC)NC(=O)c2ccc(C)cc2)cc1																							0.0		AKOS015861462		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C20H24N2O3S	C20H24N2O3S			InChI=1S/C20H24N2O3S/c1-14-4-6-15(7-5-14)19(23)22-18(12-13-26-3)20(24)21-16-8-10-17(25-2)11-9-16/h4-11,18H,12-13H2,1-3H3,(H,21,24)(H,22,23)	PURBXLWUVYLVSN-UHFFFAOYSA-N	N-[1-[(4-methoxyphenyl)carbamoyl]-3-methylsulfanyl-propyl]-4-methyl-benzamide	51065704	COc1ccc(NC(=O)C(CCSC)NC(=O)c2ccc(C)cc2)cc1	N-[1-(4-methoxyanilino)-4-methylsulfanyl-1-oxobutan-2-yl]-4-methylbenzamide			2.54138													MCULE-9175812679	372.48988		372.150764	4	2	8	2			45										False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51065704)	51065704	3.5	1213			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#7]-[#6](=[#8])-[#6](-[#6]-[#6]-[#16]-[#6])-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:2):[#6]:[#6]:1	COc1ccc(NC(=O)C(CCSC)NC(=O)c2ccc(C)cc2)cc1	PURBXLWUVYLVSN		parent_pubchem_cid	AKOS015861462;N-[1-[(4-methoxyphenyl)carbamoyl]-3-methylsulfanyl-propyl]-4-methyl-benzamide		23467652.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23467652		pluskal_iocb_peptide_Peptide01_G8_id		100	G8		
4.3		0	600	P1305723	74.3		AD35	False	0	27	0	0	26	0	4	2	0	0		0.0						N#Cc1c(NCC(c2ccccc2)N2CCOCC2)oc(Cc2cccc3ccccc23)n1																							0.0		AKOS002289502		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1		C27H26N4O2	C27H26N4O2			InChI=1S/C27H26N4O2/c28-18-24-27(29-19-25(21-8-2-1-3-9-21)31-13-15-32-16-14-31)33-26(30-24)17-22-11-6-10-20-7-4-5-12-23(20)22/h1-12,25,29H,13-17,19H2	JQWHBECAJYJQKW-UHFFFAOYSA-N	5-[(2-morpholino-2-phenyl-ethyl)amino]-2-(1-naphthylmethyl)oxazole-4-carbonitrile	43842700	N#Cc1c(NCC(c2ccccc2)N2CCOCC2)oc(Cc2cccc3ccccc23)n1	5-[(2-morpholin-4-yl-2-phenylethyl)amino]-2-(naphthalen-1-ylmethyl)-1,3-oxazole-4-carbonitrile			3.747810000000003													MCULE-7166598832	438.53387		438.205576	5	1	7	5			45										False	Alkaloids				Peptide01			Compound(43842700)	43842700	5.7	1214			[#7]#[#6]-[#6]1:[#6](-[#7]-[#6]-[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#7]2-[#6]-[#6]-[#8]-[#6]-[#6]-2):[#8]:[#6](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#7]:1	N#Cc1c(NCC(c2ccccc2)N2CCOCC2)oc(Cc2cccc3ccccc23)n1	JQWHBECAJYJQKW		parent_pubchem_cid	AKOS002289502;AKOS016328343;Z1213699097;5-[(2-morpholino-2-phenyl-ethyl)amino]-2-(1-naphthylmethyl)oxazole-4-carbonitrile		24468605.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24468605		pluskal_iocb_peptide_Peptide01_G8_id		100	G8		
2.4		0	688	P6236701	100.4		AD36	False	0	19	0	0	19	0	5	1	0	1		0.0						CSCCC(NC(=O)c1c[nH]c2ccccc12)c1nnc2ccccn12																							0.0		N-[3-(methylsulfanyl)-1-([1,2,4]triazolo[4,3-a]pyridin-3-yl)propyl]-1H-indole-3-carboxamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	3	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C19H19N5OS	C19H19N5OS			InChI=1S/C19H19N5OS/c1-26-11-9-16(18-23-22-17-8-4-5-10-24(17)18)21-19(25)14-12-20-15-7-3-2-6-13(14)15/h2-8,10,12,16,20H,9,11H2,1H3,(H,21,25)	MQZVQECZUWGDME-UHFFFAOYSA-N	N-[3-methylsulfanyl-1-([1,2,4]triazolo[4,3-a]pyridin-3-yl)propyl]-1H-indole-3-carboxamide	42652542	CSCCC(NC(=O)c1c[nH]c2ccccc12)c1nnc2ccccn12	N-[3-methylsulfanyl-1-([1,2,4]triazolo[4,3-a]pyridin-3-yl)propyl]-1H-indole-3-carboxamide			2.6827500000000004													MCULE-8093976496	365.46018		365.131031	4	2	6	4			45										False	Alkaloids				Peptide01			Compound(42652542)	42652542	3.2	1215			[#6]-[#16]-[#6]-[#6]-[#6](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6]1:[#7]:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#7]:1:2	CSCCC(NC(=O)c1c[nH]c2ccccc12)c1nnc2ccccn12	MQZVQECZUWGDME		parent_pubchem_cid	N-[3-(methylsulfanyl)-1-([1,2,4]triazolo[4,3-a]pyridin-3-yl)propyl]-1H-indole-3-carboxamide;1081113-48-5;STK637791;AKOS005569681;N-[3-methylsulfanyl-1-([1,2,4]triazolo[4,3-a]pyridin-3-yl)propyl]-1H-indole-3-carboxamide		23056687.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23056687		pluskal_iocb_peptide_Peptide01_G8_id		100	G8		
3.4		0	432	P7567845	96.6		AD37	False	0	21	0	0	22	0	2	3	0	1		0.0						CSCCC(NC(=O)c1cc2c(cc1)ccn2Cc1ccccc1)C(=O)O																							0.0		AKOS025146041		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C21H22N2O3S	C21H22N2O3S			InChI=1S/C21H22N2O3S/c1-27-12-10-18(21(25)26)22-20(24)17-8-7-16-9-11-23(19(16)13-17)14-15-5-3-2-4-6-15/h2-9,11,13,18H,10,12,14H2,1H3,(H,22,24)(H,25,26)/t18-/m0/s1	QLDJQFPSPVIJQG-SFHVURJKSA-N	rac-(2S)-2-[(1-benzylindole-6-carbonyl)amino]-4-methylsulfanyl-butanoic acid	91640647	CSCC[C@H](NC(=O)c1cc2c(cc1)ccn2Cc1ccccc1)C(=O)O	(2S)-2-[(1-benzylindole-6-carbonyl)amino]-4-methylsulfanylbutanoic acid			3.087860000000001														382.48509		382.135114	4	2	8	3			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(91640647)	91640647	3.5	1216			[#6]-[#16]-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#6]:[#6]:[#7]:2-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	CSCC[C@H](NC(=O)c1cc2c(cc1)ccn2Cc1ccccc1)C(=O)O	QLDJQFPSPVIJQG		parent_pubchem_cid	AKOS025146041;(2S)-2-{[(1-BENZYL-1H-INDOL-6-YL)CARBONYL]AMINO}-4-(METHYLSULFANYL)BUTANOIC ACID;rac-(2S)-2-[(1-benzylindole-6-carbonyl)amino]-4-methylsulfanyl-butanoic acid		95055713.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=95055713		pluskal_iocb_peptide_Peptide01_G9_id		100	G9		ZINC000170625468
0.9		0	520	P2044869	129.2		AD38	False	0	12	0	0	15	0	1	6	0	1		0.0						Cc1ccc(S(=O)(=O)NC(CCC(=O)O)C(=O)O)cc1								P-toluenesulfonamides;Benzenesulfonamides;Benzenesulfonyl compounds;Organosulfonamides;Dicarboxylic acids and derivatives;Aminosulfonyl compounds;Carboxylic acids;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Aminosulfonyl compounds;Benzene and substituted derivatives;Benzenesulfonamides;Benzenesulfonyl compounds;Benzenoids;Carbonyl compounds;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Dicarboxylic acids and derivatives;Glutamic acid and derivatives;Hydrocarbon derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organic sulfonic acids and derivatives;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Organosulfonamides;Organosulfonic acids and derivatives;Organosulfur compounds;P-toluenesulfonamides;Sulfonyls;Toluenes;Tosyl compounds	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as glutamic acid and derivatives. These are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Glutamic acid and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic homomonocyclic compounds	sulfonamide (CHEBI:35358);benzenes (CHEBI:22712);organosulfur compound (CHEBI:33261);dicarboxylic acid (CHEBI:35692);organonitrogen compound (CHEBI:35352);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);glutamic acid derivative (CHEBI:24315);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);toluenes (CHEBI:27024);sulfonic acid derivative (CHEBI:33552);organooxygen compound (CHEBI:36963);sulfone (CHEBI:35850);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806);amino acid (CHEBI:33709);peptide (CHEBI:16670)	Dicarboxylic acids (FA0117)	Amino acids, peptides, and analogues	Glutamic acid or derivatives;P-toluenesulfonamide;Benzenesulfonamide;Tosyl compound;Benzenesulfonyl group;Toluene;Monocyclic benzene moiety;Dicarboxylic acid or derivatives;Organosulfonic acid amide;Benzenoid;Organic sulfonic acid or derivatives;Organosulfonic acid or derivatives;Sulfonyl;Aminosulfonyl compound;Carboxylic acid;Organic nitrogen compound;Organosulfur compound;Organooxygen compound;Organonitrogen compound;Organopnictogen compound;Organic oxide;Organic oxygen compound;Hydrocarbon derivative;Carbonyl group;Aromatic homomonocyclic compound	Organic acids and derivatives	0.0		200806-94-6		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	2	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0		C12H15NO6S	C12H15NO6S			InChI=1S/C12H15NO6S/c1-8-2-4-9(5-3-8)20(18,19)13-10(12(16)17)6-7-11(14)15/h2-5,10,13H,6-7H2,1H3,(H,14,15)(H,16,17)	KKOZKXBAPIYWAT-UHFFFAOYSA-N	2-(p-tolylsulfonylamino)pentanedioic acid	98347	Cc1ccc(S(=O)(=O)NC(CCC(=O)O)C(=O)O)cc1	2-[(4-methylphenyl)sulfonylamino]pentanedioic acid			0.4286													MCULE-5175034877	301.32045		301.062008	6	3	7	1			43									Aminoacids	False	Amino acids and Peptides;Shikimates and Phenylpropanoids	Small peptides			Peptide01			Compound(98347)	98347	0.7	1217		SCHEMBL697840	[#6]-[#6]1:[#6]:[#6]:[#6](-[#16](=[#8])(=[#8])-[#7]-[#6](-[#6]-[#6]-[#6](=[#8])-[#8])-[#6](=[#8])-[#8]):[#6]:[#6]:1	Cc1ccc(S(=O)(=O)NC(CCC(=O)O)C(=O)O)cc1	KKOZKXBAPIYWAT		parent_pubchem_cid	200806-94-6;2-(Toluene-4-Sulfonylamino)-Pentanedioic Acid;2-[(4-methylphenyl)sulfonylamino]pentanedioic acid;N-(p-Tolylsulphonyl)-L-glutamic acid;2-(4-methylbenzenesulfonamido)pentanedioic acid;tosylglutamic acid;n-[(4-methylphenyl)sulfonyl]glutamic acid;2HXU3N9FF3;NSC-109186;NSC400394;Tosyl-L-glutamicacid;2-(4-Methylphenylsulfonamido)pentanedioic acid;UNII-2HXU3N9FF3;CBDivE_003035;SCHEMBL697840;(2S)-2-[(4-methylphenyl)sulfonylamino]pentanedioic acid;DTXSID901322397;EINECS 225-390-1;MFCD00427213;NSC109186;NSC164905;AKOS001569899;AKOS016193779;NSC 109186;NSC 400394;NSC-164905;NSC-400394;LS-11507;N-[(4-Methylphenyl)sulfonyl]glutaric acid;2-(4-Methylphenylsulfonamido)pentanedioicacid;FT-0675329;SR-01000390305;SR-01000390305-1;N-[(4-Methylphenyl)sulfonyl]glutamic acid (Tos-DL-Glu-OH);2-(p-tolylsulfonylamino)pentanedioic acid		22931373.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22931373	2HXU3N9FF3	pluskal_iocb_peptide_Peptide01_G9_id		100	G9		
4.6		0	608	P1305263	63.4		AD39	False	0	25	0	0	24	0	2	3	0	0		0.0						COc1ccc(C(=O)NCC(c2ccc(OC)cc2)c2c[nH]c3ccccc23)cc1																							0.0		N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-4-methoxybenzamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C25H24N2O3	C25H24N2O3			InChI=1S/C25H24N2O3/c1-29-19-11-7-17(8-12-19)22(23-16-26-24-6-4-3-5-21(23)24)15-27-25(28)18-9-13-20(30-2)14-10-18/h3-14,16,22,26H,15H2,1-2H3,(H,27,28)	YIJIKDDSZKLWJQ-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-4-methoxy-benzamide	17014420	COc1ccc(C(=O)NCC(c2ccc(OC)cc2)c2c[nH]c3ccccc23)cc1	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-4-methoxybenzamide			3.229630000000001													MCULE-6627290206	400.48163		400.178693	3	2	7	4			45										False	Alkaloids				Peptide01			Compound(17014420)	17014420	4.7	1218			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](=[#8])-[#7]-[#6]-[#6](-[#6]2:[#6]:[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	COc1ccc(C(=O)NCC(c2ccc(OC)cc2)c2c[nH]c3ccccc23)cc1	YIJIKDDSZKLWJQ		parent_pubchem_cid	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-4-methoxybenzamide;AKOS002335501;AKOS016326576;N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-4-methoxy-benzamide		24113560.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24113560		pluskal_iocb_peptide_Peptide01_G9_id		100	G9		
3.3		0	696	P6241651	106.3		AD40	False	0	21	0	0	26	0	4	2	0	1		0.0						CC(=O)N(CC(C)C)c1nc(C)c(C(=O)NCCc2c[nH]c3ccccc23)s1								Thiazolecarboxamides;2-heteroaryl carboxamides;2,4,5-trisubstituted thiazoles;Substituted pyrroles;Benzenoids;Tertiary carboxylic acid amides;Heteroaromatic compounds;Acetamides;Tertiary amines;Secondary carboxylic acid amides;Amino acids and derivatives;Azacyclic compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	2,4,5-trisubstituted thiazoles;2-heteroaryl carboxamides;3-alkylindoles;Acetamides;Amines;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Azoles;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Tertiary amines;Tertiary carboxylic acid amides;Thiazolecarboxamides;Thiazolecarboxylic acids and derivatives;Thiazoles	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as 3-alkylindoles. These are compounds containing an indole moiety that carries an alkyl chain at the 3-position.	3-alkylindoles			Organic compounds	Aromatic heteropolycyclic compounds	aromatic amide (CHEBI:62733);thiazoles (CHEBI:48901);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);acetamides (CHEBI:22160);tertiary amine (CHEBI:32876);organonitrogen compound (CHEBI:35352);organooxygen compound (CHEBI:36963);organonitrogen heterocyclic compound (CHEBI:38101);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);indoles (CHEBI:24828);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);azole (CHEBI:68452);aromatic carboxylic acid (CHEBI:33859);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);amine (CHEBI:32952);oxygen molecular entity (CHEBI:25806);amino acid (CHEBI:33709);peptide (CHEBI:16670)		Indoles	3-alkylindole;2-heteroaryl carboxamide;2,4,5-trisubstituted 1,3-thiazole;Thiazolecarboxamide;Thiazolecarboxylic acid or derivatives;Substituted pyrrole;Benzenoid;Acetamide;Thiazole;Azole;Tertiary carboxylic acid amide;Pyrrole;Heteroaromatic compound;Secondary carboxylic acid amide;Carboxamide group;Amino acid or derivatives;Tertiary amine;Carboxylic acid derivative;Azacycle;Organonitrogen compound;Organic nitrogen compound;Hydrocarbon derivative;Carbonyl group;Organic oxide;Organic oxygen compound;Organooxygen compound;Amine;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		1219549-92-4		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C21H26N4O2S	C21H26N4O2S			InChI=1S/C21H26N4O2S/c1-13(2)12-25(15(4)26)21-24-14(3)19(28-21)20(27)22-10-9-16-11-23-18-8-6-5-7-17(16)18/h5-8,11,13,23H,9-10,12H2,1-4H3,(H,22,27)	GHYAKVMOHTWKDF-UHFFFAOYSA-N	2-[acetyl(isobutyl)amino]-N-[2-(1H-indol-3-yl)ethyl]-4-methyl-thiazole-5-carboxamide	49652552	CC(=O)N(CC(C)C)c1nc(C)c(C(=O)NCCc2c[nH]c3ccccc23)s1	2-[acetyl(2-methylpropyl)amino]-N-[2-(1H-indol-3-yl)ethyl]-4-methyl-1,3-thiazole-5-carboxamide			2.941060000000001													MCULE-7718002144	398.53097		398.177647	3	2	7	3			44										False	Alkaloids;Amino acids and Peptides	Peptide alkaloids			Peptide01			Compound(49652552)	49652552	4.1	1219			[#6]-[#6](=[#8])-[#7](-[#6]-[#6](-[#6])-[#6])-[#6]1:[#7]:[#6](-[#6]):[#6](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#16]:1	CC(=O)N(CC(C)C)c1nc(C)c(C(=O)NCCc2c[nH]c3ccccc23)s1	GHYAKVMOHTWKDF		parent_pubchem_cid	1219549-92-4;2-[acetyl(isobutyl)amino]-N-[2-(1H-indol-3-yl)ethyl]-4-methyl-1,3-thiazole-5-carboxamide;EiM08-13096;AKOS016374276;N-[2-(1H-INDOL-3-YL)ETHYL]-4-METHYL-2-[N-(2-METHYLPROPYL)ACETAMIDO]-1,3-THIAZOLE-5-CARBOXAMIDE;2-[acetyl(isobutyl)amino]-N-[2-(1H-indol-3-yl)ethyl]-4-methyl-thiazole-5-carboxamide		8989685.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=8989685		pluskal_iocb_peptide_Peptide01_G9_id		100	G9		ZINC000040312808
2.8		0	440	P1095020	98.7		AD41	False	0	21	0	0	23	0	3	4	0	0		0.0						CC(C)C1C(=O)Nc2ccccc2N1C(=O)NC(Cc1ccccc1)C(=O)O																							0.0		AKOS004937371		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	2	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C21H23N3O4	C21H23N3O4			InChI=1S/C21H23N3O4/c1-13(2)18-19(25)22-15-10-6-7-11-17(15)24(18)21(28)23-16(20(26)27)12-14-8-4-3-5-9-14/h3-11,13,16,18H,12H2,1-2H3,(H,22,25)(H,23,28)(H,26,27)/t16-,18-/m0/s1	MBZXSYCFSXPYGM-WMZOPIPTSA-N	rac-(2S)-3-phenyl-2-[[rac-(2S)-2-isopropyl-3-oxo-2,4-dihydroquinoxaline-1-carbonyl]amino]propanoic acid	7711725	CC(C)[C@H]1C(=O)Nc2ccccc2N1C(=O)N[C@@H](Cc1ccccc1)C(=O)O	(2S)-2-[[(2S)-3-oxo-2-propan-2-yl-2,4-dihydroquinoxaline-1-carbonyl]amino]-3-phenylpropanoic acid			2.05927													MCULE-8982140678	381.43516		381.168856	4	3	5	3			44										False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(7711725)	7711725	3.0	1220			[#6]-[#6](-[#6])-[#6@H]1-[#6](=[#8])-[#7]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#7]-1-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	CC(C)[C@H]1C(=O)Nc2ccccc2N1C(=O)N[C@@H](Cc1ccccc1)C(=O)O	MBZXSYCFSXPYGM		parent_pubchem_cid	AKOS004937371;rac-(2S)-3-phenyl-2-[[rac-(2S)-2-isopropyl-3-oxo-2,4-dihydroquinoxaline-1-carbonyl]amino]propanoic acid		23800662.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23800662		pluskal_iocb_peptide_Peptide01_G9_id		100	G9		ZINC000008738160
4.2		0	528	P2195093	134.6		AD42	False	0	21	1	0	27	0	4	2	0	2		0.0						CCCSc1ncc(Cl)c(C(=O)NC(CCSC)C(=O)NCc2ccc(C)cc2)n1																							0.0		AKOS015861210		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C21H27ClN4O2S2	C21H27ClN4O2S2			InChI=1S/C21H27ClN4O2S2/c1-4-10-30-21-24-13-16(22)18(26-21)20(28)25-17(9-11-29-3)19(27)23-12-15-7-5-14(2)6-8-15/h5-8,13,17H,4,9-12H2,1-3H3,(H,23,27)(H,25,28)	HBNABIPMJXWRSC-UHFFFAOYSA-N	5-chloro-N-[3-methylsulfanyl-1-(p-tolylmethylcarbamoyl)propyl]-2-propylsulfanyl-pyrimidine-4-carboxamide	51065629	CCCSc1ncc(Cl)c(C(=O)NC(CCSC)C(=O)NCc2ccc(C)cc2)n1	5-chloro-N-[1-[(4-methylphenyl)methylamino]-4-methylsulfanyl-1-oxobutan-2-yl]-2-propylsulfanylpyrimidine-4-carboxamide			3.836280000000002													MCULE-8609798252	467.05594		466.126396	6	2	11	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(51065629)	51065629	4.4	1221			[#6]-[#6]-[#6]-[#16]-[#6]1:[#7]:[#6]:[#6](-[#17]):[#6](-[#6](=[#8])-[#7]-[#6](-[#6]-[#6]-[#16]-[#6])-[#6](=[#8])-[#7]-[#6]-[#6]2:[#6]:[#6]:[#6](-[#6]):[#6]:[#6]:2):[#7]:1	CCCSc1ncc(Cl)c(C(=O)NC(CCSC)C(=O)NCc2ccc(C)cc2)n1	HBNABIPMJXWRSC		parent_pubchem_cid	AKOS015861210;5-chloro-N-[3-methylsulfanyl-1-(p-tolylmethylcarbamoyl)propyl]-2-propylsulfanyl-pyrimidine-4-carboxamide		23880471.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23880471		pluskal_iocb_peptide_Peptide01_G9_id		100	G9		
4.9		0	616	P1305406	63.4		AD43	False	0	26	0	0	26	0	2	3	0	0		0.0						COc1ccc(C(CNC(=O)COc2cccc(C)c2)c2c[nH]c3ccccc23)cc1																							0.0		N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-(3-methylphenoxy)acetamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C26H26N2O3	C26H26N2O3			InChI=1S/C26H26N2O3/c1-18-6-5-7-21(14-18)31-17-26(29)28-15-23(19-10-12-20(30-2)13-11-19)24-16-27-25-9-4-3-8-22(24)25/h3-14,16,23,27H,15,17H2,1-2H3,(H,28,29)	GMTNDPIWGBYLLN-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-(3-methylphenoxy)acetamide	17014556	COc1ccc(C(CNC(=O)COc2cccc(C)c2)c2c[nH]c3ccccc23)cc1	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-(3-methylphenoxy)acetamide			3.2946500000000016													MCULE-4038070421	414.50872		414.194343	3	2	8	4			44										False	Alkaloids				Peptide01			Compound(17014556)	17014556	5.1	1222			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6](-[#6]-[#7]-[#6](=[#8])-[#6]-[#8]-[#6]2:[#6]:[#6]:[#6]:[#6](-[#6]):[#6]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	COc1ccc(C(CNC(=O)COc2cccc(C)c2)c2c[nH]c3ccccc23)cc1	GMTNDPIWGBYLLN		parent_pubchem_cid	N-[2-(1H-indol-3-yl)-2-(4-methoxyphenyl)ethyl]-2-(3-methylphenoxy)acetamide;STL207513;AKOS002334440;AKOS016326650		23677263.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23677263		pluskal_iocb_peptide_Peptide01_G9_id		100	G9		
1.6		0	704	P6237667	102.7		AD44	False	0	18	0	0	22	0	2	4	0	1		0.0						COC(=O)C(CCSC)NC(=O)Cn1cc(C(C)=O)c2ccccc21								Alpha amino acid esters;N-acyl-alpha amino acids and derivatives;N-alkylindoles;Indoles;Aryl alkyl ketones;Fatty acid esters;Substituted pyrroles;Benzenoids;Vinylogous amides;Methyl esters;Heteroaromatic compounds;Secondary carboxylic acid amides;Sulfenyl compounds;Azacyclic compounds;Dialkylthioethers;Monocarboxylic acids and derivatives;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	Alpha amino acid esters;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Aryl alkyl ketones;Aryl ketones;Azacyclic compounds;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids and derivatives;Chemical entities;Dialkylthioethers;Fatty Acyls;Fatty acid esters;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Ketones;Lipids and lipid-like molecules;Methionine and derivatives;Methyl esters;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids and derivatives;N-alkylindoles;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Organosulfur compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Sulfenyl compounds;Thioethers;Vinylogous amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as methionine and derivatives. These are compounds containing methionine or a derivative thereof resulting from reaction of methionine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Methionine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	alpha-amino acid ester (CHEBI:46874);N-acyl-amino acid (CHEBI:51569);indoles (CHEBI:24828);aromatic ketone (CHEBI:76224);fatty acid ester (CHEBI:35748);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);enone (CHEBI:51689);enamine (CHEBI:47989);carboxylic ester (CHEBI:33308);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organosulfur compound (CHEBI:33261);organonitrogen heterocyclic compound (CHEBI:38101);aliphatic sulfide (CHEBI:22327);monocarboxylic acid (CHEBI:25384);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);alpha-amino acid (CHEBI:33704);methionine derivative (CHEBI:25230);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);carbonyl compound (CHEBI:36586);organooxygen compound (CHEBI:36963);organic heterocyclic compound (CHEBI:24532);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ketone (CHEBI:17087);lipid (CHEBI:18059);amide (CHEBI:32988);organic sulfide (CHEBI:16385);nitrogen molecular entity (CHEBI:51143);amino acid (CHEBI:33709);peptide (CHEBI:16670)	Fatty esters (FA07);Fatty Acyls (FA)	Amino acids, peptides, and analogues	Methionine or derivatives;Alpha-amino acid ester;N-acyl-alpha amino acid or derivatives;N-alkylindole;Indole or derivatives;Indole;Aryl ketone;Aryl alkyl ketone;Fatty acid ester;Benzenoid;Substituted pyrrole;Fatty acyl;Heteroaromatic compound;Vinylogous amide;Methyl ester;Pyrrole;Ketone;Secondary carboxylic acid amide;Carboxylic acid ester;Carboxamide group;Azacycle;Organoheterocyclic compound;Dialkylthioether;Monocarboxylic acid or derivatives;Sulfenyl compound;Thioether;Carbonyl group;Organic nitrogen compound;Organic oxygen compound;Organic oxide;Organonitrogen compound;Organooxygen compound;Organosulfur compound;Hydrocarbon derivative;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS016375008		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C18H22N2O4S	C18H22N2O4S			InChI=1S/C18H22N2O4S/c1-12(21)14-10-20(16-7-5-4-6-13(14)16)11-17(22)19-15(8-9-25-3)18(23)24-2/h4-7,10,15H,8-9,11H2,1-3H3,(H,19,22)/t15-/m0/s1	KCDCVNMIRYUPFM-HNNXBMFYSA-N	methyl rac-(2S)-2-[[2-(3-acetylindol-1-yl)acetyl]amino]-4-methylsulfanyl-butanoate	39378089	COC(=O)[C@H](CCSC)NC(=O)Cn1cc(C(C)=O)c2ccccc21	methyl (2S)-2-[[2-(3-acetylindol-1-yl)acetyl]amino]-4-methylsulfanylbutanoate			1.7716699999999994													MCULE-7657508674	362.45104		362.130028	5	1	9	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(39378089)	39378089	2.1	1223			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]-[#16]-[#6])-[#7]-[#6](=[#8])-[#6]-[#7]1:[#6]:[#6](-[#6](-[#6])=[#8]):[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	COC(=O)[C@H](CCSC)NC(=O)Cn1cc(C(C)=O)c2ccccc21	KCDCVNMIRYUPFM		parent_pubchem_cid	AKOS016375008;methyl rac-(2S)-2-[[2-(3-acetylindol-1-yl)acetyl]amino]-4-methylsulfanyl-butanoate		8340541.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=8340541		pluskal_iocb_peptide_Peptide01_G9_id		100	G9		ZINC000032124246
4.2		0	712	P6240795	87.1		AE1	False	1	22	0	0	20	0	3	3	0	0		0.0						O=C(CCn1ccc2c1cccc2Br)NC(Cc1c[nH]c2ccccc12)C(=O)O																							0.0		AKOS016402461		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C22H20BrN3O3	C22H20BrN3O3			InChI=1S/C22H20BrN3O3/c23-17-5-3-7-20-16(17)8-10-26(20)11-9-21(27)25-19(22(28)29)12-14-13-24-18-6-2-1-4-15(14)18/h1-8,10,13,19,24H,9,11-12H2,(H,25,27)(H,28,29)/t19-/m0/s1	CIMNFTDDDQSAQG-IBGZPJMESA-N	rac-(2S)-2-[3-(4-bromoindol-1-yl)propanoylamino]-3-(1H-indol-3-yl)propanoic acid	49652245	O=C(CCn1ccc2c1cccc2Br)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	(2S)-2-[3-(4-bromoindol-1-yl)propanoylamino]-3-(1H-indol-3-yl)propanoic acid			3.1757500000000007													MCULE-1041136571	454.327		453.068804	3	3	7	4			44									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(49652245)	49652245	3.6	1224			[#8]=[#6](-[#6]-[#6]-[#7]1:[#6]:[#6]:[#6]2:[#6]:1:[#6]:[#6]:[#6]:[#6]:2-[#35])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	O=C(CCn1ccc2c1cccc2Br)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	CIMNFTDDDQSAQG		parent_pubchem_cid	AKOS016402461;(2S)-2-{[3-(4-BROMO-1H-INDOL-1-YL)PROPANOYL]AMINO}-3-(1H-INDOL-3-YL)PROPANOIC ACID;rac-(2S)-2-[3-(4-bromoindol-1-yl)propanoylamino]-3-(1H-indol-3-yl)propanoic acid		24001217.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24001217		pluskal_iocb_peptide_Peptide01_G10_id		100	G10		ZINC000040309711
3.1		0	800	P3462487	122.2		AE2	False	0	23	0	0	23	0	1	7	0	0		0.0						CC(C)CC(NC(=O)COc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1)C(=O)O								5-hydroxyflavonoids;Leucine and derivatives;N-acyl-L-alpha-amino acids;Chromones;Phenol ethers;Pyranones and derivatives;1-hydroxy-2-unsubstituted benzenoids;1-hydroxy-4-unsubstituted benzenoids;Alkyl aryl ethers;Benzene and substituted derivatives;Vinylogous acids;Heteroaromatic compounds;Secondary carboxylic acid amides;Oxacyclic compounds;Monocarboxylic acids and derivatives;Carboxylic acids;Organonitrogen compounds;Hydrocarbon derivatives;Carbonyl compounds;Organic oxides	1-benzopyrans;1-hydroxy-2-unsubstituted benzenoids;1-hydroxy-4-unsubstituted benzenoids;5-hydroxyflavonoids;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Benzene and substituted derivatives;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Chromones;Ethers;Flavones;Flavonoids;Heteroaromatic compounds;Hydrocarbon derivatives;Hydroxyflavonoids;Leucine and derivatives;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Oxacyclic compounds;Phenol ethers;Phenols;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Secondary carboxylic acid amides;Vinylogous acids	Flavonoids	2.1	This compound belongs to the class of organic compounds known as flavones. These are flavonoids with a structure based on the backbone of 2-phenylchromen-4-one (2-phenyl-1-benzopyran-4-one).	Flavones			Organic compounds	Aromatic heteropolycyclic compounds	hydroxyflavonoid (CHEBI:71968);leucine derivative (CHEBI:47003);N-acyl-L-alpha-amino acid (CHEBI:48927);chromones (CHEBI:23238);aromatic ether (CHEBI:35618);pyranone (CHEBI:37963);phenols (CHEBI:33853);benzenes (CHEBI:22712);enone (CHEBI:51689);enol (CHEBI:33823);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);oxacycle (CHEBI:38104);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);organonitrogen compound (CHEBI:35352);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);organic oxide (CHEBI:25701);flavones (CHEBI:24043);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);flavonoids (CHEBI:72544);organic acid (CHEBI:64709);N-acyl-amino acid (CHEBI:51569);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);1-benzopyran (CHEBI:38443);benzenoid aromatic compound (CHEBI:33836);pyrans (CHEBI:26407);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ether (CHEBI:25698);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)	Flavones and Flavonols (PK1211);Benzopyranoids (PK1311)	Flavones	5-hydroxyflavonoid;Hydroxyflavonoid;Flavone;Leucine or derivatives;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;N-acyl-l-alpha-amino acid;Chromone;Alpha-amino acid or derivatives;Benzopyran;1-benzopyran;Phenol ether;1-hydroxy-4-unsubstituted benzenoid;1-hydroxy-2-unsubstituted benzenoid;Alkyl aryl ether;Phenol;Pyranone;Monocyclic benzene moiety;Pyran;Benzenoid;Heteroaromatic compound;Vinylogous acid;Carboxamide group;Secondary carboxylic acid amide;Oxacycle;Organoheterocyclic compound;Carboxylic acid derivative;Carboxylic acid;Ether;Monocarboxylic acid or derivatives;Organic oxygen compound;Carbonyl group;Organic oxide;Organooxygen compound;Hydrocarbon derivative;Organonitrogen compound;Organic nitrogen compound;Aromatic heteropolycyclic compound	Phenylpropanoids and polyketides	0.0		AKOS016376068		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	1	1	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C23H23NO7	C23H23NO7			InChI=1S/C23H23NO7/c1-13(2)8-16(23(28)29)24-21(27)12-30-15-9-17(25)22-18(26)11-19(31-20(22)10-15)14-6-4-3-5-7-14/h3-7,9-11,13,16,25H,8,12H2,1-2H3,(H,24,27)(H,28,29)/t16-/m0/s1	KWAMQJKXYGOFSY-INIZCTEOSA-N	rac-(2S)-2-[[2-(5-hydroxy-4-oxo-2-phenyl-chromen-7-yl)oxyacetyl]amino]-4-methyl-pentanoic acid	29148267	CC(C)C[C@H](NC(=O)COc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1)C(=O)O	(2S)-2-[[2-(5-hydroxy-4-oxo-2-phenylchromen-7-yl)oxyacetyl]amino]-4-methylpentanoic acid			2.32653													MCULE-1564359988	425.44226		425.147452	7	3	8	3			44									Flavones	False	Shikimates and Phenylpropanoids	Flavonoids			Peptide01			Compound(29148267)	29148267	3.1	1225			[#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#8]-[#6]1:[#6]:[#6](-[#8]):[#6]2:[#6](=[#8]):[#6]:[#6](-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#8]:[#6]:2:[#6]:1)-[#6](=[#8])-[#8]	CC(C)C[C@H](NC(=O)COc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1)C(=O)O	KWAMQJKXYGOFSY		parent_pubchem_cid	AKOS016376068;(2S)-2-({2-[(5-HYDROXY-4-OXO-2-PHENYL-4H-CHROMEN-7-YL)OXY]ACETYL}AMINO)-4-METHYLPENTANOIC ACID;rac-(2S)-2-[[2-(5-hydroxy-4-oxo-2-phenyl-chromen-7-yl)oxyacetyl]amino]-4-methyl-pentanoic acid		24736560.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24736560		pluskal_iocb_peptide_Peptide01_G10_id		100	G10		ZINC000020763042
5.0		0	888	P11569106	57.8		AE3	False	0	22	0	0	27	0	3	1	0	0		0.0						CC(C)CC(NC(=O)CCCc1ccccc1)c1nc2ccccc2[nH]1																							0.0		AKOS027473988		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C22H27N3O	C22H27N3O			InChI=1S/C22H27N3O/c1-16(2)15-20(22-24-18-12-6-7-13-19(18)25-22)23-21(26)14-8-11-17-9-4-3-5-10-17/h3-7,9-10,12-13,16,20H,8,11,14-15H2,1-2H3,(H,23,26)(H,24,25)/t20-/m0/s1	XPCRTAWYOXZUNX-FQEVSTJZSA-N	4-phenyl-N-[rac-(1S)-1-(1H-benzimidazol-2-yl)-3-methyl-butyl]butanamide	91640581	CC(C)C[C@H](NC(=O)CCCc1ccccc1)c1nc2ccccc2[nH]1	N-[(1S)-1-(1H-benzimidazol-2-yl)-3-methylbutyl]-4-phenylbutanamide			4.251360000000003														349.47999		349.215412	2	2	8	3			45										False	Alkaloids				Peptide01			Compound(91640581)	91640581	4.6	1226			[#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#6]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#7H]:1	CC(C)C[C@H](NC(=O)CCCc1ccccc1)c1nc2ccccc2[nH]1	XPCRTAWYOXZUNX		parent_pubchem_cid	AKOS027473988;4-phenyl-N-[rac-(1S)-1-(1H-benzimidazol-2-yl)-3-methyl-butyl]butanamide		93491572.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=93491572		pluskal_iocb_peptide_Peptide01_G10_id		100	G10		ZINC000218336297
3.7		0	976	P1098700	131.0		AE4	False	0	26	0	0	34	0	2	7	0	0		0.0						Cc1c2oc(=O)c3c(CCCC3)c2ccc1OCC(=O)NC(CC(C)C)C(=O)NCCCC(=O)O																							0.0		EiM07-17383		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C26H34N2O7	C26H34N2O7			InChI=1S/C26H34N2O7/c1-15(2)13-20(25(32)27-12-6-9-23(30)31)28-22(29)14-34-21-11-10-18-17-7-4-5-8-19(17)26(33)35-24(18)16(21)3/h10-11,15,20H,4-9,12-14H2,1-3H3,(H,27,32)(H,28,29)(H,30,31)/t20-/m0/s1	RMUMJDYCRHXCMP-FQEVSTJZSA-N	4-[[rac-(2S)-4-methyl-2-[[2-[(4-methyl-6-oxo-7,8,9,10-tetrahydrobenzo[c]chromen-3-yl)oxy]acetyl]amino]pentanoyl]amino]butanoic acid	24279918	Cc1c2oc(=O)c3c(CCCC3)c2ccc1OCC(=O)N[C@@H](CC(C)C)C(=O)NCCCC(=O)O	4-[[(2S)-4-methyl-2-[[2-[(4-methyl-6-oxo-7,8,9,10-tetrahydrobenzo[c]chromen-3-yl)oxy]acetyl]amino]pentanoyl]amino]butanoic acid			2.71585													MCULE-6096757036	486.57008		486.236601	7	3	11	3			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(24279918)	24279918	3.5	1227			[#6]-[#6]1:[#6]2:[#8]:[#6](=[#8]):[#6]3:[#6](-[#6]-[#6]-[#6]-[#6]-3):[#6]:2:[#6]:[#6]:[#6]:1-[#8]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]-[#6](=[#8])-[#8]	Cc1c2oc(=O)c3c(CCCC3)c2ccc1OCC(=O)N[C@@H](CC(C)C)C(=O)NCCCC(=O)O	RMUMJDYCRHXCMP		parent_pubchem_cid	EiM07-17383;STL461069;AKOS016390389;4-[(N-{[(4-methyl-6-oxo-7,8,9,10-tetrahydro-6H-benzo[c]chromen-3-yl)oxy]acetyl}-L-leucyl)amino]butanoic acid;4-{4-METHYL-2-[2-({4-METHYL-6-OXO-6H,7H,8H,9H,10H-CYCLOHEXA[C]CHROMEN-3-YL}OXY)ACETAMIDO]PENTANAMIDO}BUTANOIC ACID;4-[[rac-(2S)-4-methyl-2-[[2-[(4-methyl-6-oxo-7,8,9,10-tetrahydrobenzo[c]chromen-3-yl)oxy]acetyl]amino]pentanoyl]amino]butanoic acid		22679642.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22679642		pluskal_iocb_peptide_Peptide01_G10_id		100	G10		ZINC000011866881
4.1		0	720	P3459472	57.8		AE5	False	0	22	0	0	19	0	3	1	0	0		0.0						O=C(Cc1ccccc1)NC(c1ccccc1)c1nc2ccccc2[nH]1																							0.0		N-[1H-benzimidazol-2-yl(phenyl)methyl]-2-phenylacetamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C22H19N3O	C22H19N3O			InChI=1S/C22H19N3O/c26-20(15-16-9-3-1-4-10-16)25-21(17-11-5-2-6-12-17)22-23-18-13-7-8-14-19(18)24-22/h1-14,21H,15H2,(H,23,24)(H,25,26)	NHVRNNZJIYRAGJ-UHFFFAOYSA-N	N-[1H-benzimidazol-2-yl(phenyl)methyl]-2-phenyl-acetamide	4905937	O=C(Cc1ccccc1)NC(c1ccccc1)c1nc2ccccc2[nH]1	N-[1H-benzimidazol-2-yl(phenyl)methyl]-2-phenylacetamide			3.418650000000002													MCULE-1970663681	341.41623		341.152812	2	2	5	4			45										False	Alkaloids	Peptide alkaloids			Peptide01			Compound(4905937)	4905937	3.9	1228			[#8]=[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#7H]:1	O=C(Cc1ccccc1)NC(c1ccccc1)c1nc2ccccc2[nH]1	NHVRNNZJIYRAGJ		parent_pubchem_cid	N-[1H-benzimidazol-2-yl(phenyl)methyl]-2-phenylacetamide;900876-67-7;STK709411;AKOS005531121;N-[1H-benzimidazol-2-yl(phenyl)methyl]-2-phenyl-acetamide		23947421.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23947421		pluskal_iocb_peptide_Peptide01_G10_id		100	G10		
4.6		0	808	P6236887	107.5		AE6	False	0	23	0	0	24	0	2	3	0	1		0.0						CC(C)c1ccc(-c2nc(CC(=O)NC(Cc3ccccc3)C(=O)O)cs2)cc1																							0.0		SCHEMBL20255542		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C23H24N2O3S	C23H24N2O3S			InChI=1S/C23H24N2O3S/c1-15(2)17-8-10-18(11-9-17)22-24-19(14-29-22)13-21(26)25-20(23(27)28)12-16-6-4-3-5-7-16/h3-11,14-15,20H,12-13H2,1-2H3,(H,25,26)(H,27,28)/t20-/m0/s1	MDNYWYNEAFPQAP-FQEVSTJZSA-N	rac-(2S)-2-[[2-[2-(4-isopropylphenyl)thiazol-4-yl]acetyl]amino]-3-phenyl-propanoic acid	29139314	CC(C)c1ccc(-c2nc(CC(=O)N[C@@H](Cc3ccccc3)C(=O)O)cs2)cc1	(2S)-3-phenyl-2-[[2-[2-(4-propan-2-ylphenyl)-1,3-thiazol-4-yl]acetyl]amino]propanoic acid			3.7439500000000026													MCULE-9707494599	408.52333		408.150764	4	2	8	3			43										False	Amino acids and Peptides				Peptide01			Compound(29139314)	29139314	4.6	1229		SCHEMBL20255542	[#6]-[#6](-[#6])-[#6]1:[#6]:[#6]:[#6](-[#6]2:[#7]:[#6](-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3)-[#6](=[#8])-[#8]):[#6]:[#16]:2):[#6]:[#6]:1	CC(C)c1ccc(-c2nc(CC(=O)N[C@@H](Cc3ccccc3)C(=O)O)cs2)cc1	MDNYWYNEAFPQAP		parent_pubchem_cid	SCHEMBL20255542;BDBM513006;US11091451, Compound I-56;AKOS016376779;N-({2-[4-(propan-2-yl)phenyl]-1,3-thiazol-4-yl}acetyl)-L-phenylalanine;rac-(2S)-2-[[2-[2-(4-isopropylphenyl)thiazol-4-yl]acetyl]amino]-3-phenyl-propanoic acid		22678667.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22678667		pluskal_iocb_peptide_Peptide01_G10_id		100	G10		ZINC000020744711
4.9		0	896	P6236888	123.3		AE7	False	0	25	0	0	25	0	3	3	0	1		0.0						CC(C)c1ccc(-c2nc(CC(=O)NC(Cc3c[nH]c4ccccc34)C(=O)O)cs2)cc1																							0.0		SCHEMBL20255603		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C25H25N3O3S	C25H25N3O3S			InChI=1S/C25H25N3O3S/c1-15(2)16-7-9-17(10-8-16)24-27-19(14-32-24)12-23(29)28-22(25(30)31)11-18-13-26-21-6-4-3-5-20(18)21/h3-10,13-15,22,26H,11-12H2,1-2H3,(H,28,29)(H,30,31)/t22-/m0/s1	UNSNHLHMJSQMSO-QFIPXVFZSA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[[2-[2-(4-isopropylphenyl)thiazol-4-yl]acetyl]amino]propanoic acid	29148564	CC(C)c1ccc(-c2nc(CC(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)O)cs2)cc1	(2S)-3-(1H-indol-3-yl)-2-[[2-[2-(4-propan-2-ylphenyl)-1,3-thiazol-4-yl]acetyl]amino]propanoic acid			3.7968300000000017													MCULE-2060843272	447.5603		447.161663	4	3	8	4			43										False	Amino acids and Peptides				Peptide01			Compound(29148564)	29148564	4.0	1230		SCHEMBL20255603	[#6]-[#6](-[#6])-[#6]1:[#6]:[#6]:[#6](-[#6]2:[#7]:[#6](-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]3:[#6]:[#7H]:[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]:3:4)-[#6](=[#8])-[#8]):[#6]:[#16]:2):[#6]:[#6]:1	CC(C)c1ccc(-c2nc(CC(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)O)cs2)cc1	UNSNHLHMJSQMSO		parent_pubchem_cid	SCHEMBL20255603;AKOS016376778;N-({2-[4-(propan-2-yl)phenyl]-1,3-thiazol-4-yl}acetyl)-L-tryptophan;rac-(2S)-3-(1H-indol-3-yl)-2-[[2-[2-(4-isopropylphenyl)thiazol-4-yl]acetyl]amino]propanoic acid		23829959.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23829959		pluskal_iocb_peptide_Peptide01_G10_id		100	G10		ZINC000020763662
2.3		0	984	P3458704	91.9		AE8	False	0	15	0	0	15	0	1	4	0	1		0.0						O=C(O)C(Cc1ccccc1)NS(=O)(=O)c1ccccc1																							0.0		(S)-3-phenyl-2-(phenylsulfonamido)propanoic acid		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0		C15H15NO4S	C15H15NO4S			InChI=1S/C15H15NO4S/c17-15(18)14(11-12-7-3-1-4-8-12)16-21(19,20)13-9-5-2-6-10-13/h1-10,14,16H,11H2,(H,17,18)/t14-/m0/s1	PICQEJDBZKDWOD-AWEZNQCLSA-N	rac-(2S)-2-(benzenesulfonamido)-3-phenyl-propanoic acid	744894	O=C(O)[C@H](Cc1ccccc1)NS(=O)(=O)c1ccccc1	(2S)-2-(benzenesulfonamido)-3-phenylpropanoic acid			1.49808													MCULE-3261357471	305.3551		305.072179	4	2	6	2			43										False	Amino acids and Peptides;Shikimates and Phenylpropanoids				Peptide01			Compound(744894)	744894	2.5	1231		SCHEMBL697592	[#8]=[#6](-[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#16](=[#8])(=[#8])-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	O=C(O)[C@H](Cc1ccccc1)NS(=O)(=O)c1ccccc1	PICQEJDBZKDWOD		parent_pubchem_cid	(S)-3-phenyl-2-(phenylsulfonamido)propanoic acid;40279-95-6;starbld0020019;2-BENZENESULFONAMIDO-3-PHENYLPROPANOIC ACID;Oprea1_032481;Oprea1_212353;SCHEMBL697592;(2S)-2-(benzenesulfonamido)-3-phenylpropanoic acid;PICQEJDBZKDWOD-AWEZNQCLSA-N;N-(benzenesulfonyl)-l-phenylalanine;Nalpha-benzenesulfonyl-L-phenylalanine;AKOS010373925;SR-01000480151;SR-01000480151-1;rac-(2S)-2-(benzenesulfonamido)-3-phenyl-propanoic acid		22650926.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22650926		pluskal_iocb_peptide_Peptide01_G10_id		100	G10		ZINC000005020931
3.7		0	728	P6237060	132.5		AE9	False	0	23	0	0	21	0	3	4	0	1		0.0						COc1ccccc1-c1nc(CC(=O)NC(Cc2c[nH]c3ccccc23)C(=O)O)cs1																							0.0		SCHEMBL20255646		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C23H21N3O4S	C23H21N3O4S			InChI=1S/C23H21N3O4S/c1-30-20-9-5-3-7-17(20)22-25-15(13-31-22)11-21(27)26-19(23(28)29)10-14-12-24-18-8-4-2-6-16(14)18/h2-9,12-13,19,24H,10-11H2,1H3,(H,26,27)(H,28,29)/t19-/m0/s1	RUYHOQSAHIXKLV-IBGZPJMESA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[[2-[2-(2-methoxyphenyl)thiazol-4-yl]acetyl]amino]propanoic acid	29147531	COc1ccccc1-c1nc(CC(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)cs1	(2S)-3-(1H-indol-3-yl)-2-[[2-[2-(2-methoxyphenyl)-1,3-thiazol-4-yl]acetyl]amino]propanoic acid			2.274329999999999													MCULE-4729460935	435.50552		435.125277	5	3	8	4			43										False	Alkaloids				Peptide01			Compound(29147531)	29147531	3.5	1232		SCHEMBL20255646	[#6]-[#8]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1-[#6]1:[#7]:[#6](-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6](=[#8])-[#8]):[#6]:[#16]:1	COc1ccccc1-c1nc(CC(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)cs1	RUYHOQSAHIXKLV		parent_pubchem_cid	SCHEMBL20255646;AKOS016386082;rac-(2S)-3-(1H-indol-3-yl)-2-[[2-[2-(2-methoxyphenyl)thiazol-4-yl]acetyl]amino]propanoic acid		23144939.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23144939		pluskal_iocb_peptide_Peptide01_G11_id		100	G11		ZINC000020761515
3.0		0	816	P3461565	82.2		AE10	False	0	15	0	0	18	0	2	3	0	0		0.0						CCCCC(NC(=O)c1cc2ccccc2[nH]1)C(=O)O																							0.0		N-(1H-indol-2-ylcarbonyl)norleucine		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C15H18N2O3	C15H18N2O3			InChI=1S/C15H18N2O3/c1-2-3-7-12(15(19)20)17-14(18)13-9-10-6-4-5-8-11(10)16-13/h4-6,8-9,12,16H,2-3,7H2,1H3,(H,17,18)(H,19,20)	GXFLWIWAJYBOEM-UHFFFAOYSA-N	2-(1H-indole-2-carbonylamino)hexanoic acid	16415943	CCCCC(NC(=O)c1cc2ccccc2[nH]1)C(=O)O	2-(1H-indole-2-carbonylamino)hexanoic acid			2.05797													MCULE-1598018197	274.32231		274.131742	3	3	6	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(16415943)	16415943	3.5	1233			[#6]-[#6]-[#6]-[#6]-[#6](-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#7H]:1)-[#6](=[#8])-[#8]	CCCCC(NC(=O)c1cc2ccccc2[nH]1)C(=O)O	GXFLWIWAJYBOEM		parent_pubchem_cid	N-(1H-indol-2-ylcarbonyl)norleucine;1452575-02-8;2-(1H-indole-2-carbonylamino)hexanoic acid;2-[(1H-indol-2-yl)formamido]hexanoic acid;MFCD09790019;norleucine, N-(1H-indol-2-ylcarbonyl)-;DTXSID801283118;CIC57502;STK619523;AKOS005175215;SB49366;NS-04452;2-(1h-Indole-2-carboxamido)hexanoic acid;CS-0297392;EN300-302785		24274689.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24274689		pluskal_iocb_peptide_Peptide01_G11_id		100	G11		
3.3		0	904	P1098629	117.7		AE11	False	0	24	0	0	22	0	2	6	0	0		0.0						COc1cc2c(cc1)c(C)c(CC(=O)NC(Cc1c[nH]c3ccccc13)C(=O)O)c(=O)o2																							0.0		AKOS016378981		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C24H22N2O6	C24H22N2O6			InChI=1S/C24H22N2O6/c1-13-16-8-7-15(31-2)10-21(16)32-24(30)18(13)11-22(27)26-20(23(28)29)9-14-12-25-19-6-4-3-5-17(14)19/h3-8,10,12,20,25H,9,11H2,1-2H3,(H,26,27)(H,28,29)/t20-/m1/s1	JTPWJULERQEDGX-HXUWFJFHSA-N	rac-(2R)-3-(1H-indol-3-yl)-2-[[2-(7-methoxy-4-methyl-2-oxo-chromen-3-yl)acetyl]amino]propanoic acid	24279896	COc1cc2c(cc1)c(C)c(CC(=O)N[C@H](Cc1c[nH]c3ccccc13)C(=O)O)c(=O)o2	(2R)-3-(1H-indol-3-yl)-2-[[2-(7-methoxy-4-methyl-2-oxochromen-3-yl)acetyl]amino]propanoic acid			2.36243													MCULE-8365355919	434.45274		434.147786	6	3	7	4			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(24279896)	24279896	2.7	1234			[#6]-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#6](-[#6]):[#6](-[#6]-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:1:3)-[#6](=[#8])-[#8]):[#6](=[#8]):[#8]:2	COc1cc2c(cc1)c(C)c(CC(=O)N[C@H](Cc1c[nH]c3ccccc13)C(=O)O)c(=O)o2	JTPWJULERQEDGX		parent_pubchem_cid	AKOS016378981;3-(1H-INDOL-3-YL)-2-[2-(7-METHOXY-4-METHYL-2-OXO-2H-CHROMEN-3-YL)ACETAMIDO]PROPANOIC ACID;rac-(2R)-3-(1H-indol-3-yl)-2-[[2-(7-methoxy-4-methyl-2-oxo-chromen-3-yl)acetyl]amino]propanoic acid		43880493.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=43880493		pluskal_iocb_peptide_Peptide01_G11_id		100	G11		ZINC000011866852
2.8		0	992	P3461262	109.9		AE12	False	0	20	0	0	20	0	2	6	0	0		0.0						COc1c(OC)c(OC)c2[nH]c(C(=O)NC(C(=O)O)c3ccccc3)cc2c1																							0.0		AKOS016383173		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C20H20N2O6	C20H20N2O6			InChI=1S/C20H20N2O6/c1-26-14-10-12-9-13(21-15(12)18(28-3)17(14)27-2)19(23)22-16(20(24)25)11-7-5-4-6-8-11/h4-10,16,21H,1-3H3,(H,22,23)(H,24,25)/t16-/m0/s1	ZEOGSPDUAUVMRW-INIZCTEOSA-N	rac-(2S)-2-phenyl-2-[(5,6,7-trimethoxy-1H-indole-2-carbonyl)amino]acetic acid	51703651	COc1c(OC)c(OC)c2[nH]c(C(=O)N[C@H](C(=O)O)c3ccccc3)cc2c1	(2S)-2-phenyl-2-[(5,6,7-trimethoxy-1H-indole-2-carbonyl)amino]acetic acid			0.8243300000000007													MCULE-3944455396	384.3922		384.132136	6	3	7	3			44									Carbazole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(51703651)	51703651	2.9	1235			[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]):[#6](-[#8]-[#6]):[#6]2:[#7H]:[#6](-[#6](=[#8])-[#7]-[#6@H](-[#6](=[#8])-[#8])-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#6]:[#6]:2:[#6]:1	COc1c(OC)c(OC)c2[nH]c(C(=O)N[C@H](C(=O)O)c3ccccc3)cc2c1	ZEOGSPDUAUVMRW		parent_pubchem_cid	AKOS016383173;(2S)-phenyl[(5,6,7-trimethoxy-1H-indole-2-carbonyl)amino]acetic acid;rac-(2S)-2-phenyl-2-[(5,6,7-trimethoxy-1H-indole-2-carbonyl)amino]acetic acid		23851164.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23851164		pluskal_iocb_peptide_Peptide01_G11_id		100	G11		ZINC000035686333
2.5		0	736	P6239447	116.7		AE13	False	0	18	0	0	18	0	6	1	0	1		0.0						Cc1c(C)c(C(=O)NCCc2c[nH]c3ccccc23)c(-n2cnnn2)s1								Thiophene carboxamides;Substituted pyrroles;Benzenoids;Vinylogous amides;Tetrazoles;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Organooxygen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	3-alkylindoles;Azacyclic compounds;Azoles;Benzenoids;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Tetrazoles;Thiophene carboxamides;Thiophene carboxylic acids and derivatives;Thiophenes;Vinylogous amides	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as 3-alkylindoles. These are compounds containing an indole moiety that carries an alkyl chain at the 3-position.	3-alkylindoles			Organic compounds	Aromatic heteropolycyclic compounds	thiophenes (CHEBI:26961);aromatic amide (CHEBI:62733);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);enone (CHEBI:51689);enamine (CHEBI:47989);tetrazoles (CHEBI:35689);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organonitrogen heterocyclic compound (CHEBI:38101);organooxygen compound (CHEBI:36963);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);indoles (CHEBI:24828);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);thiophenecarboxylic acid (CHEBI:48436);organic acid (CHEBI:64709);azole (CHEBI:68452);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143)		Indoles	3-alkylindole;Thiophene carboxylic acid or derivatives;Thiophene carboxamide;Substituted pyrrole;Benzenoid;Azole;Pyrrole;Heteroaromatic compound;Vinylogous amide;Thiophene;Tetrazole;Carboxamide group;Secondary carboxylic acid amide;Carboxylic acid derivative;Azacycle;Organic oxide;Organooxygen compound;Organonitrogen compound;Organic oxygen compound;Hydrocarbon derivative;Organic nitrogen compound;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		N-[2-(1H-indol-3-yl)ethyl]-4,5-dimethyl-2-(1H-tetrazol-1-yl)thiophene-3-carboxamide		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	4	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C18H18N6OS	C18H18N6OS			InChI=1S/C18H18N6OS/c1-11-12(2)26-18(24-10-21-22-23-24)16(11)17(25)19-8-7-13-9-20-15-6-4-3-5-14(13)15/h3-6,9-10,20H,7-8H2,1-2H3,(H,19,25)	VYQAKIDQFZSXMM-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)ethyl]-4,5-dimethyl-2-(tetrazol-1-yl)thiophene-3-carboxamide	45491558	Cc1c(C)c(C(=O)NCCc2c[nH]c3ccccc23)c(-n2cnnn2)s1	N-[2-(1H-indol-3-yl)ethyl]-4,5-dimethyl-2-(tetrazol-1-yl)thiophene-3-carboxamide			1.95717													MCULE-9936053858	366.44776		366.12628	4	2	5	4			44									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(45491558)	45491558	3.4	1236			[#6]-[#6]1:[#6](-[#6]):[#6](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6](-[#7]2:[#6]:[#7]:[#7]:[#7]:2):[#16]:1	Cc1c(C)c(C(=O)NCCc2c[nH]c3ccccc23)c(-n2cnnn2)s1	VYQAKIDQFZSXMM		parent_pubchem_cid	N-[2-(1H-indol-3-yl)ethyl]-4,5-dimethyl-2-(1H-tetrazol-1-yl)thiophene-3-carboxamide;1190298-60-2;EiM08-10137;AKOS005666022;N-[2-(1H-indol-3-yl)ethyl]-4,5-dimethyl-2-(tetrazol-1-yl)thiophene-3-carboxamide		14556119.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=14556119		pluskal_iocb_peptide_Peptide01_G11_id		100	G11		ZINC000036354482
4.0		0	824	P1107637	111.2		AE14	False	0	26	0	0	27	0	1	7	0	0		0.0						Cc1cc(=O)oc2c3CCC(C)(C)Oc3cc(OCC(=O)NC(Cc3ccccc3)C(=O)O)c12																							0.0		AKOS016377406		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C26H27NO7	C26H27NO7			InChI=1S/C26H27NO7/c1-15-11-22(29)33-24-17-9-10-26(2,3)34-19(17)13-20(23(15)24)32-14-21(28)27-18(25(30)31)12-16-7-5-4-6-8-16/h4-8,11,13,18H,9-10,12,14H2,1-3H3,(H,27,28)(H,30,31)/t18-/m1/s1	RNQGLADNZZASLE-GOSISDBHSA-N	rac-(2R)-3-phenyl-2-[[2-[(4,8,8-trimethyl-2-oxo-9,10-dihydropyrano[2,3-h]chromen-5-yl)oxy]acetyl]amino]propanoic acid	24280489	Cc1cc(=O)oc2c3CCC(C)(C)Oc3cc(OCC(=O)N[C@H](Cc3ccccc3)C(=O)O)c12	(2R)-3-phenyl-2-[[2-[(4,8,8-trimethyl-2-oxo-9,10-dihydropyrano[2,3-h]chromen-5-yl)oxy]acetyl]amino]propanoic acid			2.7784400000000007													MCULE-5879630254	465.50759		465.178752	7	2	7	4			44									Pyranocoumarins;Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(24280489)	24280489	3.7	1237			[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]3-[#6]-[#6]-[#6](-[#6])(-[#6])-[#8]-[#6]:3:[#6]:[#6](-[#8]-[#6]-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3)-[#6](=[#8])-[#8]):[#6]:1:2	Cc1cc(=O)oc2c3CCC(C)(C)Oc3cc(OCC(=O)N[C@H](Cc3ccccc3)C(=O)O)c12	RNQGLADNZZASLE		parent_pubchem_cid	AKOS016377406;3-PHENYL-2-[2-({4,8,8-TRIMETHYL-2-OXO-2H,8H,9H,10H-PYRANO[2,3-H]CHROMEN-5-YL}OXY)ACETAMIDO]PROPANOIC ACID;rac-(2R)-3-phenyl-2-[[2-[(4,8,8-trimethyl-2-oxo-9,10-dihydropyrano[2,3-h]chromen-5-yl)oxy]acetyl]amino]propanoic acid		24592995.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24592995		pluskal_iocb_peptide_Peptide01_G11_id		100	G11		ZINC000011865490
2.4		0	912	P6238638	85.6		AE15	False	0	17	0	0	20	0	2	3	0	1		0.0						COC(=O)C(CCSC)NC(=O)c1cc(-n2cccc2)ccc1								Alpha amino acid esters;N-acyl-alpha amino acids and derivatives;Hippuric acids and derivatives;Phenylpyrroles;Benzoyl derivatives;Fatty acid esters;Methyl esters;Heteroaromatic compounds;Secondary carboxylic acid amides;Sulfenyl compounds;Azacyclic compounds;Monocarboxylic acids and derivatives;Dialkylthioethers;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organonitrogen compounds	Alpha amino acid esters;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzamides;Benzene and substituted derivatives;Benzenoids;Benzoic acids and derivatives;Benzoyl derivatives;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids and derivatives;Chemical entities;Dialkylthioethers;Fatty Acyls;Fatty acid esters;Heteroaromatic compounds;Hippuric acids and derivatives;Hydrocarbon derivatives;Lipids and lipid-like molecules;Methionine and derivatives;Methyl esters;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Organosulfur compounds;Phenylpyrroles;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Sulfenyl compounds;Thioethers	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as methionine and derivatives. These are compounds containing methionine or a derivative thereof resulting from reaction of methionine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Methionine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteromonocyclic compounds	alpha-amino acid ester (CHEBI:46874);N-acyl-amino acid (CHEBI:51569);N-acylglycine (CHEBI:16180);pyrroles (CHEBI:26455);carbonyl compound (CHEBI:36586);fatty acid ester (CHEBI:35748);carboxylic ester (CHEBI:33308);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organosulfur compound (CHEBI:33261);organonitrogen heterocyclic compound (CHEBI:38101);monocarboxylic acid (CHEBI:25384);aliphatic sulfide (CHEBI:22327);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);alpha-amino acid (CHEBI:33704);methionine derivative (CHEBI:25230);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);organooxygen compound (CHEBI:36963);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);benzoic acids (CHEBI:22723);benzamides (CHEBI:22702);organic heterocyclic compound (CHEBI:24532);lipid (CHEBI:18059);amide (CHEBI:32988);organic sulfide (CHEBI:16385);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143);phenols (CHEBI:33853);amino acid (CHEBI:33709);peptide (CHEBI:16670)	Fatty esters (FA07);Fatty Acyls (FA)	Amino acids, peptides, and analogues	Methionine or derivatives;Alpha-amino acid ester;Hippuric acid or derivatives;N-acyl-alpha amino acid or derivatives;1-phenylpyrrole;Benzamide;Benzoic acid or derivatives;Benzoyl;Fatty acid ester;Monocyclic benzene moiety;Fatty acyl;Benzenoid;Substituted pyrrole;Heteroaromatic compound;Methyl ester;Pyrrole;Carboxamide group;Carboxylic acid ester;Secondary carboxylic acid amide;Sulfenyl compound;Monocarboxylic acid or derivatives;Dialkylthioether;Organoheterocyclic compound;Azacycle;Thioether;Organooxygen compound;Organonitrogen compound;Organic nitrogen compound;Carbonyl group;Hydrocarbon derivative;Organic oxide;Organosulfur compound;Organic oxygen compound;Aromatic heteromonocyclic compound	Organic acids and derivatives	0.0		AKOS016382710		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C17H20N2O3S	C17H20N2O3S			InChI=1S/C17H20N2O3S/c1-22-17(21)15(8-11-23-2)18-16(20)13-6-5-7-14(12-13)19-9-3-4-10-19/h3-7,9-10,12,15H,8,11H2,1-2H3,(H,18,20)/t15-/m0/s1	KREJLXSJRYRZGN-HNNXBMFYSA-N	methyl rac-(2S)-4-methylsulfanyl-2-[(3-pyrrol-1-ylbenzoyl)amino]butanoate	39377907	COC(=O)[C@H](CCSC)NC(=O)c1cc(-n2cccc2)ccc1	methyl (2S)-4-methylsulfanyl-2-[(3-pyrrol-1-ylbenzoyl)amino]butanoate			2.25708													MCULE-9708579043	332.42455		332.119463	4	1	8	2			44									Aminoacids	False	Amino acids and Peptides;Shikimates and Phenylpropanoids	Small peptides			Peptide01			Compound(39377907)	39377907	2.6	1238			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]-[#16]-[#6])-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6](-[#7]2:[#6]:[#6]:[#6]:[#6]:2):[#6]:[#6]:[#6]:1	COC(=O)[C@H](CCSC)NC(=O)c1cc(-n2cccc2)ccc1	KREJLXSJRYRZGN		parent_pubchem_cid	AKOS016382710;METHYL 4-(METHYLSULFANYL)-2-{[3-(1H-PYRROL-1-YL)PHENYL]FORMAMIDO}BUTANOATE;methyl rac-(2S)-4-methylsulfanyl-2-[(3-pyrrol-1-ylbenzoyl)amino]butanoate		18488915.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=18488915		pluskal_iocb_peptide_Peptide01_G11_id		100	G11		ZINC000032124110
3.0		0	1000	P11183604	88.5		AE16	False	0	21	0	0	20	0	6	1	0	0		0.0						O=C(NC1CCCc2c1[nH]c1ccccc21)C(c1ccccc1)n1cnnn1																							0.0		AKOS027471857		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	4	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C21H20N6O	C21H20N6O			InChI=1S/C21H20N6O/c28-21(20(27-13-22-25-26-27)14-7-2-1-3-8-14)24-18-12-6-10-16-15-9-4-5-11-17(15)23-19(16)18/h1-5,7-9,11,13,18,20,23H,6,10,12H2,(H,24,28)/t18?,20-/m0/s1	HODLLTGRJQPTLU-IJHRGXPZSA-N	rac-(2S)-2-phenyl-N-(2,3,4,9-tetrahydro-1H-carbazol-1-yl)-2-(tetrazol-1-yl)acetamide	75490441	O=C(NC1CCCc2c1[nH]c1ccccc21)[C@H](c1ccccc1)n1cnnn1	(2S)-2-phenyl-N-(2,3,4,9-tetrahydro-1H-carbazol-1-yl)-2-(tetrazol-1-yl)acetamide			2.3450500000000005														372.43315		372.169859	4	2	4	5			46									Carboline alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(75490441)	75490441	3.1	1239			[#8]=[#6](-[#7]-[#6]1-[#6]-[#6]-[#6]-[#6]2:[#6]-1:[#7H]:[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:2:1)-[#6@H](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]1:[#6]:[#7]:[#7]:[#7]:1	O=C(NC1CCCc2c1[nH]c1ccccc21)[C@H](c1ccccc1)n1cnnn1	HODLLTGRJQPTLU		parent_pubchem_cid	AKOS027471857;rac-(2S)-2-phenyl-N-(2,3,4,9-tetrahydro-1H-carbazol-1-yl)-2-(tetrazol-1-yl)acetamide		80414862.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=80414862		pluskal_iocb_peptide_Peptide01_G11_id		100	G11		
1.6		0	744	P6240804	126.5		AE17	False	1	17	0	0	21	0	4	4	0	0		0.0						NC(=O)NCCCC(NC(=O)CCn1ccc2c(Br)cccc21)C(=O)O								N-alkylindoles;Indoles;Substituted pyrroles;Aryl bromides;Benzenoids;Heteroaromatic compounds;Ureas;Secondary carboxylic acid amides;Azacyclic compounds;Carboxylic acids;Monocarboxylic acids and derivatives;Organonitrogen compounds;Carbonyl compounds;Organic oxides;Hydrocarbon derivatives;Organobromides	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Aryl bromides;Aryl halides;Azacyclic compounds;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;N-alkylindoles;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organobromides;Organohalogen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Ureas	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as n-acyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom.	N-acyl-alpha amino acids		Amino acids and derivatives;Alpha amino acids and derivatives;N-acyl-alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	indoles (CHEBI:24828);pyrroles (CHEBI:26455);organobromine compound (CHEBI:37141);benzenoid aromatic compound (CHEBI:33836);organic aromatic compound (CHEBI:33659);ureas (CHEBI:47857);carboxamide (CHEBI:37622);organonitrogen heterocyclic compound (CHEBI:38101);carboxylic acid (CHEBI:33575);monocarboxylic acid (CHEBI:25384);organonitrogen compound (CHEBI:35352);carbonyl compound (CHEBI:36586);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);N-acyl-amino acid (CHEBI:51569);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);organohalogen compound (CHEBI:36684);haloarene (CHEBI:50887);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806)		Amino acids, peptides, and analogues	N-acyl-alpha-amino acid;N-alkylindole;Indole;Indole or derivatives;Aryl bromide;Aryl halide;Benzenoid;Substituted pyrrole;Heteroaromatic compound;Pyrrole;Carboxamide group;Urea;Secondary carboxylic acid amide;Carboxylic acid;Azacycle;Monocarboxylic acid or derivatives;Organoheterocyclic compound;Carbonyl group;Organic oxygen compound;Organic nitrogen compound;Hydrocarbon derivative;Organic oxide;Organohalogen compound;Organobromide;Organonitrogen compound;Organooxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		EiM08-12025		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C17H21BrN4O4	C17H21BrN4O4			InChI=1S/C17H21BrN4O4/c18-12-3-1-5-14-11(12)6-9-22(14)10-7-15(23)21-13(16(24)25)4-2-8-20-17(19)26/h1,3,5-6,9,13H,2,4,7-8,10H2,(H,21,23)(H,24,25)(H3,19,20,26)/t13-/m1/s1	PNLACOFCRVYEKU-CYBMUJFWSA-N	rac-(2R)-2-[3-(4-bromoindol-1-yl)propanoylamino]-5-ureido-pentanoic acid	49652039	NC(=O)NCCC[C@@H](NC(=O)CCn1ccc2c(Br)cccc21)C(=O)O	(2R)-2-[3-(4-bromoindol-1-yl)propanoylamino]-5-(carbamoylamino)pentanoic acid			1.3833799999999998													MCULE-8106019948	425.28532		424.074617	4	4	9	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(49652039)	49652039	1.0	1240			[#7]-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]-[#6@@H](-[#7]-[#6](=[#8])-[#6]-[#6]-[#7]1:[#6]:[#6]:[#6]2:[#6](-[#35]):[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	NC(=O)NCCC[C@@H](NC(=O)CCn1ccc2c(Br)cccc21)C(=O)O	PNLACOFCRVYEKU		parent_pubchem_cid	EiM08-12025;AKOS016397972;rac-(2R)-2-[3-(4-bromoindol-1-yl)propanoylamino]-5-ureido-pentanoic acid		22638658.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22638658		pluskal_iocb_peptide_Peptide01_G12_id		100	G12		ZINC000040308956
3.7		0	832	P1108434	117.7		AE18	False	0	24	0	0	22	0	2	6	0	0		0.0						Cc1cc(=O)oc2c1ccc(OC(C)C(=O)NC(Cc1c[nH]c3ccccc13)C(=O)O)c2																							0.0		AKOS004938105		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C24H22N2O6	C24H22N2O6			InChI=1S/C24H22N2O6/c1-13-9-22(27)32-21-11-16(7-8-17(13)21)31-14(2)23(28)26-20(24(29)30)10-15-12-25-19-6-4-3-5-18(15)19/h3-9,11-12,14,20,25H,10H2,1-2H3,(H,26,28)(H,29,30)/t14?,20-/m0/s1	NHPPCDZCRMDZNC-LGTGAQBVSA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[2-(4-methyl-2-oxo-chromen-7-yl)oxypropanoylamino]propanoic acid	24280676	Cc1cc(=O)oc2c1ccc(OC(C)C(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)O)c2	(2S)-3-(1H-indol-3-yl)-2-[2-(4-methyl-2-oxochromen-7-yl)oxypropanoylamino]propanoic acid			2.6333400000000005													MCULE-2843212566	434.45274		434.147786	6	3	7	4			45									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(24280676)	24280676	2.6	1241			[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6](-[#6])-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:1:3)-[#6](=[#8])-[#8]):[#6]:2	Cc1cc(=O)oc2c1ccc(OC(C)C(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)O)c2	NHPPCDZCRMDZNC		parent_pubchem_cid	AKOS004938105;(2R)-3-(1H-indol-3-yl)-2-(2-((4-methyl-2-oxo-2H-chromen-7-yl)oxy)propanamido)propanoic acid;rac-(2S)-3-(1H-indol-3-yl)-2-[2-(4-methyl-2-oxo-chromen-7-yl)oxypropanoylamino]propanoic acid		24483606.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24483606		pluskal_iocb_peptide_Peptide01_G12_id		100	G12		
1.6		0	920	P6237073	107.5		AE19	False	0	12	0	0	18	0	2	3	0	1		0.0						CCC(C)C(NC(=O)c1c(C)nc(C)s1)C(=O)O																							0.0		AKOS016387017		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C12H18N2O3S	C12H18N2O3S			InChI=1S/C12H18N2O3S/c1-5-6(2)9(12(16)17)14-11(15)10-7(3)13-8(4)18-10/h6,9H,5H2,1-4H3,(H,14,15)(H,16,17)/t6-,9+/m1/s1	VCAJRRWBUFNICO-MUWHJKNJSA-N	rac-(2S,3R)-2-[(2,4-dimethylthiazole-5-carbonyl)amino]-3-methyl-pentanoic acid	29131629	CC[C@@H](C)[C@H](NC(=O)c1c(C)nc(C)s1)C(=O)O	(2S,3R)-2-[(2,4-dimethyl-1,3-thiazole-5-carbonyl)amino]-3-methylpentanoic acid			1.82491													MCULE-5219441289	270.35286		270.103813	4	2	5	1			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(29131629)	29131629	2.7	1242			[#6]-[#6]-[#6@@H](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#6]1:[#6](-[#6]):[#7]:[#6](-[#6]):[#16]:1)-[#6](=[#8])-[#8]	CC[C@@H](C)[C@H](NC(=O)c1c(C)nc(C)s1)C(=O)O	VCAJRRWBUFNICO		parent_pubchem_cid	AKOS016387017;rac-(2S,3R)-2-[(2,4-dimethylthiazole-5-carbonyl)amino]-3-methyl-pentanoic acid		23741794.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23741794		pluskal_iocb_peptide_Peptide01_G12_id		100	G12		ZINC000020723256
2.6		0	1008	P1157560	105.7		AE20	False	0	23	0	0	24	0	4	4	0	0		0.0						O=C(O)C(Cc1ccccc1)NC(=O)N1CCN(C(=O)c2cc3ccccc3[nH]2)CC1																							0.0		AKOS016402569		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0		C23H24N4O4	C23H24N4O4			InChI=1S/C23H24N4O4/c28-21(19-15-17-8-4-5-9-18(17)24-19)26-10-12-27(13-11-26)23(31)25-20(22(29)30)14-16-6-2-1-3-7-16/h1-9,15,20,24H,10-14H2,(H,25,31)(H,29,30)/t20-/m0/s1	ALYKQAJYQFMCTF-FQEVSTJZSA-N	rac-(2S)-2-[[4-(1H-indole-2-carbonyl)piperazine-1-carbonyl]amino]-3-phenyl-propanoic acid	17593016	O=C(O)[C@H](Cc1ccccc1)NC(=O)N1CCN(C(=O)c2cc3ccccc3[nH]2)CC1	(2S)-2-[[4-(1H-indole-2-carbonyl)piperazine-1-carbonyl]amino]-3-phenylpropanoic acid			1.7933599999999996													MCULE-5275429655	420.47213		420.179755	4	3	5	4			44										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(17593016)	17593016	2.5	1243			[#8]=[#6](-[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#7]1-[#6]-[#6]-[#7](-[#6](=[#8])-[#6]2:[#6]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3:[#7H]:2)-[#6]-[#6]-1	O=C(O)[C@H](Cc1ccccc1)NC(=O)N1CCN(C(=O)c2cc3ccccc3[nH]2)CC1	ALYKQAJYQFMCTF		parent_pubchem_cid	AKOS016402569;(2S)-2-({[4-(1H-INDOL-2-YLCARBONYL)PIPERAZINO]CARBONYL}AMINO)-3-PHENYLPROPANOIC ACID;rac-(2S)-2-[[4-(1H-indole-2-carbonyl)piperazine-1-carbonyl]amino]-3-phenyl-propanoic acid		23472424.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23472424		pluskal_iocb_peptide_Peptide01_G12_id		100	G12		ZINC000008991093
3.0		0	752	P6244029	72.7		AE21	False	0	16	0	0	29	0	5	1	0	0		0.0						CC(C)CCCC(C)NC(=O)C1(n2cnnn2)CCCCC1																							0.0		N-(6-methylheptan-2-yl)-1-(1H-tetrazol-1-yl)cyclohexanecarboxamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	4	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C16H29N5O	C16H29N5O			InChI=1S/C16H29N5O/c1-13(2)8-7-9-14(3)18-15(22)16(10-5-4-6-11-16)21-12-17-19-20-21/h12-14H,4-11H2,1-3H3,(H,18,22)	ZXJCRQNIAHUJLI-UHFFFAOYSA-N	N-(1,5-dimethylhexyl)-1-(tetrazol-1-yl)cyclohexanecarboxamide	51049374	CC(C)CCCC(C)NC(=O)C1(n2cnnn2)CCCCC1	N-(6-methylheptan-2-yl)-1-(tetrazol-1-yl)cyclohexane-1-carboxamide			2.663500000000001													MCULE-2395736680	307.44243		307.237211	4	1	7	2			45										False	Alkaloids				Peptide01			Compound(51049374)	51049374	3.6	1244			[#6]-[#6](-[#6])-[#6]-[#6]-[#6]-[#6](-[#6])-[#7]-[#6](=[#8])-[#6]1(-[#7]2:[#6]:[#7]:[#7]:[#7]:2)-[#6]-[#6]-[#6]-[#6]-[#6]-1	CC(C)CCCC(C)NC(=O)C1(n2cnnn2)CCCCC1	ZXJCRQNIAHUJLI		parent_pubchem_cid	N-(6-methylheptan-2-yl)-1-(1H-tetrazol-1-yl)cyclohexanecarboxamide;1232793-07-5;AKOS005671840;N-(6-METHYLHEPTAN-2-YL)-1-(1H-1,2,3,4-TETRAZOL-1-YL)CYCLOHEXANE-1-CARBOXAMIDE;N-(1,5-dimethylhexyl)-1-(tetrazol-1-yl)cyclohexanecarboxamide		24700972.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24700972		pluskal_iocb_peptide_Peptide01_G12_id		100	G12		
4.8		0	840	P1107413	121.6		AE22	False	0	28	0	0	26	0	2	6	0	0		0.0						Cc1c(C)c2cc3c(cc2o1)oc(=O)c(CCC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)O)c3C																							0.0		STL463419		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C28H26N2O6	C28H26N2O6			InChI=1S/C28H26N2O6/c1-14-16(3)35-24-12-25-21(11-20(14)24)15(2)18(28(34)36-25)8-9-26(31)30-23(27(32)33)10-17-13-29-22-7-5-4-6-19(17)22/h4-7,11-13,23,29H,8-10H2,1-3H3,(H,30,31)(H,32,33)/t23-/m1/s1	CUAQFXVLDHTMTG-HSZRJFAPSA-N	rac-(2R)-3-(1H-indol-3-yl)-2-[3-(2,3,5-trimethyl-7-oxo-furo[3,2-g]chromen-6-yl)propanoylamino]propanoic acid	24280399	Cc1c(C)c2cc3c(cc2o1)oc(=O)c(CCC(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)O)c3C	(2R)-3-(1H-indol-3-yl)-2-[3-(2,3,5-trimethyl-7-oxofuro[3,2-g]chromen-6-yl)propanoylamino]propanoic acid			4.031540000000002													MCULE-5385389524	486.52922		486.179087	5	3	7	5			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(24280399)	24280399	4.2	1245			[#6]-[#6]1:[#6](-[#6]):[#6]2:[#6]:[#6]3:[#6](:[#6]:[#6]:2:[#8]:1):[#8]:[#6](=[#8]):[#6](-[#6]-[#6]-[#6](=[#8])-[#7]-[#6@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]):[#6]:3-[#6]	Cc1c(C)c2cc3c(cc2o1)oc(=O)c(CCC(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)O)c3C	CUAQFXVLDHTMTG		parent_pubchem_cid	STL463419;AKOS016390644;N-[3-(2,3,5-trimethyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)propanoyl]-D-tryptophan;3-(1H-INDOL-3-YL)-2-(3-{2,3,5-TRIMETHYL-7-OXO-7H-FURO[3,2-G]CHROMEN-6-YL}PROPANAMIDO)PROPANOIC ACID;rac-(2R)-3-(1H-indol-3-yl)-2-[3-(2,3,5-trimethyl-7-oxo-furo[3,2-g]chromen-6-yl)propanoylamino]propanoic acid		24347315.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24347315		pluskal_iocb_peptide_Peptide01_G12_id		100	G12		ZINC000011865398
3.0		0	928	P11185680	112.7		AE23	False	0	26	0	0	28	0	6	2	0	0		0.0						O=C(CCCCCNC(=O)c1nccnc1)NC(Cc1ccccc1)c1nc2ccccc2[nH]1								Pyrazinecarboxamides;Benzimidazoles;2-heteroaryl carboxamides;N-acyl amines;Imidazoles;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	2-heteroaryl carboxamides;Amphetamines and derivatives;Azacyclic compounds;Azoles;Benzene and substituted derivatives;Benzenoids;Benzimidazoles;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Diazines;Fatty Acyls;Fatty amides;Heteroaromatic compounds;Hydrocarbon derivatives;Imidazoles;Lipids and lipid-like molecules;N-acyl amines;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenethylamines;Pyrazine carboxylic acids and derivatives;Pyrazinecarboxamides;Pyrazines;Secondary carboxylic acid amides	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as amphetamines and derivatives. These are organic compounds containing or derived from 1-phenylpropan-2-amine.	Amphetamines and derivatives			Organic compounds	Aromatic heteropolycyclic compounds	pyrazines (CHEBI:38314);carboxamide (CHEBI:37622);benzimidazoles (CHEBI:22715);organic aromatic compound (CHEBI:33659);fatty amide (CHEBI:29348);imidazoles (CHEBI:24780);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);amphetamines (CHEBI:35338);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);diazines (CHEBI:38313);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);organooxygen compound (CHEBI:36963);amide (CHEBI:32988);lipid (CHEBI:18059);azole (CHEBI:68452);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);primary amine (CHEBI:32877)	N-acyl amines (FA0802);Fatty Acyls (FA);Fatty amides (FA08)	Phenethylamines	Amphetamine or derivatives;Benzimidazole;Pyrazinecarboxamide;Pyrazine carboxylic acid or derivatives;2-heteroaryl carboxamide;Fatty amide;Fatty acyl;Pyrazine;N-acyl-amine;Azole;Heteroaromatic compound;Imidazole;Carboxamide group;Secondary carboxylic acid amide;Carboxylic acid derivative;Azacycle;Organoheterocyclic compound;Organic nitrogen compound;Hydrocarbon derivative;Carbonyl group;Organic oxide;Organic oxygen compound;Organooxygen compound;Organonitrogen compound;Aromatic heteropolycyclic compound	Benzenoids	0.0		AKOS025257707		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	2	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0		C26H28N6O2	C26H28N6O2			InChI=1S/C26H28N6O2/c33-24(13-5-2-8-14-29-26(34)23-18-27-15-16-28-23)30-22(17-19-9-3-1-4-10-19)25-31-20-11-6-7-12-21(20)32-25/h1,3-4,6-7,9-12,15-16,18,22H,2,5,8,13-14,17H2,(H,29,34)(H,30,33)(H,31,32)	UJWGRDPNNZJTGL-UHFFFAOYSA-N	N-[6-[[1-(1H-benzimidazol-2-yl)-2-phenyl-ethyl]amino]-6-oxo-hexyl]pyrazine-2-carboxamide	91821615	O=C(CCCCCNC(=O)c1nccnc1)NC(Cc1ccccc1)c1nc2ccccc2[nH]1	N-[6-[[1-(1H-benzimidazol-2-yl)-2-phenylethyl]amino]-6-oxohexyl]pyrazine-2-carboxamide			3.1507500000000013														456.55206		456.227374	5	3	11	4			46									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(91821615)	91821615	2.8	1246			[#8]=[#6](-[#6]-[#6]-[#6]-[#6]-[#6]-[#7]-[#6](=[#8])-[#6]1:[#7]:[#6]:[#6]:[#7]:[#6]:1)-[#7]-[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#7H]:1	O=C(CCCCCNC(=O)c1nccnc1)NC(Cc1ccccc1)c1nc2ccccc2[nH]1	UJWGRDPNNZJTGL		parent_pubchem_cid	AKOS025257707;N-[6-[[1-(1H-benzimidazol-2-yl)-2-phenyl-ethyl]amino]-6-oxo-hexyl]pyrazine-2-carboxamide		100825326.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=100825326		pluskal_iocb_peptide_Peptide01_G12_id		100	G12		
5.0		0	1016	P6667701	49.4		AE24	False	0	27	0	0	34	0	2	2	0	0		0.0						CC(C)CN1C(=O)c2ccccc2C(C(=O)NCCc2ccccc2)C12CCCCC2																							0.0		EiM08-30854		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0		C27H34N2O2	C27H34N2O2			InChI=1S/C27H34N2O2/c1-20(2)19-29-26(31)23-14-8-7-13-22(23)24(27(29)16-9-4-10-17-27)25(30)28-18-15-21-11-5-3-6-12-21/h3,5-8,11-14,20,24H,4,9-10,15-19H2,1-2H3,(H,28,30)	XQROBEBGAIZDJV-UHFFFAOYSA-N	2-isobutyl-1-oxo-N-(2-phenylethyl)spiro[4H-isoquinoline-3,1'-cyclohexane]-4-carboxamide	75465669	CC(C)CN1C(=O)c2ccccc2C(C(=O)NCCc2ccccc2)C12CCCCC2	2-(2-methylpropyl)-1-oxo-N-(2-phenylethyl)spiro[4H-isoquinoline-3,1'-cyclohexane]-4-carboxamide			4.779670000000004													MCULE-4599403360	418.58423		418.262028	2	1	6	4			45										False	Alkaloids				Peptide01			Compound(75465669)	75465669	5.3	1247			[#6]-[#6](-[#6])-[#6]-[#7]1-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]-12-[#6]-[#6]-[#6]-[#6]-[#6]-2	CC(C)CN1C(=O)c2ccccc2C(C(=O)NCCc2ccccc2)C12CCCCC2	XQROBEBGAIZDJV		parent_pubchem_cid	EiM08-30854;AKOS016355396;2'-ISOBUTYL-1'-OXO-{N}-(2-PHENYLETHYL)-1',4'-DIHYDRO-2'{H}-SPIRO[CYCLOHEXANE-1,3'-ISOQUINOLINE]-4'-CARBOXAMIDE;2-isobutyl-1-oxo-N-(2-phenylethyl)spiro[4H-isoquinoline-3,1'-cyclohexane]-4-carboxamide		80390469.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=80390469		pluskal_iocb_peptide_Peptide01_G12_id		100	G12		
4.0		0	760	P6236782	65.2		AE25	False	0	24	0	0	27	0	3	2	0	0		0.0						CC(C)CC(C(=O)NCCc1c[nH]c2ccccc12)N1Cc2ccccc2C1=O																							0.0		AKOS016375997		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C24H27N3O2	C24H27N3O2			InChI=1S/C24H27N3O2/c1-16(2)13-22(27-15-18-7-3-4-9-20(18)24(27)29)23(28)25-12-11-17-14-26-21-10-6-5-8-19(17)21/h3-10,14,16,22,26H,11-13,15H2,1-2H3,(H,25,28)/t22-/m0/s1	ZTYPJSDXXMPVDI-QFIPXVFZSA-N	rac-(2S)-N-[2-(1H-indol-3-yl)ethyl]-4-methyl-2-(1-oxoisoindolin-2-yl)pentanamide	40649863	CC(C)C[C@@H](C(=O)NCCc1c[nH]c2ccccc12)N1Cc2ccccc2C1=O	(2S)-N-[2-(1H-indol-3-yl)ethyl]-4-methyl-2-(3-oxo-1H-isoindol-2-yl)pentanamide			3.304750000000002													MCULE-7336800818	389.50169		389.210327	2	2	7	4			44										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(40649863)	40649863	4.1	1248			[#6]-[#6](-[#6])-[#6]-[#6@@H](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]1-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6]-1=[#8]	CC(C)C[C@@H](C(=O)NCCc1c[nH]c2ccccc12)N1Cc2ccccc2C1=O	ZTYPJSDXXMPVDI		parent_pubchem_cid	AKOS016375997;rac-(2S)-N-[2-(1H-indol-3-yl)ethyl]-4-methyl-2-(1-oxoisoindolin-2-yl)pentanamide		9907669.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=9907669		pluskal_iocb_peptide_Peptide01_G13_id		100	G13		ZINC000006874235
4.2		0	848	P11184664	62.7		AE26	False	0	22	0	0	24	0	4	1	0	0		0.0						CC(C)C(NC(=O)Cc1cn(C)c2ccccc12)c1nc2ccccc2[nH]1																							0.0		AKOS027472374		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C22H24N4O	C22H24N4O			InChI=1S/C22H24N4O/c1-14(2)21(22-23-17-9-5-6-10-18(17)24-22)25-20(27)12-15-13-26(3)19-11-7-4-8-16(15)19/h4-11,13-14,21H,12H2,1-3H3,(H,23,24)(H,25,27)/t21-/m0/s1	RWZXZEONEOKXQS-NRFANRHFSA-N	2-(1-methylindol-3-yl)-N-[rac-(1S)-1-(1H-benzimidazol-2-yl)-2-methyl-propyl]acetamide	91640313	CC(C)[C@H](NC(=O)Cc1cn(C)c2ccccc12)c1nc2ccccc2[nH]1	N-[(1S)-1-(1H-benzimidazol-2-yl)-2-methylpropyl]-2-(1-methylindol-3-yl)acetamide			3.144340000000001														360.46278		360.195011	2	2	5	4			45									Carboline alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(91640313)	91640313	3.7	1249			[#6]-[#6](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#6]1:[#6]:[#7](-[#6]):[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6]1:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#7H]:1	CC(C)[C@H](NC(=O)Cc1cn(C)c2ccccc12)c1nc2ccccc2[nH]1	RWZXZEONEOKXQS		parent_pubchem_cid	AKOS027472374;N-[(1S)-1-(1H-13-BENZODIAZOL-2-YL)-2-METHYLPROPYL]-2-(1-METHYL-1H-INDOL-3-YL)ACETAMIDE;2-(1-methylindol-3-yl)-N-[rac-(1S)-1-(1H-benzimidazol-2-yl)-2-methyl-propyl]acetamide		6701872.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=6701872		pluskal_iocb_peptide_Peptide01_G13_id		100	G13		ZINC000065850512
4.4		0	936	P11185757	103.8		AE27	False	0	23	0	0	19	0	5	1	0	1		0.0						O=C(Cc1csc(-n2cccc2)n1)NC(c1ccccc1)c1nc2ccccc2[nH]1																							0.0		N-[1H-benzimidazol-2-yl(phenyl)methyl]-2-[2-(1H-pyrrol-1-yl)-1,3-thiazol-4-yl]acetamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	3	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C23H19N5OS	C23H19N5OS			InChI=1S/C23H19N5OS/c29-20(14-17-15-30-23(24-17)28-12-6-7-13-28)27-21(16-8-2-1-3-9-16)22-25-18-10-4-5-11-19(18)26-22/h1-13,15,21H,14H2,(H,25,26)(H,27,29)	XFOGKMRWKRGZHQ-UHFFFAOYSA-N	N-[1H-benzimidazol-2-yl(phenyl)methyl]-2-(2-pyrrol-1-ylthiazol-4-yl)acetamide	118986134	O=C(Cc1csc(-n2cccc2)n1)NC(c1ccccc1)c1nc2ccccc2[nH]1	N-[1H-benzimidazol-2-yl(phenyl)methyl]-2-(2-pyrrol-1-yl-1,3-thiazol-4-yl)acetamide			3.4758400000000016														413.50478		413.131031	3	2	6	5			46										False	Alkaloids				Peptide01			Compound(118986134)	118986134	3.7	1250			[#8]=[#6](-[#6]-[#6]1:[#6]:[#16]:[#6](-[#7]2:[#6]:[#6]:[#6]:[#6]:2):[#7]:1)-[#7]-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#7H]:1	O=C(Cc1csc(-n2cccc2)n1)NC(c1ccccc1)c1nc2ccccc2[nH]1	XFOGKMRWKRGZHQ		parent_pubchem_cid	N-[1H-benzimidazol-2-yl(phenyl)methyl]-2-[2-(1H-pyrrol-1-yl)-1,3-thiazol-4-yl]acetamide;STL476974;AKOS027473187;N-[1H-1,3-BENZIMIDAZOL-2-YL(PHENYL)METHYL]-2-[2-(1H-PYRROL-1-YL)-1,3-THIAZOL-4-YL]ACETAMIDE;N-[1H-benzimidazol-2-yl(phenyl)methyl]-2-(2-pyrrol-1-ylthiazol-4-yl)acetamide		145498506.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=145498506		pluskal_iocb_peptide_Peptide01_G13_id		100	G13		
4.5		0	1024	P1157527	88.1		AE28	False	0	27	0	1	27	0	2	5	0	0		0.0						COc1c(OC)cc2c(c1)CCN(C(=O)NC(Cc1ccccc1)C(=O)O)C2c1ccc(F)cc1																							0.0		AKOS005533383		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C27H27FN2O5	C27H27FN2O5			InChI=1S/C27H27FN2O5/c1-34-23-15-19-12-13-30(27(33)29-22(26(31)32)14-17-6-4-3-5-7-17)25(21(19)16-24(23)35-2)18-8-10-20(28)11-9-18/h3-11,15-16,22,25H,12-14H2,1-2H3,(H,29,33)(H,31,32)/t22-,25?/m0/s1	ACLRKOPAEXVBEP-XADRRFQNSA-N	rac-(2S)-2-[[1-(4-fluorophenyl)-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-2-carbonyl]amino]-3-phenyl-propanoic acid	16420770	COc1c(OC)cc2c(c1)CCN(C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C2c1ccc(F)cc1	(2S)-2-[[1-(4-fluorophenyl)-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-2-carbonyl]amino]-3-phenylpropanoic acid			3.0522400000000003													MCULE-2240096620	478.52504		478.1904	5	2	7	4			45									Isoquinoline alkaloids	False	Alkaloids	Tyrosine alkaloids			Peptide01			Compound(16420770)	16420770	4.4	1251			[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]):[#6]:[#6]2:[#6](:[#6]:1)-[#6]-[#6]-[#7](-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8])-[#6]-2-[#6]1:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:1	COc1c(OC)cc2c(c1)CCN(C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C2c1ccc(F)cc1	ACLRKOPAEXVBEP		parent_pubchem_cid	AKOS005533383;956957-06-5;N-{[1-(4-fluorophenyl)-6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl]carbonyl}-L-phenylalanine;(2S)-2-({[1-(4-FLUOROPHENYL)-6,7-DIMETHOXY-3,4-DIHYDRO-2(1H)-ISOQUINOLINYL]CARBONYL}AMINO)-3-PHENYLPROPANOIC ACID;(2S)-2-[[1-(4-fluorophenyl)-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-2-carbonyl]amino]-3-phenylpropanoic acid;rac-(2S)-2-[[1-(4-fluorophenyl)-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-2-carbonyl]amino]-3-phenyl-propanoic acid		24658159.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24658159		pluskal_iocb_peptide_Peptide01_G13_id		100	G13		
1.1		0	768	P6236304	151.6		AE29	False	0	18	0	0	23	0	3	6	0	1		0.0						COc1c(OC)cc2c(=O)nc(CSCC(=O)NC(C(=O)O)C(C)C)[nH]c2c1																							0.0		rac-(2S)-2-[[2-[(6,7-dimethoxy-4-oxo-3H-quinazolin-2-yl)methylsulfanyl]acetyl]amino]-3-methyl-butanoic acid		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C18H23N3O6S	C18H23N3O6S			InChI=1S/C18H23N3O6S/c1-9(2)16(18(24)25)21-15(22)8-28-7-14-19-11-6-13(27-4)12(26-3)5-10(11)17(23)20-14/h5-6,9,16H,7-8H2,1-4H3,(H,21,22)(H,24,25)(H,19,20,23)/t16-/m0/s1	FGLXWVGOHOGSIZ-INIZCTEOSA-N	rac-(2S)-2-[[2-[(6,7-dimethoxy-4-oxo-3H-quinazolin-2-yl)methylsulfanyl]acetyl]amino]-3-methyl-butanoic acid	29129735	COc1c(OC)cc2c(=O)nc(CSCC(=O)N[C@H](C(=O)O)C(C)C)[nH]c2c1	(2S)-2-[[2-[(6,7-dimethoxy-4-oxo-1H-quinazolin-2-yl)methylsulfanyl]acetyl]amino]-3-methylbutanoic acid			0.8908399999999994													MCULE-1358141884	409.46451		409.130756	8	3	9	2			44										False	Alkaloids				Peptide01			Compound(29129735)	29129735	1.6	1252			[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]):[#6]:[#6]2:[#6](=[#8]):[#7]:[#6](-[#6]-[#16]-[#6]-[#6](=[#8])-[#7]-[#6@H](-[#6](=[#8])-[#8])-[#6](-[#6])-[#6]):[#7H]:[#6]:2:[#6]:1	COc1c(OC)cc2c(=O)nc(CSCC(=O)N[C@H](C(=O)O)C(C)C)[nH]c2c1	FGLXWVGOHOGSIZ		parent_pubchem_cid	rac-(2S)-2-[[2-[(6,7-dimethoxy-4-oxo-3H-quinazolin-2-yl)methylsulfanyl]acetyl]amino]-3-methyl-butanoic acid		22660077.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22660077		pluskal_iocb_peptide_Peptide01_G13_id		100	G13		ZINC000020719333
4.5		0	856	P7130996	77.6		AE30	False	0	24	1	0	25	0	4	2	0	0		0.0						CC(C)Cn1nc(CC(=O)NCCc2c[nH]c3c2cc(Cl)cc3)c2ccccc2c1=O								3-alkylindoles;Pyridazinones;Substituted pyrroles;Benzenoids;Aryl chlorides;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactams;Azacyclic compounds;Organonitrogen compounds;Organochlorides;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	3-alkylindoles;Aryl chlorides;Aryl halides;Azacyclic compounds;Benzenoids;Benzodiazines;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Diazanaphthalenes;Diazines;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Lactams;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organochlorides;Organohalogen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phthalazines;Phthalazinones;Pyridazines and derivatives;Pyridazinones;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Diazanaphthalenes	2.1	This compound belongs to the class of organic compounds known as phthalazinones. These are compounds containing a phthalazine bearing a ketone group.	Phthalazinones		Phthalazines	Organic compounds	Aromatic heteropolycyclic compounds	indoles (CHEBI:24828);pyridazinone (CHEBI:26414);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);organochlorine compound (CHEBI:36683);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactam (CHEBI:24995);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);phthalazines (CHEBI:38768);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);diazines (CHEBI:38313);pyridazines (CHEBI:37921);organohalogen compound (CHEBI:36684);haloarene (CHEBI:50887);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);organooxygen compound (CHEBI:36963);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);oxygen molecular entity (CHEBI:25806);azaarene (CHEBI:50893)		Benzodiazines	Phthalazinone;3-alkylindole;Indole;Indole or derivatives;Pyridazinone;Aryl chloride;Aryl halide;Pyridazine;Substituted pyrrole;Benzenoid;Pyrrole;Heteroaromatic compound;Carboxamide group;Secondary carboxylic acid amide;Lactam;Carboxylic acid derivative;Azacycle;Organonitrogen compound;Organochloride;Organohalogen compound;Hydrocarbon derivative;Organic oxide;Carbonyl group;Organooxygen compound;Organic nitrogen compound;Organic oxygen compound;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		1436004-30-6		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C24H25ClN4O2	C24H25ClN4O2			InChI=1S/C24H25ClN4O2/c1-15(2)14-29-24(31)19-6-4-3-5-18(19)22(28-29)12-23(30)26-10-9-16-13-27-21-8-7-17(25)11-20(16)21/h3-8,11,13,15,27H,9-10,12,14H2,1-2H3,(H,26,30)	KESQPGRJHFLFKC-UHFFFAOYSA-N	N-[2-(5-chloro-1H-indol-3-yl)ethyl]-2-(3-isobutyl-4-oxo-phthalazin-1-yl)acetamide	71707802	CC(C)Cn1nc(CC(=O)NCCc2c[nH]c3c2cc(Cl)cc3)c2ccccc2c1=O	N-[2-(5-chloro-1H-indol-3-yl)ethyl]-2-[3-(2-methylpropyl)-4-oxophthalazin-1-yl]acetamide			4.022230000000002													MCULE-6813379357	436.94545		436.166604	3	2	7	4			44										False	Alkaloids				Peptide01			Compound(71707802)	71707802	4.7	1253			[#6]-[#6](-[#6])-[#6]-[#7]1:[#7]:[#6](-[#6]-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:2:[#6]:[#6](-[#17]):[#6]:[#6]:3):[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8]	CC(C)Cn1nc(CC(=O)NCCc2c[nH]c3c2cc(Cl)cc3)c2ccccc2c1=O	KESQPGRJHFLFKC		parent_pubchem_cid	1436004-30-6;N-[2-(5-chloro-1H-indol-3-yl)ethyl]-2-[3-(2-methylpropyl)-4-oxo-3,4-dihydrophthalazin-1-yl]acetamide;EiM08-29920;AKOS022099194;N-[2-(5-CHLORO-1H-INDOL-3-YL)ETHYL]-2-(3-ISOBUTYL-4-OXO-3,4-DIHYDRO-1-PHTHALAZINYL)ACETAMIDE;N-[2-(5-chloro-1H-indol-3-yl)ethyl]-2-(3-isobutyl-4-oxo-phthalazin-1-yl)acetamide		56397529.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=56397529		pluskal_iocb_peptide_Peptide01_G13_id		100	G13		ZINC000095478624
2.6		0	944	P3460895	91.5		AE31	False	0	23	0	1	22	0	3	4	0	0		0.0						COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C1CC(=O)N(c2ccc(F)cc2)C1								N-acyl-alpha amino acids and derivatives;Alpha amino acid esters;Indolyl carboxylic acids and derivatives;Phenylpyrrolidines;3-alkylindoles;Pyrrolidinecarboxamides;Fluorobenzenes;Fatty acid esters;Substituted pyrroles;Pyrrolidine-2-ones;Aryl fluorides;Tertiary carboxylic acid amides;Methyl esters;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactams;Monocarboxylic acids and derivatives;Azacyclic compounds;Organopnictogen compounds;Organonitrogen compounds;Organofluorides;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	3-alkylindoles;Alpha amino acid esters;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Aryl fluorides;Aryl halides;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids and derivatives;Chemical entities;Fatty Acyls;Fatty acid esters;Fluorobenzenes;Halobenzenes;Heteroaromatic compounds;Hybrid peptides;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Indolyl carboxylic acids and derivatives;Lactams;Lipids and lipid-like molecules;Methyl esters;Monocarboxylic acids and derivatives;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organofluorides;Organohalogen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Peptidomimetics;Phenylpyrrolidines;Pyrroles;Pyrrolidine carboxylic acids and derivatives;Pyrrolidine-2-ones;Pyrrolidinecarboxamides;Pyrrolidines;Pyrrolidones;Secondary carboxylic acid amides;Substituted pyrroles;Tertiary carboxylic acid amides	Peptidomimetics	2.1	This compound belongs to the class of organic compounds known as hybrid peptides. These are compounds containing at least two different types of amino acids (alpha, beta, gamma, delta) linked to each other through a peptide bond.	Hybrid peptides			Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-amino acid (CHEBI:51569);alpha-amino acid ester (CHEBI:46874);indolyl carboxylic acid (CHEBI:46867);pyrrolidines (CHEBI:38260);indoles (CHEBI:24828);pyrrolidinecarboxamide (CHEBI:46770);organofluorine compound (CHEBI:37143);fatty acid ester (CHEBI:35748);pyrroles (CHEBI:26455);pyrrolidin-2-ones (CHEBI:74223);carboxamide (CHEBI:37622);carboxylic ester (CHEBI:33308);organic aromatic compound (CHEBI:33659);lactam (CHEBI:24995);carbonyl compound (CHEBI:36586);organonitrogen heterocyclic compound (CHEBI:38101);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);peptide (CHEBI:16670);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);amino acid (CHEBI:33709);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);organohalogen compound (CHEBI:36684);lipid (CHEBI:18059);pyrrolidinone (CHEBI:38275);haloarene (CHEBI:50887);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806);peptidomimetic (CHEBI:63175)	Fatty esters (FA07);Fatty Acyls (FA)	Hybrid peptides	Hybrid peptide;N-acyl-alpha amino acid or derivatives;Alpha-amino acid ester;Indolyl carboxylic acid derivative;1-phenylpyrrolidine;3-alkylindole;Alpha-amino acid or derivatives;Indole or derivatives;Indole;Pyrrolidine-3-carboxamide;Pyrrolidine carboxylic acid or derivatives;Halobenzene;Fluorobenzene;Fatty acid ester;Fatty acyl;Benzenoid;Substituted pyrrole;2-pyrrolidone;Pyrrolidone;Monocyclic benzene moiety;Aryl halide;Aryl fluoride;Heteroaromatic compound;Methyl ester;Tertiary carboxylic acid amide;Pyrrolidine;Pyrrole;Secondary carboxylic acid amide;Lactam;Carboxylic acid ester;Carboxamide group;Azacycle;Organoheterocyclic compound;Monocarboxylic acid or derivatives;Carboxylic acid derivative;Organic nitrogen compound;Organic oxygen compound;Organopnictogen compound;Organic oxide;Hydrocarbon derivative;Organooxygen compound;Organonitrogen compound;Organofluoride;Organohalogen compound;Carbonyl group;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS016382149		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C23H22FN3O4	C23H22FN3O4			InChI=1S/C23H22FN3O4/c1-31-23(30)20(10-14-12-25-19-5-3-2-4-18(14)19)26-22(29)15-11-21(28)27(13-15)17-8-6-16(24)7-9-17/h2-9,12,15,20,25H,10-11,13H2,1H3,(H,26,29)	VOHDYHGAMIMRFR-UHFFFAOYSA-N	methyl 2-[[1-(4-fluorophenyl)-5-oxo-pyrrolidine-3-carbonyl]amino]-3-(1H-indol-3-yl)propanoate	56725835	COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C1CC(=O)N(c2ccc(F)cc2)C1	methyl 2-[[1-(4-fluorophenyl)-5-oxopyrrolidine-3-carbonyl]amino]-3-(1H-indol-3-yl)propanoate			1.6966599999999994													MCULE-9772766246	423.44789		423.159434	4	2	7	4			45										False					Peptide01			Compound(56725835)	56725835	2.4	1254			[#6]-[#8]-[#6](=[#8])-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#6](=[#8])-[#6]1-[#6]-[#6](=[#8])-[#7](-[#6]2:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:2)-[#6]-1	COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C1CC(=O)N(c2ccc(F)cc2)C1	VOHDYHGAMIMRFR		parent_pubchem_cid	AKOS016382149;methyl 2-[[1-(4-fluorophenyl)-5-oxo-pyrrolidine-3-carbonyl]amino]-3-(1H-indol-3-yl)propanoate		24313003.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24313003		pluskal_iocb_peptide_Peptide01_G13_id		100	G13		
3.0		0	1032	P1157537	100.2		AE32	False	0	27	0	0	36	0	4	5	0	0		0.0						COc1ccc(CNC(=O)C(Cc2ccccc2)NC(=O)N2CCN(C(=O)OC(C)(C)C)CC2)cc1																							0.0		AKOS005533501		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	4	0	1	0	0	0	0	0	0	1	0	3	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C27H36N4O5	C27H36N4O5			InChI=1S/C27H36N4O5/c1-27(2,3)36-26(34)31-16-14-30(15-17-31)25(33)29-23(18-20-8-6-5-7-9-20)24(32)28-19-21-10-12-22(35-4)13-11-21/h5-13,23H,14-19H2,1-4H3,(H,28,32)(H,29,33)/t23-/m0/s1	GTROEMKBKCNALC-QHCPKHFHSA-N	tert-butyl 4-[[rac-(1S)-1-benzyl-2-[(4-methoxyphenyl)methylamino]-2-oxo-ethyl]carbamoyl]piperazine-1-carboxylate	16416638	COc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)N2CCN(C(=O)OC(C)(C)C)CC2)cc1	tert-butyl 4-[[(2S)-1-[(4-methoxyphenyl)methylamino]-1-oxo-3-phenylpropan-2-yl]carbamoyl]piperazine-1-carboxylate			2.61317													MCULE-8675222113	496.61177		496.26857	5	2	9	3			44										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(16416638)	16416638	3.0	1255			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6]-[#7]-[#6](=[#8])-[#6@H](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#7]-[#6](=[#8])-[#7]2-[#6]-[#6]-[#7](-[#6](=[#8])-[#8]-[#6](-[#6])(-[#6])-[#6])-[#6]-[#6]-2):[#6]:[#6]:1	COc1ccc(CNC(=O)[C@H](Cc2ccccc2)NC(=O)N2CCN(C(=O)OC(C)(C)C)CC2)cc1	GTROEMKBKCNALC		parent_pubchem_cid	AKOS005533501;tert-butyl 4-[[rac-(1S)-1-benzyl-2-[(4-methoxyphenyl)methylamino]-2-oxo-ethyl]carbamoyl]piperazine-1-carboxylate		17773798.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=17773798		pluskal_iocb_peptide_Peptide01_G13_id		100	G13		ZINC000009134221
3.2		0	776	P6246865	94.3		AE33	False	0	21	0	0	23	0	3	4	0	0		0.0						COC(=O)C(Cc1ccccc1)NC(=O)c1c2c(C)noc2nc(C(C)C)c1																							0.0		EiM08-20111		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C21H23N3O4	C21H23N3O4			InChI=1S/C21H23N3O4/c1-12(2)16-11-15(18-13(3)24-28-20(18)23-16)19(25)22-17(21(26)27-4)10-14-8-6-5-7-9-14/h5-9,11-12,17H,10H2,1-4H3,(H,22,25)/t17-/m0/s1	VFATYZYACIYOAV-KRWDZBQOSA-N	methyl rac-(2S)-2-[(6-isopropyl-3-methyl-isoxazolo[5,4-b]pyridine-4-carbonyl)amino]-3-phenyl-propanoate	56723859	COC(=O)[C@H](Cc1ccccc1)NC(=O)c1c2c(C)noc2nc(C(C)C)c1	methyl (2S)-2-[(3-methyl-6-propan-2-yl-[1,2]oxazolo[5,4-b]pyridine-4-carbonyl)amino]-3-phenylpropanoate			2.5214600000000003													MCULE-9510936088	381.43516		381.168856	5	1	7	3			44									Pyrazine and Piperazine alkaloids	False	Alkaloids;Amino acids and Peptides	Tetramate alkaloids;Peptide alkaloids			Peptide01			Compound(56723859)	56723859	3.7	1256			[#6]-[#8]-[#6](=[#8])-[#6@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6](-[#6](-[#6])-[#6]):[#7]:[#6]2:[#6]:1:[#6](-[#6]):[#7]:[#8]:2	COC(=O)[C@H](Cc1ccccc1)NC(=O)c1c2c(C)noc2nc(C(C)C)c1	VFATYZYACIYOAV		parent_pubchem_cid	EiM08-20111;AKOS016389564;METHYL 2-{[3-METHYL-6-(PROPAN-2-YL)-[1,2]OXAZOLO[5,4-B]PYRIDIN-4-YL]FORMAMIDO}-3-PHENYLPROPANOATE;methyl rac-(2S)-2-[(6-isopropyl-3-methyl-isoxazolo[5,4-b]pyridine-4-carbonyl)amino]-3-phenyl-propanoate		6116869.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=6116869		pluskal_iocb_peptide_Peptide01_G14_id		100	G14		ZINC000071281010
3.0		0	864	P11184222	75.6		AE34	False	0	18	0	0	25	0	1	4	0	0		0.0						CC(C)C(NC(=O)Cc1cc2c(cc1)OC(C)(C)CC2)C(=O)O																							0.0		AKOS027472140		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C18H25NO4	C18H25NO4			InChI=1S/C18H25NO4/c1-11(2)16(17(21)22)19-15(20)10-12-5-6-14-13(9-12)7-8-18(3,4)23-14/h5-6,9,11,16H,7-8,10H2,1-4H3,(H,19,20)(H,21,22)/t16-/m0/s1	HERQPUAQEPHWHT-INIZCTEOSA-N	rac-(2S)-2-[[2-(2,2-dimethylchroman-6-yl)acetyl]amino]-3-methyl-butanoic acid	75491303	CC(C)[C@H](NC(=O)Cc1cc2c(cc1)OC(C)(C)CC2)C(=O)O	(2S)-2-[[2-(2,2-dimethyl-3,4-dihydrochromen-6-yl)acetyl]amino]-3-methylbutanoic acid			1.98627														319.40425		319.178358	4	2	5	2			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(75491303)	75491303	3.1	1257			[#6]-[#6](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1)-[#8]-[#6](-[#6])(-[#6])-[#6]-[#6]-2)-[#6](=[#8])-[#8]	CC(C)[C@H](NC(=O)Cc1cc2c(cc1)OC(C)(C)CC2)C(=O)O	HERQPUAQEPHWHT		parent_pubchem_cid	AKOS027472140;N-[(2,2-dimethyl-3,4-dihydro-2H-1-benzopyran-6-yl)acetyl]-L-valine;rac-(2S)-2-[[2-(2,2-dimethylchroman-6-yl)acetyl]amino]-3-methyl-butanoic acid		80415715.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=80415715		pluskal_iocb_peptide_Peptide01_G14_id		100	G14		ZINC000096221259
0.5		0	952	P7138704	104.3		AE35	False	0	11	0	0	17	0	3	4	0	0	-1.0	0.0						CC(C)(C)OC(=O)NC(Cc1cnc[nH]1)C(=O)O		0.93		0.0	-0.67	CHEMBL1222274		Imidazolyl carboxylic acids and derivatives;Heteroaromatic compounds;Carbamate esters;Organic carbonic acids and derivatives;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Azoles;Carbamate esters;Carbamic acids and derivatives;Carbonyl compounds;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Histidine and derivatives;Hydrocarbon derivatives;Imidazoles;Imidazolyl carboxylic acids and derivatives;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Substituted imidazoles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as histidine and derivatives. These are compounds containing cysteine or a derivative thereof resulting from reaction of cysteine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Histidine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteromonocyclic compounds	imidazolyl carboxylic acid (CHEBI:38307);organic aromatic compound (CHEBI:33659);carbamate ester (CHEBI:23003);organooxygen compound (CHEBI:36963);carbonyl compound (CHEBI:36586);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);organonitrogen heterocyclic compound (CHEBI:38101);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);histidine derivative (CHEBI:24599);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);azole (CHEBI:68452);imidazoles (CHEBI:24780);amino acid (CHEBI:33709);peptide (CHEBI:16670);carbon oxoacid (CHEBI:35605);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806)		Amino acids, peptides, and analogues	Histidine or derivatives;Imidazolyl carboxylic acid derivative;Azole;Imidazole;Carbamic acid ester;Heteroaromatic compound;Carbonic acid derivative;Carboxylic acid;Azacycle;Organoheterocyclic compound;Monocarboxylic acid or derivatives;Carbonyl group;Organooxygen compound;Organonitrogen compound;Organic oxygen compound;Hydrocarbon derivative;Organic nitrogen compound;Organic oxide;Organopnictogen compound;Aromatic heteromonocyclic compound	Organic acids and derivatives	0.0		Boc-His-OH	DTXSID80170396	2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	2	1	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C11H17N3O4	C11H17N3O4			InChI=1S/C11H17N3O4/c1-11(2,3)18-10(17)14-8(9(15)16)4-7-5-12-6-13-7/h5-6,8H,4H2,1-3H3,(H,12,13)(H,14,17)(H,15,16)/t8-/m0/s1	AYMLQYFMYHISQO-QMMMGPOBSA-N	rac-(2S)-2-(tert-butoxycarbonylamino)-3-(1H-imidazol-4-yl)propanoic acid	87308	CC(C)(C)OC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O	(2S)-3-(1H-imidazol-5-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid			0.8753899999999999													MCULE-8466525862	255.27584	ACID	255.121906	5	3	6	1	1.0		27									Dipeptides	False	Amino acids and Peptides	Small peptides	False	False	Peptide01		-1.0	Compound(87308)	87308	0.7	1258		SCHEMBL214302	[#6]-[#6](-[#6])(-[#6])-[#8]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7]:[#6]:[#7H]:1)-[#6](=[#8])-[#8]	CC(C)(C)OC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O	AYMLQYFMYHISQO		parent_pubchem_cid	Boc-His-OH;17791-52-5;N-Boc-L-Histidine;Boc-L-Histidine;Boc-His;tert-Butyloxycarbonyl-L-histidine;L-Histidine, N-[(1,1-dimethylethoxy)carbonyl]-;Nalpha-(tert-Butoxycarbonyl)-L-histidine;N-tert-Butyloxycarbonyl-L-histidine;N-(tert-Butoxycarbonyl)-L-histidine;MFCD00065576;EINECS 241-768-9;NSC 334942;(2S)-2-{[(tert-butoxy)carbonyl]amino}-3-(1H-imidazol-5-yl)propanoic acid;(S)-2-(TERT-BUTOXYCARBONYLAMINO)-3-(1H-IMIDAZOL-4-YL)PROPANOIC ACID;Nalpha-boc-L-histidine;BOC-L-HIS-OH;Na-Boc-L-histidine;(TERT-BUTOXYCARBONYL)-L-HISTIDINE;Boc-His-OH, 99%;N.alpha.-boc-L-histidine;N-t-butoxycarbonylhistidine;(L)-BOC-L-His-OH;N-[(1,1-dimethylethoxy)carbonyl]-L-histidine;(2S)-3-(1H-imidazol-5-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid;SCHEMBL214302;N-.alpha.-t-Boc-L-histidine;N-t-butoxycarbonyl-L-histidine;CHEMBL1222274;DTXSID80170396;N-t-Butoxycarbonyl-(L)-histidine;AMY22586;(2S)-2-{[(tert-butoxy)carbonyl]amino}-3-(1H-imidazol-4-yl)propanoic acid;AKOS015892670;AKOS015924146;AKOS016002035;CS-W008134;HY-W008134;N-(tert-Butoxycarbonyl)histidine, (L)-;AC-19270;AS-12137;Boc-His-OH, puriss., >=99.0% (T);B1634;N-.alpha.-(tert-Butoxycarbonyl)-L-histidine;EN300-267448;Q-101819;N-alpha-t-Butyloxycarbonyl-L-histidine (Boc-L-His-OH);2-[(tert-butoxy)carbonylamino]-3-imidazol-5-ylpropanoic acid;rac-(2S)-2-(tert-butoxycarbonylamino)-3-(1H-imidazol-4-yl)propanoic acid	False	638571.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=638571		pluskal_iocb_peptide_Peptide01_G14_id		100	G14	False	ZINC000035024354
3.1		0	1040	P6245669	88.5		AE36	False	0	20	0	0	20	0	6	1	0	0		0.0						Cc1c(C)c(-n2cnnn2)c(C(=O)NCCc2c[nH]c3ccccc23)cc1								3-alkylindoles;Benzamides;o-Xylenes;Benzoyl derivatives;Substituted pyrroles;Vinylogous amides;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Organooxygen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	3-alkylindoles;Azacyclic compounds;Azoles;Benzamides;Benzene and substituted derivatives;Benzenoids;Benzoic acids and derivatives;Benzoyl derivatives;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenyltetrazoles and derivatives;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Tetrazoles;Vinylogous amides;Xylenes;o-Xylenes	Azoles	2.1	This compound belongs to the class of organic compounds known as phenyltetrazoles and derivatives. These are compounds containing a phenyltetrazole skeleton, which consists of a tetrazole bound to a phenyl group.	Phenyltetrazoles and derivatives			Organic compounds	Aromatic heteropolycyclic compounds	indoles (CHEBI:24828);benzamides (CHEBI:22702);xylene (CHEBI:27338);carbonyl compound (CHEBI:36586);pyrroles (CHEBI:26455);enone (CHEBI:51689);enamine (CHEBI:47989);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organonitrogen heterocyclic compound (CHEBI:38101);organooxygen compound (CHEBI:36963);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);tetrazoles (CHEBI:35689);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);benzoic acids (CHEBI:22723);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143);azole (CHEBI:68452)		Tetrazoles	Phenyltetrazole;3-alkylindole;Benzamide;Benzoic acid or derivatives;Indole;Indole or derivatives;O-xylene;Xylene;Benzoyl;Monocyclic benzene moiety;Benzenoid;Substituted pyrrole;Heteroaromatic compound;Vinylogous amide;Pyrrole;Carboxamide group;Secondary carboxylic acid amide;Azacycle;Carboxylic acid derivative;Organic nitrogen compound;Hydrocarbon derivative;Organic oxide;Organic oxygen compound;Organonitrogen compound;Organooxygen compound;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		N-(2-(1H-indol-3-yl)ethyl)-3,4-dimethyl-2-(1H-tetrazol-1-yl)benzamide		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	4	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C20H20N6O	C20H20N6O			InChI=1S/C20H20N6O/c1-13-7-8-17(19(14(13)2)26-12-23-24-25-26)20(27)21-10-9-15-11-22-18-6-4-3-5-16(15)18/h3-8,11-12,22H,9-10H2,1-2H3,(H,21,27)	OUZKUHHWDUTECJ-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)ethyl]-3,4-dimethyl-2-(tetrazol-1-yl)benzamide	51044512	Cc1c(C)c(-n2cnnn2)c(C(=O)NCCc2c[nH]c3ccccc23)cc1	N-[2-(1H-indol-3-yl)ethyl]-3,4-dimethyl-2-(tetrazol-1-yl)benzamide			1.8956699999999995													MCULE-2342590143	360.422		360.169859	4	2	5	4			44										False	Alkaloids				Peptide01			Compound(51044512)	51044512	3.3	1259			[#6]-[#6]1:[#6](-[#6]):[#6](-[#7]2:[#6]:[#7]:[#7]:[#7]:2):[#6](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:[#6]:1	Cc1c(C)c(-n2cnnn2)c(C(=O)NCCc2c[nH]c3ccccc23)cc1	OUZKUHHWDUTECJ		parent_pubchem_cid	N-(2-(1H-indol-3-yl)ethyl)-3,4-dimethyl-2-(1H-tetrazol-1-yl)benzamide;1232807-17-8;AKOS005660630;N-[2-(1H-indol-3-yl)ethyl]-3,4-dimethyl-2-(tetrazol-1-yl)benzamide		9413634.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=9413634		pluskal_iocb_peptide_Peptide01_G14_id		100	G14		ZINC000044891113
3.5		0	784	P6237866	74.4		AE37	False	0	27	0	0	31	0	3	3	0	0		0.0						COCCN1C(=O)c2ccccc2C(C(=O)NCCc2c[nH]c3ccccc23)C12CCCC2								Tetrahydroisoquinolines;3-alkylindoles;Substituted pyrroles;Benzenoids;Tertiary carboxylic acid amides;Heteroaromatic compounds;Tertiary amines;Secondary carboxylic acid amides;Lactams;Amino acids and derivatives;Dialkyl ethers;Azacyclic compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	3-alkylindoles;Amines;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Dialkyl ethers;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Isoquinolines and derivatives;Isoquinolones and derivatives;Lactams;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Tertiary amines;Tertiary carboxylic acid amides;Tetrahydroisoquinolines	Isoquinolines and derivatives	2.1	This compound belongs to the class of organic compounds known as isoquinolones and derivatives. These are aromatic polycyclic compounds containing a ketone bearing isoquinoline moiety.	Isoquinolones and derivatives			Organic compounds	Aromatic heteropolycyclic compounds	isoquinolines (CHEBI:24922);indoles (CHEBI:24828);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);carboxamide (CHEBI:37622);organic aromatic compound (CHEBI:33659);tertiary amine (CHEBI:32876);lactam (CHEBI:24995);organonitrogen compound (CHEBI:35352);organooxygen compound (CHEBI:36963);ether (CHEBI:25698);organonitrogen heterocyclic compound (CHEBI:38101);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);organic molecular entity (CHEBI:50860);amine (CHEBI:32952);oxygen molecular entity (CHEBI:25806)		Isoquinolones and derivatives	Isoquinolone;Tetrahydroisoquinoline;3-alkylindole;Indole;Indole or derivatives;Substituted pyrrole;Benzenoid;Pyrrole;Tertiary carboxylic acid amide;Heteroaromatic compound;Tertiary amine;Secondary carboxylic acid amide;Amino acid or derivatives;Carboxamide group;Lactam;Azacycle;Carboxylic acid derivative;Dialkyl ether;Ether;Hydrocarbon derivative;Organic nitrogen compound;Organic oxygen compound;Organic oxide;Organonitrogen compound;Organooxygen compound;Carbonyl group;Amine;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		1212467-92-9		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	1	0		C27H31N3O3	C27H31N3O3			InChI=1S/C27H31N3O3/c1-33-17-16-30-26(32)22-10-3-2-9-21(22)24(27(30)13-6-7-14-27)25(31)28-15-12-19-18-29-23-11-5-4-8-20(19)23/h2-5,8-11,18,24,29H,6-7,12-17H2,1H3,(H,28,31)	CPHKSXYZLCNIDB-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)ethyl]-2-(2-methoxyethyl)-1-oxo-spiro[4H-isoquinoline-3,1'-cyclopentane]-4-carboxamide	42653686	COCCN1C(=O)c2ccccc2C(C(=O)NCCc2c[nH]c3ccccc23)C12CCCC2	N-[2-(1H-indol-3-yl)ethyl]-2-(2-methoxyethyl)-1-oxospiro[4H-isoquinoline-3,1'-cyclopentane]-4-carboxamide			3.432850000000002													MCULE-6452245135	445.56642		445.236542	3	2	7	5			45										False	Alkaloids				Peptide01			Compound(42653686)	42653686	3.4	1260			[#6]-[#8]-[#6]-[#6]-[#7]1-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6]-12-[#6]-[#6]-[#6]-[#6]-2	COCCN1C(=O)c2ccccc2C(C(=O)NCCc2c[nH]c3ccccc23)C12CCCC2	CPHKSXYZLCNIDB		parent_pubchem_cid	1212467-92-9;N-[2-(1H-indol-3-yl)ethyl]-2'-(2-methoxyethyl)-1'-oxo-1',4'-dihydro-2'H-spiro[cyclopentane-1,3'-isoquinoline]-4'-carboxamide;EiM08-07209;AKOS005710977;AKOS023432438;NCGC00423458-01;N-[2-(1H-indol-3-yl)ethyl]-2-(2-methoxyethyl)-1-oxo-spiro[4H-isoquinoline-3,1'-cyclopentane]-4-carboxamide		24459631.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24459631		pluskal_iocb_peptide_Peptide01_G14_id		100	G14		
2.9		0	872	P3460957	80.6		AE38	False	0	20	0	0	20	0	2	4	0	0		0.0						COc1cc2c(cc1)n(CC(=O)NC(Cc1ccccc1)C(=O)O)cc2								N-acyl-L-alpha-amino acids;Phenylpropanoic acids;Amphetamines and derivatives;N-alkylindoles;Indoles;Anisoles;Alkyl aryl ethers;Substituted pyrroles;Heteroaromatic compounds;Secondary carboxylic acid amides;Monocarboxylic acids and derivatives;Carboxylic acids;Azacyclic compounds;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organonitrogen compounds	Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Amphetamines and derivatives;Anisoles;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;N-alkylindoles;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Phenethylamines;Phenol ethers;Phenylalanine and derivatives;Phenylpropanoic acids;Phenylpropanoids and polyketides;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Phenylalanine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-L-alpha-amino acid (CHEBI:48927);benzenes (CHEBI:22712);carboxylic acid (CHEBI:33575);amphetamines (CHEBI:35338);indoles (CHEBI:24828);methoxybenzene (CHEBI:51683);aromatic ether (CHEBI:35618);pyrroles (CHEBI:26455);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);monocarboxylic acid (CHEBI:25384);organonitrogen heterocyclic compound (CHEBI:38101);carbonyl compound (CHEBI:36586);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);phenylalanine derivative (CHEBI:25985);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);N-acyl-amino acid (CHEBI:51569);benzenoid aromatic compound (CHEBI:33836);primary amine (CHEBI:32877);organic heterocyclic compound (CHEBI:24532);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);ether (CHEBI:25698);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)		Amino acids, peptides, and analogues	Phenylalanine or derivatives;N-acyl-l-alpha-amino acid;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;3-phenylpropanoic-acid;Amphetamine or derivatives;N-alkylindole;Indole;Indole or derivatives;Anisole;Phenol ether;Alkyl aryl ether;Monocyclic benzene moiety;Benzenoid;Substituted pyrrole;Heteroaromatic compound;Pyrrole;Secondary carboxylic acid amide;Carboxamide group;Organoheterocyclic compound;Monocarboxylic acid or derivatives;Azacycle;Ether;Carboxylic acid;Organonitrogen compound;Organic nitrogen compound;Carbonyl group;Hydrocarbon derivative;Organic oxide;Organooxygen compound;Organic oxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS004938825		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1		C20H20N2O4	C20H20N2O4			InChI=1S/C20H20N2O4/c1-26-16-7-8-18-15(12-16)9-10-22(18)13-19(23)21-17(20(24)25)11-14-5-3-2-4-6-14/h2-10,12,17H,11,13H2,1H3,(H,21,23)(H,24,25)/t17-/m0/s1	ONQQHCJAXBGEMN-KRWDZBQOSA-N	rac-(2S)-2-[[2-(5-methoxyindol-1-yl)acetyl]amino]-3-phenyl-propanoic acid	39377673	COc1cc2c(cc1)n(CC(=O)N[C@@H](Cc1ccccc1)C(=O)O)cc2	(2S)-2-[[2-(5-methoxyindol-1-yl)acetyl]amino]-3-phenylpropanoic acid			1.5164599999999997													MCULE-1190487788	352.3934		352.142307	4	2	7	3			44										False	Alkaloids;Amino acids and Peptides				Peptide01			Compound(39377673)	39377673	3.0	1261			[#6]-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#7](-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]):[#6]:[#6]:2	COc1cc2c(cc1)n(CC(=O)N[C@@H](Cc1ccccc1)C(=O)O)cc2	ONQQHCJAXBGEMN		parent_pubchem_cid	AKOS004938825;rac-(2S)-2-[[2-(5-methoxyindol-1-yl)acetyl]amino]-3-phenyl-propanoic acid		23148854.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23148854		pluskal_iocb_peptide_Peptide01_G14_id		100	G14		ZINC000032123936
2.4		0	960	P3463137	95.9		AE39	False	0	27	0	0	25	0	1	5	0	0		0.0						Cc1c(Cc2ccccc2)c(=O)oc2c1ccc(O)c2CNC(Cc1ccccc1)C(=O)O																							0.0		rac-(2R)-2-[(3-benzyl-7-hydroxy-4-methyl-2-oxo-chromen-8-yl)methylamino]-3-phenyl-propanoic acid		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C27H25NO5	C27H25NO5			InChI=1S/C27H25NO5/c1-17-20-12-13-24(29)22(16-28-23(26(30)31)15-19-10-6-3-7-11-19)25(20)33-27(32)21(17)14-18-8-4-2-5-9-18/h2-13,23,28-29H,14-16H2,1H3,(H,30,31)/t23-/m1/s1	MSSBDBFFFOEGKG-HSZRJFAPSA-N	rac-(2R)-2-[(3-benzyl-7-hydroxy-4-methyl-2-oxo-chromen-8-yl)methylamino]-3-phenyl-propanoic acid	51703607	Cc1c(Cc2ccccc2)c(=O)oc2c1ccc(O)c2CN[C@H](Cc1ccccc1)C(=O)O	(2R)-2-[(3-benzyl-7-hydroxy-4-methyl-2-oxochromen-8-yl)methylazaniumyl]-3-phenylpropanoate			3.9188300000000016													MCULE-1731906613	443.504		443.173273	6	3	8	4			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(51703607)	51703607	3.3	1262			[#6]-[#6]1:[#6](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]):[#6]:2-[#6]-[#7]-[#6@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	Cc1c(Cc2ccccc2)c(=O)oc2c1ccc(O)c2CN[C@H](Cc1ccccc1)C(=O)O	MSSBDBFFFOEGKG		parent_pubchem_cid	rac-(2R)-2-[(3-benzyl-7-hydroxy-4-methyl-2-oxo-chromen-8-yl)methylamino]-3-phenyl-propanoic acid		3799573.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=3799573		pluskal_iocb_peptide_Peptide01_G14_id		100	G14		ZINC000035686308
4.6		0	1048	P6667707	49.4		AE40	False	0	26	0	0	32	0	2	2	0	0		0.0						CC(C)CN1C(=O)c2ccccc2C(C(=O)NCCc2ccccc2)C12CCCC2																							0.0		EiM08-30860		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0		C26H32N2O2	C26H32N2O2			InChI=1S/C26H32N2O2/c1-19(2)18-28-25(30)22-13-7-6-12-21(22)23(26(28)15-8-9-16-26)24(29)27-17-14-20-10-4-3-5-11-20/h3-7,10-13,19,23H,8-9,14-18H2,1-2H3,(H,27,29)	JBSAHLLBOITWJW-UHFFFAOYSA-N	2-isobutyl-1-oxo-N-(2-phenylethyl)spiro[4H-isoquinoline-3,1'-cyclopentane]-4-carboxamide	75465675	CC(C)CN1C(=O)c2ccccc2C(C(=O)NCCc2ccccc2)C12CCCC2	2-(2-methylpropyl)-1-oxo-N-(2-phenylethyl)spiro[4H-isoquinoline-3,1'-cyclopentane]-4-carboxamide			4.389570000000004													MCULE-1734523713	404.55714		404.246378	2	1	6	4			45										False	Alkaloids				Peptide01			Compound(75465675)	75465675	4.8	1263			[#6]-[#6](-[#6])-[#6]-[#7]1-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#6](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2)-[#6]-12-[#6]-[#6]-[#6]-[#6]-2	CC(C)CN1C(=O)c2ccccc2C(C(=O)NCCc2ccccc2)C12CCCC2	JBSAHLLBOITWJW		parent_pubchem_cid	EiM08-30860;AKOS016375718;2-isobutyl-1-oxo-N-(2-phenylethyl)spiro[4H-isoquinoline-3,1'-cyclopentane]-4-carboxamide		80390475.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=80390475		pluskal_iocb_peptide_Peptide01_G14_id		100	G14		
4.6		0	792	P3460524	70.7		AE41	False	0	25	0	0	20	0	4	1	0	0		0.0						O=C(NCCc1c[nH]c2ccccc12)c1cc(-c2ccccn2)nc2ccccc12								Bipyridines and oligopyridines;3-alkylindoles;Pyridinecarboxylic acids and derivatives;Substituted pyrroles;Benzenoids;Heteroaromatic compounds;Secondary carboxylic acid amides;Azacyclic compounds;Organooxygen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	3-alkylindoles;Azacyclic compounds;Benzenoids;Bipyridines and oligopyridines;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Pyridinecarboxylic acids and derivatives;Pyridines and derivatives;Pyrroles;Quinoline carboxamides;Quinolines and derivatives;Secondary carboxylic acid amides;Substituted pyrroles	Quinolines and derivatives	2.1	This compound belongs to the class of organic compounds known as quinoline carboxamides. These are quinolines in which the quinoline ring system is substituted by one or more carboxamide groups.	Quinoline carboxamides			Organic compounds	Aromatic heteropolycyclic compounds	bipyridines (CHEBI:50511);indoles (CHEBI:24828);aromatic carboxylic acid (CHEBI:33859);pyridinemonocarboxylic acid (CHEBI:26420);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);organonitrogen heterocyclic compound (CHEBI:38101);organooxygen compound (CHEBI:36963);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);quinolines (CHEBI:26513);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);pyridines (CHEBI:26421);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143)		Quinoline carboxamides	Quinoline-4-carboxamide;Bipyridine;3-alkylindole;Indole;Indole or derivatives;Pyridine carboxylic acid or derivatives;Benzenoid;Substituted pyrrole;Pyridine;Pyrrole;Heteroaromatic compound;Secondary carboxylic acid amide;Carboxamide group;Carboxylic acid derivative;Azacycle;Organic oxide;Organic oxygen compound;Organooxygen compound;Organonitrogen compound;Organic nitrogen compound;Hydrocarbon derivative;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		1111434-87-7		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C25H20N4O	C25H20N4O			InChI=1S/C25H20N4O/c30-25(27-14-12-17-16-28-21-9-3-1-7-18(17)21)20-15-24(23-11-5-6-13-26-23)29-22-10-4-2-8-19(20)22/h1-11,13,15-16,28H,12,14H2,(H,27,30)	PQJUQBZABSMIKR-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)ethyl]-2-(2-pyridyl)quinoline-4-carboxamide	26710958	O=C(NCCc1c[nH]c2ccccc12)c1cc(-c2ccccn2)nc2ccccc12	N-[2-(1H-indol-3-yl)ethyl]-2-pyridin-2-ylquinoline-4-carboxamide			3.404320000000002													MCULE-8128646321	392.46435		392.163711	3	2	5	5			44									Carboline alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(26710958)	26710958	4.2	1264			[#8]=[#6](-[#7]-[#6]-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6]1:[#6]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#7]:2):[#7]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	O=C(NCCc1c[nH]c2ccccc12)c1cc(-c2ccccn2)nc2ccccc12	PQJUQBZABSMIKR		parent_pubchem_cid	1111434-87-7;N-[2-(1H-indol-3-yl)ethyl]-2-pyridin-2-ylquinoline-4-carboxamide;N-[2-(1H-indol-3-yl)ethyl]-2-(pyridin-2-yl)quinoline-4-carboxamide;AKOS004995907;BRD-K24141140-001-01-8;N-[2-(1H-indol-3-yl)ethyl]-2-(2-pyridyl)quinoline-4-carboxamide		8187516.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=8187516		pluskal_iocb_peptide_Peptide01_G15_id		100	G15		ZINC000015616332
4.1		0	880	P7564851	80.2		AE42	False	0	23	0	1	22	0	3	3	0	0		0.0						COc1noc(CCC(=O)NCC(c2ccc(F)cc2)c2c[nH]c3ccccc23)c1																							0.0		N-[2-(4-fluorophenyl)-2-(1H-indol-3-yl)ethyl]-3-(3-methoxy-1,2-oxazol-5-yl)propanamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C23H22FN3O3	C23H22FN3O3			InChI=1S/C23H22FN3O3/c1-29-23-12-17(30-27-23)10-11-22(28)26-13-19(15-6-8-16(24)9-7-15)20-14-25-21-5-3-2-4-18(20)21/h2-9,12,14,19,25H,10-11,13H2,1H3,(H,26,28)	YWWMHPNJCQPEAI-UHFFFAOYSA-N	N-[2-(4-fluorophenyl)-2-(1H-indol-3-yl)ethyl]-3-(3-methoxyisoxazol-5-yl)propanamide	71702546	COc1noc(CCC(=O)NCC(c2ccc(F)cc2)c2c[nH]c3ccccc23)c1	N-[2-(4-fluorophenyl)-2-(1H-indol-3-yl)ethyl]-3-(3-methoxy-1,2-oxazol-5-yl)propanamide			3.1295400000000013													MCULE-1252948627	407.44849		407.16452	3	2	8	4			45										False	Alkaloids				Peptide01			Compound(71702546)	71702546	3.9	1265			[#6]-[#8]-[#6]1:[#7]:[#8]:[#6](-[#6]-[#6]-[#6](=[#8])-[#7]-[#6]-[#6](-[#6]2:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:2)-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]:1	COc1noc(CCC(=O)NCC(c2ccc(F)cc2)c2c[nH]c3ccccc23)c1	YWWMHPNJCQPEAI		parent_pubchem_cid	N-[2-(4-fluorophenyl)-2-(1H-indol-3-yl)ethyl]-3-(3-methoxy-1,2-oxazol-5-yl)propanamide;1401605-47-7;EiM08-27894;AKOS022115847;N-[2-(4-fluorophenyl)-2-(1H-indol-3-yl)ethyl]-3-(3-methoxyisoxazol-5-yl)propanamide		52805914.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=52805914		pluskal_iocb_peptide_Peptide01_G15_id		100	G15		
0.9		0	968	P5012722	112.9		AE43	False	0	12	0	0	13	0	1	6	0	0	-1.0	0.0						O=C(O)CC(NC(=O)OCc1ccccc1)C(=O)O		0.84		0.0	0.94	CHEMBL1222275		Benzyloxycarbonyls;Dicarboxylic acids and derivatives;Carbamate esters;Organic carbonic acids and derivatives;Carboxylic acids;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Aspartic acid and derivatives;Benzene and substituted derivatives;Benzenoids;Benzyloxycarbonyls;Carbamate esters;Carbamic acids and derivatives;Carbonyl compounds;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Dicarboxylic acids and derivatives;Hydrocarbon derivatives;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as aspartic acid and derivatives. These are compounds containing an aspartic acid or a derivative thereof resulting from reaction of aspartic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Aspartic acid and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic homomonocyclic compounds	carboxylic ester (CHEBI:33308);dicarboxylic acid (CHEBI:35692);carbamate ester (CHEBI:23003);organooxygen compound (CHEBI:36963);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);aspartic acid derivative (CHEBI:22661);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);amino acid (CHEBI:33709);peptide (CHEBI:16670);carbon oxoacid (CHEBI:35605);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806)	Dicarboxylic acids (FA0117)	Amino acids, peptides, and analogues	Aspartic acid or derivatives;Benzyloxycarbonyl;Monocyclic benzene moiety;Dicarboxylic acid or derivatives;Benzenoid;Carbamic acid ester;Carbonic acid derivative;Carboxylic acid;Organooxygen compound;Organonitrogen compound;Organic oxide;Organopnictogen compound;Carbonyl group;Organic oxygen compound;Organic nitrogen compound;Hydrocarbon derivative;Aromatic homomonocyclic compound	Organic acids and derivatives	0.0		1152-61-0	DTXSID9027368	2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00	2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	1	0	3	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C12H13NO6	C12H13NO6			InChI=1S/C12H13NO6/c14-10(15)6-9(11(16)17)13-12(18)19-7-8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H,13,18)(H,14,15)(H,16,17)/t9-/m0/s1	XYXYXSKSTZAEJW-VIFPVBQESA-N	(2S)-2-(benzyloxycarbonylamino)butanedioic acid	2723942	O=C(O)C[C@H](NC(=O)OCc1ccccc1)C(=O)O	(2S)-2-(phenylmethoxycarbonylamino)butanedioic acid			0.78599													MCULE-3490812898	267.24051	ACID	267.074287	6	3	7	1	1.0		26									Dipeptides	False	Amino acids and Peptides	Small peptides	False	False	Peptide01		-1.0	Compound(2723942)	2723942	0.6	1266		SCHEMBL613386	[#8]=[#6](-[#8])-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]	O=C(O)C[C@H](NC(=O)OCc1ccccc1)C(=O)O	XYXYXSKSTZAEJW		parent_pubchem_cid	1152-61-0;Z-Asp-OH;N-Carbobenzyloxy-L-aspartic acid;Cbz-Asp-OH;N-Carbobenzoxy-L-aspartic acid;Z-L-aspartic acid;N-[(benzyloxy)carbonyl]-L-aspartic acid;N-(Benzyloxycarbonyl)aspartic acid;Carbobenzoxy-L-aspartic acid;N-Benzyloxycarbonylaspartic acid;L-Aspartic acid, N-[(phenylmethoxy)carbonyl]-;(2S)-2-(phenylmethoxycarbonylamino)butanedioic acid;N-Cbz-L-aspartic Acid;N-Benzyloxycarbonyl-L-aspartic acid;Aspartic acid, N-carboxy-, N-benzyl ester, L-;Aspartic acid, N-(benzyloxy)carbonyl-;DTXSID9027368;L-Aspartic acid, N-((phenylmethoxy)carbonyl)-;56P9JC41T2;N-(Benzyloxycarbonyl)-L-aspartic acid;C12H13NO6;(S)-2-(Benzyloxycarbonylamino)Succinic Acid;(S)-2-(((Benzyloxy)carbonyl)amino)succinic acid;MFCD00002719;N-Z-L-aspartic acid;Z-L-Asp-OH;Na-CBZ-L-aspaitic acid;BENZYLOXYCARBONYL-L-ASPARTIC ACID;NSC-9972;UNII-56P9JC41T2;NSC-88479;Aspartic acid, N-[(phenylmethoxy)carbonyl]-;NSC 9972;NX6;Cbz-L-Asp;EINECS 214-568-4;Z-Asp;(2S)-2-{[(benzyloxy)carbonyl]amino}butanedioic acid;NSC 88479;N-CBZ aspartic acid;Z-ASPARTIC ACID;SCHEMBL613386;N-Z-L-aspartic acid, 99%;DTXCID307368;CHEMBL1222275;BDBM36137;N-benzyloxycarbonyl aspartic acid;N-benzyloxycarbonyl-L aspartic acid;Tox21_200211;((Benzyloxy)carbonyl)-L-aspartic acid;AKOS015888161;AM81591;CS-W012419;HY-W011703;NCGC00248564-01;NCGC00257765-01;AC-12399;AC-26239;AS-12749;J80.205K;CAS-1152-61-0;N-[(phenylmethoxy)carbonyl]-L-Asparticacid;D77735;EN300-149915;M03043;N-ALPHA-BENZYLOXYCARBONYL-L-ASPARTIC ACID;A803398;J-300061;N-((PHENYLMETHOXY)CARBONYL)-L-ASPARTIC ACID;Q-101786;Q27261416;(S)-2-(((BENZYLOXY)CARBONYL)AMINO)BUTANEDIOIC ACID;(2S)-2-(benzyloxycarbonylamino)butanedioic acid	False	645081.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=645081	56P9JC41T2	pluskal_iocb_peptide_Peptide01_G15_id		100	G15	False	ZINC000001700285
4.6		0	1056	P1094946	61.9		AE44	False	0	25	0	2	31	0	3	3	0	0		0.0						CCC(C)C(NC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)C(=O)OC																							0.0		C25H31F2N3O3		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1		C25H31F2N3O3	C25H31F2N3O3			InChI=1S/C25H31F2N3O3/c1-4-17(2)22(24(31)33-3)28-25(32)30-15-13-29(14-16-30)23(18-5-9-20(26)10-6-18)19-7-11-21(27)12-8-19/h5-12,17,22-23H,4,13-16H2,1-3H3,(H,28,32)/t17?,22-/m0/s1	DQHVFHRZBSQXOZ-UGNFMNBCSA-N	methyl rac-(2S)-2-[[4-[bis(4-fluorophenyl)methyl]piperazine-1-carbonyl]amino]-3-methyl-pentanoate	17580780	CCC(C)[C@H](NC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)C(=O)OC	methyl (2S)-2-[[4-[bis(4-fluorophenyl)methyl]piperazine-1-carbonyl]amino]-3-methylpentanoate			3.859680000000004														459.54092		459.233348	4	1	8	3			46										False	Alkaloids				Peptide01			Compound(17580780)	17580780	4.4	1267			[#6]-[#6]-[#6](-[#6])-[#6@H](-[#7]-[#6](=[#8])-[#7]1-[#6]-[#6]-[#7](-[#6](-[#6]2:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:2)-[#6]2:[#6]:[#6]:[#6](-[#9]):[#6]:[#6]:2)-[#6]-[#6]-1)-[#6](=[#8])-[#8]-[#6]	CCC(C)[C@H](NC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)C(=O)OC	DQHVFHRZBSQXOZ		parent_pubchem_cid	C25H31F2N3O3;1014064-96-0;AKOS005533609;METHYL (2S,3R)-2-[({4-[BIS(4-FLUOROPHENYL)METHYL]PIPERAZINO}CARBONYL)AMINO]-3-METHYLPENTANOATE;methyl rac-(2S)-2-[[4-[bis(4-fluorophenyl)methyl]piperazine-1-carbonyl]amino]-3-methyl-pentanoate		23441311.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23441311		pluskal_iocb_peptide_Peptide01_G15_id		100	G15		
3.2		0	1064	P11185712	103.1		AF1	False	0	28	0	0	26	0	4	3	0	0		0.0						O=C(CCC1NC(=O)c2ccccc2NC1=O)NCC(c1ccccc1)c1c[nH]c2ccccc12								Alpha amino acids and derivatives;3-alkylindoles;Substituted pyrroles;Fatty amides;Benzene and substituted derivatives;Vinylogous amides;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactams;Azacyclic compounds;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	1,4-benzodiazepines;3-alkylindoles;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Benzodiazepines;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Fatty Acyls;Fatty amides;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Lactams;Lipids and lipid-like molecules;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Vinylogous amides	Benzodiazepines	2.1	This compound belongs to the class of organic compounds known as 1,4-benzodiazepines. These are organic compounds containing a benzene ring fused to a 1,4-azepine.	1,4-benzodiazepines			Organic compounds	Aromatic heteropolycyclic compounds	organonitrogen compound (CHEBI:35352);organooxygen compound (CHEBI:36963);indoles (CHEBI:24828);pyrroles (CHEBI:26455);fatty amide (CHEBI:29348);benzenes (CHEBI:22712);enone (CHEBI:51689);enamine (CHEBI:47989);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactam (CHEBI:24995);organonitrogen heterocyclic compound (CHEBI:38101);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);benzodiazepine (CHEBI:22720);chemical entity (CHEBI:24431);amino acid (CHEBI:33709);peptide (CHEBI:16670);organic heterocyclic compound (CHEBI:24532);lipid (CHEBI:18059);benzenoid aromatic compound (CHEBI:33836);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806)	Fatty amides (FA08);Fatty Acyls (FA)	1,4-benzodiazepines	1,4-benzodiazepine;3-alkylindole;Alpha-amino acid or derivatives;Indole or derivatives;Indole;Fatty acyl;Benzenoid;Substituted pyrrole;Fatty amide;Monocyclic benzene moiety;Heteroaromatic compound;Vinylogous amide;Pyrrole;Secondary carboxylic acid amide;Lactam;Carboxamide group;Azacycle;Carboxylic acid derivative;Organic nitrogen compound;Organic oxygen compound;Organopnictogen compound;Organic oxide;Hydrocarbon derivative;Organooxygen compound;Organonitrogen compound;Carbonyl group;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		AKOS027473166		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	0	0		C28H26N4O3	C28H26N4O3			InChI=1S/C28H26N4O3/c33-26(15-14-25-28(35)31-24-13-7-5-11-20(24)27(34)32-25)30-16-21(18-8-2-1-3-9-18)22-17-29-23-12-6-4-10-19(22)23/h1-13,17,21,25,29H,14-16H2,(H,30,33)(H,31,35)(H,32,34)	NADMPAFNMBXORS-UHFFFAOYSA-N	3-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)-N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]propanamide	118986119	O=C(CCC1NC(=O)c2ccccc2NC1=O)NCC(c1ccccc1)c1c[nH]c2ccccc12	3-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)-N-[2-(1H-indol-3-yl)-2-phenylethyl]propanamide			2.973740000000001														466.54442		466.200491	3	4	7	5			46										False	Alkaloids				Peptide01			Compound(118986119)	118986119	3.4	1268			[#8]=[#6](-[#6]-[#6]-[#6]1-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#7]-[#6]-1=[#8])-[#7]-[#6]-[#6](-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	O=C(CCC1NC(=O)c2ccccc2NC1=O)NCC(c1ccccc1)c1c[nH]c2ccccc12	NADMPAFNMBXORS		parent_pubchem_cid	AKOS027473166;AKOS037499744;3-(2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl)-N-[2-(1H-indol-3-yl)-2-phenylethyl]propanamide;3-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)-N-[2-(1H-indol-3-yl)-2-phenyl-ethyl]propanamide		145498491.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=145498491		pluskal_iocb_peptide_Peptide01_G15_id		100	G15		
2.5		0	1152	P6238524	117.8		AF2	False	0	21	0	0	19	0	3	4	0	1		0.0						O=C(Nc1nccs1)C(Cc1ccccc1)NC(=O)C1COc2ccccc2O1																							0.0		AKOS016400212		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	1	0	0	2	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0		C21H19N3O4S	C21H19N3O4S			InChI=1S/C21H19N3O4S/c25-19(24-21-22-10-11-29-21)15(12-14-6-2-1-3-7-14)23-20(26)18-13-27-16-8-4-5-9-17(16)28-18/h1-11,15,18H,12-13H2,(H,23,26)(H,22,24,25)/t15-,18?/m1/s1	GUPBCRGHPPDZGV-NNJIEVJOSA-N	N-[rac-(1R)-1-benzyl-2-oxo-2-(thiazol-2-ylamino)ethyl]-2,3-dihydro-1,4-benzodioxine-3-carboxamide	71695126	O=C(N[C@H](Cc1ccccc1)C(=O)Nc1nccs1)C1COc2ccccc2O1	N-[(2R)-1-oxo-3-phenyl-1-(1,3-thiazol-2-ylamino)propan-2-yl]-2,3-dihydro-1,4-benzodioxine-3-carboxamide			1.2889599999999992														409.46728		409.109627	5	2	6	4			46										False	Amino acids and Peptides				Peptide01			Compound(71695126)	71695126	3.3	1269			[#8]=[#6](-[#7]-[#6@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#7]-[#6]1:[#7]:[#6]:[#6]:[#16]:1)-[#6]1-[#6]-[#8]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2-[#8]-1	O=C(N[C@H](Cc1ccccc1)C(=O)Nc1nccs1)C1COc2ccccc2O1	GUPBCRGHPPDZGV		parent_pubchem_cid	AKOS016400212;2-[(2,3-DIHYDRO-1,4-BENZODIOXIN-2-YL)FORMAMIDO]-3-PHENYL-N-(1,3-THIAZOL-2-YL)PROPANAMIDE;N-[rac-(1R)-1-benzyl-2-oxo-2-(thiazol-2-ylamino)ethyl]-2,3-dihydro-1,4-benzodioxine-3-carboxamide		58567005.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=58567005		pluskal_iocb_peptide_Peptide01_G15_id		100	G15		
1.8		0	1240	P6248929	131.2		AF3	False	0	20	0	0	20	0	4	5	0	1		0.0						Cn1c(=O)n(C)c2c1ccc(S(=O)(=O)NC(Cc1c[nH]c3ccccc13)C(=O)O)c2																							0.0		AKOS016382240		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	2	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0		C20H20N4O5S	C20H20N4O5S			InChI=1S/C20H20N4O5S/c1-23-17-8-7-13(10-18(17)24(2)20(23)27)30(28,29)22-16(19(25)26)9-12-11-21-15-6-4-3-5-14(12)15/h3-8,10-11,16,21-22H,9H2,1-2H3,(H,25,26)	LNTCMUQRCOMGGU-UHFFFAOYSA-N	2-[(1,3-dimethyl-2-oxo-benzimidazol-5-yl)sulfonylamino]-3-(1H-indol-3-yl)propanoic acid	56727517	Cn1c(=O)n(C)c2c1ccc(S(=O)(=O)NC(Cc1c[nH]c3ccccc13)C(=O)O)c2	2-[(1,3-dimethyl-2-oxobenzimidazol-5-yl)sulfonylamino]-3-(1H-indol-3-yl)propanoic acid			1.2128299999999994													MCULE-6298547093	428.4702		428.115441	5	3	6	4			45										False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(56727517)	56727517	1.6	1270			[#6]-[#7]1:[#6](=[#8]):[#7](-[#6]):[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#16](=[#8])(=[#8])-[#7]-[#6](-[#6]-[#6]1:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:1:3)-[#6](=[#8])-[#8]):[#6]:2	Cn1c(=O)n(C)c2c1ccc(S(=O)(=O)NC(Cc1c[nH]c3ccccc13)C(=O)O)c2	LNTCMUQRCOMGGU		parent_pubchem_cid	AKOS016382240;2-[(1,3-dimethyl-2-oxo-benzimidazol-5-yl)sulfonylamino]-3-(1H-indol-3-yl)propanoic acid		24305727.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24305727		pluskal_iocb_peptide_Peptide01_G15_id		100	G15		
3.2		0	1072	P11184872	127.8		AF5	False	0	21	0	0	19	0	3	4	0	1		0.0						O=C(CCn1c(=O)sc2ccccc21)NC(Cc1c[nH]c2ccccc12)C(=O)O																							0.0		AKOS027472528		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	1	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C21H19N3O4S	C21H19N3O4S			InChI=1S/C21H19N3O4S/c25-19(9-10-24-17-7-3-4-8-18(17)29-21(24)28)23-16(20(26)27)11-13-12-22-15-6-2-1-5-14(13)15/h1-8,12,16,22H,9-11H2,(H,23,25)(H,26,27)/t16-/m0/s1	NYVNTMSXKLAYRO-INIZCTEOSA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[3-(2-oxo-1,3-benzothiazol-3-yl)propanoylamino]propanoic acid	121595444	O=C(CCn1c(=O)sc2ccccc21)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	(2S)-3-(1H-indol-3-yl)-2-[3-(2-oxo-1,3-benzothiazol-3-yl)propanoylamino]propanoic acid			2.73484														409.46728		409.109627	5	3	7	4			45										False					Peptide01			Compound(121595444)	121595444	2.8	1271			[#8]=[#6](-[#6]-[#6]-[#7]1:[#6](=[#8]):[#16]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]	O=C(CCn1c(=O)sc2ccccc21)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O	NYVNTMSXKLAYRO		parent_pubchem_cid	AKOS027472528;rac-(2S)-3-(1H-indol-3-yl)-2-[3-(2-oxo-1,3-benzothiazol-3-yl)propanoylamino]propanoic acid		147966416.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=147966416		pluskal_iocb_peptide_Peptide01_G15_id		100	G15		ZINC000334162090
3.1		0	1160	P1157889	82.2		AF6	False	0	18	0	0	16	0	2	3	0	0		0.0						O=C(NC(Cc1ccccc1)C(=O)O)c1cc2ccccc2[nH]1																							0.0		Oprea1_750453		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C18H16N2O3	C18H16N2O3			InChI=1S/C18H16N2O3/c21-17(15-11-13-8-4-5-9-14(13)19-15)20-16(18(22)23)10-12-6-2-1-3-7-12/h1-9,11,16,19H,10H2,(H,20,21)(H,22,23)/t16-/m0/s1	MDGSLYWHCJHBAA-INIZCTEOSA-N	rac-(2S)-2-(1H-indole-2-carbonylamino)-3-phenyl-propanoic acid	17594016	O=C(N[C@@H](Cc1ccccc1)C(=O)O)c1cc2ccccc2[nH]1	(2S)-2-(1H-indole-2-carbonylamino)-3-phenylpropanoic acid			2.0557600000000003													MCULE-1776279032	308.33982		308.116092	3	3	5	3			44										False	Alkaloids				Peptide01			Compound(17594016)	17594016	3.2	1272			[#8]=[#6](-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8])-[#6]1:[#6]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#7H]:1	O=C(N[C@@H](Cc1ccccc1)C(=O)O)c1cc2ccccc2[nH]1	MDGSLYWHCJHBAA		parent_pubchem_cid	Oprea1_750453;AKOS016402585;2-[(1H-INDOL-2-YL)FORMAMIDO]-3-PHENYLPROPANOIC ACID;rac-(2S)-2-(1H-indole-2-carbonylamino)-3-phenyl-propanoic acid		22974928.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22974928		pluskal_iocb_peptide_Peptide01_G16_id		100	G16		ZINC000009051970
1.5		0	1248	P7008302	87.9		AF7	False	0	14	0	0	16	0	6	1	0	0		0.0						Cn1ncc2c(Nc3ccccc3)nc(NCCO)nc21																							0.0		878063-20-8		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1		C14H16N6O	C14H16N6O			InChI=1S/C14H16N6O/c1-20-13-11(9-16-20)12(17-10-5-3-2-4-6-10)18-14(19-13)15-7-8-21/h2-6,9,21H,7-8H2,1H3,(H2,15,17,18,19)	SCTLSVQJTFHTHP-UHFFFAOYSA-N	2-[(4-anilino-1-methyl-pyrazolo[3,4-d]pyrimidin-6-yl)amino]ethanol	16456615	Cn1ncc2c(Nc3ccccc3)nc(NCCO)nc21	2-[(4-anilino-1-methylpyrazolo[3,4-d]pyrimidin-6-yl)amino]ethanol			-0.0591500000000003													MCULE-4835434652	284.32322		284.138559	6	3	5	3			44										False	Alkaloids				Peptide01			Compound(16456615)	16456615	1.7	1273			[#6]-[#7]1:[#7]:[#6]:[#6]2:[#6](-[#7]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#7]:[#6](-[#7]-[#6]-[#6]-[#8]):[#7]:[#6]:1:2	Cn1ncc2c(Nc3ccccc3)nc(NCCO)nc21	SCTLSVQJTFHTHP		parent_pubchem_cid	878063-20-8;2-((1-methyl-4-(phenylamino)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)amino)ethanol;2-{[1-methyl-4-(phenylamino)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]amino}ethanol;STK643338;AKOS002311154;CCG-170382;F2031-0023;2-((1-methyl-4-(phenylamino)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)amino)ethan-1-ol;2-[(4-anilino-1-methyl-pyrazolo[3,4-d]pyrimidin-6-yl)amino]ethanol		14438787.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=14438787		pluskal_iocb_peptide_Peptide01_G16_id		100	G16		ZINC000009212204
3.1		0	1080	P1157522	122.6		AF9	False	0	24	0	0	30	0	2	6	0	1		0.0						COc1ccc(C2c3cc(OC)c(OC)cc3CCN2C(=O)NC(CCSC)C(=O)O)cc1																							0.0		AKOS016387080		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	2	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C24H30N2O6S	C24H30N2O6S			InChI=1S/C24H30N2O6S/c1-30-17-7-5-15(6-8-17)22-18-14-21(32-3)20(31-2)13-16(18)9-11-26(22)24(29)25-19(23(27)28)10-12-33-4/h5-8,13-14,19,22H,9-12H2,1-4H3,(H,25,29)(H,27,28)/t19-,22?/m0/s1	STIUCRPIPHGCTG-YDNXMHBPSA-N	rac-(2S)-2-[[6,7-dimethoxy-1-(4-methoxyphenyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]amino]-4-methylsulfanyl-butanoic acid	16407166	COc1ccc(C2c3cc(OC)c(OC)cc3CCN2C(=O)N[C@@H](CCSC)C(=O)O)cc1	(2S)-2-[[6,7-dimethoxy-1-(4-methoxyphenyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]amino]-4-methylsulfanylbutanoic acid			2.02444													MCULE-4894891106	474.5805		474.182458	7	2	9	3			45									Isoquinoline alkaloids	False	Alkaloids	Tyrosine alkaloids			Peptide01			Compound(16407166)	16407166	3.3	1274			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#6]2-[#6]3:[#6]:[#6](-[#8]-[#6]):[#6](-[#8]-[#6]):[#6]:[#6]:3-[#6]-[#6]-[#7]-2-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]-[#16]-[#6])-[#6](=[#8])-[#8]):[#6]:[#6]:1	COc1ccc(C2c3cc(OC)c(OC)cc3CCN2C(=O)N[C@@H](CCSC)C(=O)O)cc1	STIUCRPIPHGCTG		parent_pubchem_cid	AKOS016387080;956935-88-9;N-{[6,7-dimethoxy-1-(4-methoxyphenyl)-3,4-dihydroisoquinolin-2(1H)-yl]carbonyl}-L-methionine;(2S)-2-({[6,7-DIMETHOXY-1-(4-METHOXYPHENYL)-3,4-DIHYDRO-2(1H)-ISOQUINOLINYL]CARBONYL}AMINO)-4-(METHYLSULFANYL)BUTANOIC ACID;(2S)-2-[[6,7-dimethoxy-1-(4-methoxyphenyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]amino]-4-methylsulfanylbutanoic acid;rac-(2S)-2-[[6,7-dimethoxy-1-(4-methoxyphenyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]amino]-4-methylsulfanyl-butanoic acid		22678323.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22678323		pluskal_iocb_peptide_Peptide01_G16_id		100	G16		
4.3		0	1168	P1098369	101.9		AF10	False	0	24	0	0	25	0	1	6	0	0		0.0						Cc1c(C)c2c(oc1=O)c(C)c(OC(C)C(=O)NC(Cc1ccccc1)C(=O)O)cc2																							0.0		EiM07-17047		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C24H25NO6	C24H25NO6			InChI=1S/C24H25NO6/c1-13-14(2)24(29)31-21-15(3)20(11-10-18(13)21)30-16(4)22(26)25-19(23(27)28)12-17-8-6-5-7-9-17/h5-11,16,19H,12H2,1-4H3,(H,25,26)(H,27,28)/t16?,19-/m0/s1	XZWXSOOCPGIRQF-CVMIBEPCSA-N	rac-(2S)-3-phenyl-2-[2-(3,4,8-trimethyl-2-oxo-chromen-7-yl)oxypropanoylamino]propanoic acid	16399349	Cc1c(C)c2c(oc1=O)c(C)c(OC(C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)cc2	(2S)-3-phenyl-2-[2-(3,4,8-trimethyl-2-oxochromen-7-yl)oxypropanoylamino]propanoic acid			3.087880000000001													MCULE-1009093769	423.46995		423.168188	6	2	7	3			45									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(16399349)	16399349	3.9	1275			[#6]-[#6]1:[#6](-[#6]):[#6]2:[#6](:[#8]:[#6]:1=[#8]):[#6](-[#6]):[#6](-[#8]-[#6](-[#6])-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8]):[#6]:[#6]:2	Cc1c(C)c2c(oc1=O)c(C)c(OC(C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)cc2	XZWXSOOCPGIRQF		parent_pubchem_cid	EiM07-17047;AKOS004937384;(2S)-3-PHENYL-2-({2-[(3,4,8-TRIMETHYL-2-OXO-2H-CHROMEN-7-YL)OXY]PROPANOYL}AMINO)PROPANOIC ACID;rac-(2S)-3-phenyl-2-[2-(3,4,8-trimethyl-2-oxo-chromen-7-yl)oxypropanoylamino]propanoic acid		23026842.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23026842		pluskal_iocb_peptide_Peptide01_G16_id		100	G16		
3.8		0	1256	P7008378	71.3		AF11	False	0	24	0	0	27	0	7	1	0	0		0.0						COc1ccc(Nc2c3cnn(C)c3nc(N3CCN(Cc4ccccc4)CC3)n2)cc1																							0.0		AKOS001910285		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	3		C24H27N7O	C24H27N7O			InChI=1S/C24H27N7O/c1-29-23-21(16-25-29)22(26-19-8-10-20(32-2)11-9-19)27-24(28-23)31-14-12-30(13-15-31)17-18-6-4-3-5-7-18/h3-11,16H,12-15,17H2,1-2H3,(H,26,27,28)	HUDKRXBQDHWXBQ-UHFFFAOYSA-N	6-(4-benzylpiperazin-1-yl)-N-(4-methoxyphenyl)-1-methyl-pyrazolo[3,4-d]pyrimidin-4-amine	16456740	COc1ccc(Nc2c3cnn(C)c3nc(N3CCN(Cc4ccccc4)CC3)n2)cc1	6-(4-benzylpiperazin-1-yl)-N-(4-methoxyphenyl)-1-methylpyrazolo[3,4-d]pyrimidin-4-amine			1.35033													MCULE-9941017498	429.52909		429.227708	7	1	6	5			44										False	Alkaloids				Peptide01			Compound(16456740)	16456740	3.8	1276			[#6]-[#8]-[#6]1:[#6]:[#6]:[#6](-[#7]-[#6]2:[#6]3:[#6]:[#7]:[#7](-[#6]):[#6]:3:[#7]:[#6](-[#7]3-[#6]-[#6]-[#7](-[#6]-[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]:4)-[#6]-[#6]-3):[#7]:2):[#6]:[#6]:1	COc1ccc(Nc2c3cnn(C)c3nc(N3CCN(Cc4ccccc4)CC3)n2)cc1	HUDKRXBQDHWXBQ		parent_pubchem_cid	AKOS001910285;6-(4-benzylpiperazin-1-yl)-N-(4-methoxyphenyl)-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine;6-(4-benzylpiperazin-1-yl)-N-(4-methoxyphenyl)-1-methyl-pyrazolo[3,4-d]pyrimidin-4-amine		13986148.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=13986148		pluskal_iocb_peptide_Peptide01_G16_id		100	G16		ZINC000020560428
1.8		0	1088	P11184877	136.7		AF13	False	0	20	0	0	21	0	3	5	0	1		0.0						CS(=O)(=O)Nc1ccc(CC(=O)NC(Cc2c[nH]c3ccccc23)C(=O)O)cc1																							0.0		AKOS027472533		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	2	0	0	1	0	0	0	0	0	0	0		C20H21N3O5S	C20H21N3O5S			InChI=1S/C20H21N3O5S/c1-29(27,28)23-15-8-6-13(7-9-15)10-19(24)22-18(20(25)26)11-14-12-21-17-5-3-2-4-16(14)17/h2-9,12,18,21,23H,10-11H2,1H3,(H,22,24)(H,25,26)/t18-/m0/s1	IPXWPUAVXDMELA-SFHVURJKSA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[[2-[4-(methanesulfonamido)phenyl]acetyl]amino]propanoic acid	91638924	CS(=O)(=O)Nc1ccc(CC(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)cc1	(2S)-3-(1H-indol-3-yl)-2-[[2-[4-(methanesulfonamido)phenyl]acetyl]amino]propanoic acid			0.9755500000000008														415.47147		415.120192	5	4	8	3			45									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(91638924)	91638924	1.0	1277			[#6]-[#16](=[#8])(=[#8])-[#7]-[#6]1:[#6]:[#6]:[#6](-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3)-[#6](=[#8])-[#8]):[#6]:[#6]:1	CS(=O)(=O)Nc1ccc(CC(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)cc1	IPXWPUAVXDMELA		parent_pubchem_cid	AKOS027472533;(2S)-3-(1H-INDOL-3-YL)-2-[(2-{4-[(METHYLSULFONYL)AMINO]PHENYL}ACETYL)AMINO]PROPANOIC ACID;rac-(2S)-3-(1H-indol-3-yl)-2-[[2-[4-(methanesulfonamido)phenyl]acetyl]amino]propanoic acid		92073927.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=92073927		pluskal_iocb_peptide_Peptide01_G16_id		100	G16		ZINC000218144400
0.6		0	1176	P1157631	141.1		AF14	False	0	16	0	0	19	0	3	5	0	1		0.0						CSCCC(NC(=O)C(C)n1c(=O)[nH]c2ccccc2c1=O)C(=O)O																							0.0		EiM07-17664		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	4	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0		C16H19N3O5S	C16H19N3O5S			InChI=1S/C16H19N3O5S/c1-9(13(20)17-12(15(22)23)7-8-25-2)19-14(21)10-5-3-4-6-11(10)18-16(19)24/h3-6,9,12H,7-8H2,1-2H3,(H,17,20)(H,18,24)(H,22,23)/t9-,12-/m0/s1	SHMHJTVSNICKHD-CABZTGNLSA-N	rac-(2S)-4-methylsulfanyl-2-[[rac-(2S)-2-(2,4-dioxo-1H-quinazolin-3-yl)propanoyl]amino]butanoic acid	1788739	CSCC[C@H](NC(=O)[C@H](C)n1c(=O)[nH]c2ccccc2c1=O)C(=O)O	(2S)-2-[[(2S)-2-(2,4-dioxo-1H-quinazolin-3-yl)propanoyl]amino]-4-methylsulfanylbutanoic acid			1.94466													MCULE-8667300729	365.41093		365.104542	6	3	7	2			44									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(1788739)	1788739	1.0	1278			[#6]-[#16]-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6@H](-[#6])-[#7]1:[#6](=[#8]):[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2:[#6]:1=[#8])-[#6](=[#8])-[#8]	CSCC[C@H](NC(=O)[C@H](C)n1c(=O)[nH]c2ccccc2c1=O)C(=O)O	SHMHJTVSNICKHD		parent_pubchem_cid	EiM07-17664;AKOS016386937;AKOS037496678;2-[2-(2,4-DIOXO-1,2,3,4-TETRAHYDROQUINAZOLIN-3-YL)PROPANAMIDO]-4-(METHYLSULFANYL)BUTANOIC ACID;rac-(2S)-4-methylsulfanyl-2-[[rac-(2S)-2-(2,4-dioxo-1H-quinazolin-3-yl)propanoyl]amino]butanoic acid		24307471.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24307471		pluskal_iocb_peptide_Peptide01_G16_id		100	G16		ZINC000002133434
1.7		0	1264	P7008516	70.5		AF15	False	0	21	0	0	25	0	7	1	0	0		0.0						c1ccc(CN2CCN(c3nc4nccnc4c(N4CCOCC4)n3)CC2)cc1																							0.0		2-(4-benzylpiperazin-1-yl)-4-(morpholin-4-yl)pteridine		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3		C21H25N7O	C21H25N7O			InChI=1S/C21H25N7O/c1-2-4-17(5-3-1)16-26-8-10-28(11-9-26)21-24-19-18(22-6-7-23-19)20(25-21)27-12-14-29-15-13-27/h1-7H,8-16H2	PDLOQNDEGQUXEQ-UHFFFAOYSA-N	4-[2-(4-benzylpiperazin-1-yl)pteridin-4-yl]morpholine	39038972	c1ccc(CN2CCN(c3nc4nccnc4c(N4CCOCC4)n3)CC2)cc1	4-[2-(4-benzylpiperazin-1-yl)pteridin-4-yl]morpholine			0.334250000000001													MCULE-7812989199	391.4797		391.212058	8	0	4	5			44									Carboline alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(39038972)	39038972	1.7	1279			[#6]1:[#6]:[#6]:[#6](-[#6]-[#7]2-[#6]-[#6]-[#7](-[#6]3:[#7]:[#6]4:[#7]:[#6]:[#6]:[#7]:[#6]:4:[#6](-[#7]4-[#6]-[#6]-[#8]-[#6]-[#6]-4):[#7]:3)-[#6]-[#6]-2):[#6]:[#6]:1	c1ccc(CN2CCN(c3nc4nccnc4c(N4CCOCC4)n3)CC2)cc1	PDLOQNDEGQUXEQ		parent_pubchem_cid	2-(4-benzylpiperazin-1-yl)-4-(morpholin-4-yl)pteridine;1144452-14-1;AKOS002337547;CCG-313825;Z1013750856;4-[2-(4-benzylpiperazin-1-yl)pteridin-4-yl]morpholine		20893803.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=20893803		pluskal_iocb_peptide_Peptide01_G16_id		100	G16		ZINC000031812302
2.1		0	1096	P1098235	139.2		AF17	False	0	19	0	0	21	0	1	8	0	0		0.0						CCCc1cc(=O)oc2c1ccc(OCC(=O)NC(CC(=O)O)C(=O)O)c2C																							0.0		EiM07-16913		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	3	2	0	0	0	0	0	0	0	0	1	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C19H21NO8	C19H21NO8			InChI=1S/C19H21NO8/c1-3-4-11-7-17(24)28-18-10(2)14(6-5-12(11)18)27-9-15(21)20-13(19(25)26)8-16(22)23/h5-7,13H,3-4,8-9H2,1-2H3,(H,20,21)(H,22,23)(H,25,26)/t13-/m0/s1	RUECZFXGDRDGQX-ZDUSSCGKSA-N	rac-(2S)-2-[[2-(8-methyl-2-oxo-4-propyl-chromen-7-yl)oxyacetyl]amino]butanedioic acid	24279861	CCCc1cc(=O)oc2c1ccc(OCC(=O)N[C@@H](CC(=O)O)C(=O)O)c2C	(2S)-2-[[2-(8-methyl-2-oxo-4-propylchromen-7-yl)oxyacetyl]amino]butanedioic acid			1.3764599999999998													MCULE-6678385535	391.38112		391.126717	8	3	9	2			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(24279861)	24279861	1.6	1280			[#6]-[#6]-[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6](=[#8])-[#8])-[#6](=[#8])-[#8]):[#6]:2-[#6]	CCCc1cc(=O)oc2c1ccc(OCC(=O)N[C@@H](CC(=O)O)C(=O)O)c2C	RUECZFXGDRDGQX		parent_pubchem_cid	EiM07-16913;AKOS004937246;2-({2-[(8-METHYL-2-OXO-4-PROPYL-2H-CHROMEN-7-YL)OXY]ACETYL}AMINO)SUCCINIC ACID;rac-(2S)-2-[[2-(8-methyl-2-oxo-4-propyl-chromen-7-yl)oxyacetyl]amino]butanedioic acid		23794459.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23794459		pluskal_iocb_peptide_Peptide01_G17_id		100	G17		ZINC000011866786
1.6		0	1184	P1098614	95.9		AF18	False	0	20	0	0	27	0	1	5	0	0		0.0						CCCCc1cc(=O)oc2c1ccc(O)c2CNC(C(=O)O)C(C)CC								7-hydroxycoumarins;1-benzopyrans;L-alpha-amino acids;Pyranones and derivatives;1-hydroxy-2-unsubstituted benzenoids;Aralkylamines;Heteroaromatic compounds;Amino acids;Lactones;Carboxylic acid salts;Oxacyclic compounds;Monocarboxylic acids and derivatives;Dialkylamines;Carboxylic acids;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organic salts;Organic zwitterions;Organopnictogen compounds	1-benzopyrans;1-hydroxy-2-unsubstituted benzenoids;7-hydroxycoumarins;Alpha amino acids;Alpha amino acids and derivatives;Amines;Amino acids;Amino acids and derivatives;Amino acids, peptides, and analogues;Aralkylamines;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acid derivatives;Carboxylic acid salts;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;Dialkylamines;Heteroaromatic compounds;Hydrocarbon derivatives;Hydroxycoumarins;Isoleucine and derivatives;L-alpha-amino acids;Lactones;Monocarboxylic acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organic salts;Organic zwitterions;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenols;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Secondary amines	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as isoleucine and derivatives. These are compounds containing isoleucine or a derivative thereof resulting from reaction of isoleucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Isoleucine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	hydroxycoumarin (CHEBI:37912);1-benzopyran (CHEBI:38443);L-alpha-amino acid (CHEBI:15705);pyranone (CHEBI:37963);phenols (CHEBI:33853);aralkylamine (CHEBI:18000);organic aromatic compound (CHEBI:33659);amino acid (CHEBI:33709);lactone (CHEBI:25000);organic salt (CHEBI:24868);oxacycle (CHEBI:38104);monocarboxylic acid (CHEBI:25384);secondary amino compound (CHEBI:50995);carboxylic acid (CHEBI:33575);carbonyl compound (CHEBI:36586);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);zwitterion (CHEBI:27369);organic molecular entity (CHEBI:50860);pnictogen molecular entity (CHEBI:33302);isoleucine derivative (CHEBI:24899);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);coumarins (CHEBI:23403);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);organic acid (CHEBI:64709);organonitrogen compound (CHEBI:35352);alpha-amino acid (CHEBI:33704);pyrans (CHEBI:26407);benzenoid aromatic compound (CHEBI:33836);nitrogen molecular entity (CHEBI:51143);amine (CHEBI:32952);secondary amine (CHEBI:32863);oxygen molecular entity (CHEBI:25806);carboxylic acid anion (CHEBI:29067);peptide (CHEBI:16670)	Benzopyranoids (PK1311)	Amino acids, peptides, and analogues	Isoleucine or derivatives;7-hydroxycoumarin;Hydroxycoumarin;Coumarin;Alpha-amino acid;Benzopyran;L-alpha-amino acid;1-benzopyran;1-hydroxy-2-unsubstituted benzenoid;Pyranone;Aralkylamine;Pyran;Benzenoid;Heteroaromatic compound;Carboxylic acid salt;Amino acid;Lactone;Organoheterocyclic compound;Oxacycle;Secondary amine;Carboxylic acid;Secondary aliphatic amine;Monocarboxylic acid or derivatives;Organic salt;Organonitrogen compound;Organooxygen compound;Hydrocarbon derivative;Organic oxide;Organic nitrogen compound;Organic zwitterion;Carbonyl group;Organopnictogen compound;Amine;Organic oxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS016387022		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	1	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0		C20H27NO5	C20H27NO5			InChI=1S/C20H27NO5/c1-4-6-7-13-10-17(23)26-19-14(13)8-9-16(22)15(19)11-21-18(20(24)25)12(3)5-2/h8-10,12,18,21-22H,4-7,11H2,1-3H3,(H,24,25)/t12-,18+/m1/s1	DGCSYLIWTOPBBP-XIKOKIGWSA-N	rac-(2S,3R)-2-[(4-butyl-7-hydroxy-2-oxo-chromen-8-yl)methylamino]-3-methyl-pentanoic acid	5579948	CCCCc1cc(=O)oc2c1ccc(O)c2CN[C@H](C(=O)O)[C@H](C)CC	(2S,3R)-2-[(4-butyl-7-hydroxy-2-oxochromen-8-yl)methylamino]-3-methylpentanoic acid			3.329740000000002													MCULE-4012652049	361.44189		361.188923	6	3	9	2			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(11963719)	11963719	1.9	1281			[#6]-[#6]-[#6]-[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]):[#6]:2-[#6]-[#7]-[#6@H](-[#6](=[#8])-[#8])-[#6@H](-[#6])-[#6]-[#6]	CCCCc1cc(=O)oc2c1ccc(O)c2CN[C@H](C(=O)O)[C@H](C)CC	DGCSYLIWTOPBBP		parent_pubchem_cid	AKOS016387022;(2S,3R)-2-{[(4-butyl-7-hydroxy-2-oxo-2H-chromen-8-yl)methyl]amino}-3-methylpentanoic acid;rac-(2S,3R)-2-[(4-butyl-7-hydroxy-2-oxo-chromen-8-yl)methylamino]-3-methyl-pentanoic acid		5577430.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=5577430		pluskal_iocb_peptide_Peptide01_G17_id		100	G17		ZINC000002137304
2.2		0	1272	P7010543	90.6		AF19	False	0	20	0	0	26	0	6	3	0	0		0.0						Cc1c([N+](=O)[O-])c(N2CCOCC2)nc(N2CCN(Cc3ccccc3)CC2)n1																							0.0		4-[2-(4-benzylpiperazin-1-yl)-6-methyl-5-nitropyrimidin-4-yl]morpholine		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4		C20H26N6O3	C20H26N6O3			InChI=1S/C20H26N6O3/c1-16-18(26(27)28)19(24-11-13-29-14-12-24)22-20(21-16)25-9-7-23(8-10-25)15-17-5-3-2-4-6-17/h2-6H,7-15H2,1H3	IZUWCUNNBXAGNC-UHFFFAOYSA-N	4-[2-(4-benzylpiperazin-1-yl)-6-methyl-5-nitro-pyrimidin-4-yl]morpholine	45503328	Cc1c([N+](=O)[O-])c(N2CCOCC2)nc(N2CCN(Cc3ccccc3)CC2)n1	4-[2-(4-benzylpiperazin-1-yl)-6-methyl-5-nitropyrimidin-4-yl]morpholine			0.6007700000000011													MCULE-8466250170	398.46862		398.206639	8	0	5	4			44										False	Alkaloids				Peptide01			Compound(45503328)	45503328	2.3	1282			[#6]-[#6]1:[#6](-[#7+](=[#8])-[#8-]):[#6](-[#7]2-[#6]-[#6]-[#8]-[#6]-[#6]-2):[#7]:[#6](-[#7]2-[#6]-[#6]-[#7](-[#6]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3)-[#6]-[#6]-2):[#7]:1	Cc1c([N+](=O)[O-])c(N2CCOCC2)nc(N2CCN(Cc3ccccc3)CC2)n1	IZUWCUNNBXAGNC		parent_pubchem_cid	4-[2-(4-benzylpiperazin-1-yl)-6-methyl-5-nitropyrimidin-4-yl]morpholine;1211771-92-4;4-(2-(4-benzylpiperazin-1-yl)-6-methyl-5-nitropyrimidin-4-yl)morpholine;F5736-0182;AKOS024255425;CCG-312786;VU0519335-1;SR-01000924492;SR-01000924492-1;4-[2-(4-benzylpiperazin-1-yl)-6-methyl-5-nitro-pyrimidin-4-yl]morpholine		21315240.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=21315240		pluskal_iocb_peptide_Peptide01_G17_id		100	G17		ZINC000038488491
4.6		0	1104	P1105696	99.7		AF21	False	0	25	0	0	23	0	3	4	0	0		0.0						COc1c(OC)cc(-c2cnc(N)nc2-c2c(O)cc(OCc3ccccc3)cc2)cc1								Dimethoxybenzenes;Phenoxy compounds;Anisoles;Aminopyrimidines and derivatives;Alkyl aryl ethers;1-hydroxy-4-unsubstituted benzenoids;1-hydroxy-2-unsubstituted benzenoids;Heteroaromatic compounds;Azacyclic compounds;Primary amines;Organopnictogen compounds;Hydrocarbon derivatives	1-hydroxy-2-unsubstituted benzenoids;1-hydroxy-4-unsubstituted benzenoids;Alkyl aryl ethers;Amines;Aminopyrimidines and derivatives;Anisoles;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Chemical entities;Diazines;Dimethoxybenzenes;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Methoxybenzenes;Organic compounds;Organic nitrogen compounds;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenol ethers;Phenols;Phenoxy compounds;Phenylpyrimidines;Primary amines;Pyrimidines and pyrimidine derivatives	Diazines	2.1	This compound belongs to the class of organic compounds known as phenylpyrimidines. These are polycyclic aromatic compounds containing a benzene ring linked to a pyrimidine ring through a CC or CN bond.  Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions.	Phenylpyrimidines			Organic compounds	Aromatic heteromonocyclic compounds	dimethoxybenzene (CHEBI:51681);benzenes (CHEBI:22712);methoxybenzene (CHEBI:51683);aminopyrimidine (CHEBI:38338);aromatic ether (CHEBI:35618);phenols (CHEBI:33853);organic aromatic compound (CHEBI:33659);organonitrogen heterocyclic compound (CHEBI:38101);primary amine (CHEBI:32877);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organic molecule (CHEBI:72695);pyrimidines (CHEBI:39447);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);organic heterocyclic compound (CHEBI:24532);diazines (CHEBI:38313);oxygen molecular entity (CHEBI:25806);organooxygen compound (CHEBI:36963);ether (CHEBI:25698);nitrogen molecular entity (CHEBI:51143);organonitrogen compound (CHEBI:35352);amine (CHEBI:32952)		Pyrimidines and pyrimidine derivatives	5-phenylpyrimidine;4-phenylpyrimidine;O-dimethoxybenzene;Dimethoxybenzene;Phenoxy compound;Methoxybenzene;Phenol ether;Anisole;1-hydroxy-4-unsubstituted benzenoid;1-hydroxy-2-unsubstituted benzenoid;Phenol;Aminopyrimidine;Alkyl aryl ether;Benzenoid;Monocyclic benzene moiety;Heteroaromatic compound;Azacycle;Ether;Organic nitrogen compound;Organic oxygen compound;Organopnictogen compound;Hydrocarbon derivative;Primary amine;Organooxygen compound;Organonitrogen compound;Amine;Aromatic heteromonocyclic compound	Organoheterocyclic compounds	0.0		850230-34-1		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0		C25H23N3O4	C25H23N3O4			InChI=1S/C25H23N3O4/c1-30-22-11-8-17(12-23(22)31-2)20-14-27-25(26)28-24(20)19-10-9-18(13-21(19)29)32-15-16-6-4-3-5-7-16/h3-14,29H,15H2,1-2H3,(H2,26,27,28)	XICDHUKYRLTMOC-UHFFFAOYSA-N	2-[2-amino-5-(3,4-dimethoxyphenyl)pyrimidin-4-yl]-5-benzyloxy-phenol	1957225	COc1c(OC)cc(-c2cnc(N)nc2-c2c(O)cc(OCc3ccccc3)cc2)cc1	2-[2-amino-5-(3,4-dimethoxyphenyl)pyrimidin-4-yl]-5-phenylmethoxyphenol			1.6496													MCULE-2616707881	429.47976		429.168856	7	2	7	4			44										False	Alkaloids				Peptide01			Compound(1957225)	1957225	4.2	1283			[#6]-[#8]-[#6]1:[#6](-[#8]-[#6]):[#6]:[#6](-[#6]2:[#6]:[#7]:[#6](-[#7]):[#7]:[#6]:2-[#6]2:[#6](-[#8]):[#6]:[#6](-[#8]-[#6]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#6]:[#6]:2):[#6]:[#6]:1	COc1c(OC)cc(-c2cnc(N)nc2-c2c(O)cc(OCc3ccccc3)cc2)cc1	XICDHUKYRLTMOC		parent_pubchem_cid	850230-34-1;2-(2-amino-5-(3,4-dimethoxyphenyl)pyrimidin-4-yl)-5-(benzyloxy)phenol;2-[2-amino-5-(3,4-dimethoxyphenyl)pyrimidin-4-yl]-5-(benzyloxy)phenol;2-[2-amino-5-(3,4-dimethoxyphenyl)pyrimidin-4-yl]-5-phenylmethoxyphenol;AKOS002226552;VU0616842-1;F3385-1402;2-[2-amino-5-(3,4-dimethoxyphenyl)pyrimidin-4-yl]-5-benzyloxy-phenol		10776225.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=10776225		pluskal_iocb_peptide_Peptide01_G17_id		100	G17		ZINC000002343889
4.0		0	1192	P1098215	101.9		AF22	False	0	21	0	0	27	0	1	6	0	0		0.0						CCCc1cc(=O)oc2c1ccc(OC(C)C(=O)NC(CC(C)C)C(=O)O)c2																							0.0		AKOS004937569		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C21H27NO6	C21H27NO6			InChI=1S/C21H27NO6/c1-5-6-14-10-19(23)28-18-11-15(7-8-16(14)18)27-13(4)20(24)22-17(21(25)26)9-12(2)3/h7-8,10-13,17H,5-6,9H2,1-4H3,(H,22,24)(H,25,26)/t13?,17-/m0/s1	KZSXEVWCVFPLEU-RUINGEJQSA-N	rac-(2S)-4-methyl-2-[2-(2-oxo-4-propyl-chromen-7-yl)oxypropanoylamino]pentanoic acid	16400020	CCCc1cc(=O)oc2c1ccc(OC(C)C(=O)N[C@@H](CC(C)C)C(=O)O)c2	(2S)-4-methyl-2-[2-(2-oxo-4-propylchromen-7-yl)oxypropanoylamino]pentanoic acid			3.082650000000001													MCULE-7551401262	389.45244		389.183838	6	2	9	2			45									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(16400020)	16400020	3.8	1284			[#6]-[#6]-[#6]-[#6]1:[#6]:[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6](-[#6])-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=[#8])-[#8]):[#6]:2	CCCc1cc(=O)oc2c1ccc(OC(C)C(=O)N[C@@H](CC(C)C)C(=O)O)c2	KZSXEVWCVFPLEU		parent_pubchem_cid	AKOS004937569;(2S)-4-methyl-2-(2-((2-oxo-4-propyl-2H-chromen-7-yl)oxy)propanamido)pentanoic acid;4-METHYL-2-{2-[(2-OXO-4-PROPYL-2H-CHROMEN-7-YL)OXY]PROPANAMIDO}PENTANOIC ACID;rac-(2S)-4-methyl-2-[2-(2-oxo-4-propyl-chromen-7-yl)oxypropanoylamino]pentanoic acid		24550100.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24550100		pluskal_iocb_peptide_Peptide01_G17_id		100	G17		
1.3		0	1280	P11570246	90.9		AF23	False	0	14	0	0	18	0	4	2	0	0		0.0						CC(C)C(CO)NC(=O)c1cc(-c2ccncc2)n[nH]1																							0.0		AKOS027474949		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C14H18N4O2	C14H18N4O2			InChI=1S/C14H18N4O2/c1-9(2)13(8-19)16-14(20)12-7-11(17-18-12)10-3-5-15-6-4-10/h3-7,9,13,19H,8H2,1-2H3,(H,16,20)(H,17,18)/t13-/m1/s1	KAIVNLFDYZIECY-CYBMUJFWSA-N	5-(4-pyridyl)-N-[rac-(1S)-1-(hydroxymethyl)-2-methyl-propyl]-1H-pyrazole-3-carboxamide	91638869	CC(C)[C@@H](CO)NC(=O)c1cc(-c2ccncc2)n[nH]1	N-[(2S)-1-hydroxy-3-methylbutan-2-yl]-3-pyridin-4-yl-1H-pyrazole-5-carboxamide			0.7836699999999999														274.32516		274.142976	4	3	5	2			45									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(91638869)	91638869	1.1	1285			[#6]-[#6](-[#6])-[#6@@H](-[#6]-[#8])-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6](-[#6]2:[#6]:[#6]:[#7]:[#6]:[#6]:2):[#7]:[#7H]:1	CC(C)[C@@H](CO)NC(=O)c1cc(-c2ccncc2)n[nH]1	KAIVNLFDYZIECY		parent_pubchem_cid	AKOS027474949;5-(4-pyridyl)-N-[rac-(1S)-1-(hydroxymethyl)-2-methyl-propyl]-1H-pyrazole-3-carboxamide		95501785.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=95501785		pluskal_iocb_peptide_Peptide01_G17_id		100	G17		ZINC000218138464
5.0		0	1112	P1098432	101.9		AF25	False	0	26	0	0	29	0	1	6	0	0		0.0						Cc1c(Cc2ccccc2)c(=O)oc2c1ccc(OCC(=O)NC(CC(C)C)C(=O)O)c2C								N-acyl-L-alpha-amino acids;Coumarins and derivatives;1-benzopyrans;Pyranones and derivatives;Alkyl aryl ethers;Benzene and substituted derivatives;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactones;Oxacyclic compounds;Carboxylic acids;Monocarboxylic acids and derivatives;Organopnictogen compounds;Carbonyl compounds;Organic oxides;Organonitrogen compounds;Hydrocarbon derivatives	1-benzopyrans;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Benzene and substituted derivatives;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Lactones;Leucine and derivatives;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Secondary carboxylic acid amides	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as leucine and derivatives. These are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Leucine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-L-alpha-amino acid (CHEBI:48927);coumarins (CHEBI:23403);1-benzopyran (CHEBI:38443);pyranone (CHEBI:37963);aromatic ether (CHEBI:35618);benzenes (CHEBI:22712);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactone (CHEBI:25000);oxacycle (CHEBI:38104);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);carbonyl compound (CHEBI:36586);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);organic molecule (CHEBI:72695);leucine derivative (CHEBI:47003);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);amino acid (CHEBI:33709);peptide (CHEBI:16670);N-acyl-amino acid (CHEBI:51569);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);pyrans (CHEBI:26407);oxygen molecular entity (CHEBI:25806);ether (CHEBI:25698);benzenoid aromatic compound (CHEBI:33836);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)	Benzopyranoids (PK1311)	Amino acids, peptides, and analogues	Leucine or derivatives;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;N-acyl-l-alpha-amino acid;Coumarin;Benzopyran;1-benzopyran;Alkyl aryl ether;Pyranone;Benzenoid;Monocyclic benzene moiety;Pyran;Heteroaromatic compound;Secondary carboxylic acid amide;Carboxamide group;Lactone;Organoheterocyclic compound;Oxacycle;Carboxylic acid;Ether;Monocarboxylic acid or derivatives;Organic nitrogen compound;Organic oxygen compound;Hydrocarbon derivative;Organooxygen compound;Carbonyl group;Organopnictogen compound;Organic oxide;Organonitrogen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		AKOS016355433		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C26H29NO6	C26H29NO6			InChI=1S/C26H29NO6/c1-15(2)12-21(25(29)30)27-23(28)14-32-22-11-10-19-16(3)20(13-18-8-6-5-7-9-18)26(31)33-24(19)17(22)4/h5-11,15,21H,12-14H2,1-4H3,(H,27,28)(H,29,30)/t21-/m0/s1	IQVVGRBSBOLZLC-NRFANRHFSA-N	rac-(2S)-2-[[2-(3-benzyl-4,8-dimethyl-2-oxo-chromen-7-yl)oxyacetyl]amino]-4-methyl-pentanoic acid	1805698	Cc1c(Cc2ccccc2)c(=O)oc2c1ccc(OCC(=O)N[C@@H](CC(C)C)C(=O)O)c2C	(2S)-2-[[2-(3-benzyl-4,8-dimethyl-2-oxochromen-7-yl)oxyacetyl]amino]-4-methylpentanoic acid			3.785160000000003													MCULE-8262608295	451.52413		451.199488	6	2	9	3			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(1805698)	1805698	4.8	1286			[#6]-[#6]1:[#6](-[#6]-[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:2):[#6](=[#8]):[#8]:[#6]2:[#6]:1:[#6]:[#6]:[#6](-[#8]-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6](-[#6])-[#6])-[#6](=[#8])-[#8]):[#6]:2-[#6]	Cc1c(Cc2ccccc2)c(=O)oc2c1ccc(OCC(=O)N[C@@H](CC(C)C)C(=O)O)c2C	IQVVGRBSBOLZLC		parent_pubchem_cid	AKOS016355433;(S)-2-(2-((3-benzyl-4,8-dimethyl-2-oxo-2H-chromen-7-yl)oxy)acetamido)-4-methylpentanoic acid;2-{2-[(3-BENZYL-4,8-DIMETHYL-2-OXO-2H-CHROMEN-7-YL)OXY]ACETAMIDO}-4-METHYLPENTANOIC ACID;rac-(2S)-2-[[2-(3-benzyl-4,8-dimethyl-2-oxo-chromen-7-yl)oxyacetyl]amino]-4-methyl-pentanoic acid		22766508.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22766508		pluskal_iocb_peptide_Peptide01_G17_id		100	G17		ZINC000002157381
2.8		0	1200	P3462630	101.9		AF26	False	0	19	0	0	19	0	1	6	0	0		0.0						O=C(CC(NC(=O)OCc1ccccc1)C(=O)O)OCc1ccccc1								Benzyloxycarbonyls;Fatty acid esters;Dicarboxylic acids and derivatives;Carbamate esters;Organic carbonic acids and derivatives;Carboxylic acid esters;Carboxylic acids;Organopnictogen compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives;Carbonyl compounds	Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Aspartic acid and derivatives;Benzene and substituted derivatives;Benzenoids;Benzyloxycarbonyls;Carbamate esters;Carbamic acids and derivatives;Carbonyl compounds;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Dicarboxylic acids and derivatives;Fatty Acyls;Fatty acid esters;Hydrocarbon derivatives;Lipids and lipid-like molecules;Organic acids and derivatives;Organic carbonic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as aspartic acid and derivatives. These are compounds containing an aspartic acid or a derivative thereof resulting from reaction of aspartic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Aspartic acid and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic homomonocyclic compounds	carboxylic ester (CHEBI:33308);fatty acid ester (CHEBI:35748);dicarboxylic acid (CHEBI:35692);carbamate ester (CHEBI:23003);organooxygen compound (CHEBI:36963);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);carbonyl compound (CHEBI:36586);aspartic acid derivative (CHEBI:22661);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);lipid (CHEBI:18059);amino acid (CHEBI:33709);peptide (CHEBI:16670);carbon oxoacid (CHEBI:35605);nitrogen molecular entity (CHEBI:51143);oxygen molecular entity (CHEBI:25806)	Fatty esters (FA07);Dicarboxylic acids (FA0117);Fatty Acyls (FA)	Amino acids, peptides, and analogues	Aspartic acid or derivatives;Benzyloxycarbonyl;Fatty acid ester;Monocyclic benzene moiety;Dicarboxylic acid or derivatives;Fatty acyl;Benzenoid;Carbamic acid ester;Carboxylic acid ester;Carbonic acid derivative;Carboxylic acid;Organooxygen compound;Hydrocarbon derivative;Organic oxide;Organopnictogen compound;Carbonyl group;Organic oxygen compound;Organic nitrogen compound;Organonitrogen compound;Aromatic homomonocyclic compound	Organic acids and derivatives	0.0		Z-Asp(OBzl)-OH	DTXSID60188333	2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	1	0	3	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		C19H19NO6	C19H19NO6			InChI=1S/C19H19NO6/c21-17(25-12-14-7-3-1-4-8-14)11-16(18(22)23)20-19(24)26-13-15-9-5-2-6-10-15/h1-10,16H,11-13H2,(H,20,24)(H,22,23)/t16-/m0/s1	VUKCNAATVIWRTF-INIZCTEOSA-N	rac-(2S)-4-benzyloxy-2-(benzyloxycarbonylamino)-4-oxo-butanoic acid	47602	O=C(C[C@H](NC(=O)OCc1ccccc1)C(=O)O)OCc1ccccc1	(2S)-4-oxo-4-phenylmethoxy-2-(phenylmethoxycarbonylamino)butanoic acid			2.390080000000001													MCULE-1611792115	357.36638		357.121237	6	2	10	2			42									Dipeptides	False	Amino acids and Peptides	Small peptides			Peptide01			Compound(47602)	47602	2.4	1287		SCHEMBL7583002	[#8]=[#6](-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1)-[#6](=[#8])-[#8])-[#8]-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1	O=C(C[C@H](NC(=O)OCc1ccccc1)C(=O)O)OCc1ccccc1	VUKCNAATVIWRTF		parent_pubchem_cid	Z-Asp(OBzl)-OH;3479-47-8;Cbz-Asp(OBzl)-OH;N-Cbz-L-aspartic Acid 4-Benzyl Ester;N-Carbobenzoxy-L-aspartic Acid 4-Benzyl Ester;4-Benzyl hydrogen N-((phenylmethoxy)carbonyl)-L-aspartate;(2S)-4-oxo-4-phenylmethoxy-2-(phenylmethoxycarbonylamino)butanoic acid;Z-D-Aspartic acid beta-benzyl ester;(S)-4-(Benzyloxy)-2-(((benzyloxy)carbonyl)amino)-4-oxobutanoic acid;Cbz-L-aspartic acid b-benzyl ester;EINECS 222-456-1;N-Benzyloxycarbonyl-L-Aspartic Acid 4-Benzyl Ester;4-Benzyl N-Carbobenzoxy-L-aspartate;MFCD00037820;Z-Asp(OBzl);4-Benzyl N-Cbz-L-aspartate;SCHEMBL7583002;DTXSID60188333;VUKCNAATVIWRTF-INIZCTEOSA-N;Z-Asp(OBzl)-OH, >=98.0%;AKOS015924111;Cbz-L-aspartic acid -beta benzyl ester;NSC 118536;NSC 163521;DS-13957;HY-30231;N-carbobenzoxy-4-O-benzyl-L-aspartic acid;B3903;CS-0000174;M06226;EN300-7358401;Q-101673;(S)-4-(benzyloxy)-2-(benzyloxycarbonylamino)-4-oxobutanoic acid;(2S)-4-(BENZYLOXY)-2-{[(BENZYLOXY)CARBONYL]AMINO}-4-OXOBUTANOIC ACID;rac-(2S)-4-benzyloxy-2-(benzyloxycarbonylamino)-4-oxo-butanoic acid		24482885.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=24482885		pluskal_iocb_peptide_Peptide01_G17_id		100	G17		ZINC000001708468
1.8		0	1288	P11569969	87.1		AF27	False	0	17	0	0	22	0	4	2	0	0		0.0						CCC(C)C(CO)NC(=O)c1ccc(Nc2ncccn2)cc1																							0.0		AKOS027474696		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C17H22N4O2	C17H22N4O2			InChI=1S/C17H22N4O2/c1-3-12(2)15(11-22)21-16(23)13-5-7-14(8-6-13)20-17-18-9-4-10-19-17/h4-10,12,15,22H,3,11H2,1-2H3,(H,21,23)(H,18,19,20)/t12-,15-/m1/s1	LZZWSZLXRWFGNP-IUODEOHRSA-N	4-(pyrimidin-2-ylamino)-N-[rac-(1S,2R)-1-(hydroxymethyl)-2-methyl-butyl]benzamide	110204985	CC[C@@H](C)[C@@H](CO)NC(=O)c1ccc(Nc2ncccn2)cc1	N-[(2S,3R)-1-hydroxy-3-methylpentan-2-yl]-4-(pyrimidin-2-ylamino)benzamide			1.54107														314.39049		314.174276	5	3	7	2			45									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(110204985)	110204985	2.4	1288			[#6]-[#6]-[#6@@H](-[#6])-[#6@@H](-[#6]-[#8])-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6]:[#6](-[#7]-[#6]2:[#7]:[#6]:[#6]:[#6]:[#7]:2):[#6]:[#6]:1	CC[C@@H](C)[C@@H](CO)NC(=O)c1ccc(Nc2ncccn2)cc1	LZZWSZLXRWFGNP		parent_pubchem_cid	AKOS027474696;4-(pyrimidin-2-ylamino)-N-[rac-(1S,2R)-1-(hydroxymethyl)-2-methyl-butyl]benzamide		117133196.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=117133196		pluskal_iocb_peptide_Peptide01_G18_id		100	G18		ZINC000252491938
3.3		0	1120	P1104647	99.7		AF29	False	0	19	0	0	19	0	3	4	0	0		0.0						COc1cc(Oc2c(C)nc(N)nc2-c2c(O)cc(OC)cc2)ccc1								Diarylethers;Methoxyphenols;Phenoxy compounds;Methoxybenzenes;Anisoles;Aminopyrimidines and derivatives;Alkyl aryl ethers;1-hydroxy-4-unsubstituted benzenoids;1-hydroxy-2-unsubstituted benzenoids;Heteroaromatic compounds;Azacyclic compounds;Primary amines;Organopnictogen compounds;Hydrocarbon derivatives	1-hydroxy-2-unsubstituted benzenoids;1-hydroxy-4-unsubstituted benzenoids;Alkyl aryl ethers;Amines;Aminopyrimidines and derivatives;Anisoles;Azacyclic compounds;Benzene and substituted derivatives;Benzenoids;Chemical entities;Diarylethers;Diazines;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Methoxybenzenes;Methoxyphenols;Organic compounds;Organic nitrogen compounds;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Phenol ethers;Phenols;Phenoxy compounds;Phenylpyrimidines;Primary amines;Pyrimidines and pyrimidine derivatives	Diazines	2.1	This compound belongs to the class of organic compounds known as phenylpyrimidines. These are polycyclic aromatic compounds containing a benzene ring linked to a pyrimidine ring through a CC or CN bond.  Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions.	Phenylpyrimidines			Organic compounds	Aromatic heteromonocyclic compounds	aromatic ether (CHEBI:35618);methoxybenzene (CHEBI:51683);phenols (CHEBI:33853);benzenes (CHEBI:22712);aminopyrimidine (CHEBI:38338);organic aromatic compound (CHEBI:33659);organonitrogen heterocyclic compound (CHEBI:38101);primary amine (CHEBI:32877);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);organic molecule (CHEBI:72695);pyrimidines (CHEBI:39447);chemical entity (CHEBI:24431);oxygen molecular entity (CHEBI:25806);organooxygen compound (CHEBI:36963);ether (CHEBI:25698);benzenoid aromatic compound (CHEBI:33836);organic heterocyclic compound (CHEBI:24532);diazines (CHEBI:38313);nitrogen molecular entity (CHEBI:51143);organonitrogen compound (CHEBI:35352);amine (CHEBI:32952)		Pyrimidines and pyrimidine derivatives	5-phenylpyrimidine;4-phenylpyrimidine;Diaryl ether;Methoxyphenol;Phenoxy compound;Methoxybenzene;Phenol ether;Anisole;1-hydroxy-4-unsubstituted benzenoid;1-hydroxy-2-unsubstituted benzenoid;Phenol;Aminopyrimidine;Alkyl aryl ether;Benzenoid;Monocyclic benzene moiety;Heteroaromatic compound;Azacycle;Ether;Organic nitrogen compound;Organic oxygen compound;Organopnictogen compound;Hydrocarbon derivative;Primary amine;Organooxygen compound;Organonitrogen compound;Amine;Aromatic heteromonocyclic compound	Organoheterocyclic compounds	0.0		2-[2-amino-5-(3-methoxyphenoxy)-6-methylpyrimidin-4-yl]-5-methoxyphenol		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0		C19H19N3O4	C19H19N3O4			InChI=1S/C19H19N3O4/c1-11-18(26-14-6-4-5-12(9-14)24-2)17(22-19(20)21-11)15-8-7-13(25-3)10-16(15)23/h4-10,23H,1-3H3,(H2,20,21,22)	NIBVQCSJCPBPEY-UHFFFAOYSA-N	2-[2-amino-5-(3-methoxyphenoxy)-6-methyl-pyrimidin-4-yl]-5-methoxy-phenol	3380847	COc1cc(Oc2c(C)nc(N)nc2-c2c(O)cc(OC)cc2)ccc1	2-[2-amino-5-(3-methoxyphenoxy)-6-methylpyrimidin-4-yl]-5-methoxyphenol			0.4219300000000002													MCULE-6477520252	353.38098		353.137556	7	2	5	3			43										False	Alkaloids				Peptide01			Compound(3380847)	3380847	3.0	1289		SCHEMBL24189918	[#6]-[#8]-[#6]1:[#6]:[#6](-[#8]-[#6]2:[#6](-[#6]):[#7]:[#6](-[#7]):[#7]:[#6]:2-[#6]2:[#6](-[#8]):[#6]:[#6](-[#8]-[#6]):[#6]:[#6]:2):[#6]:[#6]:[#6]:1	COc1cc(Oc2c(C)nc(N)nc2-c2c(O)cc(OC)cc2)ccc1	NIBVQCSJCPBPEY		parent_pubchem_cid	2-[2-amino-5-(3-methoxyphenoxy)-6-methylpyrimidin-4-yl]-5-methoxyphenol;877790-35-7;2-(2-amino-5-(3-methoxyphenoxy)-6-methylpyrimidin-4-yl)-5-methoxyphenol;SCHEMBL24189918;AKOS002223481;VU0616695-1;F3385-0489;2-[2-amino-5-(3-methoxyphenoxy)-6-methyl-pyrimidin-4-yl]-5-methoxy-phenol		14959781.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=14959781		pluskal_iocb_peptide_Peptide01_G18_id		100	G18		ZINC000005562781
3.6		0	1208	P7565658	59.1		AF30	False	0	22	0	0	23	0	3	2	0	0		0.0						COCCn1cc(C(=O)NCCc2c[nH]c3ccccc23)c2ccccc21								N-alkylindoles;3-alkylindoles;Pyrrole carboxamides;Substituted pyrroles;Benzenoids;Vinylogous amides;Heteroaromatic compounds;Secondary carboxylic acid amides;Dialkyl ethers;Azacyclic compounds;Organonitrogen compounds;Organic oxides;Hydrocarbon derivatives	3-alkylindoles;Azacyclic compounds;Benzenoids;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids and derivatives;Chemical entities;Dialkyl ethers;Ethers;Heteroaromatic compounds;Hydrocarbon derivatives;Indolecarboxamides and derivatives;Indolecarboxylic acids and derivatives;Indoles;Indoles and derivatives;N-alkylindoles;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Pyrrole carboxamides;Pyrrole carboxylic acids and derivatives;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles;Vinylogous amides	Indoles and derivatives	2.1	This compound belongs to the class of organic compounds known as indolecarboxamides and derivatives. These are compounds containing a carboxamide group attached to an indole.	Indolecarboxamides and derivatives			Organic compounds	Aromatic heteropolycyclic compounds	indoles (CHEBI:24828);pyrroles (CHEBI:26455);carboxamide (CHEBI:37622);benzenoid aromatic compound (CHEBI:33836);enone (CHEBI:51689);enamine (CHEBI:47989);organic aromatic compound (CHEBI:33659);ether (CHEBI:25698);organonitrogen heterocyclic compound (CHEBI:38101);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);indolecarboxamide (CHEBI:46921);chemical entity (CHEBI:24431);organic heterocyclic compound (CHEBI:24532);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);organooxygen compound (CHEBI:36963);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);organic molecular entity (CHEBI:50860);nitrogen molecular entity (CHEBI:51143);indolyl carboxylic acid (CHEBI:46867)		Indolecarboxylic acids and derivatives	Indolecarboxamide derivative;N-alkylindole;3-alkylindole;Indole;Pyrrole-3-carboxamide;Pyrrole-3-carboxylic acid or derivatives;Substituted pyrrole;Benzenoid;Pyrrole;Heteroaromatic compound;Vinylogous amide;Secondary carboxylic acid amide;Carboxamide group;Ether;Dialkyl ether;Azacycle;Carboxylic acid derivative;Hydrocarbon derivative;Organic oxide;Organooxygen compound;Organonitrogen compound;Organic oxygen compound;Organic nitrogen compound;Aromatic heteropolycyclic compound	Organoheterocyclic compounds	0.0		N-[2-(1H-indol-3-yl)ethyl]-1-(2-methoxyethyl)-1H-indole-3-carboxamide		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	1		C22H23N3O2	C22H23N3O2			InChI=1S/C22H23N3O2/c1-27-13-12-25-15-19(18-7-3-5-9-21(18)25)22(26)23-11-10-16-14-24-20-8-4-2-6-17(16)20/h2-9,14-15,24H,10-13H2,1H3,(H,23,26)	WPQZCGNJXXPRRL-UHFFFAOYSA-N	N-[2-(1H-indol-3-yl)ethyl]-1-(2-methoxyethyl)indole-3-carboxamide	71754237	COCCn1cc(C(=O)NCCc2c[nH]c3ccccc23)c2ccccc21	N-[2-(1H-indol-3-yl)ethyl]-1-(2-methoxyethyl)indole-3-carboxamide			2.775240000000001													MCULE-2593374533	361.44751		361.179027	2	2	7	4			44									Simple indole alkaloids	False	Alkaloids	Tryptophan alkaloids			Peptide01			Compound(71754237)	71754237	3.1	1290			[#6]-[#8]-[#6]-[#6]-[#7]1:[#6]:[#6](-[#6](=[#8])-[#7]-[#6]-[#6]-[#6]2:[#6]:[#7H]:[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:2:3):[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2	COCCn1cc(C(=O)NCCc2c[nH]c3ccccc23)c2ccccc21	WPQZCGNJXXPRRL		parent_pubchem_cid	N-[2-(1H-indol-3-yl)ethyl]-1-(2-methoxyethyl)-1H-indole-3-carboxamide;1401544-44-2;EiM08-29348;AKOS025144420;N-[2-(1H-indol-3-yl)ethyl]-1-(2-methoxyethyl)indole-3-carboxamide		69446097.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=69446097		pluskal_iocb_peptide_Peptide01_G18_id		100	G18		ZINC000057419387
2.1		0	1296	P11569933	90.9		AF31	False	0	15	0	0	20	0	4	2	0	0		0.0						CCC(C)C(CO)NC(=O)c1cc(-c2ccccn2)n[nH]1																							0.0		AKOS027474660		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C15H20N4O2	C15H20N4O2			InChI=1S/C15H20N4O2/c1-3-10(2)14(9-20)17-15(21)13-8-12(18-19-13)11-6-4-5-7-16-11/h4-8,10,14,20H,3,9H2,1-2H3,(H,17,21)(H,18,19)/t10-,14-/m1/s1	HPARJJSAJYFQDX-QMTHXVAHSA-N	3-(2-pyridyl)-N-[rac-(1S,2R)-1-(hydroxymethyl)-2-methyl-butyl]-1H-pyrazole-5-carboxamide	91639326	CC[C@@H](C)[C@@H](CO)NC(=O)c1cc(-c2ccccn2)n[nH]1	N-[(2S,3R)-1-hydroxy-3-methylpentan-2-yl]-3-pyridin-2-yl-1H-pyrazole-5-carboxamide			1.1737700000000002														288.35225		288.158626	4	3	6	2			45									Pyridine alkaloids	False	Alkaloids	Nicotinic acid alkaloids			Peptide01			Compound(91639326)	91639326	1.5	1291			[#6]-[#6]-[#6@@H](-[#6])-[#6@@H](-[#6]-[#8])-[#7]-[#6](=[#8])-[#6]1:[#6]:[#6](-[#6]2:[#6]:[#6]:[#6]:[#6]:[#7]:2):[#7]:[#7H]:1	CC[C@@H](C)[C@@H](CO)NC(=O)c1cc(-c2ccccn2)n[nH]1	HPARJJSAJYFQDX		parent_pubchem_cid	AKOS027474660;AKOS032419475;3-(2-pyridyl)-N-[rac-(1S,2R)-1-(hydroxymethyl)-2-methyl-butyl]-1H-pyrazole-5-carboxamide		95990070.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=95990070		pluskal_iocb_peptide_Peptide01_G18_id		100	G18		ZINC000218197059
3.6		0	1128	P1098421	127.2		AF33	False	0	24	0	0	25	0	1	6	0	1		0.0						CSCCC(NC(=O)COc1cc2c(cc1)c(C)c(Cc1ccccc1)c(=O)o2)C(=O)O								N-acyl-L-alpha-amino acids;Coumarins and derivatives;1-benzopyrans;Thia fatty acids;Pyranones and derivatives;Alkyl aryl ethers;Benzene and substituted derivatives;Heteroaromatic compounds;Secondary carboxylic acid amides;Lactones;Sulfenyl compounds;Oxacyclic compounds;Carboxylic acids;Dialkylthioethers;Monocarboxylic acids and derivatives;Organonitrogen compounds;Carbonyl compounds;Organic oxides;Hydrocarbon derivatives;Organopnictogen compounds	1-benzopyrans;Alkyl aryl ethers;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Benzene and substituted derivatives;Benzenoids;Benzopyrans;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;Dialkylthioethers;Ethers;Fatty Acyls;Fatty acids and conjugates;Heteroaromatic compounds;Hydrocarbon derivatives;Lactones;Lipids and lipid-like molecules;Methionine and derivatives;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Organosulfur compounds;Oxacyclic compounds;Phenylpropanoids and polyketides;Pyranones and derivatives;Pyrans;Secondary carboxylic acid amides;Sulfenyl compounds;Thia fatty acids;Thioethers	Carboxylic acids and derivatives	2.1	This compound belongs to the class of organic compounds known as methionine and derivatives. These are compounds containing methionine or a derivative thereof resulting from reaction of methionine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.	Methionine and derivatives		Amino acids and derivatives;Alpha amino acids and derivatives	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-L-alpha-amino acid (CHEBI:48927);coumarins (CHEBI:23403);1-benzopyran (CHEBI:38443);thia fatty acid (CHEBI:59643);pyranone (CHEBI:37963);aromatic ether (CHEBI:35618);benzenes (CHEBI:22712);organic aromatic compound (CHEBI:33659);carboxamide (CHEBI:37622);lactone (CHEBI:25000);organosulfur compound (CHEBI:33261);oxacycle (CHEBI:38104);carboxylic acid (CHEBI:33575);carboxylic acid anion (CHEBI:29067);aliphatic sulfide (CHEBI:22327);carbonyl compound (CHEBI:36586);organonitrogen compound (CHEBI:35352);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);alpha-amino acid (CHEBI:33704);methionine derivative (CHEBI:25230);chemical entity (CHEBI:24431);organooxygen compound (CHEBI:36963);amino acid (CHEBI:33709);peptide (CHEBI:16670);N-acyl-amino acid (CHEBI:51569);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);lipid (CHEBI:18059);monocarboxylic acid (CHEBI:25384);pyrans (CHEBI:26407);oxygen molecular entity (CHEBI:25806);ether (CHEBI:25698);benzenoid aromatic compound (CHEBI:33836);amide (CHEBI:32988);organic sulfide (CHEBI:16385);nitrogen molecular entity (CHEBI:51143)	Thia fatty acids (FA0113);Benzopyranoids (PK1311);Fatty Acyls (FA);Fatty Acids and Conjugates (FA01)	Amino acids, peptides, and analogues	Methionine or derivatives;N-acyl-alpha-amino acid;N-acyl-l-alpha-amino acid;N-acyl-alpha amino acid or derivatives;Coumarin;Benzopyran;1-benzopyran;Alkyl aryl ether;Pyranone;Thia fatty acid;Monocyclic benzene moiety;Fatty acyl;Pyran;Benzenoid;Heteroaromatic compound;Carboxamide group;Lactone;Secondary carboxylic acid amide;Dialkylthioether;Organoheterocyclic compound;Thioether;Sulfenyl compound;Carboxylic acid;Oxacycle;Ether;Monocarboxylic acid or derivatives;Organosulfur compound;Hydrocarbon derivative;Organic oxide;Organonitrogen compound;Organic nitrogen compound;Carbonyl group;Organopnictogen compound;Organic oxygen compound;Organooxygen compound;Aromatic heteropolycyclic compound	Organic acids and derivatives	0.0		EiM07-17099		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C24H25NO6S	C24H25NO6S			InChI=1S/C24H25NO6S/c1-15-18-9-8-17(30-14-22(26)25-20(23(27)28)10-11-32-2)13-21(18)31-24(29)19(15)12-16-6-4-3-5-7-16/h3-9,13,20H,10-12,14H2,1-2H3,(H,25,26)(H,27,28)/t20-/m0/s1	NNHPAXDGGSLXOK-FQEVSTJZSA-N	rac-(2S)-2-[[2-(3-benzyl-4-methyl-2-oxo-chromen-7-yl)oxyacetyl]amino]-4-methylsulfanyl-butanoic acid	1798497	CSCC[C@H](NC(=O)COc1cc2c(cc1)c(C)c(Cc1ccccc1)c(=O)o2)C(=O)O	(2S)-2-[[2-(3-benzyl-4-methyl-2-oxochromen-7-yl)oxyacetyl]amino]-4-methylsulfanylbutanoic acid			3.238450000000001													MCULE-6470752665	455.53395		455.140259	7	2	10	3			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(1798497)	1798497	3.7	1292			[#6]-[#16]-[#6]-[#6]-[#6@H](-[#7]-[#6](=[#8])-[#6]-[#8]-[#6]1:[#6]:[#6]2:[#6](:[#6]:[#6]:1):[#6](-[#6]):[#6](-[#6]-[#6]1:[#6]:[#6]:[#6]:[#6]:[#6]:1):[#6](=[#8]):[#8]:2)-[#6](=[#8])-[#8]	CSCC[C@H](NC(=O)COc1cc2c(cc1)c(C)c(Cc1ccccc1)c(=O)o2)C(=O)O	NNHPAXDGGSLXOK		parent_pubchem_cid	EiM07-17099;AKOS016378768;2-{2-[(3-BENZYL-4-METHYL-2-OXO-2H-CHROMEN-7-YL)OXY]ACETAMIDO}-4-(METHYLSULFANYL)BUTANOIC ACID;rac-(2S)-2-[[2-(3-benzyl-4-methyl-2-oxo-chromen-7-yl)oxyacetyl]amino]-4-methylsulfanyl-butanoic acid		23457976.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=23457976		pluskal_iocb_peptide_Peptide01_G18_id		100	G18		ZINC000002146066
2.1		0	1216	P7119830416	100.2		AF34	False	0	19	0	0	17	0	1	7	0	0		0.0						COC(=O)c1cc(NC(=O)c2cc3c(cc2)OCCO3)c(C(=O)OC)cc1								p-Phthalate esters;P-phthalic acid and derivatives;Benzo-1,4-dioxanes;Benzoic acid esters;Benzoyl derivatives;Alkyl aryl ethers;Para dioxins;Dicarboxylic acids and derivatives;Methyl esters;Vinylogous amides;Secondary carboxylic acid amides;Oxacyclic compounds;Organic oxides;Hydrocarbon derivatives;Organonitrogen compounds;Organopnictogen compounds	Alkyl aryl ethers;Anilides;Aromatic anilides;Benzene and substituted derivatives;Benzenoids;Benzo-1,4-dioxanes;Benzodioxanes;Benzoic acid esters;Benzoic acids and derivatives;Benzoyl derivatives;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acid esters;Carboxylic acids and derivatives;Chemical entities;Dicarboxylic acids and derivatives;Dioxins;Ethers;Hydrocarbon derivatives;Methyl esters;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;P-phthalic acid and derivatives;Para dioxins;Phthalate esters;Phthalic acid and derivatives;Secondary carboxylic acid amides;Vinylogous amides;p-Phthalate esters	Benzene and substituted derivatives	2.1	This compound belongs to the class of organic compounds known as aromatic anilides. These are aromatic compounds containing an anilide group in which the carboxamide group is substituted with an aromatic group. They have the general structure RNC(=O)R', where R= benzene, and R = aryl group.	Aromatic anilides			Organic compounds	Aromatic heteropolycyclic compounds	phthalate ester (CHEBI:35484);benzenedicarboxylic acid (CHEBI:26094);benzodioxine (CHEBI:64096);benzoate ester (CHEBI:36054);carbonyl compound (CHEBI:36586);aromatic ether (CHEBI:35618);oxacycle (CHEBI:38104);dicarboxylic acid (CHEBI:35692);carboxylic ester (CHEBI:33308);enone (CHEBI:51689);enamine (CHEBI:47989);carboxamide (CHEBI:37622);organic oxide (CHEBI:25701);organic molecule (CHEBI:72695);organonitrogen compound (CHEBI:35352);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);anilide (CHEBI:13248);chemical entity (CHEBI:24431);benzenoid aromatic compound (CHEBI:33836);benzenes (CHEBI:22712);benzoic acids (CHEBI:22723);organooxygen compound (CHEBI:36963);organic heterocyclic compound (CHEBI:24532);oxygen molecular entity (CHEBI:25806);ether (CHEBI:25698);organic acid (CHEBI:64709);carboxylic acid (CHEBI:33575);amide (CHEBI:32988);nitrogen molecular entity (CHEBI:51143)	Dicarboxylic acids (FA0117)	Anilides	Aromatic anilide;Para-phthalic acid ester;Phthalate ester;Para_phthalic_acid;Benzo-1,4-dioxane;Benzodioxane;Benzoate ester;Benzoic acid or derivatives;Benzoyl;Alkyl aryl ether;Dicarboxylic acid or derivatives;Para-dioxin;Vinylogous amide;Methyl ester;Carboxylic acid ester;Carboxamide group;Secondary carboxylic acid amide;Ether;Organoheterocyclic compound;Carboxylic acid derivative;Oxacycle;Organopnictogen compound;Organooxygen compound;Organonitrogen compound;Organic nitrogen compound;Organic oxygen compound;Hydrocarbon derivative;Organic oxide;Aromatic heteropolycyclic compound	Benzenoids	0.0		878692-36-5		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	2	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0		C19H17NO7	C19H17NO7			InChI=1S/C19H17NO7/c1-24-18(22)12-3-5-13(19(23)25-2)14(9-12)20-17(21)11-4-6-15-16(10-11)27-8-7-26-15/h3-6,9-10H,7-8H2,1-2H3,(H,20,21)	TYBVMWVYXFLJHV-UHFFFAOYSA-N	dimethyl 2-(2,3-dihydro-1,4-benzodioxine-6-carbonylamino)benzene-1,4-dicarboxylate	6490723	COC(=O)c1cc(NC(=O)c2cc3c(cc2)OCCO3)c(C(=O)OC)cc1	dimethyl 2-(2,3-dihydro-1,4-benzodioxine-6-carbonylamino)benzene-1,4-dicarboxylate			0.8137399999999997													MCULE-8404653917	371.34984		371.100502	7	1	6	3			43									Anthranillic acid derivatives	False	Alkaloids	Anthranilic acid alkaloids			Peptide01			Compound(6490723)	6490723	2.7	1293			[#6]-[#8]-[#6](=[#8])-[#6]1:[#6]:[#6](-[#7]-[#6](=[#8])-[#6]2:[#6]:[#6]3:[#6](:[#6]:[#6]:2)-[#8]-[#6]-[#6]-[#8]-3):[#6](-[#6](=[#8])-[#8]-[#6]):[#6]:[#6]:1	COC(=O)c1cc(NC(=O)c2cc3c(cc2)OCCO3)c(C(=O)OC)cc1	TYBVMWVYXFLJHV		parent_pubchem_cid	878692-36-5;dimethyl 2-(2,3-dihydrobenzo[b][1,4]dioxine-6-carboxamido)terephthalate;1,4-DIMETHYL 2-(2,3-DIHYDRO-1,4-BENZODIOXINE-6-AMIDO)BENZENE-1,4-DICARBOXYLATE;STL017485;AKOS000767264;dimethyl 2-(2,3-dihydro-1,4-benzodioxine-6-carbonylamino)benzene-1,4-dicarboxylate;F1787-0719;dimethyl 2-[(2,3-dihydro-1,4-benzodioxin-6-ylcarbonyl)amino]benzene-1,4-dicarboxylate		4863244.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=4863244		pluskal_iocb_peptide_Peptide01_G18_id		100	G18		ZINC000004292116
4.3		0	1136	P1098642	121.6		AF37	False	0	27	0	0	24	0	2	6	0	0		0.0						Cc1c(C)c2cc3c(cc2o1)oc(=O)c(CC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)O)c3C								N-acyl-L-alpha-amino acids;1-benzopyrans;3-alkylindoles;Benzofurans;Pyranones and derivatives;Substituted pyrroles;Benzenoids;Heteroaromatic compounds;Furans;Secondary carboxylic acid amides;Lactones;Oxacyclic compounds;Azacyclic compounds;Monocarboxylic acids and derivatives;Carboxylic acids;Carbonyl compounds;Hydrocarbon derivatives;Organic oxides;Organonitrogen compounds;Organopnictogen compounds	1-benzopyrans;3-alkylindoles;Alpha amino acids and derivatives;Amino acids and derivatives;Amino acids, peptides, and analogues;Azacyclic compounds;Benzenoids;Benzofurans;Benzopyrans;Carbonyl compounds;Carboxylic acid amides;Carboxylic acid derivatives;Carboxylic acids;Carboxylic acids and derivatives;Chemical entities;Coumarins and derivatives;Furanocoumarins;Furans;Heteroaromatic compounds;Hydrocarbon derivatives;Indoles;Indoles and derivatives;Lactones;Linear furanocoumarins;Monocarboxylic acids and derivatives;N-acyl-L-alpha-amino acids;N-acyl-alpha amino acids;N-acyl-alpha amino acids and derivatives;Organic acids and derivatives;Organic compounds;Organic nitrogen compounds;Organic oxides;Organic oxygen compounds;Organoheterocyclic compounds;Organonitrogen compounds;Organooxygen compounds;Organopnictogen compounds;Oxacyclic compounds;Phenylpropanoids and polyketides;Psoralens;Pyranones and derivatives;Pyrans;Pyrroles;Secondary carboxylic acid amides;Substituted pyrroles	Coumarins and derivatives	2.1	This compound belongs to the class of organic compounds known as psoralens. These are organic compounds containing a psoralen moiety, which consists of a furan fused to a chromenone to for 7H-furo[3,2-g]chromen-7-one.	Psoralens		Linear furanocoumarins	Organic compounds	Aromatic heteropolycyclic compounds	N-acyl-L-alpha-amino acid (CHEBI:48927);1-benzopyran (CHEBI:38443);indoles (CHEBI:24828);benzofurans (CHEBI:35259);pyranone (CHEBI:37963);pyrroles (CHEBI:26455);benzenoid aromatic compound (CHEBI:33836);organic aromatic compound (CHEBI:33659);furans (CHEBI:24129);carboxamide (CHEBI:37622);lactone (CHEBI:25000);oxacycle (CHEBI:38104);organonitrogen heterocyclic compound (CHEBI:38101);monocarboxylic acid (CHEBI:25384);carboxylic acid (CHEBI:33575);carbonyl compound (CHEBI:36586);organic molecule (CHEBI:72695);organic oxide (CHEBI:25701);organonitrogen compound (CHEBI:35352);pnictogen molecular entity (CHEBI:33302);organic molecular entity (CHEBI:50860);psoralens (CHEBI:26369);chemical entity (CHEBI:24431);organic acid (CHEBI:64709);organooxygen compound (CHEBI:36963);N-acyl-amino acid (CHEBI:51569);organic heterocyclic compound (CHEBI:24532);benzopyran (CHEBI:22727);pyrans (CHEBI:26407);amide (CHEBI:32988);oxygen molecular entity (CHEBI:25806);nitrogen molecular entity (CHEBI:51143);coumarins (CHEBI:23403);furanocoumarin (CHEBI:24128)	Benzofuranoids (PK1310);Benzopyranoids (PK1311)	Furanocoumarins	Psoralen;N-acyl-l-alpha-amino acid;N-acyl-alpha-amino acid;N-acyl-alpha amino acid or derivatives;Alpha-amino acid or derivatives;Benzopyran;1-benzopyran;3-alkylindole;Benzofuran;Indole;Indole or derivatives;Pyranone;Benzenoid;Substituted pyrrole;Pyran;Pyrrole;Furan;Heteroaromatic compound;Secondary carboxylic acid amide;Carboxamide group;Lactone;Organoheterocyclic compound;Carboxylic acid derivative;Carboxylic acid;Azacycle;Monocarboxylic acid or derivatives;Oxacycle;Organopnictogen compound;Organic oxygen compound;Organic oxide;Hydrocarbon derivative;Organooxygen compound;Carbonyl group;Organonitrogen compound;Organic nitrogen compound;Aromatic heteropolycyclic compound	Phenylpropanoids and polyketides	0.0		EiM07-17320		2023-12-20T18:18:56+01:00		2023-12-20T22:39:18+01:00	2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	1	0	1	0	0	0	0	0	0	0	0	2	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0		C27H24N2O6	C27H24N2O6			InChI=1S/C27H24N2O6/c1-13-15(3)34-23-11-24-19(9-18(13)23)14(2)20(27(33)35-24)10-25(30)29-22(26(31)32)8-16-12-28-21-7-5-4-6-17(16)21/h4-7,9,11-12,22,28H,8,10H2,1-3H3,(H,29,30)(H,31,32)/t22-/m0/s1	AIHRWHPASCEREG-QFIPXVFZSA-N	rac-(2S)-3-(1H-indol-3-yl)-2-[[2-(2,3,5-trimethyl-7-oxo-furo[3,2-g]chromen-6-yl)acetyl]amino]propanoic acid	6851164	Cc1c(C)c2cc3c(cc2o1)oc(=O)c(CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)c3C	(2S)-3-(1H-indol-3-yl)-2-[[2-(2,3,5-trimethyl-7-oxofuro[3,2-g]chromen-6-yl)acetyl]amino]propanoic acid			3.641440000000002													MCULE-2319921121	472.50213		472.163436	5	3	6	5			44									Simple coumarins	False	Shikimates and Phenylpropanoids	Coumarins			Peptide01			Compound(6851164)	6851164	3.9	1294			[#6]-[#6]1:[#6](-[#6]):[#6]2:[#6]:[#6]3:[#6](:[#6]:[#6]:2:[#8]:1):[#8]:[#6](=[#8]):[#6](-[#6]-[#6](=[#8])-[#7]-[#6@@H](-[#6]-[#6]1:[#6]:[#7H]:[#6]2:[#6]:[#6]:[#6]:[#6]:[#6]:1:2)-[#6](=[#8])-[#8]):[#6]:3-[#6]	Cc1c(C)c2cc3c(cc2o1)oc(=O)c(CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)c3C	AIHRWHPASCEREG		parent_pubchem_cid	EiM07-17320;AKOS016390639;N-[(2,3,5-trimethyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)acetyl]-L-tryptophan;rac-(2S)-3-(1H-indol-3-yl)-2-[[2-(2,3,5-trimethyl-7-oxo-furo[3,2-g]chromen-6-yl)acetyl]amino]propanoic acid		52841357.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=52841357		pluskal_iocb_peptide_Peptide01_G18_id		100	G18		ZINC000011866856
1.3		0	1224	P1032769	87.9		AF38	False	0	14	0	2	14	0	6	1	0	0	-1.0	0.0						Cn1ncc2c(NCCO)nc(Nc3cc(F)c(F)cc3)nc21		1.79		0.0	1.65	CHEMBL3989175																	0.0		2-((6-((3,4-difluorophenyl)amino)-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino)ethanol		2023-12-20T18:18:56+01:00	2023-12-20T18:18:55+01:00		2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1		C14H14F2N6O	C14H14F2N6O			InChI=1S/C14H14F2N6O/c1-22-13-9(7-18-22)12(17-4-5-23)20-14(21-13)19-8-2-3-10(15)11(16)6-8/h2-3,6-7,23H,4-5H2,1H3,(H2,17,19,20,21)	QMPPAKDZBNMJEV-UHFFFAOYSA-N	2-[[6-(3,4-difluoroanilino)-1-methyl-pyrazolo[3,4-d]pyrimidin-4-yl]amino]ethanol	7216376	Cn1ncc2c(NCCO)nc(Nc3cc(F)c(F)cc3)nc21	2-[[6-(3,4-difluoroanilino)-1-methylpyrazolo[3,4-d]pyrimidin-4-yl]amino]ethanol			0.2190499999999996													MCULE-6908176177	320.30408	NEUTRAL	320.119716	6	3	5	3	0.0		29										False	Alkaloids		False	False	Peptide01		-1.0	Compound(7216376)	7216376	1.9	1295			[#6]-[#7]1:[#7]:[#6]:[#6]2:[#6](-[#7]-[#6]-[#6]-[#8]):[#7]:[#6](-[#7]-[#6]3:[#6]:[#6](-[#9]):[#6](-[#9]):[#6]:[#6]:3):[#7]:[#6]:1:2	Cn1ncc2c(NCCO)nc(Nc3cc(F)c(F)cc3)nc21	QMPPAKDZBNMJEV		parent_pubchem_cid	2-((6-((3,4-difluorophenyl)amino)-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino)ethanol;897758-27-9;2-({6-[(3,4-difluorophenyl)amino]-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl}amino)ethanol;CHEMBL3989175;STK890758;AKOS002311203;2-[[6-(3,4-difluoroanilino)-1-methylpyrazolo[3,4-d]pyrimidin-4-yl]amino]ethanol;F2031-0964;2-[[6-(3,4-difluoroanilino)-1-methyl-pyrazolo[3,4-d]pyrimidin-4-yl]amino]ethanol	False	15859170.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=15859170		pluskal_iocb_peptide_Peptide01_G18_id		100	G18	False	ZINC000004374992
4.1		0	1144	P1158303	91.1		AF41	False	0	25	0	0	27	0	3	3	0	0		0.0						CCC1(c2ccc(NC(=O)CCCc3c[nH]c4ccccc34)cc2)CCC(=O)NC1=O																							0.0		N-[4-(3-ethyl-2,6-dioxopiperidin-3-yl)phenyl]-4-(1H-indol-3-yl)butanamide		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00	2023-12-20T18:14:59+01:00	2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	3	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	3	1	0	0	0	0	0	0	0	0	0	0		C25H27N3O3	C25H27N3O3			InChI=1S/C25H27N3O3/c1-2-25(15-14-23(30)28-24(25)31)18-10-12-19(13-11-18)27-22(29)9-5-6-17-16-26-21-8-4-3-7-20(17)21/h3-4,7-8,10-13,16,26H,2,5-6,9,14-15H2,1H3,(H,27,29)(H,28,30,31)	DKIGTEGEDFZRON-UHFFFAOYSA-N	N-[4-(3-ethyl-2,6-dioxo-3-piperidyl)phenyl]-4-(1H-indol-3-yl)butanamide	16423138	CCC1(c2ccc(NC(=O)CCCc3c[nH]c4ccccc34)cc2)CCC(=O)NC1=O	N-[4-(3-ethyl-2,6-dioxopiperidin-3-yl)phenyl]-4-(1H-indol-3-yl)butanamide			3.295250000000001													MCULE-9869598311	417.51224		417.205242	3	3	7	4			44										False	Alkaloids				Peptide01			Compound(16423138)	16423138	3.3	1296			[#6]-[#6]-[#6]1(-[#6]2:[#6]:[#6]:[#6](-[#7]-[#6](=[#8])-[#6]-[#6]-[#6]-[#6]3:[#6]:[#7H]:[#6]4:[#6]:[#6]:[#6]:[#6]:[#6]:3:4):[#6]:[#6]:2)-[#6]-[#6]-[#6](=[#8])-[#7]-[#6]-1=[#8]	CCC1(c2ccc(NC(=O)CCCc3c[nH]c4ccccc34)cc2)CCC(=O)NC1=O	DKIGTEGEDFZRON		parent_pubchem_cid	N-[4-(3-ethyl-2,6-dioxopiperidin-3-yl)phenyl]-4-(1H-indol-3-yl)butanamide;929854-31-9;EiM07-18664;STK630718;STL461555;AKOS004937039;AKOS005563160;N-[4-(3-ETHYL-2,6-DIOXO-3-PIPERIDYL)PHENYL]-4-(1H-INDOL-3-YL)BUTANAMIDE;N-[4-(3-ethyl-2-hydroxy-6-oxo-3,4,5,6-tetrahydropyridin-3-yl)phenyl]-4-(1H-indol-3-yl)butanamide		22966255.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=22966255		pluskal_iocb_peptide_Peptide01_G19_id		100	G19		
4.0		0	1232	P1578446	67.7		AF42	False	0	20	0	0	20	0	6	0	0	0		0.0						Cc1cc(C)c(Nc2c3cnn(C)c3nc(Nc3ccccc3)n2)cc1																							0.0		N4-(2,4-dimethylphenyl)-1-methyl-N6-phenyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine		2023-12-20T18:18:56+01:00			2024-08-27T11:48:42+02:00	2023-12-20T18:19:04+01:00	2023-12-20T18:19:36+01:00		2023-12-20T18:29:23+01:00		2023-12-20T18:16:00+01:00	2023-12-20T18:15:35+01:00				0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1		C20H20N6	C20H20N6			InChI=1S/C20H20N6/c1-13-9-10-17(14(2)11-13)23-18-16-12-21-26(3)19(16)25-20(24-18)22-15-7-5-4-6-8-15/h4-12H,1-3H3,(H2,22,23,24,25)	GCDPHYMMRNNQBL-UHFFFAOYSA-N	N4-(2,4-dimethylphenyl)-1-methyl-N6-phenyl-pyrazolo[3,4-d]pyrimidine-4,6-diamine	27486833	Cc1cc(C)c(Nc2c3cnn(C)c3nc(Nc3ccccc3)n2)cc1	4-N-(2,4-dimethylphenyl)-1-methyl-6-N-phenylpyrazolo[3,4-d]pyrimidine-4,6-diamine			2.4070600000000004													MCULE-8453355459	344.4226		344.174945	5	2	4	4			44										False	Alkaloids				Peptide01			Compound(27486833)	27486833	4.7	1297			[#6]-[#6]1:[#6]:[#6](-[#6]):[#6](-[#7]-[#6]2:[#6]3:[#6]:[#7]:[#7](-[#6]):[#6]:3:[#7]:[#6](-[#7]-[#6]3:[#6]:[#6]:[#6]:[#6]:[#6]:3):[#7]:2):[#6]:[#6]:1	Cc1cc(C)c(Nc2c3cnn(C)c3nc(Nc3ccccc3)n2)cc1	GCDPHYMMRNNQBL		parent_pubchem_cid	N4-(2,4-dimethylphenyl)-1-methyl-N6-phenyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine;896001-58-4;AKOS002329220;F2031-0115;N4-(2,4-dimethylphenyl)-1-methyl-N6-phenyl-pyrazolo[3,4-d]pyrimidine-4,6-diamine		10568968.0	https://www.ebi.ac.uk/unichem/compoundsources?type=uci&compound=10568968		pluskal_iocb_peptide_Peptide01_G19_id		100	G19		ZINC000017025968
